Citrus Sinensis ID: 045539

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------
Protein Sequence
MERTHFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccEEEEEEcccccEEEccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHcccccccccEEccccccccccccccccccccccEEcccccccccccHHHHcccccccEEEEccccccccccHHHHHcccccEEEccccEEEEEcccccccccccccccccccccccccccccccccEEEccccccccccccHHHcccccccEEEEEccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHHccccccccccccEEcccccccccccccccccccccccccccccHHHHcccccccEEcccccccccccEEcccccccccccHHHHccccccEEccccccccccccHHHHcccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccEEEEccccccccccccccccEEEEcccccccccccccccccccccccEEEHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEEcccccEEEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHHHcHcccEEEEccccccccccHHHccccccEEEEEccccccccccHHHHcHHHcccccccccccccccccccccccEEEcccccccEEccccccccccccEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEcccccccccEEEEcccccccccccHHHcccccEEEEEcccccccccccHHHHccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHcccHccEEEcccccEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHccHHHHHHHHHEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEEcccccccccEEEEccccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccHHHccHHHcccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHccc
Coil and Loop (DISEMBL)
MERTHFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYdhtnlfarnwtsstsvCSWIGitcdvnshrviglnissfnlqgtippqlgnlsslqtldlshnklsgnipssifNMHTLKLLyfsdnqlfgsLSFFIFNVSsvttidlsinglsgempreignlpyLARLAFATnnlvgvapVTIFNMSALKEIYLLNnslsgslpsridlslpnvetlnLGINSfygtvpssitnasklsdleLGVNlfsgfipntfvnmadnyltsstpelsflssltnckKLKVLILtgnpldgilpkskgnlsLSLEIILMdncsisgnipqvVGNLGNLLVLElggnnltepipitFSQLQTLQALGltrnklagpitDELCHLARLHSLVLqgnkfsgsipsclgnlTSLRVLYLGLNrftsalpstiwnlKDILFIDVSSNSLNVLIGLNfsrnnlsgdipitigGLKNLQQMFLEYnrlegsipesfgdlsslevldlsknkisgaiPASLQKLLYLKHLNLSFnklegeiprggpfanltaksFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIEcwksrtgpsndginspqaiRRFSYHELLRAtdrfsennligigSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKympngslenclysgtCMLDIFQRLNIMIDVALALEYlhfghstpiihcdlkpsnvlldeDMVAHISDFGIakllsgedqLSIQIQTLATigymapeygtkgrvctrgdvYSYGIMLMEMFtkkkptdeifigelslnrwindllpvsVMEVIDTNLLRGEERFFAAKEQILLSVLNLATectiesrdgngadmGWIFSALDPNP
Flexible Loop (DISEMBL)
MERTHFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTgnpldgilpkSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWksrtgpsndginspqAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGymapeygtkgrvctRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIesrdgngadMGWIFSALDPNP
Low Complexity Region (SEG)
MERTHFLSMITRslvhslllslviaaaasNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYllnnslsgslpsRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQvvgnlgnllvlelggnnlTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASlqkllylkhlnlSFNKLEGEIPRGGPFANLTAKSFMGNEllkmlllviilplstalIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP
Disordered region (IsUnstruct)
****HFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRT**********QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS******
Disordered Region (DISOPRED)
********MITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHIS**********WTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLI*******************IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE*ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS**********TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESR**NGADMGWIFSALDPN*
Disordered Region (DISEMBL)
MERTHFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP
Disordered Region (DISPRO)
****HFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRD*NGAD*GWI***L****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERTHFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFxxxxxxxxxxxxxxxxxxxxxRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	897	2.2.26 [Sep-21-2011]
C0LGT6	1031	LRR receptor-like serine/	yes	no	0.913	0.794	0.352	1e-141
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.931	0.827	0.353	1e-141
Q9SD62	1025	Putative receptor-like pr	no	no	0.960	0.840	0.339	1e-127
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.876	0.802	0.341	1e-115
Q9FL28	1173	LRR receptor-like serine/	no	no	0.885	0.676	0.332	1e-109
C0LGW6	966	LRR receptor-like serine/	no	no	0.915	0.849	0.326	1e-107
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.866	0.620	0.326	1e-105
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.880	0.632	0.316	1e-103
Q42371	976	LRR receptor-like serine/	no	no	0.919	0.845	0.313	1e-101
Q6XAT2	967	LRR receptor-like serine/	no	no	0.913	0.846	0.317	1e-100

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  503 bits (1294), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 331/939 (35%), Positives = 482/939 (51%), Gaps = 120/939 (12%)

Query: 17  SLLLSLVIAAAAS-NITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNS 75
           +LLL + I A A  +  TD QALL  K+ +S ++      +W  S+  C+WIG+TC    
Sbjct: 13  TLLLQVCIFAQARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRR 72

Query: 76  HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ 135
            RVI LN+  F L G I P +GNLS L+ L+L+ N     IP  +  +  L+ L  S N 
Sbjct: 73  ERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNL 132

Query: 136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNM 195
           L G +   + N S ++T+DLS N L   +P E+G+L  LA L  + NNL G  P ++ N+
Sbjct: 133 LEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNL 192

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL--- 252
           ++L+++    N + G +P  +   L  +    + +NSF G  P ++ N S L  L L   
Sbjct: 193 TSLQKLDFAYNQMRGEIPDEV-ARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADN 251

Query: 253 ----------------------GVNLFSGFIPNTFVN--------MADNYLTSSTP---- 278
                                 G N F+G IP T  N        ++ NYL+ S P    
Sbjct: 252 SFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFG 311

Query: 279 ---------------------ELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
                                 L F+ ++ NC +L+ L +  N L G LP S  NLS +L
Sbjct: 312 KLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTL 371

Query: 318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG 377
             + +    ISG IP  +GNL +L  L L  N L+  +P++F +L  LQ + L  N ++G
Sbjct: 372 TSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISG 431

Query: 378 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDI 437
            I     ++ RL  L L  N F G IP  LG    L  L++  NR    +P  I  +  +
Sbjct: 432 EIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSL 491

Query: 438 LFIDVSSN-----------SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG 486
            +ID+S+N            L +L+GL  S N LSG +P  IGG  +++ +F++ N  +G
Sbjct: 492 AYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDG 551

Query: 487 SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +IP+    L SL+ +D S N +SG IP  L  L  L++LNLS NK EG +P  G F N T
Sbjct: 552 AIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNAT 610

Query: 547 AKSFMGN---------------------------ELLKMLLLVIILPLSTALIVVVTLTL 579
           A S  GN                            + K ++  I + +++ L++++  +L
Sbjct: 611 AVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASL 670

Query: 580 KWKLIECWKSRTGPSNDGINSPQAI--RRFSYHELLRATDRFSENNLIGIGSFGSIYVAR 637
            W +    K+     N   ++   +   + SY EL  AT RFS  NLIG G+FG+++   
Sbjct: 671 CWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGL 730

Query: 638 L-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-----DDFKALI 691
           L  +   VAVKV +     A KSF  ECE  K IRHRNLVK+I+ CS+     +DF+AL+
Sbjct: 731 LGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALV 790

Query: 692 MKYMPNGSLENCLY--------SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
            ++MP GSL+  L           +  L   ++LNI IDVA ALEYLH     P+ HCD+
Sbjct: 791 YEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDI 850

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-----TLATIGYMAPEYGTKGRVCT 798
           KPSN+LLD+D+ AH+SDFG+A+LL   D+ S   Q        TIGY APEYG  G+   
Sbjct: 851 KPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSI 910

Query: 799 RGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL 837
           +GDVYS+GI+L+EMF+ KKPTDE F G+ +L+ +   +L
Sbjct: 911 QGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 342/967 (35%), Positives = 500/967 (51%), Gaps = 131/967 (13%)

Query: 33  TDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTI 92
           TD+QALL  K+ +S D   + + +W  S  +C+W G+TC   + RV  L +    L G I
Sbjct: 24  TDRQALLQFKSQVSEDKRVVLS-SWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82

Query: 93  PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTT 152
            P +GNLS L +LDL  N   G IP  +  +  L+ L    N L G +   ++N S +  
Sbjct: 83  SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142

Query: 153 IDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSL 212
           + L  N L G +P E+G+L  L +L    NN+ G  P ++ N++ L+++ L +N+L G +
Sbjct: 143 LRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEI 202

Query: 213 PS----------------------------------------------RIDLS--LPNVE 224
           PS                                              R DL   LPN+ 
Sbjct: 203 PSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLL 262

Query: 225 TLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYL---------TS 275
           + N+G N F G++P++++N S L  L +  N  +G IP TF N+ +  L         + 
Sbjct: 263 SFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSD 321

Query: 276 STPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV 335
           S+ +L FL+SLTNC +L+ L +  N L G LP S  NLS  L  + +    ISG+IP  +
Sbjct: 322 SSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDI 381

Query: 336 GNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ 395
           GNL NL  L L  N L+ P+P +  +L  L+ L L  N+L+G I   + ++  L +L L 
Sbjct: 382 GNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLS 441

Query: 396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS--------- 446
            N F G +P+ LGN + L  L++G N+    +P  I  ++ +L +D+S NS         
Sbjct: 442 NNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDI 501

Query: 447 --LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
             L  L  L+   N LSG +P T+G    ++ +FLE N   G IP+  G +   EV DLS
Sbjct: 502 GALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEV-DLS 560

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGN----------- 553
            N +SG+IP        L++LNLSFN LEG++P  G F N T  S +GN           
Sbjct: 561 NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQ 620

Query: 554 -----------------ELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSND 596
                             L K+++ V +      L+ + ++TL W        R    N 
Sbjct: 621 LKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWL-------RKRKKNK 673

Query: 597 GINSPQAI------RRFSYHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVF 649
             N+P          + SY +L  AT+ FS +N++G GSFG++Y A  L +   VAVKV 
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733

Query: 650 HQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-----DDFKALIMKYMPNGSLENCL 704
           + Q   A+KSF  ECE +K IRHRNLVK++++CS+     ++F+ALI ++MPNGSL+  L
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793

Query: 705 YSGTC--------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA 756
           +             L + +RLNI IDVA  L+YLH     PI HCDLKPSNVLLD+D+ A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853

Query: 757 HISDFGIAKLLSGEDQLSIQIQ-----TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLME 811
           H+SDFG+A+LL   D+ S   Q        TIGY APEYG  G+    GDVYS+GI+L+E
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLE 913

Query: 812 MFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLA 871
           MFT K+PT+E+F G  +LN +    LP  +++++D ++L    R      + L  V  + 
Sbjct: 914 MFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVG 973

Query: 872 TECTIES 878
             C  ES
Sbjct: 974 LRCCEES 980

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  456 bits (1172), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 336/990 (33%), Positives = 504/990 (50%), Gaps = 128/990 (12%)

Query: 14  LVHSLLLSL------VIAAAASNIT--TDQQALLALKAHISYDHTNLFARNWTSSTSVCS 65
           LV +LL+S+      ++ A    +T  TD+QALL  K+ +S + + +   +W  S  +CS
Sbjct: 12  LVSALLVSVSLEHSDMVCAQTIRLTEETDKQALLEFKSQVS-ETSRVVLGSWNDSLPLCS 70

Query: 66  WIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT 125
           W G+ C +   RV G+++    L G + P +GNLS L++L+L+ N   G IPS + N+  
Sbjct: 71  WTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFR 130

Query: 126 LKLLYFSDN------------------------------------------------QLF 137
           L+ L  S+N                                                 L 
Sbjct: 131 LQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLT 190

Query: 138 GSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA 197
           G     + N++S+  +D   N + GE+P +I  L  +     A N   GV P  I+N+S+
Sbjct: 191 GKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSS 250

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           L  + +  NS SG+L       LPN++ L +GINSF GT+P +++N S L  L++  N  
Sbjct: 251 LIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHL 310

Query: 258 SGFIPNTF---------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK 308
           +G IP +F             ++    S+ +L FL +LTNC +L+ L +  N L G LP 
Sbjct: 311 TGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPV 370

Query: 309 SKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQAL 368
              NLS  L  + +    ISG+IP  +GNL +L  L+LG N LT  +P +  +L  L+ +
Sbjct: 371 FIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKV 430

Query: 369 GLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP 428
            L  N L+G I   L +++ L  L L  N F GSIPS LG+ + L  L LG N+   ++P
Sbjct: 431 LLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIP 490

Query: 429 STIWNLKDILFIDVSSN-----------SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQM 477
             +  L  ++ ++VS N            L  L+ L+ S N LSG IP T+    +L+ +
Sbjct: 491 HELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFL 550

Query: 478 FLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            L+ N   G IP+  G L+ L  LDLSKN +SG IP  +     L++LNLS N  +G +P
Sbjct: 551 LLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVP 609

Query: 538 RGGPFANLTAKSFMGN-------ELLKMLLLVIILPL---STALIVVVTLT--------- 578
             G F N +A S  GN         L++    + LP    S   I+ + ++         
Sbjct: 610 TEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLL 669

Query: 579 ------LKWKLIECWKSRTGPSNDGINSPQAIRRF----SYHELLRATDRFSENNLIGIG 628
                 L W  +   KS    +N+   S   ++ F    SY EL + T  FS +NLIG G
Sbjct: 670 CLCVVYLCWYKLRV-KSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSG 728

Query: 629 SFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN--- 684
           +FG+++   L      VA+KV +     A KSF  ECE +  IRHRNLVK+++ CS+   
Sbjct: 729 NFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDF 788

Query: 685 --DDFKALIMKYMPNGSLENCLY--------SGTCMLDIFQRLNIMIDVALALEYLHFGH 734
             +DF+AL+ ++MPNG+L+  L+        + +  L +F RLNI IDVA AL YLH   
Sbjct: 789 EGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYC 848

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-----TLATIGYMAPE 789
             PI HCD+KPSN+LLD+D+ AH+SDFG+A+LL   D+ +  IQ        TIGY APE
Sbjct: 849 HNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPE 908

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL-PVSVMEVIDTN 848
           YG  G     GDVYS+GI+L+E+FT K+PT+++F+  L+L+ +    L     +++ D  
Sbjct: 909 YGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDET 968

Query: 849 LLRGEERFFAAKEQILLSVLNLATECTIES 878
           +LRG         + L  V  +   C+ ES
Sbjct: 969 ILRGAYAQHFNMVECLTLVFRVGVSCSEES 998

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  418 bits (1074), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 311/911 (34%), Positives = 470/911 (51%), Gaps = 125/911 (13%)

Query: 63  VCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFN 122
           VC+W G+ C+  S +VI L+IS  +L G I P + NL+ L  LDLS N   G IP  I +
Sbjct: 53  VCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGS 112

Query: 123 MH-TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFAT 181
           +H TLK L  S+N L G++                        P+E+G L  L  L   +
Sbjct: 113 LHETLKQLSLSENLLHGNI------------------------PQELGLLNRLVYLDLGS 148

Query: 182 NNLVGVAPVTIF---NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVP 238
           N L G  PV +F   + S+L+ I L NNSL+G +P      L  +  L L  N   GTVP
Sbjct: 149 NRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVP 208

Query: 239 SSITNASKLSDLELGVNLFSGFIPNT---------FVNMADNYLTS---STPELSFLSSL 286
           SS++N++ L  ++L  N+ SG +P+          F+ ++ N+  S   +T    F +SL
Sbjct: 209 SSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASL 268

Query: 287 TNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
            N   L+ L L GN L G +  S  +LS++L  I +D   I G+IP  + NL NL +L L
Sbjct: 269 ANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNL 328

Query: 347 GGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 406
             N L+ PIP    +L  L+ + L+ N L G I  EL  + RL  L +  N  SGSIP  
Sbjct: 329 SSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDS 388

Query: 407 LGNLTSLRVLYLGLNRFTSALPST-------------------------IWNLKDI-LFI 440
            GNL+ LR L L  N  +  +P +                         + NL+++ L++
Sbjct: 389 FGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYL 448

Query: 441 DVSSNSL-----------NVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
           ++SSN L           ++++ ++ S N LSG IP  +G    L+ + L  N    ++P
Sbjct: 449 NLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLP 508

Query: 490 ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKS 549
            S G L  L+ LD+S N+++GAIP S Q+   LKHLN SFN L G +   G F+ LT +S
Sbjct: 509 SSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIES 568

Query: 550 FMGNELL-------------KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPS-- 594
           F+G+ LL                  V++  L + +   V     + L++  +SR G +  
Sbjct: 569 FLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQ--RSRFGKNLT 626

Query: 595 -----------NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGME 643
                          N P+   R SY +L+ AT  F+ ++LIG G FG +Y   L++  +
Sbjct: 627 VYAKEEVEDEEKQNQNDPK-YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK 685

Query: 644 VAVKVFHQQYERALK-SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
           VAVKV   +       SF+ EC+++KR RHRNL++II++CS   F AL++  MPNGSLE 
Sbjct: 686 VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLER 745

Query: 703 CLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS 759
            LY G   +  LD+ Q +NI  DVA  + YLH      ++HCDLKPSN+LLD++M A ++
Sbjct: 746 HLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVT 805

Query: 760 DFGIAKLLSG-EDQLSIQIQT---------LATIGYMAPEYGTKGRVCTRGDVYSYGIML 809
           DFGI++L+ G E+ +S                ++GY+APEYG   R  T GDVYS+G++L
Sbjct: 806 DFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 865

Query: 810 MEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK-----EQIL 864
           +E+ + ++PTD +     SL+ ++    P S+  +I+  L R + +    K      +++
Sbjct: 866 LEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVI 925

Query: 865 LSVLNLATECT 875
           L ++ L   CT
Sbjct: 926 LEMIELGLVCT 936

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  395 bits (1015), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 304/914 (33%), Positives = 464/914 (50%), Gaps = 120/914 (13%)

Query: 88   LQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNV 147
            L+G IP ++GN SSL  L+L  N+L+G IP+ + N+  L+ L    N+L  S+   +F +
Sbjct: 252  LEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRL 311

Query: 148  SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
            + +T + LS N L G +  EIG L  L  L   +NN  G  P +I N+  L  + +  N+
Sbjct: 312  TQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNN 371

Query: 208  LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN---- 263
            +SG LP+ + L L N+  L+   N   G +PSSI+N + L  L+L  N  +G IP     
Sbjct: 372  ISGELPADLGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGR 430

Query: 264  ---TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII 320
               TF+++  N+ T   P+  F     NC  L+ L +  N L G L    G L   L I+
Sbjct: 431  MNLTFISIGRNHFTGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQ-KLRIL 484

Query: 321  LMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPIT 380
             +   S++G IP+ +GNL +L +L L  N  T  IP   S L  LQ L +  N L GPI 
Sbjct: 485  QVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIP 544

Query: 381  DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPS-----TIWNLK 435
            +E+  +  L  L L  NKFSG IP+    L SL  L L  N+F  ++P+     ++ N  
Sbjct: 545  EEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTF 604

Query: 436  DI---------------------LFIDVSSNSL---------------------NVLIG- 452
            DI                     L+++ S+N L                     N+  G 
Sbjct: 605  DISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGS 664

Query: 453  -------------LNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPESFGDLSSL 498
                         L+FS+NNLSG IP  +  G+  +  + L  N   G IP+SFG+++ L
Sbjct: 665  IPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHL 724

Query: 499  EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGN----- 553
              LDLS N ++G IP SL  L  LKHL L+ N L+G +P  G F N+ A   MGN     
Sbjct: 725  VSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG 784

Query: 554  --ELLKMLLL------------VIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDG-- 597
              + LK   +            VI++ L +A  +++ L L   L  C K      N    
Sbjct: 785  SKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSES 844

Query: 598  ----INSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY 653
                ++S   ++RF   EL +ATD F+  N+IG  S  ++Y  +L+DG  +AVKV + + 
Sbjct: 845  SLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKE 904

Query: 654  ERAL--KSFEDECEVMKRIRHRNLVKIIS-SCSNDDFKALIMKYMPNGSLENCLY-SGTC 709
              A   K F  E + + +++HRNLVKI+  +  +   KAL++ +M NG+LE+ ++ S   
Sbjct: 905  FSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAP 964

Query: 710  MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 769
            +  + +++++ + +A  ++YLH G+  PI+HCDLKP+N+LLD D VAH+SDFG A++L  
Sbjct: 965  IGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGF 1024

Query: 770  EDQLSIQIQTLA---TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
             +  S    T A   TIGY+APE+    +V T+ DV+S+GI++ME+ TK++PT      E
Sbjct: 1025 REDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTS--LNDE 1082

Query: 827  LSLNRWINDLLPVSV-------MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESR 879
             S +  +  L+  S+       + V+D  L  G+      +E+ +   L L   CT  SR
Sbjct: 1083 DSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCT-SSR 1139

Query: 880  DGNGADMGWIFSAL 893
              +  DM  I + L
Sbjct: 1140 PEDRPDMNEILTHL 1153

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  391 bits (1004), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 289/885 (32%), Positives = 446/885 (50%), Gaps = 64/885 (7%)

Query: 10  ITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGI 69
           + R ++   ++  ++   AS +  + +AL+A+K   S     L   +   ++ +CSW G+
Sbjct: 5   MQRMVLSLAMVGFMVFGVASAMNNEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCSWRGV 64

Query: 70  TCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLL 129
            CD  S+ V+ LN+SS NL G I P +G+L +LQ++DL  NKL+G IP  I N  +L  L
Sbjct: 65  FCDNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYL 124

Query: 130 YFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP 189
             S+N L+G + F I  +  + T++L  N L+G +P  +  +P L RL  A N+L G   
Sbjct: 125 DLSENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEIS 184

Query: 190 VTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSD 249
             ++    L+ + L  N L+G+L S +   L  +   ++  N+  GT+P SI N +    
Sbjct: 185 RLLYWNEVLQYLGLRGNMLTGTLSSDM-CQLTGLWYFDVRGNNLTGTIPESIGNCTSFQI 243

Query: 250 LELGVNLFSGFIPNTF-------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPL 302
           L++  N  +G IP          +++  N LT   PE+  L      + L VL L+ N L
Sbjct: 244 LDISYNQITGEIPYNIGFLQVATLSLQGNRLTGRIPEVIGL-----MQALAVLDLSDNEL 298

Query: 303 DGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQL 362
            G +P   GNLS + ++ L  N  ++G IP  +GN+  L  L+L  N L   IP    +L
Sbjct: 299 VGPIPPILGNLSFTGKLYLHGNM-LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKL 357

Query: 363 QTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR 422
           + L  L L  N+L GPI   +   A L+   + GN  SGSIP    NL SL  L L  N 
Sbjct: 358 EQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNN 417

Query: 423 FTSALPSTIWNLKDILFIDVSSNS-----------LNVLIGLNFSRNNLSGDIPITIGGL 471
           F   +P  + ++ ++  +D+S N+           L  L+ LN SRN+LSG +P   G L
Sbjct: 418 FKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNL 477

Query: 472 KNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK 531
           +++Q + + +N L G IP   G L +L  L L+ NK+ G IP  L     L +LN+SFN 
Sbjct: 478 RSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNN 537

Query: 532 LEGEIPRGGPFANLTAKSFMGNELL-------------------KMLLLVIILPLSTALI 572
           L G +P    F+     SF+GN  L                   +  L+ I+L + T L 
Sbjct: 538 LSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLC 597

Query: 573 VVVTLTLKWKLIECWKSRTGPSNDG--------INSPQAIRRFSYHELLRATDRFSENNL 624
           ++      +K ++  K   G S           ++   AI  F   +++R T+  +E  +
Sbjct: 598 MIFLAV--YKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFD--DIMRVTENLNEKFI 653

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G+  ++Y   L+    +A+K  + QY   L+ FE E E +  IRHRN+V +     +
Sbjct: 654 IGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALS 713

Query: 685 DDFKALIMKYMPNGSLENCLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                L   YM NGSL + L+       LD   RL I +  A  L YLH   +  IIH D
Sbjct: 714 PTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRD 773

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           +K SN+LLDE+  AH+SDFGIAK +    +       L TIGY+ PEY    R+  + D+
Sbjct: 774 IKSSNILLDENFEAHLSDFGIAKSIPAS-KTHASTYVLGTIGYIDPEYARTSRINEKSDI 832

Query: 803 YSYGIMLMEMFTKKKPTD-EIFIGELSLNRWINDLLPVSVMEVID 846
           YS+GI+L+E+ T KK  D E  + +L L++  ++    +VME +D
Sbjct: 833 YSFGIVLLELLTGKKAVDNEANLHQLILSKADDN----TVMEAVD 873

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  382 bits (980), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 290/888 (32%), Positives = 438/888 (49%), Gaps = 111/888 (12%)

Query: 83   ISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSF 142
            +S   L G IP ++ N  SL+ LDLS+N L+G IP S+F +  L  LY ++N L G+LS 
Sbjct: 344  LSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSS 403

Query: 143  FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIY 202
             I N++++    L  N L G++P+EIG L  L  +    N   G  PV I N + L+EI 
Sbjct: 404  SISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEID 463

Query: 203  LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
               N LSG +PS I   L ++  L+L  N   G +P+S+ N  +++ ++L  N  SG IP
Sbjct: 464  WYGNRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIP 522

Query: 263  NTF--------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG-ILPKSKGNL 313
            ++F          + +N L  + P+     SL N K L  +  + N  +G I P    + 
Sbjct: 523  SSFGFLTALELFMIYNNSLQGNLPD-----SLINLKNLTRINFSSNKFNGSISPLCGSSS 577

Query: 314  SLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
             LS ++         G+IP  +G   NL  L LG N  T  IP TF ++  L  L ++RN
Sbjct: 578  YLSFDVT---ENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRN 634

Query: 374  KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWN 433
             L+G I  EL    +L  + L  N  SG IP+ LG L  L  L L  N+F  +LP+ I++
Sbjct: 635  SLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFS 694

Query: 434  LKDILFIDVSSNSLN-----------------------------------VLIGLNFSRN 458
            L +IL + +  NSLN                                    L  L  SRN
Sbjct: 695  LTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRN 754

Query: 459  NLSGDIPITIGGLKNLQQMF-LEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQ 517
             L+G+IP+ IG L++LQ    L YN   G IP +   L  LE LDLS N++ G +P  + 
Sbjct: 755  ALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIG 814

Query: 518  KLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGN-------------------ELLKM 558
             +  L +LNLS+N LEG++ +   F+   A +F+GN                     L  
Sbjct: 815  DMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSP 872

Query: 559  LLLVIILPLST----ALIVVVTLTLKWKLIECWKSRTGP----------------SNDGI 598
              +VII  +S+    AL+V+V +    +  + +K   G                 SN G 
Sbjct: 873  KTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGA 932

Query: 599  NSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVK-VFHQQYERAL 657
             S        + +++ AT   +E  +IG G  G +Y A L++G  +AVK +  +    + 
Sbjct: 933  KS-----DIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSN 987

Query: 658  KSFEDECEVMKRIRHRNLVKIISSCSN--DDFKALIMKYMPNGSLENCLYSGTC-----M 710
            KSF  E + +  IRHR+LVK++  CS+  D    LI +YM NGS+ + L++        +
Sbjct: 988  KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047

Query: 711  LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
            L    RL I + +A  +EYLH+    PI+H D+K SNVLLD ++ AH+ DFG+AK+L+G 
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107

Query: 771  DQLSIQIQTL--ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS 828
               + +  T+   + GY+APEY    +   + DVYS GI+LME+ T K PT+ +F  E  
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167

Query: 829  LNRWINDLLPVSVMEVIDTNLLRGE-ERFFAAKEQILLSVLNLATECT 875
            + RW+  +L           L+  E +     +E+    VL +A +CT
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCT 1215

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  377 bits (969), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 304/962 (31%), Positives = 451/962 (46%), Gaps = 172/962 (17%)

Query: 81   LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
            L++ +  LQG IP  L +L +LQTLDLS N L+G IP   +NM  L  L  ++N L GSL
Sbjct: 268  LSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSL 327

Query: 141  SFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK 199
               I  N +++  + LS   LSGE+P E+     L +L  + N+L G  P  +F +  L 
Sbjct: 328  PKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELT 387

Query: 200  EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
            ++YL NN+L G+L   I  +L N++ L L  N+  G +P  I+   KL  L L  N FSG
Sbjct: 388  DLYLHNNTLEGTLSPSIS-NLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSG 446

Query: 260  FIPN--------TFVNMADNYLTSSTP-------ELSFL------------SSLTNCKKL 292
             IP           ++M  N+     P       EL+ L            +SL NC +L
Sbjct: 447  EIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQL 506

Query: 293  KVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV----------------- 335
             +L L  N L G +P S G L   LE +++ N S+ GN+P  +                 
Sbjct: 507  NILDLADNQLSGSIPSSFGFLK-GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLN 565

Query: 336  ------------------------------GNLGNLLVLELGGNNLTEPIPITFSQLQTL 365
                                          GN  NL  L LG N LT  IP T  +++ L
Sbjct: 566  GTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIREL 625

Query: 366  QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS 425
              L ++ N L G I  +L    +L  + L  N  SG IP  LG L+ L  L L  N+F  
Sbjct: 626  SLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVE 685

Query: 426  ALPSTIWNLKDILFIDVSSNSLN-----------------------------------VL 450
            +LP+ ++N   +L + +  NSLN                                    L
Sbjct: 686  SLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKL 745

Query: 451  IGLNFSRNNLSGDIPITIGGLKNLQQMF-LEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
              L  SRN+L+G+IP+ IG L++LQ    L YN   G IP + G LS LE LDLS N+++
Sbjct: 746  YELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLT 805

Query: 510  GAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL------------- 556
            G +P S+  +  L +LN+SFN L G++ +   F+   A SF+GN  L             
Sbjct: 806  GEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRS 863

Query: 557  ----------KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGIN----SPQ 602
                       ++++  I  L+   ++++ + L +K    +  + G  +        S Q
Sbjct: 864  NNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQ 923

Query: 603  AIRR-----------FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAV-KVFH 650
            A  +             + +++ AT   SE  +IG G  G +Y A L++G  VAV K+  
Sbjct: 924  ATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILW 983

Query: 651  QQYERALKSFEDECEVMKRIRHRNLVKIISSCS--NDDFKALIMKYMPNGSLENCLYSGT 708
            +    + KSF  E + + RIRHR+LVK++  CS  ++    LI +YM NGS+ + L+   
Sbjct: 984  KDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDK 1043

Query: 709  C-------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF 761
                    +LD   RL I + +A  +EYLH     PI+H D+K SNVLLD +M AH+ DF
Sbjct: 1044 PVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDF 1103

Query: 762  GIAKLLSGEDQLSIQIQTL--ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPT 819
            G+AK+L+     +    T    + GY+APEY    +   + DVYS GI+LME+ T K PT
Sbjct: 1104 GLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT 1163

Query: 820  DEIFIGELSLNRWINDLLPVSVM---EVIDTNLLRGEERFFAAKEQILLSVLNLATECTI 876
            D +F  E+ + RW+   L V+     ++ID  L    +     +E     VL +A +CT 
Sbjct: 1164 DSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL----KPLLPFEEDAACQVLEIALQCTK 1219

Query: 877  ES 878
             S
Sbjct: 1220 TS 1221

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  371 bits (952), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 283/902 (31%), Positives = 449/902 (49%), Gaps = 77/902 (8%)

Query: 28  ASNITTDQQALLALKAHISYDHTNLFARNWTSSTS--VCSWIGITCDVNSHRVIGLNISS 85
            + +T+++ A L L+   S+   N    +WT+S S   C W G++C+  +  V+ LN+S 
Sbjct: 19  VATVTSEEGATL-LEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSD 77

Query: 86  FNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF 145
            NL G I P +G+L SL ++DL  N+LSG IP  I +  +L+ L  S N+L G + F I 
Sbjct: 78  LNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSIS 137

Query: 146 NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLN 205
            +  +  + L  N L G +P  +  +P L  L  A N L G  P  I+    L+ + L  
Sbjct: 138 KLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRG 197

Query: 206 NSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTF 265
           N+L G++   +   L  +   ++  NS  G++P +I N +    L+L  N  +G IP   
Sbjct: 198 NNLVGNISPDL-CQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDI 256

Query: 266 -------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE 318
                  +++  N L+   P +  L      + L VL L+GN L G +P   GNL+ + +
Sbjct: 257 GFLQVATLSLQGNQLSGKIPSVIGL-----MQALAVLDLSGNLLSGSIPPILGNLTFTEK 311

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP 378
           + L  N  ++G+IP  +GN+  L  LEL  N+LT  IP    +L  L  L +  N L GP
Sbjct: 312 LYLHSN-KLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGP 370

Query: 379 ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL 438
           I D L     L+SL + GNKFSG+IP     L S+  L L  N     +P  +  + ++ 
Sbjct: 371 IPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLD 430

Query: 439 FIDVSSNSLNVLI-----------GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGS 487
            +D+S+N +N +I            +N SRN+++G +P   G L+++ ++ L  N + G 
Sbjct: 431 TLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGP 490

Query: 488 IPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
           IPE    L ++ +L L  N ++G +  SL   L L  LN+S N L G+IP+   F+  + 
Sbjct: 491 IPEELNQLQNIILLRLENNNLTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSP 549

Query: 548 KSFMGNELLKMLLL-----------------VIILPLSTALIVVVTLTLKWKLIECWKSR 590
            SF+GN  L    L                   IL ++   +V++ + L   +  C    
Sbjct: 550 DSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVL---IAACRPHN 606

Query: 591 TGPSNDG-------INSPQAI------RRFSYHELLRATDRFSENNLIGIGSFGSIYVAR 637
             P  DG        ++P+ +          Y +++R T+  SE  +IG G+  ++Y   
Sbjct: 607 PPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCV 666

Query: 638 LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN 697
           L++   VA+K  +    +++K FE E E++  I+HRNLV + +   +     L   Y+ N
Sbjct: 667 LKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLEN 726

Query: 698 GSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 755
           GSL + L+  T    LD   RL I    A  L YLH   S  IIH D+K SN+LLD+D+ 
Sbjct: 727 GSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLE 786

Query: 756 AHISDFGIAK-LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           A ++DFGIAK L   +   S  +  + TIGY+ PEY    R+  + DVYSYGI+L+E+ T
Sbjct: 787 ARLTDFGIAKSLCVSKSHTSTYV--MGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLT 844

Query: 815 KKKPT-DEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATE 873
           ++K   DE  +  L +++  N+     VME+ D ++    +     K+     V  LA  
Sbjct: 845 RRKAVDDESNLHHLIMSKTGNN----EVMEMADPDITSTCKDLGVVKK-----VFQLALL 895

Query: 874 CT 875
           CT
Sbjct: 896 CT 897

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1

 Score =  366 bits (940), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 278/876 (31%), Positives = 430/876 (49%), Gaps = 57/876 (6%)

Query: 19  LLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRV 78
           ++  ++  + S +  + +AL+A+KA  S     L   +   +   CSW G+ CD  S  V
Sbjct: 16  MVVFMLLGSVSPMNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNV 75

Query: 79  IGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFG 138
           + LN+S+ NL G I   LG+L +LQ++DL  NKL G IP  I N  +L  + FS N LFG
Sbjct: 76  VSLNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFG 135

Query: 139 SLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL 198
            + F I  +  +  ++L  N L+G +P  +  +P L  L  A N L G  P  ++    L
Sbjct: 136 DIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVL 195

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           + + L  N L+G+L   +   L  +   ++  N+  GT+P SI N +    L++  N  +
Sbjct: 196 QYLGLRGNMLTGTLSPDM-CQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQIT 254

Query: 259 GFIPNTF-------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
           G IP          +++  N LT   PE+  L      + L VL L+ N L G +P   G
Sbjct: 255 GVIPYNIGFLQVATLSLQGNKLTGRIPEVIGL-----MQALAVLDLSDNELTGPIPPILG 309

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           NLS + ++ L  N  ++G IP  +GN+  L  L+L  N L   IP    +L+ L  L L 
Sbjct: 310 NLSFTGKLYLHGN-KLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLA 368

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
            N L G I   +   A L+   + GN  SG++P    NL SL  L L  N F   +P+ +
Sbjct: 369 NNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAEL 428

Query: 432 WNLKDILFIDVSSNS-----------LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLE 480
            ++ ++  +D+S N+           L  L+ LN SRN+L+G +P   G L+++Q + + 
Sbjct: 429 GHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVS 488

Query: 481 YNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGG 540
           +N L G IP   G L ++  L L+ NKI G IP  L     L +LN+SFN L G IP   
Sbjct: 489 FNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMK 548

Query: 541 PFANLTAKSFMGNELLKMLLLVII----LPLSTAL--IVVVTLTLKWKLIEC------WK 588
            F   +  SF GN  L    +  I    LP S     + V+ + L +  + C      +K
Sbjct: 549 NFTRFSPASFFGNPFLCGNWVGSICGPSLPKSQVFTRVAVICMVLGFITLICMIFIAVYK 608

Query: 589 SR------TGPSNDGINSPQAI------RRFSYHELLRATDRFSENNLIGIGSFGSIYVA 636
           S+       G S     S + +         ++ +++R T+   E  +IG G+  ++Y  
Sbjct: 609 SKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKC 668

Query: 637 RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP 696
             +    +A+K  + QY    + FE E E +  IRHRN+V +     +     L   YM 
Sbjct: 669 TSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYME 728

Query: 697 NGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM 754
           NGSL + L+       LD   RL I +  A  L YLH   +  IIH D+K SN+LLD + 
Sbjct: 729 NGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNF 788

Query: 755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            A +SDFGIAK +      +     L TIGY+ PEY    R+  + D+YS+GI+L+E+ T
Sbjct: 789 EARLSDFGIAKSIPATKTYA-STYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLT 847

Query: 815 KKKPTD-EIFIGELSLNRWINDLLPVSVMEVIDTNL 849
            KK  D E  + ++ L++  ++    +VME +D  +
Sbjct: 848 GKKAVDNEANLHQMILSKADDN----TVMEAVDAEV 879

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	897
224139658	1019	predicted protein [Populus trichocarpa]	0.959	0.844	0.446	0.0
224116832	1061	predicted protein [Populus trichocarpa]	0.882	0.746	0.483	0.0
298204751	1979	unnamed protein product [Vitis vinifera]	0.920	0.417	0.441	0.0
255572272	1089	serine-threonine protein kinase, plant-t	0.894	0.736	0.474	0.0
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.878	0.554	0.481	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.876	0.653	0.483	0.0
255583725	973	serine-threonine protein kinase, plant-t	0.968	0.893	0.457	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.888	0.733	0.477	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.887	0.547	0.455	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.869	0.745	0.451	0.0

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  762 bits (1968), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/985 (44%), Positives = 588/985 (59%), Gaps = 124/985 (12%)

Query: 14  LVHSLLLSL---VIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGIT 70
           LV  LL+SL    I+   SN T DQ ALLA K HI++D  N+   +W+S TS C+W+G++
Sbjct: 9   LVSMLLMSLPKKCISIPTSNFT-DQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVS 67

Query: 71  CDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM------- 123
           C +   RV  L++SS  L GTIPPQLGNLS LQ L L +N   G++PS I N+       
Sbjct: 68  CSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMD 127

Query: 124 ------------------HTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMP 165
                             H L+ L F  N L G++   IFN+SS+  +DL  NGL G +P
Sbjct: 128 IGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLP 187

Query: 166 R-------------------------------------------------EIGNLPYLAR 176
           +                                                 E+G LP L  
Sbjct: 188 KNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEV 247

Query: 177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT 236
           L    N L G  P +IFNM++L+ + +  N+LSGS+P    + LPN+E L L +N   G+
Sbjct: 248 LNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGS 307

Query: 237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNM--------ADNYLTS--STPELSFLSSL 286
           +P  + N S+L  L+L  N  +G +   F N+          N  T+  S+  L+F++SL
Sbjct: 308 MPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSL 367

Query: 287 TNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
           TN ++LK L +  NPLDG+LP S GNLS  L    +    + GNIP  +GNL NL+VL L
Sbjct: 368 TNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSL 427

Query: 347 GGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 406
             N+L  PIP T   L+ +Q L L +N L G I  ++C   RL  + L  N  SG IPSC
Sbjct: 428 EENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSC 487

Query: 407 LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-----------SLNVLIGLNF 455
           +GNLTSLR LYL  N  +S +P  +W+LKD+L +++ SN            +   IG+  
Sbjct: 488 IGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRL 547

Query: 456 SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS 515
           S N LSG+IP TIG L+NL +  L  N  +GSIPE+FG L SLE+LDLS+N +SG IP S
Sbjct: 548 SSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKS 607

Query: 516 LQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL------------------- 556
           L+ L YL+  ++SFN L+GEIPRGGPFAN TA+SF+ N+ L                   
Sbjct: 608 LEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDS 667

Query: 557 --KMLLLVIILPLSTALIVVVTLTLKWKLIECWKS-RTGPSNDGINSPQAIRRFSYHELL 613
             K  LL   LP   ++++VV     + ++ C +  R  P  + +      RR SY ELL
Sbjct: 668 KTKSRLLRFSLPTVASILLVVAFI--FLVMGCRRRYRKDPIPEALPVTAIQRRISYLELL 725

Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR 673
            AT+ F E+NL+GIGSFGS+Y  RL+DG+ VAVK+F+ Q +RA +SF+ ECE+M+ IRHR
Sbjct: 726 HATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHR 785

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           NLVKII SCSN DFKAL+++YMP GSLE  LYS    LDI QR+NIMIDVA ALEYLH G
Sbjct: 786 NLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHG 845

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           + +P++HCDLKPSNVLLDEDMVAH+ DFGIAKLL GE++   Q +TLATIGYMAPEYG  
Sbjct: 846 YPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLD 904

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE 853
           G V T+ DVYS+GIMLMEM T+K+PTDE+F GE+SL R + + LP SV++++D+N+L   
Sbjct: 905 GLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRG 964

Query: 854 ERFFAAKEQILLSVLNLATECTIES 878
           + +   KE  + S++ LA +C  ES
Sbjct: 965 DGYSVKKEHCVTSIMELALQCVNES 989

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  724 bits (1868), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/865 (48%), Positives = 529/865 (61%), Gaps = 73/865 (8%)

Query: 81   LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
            LN+    L G IP  L   + L+ LDL  N+ +G+IP  I  +  LK LY   N L G +
Sbjct: 168  LNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNNLTGQI 227

Query: 141  SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP----------- 189
               I  + S+  + L +NGL+G +PREIGN  YL  +    NNL GV P           
Sbjct: 228  PGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNLHTLQE 287

Query: 190  -------------VTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT 236
                          T FN S L+ + +  N LSG LPS   L LPN+E L L  N   G 
Sbjct: 288  LDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGP 347

Query: 237  VPSSITNASKLSDLELGVNLFSGFIPNTF--------VNMADNYLTSSTPELSFLSSLT- 287
            +P SI NASKL  L+L  N FSG IP+          +N+A+N LTS +         + 
Sbjct: 348  IPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSL 407

Query: 288  -NCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
             NC+ L  L   GNPL G LP S GNLS SLE +   +C I GNIP+ +GNL NL+ L L
Sbjct: 408  SNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLIL 467

Query: 347  GGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 406
              N LT  IP    +L+ LQ   L  NKL G I +E+CHL RL  L L  N FSGS+P+C
Sbjct: 468  QQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPAC 527

Query: 407  LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL-----------NVLIGLNF 455
            L N+TSLR LYLG NRFTS +P+T W+LKD+L I++S NSL            V+  ++F
Sbjct: 528  LSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDF 586

Query: 456  SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS 515
            S N LSGDIP +I  L+NL    L  NR++G IP SFGDL SLE LDLS+N +SGAIP S
Sbjct: 587  SSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKS 646

Query: 516  LQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL------------------- 556
            L+KL++LK  N+SFN+L+GEI  GGPFAN + +SFM NE L                   
Sbjct: 647  LEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQ 706

Query: 557  ----KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHEL 612
                +  ++  I+P + A I++V L L   +      R   + +    P   R+ SYHEL
Sbjct: 707  SKRPREFVIRYIVP-AIAFIILV-LALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHEL 764

Query: 613  LRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH 672
             RAT+ F+E NL+G GS GS+Y   L DG+ +AVKVFH Q E  L  F+ ECEV++ +RH
Sbjct: 765  YRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRH 824

Query: 673  RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            RNLVKIISSC N DFKALI++++P+GSLE  LYS    LDI QRLNIMIDVA ALEYLH 
Sbjct: 825  RNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHH 884

Query: 733  GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            G + P++HCDLKPSNVL++EDMVAH+SDFGI++LL GE     Q  TLATIGYMAPEYG 
Sbjct: 885  GCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLATIGYMAPEYGL 943

Query: 793  KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG 852
            +G V  +GDVYSYGI LME FT+KKPTD++F GE+SL  W+   LP ++ EVID NLL  
Sbjct: 944  EGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLI- 1002

Query: 853  EERFFAAKEQILLSVLNLATECTIE 877
            EE  F AK+  + S+LNLA EC+ +
Sbjct: 1003 EEEHFVAKKDCITSILNLALECSAD 1027

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera]

 Score =  719 bits (1857), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 443/1004 (44%), Positives = 574/1004 (57%), Gaps = 178/1004 (17%)

Query: 20   LSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVI 79
             S  +A + SN T DQ +LLALKAHI+ D  ++ A NW++ TS C WIG++C+    RVI
Sbjct: 494  FSACVAMSLSNFT-DQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVI 552

Query: 80   GLNISSFNLQGTI----------------------------------------------- 92
             L++S+  L+GTI                                               
Sbjct: 553  ALDLSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGT 612

Query: 93   -PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL----SFF---- 143
             PP +GN+S L+TLD+  N+L G IPS+IFN+ +L+ +  + N L G++    SF     
Sbjct: 613  IPPSIGNMSMLETLDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGTIPEEISFLPSLE 672

Query: 144  ----------------IFNVSSVTTIDLSINGLSG------------------------- 162
                            IF +S++  IDL  NG SG                         
Sbjct: 673  YLYLRSNSFTSPIPSAIFKISTLKAIDLGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFT 732

Query: 163  --------------------------EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMS 196
                                      E+P EIG+L  L  L    N+L G  P  IFN+S
Sbjct: 733  GTIHGGIGNCTSLRELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNIS 792

Query: 197  ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL 256
            ++    L  N+LSG+LP      LPN+E L L IN   G +PSSI NASKL  L+ G N+
Sbjct: 793  SMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNM 852

Query: 257  FSGFIPNTF--------VNMADNYLT--SSTPELSFLSSLTNCKKLKVLILTGNPLDGIL 306
             +G IP+          +N+  N L   S   ELSFL+SLTNCK+L++L L+ NPL GIL
Sbjct: 853  LTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGIL 912

Query: 307  PKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ 366
            P S GNLS SL+    + C + GNIP  +GNL NL +L L  N+LT  IP +  QLQ LQ
Sbjct: 913  PISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQ 972

Query: 367  ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSA 426
             L L  NKL G I +++C L  L  L L  N+ SGSIP+CLG LT LR LYLG N+  S 
Sbjct: 973  GLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNST 1032

Query: 427  LPSTIWNLKDILFIDVSSN-----------SLNVLIGLNFSRNNLSGDIPITIGGLKNLQ 475
            +PST+W+L  IL +D+SSN           +L VL+ ++ SRN LSG+IP  IGGL++L 
Sbjct: 1033 IPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLT 1092

Query: 476  QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE 535
             + L +NR EG I  SF +L SLE +DLS N + G IP SL+ L+YLK+L++SFN L GE
Sbjct: 1093 SLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGE 1152

Query: 536  IPRGGPFANLTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSN 595
            IP  GPFAN +A+SFM N+ L      ++   S +L     LT  W              
Sbjct: 1153 IPPEGPFANFSAESFMMNKALCRKRNAVLPTQSESL-----LTATW-------------- 1193

Query: 596  DGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER 655
                     RR SY E+ +AT+ FS  NL+G GS GS+Y   L DG   A+KVF+ Q E 
Sbjct: 1194 ---------RRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEA 1244

Query: 656  ALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKALIMKYMPNGSLENCLYSGTCMLDI 713
            A KSF+ ECEVM  IRHRNL+KI+SSCSN   DFKAL+++Y+PNGSLE  LYS    LDI
Sbjct: 1245 AFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDI 1304

Query: 714  FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
             QRLNIMIDVALA+EYLH G STP++HCDLKPSN+LLDED   H+ DFGIAKLL  E+ +
Sbjct: 1305 LQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESI 1364

Query: 774  SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI 833
              + QTLATIGYMAP+Y + G V T GDVYSYGI+LME FT+++PTDEIF  E+S+  W+
Sbjct: 1365 R-ETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWV 1423

Query: 834  NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIE 877
             D L  S+ EV+D NLLRGE+  F   E++ L   NL  E +I+
Sbjct: 1424 WDWLCGSITEVVDANLLRGEDEQFL--ERLHLGANNLKGESSIQ 1465

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  715 bits (1845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/851 (47%), Positives = 544/851 (63%), Gaps = 49/851 (5%)

Query: 72   DVNSHRVIGLNISSFNLQGTIPPQLGNLSS-LQTLDLSHNKLSGNIPSSIFNMHTLKLLY 130
            D+ S + I L ++  NL G +   L N +S LQ L+L+ N+L G IPS ++    L+ L 
Sbjct: 213  DLPSLKFIYLQVN--NLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLA 270

Query: 131  FSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPV 190
               N+  GS+   I N++ +  + L  N L+G +P EIGNL  L  +  + NNL G  P 
Sbjct: 271  LHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPH 330

Query: 191  TIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL 250
             +FN+S +K I + +N+L G+LP+ + L LPN+  L LGIN   G +PS I+NASKL+ L
Sbjct: 331  ALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTIL 390

Query: 251  ELGVNLFSGFIPNTF--------VNMADNYLTS--STPELSFLSSLTNCKKLKVLILTGN 300
            EL  N F+GFIP++         + +  N L+S  ++ EL+  SSL NC+ LK L L+ N
Sbjct: 391  ELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYN 450

Query: 301  PLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFS 360
            PLDG LP S GNLS SLE  L  +  I G++ + +GNL +L  L LG N+LT  IP T  
Sbjct: 451  PLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIG 510

Query: 361  QLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL 420
             L+ LQ L L  N L G I  ELC L  L++L L GNK SGSIP+C  NLTSLR L+L  
Sbjct: 511  TLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLAS 570

Query: 421  NRFTSALPSTIWNLKDILFIDVSSN-----------SLNVLIGLNFSRNNLSGDIPITIG 469
            NRF S + ST+W LKDIL ++++SN           +L  +  +N S+N LSG+IPI+IG
Sbjct: 571  NRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIG 630

Query: 470  GLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF 529
            GL++L Q++L  N+L+G IP+S GD+ SLE LDLS N +SG IP SL  LLYLK+ N+SF
Sbjct: 631  GLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSF 690

Query: 530  NKLEGEIPRGGPFANLTAKSFMGNELL-----------------------KMLLLVIILP 566
            N L+GEIP GG F+N +A+SF+GNE L                         ++L  +LP
Sbjct: 691  NYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLP 750

Query: 567  LSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIG 626
                 + V+   +  K   C +       D   +   IRR SYHEL  AT+ F E+N +G
Sbjct: 751  AIVFAVFVLAFVIMLKRY-CERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLG 809

Query: 627  IGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD 686
            +GSFGS+Y   L DG  +A KVF+ Q ERA KSF+ ECEV++ +RHRNLVKII+SCS  +
Sbjct: 810  MGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPN 869

Query: 687  FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPS 746
            FKAL++++MPN SLE  LYS    L+  QRLNIM+DVA  LEYLH G++ P+ HCD+KPS
Sbjct: 870  FKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPS 929

Query: 747  NVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYG 806
            NVLL+EDMVA ++DFGI+KLL GE+   +Q  TLATIGYMAPEYG++G V  RGDVYSYG
Sbjct: 930  NVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYG 988

Query: 807  IMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLS 866
            ++LME FT+KKPTD++F  +LSL  W+   L   V +VID NLL  EE   AAK+  ++S
Sbjct: 989  VLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVS 1048

Query: 867  VLNLATECTIE 877
            +L LA +C+ +
Sbjct: 1049 ILKLALQCSAD 1059

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  707 bits (1824), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/869 (48%), Positives = 538/869 (61%), Gaps = 81/869 (9%)

Query: 81   LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG- 138
            L + S  + G IPP++ N+SSLQ +DL+ N L G++P  I  ++H L+ LY S NQL G 
Sbjct: 316  LQLGSCGISGPIPPEIFNISSLQMIDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQ 375

Query: 139  ------------SLSFF-----------IFNVSSVTTIDLSINGLSGEMPREIGNLPYLA 175
                        SLS +             N++ +  ++L  N + G +P E+GNL  L 
Sbjct: 376  LPTTLSLCGQLLSLSLWGNRFTGNIPPSFGNLTVLQDLELXENNIQGNIPNELGNLINLQ 435

Query: 176  RLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG 235
             L  + NNL G+ P  IFN+S L+ + L  N  SGSLPS I   LP++E L +G N F G
Sbjct: 436  NLKLSVNNLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSG 495

Query: 236  TVPSSITNASKLSDLELGVNLFSGFIPN--------TFVNMADNYLTS--STPELSFLSS 285
             +P SI+N S+L+ L++  N F+G +P          F+N+  N LT   ST E+ FL+S
Sbjct: 496  IIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTS 555

Query: 286  LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLE 345
            LTNCK L+ L +  NPL GILP S GNLS+SLE      C   G IP  +GNL NL+ L 
Sbjct: 556  LTNCKFLRRLWIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLR 615

Query: 346  LGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
            L  N+LT  IPI+F  LQ LQ   ++ N++ G I   LCHL  L  L L  NK SG+IP 
Sbjct: 616  LNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPG 675

Query: 406  CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV-----------LIGLN 454
            C GNLT+LR + L  N   S +PS++W L+D+L +++SSN LN            L+ L+
Sbjct: 676  CFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLD 735

Query: 455  FSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA 514
             S+N  SG+IP TI  L+NL Q++L +N+L+G +P +FG L SLE LDLS N  SG IP 
Sbjct: 736  LSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPT 795

Query: 515  SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL------------------ 556
            SL+ L YLK+LN+SFNKL+GEIP  GPFAN TA+SF+ N  L                  
Sbjct: 796  SLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDARRN 855

Query: 557  -KMLLLVIILPLSTAL---IVVVTLTLKWKLIECWKSRTGPSNDGINS----PQAIRRFS 608
             K LLL  I+PLS +L   I+VV  TL       WK R   S   +      P+  R  S
Sbjct: 856  TKSLLLKCIVPLSVSLSTMILVVLFTL-------WKRRQTESESPVQVDLLLPRMHRLIS 908

Query: 609  YHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMK 668
            + ELL AT  F E NLIG GS G +Y   L DG+ VAVKVF+ +   A KSFE ECEVM+
Sbjct: 909  HQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMR 968

Query: 669  RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
             IRHRNL KIISSCSN DFKAL+++YMPN SLE  LYS    LD  QRL IMIDVA  LE
Sbjct: 969  NIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLE 1028

Query: 729  YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            YLH  +S P++HCDLKPSNVLLD+DMVAHISDFGIAKLL G + +  + +TL TIGYMAP
Sbjct: 1029 YLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTIGYMAP 1087

Query: 789  EYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN 848
            EYG++G V T+ D YSYGI+LME+F +KKPTDE+F+ EL+L  W+      ++MEVID N
Sbjct: 1088 EYGSEGIVSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVES-SANNIMEVIDAN 1146

Query: 849  LLRGEERFFAAKEQILLSVLNLATECTIE 877
            LL  E+  FA K+    S++ LA +CTIE
Sbjct: 1147 LLTEEDESFALKQACFSSIMTLALDCTIE 1175

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  706 bits (1823), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/857 (48%), Positives = 543/857 (63%), Gaps = 71/857 (8%)

Query: 88   LQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFN 146
            L G IP ++ N+SSLQ +  ++N LSG++P  I  ++  L+ L  S NQL G L   +  
Sbjct: 322  LSGPIPAEIFNISSLQEIGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTTLSL 381

Query: 147  VSSVTTIDLSINGLSGEMPREIGNLPYLARLAFA------------------------TN 182
               + T+ L+ N  +G +PREIGNL  L ++ F                          N
Sbjct: 382  CGELLTLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVN 441

Query: 183  NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSIT 242
            NL G+ P  IFN+S L+ + L  N LSGSLPS I   LPN+E L +G N F G +P SI+
Sbjct: 442  NLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSIS 501

Query: 243  NASKLSDLELGVNLFSGFIPNTFVNM--------ADNYLTS--STPELSFLSSLTNCKKL 292
            N S L  L++  N F G +P    N+        + N LT+  S  EL+FL+SLTNC  L
Sbjct: 502  NMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFL 561

Query: 293  KVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT 352
            + L ++ NPL G++P S GNLS+SLEII   +C + G IP  + NL NL+ L L  N+LT
Sbjct: 562  RTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLT 621

Query: 353  EPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 412
              IP  F +LQ LQ L +++N++ G I   LCHL  L  L L  NK SG+IPSC GNLT 
Sbjct: 622  GLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTG 681

Query: 413  LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV-----------LIGLNFSRNNLS 461
            LR +YL  N   S +PS++ NL+ +L +++SSN LN            L+ L+ S+N  S
Sbjct: 682  LRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFS 741

Query: 462  GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY 521
            G+IP TI  L+NL Q++L +N+L+G IP +FGDL SLE LDLS N +SG IP SL+ L Y
Sbjct: 742  GNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKY 801

Query: 522  LKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL-------------------KMLLLV 562
            L++LN+SFNKL+GEIP GGPFAN TA+SF+ N  L                   K LLL 
Sbjct: 802  LEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDSRKNTKSLLLK 861

Query: 563  IILPLSTAL--IVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFS 620
             I+PLS +L  I++V L ++WK  +  KS T P    ++ P+  R   + ELL AT+ F 
Sbjct: 862  CIVPLSVSLSTIILVVLFVQWKRRQT-KSET-PIQVDLSLPRMHRMIPHQELLYATNYFG 919

Query: 621  ENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
            E+NLIG GS G +Y   L DG+ VAVKVF+ + + A KSFE ECEVM+ IRHRNL KIIS
Sbjct: 920  EDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIIS 979

Query: 681  SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            SCSN DFKAL+++YMPNGSLE  LYS    LD  QRL IMIDVA  LEYLH  +S P++H
Sbjct: 980  SCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVH 1039

Query: 741  CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            CDLKPSNVLLD+DMVAHISDFGIAKLL G + +  + +TL T+GYMAPEYG++G V T+G
Sbjct: 1040 CDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTVGYMAPEYGSEGIVSTKG 1098

Query: 801  DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK 860
            D+YSYGI+LME F +KKPTDE+F+ EL+L  W+      ++MEVID NLL  E+  FA K
Sbjct: 1099 DIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALK 1157

Query: 861  EQILLSVLNLATECTIE 877
                 S++ LA +CT+E
Sbjct: 1158 RACFSSIMTLALDCTVE 1174

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  705 bits (1819), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/943 (45%), Positives = 581/943 (61%), Gaps = 74/943 (7%)

Query: 5   HFLSMITRSLVHSLLLSLVIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVC 64
           ++L++    L +S   SLV     +NI+TDQ ALLALK  I  D  +L   NW+++TSVC
Sbjct: 8   YYLTLSMMMLFYSFFTSLV--DGVTNISTDQDALLALKVRIVGDPNSLLTTNWSTATSVC 65

Query: 65  SWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLS------------------------ 100
           +WIG+TC    +RV  LN+S   L GTIPP LGNLS                        
Sbjct: 66  TWIGVTCGARHNRVTALNLSHMGLAGTIPPHLGNLSFLVFGCLNMFAVLYIGVIPTSLFN 125

Query: 101 --SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN 158
              L    LS N L G IP +I N+++L+LL    N+   S+   IFN+SS+  ID S N
Sbjct: 126 LSKLSIFYLSSNNLQGYIPEAIGNLYSLRLLSLEKNEFSDSIPSSIFNISSLEQIDFSNN 185

Query: 159 GLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDL 218
             SG +P EIGNL  L  +    N L GV P  I+N S +  I L +N LSG LPS + L
Sbjct: 186 RFSGIIPDEIGNLANLELINLGVNRLAGVVPSGIYNASKMMVISLSSNQLSGHLPSSLGL 245

Query: 219 SLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD-------- 270
            LPN+  L LG N+F G +P S++NAS+L+ + L  N F G IP+   N+          
Sbjct: 246 LLPNLRRLFLGGNNFTGPIPISLSNASELTLIALPSNSFFGHIPDELGNLRSLQYLYLWG 305

Query: 271 NYLT--SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS 328
           N+LT  S +  LS  +SLT CK L++L L  NPL+G LP S GNLS SLE++    C I+
Sbjct: 306 NHLTIKSLSSGLSLFNSLTKCKDLRILYLHDNPLNGTLPISVGNLSSSLEVLSAYRCGIT 365

Query: 329 GNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR 388
           G IP  +GNL NL +L L  N+L   IP T  +L+ LQAL L  NKL G    ELC L  
Sbjct: 366 GTIPIEIGNLSNLTLLSLYENDLRGTIPATIGKLRKLQALLLDHNKLEGVFPPELCDLQS 425

Query: 389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN 448
           L  L L  N  SGSIPSCLGN+ SLR L + +N+F S +PST+W L++IL +++S NSL+
Sbjct: 426 LAILSLGVNTLSGSIPSCLGNVDSLRNLSMQMNKFNSTIPSTLWRLENILIVNLSFNSLS 485

Query: 449 ----VLIG-------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSS 497
               V IG       ++ S N LSG IP  +G LK+L  + L  NR EGSIP+SFGD  S
Sbjct: 486 GALAVDIGNLKVATIIDLSGNQLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQSFGDAIS 545

Query: 498 LEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLK 557
           L+ LDLS N +SG IP  L+ L YL + N+SFN+L+GEIP GG F NL+A+SFMGN+   
Sbjct: 546 LQFLDLSNNTLSGEIPKYLEILRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFMGNKGFC 605

Query: 558 MLLLVIILP---------------------LSTALIVVVTLTLKWKLIECWKSRTGPSND 596
                 + P                     ++T L ++    +    I   K R   + +
Sbjct: 606 GAAKFQVQPCKTRTDQGSKAGSKLALRYGLMATGLTILAVAAVVIIFIRSRK-RNRRTTE 664

Query: 597 GINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERA 656
           G+     + R SY EL +ATD+F+E NL+G GSFGS+Y     DG  VAVKVF+ Q E A
Sbjct: 665 GLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVFNLQAEGA 724

Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCS--NDDFKALIMKYMPNGSLENCLYSGTCMLDIF 714
            KSF+ E EV++ IRHRNLVKII+SCS  N +FKAL++++MPN SLE  LYS    L+  
Sbjct: 725 FKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSPNHFLEFL 784

Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 774
           QRLNIM+DVA A+EYLH G++TPI+HCDLKP+N+LLDE+M AH++DFGIAKLL G+++  
Sbjct: 785 QRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMAAHVTDFGIAKLL-GDERSF 843

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           I+  TLAT+GYMAPEYG++G V T GDVYS+GI+++E FT +KPTD++F  E+++ +W+ 
Sbjct: 844 IRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEMNMKQWVQ 903

Query: 835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIE 877
           + L   V ++ D NLLR E+   +AK+  ++S++ LA +C+ +
Sbjct: 904 ESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLALQCSAD 946

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/871 (47%), Positives = 538/871 (61%), Gaps = 74/871 (8%)

Query: 81   LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH---------------- 124
            L+I S  L G IP  + N+SSLQ + L++N LSG++PSS+ N                  
Sbjct: 199  LDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTG 258

Query: 125  ----------TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL 174
                       L+ LY S N+  G +   I +++ +T + L+ N LSGE+P EIG+L  L
Sbjct: 259  PIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTL 318

Query: 175  ARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFY 234
              L    N+L G  P  IFN+S++    L  N+LSG+LP      LPN+E L L IN   
Sbjct: 319  NVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLS 378

Query: 235  GTVPSSITNASKLSDLELGVNLFSGFIPNTF--------VNMADNYLT--SSTPELSFLS 284
            G +PSSI NASKL  L+ G N+ +G IP+          +N+  N L   S   ELSFL+
Sbjct: 379  GIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLT 438

Query: 285  SLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVL 344
            SLTNCK+L++L L+ NPL GILP S GNLS SL+    + C + GNIP  +GNL NL +L
Sbjct: 439  SLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLL 498

Query: 345  ELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 404
             L  N+LT  IP +  QLQ LQ L L  NKL G I +++C L  L  L L  N+ SGSIP
Sbjct: 499  SLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIP 558

Query: 405  SCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-----------SLNVLIGL 453
            +CLG LT LR LYLG N+  S +PST+W+L  IL +D+SSN           +L VL+ +
Sbjct: 559  ACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKI 618

Query: 454  NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP 513
            + SRN LSG+IP  IGGL++L  + L +NR EG I  SF +L SLE +DLS N + G IP
Sbjct: 619  DLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIP 678

Query: 514  ASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL----------------- 556
             SL+ L+YLK+L++SFN L GEIP  GPFAN +A+SFM N+ L                 
Sbjct: 679  KSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRW 738

Query: 557  ----KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTG-PSNDGINSPQAIRRFSYHE 611
                  LLL  ILP   + ++ + L   W    C K     P+          RR SY E
Sbjct: 739  STTISWLLLKYILPAILSTLLFLALIFVWT--RCRKRNAVLPTQSESLLTATWRRISYQE 796

Query: 612  LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
            + +AT+ FS  NL+G GS GS+Y   L DG   A+KVF+ Q E A KSF+ ECEVM  IR
Sbjct: 797  IFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIR 856

Query: 672  HRNLVKIISSCSND--DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
            HRNL+KI+SSCSN   DFKAL+++Y+PNGSLE  LYS    LDI QRLNIMIDVALA+EY
Sbjct: 857  HRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEY 916

Query: 730  LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            LH G STP++HCDLKPSN+LLDED   H+ DFGIAKLL  E+ +  + QTLATIGYMAP+
Sbjct: 917  LHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIR-ETQTLATIGYMAPK 975

Query: 790  YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL 849
            Y + G V T GDVYSYGI+LME FT+++PTDEIF  E+S+  W+ D L  S+ EV+D NL
Sbjct: 976  YVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANL 1035

Query: 850  LRGEERFFAAKEQILLSVLNLATECTIESRD 880
            LRGE+  F AK+Q +  +L LA +C  +S +
Sbjct: 1036 LRGEDEQFMAKKQCISLILGLAMDCVADSPE 1066

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  696 bits (1795), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/868 (45%), Positives = 541/868 (62%), Gaps = 72/868 (8%)

Query: 81   LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG- 138
            L+  S  + G IPP++ N+SSLQ  DL+ N L G++P  I+ ++  L+ LY S N+L G 
Sbjct: 570  LDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWNKLSGQ 629

Query: 139  ------------SLSFF-----------IFNVSSVTTIDLSINGLSGEMPREIGNLPYLA 175
                        SLS +             N++++  ++L  N + G +P E+GNL  L 
Sbjct: 630  LPSTLSLCGQLQSLSLWGNRFTGNIPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQ 689

Query: 176  RLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG 235
             L  + NNL G+ P  IFN+S L+ + L  N  SGSLPS +   LP++E L +G N F G
Sbjct: 690  NLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSG 749

Query: 236  TVPSSITNASKLSDLELGVNLFSGFIPN--------TFVNMADNYLTS--STPELSFLSS 285
             +P SI+N S+L++L++  N F+G +P          F+N+  N LT   S  E+ FL+S
Sbjct: 750  IIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTS 809

Query: 286  LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLE 345
            LTNC  L+ L +  NPL GILP S GNLS+SLE      C   G IP  +GNL +L+ LE
Sbjct: 810  LTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFRGTIPTGIGNLTSLISLE 869

Query: 346  LGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
            LG N+LT  IP T  QL+ LQ LG+  N+L G I ++LC L  L  L L  N+ +GSIPS
Sbjct: 870  LGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPS 929

Query: 406  CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-----------SLNVLIGLN 454
            CLG L  LR LYL  N   S +P ++W L+ +L +++SSN           ++  +  L+
Sbjct: 930  CLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLD 989

Query: 455  FSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA 514
             S+N +SG IP T+G L+NL+ + L  NRL+G IP  FGDL SL+ LDLS+N +SG IP 
Sbjct: 990  LSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPK 1049

Query: 515  SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL------------------ 556
            SL+ L YLK+LN+SFNKL+GEIP GGPF N TA+SF+ NE L                  
Sbjct: 1050 SLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSR 1109

Query: 557  ----KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHEL 612
                K+ +L  ILP   ++I +V   + W  I   K+   P+      P +  + S+ +L
Sbjct: 1110 SWRTKLFILKYILPPVISIITLVVFLVLW--IRRRKNLEVPTPIDSWLPGSHEKISHQQL 1167

Query: 613  LRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH 672
            L AT+ F E+NLIG GS   +Y   L +G+ VAVKVF+ +++ A +SF+ ECEVM+ IRH
Sbjct: 1168 LYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRH 1227

Query: 673  RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            RNLVKII+ CSN DFKAL+++YMP GSL+  LYS    LD+ QRLNIMIDVA ALEYLH 
Sbjct: 1228 RNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHH 1287

Query: 733  GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
               + ++HCDLKP+N+LLD+DMVAH+ DFGIA+LL+  + +  Q +TL TIGYMAPEYG+
Sbjct: 1288 DCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTETESMQ-QTKTLGTIGYMAPEYGS 1346

Query: 793  KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG 852
             G V T+GDV+SYGIMLME+F +KKP DE+F G+L+L  W+  L   S++EV+D NLLR 
Sbjct: 1347 DGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVESLAD-SMIEVVDANLLRR 1405

Query: 853  EERFFAAKEQILLSVLNLATECTIESRD 880
            E+  FA K   L S++ LA  CT +S +
Sbjct: 1406 EDEDFATKLSCLSSIMALALACTTDSPE 1433

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  687 bits (1774), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/880 (45%), Positives = 537/880 (61%), Gaps = 100/880 (11%)

Query: 88   LQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFN- 146
            L G IP ++GNLS+L  L L  N +SG IP+ IF + +L+ + F++N L GSL   I   
Sbjct: 159  LTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFTVSSLQRIIFANNSLSGSLPMDICKH 218

Query: 147  ------------------------VSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN 182
                                       + ++ L +N  +G +PREIGNL  L  +  + N
Sbjct: 219  LPNLQGLYLSQNHLSGQLPTTLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSEN 278

Query: 183  NLVGVAPVTI----------FNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINS 232
            +L+G  P +           FN+S L+ + L+ N LSGSLPS I   LP++E L +GIN 
Sbjct: 279  SLIGSIPTSFGNLMTLKFLSFNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINE 338

Query: 233  FYGTVPSSITNASKLSDLELGVNLFSGFIPN--------TFVNMADNYLTSS--TPELSF 282
            F GT+P SI+N SKL+ L L  N F+G +P          F+++A N LT       + F
Sbjct: 339  FSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGF 398

Query: 283  LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
            L+SLTNCK L+ L +  NPL G LP S GNL ++LEI +   C   G IP  +GNL NL+
Sbjct: 399  LTSLTNCKFLRNLWIGYNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLI 458

Query: 343  VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
             L+LG N+LT  IP T  QLQ LQAL +  N++ G I ++LCHL  L  L L  NK SGS
Sbjct: 459  WLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGS 518

Query: 403  IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-----------SLNVLI 451
            IPSC G+L +LR L L  N     +P + W+L+D+L +++SSN           ++  + 
Sbjct: 519  IPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSIT 578

Query: 452  GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA 511
             L+ S+N +SG IP  +G L+NL  + L  N+L+G IP  FGDL SLE LDLS+N +SG 
Sbjct: 579  TLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGT 638

Query: 512  IPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL--------------- 556
            IP +L+ L+YLK+LN+SFNKL+GEIP GGPF   TA+SFM NE L               
Sbjct: 639  IPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNN 698

Query: 557  --------KMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAI---- 604
                      +L  I+LP+ + + +VV + L       W  R     D +  P  I    
Sbjct: 699  RTQSWKTKSFILKYILLPVGSTVTLVVFIVL-------WIRR----RDNMEIPTPIDSWL 747

Query: 605  ----RRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSF 660
                 + S+ +LL AT+ F E+NLIG GS G +Y   L +G+ VA+KVF+ +++ AL+SF
Sbjct: 748  PGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSF 807

Query: 661  EDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM 720
              ECEVM+ IRHRNLV+II+ CSN DFKAL++KYMPNGSLE  LYS    LD+ QRLNIM
Sbjct: 808  NSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIM 867

Query: 721  IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            IDVA ALEYLH   S+ ++HCDLKPSNVLLD+DMVAH++DFGIAKLL+  + +  Q +TL
Sbjct: 868  IDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQ-QTKTL 926

Query: 781  ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS 840
            +TIGYMAPE+G+ G V T+ DVYSYGI+LME+F +KKP DE+F G+L+L  W+   L  S
Sbjct: 927  STIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNS 985

Query: 841  VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRD 880
            V++V+D NLLR E+   A K   L S++ LA  CT +S +
Sbjct: 986  VIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDSPE 1025

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	897
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.774	0.688	0.321	1.6e-77
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.688	0.602	0.296	7.9e-53
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.550	0.479	0.296	1.1e-102
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.863	0.756	0.338	1.1e-101
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.676	0.600	0.305	3.1e-101
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.571	0.531	0.318	5.3e-99
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.522	0.478	0.311	1.8e-96
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.562	0.404	0.295	3.9e-91
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.576	0.412	0.296	9.6e-91
TAIR|locus:2005507	976	ER "ERECTA" [Arabidopsis thali	0.577	0.530	0.302	1.7e-89

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
 Identities = 241/749 (32%), Positives = 350/749 (46%)

Query:    68 GITCDVNSHR-VIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTL 126
             G+  ++ S R ++ L +   +L+G  P  + NL+SL  L+L +N L G IP  I  +  +
Sbjct:   153 GVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQM 212

Query:   127 KLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNL-PYLARLAFATNNLV 185
               L  + N   G      +N+SS+  + L  NG SG +  + GNL P +  L+   N L 
Sbjct:   213 VSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLT 272

Query:   186 GVAPVTIFNMSALKEIYXXXXXXXXXXXXRIDLSLPNVETLNLGINSF----YGTVP--S 239
             G  P T+ N+S L E++                 L N+  L L  NS     +G +    
Sbjct:   273 GAIPTTLANISTL-EMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLD 331

Query:   240 SITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTP-ELSFLS---SLTNCKKLKVL 295
             ++TN S L  L +  N   G +P + VNM+      +    L + S    + N   L+ L
Sbjct:   332 ALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSL 391

Query:   296 ILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQXXXXXXXXXXXXXXXXXXTEPI 355
             +L  N L G LP S GNL    E+IL  N   SG IP                      +
Sbjct:   392 LLADNLLTGPLPTSLGNLVGLGELILFSN-RFSGEIPSFIGNLTQLVKLYLSNNSFEGIV 450

Query:   356 PITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRV 415
             P +      +  L +  NKL G I  E+  +  L  L ++ N  SGS+P+ +G L +L  
Sbjct:   451 PPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVE 510

Query:   416 LYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ 475
             L LG N  +  LP T   L   L ++V          +    N+  G IP  I GL  ++
Sbjct:   511 LLLGNNNLSGHLPQT---LGKCLSMEV----------IYLQENHFDGTIP-DIKGLMGVK 556

Query:   476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGE 535
              + L  N L GSI E F + S LE L+LS N   G +P                  L G 
Sbjct:   557 NVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGS 616

Query:   536 IP--RGGPFANLTAKSFMGNEXXXXXXXXXXXXXXXXXIVVVTLTLKWKLIECWKSRTGP 593
             I   +  P           +                  +++  ++L W     +K R   
Sbjct:   617 IKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSW-----FKKRKNN 671

Query:   594 SNDGINSPQAIRRF----SYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKV 648
                  ++P  +  F    SY +L  ATD FS +N++G GSFG+++ A LQ +   VAVKV
Sbjct:   672 QKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKV 731

Query:   649 FHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-----KALIMKYMPNGSLENC 703
              + Q   A+KSF  ECE +K IRHRNLVK++++C++ DF     +ALI ++MPNGSL+  
Sbjct:   732 LNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKW 791

Query:   704 LYSGTC--------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 755
             L+             L + +RLNI IDVA  L+YLH     PI HCDLKPSN+LLD+D+ 
Sbjct:   792 LHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLT 851

Query:   756 AHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             AH+SDFG+A+LL   DQ S   Q L++ G
Sbjct:   852 AHVSDFGLARLLLKFDQESFFNQ-LSSAG 879

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 7.9e-53, P = 7.9e-53
 Identities = 197/664 (29%), Positives = 301/664 (45%)

Query:    68 GITCDVNS-HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTL 126
             G+  +  S  +++ L++   NL G  P  LGNL+SLQ LD  +N++ G IP  I  +  +
Sbjct:   168 GVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQM 227

Query:   127 KLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNL-PYLARLAFATNNLV 185
                  + N+  G     I+N+SS+  + ++ N  SG +  + G+L P L  L    N+  
Sbjct:   228 IFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFT 287

Query:   186 GVAPVTIFNMSALKEIYXXXXXXXXXXXXRIDLSLPNVETLNL-GINSFYGTVPSSITNA 244
             G  P T+ N+S+L+++             +I LS   ++ L L G+N+      +S+ N 
Sbjct:   288 GTIPETLSNISSLRQL----DIPSNHLTGKIPLSFGRLQNLLLLGLNN------NSLGNY 337

Query:   245 SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG 304
             S   DL+  +   +      ++N+  N L    P   F+++L+   +L  L L GN + G
Sbjct:   338 SS-GDLDF-LGALTNCSQLQYLNVGFNKLGGQLPV--FIANLST--QLTELSLGGNLISG 391

Query:   305 ILPKSKGNLSLSLEIILMDNCSISGNIPQXXXXXXXXXXXXXXXXXXTEPIPITFSQLQT 364
              +P   GNL +SL+ + +    ++G +P                   +  IP +   +  
Sbjct:   392 SIPHGIGNL-VSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450

Query:   365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT 424
             L  L L  N   G I   L   + L  L L  NK +GSIP  L  L SL VL +  N   
Sbjct:   451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510

Query:   425 SALPSTIWNLKDILFIDVSSNSLNVLI--------GLNF---SRNNLSGDIPITIGGLKN 473
               L   I  LK +L +DVS N L+  I         L F     N+  G IP  I GL  
Sbjct:   511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTG 569

Query:   474 LQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLE 533
             L+ + L  N L G+IPE   + S L+ L+LS N   GA+P                  L 
Sbjct:   570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629

Query:   534 GEIP--RGGPFA-NLTAKSFMGNEXXXXXXXXXXXXXXXXXIVVVTLTLKWKLIECWKSR 590
             G IP  +  P +  L  +     +                 + VV L   W  +     R
Sbjct:   630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLC--WYKLRVKSVR 687

Query:   591 TGPS-NDGINSP--QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARL-QDGMEVAV 646
                + ND   SP      + SY EL + T  FS +NLIG G+FG+++   L      VA+
Sbjct:   688 ANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAI 747

Query:   647 KVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-----DDFKALIMKYMPNGSLE 701
             KV +     A KSF  ECE +  IRHRNLVK+++ CS+     +DF+AL+ ++MPNG+L+
Sbjct:   748 KVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLD 807

Query:   702 NCLY 705
               L+
Sbjct:   808 MWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 1.1e-102, Sum P(2) = 1.1e-102
 Identities = 154/520 (29%), Positives = 244/520 (46%)

Query:    33 TDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTI 92
             TD QALL  K+ +S ++      +W  S+  C+WIG+TC     RVI LN+  F L G I
Sbjct:    30 TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVI 89

Query:    93 PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTT 152
              P +GNLS L+ L+L+ N     IP  +  +  L+ L  S N L G +   + N S ++T
Sbjct:    90 SPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLST 149

Query:   153 IDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYXXXXXXXXXX 212
             +DLS N L   +P E+G+L  LA L  + NNL G  P ++ N+++L+++           
Sbjct:   150 VDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEI 209

Query:   213 XXRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNY 272
                +   L  +    + +NSF G  P ++ N S L  L L  N FSG +   F  +  N 
Sbjct:   210 PDEV-ARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268

Query:   273 --LTSSTPELS--FLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS----LSLEIILMDN 324
               L   T + +     +L N   L+   ++ N L G +P S G L     L +    + N
Sbjct:   269 RRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGN 328

Query:   325 CSISG-NIPQXXXXXXXXXXXXXXXXXXTEPIPITFSQLQT-LQALGLTRNKLAGPITDE 382
              S SG                          +P + + L T L +L L +N ++G I  +
Sbjct:   329 NSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHD 388

Query:   383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDV 442
             + +L  L  L L+ N  SG +P   G L +L+V+ L  N  +  +PS   N+  +  + +
Sbjct:   389 IGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHL 448

Query:   443 SSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD 502
             +SNS +             G IP ++G  + L  ++++ NRL G+IP+    + SL  +D
Sbjct:   449 NSNSFH-------------GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYID 495

Query:   503 LSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPR--GG 540
             LS N ++G  P              S+NKL G++P+  GG
Sbjct:   496 LSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGG 535

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
 Identities = 288/851 (33%), Positives = 421/851 (49%)

Query:    77 RVIGLNISSFNLQGTIPPQLG-NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ 135
             ++  L++S   L+G IP ++G +L  L  L L  N LSG IPS++ N+ +L+    S N+
Sbjct:   152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211

Query:   136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNM 195
             L G++   +  +SS+ T++L  N LSG +P  I NL  L   +   N L G+ P   F  
Sbjct:   212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271

Query:   196 SALKEIYXXXXXXXXXXXXRIDLSLPNVETLN-LGI--NSFYGTVPSSITNASKLSDLEL 252
               L E+             +I  S+ N   L  + I  N F G + S       L++L L
Sbjct:   272 LHLLEVIDMGTNRFHG---KIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYL 328

Query:   253 GVNLFS-------GFIPNTF-------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILT 298
               NLF        GFI +         +N+ +N L    P  SF S+L+    L  L L 
Sbjct:   329 WRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPN-SF-SNLST--SLSFLALE 384

Query:   299 GNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQXXXXXXXXXXXXXXXXXXTEPIPIT 358
              N + G +PK  GNL + L+ + + N +  G++P                   +  IP+ 
Sbjct:   385 LNKITGSIPKDIGNL-IGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLA 443

Query:   359 FSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY- 417
                L  L  L L  NK +G I   L +L  L SL L  N  SG IPS L N+ +L ++  
Sbjct:   444 IGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMIN 503

Query:   418 LGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQM 477
             +  N    ++P  I +LK+++     SN              LSG IP T+G  + L+ +
Sbjct:   504 VSKNNLEGSIPQEIGHLKNLVEFHAESN-------------RLSGKIPNTLGDCQLLRYL 550

Query:   478 FLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIP 537
             +L+ N L GSIP + G L  LE LDLS N +SG IP S            SFN   GE+P
Sbjct:   551 YLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVP 610

Query:   538 RGGPFANLTAKSFMGN--------EXXXXXXXXXXXXXXXXXIVVVTLTL--------KW 581
               G FA  +  S  GN        +                 ++ ++++L          
Sbjct:   611 TIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSL 670

Query:   582 KLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG 641
              L+  W  RT        S +     SY +L++ATD F+  NL+G GSFGS+Y  +L   
Sbjct:   671 YLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQ 730

Query:   642 MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-----DDFKALIMKYMP 696
               VAVKV   +  +ALKSF  ECE ++ +RHRNLVKI++ CS+     +DFKA++  +MP
Sbjct:   731 DHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMP 790

Query:   697 NGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL 750
             NGSLE+ ++  T        L++ +R+ I++DVA AL+YLH     P++HCD+K SNVLL
Sbjct:   791 NGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLL 850

Query:   751 DEDMVAHISDFGIAKLLSGEDQLSIQIQT-----LATIGYMAPEYGTKGRVCTRGDVYSY 805
             D DMVAH+ DFG+A++L     L IQ  T     + TIGY APEYG      T GD+YSY
Sbjct:   851 DSDMVAHVGDFGLARILVDGTSL-IQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSY 909

Query:   806 GIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILL 865
             GI+++E+ T K+PTD  F  +L L +++   L   V +V+DT L+   E +  +      
Sbjct:   910 GILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNN--- 966

Query:   866 SVLNLATECTI 876
             S     TEC +
Sbjct:   967 SPCRRITECIV 977

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 619 (223.0 bits), Expect = 3.1e-101, Sum P(2) = 3.1e-101
 Identities = 199/652 (30%), Positives = 303/652 (46%)

Query:    78 VIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLF 137
             ++ LN+   N++G +P  LGNL+ L+ L LSHN L G IPS +  +  +  L    N   
Sbjct:   164 LVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFS 223

Query:   138 GSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNL-PYLARLAFATNNLVGVAPVTIFNMS 196
             G     ++N+SS+  + +  N  SG +  ++G L P L       N   G  P T+ N+S
Sbjct:   224 GVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNIS 283

Query:   197 ALKEIYXXXXXXXXXXXXRIDLSLPNVETLNLGINSFYGTVPS-------SITNASKLSD 249
              L+ +                 ++PN++ L L  NS  G+  S       S+TN ++L  
Sbjct:   284 TLERL--GMNENNLTGSIPTFGNVPNLKLLFLHTNSL-GSDSSRDLEFLTSLTNCTQLET 340

Query:   250 LELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLT----NCKKLKVLILTGNPLDGI 305
             L +G N   G +P +  N++   +T          S+     N   L+ LIL  N L G 
Sbjct:   341 LGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGP 400

Query:   306 LPKSKGNLSLSLEIILMDNCSISGNIPQXXXXXXXXXXXXXXXXXXTEPIPITFSQLQTL 365
             LP S G L L+L  + + +  +SG IP                      +P +      L
Sbjct:   401 LPTSLGKL-LNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHL 459

Query:   366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS 425
               L +  NKL G I  E+  + +L  L + GN   GS+P  +G L +L  L LG N+ + 
Sbjct:   460 LELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSG 519

Query:   426 ALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS-GDIPITIGGLKNLQQMFLEYNRL 484
              LP T+ N        ++  SL       F   NL  GDIP  + GL  ++++ L  N L
Sbjct:   520 KLPQTLGNC-------LTMESL-------FLEGNLFYGDIP-DLKGLVGVKEVDLSNNDL 564

Query:   485 EGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGPFAN 544
              GSIPE F   S LE L+LS N + G +P                N L G I        
Sbjct:   565 SGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPC 624

Query:   545 LT-AKSFMGNEXXXXXXXXXXXXXXXXXIVVV---TLTLKWKLIECWKSRTGPSNDGINS 600
             L+ A S +                    ++++   ++TL W  +   K     +N   ++
Sbjct:   625 LSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW--LRKRKKNKETNNPTPST 682

Query:   601 PQAIR-RFSYHELLRATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALK 658
              + +  + SY +L  AT+ FS +N++G GSFG++Y A L  +   VAVKV + Q   A+K
Sbjct:   683 LEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK 742

Query:   659 SFEDECEVMKRIRHRNLVKIISSCSNDDF-----KALIMKYMPNGSLENCLY 705
             SF  ECE +K IRHRNLVK++++CS+ DF     +ALI ++MPNGSL+  L+
Sbjct:   743 SFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 624 (224.7 bits), Expect = 5.3e-99, Sum P(2) = 5.3e-99
 Identities = 173/544 (31%), Positives = 262/544 (48%)

Query:    31 ITTDQQALLALKAHISYDHTNLFARNWTS--STSVCSWIGITCDVNSHRVIGLNISSFNL 88
             +  + +AL+A+K   S +  N+   +W    ++ +CSW G+ CD  S+ V+ LN+SS NL
Sbjct:    26 MNNEGKALMAIKGSFS-NLVNMLL-DWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSLNL 83

Query:    89 QGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVS 148
              G I P +G+L +LQ++DL  NKL+G IP  I N  +L  L  S+N L+G + F I  + 
Sbjct:    84 GGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLK 143

Query:   149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYXXXXXX 208
              + T++L  N L+G +P  +  +P L RL  A N+L G     ++    L+  Y      
Sbjct:   144 QLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQ--YLGLRGN 201

Query:   209 XXXXXXRIDL-SLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNT--F 265
                     D+  L  +   ++  N+  GT+P SI N +    L++  N  +G IP    F
Sbjct:   202 MLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGF 261

Query:   266 VNMAD-----NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII 320
             + +A      N LT   PE+  L      + L VL L+ N L G +P   GNLS + ++ 
Sbjct:   262 LQVATLSLQGNRLTGRIPEVIGLM-----QALAVLDLSDNELVGPIPPILGNLSFTGKLY 316

Query:   321 LMDNCSISGNIPQXXXXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPIT 380
             L  N  ++G IP                      IP    +L+ L  L L  N+L GPI 
Sbjct:   317 LHGNM-LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIP 375

Query:   381 DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFI 440
               +   A L+   + GN  SGSIP    NL SL  L L  N F   +P  + ++ ++  +
Sbjct:   376 SNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKL 435

Query:   441 DVSSN----SLNVLIG-------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
             D+S N    S+ + +G       LN SRN+LSG +P   G L+++Q + + +N L G IP
Sbjct:   436 DLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIP 495

Query:   490 ESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGPFANLTAKS 549
                G L +L  L L+ NK+ G IP              SFN L G +P    F+     S
Sbjct:   496 TELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPAS 555

Query:   550 FMGN 553
             F+GN
Sbjct:   556 FVGN 559

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 1.8e-96, Sum P(2) = 1.8e-96
 Identities = 158/508 (31%), Positives = 244/508 (48%)

Query:    56 NWTSSTS--------VCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDL 107
             +W SS+S        VC+W G+ C+  S +VI L+IS  +L G I P + NL+ L  LDL
Sbjct:    38 SWISSSSSSSSMLVDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDL 97

Query:   108 SHNKLSGNIPSSIFNMH-TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPR 166
             S N   G IP  I ++H TLK L  S+N L G++   +  ++ +  +DL  N L+G +P 
Sbjct:    98 SRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPV 157

Query:   167 EI---GNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYXXXXXXXXXXXXRIDLSLPN 222
             ++   G+   L  +  + N+L G  P+    ++  L+ +              +  S  N
Sbjct:   158 QLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNST-N 216

Query:   223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSF 282
             ++ ++L  N   G +PS +   SK+  L+    L+  +  N FV+  +N  T+  P   F
Sbjct:   217 LKWMDLESNMLSGELPSQVI--SKMPQLQF---LYLSY--NHFVSHNNN--TNLEP---F 264

Query:   283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQXXXXXXXXX 342
              +SL N   L+ L L GN L G +  S  +LS++L  I +D   I G+IP          
Sbjct:   265 FASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLT 324

Query:   343 XXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
                      + PIP    +L  L+ + L+ N L G I  EL  + RL  L +  N  SGS
Sbjct:   325 LLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGS 384

Query:   403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL-------------NV 449
             IP   GNL+ LR L L  N  +  +P ++    ++  +D+S N+L             N+
Sbjct:   385 IPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNL 444

Query:   450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
              + LN S N+LSG IP+ +  +  +  + L  N L G IP   G   +LE L+LS+N  S
Sbjct:   445 KLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFS 504

Query:   510 GAIPASXXXXXXXXXXXXSFNKLEGEIP 537
               +P+S            SFN+L G IP
Sbjct:   505 STLPSSLGQLPYLKELDVSFNRLTGAIP 532

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 559 (201.8 bits), Expect = 3.9e-91, Sum P(2) = 3.9e-91
 Identities = 155/525 (29%), Positives = 250/525 (47%)

Query:    31 ITTDQQALLALKAH-ISYDHTNLFARNWTSST-SVCSWIGITCD-VNSHRVIGLNISSFN 87
             I  D Q LL +K   ++    +   R W S   + CSW G+TCD     RVI LN++   
Sbjct:    23 INNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLG 82

Query:    88 LQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNV 147
             L G+I P  G   +L  LDLS N L G IP+++ N+ +L+ L+   NQL G +   + ++
Sbjct:    83 LTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSL 142

Query:   148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYXXXXX 207
              ++ ++ +  N L G++P  +GNL  L  LA A+  L G  P  +  +  ++ +      
Sbjct:   143 VNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNY 202

Query:   208 XXXXXXXRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
                     +  +  ++       N   GT+P+ +     L  L L  N  +G IP+    
Sbjct:   203 LEGPIPAELG-NCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGE 261

Query:   268 MAD-NYLTSSTPELSFL--SSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDN 324
             M+   YL+    +L  L   SL +   L+ L L+ N L G +P+   N+S  L+++L +N
Sbjct:   262 MSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANN 321

Query:   325 CSISGNIPQXX-XXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDEL 383
               +SG++P+                   +  IP+  S+ Q+L+ L L+ N LAG I + L
Sbjct:   322 -HLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEAL 380

Query:   384 CHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK--DILFID 441
               L  L  L L  N   G++   + NLT+L+ L L  N     LP  I  L+  ++LF+ 
Sbjct:   381 FELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLY 440

Query:   442 VS--SNSLNVLIG-------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF 492
              +  S  +   IG       ++   N+  G+IP +IG LK L  + L  N L G +P S 
Sbjct:   441 ENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASL 500

Query:   493 GDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIP 537
             G+   L +LDL+ N++SG+IP+S              N L+G +P
Sbjct:   501 GNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLP 545

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 555 (200.4 bits), Expect = 9.6e-91, Sum P(2) = 9.6e-91
 Identities = 160/540 (29%), Positives = 258/540 (47%)

Query:    34 DQQALLALK-AHISYDHTNLFARNWTS-STSVCSWIGITCDVNSHRVIGLNISSFNLQGT 91
             D Q LL LK + I+        R+W S S S C+W G+TC      +IGLN+S   L G+
Sbjct:    29 DLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTC--GGREIIGLNLSGLGLTGS 86

Query:    92 IPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGSLSFFIFNVSSV 150
             I P +G  ++L  +DLS N+L G IP+++ N+ + L+ L+   N L G +   + ++ ++
Sbjct:    87 ISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNL 146

Query:   151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYXXXXXXXX 210
              ++ L  N L+G +P   GNL  L  LA A+  L G+ P     +  L+ +         
Sbjct:   147 KSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEG 206

Query:   211 XXXXRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD 270
                  I  +  ++       N   G++P+ +     L  L LG N FSG IP+   ++  
Sbjct:   207 PIPAEIG-NCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVS 265

Query:   271 -NYLTSSTPELSFL--SSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
               YL     +L  L    LT    L+ L L+ N L G++ +    ++  LE +++    +
Sbjct:   266 IQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMN-QLEFLVLAKNRL 324

Query:   328 SGNIPQXX-XXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
             SG++P+                   +  IP   S  Q+L+ L L+ N L G I D L  L
Sbjct:   325 SGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQL 384

Query:   387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK--DILFIDVS- 443
               L +L L  N   G++ S + NLT+L+   L  N     +P  I  L   +I+++  + 
Sbjct:   385 VELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENR 444

Query:   444 -SNSLNVLIG-------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL 495
              S  + V IG       +++  N LSG+IP +IG LK+L ++ L  N L G+IP S G+ 
Sbjct:   445 FSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC 504

Query:   496 SSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGG-PFANLTAKSFMGNE 554
               + V+DL+ N++SG+IP+S              N L+G +P       NLT  +F  N+
Sbjct:   505 HQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNK 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 1.7e-89, Sum P(2) = 1.7e-89
 Identities = 163/539 (30%), Positives = 256/539 (47%)

Query:    31 ITTDQQALLALKAHISYDHTNLFARNWTSSTS--VCSWIGITCDVNSHRVIGLNISSFNL 88
             +T+++ A L L+   S+   N    +WT+S S   C W G++C+  +  V+ LN+S  NL
Sbjct:    22 VTSEEGATL-LEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNL 80

Query:    89 QGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVS 148
              G I P +G+L SL ++DL  N+LSG IP  I +  +L+ L  S N+L G + F I  + 
Sbjct:    81 DGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSISKLK 140

Query:   149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYXXXXXX 208
              +  + L  N L G +P  +  +P L  L  A N L G  P  I+    L+  Y      
Sbjct:   141 QLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQ--YLGLRGN 198

Query:   209 XXXXXXRIDL-SLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNT--F 265
                     DL  L  +   ++  NS  G++P +I N +    L+L  N  +G IP    F
Sbjct:   199 NLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGF 258

Query:   266 VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNC 325
             + +A   L  +       S +   + L VL L+GN L G +P   GNL+ + ++ L  N 
Sbjct:   259 LQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSN- 317

Query:   326 SISGNIPQXXXXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
              ++G+IP                   T  IP    +L  L  L +  N L GPI D L  
Sbjct:   318 KLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSS 377

Query:   386 LARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
                L+SL + GNKFSG+IP     L S+  L L  N     +P  +  + ++  +D+S+N
Sbjct:   378 CTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNN 437

Query:   446 SLNVLI----G-------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGD 494
              +N +I    G       +N SRN+++G +P   G L+++ ++ L  N + G IPE    
Sbjct:   438 KINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQ 497

Query:   495 LSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGPFANLTAKSFMGN 553
             L ++ +L L  N ++G +  S            S N L G+IP+   F+  +  SF+GN
Sbjct:   498 LQNIILLRLENNNLTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGN 555

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048281 "inflorescence morphogenesis" evidence=IMP

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005739 "mitochondrion" evidence=IDA

GO:0050832 "defense response to fungus" evidence=IMP

GO:0010103 "stomatal complex morphogenesis" evidence=RCA;IMP

GO:0001558 "regulation of cell growth" evidence=IGI;IMP

GO:0009965 "leaf morphogenesis" evidence=RCA;IMP

GO:0010148 "transpiration" evidence=IMP

GO:0030155 "regulation of cell adhesion" evidence=IMP

GO:0051302 "regulation of cell division" evidence=IGI;IMP

GO:0009664 "plant-type cell wall organization" evidence=IMP

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0031540 "regulation of anthocyanin biosynthetic process" evidence=RCA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:2000027 "regulation of organ morphogenesis" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_XVI000210 hypothetical protein (1019 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	897
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-79
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-74
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-37
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-35
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	3e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  277 bits (711), Expect = 1e-79
 Identities = 225/787 (28%), Positives = 356/787 (45%), Gaps = 113/787 (14%)

Query: 88  LQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNV 147
           L G IP  L NL+SL+ L L+ N+L G IP  +  M +LK +Y   N L G + + I  +
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
           +S+  +DL  N L+G +P  +GNL  L  L    N L G  P +IF++  L  + L +NS
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN---- 263
           LSG +P  + + L N+E L+L  N+F G +P ++T+  +L  L+L  N FSG IP     
Sbjct: 296 LSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 264 ----TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI 319
               T ++++ N LT   PE      L +   L  LIL  N L+G +PKS G    SL  
Sbjct: 355 HNNLTVLDLSTNNLTGEIPE-----GLCSSGNLFKLILFSNSLEGEIPKSLGACR-SLRR 408

Query: 320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI 379
           + + + S SG +P                          F++L  +  L ++ N L G I
Sbjct: 409 VRLQDNSFSGELPS------------------------EFTKLPLVYFLDISNNNLQGRI 444

Query: 380 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF 439
                 +  L  L L  NKF G +P   G+   L  L L  N+F+ A+P  + +L +++ 
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELM- 502

Query: 440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE 499
                        L  S N LSG+IP  +   K L  + L +N+L G IP SF ++  L 
Sbjct: 503 ------------QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550

Query: 500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL--- 556
            LDLS+N++SG IP +L  +  L  +N+S N L G +P  G F  + A +  GN  L   
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610

Query: 557 -------------KMLLLVIILPLSTALIVVVTLT------------LKWKLIECWKSRT 591
                        K       +  +    +V+ L             L+ K +E      
Sbjct: 611 DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE------ 664

Query: 592 GPSNDGINSPQ-----AIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVA 645
             + DG    Q       +  + +++L +     E N+I  G  G+ Y  + +++GM+  
Sbjct: 665 --NEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFV 719

Query: 646 VKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY 705
           VK  +           D    M +++H N+VK+I  C ++    LI +Y+   +L   L 
Sbjct: 720 VKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775

Query: 706 SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
           +    L   +R  I I +A AL +LH   S  ++  +L P  +++D     H+       
Sbjct: 776 N----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------- 824

Query: 766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG 825
            LS    L    +   +  Y+APE      +  + D+Y +G++L+E+ T K P D  F  
Sbjct: 825 RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884

Query: 826 ELSLNRW 832
             S+  W
Sbjct: 885 HGSIVEW 891

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  263 bits (674), Expect = 1e-74
 Identities = 181/521 (34%), Positives = 272/521 (52%), Gaps = 35/521 (6%)

Query: 38  LLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLG 97
           LL+ K+ I+     L   NW SS  VC W GITC+ NS RV+ +++S  N+ G I   + 
Sbjct: 34  LLSFKSSINDPLKYLS--NWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIFNM-HTLKLLYFSDNQLFGSLSF-FIFNVSSVTTIDL 155
            L  +QT++LS+N+LSG IP  IF    +L+ L  S+N   GS+    I N+    T+DL
Sbjct: 91  RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLE---TLDL 147

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSR 215
           S N LSGE+P +IG+   L  L    N LVG  P ++ N+++L+ + L +N L G +P  
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE 207

Query: 216 IDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD----- 270
           +   + +++ + LG N+  G +P  I   + L+ L+L  N  +G IP++  N+ +     
Sbjct: 208 LG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266

Query: 271 ---NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
              N L+   P      S+ + +KL  L L+ N L G +P+    L  +LEI+ + + + 
Sbjct: 267 LYQNKLSGPIPP-----SIFSLQKLISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNF 320

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA 387
           +G IP  + +L  L VL+L  N  +  IP    +   L  L L+ N L G I + LC   
Sbjct: 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG 380

Query: 388 RLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL 447
            L  L+L  N   G IP  LG   SLR + L  N F+  LPS    L  + F+D+S+N+L
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440

Query: 448 NVLIG-----------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS 496
              I            L+ +RN   G +P + G  K L+ + L  N+  G++P   G LS
Sbjct: 441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499

Query: 497 SLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            L  L LS+NK+SG IP  L     L  L+LS N+L G+IP
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (410), Expect = 3e-45
 Identities = 66/192 (34%), Positives = 107/192 (55%), Gaps = 9/192 (4%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSC 682
           +G G FG++Y+AR  + G +VA+K+  ++     L+    E E++K++ H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
            +++   L+M+Y   GSL++ L      L   + L I++ +   LEYL   HS  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117

Query: 743 LKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR-G 800
           LKP N+LLD D     ++DFG++KLL+ +  L   I    T  YMAPE        +   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKS 175

Query: 801 DVYSYGIMLMEM 812
           D++S G++L E+
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 2e-43
 Identities = 73/205 (35%), Positives = 106/205 (51%), Gaps = 24/205 (11%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G GSFG++Y A+ +  G  VAVK+     +  +  ++   E  +++R+ H N+V++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
             + D   L+M+Y   G L + L  G   L   +   I + +   LEYLH   S  IIH 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE-------YGTK 793
           DLKP N+LLDE+ V  I+DFG+AK L           T   T  YMAPE       YG K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                  DV+S G++L E+ T K P
Sbjct: 180 ------VDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (375), Expect = 5e-40
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)

Query: 623 NLIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKIIS 680
             +G GSFG +Y+AR  + G  VA+KV   ++ ++  +    E +++K+++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              ++D   L+M+Y   G L + L      L   +    +  +  ALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YGTKG 794
            DLKP N+LLDED    ++DFG+A+ L   ++L+  + T     YMAPE      YG   
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKA- 176

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D++S G++L E+ T K P
Sbjct: 177 -----VDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  145 bits (369), Expect = 4e-39
 Identities = 62/199 (31%), Positives = 109/199 (54%), Gaps = 10/199 (5%)

Query: 622 NNLIGIGSFGSIYVARLQD-----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNL 675
              +G G+FG +Y  +L+       +EVAVK   +   E+ ++ F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           VK++  C+ ++   ++M+YM  G L + L      L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL---ES 120

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
              IH DL   N L+ E++V  ISDFG+++ L  +D    +      I +MAPE   +G+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-GGKLPIRWMAPESLKEGK 179

Query: 796 VCTRGDVYSYGIMLMEMFT 814
             ++ DV+S+G++L E+FT
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  142 bits (361), Expect = 5e-38
 Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 9/196 (4%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +Y   L         +VAVK   +   E   + F +E  +MK++ H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
           +  C+  +   ++ +YMP G L + L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL---ESKNF 123

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DL   N L+ E++V  ISDFG+++ +  +D    +      I +MAPE    G+  +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 799 RGDVYSYGIMLMEMFT 814
           + DV+S+G++L E+FT
Sbjct: 184 KSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (359), Expect = 7e-38
 Identities = 63/200 (31%), Positives = 111/200 (55%), Gaps = 11/200 (5%)

Query: 622 NNLIGIGSFGSIYVARLQDG-----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNL 675
              +G G+FG +Y   L+       +EVAVK   +   E+ ++ F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           VK++  C+ ++   ++M+YMP G L + L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---E 120

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S   IH DL   N L+ E++V  ISDFG+++ L  +D   ++      I +MAPE   +G
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-GGKLPIRWMAPESLKEG 179

Query: 795 RVCTRGDVYSYGIMLMEMFT 814
           +  ++ DV+S+G++L E+FT
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  140 bits (356), Expect = 2e-37
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 21/212 (9%)

Query: 618 RFSENNLIGIGSFGSIYVARLQD-GMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRN 674
            ++   L+G GSFGS+Y+A  +D G  +AVK        E  L++ E E  ++  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 675 LVKIISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQRLNI------MIDVALA 726
           +V+   S  +++   L   ++Y+  GSL +       +L  F +L           +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEG 113

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           L YLH   S  I+H D+K +N+L+D D V  ++DFG AK L   +          T  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           APE           D++S G  ++EM T K P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  150 bits (380), Expect = 5e-37
 Identities = 112/323 (34%), Positives = 160/323 (49%), Gaps = 29/323 (8%)

Query: 242 TNASKLSDLELGVNLFSGFI-PNTF-------VNMADNYLTSSTPELSFLSSLTNCKKLK 293
            N+S++  ++L     SG I    F       +N+++N L+   P+  F    T    L+
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF----TTSSSLR 121

Query: 294 VLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE 353
            L L+ N   G +P+  G++   LE + + N  +SG IP  +G+  +L VL+LGGN L  
Sbjct: 122 YLNLSNNNFTGSIPR--GSIPN-LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178

Query: 354 PIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSL 413
            IP + + L +L+ L L  N+L G I  EL  +  L  + L  N  SG IP  +G LTSL
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238

Query: 414 RVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKN 473
             L L  N  T  +PS++ NLK++ +             L   +N LSG IP +I  L+ 
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQY-------------LFLYQNKLSGPIPPSIFSLQK 285

Query: 474 LQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE 533
           L  + L  N L G IPE    L +LE+L L  N  +G IP +L  L  L+ L L  NK  
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345

Query: 534 GEIPRG-GPFANLTAKSFMGNEL 555
           GEIP+  G   NLT      N L
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNL 368

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  135 bits (342), Expect = 2e-35
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 623 NLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVK 677
             +G G+FG +Y  +L+       EVAVK   +      +  F  E  VMK++ H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 678 IISSCSNDDFKALIMKYMPNGSL-----ENCLYSGTCMLDIF---QRLNIMIDVALALEY 729
           ++  C+ ++   L+++YM  G L     ++     +           L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L    S   +H DL   N L+ ED+V  ISDFG+++ +  +D    +      I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G   ++ DV+S+G++L E+FT
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  136 bits (344), Expect = 9e-33
 Identities = 97/329 (29%), Positives = 168/329 (51%), Gaps = 24/329 (7%)

Query: 77  RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL 136
           ++I L++S  +L G IP  +  L +L+ L L  N  +G IP ++ ++  L++L    N+ 
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344

Query: 137 FGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMS 196
            G +   +   +++T +DLS N L+GE+P  + +   L +L   +N+L G  P ++    
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404

Query: 197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL 256
           +L+ + L +NS SG LPS     LP V  L++  N+  G + S   +   L  L L  N 
Sbjct: 405 SLRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463

Query: 257 FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS 316
           F G +P++F                        K+L+ L L+ N   G +P+  G+LS  
Sbjct: 464 FFGGLPDSF----------------------GSKRLENLDLSRNQFSGAVPRKLGSLSEL 501

Query: 317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLA 376
           +++ L +N  +SG IP  + +   L+ L+L  N L+  IP +FS++  L  L L++N+L+
Sbjct: 502 MQLKLSEN-KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560

Query: 377 GPITDELCHLARLHSLVLQGNKFSGSIPS 405
           G I   L ++  L  + +  N   GS+PS
Sbjct: 561 GEIPKNLGNVESLVQVNISHNHLHGSLPS 589

Length = 968

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 9e-31
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 11/192 (5%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
            IG G FG + +   + G +VAVK   +    A ++F  E  VM  +RH NLV+++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 684 NDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
             +   ++ +YM  GSL + L S G  ++ + Q+L   +DV   +EYL        +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRD 127

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED+VA +SDFG+AK    E         L  + + APE   + +  T+ DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLP-VKWTAPEALREKKFSTKSDV 182

Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (294), Expect = 4e-29
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 623 NLIGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKII 679
             IG GSFG +Y V R  DG    +K        E+  +   +E +++K++ H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALALEYLHFGHST 736
            S        ++M+Y   G L   +         F   Q L+  + + LAL+YLH   S 
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE------ 789
            I+H D+KP N+ L  + +  + DFGI+K+LS    L+   +T+  T  Y++PE      
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPYYLSPELCQNKP 179

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y  K       D++S G +L E+ T K P
Sbjct: 180 YNYK------SDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  116 bits (293), Expect = 4e-29
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 31/207 (14%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG G FG +Y AR  + G EVA+KV   + +   +   +E +++K+ +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHSTP 737
             D   ++M++   GSL++ L   T      Q L       +  ++   LEYLH      
Sbjct: 68  KKDELWIVMEFCSGGSLKD-LLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNG--- 118

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YG 791
           IIH D+K +N+LL  D    + DFG++  LS       +   + T  +MAPE      Y 
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            K       D++S GI  +E+   K P
Sbjct: 176 YK------ADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 12/197 (6%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNLVKIISSC 682
            IG G+FG +Y   L+   EVAVK         LK  F  E E++K+  H N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                  ++M+ +P GSL   L      L + + L + +D A  +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRD 118

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT----IGYMAPEYGTKGRVCT 798
           L   N L+ E+ V  ISDFG    +S E++  I   +       I + APE    GR  +
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 799 RGDVYSYGIMLMEMFTK 815
             DV+SYGI+L E F+ 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  113 bits (283), Expect = 6e-27
 Identities = 72/209 (34%), Positives = 105/209 (50%), Gaps = 19/209 (9%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYER---ALKSFEDECEVMKRIRH-RNLVKII 679
            +G GSFG +Y+AR  D   VA+KV  ++ E     ++ F  E +++  + H  N+VK+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 680 SSCSNDDFKALIMKYMPNGSLEN--CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
               ++    L+M+Y+  GSLE+          L   + L I+  +  ALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 738 IIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLA----TIGYMAPEY-- 790
           IIH D+KP N+LLD D  V  + DFG+AKLL      S      +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +     +  D++S GI L E+ T   P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)

Query: 623 NLIGIGSFGSIYVARL-----QDGMEVAVKVF-HQQYERALKSFEDECEVMKRIRHRNLV 676
             +G G FG + + R        G +VAVK   H   E+    FE E E+++ + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 677 KIISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           K    C     ++  LIM+Y+P+GSL + L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGYMAPEYGTK 793
           S   IH DL   N+L++ + +  ISDFG+AK+L   +D   ++    + I + APE    
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPT 819
            +  +  DV+S+G+ L E+FT   P+
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  108 bits (272), Expect = 3e-26
 Identities = 59/202 (29%), Positives = 107/202 (52%), Gaps = 6/202 (2%)

Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR 673
           R  + F+    +G G FG ++    ++ + VA+K+         + F+ E + +KR+RH+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHF 732
           +L+ + + CS  +   +I + M  GSL   L S    +L +   +++   VA  + YL  
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            +    IH DL   N+L+ ED+V  ++DFG+A+L+  ++ + +         + APE  +
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAAS 177

Query: 793 KGRVCTRGDVYSYGIMLMEMFT 814
            G   T+ DV+S+GI+L EMFT
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 1e-25
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVK--VFHQQYERALKSFEDECEVMKRIRHRN 674
            +   +LIG G+FG +Y    L+ G  VA+K     +  E ALKS   E +++K ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK I S    D   +I++Y  NGSL   +         F    + + V   L+ L + H
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              +IH D+K +N+L  +D V  ++DFG+A  L+   +    +    T  +MAPE     
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMAPEVIEMS 174

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
              T  D++S G  ++E+ T   P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 62/195 (31%), Positives = 106/195 (54%), Gaps = 12/195 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VAVK   +    + ++F  E ++MK++RH  LV++ + CS 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID----VALALEYLHFGHSTPIIH 740
           ++   ++ +YM  GSL + L SG        RL  ++D    +A  + YL    S   IH
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYL---ESRNYIH 126

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N+L+ E++V  I+DFG+A+L+  +D+ + +      I + APE    GR   + 
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185

Query: 801 DVYSYGIMLMEMFTK 815
           DV+S+GI+L E+ T 
Sbjct: 186 DVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKIIS 680
           +G GSFG + + R    G   A+KV  ++     K  E    E  ++ RI H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +   ++   L+++Y P G L + L       +   R     ++ LALEYLH   S  II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPEYGTKGRVCTR 799
            DLKP N+LLD D    ++DFG+AK LS E     +  T   T  Y+APE          
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D +S G++L EM T K P
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  107 bits (269), Expect = 2e-25
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 43/207 (20%)

Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+ G +Y A     G EVA+K     +Q +  +    +E  +MK  +H N+V    S
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYDS 83

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHS 735
               D   ++M+YM  GSL + +         F R+N      +  +V   LEYLH   S
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQ------NFVRMNEPQIAYVCREVLQGLEYLH---S 134

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI-G---YMAPE-- 789
             +IH D+K  N+LL +D    ++DFG A       QL+ +     ++ G   +MAPE  
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAA------QLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEM 812
               YG K  V    D++S GIM +EM
Sbjct: 189 KRKDYGPK--V----DIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 2e-25
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 14/210 (6%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRN 674
           R+   N IG G+FG +Y A  L  G  +AVK         + +K   DE +V++ ++H N
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFG 733
           LVK      + +   + M+Y   G+LE  L  G  +   + +   + +   LA  YLH  
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA--YLH-- 116

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLA-TIGYMAPEYG 791
            S  I+H D+KP+N+ LD + V  + DFG A  L      +  ++Q+LA T  YMAPE  
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 792 TKGRVCTRG---DVYSYGIMLMEMFTKKKP 818
           T G+    G   D++S G +++EM T K+P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 30/218 (13%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +++          D   VAVK   +     A K FE E E++   +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSG-------------TCMLDIFQRLNIMIDVA 724
               C+  D   ++ +YM +G L   L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 725 LALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
             + YL   HF      +H DL   N L+  D+V  I DFG+++ +   D   +   T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKP 818
            I +M PE     +  T  DV+S+G++L E+FT  K+P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 64/207 (30%), Positives = 114/207 (55%), Gaps = 16/207 (7%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG++       G +VAVK    + +   ++F +E  VM ++ H+NLV+++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 685 DDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++M+ M  G+L N L + G  ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
              N+L+ ED VA +SDFG+A++ S G D       +   + + APE     +  ++ DV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVD------NSKLPVKWTAPEALKHKKFSSKSDV 180

Query: 803 YSYGIMLMEMFT-KKKPTDEIFIGELS 828
           +SYG++L E+F+  + P  ++ + E+ 
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVK 207

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK    + +   ++F  E  VM ++RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 685 DDFKALIM-KYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     I+ +YM  GSL + L S G  +L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   + +  T+ DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 18/215 (8%)

Query: 619 FSENN---LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
           + EN    ++G G++G +Y AR L   + +A+K   ++  R ++   +E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V+ + S S + F  + M+ +P GSL   L S    L   ++  I+      LE L + H
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLH 125

Query: 735 STPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYGT 792
              I+H D+K  NVL++    V  ISDFG +K L+G   ++   +T   T+ YMAPE   
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---INPCTETFTGTLQYMAPEVID 182

Query: 793 KGRVCTRG-----DVYSYGIMLMEMFTKKKPTDEI 822
           KG    RG     D++S G  ++EM T K P  E+
Sbjct: 183 KG---PRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQ---YERALKSFEDECEVMKRIRHRN 674
           F    +IG G+FG + + + +D  ++ A+K  ++Q    + ++++  +E  +++ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           LV +  S  +++   L++  +  G L   L       +   +   + ++ LALEYLH   
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH--- 117

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  IIH D+KP N+LLDE    HI+DF IA  ++ +   +    T  T GYMAPE     
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT---STSGTPGYMAPEV---- 170

Query: 795 RVCTRG-----DVYSYGIMLMEMFTKKKP 818
            +C +G     D +S G+   E    K+P
Sbjct: 171 -LCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKI 678
           +IG GSF ++ +A+ +    E A+K+  ++    E+ +K  + E EV+ R+  H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
             +  +++    +++Y PNG L   +   G+  LD         ++ LALEYLH   S  
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH---SKG 122

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG------------- 784
           IIH DLKP N+LLD+DM   I+DFG AK+L   +      +  AT               
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 785 ------YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                 Y++PE   +       D+++ G ++ +M T K P
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.1 bits (244), Expect = 2e-22
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD M VAVK   +  E A + F+ E E++  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS--------------GTCMLDIFQRLNIMIDVA 724
              C+      ++ +YM +G L   L S                  L + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             + YL   H    +H DL   N L+ + +V  I DFG+++ +   D   +  +T+  I 
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
           +M PE     +  T  D++S+G++L E+FT  K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 62/192 (32%), Positives = 96/192 (50%), Gaps = 5/192 (2%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNLVKIISSC 682
           L+G G+FG ++   L+D   VAVK   +   + LK  F  E  ++K+  H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++M+ +P G   + L      L   Q +   +D A  + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E+ V  ISDFG+++        S  ++ +  I + APE    GR  +  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-IKWTAPEALNYGRYSSESDV 177

Query: 803 YSYGIMLMEMFT 814
           +SYGI+L E F+
Sbjct: 178 WSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 7e-22
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 27/226 (11%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARL--QDGME----VAVKVFHQQYERALKS-FEDE 663
           E+  +  RF E   +G G+FG +Y   L   +       VA+K   +  E  ++  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS---------------GT 708
            E+M  ++H N+V ++  C+ +    ++ +Y+ +G L   L                   
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 709 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
             LD    L+I I +A  +EYL   H    +H DL   N L+ E +   ISDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             D   +Q ++L  + +M PE    G+  T  D++S+G++L E+F+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 9/195 (4%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVKIISSC 682
           +G G FG +++ + +  ++VA+K+     E A+    F +E +VM ++ H NLV++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++ +YM NG L N L      L     L++  DV  A+EYL    S   IH D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRD 125

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ ED V  +SDFG+A+ +  +DQ +    T   + +  PE     R  ++ DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 803 YSYGIMLMEMFTKKK 817
           +S+G+++ E+F++ K
Sbjct: 185 WSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.4 bits (238), Expect = 9e-22
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 47/216 (21%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFH----QQYERALKSFEDECEVMKRIRHRNLVKII 679
           +G GS G +Y  R +  G   A+K  H    +++ + L     E + ++      +VK  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCESPYVVK-- 63

Query: 680 SSCSNDDFK----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
             C    +K    +++++YM  GSL + L     + +      I   +   L+YLH    
Sbjct: 64  --CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHTKRH 120

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-------TIGYMAP 788
             IIH D+KPSN+L++      I+DFGI+K+L           TL        T+ YM+P
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLE---------NTLDQCNTFVGTVTYMSP 169

Query: 789 E------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E      Y          D++S G+ L+E    K P
Sbjct: 170 ERIQGESYSYA------ADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           F     +G GS+GS+Y A   + G  VA+KV     E  L+    E  ++K+     +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN----------IMIDVALAL 727
              S   +    ++M+Y   GS+           DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           EYLH       IH D+K  N+LL+E+  A ++DFG++  L+       +  T+  IG   
Sbjct: 113 EYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---KRNTV--IGTPF 164

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
           +MAPE   +     + D++S GI  +EM   K P  +I
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 21/201 (10%)

Query: 625 IGIGSFGSIY--VARLQDG--MEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKII 679
           +G G+FGS+   V  ++ G  +EVAVK   Q++  A K  F  E  VM ++ H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 680 SSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYL---HFGH 734
             C  +    L+M+  P G L   L       + D+     +   VA+ + YL   HF  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTK 793
               +H DL   NVLL     A ISDFG+++ L +G D           + + APE    
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 794 GRVCTRGDVYSYGIMLMEMFT 814
           G+  ++ DV+SYG+ L E F+
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 6/191 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG ++     +   VAVK   +      K F  E ++MK++RH  L+++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           ++   ++ + M  GSL   L  G    L + Q +++   VA  + YL    +   IH DL
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDL 129

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
              NVL+ E+ +  ++DFG+A+++  ED    +      I + APE     R   + DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 804 SYGIMLMEMFT 814
           S+GI+L E+ T
Sbjct: 189 SFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 5/193 (2%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E +VM ++ H  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +          L + +DV   + YL    S+ +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLA 127

Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  +  ++ DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 187 FGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L       L + Q +++   +A  + Y+        +H DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187

Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 188 SFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 7/194 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VAVK   +    + +SF +E ++MK++RH  LV++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L  G    L +   +++   VA  + Y+        IH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ + +V  I+DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187

Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 188 SFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 16/209 (7%)

Query: 619 FSENNLI-----GIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVMK 668
           F E +L      G G+FGS+ + R   LQD  G  VAVK         L+ FE E E++K
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 669 RIRHRNLVKIISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            ++H N+VK    C +   +   L+M+Y+P GSL + L      LD  + L     +   
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGY 785
           +EYL    S   +H DL   N+L++ +    I DFG+ K+L   ++   ++    + I +
Sbjct: 121 MEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            APE  T+ +     DV+S+G++L E+FT
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 5/199 (2%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM ++ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                ++ +YM NG L N L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127

Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+D+     +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 187 FGVLMWEVYSLGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 52/194 (26%), Positives = 99/194 (51%), Gaps = 7/194 (3%)

Query: 623 NLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           + +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 682 CSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           C+ +    +I ++M  G+L + L       ++    L +   ++ A+EYL   +    IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 187 DVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.9 bits (236), Expect = 8e-20
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 10/213 (4%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD 133
           +S  +  L + S +L+G IP  LG   SL+ + L  N  SG +PS    +  +  L  S+
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437

Query: 134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF 193
           N L G ++   +++ S+  + L+ N   G +P   G+   L  L  + N   G  P  + 
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELG 253
           ++S L ++ L  N LSG +P  +  S   + +L+L  N   G +P+S +    LS L+L 
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELS-SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555

Query: 254 VNLFSGFIPNTF--------VNMADNYLTSSTP 278
            N  SG IP           VN++ N+L  S P
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 90.7 bits (225), Expect = 8e-20
 Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG G+ G++Y A  +  G EVA+K  + Q +   +   +E  VM+  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+     + D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 804 SYGIMLMEMFTKKKP 818
           S GIM +EM   + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 90.3 bits (225), Expect = 9e-20
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 49/210 (23%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKIIS 680
           +G GSFG + + R +   +  A+K+  +     LK  E   +E  +++ IRH  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM----IDVA--------LALE 728
           S  +D    L+M+Y+P G             ++F  L         VA        LALE
Sbjct: 69  SFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMA 787
           YLH   S  I++ DLKP N+LLD D    I+DFG AK + G      +  TL  T  Y+A
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLA 166

Query: 788 PEYGTKGRVCTRG-----DVYSYGIMLMEM 812
           PE      + ++G     D ++ GI++ EM
Sbjct: 167 PEI-----ILSKGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD + VAVK      + A K F  E E++  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS----GTCM--------LDIFQRLNIMIDVALA 726
              C   D   ++ +YM +G L   L +       M        L   Q L+I   +A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           + YL   H    +H DL   N L+ E+++  I DFG+++ +   D   +   T+  I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
            PE     +  T  DV+S G++L E+FT  K
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 20/208 (9%)

Query: 625 IGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE-----DECEVMKRIRHRNLVKI 678
           IG GSFG++  V R  DG  +  K     Y   +   E      E  +++ ++H N+V+ 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEID--YGN-MTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 679 ISSCSNDDFKAL--IMKYMPNGSLENCL---YSGTCMLDIFQRLNIMIDVALALEYLHFG 733
                +   + L  +M+Y   G L   +         ++      I+  + LAL   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 734 H--STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT-LATIGYMAPEY 790
                 ++H DLKP+N+ LD +    + DFG+AK+L  +   +   +T + T  YM+PE 
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYVGTPYYMSPEQ 181

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   + D++S G ++ E+     P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKIISSC 682
           IG G+FG ++  RL+ D   VAVK   +     LK+ F  E  ++K+  H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++M+ +  G     L +    L + + + ++ + A  +EYL   H    IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI--GYMAPEYGTKGRVCTRG 800
           L   N L+ E  V  ISDFG+++    ED +      +  I   + APE    GR  +  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 801 DVYSYGIMLMEMFT 814
           DV+S+GI+L E F+
Sbjct: 178 DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 35/214 (16%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFH-----QQYERALKSFEDECEVMKRIRHRNLVK 677
           L+G G+FG +Y+    D G E+AVK         + ++ + + E E +++K ++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-LNIMIDVALALEYLHFGHST 736
                 +D+  ++ M+YMP GS+++ L +   + +   R     I     LE + + HS 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-----LEGVEYLHSN 123

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT------LATIGYMAPE- 789
            I+H D+K +N+L D      + DFG +K L      +I            T  +M+PE 
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-----TICSSGTGMKSVTGTPYWMSPEV 178

Query: 790 -----YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                YG K       DV+S G  ++EM T+K P
Sbjct: 179 ISGEGYGRK------ADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 67/254 (26%), Positives = 126/254 (49%), Gaps = 24/254 (9%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
           ++G G+FG +++  R  D   V +K     Q  +    + ++EC+V+K + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
           +   D    ++M+Y P G+L   +      +LD    L+  + + LAL ++   H+  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLIL 123

Query: 740 HCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           H DLK  N+LLD+  MV  I DFGI+K+LS + +    +    T  Y++PE         
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCEGKPYNQ 180

Query: 799 RGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFA 858
           + D+++ G +L E+ + K+  +       + N      LP  V++++        +R+  
Sbjct: 181 KSDIWALGCVLYELASLKRAFE-------AAN------LPALVLKIMSGTFAPISDRYSP 227

Query: 859 AKEQILLSVLNLAT 872
              Q++LS+LNL  
Sbjct: 228 DLRQLILSMLNLDP 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)

Query: 625 IGIGSFGSIYVAR------LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        +D M VAVK        A K F+ E E++  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS---------------GTCMLDIFQRLNIMIDV 723
              C + D   ++ +YM +G L   L +                   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           A  + YL   H    +H DL   N L+  +++  I DFG+++ +   D   +   T+  I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
            +M PE     +  T  DV+S+G++L E+FT  K
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VA+K   +      ++F  E ++MK++RH  LV + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ ++M  GSL + L  G    L + Q +++   +A  + Y+        IH DL
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ +++V  I+DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187

Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 188 SFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 623 NLIGIGSFGSIYVARLQD-------GMEVAVKVFHQ-QYERALKSFEDECEVMKRIRHRN 674
           N +G G+FG +Y     D        + VAVK   +   ++  K F  E  +M    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS------GTCMLDIFQRLNIMIDVALALE 728
           +VK++  C  ++ + +IM+ M  G L + L        G  +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           YL   H    IH DL   N L+ E     D V  I DFG+A+ +   D    + + L  +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +MAPE    G+  T+ DV+S+G+++ E+ T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERAL-KSFEDECEVMKRIRHRNLVKIISSC 682
           +G G+ G +     +  G  +AVK    +   A+ K    E +++ +     +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 683 SNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            N+   ++ M+YM  GSL+  L    G     I  +  I + V   L YLH  H   IIH
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+KPSN+L++      + DFG+    SG+   S+    + T  YMAPE         + 
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGV----SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 801 DVYSYGIMLMEMFTKKKP 818
           D++S G+ L+E+ T + P
Sbjct: 181 DIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 19/206 (9%)

Query: 625 IGIGSFGSIY---VARLQDG---MEVAVK-VFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y      +  G     VA+K V      R    F +E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS------GTCMLDIFQRLNIM---IDVALALE 728
           ++   S      ++M+ M  G L++ L S          L        +    ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL    +   +H DL   N ++ ED+   I DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFT 814
           E    G   T+ DV+S+G++L EM T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 90.6 bits (225), Expect = 1e-18
 Identities = 46/122 (37%), Positives = 61/122 (50%), Gaps = 2/122 (1%)

Query: 416 LYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ 475
           L  G N          W+  D  F          + GL      L G IP  I  L++LQ
Sbjct: 388 LRFGWNGDPCVPQQHPWSGADCQFDSTKGKW--FIDGLGLDNQGLRGFIPNDISKLRHLQ 445

Query: 476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE 535
            + L  N + G+IP S G ++SLEVLDLS N  +G+IP SL +L  L+ LNL+ N L G 
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505

Query: 536 IP 537
           +P
Sbjct: 506 VP 507

Length = 623

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 38/219 (17%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVFH---------QQYERALKSFEDECEVMKRIRHR 673
           LIG GSFGS+Y+      G  +AVK             +    L +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------NIMIDVALAL 727
           N+V+ + S  + D   + ++Y+P GS+         +L+ +         N +  +   L
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV-------AALLNNYGAFEETLVRNFVRQILKGL 119

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--------SGEDQLSIQIQT 779
            YLH   +  IIH D+K +N+L+D      ISDFGI+K L        +   + S+Q   
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--- 173

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             ++ +MAPE   +     + D++S G +++EM T K P
Sbjct: 174 -GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 63/223 (28%), Positives = 113/223 (50%), Gaps = 35/223 (15%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVF---------HQQYERAL-KSFEDECEVMKRIRH 672
           LIG G++G +Y+A  +  G  +AVK           H   ++ + K+   E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V+ +   + +++ ++ ++Y+P GS+ +CL         F+   +       LE L +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAY 123

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK----LLSGEDQLSIQIQTLATIGYMAP 788
            HS  I+H DLK  N+L+D D +  ISDFGI+K    +   +  +S+Q     ++ +MAP
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ----GSVFWMAP 179

Query: 789 E------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP--TDEIF 823
           E       G   +V    D++S G +++EMF  ++P   +E  
Sbjct: 180 EVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG+G+   +Y A  L +  +VA+K    ++ + ++     E + M +  H N+VK  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 683 SNDDFKALIMKYMPNGSLENCLYSG--TCMLDIFQRLNIMIDVALALEYLH-FGHSTPII 739
              D   L+M Y+  GSL + + S      LD      ++ +V   LEYLH  G     I
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ----I 124

Query: 740 HCDLKPSNVLLDEDMVAHISDFGI-AKLLSGEDQLSIQIQTLA-TIGYMAPE-------Y 790
           H D+K  N+LL ED    I+DFG+ A L  G D+     +T   T  +MAPE       Y
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             K       D++S+GI  +E+ T   P
Sbjct: 185 DFK------ADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVF-----HQQYERALKSFEDECEVMKRIR 671
           R+ +  L+G GSFGS+Y    L DG   AVK        Q  + A+K  E E  ++ +++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+ + +   +D   + ++ +P GSL   L                  + L LEYLH
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAP 788
                  +H D+K +N+L+D + V  ++DFG+AK      Q+       +  G   +MAP
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP 170

Query: 789 EY-GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E    +G      D++S G  ++EM T K P
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 11/205 (5%)

Query: 625 IGIGSFGSIYVAR-LQDG----MEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG++Y    + +G    + VA+KV  ++    A K   DE  VM  + H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
           +  C +     LI + MP G L + + +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DL   NVL+       I+DFG+AKLL  +++          I +MA E         
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 799 RGDVYSYGIMLMEMFT-KKKPTDEI 822
           + DV+SYG+ + E+ T   KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 54/196 (27%), Positives = 106/196 (54%), Gaps = 10/196 (5%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++    +  +VAVK   +    ++++F +E  +MK ++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 685 DDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           ++   +I +YM  GSL + L S   G  +L   + ++    +A  + Y+        IH 
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +NVL+ E ++  I+DFG+A+++  +++ + +      I + APE    G    + D
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 802 VYSYGIMLMEMFTKKK 817
           V+S+GI+L E+ T  K
Sbjct: 187 VWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 11/207 (5%)

Query: 619 FSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE--DECEVMKRIRHRNL 675
           F   N IG GSFG ++ V R  D    A+K          +  E  DE  V+ ++    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           ++   S  +     ++M+Y  NG L   L    G  + +  Q     I + L L +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED-QVWRFFIQILLGLAHLH-- 118

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
            S  I+H D+K  N+ LD      I D G+AKLLS     +  I  + T  Y++PE    
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPELCED 175

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTD 820
                + DV++ G++L E  T K P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ------YERALKSFEDECEVMKRIRHRNLV 676
            +G G+F S Y AR ++ G  +AVK            E  +++   E  +M R+ H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLHFG 733
           +++ +   D    L +++M  GS+ + L         F+    +N    +   L YL   
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL--- 119

Query: 734 HSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLL----SGEDQLSIQIQTLATIGYMAP 788
           H   IIH D+K +N+L+D       I+DFG A  L    +G  +   Q Q L TI +MAP
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQLLGTIAFMAP 177

Query: 789 EY---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E       GR C   DV+S G +++EM T K P
Sbjct: 178 EVLRGEQYGRSC---DVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR       +    VAVK+  ++    +++ F+ E  +M    H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------------------GTCMLDIFQR 716
           ++  C+      L+ +YM  G L   L                           L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           L I   VA  + YL        +H DL   N L+ E+MV  I+DFG+++ +   D     
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                 I +M PE     R  T  DV++YG++L E+F+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 33/229 (14%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGME----VAVKVFHQQYERALK--SFEDE 663
           EL  +  RF E   +G  +FG IY   L   GM+    VA+K   +      +   F+ E
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQE 57

Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY--------------SGTC 709
             +M  + H N+V ++   + +    ++ +Y+  G L   L                GT 
Sbjct: 58  ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117

Query: 710 M--LDIFQRLNIMIDVALALEYL--HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
              LD    L+I I +A  +EYL  HF      +H DL   N+L+ E +   ISD G+++
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSR 172

Query: 766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +   D   +Q ++L  I +M PE    G+  +  D++S+G++L E+F+
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 11/198 (5%)

Query: 624 LIGIGSFGSI----YVARLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKI 678
            +G GSFG +    +       + VAVK     +    +  F  E  +M  + H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
                      ++ +  P GSL + L         I    +  + +A  + YL       
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            IH DL   N+LL  D    I DFG+ + L   ED   ++        + APE       
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 797 CTRGDVYSYGIMLMEMFT 814
               DV+ +G+ L EMFT
Sbjct: 178 SHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.5 bits (203), Expect = 5e-17
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 135

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 43/217 (19%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           + +     IG G++G +Y AR +  G  VA+KV   +     +  + E  ++K  RH N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN----------IMIDVAL 725
           V    S    D   ++M+Y   GSL+          DI+Q             +  +   
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLK 112

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--- 782
            L YLH    T  IH D+K +N+LL ED    ++DFG++  L+          T+A    
Sbjct: 113 GLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---------ATIAKRKS 160

Query: 783 -IG---YMAPEYG---TKGRVCTRGDVYSYGIMLMEM 812
            IG   +MAPE      KG    + D+++ GI  +E+
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 39/212 (18%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +Y AR  + G  VA+K    + E+      A++    E ++++++RH N+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 678 II----SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +     S      +  ++ +YM +  L   L S        Q    M  +   L+YLH  
Sbjct: 63  LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPE-- 789
            S  I+H D+K SN+L++ D V  ++DFG+A+  +     +    T  + T+ Y  PE  
Sbjct: 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR---NSADYTNRVITLWYRPPELL 173

Query: 790 -----YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
                YG +  V    D++S G +L E+F  K
Sbjct: 174 LGATRYGPE--V----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 1e-16
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 27/215 (12%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE------RALKSFEDECEVMKRI 670
           R+     IG G++G +  A   + G +VA+K     ++      R L+    E ++++ +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHL 56

Query: 671 RHRNLVK---IISSCSNDDFKAL--IMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVA 724
           RH N++    I+   S +DF  +  + + M    L   + S      D  Q    +  + 
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLYQIL 113

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LAT 782
             L+YLH  +   +IH DLKPSN+L++ +    I DFG+A+ +   D+      T  + T
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDEDEKGFLTEYVVT 169

Query: 783 IGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
             Y APE        T+  D++S G +  E+ T+K
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 8/202 (3%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G+++ A  +  G EVA+K  + Q +   +   +E  VMK +++ N+V
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   + 
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCM-DEAQIAAVCRECLQALEFLH---AN 134

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  NVLL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 192

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 625 IGIGSFGSIYVARLQ-----DGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG + +          G  VAVK   ++  +   S ++ E  ++K + H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              CS    K   LIM+Y+P GSL + L      L++ Q L     +   + YLH  H  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH-- 127

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH DL   NVLLD D +  I DFG+AK +  G +   ++    + + + A E   + +
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 796 VCTRGDVYSYGIMLMEMFTKKKP 818
                DV+S+G+ L E+ T    
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA+K  + Q +   +   +E  VM+  ++ N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   AL++LH   S 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALDFLH---SN 134

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 192

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 31/215 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           + F+    IG GSFG +Y A   +    VA+KV        L+  EDE E +++      
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDIQQ-----E 49

Query: 676 VKIISSCSN-----------DDFK-ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           ++ +S C +              K  +IM+Y   GS  + L  G   LD      I+ +V
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREV 107

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
            L LEYLH       IH D+K +N+LL E+    ++DFG++  L+    +S +   + T 
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTP 162

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            +MAPE   +     + D++S GI  +E+   + P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 38/242 (15%)

Query: 615 ATDRFSENNLIGIGSFGSIYVARLQDGME---------VAVKVFHQQ-YERALKSFEDEC 664
             DR      +G G FG + +A    G++         VAVK+      E+ L     E 
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 665 EVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL-----------YSGTC--- 709
           E+MK I +H+N++ ++ +C+ D    +I++Y   G+L   L           Y+ T    
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 710 -MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
             L     ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT------KKKPTDE 821
             D           + +MAPE     R+ T + DV+S+G++L E+FT         P +E
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250

Query: 822 IF 823
           +F
Sbjct: 251 LF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQ-YERALKSFEDE 663
           EL R  DR +    +G G+FG +  A             VAVK+      E+ L     E
Sbjct: 8   ELPR--DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65

Query: 664 CEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDI 713
            E+MK I +H+N++ ++  C+ +    ++++Y  +G+L + L          S       
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 714 FQRL------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
            + L      +    VA  +E+L    S   IH DL   NVL+ ED V  I+DFG+A+ +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
              D           + +MAPE     RV T + DV+S+G++L E+FT
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 31/203 (15%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED--------ECEVMKRIRHRNL 675
           IG G+ G ++ A+  + G  VA+K         L+  E         E + ++  +H  +
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVA------LRRLEGGIPNQALREIKALQACQHPYV 61

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ--RLNIMIDVALALEYLHFG 733
           VK++    +     L+M+YMP   L   L      L   Q      M+     L+ + + 
Sbjct: 62  VKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGVAYM 115

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED--QLSIQIQTLATIGYMAPE-- 789
           H+  I+H DLKP+N+L+  D V  I+DFG+A+L S E+    S Q+   AT  Y APE  
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWYRAPELL 172

Query: 790 YGTKGRVCTRGDVYSYGIMLMEM 812
           YG + +     D+++ G +  E+
Sbjct: 173 YGAR-KYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 68/247 (27%), Positives = 111/247 (44%), Gaps = 38/247 (15%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGME---------------VAVKVFHQQYER 655
           E  R   R  E   +G G FG +++   +   E               VAVK+      +
Sbjct: 1   EFPRQQLRLKEK--LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK 58

Query: 656 -ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL-----YSGTC 709
            A   F  E ++M R+++ N+++++  C +DD   +I +YM NG L   L      S   
Sbjct: 59  TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118

Query: 710 M------LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
                  + I   L + + +A  ++YL    S   +H DL   N L+       I+DFG+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGM 175

Query: 764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKP--- 818
           ++ L   D   IQ + +  I +MA E    G+  T  DV+++G+ L EMFT  K++P   
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235

Query: 819 -TDEIFI 824
            +DE  I
Sbjct: 236 LSDEQVI 242

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 52/191 (27%), Positives = 105/191 (54%), Gaps = 7/191 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VA+K   +Q   + ++F  E  +MK+++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    +I +YM NGSL + L +   + L I + +++   +A  + ++   +    IH DL
Sbjct: 73  EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E +   I+DFG+A+L+  +++ + +      I + APE    G    + DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 804 SYGIMLMEMFT 814
           S+GI+L E+ T
Sbjct: 188 SFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+  + G+  A K+   + E  L+ F  E +++   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
            ++   +++++   G+L++ +      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC------ 797
           K  N+LL  D    ++DFG++       Q       + T  +MAPE       C      
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEV----VACETFKDN 183

Query: 798 ---TRGDVYSYGIMLMEMFTKKKPTDEI 822
               + D++S GI L+E+   + P  E+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQ--QYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           +G G FG +++ + +  ++VA+K  ++    E   + F +E +VM ++ H  LV++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++ ++M NG L N L      L     L++  DV   +EYL        IH D
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRD 125

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+    V  +SDFG+ + +  +D+ +        + +  PE     +  ++ DV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 803 YSYGIMLMEMFTKKK 817
           +S+G+++ E+FT+ K
Sbjct: 185 WSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 7e-16
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHR 673
            F++   IG GSFG++Y AR ++    VA+K      +++ + ++D   E   ++++RH 
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 674 NLVKIISSCSNDDFKA-LIMKYMPNGSLENCLYSGTCMLDI----FQRLNIMIDVALALE 728
           N ++    C   +  A L+M+Y        CL S + +L++     Q + I      AL+
Sbjct: 76  NTIEY-KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS   IH D+K  N+LL E     ++DFG A L+S  +        + T  +MAP
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF------VGTPYWMAP 180

Query: 789 EY---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E      +G+   + DV+S GI  +E+  +K P
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 618 RFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFH----QQYERALKSFEDECEVMKRIRH 672
            F     +G GS+GS+Y V RL D    A+K        Q ER      +E  ++  + H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAVNEIRILASVNH 58

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEY 729
            N++    +  + +   ++M+Y P G L   +        +        I I +   L+ 
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH      I+H DLK +N+LL  + +  I D GI+K+L   +    QI    T  YMAPE
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK-NMAKTQI---GTPHYMAPE 171

Query: 790 YGTKGRVCT-RGDVYSYGIMLMEMFTKKKP 818
              KGR  + + D++S G +L EM T   P
Sbjct: 172 V-WKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 23/213 (10%)

Query: 619 FSENNL-----IGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKSFEDE 663
           F  NNL     +G G+FG +  A      +    M+VAVK+     H     AL S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 664 CEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMI 721
            ++M  +  H N+V ++ +C+      +I +Y   G L N L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            VA  + +L    S   IH DL   NVLL    +  I DFG+A+ +  +    ++     
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + +MAPE           DV+SYGI+L E+F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVF---HQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
           I  G++G +++A+    G   A+KV        +  +     E +++ + +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           S        L+M+Y+P G L + L +   + +   R   + ++ LALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLH---SNGIIH 116

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI------QTLATIGYMAPE----- 789
            DLKP N+L+D +    ++DFG++K+     Q+++        + + T  Y+APE     
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFT 814
            +          D +S G +L E   
Sbjct: 177 GHSKT------VDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 48/249 (19%)

Query: 589 SRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVK 647
           S +  S+   +        S  EL R        N IG G+ G++Y    +  G   A+K
Sbjct: 53  SSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALK 105

Query: 648 VFHQQYERALK-SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
           V +  +E  ++     E E+++ + H N+VK      ++    +++++M  GSLE     
Sbjct: 106 VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----- 160

Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
           GT + D     ++   +   + YLH  H   I+H D+KPSN+L++      I+DFG++++
Sbjct: 161 GTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 767 LSGEDQLSIQIQTL-------ATIGYMAPEYGTKGRVCT----------RGDVYSYGIML 809
           L+         QT+        TI YM+PE     R+ T           GD++S G+ +
Sbjct: 218 LA---------QTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSI 263

Query: 810 MEMFTKKKP 818
           +E +  + P
Sbjct: 264 LEFYLGRFP 272

Length = 353

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 27/208 (12%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECE-------VMKRIRH--- 672
           LIG G++G++Y  + +  G  VA+K+ +      L + +D+         ++ ++R    
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIIN------LDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+ K   S        +IM+Y   GS+   + +G  + + +  + I+ +V +AL+Y+H 
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISV-IIREVLVALKYIH- 118

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY-MAPEYG 791
                +IH D+K +N+L+       + DFG+A LL+   Q S +  T     Y MAPE  
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVI 173

Query: 792 TKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           T+G+   T+ D++S GI + EM T   P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 623 NLIGIGSFGSIYVARLQ-DG--MEVAVKVFHQ-QYERALKSFEDECEVMKRI-RHRNLVK 677
           ++IG G+FG +  A ++ DG  M  A+K+  +   E   + F  E EV+ ++  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCMLDIFQRLNIMID 722
           ++ +C N  +  + ++Y P G+L + L               +     L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  ++YL        IH DL   NVL+ E++ + I+DFG+++   GE+    +      
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MA E        T+ DV+S+G++L E+ +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 74/245 (30%), Positives = 115/245 (46%), Gaps = 38/245 (15%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQ-YERALKSFE 661
           EL R   R +    +G G FG + +A        +    + VAVK+      ++ L    
Sbjct: 8   ELSRT--RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 662 DECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YS-GTCM 710
            E E+MK I +H+N++ ++ +C+ D    ++++Y   G+L   L         YS  TC 
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 711 LD----IFQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
           L      F+ L +    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFTKKK------P 818
            +   D           + +MAPE     RV T + DV+S+G++L E+FT         P
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241

Query: 819 TDEIF 823
            +E+F
Sbjct: 242 VEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 27/226 (11%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKS-FEDE 663
           E+  +T RF E   +G   FG +Y   L      +    VA+K    + E  L+  F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR------- 716
             +  R++H N+V ++   + +   ++I  Y  +  L   L   +   D+          
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 717 --------LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
                   ++I+  +A  +E+L   H   ++H DL   NVL+ + +   ISD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             D   +   +L  I +M+PE    G+     D++SYG++L E+F+
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 624 LIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +IG G FG +   RL+      + VA+K     Y E+  + F  E  +M +  H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
               +      ++ +YM NGSL+  L        + Q + ++  +A  ++YL        
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA---TIGYMAPEYGTKGR 795
           +H DL   N+L++ ++V  +SDFG++++L  ED       T      I + APE     +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 796 VCTRGDVYSYGIMLMEMFT 814
             +  DV+SYGI++ E+ +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 50/211 (23%), Positives = 106/211 (50%), Gaps = 16/211 (7%)

Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVK--VFHQQ----YERALKSFEDECEVMKRIRH 672
           +++  ++G G++G++Y      G  +AVK            E+  +  ++E +++K ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLH 731
            N+V+ + +C +D+  ++ M+++P GS+ + L   G     +F +    I     L+ + 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-----LDGVA 116

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG----YMA 787
           + H+  ++H D+K +NV+L  + +  + DFG A+ L+           L ++     +MA
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE   +     + D++S G  + EM T K P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 68/239 (28%), Positives = 114/239 (47%), Gaps = 36/239 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQ-YERALKSFEDECEVM 667
           D+ +    +G G FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL-----------YSGTCMLD--- 712
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L           Y    + D   
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 713 IFQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    VA  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 135 TFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT------KKKPTDEIF 823
                      + +MAPE     RV T + DV+S+G+++ E+FT         P +E+F
Sbjct: 192 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G GS+G + + R   DG +  +K  + +    R  K+ E E +++ +++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 682 CSNDD-FKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
              +D    ++M +   G L + L    G  + +  Q +   + +A+AL+YLH  H   I
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEKH---I 123

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DLK  NV L    +  + D GIA++L  E+Q  +    + T  YM+PE  +      
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 799 RGDVYSYGIMLMEMFTKK 816
           + DV++ G  + EM T K
Sbjct: 182 KSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 624 LIGIGSFGSIYVARL--QDG--MEVAVKVF----HQQYERALKSFEDECEVMKRIRHRNL 675
           ++G G FGS+   +L   DG  ++VAVK      H   E  ++ F  E   MK   H N+
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNV 63

Query: 676 VKIISSC----SNDDFKA--LIMKYMPNGSLEN-CLYSGTCMLDIF---QRL-NIMIDVA 724
           +K+I  C    S        +I+ +M +G L +  LYS    L      Q L   M+D+A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
           L +EYL    +   IH DL   N +L EDM   ++DFG++K +   D           + 
Sbjct: 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
           ++A E        ++ DV+++G+ + E+ T+
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++ G   A KV   + E  L+ +  E E++    H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDI---FQRLNIMIDVALALEYLHFGHSTPIIH 740
            D    +++++ P G+++        ML++        I +     LE L + HS  IIH
Sbjct: 80  WDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 741 CDLKPSNVLLDEDMVAHISDFGIA----KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            DLK  NVLL  D    ++DFG++    K L   D        + T  +MAPE      +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF------IGTPYWMAPEV----VM 183

Query: 797 CT---------RGDVYSYGIMLMEMFTKKKPTDEI 822
           C          + D++S GI L+EM   + P  E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 50/203 (24%), Positives = 98/203 (48%), Gaps = 13/203 (6%)

Query: 620 SENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRN 674
           ++  +IG G FG ++   L+      + VA+K     Y E+  + F  E  +M +  H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           ++++    +      +I +YM NG+L+  L         +Q + ++  +A  ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA---TIGYMAPEYG 791
               +H DL   N+L++ ++   +SDFG++++L  ED       T      I + APE  
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 792 TKGRVCTRGDVYSYGIMLMEMFT 814
              +  +  DV+S+GI++ E+ +
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 35/235 (14%)

Query: 618 RFSENNLIGIGSFGSIYVA---RLQDGME--------------VAVKVFHQQY-ERALKS 659
            F E   +G G FG +++     LQD  E              VAVKV      + A + 
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 660 FEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY------SGTCM--- 710
           F  E +++ R+   N+ +++  C+ D    +IM+YM NG L   L       SG      
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 711 -LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 769
            L     L +   +A  + YL    S   +H DL   N L+ ++    I+DFG+++ L  
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKPTDEI 822
            D   +Q +    I +MA E    G+  T+ DV+++G+ L E+ T  +++P + +
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 3e-15
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 26/212 (12%)

Query: 623 NLIGIGSFGSIYVARL-QDG--MEVAVKVFHQQYERA-LKSFEDECEVMKRI-RHRNLVK 677
           ++IG G+FG +  AR+ +DG  M+ A+K   +   +   + F  E EV+ ++  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCMLDIFQRLNIMID 722
           ++ +C +  +  L ++Y P+G+L + L                S    L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  ++YL        IH DL   N+L+ E+ VA I+DFG+++   G++    +      
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MA E        T  DV+SYG++L E+ +
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 625 IGIGSFGSIY--VARLQDG-MEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNLVKIIS 680
           +G G+FG +   V +++   ++VA+KV   + E++++     E E+M ++ +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            C  +    L+M+    G L   L      + +   + +M  V++ ++YL        +H
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG-----YMAPEYGTKGR 795
            DL   NVLL     A ISDFG++K L  +D          + G     + APE     +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECINFRK 174

Query: 796 VCTRGDVYSYGIMLMEMFT-KKKP 818
             +R DV+SYGI + E F+  +KP
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG GS G + +A     G +VAVK     +Q  R L    +E  +M+  +H N+V++ SS
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSS 84

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
               D   ++M+++  G+L + +      ++  Q   + + V  AL +LH   +  +IH 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           D+K  ++LL  D    +SDFG    +S   ++  +   + T  +MAPE  ++    T  D
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVS--KEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 802 VYSYGIMLMEMFTKKKP 818
           ++S GIM++EM   + P
Sbjct: 198 IWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 7/191 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++A      +VAVK   +    ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHCDL 743
           +    +I ++M  GSL + L S        Q L  +ID +  + E + F      IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+   +V  I+DFG+A+++   +  + +      I + APE    G    + DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 187

Query: 804 SYGIMLMEMFT 814
           S+GI+LME+ T
Sbjct: 188 SFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 624 LIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVK 677
           L+G G FG+++    + +G    + VA+K    +  R   +   D    M  + H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++  C     + L+ +  P GSL + +      LD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC 797
           ++H +L   N+LL  D +  I+DFG+A LL  +D+     +    I +MA E    GR  
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 798 TRGDVYSYGIMLMEMFT 814
            + DV+SYG+ + EM +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIY--VARLQDG----MEVAVKVFHQQYERALKS-FEDE 663
            LLRA         +G G+FG +Y  + R +DG    ++VAVK   +      +S F  E
Sbjct: 9   TLLRA---------LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME 59

Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIF 714
             +M +  H+N+V++I        + ++++ M  G L++ L          S   M D+ 
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL- 118

Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGED 771
             L    DVA   +YL   H    IH D+   N LL       VA I+DFG+A+ +    
Sbjct: 119 --LFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                 + +  I +M PE    G   ++ DV+S+G++L E+F+
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 65/243 (26%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF-----HQQYERALKSFEDECEVMKRI 670
           D F    +IG G+FG +++ R    G   A+KV       ++ + A      E +++   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADA 58

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ----RLNIMIDVALA 726
               +VK+  S  +++   L+M+YMP G L N L       D+F     R  I  ++ LA
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFYIA-ELVLA 113

Query: 727 LEYLH-FGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIA-KLLSGEDQLSIQIQ---- 778
           L+ +H  G     IH D+KP N+L+D D   HI  +DFG+  K+   +D+          
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 779 ----------------------TLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLM 810
                                 T+ T  Y+APE      YG +   C   D +S G++L 
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE---C---DWWSLGVILY 221

Query: 811 EMF 813
           EM 
Sbjct: 222 EML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 6e-15
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG + + R        G +VAVK    +     +   + E E+++ + H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C+ D      LIM+++P+GSL+  L      +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSR 128

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVL++ +    I DFG+ K + + ++  +++    + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 189 FYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 39/220 (17%)

Query: 624 LIGIGSFGSIYVARLQDG-------MEVAVK--VFHQQYERALKSFED---ECEVMK-RI 670
            +G G+FG +Y  R ++         E+ V    F +      KS  D   E  ++K ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------NIMIDVA 724
           RH N+V+   +   +D   ++M  +    L     S   + +  QR       NI + + 
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEERIWNIFVQMV 123

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
           LAL YLH      I+H DL P+N++L ED    I+DFG+AK    E +L+     + TI 
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT---SVVGTIL 178

Query: 785 YMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y  PE      YG K       DV+++G +L +M T + P
Sbjct: 179 YSCPEIVKNEPYGEK------ADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 624 LIGIGSFGSIYVARL-QDGME---VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +IG G FG +   RL   G     VA+K     Y E+  + F  E  +M +  H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
               +      +I ++M NG+L++ L        + Q + ++  +A  ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-----TIGYMAPEYGTK 793
           +H DL   N+L++ ++V  +SDFG+++ L  ED  S    T +      I + APE    
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 794 GRVCTRGDVYSYGIMLMEMFT 814
            +  +  DV+SYGI++ E+ +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 25/213 (11%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFH-----QQYERALKSFEDECEVMKRIRHRNLVK 677
           L+G G+FG +Y+    D G E+AVK         +  + + + E E +++K + H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 678 IISSCSNDDFK---ALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
               C  D  +   ++ M++MP GS+++ L S G    ++ ++    I     LE + + 
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK-----LLSGEDQLSIQIQTLATIGYMAP 788
           HS  I+H D+K +N+L D      + DFG +K      LSG    S+      T  +M+P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSP 178

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
           E  +      + D++S G  ++EM T+K P  E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 622 NNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
             +IG G FG +   RL+      ++VA+K       ++    F  E  +M +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++    +      +I +YM NGSL+  L        + Q + ++  +A  ++YL      
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EM 125

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG------YMAPEY 790
             +H DL   N+L++ ++V  +SDFG+++ L   +       T  T G      + APE 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE------ATYTTKGGKIPIRWTAPEA 179

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFT 814
               +  +  DV+S+GI++ E+ +
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D       +G G+FG +++ R +      A+KV        LK  +   +E  V+K + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCL-----YSGTCMLDIFQRLNIMIDVALAL 727
             ++++  +  +  F  ++M+Y+P G L + L     +S +  L  F    I+     AL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL--FYASEIVC----AL 114

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYM 786
           EYLH   S  I++ DLKP N+LLD++    ++DFG AK      +L  +  TL  T  Y+
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYL 165

Query: 787 APE-YGTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           APE   +KG    +  D ++ GI++ EM     P
Sbjct: 166 APEVIQSKGH--NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 8/195 (4%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +AR +  G +VAVK+   + ++  +   +E  +M+  +H+N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             +   ++M+++  G+L + +      L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S +  +  +   + T  +MAPE  ++    T  D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201

Query: 804 SYGIMLMEMFTKKKP 818
           S GIM++EM   + P
Sbjct: 202 SLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKIIS 680
           +G G FG +   +++  G   A K   ++  +  K  +   +E ++++++  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
           +    D   L+M  M  G L+  +Y+ G       + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           + DLKP NVLLD+     ISD G+A  L G  ++        T GYMAPE          
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEVYDFS 174

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D ++ G  L EM   + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 21/156 (13%)

Query: 439 FIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL 498
           FI    + L  L  +N S N++ G+IP ++G + +L+ + L YN   GSIPES G L+SL
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492

Query: 499 EVLDLSKNKISGAIPASL-QKLLYLKHLNLSFNKLEGEIP---RGGPFANLTAKSFMGNE 554
            +L+L+ N +SG +PA+L  +LL+    N + N     IP     GP  ++ AK      
Sbjct: 493 RILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAK------ 546

Query: 555 LLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSR 590
                 + I   +S A + +V   + W     WK R
Sbjct: 547 ------IGIAFGVSVAFLFLVICAMCW-----WKRR 571

Length = 623

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 74.4 bits (184), Expect = 2e-14
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 38/210 (18%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           +G G++G +Y AR  + G  VA+K      E       AL+    E  ++K ++H N+VK
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNIVK 62

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++     +    L+ +Y     L+  L      L      +IM  +   L Y H   S  
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHR 118

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL----ATIGYMAPE---- 789
           I+H DLKP N+L++ D V  ++DFG+A+         I ++T      T+ Y APE    
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLWYRAPEILLG 172

Query: 790 ---YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              Y T   V    D++S G +  EM T K
Sbjct: 173 SKHYSTA--V----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIIS 680
           ++G G++G +   R +  G  VA+K F +    E   K+   E +V++++RH N+V +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 681 SCSNDDFKALIMKYMPNGSLE------NCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +        L+ +Y+    LE        L        I+Q L        A+ Y H   
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ-------AIAYCH--- 117

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE----- 789
           S  IIH D+KP N+L+ E  V  + DFG A+ L      S     +AT  Y APE     
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGD 176

Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFT 814
             YG K       DV++ G ++ E+  
Sbjct: 177 TNYG-KPV-----DVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 15/208 (7%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVF-----HQQYERALKSFEDECEVMKRIRHRNLVK 677
           L+G G+FG +Y+    D G E+AVK        Q+  + + + E E +++K +RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 678 IISSCSNDDFKAL--IMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 734
                 + + K L   ++YMP GS+++ L + G    ++ +R    I     L+ + + H
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVSYLH 123

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY-MAPEYGTK 793
           S  I+H D+K +N+L D      + DFG +K +         I+++    Y M+PE  + 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
                + DV+S    ++EM T+K P  E
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 25/211 (11%)

Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRN 674
           F++   IG GSFG++Y AR ++    VA+K      +++ + ++D   E + ++RI+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYL 730
            ++       +    L+M+Y        CL S + +L++ ++    +++A     AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
            + HS  +IH D+K  N+LL E     ++DFG A + S  +        + T  +MAPE 
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF------VGTPYWMAPEV 192

Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +G+   + DV+S GI  +E+  +K P
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFH-----QQYERALKSFEDECEVMKRIRHRNLVK 677
           L+G G+FG +Y+    D G E+A K         +  + + + E E +++K ++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 678 IISSCSNDDFKAL--IMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 734
                 +   K L   M+YMP GS+++ L + G     + ++    I     LE + + H
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI-----LEGMSYLH 123

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY-MAPEYGTK 793
           S  I+H D+K +N+L D      + DFG +K L         I+++    Y M+PE  + 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
                + DV+S G  ++EM T+K P  E
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 18/200 (9%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE------RALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +Y AR    G  VA+K    ++E       AL+    E +++K + H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++    +     L+ ++M +  L   +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC 797
           I+H DLKP N+L++ + V  ++DFG+A+      +       + T  Y APE     +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKGY 176

Query: 798 TRG-DVYSYGIMLMEMFTKK 816
           +   D++S G +  E+ +++
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 623 NLIGIGSFGSIYVARL--QDGMEV--AVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
            +IG G FG +Y   L   DG ++  AVK  ++  +   ++ F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 678 IISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++  C   +   L+ + YM +G L N + S T    +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTKG 794
             +H DL   N +LDE     ++DFG+A+ +  ++  S+   T A   + +MA E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
           +  T+ DV+S+G++L E+ T+  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 26/212 (12%)

Query: 623 NLIGIGSFGSIYVARLQ-DG--MEVAVKVFHQ-QYERALKSFEDECEVMKRI-RHRNLVK 677
           ++IG G+FG +  AR++ DG  M+ A+K   +   +   + F  E EV+ ++  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCMLDIFQRLNIMID 722
           ++ +C +  +  L ++Y P+G+L + L                S    L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  ++YL        IH DL   N+L+ E+ VA I+DFG+++   G++    +      
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MA E        T  DV+SYG++L E+ +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 39/243 (16%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME------------------VAVKVFHQQYER-AL 657
            R +    +G G FG +++   + GME                  VAVK+  +   + A 
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63

Query: 658 KSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL---------ENCLYSGT 708
             F  E ++M R++  N++++++ C   D   +I +YM NG L         +       
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 709 CMLDIFQRLNIM-IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
            +   +  L  M   +A  ++YL    S   +H DL   N L+ ++    I+DFG+++ L
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKP----TDE 821
              D   IQ + +  I +M+ E    G+  T  DV+++G+ L E+ T  K++P    +DE
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Query: 822 IFI 824
             I
Sbjct: 241 QVI 243

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 5e-14
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 612 LLRATDRFSENNLIGIGSFGSIYVAR-LQDG----MEVAVKVFHQQYE-RALKSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G    + VA+K   +    +A K   DE  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR--------- 716
           VM  + + ++ +++  C     + LI + MP G          C+LD  +          
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGSQY 110

Query: 717 -LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
            LN  + +A  + YL       ++H DL   NVL+       I+DFG+AKLL  +++   
Sbjct: 111 LLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELS 828
                  I +MA E         + DV+SYG+ + E+ T   KP D I   E+S
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 34/213 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKV--------FHQQYERALKSFEDECEVM 667
           ++  E + +G G+ GS+   RL   GM  A+K           +Q  R       E E+ 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53

Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLY------SGTCMLDIFQRLNI 719
           K  +   +VK   +  ++      + M+Y   GSL++ +Y       G     +  +  I
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGK--I 110

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
              V   L YLH   S  IIH D+KPSN+LL       + DFG+    SGE   S+    
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTF 163

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEM 812
             T  YMAPE           DV+S G+ L+E+
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 11/200 (5%)

Query: 625 IGIGSFGSI-YVARLQDGMEVAVKVFHQQYERAL-KSFEDECEVMKRIRHRNLVKIISSC 682
           +G G+ GS+  V  +  G  +A KV H   + ++ K    E ++M   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 683 SNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
            N++   + M++M  GSL+      G   ++I  +  I + V   L YL+  H   I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           D+KPSN+L++      + DFG+    SGE   SI    + T  YM+PE    G+   + D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 802 VYSYGIMLMEMFTKKKPTDE 821
           V+S GI ++E+   K P   
Sbjct: 185 VWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.2 bits (179), Expect = 7e-14
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 25/211 (11%)

Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRN 674
           FS+   IG GSFG++Y AR +++   VA+K      +++ + ++D   E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYL 730
            ++       +    L+M+Y        CL S + +L++ ++    +++A     AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
            + HS  +IH D+K  N+LL E  +  + DFG A +++  +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEV 182

Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +G+   + DV+S GI  +E+  +K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 15/232 (6%)

Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A     G +VAVK    + ++  +   +E  +M+   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   ++M+++  G+L + +      ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++    T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 804 SYGIMLMEMFTKKKPTDEIFIGELSLN--RWINDLLPVSVMEVID-TNLLRG 852
           S GIM++EM   + P    +  E  L   R I D LP  V +    +++LRG
Sbjct: 203 SLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 19/211 (9%)

Query: 619 FSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ +     
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYG 791
           S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE  
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVI 173

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            +    ++ D++S GI  +E+   + P  E+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)

Query: 619 FSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ +     
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           + K   S        +IM+Y+  GS  + L +G    D FQ   ++ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH--- 118

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYG 791
           S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE  
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVI 173

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            +    ++ D++S GI  +E+   + P  ++
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 29/222 (13%)

Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYER------ALKSFEDECEV 666
           R  D+F     IG G++G +Y AR +D G  VA+K      E+      A++    E ++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKI 59

Query: 667 MKRIRHRNLVKIISSCSND----DFKA------LIMKYMPNGSLENCLYSGTCMLDIFQR 716
           ++++ HRN+V +    ++     DFK       L+ +YM +  L   L SG  ++  F  
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESG--LVH-FSE 115

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
            +I   +   LE L++ H    +H D+K SN+LL+      ++DFG+A+L + E+     
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPY 174

Query: 777 IQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              + T+ Y  PE   G + R     DV+S G +L E+FTKK
Sbjct: 175 TNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 44/218 (20%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALK-SFEDECEVMKRIR---HRNLVKI 678
           IG+G++G++Y AR    G  VA+K V  Q  E  L  S   E  ++KR+    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 679 ISSCS-----------------NDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIM 720
           +  C+                 + D +  + K  P G   E        + D+ ++    
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-------IKDLMRQF--- 117

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
                 L  L F H+  I+H DLKP N+L+       ++DFG+A++ S +  L+     +
Sbjct: 118 ------LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT---PVV 168

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            T+ Y APE   +    T  D++S G +  EMF ++KP
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 40/215 (18%)

Query: 624 LIGIGSFGSIYVARLQDG--------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           ++G GSFG +++ R   G        M+V  K   +  +R     E +  ++  + H  +
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD--ILAEVNHPFI 60

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN--IMI----------DV 723
           VK+  +   +    LI+ ++  G             D+F RL+  +M           ++
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAEL 107

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           ALAL++LH   S  II+ DLKP N+LLDE+    ++DFG++K     D          T+
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 162

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            YMAPE   +       D +S+G+++ EM T   P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.5 bits (175), Expect = 3e-13
 Identities = 65/256 (25%), Positives = 115/256 (44%), Gaps = 47/256 (18%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGME-----------------VAVKVFHQQY 653
           +  R    F E   +G G FG +++  + +  +                 VAVK+     
Sbjct: 1   KFPRGHLLFKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA 58

Query: 654 ER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS------ 706
            + A   F  E +++ R++  N+++++  C ++D   +I +YM NG L   L S      
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 707 ----------GTCMLDI-FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM 754
                       C+  I +  L ++ + +A  ++YL    S   +H DL   N L+ E++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENL 175

Query: 755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLME--M 812
              I+DFG+++ L   D   IQ + +  I +MA E    G+  T  DV+++G+ L E  M
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Query: 813 FTKKKP----TDEIFI 824
             K++P    TDE  I
Sbjct: 236 LCKEQPYGELTDEQVI 251

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 49/228 (21%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 620 SENNLIGIGSFGSIYVARLQDGME------VAVKVF-HQQYERALKSFEDECEVMKRIRH 672
            E   +G G FG +++A+ +   E      V VK     + E     F  E ++ +++ H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCL--------YSGTCMLDIFQRLNIMIDVA 724
           +N+V+++  C   +   +I++Y   G L+  L              L   Q++ +   +A
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
           L +++L        +H DL   N L+       +S   ++K +   +   ++   L  + 
Sbjct: 128 LGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIPLR 183

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-----KKPTDEIFIGEL 827
           ++APE   +    T+ DV+S+G+++ E+FT+        +DE  +  L
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 11/206 (5%)

Query: 624 LIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           ++G G+FG++Y    + +G    + VA+K+ ++    +A   F DE  +M  + H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++  C +   + L+ + MP+G L + ++     +     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC 797
           ++H DL   NVL+       I+DFG+A+LL G+++          I +MA E     +  
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 798 TRGDVYSYGIMLMEMFT-KKKPTDEI 822
            + DV+SYG+ + E+ T   KP D I
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.3 bits (180), Expect = 4e-13
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 16/190 (8%)

Query: 639 QDGMEVAVKVF---HQQYERALKSFEDECEVMKRIRHRNLVKIISS-CSNDDFKALIMKY 694
             G EVA+K+      + E     F  E  +  R+ H N+V ++ S  +       + +Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---D 751
           +P  +L   L +    L   +   +M+ V   L+ L   H+  I+H DLKP N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 752 EDMVAHISDFGIAKLLSG-----EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYG 806
               A + DFGI  LL G        L+   + L T  Y APE      V    D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 807 IMLMEMFTKK 816
           ++ +E  T +
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 29/221 (13%)

Query: 625 IGIGSFGSIYVA-RLQDGMEVAVK----VF--HQQYERALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +  A   + G +VA+K     F      +R L+    E ++++  +H N++ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNIIA 68

Query: 678 I--ISSCSNDDFKA--LIMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHF 732
           I  I      DFK   ++M  M +  L + ++S      +  +    +  +   L+Y+H 
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYIH- 124

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGEDQLSIQIQTLATIGYMAPEY 790
             S  +IH DLKPSN+L++ED    I DFG+A+ L  S  +      + +AT  Y APE 
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Query: 791 G-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN 830
             +     T  D++S G +  EM  ++    ++F G+  ++
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPGKNYVH 219

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 36/227 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQ-YERALKSFEDECEVM 667
           DR      +G G FG +  A        R    + VAVK+      ++ L     E E+M
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL-----------YSGT------- 708
           K I +H+N++ ++  C+ +    +I++Y   G+L   L           +  T       
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 709 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
              D+   ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ + 
Sbjct: 132 SFKDL---VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
             D           + +MAPE     RV T + DV+S+GI++ E+FT
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 10/206 (4%)

Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRN 674
           R+     IG GSFG IY+A+ + D     +K     +   +  ++ + E  ++ +++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSL-ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V   +S   +    ++M+Y   G L +        +    Q L+  + ++L L+++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118

Query: 734 HSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
               I+H D+K  N+ L ++ MVA + DFGIA+ L+  D + +    + T  Y++PE   
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                 + D++S G +L E+ T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 26/241 (10%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRH 672
           T+R+ +   +G+G+FG +  AR Q  G  VA+K   + +   +  K    E +++K +RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 673 RNLV---KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
            N++    I  S   D +   + + +    L   L S        Q    +  +   L+Y
Sbjct: 69  ENIISLSDIFISPLEDIY--FVTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRGLKY 123

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           +H   S  ++H DLKPSN+L++E+    I DFG+A++     Q       ++T  Y APE
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPE 175

Query: 790 YG-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--INDLLPVSVMEVID 846
              T  +     D++S G +  EM   K     +F G+  +N++  I DLL     +VI+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKP----LFPGKDHVNQFSIITDLLGTPPDDVIN 231

Query: 847 T 847
           T
Sbjct: 232 T 232

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 36/236 (15%)

Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRN 674
           F     +G GSFG + +A+ +  G   A+K   ++    +K  +    E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V ++ S  +++    +++++  G L   L   G    D+ +  +   ++ LA EYLH  
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLH-- 135

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYGT 792
            S  II+ DLKP N+LLD      ++DFG AK      ++  +  TL  T  Y+APE   
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPEV-- 186

Query: 793 KGRVCTRG-----DVYSYGIMLMEMFTKKKP---------TDEIFIGELSLNRWIN 834
              + ++G     D ++ G++L E      P          ++I  G L    W +
Sbjct: 187 ---IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 29/221 (13%)

Query: 625 IGIGSFGSIYVARLQDGME-VAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIIS 680
           +G G +G +++A+ +D  E VA+K   +     L   +    E +++   +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH-FGHSTPII 739
           +  +D++  L M+Y+P G     L +   +L        M ++  A++ LH  G     I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELG----YI 123

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YGTK-GRV 796
           H DLKP N L+D      ++DFG++K       ++     + +  YMAPE   G      
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 797 CTRGDVYSYGIMLMEMFTKKKP-----TDEIFIGELSLNRW 832
               D +S G ML E      P      +E +    +L  W
Sbjct: 179 V---DYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 9e-13
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVK--VFHQQYERALKSFEDECEVMKRIR---H 672
           + E   IG G++G++Y AR L  G  VA+K        E    S   E  ++K++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 673 RNLVKIISSCSNDDFK-----ALIMKYMP---NGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            N+V+++  C            L+ +++       L  C   G   L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             +++LH   S  I+H DLKP N+L+  D    I+DFG+A++ S E  L+  + TL    
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL---W 171

Query: 785 YMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           Y APE      Y T   V    D++S G +  E+F ++
Sbjct: 172 YRAPEVLLQSSYATP--V----DMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 21/209 (10%)

Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++ G+  A KV   + E  L+ +  E +++    H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
            ++   +++++   G+++        ML++ + L    I +     LE L++ H   IIH
Sbjct: 73  YENNLWILIEFCAGGAVD------AVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPEY----GTKG 794
            DLK  N+L   D    ++DFG+    S ++  +IQ +   + T  +MAPE      +K 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 795 RVCT-RGDVYSYGIMLMEMFTKKKPTDEI 822
           R    + DV+S GI L+EM   + P  E+
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVKIIS 680
           L+G GS+G +   + ++ G  VA+K F +  +  +  K    E  ++K++RH NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 681 SCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
                    L+ +++ +  L       N L        +FQ L         +E+ H   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR-------GIEFCH--- 117

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY---G 791
           S  IIH D+KP N+L+ +  V  + DFG A+ L+   +  +    +AT  Y APE     
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGD 175

Query: 792 TK-GRVCTRGDVYSYGIMLMEMFT 814
           TK GR     D+++ G ++ EM T
Sbjct: 176 TKYGRAV---DIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 25/215 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQYERALKS-FEDECEVMKRIR 671
           +  +    IG G FG +Y           + VAVK        +++  F  E  +M++  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSL-------ENCLYSGTCMLDIFQRLNIMIDVA 724
           H ++VK+I   + ++   ++M+  P G L       +  L   + +L  +Q       ++
Sbjct: 66  HPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ-------LS 117

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+       + DFG+++ L  E         L  I 
Sbjct: 118 TALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-IK 173

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKP 818
           +MAPE     R  +  DV+ +G+ + E+     KP
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)

Query: 619 FSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQYERA--LKSFEDECEVMKRIRH 672
           F+   ++G G FGS+  A+L+       +VAVK+       +  ++ F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 673 RNLVKIISSCSNDDFKA------LIMKYMPNGSLENCLYSGTCMLDIFQ-----RLNIMI 721
            N++K+I        K       +I+ +M +G L   L       + F       +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           D+A  +EYL    S   IH DL   N +L+E+M   ++DFG++K +   D       +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
            + ++A E        T  DV+++G+ + E+ T+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 47/216 (21%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVK------VFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           +G+G FG + + +++      A+K      +     +  + S   E E+++   H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID---------VALALE 728
           +  +  +  +  ++M+Y   G L            I +   +  +         V LA E
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMA 787
           YLH   +  II+ DLKP N+LLD +    + DFG AK L SG+   +       T  Y+A
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF----CGTPEYVA 160

Query: 788 PEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKP 818
           PE      +  +G     D +S GI+L E+ T + P
Sbjct: 161 PEI-----ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           DR+   + +G G++G +  A     G +VA+K   + ++ A+  K    E  ++K + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 674 NLVKIIS----SCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLN---IMIDVA 724
           N++ ++     + S +DF+   L+   M    L N +          Q+L+   I   V 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVY 125

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             L  L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++     +AT  
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT---GYVATRW 180

Query: 785 YMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTKK 816
           Y APE            D++S G ++ E+ T K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + + R +   +V       ++E   +S    F +E ++M       +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +  +D +  ++M+YMP G L N L S   + + + R     +V LAL+ +H   S   I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 164

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-------GT 792
           H D+KP N+LLD+     ++DFG    ++ E  +      + T  Y++PE        G 
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD-TAVGTPDYISPEVLKSQGGDGY 223

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
            GR C   D +S G+ L EM     P
Sbjct: 224 YGREC---DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 625 IGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKIIS 680
           IG GSFG++Y A      E VAVK      ++  + ++D   E + +++++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYLHFGHST 736
               +    L+M+Y        CL S + +L++ ++    +++A     AL+ L + HS 
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY---GTK 793
            +IH D+K  N+LL E     ++DFG A   S  +        + T  +MAPE      +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF------VGTPYWMAPEVILAMDE 194

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
           G+   + DV+S GI  +E+  +K P
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 11/205 (5%)

Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRN 674
           F +  ++G G FG +   +++  G   A K   ++  +  K      +E ++++++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V +  +    D   L++  M  G L+  +Y  G    +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
               I++ DLKP N+LLD+     ISD G+A  +  E Q +I+ + + T+GYMAPE    
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQ-TIKGR-VGTVGYMAPEVVKN 175

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            R     D ++ G +L EM   + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 625 IGIGSFGSIYVARL-QDG--MEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKII 679
           +G G FGS+   +L QD   ++VAVK           ++ F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 680 SSC----SNDDFKA--LIMKYMPNGSLEN-CLYS--GTCMLDIFQRL--NIMIDVALALE 728
             C     ++ + +  +I+ +M +G L +  LYS  G C   +  ++    M D+A  +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL    S   IH DL   N +L+E+M   ++DFG++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTK 815
           E        T+ DV+S+G+ + E+ T+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 625 IGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y      V + +    VA+K  ++    R    F +E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      +IM+ M  G L++ L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++ ED    I DFG+ + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFT 814
           E    G   T  DV+S+G++L E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.5 bits (162), Expect = 8e-12
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRN 674
           F +  ++G G FG +   +++  G   A K   ++  +  K      +E ++++++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V +  +    D   L++  M  G L+  +Y+ G    +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                ++ DLKP N+LLD+     ISD G+A K+  GE   SI+ + + T+GYMAPE   
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGR-VGTVGYMAPEVLN 174

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
             R     D +  G ++ EM   + P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.1 bits (164), Expect = 9e-12
 Identities = 70/245 (28%), Positives = 116/245 (47%), Gaps = 36/245 (14%)

Query: 618 RFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           R+ +   +G GS G ++ A   D    VAVK       +++K    E ++++R+ H N+V
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 677 KII------SSCSNDDFKAL--------IMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           K+        S   +D  +L        + +YM    L N L  G  + +   RL  M  
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LSEEHARL-FMYQ 122

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLL----SGEDQLSIQI 777
           +   L+Y+H   S  ++H DLKP+NV ++ ED+V  I DFG+A+++    S +  LS   
Sbjct: 123 LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS--- 176

Query: 778 QTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIG--ELSLNRWIN 834
           + L T  Y +P         T+  D+++ G +  EM T K     +F G  EL   + I 
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLIL 232

Query: 835 DLLPV 839
           + +PV
Sbjct: 233 ESVPV 237

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.4 bits (163), Expect = 1e-11
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYER--------ALKSFEDECEVM 667
           R+ +   +G G++  +Y AR  + G  VA+K +   + +         AL+    E +++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLL 56

Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           + ++H N++ ++    +     L+ ++M    LE  +   + +L      + M+     L
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYM 786
           EYLH   S  I+H DLKP+N+L+  D V  ++DFG+A+   S   +++ Q+    T  Y 
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV---VTRWYR 169

Query: 787 APE--YGTK--GRVCTRGDVYSYGIMLMEMFTKK 816
           APE  +G +  G      D++S G +  E+  + 
Sbjct: 170 APELLFGARHYGVGV---DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + + R +   +V       ++E   +S    F +E ++M       +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +  +D +  ++M+YMP G L N L S   + + + +     +V LAL+ +H   S  +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGLI 164

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-------GT 792
           H D+KP N+LLD+     ++DFG    +     +      + T  Y++PE        G 
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD-TAVGTPDYISPEVLKSQGGDGY 223

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
            GR C   D +S G+ L EM     P
Sbjct: 224 YGREC---DWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 8/195 (4%)

Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A ++  G  VAVK    + ++  +   +E  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   ++M+++  G+L + + + T M +  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNE-EQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S E      +  + T  +MAPE  ++       D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPELISRLPYGPEVDIW 200

Query: 804 SYGIMLMEMFTKKKP 818
           S GIM++EM   + P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 10/198 (5%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG G++G +Y AR +  G   A+KV   +        + E  +MK  +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   + M++   GSL++ +Y  T  L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT---KGRVCTRG 800
           K +N+LL ++    ++DFG++  ++    ++ +   + T  +MAPE      KG      
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190

Query: 801 DVYSYGIMLMEMFTKKKP 818
           D+++ GI  +E+   + P
Sbjct: 191 DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 29/235 (12%)

Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV-AVKVFH-QQYERALKSFEDECEVMKRIRHRNLV 676
           F++   IG GSFG +Y        EV A+K+   ++ E  ++  + E  V+ +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +   S        +IM+Y+  GS  + L  G   L+      I+ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYGTK 793
             IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE   +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN 848
                + D++S GI  +E+   + P               +DL P+ V+ +I  N
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLIPKN 216

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.8 bits (163), Expect = 3e-11
 Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 5/122 (4%)

Query: 66  WIGITC---DVNSHRVI-GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF 121
           W G  C          I GL + +  L+G IP  +  L  LQ+++LS N + GNIP S+ 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 122 NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLP-YLARLAFA 180
           ++ +L++L  S N   GS+   +  ++S+  ++L+ N LSG +P  +G    + A   F 
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523

Query: 181 TN 182
            N
Sbjct: 524 DN 525

Length = 623

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 624 LIGIGSFGSIYVARLQDG--------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRN- 674
           ++G G++G +++ R   G        M+V  K    Q  + ++    E  V++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI---DVALALEYLH 731
           LV +  +   +    LI+ Y+  G +   LY      D F    +     ++ LALE+LH
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLH 122

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSIQIQTLATIGYMAPEY 790
                 I++ D+K  N+LLD +    ++DFG++K  LS E + +       TI YMAPE 
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--CGTIEYMAPEI 177

Query: 791 ----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               G  G+     D +S GI++ E+ T   P
Sbjct: 178 IRGKGGHGKAV---DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 25/204 (12%)

Query: 625 IGIGSFG-SIYVARLQDGMEVAVKVFH----QQYERALKSFEDECEVMKRIRHRNLVKII 679
           IG GSFG +I V   +DG +  +K  +       ER  +    E  V+  ++H N+V+  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER--EESRKEVAVLSNMKHPNIVQYQ 65

Query: 680 SSCSNDDFKALIMKYMPNGSL-------ENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            S   +    ++M Y   G L          L+    +LD F      + + LAL+++H 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH- 118

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                I+H D+K  N+ L +D    + DFGIA++L+   +L+     + T  Y++PE   
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA--RTCIGTPYYLSPEICE 174

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKK 816
                 + D+++ G +L EM T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.7 bits (161), Expect = 3e-11
 Identities = 55/161 (34%), Positives = 87/161 (54%), Gaps = 15/161 (9%)

Query: 665 EVM--KRIR-HRNLVKIIS--SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
           E+M  + +  H N+VK+++     ND    L+ +YM    L   + +   + D+ +R  I
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANI-LEDVHKRY-I 112

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQ 778
           M  +  AL+Y+H G+   +IH DLKPSN+LL+ D    ++DFG+A+ LS  E+     + 
Sbjct: 113 MYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169

Query: 779 T--LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           T  +AT  Y APE        T+G D++S G +L EM   K
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVA---VKVFHQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
           IG G F  +Y A  L DG  VA   V++F     +A +    E +++K++ H N++K ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID----------VALALEYL 730
           S   ++   ++++    G L         M+  F++   +I           +  ALE++
Sbjct: 70  SFIENNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE 789
           H   S  I+H D+KP+NV +    V  + D G+ +  S +   +    +L  T  YM+PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPYYMSPE 176

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              +     + D++S G +L EM   + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVF----HQQY-ERALKSFEDECEVMKRI 670
            R+   + IG G++G +  A     G++VA+K      HQ + +R L+    E ++++R 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRF 60

Query: 671 RHRNLVKI---ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLD-----IFQRLNIM 720
           +H N++ I   I   S + F    ++ + M    L   + +     D     ++Q L   
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-- 117

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQT 779
                 L+Y+H   S  ++H DLKPSN+LL+ +    I DFG+A++     D      + 
Sbjct: 118 -----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 780 LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           +AT  Y APE     +  T+  D++S G +L EM + +
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK----SFEDECEVMKRIRHRNLVKIIS 680
           IG G FG + +     GM  A  V  +    A       F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCML------DIFQRLNIMIDVALALEYLHFGH 734
            C       L++++ P G L+N L S   M+      D+ QR+    +VA  L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK- 793
               IH DL   N  L  D+   I D+G+A     ED    +      + ++APE     
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 794 ------GRVCTRGDVYSYGIMLMEMFT 814
                      + +++S G+ + E+FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 65/229 (28%), Positives = 96/229 (41%), Gaps = 51/229 (22%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKV---FHQQYERALKSFEDECEVMKRIRHRNLVKII 679
           L+G G  G +++ RL+   ++ A+KV           +K    E E++  + H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 680 SSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLH-FGHST 736
           +S   + +  L+M Y P G L   L    G C+ +   R     +V LALEYLH  G   
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG--- 123

Query: 737 PIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQL---------------SIQIQT 779
            I++ DLKP N+LL E    HI  SDF ++K    E                  SI  +T
Sbjct: 124 -IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 780 LATIG------------YMAPE----YGTKGRVCTRGDVYSYGIMLMEM 812
            +               Y+APE     G    V    D ++ GI+L EM
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 20/211 (9%)

Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVK---VFHQQYERALKSFEDECEVMKRIRHRN 674
           F     IG G F  +Y A  L DG+ VA+K   +F     +A      E +++K++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY----- 729
           ++K  +S   D+   ++++    G L         M+  F++   +I      +Y     
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSR-------MIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 730 --LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L   HS  ++H D+KP+NV +    V  + D G+ +  S +   +  +  + T  YM+
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMS 174

Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE   +     + D++S G +L EM   + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 617 DRFSENNLIGIGSFGSI-YVARLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           DR+ +   +G G++G++      + G +VA+K  ++ ++  L  K    E  ++K ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 674 NLVKII----SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIF--QRLN---IMID 722
           N++ ++       S D F    L+M +M           GT +  +   ++L+   I   
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM-----------GTDLGKLMKHEKLSEDRIQFL 123

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           V   L+ L + H+  IIH DLKP N+ ++ED    I DFG+A+    E         + T
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVT 178

Query: 783 IGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
             Y APE        T+  D++S G ++ EM T K
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 11/206 (5%)

Query: 624 LIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           ++G G+FG++Y    + DG    + VA+KV  +    +A K   DE  VM  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++  C     + L+ + MP G L + +      +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC 797
           ++H DL   NVL+       I+DFG+A+LL  ++           I +MA E     R  
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 798 TRGDVYSYGIMLMEMFT-KKKPTDEI 822
            + DV+SYG+ + E+ T   KP D I
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR-----NLVKI 678
           I  G+FGS+Y+A+ +  G   A+KV  +    A     +  +  + I         + K+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKL 62

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             S  + D+  L+M+Y+  G   + + +   + + + +   + +V L +E LH      I
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGI 118

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           IH D+KP N+L+D+     ++DFG+++   G        + + T  Y+APE         
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN--GL----ENKKFVGTPDYLAPETILGVGDDK 172

Query: 799 RGDVYSYGIMLMEMFTKKKP-----TDEIF 823
             D +S G ++ E      P      D +F
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 33/220 (15%)

Query: 625 IGIGSFGSI------YVARLQDGMEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLVK 677
           +G G FG +       +        VAVK+  +    + L+    E  ++K++ H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 678 IISSCSNDDFKALIMKYMPNGSLEN---------CLYSGTCM--------------LDIF 714
           +  +CS D    LI++Y   GSL +           Y G+                L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 774
             ++    ++  ++YL       ++H DL   NVL+ E     ISDFG+++ +  ED   
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + +    + +MA E        T+ DV+S+G++L E+ T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 35/229 (15%)

Query: 624 LIGIGSFGSIYVARLQDGME----VAVKVFHQQYERALKSFED------ECEVMKRIRHR 673
           ++G G +G ++  R   G +     A+KV   +    +++ +D      E  +++ ++H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVL--KKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCL-YSGTCMLDI--FQRLNIMIDVALALEYL 730
            +V +I +        LI++Y+  G L   L   G  M D   F     + +++LALE+L
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF----YLSEISLALEHL 116

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE 789
           H      II+ DLKP N+LLD      ++DFG+ K    E  ++    T   TI YMAPE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPE 170

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT---------KKKPTDEIFIGELSL 829
              +       D +S G ++ +M T         +KK  D+I  G+L+L
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFT 814
           E    G   T  D++S+G++L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)

Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER---ALKSFEDECEVMK 668
            R+   F + N IG G++G +Y AR    G  VA+K      ER    + S   E  ++ 
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 669 RIRHRNLVKIISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            +RH N+V++          +  L+M+Y     L + L +        Q   +M+ +   
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           L+YLH      IIH DLK SN+LL +     I+DFG+A+      +       + T+ Y 
Sbjct: 121 LQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYR 175

Query: 787 APEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           APE        T   D+++ G +L E+   K
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVK---VFHQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
           IG G F  +Y A  L D   VA+K   +F     +A +    E +++K++ H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI----------DVALALEYL 730
           S   D+   ++++    G L         M+  F++   +I           +  A+E++
Sbjct: 70  SFIEDNELNIVLELADAGDLSQ-------MIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  ++H D+KP+NV +    V  + D G+ +  S +   +  +  + T  YM+PE 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPER 177

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +     + D++S G +L EM   + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 619 FSENNL-----IGIGSFGSIYVARLQD-GMEVAVK-VFHQQYERALKSFEDECEVMKRIR 671
           F+  +L     IG G+FG++     +  G  +AVK +     E+  K    + +V+ R  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 672 H-RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----A 726
               +VK   +   +    + M+ M + SL+        +L       I+  +A+    A
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-QIQTLATIGY 785
           L YL       IIH D+KPSN+LLD +    + DFGI    SG+   SI + +      Y
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAGCRPY 173

Query: 786 MAPEYGTKGRVCT--------RGDVYSYGIMLMEMFTKKKPTDE 821
           MAPE     R+          R DV+S GI L E+ T K P  +
Sbjct: 174 MAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)

Query: 612 LLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           L   T  F    +IG G++G +Y AR  + G  VA+K+     +   +  ++E  ++++ 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59

Query: 671 -RHRNLVKII------SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN----- 718
             H N+          +   NDD   L+M+    GS+ + L  G       +RL      
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGL--RKKGKRLKEEWIA 116

Query: 719 -IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI 777
            I+ +    L YLH      +IH D+K  N+LL ++    + DFG++       QL   +
Sbjct: 117 YILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA------QLDSTL 167

Query: 778 QTLAT-IG---YMAPEY--GTKGRVCT---RGDVYSYGIMLMEMFTKKKP 818
               T IG   +MAPE     +    +   R DV+S GI  +E+   K P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 34/88 (38%), Positives = 47/88 (53%)

Query: 344 LELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI 403
           L L    L   IP   S+L+ LQ++ L+ N + G I   L  +  L  L L  N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 404 PSCLGNLTSLRVLYLGLNRFTSALPSTI 431
           P  LG LTSLR+L L  N  +  +P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A+++    E +V+       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 176

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                + D++S G+ L+EM   + P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKS----FEDECEVMKRIRHR 673
           F    +IG G+FG + + R +   +V A+K+   ++E   +S    F +E ++M      
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
            +V++  +  +D +  ++M+YMP G L N L S   + + + R     +V LAL+ +H  
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIH-- 159

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
            S   IH D+KP N+LLD+     ++DFG    +   + +      + T  Y++PE    
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKS 217

Query: 790 ---YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               G  GR C   D +S G+ L EM     P
Sbjct: 218 QGGDGYYGREC---DWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFE------DECEVMKRIRHRNLV 676
           +IG GSFG + +A R  DG   AVKV  ++    LK  E      +   ++K ++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKK--TILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            +  S    +    ++ Y+  G L   L    C L+   R     +VA A+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            II+ DLKP N+LLD      ++DFG+ K   G +          T  Y+APE   K   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
               D +  G +L EM     P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ--QYERALKSFEDECEVMKRIRHRN 674
           R++    +G G++GS+  A   + G +VA+K   +  Q E   K    E  ++K ++H N
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 675 LVKII----SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           ++ ++    S+ S D+F+   L+M YM    L+        M        +   V   L 
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKI------MGHPLSEDKVQYLVYQMLC 128

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKP N+ ++ED    I DFG+A+    E         + T  Y AP
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 183

Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ EM T K
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 22/206 (10%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERA----LKSFEDECEVMKRIRHRNLVKIIS 680
           IG G FG + +  +  G   A  V  +    A       F +E +  + ++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSG------TCMLDIFQRLNIMIDVALALEYLHFGH 734
            C+      L+M++ P G L+  L S       T      QR+    ++AL L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE----- 789
               IH DL   N LL  D+   I D+G++     ED      Q    + ++APE     
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 790 YGTKGRV--CTRGDVYSYGIMLMEMF 813
           +G    V      +V+S G+ + E+F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 625 IGIGSFGSIYVARLQDG--------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRN-L 675
           +G G++G +++ R   G        M+V  K    Q  +  +    E +V++ +R    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V +  +   D    LI+ Y+  G L   LY      +   R+ I  ++ LAL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             II+ D+K  N+LLD +    ++DFG++K    E +         TI YMAPE    G 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGG- 181

Query: 796 VCTRG-----DVYSYGIMLMEMFTKKKP 818
             + G     D +S G++  E+ T   P
Sbjct: 182 --SGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G++G +Y AR L  G   AVK+   +        + E  ++K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           + +   + M+Y   GSL++ +Y  T  L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY------GTKGRVC 797
           K +N+LL ++    ++DFG+A  ++    ++ +   + T  +MAPE       G   ++C
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190

Query: 798 TRGDVYSYGIMLMEMFTKKKP 818
              D+++ GI  +E+   + P
Sbjct: 191 ---DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 46/197 (23%), Positives = 92/197 (46%), Gaps = 9/197 (4%)

Query: 625 IGIGSFGS-IYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G+FG      R +D   V  K     +  E+  +   +E  ++  ++H N++   + 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 682 CSNDDFKALIMKYMPNGSL-ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
             +D+   + M+Y   G+L +  +     + +    L  +  +  A+ Y+H      I+H
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+K  N+ L +  +  + DFGI+K+L  E   S+    + T  YM+PE     +   + 
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNFKS 182

Query: 801 DVYSYGIMLMEMFTKKK 817
           D+++ G +L E+ T K+
Sbjct: 183 DIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.3 bits (151), Expect = 5e-10
 Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 19/292 (6%)

Query: 274 TSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQ 333
            SS   L   SSL+    L +L  +G        ++  NL     + L  N  +  NI +
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLDLNLN-RLRSNISE 111

Query: 334 VVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLV 393
           ++  L NL  L+L  NN+T+  P+       L+ L L+ NK+   +   L +L  L +L 
Sbjct: 112 LL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169

Query: 394 LQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-------S 446
           L  N  S  +P  L NL++L  L L  N+ +  LP  I  L  +  +D+S+N       S
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLSS 227

Query: 447 LNVLIGLNFSR--NNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
           L+ L  L+     NN   D+P +IG L NL+ + L  N++  S   S G L++L  LDLS
Sbjct: 228 LSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLS 285

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
            N +S A+P     LL L    L    L  +       + L   + + N   
Sbjct: 286 GNSLSNALPLIALLLLLL--ELLLNLLLTLKALELKLNSILLNNNILSNGET 335

Length = 394

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 41/212 (19%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +Y AR    G  VA+K      E       A++    E  ++K + H N+VK
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVK 63

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH------ 731
           ++     ++   L+ +++ +  L+         +D      I   + L   YL       
Sbjct: 64  LLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGI--PLPLIKSYLFQLLQGL 113

Query: 732 -FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT----LATIGYM 786
            F HS  ++H DLKP N+L++ +    ++DFG+A+         + ++T    + T+ Y 
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLWYR 167

Query: 787 APE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   G K    T  D++S G +  EM T++
Sbjct: 168 APEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 22/219 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRH 672
             F   +L+G G FG + V R    G   A+KV  +     +  +  FE+E +++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYL 730
             + ++  +  + D   L+M+Y P G L + L  Y      D F        +A  +  +
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAI 115

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           H  H    +H D+KP NVL+D     HI  +DFG A  L+  +++      + T  Y+AP
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDR--TGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAP 172

Query: 789 EYGTK---GRVCTRG---DVYSYGIMLMEMFTKKKPTDE 821
           E  T        T G   D +S G++  EM   + P  E
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 44/217 (20%)

Query: 625 IGIGSFGSIYVAR-LQDGME-VAVKVFHQQYE---------------RALKSFE------ 661
           IG G++G ++ AR L++G   VA+K    Q                 R L++FE      
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 662 --DECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
             D C V +  R   L  +      D    L     P    E        M  + + L+ 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLD- 124

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
                       F HS  ++H DLKP N+L+       ++DFG+A++ S +  L+  + T
Sbjct: 125 ------------FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 172

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           L    Y APE   +    T  D++S G +  EMF +K
Sbjct: 173 L---WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.8 bits (148), Expect = 7e-10
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 36/215 (16%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFED---------ECEV 666
           +++ + + IG GS+G ++  R ++ G  VA+K F       ++S +D         E  +
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRM 53

Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +K+++H NLV +I          L+ +Y  + ++ N L      +       I+     A
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           +    F H    IH D+KP N+L+ +     + DFG A++L+G          +AT  Y 
Sbjct: 113 VN---FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYR 167

Query: 787 APE-------YGTKGRVCTRGDVYSYGIMLMEMFT 814
           APE       YG         DV++ G +  E+ T
Sbjct: 168 APELLVGDTQYGPP------VDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 625 IGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFE-DECEVMKRIRHRNLVKIISSC 682
           +G G++ ++Y  R +   E VA+K  H   E    S    E  +MK ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 683 SNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
             ++   L+ +YM +  L+  +  +     LD     +    +   L+ + F H   ++H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA----TIGYMAPEYGTKGRV 796
            DLKP N+L+++     ++DFG+A+         I + T +    T+ Y AP+     R 
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 797 -CTRGDVYSYGIMLMEMFT 814
             T  D++S G ++ EM T
Sbjct: 178 YSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 38/221 (17%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVMKR------IRHRNLV 676
           ++G GSFG + +A L+   E  A+K   +  +  L+  + EC +++R        H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKK--DVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY------- 729
            +  +    +    +M+Y+  G L         M  I        D A A  Y       
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL---------MFHIQSSGRF--DEARARFYAAEIICG 108

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAP 788
           L F H   II+ DLK  NVLLD+D    I+DFG+ K  ++GE + S       T  Y+AP
Sbjct: 109 LQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS---TFCGTPDYIAP 165

Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
           E   KG+      D +S+G++L EM   + P      DE+F
Sbjct: 166 EI-LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 624 LIGIGSFGSIYVARLQDG--------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRN- 674
           ++G G++G +++ R   G        M+V  K    Q  +  +    E +V++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI---DVALALEYLH 731
           LV +  +   D    LI+ Y+  G L    ++     + F+   + I   ++ LALE+LH
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLALEHLH 122

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY- 790
                 II+ D+K  N+LLD +    ++DFG++K    ED++        TI YMAP+  
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIV 178

Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            G  G      D +S G+++ E+ T   P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 7/158 (4%)

Query: 662 DECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIM 720
           +E ++++++  R +V +  +    D   L++  M  G L+  +Y+ G    D  + +   
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            ++   LE LH      I++ DLKP N+LLD+     ISD G+A  +   + +  ++   
Sbjct: 109 AEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--- 162

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            T+GYMAPE     R     D +  G ++ EM   K P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 60/225 (26%), Positives = 88/225 (39%), Gaps = 59/225 (26%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI-ISS 681
            IG G+ G +Y  R  + G  +AVK   +             E  KRI    L+ + +  
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---------GNKEENKRI----LMDLDVVL 68

Query: 682 CSND-------------DFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLN--------- 718
            S+D             D    I M+ M            TC+  + +R+          
Sbjct: 69  KSHDCPYIVKCYGYFITDSDVFICMELM-----------STCLDKLLKRIQGPIPEDILG 117

Query: 719 -IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI 777
            + + +  AL YL   H   +IH D+KPSN+LLD      + DFGI+  L      +   
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175

Query: 778 QTLATIGYMAPEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              A   YMAPE         +   R DV+S GI L+E+ T + P
Sbjct: 176 GCAA---YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 54/223 (24%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFE----DECEVMKRIRHRNLVKII 679
           IG G+FG ++ AR  +    VA+K      E   + F      E ++++ ++H N+V +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 680 SSCSN-----DDFKA---LIMKYMPNGSLENCLYSGTCMLDIFQRL-NIMIDVALA---- 726
             C       + +K    L+ ++              C  D+   L N  +   L+    
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEF--------------CEHDLAGLLSNKNVKFTLSEIKK 123

Query: 727 -----LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQT 779
                L  L++ H   I+H D+K +N+L+ +D +  ++DFG+A+   LS   + +     
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 780 LATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTK 815
           + T+ Y  PE       YG         D++  G ++ EM+T+
Sbjct: 184 VVTLWYRPPELLLGERDYGPP------IDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 17/203 (8%)

Query: 624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVM-------KRIRHRNL 675
           +IG GSFG + +AR + +    AVKV  +   +A+   ++E  +M       K ++H  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V +  S    D    ++ Y+  G L   L    C L+   R     ++A AL YLH   S
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             I++ DLKP N+LLD      ++DFG+ K     +          T  Y+APE   K  
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 796 VCTRGDVYSYGIMLMEMFTKKKP 818
                D +  G +L EM     P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 62/197 (31%), Positives = 86/197 (43%), Gaps = 19/197 (9%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVM-------KRIRHRNLV 676
           IG GSFG + +A+   DG   AVKV   Q +  LK  E +  +M       K ++H  LV
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVL--QKKAILKKKEQK-HIMAERNVLLKNVKHPFLV 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            +  S    D    ++ Y+  G L   L       +   R     ++A AL YLH   S 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
            II+ DLKP N+LLD      ++DFG+ K  +      S       T  Y+APE   K  
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS---TFCGTPEYLAPEVLRKQP 172

Query: 796 VCTRGDVYSYGIMLMEM 812
                D +  G +L EM
Sbjct: 173 YDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 43/230 (18%)

Query: 624 LIGIGSFGSIYVARLQD---GMEVAVKVFHQ---QYERALKSFEDECEVMKRIRHRNLVK 677
           LIG G  G +Y+A   D      VA+K   +   +     K F  E ++   + H  +V 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-----------LNIMIDVALA 726
           + S CS+ D     M Y+   +L++ L S     +   +           L+I   +   
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKS-VWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE--DQLSIQI------- 777
           +EY+H   S  ++H DLKP N+LL       I D+G A     E  D L I +       
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 778 -------QTLATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                  + + T  YMAPE   G      T  D+Y+ G++L +M T   P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASEST--DIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 10/141 (7%)

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           + I V LA+   H  HS  +IH D+K +N+LL  + +  + DFG +K+ +      +   
Sbjct: 148 LFIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN---D 835
              T  Y+APE   +     + D++S G++L E+ T K+P D   + E+ +++ +    D
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHKTLAGRYD 263

Query: 836 LLPVSV---MEVIDTNLLRGE 853
            LP S+   M+ I T LL  +
Sbjct: 264 PLPPSISPEMQEIVTALLSSD 284

Length = 496

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 1e-09
 Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 26/209 (12%)

Query: 624 LIGIGSFGSIYVA-RLQDGME-VAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           L+G     + +VA R  D  E V  K      ER       E   +    H  +VK    
Sbjct: 74  LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDD 133

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------------IMIDVALALEY 729
             +DD   LIM+Y   G L            I QRL             +   + LAL+ 
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDE 184

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           +H   S  ++H DLK +N+ L    +  + DFG +K  S    L +      T  Y+APE
Sbjct: 185 VH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              + R   + D++S G++L E+ T  +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 40/212 (18%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED--------ECEVMKRIRHRNL 675
           IG G++G +Y  R  + G  VA+K         L+S E+        E  ++K ++H N+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLKELQHPNI 61

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH---- 731
           V +      +    LI +++   S++   Y     LD        +D  L   YL+    
Sbjct: 62  VCLQDVLMQESRLYLIFEFL---SMDLKKY-----LDSL-PKGQYMDAELVKSYLYQILQ 112

Query: 732 ---FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYM 786
              F HS  ++H DLKP N+L+D   V  ++DFG+A+       + +++ T  + T+ Y 
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG----IPVRVYTHEVVTLWYR 168

Query: 787 APE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   G+  R  T  D++S G +  EM TKK
Sbjct: 169 APEVLLGSP-RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 625 IGIGSFGSI---YVARLQDGMEVAVKVF-HQQYERALK-SFEDECEVMKRIRHRNLVKII 679
           +G G+FG++        +    VAVK+  +   + ALK     E  VM+++ +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
             C  + +  L+M+    G L   L     + +      ++  V++ ++YL     T  +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTKGRVC 797
           H DL   NVLL     A ISDFG++K L G D+   + +T     + + APE     +  
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 798 TRGDVYSYGIMLMEMFT-KKKP 818
           ++ DV+S+G+++ E F+  +KP
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 38/160 (23%)

Query: 625 IGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFEDEC----EV---MKRIRHRNLV 676
           +G G+FGS+Y+AR ++  E VA+K   +++     S+E EC    EV    K   H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL-------NIMIDVALALEY 729
           K+      +D    + +YM     E  LY    M D   +        +I+  +   L +
Sbjct: 62  KLKEVFRENDELYFVFEYM-----EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 730 LH----FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
           +H    F       H DLKP N+L+    V  I+DFG+A+
Sbjct: 115 IHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           I + +  ALEYLH   S  +IH D+KPSNVL++ +    + DFGI+  L   D ++  I 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTID 163

Query: 779 TLATIG---YMAPEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
                G   YMAPE       +     + DV+S GI ++E+ T + P D
Sbjct: 164 ----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG +++A L+      A+K   +  +  L   + EC  V KR+      H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHS 735
            +  +    +    +M+Y+  G L    +  +C   D+ +      ++   L++LH   S
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---S 114

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGTKG 794
             I++ DLK  N+LLD D    I+DFG+ K  + G+ +         T  Y+APE     
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC---TFCGTPDYIAPEILLGQ 171

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
           +  T  D +S+G++L EM   + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 41/221 (18%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y AR ++ G  VA+K      E+      AL+    E +++K+++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 678 II------SSCSNDDFKA--LIMKYMP---NGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +I         S     +  ++  YM    +G LEN     +  L   Q    M+ +   
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLEG 127

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA----- 781
           + YLH  H   I+H D+K +N+L+D   +  I+DFG+A+   G                 
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 782 ----TIGYMAPEY--GTKGRVCTRGDVYSYGIMLMEMFTKK 816
               T  Y  PE   G + R  T  D++  G +  EMFT++
Sbjct: 185 NLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 47/249 (18%)

Query: 617 DRFSENNLIGIGSFGSI---YVARLQDGMEVAVKVFHQQYERALKSFED--ECEVMKRIR 671
           +R+     +G G++GS+   Y  RL+   +VAVK   + ++  + +     E  ++K ++
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMK 72

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCML--DI-----FQRL---NI 719
           H N++             L+  + P  S+EN   +Y  T ++  D+      Q+L   ++
Sbjct: 73  HENVI------------GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
              +   L  L + HS  IIH DLKPSNV ++ED    I DFG+A+    +D+++     
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT---GY 175

Query: 780 LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
           +AT  Y APE         +  D++S G ++ E+   K     +F G    N +I+ L  
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA----LFPG----NDYIDQL-- 225

Query: 839 VSVMEVIDT 847
             +MEV+ T
Sbjct: 226 KRIMEVVGT 234

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 9/128 (7%)

Query: 692 MKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL 750
           M++M  GSL+  L   G    +I  +  I I V   L YL   H   I+H D+KPSN+L+
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNILV 133

Query: 751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLM 810
           +      + DFG+    SG+   S+    + T  YM+PE         + D++S G+ L+
Sbjct: 134 NSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189

Query: 811 EMFTKKKP 818
           EM   + P
Sbjct: 190 EMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 674 NLVKIIS----SCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F  + ++ ++    L N +       D  Q L   I     L 
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 131

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    E         +AT  Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186

Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 30/87 (34%), Positives = 45/87 (51%)

Query: 322 MDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD 381
           +DN  + G IP  +  L +L  + L GN++   IP +   + +L+ L L+ N   G I +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 382 ELCHLARLHSLVLQGNKFSGSIPSCLG 408
            L  L  L  L L GN  SG +P+ LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 13/105 (12%)

Query: 367 ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSA 426
            LGL    L G I +++  L  L S+ L GN   G+IP  LG++TSL VL L  N F  +
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 427 LPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGL 471
           +P ++               L  L  LN + N+LSG +P  +GG 
Sbjct: 482 IPESL-------------GQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 8/199 (4%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKIIS 680
           +G G FG +   +++  G   A K  +++  +  K +E    E  ++ ++  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +        L+M  M  G L   +Y+       F         A  +  L   H   II+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 741 CDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
            DLKP NVLLD D    ISD G+A +L  G+ +         T G+MAPE          
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK---GYAGTPGFMAPELLQGEEYDFS 177

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D ++ G+ L EM   + P
Sbjct: 178 VDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 11/200 (5%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVFHQQY---ERALKSFEDECEVM-KRIRHRNLVKI 678
           +IG GSFG + +A R  DG   AVKV  ++     +  K    E  V+ K ++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             S    +    ++ ++  G L   L       +   R     ++A AL YLH   S  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           ++ DLKP N+LLD      ++DFG+ K   G  Q         T  Y+APE   K     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 799 RGDVYSYGIMLMEMFTKKKP 818
             D +  G +L EM     P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 33/229 (14%)

Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-KSFEDECEVMKRIRHRNLVKIISSC 682
           +G G+ G++Y A  L     +AVKV        L K    E E++ +     ++    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------NIMIDVALALEYLHFGHST 736
             ++  ++  ++M  GSL           D+++++       I + V   L YL    S 
Sbjct: 69  FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYLW---SL 114

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            I+H D+KPSN+L++      + DFG++  L      SI    + T  YMAPE  +  + 
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQY 170

Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI 845
               DV+S GI  ME+   + P  +I   + S       L+P+ +++ I
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------LMPLQLLQCI 212

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.2 bits (140), Expect = 7e-09
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 10/199 (5%)

Query: 624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
           L+G G+FG + + R +  G   A+K+  ++   A         E  V+K  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            S    D    +M+Y+  G L   L       +   R     ++  AL+YLH G    I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK---IV 117

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           + DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE          
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D +  G+++ EM   + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 55/237 (23%), Positives = 101/237 (42%), Gaps = 71/237 (29%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +Y AR    G  VA+K    + E       A++    E  ++K + H N+V+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------------IMIDVAL 725
                                 L + ++S   +  +F+ L+              +D  L
Sbjct: 63  ----------------------LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL 100

Query: 726 ALEYLH-------FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
              YL+       + HS  ++H DLKP N+L+D +    ++DFG+A+         + ++
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR------AFGVPVR 154

Query: 779 T----LATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKK------KPTDEIF 823
           T    + T+ Y APE   G++ +  T  D++S G +  EM  ++         D++F
Sbjct: 155 TYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 8e-09
 Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 48/249 (19%)

Query: 590 RTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-------IGIGSFGSIYVARLQDGM 642
              P  D    P         E   ++D  S   +       +  GS G ++V       
Sbjct: 66  SLSPQTDVCQEP--------CETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE 117

Query: 643 E---VAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM-KYMPNG 698
           +   V VK          K+   E +++K I HR ++ +I +        ++M KY    
Sbjct: 118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY---- 168

Query: 699 SLENCLYSGTCMLDIFQRLNIMIDVALA---------LEYLHFGHSTPIIHCDLKPSNVL 749
                     C  D+F  ++    + L          LE L + H   IIH D+K  N+ 
Sbjct: 169 ---------KC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217

Query: 750 LDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIML 809
           LDE   A + DFG A  L              T+   +PE       C + D++S G++L
Sbjct: 218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277

Query: 810 MEMFTKKKP 818
            EM  K   
Sbjct: 278 FEMSVKNVT 286

Length = 392

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 50/227 (22%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDEC-EVMKRI-----RHRNLV 676
           ++G GSFG + +A L+   E+ AVKV  +  +  L+  + EC    KR+     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM---------IDVALAL 727
           ++ S     D    +M+Y+  G L         M  I QR              ++ L L
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDL---------MFHI-QRSGRFDEPRARFYAAEIVLGL 109

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATI-- 783
           ++LH      II+ DLK  NVLLD +    I+DFG+ K  +L G         T +T   
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--------VTTSTFCG 158

Query: 784 --GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
              Y+APE  +        D ++ G++L EM   + P      DE+F
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 9e-09
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 40/223 (17%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFE----DECEVMK 668
           R+ D + + N I  G++G +Y AR  + G  VA+K    + E+  + F      E  ++ 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59

Query: 669 RIRHRNLVKI--ISSCSNDDFKALIMKYMPN---GSLENCLYSGTCMLDIF---QRLNIM 720
           +++H N+V +  +   SN D   ++M+Y+ +     +E        M   F   +   +M
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-------MKQPFLQSEVKCLM 112

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
           + +   + +LH      I+H DLK SN+LL+   +  I DFG+A+       L    Q +
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLV 167

Query: 781 ATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            T+ Y APE       Y T        D++S G +  E+ TKK
Sbjct: 168 VTLWYRAPELLLGAKEYSTA------IDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRN 674
           D F   + +G G+ G +   + +  G+ +A K+ H + + A+++    E +V+       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L     +  +I  +++I +   LA  YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 122

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 176

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                + D++S G+ L+E+   + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 42/213 (19%)

Query: 625 IGIGSFGSIYVARLQDG--MEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKII 679
           +G GSFG + +A  ++     VA+K F +     ++ +     E +++  I H   V + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 680 SSCSNDDFKALIMKYMPNGSL-------------ENCLYSGTCMLDIFQRLNIMIDVALA 726
            S  ++ +  L+++++  G                 C Y+                + L 
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA--------------QIVLI 143

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
            EYL    S  I++ DLKP N+LLD+D    ++DFG AK+      +  +  TL  T  Y
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------VDTRTYTLCGTPEY 194

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +APE           D ++ GI + E+     P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 43/242 (17%)

Query: 616 TDRFSE-NNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALKSFED---------- 662
           ++R+ +    +G G++G +  A     G  VA+K V   +    +               
Sbjct: 7   SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66

Query: 663 ---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
              E ++M  I+H N++ ++      DF  L+M  M    L+  +      L   Q   I
Sbjct: 67  TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI-RLTESQVKCI 124

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE---DQLSIQ 776
           ++ +   L  LH       +H DL P+N+ ++   +  I+DFG+A+        D LS  
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 777 IQT---------LATIGYMAPE--YGTK--GRVCTRGDVYSYGIMLMEMFTKKK---PTD 820
                       + T+ Y APE   G +         D++S G +  E+ T K      +
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV---DMWSVGCIFAELLTGKPLFPGEN 238

Query: 821 EI 822
           EI
Sbjct: 239 EI 240

Length = 335

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 7/157 (4%)

Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMI 721
           E E+++++    +V +  +  +     L+M  M  G L+  +Y+ G   L++ +R+ I  
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM-ERV-IHY 100

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
              +    LH  HS  I++ D+KP NVLLD+     +SD G+A  L     ++   Q   
Sbjct: 101 SAQITCGILHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT---QRAG 156

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           T GYMAPE   +       D ++ G  + EM   + P
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)

Query: 625 IGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFED-----ECEVMKRIRHRNLVKI 678
           +G GSFG++Y V   +   E  +KV  +     L   E      E +++ ++ H  +VK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 679 ISSCSNDDFKALIMKYMPNGSL----ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            +S    D   +I +Y     L    E   ++G  + +  Q     I + L + Y+H   
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN-QVCEWFIQLLLGVHYMH--- 123

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              I+H DLK  N+ L  +++  I DFG+++LL G   L+       T  YM+PE     
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT--GTPYYMSPEALKHQ 180

Query: 795 RVCTRGDVYSYGIMLMEM 812
              ++ D++S G +L EM
Sbjct: 181 GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 46/216 (21%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE------RALKSFEDECEVMKRIRHRNLVK 677
           IG G++G +  A+  +   +VA+K     ++      R L+    E ++++ + H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 678 ---IISSCSNDDFKALIMKY-MPNGSLENCLYSGT------CMLDIFQRLNIMIDVALAL 727
              I+     + F  + + Y + +  L   + S        C   ++Q L         L
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           +Y+H   S  ++H DLKPSN+LL+ +    I DFG+A+  S +       + + T  Y A
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRA 176

Query: 788 PE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           PE       Y T        DV+S G +  E+  +K
Sbjct: 177 PELLLNCSEYTTA------IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 36/225 (16%)

Query: 625 IGIGSFGSIYVARLQ---DGMEVAVKVFHQ---QYERALKSFEDECEVMKRIRHRNLVKI 678
           IG G++G +Y A+ +   DG E A+K F     QY    +S   E  +++ ++H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 679 ISSCSNDDFKALIM--KYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +        K++ +   Y  +   +   +   +    +      +++  +   L  +H+ 
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---LNGVHYL 124

Query: 734 HSTPIIHCDLKPSNVLL----DEDMVAHISDFGIA-------KLLSGEDQLSIQIQTLAT 782
           HS  ++H DLKP+N+L+     E  V  I D G+A       K L+  D + +      T
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV------T 178

Query: 783 IGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGE 826
           I Y APE     R  T+  D+++ G +  E+ T  +P   IF G 
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEP---IFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 18/226 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGM-----EVAVK-VFHQQYERALKSFEDECEVMKRI 670
           DR + ++L+  G+FG I+   L D       EV VK V     E  +     E  ++  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 671 RHRNLVKIISSCSND-DFKALIMKYMPNGSL----ENCLYSGTCM---LDIFQRLNIMID 722
            H+N++ I+  C  D +   ++  YM  G+L    + C          L   Q +++ I 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           +A  + YLH      +IH D+   N ++DE++   I+D  +++ L   D   +       
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGEL 827
           + +MA E        +  DV+S+G++L E+ T  + P  EI   E+
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 11/205 (5%)

Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRN 674
           F    ++G G FG +   +++  G   A K   ++  +  K      +E  +++++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V +  +    D   L++  M  G L+  +Y+ G    D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
               I++ DLKP N+LLD+     ISD G+A  +   + +  ++    T+GYMAPE    
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVINN 175

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +     D +  G ++ EM   + P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 28/209 (13%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS- 681
           +IG G FG +Y  R  D G   A+K   +   + +K  + E   +     R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNE---RIMLSLVSTG 54

Query: 682 ------CSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
                 C    F        I+  M  G L   L       +   R     ++ L LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ T GYMAPE 
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166

Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             KG    +  D +S G ML ++     P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 45/200 (22%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 624 LIGIGSFGSIYVARLQ----DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKI 678
           ++G G FG +    L+      + VA+        ++  + F  E   + +  H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL-HFGHSTP 737
               +  +   ++ +YM NG+L++ L      L   Q + ++  +A  ++YL   G+   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL---ATIGYMAPEYGTKG 794
            +H  L    VL++ D+V  IS F   +    ED+      T+   + + + APE     
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 795 RVCTRGDVYSYGIMLMEMFT 814
              +  DV+S+GI++ E+ +
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 624 LIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + +A L+   E  AVK   +  +  L   + EC  V KR+      +  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKK--DVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            +  +    +    +M+++  G L   +       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
            II+ DLK  NV+LD D    I+DFG+ K  + G+++ S       T  Y+APE     +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS---TFCGTPDYIAPEILQGLK 172

Query: 796 VCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
                D +S+G++L EM   + P      DE+F
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 10/126 (7%)

Query: 693 KYMPNGSLENCL----YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV 748
           K   +  ++N L      G   LD+   L+    VA  +E+L    S   +H DL   NV
Sbjct: 215 KGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFLA---SKNCVHRDLAARNV 268

Query: 749 LLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM 808
           LL +  +  I DFG+A+ +  +     +  T   + +MAPE        T  DV+SYGI+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328

Query: 809 LMEMFT 814
           L E+F+
Sbjct: 329 LWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 68/239 (28%), Positives = 115/239 (48%), Gaps = 45/239 (18%)

Query: 625 IGIGSFGSIYVAR---LQDGMEVAVK----VFHQQY--ERALKSFEDECEVMKRIR-HRN 674
           +G G++G +  AR     +   VA+K    VF ++   +RAL+    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 675 LVKI----ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD------IFQRLNIMIDVA 724
           +  +    I    N +   L  + M    L   + SG  + D      I+Q L       
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL------- 115

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS---GEDQLSIQIQTLA 781
             L+Y+H   S  ++H DLKP N+L++ D    I DFG+A+  S   GE+   +  + +A
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT-EYVA 171

Query: 782 TIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV 839
           T  Y APE     +  T+  DV+S G +L E    +KP   +F G+  +++ +N +L V
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYVDQ-LNQILQV 225

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 50.0 bits (120), Expect = 3e-08
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 2/41 (4%)

Query: 33 TDQQALLALKAHISYDHTNLFARNWTSSTSV-CSWIGITCD 72
           D+ ALLA K+ ++ D +   + +W  S+S  CSW G+TCD
Sbjct: 3  DDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           ++ L LE++H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ 
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 157

Query: 782 TIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           T GYMAPE   KG    +  D +S G ML ++     P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 35/219 (15%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVKVFHQQY--ER----ALKSFEDECEVMKRIRHRNLVK 677
           +G G FG + +A  +   E+ A+K   +     R    +L   +   E     RH  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCML----DIFQRLNIMI---DVALALEYL 730
           + +    +D    +M+Y   G L         M+    D+F     +     V L L+YL
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDL---------MMHIHTDVFSEPRAVFYAACVVLGLQYL 117

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE 789
           H      I++ DLK  N+LLD +    I+DFG+ K   G      +  T   T  ++APE
Sbjct: 118 H---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPE 171

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
             T+       D +  G+++ EM   + P      +E+F
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKV--FHQQYERALKSFEDECEVMKRIRHR 673
           D++ +   IG G++G +Y AR +   E +A+K     Q+ E    +   E  ++K ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL--ALEYLH 731
           N+V++     ++    L+ +Y+    L+   +  +     F +   +I   L   L  + 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIA 116

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVA-HISDFGIAKLLSGEDQLSIQIQT----LATIGYM 786
           + HS  ++H DLKP N+L+D    A  ++DFG+A+         I ++T    + T+ Y 
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWYR 170

Query: 787 APE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   G++    T  D++S G +  EM  +K
Sbjct: 171 APEILLGSR-HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 40/222 (18%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLV 676
           ++G GSFG + +A L+   EV A+KV  +  +  L+  + +C +  KRI     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKK--DVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN---------IMIDVALAL 727
            +       D    +M+Y+  G L         M  I QR              +V LAL
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDL---------MFQI-QRSRKFDEPRSRFYAAEVTLAL 109

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYM 786
            +LH      +I+ DLK  N+LLD +    ++DFG+ K        +    T   T  Y+
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYI 163

Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
           APE   +       D ++ G+++ EM   + P      D++F
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 63/246 (25%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVK------VFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           IGIG+FG + + R  D   + A+K      V  +     +K+   E +++    +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ----RLNIMIDVALALEYLHFG 733
           +  S  + D    +M Y+P G + + L      L IF+    R  I  ++  A+E +H  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESVH-- 118

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIA----------------------------- 764
                IH D+KP N+L+D D    ++DFG+                              
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 765 -----------KLLSGEDQLSIQIQTL-ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEM 812
                      +             +L  T  Y+APE   +       D +S G++L EM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 813 FTKKKP 818
              + P
Sbjct: 238 LVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 17/206 (8%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + V +L++  +V A+K+ +  +  +RA  + F +E +V+    ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +  +++   L+M Y   G L   L      L        + ++ +A++ +H  H    +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YV 124

Query: 740 HCDLKPSNVLLDEDMVAHISDFG-IAKLLS-GEDQLSIQIQTLATIGYMAPEY-----GT 792
           H D+KP N+L+D +    ++DFG   KL+  G  Q S+ +    T  Y++PE        
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV---GTPDYISPEILQAMEDG 181

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
           KG+     D +S G+ + EM   + P
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRH 672
           D F    +IG G+FG + V ++++  +V A+K+ +  +  +RA  + F +E +V+     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL-- 730
           R +  +  +  +++   L+M Y          Y G  +L +  +    +   +A  YL  
Sbjct: 61  RWITNLHYAFQDENNLYLVMDY----------YVGGDLLTLLSKFEDRLPEDMARFYLAE 110

Query: 731 -----HFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFG-IAKLLS-GEDQLSIQIQTLA 781
                   H    +H D+KP NVLL  D   HI  +DFG   +LL+ G  Q ++ +    
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAV---G 165

Query: 782 TIGYMAPEY-----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           T  Y++PE        KGR     D +S G+ + EM   + P
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.5 bits (133), Expect = 7e-08
 Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 17/169 (10%)

Query: 655 RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK--------YMPNGSLENCLYS 706
           RA    E+E   + R+ H N++KI     ++    +I +        +M + + +   + 
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---WK 261

Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
              +L   Q   IM  +  A+EY+H      +IH D+K  N+ L+ D    + DFG A  
Sbjct: 262 DRPLL--KQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
              E + +     + T+   +PE       C   D++S G++L++M + 
Sbjct: 317 FEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.1 bits (131), Expect = 9e-08
 Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 36/206 (17%)

Query: 628 GSFGSIYVARLQDGMEVAVKVFHQQYERALKSF-EDECEV---MKRIRHRNLVKIISSCS 683
           G FG + V + +       K+F Q+  +A K+F   E  V   MK   + N +K+  S +
Sbjct: 27  GKFGKVSVLKHKPTQ----KLFVQKIIKA-KNFNAIEPMVHQLMKD--NPNFIKLYYSVT 79

Query: 684 NDDFKALIMKYMPNGSL------ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
                 LIM Y+ +G L      E  L        I Q +        AL  LH  +   
Sbjct: 80  TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVE-------ALNDLHKHN--- 129

Query: 738 IIHCDLKPSNVLLDEDMV-AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           IIH D+K  NVL D      ++ D+G+ K+       S    TL    Y +PE   KG  
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD---YFSPE-KIKGHN 182

Query: 797 CTRG-DVYSYGIMLMEMFTKKKPTDE 821
                D ++ G++  E+ T K P  E
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 1/92 (1%)

Query: 150 VTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS 209
           +  + L   GL G +P +I  L +L  +  + N++ G  P ++ ++++L+ + L  NS +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 210 GSLPSRIDLSLPNVETLNLGINSFYGTVPSSI 241
           GS+P  +   L ++  LNL  NS  G VP+++
Sbjct: 480 GSIPESLGQ-LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 3/117 (2%)

Query: 698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH 757
            S +      +  LD+   L     VA  +++L    S   IH D+   NVLL +  VA 
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAK 252

Query: 758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           I DFG+A+ +  +    ++      + +MAPE         + DV+SYGI+L E+F+
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 13/146 (8%)

Query: 624 LIGIGSFG--SIYVARLQD-GMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKI 678
           LIG        +++A+ +     VAVK  +     +  LK  + E    ++++H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHS 735
           ++S   D    ++   M  GS E+ L +     +    L    I+ DV  AL+Y+   HS
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYI---HS 119

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDF 761
              IH  +K S++LL  D    +S  
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 632 SIYVARLQDGMEVAVKVF---HQQYERALKSFEDECEVMKRIRHRNLVKI----ISSCSN 684
           SIY     +  EV ++ F   H+ ++  +   E+E + ++RI   N++KI    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
               +LI++Y   G L   L      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP--------EYGTKGRV 796
             + L+ E+    I   G+ K+LS     S   + +  + Y +         EY  K   
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFSEYTIKD-- 203

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
               D+YS G++L E+FT K P
Sbjct: 204 ----DIYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRI-RHRNLVKII 679
           ++G G++G +Y  R ++ G   A+KV    +  E  +K    E  ++K+   HRN+    
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYY 79

Query: 680 ------SSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLH 731
                 S   +DD   L+M++   GS+ + + +  G  + + +    I  ++   L +LH
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH 138

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY- 790
                 +IH D+K  NVLL E+    + DFG++  L  +  +  +   + T  +MAPE  
Sbjct: 139 AHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVI 193

Query: 791 ----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                       R D++S GI  +EM     P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 18/199 (9%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLVKIISSC 682
           +G G++GS+Y    +  G+ +A+K    + + +       E +++ +     +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALALEYLHFGHSTPII 739
             +    + M+YM  GSL+  LY+G    +         I   V   L++L   H+  II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           H D+KP+NVL++ +    + DFG+    SG    S+    +    YMAPE    G     
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 800 G------DVYSYGIMLMEM 812
                  DV+S G+ ++EM
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 16/219 (7%)

Query: 624 LIGIGSFGSIYVA--RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           ++G GSFG   +      D      ++   +   A++    E  ++ +++H N+V    S
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-LNIMIDVALALEYLHFGHSTPIIH 740
              D    ++M+Y   G L   +      L      L   + + L ++++H      ++H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLH 123

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+K  N+ L ++    + DFG A+LL+     +     + T  Y+ PE         + 
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPYNNKS 181

Query: 801 DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV 839
           D++S G +L E+ T K P           N W N +L V
Sbjct: 182 DIWSLGCILYELCTLKHP--------FQANSWKNLILKV 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 19/100 (19%)

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--------SGEDQLS 774
           VA  +E+L    S   IH DL   N+LL E+ V  I DFG+A+ +         G+ +L 
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++        +MAPE        T+ DV+S+G++L E+F+
Sbjct: 239 LK--------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.3 bits (116), Expect = 2e-07
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 473 NLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL 532
           NL+ + L  NRL      +F  L +L+VLDLS N ++   P +   L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 10/199 (5%)

Query: 624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
           L+G G+FG + + R +  G   A+K+  ++   A         E  V++  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +    D    +M+Y   G L   L       +   R     ++  ALEYLH   S  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           + D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE          
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D +  G+++ EM   + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 711 LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
           LD    L+    VA  + +L    S   IH DL   N+LL    +  I DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
               ++      + +MAPE           DV+SYGI+L E+F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 28/203 (13%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVMKRIRHRN--------- 674
           IG G+FG +Y  R +D   + A+KV  ++   A K      EV   I  RN         
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 675 ---LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI-DVALALEYL 730
              +V +  S   D    L+  YM  G L   L       +   R    I ++ LALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHL 112

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H      I++ DLKP N+LLD      + DFG++K    +++ +       T  Y+APE 
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEV 167

Query: 791 GTKGRVCTRG-DVYSYGIMLMEM 812
               +  T+  D +S G+++ EM
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 53/227 (23%), Positives = 103/227 (45%), Gaps = 36/227 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           ++F    ++G G++G +   R ++  E VA+K F   ++ E   ++   E ++++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 674 NLVKIISSCSNDDFKALIMKY-----------MPNGSLENCLYSGTCMLDIFQRLNIMID 722
           N+V++  +        L+ +Y           MPNG     + S      I+Q       
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY-----IYQ------- 108

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
               ++ +H+ H   I+H D+KP N+L+  + V  + DFG A+ LS E   +   + +AT
Sbjct: 109 ---LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLME------MFTKKKPTDEIF 823
             Y +PE           D++S G +L E      +F  +   D++F
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 3/119 (2%)

Query: 696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 755
           P  +  + L + +  L     +     VA  +E+L    S   +H DL   NVL+ E  +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277

Query: 756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I DFG+A+ +  +     +  T   + +MAPE        T  DV+S+GI+L E+FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.4 bits (126), Expect = 6e-07
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 23/205 (11%)

Query: 625 IGIGSFGSIY-VARLQDGMEVAVK----VFHQ--QYERALKSFEDECEVMKRIRHRN--- 674
           IG G+FG ++ V   +DG  VA+K    VF      +R  +    E +++   +H N   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63

Query: 675 LVKIISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            + I+     D F+ +  + + M    L   + S   +     ++  +  +   L+YLH 
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH- 120

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  I+H D+KP N+L++ + V  I DFG+A+ +   D+     Q + T  Y APE   
Sbjct: 121 --SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILM 177

Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKK 816
             R  T   D++S G +  E+  ++
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 30/138 (21%), Positives = 61/138 (44%), Gaps = 19/138 (13%)

Query: 635 VARLQDGME-VAVKVFHQQYERALKSFEDECEVMKRIRHRNLV--KIISSCSNDDFKALI 691
           V  L    E   +K+   + + A    E E  +++ +  + L   K+++S  +D +  L+
Sbjct: 14  VYLLGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLASGESDGWSYLL 71

Query: 692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI---IHCDLKPSNV 748
           M+++   +L+         +   ++ +I   +A   E L   H  P+    H DL P N+
Sbjct: 72  MEWIEGETLDE--------VSEEEKEDIAEQLA---ELLAKLHQLPLLVLCHGDLHPGNI 120

Query: 749 LLDEDMVAHISDFGIAKL 766
           L+D+  +  I D+  A  
Sbjct: 121 LVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 66/226 (29%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK--SFEDECE-----------VMKRIR 671
           IG G++G+++ A+ ++  E+           ALK    +D+ E           ++K ++
Sbjct: 8   IGEGTYGTVFKAKNRETHEIV----------ALKRVRLDDDDEGVPSSALREICLLKELK 57

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI---FQRLNIMIDVALA-- 726
           H+N+V++     +D    L+ +Y              C  D+   F   N  ID  +   
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEY--------------CDQDLKKYFDSCNGDIDPEIVKS 103

Query: 727 -----LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-------KLLSGEDQLS 774
                L+ L F HS  ++H DLKP N+L++++    ++DFG+A       +  S E    
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE---- 159

Query: 775 IQIQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                + T+ Y  P+  +G K    T  D++S G +  E+    +P
Sbjct: 160 -----VVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 624 LIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLV 676
           ++G GSFG + +ARL + G   AVKV  +  +  L+  + EC +  KRI      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKK--DVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI-----FQRLNIMIDVALALEYLH 731
           ++       D    +M+++  G L         M  I     F         A     L 
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL---------MFHIQKSRRFDEARARFYAAEITSALM 110

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
           F H   II+ DLK  NVLLD +    ++DFG+ K   G            T  Y+APE  
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
            +       D ++ G++L EM     P      D++F
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E+ V  I DFG+A+ +  +     +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE        T+ DV+S+G++L E+F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + +A  +   E+ A+K+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKK--DVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ--RLNIMIDVALALEY---LH 731
           ++ S     D    +M+Y+  G L         M  I Q  +      V  A E    L 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE- 789
           F HS  II+ DLK  NV+LD +    I+DFG+ K      + +   +T   T  Y+APE 
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEI 172

Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
             Y   G+     D +++G++L EM   + P D
Sbjct: 173 IAYQPYGKSV---DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 8/149 (5%)

Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRN 674
           F +   +GIG+FG + +A   D     A+K   ++       +   + E +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK+  S  + D    +M Y+P G + + L       ++  R  I  ++ LA+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGI 763
               IH D+KP N+L+D D    ++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 14/186 (7%)

Query: 628 GSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF 687
           GS G ++VA  + G    V +   Q    L     E  +++ + H +++++  +  +   
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQKGTTLI----EAMLLQNVNHPSVIRMKDTLVSGAI 131

Query: 688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSN 747
             +++ +  +  L   L   +  L I Q L I   +   L YLH      IIH D+K  N
Sbjct: 132 TCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH-AQR--IIHRDVKTEN 187

Query: 748 VLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYG 806
           + +++     I D G A+  +     L +      T+   APE   + +  ++ D++S G
Sbjct: 188 IFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVETNAPEVLARDKYNSKADIWSAG 243

Query: 807 IMLMEM 812
           I+L EM
Sbjct: 244 IVLFEM 249

Length = 357

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + +A  +   E+ A+K+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKK--DVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++ S     D    +M+Y+  G L   +Y    +    +   +     +++  L F H  
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVG-LFFLHRR 120

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTL-ATIGYMAPE---Y 790
            II+ DLK  NV+LD +    I+DFG+ K  ++ G     +  +T   T  Y+APE   Y
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-----VTTRTFCGTPDYIAPEIIAY 175

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
              G+     D ++YG++L EM   + P D
Sbjct: 176 QPYGKSV---DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)

Query: 625 IGIGSFGSIY--VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNLVKIISS 681
           +G GS+ ++Y  ++R+ +G  VA+KV   + E  +  +   E  ++K ++H N+V +   
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 682 CSNDDFKALIMKYM-----------PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
               +    + +YM           P G     L+     L +FQ L         L Y+
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-------GLAYI 119

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT----LATIGYM 786
           H  H   I+H DLKP N+L+       ++DFG+A+        SI  QT    + T+ Y 
Sbjct: 120 HGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWYR 170

Query: 787 APE--YGTKGRVCTRGDVYSYGIMLMEMF 813
            P+   G      +  D++  G + +EM 
Sbjct: 171 PPDVLLGAT-DYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 42/223 (18%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + +A  +   E+ A+K+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKK--DVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ--RLNIMIDVALALEY---LH 731
           ++ S     D    +M+Y+  G L         M  I Q  R      V  A E    L 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---------MYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTL-ATIGYMAP 788
           F HS  II+ DLK  NV+LD +    I+DFG+ K  +  G     +  +T   T  Y+AP
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-----VTTKTFCGTPDYIAP 170

Query: 789 E---YGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
           E   Y   G+     D +++G++L EM   + P      DE+F
Sbjct: 171 EIIAYQPYGKSV---DWWAFGVLLYEMLAGQAPFEGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRH 672
           D F    +IG G+FG + V +++    + A+K+ +  +  +RA  + F +E  V+     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           + +  +  +  ++++  L+M Y   G L   L      L        + ++ LA+  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFG--IAKLLSGEDQLSIQIQTLATIGYMAPE- 789
            H    +H D+KP NVLLD +    ++DFG  +     G  Q S+ +    T  Y++PE 
Sbjct: 121 LH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV---GTPDYISPEI 174

Query: 790 -------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   G  G  C   D +S G+ + EM   + P
Sbjct: 175 LQAMEDGMGKYGPEC---DWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.0 bits (122), Expect = 3e-06
 Identities = 40/131 (30%), Positives = 59/131 (45%), Gaps = 26/131 (19%)

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
           L N  L G +P+ I   L +++++NL  NS  G +P S+ + + L  L+L  N F+G IP
Sbjct: 425 LDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Query: 263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII-L 321
            +                  L  LT+   L++L L GN L G +P + G   L       
Sbjct: 484 ES------------------LGQLTS---LRILNLNGNSLSGRVPAALGGRLLHRASFNF 522

Query: 322 MDN---CSISG 329
            DN   C I G
Sbjct: 523 TDNAGLCGIPG 533

Length = 623

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E+ V  I DFG+A+ +  +     +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+S+G++L E+F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 27/226 (11%)

Query: 618 RFSENNLIGIGSFGSIYVARLQD--GMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           R+ +   IG G+ G I  A      G+ VAVK   + ++    A +++  E  ++K + H
Sbjct: 22  RYQQLKPIGSGAQG-IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79

Query: 673 RNLVKIIS----SCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +N++ +++      S ++F+   L+M+ M + +L   ++     LD  +   ++  +   
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCG 135

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           +++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  + T     Y 
Sbjct: 136 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---YR 189

Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           APE           D++S G ++ E+         IF G   +++W
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 8/149 (5%)

Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRN 674
           F +   +GIG+FG + +AR  D     A+K   ++       +   + E +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V++  S  + D    +M Y+P G + + L       +   R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGI 763
               IH D+KP N+L+D D    ++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 32/247 (12%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE------RALKSFEDECEVMKRI 670
           R+    +IG GS+G +  A     G +VA+K  +  +E      R L+    E ++++ +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLL 56

Query: 671 RHRNLVK---IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           RH ++V+   I+   S  +FK +   Y+    +E+ L+      D     +    +   L
Sbjct: 57  RHPDIVEIKHIMLPPSRREFKDI---YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL 113

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-QIQTLATIGYM 786
             L + H+  + H DLKP N+L + D    I DFG+A++   +   +I     +AT  Y 
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 787 APEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG-----ELSLNRWINDLLPV 839
           APE       +     D++S G +  E+ T K     +F G     +L L   I DLL  
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKNVVHQLDL---ITDLLGT 226

Query: 840 SVMEVID 846
              E I 
Sbjct: 227 PSPETIS 233

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 40/224 (17%)

Query: 611 ELLRATDR-FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQ--QYERALKSFEDECEV 666
           ++ R+ ++ +   N+IG GSFG +Y A   D  E VA+K   Q  QY+        E  +
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR------ELLI 112

Query: 667 MKRIRHRNLVKIISSCSNDDFKA--------LIMKYMPNGSLENCLYSGTCMLDIFQRLN 718
           MK + H N++ +      + FK         ++M+++P    +   +        + R N
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH--------YARNN 164

Query: 719 IMIDVALALEY-------LHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAK-LLSG 769
             + + L   Y       L + HS  I H DLKP N+L+D +     + DFG AK LL+G
Sbjct: 165 HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 770 EDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEM 812
           +  +S     + +  Y APE         T  D++S G ++ EM
Sbjct: 225 QRSVSY----ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED---------ECEVMKRIRHRNL 675
           +G G++G +Y A+ +DG +        + E ALK  E          E  +++ ++H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 676 VKIISS-CSNDDFKALIMKYMPNGSLENCL---YSGTCMLDIFQRLNIMIDVAL--ALEY 729
           + +     S+ D K  ++       L + +    +        Q    M+   L   L+ 
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 730 LHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIG 784
           +H+ H+  ++H DLKP+N+L+     E     I+D G A+L +     L+     + T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 785 YMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           Y APE     R  T+  D+++ G +  E+ T +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIIS 680
           IG GSFG +   R +D   + A+K   + +      +     E  V+ ++    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           S  + +   L++ ++  G L + L       D+ +      ++  ALE LH      +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
            DLKP N+LLD      + DFG+ KL +  +D+ +       T  Y+APE          
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN---TFCGTPEYLAPELLLGHGYTKA 173

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D ++ G++L EM T   P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 22/205 (10%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
           L+G G+FG + + R +   +  A+K+  ++   A         E  V++  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            S    D    +M+Y   G L   L       +   R     ++  AL YLH   S  ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCDVV 117

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEY---GTK 793
           + DLK  N++LD+D    I+DFG+ K     + +S         G   Y+APE       
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
           GR     D +  G+++ EM   + P
Sbjct: 173 GRAV---DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.4 bits (115), Expect = 8e-06
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 41/225 (18%)

Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERA---LKSFEDECEVMKRIRHRNLVKIIS 680
           LIG G FG +Y        E      H    +A   +++ E+E  VM+ + + N+  I  
Sbjct: 19  LIGCGGFGCVY--------ETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70

Query: 681 SCSNDDFKAL----IMKYMPNGSLENC-LYSGTCMLD--------IFQRL---------N 718
                +   +    I KY   GS + C +Y    +L+        IF+R+         N
Sbjct: 71  IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGED-QLSI 775
           IM D+   LEY+H      I H D+KP N+++D +   +I D+GIA   ++ G+  + S 
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 776 QIQTL--ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           + + L   T+ Y   +      V  RGD+ S G  +++    K P
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 37/213 (17%)

Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE------RALKSFEDECEVMKRI 670
           R+     IG G+ G +  A     G  VA+K   + ++      RA +       +MK +
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLV 72

Query: 671 RHRNLVKIIS----SCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            H+N++ +++      S ++F+   L+M+ M + +L   +     M    +R++ ++   
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ----MDLDHERMSYLLYQM 127

Query: 725 L-ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           L  +++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  + T    
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 182

Query: 784 GYMAPE----YGTKGRVCTRGDVYSYGIMLMEM 812
            Y APE     G K  V    D++S G ++ EM
Sbjct: 183 -YRAPEVILGMGYKENV----DIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 9/199 (4%)

Query: 624 LIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
           L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            S    D    +M+Y   G L   L       +   R     ++  AL+YLH      ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           + DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE          
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D +  G+++ EM   + P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.6 bits (115), Expect = 1e-05
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 36/226 (15%)

Query: 625 IGIGSFGSIYVA---RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G FG +++    R Q+        +    ER       E  VM+ ++H+N+V+ I  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 682 CSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLHFGHST 736
             N   + L  +M++   G L   +     M    +    ++I   +  AL Y H     
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 737 P----IIHCDLKPSNVLLDEDM-----------------VAHISDFGIAKLLSGEDQLSI 775
           P    ++H DLKP N+ L   +                 +A I DFG++K +  E   S+
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SM 197

Query: 776 QIQTLATIGYMAPE---YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               + T  Y +PE   + TK     + D+++ G ++ E+ + K P
Sbjct: 198 AHSCVGTPYYWSPELLLHETKS-YDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)

Query: 623 NLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLV 676
           NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N++
Sbjct: 28  NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLHF 732
                        L+  + P  SLE    +Y    ++D  + Q + + +D    + YL +
Sbjct: 87  ------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLY 133

Query: 733 G--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
                    HS  IIH DLKPSN+++  D    I DFG+A+       ++  + T     
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 190

Query: 785 YMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YRAPEVILGMGYKENV----DIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+   ++ A+KV  ++    +  +   + E  V ++      +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 680 SSCSNDDFKA-LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC     +  L+++Y+  G L   +     + +   R     ++ +AL +LH      I
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           I+ DLK  NVLLD D    ++D+G+ K  L  G+   +       T  Y+APE       
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF----CGTPNYIAPEILRGEEY 173

Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
               D ++ G+++ EM   + P D I
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 41/181 (22%), Positives = 84/181 (46%), Gaps = 22/181 (12%)

Query: 643 EVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
            V +KV    +  +L +F +   +M ++ H++LVK+   C  D+   ++ +Y+  G L+ 
Sbjct: 32  SVVLKVLGSDHRDSL-AFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDV 89

Query: 703 CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-------MV 755
            L+     + +  +L++   +A AL YL       ++H ++   N+L+            
Sbjct: 90  FLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPF 146

Query: 756 AHISDFGIAK-LLSGEDQLSIQIQTLATIGYMAPEY--GTKGRVCTRGDVYSYGIMLMEM 812
             +SD GI   +LS E+++         I ++APE     +  +    D +S+G  L+E+
Sbjct: 147 IKLSDPGIPITVLSREERVE-------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Query: 813 F 813
            
Sbjct: 200 C 200

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 50/242 (20%), Positives = 98/242 (40%), Gaps = 59/242 (24%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D + +   IG G++G +Y AR    G  VA+K       +     ++E      +R  +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISL 53

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------------ 717
           ++++S       + L ++++   + +  LY       +F+ L                  
Sbjct: 54  LQMLSES-IYIVRLLDVEHVEEKNGKPSLYL------VFEYLDSDLKKFMDSNGRGPGRP 106

Query: 718 -------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSG 769
                  + M  +   + + H      ++H DLKP N+L+D+   +  I+D G+ +    
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR---- 159

Query: 770 EDQLSIQIQT----LATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFI 824
               SI +++    + T+ Y APE         T  D++S G +  EM  K+     +F 
Sbjct: 160 --AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP----LFP 213

Query: 825 GE 826
           G+
Sbjct: 214 GD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 49/226 (21%)

Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI---- 670
           TD +     IG G++G +Y V   +DG   AVK+        +   ++E E    I    
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75

Query: 671 -RHRNLVKIISSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLN------ 718
             H N+VK        D        L+++    GS+   L  G  +L   QRL+      
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE-LVKG--LLICGQRLDEAMISY 132

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           I+    L L++LH   +  IIH D+K +N+LL  +    + DFG++  L+     S +++
Sbjct: 133 ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-----STRLR 184

Query: 779 TLATIG---YMAPE---------YGTKGRVCTRGDVYSYGIMLMEM 812
              ++G   +MAPE         Y    R     DV+S GI  +E+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 8/152 (5%)

Query: 617 DRFSENNLIGIGSFGSI-YVARLQDGMEVAVKVF--HQQYER-ALKSFEDECEVMKRIRH 672
           + F    +IG G+FG +  V +   G   A+K     + +++  L   + E +V+     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             +V +  S  +  +  LIM+++P G L   L       +   R   M +  LA+E +H 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH- 118

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
                 IH D+KP N+L+D      +SDFG++
Sbjct: 119 --KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 22/56 (39%), Positives = 28/56 (50%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKI 508
           L+ S N L+        GL NL+ + L  N L    PE+F  L SL  LDLS N +
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 625 IGIGSFGSIYVA---RLQDG-----MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +G G+F  I+      + D       EV +KV  + +    +SF +   +M ++ H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
                C   D   ++ +Y+  GSL+  L     +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119

Query: 737 PIIHCDLKPSNVLL--DEDMVA------HISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            + H ++   NVLL  +ED          +SD GI+  +  ++ L      L  I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIPWVPP 173

Query: 789 EYGTKGRVCT-RGDVYSYGIMLMEMFT 814
           E     +  +   D +S+G  L E+F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 39/147 (26%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 625 IGIGSFGSIYVAR--LQDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G++ +++  R  L + + VA+K    ++E  A  +   E  ++K ++H N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              D    L+ +Y+ +  L+   Y   C  +I    N+ I +   L  L + H   ++H 
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQ--YMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLS 768
           DLKP N+L++E     ++DFG+A+  S
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKS 155

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+    + A+KV  ++    +  +   + E  V ++  +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 680 SSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC   + +   +++Y+  G L   +     + +   R     +++LAL YLH      I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           I+ DLK  NVLLD +    ++D+G+ K  L  G+   +       T  Y+APE       
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEILRGEDY 173

Query: 797 CTRGDVYSYGIMLMEMFTKKKPTD 820
               D ++ G+++ EM   + P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 623 NLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVK 677
           NL  IGS     V    D +    VA+K   + ++     K    E  +MK + H+N++ 
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 678 IISSCSN----DDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           +++  +     ++F+   L+M+ M      N        LD  +   ++  +   +++LH
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
              S  IIH DLKPSN+++  D    I DFG+A+       ++  + T     Y APE  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEVI 190

Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
              G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 191 LGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 67/232 (28%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED---------ECEVMKRIRHRNL 675
           +G G++G +Y A+ +DG +          + ALK  E          E  +++ ++H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKD--------DRDYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 676 VKIISS-CSNDDFKA-LIMKY-----------------------MPNGSLENCLYSGTCM 710
           + +     S+ D K  L+  Y                       +P G +++ LY     
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ---- 116

Query: 711 LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKL 766
                           L+ +H+ H+  ++H DLKP+N+L+     E     I+D G A+L
Sbjct: 117 ---------------ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 767 LSGE-DQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
            +     L+     + T  Y APE     R  T+  D+++ G +  E+ T +
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 20/100 (20%)

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMA 787
           L+F H   II+ DLK  NVLLD +    ++D+G+ K  +  G+   +       T  Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF----CGTPNYIA 164

Query: 788 PEYGTKGRVCTRGDVYSY-------GIMLMEMFTKKKPTD 820
           PE         RG+ Y +       G+++ EM   + P D
Sbjct: 165 PE-------ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.5 bits (107), Expect = 5e-05
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISS 681
           L+G G++G +Y  R ++ G   A+KV     +   +  + E  ++K+   HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71

Query: 682 C------SNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFG 733
                    DD   L+M++   GS+ + + +  G  + + +    I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH-- 128

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
               +IH D+K  NVLL E+    + DFG++  L  +  +  +   + T  +MAPE    
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 791 --GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                     + D++S GI  +EM     P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 83/295 (28%), Positives = 127/295 (43%), Gaps = 35/295 (11%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L+++   L+  I   L  L++L +LDL +N ++   P        LK L  SDN++  SL
Sbjct: 98  LDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
              + N+ ++  +DLS N LS ++P+ + NL  L  L   + N +   P  I  +SAL+E
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD-LSGNKISDLPPEIELLSALEE 213

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF 260
           + L NNS+   L S  +L   N+  L L  N     +P SI N S L  L+L  N     
Sbjct: 214 LDLSNNSIIELLSSLSNLK--NLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQ---- 266

Query: 261 IPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII 320
                              +S +SSL +   L+ L L+GN L   LP     L L   ++
Sbjct: 267 -------------------ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307

Query: 321 LMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
            +     +      +     LL   +  N  T   P   S L++L  L    N L
Sbjct: 308 NLLLTLKALE----LKLNSILLNNNILSNGETS-SPEALSILESLNNLWTLDNAL 357

Length = 394

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 45/207 (21%), Positives = 90/207 (43%), Gaps = 25/207 (12%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKR------IRHRNLVKI 678
           IG G FG + ++ +     VA  V  +   +A  S +++ E +++      ++H N+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS-----GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +  C       L+ +Y   G L++ L           L + QR+    ++A  + ++H  
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKH 118

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT- 792
           +    +H DL   N  L  D+   + D+GI      ED +  +      + ++APE    
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 793 -KGRVCTR-----GDVYSYGIMLMEMF 813
             G + T       +V++ G+ L E+F
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 35/212 (16%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D + +   +G GS+ ++Y  + + +G  VA+KV   Q E     +   E  ++K ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 675 LVKIISSCSNDDFKALIMKYM-----------PNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           +V +       +   L+ +Y+           P G     L+     L +FQ L      
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR----- 114

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
              L Y+H  +   I+H DLKP N+L+ +     ++DFG+A+  S           + T+
Sbjct: 115 --GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTL 167

Query: 784 GYMAPEY---GTKGRVCTRGDVYSYGIMLMEM 812
            Y  P+     T+   C   D++  G + +EM
Sbjct: 168 WYRPPDVLLGSTEYSTCL--DMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 51/239 (21%), Positives = 94/239 (39%), Gaps = 41/239 (17%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQ---YERALKSFEDECEVMKRIRH 672
           D F    +IG G+FG + + + +D G   A+K+  +     +  +     E +++     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             +VK+  S  +     LIM+++P G +   L     + +   +  I  +  LA++ +H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH- 118

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS------------------------ 768
                 IH D+KP N+LLD      +SDFG+   L                         
Sbjct: 119 --QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 769 ---------GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                     +++  +   T+ T  Y+APE   +       D +S G+++ EM     P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 1/76 (1%)

Query: 302 LDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQ 361
           L G +P     L   L+ I +   SI GNIP  +G++ +L VL+L  N+    IP +  Q
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 362 LQTLQALGLTRNKLAG 377
           L +L+ L L  N L+G
Sbjct: 489 LTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 12/149 (8%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSC 682
           +G G++ +++  R +     VA+K    ++E  A  +   E  ++K ++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 683 SNDDFKALIMKYMPNG---SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
             +    L+ +Y+ +     L+NC   G  M       N+ I +   L  L + H   I+
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNC---GNLM----SMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
           H DLKP N+L++E     ++DFG+A+  S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 41/237 (17%)

Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRN 674
           F    +IG G+FG + + + +D G   A+K+  +     +  +     E +++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK+  S  +     LIM+++P G +   L     + +   +  I  +  LA++ +H   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-------------------------- 768
               IH D+KP N+LLD      +SDFG+   L                           
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 769 -------GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    ++  +   T+ T  Y+APE   +       D +S G+++ EM     P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 24/67 (35%), Positives = 45/67 (67%), Gaps = 1/67 (1%)

Query: 290 KKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGN 349
           + L+ + L+GN + G +P S G+++ SLE++ +   S +G+IP+ +G L +L +L L GN
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 350 NLTEPIP 356
           +L+  +P
Sbjct: 501 SLSGRVP 507

Length = 623

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 1e-04
 Identities = 28/80 (35%), Positives = 48/80 (60%), Gaps = 10/80 (12%)

Query: 690 LIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLHFGHSTPIIHCDLKPS 746
           L+M+Y+  G +++ L+    +   F     +  + +VALAL+YLH  H   IIH DLKP 
Sbjct: 81  LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLH-RHG--IIHRDLKPD 133

Query: 747 NVLLDEDMVAHISDFGIAKL 766
           N+L+  +    ++DFG++K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 21/201 (10%)

Query: 625 IGIGSFGSIYVAR--LQDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G++ ++Y  R  L D + VA+K    ++E  A  +   E  ++K ++H N+V +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+ +Y+ +  L+   Y   C  +     N+ + +   L  L++ H   ++H 
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQ--YLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT----LATIGYMAPE--YGTKGR 795
           DLKP N+L++E     ++DFG+A+        SI  +T    + T+ Y  P+   G+   
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPDILLGST-D 181

Query: 796 VCTRGDVYSYGIMLMEMFTKK 816
             T+ D++  G +  EM T +
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 36/160 (22%)

Query: 624 LIGIGSFGSIYVARLQD-GMEVAVK------------VFHQQYERALKSFEDECEVMKRI 670
           +IG G+FG + + + +D G   A+K            V H + ER + +  D   V    
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV---- 63

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALAL 727
                VK+  S  ++++  LIM+Y+P G +   L       D F   +    + +  LA+
Sbjct: 64  -----VKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAI 114

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAK 765
           + +H       IH D+KP N+LLD     HI  SDFG+  
Sbjct: 115 DSIH---KLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 66/242 (27%)

Query: 615 ATDRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQ--QYERALKSFEDECEVMKRIR 671
           +T RF   +L+G G+FG +  A  +   E  AVK+     +Y R  K    E + M+++R
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKI---EIQFMEKVR 183

Query: 672 HRNLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYS---GTCMLDIFQR---------LN 718
             +          D F  + I +Y  N +   C+     G C+LD   +           
Sbjct: 184 QAD--------PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-----DMVAH-----------ISDFG 762
           I+    +AL+Y H      ++H DLKP N+L++      D V +           I D G
Sbjct: 236 IIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 763 IAKLLSGEDQLSIQIQTLATIGYMAPE--------YGTKGRVCTRGDVYSYGIMLMEMFT 814
                   D+   +   ++T  Y +PE        Y T        D++S G ++ E++T
Sbjct: 294 -----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--------DMWSMGCIIYELYT 340

Query: 815 KK 816
            K
Sbjct: 341 GK 342

Length = 467

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 34/206 (16%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED-----ECEVMKRIR-HRNLVK 677
           IG G+F  +  A+  + G   A+K   + +    KS E      E + ++R+  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSPHPNILR 62

Query: 678 IISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRL------NIMIDVALALEY 729
           +I    +      AL+ + M     +  LY    +    + L      + M  +  +L++
Sbjct: 63  LIEVLFDRKTGRLALVFELM-----DMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           +H      I H D+KP N+L+ +D++  ++DFG  + +  +   +  I   +T  Y APE
Sbjct: 116 MH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYI---STRWYRAPE 168

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFT 814
              T G    + D+++ G +  E+ +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 16/60 (26%), Positives = 29/60 (48%), Gaps = 5/60 (8%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH----QQYERALKSFEDECEVMKRIR-HRNLVKII 679
           I   S   ++ A L+DG EVAVKV      ++    LK  +   +++K+     +L  ++
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKVQRPGVKKRIRSDLKLLKFLAKILKKFFPGFDLDWLV 78

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 33/219 (15%)

Query: 625 IGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSC 682
           IG G++G ++ V   ++G + AVK+    ++   +  E E  ++K +  H N+VK     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 683 SNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEYLH 731
              D K      L+++    GS+ + L  G   L   +R+       I+ +  + L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTD-LVKG--FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAP 788
              +   IH D+K +N+LL  +    + DFG++  L+     S +++   ++G   +MAP
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLT-----STRLRRNTSVGTPFWMAP 193

Query: 789 EY-----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
           E              R DV+S GI  +E+     P  ++
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 4e-04
 Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 22/114 (19%)

Query: 223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSF 282
           ++ L L      G +P+ I+    L  + L  N   G IP +  ++              
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT------------- 466

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG 336
                    L+VL L+ N  +G +P+S G L+ SL I+ ++  S+SG +P  +G
Sbjct: 467 --------SLEVLDLSYNSFNGSIPESLGQLT-SLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 4e-04
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 49/232 (21%)

Query: 624 LIGIGSFGSIYVARLQDGME-VAVKVFHQQ------------YERALKSFEDECEVMKRI 670
           LI  G++G++Y+ R ++  +  A+K  ++Q             ER + +F +   V    
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFV---- 63

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEY 729
                V +  S        ++M+Y+  G     L + G   +D+  R+    +  LALEY
Sbjct: 64  -----VSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARM-YFAETVLALEY 116

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKL-------------LSGEDQLS 774
           LH   +  I+H DLKP N+L+    + HI  +DFG++K+             +  + +  
Sbjct: 117 LH---NYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +  Q   T  Y+APE   +       D ++ GI+L E      P    F G+
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP----FFGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.7 bits (100), Expect = 7e-04
 Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 8/153 (5%)

Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIM-KYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           E  +++ I H +++++  + + + F  LI+ +Y  +     C  +    + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD---LYCYLAAKRNIAICDILAIER 189

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            V  A++YLH      IIH D+K  N+ ++      + DFG A      +  +       
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAG 245

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           TI   APE   +       D++S GI+L EM T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 19/60 (31%), Positives = 27/60 (45%)

Query: 388 RLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL 447
            L SL L  N+ +         L +L+VL L  N  TS  P     L  +  +D+S N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 18/53 (33%), Positives = 25/53 (47%), Gaps = 1/53 (1%)

Query: 85  SFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL 136
           S N    IP      L +L+ LDLS N L+   P +   + +L+ L  S N L
Sbjct: 8   SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 22/60 (36%), Positives = 33/60 (55%)

Query: 316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           +L+ + + N  ++         L NL VL+L GNNLT   P  FS L +L++L L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	897
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PLN03150	623	hypothetical protein; Provisional	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
PLN03150	623	hypothetical protein; Provisional	99.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.32
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.19
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.18
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.04
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.96
COG4248	637	Uncharacterized protein with protein kinase and he	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.9
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.78
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.78
PRK09902	216	hypothetical protein; Provisional	98.68
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.56
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.54

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.5e-108  Score=1025.23  Aligned_cols=835  Identities=29%  Similarity=0.475  Sum_probs=589.4

Q ss_pred             ChhHHHHHHHHHhccccCCCcccccCCCCCCCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCc
Q 045539           31 ITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHN  110 (897)
Q Consensus        31 ~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n  110 (897)
                      .+.|+.||++||+++. +|.+.+. +|+.+++||.|.||+|+. .++|+.|||++++++|.+++++..+++|+.|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~~~~~~-~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DPLKYLS-NWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CCcccCC-CCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence            5689999999999995 6666665 998888999999999985 569999999999999999999999999999999999


Q ss_pred             cccCcCCcccc-CCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccc
Q 045539          111 KLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP  189 (897)
Q Consensus       111 ~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  189 (897)
                      +++|.+|..+. ++++|++|+|++|++.+.+|.  +.+++|++|||++|.+++.+|..++++++|++|+|++|.+.+..|
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  181 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP  181 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence            99998998765 888888888888888776664  346666777777777666666666667777777777776666666


Q ss_pred             ccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccc
Q 045539          190 VTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMA  269 (897)
Q Consensus       190 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~  269 (897)
                      ..+.++++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|..++++++|++|++++|.+++..|..|.++.
T Consensus       182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  260 (968)
T PLN00113        182 NSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK  260 (968)
T ss_pred             hhhhhCcCCCeeeccCCCCcCcCChHHc-CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence            6666666666666666666666665554 556666666666666666666666666666666666666666665554332


Q ss_pred             c---ccccCCCCcccccccccccCCCcEEEecCCCCCCCCCC------------------------cccCchHHHHHHHh
Q 045539          270 D---NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK------------------------SKGNLSLSLEIILM  322 (897)
Q Consensus       270 ~---~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~------------------------~~~~l~~~L~~L~l  322 (897)
                      .   ..++.+.........+.++++|++|++++|.+.+.+|.                        .+..++ +|+.|++
T Consensus       261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L  339 (968)
T PLN00113        261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQL  339 (968)
T ss_pred             CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEEC
Confidence            1   11111111111122334444455555555554444444                        444443 4445555


Q ss_pred             ccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccC
Q 045539          323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS  402 (897)
Q Consensus       323 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  402 (897)
                      ++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.
T Consensus       340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~  419 (968)
T PLN00113        340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE  419 (968)
T ss_pred             cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence            55555555555555555555555555555555555555555555555555555555666666667777777777777777


Q ss_pred             CCcccccccccceeccccccccCCccccccccccceEEeecCCcc-----------------------c-----------
Q 045539          403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL-----------------------N-----------  448 (897)
Q Consensus       403 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l-----------------------~-----------  448 (897)
                      +|..+.++++|+.|++++|.+++.+|..++.+++|+.|++++|.+                       .           
T Consensus       420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~  499 (968)
T PLN00113        420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS  499 (968)
T ss_pred             CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence            777777777777777777777777766666666555555555543                       2           


Q ss_pred             ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEecc
Q 045539          449 VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLS  528 (897)
Q Consensus       449 ~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  528 (897)
                      .|+.|+|++|++++.+|..++.+++|++|+|++|+++|.+|..|..+++|+.|||++|+++|.+|..+.++++|+.|+++
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  579 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS  579 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence            24566777777777777778888888888888888888888888888899999999999998899999999999999999


Q ss_pred             CCcccccCCCCCCCCCCCcccccchhhhhhhhhh----------------hhhhhhhH----HHHHHHhhhhhhhhhccc
Q 045539          529 FNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLV----------------IILPLSTA----LIVVVTLTLKWKLIECWK  588 (897)
Q Consensus       529 ~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~l~----------------~vi~~~~~----~~~~~~~~~~~~~~~~~~  588 (897)
                      +|+++|.+|..+++.++.+.++.||+.+|+....                +++.++++    +++++++++.+++++..+
T Consensus       580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  659 (968)
T PLN00113        580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE  659 (968)
T ss_pred             CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence            9999999999999999999999999999963210                11111111    111122222222222111


Q ss_pred             cCCCCCCCCCCC-----ccccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHH
Q 045539          589 SRTGPSNDGINS-----PQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFED  662 (897)
Q Consensus       589 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~  662 (897)
                      .+..+...+...     ....+.++++++   ...|...+.||+|+||.||+|+. .+|+.||||+++....    ...+
T Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~  732 (968)
T PLN00113        660 LKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSS  732 (968)
T ss_pred             ccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHH
Confidence            111111111100     011122334443   35678889999999999999987 4789999999864422    1234


Q ss_pred             HHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCC
Q 045539          663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD  742 (897)
Q Consensus       663 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~D  742 (897)
                      |++++++++|||||+++++|.+++..|+||||+++|+|.++++.    ++|.++..++.|+++|++|||+.++.+|+|||
T Consensus       733 ~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d  808 (968)
T PLN00113        733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN  808 (968)
T ss_pred             HHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence            68899999999999999999999999999999999999999863    78999999999999999999755588999999


Q ss_pred             CCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       743 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      |||+||+++.++.+++. ||.+......      ....+++.|+|||+..+..++.++|||||||++|||+||+.||+..
T Consensus       809 lkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        809 LSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             CCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            99999999999888875 6655432211      1235789999999999999999999999999999999999999765


Q ss_pred             ccCccchhHHhhhcCCch-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          823 FIGELSLNRWINDLLPVS-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ........+|........ ....+++.+.....    ...+...++.+++.+||+.|| ++||||+||+++|++
T Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P-~~RPt~~evl~~L~~  950 (968)
T PLN00113        882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----VNQNEIVEVMNLALHCTATDP-TARPCANDVLKTLES  950 (968)
T ss_pred             cCCCCcHHHHHHHhcCccchhheeCccccCCCC----ccHHHHHHHHHHHHhhCcCCc-hhCcCHHHHHHHHHH
Confidence            555556666665443332 44455555433221    112345678899999999999 999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-52  Score=526.04  Aligned_cols=454  Identities=32%  Similarity=0.498  Sum_probs=303.9

Q ss_pred             EEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeec
Q 045539           79 IGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN  158 (897)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N  158 (897)
                      ..|+|++|.+++.+|..++++++|++|||++|.+.+.+|..|+++++|++|+|++|++.+.+|..+.++++|++|+|++|
T Consensus       143 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  222 (968)
T PLN00113        143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN  222 (968)
T ss_pred             CEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCC
Confidence            34444444444445555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccccc
Q 045539          159 GLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVP  238 (897)
Q Consensus       159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p  238 (897)
                      ++++.+|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++.+|..+. .+++|++|+|++|.+.+.+|
T Consensus       223 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p  301 (968)
T PLN00113        223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIP  301 (968)
T ss_pred             ccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCC
Confidence            55555555555555555555555555555555555555555555555555555554443 44555555555555555555


Q ss_pred             ccccCCCcccEEEccccccccccCcccccccc---ccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchH
Q 045539          239 SSITNASKLSDLELGVNLFSGFIPNTFVNMAD---NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL  315 (897)
Q Consensus       239 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~---~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (897)
                      ..+.++++|+.|++++|.+.+..|..+..+..   ..++.+.........+..+++|+.|++++|++.+.+|..+..+. 
T Consensus       302 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-  380 (968)
T PLN00113        302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-  380 (968)
T ss_pred             hhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcC-
Confidence            55555555555555555555555544433221   11111111111223355566666666666666666666665554 


Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      +++.|++.+|++.+.+|..++.+++|+.|++++|++++.+|..|.++++|+.|++++|++++.+|..+..+++|+.|+|+
T Consensus       381 ~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  460 (968)
T PLN00113        381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA  460 (968)
T ss_pred             CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECc
Confidence            56666777777777777777777777777777777777777777777777888888888877777777777888888888


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCccc-----------ccceeecccCcCCCCC
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN-----------VLIGLNFSRNNLSGDI  464 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----------~l~~l~ls~n~l~~~~  464 (897)
                      +|++.+.+|..+ ..++|+.|++++|++++.+|..+.++++|+.|++++|.+.           .|+.|++++|.++|.+
T Consensus       461 ~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  539 (968)
T PLN00113        461 RNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI  539 (968)
T ss_pred             CceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccC
Confidence            888887777755 3578899999999999999999999999999999999764           5789999999999999


Q ss_pred             cccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCc-ccccC
Q 045539          465 PITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK-LEGEI  536 (897)
Q Consensus       465 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~  536 (897)
                      |..++.+++|+.|+|++|+++|.+|..+.++++|+.|++++|+++|.+|.. +.+..+....+.+|+ ++|..
T Consensus       540 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~  611 (968)
T PLN00113        540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCGGD  611 (968)
T ss_pred             ChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccCCc
Confidence            999999999999999999999999999999999999999999999999964 444455666778887 55543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-49  Score=426.01  Aligned_cols=286  Identities=41%  Similarity=0.673  Sum_probs=246.8

Q ss_pred             ccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee
Q 045539          603 AIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC  682 (897)
Q Consensus       603 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  682 (897)
                      ..+.|+++|+..||++|...++||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            67889999999999999999999999999999999999999999988765432135599999999999999999999999


Q ss_pred             cCCC-ceEEEEEeccCCChhHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          683 SNDD-FKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       683 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                      .+++ ..++|||||++|+|+++++.... .++|.++.+||.++|+||+|||+.....|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 49999999999999999998776 899999999999999999999876666899999999999999999999999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccc-cCccchhHHhhhcCCc
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIF-IGELSLNRWINDLLPV  839 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~  839 (897)
                      ||+|+....... .......||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .++..+..|....+..
T Consensus       221 FGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999976543111 11111179999999999999999999999999999999999999988654 3455588888776666


Q ss_pred             -hHHHHhhhhhcc-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          840 -SVMEVIDTNLLR-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       840 -~~~~~i~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                       .+.+++|+.+.. .+..     .+...++.+++.+|++.+| ++||+|.||+++|+.
T Consensus       300 ~~~~eiiD~~l~~~~~~~-----~~~~~~~~~~a~~C~~~~~-~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPD-----EKEVKKLAELALRCLRPDP-KERPTMSQVVKELEG  351 (361)
T ss_pred             cchhheeCCCccCCCCCh-----HHHHHHHHHHHHHHcCcCC-CcCcCHHHHHHHHHh
Confidence             589999999873 3321     1456779999999999999 999999999999853

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-46  Score=377.03  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=213.0

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc-eEEEEEecc
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-KALIMKYMP  696 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~  696 (897)
                      +..+.||+|..|+||+++++ +++.+|+|++.... ....+++.+|+++++.++||+||++||.|..++. .+++||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            34688999999999999887 68899999995443 4456889999999999999999999999999884 999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +|+|++++...+ ++++....+|+.++++||.|||  ++++||||||||+|||++..|++||+|||.+......    ..
T Consensus       162 gGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  162 GGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             CCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            999999887654 5999999999999999999995  4699999999999999999999999999999876543    44


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ...+||..|||||.+.+..|+.++||||||++++|+++|+.||.....            -...+.++++....+.+++.
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------------~~~~~~~Ll~~Iv~~ppP~l  302 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------------PYLDIFELLCAIVDEPPPRL  302 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC------------CCCCHHHHHHHHhcCCCCCC
Confidence            567899999999999999999999999999999999999999976311            11234555655555554432


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +..  .+..++..++..|+++|| .+|||+.|+++
T Consensus       303 P~~--~fS~ef~~FV~~CL~Kdp-~~R~s~~qLl~  334 (364)
T KOG0581|consen  303 PEG--EFSPEFRSFVSCCLRKDP-SERPSAKQLLQ  334 (364)
T ss_pred             Ccc--cCCHHHHHHHHHHhcCCc-ccCCCHHHHhc
Confidence            222  467789999999999999 99999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-45  Score=374.72  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=210.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHH-------HHHHHHHHHHHHHhcCCCccceEeeeecCCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYER-------ALKSFEDECEVMKRIRHRNLVKIISSCSNDD  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  686 (897)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++....       .....++|+++|++++|||||+++++|+.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            356788999999999999999965 47999999999865421       1233579999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC---CcEEEeeccC
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHISDFGI  763 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~  763 (897)
                      ..|+||||++||.|.+.+-.++ .+.+..-..+++|++.|+.||   |++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999987766 477778889999999999999   99999999999999999755   7999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCC---CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV---CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      |+..+.   .......+|||.|.|||++.+..+   ..++|+||+||++|-+++|.+||.+....               
T Consensus       326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------------  387 (475)
T KOG0615|consen  326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------------  387 (475)
T ss_pred             hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---------------
Confidence            998753   244567789999999999876543   34789999999999999999999874322               


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ..+.++...+.+.-.+..+.++.++..+++.+++..|| ++|||++|+++
T Consensus       388 -~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP-~~R~s~~eaL~  436 (475)
T KOG0615|consen  388 -PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDP-ENRPSADEALN  436 (475)
T ss_pred             -ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCc-ccCcCHHHHhc
Confidence             11223333444443445667788889999999999999 99999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=368.62  Aligned_cols=261  Identities=27%  Similarity=0.386  Sum_probs=206.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..++|...+.||+|+||+||+|+++ ++..||||.+.+.  ..+..+.+..|+++|+.++|||||++++++..+++.|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3568888999999999999999876 5899999999876  455667889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC------CcEEEeeccCcc
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED------MVAHISDFGIAK  765 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~------~~~kL~DFg~a~  765 (897)
                      ||||+||+|.+|++..+ .+++..+..++.|+|.||++|   |+++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999876 599999999999999999999   99999999999999999764      468999999999


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc--------chhHHhhhcC
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL--------SLNRWINDLL  837 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~  837 (897)
                      ...+..   .....+|++.|||||++...+|+.|+|+||+|+|+|++++|+.||+.....+.        ..........
T Consensus       164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            986443   34467899999999999999999999999999999999999999985322111        0111111111


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHH
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                      .....+++-..+..+..++...       ...+....+..+| .+|+.+.++-
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~-------~~~~~~~~l~~~p-~~~~~~~~~~  285 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISF-------EDFFDHPFLAANP-QDRADAFELE  285 (429)
T ss_pred             cCchhhhhhHHHhcCccccCch-------HHhhhhhhcccCc-ccccCccccc
Confidence            2223344444444443322222       2334445567777 7777665543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-44  Score=384.84  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=213.8

Q ss_pred             cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .+|...+.||+|||+.||.++. .+|..||+|++.+..   ....+.+.+|++|.+.++|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999987 789999999998643   445678899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+|+.++|..+++ +++.+++.+++.++.||+.||.||   |+++|+|||||-.|++++++.++||+|||+|.....++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999888 455799999999999999999999   999999999999999999999999999999998864433


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        .....+|||.|+|||++.+...+..+||||+|||+|.|+.|++||+..                 .+.+..++.-..+
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----------------~vkety~~Ik~~~  234 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----------------TVKETYNKIKLNE  234 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----------------hHHHHHHHHHhcC
Confidence              344678999999999999999999999999999999999999999862                 2334444333333


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.. +   .....+..+++.+++++|| .+|||+++|+.
T Consensus       235 Y~~-P---~~ls~~A~dLI~~lL~~~P-~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 YSM-P---SHLSAEAKDLIRKLLRPNP-SERPSLDEVLD  268 (592)
T ss_pred             ccc-c---cccCHHHHHHHHHHhcCCc-ccCCCHHHHhc
Confidence            321 1   1334456789999999999 99999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=384.57  Aligned_cols=252  Identities=29%  Similarity=0.446  Sum_probs=207.0

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCC-ceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDD-FKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  694 (897)
                      .....+.+|+|+||+||+|.+.....||||++.....  ...+.|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3344566999999999999998433499999986532  22569999999999999999999999999887 79999999


Q ss_pred             ccCCChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEeCCCCCCCeeeCCCC-cEEEeeccCccccCCCC
Q 045539          695 MPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTP-IIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGED  771 (897)
Q Consensus       695 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~  771 (897)
                      +++|+|.++++. ....+++..+..++.|||+|+.||   |+.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999988 366799999999999999999999   8888 99999999999999997 99999999998765322


Q ss_pred             ceeeeeccccCcccCCcCccC--CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          772 QLSIQIQTLATIGYMAPEYGT--KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                        ...+...||+.|||||++.  ...++.|+|||||||++|||+||+.||......  ..           ...++....
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~-----------~~~v~~~~~  263 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QV-----------ASAVVVGGL  263 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HH-----------HHHHHhcCC
Confidence              2233467999999999999  669999999999999999999999999874321  00           112222222


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +...+      ..+...+..++.+||..|| +.||++.|++..|+
T Consensus       264 Rp~~p------~~~~~~l~~l~~~CW~~dp-~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  264 RPPIP------KECPPHLSSLMERCWLVDP-SRRPSFLEIVSRLE  301 (362)
T ss_pred             CCCCC------ccCCHHHHHHHHHhCCCCC-CcCCCHHHHHHHHH
Confidence            22111      1255678899999999999 99999999999886

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-44  Score=347.60  Aligned_cols=254  Identities=21%  Similarity=0.314  Sum_probs=204.8

Q ss_pred             cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEee-eecCC-CceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIIS-SCSND-DFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~-~~~~lv  691 (897)
                      .+|.+.++||+|.||+||++.. .+|..||.|.++-..  .+..+.+..|+.+|++++|||||++++ -+.++ +..++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4677889999999999999964 589999999887432  455678889999999999999999998 44444 448999


Q ss_pred             EEeccCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          692 MKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       692 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ||+|.+|+|.+.++   +..+.+++..+++++.|++.||.++|+.- ..  |+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999875   34467999999999999999999994321 44  89999999999999999999999999998


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      +....  ......+|||.||+||.+...+|++||||||+||++|||+.-+.||...                 ...++..
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----------------n~~~L~~  238 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----------------NLLSLCK  238 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----------------cHHHHHH
Confidence            86433  3345678999999999999999999999999999999999999999762                 2333333


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      +.-+.+++..+  .+....++..++..|+..|| +.||+...++..+
T Consensus       239 KI~qgd~~~~p--~~~YS~~l~~li~~ci~vd~-~~RP~t~~~v~di  282 (375)
T KOG0591|consen  239 KIEQGDYPPLP--DEHYSTDLRELINMCIAVDP-EQRPDTVPYVQDI  282 (375)
T ss_pred             HHHcCCCCCCc--HHHhhhHHHHHHHHHccCCc-ccCCCcchHHHHH
Confidence            33333333211  12345678899999999999 9999854444433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=374.59  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=212.0

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      .+...+.||+|.||+||.|++.....||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..|||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34456889999999999999997779999998865 33346788999999999999999999999999999999999999


Q ss_pred             CChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          698 GSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       698 gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      |+|.++++. .+..+...+.+.++.|||+|++||   +++++|||||.++|||++++..+||+|||+|+... ++.....
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTAS  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccC-CCceeec
Confidence            999999997 557799999999999999999999   99999999999999999999999999999999544 3333333


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....-+..|.|||.+..+.++.|||||||||+||||+| |+.||......              ++.+.+++.    +  
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------ev~~~le~G----y--  421 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------EVLELLERG----Y--  421 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------------HHHHHHhcc----C--
Confidence            34445678999999999999999999999999999999 88888763211              222333322    2  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      |.+..+.|+.++-++|..||+.+| ++|||++.+...++.
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P-~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDP-EDRPTFETLREVLED  460 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCc-ccCCCHHHHHHHHHH
Confidence            233334677889999999999999 999999998887753

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=353.47  Aligned_cols=256  Identities=27%  Similarity=0.324  Sum_probs=205.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|++.++||+|+||.||.++.+ +++.||+|++++..   ..+.+...+|..+|.+++||.||+++..|++++..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3568999999999999999999765 58999999998764   2346778899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+||+.||.|...+++.+ .+++..+.-++.+|+.||.||   |++||||||+||+|||+|++|.++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999988765 589999999999999999999   9999999999999999999999999999999864333


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      +.  .....+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...                 ...++.++.+.
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----------------~~~~~~~~I~~  239 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----------------DVKKMYDKILK  239 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----------------cHHHHHHHHhc
Confidence            22  234578999999999999999999999999999999999999999762                 22233333222


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                      ..... ++  .-...+..+++.+.+..|| ++|-.+..=.+.+++||
T Consensus       240 ~k~~~-~p--~~ls~~ardll~~LL~rdp-~~RLg~~~d~~~ik~Hp  282 (357)
T KOG0598|consen  240 GKLPL-PP--GYLSEEARDLLKKLLKRDP-RQRLGGPGDAEEIKRHP  282 (357)
T ss_pred             CcCCC-CC--ccCCHHHHHHHHHHhccCH-HHhcCCCCChHHhhcCc
Confidence            22000 00  0122345677777788999 88853222223345444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.5e-42  Score=335.50  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=207.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|+...++|+|+||.||+++.+ +|+.||||++....  +...+...+|+++|++++|||+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            57888899999999999999987 59999999997543  3445677899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ||+..-| +-+......++...+.+++.|++.|+.|+   |+++++||||||+||+++.+|.+||||||+|+......  
T Consensus        82 ~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            9976444 44555555689999999999999999999   99999999999999999999999999999999887433  


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh---cCCchHHHHhhhh-
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND---LLPVSVMEVIDTN-  848 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~-  848 (897)
                      ...+..+.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+-|....  +.+....+..   ...++...++... 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            23456789999999998776 789999999999999999999999886532  2222111211   1222222332211 


Q ss_pred             -----------hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 -----------LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 -----------l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                 -.+.-+++++   ....-+++++..|++.|| ++|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p---~~s~~~ld~~k~cL~~dP-~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYP---KISNVLLDLLKKCLKMDP-DDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcc---cchHHHHHHHHHHhcCCc-cccccHHHHhc
Confidence                       0111122222   233468899999999999 99999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=366.95  Aligned_cols=269  Identities=26%  Similarity=0.376  Sum_probs=216.1

Q ss_pred             ccCCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 045539          605 RRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC  682 (897)
Q Consensus       605 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  682 (897)
                      ...+.++++...+.+.+.+.||+|.||+||+|+|.  ..||||+++...  .+..+.|++|+..+++-+|.||+-++|||
T Consensus       380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CCccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            33444666667777888999999999999999987  469999987543  45678999999999999999999999999


Q ss_pred             cCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       683 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      ..+.. .||+.+|+|.+|+.+++.....++..+.+.|++||++|+.||   |.++|||||+|..||++.+++.|||+|||
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEeccc
Confidence            99887 999999999999999998888899999999999999999999   99999999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      ++..-..-..........|...|||||++.   ..+|++.+||||||+|+|||+||..||.. ...+..+...-+.... 
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~-  611 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLM-  611 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccC-
Confidence            987543221122223445788899999864   45789999999999999999999999983 2221111000000000 


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCC
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPN  896 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~  896 (897)
                                    ++.......+..++.+|+..||..++ ++||.+.+|+..|+..
T Consensus       612 --------------pd~s~~~s~~pk~mk~Ll~~C~~~~~-~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  612 --------------PDLSKIRSNCPKAMKRLLSDCWKFDR-EERPLFPQLLSKLEEL  653 (678)
T ss_pred             --------------ccchhhhccCHHHHHHHHHHHHhcCc-ccCccHHHHHHHHHHh
Confidence                          11122233556679999999999999 9999999999977653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=358.75  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=206.8

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .+..++|...+.||+|+|++|++|+.. +++.||||++.+..   +...+.+..|-.+|.++ .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344678999999999999999999755 69999999997653   33456677899999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+|+||+++|+|.+++.+-+ .+++...+.++.+|+.||+||   |++|||||||||+|||+|+||++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998875 599999999999999999999   9999999999999999999999999999999987


Q ss_pred             CCCCce-----------eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc
Q 045539          768 SGEDQL-----------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       768 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      .+....           .....++||..|.+||++..+..++.+|+|+||||+|+|+.|++||.... +           
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-e-----------  292 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-E-----------  292 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-H-----------
Confidence            643221           11245789999999999999999999999999999999999999997621 1           


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           .-++.+.+.-.++ +   .+.......+|+.+.+..|| .+|+|++||.+
T Consensus       293 -----yliFqkI~~l~y~-f---p~~fp~~a~dLv~KLLv~dp-~~Rlt~~qIk~  337 (604)
T KOG0592|consen  293 -----YLIFQKIQALDYE-F---PEGFPEDARDLIKKLLVRDP-SDRLTSQQIKA  337 (604)
T ss_pred             -----HHHHHHHHHhccc-C---CCCCCHHHHHHHHHHHccCc-cccccHHHHhh
Confidence                 1111111111111 0   01122345677888889999 99999977654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=341.38  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .+.|+..+.||.|..++||+|+.. .+..||||++.-+.. ...+.+.+|+..++.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            468999999999999999999754 689999999986543 346889999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC-
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED-  771 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~-  771 (897)
                      ||.+|++.+.++..- ..+++..+..|.+++++||.||   |++|.||||||+.|||++.+|.+||+|||.+..+...+ 
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999887543 4489999999999999999999   99999999999999999999999999999876554332 


Q ss_pred             ceeee-eccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          772 QLSIQ-IQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       772 ~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ..... ...+||+.|||||++..  ..|+.|+||||||++..|+.+|..||....                 ..+++-..
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-----------------PmkvLl~t  244 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-----------------PMKVLLLT  244 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-----------------hHHHHHHH
Confidence            11222 45689999999998433  468999999999999999999999998732                 12222222


Q ss_pred             hcchhh------hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEE------RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ++..++      ...+........+.+++..|++.|| ++||||+++++
T Consensus       245 Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP-~kRptAskLlk  292 (516)
T KOG0582|consen  245 LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDP-SKRPTASKLLK  292 (516)
T ss_pred             hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCc-ccCCCHHHHhc
Confidence            222221      1122333444578899999999999 99999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=363.84  Aligned_cols=366  Identities=25%  Similarity=0.276  Sum_probs=267.3

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.||+|+|.++..-+..|.++++|+++++..|.+                        + .||...+...+|+.|+|.+|
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~L------------------------t-~IP~f~~~sghl~~L~L~~N  135 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNEL------------------------T-RIPRFGHESGHLEKLDLRHN  135 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchh------------------------h-hcccccccccceeEEeeecc
Confidence            4466666666655555566666666666666655                        3 44443333444445555555


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccC
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  262 (897)
                      .|+.+....+.-++.|+.||||.|.|+ ++|..-|..-.++++|+|++|+|+..-...|.++.+|..|.|+.|+++..++
T Consensus       136 ~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~  214 (873)
T KOG4194|consen  136 LISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ  214 (873)
T ss_pred             ccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH
Confidence            555444445555555555555555555 5554444444555666666666655555566666666666666666665555


Q ss_pred             ccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCc
Q 045539          263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL  342 (897)
Q Consensus       263 ~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  342 (897)
                      ..|                     .++++|+.|+|..|+|.-+---.|..+. +|+.|.|..|.|+.....+|-.+.+++
T Consensus       215 r~F---------------------k~L~~L~~LdLnrN~irive~ltFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme  272 (873)
T KOG4194|consen  215 RSF---------------------KRLPKLESLDLNRNRIRIVEGLTFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKME  272 (873)
T ss_pred             HHh---------------------hhcchhhhhhccccceeeehhhhhcCch-hhhhhhhhhcCcccccCcceeeecccc
Confidence            433                     4456666666666666543334455555 788888888888888888999999999


Q ss_pred             EEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecccccc
Q 045539          343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR  422 (897)
Q Consensus       343 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  422 (897)
                      +|+|+.|+++..-..++.+|++|+.|+||+|.|..+-++.+...++|+.|+|++|+|+...+..|..+..|+.|+|++|+
T Consensus       273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns  352 (873)
T KOG4194|consen  273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS  352 (873)
T ss_pred             eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence            99999999999889999999999999999999999999999999999999999999998888999999999999999999


Q ss_pred             ccCCccccccccccceEEeecCCcccccceeecccCcCCCCC---cccccCCcccccccccCceecccCCCCCCCcCCCc
Q 045539          423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDI---PITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE  499 (897)
Q Consensus       423 l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~---p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  499 (897)
                      ++..-...|..+++|+.||+++|             .+++.|   ...|.+|++|+.|.|.+|+|....-..|.++++|+
T Consensus       353 i~~l~e~af~~lssL~~LdLr~N-------------~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE  419 (873)
T KOG4194|consen  353 IDHLAEGAFVGLSSLHKLDLRSN-------------ELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE  419 (873)
T ss_pred             hHHHHhhHHHHhhhhhhhcCcCC-------------eEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence            99877788888998885555555             444443   34577899999999999999965557899999999


Q ss_pred             EEeccCCccCCCCchhhhhhcccceEeccCC
Q 045539          500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFN  530 (897)
Q Consensus       500 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  530 (897)
                      .|||.+|.|...-|..|..+ .|++|-++.-
T Consensus       420 ~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  420 HLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             eecCCCCcceeecccccccc-hhhhhhhccc
Confidence            99999999998889999988 8888766543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-41  Score=348.90  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--ceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--FKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  692 (897)
                      ..+|...+.||+|+||.||.+...+ |...|||.+........+.+.+|+++|.+++|||||+++|.....+  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3467778999999999999998764 8999999987653333677899999999999999999999854444  689999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCccccCC-C
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSG-E  770 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~-~  770 (897)
                      ||+++|+|.+++...+..+++..+..++.||++||+||   |++|||||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999999988765799999999999999999999   8999999999999999999 79999999999987653 1


Q ss_pred             CceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........||+.|||||++..+ ...+++||||+||++.||+||+.||......    ..+        ...+.....
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~--------~~~ig~~~~  240 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEA--------LLLIGREDS  240 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHH--------HHHHhccCC
Confidence            112223456899999999998854 3446999999999999999999999863111    000        001110000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+..+      +....+..+++.+|+..|| ++||||+|+++.
T Consensus       241 ~P~ip------~~ls~~a~~Fl~~C~~~~p-~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 LPEIP------DSLSDEAKDFLRKCFKRDP-EKRPTAEELLEH  276 (313)
T ss_pred             CCCCC------cccCHHHHHHHHHHhhcCc-ccCcCHHHHhhC
Confidence            00000      1233456889999999999 999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=358.88  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=211.9

Q ss_pred             cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      ..|...++||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|..++..++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4678889999999999999964 468999999998776666678899999999999999999999998889999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +||+|.|.+....  +++.++..|++++++||+||   |.+||+|||||.+||+++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999988765  89999999999999999999   999999999999999999999999999999987765443  4


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....+||+.|||||+.....|++|.||||||++++||+-|.+||-..                ..+..+..-+..+.+  
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----------------~PlrAlyLIa~ng~P--  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----------------NPLRALYLIATNGTP--  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----------------ChHHHHHHHhhcCCC--
Confidence            55678999999999999999999999999999999999999998641                111111111111111  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+.....+.+++.+|++.|| ++||+|.|+++.
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv-~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDV-EQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcch-hcCCCHHHHhcC
Confidence            122234556678999999999999 999999999863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=353.01  Aligned_cols=269  Identities=19%  Similarity=0.282  Sum_probs=208.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHH-HHHHHHHHHHhcC-CCccceEeeeecCCC-ceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK-SFEDECEVMKRIR-HRNLVKIISSCSNDD-FKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  690 (897)
                      ..++|...++||.|.||.||+|+.. +|..||||++++......+ .=.+|++.|+++. ||||+++.+++.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3568999999999999999999754 6899999999876543222 2358999999999 999999999999888 9999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||| ..+|.+.++.++..+++.++..|+.||++||+|+   |++|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccC
Confidence            99999 5699999999999999999999999999999999   9999999999999999998889999999999987654


Q ss_pred             CceeeeeccccCcccCCcCcc-CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh-------hhcCCch--
Q 045539          771 DQLSIQIQTLATIGYMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI-------NDLLPVS--  840 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~--  840 (897)
                      ..   .+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++-|.+..+-+ ++.+..       .+.++..  
T Consensus       164 pP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  164 PP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccchhHHH
Confidence            43   3466799999999975 66788999999999999999999988776521111 111110       0111110  


Q ss_pred             HHHHhhhhhcchhhhh-HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 VMEVIDTNLLRGEERF-FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +...+.-.+....+.. ..-...+..+..+++.+|+++|| .+||||+|.++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP-~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDP-DKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCC-ccCccHHHHhcC
Confidence            1111111111111111 11112345678899999999999 999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.3e-44  Score=361.90  Aligned_cols=417  Identities=30%  Similarity=0.428  Sum_probs=347.9

Q ss_pred             EEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeee
Q 045539           78 VIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSI  157 (897)
Q Consensus        78 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~  157 (897)
                      .+.+++++|+++ ++|++++.+..++.|+.|+|+++ .+|++++++.+|+.|+.++|++. ..++.++.+..|+.||..+
T Consensus        70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~  146 (565)
T KOG0472|consen   70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN  146 (565)
T ss_pred             eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence            567888888887 78888999999999999999988 88888999999999999999884 5667788888899999999


Q ss_pred             cCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccc
Q 045539          158 NGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV  237 (897)
Q Consensus       158 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  237 (897)
                      |+++ ..|..++++.+|..|++.+|+++...|..+. |+.|++||+.+|-++ ++|..++ .+.+|+.|+|..|+|. .+
T Consensus       147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg-~l~~L~~LyL~~Nki~-~l  221 (565)
T KOG0472|consen  147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELG-GLESLELLYLRRNKIR-FL  221 (565)
T ss_pred             cccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhc-chhhhHHHHhhhcccc-cC
Confidence            9998 7888888999999999999999988777666 899999999999887 8888887 7888999999999986 55


Q ss_pred             cccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHH
Q 045539          238 PSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL  317 (897)
Q Consensus       238 p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L  317 (897)
                      | +|..++.|++|+++.|+|+....+                     -+.++++|.+|||.+|+++. .|+.+.-+. +|
T Consensus       222 P-ef~gcs~L~Elh~g~N~i~~lpae---------------------~~~~L~~l~vLDLRdNklke-~Pde~clLr-sL  277 (565)
T KOG0472|consen  222 P-EFPGCSLLKELHVGENQIEMLPAE---------------------HLKHLNSLLVLDLRDNKLKE-VPDEICLLR-SL  277 (565)
T ss_pred             C-CCCccHHHHHHHhcccHHHhhHHH---------------------Hhcccccceeeecccccccc-CchHHHHhh-hh
Confidence            6 888899999999999988755443                     25688999999999999994 688888776 89


Q ss_pred             HHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCC--------------------------------------ccccc
Q 045539          318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP--------------------------------------IPITF  359 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------------------------------------~~~~~  359 (897)
                      ++|++++|.|+ .+|..++++ .|+.|.+.+|.+..+                                      ++..|
T Consensus       278 ~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~  355 (565)
T KOG0472|consen  278 ERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESF  355 (565)
T ss_pred             hhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcc
Confidence            99999999999 567789999 999999999988521                                      11111


Q ss_pred             ---cCccchhhhcccCcccccccchhhhcccc---cccccccccccccCCCcccccccccc-eeccccccccCCcccccc
Q 045539          360 ---SQLQTLQALGLTRNKLAGPITDELCHLAR---LHSLVLQGNKFSGSIPSCLGNLTSLR-VLYLGLNRFTSALPSTIW  432 (897)
Q Consensus       360 ---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~  432 (897)
                         ..+-+.+.|++++-+++ .+|+++....+   .+..+++.|++. .+|..+..+..+. .+.+++|.+ +.+|..+.
T Consensus       356 ~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~  432 (565)
T KOG0472|consen  356 PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELS  432 (565)
T ss_pred             cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHH
Confidence               22456788999999998 56776665555   788999999998 8888888877754 455555555 47888999


Q ss_pred             ccccceEEeecCCccc----------ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEe
Q 045539          433 NLKDILFIDVSSNSLN----------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD  502 (897)
Q Consensus       433 ~l~~L~~L~ls~N~l~----------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  502 (897)
                      .+++|.+|++++|.+.          .|+.||+|.|+|. .+|..+..+..|+.+-.++|++....|..+.+|.+|..||
T Consensus       433 ~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD  511 (565)
T KOG0472|consen  433 QLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD  511 (565)
T ss_pred             hhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence            9999999999998654          4678899999887 6788888888899988899999866666699999999999


Q ss_pred             ccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          503 LSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       503 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      |.+|.|. .||+.++++++|++|+|+||+|.
T Consensus       512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cCCCchh-hCChhhccccceeEEEecCCccC
Confidence            9999998 89999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5e-40  Score=348.37  Aligned_cols=259  Identities=24%  Similarity=0.306  Sum_probs=204.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|+..+.||+|+||.||.|+-+ +|..||+|++++..   ....+.++.|-.+|....+|.||++|..|++.++.|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999765 69999999998765   3446778899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC-
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG-  769 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~-  769 (897)
                      ||||++||++...+...+ .+++..+..++.+++-|++.+   |+.|||||||||+|+|||..|++||+|||++..... 
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999988766 589999999999999999999   999999999999999999999999999999853311 


Q ss_pred             ---------------------CCcee----e-------------------eeccccCcccCCcCccCCCCCCccchHHHH
Q 045539          770 ---------------------EDQLS----I-------------------QIQTLATIGYMAPEYGTKGRVCTRGDVYSY  805 (897)
Q Consensus       770 ---------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~sl  805 (897)
                                           .+...    .                   ....+|||.|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 00000    0                   013479999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC
Q 045539          806 GIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD  885 (897)
Q Consensus       806 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt  885 (897)
                      |||+|||+.|.+||......                 +...+.+.-...-.++....+..+..++|.+|+. || ++|-.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~-----------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~-~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQ-----------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP-ENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH-HHhcC
Confidence            99999999999999763211                 1111111111001111222333567889999988 99 99976


Q ss_pred             HHHHHhhcCCCC
Q 045539          886 MGWIFSALDPNP  897 (897)
Q Consensus       886 ~~evl~~L~~~~  897 (897)
                       .-=++++++||
T Consensus       436 -~~G~~EIK~HP  446 (550)
T KOG0605|consen  436 -SKGAEEIKKHP  446 (550)
T ss_pred             -cccHHHHhcCC
Confidence             33334444444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-40  Score=344.94  Aligned_cols=266  Identities=24%  Similarity=0.301  Sum_probs=207.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  690 (897)
                      .+.|+..++||+|.||.||+|+. .+|+.||+|+++...  ........+|+.||+++.||||+++.+...+.  ...|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45677889999999999999975 479999999987654  34456678999999999999999999988766  78999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+|||+. +|.-++......+++.++..++.|++.||+|+   |++||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999954 88888888877899999999999999999999   9999999999999999999999999999999988755


Q ss_pred             CceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--------cCCc--
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--------LLPV--  839 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~--  839 (897)
                      ... ..+..+-|.+|+|||.+.+ ..|+.+.|+||.|||+.||++|++.|....  +....+.+..        .++.  
T Consensus       272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChhcccccc
Confidence            433 3456678999999998765 478999999999999999999999987631  1111111110        0110  


Q ss_pred             -hHHHHhhhhhcchhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 -SVMEVIDTNLLRGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 -~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       .....+.  -...+.++. +.........++++..++..|| .+|.||.++++
T Consensus       349 LP~~~~~k--p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP-~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFK--PQQPYKRRLRETFKDFPASALDLLEKLLSLDP-DKRGTASSALQ  399 (560)
T ss_pred             CCcccccC--CCCcccchHHHHhccCCHHHHHHHHHHhccCc-cccccHHHHhc
Confidence             0001111  011111111 1223344567889999999999 99999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=353.35  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh----hH-HHHHHHHHHHHHHHhcC-CCccceEeeeecCCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ----YE-RALKSFEDECEVMKRIR-HRNLVKIISSCSNDD  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  686 (897)
                      ...++|...+.||+|+||.|+.|++. +|+.||+|++.+.    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34679999999999999999999754 6899999987654    12 33567779999999999 999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCcc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK  765 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~  765 (897)
                      ..|+||||+.||+|.+++.. ..++.+.+...++.|++.|++|+   |++||+||||||+||+++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 55688999999999999999999   99999999999999999999 999999999999


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCC-C-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGR-V-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....  .......+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||++.                 ....
T Consensus       170 ~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----------------~~~~  230 (370)
T KOG0583|consen  170 ISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----------------NVPN  230 (370)
T ss_pred             ccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----------------cHHH
Confidence            87411  12334568999999999998866 7 58899999999999999999999872                 1111


Q ss_pred             HhhhhhcchhhhhHHHHHHH-HHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQI-LLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +..+.....+. .+   ..+ ..+..+++.+|+..|| .+|+|+.|+++
T Consensus       231 l~~ki~~~~~~-~p---~~~~S~~~~~Li~~mL~~~P-~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 LYRKIRKGEFK-IP---SYLLSPEARSLIEKMLVPDP-STRITLLEILE  274 (370)
T ss_pred             HHHHHhcCCcc-CC---CCcCCHHHHHHHHHHcCCCc-ccCCCHHHHhh
Confidence            22211111111 00   011 3457899999999999 99999999983

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-39  Score=343.26  Aligned_cols=246  Identities=26%  Similarity=0.377  Sum_probs=209.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..  +++.+.+.+|++|++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999766 58899999987543  4567889999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+.| +|..++...+ .++++++..++.|++.||.||   |+.+|.|||+||.||+++..|.+|++|||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 9999988766 599999999999999999999   999999999999999999999999999999998764  34


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ...+...|||.|||||...+.+|+..+|+||+||++||+++|++||..                 ..+.+++...+....
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----------------~si~~Lv~~I~~d~v  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----------------RSITQLVKSILKDPV  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----------------HHHHHHHHHHhcCCC
Confidence            556678899999999999999999999999999999999999999975                 123344443333322


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      . .+.   .....+..++...+.+|| .+|-|-.+++.
T Consensus       218 ~-~p~---~~S~~f~nfl~gLL~kdP-~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 K-PPS---TASSSFVNFLQGLLIKDP-AQRLTWTDLLG  250 (808)
T ss_pred             C-Ccc---cccHHHHHHHHHHhhcCh-hhcccHHHHhc
Confidence            1 111   334457778888889999 99998887754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-40  Score=370.27  Aligned_cols=253  Identities=31%  Similarity=0.495  Sum_probs=214.4

Q ss_pred             CCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      +-...+.||+|+||+||+|+..      +.+.||||.++..... ..+.|++|++.+..++|||||+++|+|.+++..|+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4455688999999999999743      3567999999877655 78899999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEE
Q 045539          691 IMKYMPNGSLENCLYSGT-------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  757 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~k  757 (897)
                      |+|||..|+|.+++....             .+++..+.+.||.|||.|++||   -++.+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceEEE
Confidence            999999999999987543             2378889999999999999999   788899999999999999999999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhc
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      |+|||+++..-..+.+.......-...|||||.+..++++.+||||||||++||+++ |+.||.+...+           
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-----------  712 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-----------  712 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-----------
Confidence            999999998776666655545556789999999999999999999999999999999 99998774322           


Q ss_pred             CCchHHHHhh-hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          837 LPVSVMEVID-TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       837 ~~~~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         ++.+.+. ..+.       +..+.++.++.+||..||+..| ++||+++||-..|+.
T Consensus       713 ---EVIe~i~~g~lL-------~~Pe~CP~~vY~LM~~CW~~~P-~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  713 ---EVIECIRAGQLL-------SCPENCPTEVYSLMLECWNENP-KRRPSFKEIHSRLQA  761 (774)
T ss_pred             ---HHHHHHHcCCcc-------cCCCCCCHHHHHHHHHHhhcCc-ccCCCHHHHHHHHHH
Confidence               2222222 2222       2234677889999999999999 999999999998863

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-39  Score=313.07  Aligned_cols=266  Identities=21%  Similarity=0.304  Sum_probs=206.3

Q ss_pred             cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHH--HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYER--ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|...+++|+|.||.||+|++ ++|+.||||+++.....  ......+|++.|+.++||||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788899999999999999975 47999999999755322  23456799999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++ .+|+..++.....++..++..++.++++|++|+   |++.|+|||+||.|+|++.+|.+||+|||+|+.+......
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 599999999998999999999999999999999   9999999999999999999999999999999998765543


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh--------hcCCch--HH
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN--------DLLPVS--VM  842 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~--~~  842 (897)
                      .  +..+-|.+|+|||.+.+ ..|+...||||.|||+.||+-|.+-|....  +.+....+-        +.+|+-  +.
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCccccccc
Confidence            3  23378999999998765 478999999999999999999987665421  111111111        111110  11


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +..+-.....+... .-...+....++++..++..|| .+|.|++|++++
T Consensus       234 dY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP-~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNP-KKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCc-hhcccHHHHhcc
Confidence            11110100111100 0112233456899999999999 999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=352.22  Aligned_cols=338  Identities=24%  Similarity=0.233  Sum_probs=302.0

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      .+..||+++|.+...-+..|-++++|+.++|..|.++ .||...+-..+|+.|+|.+|.|+..-...+.-++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4677999999999888888999999999999999998 899877777889999999999999999999999999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      .|.|+..--..|..-.++++|+|++|+|+.+..+.|.++.+|..|.|++|+++ .+|...|..+++|+.|+|..|+|.-.
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeee
Confidence            99999444467888899999999999999999999999999999999999999 99999998999999999999999755


Q ss_pred             ccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHH
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS  316 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~  316 (897)
                      ---.|.++++|+.|.|..|.|+......|                     ..|.++++|+|+.|+++..-..++.++. +
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~F---------------------y~l~kme~l~L~~N~l~~vn~g~lfgLt-~  294 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAF---------------------YGLEKMEHLNLETNRLQAVNEGWLFGLT-S  294 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcce---------------------eeecccceeecccchhhhhhcccccccc-h
Confidence            56789999999999999999998877765                     4678999999999999998888899988 8


Q ss_pred             HHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccc
Q 045539          317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG  396 (897)
Q Consensus       317 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  396 (897)
                      |+.|+++.|.|..+-++.++..++|++|+|++|+|+...+..|..|..|++|+|++|++...-..+|..+++|+.|||++
T Consensus       295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~  374 (873)
T KOG4194|consen  295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRS  374 (873)
T ss_pred             hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcC
Confidence            99999999999999999999999999999999999999999999999999999999999987778899999999999999


Q ss_pred             cccccCCCc---ccccccccceeccccccccCCccccccccccce
Q 045539          397 NKFSGSIPS---CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL  438 (897)
Q Consensus       397 N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  438 (897)
                      |.+++.+.+   .|..|++|+.|+|.+|++..+...+|.++.+|+
T Consensus       375 N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE  419 (873)
T KOG4194|consen  375 NELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE  419 (873)
T ss_pred             CeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence            999877654   366778888888888877754444555555444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-39  Score=356.38  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC-C
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND-D  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  686 (897)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|+++... ....+.+.+|+++++++ +||||++++++|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999964      235689999987543 33456788999999999 899999999988764 4


Q ss_pred             ceEEEEEeccCCChhHhhhcCC----------------------------------------------------------
Q 045539          687 FKALIMKYMPNGSLENCLYSGT----------------------------------------------------------  708 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  708 (897)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999999886532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCccc
Q 045539          709 ---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY  785 (897)
Q Consensus       709 ---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y  785 (897)
                         ..+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               2377888899999999999999   8899999999999999999999999999999865433222222233467889


Q ss_pred             CCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHH
Q 045539          786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQIL  864 (897)
Q Consensus       786 ~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~  864 (897)
                      +|||++.+..++.++|||||||++|||++ |..||......+ .....           +.+......+       ....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~-----------~~~~~~~~~~-------~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQR-----------LKDGTRMRAP-------ENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHH-----------HhcCCCCCCC-------CCCC
Confidence            99999988899999999999999999997 999987532111 00000           0000000000       1223


Q ss_pred             HHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          865 LSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       865 ~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .++.+++.+||+.|| ++|||+.|+++.|++
T Consensus       304 ~~l~~li~~cl~~dp-~~RPs~~el~~~l~~  333 (338)
T cd05102         304 PEIYRIMLACWQGDP-KERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=312.63  Aligned_cols=196  Identities=31%  Similarity=0.460  Sum_probs=179.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|+..+.||.|+||.|..++.+ +|..||+|++.+..-   +..+...+|..+|+.+.||.++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46778899999999999999876 588999999987652   34566778999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||++||.|..++++.+ ++++..++-++.||+.|++||   |+.+|++||+||+|||+|.+|.+||+|||+|+...+.  
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            9999999999998765 599999999999999999999   8999999999999999999999999999999987533  


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                         ....+|||.|+|||++....++.++|-|||||++|||+.|.+||..
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~  243 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD  243 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence               3456899999999999999999999999999999999999999976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-39  Score=345.67  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=211.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .+-|+..+.||.|+.|.|..|++. +|+.+|||++.+..   ......+++|+-||+.+.|||++++|+++++..+.|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            356788899999999999999865 79999999997663   22356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      .||++||.|.+++..++ ++++.++.+++.||+.|+.|+   |..+|+|||+||+|+++|..+++||+|||+|....++.
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999998776 488899999999999999999   88999999999999999999999999999998754332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         .-...+|.+.|+|||++.+.+| +.++||||.|||+|.|+||+.||++                 +.+..++.+.-.
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----------------dNir~LLlKV~~  226 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----------------DNIRVLLLKVQR  226 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----------------ccHHHHHHHHHc
Confidence               3345689999999999999888 6799999999999999999999986                 234455544444


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.++.    ...+..+..+|+.+|+..|| +.|-|++||++.
T Consensus       227 G~f~M----Ps~Is~eaQdLLr~ml~VDp-~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 GVFEM----PSNISSEAQDLLRRMLDVDP-STRITTEEILKH  263 (786)
T ss_pred             CcccC----CCcCCHHHHHHHHHHhccCc-cccccHHHHhhC
Confidence            44432    12344567889999999999 999999999864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=329.43  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--------------HHHHHHHHHHHHHHhcCCCccc
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--------------RALKSFEDECEVMKRIRHRNLV  676 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv  676 (897)
                      -....+.|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.||++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3455789999999999999999999865 699999999975421              1235788999999999999999


Q ss_pred             eEeeeecCC--CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          677 KIISSCSND--DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       677 ~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      +++.+..+.  +..|+|+|||..|.+...-... ..+++.++++++.++..||+||   |.+||+||||||+|+|++++|
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCC
Confidence            999998664  6889999999999876432222 2289999999999999999999   899999999999999999999


Q ss_pred             cEEEeeccCccccCCCC---ceeeeeccccCcccCCcCccCCC----CCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          755 VAHISDFGIAKLLSGED---QLSIQIQTLATIGYMAPEYGTKG----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ++||+|||.+.......   ....-...+|||.|+|||...++    ..+.+.||||+||+||.|+.|+.||.+.     
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-----  322 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-----  322 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-----
Confidence            99999999988663221   11112236899999999987653    2366889999999999999999999763     


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                  ...++.++......  .+++.++....+.+++.+++.+|| ++|.+..||..
T Consensus       323 ------------~~~~l~~KIvn~pL--~fP~~pe~~e~~kDli~~lL~KdP-~~Ri~l~~ik~  371 (576)
T KOG0585|consen  323 ------------FELELFDKIVNDPL--EFPENPEINEDLKDLIKRLLEKDP-EQRITLPDIKL  371 (576)
T ss_pred             ------------hHHHHHHHHhcCcc--cCCCcccccHHHHHHHHHHhhcCh-hheeehhhhee
Confidence                        22233333332222  123334556678899999999999 99999999864

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-37  Score=339.25  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-----------------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-----------------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK  677 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  677 (897)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578899999999999999997532                 3469999987543 334567899999999999999999


Q ss_pred             EeeeecCCCceEEEEEeccCCChhHhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 045539          678 IISSCSNDDFKALIMKYMPNGSLENCLYSGT------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPII  739 (897)
Q Consensus       678 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~iv  739 (897)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..+..++.|++.||+||   |+.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCcc
Confidence            9999999999999999999999999885432                  2367788999999999999999   889999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc--CCC
Q 045539          740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKK  817 (897)
Q Consensus       740 H~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt--g~~  817 (897)
                      ||||||+||+++.++.+||+|||+++...............++..|+|||+...+.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999987654433333334456788999999888889999999999999999987  556


Q ss_pred             CCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          818 PTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       818 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ||......  .....+.        +...........   .....+...+.+++.+||+.|| ++|||++||.+.|++
T Consensus       241 p~~~~~~~--~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p-~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDE--QVIENAG--------EFFRDQGRQVYL---FRPPPCPQGLYELMLQCWSRDC-RERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHH--HHHHHHH--------HHhhhccccccc---cCCCCCCHHHHHHHHHHccCCc-hhCcCHHHHHHHHhC
Confidence            77652111  1111110        000000000000   0001233568899999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-39  Score=305.04  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=207.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .....++.+|++|-..++||||.++|+||.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            457889999999999999999765 57889999987653   23457899999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      +||..+|++...+..+. ..+++.....++.|+|.|+.|+   |.++|+||||||+|+|++.++..|++|||.+...+. 
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence            99999999999998655 5689999999999999999999   999999999999999999999999999999986542 


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ......+||..|.|||+..+..++..+|+|++|+..||++.|.+||+... ....+.+             +.+.-.
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkr-------------I~k~~~  239 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKR-------------IRKVDL  239 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHH-------------HHHccc
Confidence               23445689999999999999999999999999999999999999998743 1111111             111100


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..+       ..+.....+++.+|+..+| .+|.+..||++.
T Consensus       240 ~~p-------~~is~~a~dlI~~ll~~~p-~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 KFP-------STISGGAADLISRLLVKNP-IERLALTEVMDH  273 (281)
T ss_pred             cCC-------cccChhHHHHHHHHhccCc-cccccHHHHhhh
Confidence            111       2233456899999999999 999999998763

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=306.76  Aligned_cols=260  Identities=21%  Similarity=0.287  Sum_probs=208.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEE-ecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-----ce
Q 045539          615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-----FK  688 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  688 (897)
                      ..++|++.+.+|+|||+.||.++ ..+++.||+|++.....+..+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35699999999999999999997 4578999999998777777889999999999999999999999885443     58


Q ss_pred             EEEEEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          689 ALIMKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      |++++|+..|+|.+.+...   +..+++.+++.|+.++++||++|   |+..  ++||||||.||++.+++.++++|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999987543   35799999999999999999999   7776  99999999999999999999999999


Q ss_pred             ccccCCCCc-------eeeeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          764 AKLLSGEDQ-------LSIQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       764 a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      +....-.-.       ........+|..|+|||.+   .+...++++|||||||++|+|+.|..||+.......++.-  
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--  253 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--  253 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE--
Confidence            876531111       0111234689999999975   4556789999999999999999999999886544333211  


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                               .+....+......      ...+.+.+++.+|++.|| .+||++.|++..++.
T Consensus       254 ---------Av~n~q~s~P~~~------~yse~l~~lik~mlqvdP-~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  254 ---------AVQNAQISIPNSS------RYSEALHQLIKSMLQVDP-NQRPTIPELLSKLDD  299 (302)
T ss_pred             ---------eeeccccccCCCC------CccHHHHHHHHHHhcCCc-ccCCCHHHHHHHHHh
Confidence                     1111122111111      134568899999999999 999999999988753

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=312.47  Aligned_cols=252  Identities=19%  Similarity=0.298  Sum_probs=208.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..+.|++.+.||+|+|+.||++.. .+|+.+|+|++...  .....+.+.+|++|.+.++||||+++.+.+.+.++.|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            356788889999999999999854 47999999988643  244668899999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~  768 (897)
                      +|+|.|++|..-+-.+ ..+++..+-..++||++||.|+   |.+||||||+||+|+++.   ..-.+||+|||.|....
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999986655443 3478888999999999999999   999999999999999995   33479999999999876


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ++   ....+.+|||+|||||++.+.+|+..+|||+.|||+|-++.|..||.+.                 ....+.++.
T Consensus       165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----------------~~~rlye~I  224 (355)
T KOG0033|consen  165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----------------DQHRLYEQI  224 (355)
T ss_pred             Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----------------cHHHHHHHH
Confidence            22   3345678999999999999999999999999999999999999999762                 112333333


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +++.+.-..+.++.+.++..+++++|+..|| ++|.|+.|.++
T Consensus       225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP-~kRIta~EAL~  266 (355)
T KOG0033|consen  225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNP-KKRITADEALK  266 (355)
T ss_pred             hccccCCCCcccCcCCHHHHHHHHHHhccCh-hhhccHHHHhC
Confidence            3333332233444555667899999999999 99999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=322.24  Aligned_cols=247  Identities=21%  Similarity=0.312  Sum_probs=208.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+++..   .++.-.+++|++||..++||||+.+|.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45899999999999999999975 579999999988664   34556788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||..+|.|.||+...+ .+++.+...++.||..|+.|+   |+++++|||+|.+|||+|+++++||+|||++-.+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998876 599999999999999999999   99999999999999999999999999999998876443


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ....++|++-|.+||+..+.+| ++.+|-||+||++|.++.|..||+..                 +...++.+.-.
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----------------Dhk~lvrQIs~  267 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----------------DHKRLVRQISR  267 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----------------hHHHHHHHhhc
Confidence               2346789999999999998887 68999999999999999999999872                 22233333222


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.+...     +-+....-++++|+..+| +.|.|+.+|...
T Consensus       268 GaYrEP-----~~PSdA~gLIRwmLmVNP-~RRATieDiAsH  303 (668)
T KOG0611|consen  268 GAYREP-----ETPSDASGLIRWMLMVNP-ERRATIEDIASH  303 (668)
T ss_pred             ccccCC-----CCCchHHHHHHHHHhcCc-ccchhHHHHhhh
Confidence            222110     001123467888999999 999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-37  Score=334.51  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=202.3

Q ss_pred             ccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEe
Q 045539          603 AIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKII  679 (897)
Q Consensus       603 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~  679 (897)
                      .++.++.+++.     ......||+|++|.||+|.+ +|+.||||+++....   ...+.+.+|++++++++||||++++
T Consensus        11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            34555666652     22236799999999999998 489999999875432   2257788999999999999999999


Q ss_pred             eeecC----CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCC
Q 045539          680 SSCSN----DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       680 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~  754 (897)
                      +++.+    ....++||||+++|+|.+++.... .+++.....++.|++.|++||   |+ .+++||||||+||++++++
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~  160 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENY  160 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCC
Confidence            99866    346889999999999999997754 588999999999999999999   65 5889999999999999999


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW  832 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~  832 (897)
                      .+||+|||+++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......  .... 
T Consensus       161 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~-  232 (283)
T PHA02988        161 KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYD-  232 (283)
T ss_pred             cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHH-
Confidence            99999999988654321     23457899999999865  68899999999999999999999999763111  0000 


Q ss_pred             hhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          833 INDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       833 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                .++........+      ..+...+.+++.+||+.|| ++|||++|+++.|+.
T Consensus       233 ----------~i~~~~~~~~~~------~~~~~~l~~li~~cl~~dp-~~Rps~~ell~~l~~  278 (283)
T PHA02988        233 ----------LIINKNNSLKLP------LDCPLEIKCIVEACTSHDS-IKRPNIKEILYNLSL  278 (283)
T ss_pred             ----------HHHhcCCCCCCC------CcCcHHHHHHHHHHhcCCc-ccCcCHHHHHHHHHH
Confidence                      111100000000      1234568899999999999 999999999998864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=354.67  Aligned_cols=253  Identities=25%  Similarity=0.468  Sum_probs=213.2

Q ss_pred             CCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          619 FSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..+.++||.|.||+||+|+.+-    ...||||.++... ++....|..|+.||.+++||||+++.|+........||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3467899999999999998752    3569999998665 4456789999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ||++|+|+.+++.+.+.+.+.+...+.++||.|++||   -++++|||||..+|||++.+..+|++|||+++...++...
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            9999999999999998899999999999999999999   9999999999999999999999999999999987644422


Q ss_pred             e-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          774 S-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       774 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      . ...+-.-...|.|||.+...+++.+|||||||||+||.++ |.+||.+....              ++...++.    
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------------dVIkaIe~----  849 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------DVIKAIEQ----  849 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------------HHHHHHHh----
Confidence            1 1111222578999999999999999999999999999776 99998774322              22222332    


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ++  |.+..-+|+..+-+||+.||++|- ..||++++|+..|++
T Consensus       850 gy--RLPpPmDCP~aL~qLMldCWqkdR-~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  850 GY--RLPPPMDCPAALYQLMLDCWQKDR-NRRPKFAQIVSTLDK  890 (996)
T ss_pred             cc--CCCCCCCCcHHHHHHHHHHHHHHh-hcCCCHHHHHHHHHH
Confidence            22  233345788889999999999999 999999999998753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-38  Score=350.23  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999963      235689999987443 33456788999999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-----------------------------------------------------------
Q 045539          688 KALIMKYMPNGSLENCLYSGT-----------------------------------------------------------  708 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  708 (897)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          709 ---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       709 ---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                                     ..+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           2478888999999999999999   8899999999999999999999999999999866433322


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......++..|+|||+..+..++.++|||||||++|||++ |..||...... ....+            .+.......
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~------------~~~~~~~~~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYK------------MIKEGYRML  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHH------------HHHhCccCC
Confidence            22223345678999999999999999999999999999998 88888653211 11111            111111000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+      .....++.+++.+||+.|| ++|||++||++.|++
T Consensus       338 ~~------~~~~~~l~~li~~cl~~dP-~~RPs~~eil~~l~~  373 (375)
T cd05104         338 SP------ECAPSEMYDIMKSCWDADP-LKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CC------CCCCHHHHHHHHHHccCCh-hHCcCHHHHHHHHHh
Confidence            00      0123457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=317.39  Aligned_cols=273  Identities=22%  Similarity=0.265  Sum_probs=209.9

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC----
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN----  684 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  684 (897)
                      ......+|...+.||+|+||.|+.|... +|+.||||++....  ....++..+|+++++.++|+||+.+.+++..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3445667777899999999999999765 79999999987433  4456788899999999999999999999855    


Q ss_pred             -CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          685 -DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       685 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                       -...|+|+|+| +.+|.+.++.+. .++...+.-++.|+++||+|+   |+.+|+|||+||+|++++.++..||+|||+
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccc
Confidence             35789999999 678999888765 488899999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCcc-CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc---
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV---  839 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  839 (897)
                      |+...........+..+.|.+|+|||++ ....|+.+.||||.|||+.||++|+.-|.+.  +.....+.+....+.   
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVHQLQLILELLGTPSE  249 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHHHHHHHHHhcCCCCH
Confidence            9988644333445677889999999975 5568899999999999999999999988652  111111112222211   


Q ss_pred             ---------hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          840 ---------SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       840 ---------~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               .+...+...-...+..+..-.........+++.+|+..|| .+|+|++|.++.
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP-~kRita~eAL~h  310 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP-KKRITAEEALAH  310 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc-cccCCHHHHhcC
Confidence                     1222222211111111122223344567899999999999 999999998863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=332.06  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ...|+..+.||+|.||.||+|.+. .++.||+|++.-.. ....+.+++|+.++.+++++||.++|+.+..+...+++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            346778899999999999999754 68999999998554 4456788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+.||++.+.+..+. .+++..+.-|++++..|+.|+   |.++.+|||||+.||++..+|.+|++|||.+........ 
T Consensus        92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            999999999988766 348888888999999999999   899999999999999999999999999999987754332 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ....++||+.|||||++....|+.|+||||||++.+||++|.+|+.+....  .+.-.+....|+.        +.+  
T Consensus       167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--rvlflIpk~~PP~--------L~~--  233 (467)
T KOG0201|consen  167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--RVLFLIPKSAPPR--------LDG--  233 (467)
T ss_pred             -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--eEEEeccCCCCCc--------ccc--
Confidence             235678999999999999889999999999999999999999999774321  1111111111111        111  


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                              .+...+.+++..|+.+|| +.||+|.++++.
T Consensus       234 --------~~S~~~kEFV~~CL~k~P-~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 --------DFSPPFKEFVEACLDKNP-EFRPSAKELLKH  263 (467)
T ss_pred             --------ccCHHHHHHHHHHhhcCc-ccCcCHHHHhhh
Confidence                    334457899999999999 999999999863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=344.89  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=205.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecC--C---ceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQD--G---MEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDD  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  686 (897)
                      .-++-...++||+|+||.||+|+...  +   ..||||..+..   .....+.+.+|++++++++|||||++||++..+.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34455566999999999999997653  2   23899998852   3567789999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..++|||+|.||+|.+++...+..++..++..++.+.|.||+||   |+++++||||-.+|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            99999999999999999999887799999999999999999999   999999999999999999999999999999875


Q ss_pred             cCCCCceeeee-ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQI-QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      -.   ...... ...-...|+|||.+..+.+++++|||||||++||+++ |..||......  ....++           
T Consensus       312 ~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI-----------  375 (474)
T KOG0194|consen  312 GS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI-----------  375 (474)
T ss_pred             Cc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH-----------
Confidence            42   111111 2234678999999999999999999999999999999 88898763211  111111           


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                          ....+...  .....+..+..++.+||..|| ++||||.++.+.++
T Consensus       376 ----~~~~~r~~--~~~~~p~~~~~~~~~c~~~~p-~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  376 ----VKNGYRMP--IPSKTPKELAKVMKQCWKKDP-EDRPTMSTIKKKLE  418 (474)
T ss_pred             ----HhcCccCC--CCCCCHHHHHHHHHHhccCCh-hhccCHHHHHHHHH
Confidence                11111100  001233457788889999999 99999999999875

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=337.88  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=212.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc-eEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-KALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  691 (897)
                      .++|...+++|+|+||.++.++++ +++.||+|.+....  ....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357899999999999999999766 57899999886443  3445577899999999999999999999998888 9999


Q ss_pred             EEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+|++||++.+.+.... ..++++.+..|+.|++.|+.||   |+.+|+|||||+.||+++.++.+||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999887665 7899999999999999999999   8999999999999999999999999999999998765


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .  ......+||+.|+.||.+.+.+|+.|+||||+||++|||++-+++|...                 +...++.+...
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----------------~m~~Li~ki~~  220 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----------------NMSELILKINR  220 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----------------chHHHHHHHhh
Confidence            4  2344678999999999999999999999999999999999999999862                 22233333222


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....   +.......++..++..|++.+| +.||++.+++.+
T Consensus       221 ~~~~---Plp~~ys~el~~lv~~~l~~~P-~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 GLYS---PLPSMYSSELRSLVKSMLRKNP-EHRPSALELLRR  258 (426)
T ss_pred             ccCC---CCCccccHHHHHHHHHHhhcCC-ccCCCHHHHhhC
Confidence            2211   1112334568899999999999 999999999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=366.05  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=211.8

Q ss_pred             CCCcCCeeecccceEEEEEEecC--Cc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD--GM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..+..+.||+|+||.||.|...+  |.    .||+|.+++.. .+....|.+|+.+|++++|||||+++|+|.+.+..++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44566889999999999997653  43    38999887653 5567899999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          691 IMKYMPNGSLENCLYSG------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++|||++|+|..++++.      ...+...+.+.++.|||+|+.||   +++++|||||..+|+|++....+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999987      56789999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      +.+...+.+.......-...|||||.+..+.++.|+|||||||++||++| |..||.....                 .+
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------~~  912 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------FE  912 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------HH
Confidence            96655554444333234568999999999999999999999999999999 8899876321                 12


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ++...+.+.   |.+....|+.++.++|..||+.+| ++||++.+++++++.
T Consensus       913 v~~~~~~gg---RL~~P~~CP~~ly~lM~~CW~~~p-e~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  913 VLLDVLEGG---RLDPPSYCPEKLYQLMLQCWKHDP-EDRPSFRTIVEQDPA  960 (1025)
T ss_pred             HHHHHHhCC---ccCCCCCCChHHHHHHHHHccCCh-hhCccHHHHHhhhhh
Confidence            222222222   333345677889999999999999 999999999997753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=337.88  Aligned_cols=238  Identities=26%  Similarity=0.423  Sum_probs=199.6

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChh
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLE  701 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  701 (897)
                      .+-||.|+.|.||+|+.+ ++.||||+++.-.       +.+++-|++++||||+.+.|+|.....+|||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            577999999999999998 6899999876432       35788899999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecccc
Q 045539          702 NCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA  781 (897)
Q Consensus       702 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  781 (897)
                      .+++.+. .+......+|..+||.|+.||   |.+.|||||||.-||||..+..+||+|||-++.....   .....+.|
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG  273 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG  273 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence            9999877 477788899999999999999   8999999999999999999999999999999876432   23346789


Q ss_pred             CcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHH
Q 045539          782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKE  861 (897)
Q Consensus       782 t~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~  861 (897)
                      |..|||||++.+.+.++|+||||||||||||+||..||.+......     ++.. .       ...+.      .+...
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGV-G-------sNsL~------LpvPs  334 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGV-G-------SNSLH------LPVPS  334 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEec-c-------CCccc------ccCcc
Confidence            9999999999999999999999999999999999999987422210     0000 0       00010      11223


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          862 QILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       862 ~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .++..+.-+++.||+-.| ..||++.+++..|+
T Consensus       335 tcP~GfklL~Kqcw~sKp-RNRPSFrqil~Hld  366 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKP-RNRPSFRQILLHLD  366 (904)
T ss_pred             cCchHHHHHHHHHHhcCC-CCCccHHHHHHHHh
Confidence            566678889999999999 99999999998774

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-37  Score=333.50  Aligned_cols=250  Identities=20%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|+..+.||+|+||.||+|... +|+.||+|++....   ......+.+|++++++++|++|+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3777899999999999999864 68999999987543   2233467889999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            999999998876433 4589999999999999999999   899999999999999999999999999999987543221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||..|+|||++.+..++.++|||||||++|||++|+.||.......              ..+.+...+...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------------~~~~~~~~~~~~  220 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--------------KREEVDRRVKED  220 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--------------hHHHHHHHhhcc
Confidence               234568999999999999999999999999999999999999997632110              001111111110


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      ....   .......+.+++.+||+.|| ++||+     ++|+++
T Consensus       221 ~~~~---~~~~s~~~~~li~~~l~~~P-~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEY---SEKFSEDAKSICRMLLTKNP-KERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccC---CccCCHHHHHHHHHHhhcCH-HHhcCCCCCCHHHHhc
Confidence            0000   01223457889999999999 99997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=335.31  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   .+..+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999876 68999999987543   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999999987654 588999999999999999999   89999999999999999999999999999998654321 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                          ....|++.|+|||++.+..++.++|||||||++|||++|+.||......     ..        ...+..... ..
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~--------~~~i~~~~~-~~  217 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GI--------YEKILAGKL-EF  217 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH--------HHHHHhCCc-CC
Confidence                2346899999999998888999999999999999999999999752111     00        001111100 00


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~~  892 (897)
                      +       ......+.+++.+|++.|| .+||+     ++|+++.
T Consensus       218 ~-------~~~~~~~~~li~~~l~~dp-~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 P-------RHLDLYAKDLIKKLLVVDR-TRRLGNMKNGADDVKNH  254 (291)
T ss_pred             C-------ccCCHHHHHHHHHHcCCCH-HHccCCccCCHHHHhcC
Confidence            0       0112347889999999999 99995     7877653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-37  Score=346.28  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=203.2

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDD  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  686 (897)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||+|+++... ....+.+.+|+++++.+ +||||++++++|.+.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457999999999999999998742      24579999987543 33456788999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCC----------------------------------------------------------
Q 045539          687 FKALIMKYMPNGSLENCLYSGT----------------------------------------------------------  708 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  708 (897)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999875421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          709 -----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       709 -----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                                 .++++.++..++.||++||+||   |++||+||||||+||++++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       2478888999999999999999   89999999999999999999999999999997654333222222


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ...++..|+|||+..+..++.++|||||||++|||++ |+.||....... .            ....+........+  
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~------------~~~~~~~~~~~~~~--  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K------------FYKMVKRGYQMSRP--  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H------------HHHHHHcccCccCC--
Confidence            3345678999999988899999999999999999997 999987632111 1            11111111100000  


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          .....++.+++.+||+.|| ++|||+.||+++|++
T Consensus       338 ----~~~~~~l~~li~~cl~~dp-~~RPs~~~l~~~l~~  371 (374)
T cd05106         338 ----DFAPPEIYSIMKMCWNLEP-TERPTFSQISQLIQR  371 (374)
T ss_pred             ----CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence                0113457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=342.14  Aligned_cols=253  Identities=22%  Similarity=0.276  Sum_probs=202.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|++. +++.||+|++++..   ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999876 58999999998653   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987654 588999999999999999999   899999999999999999999999999999976543   


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+..        . ...+...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~--------~-~~~~~~~  220 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKY--------W-KETLQRP  220 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHh--------c-cccccCC
Confidence              2234568999999999988899999999999999999999999997531110  0000000        0 0000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..  .........++.+++.+|+..+| ++||+++|+++.
T Consensus       221 ~~--~~~~~~~s~~~~~li~~~l~~~~-~rr~s~~~ll~h  257 (333)
T cd05600         221 VY--DDPRFNLSDEAWDLITKLINDPS-RRFGSLEDIKNH  257 (333)
T ss_pred             CC--CccccccCHHHHHHHHHHhhChh-hhcCCHHHHHhC
Confidence            00  00001233457889999999999 999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.6e-37  Score=324.70  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=202.8

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|++.+.||+|+||.||+|++.++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999998888899999876432 224678889999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            9999999876555689999999999999999999   899999999999999999999999999999876543221 112


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....++..|+|||+.....++.++||||||+++|||++ |+.||......  .....+..           ......+  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~-----------~~~~~~~--  223 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISR-----------GFRLYRP--  223 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC-----------CCCCCCC--
Confidence            22345678999999888889999999999999999999 89998652110  11111110           0000000  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           .....++.+++.+||+.|| ++||+++|+++.|.
T Consensus       224 -----~~~~~~~~~li~~c~~~~p-~~Rps~~~l~~~l~  256 (256)
T cd05114         224 -----KLASMTVYEVMYSCWHEKP-EGRPTFAELLRAIT  256 (256)
T ss_pred             -----CCCCHHHHHHHHHHccCCc-ccCcCHHHHHHhhC
Confidence                 0122457899999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.6e-38  Score=302.02  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=217.4

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhcC-CCccceEeee
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIR-HRNLVKIISS  681 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~  681 (897)
                      -...-+.|...+.+|.|..++|.++.++ +|+.+|+|++....        .+..+.-.+|+.||+++. ||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3445678888999999999999998654 68899999885321        233456678999999995 9999999999


Q ss_pred             ecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       682 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      |+.+.+.++|+|.|+.|.|.|++.+.. .+++.+..+|++|+.+|++||   |.++|||||+||+||++|++.++||+||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEecc
Confidence            999999999999999999999998875 589999999999999999999   9999999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccC------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGT------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND  835 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~  835 (897)
                      |+|+...++..   ....+|||+|.|||.+.      ...|+...|+||.|||+|.++.|.+||...             
T Consensus       168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------------  231 (411)
T KOG0599|consen  168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------------  231 (411)
T ss_pred             ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------------
Confidence            99998876543   34568999999999653      346788999999999999999999998651             


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          .-.-++.-.+.+.++-+.+++.+......+++.+|++.|| .+|-|++|+++
T Consensus       232 ----kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp-~~Ritake~La  282 (411)
T KOG0599|consen  232 ----KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDP-TKRITAKEALA  282 (411)
T ss_pred             ----HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCc-hhcccHHHHhc
Confidence                2233444455666666677788888899999999999999 99999999876

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-37  Score=327.87  Aligned_cols=255  Identities=20%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357889999999999999999753    35689999987553 3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++......+++.++..++.|++.||+||   |++|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999987656789999999999999999999   8999999999999999999999999999987653222


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .. .......++..|+|||...+..++.++|||||||++||+++ |+.||......  ...+.            +....
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~------------~~~~~  225 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA------------VEDGF  225 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH------------HHCCC
Confidence            11 11112235678999999988999999999999999999775 99999753111  11111            11100


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...      ....+...+.+++.+||+.+| ++||+++|+.+.|++
T Consensus       226 ~~~------~~~~~~~~~~~li~~c~~~~p-~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 RLP------APRNCPNLLHQLMLDCWQKER-GERPRFSQIHSILSK  264 (266)
T ss_pred             CCC------CCCCCCHHHHHHHHHHcCCCc-hhCCCHHHHHHHHHh
Confidence            000      011234568899999999999 999999999998854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.2e-37  Score=337.80  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+.. +|+.||+|++++..   ......+.+|++++++++||||+++++++.+++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999998653   233456788999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeec
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ  778 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~  778 (897)
                      +|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999887654 589999999999999999999   89999999999999999999999999999987532221  11234


Q ss_pred             cccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHH
Q 045539          779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFA  858 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  858 (897)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......                 ............ .. 
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----------------~~~~~~~~~~~~-~p-  215 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELILMEEIR-FP-  215 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----------------HHHHHHHcCCCC-CC-
Confidence            56999999999999889999999999999999999999999652110                 000100000000 00 


Q ss_pred             HHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          859 AKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       859 ~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                        .....++.+++.+|++.|| ++||     ++.|+++
T Consensus       216 --~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 --RTLSPEAKSLLAGLLKKDP-KQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCH-HHcCCCCCCCHHHHHc
Confidence              1223457889999999999 9999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.5e-37  Score=330.51  Aligned_cols=265  Identities=19%  Similarity=0.274  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999865 68999999987443 2233567789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ +|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9975 89988877666688999999999999999999   899999999999999999999999999999876432221 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch------------
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS------------  840 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  840 (897)
                       ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+ ..+....+..            
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-EL-HLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHhCCCChHHhhccccch
Confidence             1223457899999998765 568999999999999999999999996532111 01 0111000000            


Q ss_pred             -HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 -VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 -~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ......+.....+  ..........+..+++.+|++.|| ++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~mL~~dp-~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQP--LINHAPRLDTDGIDLLSSLLLYET-KSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCc--hHHhCCCCCHHHHHHHHHhcCcCc-ccCCCHHHHhc
Confidence             0000000000000  000111223457899999999999 99999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-37  Score=329.37  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=205.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|.+.+.||+|+||.||+|+..+      ++.||+|+++..... ..+.+.+|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999997642      478999998765433 457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      ++||||+++++|.+++...+             ..+++.++..++.|++.|++||   |++|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCe
Confidence            99999999999999986542             3478889999999999999999   8999999999999999999999


Q ss_pred             EEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhh
Q 045539          756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~  834 (897)
                      +||+|||.+................+++.|+|||++.+..+++++|||||||++|||++ |..||......  ..     
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~-----  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EV-----  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH-----
Confidence            99999999976543332222233446788999999999999999999999999999998 99998652111  11     


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             .+.+.......+.      ......+.+++.+||+.|| ++||++.||++.|++
T Consensus       234 -------~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 -------IECITQGRLLQRP------RTCPSEVYDIMLGCWKRDP-QQRINIKDIHERLQK  280 (280)
T ss_pred             -------HHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCCc-ccCCCHHHHHHHhhC
Confidence                   1111110000000      1233557899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-37  Score=338.61  Aligned_cols=245  Identities=21%  Similarity=0.280  Sum_probs=199.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357899999999999999999876 58999999997643   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999987654 578889999999999999999   89999999999999999999999999999998764322


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||......     +..        ..+...... 
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~--------~~i~~~~~~-  233 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIY--------EKILAGRLK-  233 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHH--------HHHhcCCcC-
Confidence                 1346899999999999888999999999999999999999999652110     000        011111000 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .+.       ....++.+++.+||+.|| ++||+     ++|+++
T Consensus       234 ~p~-------~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 FPN-------WFDGRARDLVKGLLQTDH-TKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCC-------CCCHHHHHHHHHHhhcCH-HHcCCCCCCCHHHHhc
Confidence            000       122346789999999999 99997     566553

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.5e-37  Score=328.92  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=205.8

Q ss_pred             cCCCcCCeeecccceEEEEEEecC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      ++|++.+.||+|+||.||+|....      .+.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999997642      2579999886443 334567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          690 LIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      ++|||+++++|.+++....               ..+++.++..++.|++.||+||   |++|++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence            9999999999999986542               3478889999999999999999   889999999999999999999


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHh
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~  833 (897)
                      .+||+|||++................+++.|+|||......++.++|||||||++|||++ |..||......        
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999986543333233334456888999999888899999999999999999998 99998753211        


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            +..+.+.......      ....+..++.+++.+||+.|| ++||+++||+++|++
T Consensus       234 ------~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p-~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 ------EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIP-ARRPRFKDIHTRLRS  282 (283)
T ss_pred             ------HHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHhc
Confidence                  1111111111000      012344668999999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.7e-37  Score=330.56  Aligned_cols=268  Identities=18%  Similarity=0.201  Sum_probs=202.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999876 58899999987542  2334677899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++++.+..+... ...+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            9998877655433 34589999999999999999999   899999999999999999999999999999987643221 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH--hhhcCCchHHHHhh-----
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--INDLLPVSVMEVID-----  846 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~i~-----  846 (897)
                      .......|++.|+|||+..+..++.++||||+||++|||++|+.||......+ .....  .....+........     
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence            11223468999999999988889999999999999999999999997532111 00000  00111111100000     


Q ss_pred             -----hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 -----TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 -----~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           +...................+.+++.+|++.|| ++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P-~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNP-TDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCc-ccCCCHHHHhc
Confidence                 000000000000111234568999999999999 99999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-37  Score=352.61  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             CCCcCCeeecccceEEEEEEec-C-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-D-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999754 3 6789999876555555567888999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          696 PNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       696 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ++|+|.+++...   ..++++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542   34588999999999999999999   889999999999999999999999999999987654333


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....                 .+++...+...
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------------~~~~~~~~~~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------------REIMQQVLYGK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence            2233455699999999999988999999999999999999999999865211                 11111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .....   .....++.+++.+|++.|| ++||+++++++
T Consensus       288 ~~~~~---~~~s~~~~~li~~~L~~dP-~~Rps~~~~l~  322 (478)
T PTZ00267        288 YDPFP---CPVSSGMKALLDPLLSKNP-ALRPTTQQLLH  322 (478)
T ss_pred             CCCCC---ccCCHHHHHHHHHHhccCh-hhCcCHHHHHh
Confidence            10000   1123457899999999999 99999999875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-36  Score=333.50  Aligned_cols=264  Identities=21%  Similarity=0.308  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+.. +|..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999876 58889999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... .+++..+..++.|++.||+||   |+ .+|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYL---REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999987654 488999999999999999999   55 479999999999999999999999999987653221 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC---------------
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL---------------  837 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------------  837 (897)
                         .....|++.|+|||++.+..++.++|||||||++|||++|+.||......  .+...+....               
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccc
Confidence               22346899999999999889999999999999999999999999642111  1111100000               


Q ss_pred             ---------------Cc-hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          838 ---------------PV-SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       838 ---------------~~-~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                                     +. ...+..+.......+...  ......++.+++.+||+.|| ++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P-~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNP-AERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCc-ccCCCHHHHhcC
Confidence                           00 011111111111110000  01133568899999999999 999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-37  Score=329.92  Aligned_cols=249  Identities=31%  Similarity=0.501  Sum_probs=195.4

Q ss_pred             cCCeeecccceEEEEEEec-----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          621 ENNLIGIGSFGSIYVARLQ-----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+.||.|.||.||+|.+.     .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     25779999996543 33478899999999999999999999999988889999999


Q ss_pred             ccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++|+|.+++... ...+++.++..|+.||++||+||   |+++++||||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 56799999999999999999999   7889999999999999999999999999999877433333


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......+...|+|||.+....++.++||||||+++||+++ |+.||.+....              ...+.+.......
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------------~~~~~~~~~~~~~  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------------EIIEKLKQGQRLP  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------------HHHHHHHTTEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------cccccccccccce
Confidence            33444557889999999988889999999999999999999 67887653111              1111111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      .+      ..+...+.+++..||+.|| ++|||++|++++|
T Consensus       226 ~~------~~~~~~~~~li~~C~~~~p-~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IP------DNCPKDIYSLIQQCWSHDP-EKRPSFQEILQEL  259 (259)
T ss_dssp             SB------TTSBHHHHHHHHHHT-SSG-GGS--HHHHHHHH
T ss_pred             ec------cchhHHHHHHHHHHcCCCh-hhCcCHHHHHhcC
Confidence            11      1233457899999999999 9999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=330.34  Aligned_cols=263  Identities=24%  Similarity=0.403  Sum_probs=218.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .+...+.++||+|.||+|..++...+..||||.++..... ....|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3566788999999999999999987899999999977644 458899999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++|+|.+++.+...+ .+.....+|+.||+.|++||   .+.++||||+.+.|+|+|.++++||+|||+++-.-..+..
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999887533 35666788999999999999   9999999999999999999999999999999977767777


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc--CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ......+-...|||||.+.-++++.+||||+||+++||+++  ...||.+..+++  ..+        ...++++..-..
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vve--------n~~~~~~~~~~~  763 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVE--------NAGEFFRDQGRQ  763 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHH--------hhhhhcCCCCcc
Confidence            77777777899999999999999999999999999999876  788987643321  111        111222211111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         ........+..++.+++.+||..|. ++||+++++...|++
T Consensus       764 ---~~l~~P~~cp~~lyelml~Cw~~es-~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  764 ---VVLSRPPACPQGLYELMLRCWRRES-EQRPSFEQLHLFLQE  803 (807)
T ss_pred             ---eeccCCCcCcHHHHHHHHHHhchhh-hcCCCHHHHHHHHHH
Confidence               1112223456778899999999999 999999999988765

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.2e-37  Score=337.21  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----CceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DFKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  689 (897)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999865 68999999987432  23345688999999999999999999987543     2479


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68988887654 589999999999999999999   899999999999999999999999999999976432


Q ss_pred             CCc-eeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch------
Q 045539          770 EDQ-LSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS------  840 (897)
Q Consensus       770 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  840 (897)
                      ... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....  ....+.+.......      
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence            221 111234568999999998765  6789999999999999999999999965211  11111111111110      


Q ss_pred             ------HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 ------VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ------~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                            ..+.+.......+.............+.+++.+|++.|| ++|||++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP-KDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc-ccCCCHHHHhcC
Confidence                  111111111111100011111223457899999999999 999999999863

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-36  Score=320.19  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      +.||+|+||.||+|... +++.||+|.+.... .+....+.+|++++++++||||+++++++..++..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999875 68999999876443 33456789999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                      .+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999977666689999999999999999999   89999999999999999999999999999987644221111111112


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAA  859 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  859 (897)
                      ++..|+|||...++.++.++||||||+++|||++ |..||......              .....+........      
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~~~~~~~~~~~------  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTREAIEQGVRLPC------  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHHHHHcCCCCCC------
Confidence            3457999999988889999999999999999998 88888652111              11111111111111      


Q ss_pred             HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          860 KEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       860 ~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ......++.+++.+|++.|| ++|||++||+++|++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p-~~Rps~~~~~~~l~~  252 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDP-GQRPSFSTVHQELQS  252 (252)
T ss_pred             cccCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHhC
Confidence            01223468899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=323.37  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=206.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|.+..    ...||+|+++... ......+.+|+.++++++||||+++++++.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578999999999999999998752    4579999987543 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|++.|++||   |+++|+||||||+||++++++.+||+|||.+......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999987666789999999999999999999   8999999999999999999999999999999877532


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........++..|+|||...+..++.++||||||+++|||++ |..||......  ...+.+            ....
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~------------~~~~  225 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV------------EDGY  225 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH------------HcCC
Confidence            22222223345678999999988899999999999999999998 99998652111  111111            1000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....      .......+.+++.+|++.+| ++||+++||++.|++
T Consensus       226 ~~~~------~~~~~~~l~~li~~cl~~~p-~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 RLPP------PMDCPSALYQLMLDCWQKDR-NERPTFSQIVSTLDK  264 (266)
T ss_pred             CCCC------CCCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHh
Confidence            0000      01223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-37  Score=308.14  Aligned_cols=266  Identities=22%  Similarity=0.245  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH--HHHHHHHHHHHHHhcCCCccceEeeeec--CCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER--ALKSFEDECEVMKRIRHRNLVKIISSCS--NDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  690 (897)
                      .+.|+..++|++|+||.||+|+++ +++.||+|+++...+.  ..-...+|+.+|.+++|||||.+-.+..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            346778899999999999999865 6899999999865432  1234568999999999999999988774  3457999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |||||+. +|...+..-..++...++..++.|+++|++||   |++.|+|||+||+|+|+.+.|.+||+|||+|+.++..
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999965 88888888777899999999999999999999   9999999999999999999999999999999998754


Q ss_pred             CceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--------cCCch-
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--------LLPVS-  840 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~-  840 (897)
                      .  ...+..+-|.+|+|||.+.+ ..|+++.|+||+|||+.|++++++-|....  +.+....+-.        .+|.- 
T Consensus       231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             c--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCcc
Confidence            2  34456678999999998765 468999999999999999999999886521  1111111111        11110 


Q ss_pred             HHHHhhh-hh-cchhhh---hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VMEVIDT-NL-LRGEER---FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~~i~~-~l-~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....+.. .. ...+..   ++.... ..+.-.+++...+..|| ++|.||+|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP-~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDP-GKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCc-cccccHHHhhc
Confidence            0000000 00 000100   111111 22445688888999999 99999999875

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-36  Score=321.97  Aligned_cols=252  Identities=21%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|++.+.||+|+||.||.|++.++..||+|.++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688889999999999999988877789999887542 224678899999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++......+++.++..++.|++.||+||   |+.|++|+||||+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            9999999987655789999999999999999999   899999999999999999999999999999876543321 112


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....++..|+|||+.....++.++||||||+++|||++ |+.||......  .            ..+.+......... 
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~------------~~~~~~~~~~~~~~-  223 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--E------------TVEKVSQGLRLYRP-  223 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--H------------HHHHHhcCCCCCCC-
Confidence            22345678999999988889999999999999999999 99998652111  0            00111100000000 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           ......+.+++.+||+.|| ++|||+.++++.|+
T Consensus       224 -----~~~~~~~~~li~~cl~~~p-~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 -----HLASEKVYAIMYSCWHEKA-EERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCHHHHHHHHHHcCCCc-ccCCCHHHHHHhhC
Confidence                 0123457899999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-36  Score=339.33  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=175.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++++..   ......+.+|++++.+++||+|+++++++.++...|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999765 58999999997643   233467888999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 589999999999999999999   899999999999999999999999999999875432110


Q ss_pred             e---------------------------------eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 045539          773 L---------------------------------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPT  819 (897)
Q Consensus       773 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~  819 (897)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999998889999999999999999999999999


Q ss_pred             cc
Q 045539          820 DE  821 (897)
Q Consensus       820 ~~  821 (897)
                      ..
T Consensus       237 ~~  238 (363)
T cd05628         237 CS  238 (363)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-36  Score=328.47  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999742      345699999876655666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          691 IMKYMPNGSLENCLYSGT------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      ||||+++++|.+++....            ..+++.++..++.|++.||+||   |++|++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            2489999999999999999999   8999999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +|||.+................++..|+|||+..+..++.++|||||||++|||++ |..||......+  ..+.     
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~-----  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC-----  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-----
Confidence            99999986643333222333446788999999988889999999999999999998 899986532110  0000     


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            +........+       .....++.+++.+||+.|| .+|||+.||.+.|++
T Consensus       235 ------i~~~~~~~~~-------~~~~~~l~~li~~~l~~~p-~~Rpt~~~v~~~l~~  278 (288)
T cd05093         235 ------ITQGRVLQRP-------RTCPKEVYDLMLGCWQREP-HMRLNIKEIHSLLQN  278 (288)
T ss_pred             ------HHcCCcCCCC-------CCCCHHHHHHHHHHccCCh-hhCCCHHHHHHHHHH
Confidence                  0000000000       1123458999999999999 999999999888753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-37  Score=340.08  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=201.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999865 689999999986532   34567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999987756799999999999999999999   899999999999999999999999999999987653332


Q ss_pred             eeeeeccccCcccCCcCccC------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          773 LSIQIQTLATIGYMAPEYGT------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      . ......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     ..        ...+..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~--------~~~i~~  223 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KT--------YNNIMN  223 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HH--------HHHHHc
Confidence            2 223456899999999875      456789999999999999999999999752111     00        011111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .......    +........+.+++..|++ +| ++|||++++++
T Consensus       224 ~~~~~~~----~~~~~~~~~~~~li~~ll~-~p-~~R~t~~~l~~  262 (330)
T cd05601         224 FQRFLKF----PEDPKVSSDFLDLIQSLLC-GQ-KERLGYEGLCC  262 (330)
T ss_pred             CCCccCC----CCCCCCCHHHHHHHHHHcc-Ch-hhCCCHHHHhC
Confidence            0000000    0001123457788889997 99 99999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=335.01  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=200.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  689 (897)
                      ..++|+..++||+|.||.|+.|..+ +++.||||++++..   .++.+..+.|.+|+.... ||.+++++..|+..++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3568999999999999999999876 58899999998764   456678889999998886 999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+.||++..+.+.  ..+++..+.-++..++.||+||   |++||||||||-+|||+|.+|.+||+|||+++.--.
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999996554443  3599999999999999999999   999999999999999999999999999999986432


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .  ...+...+|||.|||||++.+..|+.++|-|||||++|||+.|+.||....                 -.++.+..+
T Consensus       521 ~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-----------------Eee~FdsI~  581 (694)
T KOG0694|consen  521 Q--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-----------------EEEVFDSIV  581 (694)
T ss_pred             C--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-----------------HHHHHHHHh
Confidence            2  234567899999999999999999999999999999999999999998621                 123333333


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      ..++.  ++  .-+..+.+.++.+.+..+| ++|--+
T Consensus       582 ~d~~~--yP--~~ls~ea~~il~~ll~k~p-~kRLG~  613 (694)
T KOG0694|consen  582 NDEVR--YP--RFLSKEAIAIMRRLLRKNP-EKRLGS  613 (694)
T ss_pred             cCCCC--CC--CcccHHHHHHHHHHhccCc-ccccCC
Confidence            32221  11  1223446777788888888 888754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-36  Score=326.48  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=202.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      ..++|+..+.||+|+||.||+|.+.      ++..||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      25679999886432 2344678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          688 KALIMKYMPNGSLENCLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      .++||||+++++|.+++....         ..+++..+..++.|++.||+||   |+.|++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         2357788999999999999999   8899999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +|||++................+++.|+|||+..++.++.++|||||||++|||++ |..||......  ...+.     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~-----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF-----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-----
Confidence            99999876543332222222345778999999988889999999999999999999 68888652111  11111     


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            +........+       ..+...+.+++.+|++.|| ++|||+.|+++.|++
T Consensus       234 ------~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p-~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 ------VMEGGLLDKP-------DNCPDMLFELMRMCWQYNP-KMRPSFLEIISSIKE  277 (277)
T ss_pred             ------HHcCCcCCCC-------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHhhC
Confidence                  0111110001       1223457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.8e-37  Score=340.90  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|++.      .+..||||+++... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            568999999999999999999753      13469999987543 334567899999999996 9999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-----------------------------------------------------------
Q 045539          688 KALIMKYMPNGSLENCLYSGT-----------------------------------------------------------  708 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  708 (897)
                      .|+||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC
Q 045539          709 ------------------------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE  752 (897)
Q Consensus       709 ------------------------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~  752 (897)
                                                          ..+++..+..++.|+++||+||   |+.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEeC
Confidence                                                2367788899999999999999   8899999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhH
Q 045539          753 DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNR  831 (897)
Q Consensus       753 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~  831 (897)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~---  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-T---  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-H---
Confidence            99999999999986543332222233456788999999988889999999999999999997 999987532111 0   


Q ss_pred             HhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          832 WINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       832 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                               ....+......      .....+..++.+++.+||+.|| ++|||+.+|.++|++
T Consensus       349 ---------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP-~~RPt~~~l~~~l~~  396 (400)
T cd05105         349 ---------FYNKIKSGYRM------AKPDHATQEVYDIMVKCWNSEP-EKRPSFLHLSDIVES  396 (400)
T ss_pred             ---------HHHHHhcCCCC------CCCccCCHHHHHHHHHHCccCH-hHCcCHHHHHHHHHH
Confidence                     00111110000      0011234568899999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.1e-37  Score=326.04  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=210.0

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      +...+|+..+.||.|+||.||+|...+++.+|+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44567999999999999999999988899999999987665556788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++.++..++.|++.|++||   |++||+||||||+||++++++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999987643 4689999999999999999999   899999999999999999999999999999976643221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        ......++..|+|||......++.++||||||+++|+|++ |+.||......  ...            ..+......
T Consensus       160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~------------~~~~~~~~~  223 (261)
T cd05148         160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVY------------DQITAGYRM  223 (261)
T ss_pred             --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHH------------HHHHhCCcC
Confidence              1223346778999999888889999999999999999998 89998652211  011            111110000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            +....+...+.+++.+|++.|| ++|||++++++.|++
T Consensus       224 ------~~~~~~~~~~~~~i~~~l~~~p-~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 ------PCPAKCPQEIYKIMLECWAAEP-EDRPSFKALREELDN  260 (261)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHhc
Confidence                  0011233557899999999999 999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-36  Score=328.84  Aligned_cols=269  Identities=20%  Similarity=0.236  Sum_probs=199.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999876 689999999875432 223456789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++ +++.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 678777776656689999999999999999999   89999999999999999999999999999987543221  


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch------HHHH--
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS------VMEV--  844 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~--  844 (897)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.+.........      ....  
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            11233468999999998754 45788999999999999999999999763221111111110000000      0000  


Q ss_pred             hh-hhhc-chhhhhHHHHH--HHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 ID-TNLL-RGEERFFAAKE--QILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~-~~l~-~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .. .... ..+........  .....+.+++.+|++.|| ++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp-~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFP-KNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCc-hhccCHHHHhc
Confidence            00 0000 00000000000  112456789999999999 99999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-36  Score=323.57  Aligned_cols=254  Identities=23%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46789999999999999999998888899999886543 23567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++... ...+++.++..++.|++.||+||   |+.+++||||||+||+++.++.+||+|||.+........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998654 35688899999999999999999   889999999999999999999999999999987643221 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||+...+.++.++|||||||++|+|++ |+.||......  .....+..            ....  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~------------~~~~--  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQR------------GYRM--  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHc------------CCCC--
Confidence            1223345678999999988889999999999999999998 99998652111  11111111            0000  


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          +.......++.+++.+|+..+| ++||+++++.+.|++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 ----PRMENCPDELYDIMKTCWKEKA-EERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCc-ccCcCHHHHHHHHhc
Confidence                0001223457899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-37  Score=333.02  Aligned_cols=239  Identities=23%  Similarity=0.250  Sum_probs=192.4

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||.||+|+.. +++.||+|++++..   ......+.+|++++++++||||+++++++.+++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 58899999987542   33456778899999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                      .+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987654 589999999999999999999   89999999999999999999999999999987543222  1223456


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .            +........... ..   
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~------------~~~~~~~~~~~~-~~---  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----N------------EMYRKILQEPLR-FP---  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----H------------HHHHHHHcCCCC-CC---
Confidence            89999999999998999999999999999999999999975211     1            111111111100 00   


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCC---HHHHHh
Q 045539          861 EQILLSVLNLATECTIESRDGNGAD---MGWIFS  891 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt---~~evl~  891 (897)
                      .....++.+++.+|++.|| ++||+   +.|+++
T Consensus       214 ~~~~~~~~~li~~~L~~dp-~~R~~~~~~~e~l~  246 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDP-TRRLGYNGAQEIKN  246 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCH-HHcCCCCCHHHHHc
Confidence            1223457889999999999 99985   566554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=341.87  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999875 58999999997643   234466788999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 589999999999999999999   899999999999999999999999999999875432110


Q ss_pred             ee------------------------------------eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCC
Q 045539          773 LS------------------------------------IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK  816 (897)
Q Consensus       773 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~  816 (897)
                      ..                                    ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011245899999999998889999999999999999999999


Q ss_pred             CCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC---HHHHHh
Q 045539          817 KPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD---MGWIFS  891 (897)
Q Consensus       817 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt---~~evl~  891 (897)
                      .||......     +.        ...++...  ...  ..+........+.+++.+|+. +| .+|++   ++|+++
T Consensus       237 ~Pf~~~~~~-----~~--------~~~i~~~~--~~~--~~~~~~~~s~~~~~li~~ll~-~p-~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQ-----ET--------YRKIINWK--ETL--QFPDEVPLSPEAKDLIKRLCC-EA-ERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHH-----HH--------HHHHHcCC--Ccc--CCCCCCCCCHHHHHHHHHHcc-CH-hhcCCCCCHHHHhc
Confidence            999753111     00        00111000  000  000000122346778888886 89 99997   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-36  Score=326.74  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .+|...+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999743      356699999876666666788999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          691 IMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      ||||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence            999999999999986532               3478999999999999999999   8999999999999999999999


Q ss_pred             EEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhh
Q 045539          756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~  834 (897)
                      +||+|||.+................++..|+|||+..+..++.++||||||+++|||++ |+.||......  ...+.+.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh
Confidence            99999999976544333223334456788999999988889999999999999999999 99998653211  0111110


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                                 .......+       ......+.+++.+||+.|| ++|||+++|+++|+
T Consensus       240 -----------~~~~~~~~-------~~~~~~~~~li~~~l~~~P-~~Rpt~~~v~~~l~  280 (291)
T cd05094         240 -----------QGRVLERP-------RVCPKEVYDIMLGCWQREP-QQRLNIKEIYKILH  280 (291)
T ss_pred             -----------CCCCCCCC-------ccCCHHHHHHHHHHcccCh-hhCcCHHHHHHHHH
Confidence                       00000000       1123457899999999999 99999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.9e-37  Score=350.29  Aligned_cols=256  Identities=22%  Similarity=0.317  Sum_probs=203.7

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC---
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDD---  686 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  686 (897)
                      ....++|.+.+.||+|+||+||+|+.. +|+.||||++...  .......+.+|+..+..++|+|++++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344579999999999999999999764 6899999998643  2344567889999999999999999988774332   


Q ss_pred             -----ceEEEEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          687 -----FKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       687 -----~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                           ..++||||+++|+|.+++....   ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999886532   4688999999999999999999   8999999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....               
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---------------  249 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---------------  249 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---------------
Confidence            99999987643322222334579999999999999999999999999999999999999997521               


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        ..+++...+.......   ......++.+++.+||+.|| ++||+++++++.
T Consensus       250 --~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP-~~RPs~~ell~~  297 (496)
T PTZ00283        250 --MEEVMHKTLAGRYDPL---PPSISPEMQEIVTALLSSDP-KRRPSSSKLLNM  297 (496)
T ss_pred             --HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCh-hhCcCHHHHHhC
Confidence              1111111111111000   01233457899999999999 999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-36  Score=331.38  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=201.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .+|+..+.||+|+||.||+|++. +|+    .||+|+++... ....+.+.+|+.+++.++||||++++++|..+ ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            57899999999999999999864 333    48999987543 34457788999999999999999999999765 5679


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999988766789999999999999999999   8999999999999999999999999999999876543


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........++..|+|||+..+..++.++|||||||++|||++ |+.||......  .            ...++....
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~------------~~~~~~~~~  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E------------ISSILEKGE  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H------------HHHHHhCCC
Confidence            33222223335678999999999999999999999999999998 99998652111  0            111111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....      ...+..++.+++.+||..|| ++||++.++++.+.
T Consensus       229 ~~~~------~~~~~~~~~~li~~cl~~~p-~~Rps~~~l~~~l~  266 (316)
T cd05108         229 RLPQ------PPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFS  266 (316)
T ss_pred             CCCC------CCCCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            0000      01123457889999999999 99999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=313.94  Aligned_cols=269  Identities=26%  Similarity=0.337  Sum_probs=203.1

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc--CCCccceEeeeecCCC----ceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSCSNDD----FKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lv  691 (897)
                      .....+++|+|.||.||+|... ++.||||++...   ..+.|.+|-+|.+..  +|+||++++++-....    .+++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4455688999999999999987 599999999854   346777888887765  6999999999876555    88999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF------GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~------~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      +||.+.|+|.+|+..+.  ++|....+++.-+++||+|||+      .|+.+|+|||||++|||+..|+++.|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999999887  8999999999999999999995      478899999999999999999999999999999


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCC------CCccchHHHHHHHHHHHHcCCCCCcc-cc-cCccchhHHhhhcC
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGR------VCTRGDVYSYGIMLMEMFTKKKPTDE-IF-IGELSLNRWINDLL  837 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvil~elltg~~p~~~-~~-~~~~~~~~~~~~~~  837 (897)
                      .+.+..........+||..|||||++.+..      .-.+.||||+|.|+|||+++-.-++. .. .-...+..-+..+-
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            987666555555678999999999876542      22468999999999999997654321 10 11111111111111


Q ss_pred             Cc-hHHH-HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          838 PV-SVME-VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       838 ~~-~~~~-~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .. +..+ ++.++.+...+..+..- ..+..+.+.+..||++|| +.|-|+.=|.+++.
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDa-eARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDA-EARLTAGCVEERMA  501 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCch-hhhhhhHHHHHHHH
Confidence            11 1222 22223333222222211 345668889999999999 99999988877664

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-36  Score=332.50  Aligned_cols=241  Identities=21%  Similarity=0.269  Sum_probs=193.9

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++.+++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997653   234456778999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeec
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ  778 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~  778 (897)
                      +|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            9998887654 589999999999999999999   899999999999999999999999999999875322211  1223


Q ss_pred             cccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHH
Q 045539          779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFA  858 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  858 (897)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..           ...+...... .+     
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~-----------~~~~~~~~~~-~p-----  215 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL-----------FELILMEEIR-FP-----  215 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HH-----------HHHHhcCCCC-CC-----
Confidence            56899999999999889999999999999999999999999652111  00           0011100000 00     


Q ss_pred             HHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          859 AKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       859 ~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                        .....++.+++.+|++.|| ++||     ++.++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 --RTLSPEAKSLLAGLLKKDP-KQRLGGGPSDAKEVME  250 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCH-HHhCCCCCCCHHHHHc
Confidence              1123457889999999999 9998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-36  Score=332.69  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=195.2

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+.. +|+.||+|++.+..   ......+.+|+++++.++||||+++++++.+++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997653   234567788999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeec
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ  778 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~  778 (897)
                      +|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9998886654 589999999999999999999   89999999999999999999999999999987543221  12234


Q ss_pred             cccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHH
Q 045539          779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFA  858 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  858 (897)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......                 +........... .  
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----------------~~~~~~~~~~~~-~--  214 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELILMEDIK-F--  214 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----------------HHHHHhccCCcc-C--
Confidence            56899999999998889999999999999999999999999652111                 111111101000 0  


Q ss_pred             HHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          859 AKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       859 ~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                       ......++.+++.+|++.|| ++||     ++.|+++.
T Consensus       215 -p~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 -PRTLSADAKSLLSGLLIKDP-NKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -CCCCCHHHHHHHHHHcCCCH-HHcCCCCCCCHHHHhcC
Confidence             01123457889999999999 9997     88988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5e-37  Score=342.00  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999875 58899999997542   2234567889999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++....  +++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+......
T Consensus       121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999887653  78888999999999999999   8899999999999999999999999999999865432


Q ss_pred             CceeeeeccccCcccCCcCccCCC----CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKG----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .. .......||+.|+|||++...    .++.++|||||||++|||++|+.||......     ..        ...+..
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~--------~~~i~~  261 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GT--------YSKIMD  261 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HH--------HHHHHc
Confidence            21 122345699999999987543    4789999999999999999999999752110     00        111111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCC--CCCHHHHHhh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGN--GADMGWIFSA  892 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~--RPt~~evl~~  892 (897)
                      ..    ....++.......++.+++.+|++.+| ++  |||++|+++.
T Consensus       262 ~~----~~~~~~~~~~~s~~~~~li~~~L~~~p-~r~~R~s~~ell~h  304 (370)
T cd05596         262 HK----NSLTFPDDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSH  304 (370)
T ss_pred             CC----CcCCCCCcCCCCHHHHHHHHHHccChh-hccCCCCHHHHhcC
Confidence            00    000001111223457889999999999 77  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-36  Score=340.76  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|+..+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999765 58899999997643   2345678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc-
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~-  772 (897)
                      |+++|+|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 488889999999999999999   899999999999999999999999999999754311000 


Q ss_pred             --------------------------------------------eeeeeccccCcccCCcCccCCCCCCccchHHHHHHH
Q 045539          773 --------------------------------------------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM  808 (897)
Q Consensus       773 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvi  808 (897)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999988889999999999999


Q ss_pred             HHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhH--ccCCCCCCCCCCH
Q 045539          809 LMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATE--CTIESRDGNGADM  886 (897)
Q Consensus       809 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~~RPt~  886 (897)
                      +|||++|+.||......+.             ...++........+    .......+..+++.+  |+..+| ..||++
T Consensus       238 l~elltG~~Pf~~~~~~~~-------------~~~i~~~~~~~~~~----~~~~~s~~~~dli~~ll~~~~~~-~~R~~~  299 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTET-------------QLKVINWENTLHIP----PQVKLSPEAVDLITKLCCSAEER-LGRNGA  299 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHH-------------HHHHHccccccCCC----CCCCCCHHHHHHHHHHccCcccc-cCCCCH
Confidence            9999999999975321110             00111000000000    000112345666666  666677 779999


Q ss_pred             HHHHhh
Q 045539          887 GWIFSA  892 (897)
Q Consensus       887 ~evl~~  892 (897)
                      +|+++.
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=341.62  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999876 68999999997653   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC-
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED-  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~-  771 (897)
                      ||+++++|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998876 4589999999999999999999   88999999999999999999999999999998664332 


Q ss_pred             --------------------------ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccC
Q 045539          772 --------------------------QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG  825 (897)
Q Consensus       772 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~  825 (897)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001122346899999999999999999999999999999999999999763211


Q ss_pred             ccchhHHhhhcCCchHHHHhh--hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-HHHHHhh
Q 045539          826 ELSLNRWINDLLPVSVMEVID--TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-MGWIFSA  892 (897)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-~~evl~~  892 (897)
                           ..        ...+..  ..+....      ......++.+++.+|+. || ++||+ ++|+++.
T Consensus       237 -----~~--------~~~i~~~~~~~~~p~------~~~~~~~~~~li~~ll~-dp-~~R~~s~~~ll~h  285 (350)
T cd05573         237 -----ET--------YNKIINWKESLRFPP------DPPVSPEAIDLICRLLC-DP-EDRLGSFEEIKSH  285 (350)
T ss_pred             -----HH--------HHHHhccCCcccCCC------CCCCCHHHHHHHHHHcc-Ch-hhcCCCHHHHhcC
Confidence                 00        011111  0000000      00123457889999997 99 99999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-36  Score=330.15  Aligned_cols=199  Identities=24%  Similarity=0.352  Sum_probs=174.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+.+|++++++++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999876 58889999887542 3345678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++.... .+++..+..++.|++.|++|||  +..+|+||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence            999999999987654 4888999999999999999994  24589999999999999999999999999987653221  


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                        .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              2234689999999999888899999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=312.42  Aligned_cols=259  Identities=23%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .+.|+..++||.|.-|+||+|+..+ +..+|+|++.+..   .+...+.+.|.+||+.++||.++.+|+.|+.+++.|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3456778899999999999999874 6889999998764   34456778899999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC-
Q 045539          692 MKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG-  769 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~-  769 (897)
                      ||||+||+|....+.+. ..+++..++-++.+++-||+||   |-.|||+|||||+|||+.++|.+.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998877654 7799999999999999999999   999999999999999999999999999998753311 


Q ss_pred             --------------------------------CCc---------------------eeeeeccccCcccCCcCccCCCCC
Q 045539          770 --------------------------------EDQ---------------------LSIQIQTLATIGYMAPEYGTKGRV  796 (897)
Q Consensus       770 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  796 (897)
                                                      ...                     .......+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     001123479999999999999999


Q ss_pred             CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccC
Q 045539          797 CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTI  876 (897)
Q Consensus       797 ~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~  876 (897)
                      +.++|.|+|||++|||+.|.-||......+             -+..++.+.+.      ++..........+||++.+.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~------Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLK------FPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCc------CCCCCcchhHHHHHHHHHhc
Confidence            999999999999999999999998743221             12233332221      22222445667889999999


Q ss_pred             CCCCCCCCCHHHHHhhcCCCC
Q 045539          877 ESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       877 ~dP~~~RPt~~evl~~L~~~~  897 (897)
                      +|| ++|-....=.+++++||
T Consensus       374 KdP-~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  374 KDP-SKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             cCh-hhhhccccchHHhhcCc
Confidence            999 99987333333344443

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-36  Score=333.98  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=192.4

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHH---HhcCCCccceEeeeecCCCceEEE
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVM---KRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      |++.+.||+|+||.||+|+.. +|+.||||++++..   ....+.+.+|++++   +.++||||+++++++.+++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999865 68999999997653   22345667777665   456799999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|..++...  .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999887654  489999999999999999999   89999999999999999999999999999987533221


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        .......|++.|+|||++.+..++.++|||||||++|||++|+.||......                 +..+.....
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----------------~~~~~i~~~  216 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----------------EVFDSIVND  216 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhC
Confidence              1223456899999999999889999999999999999999999999752111                 111111110


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .+. ..   ......+.+++.+|++.|| ++||+     +.++++
T Consensus       217 ~~~-~p---~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 EVR-YP---RFLSREAISIMRRLLRRNP-ERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCC-CC---CCCCHHHHHHHHHHhhcCH-hHcCCCCCCCHHHHhh
Confidence            000 00   1123457889999999999 99994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-36  Score=335.12  Aligned_cols=246  Identities=20%  Similarity=0.262  Sum_probs=199.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC--CceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD--GMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|.+.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999997543  3689999987543   2345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 588999999999999999999   8999999999999999999999999999999865432


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..           ...+..... 
T Consensus       185 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~-----------~~~i~~~~~-  245 (340)
T PTZ00426        185 T-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LI-----------YQKILEGII-  245 (340)
T ss_pred             c-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HH-----------HHHHhcCCC-
Confidence            1     2346899999999998888999999999999999999999999752110  00           011111110 


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                      ..+.       .....+.+++.+|++.|| ++|+     +++|+++.
T Consensus       246 ~~p~-------~~~~~~~~li~~~l~~dp-~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 YFPK-------FLDNNCKHLMKKLLSHDL-TKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCC-------CCCHHHHHHHHHHcccCH-HHcCCCCCCCHHHHHcC
Confidence            0011       112346789999999999 9995     78887653

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=319.65  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45789999999999999999988778889999987543 23466889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||.+........ .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999987654 5689999999999999999999   889999999999999999999999999999987652211 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.||......  .            ....+........
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~------------~~~~~~~~~~~~~  225 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--E------------VLQQVDQGYRMPC  225 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--H------------HHHHHHcCCCCCC
Confidence            1112223457999999988889999999999999999999 99998652111  0            1111111100000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            .......+.+++.+|++.|| ++||+++++.+.|++
T Consensus       226 ------~~~~~~~~~~li~~~l~~~P-~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 ------PPGCPKELYDIMLDCWKEDP-DDRPTFETLQWKLED  260 (261)
T ss_pred             ------CCcCCHHHHHHHHHHhhcCc-ccCCCHHHHHHHHhc
Confidence                  01223558899999999999 999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9e-37  Score=339.42  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999876 58899999987532   2234567899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++....  +++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|......
T Consensus       121 v~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999987653  78899999999999999999   8999999999999999999999999999999876432


Q ss_pred             CceeeeeccccCcccCCcCccCCC----CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKG----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .. .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||......     ..        ...+++
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~--------~~~i~~  261 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GT--------YSKIMD  261 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HH--------HHHHHh
Confidence            22 122345699999999987543    3788999999999999999999999752110     00        111111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCC--CCCHHHHHhh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGN--GADMGWIFSA  892 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~--RPt~~evl~~  892 (897)
                      ......    ++........+.+++..|+..+| ..  |||++|+++.
T Consensus       262 ~~~~~~----~p~~~~~s~~~~~li~~~L~~~~-~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKNSLN----FPEDVEISKHAKNLICAFLTDRE-VRLGRNGVEEIKQH  304 (370)
T ss_pred             CCcccC----CCCcccCCHHHHHHHHHHccCch-hccCCCCHHHHhcC
Confidence            110000    01111223456778888887554 43  8899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=341.26  Aligned_cols=201  Identities=24%  Similarity=0.367  Sum_probs=173.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999765 68999999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987654 588999999999999999999   899999999999999999999999999999864321100


Q ss_pred             e---------------------------------------------eeeeccccCcccCCcCccCCCCCCccchHHHHHH
Q 045539          773 L---------------------------------------------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGI  807 (897)
Q Consensus       773 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGv  807 (897)
                      .                                             .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246899999999998889999999999999


Q ss_pred             HHHHHHcCCCCCcc
Q 045539          808 MLMEMFTKKKPTDE  821 (897)
Q Consensus       808 il~elltg~~p~~~  821 (897)
                      ++|||++|+.||..
T Consensus       237 il~elltG~~Pf~~  250 (377)
T cd05629         237 IMFECLIGWPPFCS  250 (377)
T ss_pred             hhhhhhcCCCCCCC
Confidence            99999999999965

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-36  Score=334.56  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=200.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecC-CC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSN-DD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  686 (897)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|+.+++++ +||||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999632      35789999987432 33346778899999999 79999999998854 45


Q ss_pred             ceEEEEEeccCCChhHhhhcCC----------------------------------------------------------
Q 045539          687 FKALIMKYMPNGSLENCLYSGT----------------------------------------------------------  708 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  708 (897)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999875421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccC
Q 045539          709 --CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM  786 (897)
Q Consensus       709 --~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  786 (897)
                        ..+++..+..++.||+.||+||   |+.||+||||||+||++++++.+||+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2578999999999999999999   89999999999999999999999999999998764332222222345677899


Q ss_pred             CcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHH
Q 045539          787 APEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILL  865 (897)
Q Consensus       787 aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~  865 (897)
                      |||++.+..++.++|||||||++|||++ |..||......+ .+.            ..+........      ......
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~------------~~~~~~~~~~~------~~~~~~  303 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC------------RRLKEGTRMRA------PEYATP  303 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH------------HHHhccCCCCC------CccCCH
Confidence            9999999999999999999999999998 999986522111 111            11111000000      012234


Q ss_pred             HHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          866 SVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       866 ~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ++.+++.+||+.+| ++||++.||++.|+
T Consensus       304 ~~~~l~~~cl~~~p-~~RPs~~ell~~l~  331 (337)
T cd05054         304 EIYSIMLDCWHNNP-EDRPTFSELVEILG  331 (337)
T ss_pred             HHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            57899999999999 99999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=327.97  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=210.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH---HHHHHHHHHHHHHhcC-CCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER---ALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  689 (897)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|++.+....   ....+.+|+++|+++. |||||.++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4568999999999999999999876 4999999999876542   3468899999999998 999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC----CcEEEeeccCcc
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED----MVAHISDFGIAK  765 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~  765 (897)
                      +|||++.||.|.+.+...  .+++.++..++.|++.+++||   |+.||+|||+||+|+++...    +.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999998877  399999999999999999999   89999999999999999633    579999999999


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||........             ...+ 
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------------~~~i-  250 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------------FLAI-  250 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------------HHHH-
Confidence            8765   2344567899999999999999999999999999999999999999986322110             0111 


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         +...+.-..+..+.......+++..|+..|| .+|+|+.++++.
T Consensus       251 ---~~~~~~f~~~~w~~is~~akd~i~~ll~~dp-~~R~ta~~~L~H  293 (382)
T KOG0032|consen  251 ---LRGDFDFTSEPWDDISESAKDFIRKLLEFDP-RKRLTAAQALQH  293 (382)
T ss_pred             ---HcCCCCCCCCCccccCHHHHHHHHHhcccCc-ccCCCHHHHhcC
Confidence               1111111112233445667899999999999 999999999873

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=319.18  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .+|++.+.||+|+||.||+|+++++..+|+|++..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999999988778899999864322 23567889999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++......+++..+..++.|++.|++||   |+.||+||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            9999999987665789999999999999999999   899999999999999999999999999999876542211 111


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....++..|+|||...+..++.++||||||+++||+++ |+.||......  ...            +.+........+ 
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~------------~~~~~~~~~~~~-  223 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVV------------ESVSAGYRLYRP-  223 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHH------------HHHHcCCcCCCC-
Confidence            12234457999999988899999999999999999999 88998652111  000            111100000000 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           .....++.+++.+||..+| ++|||+.|+++.|.
T Consensus       224 -----~~~~~~~~~li~~cl~~~p-~~Rpt~~~~l~~l~  256 (256)
T cd05059         224 -----KLAPTEVYTIMYSCWHEKP-EDRPAFKKLLSQLT  256 (256)
T ss_pred             -----CCCCHHHHHHHHHHhcCCh-hhCcCHHHHHHHhC
Confidence                 1123468899999999999 99999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.4e-36  Score=323.72  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=202.8

Q ss_pred             cCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|++.+.||+|+||.||+|..     .+++.||+|.++... ....+.+.+|++++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999974     246789999987433 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          691 IMKYMPNGSLENCLYSGT----------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      ||||+++++|.+++....                ..+++.++..++.|++.||+||   |++||+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence            999999999999985321                2478888999999999999999   889999999999999999999


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHh
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~  833 (897)
                      .+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....  .      
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~------  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--Q------  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--H------
Confidence            999999999987644333223333446778999999888889999999999999999998 8889864211  0      


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ...+.+........      ...+..++.+++.+|++.|| ++||++.+|.++|++
T Consensus       234 ------~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p-~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 ------EVIEMVRKRQLLPC------SEDCPPRMYSLMTECWQEGP-SRRPRFKDIHTRLRS  282 (283)
T ss_pred             ------HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCc-ccCcCHHHHHHHhhc
Confidence                  11111111100000      01223457889999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=310.16  Aligned_cols=268  Identities=22%  Similarity=0.267  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCc-cceEeeeecCCC-----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRN-LVKIISSCSNDD-----  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  686 (897)
                      ...|...++||+|+||+||+|+.. +|+.||+|+++-...  .......+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345667788999999999999865 689999999976543  23455679999999999999 999999998776     


Q ss_pred             -ceEEEEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          687 -FKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       687 -~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                       ..++||||+ ..+|.+++....   ..++...+..++.||++||+||   |+++|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 568999988765   3577789999999999999999   99999999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-------
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-------  834 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-------  834 (897)
                      +|+...-+.  ...+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|....+. .++.+...       
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE  242 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence            998765332  224566799999999998776 7899999999999999999998888663221 11111110       


Q ss_pred             hcCCchHHHHhhhh--hcch--hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          835 DLLPVSVMEVIDTN--LLRG--EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       835 ~~~~~~~~~~i~~~--l~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..+|. .....+-.  ....  +...............+++.+|++.+| ++|.|++.++++
T Consensus       243 ~~Wp~-v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p-~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPG-VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP-AKRISAKGALTH  302 (323)
T ss_pred             cCCCC-ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc-ccCcCHHHHhcC
Confidence            00110 00000100  0000  000011111112357889999999999 999999999886

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-36  Score=325.03  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec--CCceEEEEEechhh--HHHHHHHHHHHHHHHhc---CCCccceEeeeec-----C
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ--DGMEVAVKVFHQQY--ERALKSFEDECEVMKRI---RHRNLVKIISSCS-----N  684 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  684 (897)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999863  46889999886432  12234456677777766   5999999999884     3


Q ss_pred             CCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 58888886543 4589999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc---CCch
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL---LPVS  840 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~  840 (897)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......   .+..
T Consensus       157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence            97654331   223456899999999998888999999999999999999999999763211 0111111100   0000


Q ss_pred             HHH---HhhhhhcchhhhhHH-HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VME---VIDTNLLRGEERFFA-AKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~---~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...   ............... ........+.+++.+|++.|| ++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP-AKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCc-hhcCCHHHHhc
Confidence            000   000011111100011 111234557899999999999 99999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.1e-39  Score=331.67  Aligned_cols=398  Identities=27%  Similarity=0.357  Sum_probs=298.6

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      ++.++|.+. ++|++++.+..|..||..+|+++ ..|+.++++.+|..|++.+|++...+|..+. ++.|++||..+|-+
T Consensus       119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L  195 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLL  195 (565)
T ss_pred             hhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhh
Confidence            444445544 55566666666666666666665 5666666777777777777777666666555 88899999999988


Q ss_pred             CCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSS  240 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~  240 (897)
                      + .+|..++.|.+|+.|+|.+|+|..++  .|.+++.|++|+++.|+|. .+|+.....++++.+|||.+|++. ..|+.
T Consensus       196 ~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  196 E-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             h-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence            7 89999999999999999999999884  7999999999999999998 899999889999999999999997 88999


Q ss_pred             ccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCc-hHHHHH
Q 045539          241 ITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNL-SLSLEI  319 (897)
Q Consensus       241 l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~~L~~  319 (897)
                      +.-+.+|++||+|+|.|++.++.                      ++++ .|+.|-+.+|++..+-..-+..- ..-|++
T Consensus       271 ~clLrsL~rLDlSNN~is~Lp~s----------------------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  271 ICLLRSLERLDLSNNDISSLPYS----------------------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY  327 (565)
T ss_pred             HHHhhhhhhhcccCCccccCCcc----------------------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence            99999999999999999987663                      6788 89999999999875421111111 112344


Q ss_pred             HHh--ccCCC---CC------C-cC---ccccCccCCcEEEccCCCCCCCccccccCcc--chhhhcccCcccccccchh
Q 045539          320 ILM--DNCSI---SG------N-IP---QVVGNLGNLLVLELGGNNLTEPIPITFSQLQ--TLQALGLTRNKLAGPITDE  382 (897)
Q Consensus       320 L~l--~~n~l---~~------~-~p---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~  382 (897)
                      |.=  ..-.+   .|      . .+   .....+.+.+.|++++=+++.++.+.|..-.  -.+..++++|++. .+|..
T Consensus       328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~  406 (565)
T KOG0472|consen  328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKR  406 (565)
T ss_pred             HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhh
Confidence            432  00011   11      0 11   1223456778888888888875444444322  2778888888887 67777


Q ss_pred             hhccccccc-ccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccc----------cc
Q 045539          383 LCHLARLHS-LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV----------LI  451 (897)
Q Consensus       383 ~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~----------l~  451 (897)
                      +..++.+.+ +.+++|.++ .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|+|+|..          ++
T Consensus       407 L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lE  484 (565)
T KOG0472|consen  407 LVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLE  484 (565)
T ss_pred             hHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHH
Confidence            777766554 455555554 77888888888888888888887 578888888888888888888764          33


Q ss_pred             eeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchh
Q 045539          452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS  515 (897)
Q Consensus       452 ~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  515 (897)
                      .+--++|++....|..+.+|.+|++|||.+|.+. .+|+.+++|.+|++|+|++|.+.  .|..
T Consensus       485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~  545 (565)
T KOG0472|consen  485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH  545 (565)
T ss_pred             HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence            3445568888766777999999999999999999 79999999999999999999997  4543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-36  Score=333.77  Aligned_cols=262  Identities=20%  Similarity=0.229  Sum_probs=198.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .+|++.+.||+|+||.||+|... +++.||+|+...      +.+.+|++++++++||||+++++++..+...++|||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999765 688999997432      34678999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      . ++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|........ ..
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~  239 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NK  239 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cc
Confidence            5 68888776654 588999999999999999999   889999999999999999999999999999975432211 12


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccccc--C----ccchhHHhhh------cCCch---
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFI--G----ELSLNRWIND------LLPVS---  840 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~--~----~~~~~~~~~~------~~~~~---  840 (897)
                      .....||+.|+|||++.+..+++++|||||||++|||++|+.||.....  +    ...+...+..      .++..   
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            2345699999999999888999999999999999999999988753211  0    0111111110      01111   


Q ss_pred             -HHHHhh---hhhcchhhh--hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 -VMEVID---TNLLRGEER--FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 -~~~~i~---~~l~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ..+...   ......+..  .+........++.+++.+|++.|| ++|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP-~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDA-HHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCCh-hhCCCHHHHhc
Confidence             111110   000001110  112223445678899999999999 99999999985

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-36  Score=322.60  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .+|...++||+|+||.||+|...      ++..+|+|.+........+.+.+|++++++++||||+++++++.+++..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356799999876666667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          691 IMKYMPNGSLENCLYSGT--------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      +|||+++++|.+++....              ..+++..+..++.|++.|++||   |++|++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              2478899999999999999999   89999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhh
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIND  835 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  835 (897)
                      ||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||......  ..      
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~------  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EA------  233 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HH------
Confidence            9999999876543332222223345788999999988889999999999999999998 89998652111  00      


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            .+.+........      ...+...+.+++.+||+.|| ++||+++||++.|++
T Consensus       234 ------~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~P-~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 ------IECITQGRELER------PRTCPPEVYAIMQGCWQREP-QQRMVIKDIHSRLQA  280 (280)
T ss_pred             ------HHHHHcCccCCC------CCCCCHHHHHHHHHHccCCh-hhCCCHHHHHHHHhC
Confidence                  011110000000      01223457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.5e-36  Score=320.79  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=196.8

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||.||+++.. +|+.||+|++.....   ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 589999999875332   1234556799999999999999999999999999999999999999


Q ss_pred             hHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecc
Q 045539          701 ENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT  779 (897)
Q Consensus       701 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~  779 (897)
                      .+++.... ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98876543 4588999999999999999999   89999999999999999999999999999987664322   12334


Q ss_pred             ccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHH
Q 045539          780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAA  859 (897)
Q Consensus       780 ~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  859 (897)
                      .|+..|+|||+..+..++.++||||+||++|||++|+.||...... ...            .++............   
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~------------~~~~~~~~~~~~~~~---  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAK------------EELKRRTLEDEVKFE---  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhH------------HHHHHHhhccccccc---
Confidence            6899999999998888999999999999999999999998652111 000            111111111111000   


Q ss_pred             HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          860 KEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       860 ~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                      ......++.+++.+|++.|| ++||+++|+++....+|
T Consensus       219 ~~~~~~~~~~li~~~L~~~P-~~R~~~~~~~~~~~~h~  255 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKP-EDRLGSREKNDDPRKHE  255 (277)
T ss_pred             cccCCHHHHHHHHHHhccCH-hhCCCCccchhhhhcCh
Confidence            01223457899999999999 99999988877666554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=325.79  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=201.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC---------------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD---------------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII  679 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  679 (897)
                      .++|++.+.||+|+||.||+|+...               ...||+|+++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3589999999999999999987542               2348999987542 33456789999999999999999999


Q ss_pred             eeecCCCceEEEEEeccCCChhHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCe
Q 045539          680 SSCSNDDFKALIMKYMPNGSLENCLYSGT-----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV  748 (897)
Q Consensus       680 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NI  748 (897)
                      +++..++..++||||+++++|.+++....           ..+++..+..++.|++.|++||   |+.|++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhE
Confidence            99999999999999999999999886432           2368889999999999999999   899999999999999


Q ss_pred             eeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc--CCCCCcccccCc
Q 045539          749 LLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKPTDEIFIGE  826 (897)
Q Consensus       749 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt--g~~p~~~~~~~~  826 (897)
                      ++++++.+||+|||++................++..|+|||+...+.++.++|||||||++|||++  |..||...... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            999999999999999876543332222233345778999999888889999999999999999998  56677642111 


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                       .......        +.........+.   .........+.+++.+|++.|| ++||++++|++.|++
T Consensus       240 -~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p-~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 -QVIENTG--------EFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDI-KDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHH--------HhhhhccccccC---CCCCCCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHhC
Confidence             0000000        000000000000   0000123468999999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-36  Score=329.68  Aligned_cols=241  Identities=23%  Similarity=0.316  Sum_probs=192.9

Q ss_pred             CeeecccceEEEEEEe----cCCceEEEEEechhh----HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY----ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357889999987542    22345678899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++.... .+.+..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987654 478888999999999999999   899999999999999999999999999999875432221  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..        ...+...... -+ 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~--------~~~~~~~~~~-~~-  220 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KT--------IDKILKGKLN-LP-  220 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HH--------HHHHHcCCCC-CC-
Confidence            122346899999999998888999999999999999999999999752110     00        1111111110 00 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                            .....++.+++.+|++.|| ++||     +++++++
T Consensus       221 ------~~~~~~~~~li~~~l~~~p-~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 ------PYLTPEARDLLKKLLKRNP-SSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ------CCCCHHHHHHHHHHcccCH-hHcCCCCCCCHHHHhc
Confidence                  1123457899999999999 9999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.3e-36  Score=330.12  Aligned_cols=241  Identities=21%  Similarity=0.261  Sum_probs=192.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCC-CccceEeeeecCCCceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH-RNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  692 (897)
                      +|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999866 57889999997643   2345677889999999976 56888999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999887654 588999999999999999999   889999999999999999999999999999875322211


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ....           .+..... ..
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~-----------~i~~~~~-~~  220 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQ-----------SIMEHNV-SY  220 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHcCCC-CC
Confidence              223456899999999999989999999999999999999999999752111  0000           1111000 00


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      +       .....++.+++.+|+..|| ++|++.
T Consensus       221 ~-------~~~~~~~~~li~~~l~~~P-~~R~~~  246 (324)
T cd05587         221 P-------KSLSKEAVSICKGLLTKHP-AKRLGC  246 (324)
T ss_pred             C-------CCCCHHHHHHHHHHhhcCH-HHcCCC
Confidence            0       0123457889999999999 999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.7e-39  Score=342.73  Aligned_cols=366  Identities=27%  Similarity=0.388  Sum_probs=251.5

Q ss_pred             eEEEEEeeccccc-ccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           77 RVIGLNISSFNLQ-GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        77 ~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      -|.++|+++|.++ +..|.+...++.++-|.|...++. .+|++++.|.+|++|.+++|++. .+...++.|+.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            4778888888888 577888888888888888888887 78888888888888888888874 34455677777888888


Q ss_pred             eecCCCC-CCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccc
Q 045539          156 SINGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFY  234 (897)
Q Consensus       156 s~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~  234 (897)
                      .+|++.. -+|..+..|.-|+.|+||+|+++.. |..+...+++-.|+||+|+|. +||..++.++..|-.||||+|++.
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~Ev-P~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLREV-PTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhhhc-chhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence            8887753 4577777788888888888887776 666777777777888888876 777777777777777777777775


Q ss_pred             ccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCch
Q 045539          235 GTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS  314 (897)
Q Consensus       235 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  314 (897)
                       .+|+.+..+..|++|+|++|.+...-                     +..+..+++|++|.+++.+-+-          
T Consensus       164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQ---------------------LrQLPsmtsL~vLhms~TqRTl----------  211 (1255)
T KOG0444|consen  164 -MLPPQIRRLSMLQTLKLSNNPLNHFQ---------------------LRQLPSMTSLSVLHMSNTQRTL----------  211 (1255)
T ss_pred             -hcCHHHHHHhhhhhhhcCCChhhHHH---------------------HhcCccchhhhhhhcccccchh----------
Confidence             66777777777777777777664321                     1223344555555555443221          


Q ss_pred             HHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccc
Q 045539          315 LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVL  394 (897)
Q Consensus       315 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  394 (897)
                                    ..+|.++..+.+|..+|||.|.+.- .|+.+.++.+|+.|+||+|+|+ ..........+|++|+|
T Consensus       212 --------------~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNl  275 (1255)
T KOG0444|consen  212 --------------DNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNL  275 (1255)
T ss_pred             --------------hcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhcc
Confidence                          2456666677777777777777764 6777777777777777777776 34444555567777777


Q ss_pred             cccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccc
Q 045539          395 QGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNL  474 (897)
Q Consensus       395 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L  474 (897)
                      |.|+++ .+|++++.+++|+.|++.+|+++-.                                    -||..||.+.+|
T Consensus       276 SrNQLt-~LP~avcKL~kL~kLy~n~NkL~Fe------------------------------------GiPSGIGKL~~L  318 (1255)
T KOG0444|consen  276 SRNQLT-VLPDAVCKLTKLTKLYANNNKLTFE------------------------------------GIPSGIGKLIQL  318 (1255)
T ss_pred             ccchhc-cchHHHhhhHHHHHHHhccCccccc------------------------------------CCccchhhhhhh
Confidence            777777 6777777777777777777766521                                    245555555555


Q ss_pred             ccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          475 QQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       475 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      +.+.+++|.+. .+|+.++.+..|+.|.|++|++- ++|..+.-|+.|+.|||..|+--
T Consensus       319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            55555555555 55666666666666666666654 55666666666666666666533

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-36  Score=331.10  Aligned_cols=246  Identities=26%  Similarity=0.290  Sum_probs=191.1

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECE-VMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||+||+|+.. +|+.||+|++.+..   ....+.+.+|.. +++.++||||+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 68999999997543   122344445544 56788999999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999887654 588999999999999999999   89999999999999999999999999999987532221  1223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..        ..+........+    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~--------~~i~~~~~~~~~----  217 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMY--------DNILNKPLRLKP----  217 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHH--------HHHHcCCCCCCC----
Confidence            45689999999999998999999999999999999999999975211     1110        111111111000    


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCC
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPN  896 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~  896 (897)
                          .....+.+++.+|++.|| ++||++.+.++++.++
T Consensus       218 ----~~~~~~~~li~~~l~~~p-~~R~~~~~~~~~il~~  251 (323)
T cd05575         218 ----NISVSARHLLEGLLQKDR-TKRLGAKDDFLEIKNH  251 (323)
T ss_pred             ----CCCHHHHHHHHHHhhcCH-HhCCCCCCCHHHHHcC
Confidence                123457889999999999 9999986444443333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-36  Score=335.91  Aligned_cols=248  Identities=21%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|+..+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999865 68999999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+..     ..++..+..++.||+.||+||   |++||+||||||+||++++++.+||+|||++........  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     356778889999999999999   899999999999999999999999999999986543221  


Q ss_pred             eeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          775 IQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||......  ..            ........
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~------------~~~~~~~~  289 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DW------------ASLMCAIC  289 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cH------------HHHHHHHh
Confidence            1234568999999998643     23456899999999999999999999732111  11            11111000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....   ........++.+++.+||+.|| ++|||++|+++.
T Consensus       290 ~~~~~---~~~~~~~~~l~~li~~~l~~~P-~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPP---EAPATASREFRHFISCCLQREP-AKRWSAMQLLQH  328 (353)
T ss_pred             ccCCC---CCCCccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            00000   0001233457899999999999 999999999874

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.3e-36  Score=317.98  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=203.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .+|.+.+.||+|+||.||+|.+. .++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999865 58899999987543 33467889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|+++||+||   |++|++||||||+||++++++.+||+|||.+........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999987543 4589999999999999999999   899999999999999999999999999999987643221 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||...+..++.++|||||||++|||++ |..||......     +         ....+........
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~---------~~~~~~~~~~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q---------VYELLEKGYRMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H---------HHHHHHCCCCCCC
Confidence            1112234567999999888899999999999999999998 88998652111     1         1111111111111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      +      +....++.+++.+|++.|| ++|||+.|++++|++
T Consensus       227 ~------~~~~~~~~~li~~cl~~~p-~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 P------EGCPPKVYELMRACWQWNP-SDRPSFAEIHQAFET  261 (263)
T ss_pred             C------CCCCHHHHHHHHHHccCCc-ccCCCHHHHHHHHHh
Confidence            0      1233568899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-36  Score=336.12  Aligned_cols=260  Identities=22%  Similarity=0.279  Sum_probs=200.3

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      +.++....++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3444555689999999999999999999876 58899999987532   2234567889999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..|+||||+++|+|.+++....  +++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999987654  78888999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCC----CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKG----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      ........ .......||+.|+|||++...    .++.++|||||||++|||++|+.||......     ..        
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~--------  255 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GT--------  255 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HH--------
Confidence            87643221 122345699999999987543    3788999999999999999999999752110     00        


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCC--CCCHHHHHhh
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGN--GADMGWIFSA  892 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~--RPt~~evl~~  892 (897)
                      ...+...    .....++........+.+++.+|+..++ .+  ||+++|+++.
T Consensus       256 ~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~~~-~r~~r~~~~ei~~h  304 (371)
T cd05622         256 YSKIMNH----KNSLTFPDDNDISKEAKNLICAFLTDRE-VRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHcC----CCcccCCCcCCCCHHHHHHHHHHcCChh-hhcCCCCHHHHhcC
Confidence            1111110    0000001111233456788889997433 33  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-36  Score=321.93  Aligned_cols=266  Identities=25%  Similarity=0.390  Sum_probs=204.4

Q ss_pred             cCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  689 (897)
                      ++|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788899999999999999974     2578999999887666666788999999999999999999998743  45689


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999977655689999999999999999999   899999999999999999999999999999987653


Q ss_pred             CCceee-eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC-----chHHH
Q 045539          770 EDQLSI-QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP-----VSVME  843 (897)
Q Consensus       770 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~  843 (897)
                      ...... .....++..|+|||+..+..++.++|||||||++|||++|..|+.....   ...+.+.....     ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence            332211 1112234569999999888899999999999999999998877543211   11111111100     00111


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+.....      .+....+..++.+++.+||+.+| ++|||+.||+++|++
T Consensus       238 ~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p-~~Rpt~~ei~~~l~~  282 (284)
T cd05081         238 LLKNNGR------LPAPPGCPAEIYAIMKECWNNDP-SQRPSFSELALQVEA  282 (284)
T ss_pred             HHhcCCc------CCCCCCCCHHHHHHHHHHccCCh-hhCCCHHHHHHHHHh
Confidence            1111110      01112234568899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.4e-36  Score=323.76  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=202.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .+|++.+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35777889999999999999753      257899999875432 33467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          690 LIMKYMPNGSLENCLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      +++||+++++|.+++...               ...+++..+..++.|++.||+|+   |++||+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCC
Confidence            999999999999987532               13478888999999999999999   899999999999999999999


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHh
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~  833 (897)
                      .+||+|||+++...............+++.|+|||....+.++.++|||||||++|||++ |..||......  ...+. 
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~-  238 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM-  238 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-
Confidence            999999999886644333233334456789999999888889999999999999999998 88887652111  11111 


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                +.+......+       ..+...+.+++.+||+.|| ++||+++||++.|+.
T Consensus       239 ----------i~~~~~~~~~-------~~~~~~~~~li~~cl~~~p-~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 ----------IRNRQVLPCP-------DDCPAWVYTLMLECWNEFP-SRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----------HHcCCcCCCC-------CCCCHHHHHHHHHHhCCCc-ccCCCHHHHHHHhhC
Confidence                      1111110001       1234457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=341.10  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=203.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecCC-ceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeee-ecC------C
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQDG-MEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISS-CSN------D  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~  685 (897)
                      ...++++.+.|.+|||+.||.|....+ ..||+|++....+...+.+.+|+++|++++ |||||.++|. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            456788899999999999999987765 999999988777788899999999999998 9999999993 211      1


Q ss_pred             CceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      -+++|.||||.||.|-|++..+. ..+++.++++|+.|+++|+++||+ .+..|||||||-+|||++.++..||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            35679999999999999998553 459999999999999999999965 5666999999999999999999999999998


Q ss_pred             cccCCCCcee-------eeeccccCcccCCcCc---cCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh
Q 045539          765 KLLSGEDQLS-------IQIQTLATIGYMAPEY---GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       765 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~---~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~  834 (897)
                      ..........       ..-...-|+.|+|||+   ..+...++|+||||+||+||-|+....||++...          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            6543222100       0112246899999996   4677899999999999999999999999987311          


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                             ..++.....      ++........+.+||+.||++|| .+||++.+|+.++
T Consensus       264 -------laIlng~Y~------~P~~p~ys~~l~~LI~~mL~~nP-~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  264 -------LAILNGNYS------FPPFPNYSDRLKDLIRTMLQPNP-DERPNIYQVLEEI  308 (738)
T ss_pred             -------eeEEecccc------CCCCccHHHHHHHHHHHHhccCc-ccCCCHHHHHHHH
Confidence                   112221111      11112345668999999999999 9999999998875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.1e-36  Score=323.25  Aligned_cols=244  Identities=21%  Similarity=0.246  Sum_probs=192.3

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||+||+|... +|+.||+|++.....   ...+.+..|++++++++||||+++.+++..+...|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 689999999875432   2335677899999999999999999999999999999999999999


Q ss_pred             hHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          701 ENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       701 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      .+++..   ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887743   234689999999999999999999   899999999999999999999999999999976543322  122


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||+..+..++.++|||||||++|||++|+.||....... .            ..+...........   
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~------------~~~~~~~~~~~~~~---  219 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-E------------NKELKQRILNDSVT---  219 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-h------------HHHHHHhhcccCCC---
Confidence            3468999999999999999999999999999999999999997521110 0            00111111110000   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                       ........+.+++.+|++.|| ++||     +++|+++
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P-~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 -YPDKFSPASKSFCEALLAKDP-EKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CcccCCHHHHHHHHHHhcCCH-HHhcCCCCCCHHHHhc
Confidence             001233457899999999999 9999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-36  Score=338.14  Aligned_cols=200  Identities=23%  Similarity=0.368  Sum_probs=172.8

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      +|+..+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6889999999999999999865 58899999987643   2345678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc-
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~-  772 (897)
                      |+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999887654 578889999999999999999   899999999999999999999999999999753210000 


Q ss_pred             --------------------------------------------eeeeeccccCcccCCcCccCCCCCCccchHHHHHHH
Q 045539          773 --------------------------------------------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM  808 (897)
Q Consensus       773 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvi  808 (897)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999988899999999999999


Q ss_pred             HHHHHcCCCCCcc
Q 045539          809 LMEMFTKKKPTDE  821 (897)
Q Consensus       809 l~elltg~~p~~~  821 (897)
                      +|||++|+.||..
T Consensus       238 l~elltG~~Pf~~  250 (382)
T cd05625         238 LYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHhCCCCCCC
Confidence            9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-35  Score=313.67  Aligned_cols=249  Identities=25%  Similarity=0.319  Sum_probs=203.8

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|+..+.||+|++|.||+|... +++.|++|.+...  .....+.+.+|++++++++|||++++++++.+++..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999875 6899999998643  234567788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++... ...+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998775 35689999999999999999999   889999999999999999999999999999887653322 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......|++.|+|||+..+..++.++||||||+++|||++|+.||......                 +..........
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~  218 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----------------ALILKIIRGVF  218 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHcCCC
Confidence             122345889999999998888999999999999999999999999753211                 11111111111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +...   ......+.+++.+||+.+| ++||++.|+++.
T Consensus       219 ~~~~---~~~~~~~~~~i~~~l~~~p-~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVS---QMYSQQLAQLIDQCLTKDY-RQRPDTFQLLRN  253 (256)
T ss_pred             CCCc---cccCHHHHHHHHHHccCCc-ccCcCHHHHhhC
Confidence            1000   1233568899999999999 999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=321.46  Aligned_cols=253  Identities=19%  Similarity=0.277  Sum_probs=206.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ...|++.++||.||.+.||++...+.+.||+|++...  .......|.+|+..|.+++ |.+||++|+|-..+++.|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3578899999999999999999888888999876533  3556788999999999996 999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||= ..+|..++.++....+...++.+..||+.|+.++   |++||||.||||.|+++- .|.+||+|||+|..+..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            974 5699999998876555458899999999999999   999999999999999996 56999999999999887776


Q ss_pred             eeeeeccccCcccCCcCccCCC-----------CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchH
Q 045539          773 LSIQIQTLATIGYMAPEYGTKG-----------RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      ......-+||+.||+||.+...           ..+.++||||+|||+|+|+.|+.||.......            ..+
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------------aKl  582 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------------AKL  582 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH------------HHH
Confidence            6666777899999999965321           35789999999999999999999998732111            123


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+.++...-+++...+.     .++.++|..|++.|| ++|||+.|+++
T Consensus       583 ~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdP-kkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDP-KKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCc-ccCCCcHHHhc
Confidence            344444332223221111     227899999999999 99999999986

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-36  Score=340.14  Aligned_cols=201  Identities=23%  Similarity=0.366  Sum_probs=173.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999865 58999999987543   223466889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|..+.....
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999987654 578888999999999999999   899999999999999999999999999999753210000


Q ss_pred             -----------------------------------------eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHH
Q 045539          773 -----------------------------------------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLME  811 (897)
Q Consensus       773 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~e  811 (897)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000113469999999999999899999999999999999


Q ss_pred             HHcCCCCCcc
Q 045539          812 MFTKKKPTDE  821 (897)
Q Consensus       812 lltg~~p~~~  821 (897)
                      |++|+.||..
T Consensus       237 ll~G~~Pf~~  246 (376)
T cd05598         237 MLVGQPPFLA  246 (376)
T ss_pred             hhhCCCCCCC
Confidence            9999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.9e-36  Score=323.70  Aligned_cols=263  Identities=23%  Similarity=0.376  Sum_probs=204.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-----------------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-----------------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK  677 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  677 (897)
                      .++|++.+.||+|+||.||+|+..+                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4589999999999999999997542                 2458999987543 344678899999999999999999


Q ss_pred             EeeeecCCCceEEEEEeccCCChhHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCC
Q 045539          678 IISSCSNDDFKALIMKYMPNGSLENCLYSGT----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSN  747 (897)
Q Consensus       678 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~N  747 (897)
                      +++++..++..++||||+++++|.+++....          ..+++..+..++.|++.||+||   |++||+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence            9999999999999999999999999986543          2589999999999999999999   88999999999999


Q ss_pred             eeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc--CCCCCcccccC
Q 045539          748 VLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKPTDEIFIG  825 (897)
Q Consensus       748 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt--g~~p~~~~~~~  825 (897)
                      |+++.++.++|+|||.+................+++.|+|||+.....++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876544333333334456788999999888889999999999999999998  66777542111


Q ss_pred             ccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          826 ELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       826 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                        ...+.........     .....      .+.......++.+++.+|++.|| ++|||++||++.|++
T Consensus       241 --~~~~~~~~~~~~~-----~~~~~------~~~~~~~~~~l~~li~~cl~~~p-~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 --QVIENAGHFFRDD-----GRQIY------LPRPPNCPKDIYELMLECWRRDE-EDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHhccccc-----ccccc------CCCccCCCHHHHHHHHHHhccCh-hcCCCHHHHHHHhcC
Confidence              1111110000000     00000      00001123468999999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-35  Score=316.84  Aligned_cols=256  Identities=21%  Similarity=0.339  Sum_probs=204.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++..   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999865 6899999987542   2344567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++..   ....+++..+..++.|++.||+||   |++|++||||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   234578899999999999999999   899999999999999999999999999999887643


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...  ......|++.|+|||...+..++.++||||||+++|||++|+.||......   ...+         ...+..  
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~---------~~~~~~--  222 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSL---------CQKIEQ--  222 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHH---------HHHHhc--
Confidence            221  112345888999999988888899999999999999999999998652111   1111         111111  


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                       ..+...  ........+.+++.+||..+| ++||++.||++.+++
T Consensus       223 -~~~~~~--~~~~~~~~~~~li~~cl~~~p-~~Rp~~~~vl~~~~~  264 (267)
T cd08228         223 -CDYPPL--PTEHYSEKLRELVSMCIYPDP-DQRPDIGYVHQIAKQ  264 (267)
T ss_pred             -CCCCCC--ChhhcCHHHHHHHHHHCCCCc-ccCcCHHHHHHHHHH
Confidence             000000  011234568899999999999 999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.7e-36  Score=319.70  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|++.+.||+|+||+||+|.+. +++    .|++|.+.... ......+..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999864 344    47778775432 2334677888889999999999999999864 45688


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ++||+++|+|.+++......+++..+..++.|++.||+||   |++|++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999987666789999999999999999999   8899999999999999999999999999999866433


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........++..|+|||+..++.++.++||||||+++||+++ |+.||......  .            ..+++....
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~------------~~~~~~~~~  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--E------------VPDLLEKGE  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H------------HHHHHHCCC
Confidence            32222234456788999999988899999999999999999998 99998653211  1            111111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....      ..+...+.+++.+||..|| ++|||+.|+++.|+
T Consensus       229 ~~~~~------~~~~~~~~~li~~c~~~~p-~~Rps~~el~~~l~  266 (279)
T cd05111         229 RLAQP------QICTIDVYMVMVKCWMIDE-NVRPTFKELANEFT  266 (279)
T ss_pred             cCCCC------CCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHH
Confidence            00000      0112346788999999999 99999999998774

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-36  Score=321.05  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=199.8

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|++.+.||+|+||+||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999865 689999999875432   223557789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++..+..++.|++.|++||   |+.||+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999998876543 4689999999999999999999   889999999999999999999999999999986542221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||......  .            ..+.+...+...
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~------------~~~~~~~~~~~~  220 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--V------------KREEVERRVKED  220 (285)
T ss_pred             ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--h------------HHHHHHHHhhhc
Confidence               12346899999999998888999999999999999999999999752111  0            000011111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                      ....   .......+.+++.+|++.|| ++||     +++++++.
T Consensus       221 ~~~~---~~~~~~~~~~li~~~l~~~P-~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEY---SEKFSEAARSICRQLLTKDP-GFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccc---CcccCHHHHHHHHHHccCCH-HHhcCCCCCCHHHHhcC
Confidence            0000   01234557899999999999 9999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.3e-36  Score=319.63  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|.+.+.||+|++|.||+|.+.+      +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998653      5679999876443 33346688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEe
Q 045539          689 ALIMKYMPNGSLENCLYSGT------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHIS  759 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~  759 (897)
                      ++||||+++++|.+++....      ..+++.++..++.||+.|++||   |+++++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999986643      2588999999999999999999   889999999999999998654   69999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||+++................+..|+|||+..+..++.++|||||||++|||++ |..||......             
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------------  228 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------------  228 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence            9999987643322221222234568999999988899999999999999999997 99998752111             


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                       ...+.+........+      ..+...+.+++.+|++.|| ++||++.||++.|++
T Consensus       229 -~~~~~~~~~~~~~~~------~~~~~~~~~~i~~cl~~~p-~~Rps~~~vl~~l~~  277 (277)
T cd05036         229 -EVMEFVTGGGRLDPP------KGCPGPVYRIMTDCWQHTP-EDRPNFATILERIQY  277 (277)
T ss_pred             -HHHHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHhhC
Confidence             111111111110110      1223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.5e-36  Score=318.67  Aligned_cols=255  Identities=21%  Similarity=0.272  Sum_probs=201.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999864 6889999998755444456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++.... .+++..+..++.|++.|++||   |++||+|||+||+||+++.++.+||+|||++........  
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            99999999887554 589999999999999999999   889999999999999999999999999999986542211  


Q ss_pred             eeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          775 IQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ......|++.|+|||.+.   ...++.++|||||||++|||++|+.||........ ........            ...
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~------------~~~  228 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSN------------FQP  228 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCC------------CCC
Confidence            122345889999999863   44578899999999999999999999865321100 00000000            000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      .   ...........+.+++.+||+.|| ++|||++++++.+
T Consensus       229 ~---~~~~~~~~~~~~~~li~~~l~~~P-~~Rp~~~~il~~l  266 (267)
T cd06646         229 P---KLKDKTKWSSTFHNFVKISLTKNP-KKRPTAERLLTHL  266 (267)
T ss_pred             C---CCccccccCHHHHHHHHHHhhCCh-hhCcCHHHHhcCC
Confidence            0   000011223467899999999999 9999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.6e-36  Score=322.10  Aligned_cols=267  Identities=24%  Similarity=0.360  Sum_probs=202.2

Q ss_pred             cCC-CcCCeeecccceEEEEEEe-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--Cc
Q 045539          617 DRF-SENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DF  687 (897)
Q Consensus       617 ~~y-~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  687 (897)
                      ++| ...+.||+|+||+||++..     .+++.||+|+++... ....+.+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8889999999999988642     357889999987543 23456788999999999999999999988653  46


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .++||||+++++|.+++....  +++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            789999999999999987654  89999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-cCCchHHHHh
Q 045539          768 SGEDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-LLPVSVMEVI  845 (897)
Q Consensus       768 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~i  845 (897)
                      ....... ......++..|+|||......++.++||||||+++|||++|..|+................ .......+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            4322211 1112235667999999988889999999999999999999999986532111111111100 0001122222


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      +.......      ......++.+++.+||+.|| ++|||+++|++.|++
T Consensus       238 ~~~~~~~~------~~~~~~~~~~li~~cl~~~p-~~Rps~~~i~~~l~~  280 (283)
T cd05080         238 ERGMRLPC------PKNCPQEVYILMKNCWETEA-KFRPTFRSLIPILKE  280 (283)
T ss_pred             hcCCCCCC------CCCCCHHHHHHHHHHhccCh-hhCCCHHHHHHHHHH
Confidence            22211110      11234568999999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.3e-36  Score=321.93  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=201.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999653      24579999876443 2334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          688 KALIMKYMPNGSLENCLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      .|+||||+++|+|.+++....         ...++..+..++.|++.||+||   |++||+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986422         3356778899999999999999   8999999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +|||+++...............++..|+|||....+.++.++|||||||++|||++ |..||......  ...+.     
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~-----  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKF-----  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH-----
Confidence            99999876543332222222345678999999988889999999999999999998 78888652111  01111     


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            +.+......+       +.+...+.+++.+|++.|| ++|||+.|+++.|++
T Consensus       234 ------~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p-~~Rps~~~ll~~l~~  277 (288)
T cd05061         234 ------VMDGGYLDQP-------DNCPERVTDLMRMCWQFNP-KMRPTFLEIVNLLKD  277 (288)
T ss_pred             ------HHcCCCCCCC-------CCCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHh
Confidence                  1110000000       1223468899999999999 999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3e-36  Score=330.60  Aligned_cols=247  Identities=26%  Similarity=0.299  Sum_probs=192.7

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECE-VMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||+||+|+.. +|+.||+|++.+..   ....+.+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68999999997543   223345555554 56778999999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            99998887654 589999999999999999999   899999999999999999999999999999875322211  223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....                 .++.+..+......+ 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------------~~~~~~~~~~~~~~~-  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----------------AEMYDNILHKPLVLR-  216 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----------------HHHHHHHHcCCccCC-
Confidence            45689999999999999999999999999999999999999975211                 111111111110000 


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                         ......+.+++.+|++.|| .+||++.+.++++.++|
T Consensus       217 ---~~~~~~~~~ll~~ll~~~p-~~R~~~~~~~~~i~~h~  252 (325)
T cd05604         217 ---PGASLTAWSILEELLEKDR-QRRLGAKEDFLEIQEHP  252 (325)
T ss_pred             ---CCCCHHHHHHHHHHhccCH-HhcCCCCCCHHHHhcCC
Confidence               0122346789999999999 99999876555555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.5e-37  Score=311.17  Aligned_cols=259  Identities=26%  Similarity=0.326  Sum_probs=192.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCC---C--ceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSND---D--FKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~--~~~lv  691 (897)
                      .|...+++|.|+||.||+|... +++.||||++-.+..    .-.+|+.+|++++|||||++..+|...   +  ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5677899999999999999865 579999998865422    123699999999999999999888432   2  34589


Q ss_pred             EEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCcccc
Q 045539          692 MKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLL  767 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~  767 (897)
                      ||||+ .+|.++++..   +..++...+.-+..||.+||+||   |+.||+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99995 4888888742   34578888899999999999999   88999999999999999966 89999999999988


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ..+...   ....+|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. +..++...+ +.+.....+-+.
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIi-k~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEII-KVLGTPTREDIK  251 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHH-HHhCCCCHHHHh
Confidence            655432   234579999999987664 68999999999999999999999887621 112222222 222222111111


Q ss_pred             -----------hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 -----------TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 -----------~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                 +.+...+-.+ -.......+..+++.++++.+| .+|.++.|+++
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P-~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSP-SKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccCh-hhcCCHHHHhc
Confidence                       1111111000 0111234567899999999999 99999999875

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=308.98  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=210.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      -|.++++||+|+||.||+|.++ .|+.+|||.+...  .+.+++.+|+.|+++++.|++|++||.|......++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3566789999999999999765 6999999998754  345778899999999999999999999988889999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      .|+..+.++.+.+++.+.++..+++..++||+||   |...-+|||||..||+++.+|.+||+|||.|....+.  ....
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR  186 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence            9999999999999999999999999999999999   7788899999999999999999999999998766432  2334


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ..+.||+.|||||++..-.|+.++||||+|++..||..|++||.++..-..                ++  ++...++..
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IF--MIPT~PPPT  248 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IF--MIPTKPPPT  248 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eE--eccCCCCCC
Confidence            567899999999999999999999999999999999999999987532210                00  111122222


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +...++...++.++++.|+.+.| ++|.||.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~P-E~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKP-EERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCH-HHHHHHHHHhhh
Confidence            33345667789999999999999 999999988763

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.3e-36  Score=316.38  Aligned_cols=253  Identities=23%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.++||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            357999999999999999999887777899999875332 23578899999999999999999998754 5579999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|++.||+|+   |+.|++||||||+||++++++.+||+|||.+......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            9999999997643 4578999999999999999999   8999999999999999999999999999999766433221 


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||+..+..++.++||||||+++|||++ |..||......              ...+.+.....  .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------------~~~~~~~~~~~--~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------------EVLDQVERGYR--M  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------------HHHHHHhcCCC--C
Confidence            1123346778999999888889999999999999999999 88888653111              00111110000  0


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          +...+....+.+++.+|++.|| ++||+++++++.|+.
T Consensus       223 ----~~~~~~~~~l~~li~~~l~~~p-~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 ----PCPPECPESLHDLMCQCWRKEP-EERPTFEYLQAFLED  259 (262)
T ss_pred             ----CCccccCHHHHHHHHHHccCCc-ccCCCHHHHHHHHHH
Confidence                0012334568899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-36  Score=332.17  Aligned_cols=238  Identities=25%  Similarity=0.348  Sum_probs=191.6

Q ss_pred             CeeecccceEEEEEEe----cCCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          623 NLIGIGSFGSIYVARL----QDGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+.+|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    3588999999986532  234567789999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........  ..
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            999999987654 589999999999999999999   899999999999999999999999999999876543221  22


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....|++.|+|||+..+..++.++|||||||++|||++|+.||......     ...        ..+..... .-+   
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~--------~~i~~~~~-~~p---  218 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETM--------TMILKAKL-GMP---  218 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHH--------HHHHcCCC-CCC---
Confidence            3456899999999998888899999999999999999999999752111     000        01111000 001   


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHH
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGW  888 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~e  888 (897)
                          ......+.+++.+|++.|| ++||++.+
T Consensus       219 ----~~~~~~~~~li~~~l~~~P-~~R~~a~~  245 (318)
T cd05582         219 ----QFLSPEAQSLLRALFKRNP-ANRLGAGP  245 (318)
T ss_pred             ----CCCCHHHHHHHHHHhhcCH-hHcCCCCC
Confidence                1123457789999999999 99999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.3e-36  Score=350.28  Aligned_cols=255  Identities=25%  Similarity=0.304  Sum_probs=198.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.++||+|+||.||+|++. +|+.||+|+++...   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            58999999999999999999875 58999999987532   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          693 KYMPNGSLENCLYSG----------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       693 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      ||++|++|.+++...          ....++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          12356678899999999999999   88999999999999999999999999999


Q ss_pred             CccccCCCCc----------------eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc
Q 045539          763 IAKLLSGEDQ----------------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE  826 (897)
Q Consensus       763 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~  826 (897)
                      +++.......                ........||+.|+|||+..+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001122468999999999999999999999999999999999999996521111


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-CHHHHHhhc
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-DMGWIFSAL  893 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-t~~evl~~L  893 (897)
                      ......                + ..+.. .....+....+.+++.+|++.|| ++|| +++++.+.|
T Consensus       239 i~~~~~----------------i-~~P~~-~~p~~~iP~~L~~LI~rcL~~DP-~kR~ss~eeLl~~L  287 (932)
T PRK13184        239 ISYRDV----------------I-LSPIE-VAPYREIPPFLSQIAMKALAVDP-AERYSSVQELKQDL  287 (932)
T ss_pred             hhhhhh----------------c-cChhh-ccccccCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            000000                0 00000 00012334557889999999999 9996 555565554

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.7e-36  Score=327.29  Aligned_cols=236  Identities=22%  Similarity=0.281  Sum_probs=189.4

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|.++++.. +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 58899999997643   23345677888888877 699999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999887654 589999999999999999999   89999999999999999999999999999987542221  1223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......                 ++.......... ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------------~~~~~i~~~~~~-~~  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----------------DLFEAILNDEVV-YP  216 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----------------HHHHHHhcCCCC-CC
Confidence            456899999999998889999999999999999999999999752111                 111111111000 00


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                         .....++.+++.+|++.|| ++||++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP-~~R~~~  241 (320)
T cd05590         217 ---TWLSQDAVDILKAFMTKNP-TMRLGS  241 (320)
T ss_pred             ---CCCCHHHHHHHHHHcccCH-HHCCCC
Confidence               0123457889999999999 999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6e-36  Score=329.47  Aligned_cols=251  Identities=24%  Similarity=0.278  Sum_probs=196.2

Q ss_pred             CCCcCCeeecccceEEEEEEec----CCceEEEEEechhh----HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCce
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY----ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFK  688 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  688 (897)
                      +|++.+.||+|+||.||+|+..    +++.||+|++.+..    ....+.+.+|+.++++++ ||+|+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999753    57899999987542    223456788999999995 99999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++|+|.+++..+. .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 488999999999999999999   89999999999999999999999999999997653


Q ss_pred             CCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..            ..+...
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~------------~~~~~~  222 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQ------------SEVSRR  222 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CH------------HHHHHH
Confidence            32221 22245689999999988764 47889999999999999999999996421111 00            011111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      .....+. ..   ......+.+++.+|++.|| ++||     +++|+++
T Consensus       223 ~~~~~~~-~~---~~~~~~~~~li~~~l~~dp-~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILKCDPP-FP---SFIGPEAQDLLHKLLRKDP-KKRLGAGPQGASEIKE  266 (332)
T ss_pred             HhcCCCC-CC---CCCCHHHHHHHHHHcCCCH-HHcCCCCCCCHHHHHc
Confidence            1111110 00   1123456789999999999 9999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6e-36  Score=323.62  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=204.3

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      ...++|+..+.||+|+||.||+|...      ....||+|++.... .+....+.+|+++++++ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567899999999999999999764      23679999987542 33456788999999999 799999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..+++|||+++++|.+++...               ...+++..+..++.|++.||+||   |++||+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEE
Confidence            9999999999999999998642               24688999999999999999999   89999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      ++++.+||+|||.++...............++..|+|||+..+..++.++|||||||++||+++ |..||......    
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  241 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  241 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence            9999999999999987654332222223345678999999888889999999999999999998 88988652111    


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                ...+.+........      .......+.+++.+|+..|| ++|||+.|+++.|++
T Consensus       242 ----------~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p-~~Rps~~eil~~l~~  290 (293)
T cd05053         242 ----------ELFKLLKEGYRMEK------PQNCTQELYHLMRDCWHEVP-SQRPTFKQLVEDLDR  290 (293)
T ss_pred             ----------HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCc-ccCcCHHHHHHHHHH
Confidence                      01111111100000      01223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-35  Score=321.19  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=201.6

Q ss_pred             CCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      23568999886543 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCC
Q 045539          691 IMKYMPNGSLENCLYSGT-----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSN  747 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~N  747 (897)
                      ||||+.+++|.+++....                       ..+++..+..++.|++.||+||   |++||+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence            999999999999876421                       3478899999999999999999   88999999999999


Q ss_pred             eeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCc
Q 045539          748 VLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGE  826 (897)
Q Consensus       748 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~  826 (897)
                      |++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999976543332222223345778999999888889999999999999999998 9999865211  


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                  ..+.+.+........+      .....++.+++.+|++.|| ++||+++|+++.|++
T Consensus       236 ------------~~~~~~~~~~~~~~~~------~~~~~~~~~~i~~cl~~~P-~~Rp~~~~i~~~l~~  285 (290)
T cd05045         236 ------------ERLFNLLKTGYRMERP------ENCSEEMYNLMLTCWKQEP-DKRPTFADISKELEK  285 (290)
T ss_pred             ------------HHHHHHHhCCCCCCCC------CCCCHHHHHHHHHHccCCc-ccCCCHHHHHHHHHH
Confidence                        1112222221111111      1223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.2e-36  Score=325.43  Aligned_cols=240  Identities=22%  Similarity=0.270  Sum_probs=188.9

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 57889999997653   22344556677777654 799999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887654 589999999999999999999   88999999999999999999999999999997543222  2223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......     +..         ..+.... ...+   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~---------~~i~~~~-~~~~---  216 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELF---------DSILNDR-PHFP---  216 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHH---------HHHHcCC-CCCC---
Confidence            456899999999998888999999999999999999999999752111     000         0000000 0000   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHH-HHH
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMG-WIF  890 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~-evl  890 (897)
                         .....++.+++.+||+.|| ++||++. ++.
T Consensus       217 ---~~~~~~~~~ll~~~l~~~P-~~R~~~~~~l~  246 (316)
T cd05592         217 ---RWISKEAKDCLSKLFERDP-TKRLGVDGDIR  246 (316)
T ss_pred             ---CCCCHHHHHHHHHHccCCH-HHcCCChHHHH
Confidence               0122346789999999999 9999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=321.70  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .++|.+.+.||+|+||.||+|...      ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357999999999999999999642      35579999887543 33456789999999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          688 KALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      .++||||+++++|.+++.... ..+++.++..++.|++.||+||   |+++|+|+||||+||+++.++.+|++|||.+..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999987643 3489999999999999999999   889999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ..............++..|+|||......++.++||||+||++|||++ |..||......+ .            ....+
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~------------~~~~~  257 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-K------------FYKLI  257 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-H------------HHHHH
Confidence            643332222223346788999999988889999999999999999998 999986532110 0            11111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .........      .....++.+++.+|+..+| ++|||+.||++.|++
T Consensus       258 ~~~~~~~~~------~~~~~~~~~li~~cl~~~p-~~Rpt~~ell~~l~~  300 (302)
T cd05055         258 KEGYRMAQP------EHAPAEIYDIMKTCWDADP-LKRPTFKQIVQLIGK  300 (302)
T ss_pred             HcCCcCCCC------CCCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHHh
Confidence            111100000      0122457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-35  Score=311.10  Aligned_cols=248  Identities=27%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChh
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLE  701 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  701 (897)
                      +.||+|+||.||+|...+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999998888999999987553 333457889999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecccc
Q 045539          702 NCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA  781 (897)
Q Consensus       702 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  781 (897)
                      +++......+++..+..++.|++.||.|+   |++|++||||||+||+++.++.+||+|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            99877666689999999999999999999   899999999999999999999999999999875432211 11112234


Q ss_pred             CcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       782 t~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      +..|+|||+...+.++.++||||||+++||+++ |..||......  ...            ..+........      .
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~------------~~~~~~~~~~~------~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR------------EQVEKGYRMSC------P  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH------------HHHHcCCCCCC------C
Confidence            677999999988889999999999999999998 99998653111  000            11111000000      0


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          861 EQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..+..++.+++.+|+..+| ++||++.|++++|..
T Consensus       217 ~~~~~~~~~li~~~l~~~p-~~Rp~~~~l~~~l~~  250 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKP-ENRPKFSELQKELAA  250 (250)
T ss_pred             CCCCHHHHHHHHHHcccCc-ccCCCHHHHHHHhcC
Confidence            1223568899999999999 999999999999863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-35  Score=314.56  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++||+++++++++.+ +..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            357889999999999999999988888999999875432 23568899999999999999999998864 5678999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++.++..++.|++.||+||   |++|++||||||+||++++++.++|+|||.+......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            9999999987643 4589999999999999999999   8899999999999999999999999999999765432211 


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||+.....++.++||||||+++|||++ |..||......  ...+.            +........
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~------------~~~~~~~~~  224 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ------------VERGYRMPC  224 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHcCCCCCC
Confidence            1122335678999999888889999999999999999999 88898652111  11111            111000000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            .......+.+++.+|+..|| ++|||++++.+.|++
T Consensus       225 ------~~~~~~~~~~li~~~l~~~p-~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ------PQDCPISLHELMLQCWKKDP-EERPTFEYLQSFLED  259 (260)
T ss_pred             ------CCcCCHHHHHHHHHHcccCc-ccCcCHHHHHHHHhc
Confidence                  01223458899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.3e-36  Score=328.02  Aligned_cols=246  Identities=25%  Similarity=0.274  Sum_probs=191.4

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHH-HHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDEC-EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+..|. .+++.++||||+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57889999987543   12223344444 456788999999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999887654 477888889999999999999   899999999999999999999999999999875432221  223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     +.+        ..+........     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~--------~~i~~~~~~~~-----  216 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMY--------DNILNKPLQLK-----  216 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHH--------HHHHhCCcCCC-----
Confidence            456899999999999989999999999999999999999999752111     000        11111111100     


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCC
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPN  896 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~  896 (897)
                         ......+.+++.+|++.|| .+||++.+.+.++.++
T Consensus       217 ---~~~~~~~~~li~~~l~~~p-~~R~~~~~~~~~i~~~  251 (325)
T cd05602         217 ---PNITNSARHLLEGLLQKDR-TKRLGAKDDFMEIKNH  251 (325)
T ss_pred             ---CCCCHHHHHHHHHHcccCH-HHCCCCCCCHHHHhcC
Confidence               1223457889999999999 9999988666555544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-35  Score=317.71  Aligned_cols=254  Identities=23%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|+..+.||+|+||+||+|++. +|+    .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            457888999999999999999754 444    48999986543 34456788999999999999999999999764 467


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ++|||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987666789999999999999999999   899999999999999999999999999999987653


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........++..|+|||...+..++.++|||||||++|||++ |..||.....  .....+            +...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~------------~~~~  227 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL------------LEKG  227 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH------------HHCC
Confidence            332222222345678999999988889999999999999999998 8999865211  111111            1111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....      ......++.+++.+||..|| ++||++.|+++.|+
T Consensus       228 ~~~~~------~~~~~~~~~~li~~~l~~dp-~~Rp~~~~l~~~l~  266 (279)
T cd05109         228 ERLPQ------PPICTIDVYMIMVKCWMIDS-ECRPRFRELVDEFS  266 (279)
T ss_pred             CcCCC------CccCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            00000      01123457889999999999 99999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.6e-36  Score=327.24  Aligned_cols=241  Identities=20%  Similarity=0.271  Sum_probs=192.0

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|.++++.+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57899999997653   23345677889998876 699999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99998887654 588999999999999999999   899999999999999999999999999999875432221  223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......                 +.+......... . 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----------------~~~~~i~~~~~~-~-  215 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----------------DLFESILHDDVL-Y-  215 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCC-C-
Confidence            456899999999998889999999999999999999999999753111                 111111111000 0 


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCC-------CHHHHHh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGA-------DMGWIFS  891 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RP-------t~~evl~  891 (897)
                      +  .....++.+++.+|++.|| ++||       +++++++
T Consensus       216 p--~~~~~~~~~ll~~~L~~dp-~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 P--VWLSKEAVSILKAFMTKNP-NKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             C--CCCCHHHHHHHHHHhccCH-HHcCCCCCCCCCHHHHhc
Confidence            0  0122457889999999999 9999       6777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=313.00  Aligned_cols=248  Identities=28%  Similarity=0.467  Sum_probs=203.2

Q ss_pred             CeeecccceEEEEEEecC----CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQD----GMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|....    +..||+|+++..... ..+.+.+|++.++.++|+|++++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998763    788999998765433 367889999999999999999999999999999999999999


Q ss_pred             CChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          698 GSLENCLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       698 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ++|.+++...        ...+++.++..++.|++.|++||   |++||+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        46789999999999999999999   899999999999999999999999999999987764


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........++..|+|||......++.++||||+|+++|||++ |..||.....  ....            +.+.. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~------------~~~~~-  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVL------------EYLRK-  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHH------------HHHHc-
Confidence            432223334567889999999888889999999999999999999 6999876311  1111            11110 


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                        ...   .........++.+++.+|+..|| ++|||++|+++.|+
T Consensus       223 --~~~---~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYR---LPKPEYCPDELYELMLSCWQLDP-EDRPTFSELVERLE  262 (262)
T ss_pred             --CCC---CCCCccCChHHHHHHHHHccCCc-ccCcCHHHHHHhhC
Confidence              000   00011224568899999999999 99999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=315.80  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=198.5

Q ss_pred             CCcCCeeecccceEEEEEEecC----CceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc-----
Q 045539          619 FSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-----  687 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  687 (897)
                      |.+.+.||+|+||.||+|....    +..||+|+++...  ....+.+.+|++.++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997642    3679999987432  3445678999999999999999999998866544     


Q ss_pred             -eEEEEEeccCCChhHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          688 -KALIMKYMPNGSLENCLYSG-----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       688 -~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                       .+++|||+++++|.+++...     ...+++..+..++.|++.||+||   |+.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999887543     24589999999999999999999   8899999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCch
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      |.++...............++..|+|||......++.++|||||||++|||++ |..||......  ...+++.      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~------  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR------  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH------
Confidence            99987654332222222335678999999988889999999999999999999 88888652211  1111111      


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           .......+       ..+..++.+++.+||+.|| ++|||+.||++.|++
T Consensus       230 -----~~~~~~~~-------~~~~~~~~~li~~~l~~~p-~~Rp~~~e~~~~l~~  271 (273)
T cd05035         230 -----HGNRLKQP-------EDCLDELYDLMYSCWRADP-KDRPTFTKLREVLEN  271 (273)
T ss_pred             -----cCCCCCCC-------cCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHh
Confidence                 00000001       1234568899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.7e-36  Score=329.03  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=193.6

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+.. +|+.||+|++++..   ......+.+|+++++.++||||+++++++.+++..|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997653   233456778999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      +|.+++.... .+++..+..++.|++.||+||   |+ +||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9998887654 589999999999999999999   76 7999999999999999999999999999875432211  122


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......     .         ....+...-...+    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~---------~~~~i~~~~~~~p----  216 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----K---------LFELILMEEIRFP----  216 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----H---------HHHHHhcCCCCCC----
Confidence            346899999999998889999999999999999999999999652111     0         0111100000000    


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                         .....++.+++.+|++.|| ++|+     +++|+++.
T Consensus       217 ---~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 ---RTLSPEAKSLLSGLLKKDP-KQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CCCCHHHHHHHHHHhhcCH-HHhCCCCCCCHHHHhcC
Confidence               0123457889999999999 9996     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=317.48  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=204.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578899999999999999997642      4679999986443 33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEe
Q 045539          689 ALIMKYMPNGSLENCLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS  759 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~  759 (897)
                      ++||||+++++|.+++....         ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         2367889999999999999999   89999999999999999999999999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||.++...............++..|+|||....+.++.++|||||||++||+++ |..||......  ...+...    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~----  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVI----  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHh----
Confidence            9999886654333222233456788999999888889999999999999999998 89898642111  1111111    


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             .......+       ..+..++.+++.+||+.+| ++|||+.|+++.|++
T Consensus       236 -------~~~~~~~~-------~~~~~~~~~li~~~l~~~p-~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -------DGGHLDLP-------ENCPDKLLELMRMCWQYNP-KMRPTFLEIVSSLKD  277 (277)
T ss_pred             -------cCCCCCCC-------CCCCHHHHHHHHHHcCCCh-hhCCCHHHHHHHhcC
Confidence                   00000001       1123568899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=312.07  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      ++|++.+.||.|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57899999999999999999875 57889999998665556688899999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++......+++.++..++.|++.|++||   |+.|++||||+|+||++++++.+||+|||.+........  .
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence            99999999887655689999999999999999999   889999999999999999999999999999876543211  1


Q ss_pred             eeccccCcccCCcCccCCC---CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          776 QIQTLATIGYMAPEYGTKG---RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .....++..|+|||.....   .++.++||||||+++|||++|+.||.........             ...........
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------------~~~~~~~~~~~  224 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------------FLISKSNFPPP  224 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhccCCCc
Confidence            2234678899999998766   7889999999999999999999998753211000             00000000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ..........++.+++.+||..|| .+|||++||++.
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p-~~Rpt~~~il~~  260 (262)
T cd06613         225 ---KLKDKEKWSPVFHDFIKKCLTKDP-KKRPTATKLLQH  260 (262)
T ss_pred             ---cccchhhhhHHHHHHHHHHcCCCh-hhCCCHHHHhcC
Confidence               001112334568899999999999 999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-35  Score=322.34  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=202.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            567889999999999999999641        24579999987543 34457788999999999 799999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..++||||+++++|.+++....               ..+++.++..++.|+++||+||   |++||+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEEE
Confidence            99999999999999999987542               2477888999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      ++++.+||+|||.++...............++..|+|||+..+..++.++||||||+++||+++ |..||.....     
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence            9999999999999987654332222223345678999999988889999999999999999998 7788754211     


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+.         .+.+.......      ....+...+.+++.+||+.+| ++|||+.||++.|++
T Consensus       246 ~~~---------~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p-~~Rps~~e~l~~l~~  295 (304)
T cd05101         246 EEL---------FKLLKEGHRMD------KPANCTNELYMMMRDCWHAIP-SHRPTFKQLVEDLDR  295 (304)
T ss_pred             HHH---------HHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCh-hhCCCHHHHHHHHHH
Confidence            111         11111000000      001234567889999999999 999999999998853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.5e-35  Score=315.11  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=195.3

Q ss_pred             CCcCCeeecccceEEEEEEecC-Cc--eEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCC------Cc
Q 045539          619 FSENNLIGIGSFGSIYVARLQD-GM--EVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSND------DF  687 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  687 (897)
                      |.+.+.||+|+||.||+|++.+ +.  .||+|.++..  .....+.+.+|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999998764 33  5899988643  234457788999999999999999999987432      25


Q ss_pred             eEEEEEeccCCChhHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          688 KALIMKYMPNGSLENCLYS-----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      .+++|||+++|+|.+++..     ....+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     224578999999999999999999   78999999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      .++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||......  ...+.+..      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~------  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ------  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc------
Confidence            9987654332222222345678999999988899999999999999999999 78888652111  11111110      


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           ......+       ..+...+.+++.+||+.|| ++|||++|+++.|++
T Consensus       230 -----~~~~~~~-------~~~~~~~~~li~~~l~~~p-~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 -----GNRLKQP-------PDCLDGLYSLMSSCWLLNP-KDRPSFETLRCELEK  270 (272)
T ss_pred             -----CCCCCCC-------CCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHh
Confidence                 0000000       1223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-35  Score=322.99  Aligned_cols=266  Identities=18%  Similarity=0.262  Sum_probs=199.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999876 578899999875432 2234577899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++ ++.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 88888876666689999999999999999999   899999999999999999999999999999876432221  


Q ss_pred             eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc---h-HHHHh----
Q 045539          775 IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV---S-VMEVI----  845 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~i----  845 (897)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+  ....+....+.   . ...+.    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1223457899999998754 467899999999999999999999996532111  11111111000   0 00000    


Q ss_pred             --hhhhcc-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 --DTNLLR-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 --~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        +..... .+............++.+++.+|++.|| ++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp-~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYES-KKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCCh-hhCCCHHHHhc
Confidence              000000 0000011112234567899999999999 99999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-35  Score=321.36  Aligned_cols=262  Identities=23%  Similarity=0.373  Sum_probs=201.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-----------------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-----------------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI  678 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  678 (897)
                      ++|++.+.||+|+||.||+|++.                 ++..||+|+++... ....+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998543                 23468999987543 3445788999999999999999999


Q ss_pred             eeeecCCCceEEEEEeccCCChhHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCe
Q 045539          679 ISSCSNDDFKALIMKYMPNGSLENCLYSGT----------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV  748 (897)
Q Consensus       679 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NI  748 (897)
                      ++++..++..++||||+++++|.+++....          ..+++.++..++.|++.|++||   |+.|++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheE
Confidence            999999999999999999999999986543          2367788999999999999999   899999999999999


Q ss_pred             eeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc--CCCCCcccccCc
Q 045539          749 LLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT--KKKPTDEIFIGE  826 (897)
Q Consensus       749 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt--g~~p~~~~~~~~  826 (897)
                      +++.++.++|+|||.+..+.............++..|+|||....+.++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543332222223345678999998888889999999999999999998  67887642111 


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          +.+..     ..+..........   .+....+...+.+++.+||+.|| ++||+++||++.|++
T Consensus       241 ----~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p-~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 ----QVIEN-----TGEFFRDQGRQVY---LPKPALCPDSLYKLMLSCWRRNA-KERPSFQEIHATLLE  296 (296)
T ss_pred             ----HHHHH-----HHHHHhhcccccc---CCCCCCCCHHHHHHHHHHcCCCc-ccCCCHHHHHHHHhC
Confidence                11100     0000000000000   00001123457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.7e-36  Score=324.08  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=201.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|.++... ......+.+|+++++++ +||||+++++++..+
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999999753        23569999987542 33456788899999999 799999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..|+||||+++++|.+++....               ..+++.++..++.|++.||+||   |++|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEE
Confidence            99999999999999999987542               2478899999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||.+................++..|+|||+..+..++.++|||||||++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999876543222111222234568999999988889999999999999999998 8888754211     


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .         ...+.+.......      .......++.+++.+|+..+| ++|||+.||++.|++
T Consensus       249 ~---------~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p-~~Rps~~evl~~l~~  298 (307)
T cd05098         249 E---------ELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVP-SQRPTFKQLVEDLDR  298 (307)
T ss_pred             H---------HHHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccCh-hhCcCHHHHHHHHHH
Confidence            0         1111111111000      011234567889999999999 999999999998853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-35  Score=314.98  Aligned_cols=256  Identities=24%  Similarity=0.423  Sum_probs=203.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++.    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888999999999999999764    23479999886543 3345688999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||+++.++.++++|||.+......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999987666789999999999999999999   8999999999999999999999999999999876533


Q ss_pred             Cceee-eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQLSI-QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ..... .....++..|+|||+..+..++.++||||||+++||+++ |..||......  .....+...            
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~------------  225 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEG------------  225 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCC------------
Confidence            22111 112223567999999988889999999999999999886 99998653111  111111110            


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..  .    +........+.+++.+|++.+| .+||++.++++.|++
T Consensus       226 ~~--~----~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~~  265 (267)
T cd05066         226 YR--L----PAPMDCPAALHQLMLDCWQKDR-NERPKFEQIVSILDK  265 (267)
T ss_pred             Cc--C----CCCCCCCHHHHHHHHHHcccCc-hhCCCHHHHHHHHHh
Confidence            00  0    0001223457899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=316.19  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             cCCCcCCeeecccceEEEEEEecC-C---ceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQD-G---MEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|++.+.||+|+||.||+|+... +   ..||+|+++.. .....+.+..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998653 3   36999998754 244567899999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++......+++.++..++.|++.|++||   |++|++||||||+||+++.++.+||+|||.+.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999987666789999999999999999999   88999999999999999999999999999987654322


Q ss_pred             ceeeeeccc---cCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          772 QLSIQIQTL---ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       772 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .........   .+..|+|||+.....++.++|||||||++||+++ |..||......  ....++....+         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~---------  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR---------  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence            211111111   2457999999988899999999999999999886 99998652111  11111111000         


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         .      +...+++..+.+++.+||+.+| ++||++++|++.|++
T Consensus       230 ---~------~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 ---L------PPPMDCPTALHQLMLDCWQKDR-NARPKFGQIVSTLDK  267 (269)
T ss_pred             ---C------CCcccCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHh
Confidence               0      0011233457889999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.3e-36  Score=325.28  Aligned_cols=195  Identities=26%  Similarity=0.354  Sum_probs=171.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-C-----CccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-H-----RNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~  689 (897)
                      -+|.+.+.||+|+||.|.+|.+. +++.||||+++... ....+...|+++|..++ |     -|+|++++||...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            38999999999999999999765 69999999998663 33455678999999997 4     38999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC--CcEEEeeccCccc
Q 045539          690 LIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED--MVAHISDFGIAKL  766 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~--~~~kL~DFg~a~~  766 (897)
                      +|+|.+ ..+|.++++.+. ..++...++.++.||+.||.+|   |+.||||+||||+|||+.+.  ..+||+|||+|..
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999998 669999998776 5689999999999999999999   89999999999999999643  4899999999998


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ......     ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            654332     34567889999999999999999999999999999999776654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.9e-36  Score=326.52  Aligned_cols=241  Identities=21%  Similarity=0.261  Sum_probs=192.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+..|..++.... |++|+++++++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999876 57899999988653   223345677888888774 899999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999999887654 488999999999999999999   889999999999999999999999999999875432221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...           ..+...... .
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~-----------~~i~~~~~~-~  220 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF-----------QSIMEHNVA-Y  220 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHH-----------HHHHhCCCC-C
Confidence              223456899999999999999999999999999999999999999752111  111           111111100 0


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      +       .....++.+++.+|++.|| ++|++.
T Consensus       221 p-------~~~s~~~~~li~~~l~~~p-~~R~~~  246 (323)
T cd05616         221 P-------KSMSKEAVAICKGLMTKHP-GKRLGC  246 (323)
T ss_pred             C-------CcCCHHHHHHHHHHcccCH-HhcCCC
Confidence            0       1123457889999999999 999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-35  Score=315.74  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=200.2

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHH--HHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERA--LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      |++.+.||+|+||+||+|+.. +++.||+|++.......  .....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999876 46789999998664332  223456999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++... ..+++..+..++.|+++||++|   |+.||+|+||||+||+++.++.++|+|||.+......  ...
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred             cccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--ccc
Confidence            999999999833 3589999999999999999999   7889999999999999999999999999999764211  123


Q ss_pred             eeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....++..|+|||+.. ...++.++||||+|+++|+|++|..||......              +....+.+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--------------~~~~~~~~~~~~~~~  220 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--------------DQLEIIEKILKRPLP  220 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--------------HHHHHHHHHHHTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccch--------------hhhhhhhhccccccc
Confidence            34556899999999988 888999999999999999999999999863000              111112111111111


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...........++.+++.+|++.|| ++||++.|+++.
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p-~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDP-EQRPSAEELLKH  257 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSG-GGSTTHHHHHTS
T ss_pred             ccccccchhHHHHHHHHHHHccCCh-hHCcCHHHHhcC
Confidence            0000000112568999999999999 999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-35  Score=317.25  Aligned_cols=251  Identities=23%  Similarity=0.283  Sum_probs=201.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            57899999999999999999876 48999999998766666788899999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|..++.+....+++..+..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||.+.......  ..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence            99999988876556689999999999999999999   89999999999999999999999999999887543221  11


Q ss_pred             eeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          776 QIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .....+++.|+|||++.     ...++.++|||||||++|||++|+.||...... ......            .    .
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~------------~----~  229 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKI------------A----K  229 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHH------------h----c
Confidence            22345788999999874     345688999999999999999999998652110 000000            0    0


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...+ ..........++.+++.+||..|| ++||+++|+++
T Consensus       230 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~  268 (292)
T cd06644         230 SEPP-TLSQPSKWSMEFRDFLKTALDKHP-ETRPSAAQLLE  268 (292)
T ss_pred             CCCc-cCCCCcccCHHHHHHHHHHhcCCc-ccCcCHHHHhc
Confidence            0000 000011223457889999999999 99999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-35  Score=332.22  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=202.9

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSND  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  685 (897)
                      ...++|.+.+.||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++..+
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888999999999999999854      24679999997543 233457889999999997 99999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------------------------------------------------
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------------------------------------------------  708 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  708 (897)
                      +..++||||+++|+|.++++...                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999886432                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCe
Q 045539          709 ----------------------------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV  748 (897)
Q Consensus       709 ----------------------------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NI  748 (897)
                                                              ..+++..+..++.|++.||+||   |+.+|+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceE
Confidence                                                    2356778889999999999999   899999999999999


Q ss_pred             eeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCcc
Q 045539          749 LLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGEL  827 (897)
Q Consensus       749 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~  827 (897)
                      ++++++.+||+|||+++...............++..|+|||......++.++|||||||++|||++ |..||......+ 
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence            999999999999999986543222122223456788999999988889999999999999999998 888986531110 


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .            ..+.+........+      ..+..++.+++.+||..+| ++||+++||++.|++
T Consensus       350 ~------------~~~~~~~~~~~~~p------~~~~~~l~~li~~cl~~~P-~~RPs~~ell~~L~~  398 (401)
T cd05107         350 Q------------FYNAIKRGYRMAKP------AHASDEIYEIMQKCWEEKF-EIRPDFSQLVHLVGD  398 (401)
T ss_pred             H------------HHHHHHcCCCCCCC------CCCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence            0            11111111100000      1123568899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-35  Score=310.94  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=195.1

Q ss_pred             eeecccceEEEEEEec---CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCC
Q 045539          624 LIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   35579999987553 3344678999999999999999999999864 46799999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee-eec
Q 045539          700 LENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-QIQ  778 (897)
Q Consensus       700 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-~~~  778 (897)
                      |.+++......+++.++..++.|++.|++||   |++|++||||||+||+++.++.+||+|||.+........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999986666789999999999999999999   889999999999999999999999999999976543322111 111


Q ss_pred             cccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ..++..|+|||+.....++.++||||||+++||+++ |..||......              .....+........+   
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~---  220 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------------EVMSFIEQGKRLDCP---  220 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHHHHHHCCCCCCCC---
Confidence            223578999999888889999999999999999996 99998763211              111111111110000   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         ..+..++.+++.+||..|| ++||++.+|.+.|+.
T Consensus       221 ---~~~~~~l~~li~~c~~~~~-~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 ---AECPPEMYALMKDCWIYKW-EDRPNFAKVEERMRT  254 (257)
T ss_pred             ---CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHhh
Confidence               1223567899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-35  Score=309.58  Aligned_cols=249  Identities=29%  Similarity=0.420  Sum_probs=199.9

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChh
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLE  701 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  701 (897)
                      ++||+|+||.||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999887799999998875433 35578899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecccc
Q 045539          702 NCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA  781 (897)
Q Consensus       702 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  781 (897)
                      +++......+++..+..++.+++.|++||   |+++++||||||+||+++.++.+||+|||.+................+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99977665688999999999999999999   899999999999999999999999999999876542221111112234


Q ss_pred             CcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       782 t~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      +..|+|||...++.++.++||||||+++|||++ |..||......  ..            .+.+........      .
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~------------~~~~~~~~~~~~------~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QT------------RERIESGYRMPA------P  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HH------------HHHHhcCCCCCC------C
Confidence            567999999888889999999999999999999 88888652111  11            111111100000      0


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          861 EQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .....++.+++.+|+..+| ++|||+.||++.|++
T Consensus       218 ~~~~~~~~~li~~~l~~~p-~~Rp~~~ell~~l~~  251 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDP-ENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCHHHHHHHHHHhccCh-hhCcCHHHHHHHhhC
Confidence            1223468899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-35  Score=323.89  Aligned_cols=240  Identities=23%  Similarity=0.287  Sum_probs=190.3

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +|+.||+|++++..   ....+....|.+++... +||+|+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 58899999998653   22345567788888765 799999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999887654 588999999999999999999   89999999999999999999999999999987432111  1223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..            .+.+.......+    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~------------~~~~~~~~~~~~----  216 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--EL------------FESIRVDTPHYP----  216 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH------------HHHHHhCCCCCC----
Confidence            456899999999999889999999999999999999999999752111  11            111110000000    


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHH-HHH
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMG-WIF  890 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~-evl  890 (897)
                         .....++.+++.+|++.|| ++||++. ++.
T Consensus       217 ---~~~~~~~~~li~~~l~~dP-~~R~~~~~~~~  246 (316)
T cd05620         217 ---RWITKESKDILEKLFERDP-TRRLGVVGNIR  246 (316)
T ss_pred             ---CCCCHHHHHHHHHHccCCH-HHcCCChHHHH
Confidence               0122456789999999999 9999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-35  Score=323.62  Aligned_cols=241  Identities=22%  Similarity=0.268  Sum_probs=193.4

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999998653   23445677899999888 699999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++.++..++.|++.||+||   |+.||+||||||+||++++++.+||+|||++........  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99998887654 589999999999999999999   899999999999999999999999999999865322211  122


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......  ....           .+...... .+    
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~-----------~i~~~~~~-~~----  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ-----------SILEDEVR-YP----  216 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHH-----------HHHcCCCC-CC----
Confidence            346899999999999999999999999999999999999999752111  0100           01110000 00    


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCH-----HHHHh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADM-----GWIFS  891 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~-----~evl~  891 (897)
                         ......+.+++.+||+.|| ++||++     .++++
T Consensus       217 ---~~~~~~~~~li~~~l~~dP-~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ---RWLSKEAKSILKSFLTKNP-EKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CcCCHHHHHHHHHHccCCH-HHcCCCCCCCHHHHhc
Confidence               1123457899999999999 999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.6e-35  Score=312.14  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             CeeecccceEEEEEEecC--C--ceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQD--G--MEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3699999987655 566789999999999999999999999988 889999999999


Q ss_pred             CChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce-ee
Q 045539          698 GSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SI  775 (897)
Q Consensus       698 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~  775 (897)
                      ++|.+++.... ..+++..+..++.|++.||+||   |++|++||||||+||+++.++.+||+|||.+......... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987765 5689999999999999999999   8999999999999999999999999999999876543221 12


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....++..|+|||+.....++.++|||||||++|||++ |+.||......  ...+.+            ......   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~------------~~~~~~---  219 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKI------------DKEGER---  219 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH------------HhcCCc---
Confidence            223457789999999988889999999999999999998 99998652111  011111            000000   


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                        ..........+.+++.+|++.+| ++||++.||++.|.+
T Consensus       220 --~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~~~~~l~~  257 (257)
T cd05040         220 --LERPEACPQDIYNVMLQCWAHNP-ADRPTFAALREFLPE  257 (257)
T ss_pred             --CCCCccCCHHHHHHHHHHCCCCc-ccCCCHHHHHHHhcC
Confidence              00001223458899999999999 999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.8e-35  Score=311.39  Aligned_cols=252  Identities=24%  Similarity=0.410  Sum_probs=201.2

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|.+.+.||+|++|.||+|.+..+..+|+|++.... ...+.+.+|++++++++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688999999999999999998877789999876543 234678889999999999999999998854 56789999999


Q ss_pred             CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          697 NGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       697 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +++|.+++.... ..+++..+..++.|++.||+||   |+.|++||||||+||++++++.++|+|||.+........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999987643 4578999999999999999999   899999999999999999999999999999976543221 11


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......  ...+++.....            ... 
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------~~~-  224 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR------------MPC-  224 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------CCC-
Confidence            122345678999999888889999999999999999999 89998753211  11111111000            000 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           .......+.+++.+||..|| ++||++++|.+.|++
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 -----PQGCPESLHELMKLCWKKDP-DERPTFEYIQSFLED  259 (260)
T ss_pred             -----CcccCHHHHHHHHHHccCCc-ccCcCHHHHHHHHhc
Confidence                 01233567899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=324.62  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=174.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999865 58999999997532   233466889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999976555689999999999999999999   899999999999999999999999999999876543222


Q ss_pred             eeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                       .......||+.|+|||++..     ..++.++||||+||++|||++|+.||..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence             11223458999999998753     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-35  Score=318.77  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..+...|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            58889999999999999999864 68999999987655555577889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++...  .+++.++..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||.+........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998654  378999999999999999999   899999999999999999999999999999876543221  1


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....|++.|+|||...+..++.++|||||||++|+|++|+.||........ ......           .    ..+. 
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~-----------~----~~~~-  235 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT-----------N----GTPE-  235 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc-----------C----CCCC-
Confidence            2234688999999998888889999999999999999999999965321100 000000           0    0000 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       ..........+.+++.+||..|| ++|||+.|+++.
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~p-~~Rpt~~eil~~  270 (296)
T cd06654         236 -LQNPEKLSAIFRDFLNRCLDMDV-EKRGSAKELLQH  270 (296)
T ss_pred             -CCCccccCHHHHHHHHHHCcCCc-ccCcCHHHHhhC
Confidence             00011233457889999999999 999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-35  Score=317.53  Aligned_cols=268  Identities=21%  Similarity=0.380  Sum_probs=203.0

Q ss_pred             CCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceE
Q 045539          618 RFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  689 (897)
                      -|.+.+.||+|+||.||.|+.     .++..||+|.++... ....+.+.+|++++++++|||++++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     357889999987543 34456789999999999999999999998765  5689


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999999999999877655689999999999999999999   899999999999999999999999999999987653


Q ss_pred             CCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC-chHHHHhhh
Q 045539          770 EDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP-VSVMEVIDT  847 (897)
Q Consensus       770 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~  847 (897)
                      .... .......++..|+|||+..+..++.++||||||+++|||++++.|+................... ......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            3221 11223456778999999888889999999999999999999887654321100000000000000 001111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...      .+....+..++.+++.+|++.|| ++|||++|+++.+++
T Consensus       242 ~~~------~~~~~~~~~~~~~li~~~l~~~p-~~Rpt~~~il~~l~~  282 (284)
T cd05079         242 GKR------LPRPPNCPEEVYQLMRKCWEFQP-SKRTTFQNLIEGFEA  282 (284)
T ss_pred             Ccc------CCCCCCCCHHHHHHHHHHccCCc-ccCcCHHHHHHHHHh
Confidence            000      00111234568999999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-35  Score=312.77  Aligned_cols=253  Identities=23%  Similarity=0.410  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467889999999999999999988899999999875432 2457889999999999999999999875 45689999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++.++..++.|++.||+||   |+.|++||||||+||++++++.++|+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999886533 4689999999999999999999   899999999999999999999999999999976542221 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||+.....++.++||||||+++||+++ |+.||......  ..            .+.+........
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~------------~~~~~~~~~~~~  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EV------------IQNLERGYRMPR  224 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HH------------HHHHHcCCCCCC
Confidence            1223345678999999988889999999999999999999 99998752111  11            111111100000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ......++.+++.+|+..+| ++|||++++.+.|+.
T Consensus       225 ------~~~~~~~~~~li~~~l~~~p-~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ------PDNCPEELYELMRLCWKEKP-EERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCHHHHHHHHHHccCCh-hhCCCHHHHHHHhhc
Confidence                  01123458899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-35  Score=320.73  Aligned_cols=240  Identities=23%  Similarity=0.283  Sum_probs=190.0

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999998653   23345566788888764 899999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999887643 588999999999999999999   899999999999999999999999999999875322211  123


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.            +...- ...+   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~------------i~~~~-~~~~---  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS------------IRMDN-PCYP---  216 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH------------HHhCC-CCCC---
Confidence            456899999999998889999999999999999999999999752111  01111            10000 0000   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHH-HHH
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMG-WIF  890 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~-evl  890 (897)
                         .....++.+++.+|++.|| ++||++. ++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~P-~~R~~~~~~l~  246 (316)
T cd05619         217 ---RWLTREAKDILVKLFVREP-ERRLGVKGDIR  246 (316)
T ss_pred             ---ccCCHHHHHHHHHHhccCH-hhcCCChHHHH
Confidence               0122346789999999999 9999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-35  Score=311.65  Aligned_cols=249  Identities=19%  Similarity=0.283  Sum_probs=201.2

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788899999999999999865 6899999998643 2344567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++... ...+++..+..++.|++.||+||   |++||+|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999987653 34578999999999999999999   899999999999999999999999999999876543222  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......|++.|+|||+..+..++.++||||||+++|+|++|+.||......                 ............
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~  218 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----------------NLILKVCQGSYK  218 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----------------HHHHHHhcCCCC
Confidence            222346889999999998888999999999999999999999999752110                 001000000000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...   ......+.+++.+||+.|| ++|||+.|++++
T Consensus       219 ~~~---~~~~~~~~~li~~~l~~~P-~~Rp~~~~il~~  252 (255)
T cd08219         219 PLP---SHYSYELRSLIKQMFKRNP-RSRPSATTILSR  252 (255)
T ss_pred             CCC---cccCHHHHHHHHHHHhCCc-ccCCCHHHHhhc
Confidence            000   1123457889999999999 999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.3e-35  Score=318.19  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|+..+.||+|+||.||+|...      ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999753      46789999987543 33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCC
Q 045539          689 ALIMKYMPNGSLENCLYSGT---------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSN  747 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~N  747 (897)
                      ++||||+++++|.+++....                     ..+++.+++.++.|++.||+||   |++|++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence            99999999999999986432                     2467888999999999999999   88999999999999


Q ss_pred             eeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCc
Q 045539          748 VLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGE  826 (897)
Q Consensus       748 Ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~  826 (897)
                      |++++++.+||+|||.+................++..|+|||...+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322222222345677999999888889999999999999999998 88888542111 


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          +..        ..+.+......+       +....++.+++.+|++.|| ++|||+.|+++.|++
T Consensus       240 ----~~~--------~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p-~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVI--------YYVRDGNVLSCP-------DNCPLELYNLMRLCWSKLP-SDRPSFASINRILQR  288 (288)
T ss_pred             ----HHH--------HHHhcCCCCCCC-------CCCCHHHHHHHHHHcccCc-ccCCCHHHHHHHhhC
Confidence                111        011111110001       1223568899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-35  Score=326.43  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=193.5

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|..+++++ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 58899999998643   23346678899999998 699999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence            99998886553 589999999999999999999   899999999999999999999999999999875321111  123


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc---cchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE---LSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||+......   ....++        ..+.+......-+ 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~p-  225 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--------LFQVILEKQIRIP-  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH--------HHHHHHcCCCCCC-
Confidence            4568999999999999899999999999999999999999997421111   001111        1111111100001 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCC------HHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGAD------MGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt------~~evl~  891 (897)
                            .....++.+++.+|++.|| ++||+      ++|+++
T Consensus       226 ------~~~~~~~~~li~~~L~~dP-~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         226 ------RSLSVKASSVLKGFLNKDP-KERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ------CCCCHHHHHHHHHHhccCH-HHcCCCCCCCCHHHHhc
Confidence                  1123457889999999999 99997      556653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=311.11  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|...+.||+|++|.||.|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999764 58999999886432     2234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++.... .+++..+..++.|++.|++||   |+.||+||||+|+||++++++.++|+|||.+......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887654 478899999999999999999   8999999999999999999999999999998765432


Q ss_pred             Cceee-eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSI-QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..... .....++..|+|||+..+..++.++||||+|+++|||++|+.||......    ..         .........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~---------~~~~~~~~~  224 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AA---------IFKIATQPT  224 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HH---------HHHHhccCC
Confidence            11111 12345788999999998888999999999999999999999998652110    00         000000000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....      .......+.+++.+||..+| ++|||+.|+++.
T Consensus       225 ~~~~------~~~~~~~~~~li~~~l~~~p-~~Rpt~~~ll~~  260 (263)
T cd06625         225 NPQL------PSHVSPDARNFLRRTFVENA-KKRPSAEELLRH  260 (263)
T ss_pred             CCCC------CccCCHHHHHHHHHHhhcCc-ccCCCHHHHhhC
Confidence            0000      01233457889999999999 999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-36  Score=332.30  Aligned_cols=201  Identities=25%  Similarity=0.393  Sum_probs=174.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++.+++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999875 58999999997543   234567888999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987654 589999999999999999999   899999999999999999999999999999875432110


Q ss_pred             e---------------------------------eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 045539          773 L---------------------------------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPT  819 (897)
Q Consensus       773 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~  819 (897)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346999999999999999999999999999999999999999


Q ss_pred             cc
Q 045539          820 DE  821 (897)
Q Consensus       820 ~~  821 (897)
                      ..
T Consensus       237 ~~  238 (360)
T cd05627         237 CS  238 (360)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=310.77  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999876 78999999986644 4678899999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |++|++||||||+||+++.++.+||+|||.+........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999987654 3589999999999999999999   899999999999999999999999999999986532211  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                         ....+..|+|||+...+.++.++||||||+++||+++ |+.||......  .            ..+.+........
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~------------~~~~~~~~~~~~~  220 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D------------VVPHVEKGYRMEA  220 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--H------------HHHHHhcCCCCCC
Confidence               2234667999999988889999999999999999997 99998652111  1            1111111100000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ......++.+++.+|+..+| ++|||++|++++|++
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p-~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ------PEGCPPEVYKVMKDCWELDP-AKRPTFKQLREQLAL  255 (256)
T ss_pred             ------ccCCCHHHHHHHHHHhccCh-hhCcCHHHHHHHHhc
Confidence                  01233567899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.7e-35  Score=313.93  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=203.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999864 78999999876432   234467889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++..   ....+++..+..++.|++.|++||   |++|++|+||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998763   234589999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...  ......|+..|+|||+..+..++.++||||||+++|+|++|..||.....+   ....            .....
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~------------~~~~~  221 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSL------------CKKIE  221 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHH------------hhhhh
Confidence            221  112345889999999998888999999999999999999999998642111   0111            01000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...+...  .......++.+++.+||+.|| ++|||+.+|++++++
T Consensus       222 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p-~~Rpt~~~i~~~~~~  264 (267)
T cd08229         222 QCDYPPL--PSDHYSEELRQLVNMCINPDP-EKRPDITYVYDVAKR  264 (267)
T ss_pred             cCCCCCC--CcccccHHHHHHHHHhcCCCc-ccCCCHHHHHHHHhh
Confidence            0000000  001234568899999999999 999999999888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-35  Score=310.58  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|+..+.||+|+||.||+|.+.+ ++.||+|.+.....  .+.+.+|++++++++||||+++++++.+++..|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3679999999999999999998774 78999999876533  57899999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++......+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.+||+|||.+........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999999999987666789999999999999999999   889999999999999999999999999999887653321  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......++..|+|||+..+..++.++||||||+++|+|++|+.||........              ...+......   
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~---  217 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------------IFMIPNKPPP---  217 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------------hhhhccCCCC---
Confidence            12234578899999999888899999999999999999999999875321110              0000000000   


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ...........+.+++.+|++.|| ++|||+.||++
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~P-~~Rps~~~il~  252 (256)
T cd06612         218 -TLSDPEKWSPEFNDFVKKCLVKDP-EERPSAIQLLQ  252 (256)
T ss_pred             -CCCchhhcCHHHHHHHHHHHhcCh-hhCcCHHHHhc
Confidence             001111233457889999999999 99999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=312.24  Aligned_cols=255  Identities=25%  Similarity=0.453  Sum_probs=205.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..++|++.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            356899999999999999999998878899999987543 2346788999999999999999999999998999999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++.... ..+++..+..++.|++.|++||   |+.|++|+||||+||++++++.+||+|||.+........ 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            99999999987654 4689999999999999999999   889999999999999999999999999999876643211 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......++..|+|||...+..++.++||||+|+++||+++ |+.||......  ...+.            +.......
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~------------~~~~~~~~  224 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQ------------VERGYRMP  224 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHcCCCCC
Confidence            11112234678999999988889999999999999999998 99998652111  01111            11000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .      ......++.+++.+|++.+| ++||+++|+.+.|+.
T Consensus       225 ~------~~~~~~~~~~~i~~~l~~~p-~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 R------PPNCPEELYDLMLQCWDKDP-EERPTFEYLQSFLED  260 (261)
T ss_pred             C------CCCCCHHHHHHHHHHcccCc-ccCCCHHHHHHHHhc
Confidence            0      01123457899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=323.62  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             CeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChh
Q 045539          623 NLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLE  701 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  701 (897)
                      -+||+|.||+||.|++.+ ...+|||.+.....+..+.+..|+..-++++|+|||+++|.+.++++.-+.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            469999999999998764 5679999998777777888999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEeeccCccccCCCCceeeeec
Q 045539          702 NCLYSGTCML--DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQ  778 (897)
Q Consensus       702 ~~l~~~~~~~--~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~  778 (897)
                      +.++..-+++  .+..+--+.+||++||.||   |+..|||||||-+||+++ ..|.+||+|||-++...+-.  ..+..
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            9999877667  7778888999999999999   899999999999999996 67899999999998875433  33445


Q ss_pred             cccCcccCCcCccCCC--CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          779 TLATIGYMAPEYGTKG--RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~--~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      +.||..|||||++..+  .|++++|||||||++.||.||++||.+....               -..++.-.+-+..+  
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGmyKvHP--  798 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGMYKVHP--  798 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhcceecCC--
Confidence            6799999999998766  5789999999999999999999999763211               11222222211111  


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       +-.++...+...++.+|+.+|| .+||+|.++++
T Consensus       799 -~iPeelsaeak~FilrcFepd~-~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 -PIPEELSAEAKNFILRCFEPDP-CDRPSAKDLLQ  831 (1226)
T ss_pred             -CCcHHHHHHHHHHHHHHcCCCc-ccCccHHHhcc
Confidence             1224555667889999999999 99999999875

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.1e-35  Score=310.65  Aligned_cols=256  Identities=21%  Similarity=0.322  Sum_probs=205.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999876 79999999886422   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++..   ....+++.++..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998854   234588999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...  ......++..|+|||...+..++.++|||||||++|+|++|+.||.....   ...            +..+...
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~------------~~~~~~~  221 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLY------------SLCKKIE  221 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHH------------HHHhhhh
Confidence            221  12234588899999998888899999999999999999999999864211   111            1111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ........  .+.....+.+++.+||..+| ++|||+.+|+++|++
T Consensus       222 ~~~~~~~~--~~~~~~~~~~~i~~cl~~~p-~~Rp~~~~il~~~~~  264 (267)
T cd08224         222 KCDYPPLP--ADHYSEELRDLVSRCINPDP-EKRPDISYVLQVAKE  264 (267)
T ss_pred             cCCCCCCC--hhhcCHHHHHHHHHHcCCCc-ccCCCHHHHHHHHHH
Confidence            10000000  11234467899999999999 999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-35  Score=325.12  Aligned_cols=237  Identities=24%  Similarity=0.286  Sum_probs=186.1

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHH-HHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECE-VMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +|+.||+|++.+..   ......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999987543   222344555554 67889999999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++.++..++.||+.||+||   |+.||+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998886543 578889999999999999999   89999999999999999999999999999987532221  1223


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....        ..+......- +    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~--------~~i~~~~~~~-~----  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMY--------DNILHKPLQL-P----  216 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHH--------HHHhcCCCCC-C----
Confidence            45689999999999888899999999999999999999999965211     1111        1111111100 0    


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHH
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMG  887 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~  887 (897)
                         .....++.+++.+|++.|| ++||++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~p-~~R~~~~  242 (321)
T cd05603         217 ---GGKTVAACDLLVGLLHKDQ-RRRLGAK  242 (321)
T ss_pred             ---CCCCHHHHHHHHHHccCCH-hhcCCCC
Confidence               0122357889999999999 9999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.2e-35  Score=309.78  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             eeecccceEEEEEEec---CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          624 LIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      .||+|+||.||+|.++   +++.||+|+++...  ....+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999653   57889999986443  3345778899999999999999999999864 4678999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee-ee
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-QI  777 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-~~  777 (897)
                      +|.+++.... .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||.+........... ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987554 589999999999999999999   899999999999999999999999999999987654332211 12


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ...++..|+|||......++.++|||||||++|||++ |+.||......  .            ..+.++.......+  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~------------~~~~i~~~~~~~~~--  220 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--E------------VTQMIESGERMECP--  220 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H------------HHHHHHCCCCCCCC--
Confidence            2234578999999888889999999999999999998 99998753111  1            11112211110000  


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          ..+..++.+++.+||+.|| ++||++++|.++|++
T Consensus       221 ----~~~~~~l~~li~~~~~~~p-~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ----QRCPPEMYDLMKLCWTYGV-DERPGFAVVELRLRN  254 (257)
T ss_pred             ----CCCCHHHHHHHHHHhccCc-hhCcCHHHHHHHHhc
Confidence                1233557899999999999 999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-35  Score=311.03  Aligned_cols=252  Identities=23%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|++..... ....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46888899999999999999887788999998875422 23568899999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            9999999987666688999999999999999999   899999999999999999999999999999876543221 111


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....++..|+|||...++.++.++||||||+++|||++ |+.||......     +.         .+.+........+.
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~---------~~~~~~~~~~~~~~  224 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EV---------VETINAGFRLYKPR  224 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HH---------HHHHhCCCCCCCCC
Confidence            22335678999999988889999999999999999998 99998752211     00         01111000000000


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                            ....++.+++.+||+.+| ++|||+.||+++|.
T Consensus       225 ------~~~~~~~~l~~~~l~~~p-~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ------LASQSVYELMQHCWKERP-EDRPSFSLLLHQLA  256 (256)
T ss_pred             ------CCCHHHHHHHHHHcccCh-hhCCCHHHHHHhhC
Confidence                  112458899999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=317.02  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=203.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457899999999999999999875 6899999998866666667889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++......+++.++..++.|++.|++||   |+.||+||||||+||+++.++.++|+|||.+........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            999999999887666799999999999999999999   899999999999999999999999999998876532221  


Q ss_pred             eeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          775 IQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ......+++.|+|||+..     ...++.++||||||+++|||++|+.||...... .....+                .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~----------------~  221 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKI----------------L  221 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHH----------------h
Confidence            222345889999999864     345678999999999999999999998753111 000000                0


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...+. ..........++.+++.+||+.|| ++||++.+|++.
T Consensus       222 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~~  262 (280)
T cd06611         222 KSEPP-TLDQPSKWSSSFNDFLKSCLVKDP-DDRPTAAELLKH  262 (280)
T ss_pred             cCCCC-CcCCcccCCHHHHHHHHHHhccCh-hhCcCHHHHhcC
Confidence            00000 000011223457889999999999 999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-35  Score=318.49  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=196.5

Q ss_pred             cCCCcCCeeecccceEEEEEEecC-Cc--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQD-GM--EVAVKVFHQQ-YERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998653 33  4788887742 233456788999999999 699999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          692 MKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      |||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               2478889999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhh
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIND  835 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  835 (897)
                      ||+|||++......   ........+..|+|||+.....++.++|||||||++|||++ |..||......     +    
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~----  226 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----E----  226 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----H----
Confidence            99999998643211   11111223557999999888889999999999999999997 99998652111     0    


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           ..+.+........+      ..+...+.+++.+||+.|| .+|||+++++++|+
T Consensus       227 -----~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~  273 (297)
T cd05089         227 -----LYEKLPQGYRMEKP------RNCDDEVYELMRQCWRDRP-YERPPFAQISVQLS  273 (297)
T ss_pred             -----HHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence                 11111111100000      1223457899999999999 99999999988875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-35  Score=312.50  Aligned_cols=256  Identities=23%  Similarity=0.435  Sum_probs=203.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CC---ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DG---MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++... ....+.+.+|++++++++|||++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888899999999999999865 23   369999887542 3445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||++++++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999987666789999999999999999999   8999999999999999999999999999998766432


Q ss_pred             Cceeee-eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQLSIQ-IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...... .....+..|+|||+.....++.++|||||||++||+++ |+.||......              .....+...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------------~~~~~i~~~  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------------EVMKAINDG  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------------HHHHHHhcC
Confidence            221111 11223457999999888889999999999999999997 99998652111              111111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....      .......++.+++.+|++.|| ++||++.+|++.|++
T Consensus       227 ~~~~------~~~~~~~~~~~li~~c~~~~p-~~Rp~~~~i~~~l~~  266 (268)
T cd05063         227 FRLP------APMDCPSAVYQLMLQCWQQDR-ARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCC------CCCCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHh
Confidence            1000      011234567899999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-35  Score=323.98  Aligned_cols=242  Identities=21%  Similarity=0.272  Sum_probs=192.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++.+..   ....+.+..|.++++.+. |++|+++++++.+++..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999865 68999999997643   233456778899998886 577889999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999887654 589999999999999999999   899999999999999999999999999999875432221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..           ...+...... .
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~-----------~~~i~~~~~~-~  220 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--EL-----------FQSIMEHNVS-Y  220 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HH-----------HHHHHhCCCC-C
Confidence              122346899999999998888999999999999999999999999753111  00           0111111110 0


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHH
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMG  887 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~  887 (897)
                      +       .....++.+++.+|++.|| ++|++..
T Consensus       221 p-------~~~~~~~~~li~~~l~~~p-~~R~~~~  247 (323)
T cd05615         221 P-------KSLSKEAVSICKGLMTKHP-SKRLGCG  247 (323)
T ss_pred             C-------ccCCHHHHHHHHHHcccCH-hhCCCCC
Confidence            0       1123456889999999999 9999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=318.92  Aligned_cols=257  Identities=24%  Similarity=0.408  Sum_probs=214.3

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++-...+....++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|..+..+||
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence            33334466778999999999999999874 567999998765 4456889999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          691 IMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      |+|||..|+|.+|+++.. ..++.-..+.++.||+.|++||   .++++|||||..+|+|+.++..+|++|||+++.+.+
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            999999999999998755 4466667789999999999999   899999999999999999999999999999999875


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      +.. ....+..-...|.|||-+....++.|+|||+|||++||+.| |-.||..+..              .++.+++++.
T Consensus       418 DTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------------SqVY~LLEkg  482 (1157)
T KOG4278|consen  418 DTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYGLLEKG  482 (1157)
T ss_pred             Cce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------------HHHHHHHhcc
Confidence            443 22333344678999999999999999999999999999998 8888876311              1244555543


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+      ....+.|+.++.++|+.||++.| .+||+++|+-+.++
T Consensus       483 yR------M~~PeGCPpkVYeLMraCW~WsP-sDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  483 YR------MDGPEGCPPKVYELMRACWNWSP-SDRPSFAEIHQAFE  521 (1157)
T ss_pred             cc------ccCCCCCCHHHHHHHHHHhcCCc-ccCccHHHHHHHHH
Confidence            32      23335677889999999999999 99999999988765

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.7e-35  Score=311.03  Aligned_cols=256  Identities=27%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +.+++.+.....||+|+||.||+|++. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            445666767789999999999999865 5788999998766666667899999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCML--DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~  768 (897)
                      |||+++++|.+++......+  ++..+..++.|++.|++||   |++||+||||||+||+++. ++.+||+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999988654445  7888899999999999999   8999999999999999976 6799999999987654


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCC--CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGR--VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ....  ......|++.|+|||+.....  ++.++||||||+++|+|++|+.||........  ..+             .
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~-------------~  223 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMF-------------K  223 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHh-------------h
Confidence            3221  122335789999999876543  78899999999999999999999865211100  000             0


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..........   ......++.+++.+||+.+| ++|||+.|+++.
T Consensus       224 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p-~~Rpt~~~ll~~  265 (268)
T cd06624         224 VGMFKIHPEI---PESLSAEAKNFILRCFEPDP-DKRASAHDLLQD  265 (268)
T ss_pred             hhhhccCCCC---CcccCHHHHHHHHHHcCCCc-hhCCCHHHHHhC
Confidence            0000000000   01233457889999999999 999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-35  Score=325.92  Aligned_cols=242  Identities=21%  Similarity=0.298  Sum_probs=189.9

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 58899999998643   23446678899988877 799999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99998876654 589999999999999999999   899999999999999999999999999999875322211  123


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc---cchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE---LSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....++        .+.+......-+ 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~~i~~~~~~~p-  225 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------FQVILEKQIRIP-  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH--------HHHHhcCCCCCC-
Confidence            4568999999999999999999999999999999999999996421111   0001111        111111000001 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                            .....++.+++.+|++.|| ++||++
T Consensus       226 ------~~~~~~~~~ll~~~L~~dP-~~R~~~  250 (329)
T cd05618         226 ------RSLSVKAASVLKSFLNKDP-KERLGC  250 (329)
T ss_pred             ------CCCCHHHHHHHHHHhcCCH-HHcCCC
Confidence                  1223457899999999999 999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-35  Score=314.98  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            667788999999999999876 4788999998766555667888999999999999999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++......+++..+..++.|+++||+||   |+.|++||||||+||+++.++.+|++|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            999998876555789999999999999999999   88999999999999999999999999999987653221  1223


Q ss_pred             ccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          778 QTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      ...++..|+|||++.     ...++.++|||||||++|||++|+.||......+ .........         ...+. .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~---------~~~~~-~  230 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE---------PPTLA-Q  230 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC---------CCCCC-C
Confidence            346889999999863     4457789999999999999999999987521110 000000000         00000 0


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +       .....++.+++.+||+.|| .+||+++++++.
T Consensus       231 ~-------~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~~  262 (282)
T cd06643         231 P-------SRWSSEFKDFLKKCLEKNV-DARWTTTQLLQH  262 (282)
T ss_pred             c-------cccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            0       1123457899999999999 999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-35  Score=333.17  Aligned_cols=266  Identities=22%  Similarity=0.223  Sum_probs=199.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...     +...+|++++++++||||+++++++..+...|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            458999999999999999999653   3678999988654     34467999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |++. ++|.+++... ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 6788887433 4689999999999999999999   889999999999999999999999999999976654333


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc--cchhHHhhh------cCCch----
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE--LSLNRWIND------LLPVS----  840 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~--~~~~~~~~~------~~~~~----  840 (897)
                      ........||+.|+|||++....++.++|||||||++|||++|+.||.......  ..+...+..      .++..    
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            233334579999999999998899999999999999999999999996532211  111111110      00100    


Q ss_pred             HHHHhhhhh---cchhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 VMEVIDTNL---LRGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ~~~~i~~~l---~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .........   ...+.. ..-.......++.+++.+|+..|| ++|||+.|++..
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp-~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ-EFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh-hhCCCHHHHhhC
Confidence            000000000   000000 000000123457789999999999 999999999864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-35  Score=326.62  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=197.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecC-CC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSN-DD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  686 (897)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45899999999999999999963      347889999987543 33456788999999999 68999999998855 45


Q ss_pred             ceEEEEEeccCCChhHhhhcCC----------------------------------------------------------
Q 045539          687 FKALIMKYMPNGSLENCLYSGT----------------------------------------------------------  708 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  708 (897)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886431                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          709 --------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       709 --------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                              ..+++.++..++.|+++||+||   |++||+||||||+||++++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    2367888899999999999999   89999999999999999999999999999987654332222222334


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAA  859 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  859 (897)
                      ++..|+|||...+..++.++||||||+++|||++ |..||....... .            ....+........+     
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~------------~~~~~~~~~~~~~~-----  304 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E------------FCRRLKEGTRMRAP-----  304 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H------------HHHHHhccCCCCCC-----
Confidence            5678999999888889999999999999999997 899986521110 0            11111100000000     


Q ss_pred             HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          860 KEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       860 ~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                       .....++.+++.+||+.|| ++|||+.||++.|+
T Consensus       305 -~~~~~~~~~~~~~cl~~~p-~~Rps~~eil~~l~  337 (343)
T cd05103         305 -DYTTPEMYQTMLDCWHGEP-SQRPTFSELVEHLG  337 (343)
T ss_pred             -CCCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence             0112357899999999999 99999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5e-35  Score=314.20  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecC-CCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSN-DDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  688 (897)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.+ +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5689999999999999999998765     6889999887542 3445778899999999999999999998765 5778


Q ss_pred             EEEEEeccCCChhHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          689 ALIMKYMPNGSLENCLYSGT-------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      ++++||+++++|.+++....       ..+++.++..++.|++.||+||   |+++++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986532       3588999999999999999999   8899999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCch
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      |+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||.....  .....++...... 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~-  238 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRL-  238 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCC-
Confidence            99987654333222223446778999999988889999999999999999999 9999875211  1111111111000 


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                       .....+..++.+++.+||..|| ++|||+.||++.|++
T Consensus       239 -----------------~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~~~~~l~~  275 (280)
T cd05043         239 -----------------AQPINCPDELFAVMACCWALDP-EERPSFSQLVQCLTD  275 (280)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHHH
Confidence                             0001123457899999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-34  Score=308.30  Aligned_cols=240  Identities=18%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             CeeecccceEEEEEEecC-------------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          623 NLIGIGSFGSIYVARLQD-------------GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      +.||+|+||.||+|...+             ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358999887665555678889999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc-------EEEeecc
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-------AHISDFG  762 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~-------~kL~DFg  762 (897)
                      +||||+++++|..++......+++..+..++.||++|++||   |++||+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999998877666689999999999999999999   8999999999999999986654       8999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHH-cCCCCCcccccCccchhHHhhhcCCch
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMF-TKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      .+......      ....++..|+|||++. ...++.++|||||||++|||+ +|..|+......  ...          
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~----------  219 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKE----------  219 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHH----------
Confidence            98754322      2335788999999876 467889999999999999998 588887642111  000          


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                        ...........        .....+.+++.+||+.|| .+||++.|+++.+.
T Consensus       220 --~~~~~~~~~~~--------~~~~~~~~li~~cl~~dp-~~Rp~~~~il~~~~  262 (262)
T cd05077         220 --RFYEGQCMLVT--------PSCKELADLMTHCMNYDP-NQRPFFRAIMRDIN  262 (262)
T ss_pred             --HHHhcCccCCC--------CChHHHHHHHHHHcCCCh-hhCcCHHHHHHhcC
Confidence              00000000000        112357889999999999 99999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-35  Score=323.15  Aligned_cols=266  Identities=22%  Similarity=0.262  Sum_probs=197.3

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCC----
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSND----  685 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  685 (897)
                      ....++|.+.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345689999999999999999999764 688999999875432  2345677899999999999999999988543    


Q ss_pred             --CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          686 --DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       686 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                        ...|++||++ +++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3568999988 78998887654  489999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                      +......     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+.++... ......
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~  237 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEV-VGTPSP  237 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHH-hCCCCH
Confidence            9865432     123468999999998766 56889999999999999999999999652110 111111110 000000


Q ss_pred             HHhhh-----------hhcchhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          843 EVIDT-----------NLLRGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       843 ~~i~~-----------~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +....           .+...+.... .........+.+++.+|+..|| ++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp-~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDS-DKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCCh-hhCCCHHHHhcC
Confidence            00000           0000000000 0001122346799999999999 999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.1e-35  Score=327.84  Aligned_cols=266  Identities=20%  Similarity=0.261  Sum_probs=197.5

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-----ceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-----FKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  689 (897)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 68999999986432  234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 57877775543 589999999999999999999   899999999999999999999999999999986543


Q ss_pred             CCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch-H------
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS-V------  841 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~------  841 (897)
                      ... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||......  ...+.+....... .      
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHHh
Confidence            221 122334678999999987664 5789999999999999999999999753211  1111111111110 0      


Q ss_pred             ----HHHhhhhhcchhh--hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          842 ----MEVIDTNLLRGEE--RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       842 ----~~~i~~~l~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                          ...+.......+.  ...........++.+++.+|++.|| ++|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP-~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP-DKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCCh-hhCcCHHHHhcC
Confidence                0000000000000  0000001224567899999999999 999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-35  Score=313.89  Aligned_cols=250  Identities=21%  Similarity=0.315  Sum_probs=197.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|+..+.||+|+||+||+|.+. +++.||+|++....   ....+.+.+|++++++++|++|+++++++.+++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677789999999999999865 68999999987543   2233557789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++..+..++.|++.||.||   |++||+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999998886543 4689999999999999999999   899999999999999999999999999999876532221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....|+..|+|||+..+..++.++||||||+++|||++|+.||....... .             .+.+.......
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~-------------~~~~~~~~~~~  220 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-K-------------REEVDRRVLET  220 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-H-------------HHHHHHhhhcc
Confidence               123468999999999988899999999999999999999999997521110 0             01111111100


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      ....   .......+.+++..|++.|| ++||+     ++|+++
T Consensus       221 ~~~~---~~~~~~~~~~li~~~l~~~P-~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 EEVY---SAKFSEEAKSICKMLLTKDP-KQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccc---CccCCHHHHHHHHHHccCCH-hHcCCCcccChHHHHc
Confidence            0000   01223456889999999999 99999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-35  Score=315.34  Aligned_cols=266  Identities=25%  Similarity=0.395  Sum_probs=207.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec-----CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecC--CCce
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-----DGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFK  688 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  688 (897)
                      +.|...+.||+|+||.||+|++.     +++.||+|+++..... ..+.+.+|++++++++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777899999999999999753     3688999998765443 46789999999999999999999999877  5678


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++......+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987766799999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc----hHHH
Q 045539          769 GEDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV----SVME  843 (897)
Q Consensus       769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  843 (897)
                      ...... ......++..|+|||......++.++||||||+++|||++|+.|+.........   +.......    ...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            332211 111223556799999988888999999999999999999999998653221110   00000000    1111


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+.....      .+....+..++.+++.+||+.+| ++|||+.||+++|++
T Consensus       238 ~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p-~~Rpt~~ei~~~l~~  282 (284)
T cd05038         238 LLKEGER------LPRPPSCPDEVYDLMKLCWEAEP-QDRPSFADLILIVDR  282 (284)
T ss_pred             HHHcCCc------CCCCccCCHHHHHHHHHHhccCh-hhCCCHHHHHHHHhh
Confidence            1111111      11112334568899999999999 999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-34  Score=306.74  Aligned_cols=250  Identities=19%  Similarity=0.291  Sum_probs=203.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|+..+.||+|+||.||.++.. +++.+++|.+....  ....+.+.+|++++++++|+||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999754 58899999876432  34456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++... ...+++.++..++.|++.|++||   |+.|++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998765 35689999999999999999999   889999999999999999999999999999886643321 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......+++.|+|||...+..++.++||||||+++|||++|..||.....                 .+.......+.+
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------------~~~~~~~~~~~~  218 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------------LNLVVKIVQGNY  218 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence             22345689999999998888889999999999999999999999865211                 111111111111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      ..   .......++.+++.+|+..+| ++||++.|+++.+
T Consensus       219 ~~---~~~~~~~~~~~~i~~~l~~~p-~~R~s~~~ll~~~  254 (256)
T cd08221         219 TP---VVSVYSSELISLVHSLLQQDP-EKRPTADEVLDQP  254 (256)
T ss_pred             CC---CccccCHHHHHHHHHHcccCc-ccCCCHHHHhhCc
Confidence            00   002234557899999999999 9999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.8e-35  Score=320.44  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=200.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|.+.+.||+|+||.||+|+..        ....||+|+++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467889999999999999999742        24569999887543 34456788999999999 599999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..++||||+++++|.+++....               ..+++.++..++.|++.||+||   |++||+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEE
Confidence            99999999999999999986532               3478899999999999999999   89999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      ++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||......  . 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E-  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence            9999999999999986643222111122234567999999888889999999999999999999 88888652110  0 


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                 ..+.+........      ...+..++.+++.+|+..|| ++|||+.|+++.|++
T Consensus       245 -----------~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p-~~Rps~~~ll~~l~~  292 (314)
T cd05099         245 -----------LFKLLREGHRMDK------PSNCTHELYMLMRECWHAVP-TQRPTFKQLVEALDK  292 (314)
T ss_pred             -----------HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHH
Confidence                       1111111000000      01223457889999999999 999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.9e-35  Score=308.67  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=198.4

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee-cCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC-SNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  695 (897)
                      ++|.+.+.||+|+||.||+|... |..||+|.++...  ..+.+.+|+.++++++|++++++++++ .+++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            47888999999999999999876 7889999986543  246788999999999999999999975 4556789999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999987654 3588999999999999999999   89999999999999999999999999999987543221   


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                        ....++..|+|||+.....++.++|||||||++|||++ |+.||....     ..+.         ...+........
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~---------~~~~~~~~~~~~  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDV---------VPRVEKGYKMDA  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHH---------HHHHhcCCCCCC
Confidence              12234668999999988889999999999999999997 999986421     1111         111111000000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            .+.+...+.+++.+|++.|| ++|||++++++.|++
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p-~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 ------PDGCPPVVYDVMKQCWHLDA-ATRPSFLQLREQLEH  255 (256)
T ss_pred             ------CCCCCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHhc
Confidence                  01233457899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-35  Score=310.44  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=189.1

Q ss_pred             eeecccceEEEEEEecC-------------------------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceE
Q 045539          624 LIGIGSFGSIYVARLQD-------------------------GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI  678 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  678 (897)
                      +||+|+||.||+|....                         ...||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999996421                         23589999876655555678889999999999999999


Q ss_pred             eeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----
Q 045539          679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----  754 (897)
Q Consensus       679 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----  754 (897)
                      ++++.++...++||||+++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999877666789999999999999999999   899999999999999997543    


Q ss_pred             ---cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHH-HcCCCCCcccccCccch
Q 045539          755 ---VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEM-FTKKKPTDEIFIGELSL  829 (897)
Q Consensus       755 ---~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~el-ltg~~p~~~~~~~~~~~  829 (897)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++||+ ++|+.||......+  .
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence               4899999987643221      12347788999998765 5679999999999999998 47999986532111  0


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                                  ......... .+.       .....+.+++.+||+.+| ++|||+.+|++.|+
T Consensus       231 ------------~~~~~~~~~-~~~-------~~~~~~~~li~~cl~~~p-~~Rps~~~il~~L~  274 (274)
T cd05076         231 ------------ERFYEKKHR-LPE-------PSCKELATLISQCLTYEP-TQRPSFRTILRDLT  274 (274)
T ss_pred             ------------HHHHHhccC-CCC-------CCChHHHHHHHHHcccCh-hhCcCHHHHHHhhC
Confidence                        111111100 000       011347889999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=319.06  Aligned_cols=245  Identities=25%  Similarity=0.313  Sum_probs=200.4

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|...+.||.|+||.||.|++. +.+.||||++...   ..+....+.+|++.|++++|||++.+-|+|-.+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4666788999999999999764 6788999998633   34455778899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      || -|+-.|.+.-..+++.+.++..|+.+.+.||+||   |+++.||||||..|||+++.|.|||+|||.|..+.+.   
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            99 5678888877777899999999999999999999   8999999999999999999999999999999887543   


Q ss_pred             eeeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          774 SIQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ..++|||.|||||++   ..+.|+-|+||||+|++..|+..+++|......- ..+.+......         +.+.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNes---------PtLq  246 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES---------PTLQ  246 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcCC---------CCCC
Confidence               356899999999975   5689999999999999999999999997652110 00111111100         0111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               -.+....+..++..|+++-| .+|||.+++++.
T Consensus       247 ---------s~eWS~~F~~Fvd~CLqKip-qeRptse~ll~H  278 (948)
T KOG0577|consen  247 ---------SNEWSDYFRNFVDSCLQKIP-QERPTSEELLKH  278 (948)
T ss_pred             ---------CchhHHHHHHHHHHHHhhCc-ccCCcHHHHhhc
Confidence                     12344568889999999999 999999999874

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-34  Score=322.03  Aligned_cols=265  Identities=21%  Similarity=0.244  Sum_probs=196.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-----
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-----  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  686 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4579999999999999999999865 58999999986432  334567789999999999999999999986443     


Q ss_pred             -ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          687 -FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       687 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                       ..|+||||+++ ++.+.+..   .++...+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999965 56555543   378889999999999999999   89999999999999999999999999999997


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ........ .......+..
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~  246 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIE-QLGTPSAEFM  246 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCcHHHH
Confidence            543221   123346899999999999989999999999999999999999999753111 01111111 1111000000


Q ss_pred             -------hhhhcchh-------hhhHH---------HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          846 -------DTNLLRGE-------ERFFA---------AKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       846 -------~~~l~~~~-------~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                             .......+       ...++         .......++.+++.+|++.|| ++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP-~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP-DKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCc-ccCCCHHHHhcC
Confidence                   00000000       00000         000113457899999999999 999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-35  Score=323.23  Aligned_cols=201  Identities=23%  Similarity=0.350  Sum_probs=175.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 58889999987532   233456788999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999987555689999999999999999999   899999999999999999999999999999977643322


Q ss_pred             eeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      . ......||+.|+|||++.+     +.++.++|||||||++|||++|+.||..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            1 2223469999999998765     5678899999999999999999999965

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-35  Score=331.43  Aligned_cols=266  Identities=18%  Similarity=0.193  Sum_probs=199.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|++++++++||||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999876 478899996432      3456899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +. ++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            94 688888876656799999999999999999999   89999999999999999999999999999998664332222


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccC------ccchhHHhhh------cCCch--
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG------ELSLNRWIND------LLPVS--  840 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~------~~~~~~~~~~------~~~~~--  840 (897)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+......      ...+.+.+..      .++..  
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            223456999999999999989999999999999999999988765332111      0111111111      01110  


Q ss_pred             --HHHHhhhhh----cchhh-hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 --VMEVIDTNL----LRGEE-RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 --~~~~i~~~l----~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        .........    ..... ..+.........+.+++.+|++.|| ++|||+.|+++.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP-~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDG-ARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccCh-hhCcCHHHHhhC
Confidence              000000000    00000 0011111223457889999999999 999999999975

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-34  Score=315.82  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=202.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999865 58889999886542 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++.... .+++..+..++.|+++||+||   |+ .+++||||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999987653 588999999999999999999   65 699999999999999999999999999987553221  


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC---------------
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP---------------  838 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------  838 (897)
                        .....|+..|+|||+..+..++.++||||||+++|+|++|+.||.....  .....+......               
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence              2234688999999998888899999999999999999999999864221  111111110000               


Q ss_pred             ------chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 ------VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ------~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                            ....+..+.......+....  .....++.+++.+|+..|| ++|||++||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P-~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNP-KERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence                  00111111111111110000  0133458899999999999 999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-35  Score=313.14  Aligned_cols=253  Identities=22%  Similarity=0.268  Sum_probs=199.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47888899999999999999765 58899999987665455567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++...+ .+++.++..++.|++.|++||   |+.|++|+||||+||+++.++.+||+|||.+.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999887654 589999999999999999999   88899999999999999999999999999987654221  12


Q ss_pred             eeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          776 QIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .....|+..|+|||++.   ...++.++||||+||++|+|++|+.||........ ........            ....
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~------------~~~~  229 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSN------------FQPP  229 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccC------------CCCC
Confidence            23446899999999864   45688999999999999999999999865321110 00000000            0000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ...........+.+++.+|++.|| ++||++++|++.
T Consensus       230 ---~~~~~~~~~~~~~~li~~~l~~~P-~~R~~~~~ll~~  265 (267)
T cd06645         230 ---KLKDKMKWSNSFHHFVKMALTKNP-KKRPTAEKLLQH  265 (267)
T ss_pred             ---cccccCCCCHHHHHHHHHHccCCc-hhCcCHHHHhcC
Confidence               000000122346789999999999 999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.3e-35  Score=318.16  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=196.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCc--eEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGM--EVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++. ++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++.+++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999865 454  45777766432 33456788999999999 79999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          691 IMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      ||||+++++|.+++....               ..+++.++..++.|++.|++||   |++||+||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCc
Confidence            999999999999986432               2578999999999999999999   8999999999999999999999


Q ss_pred             EEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhh
Q 045539          756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~  834 (897)
                      +||+|||++......   .......++..|+|||+.....++.++|||||||++|||+| |..||......  ...+.  
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~--  235 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK--  235 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHH--
Confidence            999999998643211   11111234667999999888888999999999999999998 99998642111  11111  


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                                +........      .......+.+++.+|++.+| ++||++++++++|+
T Consensus       236 ----------~~~~~~~~~------~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~~l~  278 (303)
T cd05088         236 ----------LPQGYRLEK------PLNCDDEVYDLMRQCWREKP-YERPSFAQILVSLN  278 (303)
T ss_pred             ----------HhcCCcCCC------CCCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence                      100000000      00123457899999999999 99999999998874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=306.65  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=197.1

Q ss_pred             CeeecccceEEEEEEecC----CceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQD----GMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      ++||+|+||.||+|.+..    +..||+|.+..... ...+.+.+|+++++++.||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997532    36899999875543 345678899999999999999999998764 467999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee-e
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-Q  776 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-~  776 (897)
                      ++|.+++.... .+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||.+........... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 589999999999999999999   889999999999999999999999999999987643332111 1


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....++..|+|||......++.++||||||+++||+++ |+.||.....  .....++....+.           ..   
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~-----------~~---  219 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL-----------PR---  219 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC-----------CC---
Confidence            11223567999999988889999999999999999998 9999875311  1122221111000           00   


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                          ...+..++.+++.+|+..|| ++||++.+|++.|++.|
T Consensus       220 ----~~~~~~~l~~li~~cl~~~p-~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 ----PEECPQEIYSIMLSCWKYRP-EDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHHhcc
Confidence                01223467899999999999 99999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-35  Score=322.23  Aligned_cols=243  Identities=22%  Similarity=0.298  Sum_probs=190.8

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999998653   23456688999999888 599999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence            99998876544 589999999999999999999   889999999999999999999999999999875322211  123


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc-cchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE-LSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ...||+.|+|||+..+..++.++|||||||++|||++|+.||....... ....++.        ...+.......+   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~p---  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL--------FQVILEKPIRIP---  223 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH--------HHHHHhCCCCCC---
Confidence            4568999999999999999999999999999999999999996532211 1111111        111110000001   


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHH
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMG  887 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~  887 (897)
                          .....++.+++.+|++.|| ++||++.
T Consensus       224 ----~~~~~~~~~li~~~L~~dP-~~R~~~~  249 (327)
T cd05617         224 ----RFLSVKASHVLKGFLNKDP-KERLGCQ  249 (327)
T ss_pred             ----CCCCHHHHHHHHHHhccCH-HHcCCCC
Confidence                0122446789999999999 9999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.9e-35  Score=308.57  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46899999999999999999988778889999887543 334678899999999999999999999987 7789999999


Q ss_pred             cCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++... ....++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999998764 35578889999999999999999   889999999999999999999999999999876543221 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......++..|+|||+...+.++.++|||||||++|++++ |+.||.....  ....+.+......            . 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------~-  223 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------P-  223 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC------------C-
Confidence            1222345678999999988889999999999999999999 8999865211  1111111111000            0 


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           .......++.+++.+|++.+| ++||++.++.+.|+.
T Consensus       224 -----~~~~~~~~~~~~i~~~l~~~p-~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 -----RPENCPEELYNIMMRCWKNRP-EERPTFEYIQSVLDD  259 (260)
T ss_pred             -----CcccCCHHHHHHHHHHcccCc-ccCcCHHHHHHHHhc
Confidence                 001233458899999999999 999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.7e-35  Score=310.31  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=189.7

Q ss_pred             CeeecccceEEEEEEecC---CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQD---GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|.+.+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999997653   4579999887543 233457888999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          699 SLENCLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       699 sL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +|.+++....    ...++..+..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    2456778889999999999999   89999999999999999999999999999987654332222


Q ss_pred             eeeccccCcccCCcCccCCC-------CCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          775 IQIQTLATIGYMAPEYGTKG-------RVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ......++..|+|||+....       .++.++||||||+++|||++ |+.||......+  ......   .........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~---~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTV---REQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHh---hcccCCCCC
Confidence            22234577889999987532       35789999999999999996 999996532111  000000   000000001


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +.+..          .....+.+++..|| .+| ++|||++||++.|+
T Consensus       233 ~~~~~----------~~~~~~~~l~~~c~-~~P-~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL----------PLSDRWYEVMQFCW-LQP-EQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC----------CCChHHHHHHHHHh-cCc-ccCCCHHHHHHHhc
Confidence            11100          11234677889998 689 99999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-35  Score=321.89  Aligned_cols=201  Identities=22%  Similarity=0.345  Sum_probs=173.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+..   ....+.+.+|+.++..++|++|+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999876 47889999986532   223455788999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999987555689999999999999999999   899999999999999999999999999999876532222


Q ss_pred             eeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          773 LSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence             1223356999999999875     35678999999999999999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.9e-35  Score=309.38  Aligned_cols=249  Identities=23%  Similarity=0.406  Sum_probs=191.5

Q ss_pred             CeeecccceEEEEEEec----CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeec-CCCceEEEEEecc
Q 045539          623 NLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCS-NDDFKALIMKYMP  696 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  696 (897)
                      +.||+|+||.||+|.+.    ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2457999988543 2344578889999999999999999999775 4567899999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee-
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI-  775 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-  775 (897)
                      +++|.+++.......++..+..++.|++.|++||   |+.+++||||||+||++++++.+||+|||+++.......... 
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999987665678888899999999999999   889999999999999999999999999999876543221111 


Q ss_pred             -eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcC-CCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          776 -QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       776 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       .....++..|+|||......++.++||||||+++|||++| ..||.....  ......+               .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~---------------~~~~~  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL---------------LQGRR  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---------------hcCCC
Confidence             1123457789999998888899999999999999999995 455543110  0111111               00000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .   ...+..+..+.+++.+||+.+| ++||++.||+++|++
T Consensus       221 ~---~~~~~~~~~~~~li~~cl~~~p-~~Rp~~~~il~~l~~  258 (262)
T cd05058         221 L---LQPEYCPDPLYEVMLSCWHPKP-EMRPTFSELVSRIEQ  258 (262)
T ss_pred             C---CCCCcCCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHHH
Confidence            0   0001123457899999999999 999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.8e-35  Score=330.38  Aligned_cols=264  Identities=22%  Similarity=0.260  Sum_probs=189.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCC--------C
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSND--------D  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  686 (897)
                      ..+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999875 58899999886432    2335799999999999999999876322        2


Q ss_pred             ceEEEEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeecc
Q 045539          687 FKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFG  762 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg  762 (897)
                      ..++||||+++ ++.+++..   ....+++..+..++.|++.||+||   |++||+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 67666542   335689999999999999999999   899999999999999999664 79999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch-
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS-  840 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  840 (897)
                      +|+.......   .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.+.+...-... 
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence            9986643222   223468999999998765 46899999999999999999999999753211 11111111100000 


Q ss_pred             -HHHHhhhhhc-----c-h-hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 -VMEVIDTNLL-----R-G-EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 -~~~~i~~~l~-----~-~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       ......+...     . . ...+..-......++.+++.+||+.|| ++|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP-~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP-LKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh-hHCcCHHHHhCC
Confidence             0000000000     0 0 000000001123568899999999999 999999998753

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.2e-35  Score=310.74  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             cCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++.++ ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            468888999999999999997643    3468999887654 44557889999999999999999999998764 56899


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++......+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999987665689999999999999999999   89999999999999999999999999999988664332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      . .......++..|+|||......++.++||||||+++||+++ |..||......  .....+....          .. 
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~----------~~-  227 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIENGE----------RL-  227 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCC----------cC-
Confidence            2 12222334568999999888889999999999999999986 99998653211  1111110000          00 


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..+       ..+..++.+++.+|+..+| ++|||+.|+++.|++
T Consensus       228 ~~~-------~~~~~~~~~li~~~l~~~P-~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 PMP-------PNCPPTLYSLMTKCWAYDP-SKRPRFTELKAQLSD  264 (270)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence            000       1233468889999999999 999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9e-35  Score=314.65  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            368999999999999999999864 6899999998765544557788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++...  .+++.++..++.|++.||.||   |+.|++||||||+||+++.++.++|+|||.+........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998664  378899999999999999999   899999999999999999999999999999876543321  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......+++.|+|||...+..++.++|||||||++|++++|+.||............+ .               ...+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~---------------~~~~~  234 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T---------------NGTPE  234 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c---------------CCCCC
Confidence            1223458889999999988889999999999999999999999996521111000000 0               00000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        ..........+.+++.+||+.|| ++||+++|+++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~  268 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDV-DRRGSAKELLQ  268 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCCh-hhCcCHHHHhc
Confidence              00011223446789999999999 99999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-34  Score=310.19  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=197.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999764 68899999986542 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|..+.     .+++..+..++.|++.|++||   |+.||+|+||||+||+++.++.+||+|||++.......   
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            9999997542     367888999999999999999   89999999999999999999999999999987654221   


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH-hhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV-IDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~l~~~~  853 (897)
                       .....|+..|+|||+..+..++.++||||||+++|+|++|+.||..........       .+...... .+......+
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~  221 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLP  221 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHHHHHhccCCCCCC
Confidence             223468999999999988889999999999999999999999997633221110       00000000 000000000


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .      .....++.+++.+|++.|| ++||+++|+++.
T Consensus       222 ~------~~~~~~~~~li~~~l~~~P-~~Rp~~~eil~~  253 (279)
T cd06619         222 V------GQFSEKFVHFITQCMRKQP-KERPAPENLMDH  253 (279)
T ss_pred             C------CcCCHHHHHHHHHHhhCCh-hhCCCHHHHhcC
Confidence            0      1122357899999999999 999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=310.77  Aligned_cols=248  Identities=26%  Similarity=0.339  Sum_probs=202.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|||++++++++.++...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999866 58899999987543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++...  ++++..+..++.|++.|+.||   |+++++||||+|+||++++++.++|+|||.+.......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998875  589999999999999999999   89999999999999999999999999999998765332  1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......++..|+|||+..+..++.++||||||+++|+|++|+.||......              .....+.........
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------------~~~~~~~~~~~~~~~  219 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------------RVLFLIPKNNPPSLE  219 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------------HHHHHhhhcCCCCCc
Confidence            223446888999999998888999999999999999999999999652111              000011111100000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .     ......+.+++.+|+..|| ++|||++++++
T Consensus       220 ~-----~~~~~~~~~~l~~~l~~~p-~~Rpt~~~il~  250 (274)
T cd06609         220 G-----NKFSKPFKDFVSLCLNKDP-KERPSAKELLK  250 (274)
T ss_pred             c-----cccCHHHHHHHHHHhhCCh-hhCcCHHHHhh
Confidence            0     0023457889999999999 99999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.1e-35  Score=312.64  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=198.2

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+....   ....+.+.+|+.++++++|++++++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999765 68999999986542   2233567789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999999886533 4589999999999999999999   899999999999999999999999999999876542221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......  ..+.        ......... ..
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~--------~~~~~~~~~-~~  223 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREE--------VERLVKEVQ-EE  223 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHH--------HHhhhhhhh-hh
Confidence               123468999999999988899999999999999999999999997532110  0000        001111000 00


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .      .......+.+++.+|++.|| ++|||     ++|+++
T Consensus       224 ~------~~~~~~~~~~li~~~l~~~p-~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 Y------SEKFSPDARSLCKMLLCKDP-KERLGCQGGGAREVKE  260 (285)
T ss_pred             c------CccCCHHHHHHHHHHhhcCH-HHccCCCCCchHHHHc
Confidence            0      01223457899999999999 99999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=318.20  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=208.2

Q ss_pred             CCCcCCeeecccceEEEEEEecC---Cc--eEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD---GM--EVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..+..++||.|-||.||+|...+   |+  .||||..+.. ..+..+.|..|+.+|++++||||++++|+|.+. ..++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34456889999999999997532   33  4899998874 345578899999999999999999999999865 67999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||.++.|.|..|++.+...++......++.||+.||+||   |++.+|||||..+||++.....+||+|||+++.+..+.
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999999988899999999999999999999   99999999999999999999999999999999987554


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .+. .+...-...|||||.+.-..++.+||||.|||++||++. |..||......                 +++-..- 
T Consensus       546 yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------------DVI~~iE-  606 (974)
T KOG4257|consen  546 YYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----------------DVIGHIE-  606 (974)
T ss_pred             hhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----------------ceEEEec-
Confidence            433 333344677999999999999999999999999999987 99999874322                 1121111 


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                        ..+|.+-.+.|+..+..++.+||++|| .+||++.|+...|+
T Consensus       607 --nGeRlP~P~nCPp~LYslmskcWayeP-~kRPrftei~~~ls  647 (974)
T KOG4257|consen  607 --NGERLPCPPNCPPALYSLMSKCWAYEP-SKRPRFTEIKAILS  647 (974)
T ss_pred             --CCCCCCCCCCCChHHHHHHHHHhccCc-ccCCcHHHHHHHHH
Confidence              111333444667778899999999999 99999999987764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.6e-35  Score=317.18  Aligned_cols=267  Identities=17%  Similarity=0.239  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357999999999999999999875 58899999987443 2233467789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++ ++|.+++......+++..+..++.|+++||+||   |+.||+||||||+||+++.++.+||+|||.+........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            996 589888877666689999999999999999999   899999999999999999999999999999876432221 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc----hHHHHhhhh
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV----SVMEVIDTN  848 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~  848 (897)
                       ......+++.|+|||+..+ ..++.++|||||||++|||++|+.||......  .....+....+.    ....+....
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccc
Confidence             1123357889999998754 45788999999999999999999999753211  111111111110    011111100


Q ss_pred             ------hcchhhhh-HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 ------LLRGEERF-FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 ------l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                            ........ ..........+.+++.+|++.|| .+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp-~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEG-RKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCc-ccCcCHHHHhc
Confidence                  00000000 00011234457899999999999 99999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.2e-35  Score=314.70  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .+|+..+.||.|++|.||+|... +|+.||+|.+........+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46889999999999999999764 68999999987654445577889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++...  .+++.++..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988754  489999999999999999999   899999999999999999999999999999876543321  1


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....++..|+|||...+..++.++|||||||++|++++|+.||........ .. .+            .......   
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~-~~------------~~~~~~~---  234 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY-LI------------ATNGTPE---  234 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HH------------HhcCCcc---
Confidence            2234588899999999888899999999999999999999999975321100 00 00            0000000   


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ..........+.+++.+||..|| ++|||+.++++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp-~~Rpt~~~il~  268 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDV-EKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcCh-hhCCCHHHHhh
Confidence             00011233457889999999999 99999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-35  Score=312.50  Aligned_cols=260  Identities=22%  Similarity=0.304  Sum_probs=204.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888899999999999999865 58899999876543 34457889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||  +.++++||||||+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999887644 5899999999999999999995  34689999999999999999999999999986543211   


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                       .....|+..|+|||++.+..++.++|||||||++|++++|+.||......+.      ....+....+.+.........
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhhhhHHHHHHHHHhhccCC
Confidence             1234689999999998888899999999999999999999999976332110      001111122222222221111


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...  ..+....+.+++.+|++.|| ++|||++||++.
T Consensus       232 ~~~--~~~~~~~~~~li~~~l~~dp-~~Rpt~~e~~~~  266 (284)
T cd06620         232 RLP--SSDFPEDLRDFVDACLLKDP-TERPTPQQLCAM  266 (284)
T ss_pred             CCC--chhcCHHHHHHHHHHhcCCc-ccCcCHHHHhcC
Confidence            100  01244568899999999999 999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-34  Score=306.59  Aligned_cols=251  Identities=21%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhh------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +|+..+.||+|+||+||+|...+|+.+|+|.++...      .+..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999988889999999886331      23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987654 478999999999999999999   88999999999999999999999999999987643211


Q ss_pred             ----ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          772 ----QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       772 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                          .........|+..|+|||+..+..++.++||||||+++|+|++|+.||....... .........       ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~-------~~~~  228 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHR-------GLMP  228 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhcc-------CCCC
Confidence                1111223458899999999988889999999999999999999999996521110 000000000       0000


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.          .....++.+++.+||+.+| ++||++.|+++
T Consensus       229 ~~~----------~~~~~~~~~~i~~~l~~~p-~~Rp~~~~~l~  261 (265)
T cd06631         229 RLP----------DSFSAAAIDFVTSCLTRDQ-HERPSALQLLR  261 (265)
T ss_pred             CCC----------CCCCHHHHHHHHHHhcCCc-ccCCCHHHHhc
Confidence            000          1123457889999999999 99999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=311.39  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=201.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|++.+.||+|+||.||+|.+. +|+    .||+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57888999999999999999864 233    58999876553 3345678899999999999999999999987 78899


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++......+++..+..++.|++.|++||   |+.|++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999988766689999999999999999999   8899999999999999999999999999999876533


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........++..|+|||......++.++||||||+++||+++ |+.||......              +..+.+....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~~~~~~  228 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------------EIPDLLEKGE  228 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------------HHHHHHhCCC
Confidence            32222222234568999999888889999999999999999998 99998753111              1111111110


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....+      ..+...+.+++.+||..|| ++|||+.++++.|++
T Consensus       229 ~~~~~------~~~~~~~~~~~~~~l~~~p-~~Rp~~~~l~~~l~~  267 (279)
T cd05057         229 RLPQP------PICTIDVYMVLVKCWMIDA-ESRPTFKELINEFSK  267 (279)
T ss_pred             CCCCC------CCCCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHHH
Confidence            00000      0122347789999999999 999999999988753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.2e-35  Score=320.61  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=200.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      ..+|++.+.||+|+||.||+|+..        .+..||+|.++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            347899999999999999999742        12368999887543 33457888999999999 799999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..+++|||+++++|.+++....               ..+++.++..++.|++.||+||   |++||+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEE
Confidence            99999999999999999986532               3478889999999999999999   89999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||.++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            9999999999999986543322222222334567999999988899999999999999999998 8888865211     


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+.         ...+........      ......++.+++.+|++.+| ++|||+.|+++.|+
T Consensus       243 ~~~---------~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p-~~Rps~~ell~~l~  291 (334)
T cd05100         243 EEL---------FKLLKEGHRMDK------PANCTHELYMIMRECWHAVP-SQRPTFKQLVEDLD  291 (334)
T ss_pred             HHH---------HHHHHcCCCCCC------CCCCCHHHHHHHHHHcccCh-hhCcCHHHHHHHHH
Confidence            111         111111000000      01223458899999999999 99999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-34  Score=308.78  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=187.5

Q ss_pred             CeeecccceEEEEEEecC---CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQD---GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+..+   ...+|+|.+.... ......+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   4568888776443 334567889999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          699 SLENCLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       699 sL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +|.+++....    ...++.....++.|++.|++||   |++||+||||||+||++++++.+||+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999987643    2346778889999999999999   89999999999999999999999999999987543332222


Q ss_pred             eeeccccCcccCCcCccC-------CCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          775 IQIQTLATIGYMAPEYGT-------KGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ......++..|+|||+..       ...++.++|||||||++|||++ |..||......+ .........    ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~----~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ----DIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc----CccCCC
Confidence            223334677899999753       3456889999999999999999 788886531110 000000000    000000


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +.+          .......+.+++..|| .|| ++|||++||++.|.
T Consensus       233 ~~~----------~~~~~~~~~~~~~~~~-~dp-~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL----------DLKYSDRWYEVMQFCW-LDP-ETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc----------cccCCHHHHHHHHHHh-cCc-ccccCHHHHHHHhc
Confidence            000          0122344667788888 599 99999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=318.94  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=208.4

Q ss_pred             CCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      -|.++..||.|+||.||+|..++ +-..|.|++.....+..+.|.-|++||..+.||+||++++.|..++..++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45566789999999999998764 44567888887778888999999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      ||-.+..+-.-+..+.+.++.-+++|++.||.||   |+.+|+|||+|..|||++-+|.++|+|||.+....  ......
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            9999998888777899999999999999999999   99999999999999999999999999999876532  222334


Q ss_pred             eccccCcccCCcCcc-----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          777 IQTLATIGYMAPEYG-----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ..+.|||+|||||+.     ...+|+.++||||||+++.||..+.+|.++.                 ..+.++-+.-..
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----------------npMRVllKiaKS  250 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----------------NPMRVLLKIAKS  250 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----------------chHHHHHHHhhc
Confidence            567899999999974     5678999999999999999999999997652                 223333332222


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .|+. ..........+.+++.+|+..|| ..||+++++++.
T Consensus       251 ePPT-LlqPS~Ws~~F~DfLk~cL~Knp-~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPT-LLQPSHWSRSFSDFLKRCLVKNP-RNRPPAAQLLKH  289 (1187)
T ss_pred             CCCc-ccCcchhhhHHHHHHHHHHhcCC-ccCCCHHHHhhC
Confidence            3321 12223455678899999999999 999999999863

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-35  Score=310.89  Aligned_cols=240  Identities=22%  Similarity=0.329  Sum_probs=190.3

Q ss_pred             CeeecccceEEEEEEecC--------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999997542        234888887765555567888999999999999999999999998999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc--------EEEeeccCccc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--------AHISDFGIAKL  766 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~--------~kL~DFg~a~~  766 (897)
                      +++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987766789999999999999999999   8999999999999999987764        69999998875


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCC-CCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKK-KPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ....      ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+......              .....
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------------~~~~~  217 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------------KKLQF  217 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------------HHHHH
Confidence            5322      12357889999998876 45789999999999999999995 554431100              00011


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...... -+.       ....++.+++.+||+.|| ++|||++|++++|+
T Consensus       218 ~~~~~~-~~~-------~~~~~~~~li~~~l~~~p-~~Rps~~~il~~l~  258 (258)
T cd05078         218 YEDRHQ-LPA-------PKWTELANLINQCMDYEP-DFRPSFRAIIRDLN  258 (258)
T ss_pred             HHcccc-CCC-------CCcHHHHHHHHHHhccCh-hhCCCHHHHHHhcC
Confidence            110000 000       112457899999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=299.69  Aligned_cols=263  Identities=25%  Similarity=0.359  Sum_probs=202.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc--CCCccceEeeeecCCC----ceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSCSNDD----FKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~  689 (897)
                      ..+....+.||+|.||+||+|+|+ |+.||||++....   .+.+.+|.+|.+.+  +|+||..+++.-..+.    ..+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            356677899999999999999999 8999999997553   35677888888875  8999999998764332    678


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      +|++|.+.|||.||+....  ++....++++.-+|.||+|||.     .-+..|+|||||+.|||+..++...|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            9999999999999999865  8999999999999999999983     34678999999999999999999999999999


Q ss_pred             cccCCCCc--eeeeeccccCcccCCcCccCCCC------CCccchHHHHHHHHHHHHcCC----------CCCcccccCc
Q 045539          765 KLLSGEDQ--LSIQIQTLATIGYMAPEYGTKGR------VCTRGDVYSYGIMLMEMFTKK----------KPTDEIFIGE  826 (897)
Q Consensus       765 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvil~elltg~----------~p~~~~~~~~  826 (897)
                      ........  .......+||..|||||++...-      .-..+||||||.|+||++-+-          .||.+....+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            87654321  11223457999999999875431      234789999999999987543          3554433333


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .++.+.        ..-+..+.+++..+.++... +.+..+.++|+.||..+| +.|-||-.+-+.|.
T Consensus       444 Ps~eeM--------rkVVCv~~~RP~ipnrW~s~-~~l~~m~klMkeCW~~Np-~aRltALriKKtl~  501 (513)
T KOG2052|consen  444 PSFEEM--------RKVVCVQKLRPNIPNRWKSD-PALRVMAKLMKECWYANP-AARLTALRIKKTLA  501 (513)
T ss_pred             CCHHHH--------hcceeecccCCCCCcccccC-HHHHHHHHHHHHhhcCCc-hhhhHHHHHHHHHH
Confidence            222211        11122344555555555543 556889999999999999 99999988877664

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-34  Score=321.06  Aligned_cols=267  Identities=21%  Similarity=0.214  Sum_probs=196.9

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  685 (897)
                      ...++|+..+.||+|+||.||+|... .++.||+|++....  ....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35679999999999999999999765 58899999987532  33456778899999999999999999988543     


Q ss_pred             -CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 -DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                       ...|+||||+++ ++.+.+..   .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999965 56665543   378889999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC-------
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL-------  837 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------  837 (897)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+....       
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            8654321   123346899999999998888999999999999999999999999652111 00111111000       


Q ss_pred             ---CchHHHHhhhhhcch----h----hh----hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          838 ---PVSVMEVIDTNLLRG----E----ER----FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       838 ---~~~~~~~i~~~l~~~----~----~~----~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .......++......    +    ..    ..........++.+++.+|++.|| ++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP-~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP-AKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc-hhcCCHHHHhcC
Confidence               000111111000000    0    00    000001123457899999999999 999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-34  Score=304.45  Aligned_cols=250  Identities=27%  Similarity=0.491  Sum_probs=200.7

Q ss_pred             CCcCCeeecccceEEEEEEecC-----CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          619 FSENNLIGIGSFGSIYVARLQD-----GMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +++.+.||.|+||.||+|++.+     +..||+|+++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998763     378999998755432 5678899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||+++++|.+++...... +++.++..++.|++.|+++|   |+.|++||||||+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998775544 89999999999999999999   89999999999999999999999999999998765432


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .... ....+++.|+|||......++.++||||+|+++|+|++ |+.||.....  ....+.            +.....
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~------------~~~~~~  222 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY------------LKKGYR  222 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH------------HhcCCC
Confidence            2221 12336789999999888889999999999999999998 7888764211  011111            111000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      ...      ......++.+++.+|+..|| ++|||+.|+++.|
T Consensus       223 ~~~------~~~~~~~~~~~i~~~l~~~p-~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPK------PENCPPEIYKLMLQCWAEDP-EDRPTFSELVEIL  258 (258)
T ss_pred             CCC------CCcCCHHHHHHHHHHCcCCh-hhCcCHHHHHhhC
Confidence            000      01134568889999999999 9999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-34  Score=307.95  Aligned_cols=254  Identities=22%  Similarity=0.291  Sum_probs=205.5

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999876 58999999987553 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++......+++..+..++.|++.|++||   |+ .|++||||||+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            999999999987656789999999999999999999   88 9999999999999999999999999999876532211 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                         ....++..|+|||+..+..++.++||||||+++|+|++|+.||.......            ....+.+........
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~  221 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP------------DGIFELLQYIVNEPP  221 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------------ccHHHHHHHHhcCCC
Confidence               11568889999999988899999999999999999999999987532111            111222222222111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......  ....++.+++.+|+..|| ++|||+.|+++.
T Consensus       222 ~~~~~~--~~~~~~~~li~~~l~~~p-~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSG--KFSPDFQDFVNLCLIKDP-RERPSYKELLEH  257 (265)
T ss_pred             CCCChh--hcCHHHHHHHHHHcCCCc-hhCcCHHHHhhC
Confidence            111111  134568899999999999 999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-34  Score=331.74  Aligned_cols=201  Identities=23%  Similarity=0.321  Sum_probs=165.0

Q ss_pred             HHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCC------CccceEeeee
Q 045539          610 HELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRH------RNLVKIISSC  682 (897)
Q Consensus       610 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~  682 (897)
                      +++....++|++.+.||+|+||+||+|... .++.||||+++... ...+....|+++++.++|      ++++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344455789999999999999999999865 57889999986432 223445667777777754      4588899988


Q ss_pred             cCC-CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCC------
Q 045539          683 SND-DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDM------  754 (897)
Q Consensus       683 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~------  754 (897)
                      ..+ +..|+|||++ +++|.+++.... .+++..+..|+.||+.||+||   |+ .||+||||||+|||++.++      
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCcccccc
Confidence            654 5788999988 778888877654 589999999999999999999   65 6999999999999998665      


Q ss_pred             ----------cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          755 ----------VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       755 ----------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                                .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                      499999998764321     12345789999999999999999999999999999999999999975

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-34  Score=304.91  Aligned_cols=238  Identities=22%  Similarity=0.386  Sum_probs=190.2

Q ss_pred             CeeecccceEEEEEEecC-C----------ceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          623 NLIGIGSFGSIYVARLQD-G----------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +.||+|+||.||+|.+.+ +          ..|++|++...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998764 2          24788877654333 5788899999999999999999999988 778999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-------cEEEeeccCc
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-------VAHISDFGIA  764 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-------~~kL~DFg~a  764 (897)
                      |||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++       .+||+|||.+
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987665689999999999999999999   899999999999999999887       7999999998


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCC--CCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKG--RVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      .....      .....++..|+|||++...  .++.++||||||+++||+++ |..||......  ....+..       
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~-------  220 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ-------  220 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh-------
Confidence            86543      1233467889999998776  78999999999999999999 57777653211  1111110       


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                          .......+.         ...+.+++.+||..+| .+|||+.||++.|+
T Consensus       221 ----~~~~~~~~~---------~~~~~~li~~~l~~~p-~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ----DQHRLPMPD---------CAELANLINQCWTYDP-TKRPSFRAILRDLN  259 (259)
T ss_pred             ----cCCCCCCCC---------chHHHHHHHHHhccCh-hhCCCHHHHHHhcC
Confidence                000000000         1457899999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=323.81  Aligned_cols=245  Identities=21%  Similarity=0.215  Sum_probs=186.1

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhc---CCCccceEeeeecCCCceEEEEEeccC
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRI---RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      ||+|+||+||+|+.. +++.||+|++.+...   ........|..++...   +||+|+++++++.+++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 589999999875432   2234455677777665   699999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++.... .+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            99998887654 589999999999999999999   899999999999999999999999999999875432221  123


Q ss_pred             ccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          778 QTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ...||+.|+|||++.+. .++.++||||+||++|||++|+.||......     +...        .+...... .+.  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~--------~i~~~~~~-~~~--  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYR--------NIAFGKVR-FPK--  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHH--------HHHcCCCC-CCC--
Confidence            45689999999987654 4789999999999999999999998652110     0000        00000000 000  


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCC
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPN  896 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~  896 (897)
                          ......+.+++.+|++.|| ++||++.+.++++.++
T Consensus       219 ----~~~~~~~~~li~~~L~~~P-~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 ----NVLSDEGRQFVKGLLNRNP-QHRLGAHRDAVELKEH  253 (330)
T ss_pred             ----ccCCHHHHHHHHHHcCCCH-HHCCCCCCCHHHHhcC
Confidence                0123446789999999999 9999544444444333

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-34  Score=310.83  Aligned_cols=252  Identities=20%  Similarity=0.304  Sum_probs=198.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999876 68999999887542 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|..++...  ...+++..+..++.|++.|+.|||  ++.||+||||||+||+++.++.+||+|||.+....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999988764  236899999999999999999994  25699999999999999999999999999987653221 


Q ss_pred             eeeeeccccCcccCCcCccCCC------CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          773 LSIQIQTLATIGYMAPEYGTKG------RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                         .....++..|+|||...+.      .++.++|||||||++|+|++|+.||......              .....+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------------~~~~~~~  220 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--------------NIFAQLS  220 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--------------hHHHHHH
Confidence               1234578899999987543      3478999999999999999999999652111              0111111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......+....   .....++.+++.+|++.+| ++||+++|+++.
T Consensus       221 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p-~~Rp~~~~l~~~  262 (286)
T cd06622         221 AIVDGDPPTLP---SGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEH  262 (286)
T ss_pred             HHhhcCCCCCC---cccCHHHHHHHHHHcccCc-ccCCCHHHHhcC
Confidence            11111111111   1234557889999999999 999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-34  Score=308.42  Aligned_cols=249  Identities=27%  Similarity=0.443  Sum_probs=196.3

Q ss_pred             CeeecccceEEEEEEecC-------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARLQD-------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997642       2579999876543 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-----cEEEeeccC
Q 045539          695 MPNGSLENCLYSG------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-----VAHISDFGI  763 (897)
Q Consensus       695 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-----~~kL~DFg~  763 (897)
                      +++++|.+++...      ...+++.++..++.|++.|++||   |+.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      23478899999999999999999   889999999999999999877     899999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHH
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                      +................++..|+|||++.++.++.++|||||||++|||++ |+.||......  .....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~----------  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH----------  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH----------
Confidence            876543322222223345788999999999999999999999999999998 99998642111  11111          


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                        +....      +..........+.+++.+||..+| ++||++++|++.|++
T Consensus       226 --~~~~~------~~~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 --VTAGG------RLQKPENCPDKIYQLMTNCWAQDP-SERPTFDRIQEILQN  269 (269)
T ss_pred             --HhcCC------ccCCcccchHHHHHHHHHHcCCCc-ccCCCHHHHHHHHhC
Confidence              11000      000011234567899999999999 999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.5e-35  Score=312.48  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCC------
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSND------  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  685 (897)
                      .+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678999999999999999999865 58899999986543 2345678899999998 699999999998643      


Q ss_pred             CceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ...|+||||+++++|.+++.... ..+++..+..++.|++.|++||   |+++|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46799999999999999987643 4688999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      .......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||......    ....      
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~------  226 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF------  226 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHH------
Confidence            7653221  1223456899999999875     346788999999999999999999998652111    0000      


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         ...........      ......++.+++.+||..|| .+|||++|+++
T Consensus       227 ---~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p-~~Rpt~~~il~  268 (272)
T cd06637         227 ---LIPRNPAPRLK------SKKWSKKFQSFIESCLVKNH-SQRPTTEQLMK  268 (272)
T ss_pred             ---HHhcCCCCCCC------CCCcCHHHHHHHHHHcCCCh-hhCCCHHHHhh
Confidence               00000000000      01123457899999999999 99999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-34  Score=320.65  Aligned_cols=192  Identities=22%  Similarity=0.309  Sum_probs=166.3

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++.+++..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3468999999999999999999876 4788999975433      23468999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+. ++|.+++......+++..+..|+.|++.||+||   |++||+||||||+||+++.++.+||+|||.++......  
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            994 688888877666799999999999999999999   88999999999999999999999999999987533221  


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPT  819 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~  819 (897)
                       ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             122456899999999999889999999999999999999866554

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-34  Score=312.68  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=192.5

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCccceEeeeecC-----CC
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRI---RHRNLVKIISSCSN-----DD  686 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  686 (897)
                      +|++.+.||+|+||.||+|+.. +|+.||+|.++....  .....+.+|+++++++   +||||+++++++.+     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999876 689999999875321  1223455677777665   69999999998854     34


Q ss_pred             ceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          687 FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ..++||||+++ +|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999974 8888876543 4589999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC---CchHH
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL---PVSVM  842 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~  842 (897)
                      .......   .....||..|+|||++.+..++.++||||+||++|||++|+.||...... ....+......   .....
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence            6543221   22345789999999998889999999999999999999999998652111 11111111000   00000


Q ss_pred             HHh---hhhhcchhhhh-HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          843 EVI---DTNLLRGEERF-FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       843 ~~i---~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...   ........... .....+...++.+++.+|++.|| ++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNP-HKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCc-ccCCCHHHHhc
Confidence            000   00000000000 01111234567899999999999 99999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-34  Score=306.87  Aligned_cols=256  Identities=25%  Similarity=0.328  Sum_probs=203.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999865 58899999986432 33567889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|.+++....  ..+++..+..++.|++.|++||   |+.|++||||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987642  4589999999999999999999   899999999999999999999999999999877654332


Q ss_pred             ee--eeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          773 LS--IQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       773 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..  ......|+..|+|||++... .++.++||||||+++|||++|+.||...... ....+......+         ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---------~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPP---------SL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCC---------Cc
Confidence            21  22334588999999988776 7899999999999999999999999753211 111111111000         00


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..     .........++.+++.+|++.|| ++||+++|+++
T Consensus       228 ~~-----~~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~ll~  263 (267)
T cd06610         228 ET-----GADYKKYSKSFRKMISLCLQKDP-SKRPTAEELLK  263 (267)
T ss_pred             CC-----ccccccccHHHHHHHHHHcCCCh-hhCcCHHHHhh
Confidence            00     00012334567899999999999 99999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-34  Score=319.80  Aligned_cols=266  Identities=21%  Similarity=0.235  Sum_probs=196.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC------
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND------  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  685 (897)
                      ..++|.+.+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4679999999999999999999865 58899999987532  33446778899999999999999999987543      


Q ss_pred             CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 67666643   378889999999999999999   89999999999999999999999999999997


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC--chHHH
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP--VSVME  843 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  843 (897)
                      ......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...... ......+...-.  .....
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            654321   123346899999999999989999999999999999999999999753211 111111110000  00111


Q ss_pred             Hhhhhhcc----hh-------hhhH---------HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 VIDTNLLR----GE-------ERFF---------AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ~i~~~l~~----~~-------~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+.+....    .+       +..+         ........++.+++.+|++.|| ++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP-~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA-SKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCc-ccCCCHHHHhcC
Confidence            11100000    00       0000         0000112457899999999999 999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-34  Score=304.33  Aligned_cols=249  Identities=21%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|++.+.||+|+||.||.+... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999765 68999999986432  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++.... ..+++.++..++.|++.|++||   |+.|++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 3578999999999999999999   889999999999999999999999999999976543221 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......|++.|+|||+..+..++.++|||||||++++|++|+.||....                 ..+.+...+.+..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------------~~~~~~~~~~~~~  218 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----------------MKNLVLKIIRGSY  218 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----------------HHHHHHHHhcCCC
Confidence             1123457889999999988889999999999999999999999986421                 1111221111111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...   ......++.+++.+||+.+| ++||++.||++.
T Consensus       219 ~~~---~~~~~~~~~~li~~~l~~~p-~~Rp~~~~vl~~  253 (256)
T cd08218         219 PPV---SSHYSYDLRNLVSQLFKRNP-RDRPSVNSILEK  253 (256)
T ss_pred             CCC---cccCCHHHHHHHHHHhhCCh-hhCcCHHHHhhC
Confidence            100   11234458899999999999 999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-34  Score=314.12  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=199.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|++.... ......+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999764 344    57888876543 23345688999999999999999999998764 467


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +++||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999999887766689999999999999999999   899999999999999999999999999999987653


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........++..|+|||+..+..++.++||||||+++||+++ |+.||......  ...++            +...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~------------~~~~  227 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL------------LEKG  227 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHCC
Confidence            332222223345778999999988889999999999999999997 89998652111  11111            1110


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....      ...+...+.+++.+||..|| ++||+++|+++.|+
T Consensus       228 ~~~~~------~~~~~~~~~~li~~c~~~~p-~~Rp~~~~l~~~l~  266 (303)
T cd05110         228 ERLPQ------PPICTIDVYMVMVKCWMIDA-DSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCC------CCCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            00000      01122357889999999999 99999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.6e-34  Score=312.51  Aligned_cols=194  Identities=22%  Similarity=0.298  Sum_probs=158.6

Q ss_pred             CCeeecccceEEEEEEec---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCceEEEEEecc
Q 045539          622 NNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFKALIMKYMP  696 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  696 (897)
                      .++||+|+||+||+|+..   +++.||+|.+.....  ...+.+|++++++++||||+++++++.+  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   467899999875422  2456789999999999999999998854  456889999985


Q ss_pred             CCChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----CCCCcEEEeeccCc
Q 045539          697 NGSLENCLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIA  764 (897)
Q Consensus       697 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a  764 (897)
                       ++|.+++...        ...+++..+..++.|++.||+||   |++||+||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5777776432        13588899999999999999999   89999999999999999    45679999999999


Q ss_pred             cccCCCCce-eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          765 KLLSGEDQL-SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       765 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ......... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            876432211 12234568999999998766 4588999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-34  Score=301.78  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=199.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC-CCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN-DDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  693 (897)
                      +|++.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999865 57889999986542  3445678899999999999999999998764 446789999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++.++..++.|++.|+++|   |+.||+||||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999987643 4589999999999999999999   899999999999999999999999999999876643221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......+++.|+|||+..+..++.++||||+|++++++++|+.||.....     ....        .......+...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~--------~~~~~~~~~~~  222 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLV--------YRIIEGKLPPM  222 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHH--------HHHHhcCCCCC
Confidence              22334688999999999888899999999999999999999999864211     1110        01111111000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +       .....++.+++.+|++.|| ++|||+.|+++.
T Consensus       223 ~-------~~~~~~~~~li~~~l~~~p-~~Rp~~~~~l~~  254 (257)
T cd08223         223 P-------KDYSPELGELIATMLSKRP-EKRPSVKSILRQ  254 (257)
T ss_pred             c-------cccCHHHHHHHHHHhccCc-ccCCCHHHHhcC
Confidence            0       1233457899999999999 999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-34  Score=304.17  Aligned_cols=247  Identities=28%  Similarity=0.463  Sum_probs=198.7

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|++.+.||+|+||.||++.. +++.||+|+++....  .+.+.+|+.++++++|||++++++++..++ .++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            5688999999999999999975 478899999875432  357889999999999999999999987654 689999999


Q ss_pred             CCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          697 NGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       697 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +++|.+++.... ..+++..+..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||.+.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999987654 4578999999999999999999   89999999999999999999999999999987543211    


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                       .....+..|+|||+..++.++.++||||||+++|||++ |+.||......     +         ..+.+.+.....+ 
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~---------~~~~~~~~~~~~~-  218 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----E---------VKECVEKGYRMEP-  218 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----H---------HHHHHhCCCCCCC-
Confidence             12234677999999988899999999999999999997 99998653111     0         1111111111111 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPN  896 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~  896 (897)
                           ......++.+++.+||+.+| ++||+++++++.|+.+
T Consensus       219 -----~~~~~~~~~~li~~~l~~~p-~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         219 -----PEGCPADVYVLMTSCWETEP-KKRPSFHKLREKLEKE  254 (254)
T ss_pred             -----CCcCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHccC
Confidence                 11233557899999999999 9999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=303.67  Aligned_cols=249  Identities=20%  Similarity=0.300  Sum_probs=207.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH--HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER--ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +.+-|...+.||+|.|+.|-.|++- +|.+||||++.+..-+  ....+.+|++-|+.++|||||++|.+.......|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3567888899999999999999754 7999999999876533  345778999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee-CCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll-~~~~~~kL~DFg~a~~~~~~  770 (897)
                      .|.=++|+|.||+.+....+.+.-..+++.||+.|+.|+   |+..+||||+||+||.+ ..-|-+||.|||++-.+.++
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999999988887799999999999999999999   67779999999999877 46789999999999887655


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCC-ccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..   ....+|...|-|||++.+..|+ +++||||+|||+|-++.|+.||+...+.+             .+-.++|-. 
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCK-  235 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCK-  235 (864)
T ss_pred             ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccc-
Confidence            43   3456799999999999988875 67799999999999999999998743221             122222221 


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         |    ........+..++|..|+..|| ++|.+.+||..
T Consensus       236 ---Y----tvPshvS~eCrdLI~sMLvRdP-kkRAslEeI~s  269 (864)
T KOG4717|consen  236 ---Y----TVPSHVSKECRDLIQSMLVRDP-KKRASLEEIVS  269 (864)
T ss_pred             ---c----cCchhhhHHHHHHHHHHHhcCc-hhhccHHHHhc
Confidence               1    1122445567899999999999 99999999875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-35  Score=317.24  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=195.4

Q ss_pred             cCCeeecccceEEEEEEec-CCceEEEEEechh----hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc--eEEEEE
Q 045539          621 ENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ----YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF--KALIMK  693 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  693 (897)
                      ..+.||+|+|-+||+|.+. +|..||--.++..    ..+..++|..|+++|+.++||||+++|+++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999765 5777875444322    24456899999999999999999999999987665  778999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      .+..|+|..|..+.+ ..+...+..|++||++||.|||. |...|+|||||.+||+|+ ..|.|||+|.|+|....... 
T Consensus       124 L~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             cccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            999999999988766 48899999999999999999988 889999999999999997 55899999999999875332 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         ...+.|||.|||||+.. ..|+..+||||||++++||+|+.+||..-.....-+.+.....-|..+..+-|      
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------  270 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------  270 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC------
Confidence               23478999999999765 78999999999999999999999999763222222222222222222222221      


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                  .++.++|.+|+.. . ++|||+.|+++
T Consensus       271 ------------Pevr~fIekCl~~-~-~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 ------------PEVREFIEKCLAT-K-SERLSAKELLK  295 (632)
T ss_pred             ------------HHHHHHHHHHhcC-c-hhccCHHHHhh
Confidence                        3478999999999 7 89999999986

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-34  Score=311.79  Aligned_cols=261  Identities=20%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeec-
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCS-  683 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  683 (897)
                      +.++++..+.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445666778899999999999999999999765 58899999876532 2235677899999999 6999999999873 


Q ss_pred             ----CCCceEEEEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          684 ----NDDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       684 ----~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                          .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.||   |+.+|+||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCE
Confidence                45678999999999999988753   234578899999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhH
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR  831 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~  831 (897)
                      ||+|||.+........  ......|++.|+|||++.     ...++.++||||+||++|||++|+.||......    ..
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~  237 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RA  237 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HH
Confidence            9999999876543221  122346899999999864     345788999999999999999999998652111    00


Q ss_pred             HhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          832 WINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       832 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..         ....    .... ..........++.+++.+||+.|| ++|||+.||++.
T Consensus       238 ~~---------~~~~----~~~~-~~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~ell~~  283 (286)
T cd06638         238 LF---------KIPR----NPPP-TLHQPELWSNEFNDFIRKCLTKDY-EKRPTVSDLLQH  283 (286)
T ss_pred             Hh---------hccc----cCCC-cccCCCCcCHHHHHHHHHHccCCc-ccCCCHHHHhhc
Confidence            00         0000    0000 000000112357889999999999 999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-34  Score=307.74  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      +|.+.+.||+|++|.||+|... +++.||+|.+....         ....+.+.+|+.++++++||||+++++++.+++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999865 58899999886432         1234678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999987653 578899999999999999999   8899999999999999999999999999998866


Q ss_pred             CCCCc----eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          768 SGEDQ----LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       768 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....    ........|+..|+|||...+..++.++||||+|+++|+|++|+.||......    ..         ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~---------~~~  223 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA---------IFK  223 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH---------HHH
Confidence            42211    11112235788999999998888999999999999999999999999752110    00         001


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...... ...      .......+.+++.+||+.|| ++||++.||++
T Consensus       224 ~~~~~~-~~~------~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~  263 (267)
T cd06628         224 IGENAS-PEI------PSNISSEAIDFLEKTFEIDH-NKRPTAAELLK  263 (267)
T ss_pred             HhccCC-CcC------CcccCHHHHHHHHHHccCCc-hhCcCHHHHhh
Confidence            111000 000      01233457889999999999 99999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.6e-34  Score=306.11  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999875 58899999987543 34567888999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++...  .+++.++..++.|++.|++||   |+.+++|+||+|+||+++.++.++++|||.+........  
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999988764  488999999999999999999   899999999999999999999999999999976543221  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......++..|+|||+..+..++.++||||||+++|||++|+.||.......              ....+..   ..++
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~~~~~---~~~~  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------------VLFLIPK---NNPP  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------------Hhhhhhc---CCCC
Confidence            1223457889999999988889999999999999999999999987532110              0001100   0000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .   ........+.+++.+||+.+| ++||+++|+++.
T Consensus       220 ~---~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~~  253 (277)
T cd06640         220 T---LTGEFSKPFKEFIDACLNKDP-SFRPTAKELLKH  253 (277)
T ss_pred             C---CchhhhHHHHHHHHHHcccCc-ccCcCHHHHHhC
Confidence            0   012334567899999999999 999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=306.35  Aligned_cols=246  Identities=26%  Similarity=0.419  Sum_probs=191.5

Q ss_pred             CeeecccceEEEEEEecC-Cc--eEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQD-GM--EVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|+..+ +.  .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998753 43  46888887432 34456788999999999 799999999999999999999999999


Q ss_pred             CChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          698 GSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       698 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      ++|.+++....               ..+++.++..++.|++.|++||   |+.|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               2478899999999999999999   88999999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      ++......   ........+..|+|||+.....++.++||||||+++|||++ |..||......  ...+.         
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~---------  223 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK---------  223 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHH---------
Confidence            98532211   11111223567999999888889999999999999999997 99998652111  11111         


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         +........      ......++.+++.+|+..|| .+|||++|+++.|++
T Consensus       224 ---~~~~~~~~~------~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~~l~~  267 (270)
T cd05047         224 ---LPQGYRLEK------PLNCDDEVYDLMRQCWREKP-YERPSFAQILVSLNR  267 (270)
T ss_pred             ---HhCCCCCCC------CCcCCHHHHHHHHHHcccCh-hhCCCHHHHHHHHHH
Confidence               111000000      01123457899999999999 999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.3e-34  Score=308.11  Aligned_cols=255  Identities=21%  Similarity=0.360  Sum_probs=202.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      ++|+..+.||+|+||.||+|+..      +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999864      2467999988654433 4578899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          690 LIMKYMPNGSLENCLYSGT--------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      +||||+++++|.+++....        ..+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        1589999999999999999999   8999999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCch
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      |.+........ .......++..|+|||...+..++.++||||||+++|++++ |..||......  .......      
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~------  232 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ------  232 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH------
Confidence            99875432221 12223346778999999888888999999999999999998 78888652211  1111110      


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           ........      .......+.+++.+|++.|| ++|||+.|+++.|++
T Consensus       233 -----~~~~~~~~------~~~~~~~l~~~i~~~l~~~p-~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 -----AGKLELPV------PEGCPSRLYKLMTRCWAVNP-KDRPSFSELVSALGE  275 (275)
T ss_pred             -----cCCcCCCC------CCCCCHHHHHHHHHHcCCCc-ccCCCHHHHHHHhcC
Confidence                 00000000      01223458899999999999 999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-34  Score=313.14  Aligned_cols=249  Identities=24%  Similarity=0.292  Sum_probs=198.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .|.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999865 588999999876555556778899999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++...  .+++.++..++.|++.|++||   |++||+||||||+||++++++.+||+|||++........  ..
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            99999988654  488999999999999999999   889999999999999999999999999999876532221  12


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....|+..|+|||...+..++.++||||||+++|||++|+.||......  .            ....+...+....   
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~------------~~~~~~~~~~~~~---  238 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--Q------------AMRRIRDNLPPRV---  238 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H------------HHHHHHhcCCCcc---
Confidence            2345889999999988888999999999999999999999998652110  0            0000111110000   


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       .........+.+++.+|+..|| ++|||++|+++.
T Consensus       239 -~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~il~~  272 (292)
T cd06658         239 -KDSHKVSSVLRGFLDLMLVREP-SQRATAQELLQH  272 (292)
T ss_pred             -ccccccCHHHHHHHHHHccCCh-hHCcCHHHHhhC
Confidence             0001123357788999999999 999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-34  Score=311.76  Aligned_cols=255  Identities=22%  Similarity=0.278  Sum_probs=198.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|...+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999876 57899999987653   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++||||||+||+++.++.+|++|||.++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 588999999999999999999   889999999999999999999999999998864211000


Q ss_pred             -------------eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          773 -------------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       773 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                                   ........++..|+|||...+..++.++||||||+++||+++|..||......              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------------  222 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------------  222 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------
Confidence                         00111235788999999988888999999999999999999999998642111              


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                         ++.......... ...........+.+++.+|++.|| ++||++.++.+.|+
T Consensus       223 ---~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P-~~R~~~~~~~~ll~  272 (305)
T cd05609         223 ---ELFGQVISDDIE-WPEGDEALPADAQDLISRLLRQNP-LERLGTGGAFEVKQ  272 (305)
T ss_pred             ---HHHHHHHhcccC-CCCccccCCHHHHHHHHHHhccCh-hhccCccCHHHHHh
Confidence               111111100000 000001223457899999999999 99999655555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.3e-34  Score=304.30  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             CCCcCCeeecccceEEEEEEecC--CceEEEEEechh----------hHHHHHHHHHHHHHHHh-cCCCccceEeeeecC
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD--GMEVAVKVFHQQ----------YERALKSFEDECEVMKR-IRHRNLVKIISSCSN  684 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  684 (897)
                      .|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998764  688999987532          22344567788888875 689999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          685 DDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|+.||   |+ .|++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   335689999999999999999999   64 7899999999999999999999999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      ||.+.......   ......|+..|+|||...+..++.++||||||+++|||++|+.||.....     ....       
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~-------  222 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLA-------  222 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHH-------
Confidence            99998755332   22345688999999999888899999999999999999999999865210     0000       


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                       ..+..........      ......+.+++.+||+.|| ++||++.||.++++.
T Consensus       223 -~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p-~~Rp~~~e~~~~~~~  269 (269)
T cd08528         223 -TKIVEAVYEPLPE------GMYSEDVTDVITSCLTPDA-EARPDIIQVSAMISD  269 (269)
T ss_pred             -HHHhhccCCcCCc------ccCCHHHHHHHHHHCCCCC-ccCCCHHHHHHHhcC
Confidence             0111111000000      1123457889999999999 999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-34  Score=315.28  Aligned_cols=266  Identities=18%  Similarity=0.249  Sum_probs=194.2

Q ss_pred             cCCeeecc--cceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          621 ENNLIGIG--SFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       621 ~~~~lg~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.++||+|  +|++||+++.. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999765 68999999987543  334567788999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986542 4589999999999999999999   89999999999999999999999999998654332111100


Q ss_pred             -----eeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch-------
Q 045539          775 -----IQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS-------  840 (897)
Q Consensus       775 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  840 (897)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||....... ..........+..       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccccchh
Confidence                 1112346778999998865  458899999999999999999999997532211 1111111111000       


Q ss_pred             HHHHh--------hhhh----------cc-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VMEVI--------DTNL----------LR-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~~i--------~~~l----------~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+..        +...          .. ......+.......++.+++.+|++.|| ++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP-DARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCc-hhcCCHHHHhc
Confidence            00000        0000          00 0000001112234568899999999999 99999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.9e-34  Score=304.28  Aligned_cols=252  Identities=18%  Similarity=0.301  Sum_probs=185.7

Q ss_pred             CeeecccceEEEEEEecCC---ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          623 NLIGIGSFGSIYVARLQDG---MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3589999999999975433   346677665433 334578899999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          699 SLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       699 sL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +|.+++....   ...++..+..++.|+++||+||   |+.+++||||||+||+++.++.+||+|||.+...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999987642   3456777889999999999999   889999999999999999999999999999864322222122


Q ss_pred             eeccccCcccCCcCccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          776 QIQTLATIGYMAPEYGTK-------GRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .....++..|+|||+...       ..++.++||||||+++|||++ |..||.....     .+.+............++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcccccCCC
Confidence            234467889999998642       245789999999999999997 5667754211     111111000001111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+...          ...++.+++..|| .+| ++||+++||++.|.
T Consensus       233 ~~~~~----------~~~~~~~l~~~c~-~~P-~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLELP----------YSERWYEVLQFCW-LSP-EKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCC----------CcHHHHHHHHHHh-hCc-ccCCCHHHHHHHhc
Confidence            11111          2234677888999 679 99999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-34  Score=308.10  Aligned_cols=247  Identities=23%  Similarity=0.303  Sum_probs=199.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4666788999999999999765 57889999987443 344567899999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++...  .+++..+..++.|+++|++||   |++|++|+||+|+||++++++.++++|||++........  .
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence            999999988654  488999999999999999999   899999999999999999999999999999876543221  1


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....++..|+|||+..+..++.++||||||+++|||++|+.|+.......  ....            +........  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~------------~~~~~~~~~--  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL------------IPKNSPPTL--  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh------------hhcCCCCCC--
Confidence            123457889999999988889999999999999999999999986532111  0000            000000000  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                          .......+.+++.+|++.+| ++||++.||++.
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~~  253 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDP-RFRPTAKELLKH  253 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCc-ccCcCHHHHHHh
Confidence                01223457899999999999 999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-34  Score=311.43  Aligned_cols=267  Identities=19%  Similarity=0.219  Sum_probs=197.5

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5888899999999999999875 68999999986432  12235677899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++ ++|.+++......+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||.+........  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 578887766555689999999999999999999   889999999999999999999999999999876543221  


Q ss_pred             eeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch------HHHHhhh
Q 045539          775 IQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS------VMEVIDT  847 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i~~  847 (897)
                      ......++..|+|||++.+. .++.++|||||||++|||+||..|+.........+...........      ..+..+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            12234578899999987654 4689999999999999999999986442221111111111000000      0000000


Q ss_pred             hhcchhhhh---HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 NLLRGEERF---FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .........   .........++.+++.+|++.|| ++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNP-VQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCCh-hhcCCHHHHhc
Confidence            000000000   00111234567899999999999 99999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.8e-34  Score=304.54  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh----------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY----------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD  686 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  686 (897)
                      +|...+.||+|+||.||+|... +|+.||+|.++...          ....+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999765 68999999875321          112356788999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.||   |++|++||||+|+||+++.++.++++|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987764 588999999999999999999   889999999999999999999999999999876


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCC--CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGR--VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ..............|+..|+|||......  ++.++||||||+++||+++|..||......    ....         +.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~---------~~  224 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMF---------KL  224 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHH---------Hh
Confidence            54322222223345889999999876654  789999999999999999999998642110    0000         00


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..........  .....++...+.+++.+|+..|| ++|||++||++.
T Consensus       225 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~~  269 (272)
T cd06629         225 GNKRSAPPIP--PDVSMNLSPVALDFLNACFTINP-DNRPTARELLQH  269 (272)
T ss_pred             hccccCCcCC--ccccccCCHHHHHHHHHHhcCCh-hhCCCHHHHhhC
Confidence            0000000000  00011234568889999999999 999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.6e-34  Score=306.90  Aligned_cols=263  Identities=23%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999875 68999999986442  22346678899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ++ ++|.+++....  ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58888876433  5689999999999999999999   89999999999999999999999999999987654222 


Q ss_pred             eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc-------CCc-----
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL-------LPV-----  839 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~-----  839 (897)
                       .......+++.|+|||+..+ ..++.++||||||+++|||+||+.||....... .........       ++.     
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence             12223457889999998755 456889999999999999999999997531110 000000000       000     


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .............   ..........++.+++.+|+..|| ++|||+.||++
T Consensus       234 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP-~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGS---LRSAVKNLDEDGLDLLEKMLIYDP-AKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcch---hHHhcCCCCHHHHHHHHHHhcCCh-hhCCCHHHHhc
Confidence            0000000000000   000111234567899999999999 99999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.4e-34  Score=309.59  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecC
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSN  684 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  684 (897)
                      +..+++..+.++|.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444566667889999999999999999999875 68899999986542 2235677899999999 79999999999864


Q ss_pred             C-----CceEEEEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          685 D-----DFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       685 ~-----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      .     +..++||||+++++|.+++..   ....+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998753   234689999999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-----CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhH
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR  831 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~  831 (897)
                      ||+|||.+........  ......|+..|+|||.+...     .++.++|||||||++|||++|+.||...... ....+
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK  244 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH
Confidence            9999999876543221  11234588999999986543     3688999999999999999999998753111 00111


Q ss_pred             HhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          832 WINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       832 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +... .+.        .+        ...++....+.+++.+|++.|| ++||++.|+++.
T Consensus       245 ~~~~-~~~--------~~--------~~~~~~~~~l~~li~~~l~~~p-~~Rps~~~il~~  287 (291)
T cd06639         245 IPRN-PPP--------TL--------LHPEKWCRSFNHFISQCLIKDF-EARPSVTHLLEH  287 (291)
T ss_pred             HhcC-CCC--------CC--------CcccccCHHHHHHHHHHhhcCh-hhCcCHHHHhcC
Confidence            0000 000        00        0011233458899999999999 999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.4e-37  Score=325.29  Aligned_cols=307  Identities=28%  Similarity=0.432  Sum_probs=269.1

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCC-ccccccccccccEEEe
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS-LSFFIFNVSSVTTIDL  155 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~LdL  155 (897)
                      +++-|.|...+|. .+|..++.|.+|++|.+++|++. .+-.+++.|+.|+.+++.+|++..+ +|..+..+..|++|||
T Consensus        33 ~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDL  110 (1255)
T KOG0444|consen   33 QMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDL  110 (1255)
T ss_pred             heeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeec
Confidence            5777888888887 89999999999999999999998 6778899999999999999999754 7888999999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      |+|+++ +.|..+..-+++..|+||+|+|..++...|-+++.|-.||||+|++. .+|+.+- .+..|++|.|++|.+..
T Consensus       111 ShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R-RL~~LqtL~Ls~NPL~h  187 (1255)
T KOG0444|consen  111 SHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR-RLSMLQTLKLSNNPLNH  187 (1255)
T ss_pred             chhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHH-HHhhhhhhhcCCChhhH
Confidence            999999 89999999999999999999999998888999999999999999998 8888876 78999999999999987


Q ss_pred             cccccccCCCcccEEEccccccc-cccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCch
Q 045539          236 TVPSSITNASKLSDLELGVNLFS-GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS  314 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  314 (897)
                      .--..+..+++|+.|.+++.+-+ ..+|                     .++..+.+|..+|+|.|.+.           
T Consensus       188 fQLrQLPsmtsL~vLhms~TqRTl~N~P---------------------tsld~l~NL~dvDlS~N~Lp-----------  235 (1255)
T KOG0444|consen  188 FQLRQLPSMTSLSVLHMSNTQRTLDNIP---------------------TSLDDLHNLRDVDLSENNLP-----------  235 (1255)
T ss_pred             HHHhcCccchhhhhhhcccccchhhcCC---------------------CchhhhhhhhhccccccCCC-----------
Confidence            66677788899999999876543 2222                     34677788888888888776           


Q ss_pred             HHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccc
Q 045539          315 LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVL  394 (897)
Q Consensus       315 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  394 (897)
                                     .+|+.+-++.+|+.|+||+|+|+. .....+...+|++|+||+|+++ ..|+++|.+++|+.|++
T Consensus       236 ---------------~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~  298 (1255)
T KOG0444|consen  236 ---------------IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA  298 (1255)
T ss_pred             ---------------cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence                           568888899999999999999997 4555677889999999999999 79999999999999999


Q ss_pred             cccccc-cCCCcccccccccceeccccccccCCccccccccccce
Q 045539          395 QGNKFS-GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL  438 (897)
Q Consensus       395 ~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  438 (897)
                      .+|+++ .-+|+.++.+.+|+.+..++|.+. .+|..++.|..|+
T Consensus       299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~  342 (1255)
T KOG0444|consen  299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQ  342 (1255)
T ss_pred             ccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHH
Confidence            999986 347999999999999999999987 5666666655555

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=339.73  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=195.2

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCce
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFK  688 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  688 (897)
                      ...++|.+.+.||+|+||+||+|++. ++..||+|++...  .......+..|+.++++++||||++++++|.+  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44678999999999999999999876 5778999988643  23345778899999999999999999998844  4568


Q ss_pred             EEEEEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCcEeCCCCCCCeeeCC---------
Q 045539          689 ALIMKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGH----STPIIHCDLKPSNVLLDE---------  752 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h----~~~ivH~Dlkp~NIll~~---------  752 (897)
                      |+||||+++++|.+++...   ...+++..++.|+.||+.||+|||...    .++||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999988653   246899999999999999999995311    156999999999999964         


Q ss_pred             --------CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          753 --------DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       753 --------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                              .+.+||+|||++.......   ......||+.|+|||++..  ..++.++||||||||+|||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    2358999999998654322   1234568999999998753  45789999999999999999999999642


Q ss_pred             ccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          823 FIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .    .....+         ..+..    .+...   ......++.+++..||+.+| .+||++.|++.
T Consensus       247 ~----~~~qli---------~~lk~----~p~lp---i~~~S~eL~dLI~~~L~~dP-eeRPSa~QlL~  294 (1021)
T PTZ00266        247 N----NFSQLI---------SELKR----GPDLP---IKGKSKELNILIKNLLNLSA-KERPSALQCLG  294 (1021)
T ss_pred             C----cHHHHH---------HHHhc----CCCCC---cCCCCHHHHHHHHHHhcCCh-hHCcCHHHHhc
Confidence            1    111111         11110    00000   00123457899999999999 99999999984

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-33  Score=300.71  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCce
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFK  688 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  688 (897)
                      .+|...+.||+|+||.||+|... +++.||+|++....     .+..+.+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999865 58999999886431     2345678899999999999999999998865  3577


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      +++|||+++++|.+++.... .+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987654 478999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .... ........++..|+|||+..+..++.++||||+||++||+++|+.||.......             ....... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-------------~~~~~~~-  223 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-------------AIFKIAT-  223 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------------HHHHHhc-
Confidence            2111 111123457889999999988889999999999999999999999997521110             0001000 


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        ........   ......+.+++ +||..+| ++||+++||++
T Consensus       224 --~~~~~~~~---~~~~~~~~~li-~~~~~~p-~~Rp~~~eil~  260 (266)
T cd06651         224 --QPTNPQLP---SHISEHARDFL-GCIFVEA-RHRPSAEELLR  260 (266)
T ss_pred             --CCCCCCCc---hhcCHHHHHHH-HHhcCCh-hhCcCHHHHhc
Confidence              00000001   11223345555 6888999 99999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.7e-34  Score=305.99  Aligned_cols=267  Identities=21%  Similarity=0.231  Sum_probs=202.2

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|++.+.||+|++|.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999875 68999999987543  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      + +++|.+++......+++.++..++.|+++||+||   |+.|++|+||||+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 9999999876666799999999999999999999   889999999999999999999999999999887653321 1


Q ss_pred             eeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch----HHHHh---h
Q 045539          775 IQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS----VMEVI---D  846 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~i---~  846 (897)
                      ......|+..|+|||+..+. .++.++||||+|+++|||++|+.||......  .....+.......    ..+..   +
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCcch
Confidence            12234688999999987554 4689999999999999999998777542111  1111111111000    00000   0


Q ss_pred             --h-hhcchhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          847 --T-NLLRGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       847 --~-~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        . .......... ....+....+.+++.+|++.|| ++|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p-~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDP-SKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccCh-hhCCCHHHHhhC
Confidence              0 0000000000 0111234678999999999999 999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=315.87  Aligned_cols=248  Identities=22%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             CcCCeeecccceEEEEEEec--CCc--eEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          620 SENNLIGIGSFGSIYVARLQ--DGM--EVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ...++||+|.||.|++|.|.  .|+  .||||.++..... ....|.+|+.+|.+++|||++++||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999876  344  4899999866533 67899999999999999999999999987 677899999


Q ss_pred             ccCCChhHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ++.|+|.+++++ ....+-......++.|||.|+.||   .+++.||||+..+|+++.....+||+|||+.+.++..+..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999988 456788889999999999999999   9999999999999999999999999999999988766554


Q ss_pred             eeee-ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          774 SIQI-QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       774 ~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      +... ...-...|+|||.+....++.++|||+|||++|||+| |..||....              +..+.+.+|..   
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------------g~qIL~~iD~~---  331 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------------GIQILKNIDAG---  331 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------------HHHHHHhcccc---
Confidence            4333 3345678999999999999999999999999999999 788987621              11233334411   


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .|.+..+.|.+++.+++..||...| ++|||+..+.+.
T Consensus       332 ---erLpRPk~csedIY~imk~cWah~p-aDRptFsair~~  368 (1039)
T KOG0199|consen  332 ---ERLPRPKYCSEDIYQIMKNCWAHNP-ADRPTFSAIRED  368 (1039)
T ss_pred             ---ccCCCCCCChHHHHHHHHHhccCCc-cccccHHHHHHh
Confidence               1233334677889999999999999 999999999643

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-34  Score=308.63  Aligned_cols=269  Identities=19%  Similarity=0.215  Sum_probs=196.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++++++.+++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999765 689999999865432 22345678999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+. +++.+++......+++.++..++.|++.||+||   |+.||+|+||||+||+++.++.+||+|||.++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 677777665555578888999999999999999   889999999999999999999999999999875432221


Q ss_pred             eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-cCCch----------
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-LLPVS----------  840 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~----------  840 (897)
                        ......+++.|+|||+..+ ..++.++||||||+++|||++|+.||+........+.+.... ..+..          
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              1123357889999998765 357889999999999999999999997532211111111000 00000          


Q ss_pred             --HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 --VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 --~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        ..+................. .....+.+++.+|+..|| ++|||++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp-~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFP-KDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhcccc-CCChHHHHHHHHHhCcCc-ccCcCHHHHhc
Confidence              00000000000000000000 012457789999999999 99999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-34  Score=306.86  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||++++++++.++...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999876 58999999886432  2234567899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++++++..+..... .+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999998888765543 589999999999999999999   889999999999999999999999999999987654321 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccc--hhHHhhhcCCchHHHHhhh---
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS--LNRWINDLLPVSVMEVIDT---  847 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~---  847 (897)
                       ......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+..  .........+ ...+..+.   
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhcccccc
Confidence             1223457889999998765 45788999999999999999999999753221100  0000000000 00000000   


Q ss_pred             ---hhcchhhh---hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 ---NLLRGEER---FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ---~l~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .....+..   ...........+.+++.+|++.|| ++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p-~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP-TERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCc-cccCCHHHHhcC
Confidence               00000000   000111234568899999999999 999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.1e-34  Score=300.38  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=199.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5778899999999999999876 78999999886532     23457789999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.|++||   |+.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 588999999999999999999   88999999999999999999999999999987654332


Q ss_pred             ceeeeeccccCcccCCcCccCCCC-CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ......|+..|+|||...... ++.++|+||||+++|+|++|+.||......     ..        .......   
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~--------~~~~~~~---  217 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AA--------VFKIGRS---  217 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HH--------HHHHHhc---
Confidence               123455889999999877666 899999999999999999999998763210     00        0000000   


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......   .......+.+++.+||+.+| ++||+++|+++.
T Consensus       218 ~~~~~~---~~~~~~~~~~li~~~l~~~p-~~Rp~~~~~l~~  255 (258)
T cd06632         218 KELPPI---PDHLSDEAKDFILKCLQRDP-SLRPTAAELLEH  255 (258)
T ss_pred             ccCCCc---CCCcCHHHHHHHHHHhhcCc-ccCcCHHHHhcC
Confidence            000000   01123457889999999999 999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.3e-34  Score=307.28  Aligned_cols=265  Identities=20%  Similarity=0.251  Sum_probs=199.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-----HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-----RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +|...+.||+|++|.||+|... +|+.||+|+++....     .....+.+|++++++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999865 689999999875432     2345677899999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+ +++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8999999877655689999999999999999999   89999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch----HH----
Q 045539          772 QLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS----VM----  842 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~----  842 (897)
                      .  ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ........ .....    ..    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~  232 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE-ALGTPTEENWPGVTS  232 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH-HcCCCchhhhhhccc
Confidence            1  1223346788999998754 46789999999999999999997777542111 11111111 00000    00    


Q ss_pred             --HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          843 --EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       843 --~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        ............ ..........++.+++.+|++.|| ++|||++||++.
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P-~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTP-LKQIFPAASDDALDLLQRLLTLNP-NKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcc-hhhhcccccHHHHHHHHHHhcCCc-ccCcCHHHHhhC
Confidence              000000000000 001112234568899999999999 999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=305.65  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCC------
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDD------  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  686 (897)
                      .+++|++.+.||+|++|.||+|... +++.|++|++..... ..+.+.+|+++++++ +||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999875 578999999875533 346788999999999 6999999999996544      


Q ss_pred             ceEEEEEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          687 FKALIMKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||+||   |+.|++||||+|+||++++++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            589999999999999987643   35689999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      +.......  .......|+..|+|||++..     ..++.++||||||+++|+|++|+.||...... ...         
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~---------  227 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL---------  227 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH---------
Confidence            87654222  12233458899999997643     34678999999999999999999999652111 000         


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         ..+..    .... ..........++.+++.+|+..|| ++|||++|+++
T Consensus       228 ---~~~~~----~~~~-~~~~~~~~~~~~~~li~~~l~~dp-~~Rpt~~~ll~  271 (275)
T cd06608         228 ---FKIPR----NPPP-TLKSPENWSKKFNDFISECLIKNY-EQRPFMEELLE  271 (275)
T ss_pred             ---HHhhc----cCCC-CCCchhhcCHHHHHHHHHHhhcCh-hhCcCHHHHhc
Confidence               11110    0000 001112234567899999999999 99999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-34  Score=311.14  Aligned_cols=247  Identities=24%  Similarity=0.304  Sum_probs=196.9

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      .....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33457999999999999865 68999999987554444567889999999999999999999999999999999999999


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeec
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ  778 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~  778 (897)
                      +|.+++...  .+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||++........  ....
T Consensus       104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  176 (297)
T cd06659         104 ALTDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS  176 (297)
T ss_pred             CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence            999877653  488999999999999999999   899999999999999999999999999999875543221  1223


Q ss_pred             cccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHH
Q 045539          779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFA  858 (897)
Q Consensus       779 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  858 (897)
                      ..|+..|+|||+..+..++.++|||||||++|||++|+.||......  .....+.......                ..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~----------------~~  238 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPK----------------LK  238 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCC----------------cc
Confidence            46889999999998888999999999999999999999998642110  0001110000000                00


Q ss_pred             HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          859 AKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       859 ~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ........+.+++.+|++.+| ++||+++|+++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P-~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREP-QERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCc-ccCcCHHHHhhC
Confidence            011123447889999999999 999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-34  Score=308.08  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=202.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|||++++++++..++..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            68999999999999999999764 68899999987554445577889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++....  +++.++..++.|++.|++||   |++|++||||||+||+++.++.+||+|||.+........  .
T Consensus        99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            9999999987653  78899999999999999999   899999999999999999999999999998876543322  1


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....+++.|+|||......++.++||||||+++|++++|+.||......... ....               ..+.+  
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~---------------~~~~~--  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIA---------------TNGTP--  233 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehh---------------cCCCC--
Confidence            22345888999999988888899999999999999999999999753211100 0000               00000  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+.....+.+++.+||..+| ++||++++++..
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p-~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDV-EKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            001111233457889999999999 999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=283.21  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEecc
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .....||.|..|.||+++.+ +|...|||.+.+.. .+..+++...++++.+.. +|.||+.+|||..+...++.||.| 
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence            34567999999999999876 58999999987654 455678888888887775 899999999999999999999998 


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      ...++..+..-..++++.-+-++...+.+||.||.  .++||+|||+||+|||+|+.|++|+||||++-.+-+..   ..
T Consensus       174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Ah  248 (391)
T KOG0983|consen  174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AH  248 (391)
T ss_pred             HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCCEEeecccccceeeccc---cc
Confidence            44566666665667888888899999999999997  67789999999999999999999999999997765433   23


Q ss_pred             eccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          777 IQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      +...|.+.|||||-+.   ...|+.++||||||++++|+.||+.||.....+                .+++.+.+..++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----------------Fe~ltkvln~eP  312 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----------------FEVLTKVLNEEP  312 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----------------HHHHHHHHhcCC
Confidence            4556999999999764   457889999999999999999999999873222                233333333333


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +. .+........+.+++..|+++|+ .+||...++++.
T Consensus       313 P~-L~~~~gFSp~F~~fv~~CL~kd~-r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 PL-LPGHMGFSPDFQSFVKDCLTKDH-RKRPKYNKLLEH  349 (391)
T ss_pred             CC-CCcccCcCHHHHHHHHHHhhcCc-ccCcchHHHhcC
Confidence            22 22222255678899999999999 999999988763

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=311.76  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=200.5

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999876 489999999875432   24567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||+.+++|.+++.... ..+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987543 5689999999999999999999   89999999999999999999999999999987543211


Q ss_pred             cee---------------------------eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccccc
Q 045539          772 QLS---------------------------IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFI  824 (897)
Q Consensus       772 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~  824 (897)
                      ...                           ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                           01123578899999999888899999999999999999999999975321


Q ss_pred             CccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC----HHHHHh
Q 045539          825 GELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD----MGWIFS  891 (897)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt----~~evl~  891 (897)
                      . ..            ...+......-      +........+.+++.+|+..|| ++|||    ++|+++
T Consensus       238 ~-~~------------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p-~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D-ET------------FSNILKKEVTF------PGSPPVSSSARDLIRKLLVKDP-SKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H-HH------------HHHHhcCCccC------CCccccCHHHHHHHHHHccCCH-hHCCCchhhHHHHHc
Confidence            1 00            11111111100      0011134568999999999999 99999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-34  Score=306.01  Aligned_cols=269  Identities=19%  Similarity=0.226  Sum_probs=198.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            368999999999999999999876 689999999875432 223456789999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ +|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+........ 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9975 89998877666789999999999999999999   899999999999999999999999999999875432111 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh---cCCchHHHHhhh--
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND---LLPVSVMEVIDT--  847 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~--  847 (897)
                       ......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.........+......   ..+.........  
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346888999998765 457899999999999999999999996532111111111000   000000000000  


Q ss_pred             ----hhcch-hhhhHHHHHHH--HHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 ----NLLRG-EERFFAAKEQI--LLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ----~l~~~-~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          ..... ...........  ...+.+++.+|++.|| ++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p-~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEP-KKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCc-ccccCHHHHhc
Confidence                00000 00000000111  1456889999999999 99999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.3e-34  Score=306.54  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=200.8

Q ss_pred             CHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecC-
Q 045539          608 SYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSN-  684 (897)
Q Consensus       608 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  684 (897)
                      ++.++....+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45566667789999999999999999999875 58899999986543 2345678899999998 69999999999853 


Q ss_pred             -----CCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          685 -----DDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       685 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                           .+..|++|||+++++|.+++.... ..+++..+..++.|++.|++||   |+.||+||||||+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999887643 4578888999999999999999   8899999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      +|||.+........  ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||.......    .  
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~--  234 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----A--  234 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----h--
Confidence            99999875532211  122346889999999865     3467889999999999999999999996521110    0  


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                             ...... ......     ........+.+++.+||+.|| .+|||+.|+++
T Consensus       235 -------~~~~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~~p-~~Rp~~~ell~  278 (282)
T cd06636         235 -------LFLIPR-NPPPKL-----KSKKWSKKFIDFIEGCLVKNY-LSRPSTEQLLK  278 (282)
T ss_pred             -------hhhHhh-CCCCCC-----cccccCHHHHHHHHHHhCCCh-hhCcCHHHHhc
Confidence                   000000 000000     001233468899999999999 99999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-33  Score=305.55  Aligned_cols=244  Identities=27%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999876 58999999987543   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987764 589999999999999999999   8899999999999999999999999999999876433  


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....+++.|+|||...+...+.++||||||+++|+|++|+.||......  ..           ...+...... -
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~-----------~~~~~~~~~~-~  217 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QI-----------YEKILEGKVR-F  217 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HH-----------HHHHhcCCcc-C
Confidence               22345889999999988888899999999999999999999998652200  00           0011110000 0


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      +       ......+.+++.+||..|| .+||     +++|+++
T Consensus       218 ~-------~~~~~~l~~li~~~l~~~p-~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 P-------SFFSPDAKDLIRNLLQVDL-TKRLGNLKNGVNDIKN  253 (290)
T ss_pred             C-------ccCCHHHHHHHHHHccCCH-HHccCcccCCHHHHHc
Confidence            0       0113457889999999999 9999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.2e-34  Score=300.41  Aligned_cols=248  Identities=23%  Similarity=0.420  Sum_probs=199.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|+..+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999765 68899999986542  33457888999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|.+++.... ..+++..+..++.++++|++||   |++|++||||+|+||+++++ +.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997653 4589999999999999999999   89999999999999999855 4689999999987643321


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....++..|+|||...+..++.++||||||+++|+|++|+.||......     ..        ............
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~--------~~~~~~~~~~~~  221 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----AL--------VLKIMSGTFAPI  221 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HH--------HHHHHhcCCCCC
Confidence               12345788999999998888899999999999999999999998652111     00        111111000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +       ......+.+++.+||+.|| ++|||++|+++.
T Consensus       222 ~-------~~~~~~l~~li~~~l~~~p-~~Rpt~~~ll~~  253 (256)
T cd08220         222 S-------DRYSPDLRQLILSMLNLDP-SKRPQLSQIMAQ  253 (256)
T ss_pred             C-------CCcCHHHHHHHHHHccCCh-hhCCCHHHHhhC
Confidence            0       1233457899999999999 999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-33  Score=297.62  Aligned_cols=250  Identities=28%  Similarity=0.373  Sum_probs=204.8

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      +|+..+.||+|++|.||+|... +++.|++|++........+.+.+|++++++++||+++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999876 689999999987655556788999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++......+++..+..++.|++.|+++|   |+.|++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            9999999887655689999999999999999999   889999999999999999999999999999987654332   2


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....++..|+|||......++.++||||||+++|+|++|+.||......     +.         ......   ..... 
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~---------~~~~~~---~~~~~-  216 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KA---------LFKIAT---NGPPG-  216 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HH---------HHHHHh---cCCCC-
Confidence            3445889999999988888999999999999999999999998752110     00         000000   00000 


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..........+.+++.+|++.|| ++|||+.|+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p-~~R~t~~~~l~~  251 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNP-EKRPTAEQLLKH  251 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCCh-hhCCCHHHHhcC
Confidence            00001123458899999999999 999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.7e-33  Score=299.59  Aligned_cols=251  Identities=21%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--Cce
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFK  688 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  688 (897)
                      ++|++.+.||+|+||.||.|... +|+.||+|++....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999875 58999999875321     23456788999999999999999999998764  467


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+|+||||+||+++.++.+||+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 478889999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ..... .......|+..|+|||+..+..++.++||||||+++|||++|+.||....... .            ..+... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~------------~~~~~~-  223 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-A------------IFKIAT-  223 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-H------------HHHHhc-
Confidence            21111 11123458899999999888889999999999999999999999986521110 0            000000 


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        .......   .......+.+++.+|+ .+| ++||+++||++.
T Consensus       224 --~~~~~~~---~~~~~~~~~~~i~~~l-~~p-~~Rp~~~~il~~  261 (265)
T cd06652         224 --QPTNPVL---PPHVSDHCRDFLKRIF-VEA-KLRPSADELLRH  261 (265)
T ss_pred             --CCCCCCC---chhhCHHHHHHHHHHh-cCh-hhCCCHHHHhcC
Confidence              0000000   1122345677888888 499 999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=303.74  Aligned_cols=248  Identities=24%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4555679999999999999864 688999999875554555678899999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++...  .+++.++..++.|++.|++||   |++|++||||+|+||+++.++.++|+|||.+........  ..
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            99999998773  489999999999999999999   899999999999999999999999999998875543221  12


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....|++.|+|||...+..++.++||||||+++|||++|+.||.....     ...+         ..+........   
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~---------~~~~~~~~~~~---  235 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAM---------KRIRDNLPPKL---  235 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHH---------HHHHhcCCCCC---
Confidence            234588999999998888899999999999999999999999864211     0000         00000000000   


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       .........+.+++.+||+.+| ++|||+.|+++
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p-~~Rpt~~~il~  268 (285)
T cd06648         236 -KNLHKVSPRLRSFLDRMLVRDP-AQRATAAELLN  268 (285)
T ss_pred             -cccccCCHHHHHHHHHHcccCh-hhCcCHHHHcc
Confidence             0001123468899999999999 99999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=303.28  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=198.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC---CCccceEeeeecCCCceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR---HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .|+..+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999864 68999999986542 344567889999999997   999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++...  .+++..+..++.|++.||+||   |+.||+||||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998764  589999999999999999999   899999999999999999999999999999987654331


Q ss_pred             eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        ......|+..|+|||....+ .++.++||||||+++|+|++|+.||......     .........     ..+.+..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~-----~~~~~~~  224 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKS-----KPPRLED  224 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccC-----CCCCCCc
Confidence              22334688999999987654 4688999999999999999999999753111     111000000     0000000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               .....++.+++.+|++.|| ++||++.|+++.
T Consensus       225 ---------~~~~~~~~~~i~~~l~~~p-~~R~~~~~il~~  255 (277)
T cd06917         225 ---------NGYSKLLREFVAACLDEEP-KERLSAEELLKS  255 (277)
T ss_pred             ---------ccCCHHHHHHHHHHcCCCc-ccCcCHHHHhhC
Confidence                     0123457899999999999 999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-33  Score=303.90  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=205.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++.|+..+.||+|++|.||+|.+. +++.|++|++..... ..+.+.+|++++++++|+|++++++++..++..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999876 689999999976544 45678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            9999999999987654689999999999999999999   899999999999999999999999999998876543221 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......++..|+|||+..+..++.++||||||+++|+|++|+.||...... ...            ..........  
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~------------~~~~~~~~~~--  235 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RAL------------FLITTKGIPP--  235 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHH------------HHHHhcCCCC--
Confidence             112335788999999988888999999999999999999999998652111 000            0000000000  


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ......+...+.+++.+|++.+| .+|||+.++++.
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~p-~~Rpt~~~il~~  270 (286)
T cd06614         236 ---LKNPEKWSPEFKDFLNKCLVKDP-EKRPSAEELLQH  270 (286)
T ss_pred             ---CcchhhCCHHHHHHHHHHhccCh-hhCcCHHHHhhC
Confidence               01111234568899999999999 999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-33  Score=307.21  Aligned_cols=194  Identities=22%  Similarity=0.305  Sum_probs=157.9

Q ss_pred             CCeeecccceEEEEEEec---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeec--CCCceEEEEEecc
Q 045539          622 NNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS--NDDFKALIMKYMP  696 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~  696 (897)
                      ..+||+|+||.||+|+..   +++.||+|.+.....  ...+.+|++++++++||||+++++++.  .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999865   357899998875422  245678999999999999999999884  4567899999986


Q ss_pred             CCChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----CCCCcEEEeeccCc
Q 045539          697 NGSLENCLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIA  764 (897)
Q Consensus       697 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a  764 (897)
                      + +|.+++...        ...+++..+..++.|++.||+||   |+.||+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 776665421        13478889999999999999999   89999999999999999    56679999999999


Q ss_pred             cccCCCCce-eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          765 KLLSGEDQL-SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       765 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      +........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433211 11233468999999998766 4578999999999999999999999965

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-33  Score=300.23  Aligned_cols=252  Identities=28%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|...+.||+|+||.||+|... +++.||+|.++....  ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999865 689999999875543  3567889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++.... .+++..+..++.|++.|++||   |+.||+|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987754 478899999999999999999   89999999999999999999999999999988765333211


Q ss_pred             e--eeccccCcccCCcCccCCCC---CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          775 I--QIQTLATIGYMAPEYGTKGR---VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       775 ~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .  .....++..|+|||++....   .+.++||||||+++||+++|+.||....... .....+..              
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~--------------  221 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA--------------  221 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc--------------
Confidence            1  11345788999999987766   8899999999999999999999997521110 00000000              


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       .... ..+........+.+++.+|++.|| ++|||++|+++
T Consensus       222 -~~~~-~~~~~~~~~~~~~~li~~~l~~~p-~~R~~~~~i~~  260 (264)
T cd06626         222 -GHKP-PIPDSLQLSPEGKDFLDRCLESDP-KKRPTASELLQ  260 (264)
T ss_pred             -CCCC-CCCcccccCHHHHHHHHHHccCCc-ccCCCHHHHhc
Confidence             0000 001111223456789999999999 99999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=298.59  Aligned_cols=246  Identities=22%  Similarity=0.310  Sum_probs=201.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +.|+.-++||+|+||.||-++.+ +|+.||.|.+.+..   .....-..+|-.|+++++.+.||.+-..|+..+..|+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            46777889999999999999765 69999999886543   223445678999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ..|+||+|.-.+...+ +.+++..+.-++.+|+.||++|   |+.+||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999998887655 5699999999999999999999   99999999999999999999999999999999886544


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .   ....+||.+|||||++.++.|+...|-||+||++|||+.|+.||......              .-.+-++++...
T Consensus       342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEvdrr~~~  404 (591)
T KOG0986|consen  342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEVDRRTLE  404 (591)
T ss_pred             c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHHHHHHhc
Confidence            3   23458999999999999999999999999999999999999999763111              012344444444


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      .+....   +...++..++....++.|| ++|-..
T Consensus       405 ~~~ey~---~kFS~eakslc~~LL~Kdp-~~RLGc  435 (591)
T KOG0986|consen  405 DPEEYS---DKFSEEAKSLCEGLLTKDP-EKRLGC  435 (591)
T ss_pred             chhhcc---cccCHHHHHHHHHHHccCH-HHhccC
Confidence            333222   2334455667777789999 888643

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-33  Score=304.50  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|...+.||+|+||.||+|... +|+.||+|++....   .+..+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888999999999999999865 68999999886332   334467889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||++ |++.+.+......+++..+..++.|++.||.||   |+.||+||||+|+||++++++.+||+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 577777665455689999999999999999999   8999999999999999999999999999998765422  


Q ss_pred             eeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          773 LSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                          ....++..|+|||++.   .+.++.++||||||+++|||++|+.||.......  .           ...+..   
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~-----------~~~~~~---  228 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A-----------LYHIAQ---  228 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--H-----------HHHHhc---
Confidence                1345788999999863   4568899999999999999999999986521110  0           000000   


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...+. .  .......++.+++.+||+.|| ++||++.+|++.
T Consensus       229 ~~~~~-~--~~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~~  267 (307)
T cd06607         229 NDSPT-L--SSNDWSDYFRNFVDSCLQKIP-QDRPSSEELLKH  267 (307)
T ss_pred             CCCCC-C--CchhhCHHHHHHHHHHhcCCh-hhCcCHHHHhcC
Confidence            00000 0  001234568899999999999 999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-33  Score=302.10  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=196.0

Q ss_pred             CCcCCeeecccceEEEEEEec----CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          619 FSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++....  ....+.+.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999753    36889999987542  334567889999999999999999999885432      


Q ss_pred             ceEEEEEeccCCChhHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          687 FKALIMKYMPNGSLENCLYSG-----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      ..++++||+++++|.+++...     ...+++..+..++.|++.|++||   |+.||+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998886432     13478889999999999999999   8899999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCch
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      |.++...............+++.|++||......++.++||||||+++|||++ |+.||.....  .....++....   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~---  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN---  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC---
Confidence            99986643322222223345678999999988889999999999999999999 8888865211  11111111100   


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             .....        ......+.+++.+|++.+| ++||++.|+++.|++
T Consensus       233 -------~~~~~--------~~~~~~~~~l~~~~l~~~p-~~Rps~~~~~~~l~~  271 (273)
T cd05074         233 -------RLKQP--------PDCLEDVYELMCQCWSPEP-KCRPSFQHLRDQLEL  271 (273)
T ss_pred             -------cCCCC--------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHh
Confidence                   00000        1123468899999999999 999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-33  Score=298.28  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=200.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  692 (897)
                      +|++.+.||.|+||.||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5788899999999999999764 6889999988643  23445678899999999999999999998753  45678999


Q ss_pred             EeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          693 KYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       693 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h--~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||..+  +.+++||||||+||+++.++.+||+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   356899999999999999999993221  999999999999999999999999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .....  ......+++.|+|||...+..++.++||||||+++|+|++|+.||....  .....+.            +..
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~------------~~~  224 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASK------------IKE  224 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHH------------Hhc
Confidence            54332  1223468999999999988889999999999999999999999987531  1111111            111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......+      .....++.+++.+|++.+| ++||++.||++.
T Consensus       225 ~~~~~~~------~~~~~~~~~l~~~~l~~~p-~~Rp~~~~il~~  262 (265)
T cd08217         225 GKFRRIP------YRYSSELNEVIKSMLNVDP-DKRPSTEELLQL  262 (265)
T ss_pred             CCCCCCc------cccCHHHHHHHHHHccCCc-ccCCCHHHHhhC
Confidence            1000000      1233567899999999999 999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.3e-34  Score=306.17  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=199.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999876 589999998765432  234677899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++++++.++..... .+++.++..++.|+++||+||   |+.|++|||++|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999999988765543 489999999999999999999   889999999999999999999999999999876543321 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh--hhcCCchHHHHhh----
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI--NDLLPVSVMEVID----  846 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~i~----  846 (897)
                       ......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ....+..  ............+    
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence             1223457889999998765 45688999999999999999999988642110 0000000  0001111111110    


Q ss_pred             --hhhcchhh---hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 --TNLLRGEE---RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 --~~l~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        ........   ............+.+++.+||+.+| ++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDP-DDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCc-ccchhHHHHhc
Confidence              00000000   0000111334668899999999999 99999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-33  Score=297.65  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=205.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999876 489999999876543 4467889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++... ..+++..+..++.|+++|++||   |+ .|++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999998765 3589999999999999999999   88 99999999999999999999999999998876433221


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                        .....++..|+|||......++.++||||||+++|+|++|+.||......  .            ..+.+........
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~------------~~~~~~~~~~~~~  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S------------FFELMQAICDGPP  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C------------HHHHHHHHhcCCC
Confidence              12345788999999998888999999999999999999999999763220  0            0111111111000


Q ss_pred             hhhHHHHHH-HHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQ-ILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~-~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..   .... ....+.+++.+|+..+| ++||++.|+++.
T Consensus       221 ~~---~~~~~~~~~l~~li~~~l~~~p-~~R~~~~~ll~~  256 (264)
T cd06623         221 PS---LPAEEFSPEFRDFISACLQKDP-KKRPSAAELLQH  256 (264)
T ss_pred             CC---CCcccCCHHHHHHHHHHccCCh-hhCCCHHHHHhC
Confidence            00   0011 34568899999999999 999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.1e-34  Score=330.26  Aligned_cols=256  Identities=24%  Similarity=0.327  Sum_probs=193.4

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecC------
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSN------  684 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  684 (897)
                      .+...+|+..+.||+||||.||+++.+ ||+.||||++... .......+.+|++.+++++|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456778899999999999999999987 8999999998754 34456778899999999999999998743210      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 045539          685 ------------------------------------------------------------------------D-------  685 (897)
Q Consensus       685 ------------------------------------------------------------------------~-------  685 (897)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 045539          686 ----------------------------------DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH  731 (897)
Q Consensus       686 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh  731 (897)
                                                        ...||-||||+..++.+++..+...-.....++++++|++||+|+ 
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI-  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI-  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH-
Confidence                                              024788999999888888877663225778899999999999999 


Q ss_pred             hcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC----------------CCCceeeeeccccCcccCCcCccCCC-
Q 045539          732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS----------------GEDQLSIQIQTLATIGYMAPEYGTKG-  794 (897)
Q Consensus       732 ~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~-  794 (897)
                        |++|||||||||.||++|+++.|||+|||+|+...                ........+..+||.-|+|||++.+. 
T Consensus       714 --H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  714 --HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             --HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence              99999999999999999999999999999998721                01112234567899999999987654 


Q ss_pred             --CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHh
Q 045539          795 --RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLAT  872 (897)
Q Consensus       795 --~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~  872 (897)
                        .|+.|+|+||+|||++||+   .||.........+...-...+|.+ .++.+               .....-.+++.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-~~f~~---------------~~~~~e~slI~  852 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-ADFFD---------------PEHPEEASLIR  852 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-ccccc---------------ccchHHHHHHH
Confidence              4999999999999999999   456553222111111111111211 11111               11122367889


Q ss_pred             HccCCCCCCCCCCHHHHHh
Q 045539          873 ECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       873 ~cl~~dP~~~RPt~~evl~  891 (897)
                      +++++|| .+||||.|++.
T Consensus       853 ~Ll~hdP-~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDP-SKRPTATELLN  870 (1351)
T ss_pred             HHhcCCC-ccCCCHHHHhh
Confidence            9999999 99999999985

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.2e-34  Score=302.37  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      +|++.+.||.|+||.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999876 58999999987543   2446788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++... ..+++.++..++.|+++||+||   |+.|++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998776 3589999999999999999999   88999999999999999999999999999987664332  


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......|+..|+|||+.....++.++||||+|+++|+|++|+.||......   ....        ............+
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~--------~~~~~~~~~~~~~  222 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQ--------IRAKQETADVLYP  222 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHH--------HHHHhccccccCc
Confidence             123345888999999988888999999999999999999999998763211   0011        1111110000001


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH--HHHH
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADM--GWIF  890 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~--~evl  890 (897)
                             ......+.+++.+||+.|| .+||++  +|++
T Consensus       223 -------~~~~~~~~~~i~~~l~~~p-~~R~~~~~~~l~  253 (258)
T cd05578         223 -------ATWSTEAIDAINKLLERDP-QKRLGDNLKDLK  253 (258)
T ss_pred             -------ccCcHHHHHHHHHHccCCh-hHcCCccHHHHh
Confidence                   1233567899999999999 999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-33  Score=300.69  Aligned_cols=255  Identities=24%  Similarity=0.256  Sum_probs=198.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  692 (897)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||++++++|.+  ++..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999875 58899999987543 2345678899999999999999999998854  34689999


Q ss_pred             EeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++..   ....+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   234578899999999999999999   899999999999999999999999999999875432


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccC---ccchhHHhhhcCCchHHHHhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG---ELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ...    ....++..|+|||...+..++.++||||+|+++|+|++|+.||......   ......++.....        
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  225 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------  225 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--------
Confidence            211    2335788999999998888999999999999999999999999764211   1111111111000        


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+....    ........++.+++.+||+.+| ++|||+.||++
T Consensus       226 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p-~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDEP----GNGIKWSEEFKDFIKQCLEKDP-TRRPTPWDMLE  265 (287)
T ss_pred             hhhccCC----CCCCchHHHHHHHHHHHcCCCc-ccCCCHHHHHh
Confidence            0000000    0001123457899999999999 99999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-33  Score=297.82  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=199.2

Q ss_pred             CCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999976 468999999986432      2245788999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSG  769 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~  769 (897)
                      ||||+++++|.+++.... .+++..+..++.|++.||+||   |++|++|+||+|+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987654 588999999999999999999   889999999999999998775 699999999877653


Q ss_pred             CCce--eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          770 EDQL--SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       770 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ....  .......++..|+|||...+..++.++||||+|+++|++++|..||......  .....+        .+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~--------~~~~~~  226 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI--------FKIASA  226 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH--------HHHhcc
Confidence            2111  1112345788999999988888899999999999999999999998642111  000000        000000


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ......      .+....++.+++.+|+..+| ++||++.|+++
T Consensus       227 ~~~~~~------~~~~~~~~~~~i~~~l~~~p-~~R~~~~~ll~  263 (268)
T cd06630         227 TTAPSI------PEHLSPGLRDVTLRCLELQP-EDRPPSRELLK  263 (268)
T ss_pred             CCCCCC------chhhCHHHHHHHHHHcCCCc-ccCcCHHHHhc
Confidence            000000      01233557889999999999 99999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-33  Score=298.59  Aligned_cols=247  Identities=25%  Similarity=0.338  Sum_probs=199.0

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      -|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999764 68899999876432 344567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++...  .+++..+..++.|++.|++||   |+.|++|+||+|+||+++.++.++++|||.+........  .
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999999988754  488999999999999999999   899999999999999999999999999999876543221  1


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....++..|+|||......++.++|||||||++|+|++|..||......     ..         ...+...   ..+.
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~---------~~~~~~~---~~~~  220 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KV---------LFLIPKN---NPPT  220 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HH---------HHHHhcC---CCCC
Confidence            12345788999999988888899999999999999999999998652111     00         0001000   0000


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .......++.+++.+|++.+| ++||+++++++.
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p-~~Rp~~~~~l~~  253 (277)
T cd06641         221 ---LEGNYSKPLKEFVEACLNKEP-SFRPTAKELLKH  253 (277)
T ss_pred             ---CCcccCHHHHHHHHHHccCCh-hhCcCHHHHHhC
Confidence               001223457889999999999 999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.2e-33  Score=300.65  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=190.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHH-HHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEV-MKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++... ......+..|+.+ ++..+||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999876 69999999987543 2223445556665 556689999999999999999999999


Q ss_pred             eccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          694 YMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       694 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      |++ ++|.+++..   ....+++..+..++.|++.|++||   |++ +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 678777653   234689999999999999999999   776 999999999999999999999999999876532


Q ss_pred             CCceeeeeccccCcccCCcCccCC----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTK----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ..   ......++..|+|||.+.+    ..++.++||||||+++|||++|+.||.........            ....+
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~  221 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ------------LKQVV  221 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH------------HHHHH
Confidence            21   1123457889999998754    45688999999999999999999998642111001            11111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .......+.      .....++.+++.+|+..|| ++||+++++++
T Consensus       222 ~~~~~~~~~------~~~~~~l~~li~~~l~~~p-~~Rp~~~~il~  260 (283)
T cd06617         222 EEPSPQLPA------EKFSPEFQDFVNKCLKKNY-KERPNYPELLQ  260 (283)
T ss_pred             hcCCCCCCc------cccCHHHHHHHHHHccCCh-hhCcCHHHHhc
Confidence            110000000      1133557899999999999 99999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-33  Score=301.83  Aligned_cols=266  Identities=20%  Similarity=0.284  Sum_probs=196.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|+..+.||.|++|.||+|+.. +|+.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999875 68999999886443  22335788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +. ++|.+++.... ..+++..+..++.|++.||+||   |+.|++||||+|+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 68888876533 4689999999999999999999   889999999999999999999999999999876543221 


Q ss_pred             eeeeccccCcccCCcCccCCCC-CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC-Cc-hHHHHhhh---
Q 045539          774 SIQIQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL-PV-SVMEVIDT---  847 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~i~~---  847 (897)
                       ......++..|+|||+..+.. ++.++||||||+++|||+||+.||...... ....+.+...- +. .....+..   
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122334688999999876544 588999999999999999999998652111 11111111000 00 00000000   


Q ss_pred             ---hhcc-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 ---NLLR-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ---~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         .... ..............++.+++.+|++.|| ++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDP-NKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCc-ccCCCHHHHhc
Confidence               0000 0000000011233457789999999999 99999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-33  Score=302.44  Aligned_cols=267  Identities=21%  Similarity=0.224  Sum_probs=197.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  690 (897)
                      .++|+..+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.++++++||||+++++++..+  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357889999999999999999876 588999999874432  2234567899999999999999999998777  89999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||++ ++|.+++......+++.++..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||.+......
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999997 489988877655689999999999999999999   8899999999999999999999999999998876533


Q ss_pred             CceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc----hHHHHh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV----SVMEVI  845 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~i  845 (897)
                      ..  ......+++.|+|||...+. .++.++||||+|+++|||++|+.||...... ....+.. .....    ......
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~  235 (293)
T cd07843         160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIF-KLLGTPTEKIWPGFS  235 (293)
T ss_pred             cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-HHhCCCchHHHHHhh
Confidence            21  12234578899999987654 4688999999999999999999998752111 0011100 00000    000000


Q ss_pred             h------hhhc-chhhhhHHHHHH--HHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 D------TNLL-RGEERFFAAKEQ--ILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 ~------~~l~-~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .      .... ..+.........  ....+.+++.+|++.|| ++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p-~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP-AKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCc-cccCCHHHHhc
Confidence            0      0000 000000000011  24557899999999999 99999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=280.94  Aligned_cols=271  Identities=20%  Similarity=0.281  Sum_probs=208.7

Q ss_pred             CHHHHHHHhcCCCcCCeeecccceEEEEEE-ecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCC
Q 045539          608 SYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSND  685 (897)
Q Consensus       608 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  685 (897)
                      +|.|+-+.++     +.||+|+|+.|-.+. ..+|..||||++.+.......++.+|++++.+++ |+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3555555443     789999999999885 5689999999999887777889999999999997 99999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEeecc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFG  762 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DFg  762 (897)
                      ...|+|||.|.||+|...+.++. .+++.++.++.++|+.||.+|   |.+||.|||+||+|||..+..   -+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999988765 589999999999999999999   999999999999999997543   68999998


Q ss_pred             CccccCCCCc-----eeeeeccccCcccCCcCcc-----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH
Q 045539          763 IAKLLSGEDQ-----LSIQIQTLATIGYMAPEYG-----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW  832 (897)
Q Consensus       763 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~  832 (897)
                      ++.-+.....     ......++|+..|||||+.     ....|+.+.|.||+|||+|-|+.|..||...-..+-   .|
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GW  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GW  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---Cc
Confidence            8754322111     1223356789999999963     334688999999999999999999999976533221   11


Q ss_pred             hhhcCCch-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          833 INDLLPVS-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       833 ~~~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      -+...-.. -..++...-.+.++-...++..+..+..+++...+..|+ .+|-++.+++.
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda-~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDA-KQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccH-HhhhhhhhccC
Confidence            11111111 112222222233332234455666777888888889999 99999988875

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=336.26  Aligned_cols=424  Identities=30%  Similarity=0.381  Sum_probs=281.8

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +...||+++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|+|..|++ ...|..+..+++|++||+|
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l-~~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRL-QSLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchh-hcCchhHHhhhcccccccc
Confidence            3678888877765 78888899999999999999997 7888889999999999999887 5678888999999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      +|++. .+|..+..++.++.+..++|.....    ++... .+.++|..|.+.+.++.++. .+..  +|+|++|.+.  
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~--  191 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME--  191 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchh-hhhe--eeecccchhh--
Confidence            99987 8898999999999999999832222    22222 88889999998888887765 2333  5999999885  


Q ss_pred             ccccccCCCcccEEEccccccccccCc----cccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccC
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPN----TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN  312 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~----~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  312 (897)
                       ...+.++.+|+.|....|+++...-.    .+....+|.++....       ...-.+|+++|++.|++++. |.++..
T Consensus       192 -~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-------~p~p~nl~~~dis~n~l~~l-p~wi~~  262 (1081)
T KOG0618|consen  192 -VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-------HPVPLNLQYLDISHNNLSNL-PEWIGA  262 (1081)
T ss_pred             -hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-------ccccccceeeecchhhhhcc-hHHHHh
Confidence             34567788888888888887654321    111111222221100       11123444445555544432 233333


Q ss_pred             chHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccc-ccc
Q 045539          313 LSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR-LHS  391 (897)
Q Consensus       313 l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~  391 (897)
                      +. +|+.+...+|+++ .+|..+...++|+.|++..|.++. +|....+++.|++|+|..|+|....+..+.-+.. |+.
T Consensus       263 ~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~y-ip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~  339 (1081)
T KOG0618|consen  263 CA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEY-IPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNT  339 (1081)
T ss_pred             cc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhh-CCCcccccceeeeeeehhccccccchHHHhhhhHHHHH
Confidence            33 4444444444442 344444444444444444444443 3344444555555555555554222222222221 444


Q ss_pred             ccccccccccCCCcc-cccccccceeccccccccCCccccccccccceEEeecCCccc-----------ccceeecccCc
Q 045539          392 LVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN-----------VLIGLNFSRNN  459 (897)
Q Consensus       392 L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----------~l~~l~ls~n~  459 (897)
                      |+.+.|++. ..|.. =..++.|+.|++.+|.++...-..+.+.+.|+.|++++|+|.           .|+.|+||+|+
T Consensus       340 ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNk  418 (1081)
T KOG0618|consen  340 LNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNK  418 (1081)
T ss_pred             Hhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccch
Confidence            444555554 22311 123456788888888888877777888888999999988764           47778888888


Q ss_pred             CCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCC-CchhhhhhcccceEeccCCc
Q 045539          460 LSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA-IPASLQKLLYLKHLNLSFNK  531 (897)
Q Consensus       460 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~  531 (897)
                      |+ .+|.++..++.|++|....|+|. ..| .+..+++|+.+|||.|+|+.. +|.... -++|++|||+||.
T Consensus       419 L~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  419 LT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT  487 (1081)
T ss_pred             hh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence            87 67888888888888888888888 677 788888888888888888743 333332 2788888888887

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-33  Score=302.16  Aligned_cols=240  Identities=23%  Similarity=0.276  Sum_probs=188.3

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||+||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999765 68999999987543   22345667899999999999999999999999999999999999999


Q ss_pred             hHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecc
Q 045539          701 ENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT  779 (897)
Q Consensus       701 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~  779 (897)
                      .+++.... ..+++.++..++.|++.|+.||   |+.|++||||+|+||+++.++.+||+|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99987654 3589999999999999999999   89999999999999999999999999999987654321   12234


Q ss_pred             ccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHH
Q 045539          780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAA  859 (897)
Q Consensus       780 ~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  859 (897)
                      .++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ....            ++.........    ..
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~------------~~~~~~~~~~~----~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKE------------ELKRRTLEMAV----EY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHH------------HHHhccccccc----cC
Confidence            5788999999988888999999999999999999999999653211 0000            00000000000    00


Q ss_pred             HHHHHHHHHHHHhHccCCCCCCCCCCHHH
Q 045539          860 KEQILLSVLNLATECTIESRDGNGADMGW  888 (897)
Q Consensus       860 ~~~~~~~l~~l~~~cl~~dP~~~RPt~~e  888 (897)
                      .......+.+++.+||+.|| ++||+.+|
T Consensus       218 ~~~~~~~~~~li~~~l~~~p-~~R~~~~~  245 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDP-EKRLGCRG  245 (277)
T ss_pred             CccCCHHHHHHHHHHccCCh-hHccCCCc
Confidence            01123457899999999999 99994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.1e-33  Score=294.47  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=203.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|.+.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999876 58999999987543  24567788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          695 MPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       695 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      +++++|.+++...   ...+++.++..++.+++.|++||   |+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998765   26789999999999999999999   88899999999999999999999999999998765432


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        .......|++.|+|||......++.++||||+|+++++|++|+.||.....     .+..        ..........
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~--------~~~~~~~~~~  222 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELA--------LKILKGQYPP  222 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHH--------HHHhcCCCCC
Confidence              122334688899999998888899999999999999999999999865211     1110        0111111100


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+       .....++.+++.+|+..+| ++|||+.|+++.
T Consensus       223 ~~-------~~~~~~~~~~i~~~l~~~p-~~Rp~~~~ll~~  255 (258)
T cd08215         223 IP-------SQYSSELRNLVSSLLQKDP-EERPSIAQILQS  255 (258)
T ss_pred             CC-------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            01       0223457899999999999 999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-33  Score=322.39  Aligned_cols=273  Identities=19%  Similarity=0.228  Sum_probs=190.2

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEecC--CceEEEEE--------------ech---hhHHHHHHHHHHHHHHHhcCCCc
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQD--GMEVAVKV--------------FHQ---QYERALKSFEDECEVMKRIRHRN  674 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~n  674 (897)
                      ...++|++.+.||+|+||+||++..+.  +..++.|.              +.+   ........+.+|++++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            346799999999999999999986542  22222221              111   11223456889999999999999


Q ss_pred             cceEeeeecCCCceEEEEEeccCCChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       675 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      |+++++++.+++..|+|+|++. +++.+++....    ......++..++.|++.||+||   |++||+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEE
Confidence            9999999999999999999984 56766665432    2234567788999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCC-CcccccC-ccc
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP-TDEIFIG-ELS  828 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p-~~~~~~~-~~~  828 (897)
                      +.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +...... ...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987653322 122345699999999999998999999999999999999998754 4322111 111


Q ss_pred             hhHHhh------hcCCch---HHHHhhhh-hcchhhhhHHHH--HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          829 LNRWIN------DLLPVS---VMEVIDTN-LLRGEERFFAAK--EQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       829 ~~~~~~------~~~~~~---~~~~i~~~-l~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.+.+.      ..++..   ..+.++.. ....+.......  ......+.+++.+|++.|| ++|||+.|+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP-~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW-HLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc-ccCcCHHHHhhC
Confidence            111111      111211   11111111 000000000000  0122356778999999999 999999999863

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.2e-33  Score=302.76  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=195.7

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .|...+.||+|+||.||+|+.. ++..||+|++...   ..+..+.+.+|++++++++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999865 6889999998643   23345678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ ++.+.+......+++.++..++.|++.|+.||   |+.||+||||+|+||+++.++.+||+|||.+......   
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9964 77777766556689999999999999999999   8999999999999999999999999999998754322   


Q ss_pred             eeeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          774 SIQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ....|++.|+|||++   ..+.++.++|||||||++|||++|+.||...... ....            .+......
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~------------~~~~~~~~  242 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALY------------HIAQNESP  242 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHH------------HHHhccCC
Confidence               234588899999986   3457889999999999999999999998652111 0001            11110000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      ..      ........+.+++.+|++.+| ++||++.||++..
T Consensus       243 ~~------~~~~~~~~l~~li~~~l~~~p-~~Rpt~~~il~~~  278 (317)
T cd06635         243 TL------QSNEWSDYFRNFVDSCLQKIP-QDRPTSEELLKHM  278 (317)
T ss_pred             CC------CCccccHHHHHHHHHHccCCc-ccCcCHHHHHhCh
Confidence            00      011233457899999999999 9999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=308.64  Aligned_cols=268  Identities=21%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----Cce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  688 (897)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999764 68999999986432 23446678899999999999999999987544     357


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |+||||++ +++.+.+...  .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 4787777554  489999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCce-eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC----chHH
Q 045539          769 GEDQL-SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP----VSVM  842 (897)
Q Consensus       769 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~  842 (897)
                      ..... .......|+..|+|||...+ ..++.++||||+||++|+|++|+.||.....  ......+.....    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence            32211 11123468899999997644 5688999999999999999999999965211  011111111111    1111


Q ss_pred             HHhhhhhc-------chhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          843 EVIDTNLL-------RGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       843 ~~i~~~l~-------~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+......       ....... ........++.+++.+||+.|| ++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP-HKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            11111100       0000000 0111234568899999999999 999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=279.28  Aligned_cols=252  Identities=20%  Similarity=0.210  Sum_probs=202.1

Q ss_pred             HhcCCCcC-CeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecC----CCc
Q 045539          615 ATDRFSEN-NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSN----DDF  687 (897)
Q Consensus       615 ~~~~y~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  687 (897)
                      .+++|++. ++||-|-.|.|..+..+ +|+++|+|++...     ...++|++.--.. .|||||.++++|+.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            46677754 67999999999999765 7999999988644     4456788776555 49999999999854    345


Q ss_pred             eEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccC
Q 045539          688 KALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGI  763 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~  763 (897)
                      ..+|||.++||.|...+.+++ ..+++.++.+|++||+.|++||   |+.+|.||||||+|+|..   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            678999999999999988776 6799999999999999999999   999999999999999996   445899999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      |+......   .....+-|+.|.|||++...+|+...|+||+||++|-|+.|.+||.......          ++...  
T Consensus       211 AK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgM--  275 (400)
T KOG0604|consen  211 AKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGM--  275 (400)
T ss_pred             ccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhH--
Confidence            98754322   2335678999999999999999999999999999999999999997642211          11111  


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       -.+...+.++-..+++.++.+...++++..+..+| .+|-|+.|++.
T Consensus       276 -k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~P-teRlTI~~~m~  321 (400)
T KOG0604|consen  276 -KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEP-TERLTIEEVMD  321 (400)
T ss_pred             -HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCc-hhheeHHHhhc
Confidence             12222233332345667788889999999999999 99999999875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=300.13  Aligned_cols=266  Identities=21%  Similarity=0.272  Sum_probs=196.7

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      |++.+.||.|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+++..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999865 69999999987543  223356788999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      + ++|.+++.... ..+++..+..++.|+++||+||   |+++++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68998886654 4589999999999999999999   788999999999999999999999999999876532211  


Q ss_pred             eeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC-Cch-H-------HHH
Q 045539          775 IQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL-PVS-V-------MEV  844 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-~-------~~~  844 (897)
                      ......++..|+|||+..+. .++.++||||||+++|+|++|+.||...... ....+...... +.. .       .+.
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            11233568899999987554 5688999999999999999999998653111 01111111000 000 0       000


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....................++.+++.+|++.|| ++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDP-AKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCCh-hhCcCHHHHhcC
Confidence            00000000000001111223567899999999999 999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.6e-33  Score=293.28  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=204.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKALIM  692 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  692 (897)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+.+|++++++++||||+++++.+.+.  ...++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999876 68999999987654  24567889999999999999999999999888  8899999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++.++..++.|++.|++||   |+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999988765 689999999999999999999   889999999999999999999999999999987654432


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      ........++..|+|||.......+.++||||||+++|+|++|..||......    ....        ......   ..
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~--------~~~~~~---~~  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAAL--------YKIGSS---GE  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHH--------Hhcccc---CC
Confidence            11123456889999999988888999999999999999999999999763200    0000        000000   00


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...   ........+.+++.+|++.|| ++||++.|+++.
T Consensus       222 ~~~---~~~~~~~~l~~~i~~~l~~~p-~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPE---IPEHLSEEAKDFLRKCLRRDP-KKRPTADELLQH  257 (260)
T ss_pred             CcC---CCcccCHHHHHHHHHhCcCCh-hhCCCHHHHhhC
Confidence            000   001224568899999999999 999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.1e-33  Score=296.97  Aligned_cols=263  Identities=18%  Similarity=0.226  Sum_probs=194.6

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcC-CCccceEeeeecCC--CceEEEEE
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIR-HRNLVKIISSCSND--DFKALIMK  693 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  693 (897)
                      |++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |||++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677889999999999999865 689999999875422 22233457888899886 99999999999887  88999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++ +++.+.+......+++.++..++.|++.||+||   |+.|++||||+|+||+++. +.+||+|||.+.........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 578777776555689999999999999999999   8899999999999999999 99999999999866433221


Q ss_pred             eeeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch---HHHHhhhhh
Q 045539          774 SIQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS---VMEVIDTNL  849 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~i~~~l  849 (897)
                         ....++..|+|||+.. +..++.++||||+||++|||++|..||.....  .+...+........   ........-
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence               2235788999999754 45678899999999999999999999965211  11111111111111   110000000


Q ss_pred             cchh-------hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGE-------ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....       .............+.+++.+|+++|| ++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDP-DERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCc-ccccCHHHHhhC
Confidence            0000       00011112345778999999999999 999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-33  Score=302.01  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=196.0

Q ss_pred             CCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          622 NNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999875 6899999998655455567789999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                      .+++...  .+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.++|+|||.+........  ......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            9987654  378999999999999999999   889999999999999999999999999998876543221  122345


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      |++.|+|||+.....++.++||||+|+++|+|++|+.||.....  ...            ...+.......    ....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~------------~~~~~~~~~~~----~~~~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKA------------MKMIRDNLPPK----LKNL  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH------------HHHHHhhCCcc----cCCc
Confidence            88999999998888889999999999999999999999864210  000            01111111000    0011


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          861 EQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......+.+++.+|++.|| .+||++.|+++.
T Consensus       240 ~~~~~~l~~li~~~l~~~P-~~R~~~~~ll~~  270 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDP-AQRATAAELLKH  270 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCc-ccCcCHHHHhcC
Confidence            1223456788999999999 999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=301.09  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=200.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|++|.||+|.+. +++.||+|+++...  ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47889999999999999999876 58899999887543  2335778899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |++++.+..+.... ..+++.++..++.|++.|++||   |+.|++|||++|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99987776655443 4589999999999999999999   889999999999999999999999999999887654332 


Q ss_pred             eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH--hhhcCCchHHHHhh--hh
Q 045539          774 SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--INDLLPVSVMEVID--TN  848 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~i~--~~  848 (897)
                      .......++..|+|||+.... .++.++||||||+++|+|++|+.||......+ .....  .....+........  ..
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcc
Confidence            122234678899999998877 78999999999999999999999986521110 00000  00000000000000  00


Q ss_pred             h----------cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          849 L----------LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       849 l----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .          ......++  ...+..++.+++.+||..+| ++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRY--PGKVSSPALDFLKACLRMDP-KERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhc--CCccchHHHHHHHHHhccCc-hhcccHHHHhcC
Confidence            0          00000000  01125668999999999999 999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.6e-33  Score=294.85  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|...+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+||+++++++.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999876 58899999987542  23346788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|.+++.... ..+++..+..++.|+++|++||   |+.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987644 3578999999999999999999   889999999999999999875 569999999876643321


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        ......|++.|+|||+.....++.++||||||+++|||++|+.||....     ..+.+.        ..........
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~--------~~~~~~~~~~  222 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVL--------KICQGYFAPI  222 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHH--------HHhcccCCCC
Confidence              1223458899999999888889999999999999999999999986521     111111        1111111000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .       .....++.+++.+|+..+| ++|||+.|+++.
T Consensus       223 ~-------~~~~~~~~~~i~~~l~~~p-~~Rpt~~~ll~~  254 (257)
T cd08225         223 S-------PNFSRDLRSLISQLFKVSP-RDRPSITSILKR  254 (257)
T ss_pred             C-------CCCCHHHHHHHHHHhccCh-hhCcCHHHHhhC
Confidence            0       1122457899999999999 999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-33  Score=301.60  Aligned_cols=252  Identities=25%  Similarity=0.293  Sum_probs=191.9

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999865 58999999987543 334567889999999996 99999999999999999999999


Q ss_pred             ccCCChhHh---hhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          695 MPNGSLENC---LYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       695 ~~~gsL~~~---l~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      +.. ++.++   +.. ....+++..+..++.|++.||+|||  |+.+++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            854 55443   222 2256899999999999999999995  4569999999999999999999999999998765432


Q ss_pred             CceeeeeccccCcccCCcCccCCC---CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKG---RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ..   .....|+..|+|||++...   .++.++|||||||++|||++|+.||....    ...            +.+..
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~------------~~~~~  222 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVF------------DQLTQ  222 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHH------------HHHhh
Confidence            21   1233578999999988765   68899999999999999999999986521    000            00110


Q ss_pred             hhcchhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+.. ..........++.+++.+|++.|| ++|||++||++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p-~~Rpt~~~i~~~  267 (288)
T cd06616         223 VVKGDPPILSNSEEREFSPSFVNFINLCLIKDE-SKRPKYKELLEH  267 (288)
T ss_pred             hcCCCCCcCCCcCCCccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            00000000 000001234568899999999999 999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-33  Score=304.18  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .....|.+...||+|.|+.|..|++. ++..||+|++.+..-  ...+.+.+|+++|+.++|||||+++.+.+.+...|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34578999999999999999999866 699999999987642  233558899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+.+|.+.+++...+. ..+..+..++.|+.+|++|+   |+++|||||||++||+++.+.++||+|||++..+...
T Consensus       133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999999998875 44488889999999999999   9999999999999999999999999999999987633


Q ss_pred             CceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .   .....+|++.|+|||+..+..+ ++++|+||+|+++|.|+.|..||+...                 +.++-++.+
T Consensus       209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----------------lk~Lr~rvl  268 (596)
T KOG0586|consen  209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----------------LKELRPRVL  268 (596)
T ss_pred             c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----------------cccccchhe
Confidence            2   3346789999999999887766 789999999999999999999998632                 222222333


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.+.-.+    -...+..+++++++..+| .+|++++++.+
T Consensus       269 ~gk~rIp~----~ms~dce~lLrk~lvl~P-skr~~~dqim~  305 (596)
T KOG0586|consen  269 RGKYRIPF----YMSCDCEDLLRKFLVLNP-SKRGPCDQIMK  305 (596)
T ss_pred             eeeecccc----eeechhHHHHHHhhccCc-cccCCHHHhhh
Confidence            32221111    112235678888889999 99999998865

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.3e-33  Score=307.45  Aligned_cols=267  Identities=21%  Similarity=0.232  Sum_probs=197.8

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  685 (897)
                      ...++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34678999999999999999999865 68999999986432  33345677899999999999999999988543     


Q ss_pred             -CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 -DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                       ...|+||||+. ++|.+.+...   ++..++..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||.+
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 5888777543   78889999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc--CCchHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL--LPVSVM  842 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~  842 (897)
                      ........   .....++..|+|||...+..++.++|||||||++|+|++|+.||...... ......+...  .+....
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            86543221   22345788999999998889999999999999999999999998642110 0011111000  001111


Q ss_pred             HHhhhhhcchhhh-------hHHH--------------HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          843 EVIDTNLLRGEER-------FFAA--------------KEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       843 ~~i~~~l~~~~~~-------~~~~--------------~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.++.........       .+..              ......++.+++.+|++.|| ++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP-EKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            1111110000000       0000              01224457899999999999 999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.5e-33  Score=307.26  Aligned_cols=270  Identities=23%  Similarity=0.287  Sum_probs=198.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC--Cce
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRI-RHRNLVKIISSCSND--DFK  688 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  688 (897)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....  ......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4678999999999999999999876 58899999885421  23345677899999999 999999999998643  467


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||++ ++|.+++..+  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5898888765  588999999999999999999   88999999999999999999999999999998664


Q ss_pred             CCCce---eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--cCCch--
Q 045539          769 GEDQL---SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--LLPVS--  840 (897)
Q Consensus       769 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~--  840 (897)
                      .....   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ ...+....  ..+..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            33221   12223468899999997654 567889999999999999999999986422111 11111100  00000  


Q ss_pred             -------HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 -------VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 -------~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                             ...+++...................++.+++.+|++.|| ++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P-~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP-NKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc-ccccCHHHHhhC
Confidence                   011111000000000011111235678999999999999 999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-33  Score=297.08  Aligned_cols=266  Identities=20%  Similarity=0.246  Sum_probs=201.4

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      |++.+.||+|++|.||+|... +++.+++|++.....  .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            667889999999999999875 688999999875432  24567888999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++ ++.+++......+++.++..++.|++.||+||   |+.+|+|+||||+||+++.++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 88888877655789999999999999999999   88999999999999999999999999999997765433  11


Q ss_pred             eeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh---cCCch---HHHHhhhh
Q 045539          776 QIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND---LLPVS---VMEVIDTN  848 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~---~~~~i~~~  848 (897)
                      .....++..|+|||...+. .++.++||||+|+++|+|++|+.||......+ ........   ..+..   ..+.....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2234578899999987766 78999999999999999999999986532110 00000000   00000   00000000


Q ss_pred             ----hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          849 ----LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       849 ----l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                          ............+....++.+++.+||+.|| .+||+++|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDP-HKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCc-ccCcCHHHHhhC
Confidence                0000000111223456778999999999999 999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-32  Score=292.05  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=201.1

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|++.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788999999999999999765 68899999987542  33456778899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          695 MPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       695 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      +++++|.+++...   ...+++..+..++.|++.||+||   |+.|++||||+|+||++++++.+||+|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988662   24588999999999999999999   8999999999999999999999999999999876543 


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                         ......++..|+|||...+..++.++|+||+|+++|||++|+.||......                 +........
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRG  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcC
Confidence               122345788999999998888999999999999999999999998752111                 000000111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....   ......++.+++.+|+..+| ++||++.|+++.
T Consensus       217 ~~~~~---~~~~~~~~~~li~~~l~~~p-~~Rp~~~~~l~~  253 (256)
T cd08530         217 KYPPI---PPIYSQDLQNFIRSMLQVKP-KLRPNCDKILAS  253 (256)
T ss_pred             CCCCC---chhhCHHHHHHHHHHcCCCc-ccCCCHHHHhcC
Confidence            11100   11334568899999999999 999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-33  Score=303.38  Aligned_cols=270  Identities=19%  Similarity=0.247  Sum_probs=195.8

Q ss_pred             CCCcCCeeecccceEEEEEEec---CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  689 (897)
                      +|++.+.||+|+||.||+|...   +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5788899999999999999865   47899999988632   33346678899999999999999999999888  7899


Q ss_pred             EEEEeccCCChhHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC----CCcEEEeec
Q 045539          690 LIMKYMPNGSLENCLYSG----TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE----DMVAHISDF  761 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~----~~~~kL~DF  761 (897)
                      +||||+++ ++.+.+...    ...+++..+..++.|++.|++||   |+++|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 566655322    13588999999999999999999   8999999999999999999    899999999


Q ss_pred             cCccccCCCCc-eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCcc--------chhH
Q 045539          762 GIAKLLSGEDQ-LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL--------SLNR  831 (897)
Q Consensus       762 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~--------~~~~  831 (897)
                      |++........ ........++..|+|||+..+ ..++.++||||||+++|+|++|+.||........        .+.+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886643322 111223457889999997765 4578999999999999999999999975432210        0000


Q ss_pred             HhhhcCCc------------hHHHHhhhhhcc-----hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          832 WINDLLPV------------SVMEVIDTNLLR-----GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       832 ~~~~~~~~------------~~~~~i~~~l~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+......            ......+.....     ....+.........++.+++.+|++.|| ++|||+.|+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP-TKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCc-ccCcCHHHHhcC
Confidence            00000000            000000000000     0000011101233568899999999999 999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.2e-33  Score=306.96  Aligned_cols=268  Identities=23%  Similarity=0.263  Sum_probs=199.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC----CCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN----DDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  688 (897)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999865 68999999987543  2334677789999999999999999998753    3467


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+. ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||.+....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68988886654 489999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCce--eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch-----
Q 045539          769 GEDQL--SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS-----  840 (897)
Q Consensus       769 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  840 (897)
                      .....  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .....+.......     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence            32211  11223468899999998655 46889999999999999999999999652111  0111111111111     


Q ss_pred             -------HHHHhhhhhcchhhhhHH-HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 -------VMEVIDTNLLRGEERFFA-AKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 -------~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                             ..+..+.. .......+. .......++.+++.+|++.|| ++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNL-PRKQPVPWSKIFPKASPEALDLLSQMLQFDP-EERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhc-ccCCCCCHHHHcccCCHHHHHHHHHHccCCh-hhCcCHHHHHhC
Confidence                   11111100 000000011 112345678999999999999 999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.3e-33  Score=303.65  Aligned_cols=268  Identities=24%  Similarity=0.248  Sum_probs=196.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999875 589999999864432  1223456899999999999999999998654  56899


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||++ ++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||++++++.+||+|||.+......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 478888776556789999999999999999999   8999999999999999999999999999999876533


Q ss_pred             CceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH---hh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV---ID  846 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---i~  846 (897)
                      ..  ......++..|+|||...+ ..++.++||||+||++|||++|+.||......  .....+....+......   ++
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhhh
Confidence            21  1122345788999998755 45789999999999999999999999753111  11111111110000000   00


Q ss_pred             ------h-hhcchh-hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          847 ------T-NLLRGE-ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       847 ------~-~l~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                            . .+...+ ............++.+++.+|++.|| ++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp-~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDP-KKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCCh-hhCcCHHHHhcC
Confidence                  0 000000 00000011124557889999999999 999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.7e-33  Score=297.09  Aligned_cols=266  Identities=18%  Similarity=0.219  Sum_probs=198.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +|+..+.||.|++|.||+|+.. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999876 589999999875432 23456778999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          696 PNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       696 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ++ +|.+++....  ..+++.++..++.|++.||+||   |+.|++||||||+||++++++.++++|||.+........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 8888876544  4589999999999999999999   889999999999999999999999999999875532211 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc---CCchHHHHhh-hh
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL---LPVSVMEVID-TN  848 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~i~-~~  848 (897)
                       ......++..|+|||+..+ ..++.++||||||+++|+|++|+.||...... ....+.....   .......+.. +.
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCch
Confidence             1123457889999998755 45688999999999999999999999753211 1111111100   0000000000 00


Q ss_pred             hcchh-----hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGE-----ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .....     .......+.....+.+++.+|++.|| .+||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p-~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNP-ELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCc-ccCCCHHHHhc
Confidence            00000     00001112334568899999999999 99999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=293.95  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=186.5

Q ss_pred             CeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHH-hcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMK-RIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|... +|+.||+|++++...   .....+..|..++. ..+|||++++++++.+++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999865 589999999875431   22233445555443 45799999999999999999999999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      ++|.+++.... .+++..+..++.|++.||.||   |+.+++||||+|+||++++++.+||+|||.+.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987654 588999999999999999999   899999999999999999999999999999875432      12


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...++..|+|||...+..++.++||||+|+++|||++|..||......     ...        ..+....... +.   
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~--------~~~~~~~~~~-~~---  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVF--------DNILSRRINW-PE---  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHH--------HHHHhcccCC-CC---
Confidence            345888999999988888899999999999999999999999652111     000        0000000000 00   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+...+.+++.+|++.|| ++||++.++.+.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p-~~R~~~~~~~~~  248 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDP-AKRLGANGYQEI  248 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCH-HHccCCCcHHHH
Confidence            0011234568899999999999 999987655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.1e-33  Score=301.38  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=194.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            458999999999999999999875 68999999886432  222345668999999999999999999986554      


Q ss_pred             --ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          687 --FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       687 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                        ..++||||+. +++.+++......+++.++..++.|++.||+||   |++|++|+||||+||+++.++.+||+|||.+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              4599999996 578888776655689999999999999999999   7889999999999999999999999999999


Q ss_pred             cccCCCCce--eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCc-cchhHHhhhcCCch
Q 045539          765 KLLSGEDQL--SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE-LSLNRWINDLLPVS  840 (897)
Q Consensus       765 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~  840 (897)
                      .........  .......++..|+|||+..+. .++.++||||||+++|||++|+.||....... ......+....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765432211  111234578889999987654 46889999999999999999999986532110 00011111111111


Q ss_pred             H------HHHhhh-hhcchhhhhHHH-HH--HHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 V------MEVIDT-NLLRGEERFFAA-KE--QILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~------~~~i~~-~l~~~~~~~~~~-~~--~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .      .+..+. ............ ..  .....+.+++.+|+..|| ++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P-~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP-AKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh-hhccCHHHHhc
Confidence            0      000000 000000000000 00  012346789999999999 99999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=309.86  Aligned_cols=199  Identities=30%  Similarity=0.482  Sum_probs=172.4

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------ceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------FKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  689 (897)
                      -+...+.||+|+||.||+++.+ +|+.||||.+++.. ....++..+|++++++++|||||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3445688999999999999955 79999999998643 334577789999999999999999999876543      568


Q ss_pred             EEEEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCC--cEEEeeccC
Q 045539          690 LIMKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--EDM--VAHISDFGI  763 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~--~~kL~DFg~  763 (897)
                      +|||||.||+|+..+.+..  ..+++.+.+.+..+++.||.||   |++||+||||||.||++-  .+|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998654  5699999999999999999999   899999999999999994  333  679999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      |+..+++.   .....+||..|.+||... .+.|+..+|.|||||++|+.+||..||-..
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99886554   445778999999999988 488999999999999999999999999763

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-32  Score=292.63  Aligned_cols=251  Identities=22%  Similarity=0.227  Sum_probs=194.9

Q ss_pred             CHHHHHHHhcCCCcCCee--ecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeec
Q 045539          608 SYHELLRATDRFSENNLI--GIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCS  683 (897)
Q Consensus       608 ~~~~~~~~~~~y~~~~~l--g~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  683 (897)
                      +..+.....++|++.+.+  |+|+||.||+++.. +++.+|+|++.......     .|+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            345556667788888777  99999999999865 68889999987542211     122222222 6999999999999


Q ss_pred             CCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeecc
Q 045539          684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFG  762 (897)
Q Consensus       684 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg  762 (897)
                      .++..++||||+++++|.+++.... .+++.++..++.|+++|++||   |+.|++||||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999999987764 689999999999999999999   899999999999999999988 99999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                      .+.......      ...++..|+|||+..+..++.++||||+|+++|||++|+.||............+....      
T Consensus       156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  223 (267)
T PHA03390        156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------  223 (267)
T ss_pred             cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------
Confidence            987654221      23588999999999888899999999999999999999999975332221111111110      


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-HHHHHh
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-MGWIFS  891 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-~~evl~  891 (897)
                         .    ...    .........+.+++.+|++.|| .+||+ ++|+++
T Consensus       224 ---~----~~~----~~~~~~~~~~~~li~~~l~~~p-~~R~~~~~~~l~  261 (267)
T PHA03390        224 ---Q----KKL----PFIKNVSKNANDFVQSMLKYNI-NYRLTNYNEIIK  261 (267)
T ss_pred             ---c----ccC----CcccccCHHHHHHHHHHhccCh-hhCCchHHHHhc
Confidence               0    000    0011233557889999999999 99996 588874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-33  Score=297.74  Aligned_cols=267  Identities=24%  Similarity=0.279  Sum_probs=198.8

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEEEEE
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKALIMK  693 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  693 (897)
                      |++.+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677889999999999999876 48899999998653  33346678899999999999999999999887  89999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ +|.+++......+++.++..++.|+++||+||   |+.|++|+||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9974 88888877655689999999999999999999   788999999999999999999999999999987654322 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC---Cch---HHHH-h
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL---PVS---VMEV-I  845 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~---~~~~-i  845 (897)
                      .......++..|+|||...+ ..++.++||||||+++|||++|+.||...... ...........   +..   ...+ .
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence            11223456888999997654 45789999999999999999999998753211 01111110000   000   0000 0


Q ss_pred             hhhh--cchhhhhH-HHHHH-HHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          846 DTNL--LRGEERFF-AAKEQ-ILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       846 ~~~l--~~~~~~~~-~~~~~-~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....  ........ ..... ...++.+++.+|+..+| ++||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP-KKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCCh-hhCcCHHHHhhC
Confidence            0000  00000000 11112 25678999999999999 999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.9e-33  Score=302.65  Aligned_cols=270  Identities=21%  Similarity=0.283  Sum_probs=199.9

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC-CC
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN-DD  686 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  686 (897)
                      ++..++++|++.+.||+|+||.||+|... +++.||+|++.+..  ....+.+.+|++++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34457889999999999999999999765 68999999876432  2234667889999999999999999998865 56


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||+ +++|.+++....  +++..+..++.|+++||+||   |+.||+||||+|+||++++++.+||+|||.+..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999998 568988876543  78888899999999999999   899999999999999999999999999999875


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCc--cc--------hhHHhhh
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE--LS--------LNRWIND  835 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~--~~--------~~~~~~~  835 (897)
                      .....     ....++..|+|||...+ ..++.++||||||+++|+|++|+.||.......  ..        ..++...
T Consensus       158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            43221     23357888999998755 568999999999999999999999986531100  00        0111111


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .......+.+.......+............++.+++.+|++.+| ++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP-QKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh-hhCCCHHHHhcC
Confidence            11111111111110001100001111234678899999999999 999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=310.44  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=210.0

Q ss_pred             CCcCCeeecccceEEEEEEe-cCC----ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          619 FSENNLIGIGSFGSIYVARL-QDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .+..++||+|+||+||+|.| ++|    -+||+|++.... .+..+++.+|+-+|.+++|||+++++++|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999965 333    468999876443 445678999999999999999999999998776 77999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      +|++.|+|.|+++..+..+.....+.|..|||+|+.||   |++++|||||-.+|||+..-..+|+.|||+|+...+++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999999888899999999999999999999   899999999999999999999999999999998877666


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........-.+.|||=|.+....++.++|||||||++||++| |..|++.+..+              ++.+++++--  
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------------eI~dlle~ge--  917 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------------EIPDLLEKGE--  917 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------------HhhHHHhccc--
Confidence            554444445678999999999999999999999999999999 99999874322              1223332211  


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                          |.+..+-+...+..++.+||..|+ ..||+++++.+++.+
T Consensus       918 ----RLsqPpiCtiDVy~~mvkCwmid~-~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  918 ----RLSQPPICTIDVYMVMVKCWMIDA-DSRPTFKELAEEFSR  956 (1177)
T ss_pred             ----cCCCCCCccHHHHHHHHHHhccCc-ccCccHHHHHHHHHH
Confidence                233334566778999999999999 999999999887643

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-32  Score=297.70  Aligned_cols=267  Identities=20%  Similarity=0.233  Sum_probs=194.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCccceEeeeecCCCc-----
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIR-HRNLVKIISSCSNDDF-----  687 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  687 (897)
                      ++|++.+.||+|+||.||+|.+. +++.||+|+++....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47889999999999999999875 689999998865432  22356788999999995 6999999999876665     


Q ss_pred             eEEEEEeccCCChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeecc
Q 045539          688 KALIMKYMPNGSLENCLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFG  762 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg  762 (897)
                      .|+||||+++ ++.+++....    ..+++..+..++.||+.||+||   |++||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 7888775432    3579999999999999999999   8999999999999999998 8899999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc-CCc-
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL-LPV-  839 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-  839 (897)
                      .+........  ......+++.|+|||+..+ ..++.++||||||+++|+|++|..||....... ...+..... .+. 
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            9876532211  1122346888999998754 457899999999999999999999986521110 001110000 000 


Q ss_pred             ----hHHHHhhhh-h-cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 ----SVMEVIDTN-L-LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 ----~~~~~i~~~-l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          ......+.. . ...+.......+....++.+++.+|+..|| ++||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP-AKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCCh-hhcCCHHHHhc
Confidence                000000000 0 000000111112345668899999999999 99999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-32  Score=302.49  Aligned_cols=267  Identities=21%  Similarity=0.267  Sum_probs=198.1

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--  686 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  686 (897)
                      +....++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445789999999999999999999754 68999999986432  233456789999999999999999999987653  


Q ss_pred             ----ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          687 ----FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       687 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                          ..++||||+ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999998 77998887654  489999999999999999999   89999999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--cCCc
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--LLPV  839 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~  839 (897)
                      .+.......     ....+++.|+|||...+ ..++.++||||+|+++|++++|+.||...... .........  ..+.
T Consensus       164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence            987654221     23357889999998765 45789999999999999999999999753111 011111110  0011


Q ss_pred             hHHHHhhh--------hhc-chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 SVMEVIDT--------NLL-RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 ~~~~~i~~--------~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...+.+..        .+. ..+.............+.+++.+|++.|| ++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDA-ESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCCh-hhCCCHHHHhc
Confidence            11111100        000 00000001112234567899999999999 99999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.2e-33  Score=294.67  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=194.5

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999877 489999999875432   4557788999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc------ee
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ------LS  774 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~------~~  774 (897)
                      .+++.... .+++..+..++.|+++||+||   |+.|++||||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987654 589999999999999999999   899999999999999999999999999999876433211      11


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......++..|+|||.......+.++||||||+++|++++|+.||......                 +...........
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----------------EIFQNILNGKIE  219 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcCCcC
Confidence            223345788999999988888899999999999999999999998752111                 111111100000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                        ++........+.+++.+|++.+| ++|||+.++.+.|
T Consensus       220 --~~~~~~~~~~~~~~i~~~l~~~p-~~Rpt~~~~~~~l  255 (265)
T cd05579         220 --WPEDVEVSDEAIDLISKLLVPDP-EKRLGAKSIEEIK  255 (265)
T ss_pred             --CCccccCCHHHHHHHHHHhcCCH-hhcCCCccHHHHh
Confidence              00001124567899999999999 9999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=334.08  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +-++.....||.|.||.||.|... +|...|+|-++...  ....+...+|..++..++|||+|++||+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            346777889999999999999754 68889999876443  334567789999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |||++|+|++.+..++ ..++....-+..|++.|++||   |++|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999887765 466667778899999999999   999999999999999999999999999999988764421


Q ss_pred             --eeeeeccccCcccCCcCccCCC---CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          773 --LSIQIQTLATIGYMAPEYGTKG---RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       773 --~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                        ........||+.|||||++.+.   ....++||||+|||+.||+||+.||......-                +++-+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~----------------aIMy~ 1453 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW----------------AIMYH 1453 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh----------------HHHhH
Confidence              1112245799999999987654   34568899999999999999999998742221                11111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .-.+..++.+   +....+=.+++..|+..|| ++|.++.|+++.
T Consensus      1454 V~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP-~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIP---ERLSSEGRDFLEHCLEQDP-KMRWTASQLLEH 1494 (1509)
T ss_pred             HhccCCCCCc---hhhhHhHHHHHHHHHhcCc-hhhhHHHHHHHh
Confidence            1111111111   1233445688899999999 999999988763

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-32  Score=301.56  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=192.8

Q ss_pred             Ceeecc--cceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIG--SFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999875 69999999986432  34457889999999999999999999999999999999999999


Q ss_pred             CChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee--
Q 045539          698 GSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS--  774 (897)
Q Consensus       698 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~--  774 (897)
                      +++.+++.... ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887643 3588999999999999999999   89999999999999999999999999998654332111100  


Q ss_pred             ---eeeccccCcccCCcCccCCC--CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh---------cCCch
Q 045539          775 ---IQIQTLATIGYMAPEYGTKG--RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND---------LLPVS  840 (897)
Q Consensus       775 ---~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~  840 (897)
                         ......++..|+|||++.+.  .++.++|||||||++|||++|+.||........ ..+....         ..+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence               00112346679999998663  478999999999999999999999975322111 1111000         00000


Q ss_pred             HHHH-----------hhhhhc-------chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 VMEV-----------IDTNLL-------RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ~~~~-----------i~~~l~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....           .+....       .....+.+........+.+++.+||+.|| ++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP-EKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCc-ccCCCHHHHhhC
Confidence            0000           000000       00000122233456778999999999999 999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-32  Score=293.74  Aligned_cols=242  Identities=22%  Similarity=0.243  Sum_probs=184.4

Q ss_pred             eeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHh---cCCCccceEeeeecCCCceEEEEEecc
Q 045539          624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKR---IRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .||+|+||.||+|... +++.||+|.+.+..   ......+.+|..+++.   .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58999999886532   1122333445444443   469999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||++++++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999887654 589999999999999999999   88999999999999999999999999999987543221    1


Q ss_pred             eccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....|+..|+|||...+ ..++.++||||+||++|||++|..||.........   ..        ..... ......  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~--------~~~~~-~~~~~~--  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EI--------DRMTL-TVNVEL--  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HH--------HHHhh-cCCcCC--
Confidence            23468999999998764 56789999999999999999999999753221100   00        00000 000000  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                          .+....++.+++.+|+..|| ++||     |++|+++.
T Consensus       219 ----~~~~~~~~~~li~~~l~~~p-~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 ----PDSFSPELKSLLEGLLQRDV-SKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----ccccCHHHHHHHHHHhcCCH-HHhcCCCCCCHHHHHhC
Confidence                01233467889999999999 9999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-32  Score=291.18  Aligned_cols=242  Identities=24%  Similarity=0.306  Sum_probs=193.7

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||.|++|.||+|+.. +++.||+|++.+..   ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999876 48999999987543   23457789999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                      .+++.... .+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++|+|||.+.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99987654 488999999999999999999   89999999999999999999999999999998765332   122345


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      ++..|+|||......++.++|+||+|+++|+|++|..||.......   .+.        ...+.........+      
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~--------~~~~~~~~~~~~~~------  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEI--------YNDILKGNGKLEFP------  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHH--------HHHHhccCCCCCCC------
Confidence            7889999999888889999999999999999999999997632110   000        11111100011111      


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          861 EQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .....++.+++.+||+.|| ++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p-~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNP-EERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCCh-hhCcCCcccCHHHHhc
Confidence            1113568899999999999 99999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-32  Score=298.30  Aligned_cols=272  Identities=25%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  686 (897)
                      ...++|++.+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999876 58899999987543  223356778999999999999999999987654    


Q ss_pred             ------ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          687 ------FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       687 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                            ..++||||+++ ++.+.+......+++..+..++.|++.||+||   |+.||+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 67777766555689999999999999999999   889999999999999999999999999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh---hc
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN---DL  836 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~---~~  836 (897)
                      ||.+........ .......++..|+|||...+ ..++.++|||||||++|||++|+.||..... ...+.....   ..
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            999886643322 11122346788999997754 4568899999999999999999999865211 001111100   00


Q ss_pred             CCchHHHHhhhhhc------chh-hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          837 LPVSVMEVIDTNLL------RGE-ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       837 ~~~~~~~~i~~~l~------~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+....++......      ... .............+.+++.+||+.|| ++||+++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rp~~~~il~~  299 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP-SKRCTAEEALNS  299 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCCh-hhCCCHHHHhcC
Confidence            00000000000000      000 00001111234568999999999999 999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=290.83  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=201.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +|++.+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788899999999999999766 578999999876543  4567889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++... ..+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 4589999999999999999999   8999999999999999999999999999999876543321 


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                       .....++..|+|||......++.++||||+|+++|+|++|+.||.....    ....         .......... . 
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~---------~~~~~~~~~~-~-  219 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAAL---------FRIVQDDHPP-L-  219 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHH---------HHHhccCCCC-C-
Confidence             2234578899999998877789999999999999999999999875211    0000         0000000000 0 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           .......+.+++.+|+..+| ++|||+.|++.
T Consensus       220 -----~~~~~~~~~~~i~~~l~~~p-~~R~~~~~~l~  250 (254)
T cd06627         220 -----PEGISPELKDFLMQCFQKDP-NLRPTAKQLLK  250 (254)
T ss_pred             -----CCCCCHHHHHHHHHHHhCCh-hhCcCHHHHhc
Confidence                 01223457899999999999 99999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-32  Score=289.09  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=196.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCccceEeeeecCC--Cce
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ-----YERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFK  688 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  688 (897)
                      .+|++.+.||+|+||.||+|... +++.||+|++...     ..+..+.+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999865 5899999987532     233456888999999999999999999998664  467


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 478899999999999999999   89999999999999999999999999999997653


Q ss_pred             CCCc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .... ........++..|+|||+..+..++.++|||||||++|++++|+.||.....                ...+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~  221 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------------MAAIFKI  221 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------------HHHHHHH
Confidence            2111 0111234588999999999888889999999999999999999999875211                1111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......+...   .....++.+++.+|+. +| ..||++.++++.
T Consensus       222 ~~~~~~~~~p---~~~~~~~~~~i~~~l~-~~-~~r~~~~~~~~~  261 (264)
T cd06653         222 ATQPTKPMLP---DGVSDACRDFLKQIFV-EE-KRRPTAEFLLRH  261 (264)
T ss_pred             HcCCCCCCCC---cccCHHHHHHHHHHhc-Cc-ccCccHHHHhcC
Confidence            1111000001   1233557889999998 68 899999988763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-32  Score=303.30  Aligned_cols=267  Identities=20%  Similarity=0.263  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----Cc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  687 (897)
                      .++|.+.+.||+|+||+||+|+.. +++.||+|.++...  ....+.+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            468999999999999999999865 68999999986532  23345677899999999999999999988644     35


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||+. ++|.+++.... .+++..+..++.|++.||+||   |+++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68888887654 589999999999999999999   8899999999999999999999999999999866


Q ss_pred             CCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC----C----
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL----P----  838 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~----  838 (897)
                      ....  .......++..|+|||.... ..++.++|||||||++|+|++|+.||.....  ......+....    +    
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHhh
Confidence            4332  12223457889999997654 4688999999999999999999999965211  00000000000    0    


Q ss_pred             ----chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 ----VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ----~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                          ......+.................+..++.+++.+|++.|| ++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDP-SKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCCh-hhccCHHHHHcC
Confidence                00111111000000000011112345678899999999999 999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-32  Score=296.37  Aligned_cols=260  Identities=19%  Similarity=0.193  Sum_probs=184.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhhHH---H--------HHHHHHHHHHHHhcCCCccceEee
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQYER---A--------LKSFEDECEVMKRIRHRNLVKIIS  680 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~~~---~--------~~~~~~E~~~l~~l~h~niv~l~~  680 (897)
                      .++|.+.++||+|+||.||+|.+.+    +..+|+|+.......   .        ......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999998754    355677754322110   0        011223344556678999999998


Q ss_pred             eecCCC----ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          681 SCSNDD----FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       681 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      ++....    ..++++|++. .++.+.+... ...++..+..++.|++.||+||   |+++|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence            765443    4467888763 3566555443 2357888899999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhH
Q 045539          757 HISDFGIAKLLSGEDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR  831 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~  831 (897)
                      +|+|||+|+........     .......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ....
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHHH
Confidence            99999999866422211     11123469999999999999999999999999999999999999997632111 1111


Q ss_pred             HhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          832 WINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       832 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...       .+.+.+......     ....+...+.+++..|++.+| ++||+++++.+.++
T Consensus       245 ~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAK-------CDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSY-EEKPDYDALIKIFD  294 (294)
T ss_pred             HhH-------HHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCC-CCCCCHHHHHHhhC
Confidence            000       111111111100     011234568899999999999 99999999998764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-32  Score=297.47  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=193.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|.+.+ ++.||||+++... ......+.+|+.++.+.. ||||+++++++.++...|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678889999999999999998874 8999999987543 233455666777776765 999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||++ +++.+........+++..+..++.|++.|++||   |+ .||+||||+|+||++++++.+||+|||.+.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 577777665455789999999999999999999   65 699999999999999999999999999987654322


Q ss_pred             ceeeeeccccCcccCCcCccCCC----CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKG----RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .   .....++..|+|||.+...    .++.++||||||+++|+|++|+.||.........+..            .+..
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------------~~~~  234 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK------------ILQE  234 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH------------HhcC
Confidence            1   1233578899999987654    3788999999999999999999998652111101111            1111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+     .......++.+++.+|+..|| ++||+++++++.
T Consensus       235 ~~~~~~-----~~~~~~~~l~~li~~~l~~~p-~~Rp~~~~il~~  273 (296)
T cd06618         235 EPPSLP-----PNEGFSPDFCSFVDLCLTKDH-RKRPKYRELLQH  273 (296)
T ss_pred             CCCCCC-----CCCCCCHHHHHHHHHHccCCh-hhCCCHHHHhcC
Confidence            000000     000123457899999999999 999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-32  Score=302.18  Aligned_cols=267  Identities=20%  Similarity=0.255  Sum_probs=202.3

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-----ceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-----FKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  689 (897)
                      +|.+.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999876 48999999987654  344577889999999999999999999998775     789


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||++ ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58888887655 689999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCce-eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC----------
Q 045539          770 EDQL-SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL----------  837 (897)
Q Consensus       770 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------  837 (897)
                      .... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......  ...+.+....          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhh
Confidence            3210 112334578899999998877 7899999999999999999999999753211  0011111100          


Q ss_pred             --CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          838 --PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       838 --~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        .....+.+...-.................+.+++.+||+.|| ++|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP-KKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh-hhCCCHHHHHhC
Confidence              001111111100000000001111234568899999999999 999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-32  Score=296.46  Aligned_cols=266  Identities=19%  Similarity=0.250  Sum_probs=193.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999876 68999999886542  2234567889999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCccccCCCC
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~  771 (897)
                      |++ +++.+++.... ...++..+..++.||+.||+||   |++|++||||+|+||+++. ++.+||+|||.+.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57777765443 3367888889999999999999   8899999999999999985 5579999999997653221


Q ss_pred             ceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch----------
Q 045539          772 QLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS----------  840 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  840 (897)
                      .  ......+++.|+|||+..+ ..++.++||||+|+++|+|+||+.||......+ ...+... .....          
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-ILGTPNEETWPGVTS  233 (294)
T ss_pred             c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChhhcccccc
Confidence            1  1123457889999998755 457899999999999999999999996521110 1111000 00000          


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+......................++.+++.+|++.|| ++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDP-SKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCCh-hhCcCHHHHhc
Confidence            000000000000000000111234557899999999999 99999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.5e-33  Score=296.42  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|...+.||+|+||.||+|... +|+.||+|++.+..   ....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999875 68999999987532   233467889999999998 99999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987764 589999999999999999999   88999999999999999999999999999987664332


Q ss_pred             ce------------------eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          772 QL------------------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       772 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      ..                  .......++..|+|||......++.++||||||++++++++|+.||......  ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~----  230 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LT----  230 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HH----
Confidence            11                  1222345788999999988888999999999999999999999999763210  00    


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                             ......... ..+       ......+.+++.+|++.|| ++||++.+.++.+.
T Consensus       231 -------~~~~~~~~~-~~~-------~~~~~~~~~li~~~l~~~p-~~R~~~~~~~~~ll  275 (280)
T cd05581         231 -------FQKILKLEY-SFP-------PNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELK  275 (280)
T ss_pred             -------HHHHHhcCC-CCC-------CccCHHHHHHHHHHhcCCH-hhCCCcccCHHHHh
Confidence                   001110000 000       1123457899999999999 99999933333333

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-32  Score=303.44  Aligned_cols=264  Identities=23%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc----
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF----  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  687 (897)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|||++++++++..++.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999876 58899999986432  2334667789999999999999999998876654    


Q ss_pred             --eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          688 --KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       688 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                        .++|+||+ +++|.+++...  .+++.++..++.|+++||+||   |+.||+||||||+||+++.++.+||+|||.+.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999998 67999988764  489999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh----------
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN----------  834 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~----------  834 (897)
                      .....     .....++..|+|||...+ ..++.++||||+||++||+++|+.||...... ..+.....          
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHH
Confidence            65432     123457889999998754 46788999999999999999999999642111 01111110          


Q ss_pred             -hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          835 -DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       835 -~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ..........+....................++.+++.+|+..|| ++|||+.||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P-~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP-DKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCCh-hhCCCHHHHhc
Confidence             000111111111111111110111112235678899999999999 99999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-32  Score=299.34  Aligned_cols=274  Identities=21%  Similarity=0.249  Sum_probs=200.6

Q ss_pred             cCCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 045539          606 RFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC  682 (897)
Q Consensus       606 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  682 (897)
                      .....++..+.++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3345567778899999999999999999999754 68999999987542  22346678899999999999999999988


Q ss_pred             cCC------CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          683 SND------DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       683 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      ...      ...|++++++ +++|.+++...  .+++..+..++.|+++||+||   |+.||+||||||+||++++++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCE
Confidence            543      3467888887 78998887654  489999999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-  834 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-  834 (897)
                      ||+|||++......     .....++..|+|||...+ ..++.++|||||||++|||++|+.||...... ........ 
T Consensus       160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~  233 (345)
T cd07877         160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRL  233 (345)
T ss_pred             EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence            99999998764322     123457889999998755 56788999999999999999999998642111 11111110 


Q ss_pred             ---------hcCCchHHHHhhhhhcchhhhhHHH-HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          835 ---------DLLPVSVMEVIDTNLLRGEERFFAA-KEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       835 ---------~~~~~~~~~~i~~~l~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               ...+..........+...+...+.. ......++.+++.+|++.|| .+||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp-~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCCh-hhcCCHHHHhcC
Confidence                     0011110000000010000000000 00123457899999999999 999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.5e-32  Score=297.28  Aligned_cols=264  Identities=18%  Similarity=0.193  Sum_probs=191.4

Q ss_pred             cCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          621 ENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.+.+|.|+++.||++.. +++.||+|+++..  .....+.+.+|++++++++||||+++++++.+++..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555544 5899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             ChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc-----
Q 045539          699 SLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-----  772 (897)
Q Consensus       699 sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~-----  772 (897)
                      +|.+++... ...+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+|++|||.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998764 34588999999999999999999   889999999999999999999999999998875532211     


Q ss_pred             eeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc----h------
Q 045539          773 LSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV----S------  840 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~------  840 (897)
                      ........++..|+|||++..  ..++.++|||||||++|||++|+.||........ ..+......+.    .      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhc
Confidence            111123356788999998765  3578899999999999999999999975321111 11111100000    0      


Q ss_pred             --HHH----HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 --VME----VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 --~~~----~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                        ...    ..+.......  ..........++.+++.+||..|| ++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P-~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSV--DHPYTRTFSEHFHQFVELCLQRDP-ESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhh--hcchhhHHHHHHHHHHHHHhhcCC-CcCcCHHHHhcC
Confidence              000    0000000000  001112234568899999999999 999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-32  Score=300.43  Aligned_cols=263  Identities=22%  Similarity=0.268  Sum_probs=192.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      .++|...+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            479999999999999999999865 68999999986532  223456789999999999999999999986543      


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..++|+||+. .++.++..   ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4689999995 46766542   2478999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--cCCchHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--LLPVSVME  843 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  843 (897)
                      .....     ....++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+...+..  ..+....+
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            53221     23357888999998765 46889999999999999999999999752110 011111100  00001111


Q ss_pred             Hhhhh--------hcchh-hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 VIDTN--------LLRGE-ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ~i~~~--------l~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+...        ....+ ............++.+++.+|++.|| ++||+++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV-DKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            11100        00000 00000111233457899999999999 999999999854

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-32  Score=290.59  Aligned_cols=264  Identities=23%  Similarity=0.277  Sum_probs=195.8

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCccceEeeeecCCCc-----
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRI---RHRNLVKIISSCSNDDF-----  687 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  687 (897)
                      |++.+.||+|+||.||+|+++ +++.||+|+++....  .....+.+|+.+++++   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999987 489999999874322  2234566788777766   59999999999988776     


Q ss_pred             eEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          688 KALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      .+++|||+.+ +|.+++.... ..+++.++..++.|+++||+||   |+.+++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999964 7888876643 3589999999999999999999   889999999999999999999999999999877


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh-
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI-  845 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i-  845 (897)
                      ......   .....++..|+|||+..+..++.++|||||||++|||++|+.||..... .....++............. 
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            643322   1223478889999999888899999999999999999999999875221 11122221111100000000 


Q ss_pred             -----hhhhcchhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 -----DTNLLRGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 -----~~~l~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           .......... ......+....+.+++.+||+.|| ++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp-~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNP-HKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCC-ccCCCHHHHhc
Confidence                 0000000000 011122445677899999999999 99999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.5e-32  Score=294.07  Aligned_cols=244  Identities=24%  Similarity=0.280  Sum_probs=192.6

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      |...+.||+|+||.||+|+.. +|+.||+|++...   .....+.+.+|++++++++|||++++++++.+++..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999865 5889999998643   233446788899999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +. +++.+++......+++.++..++.|++.|++||   |+.|++||||+|+||+++.++.+||+|||.+......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            95 577777766556689999999999999999999   8899999999999999999999999999988643221    


Q ss_pred             eeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          775 IQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        ....|+..|+|||++.   .+.++.++|||||||++|||++|..||......  .....           ........
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~-----------~~~~~~~~  239 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-----------IAQNDSPT  239 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-----------HHhcCCCC
Confidence              2345888999999873   466888999999999999999999998652111  00000           00000000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..      .......+.+++.+|++.+| .+||++.|+++.
T Consensus       240 ~~------~~~~~~~l~~li~~~l~~~P-~~Rp~~~~~l~~  273 (313)
T cd06633         240 LQ------SNEWTDSFRGFVDYCLQKIP-QERPASAELLRH  273 (313)
T ss_pred             CC------ccccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            00      01122347889999999999 999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-32  Score=295.18  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=194.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +.|...+.||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|+++++.++|+|++++++++.+++..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999865 5788999988632   2334467788999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+. +++.+.+......+++.++..++.|++.|++||   |+.+++||||+|+||+++.++.+||+|||.+......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 588777765555689999999999999999999   8899999999999999999999999999998765432  


Q ss_pred             eeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          773 LSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                          ....+++.|+|||...   .+.++.++|||||||++|+|++|+.||...... .....+.            ....
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~------------~~~~  231 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA------------QNES  231 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHh------------hcCC
Confidence                2345788999999863   456788999999999999999999998652110 0000000            0000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       ...     ........+.+++.+||+.+| ++||++++|++.
T Consensus       232 -~~~-----~~~~~~~~~~~li~~cl~~~P-~~Rp~~~~ll~~  267 (308)
T cd06634         232 -PAL-----QSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKH  267 (308)
T ss_pred             -CCc-----CcccccHHHHHHHHHHhhCCc-ccCCCHHHHhhC
Confidence             000     001233457899999999999 999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=318.82  Aligned_cols=206  Identities=26%  Similarity=0.373  Sum_probs=183.2

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD  686 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  686 (897)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||.|++.+..   .....-|..|-++|..-..+=|++++..|+++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44445679999999999999999999876 68999999998743   334567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      +.|+|||||+||+|-..+.... ++++..+.-++..|+-||..+   |+.|+|||||||+|||+|..|++||+|||.+..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998877 799999999999999999999   999999999999999999999999999999988


Q ss_pred             cCCCCceeeeeccccCcccCCcCccC----C-CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGT----K-GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      +..++. ......+|||-|++||++.    + +.|++.+|.||+||++|||+.|..||..
T Consensus       225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            875544 3445668999999999753    3 6899999999999999999999999975

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.2e-32  Score=292.33  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             CCCcCCeeecccceEEEEEEe----cCCceEEEEEechhhH----HHHHHHHHHHHHHHhc-CCCccceEeeeecCCCce
Q 045539          618 RFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQQYE----RALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  688 (897)
                      +|++.+.||+|+||.||.|+.    .+|+.||+|+++....    ...+.+.+|+++++++ +|++|++++++++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999976    3688999999875432    2346678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |+||||+++++|.+++.... .+++..+..++.|+++||+||   |+.|++||||+|+||++++++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 578889999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCceeeeeccccCcccCCcCccCCC--CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKG--RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .... .......|+..|+|||.....  .++.++||||||+++|+|++|+.||...... ..            ..++.+
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~------------~~~~~~  222 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NS------------QAEISR  222 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-cc------------HHHHHH
Confidence            3221 112234588999999987653  4678999999999999999999998642111 01            111111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      ......++ .   .......+.+++.+|++.|| ++||     +++++++
T Consensus       223 ~~~~~~~~-~---~~~~~~~~~~ll~~~l~~~p-~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 RILKSEPP-Y---PQEMSALAKDIIQRLLMKDP-KKRLGCGPSDADEIKK  267 (290)
T ss_pred             HhhccCCC-C---CccCCHHHHHHHHHHhcCCH-HHhcCCCCCCHHHHHc
Confidence            11111110 0   01123457889999999999 9997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=2.8e-32  Score=297.66  Aligned_cols=270  Identities=21%  Similarity=0.240  Sum_probs=194.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCC-------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSND-------  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  685 (897)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999865 589999998864322  1234567899999999999999999987443       


Q ss_pred             -CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 -DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                       ...++||||+.+ ++.+.+......+++.++..++.|+++||+||   |++||+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999964 67777666555799999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCcee---------eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh
Q 045539          765 KLLSGEDQLS---------IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       765 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~  834 (897)
                      ..........         ......+++.|+|||...+ ..++.++|||||||++|||++|+.||....... .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            7654322111         1123356888999997654 457899999999999999999999986522110 0011000


Q ss_pred             h---cCCch------HHHHhh-hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          835 D---LLPVS------VMEVID-TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       835 ~---~~~~~------~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .   ..+..      .....+ ......+.............+.+++.+|++.|| ++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p-~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP-YKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCc-ccCcCHHHHhc
Confidence            0   00000      000000 000000000011112233568899999999999 99999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=2.3e-32  Score=294.70  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             CCCcCCeeecccceEEEEEEec----CCceEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCce
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY----ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  688 (897)
                      +|++.+.||+|++|.||+|+..    +++.||+|++++..    ....+.+.+|+++++++ +||+|+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999743    57889999987542    22346788999999999 499999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++.... .+++..+..++.|+++||+||   |+.|++||||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887653 588999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCC--CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGR--VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .... .......|+..|+|||...+..  .+.++||||||+++|||++|..||...... ....            ++..
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~------------~~~~  222 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS------------EISR  222 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH------------HHHH
Confidence            3321 1122345889999999876654  688999999999999999999998642111 0001            1111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......++    ........+.+++.+|++.|| ++|||+.++.+.|+
T Consensus       223 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p-~~R~t~~~~~~~l~  265 (288)
T cd05583         223 RILKSKPP----FPKTMSAEARDFIQKLLEKDP-KKRLGANGADEIKN  265 (288)
T ss_pred             HHHccCCC----CCcccCHHHHHHHHHHhcCCH-hhccCcchHHHHhc
Confidence            11111010    001123457889999999999 99999888766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-35  Score=328.95  Aligned_cols=449  Identities=26%  Similarity=0.337  Sum_probs=305.7

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +++.|+++.|-+-...-+.+.+--+|+.||||+|+++ ..|..+..+.+|+.|+++.|-|. ..|....++.+|++|.|.
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence            3777888777655322234444555999999999987 78888999999999999999885 455788888999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      +|++. ..|.++..+++|++|+++.|++... |..+..++.+..+..++|.....++.      ..++.++|..|.+.+.
T Consensus       100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~-Pl~i~~lt~~~~~~~s~N~~~~~lg~------~~ik~~~l~~n~l~~~  171 (1081)
T KOG0618|consen  100 NNRLQ-SLPASISELKNLQYLDLSFNHFGPI-PLVIEVLTAEEELAASNNEKIQRLGQ------TSIKKLDLRLNVLGGS  171 (1081)
T ss_pred             cchhh-cCchhHHhhhcccccccchhccCCC-chhHHhhhHHHHHhhhcchhhhhhcc------ccchhhhhhhhhcccc
Confidence            99888 7899999999999999999998776 66688889999999999943323332      2278889999999999


Q ss_pred             ccccccCCCcccEEEccccccccccCcccccc-----ccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCccc
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNM-----ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG  311 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l-----~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  311 (897)
                      ++..+.+++.  .|||.+|.+....-..+.++     ..|+++..         -...++|+.|+.+.|.++...+.   
T Consensus       172 ~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l---------~~~g~~l~~L~a~~n~l~~~~~~---  237 (1081)
T KOG0618|consen  172 FLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSEL---------EISGPSLTALYADHNPLTTLDVH---  237 (1081)
T ss_pred             hhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceE---------EecCcchheeeeccCcceeeccc---
Confidence            9988888888  89999998872221111111     11111110         01224555555555555532211   


Q ss_pred             CchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccc
Q 045539          312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHS  391 (897)
Q Consensus       312 ~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  391 (897)
                      ..+.+|+++++++|++++ +|++++.+.+|+.++..+|+|+. +|..+...++|+.|.+.+|.+. .+|+....+++|++
T Consensus       238 p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~~-lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~t  314 (1081)
T KOG0618|consen  238 PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLVA-LPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRT  314 (1081)
T ss_pred             cccccceeeecchhhhhc-chHHHHhcccceEecccchhHHh-hHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeee
Confidence            112245555666666553 33555666666666666666643 5555555556666666666655 44555555556666


Q ss_pred             ccccccccccCCCccc-ccccc-cceeccccccccCCccccccccccceEEeecCCccc-----------ccceeecccC
Q 045539          392 LVLQGNKFSGSIPSCL-GNLTS-LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN-----------VLIGLNFSRN  458 (897)
Q Consensus       392 L~L~~N~l~~~~p~~~-~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----------~l~~l~ls~n  458 (897)
                      |+|..|+|. ..|+.+ .-+.. |..|+.+.|++....-..=..+..|+.|.+.+|.|+           .|+.|+|++|
T Consensus       315 LdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN  393 (1081)
T KOG0618|consen  315 LDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN  393 (1081)
T ss_pred             eeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence            666666665 344332 22222 555555555555322222223456777777777764           4777888888


Q ss_pred             cCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc-ccCC
Q 045539          459 NLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE-GEIP  537 (897)
Q Consensus       459 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p  537 (897)
                      +|.......+.++..|++|+||+|+|+ .+|.++.+++.|++|...+|+|. ..| ++.++++|+.+|||.|+|+ +.+|
T Consensus       394 rL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~  470 (1081)
T KOG0618|consen  394 RLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLP  470 (1081)
T ss_pred             ccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhh
Confidence            887666667788888888888888888 68888888888888888888887 677 8889999999999999997 4566


Q ss_pred             CCCCCCCCCcccccchhhh
Q 045539          538 RGGPFANLTAKSFMGNELL  556 (897)
Q Consensus       538 ~~~~~~~~~~~~~~~N~~~  556 (897)
                      ..-+.+++..+.+.||.++
T Consensus       471 ~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  471 EALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhCCCcccceeeccCCccc
Confidence            6666688889999999853

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=3.3e-32  Score=300.67  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=194.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCC---------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSND---------  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  685 (897)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999865 5899999998765555567788999999999999999999876543         


Q ss_pred             -----CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEe
Q 045539          686 -----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHIS  759 (897)
Q Consensus       686 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~  759 (897)
                           ...|+||||++ ++|.+++...  .+++..+..++.|+++||+||   |+.||+||||||+||+++ +++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 5888887654  488999999999999999999   889999999999999997 45678999


Q ss_pred             eccCccccCCCCce-eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          760 DFGIAKLLSGEDQL-SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       760 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      |||.+......... .......++..|+|||.... ..++.++|||||||++|+|++|+.||....... ........ .
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES-V  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-c
Confidence            99998765322111 11122357889999997544 567889999999999999999999996531110 01111100 0


Q ss_pred             Cch----HHH---Hhhhhhc---chhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          838 PVS----VME---VIDTNLL---RGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       838 ~~~----~~~---~i~~~l~---~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +..    ..+   .......   ..... ..........++.+++.+|++.|| ++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP-MDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc-hhccCHHHHhC
Confidence            000    000   0000000   00000 000111234567899999999999 99999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=6.2e-32  Score=298.00  Aligned_cols=270  Identities=19%  Similarity=0.204  Sum_probs=195.3

Q ss_pred             hcCCCc-CCeeecccceEEEEEEec-CCceEEEEEechhhHHH--------------HHHHHHHHHHHHhcCCCccceEe
Q 045539          616 TDRFSE-NNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERA--------------LKSFEDECEVMKRIRHRNLVKII  679 (897)
Q Consensus       616 ~~~y~~-~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  679 (897)
                      .++|.. .+.||+|+||.||+|... +++.||+|+++......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            457764 477999999999999865 68999999986432111              12467899999999999999999


Q ss_pred             eeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEe
Q 045539          680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS  759 (897)
Q Consensus       680 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~  759 (897)
                      +++..++..++||||++ ++|.+++.... .+++.....++.|++.||+||   |+.||+||||+|+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 68988886544 489999999999999999999   89999999999999999999999999


Q ss_pred             eccCccccCCCCc------------eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCc
Q 045539          760 DFGIAKLLSGEDQ------------LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE  826 (897)
Q Consensus       760 DFg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~  826 (897)
                      |||.+........            ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999876541110            0111223467889999987654 46889999999999999999999987532111


Q ss_pred             cchhHHhh---hcCCchHHHHh-----hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          827 LSLNRWIN---DLLPVSVMEVI-----DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       827 ~~~~~~~~---~~~~~~~~~~i-----~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       .+.....   ........+..     .+.....+............++.+++.+|++.|| ++|||++|++..
T Consensus       242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~s~~~~l~~  313 (335)
T PTZ00024        242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP-LERISAKEALKH  313 (335)
T ss_pred             -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc-hhccCHHHHhcC
Confidence             0111100   00000000000     0000000000011111224567899999999999 999999999863

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=288.81  Aligned_cols=265  Identities=19%  Similarity=0.246  Sum_probs=195.6

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEec
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      |.+.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999876 478899999875432 22234457999999999 999999999999999999999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                       +++|.+++.... ..+++.++..++.|++.+|.||   |++|++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             789988887654 4689999999999999999999   889999999999999999999999999999976543221  


Q ss_pred             eeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh---hhcCCchHHH------H
Q 045539          775 IQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI---NDLLPVSVME------V  844 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~------~  844 (897)
                       .....++..|+|||+.. ...++.++||||||++++||++|+.||......+ ......   .........+      .
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             12345788999999764 4557899999999999999999999986531110 000000   0000000000      0


Q ss_pred             hhhhhcchhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+..+...... ...........+.+++.+|++.|| ++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p-~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDP-KKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCc-ccCCCHHHHhhC
Confidence            00000000000 000011113568899999999999 999999999763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.3e-31  Score=287.20  Aligned_cols=242  Identities=22%  Similarity=0.260  Sum_probs=184.4

Q ss_pred             eeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHH---HHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          624 LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECE---VMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .||+|+||.||+|+.. +++.||+|.+.+...   .....+..|..   .++...||+|+++++++.+++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999765 588999998865321   11122333433   3444579999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      |++|.+++.... .+++..+..++.|+++|++||   |+.+|+||||||+||+++.++.+||+|||.+.......    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999886543 689999999999999999999   88999999999999999999999999999987553221    1


Q ss_pred             eccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....|+..|+|||...++ .++.++||||+|+++|||++|+.||.........  .         ......   ...+. 
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~---------~~~~~~---~~~~~-  217 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E---------IDRMTL---TMAVE-  217 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--H---------HHHHhh---ccCCC-
Confidence            234689999999998654 6889999999999999999999999763211100  0         000000   00000 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                      ..   .....++.+++.+|+..|| ++||     ++.|+++.
T Consensus       218 ~~---~~~s~~~~~li~~~l~~~p-~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LP---DSFSPELRSLLEGLLQRDV-NRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CC---CcCCHHHHHHHHHHhhcCH-HhccCCCCCCHHHHHhC
Confidence            00   0123457889999999999 9999     99999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=8.1e-32  Score=289.56  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=198.8

Q ss_pred             CCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999876 48999999988653  333467788999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      + ++|.+++......+++..+..++.|++.||+||   |+.||+||||+|+||++++++.+||+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 589999987645689999999999999999999   889999999999999999999999999999876543221  1


Q ss_pred             eeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC---ch-HHHHh-----
Q 045539          776 QIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP---VS-VMEVI-----  845 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~i-----  845 (897)
                      .....++..|+|||..... .++.++||||||+++||+++|+.||......  .....+.....   .. .....     
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            2233457789999987666 7899999999999999999999998652111  00001100000   00 00000     


Q ss_pred             hhhhcchhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 DTNLLRGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 ~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +........... .........+.+++.+|++.|| ++||+++||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P-~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNP-AKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCc-ccCCCHHHHhh
Confidence            000000000000 1111224568999999999999 99999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=270.13  Aligned_cols=200  Identities=26%  Similarity=0.336  Sum_probs=176.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|...++||+|.||.|..++-+ +|+.||+|++++..   .+....-..|-++|+..+||.+..+...|+..+..|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999765 69999999998764   33445567899999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+.||.|.-.+...+ .+++....-+-..|+.||.||   |+++||.||+|.+|.++|.+|.+||+|||+++.--  .
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K  320 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhcc--c
Confidence            99999999988776654 478888888999999999999   88999999999999999999999999999997532  2


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ........+|||.|+|||++....|+.++|.|.+|||+|||+.|+.||..
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            22344567899999999999999999999999999999999999999976

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-33  Score=290.90  Aligned_cols=194  Identities=26%  Similarity=0.451  Sum_probs=172.5

Q ss_pred             CCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCC
Q 045539          622 NNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      .++||+|.||+||-|.++ +|+.||||++.+..  .+....+++|+.||+++.||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            488999999999999765 79999999987543  334478899999999999999999999999999999999999776


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC---CcEEEeeccCccccCCCCceee
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      -|+-.+.....++++....-++.||+.||+||   |-++|+|+|+||+|||+...   -.+||+|||+|+++++..   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            66666666667899999999999999999999   88999999999999999643   389999999999986543   3


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ...++||+.|+|||++....|...-|+||.|||+|.-++|..||.+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            4567899999999999999999999999999999999999999976

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.5e-32  Score=283.86  Aligned_cols=244  Identities=28%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             eecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      ||+|+||.||++... +++.||+|++.....   ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999876 589999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL  780 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~  780 (897)
                      .+++.... .+++..+..++.|++.|+.|+   |+.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987664 489999999999999999999   88999999999999999999999999999987654332  1123446


Q ss_pred             cCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       781 gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||.....     ...        ...+.....  ..+      
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~--------~~~~~~~~~--~~~------  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI--------YEKILKDPL--RFP------  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH--------HHHHhcCCC--CCC------
Confidence            78899999998888889999999999999999999999965211     000        001111000  000      


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          861 EQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                      ......+.+++.+|+..|| ++||++.+ ++.+.++|
T Consensus       214 ~~~~~~l~~~i~~~l~~~p-~~R~~~~~-~~~l~~~~  248 (250)
T cd05123         214 EFLSPEARDLISGLLQKDP-TKRLGSGG-AEEIKAHP  248 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCH-hhCCCccc-HHHHHhCC
Confidence            0113457889999999999 99999955 44444443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.4e-31  Score=294.70  Aligned_cols=266  Identities=21%  Similarity=0.240  Sum_probs=191.5

Q ss_pred             CCCcCCeeecccceEEEEEEec-C--CceEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCccceEeeeecC----CCc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-D--GMEVAVKVFHQQY--ERALKSFEDECEVMKRIR-HRNLVKIISSCSN----DDF  687 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----~~~  687 (897)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|++++++++ ||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5788899999999999999865 3  7789999986432  223456788999999994 9999999987532    245


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+++||+. ++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||.+...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999985 68988886544 589999999999999999999   8999999999999999999999999999999865


Q ss_pred             CCCCce--eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch----
Q 045539          768 SGEDQL--SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS----  840 (897)
Q Consensus       768 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  840 (897)
                      ......  .......|+..|+|||...+ ..++.++||||+||++|++++|+.||.....  ......+.......    
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence            432211  11223468999999997655 4688999999999999999999999865211  01111111000000    


Q ss_pred             HHHHhh-------hhhcchhhhhHH-HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 VMEVID-------TNLLRGEERFFA-AKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ~~~~i~-------~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...+..       ......+...+. ........+.+++.+|++.|| ++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P-~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP-TKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCc-ccCCCHHHHhc
Confidence            000000       000000000011 011123568899999999999 99999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.4e-31  Score=318.05  Aligned_cols=146  Identities=28%  Similarity=0.451  Sum_probs=131.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.++||+|+||.||+|++. +++.||+|+++...   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999876 68999999987542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      |||+++++|.+++.... .+++..++.++.||+.||+||   |++||+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987644 578899999999999999999   78899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2e-31  Score=282.87  Aligned_cols=247  Identities=22%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             CCCcCCeeecccceEEEEEEecC-CceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      +|.+.+.||+|+||.||+|++.. +..+++|+++...     ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999997653 4556666654321     22334567899999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |||+++++|.+++..   ....+++.++..++.|++.|++||   |++|++|+||+|+||++++ +.+||+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988763   234689999999999999999999   8999999999999999975 569999999987664


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....  ......|++.|+|||......++.++||||||+++|+|++|..||.....     .            +.....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~------------~~~~~~  217 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----L------------SVVLRI  217 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----H------------HHHHHH
Confidence            3222  22234578899999998888888999999999999999999999864210     0            111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ........   ......++.+++.+|++.|| ++||++.|+++
T Consensus       218 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p-~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTPSL---PETYSRQLNSIMQSMLNKDP-SLRPSAAEILR  256 (260)
T ss_pred             HcCCCCCC---cchhcHHHHHHHHHHhcCCh-hhCcCHHHHhh
Confidence            11111000   11233467889999999999 99999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=277.90  Aligned_cols=262  Identities=19%  Similarity=0.247  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-C-C----ccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-H-R----NLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  688 (897)
                      +++|.+...+|+|.||.|-.+.+. .+..||+|+++.- ....+..+-|+++++++. + |    -+|.+.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            789999999999999999999765 4788999998754 444566677999999994 2 2    378888999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---------------
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---------------  752 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---------------  752 (897)
                      |+|+|.+ |.++.+++..+. .+++...+..++.|+++++++|   |+.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 779999998865 7799999999999999999999   9999999999999999931               


Q ss_pred             -----CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc-
Q 045539          753 -----DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE-  826 (897)
Q Consensus       753 -----~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~-  826 (897)
                           ...+|++|||.|+......     ...+.|..|+|||++.+-.++.++||||+||||+|+.||..-|....+.+ 
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 2368999999998754332     45678999999999999999999999999999999999999887643211 


Q ss_pred             cchhHHhhhcCCchHHHHhhhh------------------------hcc---hhhhhHHHHHHHHHHHHHHHhHccCCCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTN------------------------LLR---GEERFFAAKEQILLSVLNLATECTIESR  879 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~------------------------l~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP  879 (897)
                      ..+.+.+...+|..   ++.+.                        ..+   .........+....++.+++.+++..||
T Consensus       318 LaMMerIlGp~P~~---mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  318 LAMMERILGPIPSR---MIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHhhCCCcHH---HhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            11222222222221   11111                        000   0001111223445679999999999999


Q ss_pred             CCCCCCHHHHHh
Q 045539          880 DGNGADMGWIFS  891 (897)
Q Consensus       880 ~~~RPt~~evl~  891 (897)
                       .+|+|+.|++.
T Consensus       395 -~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 -ARRITLREALS  405 (415)
T ss_pred             -cccccHHHHhc
Confidence             99999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-33  Score=272.09  Aligned_cols=258  Identities=26%  Similarity=0.314  Sum_probs=195.3

Q ss_pred             cccCCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEee
Q 045539          604 IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIIS  680 (897)
Q Consensus       604 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  680 (897)
                      ...|+-++++.       ...||.|+||+|++..++ .|+..|||+++... ..+.+++..|.+...+- +.|+||++||
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            44455444443       467999999999998765 69999999997554 35668888888877666 5899999999


Q ss_pred             eecCCCceEEEEEeccCCChhHhh---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          681 SCSNDDFKALIMKYMPNGSLENCL---YS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       681 ~~~~~~~~~lv~e~~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      .+..++..++.||.| ..+++.+.   +. ....+++.-.-.|+...+.||.||.  ....|+|||+||+|||++..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCE
Confidence            999999999999999 45665532   21 2245788888889999999999996  56679999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~  834 (897)
                      ||||||.+....+.   ...+...|...|||||-+..  ..|+.+|||||+|+++||+.||+.||..-.           
T Consensus       208 KLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----------  273 (361)
T KOG1006|consen  208 KLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----------  273 (361)
T ss_pred             eeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----------
Confidence            99999998665322   22345578999999997643  358899999999999999999999986511           


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHH--HHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAK--EQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           .+.+-+.....+.++......  -+....+.+++..|+.+|- ..||...++.+
T Consensus       274 -----svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~-~~Rpky~~Lk~  326 (361)
T KOG1006|consen  274 -----SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDR-SDRPKYDDLKK  326 (361)
T ss_pred             -----HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhccc-ccCcchhhhhc
Confidence                 122222222333333211111  1345678999999999999 99999998765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=293.19  Aligned_cols=240  Identities=22%  Similarity=0.235  Sum_probs=194.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++.|.....+|.|+|+.|-.+... +++.+++|++.+..    ....+|+.++... +||||+++.+.+.++.+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3668888899999999999998654 68999999998662    2334577777666 5999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee-CCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll-~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |.+.|+-+.+.+....  ....++..|+.+|+.|+.||   |++||||||+||+|||+ ++.+.++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999998888777655  23367788999999999999   89999999999999999 58999999999999876543 


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                          ....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+                .++..+...+
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------~ei~~~i~~~  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------IEIHTRIQMP  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------HHHHHhhcCC
Confidence                22335688999999999999999999999999999999999999874222                1111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...      +.+.....+++.+|++.|| .+||+|+++..
T Consensus       530 ~~s------~~vS~~AKdLl~~LL~~dP-~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 KFS------ECVSDEAKDLLQQLLQVDP-ALRLGADEIGA  562 (612)
T ss_pred             ccc------cccCHHHHHHHHHhccCCh-hhCcChhhhcc
Confidence            111      3445567899999999999 99999999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=281.35  Aligned_cols=205  Identities=27%  Similarity=0.422  Sum_probs=172.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEec--hhhH-----HHHHHHHHHHHHHHhcCCCccceEeeeec-CCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFH--QQYE-----RALKSFEDECEVMKRIRHRNLVKIISSCS-NDD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~--~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  686 (897)
                      .++|-...+||+|+|++||+|.+ ...+.||||+-.  +.+.     ...+...+|.+|-+.+.||.||++|+||. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35788889999999999999964 457889999753  3332     23455678999999999999999999995 567


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccC
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGI  763 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~  763 (897)
                      .+|-|.|||+|.+|+-|++... .+++.++..|+.||+.||.||.+ -+..|+|-|+||.|||+.   ..|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            8899999999999999988775 58999999999999999999964 567899999999999995   457999999999


Q ss_pred             ccccCCCCce-----eeeeccccCcccCCcCccCC----CCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          764 AKLLSGEDQL-----SIQIQTLATIGYMAPEYGTK----GRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       764 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      +++++++...     .......||.+|++||.+.-    ...+.|+||||.|||+|+.+.|+.||...
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            9998765433     23445679999999997543    35688999999999999999999999763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=6.9e-32  Score=266.31  Aligned_cols=202  Identities=24%  Similarity=0.327  Sum_probs=167.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec---C--CceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecC-CCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ---D--GMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSN-DDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  687 (897)
                      ...|+....||+|.||.||+|.-.   +  .+.+|+|.++....  .......+|+..++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            457899999999999999999533   2  23799999876532  223456789999999999999999999976 788


Q ss_pred             eEEEEEeccCCChhHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC----CcEEEe
Q 045539          688 KALIMKYMPNGSLENCLYSGT----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED----MVAHIS  759 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~----~~~kL~  759 (897)
                      .++++||.+. +|.+.++...    ..++...+..|+.||+.|+.||   |+.=|+|||+||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999965 6777665332    5688899999999999999999   89999999999999999877    899999


Q ss_pred             eccCccccCCCCce-eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          760 DFGIAKLLSGEDQL-SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       760 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      |||+|+.+...-.. .....++-|.+|+|||.+.+. .|+++.||||.|||+.||+|-.+-|..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999988643322 233456789999999987664 679999999999999999999887765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=3.9e-31  Score=276.23  Aligned_cols=230  Identities=17%  Similarity=0.150  Sum_probs=179.6

Q ss_pred             ccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChhHhhhc
Q 045539          628 GSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS  706 (897)
Q Consensus       628 G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  706 (897)
                      |.+|.||+|++. +++.||+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 68999999987653     233455555566799999999999999999999999999999998876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccC
Q 045539          707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM  786 (897)
Q Consensus       707 ~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  786 (897)
                      .. .+++..+..++.|+++||+||   |++||+||||||+||+++.++.++++|||.+.......     ....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence            54 489999999999999999999   89999999999999999999999999999876554321     2234577899


Q ss_pred             CcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHH
Q 045539          787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLS  866 (897)
Q Consensus       787 aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  866 (897)
                      |||......++.++||||+|+++|||++|+.|+.......               .......+   +       .....+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~~---~-------~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLNI---P-------EWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccCC---c-------ccCCHH
Confidence            9999888888999999999999999999998865421100               00000000   0       012245


Q ss_pred             HHHHHhHccCCCCCCCCCCHHHH-HhhcCCCC
Q 045539          867 VLNLATECTIESRDGNGADMGWI-FSALDPNP  897 (897)
Q Consensus       867 l~~l~~~cl~~dP~~~RPt~~ev-l~~L~~~~  897 (897)
                      +.+++.+|++.|| ++||++.+. ++++.+||
T Consensus       205 ~~~li~~~l~~dp-~~R~~~~~~~~~~~~~h~  235 (237)
T cd05576         205 ARSLLQQLLQFNP-TERLGAGVAGVEDIKSHP  235 (237)
T ss_pred             HHHHHHHHccCCH-HHhcCCCccchHHHHcCC
Confidence            7889999999999 999997433 44444444

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=240.76  Aligned_cols=196  Identities=23%  Similarity=0.367  Sum_probs=169.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .+|...++||+|.||+||+|+.. +++.||+|+++-..  +.......+|+-+++.++|+|||+++++...+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35677889999999999999865 58899999987554  2334667899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      || ..+|..+...-.+.++.+.+..++.|+++||.++   |++++.|||+||.|.+++.+|+.|++|||+|+.++-+  .
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgip--v  155 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V  155 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence            99 5588888877777799999999999999999999   8999999999999999999999999999999877533  3


Q ss_pred             eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCC
Q 045539          774 SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKP  818 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p  818 (897)
                      ......+-|.+|++|.++.+. -|+...|+||.|||+.|+.....|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            344456789999999988775 468889999999999999985555

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-31  Score=307.63  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec----C----CceEEEEEechhh-HHHHHHHHHHHHHHHhcC-CCccceEeeeecC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ----D----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIR-HRNLVKIISSCSN  684 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  684 (897)
                      ..++..+.+.+|+|+||.||+|...    .    ...||||..+... ..+.+.+..|+++++.+. ||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3444566679999999999999632    1    4569999987554 345678999999999995 9999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCee
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVL  749 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIl  749 (897)
                      ++..++|+||++.|+|.++++..+               ..++..+...++.|||.|++||   ++.++||||+..+||+
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEE
Confidence            999999999999999999998776               3488899999999999999999   8999999999999999


Q ss_pred             eCCCCcEEEeeccCccccCCCCceeeeecccc--CcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCc
Q 045539          750 LDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGE  826 (897)
Q Consensus       750 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~  826 (897)
                      +.++..+||+|||+|+.....+..... ...|  ...|||||.+....++.+||||||||++||++| |..||.....  
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--  527 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--  527 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence            999999999999999976554443322 2223  345999999999999999999999999999999 8888865210  


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                    ..+++. .+..+.  |.+..+.+..++.++|..||+.+| ++||++.|+.+.++.
T Consensus       528 --------------~~~l~~-~l~~G~--r~~~P~~c~~eiY~iM~~CW~~~p-~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  528 --------------TEELLE-FLKEGN--RMEQPEHCSDEIYDLMKSCWNADP-EDRPTFSECVEFFEK  578 (609)
T ss_pred             --------------HHHHHH-HHhcCC--CCCCCCCCCHHHHHHHHHHhCCCc-ccCCCHHHHHHHHHH
Confidence                          111111 121111  112223456678899999999999 999999999988754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.2e-32  Score=262.15  Aligned_cols=268  Identities=20%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC--------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN--------  684 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  684 (897)
                      .+.|+...+||+|.||+||+|+.+ +|++||+|++-...  ........+|+++++.++|+|++.++++|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            346777789999999999999876 58889998754322  2223445689999999999999999998843        


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ....|+||++|+. +|...+.....+++..++.+++.++..||.|+   |+..|+|||+||.|++|+.+|.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            2357999999964 78888888777899999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCc--eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-------
Q 045539          765 KLLSGEDQ--LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-------  834 (897)
Q Consensus       765 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-------  834 (897)
                      +.+...+.  ....+..+-|.+|++||.+.+ ..++++.|||+.|||+.||+||.+-+......  .....+.       
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~t  249 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSIT  249 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCC
Confidence            76643222  112344567999999997654 57899999999999999999999887653221  1111111       


Q ss_pred             -hcCCc----hHHHHhhhhhcchhhhhHHHHHHHH------HHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          835 -DLLPV----SVMEVIDTNLLRGEERFFAAKEQIL------LSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       835 -~~~~~----~~~~~i~~~l~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       +.+|.    .+.+.+..  ..-++..+...+...      .+..+++..++..|| .+|+++++++..
T Consensus       250 kevWP~~d~lpL~~sie~--ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP-~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIEL--EPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP-TKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccC--CCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc-ccCcchHhhhch
Confidence             11111    12222210  000110111111111      145788889999999 999999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=270.08  Aligned_cols=200  Identities=25%  Similarity=0.312  Sum_probs=171.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  690 (897)
                      ..+|....+||+|+||.|.+|+.+ +.+.||||++++..   .++.+--+.|-++|..-. -|.+++++.+|+.-+..|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457999999999999999999766 46779999998753   222333345667776664 7899999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+.||+|-..+++-+ .+.+..+.-++..||-||-+|   |++||+.||+|.+|||+|.+|.+||+|||+++.---+
T Consensus       428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            999999999988877665 477778888999999999999   9999999999999999999999999999999753222


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      +  ..+...+|||.|+|||++...+|+..+|.|||||++|||+.|++||+.
T Consensus       504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            2  234467899999999999999999999999999999999999999987

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=289.57  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=208.3

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeec-
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCS-  683 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-  683 (897)
                      ..++.+...++.|++.+.||.|.+|.||+++.. +|+.+|+|+...... ..++++.|.++++... |||++.+||+|. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344444555788999999999999999999754 689999999876533 3366778999999985 999999999984 


Q ss_pred             ----CCCceEEEEEeccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          684 ----NDDFKALIMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       684 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                          .++..++|||||.+|+..|.++.. +..+.|..+.-|++.++.|+.||   |+..++|||||-.||+++.++.+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEE
Confidence                457899999999999999987653 36789999999999999999999   8999999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      +|||.+.....  .........||+.|||||++..     ..|+.++|+||+|++..||.-|.+|+.+....        
T Consensus       165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------  234 (953)
T KOG0587|consen  165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------  234 (953)
T ss_pred             eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------
Confidence            99999876543  2334455689999999998643     35778999999999999999999998774221        


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                              ..++.  +.++|+......+....++.+++..|+..|- ++||++.++++
T Consensus       235 --------raLF~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~-e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 --------RALFL--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDY-EQRPSTEELLK  281 (953)
T ss_pred             --------hhhcc--CCCCCCccccchhhHHHHHHHHHHHHHhhcc-ccCcchhhhcc
Confidence                    11111  1112222233344566789999999999999 99999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4.6e-30  Score=297.26  Aligned_cols=266  Identities=21%  Similarity=0.225  Sum_probs=170.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-C----CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeee------ec
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-D----GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS------CS  683 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  683 (897)
                      ..++|...+.||+|+||.||+|++. +    +..||+|++......  +....|  .++...+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999875 4    689999987643221  111111  1111122222222221      24


Q ss_pred             CCCceEEEEEeccCCChhHhhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCC
Q 045539          684 NDDFKALIMKYMPNGSLENCLYSGTCML-------------------DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK  744 (897)
Q Consensus       684 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlk  744 (897)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+||   |++||+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence            5678899999999999999887543111                   1234567999999999999   88999999999


Q ss_pred             CCCeeeCC-CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC----------------------CCCccch
Q 045539          745 PSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG----------------------RVCTRGD  801 (897)
Q Consensus       745 p~NIll~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  801 (897)
                      |+|||++. ++.+||+|||+|+....... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 57999999999986543221 223345689999999954221                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc-CC-chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCC
Q 045539          802 VYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL-LP-VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESR  879 (897)
Q Consensus       802 v~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  879 (897)
                      |||+||++|||+++..|++....   .+.+.+... .. ......+...........+...+.......+++.+|++.||
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            99999999999998777553210   011111100 00 00111111110000000011111112345689999999999


Q ss_pred             CCCCCCHHHHHhh
Q 045539          880 DGNGADMGWIFSA  892 (897)
Q Consensus       880 ~~~RPt~~evl~~  892 (897)
                       ++|||++|+++.
T Consensus       439 -~kR~ta~e~L~H  450 (566)
T PLN03225        439 -RQRISAKAALAH  450 (566)
T ss_pred             -ccCCCHHHHhCC
Confidence             999999999873

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=278.52  Aligned_cols=198  Identities=24%  Similarity=0.360  Sum_probs=176.5

Q ss_pred             cCCCcCCeeecccceEEEEEEecCC-ceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDG-MEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++..+..||-|+||.|-.++.... ..+|+|++++..   .+..+.+..|-.||...+.|.||++|..|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            3455667899999999999987643 348999887653   344567788999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |-|-||.+...+..++ .++.....-++..+.+|++||   |++|||.||+||+|.++|.+|.+||.|||+|+.+.....
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            9999999999998876 588888899999999999999   999999999999999999999999999999999875543


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                         +-.++|||.|.|||++.+...+.++|.||+|+.+||+++|.+||..
T Consensus       576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~  621 (732)
T KOG0614|consen  576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG  621 (732)
T ss_pred             ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence               3467899999999999999999999999999999999999999976

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=265.02  Aligned_cols=263  Identities=20%  Similarity=0.265  Sum_probs=211.1

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeee
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISS  681 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  681 (897)
                      ..|+.....+++....+-+|.||.||+|.|.+      .+.|-+|.++... +-....+..|.-.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            34444455678888889999999999996543      3456777776543 3345778899999999999999999998


Q ss_pred             ec-CCCceEEEEEeccCCChhHhhh-----cCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC
Q 045539          682 CS-NDDFKALIMKYMPNGSLENCLY-----SGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED  753 (897)
Q Consensus       682 ~~-~~~~~~lv~e~~~~gsL~~~l~-----~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~  753 (897)
                      +. +.+..++++.++.-|+|..++.     +..  ..++..+...++.|++.|++||   |++||||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhh
Confidence            84 5567889999999999999987     221  4466777889999999999999   99999999999999999999


Q ss_pred             CcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHH
Q 045539          754 MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRW  832 (897)
Q Consensus       754 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~  832 (897)
                      ..+||+|=.+++..-+.+..........+..||+||.+.+..|+.++|||||||++|||+| |+.|+.++...  .+..+
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~~y  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EMEHY  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHHHH
Confidence            9999999999998877776666666667889999999999999999999999999999999 99998874221  11111


Q ss_pred             hhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          833 INDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       833 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                      +.+++  |....-.|+.++..+|..||+.+| ++||+++++...|.+
T Consensus       511 ----------------lkdGy--RlaQP~NCPDeLf~vMacCWallp-eeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  511 ----------------LKDGY--RLAQPFNCPDELFTVMACCWALLP-EERPSFSQLVICLSE  554 (563)
T ss_pred             ----------------Hhccc--eecCCCCCcHHHHHHHHHHHhcCc-ccCCCHHHHHHHHHH
Confidence                            11222  222223567789999999999999 999999999988764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.3e-29  Score=265.49  Aligned_cols=238  Identities=29%  Similarity=0.379  Sum_probs=191.9

Q ss_pred             cceEEEEEEec-CCceEEEEEechhhHHH-HHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChhHhhhc
Q 045539          629 SFGSIYVARLQ-DGMEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS  706 (897)
Q Consensus       629 ~~g~Vy~a~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  706 (897)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++..+...+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999887 48999999987654433 67889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccC
Q 045539          707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM  786 (897)
Q Consensus       707 ~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  786 (897)
                      ... +++..+..++.+++.++++|   |+.+++|+||+|+||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            543 88999999999999999999   78899999999999999999999999999998765432   223445788999


Q ss_pred             CcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHH
Q 045539          787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLS  866 (897)
Q Consensus       787 aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  866 (897)
                      |||......++.++||||+|++++++++|..||...... .            ...+.+..   .... ..........+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~------------~~~~~~~~---~~~~-~~~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-L------------ELFKKIGK---PKPP-FPPPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-H------------HHHHHHhc---cCCC-CccccccCCHH
Confidence            999988888899999999999999999999998652111 0            01111111   1100 00000003356


Q ss_pred             HHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          867 VLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       867 l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.+++.+|+..+| ++||++.++++
T Consensus       217 ~~~~i~~~l~~~p-~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDP-EKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCc-hhccCHHHHhh
Confidence            8899999999999 99999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=241.31  Aligned_cols=205  Identities=25%  Similarity=0.312  Sum_probs=168.3

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCce
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  688 (897)
                      ++...+.....+.||+|++|.|-+.++. +|+..|+|+++... .+..++..+|+.+..+. .+|.+|++||...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344455666788999999999888754 79999999987554 34557788899887776 599999999999999999


Q ss_pred             EEEEEeccCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          689 ALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ++.||.| ..+|+.+..   ..+..+++.-+-+|+..+.+||.|||  .+..++|||+||+|||++.+|.+|+||||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 457766532   34457889899999999999999997  57789999999999999999999999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccC----CCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGT----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      ...+.-..   +-..|...|||||.+.    ...|+.||||||+|+++.||.+++.||+.-
T Consensus       198 ~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            76543221   2245888999999753    447899999999999999999999999863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3.7e-30  Score=243.52  Aligned_cols=262  Identities=18%  Similarity=0.283  Sum_probs=201.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCC--CceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSND--DFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  691 (897)
                      .++|++.+++|+|.+++||.|.. .+.++++||++++-.   .+.+.+|++||+.++ ||||++++++..++  ..+.+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46899999999999999999964 467899999998553   367889999999997 99999999998765  466899


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~~~  770 (897)
                      +||+++.+......    .++..++...+.+++.||.|+   |++||+|||+||.|+++|.. -..+|+|+|+|.++.+.
T Consensus       114 FE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            99999888766543    367778899999999999999   99999999999999999955 47999999999998766


Q ss_pred             CceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH------------h---h
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW------------I---N  834 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~------------~---~  834 (897)
                      .....   .+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||....+...++.+.            +   .
T Consensus       187 ~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 KEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            55432   346788999997654 456788899999999999999999986532222222222            1   1


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHH-HHH-HHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAK-EQI-LLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~-~~~-~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      -..+++..+++.+..++....+.... ... ..+..+++.+.+..|- .+||||.|.++
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH-qeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH-QERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc-ccccchHHHhc
Confidence            22334455555555444444332221 111 2567888999999999 99999999865

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=9.2e-30  Score=272.02  Aligned_cols=214  Identities=24%  Similarity=0.382  Sum_probs=178.4

Q ss_pred             HHHHHHHh---cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeee
Q 045539          609 YHELLRAT---DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISS  681 (897)
Q Consensus       609 ~~~~~~~~---~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~  681 (897)
                      |-.+.++.   .-|..++.||-|+||+|.+++- .+...||.|.+++..   ......++.|-+||..-+.+=||++|..
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            44444443   4577889999999999999964 457789999988764   2345667889999999999999999999


Q ss_pred             ecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       682 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      |++.+..|+||||++||++-..+...+ .+++.-+.-++.++..|+++.   |+.|+|||||||+|||||.+|.+||+||
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeec
Confidence            999999999999999999998877655 588888888999999999999   9999999999999999999999999999


Q ss_pred             cCccccC---------CCCceee-------------------------------eeccccCcccCCcCccCCCCCCccch
Q 045539          762 GIAKLLS---------GEDQLSI-------------------------------QIQTLATIGYMAPEYGTKGRVCTRGD  801 (897)
Q Consensus       762 g~a~~~~---------~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sD  801 (897)
                      |++.-+.         ..+....                               ....+||+.|+|||++....++..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            9985432         1110000                               01236999999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCcccccCc
Q 045539          802 VYSYGIMLMEMFTKKKPTDEIFIGE  826 (897)
Q Consensus       802 v~slGvil~elltg~~p~~~~~~~~  826 (897)
                      .||.|||||||+.|+.||.....++
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCc
Confidence            9999999999999999998765554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.7e-29  Score=280.99  Aligned_cols=265  Identities=20%  Similarity=0.215  Sum_probs=178.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-----------------cCCceEEEEEechhhHHHHH--------------HHHHHH
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-----------------QDGMEVAVKVFHQQYERALK--------------SFEDEC  664 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E~  664 (897)
                      .++|++.++||+|+||.||+|..                 ..++.||||++........+              ....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            67899999999999999999963                 23568999998644322222              233477


Q ss_pred             HHHHhcCCCcc-----ceEeeeecC--------CCceEEEEEeccCCChhHhhhcCC-----------------------
Q 045539          665 EVMKRIRHRNL-----VKIISSCSN--------DDFKALIMKYMPNGSLENCLYSGT-----------------------  708 (897)
Q Consensus       665 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-----------------------  708 (897)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776544     677777743        356799999999999999886421                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCc
Q 045539          709 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP  788 (897)
Q Consensus       709 ~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP  788 (897)
                      ...++..+..++.|++.||+|+   |+.+|+||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            1245677889999999999999   8899999999999999999999999999999765432211 11122357899999


Q ss_pred             CccCCCCC----------------------CccchHHHHHHHHHHHHcCCC-CCcccccCccchhHHhhhcCCchHHHHh
Q 045539          789 EYGTKGRV----------------------CTRGDVYSYGIMLMEMFTKKK-PTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       789 E~~~~~~~----------------------~~~sDv~slGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      |.+.....                      ..+.||||+||++|+|++|.. |+.....-......+     ....... 
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-----~~~~~~~-  453 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-----DNDLNRW-  453 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-----cchHHHH-
Confidence            97643221                      234699999999999999875 665321110000000     0000000 


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCC--CCCCCHHHHHhh
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRD--GNGADMGWIFSA  892 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~~RPt~~evl~~  892 (897)
                      .......+  .++..........+++.+++..+|.  .+|+|++|+++.
T Consensus       454 r~~~~~~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        454 RMYKGQKY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HhhcccCC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00000000  1112223345578888888886541  579999999863

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-30  Score=285.52  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=188.9

Q ss_pred             CCcCCeeecccce-EEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEecc
Q 045539          619 FSENNLIGIGSFG-SIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       619 y~~~~~lg~G~~g-~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      |...+.+|.|+.| .||+|..+ |+.||||++-..   ..+...+|+..++.-+ |||||++|+.-.++.+.|++.|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4445678999987 46999887 899999987644   3356678999999985 999999999999999999999999 


Q ss_pred             CCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---C--CcEEEeeccCccccC
Q 045539          697 NGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---D--MVAHISDFGIAKLLS  768 (897)
Q Consensus       697 ~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~--~~~kL~DFg~a~~~~  768 (897)
                      ..+|.+++....   ........+.+..|+++||+||   |+.+|||||+||.||||+.   +  .+++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            569999998742   1111134577899999999999   8999999999999999975   3  489999999999887


Q ss_pred             CCCc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcC-CCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .+.. ........||-+|+|||++.....+.++||||+||++|+.++| ..||.+....+..+..-..        .+  
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~--------~L--  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY--------TL--  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc--------ce--
Confidence            5443 2334566799999999999998888899999999999999996 9999874333211110000        00  


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      -.+....        ++  +..++|.+|+.+|| ..||+|.+|+.
T Consensus       733 ~~L~~~~--------d~--eA~dLI~~ml~~dP-~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHLEPLP--------DC--EAKDLISRMLNPDP-QLRPSATDVLN  766 (903)
T ss_pred             eeeccCc--------hH--HHHHHHHHhcCCCc-ccCCCHHHHhC
Confidence            0011111        11  46789999999999 99999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=248.77  Aligned_cols=201  Identities=24%  Similarity=0.351  Sum_probs=176.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|...++||+|+|+.|..+++. +.+.||+|++++..   .++.+-.+.|-.+..+. +||.+|.++.+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467899999999999999999865 57889999998764   34456677788888777 49999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |.||++||+|--.++..+ .++++.+.-+...|.-||.||   |++||+.||+|.+||++|..|.+||+|+|+++.--.+
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999987776655 488999999999999999999   9999999999999999999999999999998754322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      .  ..+...+|||.|.|||++.+..|+..+|.|++||+++||+.|+.||+-.
T Consensus       405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            2  2345678999999999999999999999999999999999999999854

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=267.84  Aligned_cols=197  Identities=22%  Similarity=0.368  Sum_probs=169.9

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhcC---CCccceEeeeecC
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIR---HRNLVKIISSCSN  684 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  684 (897)
                      .+|+..+.+|+|+||.|+.|.++ +...|+||.+.+..        .+..-.+..|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999876 46679999887653        111233567999999997   9999999999999


Q ss_pred             CCceEEEEEec-cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          685 DDFKALIMKYM-PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       685 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      ++++|++||-. +|-+|.+++..+. .+++.+..-|++|++.|+++|   |+.||||||||-+||.++.+|.+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999975 4558899887765 589999999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcc
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      |.....+..    ...+||..|.|||++.+.+| +..-|||++|+++|.++....||..
T Consensus       717 aa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            987653322    34579999999999998877 6678999999999999999999854

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=249.07  Aligned_cols=265  Identities=21%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCC-----ceEEE
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDD-----FKALI  691 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  691 (897)
                      +..+.||.|+||.||.+.+. +|+.||+|++.....  ...+++.+|.+++..++|.|+...+++.+-..     +.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44678999999999999765 799999999865443  34578889999999999999999888775443     46788


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      +|.| ..+|...+-+.. .++...+.-+..||++||+||   |+.+|.||||||.|.+++.+...||+|||+|+..+.++
T Consensus       136 TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            8888 457777666544 588888999999999999999   99999999999999999999999999999999765443


Q ss_pred             ceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh---
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT---  847 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~---  847 (897)
                      . ...+..+-|..|+|||++.+. .|+.+.||||.|||+.|++.++.-|...  +.....+.+.+.......+.+..   
T Consensus       211 ~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  211 R-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             h-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            3 345566789999999988764 6789999999999999999998887652  12222333333333322222111   


Q ss_pred             -----hhcchhhh-----h--HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          848 -----NLLRGEER-----F--FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       848 -----~l~~~~~~-----~--~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                           .+++....     .  .......-.+-..+...++..|| .+|.+.++.+...
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~-dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDP-DKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCC-cccccHhhhcccc
Confidence                 11111100     0  00001112334567778889999 9999988877654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=250.38  Aligned_cols=130  Identities=25%  Similarity=0.417  Sum_probs=111.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-----C---CccceEeeeec----
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-----H---RNLVKIISSCS----  683 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~----  683 (897)
                      .+|.+.++||-|.|++||+|.+. ..+.||+|+.+.. ....+....|+++|++++     |   .+||++++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999754 6788999998754 445567788999999995     2   47999999995    


Q ss_pred             CCCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          684 NDDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       684 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      .+.++|+|+|+. |.+|..++.... +.++...+.+|++||+.||.|||  .+.||+|-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeee
Confidence            456899999999 778877776544 56899999999999999999997  57799999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1e-26  Score=237.66  Aligned_cols=211  Identities=31%  Similarity=0.533  Sum_probs=183.6

Q ss_pred             eecccceEEEEEEecC-CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChhH
Q 045539          625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN  702 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  702 (897)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998764 899999998865432 35678999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCccccCCCCceeeeecccc
Q 045539          703 CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTLA  781 (897)
Q Consensus       703 ~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  781 (897)
                      ++......+++..+..++.++++++++|   |+.|++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            9887644589999999999999999999   8889999999999999999 89999999999986643321  1223457


Q ss_pred             CcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHH
Q 045539          782 TIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAK  860 (897)
Q Consensus       782 t~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  860 (897)
                      ...|++||..... ..+.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999988777 788999999999999999                                                


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          861 EQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       861 ~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                          .++.+++.+|++.|| ++||++.++++.+
T Consensus       188 ----~~~~~~l~~~l~~~p-~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDP-EKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCc-ccCcCHHHHhhCC
Confidence                236788999999999 9999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-29  Score=258.58  Aligned_cols=389  Identities=24%  Similarity=0.239  Sum_probs=240.1

Q ss_pred             CCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee-ecCCCCCCCccccCccccccccc
Q 045539          101 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS-INGLSGEMPREIGNLPYLARLAF  179 (897)
Q Consensus       101 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs-~N~l~~~~p~~l~~l~~L~~L~L  179 (897)
                      .-+.++|..|+|+...|.+|+.+++|++||||+|+|+.+-|..|.++.+|..|-+- +|+|+..--+.|++|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            34567777777776666777777777777777777777777777777776554444 37777333356777777777777


Q ss_pred             ccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc
Q 045539          180 ATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                      .-|++.-+...+|..+++|..|.+.+|.+. .++...+..+..++++.+..|.+-.     ..+++.+.. ++.-|.+  
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-~~a~~~i--  218 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-DLAMNPI--  218 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc-----ccccchhhh-HHhhchh--
Confidence            777777777777777788878888777776 6777666677777777777776321     011111111 0111110  


Q ss_pred             ccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCC-cCccccCc
Q 045539          260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN-IPQVVGNL  338 (897)
Q Consensus       260 ~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~-~p~~~~~l  338 (897)
                                               .++...-..-..|.++++..+-+..|..-..++..-..+.+...++ ....|..+
T Consensus       219 -------------------------etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L  273 (498)
T KOG4237|consen  219 -------------------------ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKL  273 (498)
T ss_pred             -------------------------hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhc
Confidence                                     0111122222223333333333332222212222222233333323 33568899


Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      ++|+.|+|++|+|+++-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|++|+|+...|..|..+.+|..|+|
T Consensus       274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l  353 (498)
T KOG4237|consen  274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL  353 (498)
T ss_pred             ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence            99999999999999999999999999999999999998777788889999999999999999888999999999999999


Q ss_pred             ccccccCC-----ccccc-----------cccccceEEeecCCcccccc------------------------eeecccC
Q 045539          419 GLNRFTSA-----LPSTI-----------WNLKDILFIDVSSNSLNVLI------------------------GLNFSRN  458 (897)
Q Consensus       419 ~~N~l~~~-----~p~~~-----------~~l~~L~~L~ls~N~l~~l~------------------------~l~ls~n  458 (897)
                      -.|.+.-.     +-+++           .+-..++.++++++.+..-.                        ....|++
T Consensus       354 ~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk  433 (498)
T KOG4237|consen  354 LSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNK  433 (498)
T ss_pred             ccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhccc
Confidence            88877411     00000           01123445555554432110                        0111211


Q ss_pred             cCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCC
Q 045539          459 NLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN  530 (897)
Q Consensus       459 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  530 (897)
                      .+ ..+|..+-  ..-++|++.+|.++ .+|..  .+.+| .+|+|+|+|+..--..|.++++|.+|-||+|
T Consensus       434 ~l-k~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  434 LL-KLLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             ch-hhcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            11 12232221  23456677777776 56655  55666 6777777776544556667777777777665

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8.9e-29  Score=267.32  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|+...++|.|.||.||+|++. .++..|+|+++-...+..+.+++|+-+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999999865 6899999999988777788889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      |.||+|++..+-.+ ++++.++..+++...+|++||   |++|-+|||||-.||++++.|.+|+.|||.+..+...  ..
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            99999999766554 699999999999999999999   9999999999999999999999999999988765422  23


Q ss_pred             eeeccccCcccCCcCc---cCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          775 IQIQTLATIGYMAPEY---GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~---~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ....+.||+.|||||+   ...+.|...+|||+.|++..|+-.-+.|..+..              |.+..-+..+..-+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------------pmr~l~LmTkS~~q  233 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------------PMRALFLMTKSGFQ  233 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------------hHHHHHHhhccCCC
Confidence            3446789999999996   467789999999999999999998888854421              11111222222211


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.  ..+.......+-++++.|+..+| ++|||++.++.
T Consensus       234 pp~--lkDk~kws~~fh~fvK~altknp-KkRptaeklL~  270 (829)
T KOG0576|consen  234 PPT--LKDKTKWSEFFHNFVKGALTKNP-KKRPTAEKLLQ  270 (829)
T ss_pred             CCc--ccCCccchHHHHHHHHHHhcCCC-ccCCChhhhee
Confidence            111  11111233446788889999999 99999987764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=8.2e-28  Score=252.28  Aligned_cols=277  Identities=22%  Similarity=0.283  Sum_probs=206.5

Q ss_pred             cccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC------CCc
Q 045539          602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR------HRN  674 (897)
Q Consensus       602 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~n  674 (897)
                      .+..++.+.|+.  -++|.+....|+|-|++|.+|.+. -|+.||||++...... .+.=.+|++||+++.      --|
T Consensus       419 EGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  419 EGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             cceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence            344555566654  569999999999999999999866 4889999999866333 344467999999996      348


Q ss_pred             cceEeeeecCCCceEEEEEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC
Q 045539          675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE  752 (897)
Q Consensus       675 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~  752 (897)
                      +++++..|...++.|+|+|-. .-+|.+++..-+  ..+....+..++.|+.-||..|   -+.||+|.||||+|||+++
T Consensus       496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEecc
Confidence            999999999999999999987 568999987655  4578889999999999999999   8999999999999999985


Q ss_pred             C-CcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc----
Q 045539          753 D-MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL----  827 (897)
Q Consensus       753 ~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~----  827 (897)
                      . ..+||||||.|........    +...-+..|.|||++.+-+|+...|+||.||+|||+.||+.-|........    
T Consensus       572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            5 4789999999987764432    233456789999999999999999999999999999999988754211000    


Q ss_pred             -----ch-------hHHhhhcCCch------------------HHHHhh------hhhcchhhhhHHHHHHHHHHHHHHH
Q 045539          828 -----SL-------NRWINDLLPVS------------------VMEVID------TNLLRGEERFFAAKEQILLSVLNLA  871 (897)
Q Consensus       828 -----~~-------~~~~~~~~~~~------------------~~~~i~------~~l~~~~~~~~~~~~~~~~~l~~l~  871 (897)
                           .+       ..+..+++...                  ++..+.      ..+... +....+......++.+|+
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~-q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV-QRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-CCCCchhHHHHHHHHHHH
Confidence                 00       00011111100                  000000      011110 001223345677899999


Q ss_pred             hHccCCCCCCCCCCHHHHHh
Q 045539          872 TECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       872 ~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..|+..|| ++|-|..+.++
T Consensus       727 dkml~LdP-~KRit~nqAL~  745 (752)
T KOG0670|consen  727 DKMLILDP-EKRITVNQALK  745 (752)
T ss_pred             HHHhccCh-hhcCCHHHHhc
Confidence            99999999 99999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.2e-28  Score=233.43  Aligned_cols=207  Identities=20%  Similarity=0.352  Sum_probs=168.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeee-ecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISS-CSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv~  692 (897)
                      .+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+.... ...+.|.+|...--.+. |.||+.-|++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            458999999999999999999887 57889999887653 34577888887666665 8999988874 67888999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCCcEEEeeccCccccCCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||++.|+|..-+...+  +.+.....++.|+++|+.||   |++++||||||.+|||+-  +..++||||||.++..+..
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999998877755  78888899999999999999   999999999999999993  4459999999998765422


Q ss_pred             CceeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      ..     ...-+..|.|||....     -...+.+|||.||+++|.++||..||+.....+..+.+|.
T Consensus       177 V~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  177 VK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            11     2234667999996422     2457889999999999999999999997666666666664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=6e-27  Score=242.64  Aligned_cols=271  Identities=22%  Similarity=0.286  Sum_probs=199.0

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCC
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDD  686 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  686 (897)
                      +....+.|..+++||+|.|++||+|.+.    ..+.||+|.+.....  ..++.+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3345568999999999999999999643    367899998875433  366889999999996 999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEeeccCcc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAK  765 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~  765 (897)
                      ...+|+||++.....++...    ++..++..+++.+..||+++   |..|||||||||+|++.+ ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999998888765    67889999999999999999   999999999999999998 45688999999997


Q ss_pred             ccCCC---------------------------------Cc---------eeeeeccccCcccCCcCccCCC-CCCccchH
Q 045539          766 LLSGE---------------------------------DQ---------LSIQIQTLATIGYMAPEYGTKG-RVCTRGDV  802 (897)
Q Consensus       766 ~~~~~---------------------------------~~---------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv  802 (897)
                      .....                                 ..         ........||++|+|||++... ..++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            22100                                 00         0011234699999999987664 45889999


Q ss_pred             HHHHHHHHHHHcCCCCCcccccCccchhHHhhh----------------------cCCchHH-----HHhh-hhhcchhh
Q 045539          803 YSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND----------------------LLPVSVM-----EVID-TNLLRGEE  854 (897)
Q Consensus       803 ~slGvil~elltg~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~-----~~i~-~~l~~~~~  854 (897)
                      ||.|||+..+++++.||....++...+.+.+.-                      .++....     +-++ ..+.+...
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            999999999999999997654443333332110                      0000000     0000 00111000


Q ss_pred             ---hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          855 ---RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       855 ---~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .+....+.......+++.+|+..|| .+|-||+|.++.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np-~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNP-QKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCCh-hhcccHHHHhcC
Confidence               0111111222367899999999999 999999998863

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7e-26  Score=234.37  Aligned_cols=199  Identities=30%  Similarity=0.457  Sum_probs=173.0

Q ss_pred             CCcCCeeecccceEEEEEEecC-CceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      |+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999998874 899999999865444 56788999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +++|.+++......+++..+..++.+++.++.+|   |+.+++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            9999999877553378999999999999999999   788999999999999999999999999999887654321 012


Q ss_pred             eccccCcccCCcCcc-CCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          777 IQTLATIGYMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            234578889999988 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-27  Score=234.13  Aligned_cols=194  Identities=26%  Similarity=0.331  Sum_probs=163.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC------C
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND------D  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  686 (897)
                      ..+|.-.+.+|.|+- .|..|.+. .+++||+|+.....  ....++..+|...+..+.|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            457888889999998 67666544 58999999875442  22346778899999999999999999998543      3


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+|||+| ..+|.+.+..   .++-..+..|..|++.|++||   |+.||+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcc
Confidence            679999999 5688887773   367788899999999999999   999999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                      ....   ...+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+.-|.
T Consensus       168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            5432   34556778999999999888889999999999999999999998775

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-27  Score=239.96  Aligned_cols=403  Identities=20%  Similarity=0.233  Sum_probs=291.7

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccC-ccccCCccccccccccccEEEe
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD-NQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      ..++++|..|+++...|.+|+.+++|++||||+|+|+.+-|++|..|.+|..|-+.+ |+|+..+...|.+|++|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            578999999999988888999999999999999999999999999999988877766 9999999999999999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      .-|++.-...+.|..|++|..|.+-+|.+..+.-.+|.++.+++.+.+..|.+-.      ..+++.+.. ++      .
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic------dCnL~wla~-~~------a  214 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC------DCNLPWLAD-DL------A  214 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc------ccccchhhh-HH------h
Confidence            9999997778899999999999999999999988899999999999999998531      112222221 11      1


Q ss_pred             cccccccCCCcccEEEccccccccccCcccccc----ccccccCCCCcc-cccccccccCCCcEEEecCCCCCCCCCCcc
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNTFVNM----ADNYLTSSTPEL-SFLSSLTNCKKLKVLILTGNPLDGILPKSK  310 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l----~~~~l~~~~~~~-~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~  310 (897)
                      ..|..++...-..-..+.++++....+..|..-    ..-+.....++. .....+.++++|+.|+|++|+++++-+.+|
T Consensus       215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF  294 (498)
T KOG4237|consen  215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF  294 (498)
T ss_pred             hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence            333445555555555666666666655555322    111111111111 112247899999999999999999999999


Q ss_pred             cCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCccccccc-chhhhccccc
Q 045539          311 GNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI-TDELCHLARL  389 (897)
Q Consensus       311 ~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L  389 (897)
                      .... .+++|+|..|+|...-...|.++..|++|+|.+|+|+.+.|.+|..+.+|.+|+|-.|.+.-.- -.++..    
T Consensus       295 e~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~----  369 (498)
T KOG4237|consen  295 EGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE----  369 (498)
T ss_pred             cchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH----
Confidence            9998 9999999999999888899999999999999999999999999999999999999988765211 011111    


Q ss_pred             ccccccccccccCCCcccccccccceeccccccccC---Cccccccc---------cccc-eEEeecCCcccc-------
Q 045539          390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS---ALPSTIWN---------LKDI-LFIDVSSNSLNV-------  449 (897)
Q Consensus       390 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~p~~~~~---------l~~L-~~L~ls~N~l~~-------  449 (897)
                         +|.++.-.| .|.+-+ -..++.+.++++.+..   ..|+..+-         ++-+ ++...|++.++.       
T Consensus       370 ---Wlr~~~~~~-~~~Cq~-p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~  444 (498)
T KOG4237|consen  370 ---WLRKKSVVG-NPRCQS-PGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPV  444 (498)
T ss_pred             ---HHhhCCCCC-CCCCCC-CchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCc
Confidence               222333222 222211 1123344444333321   11111110         1111 122333333332       


Q ss_pred             -cceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCC
Q 045539          450 -LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN  506 (897)
Q Consensus       450 -l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  506 (897)
                       ..++++.+|.++ .+|.+  .+..| .+++|+|+++-.--..|.++.+|.+|-||+|
T Consensus       445 d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  445 DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence             345778888887 56666  67788 8999999999777788999999999999987

>PLN03210 Resistant to P

Probab=99.92  E-value=3.5e-24  Score=269.24  Aligned_cols=339  Identities=23%  Similarity=0.229  Sum_probs=208.3

Q ss_pred             CccccCCCCCcEEeccCccc------cCCccccccccc-cccEEEeeecCCCCCCCccccCccccccccccccccccccc
Q 045539          117 PSSIFNMHTLKLLYFSDNQL------FGSLSFFIFNVS-SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP  189 (897)
Q Consensus       117 p~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~-~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  189 (897)
                      +.+|.++++|+.|.+..+..      ...+|..+..++ +|+.|++.+|.+. .+|..| ...+|+.|++.+|++..+ +
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L-~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKL-W  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccc-c
Confidence            34566677777776655432      223455555543 4777777777766 666666 457777777777777654 4


Q ss_pred             ccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccc
Q 045539          190 VTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMA  269 (897)
Q Consensus       190 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~  269 (897)
                      ..+..+++|+.|+|++|...+.+|.  ...+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..     
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~-----  700 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG-----  700 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc-----
Confidence            5567777777777777664456664  235678888888887766777888888888888888876543333321     


Q ss_pred             cccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCC
Q 045539          270 DNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGN  349 (897)
Q Consensus       270 ~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N  349 (897)
                                       .++++|++|++++|...+.+|..                            .++|++|++++|
T Consensus       701 -----------------i~l~sL~~L~Lsgc~~L~~~p~~----------------------------~~nL~~L~L~~n  735 (1153)
T PLN03210        701 -----------------INLKSLYRLNLSGCSRLKSFPDI----------------------------STNISWLDLDET  735 (1153)
T ss_pred             -----------------CCCCCCCEEeCCCCCCccccccc----------------------------cCCcCeeecCCC
Confidence                             14677888888877544333321                            234555556665


Q ss_pred             CCCCCccccccCccchhhhcccCccc-------ccccchhhhcccccccccccccccccCCCcccccccccceecccccc
Q 045539          350 NLTEPIPITFSQLQTLQALGLTRNKL-------AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR  422 (897)
Q Consensus       350 ~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  422 (897)
                      .++. +|..+ .+++|+.|++.++..       ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|.
T Consensus       736 ~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~  813 (1153)
T PLN03210        736 AIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI  813 (1153)
T ss_pred             cccc-ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence            5543 33332 345555555554321       11112222334567777777777666777777777777777777765


Q ss_pred             ccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEe
Q 045539          423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD  502 (897)
Q Consensus       423 l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  502 (897)
                      ..+.+|..+ ++++|+.|++++|             .....+|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+
T Consensus       814 ~L~~LP~~~-~L~sL~~L~Ls~c-------------~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~  875 (1153)
T PLN03210        814 NLETLPTGI-NLESLESLDLSGC-------------SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLD  875 (1153)
T ss_pred             CcCeeCCCC-CccccCEEECCCC-------------Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEE
Confidence            444566554 4555654444433             222233332   246677777777776 5677777777777777


Q ss_pred             ccC-CccCCCCchhhhhhcccceEeccCCc
Q 045539          503 LSK-NKISGAIPASLQKLLYLKHLNLSFNK  531 (897)
Q Consensus       503 Ls~-N~l~~~~p~~~~~l~~L~~L~ls~N~  531 (897)
                      |++ |++. .+|..+..+++|+.+++++|.
T Consensus       876 L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        876 MNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            776 4454 566667777777777777764

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=4.6e-24  Score=268.18  Aligned_cols=357  Identities=20%  Similarity=0.243  Sum_probs=262.3

Q ss_pred             CCeEEEEEeecccccc--cCCCCCCCCCCCceecccCcc------ccCcCCccccCCC-CCcEEeccCccccCCcccccc
Q 045539           75 SHRVIGLNISSFNLQG--TIPPQLGNLSSLQTLDLSHNK------LSGNIPSSIFNMH-TLKLLYFSDNQLFGSLSFFIF  145 (897)
Q Consensus        75 ~~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~  145 (897)
                      +.+|.++.+.-..+..  .-+.+|.++.+|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| 
T Consensus       531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-  608 (1153)
T PLN03210        531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-  608 (1153)
T ss_pred             cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-
Confidence            3456655544333221  223468899999999997653      3446788888875 6999999999885 445555 


Q ss_pred             ccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccce
Q 045539          146 NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVET  225 (897)
Q Consensus       146 ~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~  225 (897)
                      ...+|+.|+|++|++. .+|..+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..+. .+++|+.
T Consensus       609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~-~L~~L~~  685 (1153)
T PLN03210        609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQ-YLNKLED  685 (1153)
T ss_pred             CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhh-ccCCCCE
Confidence            5789999999999998 7889999999999999998865555564 88899999999999987778998765 7899999


Q ss_pred             eecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCC
Q 045539          226 LNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGI  305 (897)
Q Consensus       226 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~  305 (897)
                      |++++|.....+|..+ ++++|+.|++++|......|.                        ..++|++|++++|.+.. 
T Consensus       686 L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~------------------------~~~nL~~L~L~~n~i~~-  739 (1153)
T PLN03210        686 LDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD------------------------ISTNISWLDLDETAIEE-  739 (1153)
T ss_pred             EeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc------------------------ccCCcCeeecCCCcccc-
Confidence            9999987667888776 799999999999865444432                        13578999999998763 


Q ss_pred             CCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCC-------CCCCccccccCccchhhhcccCcccccc
Q 045539          306 LPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNN-------LTEPIPITFSQLQTLQALGLTRNKLAGP  378 (897)
Q Consensus       306 ~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  378 (897)
                      +|..+                          .+++|+.|++.++.       +....+..+...++|+.|+|++|...+.
T Consensus       740 lP~~~--------------------------~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~  793 (1153)
T PLN03210        740 FPSNL--------------------------RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVE  793 (1153)
T ss_pred             ccccc--------------------------cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccc
Confidence            33322                          23445555554422       1111222233446788888888877777


Q ss_pred             cchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccC
Q 045539          379 ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRN  458 (897)
Q Consensus       379 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n  458 (897)
                      +|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|...   .+|+             .|+|++|
T Consensus       794 lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~---~nL~-------------~L~Ls~n  856 (1153)
T PLN03210        794 LPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDIS---TNIS-------------DLNLSRT  856 (1153)
T ss_pred             cChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccc---cccC-------------EeECCCC
Confidence            88888888888888888876555777766 68888999998876554555432   3444             4555555


Q ss_pred             cCCCCCcccccCCcccccccccC-ceecccCCCCCCCcCCCcEEeccCCc
Q 045539          459 NLSGDIPITIGGLKNLQQMFLEY-NRLEGSIPESFGDLSSLEVLDLSKNK  507 (897)
Q Consensus       459 ~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~  507 (897)
                      .++ .+|.++..+++|+.|++++ |+++ .+|..+..+++|+.|++++|.
T Consensus       857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            555 5688888999999999988 5565 588888899999999999884

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.2e-24  Score=265.74  Aligned_cols=195  Identities=15%  Similarity=0.174  Sum_probs=138.2

Q ss_pred             cCC-CccceEeeee-------cCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeC
Q 045539          670 IRH-RNLVKIISSC-------SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC  741 (897)
Q Consensus       670 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~  741 (897)
                      ++| +||++++++|       .+.+..+.+|||+ +++|.+++......+++.++..++.||++||+||   |++||+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence            445 5788888877       2334567788987 6699999987666699999999999999999999   89999999


Q ss_pred             CCCCCCeeeCCC-------------------CcEEEeeccCccccCCCCc--------------eeeeeccccCcccCCc
Q 045539          742 DLKPSNVLLDED-------------------MVAHISDFGIAKLLSGEDQ--------------LSIQIQTLATIGYMAP  788 (897)
Q Consensus       742 Dlkp~NIll~~~-------------------~~~kL~DFg~a~~~~~~~~--------------~~~~~~~~gt~~y~aP  788 (897)
                      ||||+|||++..                   +.+|++|||+++.......              ........||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999654                   4555666666543211000              0001123578899999


Q ss_pred             CccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHH
Q 045539          789 EYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVL  868 (897)
Q Consensus       789 E~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~  868 (897)
                      |++.+..++.++|||||||++|||++|..|+.....   .....            ....+   ++.    ......+..
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~------------~~~~~---~~~----~~~~~~~~~  242 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSL------------RHRVL---PPQ----ILLNWPKEA  242 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHH------------HHhhc---Chh----hhhcCHHHH
Confidence            999999999999999999999999999888653110   00000            00000   000    001122345


Q ss_pred             HHHhHccCCCCCCCCCCHHHHHh
Q 045539          869 NLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       869 ~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +++.+||++|| .+||+++|+++
T Consensus       243 ~~~~~~L~~~P-~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEP-SCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCCh-hhCcChHHHhh
Confidence            77889999999 99999999976

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.2e-24  Score=249.60  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=191.8

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAF  179 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L  179 (897)
                      ..-..|||++|+|+ .+|..+.  ++|+.|++++|+|+.. |.   .+++|++|+|++|+|+ .+|..   .++|+.|+|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccC-cccCc---ccccceeec
Confidence            44668999999998 6888776  4799999999998764 43   2578999999999998 56753   468889999


Q ss_pred             ccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc
Q 045539          180 ATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                      ++|+++.+.. .   .++|+.|+|++|+++ .+|.    ..++|+.|+|++|++++ +|..   ..+|+.|++++|.+++
T Consensus       270 s~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~  336 (788)
T PRK15387        270 FSNPLTHLPA-L---PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS  336 (788)
T ss_pred             cCCchhhhhh-c---hhhcCEEECcCCccc-cccc----cccccceeECCCCcccc-CCCC---cccccccccccCcccc
Confidence            9999887633 2   357888999999998 6665    24789999999999885 4442   2457788888888875


Q ss_pred             ccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCcc
Q 045539          260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLG  339 (897)
Q Consensus       260 ~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~  339 (897)
                      +.+ .                        ..+|++|+|++|+|+++ |..    +.+|+.|++++|+|++ +|..   .+
T Consensus       337 LP~-l------------------------p~~Lq~LdLS~N~Ls~L-P~l----p~~L~~L~Ls~N~L~~-LP~l---~~  382 (788)
T PRK15387        337 LPT-L------------------------PSGLQELSVSDNQLASL-PTL----PSELYKLWAYNNRLTS-LPAL---PS  382 (788)
T ss_pred             ccc-c------------------------ccccceEecCCCccCCC-CCC----Ccccceehhhcccccc-Cccc---cc
Confidence            321 0                        14788999999999863 432    2356777888888874 4543   34


Q ss_pred             CCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccc
Q 045539          340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLG  419 (897)
Q Consensus       340 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  419 (897)
                      +|+.|++++|+|++ +|..   .++|+.|++++|+|++ +|..   ..+|+.|++++|+|+ .+|..+.++++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            67888888888876 4433   2467777778877774 4543   235667777777777 677777777777777777


Q ss_pred             cccccCCccccccc
Q 045539          420 LNRFTSALPSTIWN  433 (897)
Q Consensus       420 ~N~l~~~~p~~~~~  433 (897)
                      +|+|++..|..+..
T Consensus       454 ~N~Ls~~~~~~L~~  467 (788)
T PRK15387        454 GNPLSERTLQALRE  467 (788)
T ss_pred             CCCCCchHHHHHHH
Confidence            77777766655533

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=9.2e-24  Score=209.67  Aligned_cols=164  Identities=20%  Similarity=0.162  Sum_probs=124.4

Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |+|.+++...+..+++.++..++.|++.||+||   |+++      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999987666799999999999999999999   6665      999999999999999  99988654321      


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                       ..||+.|+|||++.+..++.++|||||||++|||+||+.||..........            ..++.......+..+ 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~-  129 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL------------EILLNGMPADDPRDR-  129 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH------------HHHHHHhccCCcccc-
Confidence             258899999999999999999999999999999999999986532111111            111111111111100 


Q ss_pred             HHHHHHH--HHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          858 AAKEQIL--LSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       858 ~~~~~~~--~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      .......  .++.+++.+|+..|| ++||++.|+++.+
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p-~~Rp~~~~ll~~~  166 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLP-QRREAANHYLAHC  166 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhccc-ccccCHHHHHHHH
Confidence            0011222  258999999999999 9999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=6.1e-24  Score=247.29  Aligned_cols=267  Identities=26%  Similarity=0.344  Sum_probs=157.3

Q ss_pred             cccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeec
Q 045539          149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNL  228 (897)
Q Consensus       149 ~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L  228 (897)
                      .-..|||++|.++ .+|..+.  ++|+.|++++|+++.+..    .+++|++|+|++|+|+ .+|..    .++|+.|+|
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~L  269 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLT-SLPVL----PPGLLELSI  269 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccC-cccCc----ccccceeec
Confidence            3566777777777 5776665  367777777777776532    2467777777777777 55542    356777777


Q ss_pred             ccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCC
Q 045539          229 GINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK  308 (897)
Q Consensus       229 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~  308 (897)
                      ++|.++ .+|..   .++|+.|++++|+++....                         .+++|+.|+|++|+++++ |.
T Consensus       270 s~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~LP~-------------------------~p~~L~~LdLS~N~L~~L-p~  319 (788)
T PRK15387        270 FSNPLT-HLPAL---PSGLCKLWIFGNQLTSLPV-------------------------LPPGLQELSVSDNQLASL-PA  319 (788)
T ss_pred             cCCchh-hhhhc---hhhcCEEECcCCccccccc-------------------------cccccceeECCCCccccC-CC
Confidence            777775 33432   2457777777777764321                         125677788888777753 22


Q ss_pred             cccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccc
Q 045539          309 SKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR  388 (897)
Q Consensus       309 ~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  388 (897)
                          ++.+                        |+.|++++|+|++ +|..   ..+|+.|+|++|+|++ +|..   ..+
T Consensus       320 ----lp~~------------------------L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~  363 (788)
T PRK15387        320 ----LPSE------------------------LCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSE  363 (788)
T ss_pred             ----Cccc------------------------ccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccc
Confidence                1112                        3344444444443 2211   1244555555555552 2321   134


Q ss_pred             cccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccc
Q 045539          389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITI  468 (897)
Q Consensus       389 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~  468 (897)
                      |+.|++++|+|+ .+|...   ++|+.|++++|++++ +|...   ++|+             .|++++|+|++ +|.. 
T Consensus       364 L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l~---s~L~-------------~LdLS~N~Lss-IP~l-  420 (788)
T PRK15387        364 LYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLP---SELK-------------ELMVSGNRLTS-LPML-  420 (788)
T ss_pred             cceehhhccccc-cCcccc---cccceEEecCCcccC-CCCcc---cCCC-------------EEEccCCcCCC-CCcc-
Confidence            555666666665 344322   356667777777664 44321   2334             34444444442 4432 


Q ss_pred             cCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhh
Q 045539          469 GGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKL  519 (897)
Q Consensus       469 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  519 (897)
                        ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..+
T Consensus       421 --~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        421 --PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             --hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence              235677888888887 678888888888888888888887777766554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.7e-23  Score=222.75  Aligned_cols=165  Identities=22%  Similarity=0.223  Sum_probs=130.1

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec--CCceEEEEEechh-----hHHHHHHHHHHHHHHHhcCCCccce-EeeeecCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ--DGMEVAVKVFHQQ-----YERALKSFEDECEVMKRIRHRNLVK-IISSCSND  685 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~  685 (897)
                      ...++|...+.||+|+||+||+|++.  +++.||||+....     .....+.+.+|++++++++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            45678999999999999999999765  5778899986532     1234567899999999999999985 4442    


Q ss_pred             CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCC-CCCCeeeCCCCcEEEeeccCc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL-KPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dl-kp~NIll~~~~~~kL~DFg~a  764 (897)
                      +..|+||||++|++|... ..    ..   ...++.|+++||+||   |++||+|||| ||+||+++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999632 11    11   146789999999999   8999999999 999999999999999999999


Q ss_pred             cccCCCCceee------eeccccCcccCCcCccCC
Q 045539          765 KLLSGEDQLSI------QIQTLATIGYMAPEYGTK  793 (897)
Q Consensus       765 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  793 (897)
                      +..........      .....+++.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            87754432221      134568889999998654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=6.6e-23  Score=240.62  Aligned_cols=314  Identities=17%  Similarity=0.260  Sum_probs=162.0

Q ss_pred             HHHhhcCChhHHHHHHHHHhccccCCCcccc---cCCCCCCCCcceee----------------eEeeCCCCeEEEEEee
Q 045539           24 IAAAASNITTDQQALLALKAHISYDHTNLFA---RNWTSSTSVCSWIG----------------ITCDVNSHRVIGLNIS   84 (897)
Q Consensus        24 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~---~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~   84 (897)
                      +...+...++|.+++++..+.+.+++  ...   ..|.+++++|-=..                |.|.  .+.|+.+..-
T Consensus        54 ~~~~~~~~~~~~~~~~~~~~~l~~p~--~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~  129 (754)
T PRK15370         54 CHPPETASPEEIKSKFECLRMLAFPA--YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVT  129 (754)
T ss_pred             hCCCCCCCHHHHHHHHHHHHHhcCCc--hhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCcccccccc
Confidence            33444556788899999999996433  232   23998899996555                5663  4456666654


Q ss_pred             cccccccCCCCCCCCCCCceecccC-----ccccC----------cCCccccCCCCCcEEeccCccccCCcccccccccc
Q 045539           85 SFNLQGTIPPQLGNLSSLQTLDLSH-----NKLSG----------NIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSS  149 (897)
Q Consensus        85 ~~~l~g~~~~~l~~l~~L~~L~Ls~-----n~l~~----------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  149 (897)
                      +.-.......+   -..-.+ +..+     +.-.+          .+.+++  ..+...|+++++.++.. |..+.  ++
T Consensus       130 g~~~~~~~~~~---~~~~~~-~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl--~~~~~~L~L~~~~LtsL-P~~Ip--~~  200 (754)
T PRK15370        130 ESEQASSASGS---KDAVNY-ELIWSEWVKEAPAKEAANREEAVQRMRDCL--KNNKTELRLKILGLTTI-PACIP--EQ  200 (754)
T ss_pred             cccccccCCCC---CChhhH-HHHHHHHHhcCCCCccccHHHHHHHHHhhc--ccCceEEEeCCCCcCcC-Ccccc--cC
Confidence            42211111000   000000 0000     00000          001111  13455666666665532 33221  35


Q ss_pred             ccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecc
Q 045539          150 VTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLG  229 (897)
Q Consensus       150 L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~  229 (897)
                      |+.|+|++|+|+ .+|..+.  ++|+.|+|++|+++.+ |..+.  ++|+.|+|++|+++ .+|..+.   .+|+.|+|+
T Consensus       201 L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls  270 (754)
T PRK15370        201 ITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMELSINRIT-ELPERLP---SALQSLDLF  270 (754)
T ss_pred             CcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEECcCCccC-cCChhHh---CCCCEEECc
Confidence            666666666666 4555443  3666666666666654 33332  35777777777776 6666543   467777777


Q ss_pred             cccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCc
Q 045539          230 INSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKS  309 (897)
Q Consensus       230 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~  309 (897)
                      +|+++ .+|..+.  ++|+.|++++|++++..+. +                       .++|+.|++++|+++.+ |  
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~-l-----------------------p~sL~~L~Ls~N~Lt~L-P--  320 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAH-L-----------------------PSGITHLNVQSNSLTAL-P--  320 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCccccCccc-c-----------------------hhhHHHHHhcCCccccC-C--
Confidence            77776 4565553  4788888888877643211 0                       02344555555555432 2  


Q ss_pred             ccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccc
Q 045539          310 KGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARL  389 (897)
Q Consensus       310 ~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  389 (897)
                                             ..+  .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|
T Consensus       321 -----------------------~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L  369 (754)
T PRK15370        321 -----------------------ETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTI  369 (754)
T ss_pred             -----------------------ccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCc
Confidence                                   111  1345555555555554 333332  34555555555554 2343332  455


Q ss_pred             ccccccccccccCCCcccccccccceecccccccc
Q 045539          390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT  424 (897)
Q Consensus       390 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  424 (897)
                      ++|+|++|+|+ .+|..+.  ..|+.|++++|+++
T Consensus       370 ~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        370 TTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             CEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            55666666655 3444332  24556666666665

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-21  Score=212.59  Aligned_cols=201  Identities=25%  Similarity=0.338  Sum_probs=167.0

Q ss_pred             CCCcCCeeecccceEEEEEEecCC--ceEEEEEechhhHHHHHHHHHHHHHHHhcCC----CccceEeeee-cCCCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDG--MEVAVKVFHQQYERALKSFEDECEVMKRIRH----RNLVKIISSC-SNDDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  690 (897)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|..++..+..    +++..+++.. ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999986643  4789998765433322367788999988873    6899999999 58889999


Q ss_pred             EEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-----CcEEEeeccCc
Q 045539          691 IMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-----MVAHISDFGIA  764 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-----~~~kL~DFg~a  764 (897)
                      ||+.+ |.+|.++..... ..++..++..|+.|++.+|+++   |+.|++||||||+|+++...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999875554 6799999999999999999999   99999999999999999754     46999999999


Q ss_pred             c--ccCCCCce----e-e-eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          765 K--LLSGEDQL----S-I-QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       765 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      +  .+......    . . .....||..|++++...+...+.+.|+||++.++.|+..|..||...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            8  43222211    1 1 12356999999999999999999999999999999999999999653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.7e-22  Score=230.25  Aligned_cols=254  Identities=20%  Similarity=0.229  Sum_probs=189.3

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEec----hh-hH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH----QQ-YE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ...+.+|.|++|.|+.+... ....++.|.++    .. .. .....+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988887543 34445555432    11 11 12233667888888899999998888887777666669


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |||++ +|...+.... .+...++..+++|+..|++|+   |+.||.|||+|++|+++..+|.+||+|||.+....-+..
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 9998887763 478889999999999999999   999999999999999999999999999999876543332


Q ss_pred             e--eeeeccccCcccCCcCccCCCCCCcc-chHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          773 L--SIQIQTLATIGYMAPEYGTKGRVCTR-GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       773 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .  ......+|+.+|+|||++.+..|.++ .||||.|++++.|.+|+.||......+..+   .......+      ...
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~------~~~  546 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQ------RNI  546 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccc------ccc
Confidence            2  45567789999999999999988765 599999999999999999998654433222   00000000      001


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..++   ..-......+...++.+++++|| .+|.|+++|++
T Consensus       547 ~~~~---~~~~~~lp~~~~~~~~~~l~~~P-~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGP---NRLLSLLPRETRIIIYRMLQLDP-TKRITIEQILN  584 (601)
T ss_pred             ccCh---HHHHHhchhhHHHHHHHHccCCh-hheecHHHHhh
Confidence            1111   12223445667788999999999 99999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=185.69  Aligned_cols=202  Identities=23%  Similarity=0.305  Sum_probs=170.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEE-ecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|..+++||.|+||.+|.|. ..+|..||||+-......  .++..|.++...++ ...|..+..|..+.++..+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999996 457999999986544322  56778999999998 477888888889999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~~  769 (897)
                      |.. |.+|++...--...++..+++-++-|++.-++|+   |.++++||||||+|+++.   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 8899998876666799999999999999999999   899999999999999996   345789999999988753


Q ss_pred             CCc-----eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          770 EDQ-----LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       770 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      ...     ........||..|++-....+...+.+.|+=|+|.++.+.--|..||+..
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            221     22233456899999988777777888999999999999999999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1e-21  Score=196.91  Aligned_cols=170  Identities=12%  Similarity=0.150  Sum_probs=133.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHH---H------HHHHHHHHHHhcCCCccceEeeeecCC-
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---K------SFEDECEVMKRIRHRNLVKIISSCSND-  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~---~------~~~~E~~~l~~l~h~niv~l~~~~~~~-  685 (897)
                      .++|+..+.+|.|+||.||.+.. ++..+|+|+++.......   .      .+++|+..+.+++||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57999999999999999999876 477899999975432221   2      268999999999999999999886533 


Q ss_pred             -------CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          686 -------DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       686 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                             +..++||||++|.+|.++..     .+.    ....+++.+++.+   |+.|++|||+||+||+++.++ +++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-EEE
Confidence                   35789999999999988732     222    3466999999999   899999999999999999988 999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHH
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMF  813 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ell  813 (897)
                      +|||.+.........              ..+.....+..++|+|+||+++....
T Consensus       176 iDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999987654322111              11334445667899999999877554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=1.8e-21  Score=228.61  Aligned_cols=296  Identities=22%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             ccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceee
Q 045539          148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLN  227 (897)
Q Consensus       148 ~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  227 (897)
                      .+.+.|+++++.++ .+|..+.  +.|+.|+|++|+++.+.. .+.  ++|++|++++|+++ .+|..+.   ++|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~-~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPE-NLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCCh-hhc--cCCCEEECCCCccc-cCChhhh---ccccEEE
Confidence            45789999999998 6887664  578999999999997644 333  58999999999998 7776554   4788889


Q ss_pred             cccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCC
Q 045539          228 LGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP  307 (897)
Q Consensus       228 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p  307 (897)
                      |++|.+. .+|..+.  ++|+.|++++|+++.+ |..+                       .++|+.|++++|+|+++ |
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l-----------------------~~sL~~L~Ls~N~Lt~L-P  299 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKISCL-PENL-----------------------PEELRYLSVYDNSIRTL-P  299 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCccCcc-cccc-----------------------CCCCcEEECCCCccccC-c
Confidence            9998887 5666654  4788888888888743 3211                       14688888888877742 2


Q ss_pred             CcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccc
Q 045539          308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA  387 (897)
Q Consensus       308 ~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  387 (897)
                      .                         .+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|++++ +|..+.  +
T Consensus       300 ~-------------------------~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~  346 (754)
T PRK15370        300 A-------------------------HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--P  346 (754)
T ss_pred             c-------------------------cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--C
Confidence            1                         111  356777888888876 444332  689999999999995 676664  7


Q ss_pred             ccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccc
Q 045539          388 RLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPIT  467 (897)
Q Consensus       388 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~  467 (897)
                      +|+.|+|++|+|+ .+|..+.  ++|+.|++++|+++. +|..+.  ..|+.|++++|+|..+.          ..+|..
T Consensus       347 sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~LP----------~sl~~~  410 (754)
T PRK15370        347 ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRLP----------ESLPHF  410 (754)
T ss_pred             cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccCc----------hhHHHH
Confidence            9999999999998 6777663  689999999999995 666553  24665555555443221          123444


Q ss_pred             ccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCC-CCchhhhhhcccceEeccCCcccccCC
Q 045539          468 IGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG-AIPASLQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       468 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      .+.++.+..|++.+|.++.      ..+.+|+.| ++.+.+.| .++..+..+.+++....-.+.+.+-++
T Consensus       411 ~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~Wl~  474 (754)
T PRK15370        411 RGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQGWLT  474 (754)
T ss_pred             hhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhccCC
Confidence            5566889999999999972      355666666 55566655 334444455555443333444444433

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.4e-22  Score=192.76  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=182.7

Q ss_pred             CcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          620 SENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      ....+|.+...|+.|+|+|+ |..+++|+++...  .+..+.|..|.-.++-+.||||.++++.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34567889999999999998 6778888876432  34456788999999999999999999999999999999999999


Q ss_pred             CChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEe--eccCccccCCCCcee
Q 045539          698 GSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLS  774 (897)
Q Consensus       698 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~--DFg~a~~~~~~~~~~  774 (897)
                      |+|...+++.. ...+-.+..+++.++|+|++|||.. +.-|----+.+..|++|++.+++|+  |--++.         
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------  341 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---------
Confidence            99999998775 4467789999999999999999642 2224444688999999999988875  322221         


Q ss_pred             eeeccccCcccCCcCccCCCCC---CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          775 IQIQTLATIGYMAPEYGTKGRV---CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ...+..-.+.||+||.++..+-   -.++|+|||++++||+.|+..||.+...-+..+.-         ..+-+...+. 
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------aleglrv~ip-  411 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------ALEGLRVHIP-  411 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------hhccccccCC-
Confidence            1122234688999998876654   35789999999999999999999874322111000         0011111111 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                               ......+.+++.-|+..|| .+||.++.|+-.||+
T Consensus       412 ---------pgis~hm~klm~icmnedp-gkrpkfdmivpilek  445 (448)
T KOG0195|consen  412 ---------PGISRHMNKLMNICMNEDP-GKRPKFDMIVPILEK  445 (448)
T ss_pred             ---------CCccHHHHHHHHHHhcCCC-CcCCCcceehhhHHH
Confidence                     1233457788999999999 999999988776653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=5.4e-20  Score=202.48  Aligned_cols=257  Identities=31%  Similarity=0.406  Sum_probs=195.3

Q ss_pred             CCcCCeeecccceEEEEEEecCCceEEEEEechhhHH---HHHHHHHHHHHHHhcCCC-ccceEeeeecCCCceEEEEEe
Q 045539          619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER---ALKSFEDECEVMKRIRHR-NLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  694 (897)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999877  78999998765432   367889999999999988 799999999777778999999


Q ss_pred             ccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCCCC
Q 045539          695 MPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGED  771 (897)
Q Consensus       695 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~  771 (897)
                      +.++++.+++....  ..+.......++.|++.+++|+   |+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776654  2588999999999999999999   899999999999999999888 79999999998654333


Q ss_pred             cee----eeeccccCcccCCcCccCC---CCCCccchHHHHHHHHHHHHcCCCCCcccccC--ccchhHHhhhcCCchHH
Q 045539          772 QLS----IQIQTLATIGYMAPEYGTK---GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG--ELSLNRWINDLLPVSVM  842 (897)
Q Consensus       772 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  842 (897)
                      ...    ......|+..|+|||....   ..+....|+||+|++++++++|..||......  .......+......   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2345679999999998877   57889999999999999999999996653221  01111111111100   


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           ...........  ......+.+++..|+..+| ..|.++.+...
T Consensus       234 -----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~r~~~~~~~~  274 (384)
T COG0515         234 -----SLASPLSPSNP--ELISKAASDLLKKLLAKDP-KNRLSSSSDLS  274 (384)
T ss_pred             -----ccccccCcccc--chhhHHHHHHHHHHHhcCc-hhcCCHHHHhh
Confidence                 00000000000  1122456788888889999 99998887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=5.9e-21  Score=190.08  Aligned_cols=141  Identities=18%  Similarity=0.201  Sum_probs=110.3

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHH--H------------------------HHHHHHHHHHHHhcCCCcc
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER--A------------------------LKSFEDECEVMKRIRHRNL  675 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  675 (897)
                      ...||+|+||.||+|...+|+.||+|+++.....  .                        .....+|+++++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999998754211  0                        1123459999999988776


Q ss_pred             ceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       676 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      .....+...  ..++||||++|+++....... ..++..+...++.|++.+|+++|  |+.||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            443332222  238999999988776543322 35889999999999999999997  789999999999999998 478


Q ss_pred             EEEeeccCccccC
Q 045539          756 AHISDFGIAKLLS  768 (897)
Q Consensus       756 ~kL~DFg~a~~~~  768 (897)
                      ++|+|||+|....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=6.7e-20  Score=183.68  Aligned_cols=200  Identities=21%  Similarity=0.306  Sum_probs=172.0

Q ss_pred             cCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      -.|++.++||+|.||.++.|+. -+++.||||.-....  ...++..|.+..+.+. .+.|..+|.+..++.+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4799999999999999999974 368999999754332  2356778999998886 79999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-----CcEEEeeccCccccCC
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-----MVAHISDFGIAKLLSG  769 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-----~~~kL~DFg~a~~~~~  769 (897)
                      . |.+|+|...--+..++..++.-+|.|+..-++|+   |++..|.|||||+|+||...     ..+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 8899999888788899999999999999999999   89999999999999999643     3789999999998865


Q ss_pred             CCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          770 EDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       770 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      ....     .......||..||+-....+.+.+.+-|+=|+|=|+.+.+-|..||...
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            4321     2223446999999999888999999999999999999999999999874

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=8.2e-21  Score=216.63  Aligned_cols=247  Identities=19%  Similarity=0.201  Sum_probs=178.5

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhhH----HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE----RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      +|...+.||++.|=.|.+|++++|. |+||++-+..+    +..++-..|++ ....+|||++++..+...+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777899999999999999999877 99999876542    12223333444 555689999999988888888899999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc--CCC-
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGE-  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~--~~~-  770 (897)
                      |+ ..+|.|.+..++ .+...+.+=|+.|++.|+..+   |+.||+|||||.+|||++.-..+.|+||..-+..  +.+ 
T Consensus       102 yv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            98 558999988765 466666777999999999999   9999999999999999999999999999876432  111 


Q ss_pred             --CceeeeeccccCcccCCcCccCC----------CC-CCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhc
Q 045539          771 --DQLSIQIQTLATIGYMAPEYGTK----------GR-VCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       771 --~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  836 (897)
                        +....-.....-..|.|||-+..          .. .+++.||||+||++.|+++ |++||.-.     ++..+-.. 
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~-  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG-  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc-
Confidence              11222222234457999995322          12 5778999999999999998 68888642     11111111 


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      -.......+++ +..             ..+..++..|++.|| ++|-+|++.++.
T Consensus       251 ~~~~~e~~Le~-Ied-------------~~~Rnlil~Mi~rdP-s~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLEK-IED-------------VSLRNLILSMIQRDP-SKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHHh-CcC-------------ccHHHHHHHHHccCc-hhccCHHHHHHh
Confidence            01111111111 110             136788889999999 999999999876

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.9e-19  Score=176.17  Aligned_cols=187  Identities=17%  Similarity=0.135  Sum_probs=140.7

Q ss_pred             CcCCeeecccceEEEEEEecCCceEEEEEechhhH----HHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEe
Q 045539          620 SENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE----RALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    -....+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4568899999999998876 578888777664422    11236789999999996 5889999886    346999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCC-CCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL-KPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dl-kp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ++|.+|.+....        ....++.|++++++++   |+.||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        1235788999999999   8999999999 799999999999999999999865433311


Q ss_pred             ----ee-------eeccccCcccCCcCccC--CCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          774 ----SI-------QIQTLATIGYMAPEYGT--KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       774 ----~~-------~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                          ..       ......++.|++|+...  ...--.+.+.++-|.-+|.++||+.|....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                00       01123577788887422  222235679999999999999999987553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3.8e-19  Score=178.01  Aligned_cols=139  Identities=23%  Similarity=0.249  Sum_probs=110.6

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHH--------------------------HHHHHHHHHHHHHhcCCCcc
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER--------------------------ALKSFEDECEVMKRIRHRNL  675 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  675 (897)
                      .+.||+|++|.||+|+..+|+.||||+++.....                          ....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999998878999999998754210                          01234689999999999987


Q ss_pred             ceEeeeecCCCceEEEEEeccCCChhHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCC
Q 045539          676 VKIISSCSNDDFKALIMKYMPNGSLENC-LYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDED  753 (897)
Q Consensus       676 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~  753 (897)
                      .....+...  ..++||||++|+++... +..  ..++..+...++.|++.++.++   |+ .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhhEEEE-C
Confidence            544443332  24899999998865433 333  3477889999999999999999   66 9999999999999998 7


Q ss_pred             CcEEEeeccCccccC
Q 045539          754 MVAHISDFGIAKLLS  768 (897)
Q Consensus       754 ~~~kL~DFg~a~~~~  768 (897)
                      +.++|+|||+|....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=1.5e-20  Score=170.74  Aligned_cols=179  Identities=25%  Similarity=0.449  Sum_probs=126.1

Q ss_pred             CccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEE
Q 045539          361 QLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFI  440 (897)
Q Consensus       361 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  440 (897)
                      ++++++.|.||+|+++ .+|..+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3455555555555555 44455555556666666666665 55555666666666666666655 456666666666655


Q ss_pred             eecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhc
Q 045539          441 DVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL  520 (897)
Q Consensus       441 ~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  520 (897)
                      |++.|.+.        .    ..+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.++
T Consensus       108 dltynnl~--------e----~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt  173 (264)
T KOG0617|consen  108 DLTYNNLN--------E----NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLT  173 (264)
T ss_pred             hccccccc--------c----ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHH
Confidence            44444332        1    145777888899999999999998 89999999999999999999987 8999999999


Q ss_pred             ccceEeccCCcccccCCCCCCCCCCC---cccccchhhh
Q 045539          521 YLKHLNLSFNKLEGEIPRGGPFANLT---AKSFMGNELL  556 (897)
Q Consensus       521 ~L~~L~ls~N~l~~~~p~~~~~~~~~---~~~~~~N~~~  556 (897)
                      +|++|.+.+|+++-.+|..+.+.-..   ....+.|||.
T Consensus       174 ~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  174 RLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             HHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            99999999999998888766654332   2346677774

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.3e-19  Score=194.07  Aligned_cols=212  Identities=26%  Similarity=0.346  Sum_probs=160.5

Q ss_pred             HHhcCCCccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCC
Q 045539          667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPS  746 (897)
Q Consensus       667 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~  746 (897)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....++++|+.|++|+|  ++..-.|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence            35678999999999999999999999999999999999988778999999999999999999995  4444499999999


Q ss_pred             CeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-------CCCccchHHHHHHHHHHHHcCCCCC
Q 045539          747 NVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-------RVCTRGDVYSYGIMLMEMFTKKKPT  819 (897)
Q Consensus       747 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvil~elltg~~p~  819 (897)
                      |.++|....+|++|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998776431111112222345669999987653       2467899999999999999999999


Q ss_pred             cccccCccchhHHhhhcCCchHHHHhhhhhc-chhhhh--HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          820 DEIFIGELSLNRWINDLLPVSVMEVIDTNLL-RGEERF--FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       820 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +........             .+++.+.-. ....-|  .....+...++..++..||..+| ++||++++|-..++
T Consensus       159 ~~~~~~~~~-------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P-~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  159 DLRNLVEDP-------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIP-EKRPSIEQIRSKLL  222 (484)
T ss_pred             ccccccCCh-------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccCh-hhCccHHHHHhhhh
Confidence            874333211             111111000 000001  01111444578999999999999 99999999987764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=7.5e-19  Score=179.96  Aligned_cols=194  Identities=20%  Similarity=0.226  Sum_probs=134.9

Q ss_pred             CCCccceEeeeecC---------------------------CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHH
Q 045539          671 RHRNLVKIISSCSN---------------------------DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV  723 (897)
Q Consensus       671 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i  723 (897)
                      +|||||++.++|.+                           +...|+||..+ ..+|.+++..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence            49999999887743                           23568999887 559999998766  5667777899999


Q ss_pred             HHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCC--cEEEeeccCccccCCC----CceeeeeccccCcccCCcCccCCCC
Q 045539          724 ALALEYLHFGHSTPIIHCDLKPSNVLLD--EDM--VAHISDFGIAKLLSGE----DQLSIQIQTLATIGYMAPEYGTKGR  795 (897)
Q Consensus       724 ~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~--~~kL~DFg~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~  795 (897)
                      ++|+.||   |++||.|||+|++||++.  +|+  ...++|||++---...    ..........|.-.-||||+....+
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   999999999999999994  444  6788999987432210    0111122334677789999854322


Q ss_pred             ------CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHH
Q 045539          796 ------VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLN  869 (897)
Q Consensus       796 ------~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~  869 (897)
                            .-.|+|.|+.|.+.||+++...||......-.+...+..+..|            .-+       +.+...+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP------------alp-------~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP------------ALP-------SRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC------------CCc-------ccCChHHHH
Confidence                  2358999999999999999999997632222222222221111            111       122333567


Q ss_pred             HHhHccCCCCCCCCCCHHHHH
Q 045539          870 LATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       870 l~~~cl~~dP~~~RPt~~evl  890 (897)
                      ++...++.|| ++||+..=..
T Consensus       489 lV~~lL~r~p-skRvsp~iAA  508 (598)
T KOG4158|consen  489 LVFDLLKRDP-SKRVSPNIAA  508 (598)
T ss_pred             HHHHHhcCCc-cccCCccHHH
Confidence            7778889999 9999865433

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=3.8e-18  Score=171.16  Aligned_cols=137  Identities=16%  Similarity=0.260  Sum_probs=106.7

Q ss_pred             CCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc-----CCCccceEeeeecCCC---ceE-
Q 045539          619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-----RHRNLVKIISSCSNDD---FKA-  689 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  689 (897)
                      +...+.||+|+||.||.  +++....+||++........+.+.+|+++++.+     .||||++++|+++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34568899999999996  443333479988765444457789999999999     5799999999998763   333 


Q ss_pred             EEEEe--ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEeCCCCCCCeeeCC----CCcEEEeecc
Q 045539          690 LIMKY--MPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHCDLKPSNVLLDE----DMVAHISDFG  762 (897)
Q Consensus       690 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~Lh~~h~~~ivH~Dlkp~NIll~~----~~~~kL~DFg  762 (897)
                      +||||  +.+++|.+++.+..  +++.  ..++.+++.++ +||   |+++|+||||||+||+++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  55799999997643  5554  35678888777 899   8999999999999999973    3489999954


Q ss_pred             Cc
Q 045539          763 IA  764 (897)
Q Consensus       763 ~a  764 (897)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=1.2e-20  Score=206.60  Aligned_cols=284  Identities=25%  Similarity=0.269  Sum_probs=142.0

Q ss_pred             EEeeccccc-ccCCCCCCCCCCCceecccCccccC----cCCccccCCCCCcEEeccCccccC------Ccccccccccc
Q 045539           81 LNISSFNLQ-GTIPPQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLYFSDNQLFG------SLSFFIFNVSS  149 (897)
Q Consensus        81 l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~  149 (897)
                      |+|..+.++ +.....+..+..|+.|+|+++.++.    .++..+...++|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            445555554 2333344555556666666666632    244455555666666666665542      12234444555


Q ss_pred             ccEEEeeecCCCCCCCccccCccc---cccccccccccccc----cccccccc-ccccccccccccccccCCcccccccc
Q 045539          150 VTTIDLSINGLSGEMPREIGNLPY---LARLAFATNNLVGV----APVTIFNM-SALKEIYLLNNSLSGSLPSRIDLSLP  221 (897)
Q Consensus       150 L~~LdLs~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~  221 (897)
                      |+.|++++|.+.+..+..+..+.+   |++|++++|++++.    ....+..+ ++|++|++++|.+++...        
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~--------  154 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASC--------  154 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHH--------
Confidence            666666666555444444444333   55555555554421    11122233 444444444444442111        


Q ss_pred             ccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCC
Q 045539          222 NVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNP  301 (897)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~  301 (897)
                                   ..++..+..+++|+.|++++|.+++.....+                 ...+..+++|++|+|++|.
T Consensus       155 -------------~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l-----------------~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         155 -------------EALAKALRANRDLKELNLANNGIGDAGIRAL-----------------AEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             -------------HHHHHHHHhCCCcCEEECcCCCCchHHHHHH-----------------HHHHHhCCCCCEEeccCCc
Confidence                         1223344455566666666666553211110                 0112334566666666666


Q ss_pred             CCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccC-----ccchhhhcccCcccc
Q 045539          302 LDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQ-----LQTLQALGLTRNKLA  376 (897)
Q Consensus       302 l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~  376 (897)
                      +.+...          .           .++..+..+++|++|++++|.+++.....+..     .+.|+.|++++|.++
T Consensus       205 i~~~~~----------~-----------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         205 LTDEGA----------S-----------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             cChHHH----------H-----------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence            653211          0           11223445566667777776666432222221     256677777777665


Q ss_pred             c----ccchhhhcccccccccccccccccC----CCcccccc-cccceeccccccc
Q 045539          377 G----PITDELCHLARLHSLVLQGNKFSGS----IPSCLGNL-TSLRVLYLGLNRF  423 (897)
Q Consensus       377 ~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l  423 (897)
                      .    .+...+..+++|+++++++|.++..    ....+... +.|+.+++.+|.+
T Consensus       264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            2    2233445556777777777777743    33333334 5677777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.9e-18  Score=202.47  Aligned_cols=201  Identities=24%  Similarity=0.267  Sum_probs=159.4

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC---CCccceEeeeecCCCc
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR---HRNLVKIISSCSNDDF  687 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  687 (897)
                      +.+...+.|.+.+.+|+|+||.||+|...+|+.||+|+-+....-+   |.--.+++.+++   -+.|.++...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4445567899999999999999999998889999999866542110   000112223333   3456666666666777


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-------CCCcEEEee
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-------EDMVAHISD  760 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-------~~~~~kL~D  760 (897)
                      -++|+||.+.|+|.+++... +.+++.-++.++.|+++.+++|   |..+||||||||+|.++.       +...++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            78999999999999999844 4689999999999999999999   999999999999999994       234789999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP  818 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p  818 (897)
                      ||.+..+.--.....-...++|-.+-.+|+..+.+++..+|-|.++.+++-|+.|++-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9998765432222334566789999999999999999999999999999999999763

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=1.5e-20  Score=205.87  Aligned_cols=284  Identities=22%  Similarity=0.240  Sum_probs=187.5

Q ss_pred             eecccCcccc-CcCCccccCCCCCcEEeccCccccCC----ccccccccccccEEEeeecCCCC------CCCccccCcc
Q 045539          104 TLDLSHNKLS-GNIPSSIFNMHTLKLLYFSDNQLFGS----LSFFIFNVSSVTTIDLSINGLSG------EMPREIGNLP  172 (897)
Q Consensus       104 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~LdLs~N~l~~------~~p~~l~~l~  172 (897)
                      .|+|+.+.++ ...+..+..+.+|++|+++++.+...    ++..+...++|++|++++|.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            5788888887 44556677788888999988887543    44555666778888888877752      1223344455


Q ss_pred             cccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc----cccccccCC-Ccc
Q 045539          173 YLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG----TVPSSITNA-SKL  247 (897)
Q Consensus       173 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l-~~L  247 (897)
                      +|+.|++++|.+.+..+..+..+.+                     . ++|++|++++|++++    .+...+..+ ++|
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~---------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L  139 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLR---------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL  139 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhc---------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCc
Confidence            5555555555554433333333333                     1 225555555555542    333445556 889


Q ss_pred             cEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCC
Q 045539          248 SDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI  327 (897)
Q Consensus       248 ~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l  327 (897)
                      +.|++++|.+++.....+                 ...+..+++|++|++++|.+++.          .+.         
T Consensus       140 ~~L~L~~n~l~~~~~~~~-----------------~~~~~~~~~L~~L~l~~n~l~~~----------~~~---------  183 (319)
T cd00116         140 EKLVLGRNRLEGASCEAL-----------------AKALRANRDLKELNLANNGIGDA----------GIR---------  183 (319)
T ss_pred             eEEEcCCCcCCchHHHHH-----------------HHHHHhCCCcCEEECcCCCCchH----------HHH---------
Confidence            999999998875333222                 12356778999999999998752          111         


Q ss_pred             CCCcCccccCccCCcEEEccCCCCCCCc----cccccCccchhhhcccCcccccccchhhhc-----ccccccccccccc
Q 045539          328 SGNIPQVVGNLGNLLVLELGGNNLTEPI----PITFSQLQTLQALGLTRNKLAGPITDELCH-----LARLHSLVLQGNK  398 (897)
Q Consensus       328 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~  398 (897)
                        .++..+..+++|++|++++|.+++..    +..+..+++|++|++++|++++.....+..     .+.|++|++++|.
T Consensus       184 --~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~  261 (319)
T cd00116         184 --ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND  261 (319)
T ss_pred             --HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCC
Confidence              12234455689999999999998543    345667889999999999998744444443     3799999999999


Q ss_pred             ccc----CCCcccccccccceeccccccccCC----cccccccc-ccceEEeecCCcc
Q 045539          399 FSG----SIPSCLGNLTSLRVLYLGLNRFTSA----LPSTIWNL-KDILFIDVSSNSL  447 (897)
Q Consensus       399 l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l  447 (897)
                      ++.    .+...+..+++|+.+++++|.++..    +...+... +.++++|+.+|.+
T Consensus       262 i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         262 ITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            972    3345566778999999999999854    33334334 5778777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=3e-18  Score=177.17  Aligned_cols=231  Identities=19%  Similarity=0.241  Sum_probs=143.9

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCC----------CccceEeeee-
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH----------RNLVKIISSC-  682 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~-  682 (897)
                      .+...+.||.|+++.||.+++. +|+++|+|++....   ....+.+++|.-....+.+          -.++.-++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455788999999999999876 58999999875322   3345666666644444322          1122222221 


Q ss_pred             --------cCC---C-----ceEEEEEeccCCChhHhhh---cCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 045539          683 --------SND---D-----FKALIMKYMPNGSLENCLY---SGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIH  740 (897)
Q Consensus       683 --------~~~---~-----~~~lv~e~~~~gsL~~~l~---~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH  740 (897)
                              ...   .     ..+++|+-+ .++|.+.+.   ...   .......+..+..|+++.+++|   |+.|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEe
Confidence                    111   1     236778877 568877643   222   1233445677889999999999   8999999


Q ss_pred             CCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC--------CCCCccchHHHHHHHHHHH
Q 045539          741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK--------GRVCTRGDVYSYGIMLMEM  812 (897)
Q Consensus       741 ~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvil~el  812 (897)
                      +||+|+|++++.+|.++|+||+.....+.    ... ....+..|.|||....        -.++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc----eee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999998765431    111 1345678999996432        3578899999999999999


Q ss_pred             HcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCC
Q 045539          813 FTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNG  883 (897)
Q Consensus       813 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~R  883 (897)
                      ++|+.||+....+.....                 .....        .+.++.+.+++..+++++| ++|
T Consensus       244 WC~~lPf~~~~~~~~~~~-----------------~f~~C--------~~~Pe~v~~LI~~lL~~~~-~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-----------------DFSRC--------RDMPEPVQFLIRGLLQRNP-EDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-----------------GGTTS--------S---HHHHHHHHHHT-SSG-GGS
T ss_pred             HHccCCCCCCCccccccc-----------------cchhc--------CCcCHHHHHHHHHHccCCc-ccC
Confidence            999999986432211110                 01100        1334557888889999999 877

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.75  E-value=2.5e-20  Score=169.38  Aligned_cols=181  Identities=27%  Similarity=0.475  Sum_probs=150.1

Q ss_pred             ccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccc
Q 045539          335 VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLR  414 (897)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  414 (897)
                      +-++++.+.|.||+|+++. +|+.++.+.+|+.|++++|++. ..|..+..+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            3456788888899999985 6778889999999999999998 68888999999999999999998 8899999999999


Q ss_pred             eeccccccccC-CccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCC
Q 045539          415 VLYLGLNRFTS-ALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFG  493 (897)
Q Consensus       415 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  493 (897)
                      .|||.+|++.. ..|..|..+..|+.|.+++|.+.              .+|+.++.+++|+.|.+..|.+- .+|..++
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe--------------~lp~dvg~lt~lqil~lrdndll-~lpkeig  170 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE--------------ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG  170 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc--------------cCChhhhhhcceeEEeeccCchh-hCcHHHH
Confidence            99999998864 47888888888885555555544              56899999999999999999998 7999999


Q ss_pred             CcCCCcEEeccCCccCCCCchhhhhhccc---ceEeccCCcccc
Q 045539          494 DLSSLEVLDLSKNKISGAIPASLQKLLYL---KHLNLSFNKLEG  534 (897)
Q Consensus       494 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L---~~L~ls~N~l~~  534 (897)
                      .+..|++|.+.+|+++ .+|++++++.-+   +.+.+.+|++..
T Consensus       171 ~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  171 DLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             HHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence            9999999999999998 888888876432   344556666543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.9e-19  Score=196.69  Aligned_cols=186  Identities=27%  Similarity=0.373  Sum_probs=156.6

Q ss_pred             eeecccceEEEEEE----ecCCceEEEEEechhhHH--HHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEecc
Q 045539          624 LIGIGSFGSIYVAR----LQDGMEVAVKVFHQQYER--ALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      .+|+|+||.|+.++    ...|..||.|+.++....  .......|..++..++ ||.++++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    234778999987755321  1225566888888887 9999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      ||.+...+.... .+++.....+...++-+++++   |+.+|+|||+|++||+++.+|.+++.|||.++..-....    
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            999988777665 467777788888899999999   999999999999999999999999999999987543322    


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                        .+||..|||||+..  ....++|-||||++.+||+||..||..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence              17899999999987  567789999999999999999999976

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.6e-17  Score=168.56  Aligned_cols=143  Identities=20%  Similarity=0.175  Sum_probs=112.7

Q ss_pred             cCCCcCCeeecccceEEEEEE--ecCCceEEEEEechhhH------------------------HHHHHHHHHHHHHHhc
Q 045539          617 DRFSENNLIGIGSFGSIYVAR--LQDGMEVAVKVFHQQYE------------------------RALKSFEDECEVMKRI  670 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l  670 (897)
                      .-|.+.+.||+|++|.||+|.  ..+|+.||+|+++....                        .....+.+|++.++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  45799999999874321                        0123467899999999


Q ss_pred             CCC--ccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEeCCCCCCC
Q 045539          671 RHR--NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP-IIHCDLKPSN  747 (897)
Q Consensus       671 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-ivH~Dlkp~N  747 (897)
                      .+.  .+++++++    ...++||||++|+++........ ..+..+...++.|++.++++|   |+.| |+||||||+|
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~N  179 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYN  179 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhh
Confidence            753  34455543    23589999999988876543332 356667789999999999999   8999 9999999999


Q ss_pred             eeeCCCCcEEEeeccCccccC
Q 045539          748 VLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       748 Ill~~~~~~kL~DFg~a~~~~  768 (897)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=2.6e-16  Score=161.06  Aligned_cols=134  Identities=23%  Similarity=0.346  Sum_probs=113.4

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +.||+|++|.||+|.+ +|..|++|+.....        ......+.+|++++..++|++++....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 57889999765321        11235678899999999999988777777777788999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ++|++|.+++....    . .+..++.+++.+|+++   |+.|++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886543    2 7889999999999999   899999999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.1e-16  Score=161.77  Aligned_cols=145  Identities=23%  Similarity=0.228  Sum_probs=113.4

Q ss_pred             HHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH----------------------HHHHHHHHHHHHH
Q 045539          610 HELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE----------------------RALKSFEDECEVM  667 (897)
Q Consensus       610 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l  667 (897)
                      +++.+....|.+.+.||+|+||.||+|...+|+.||||+++....                      .....+.+|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344444445888899999999999999988899999998754210                      0112367889999


Q ss_pred             HhcCCC--ccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCC
Q 045539          668 KRIRHR--NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKP  745 (897)
Q Consensus       668 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp  745 (897)
                      .++.|+  .+++.++.    ...++||||++|++|.+....       .....++.+++.++.++   |+.||+||||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p  153 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSE  153 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCc
Confidence            999877  44555542    345899999999998765321       34567889999999999   789999999999


Q ss_pred             CCeeeCCCCcEEEeeccCccccC
Q 045539          746 SNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       746 ~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      +||++++++.++|+|||.+....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.70  E-value=3.6e-17  Score=192.16  Aligned_cols=152  Identities=28%  Similarity=0.473  Sum_probs=129.3

Q ss_pred             hcCChhHHHHHHHHHhccccCCCcccccCCCCCCCCc----ceeeeEeeCC--C--CeEEEEEeecccccccCCCCCCCC
Q 045539           28 ASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVC----SWIGITCDVN--S--HRVIGLNISSFNLQGTIPPQLGNL   99 (897)
Q Consensus        28 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l   99 (897)
                      +.+.+.|.+||+++|+++. ++..   .+|+ +.+||    .|.||+|+..  +  .+|+.|+|+++++.|.+|++++++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~-~~~~---~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L  441 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLG-LPLR---FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL  441 (623)
T ss_pred             cccCchHHHHHHHHHHhcC-Cccc---CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence            3456789999999999985 3332   3896 44553    7999999632  2  269999999999999999999999


Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCc-ccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNL-PYLARLA  178 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l-~~L~~L~  178 (897)
                      ++|+.|+|++|.++|.+|..++++++|+.|+|++|++.+.+|..++++++|++|||++|+++|.+|..++.+ .++..++
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~  521 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN  521 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence            999999999999999999999999999999999999999999999999999999999999999999988764 4566677


Q ss_pred             cccccc
Q 045539          179 FATNNL  184 (897)
Q Consensus       179 L~~N~l  184 (897)
                      +.+|..
T Consensus       522 ~~~N~~  527 (623)
T PLN03150        522 FTDNAG  527 (623)
T ss_pred             ecCCcc
Confidence            777653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=3.7e-16  Score=181.99  Aligned_cols=141  Identities=20%  Similarity=0.264  Sum_probs=114.3

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEe-chh-------hHHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVF-HQQ-------YERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      ......|...+.||+|+||+||+|.+.. +.+++|+. .+.       .....+++.+|++++++++|++++..+.++.+
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            3344566778999999999999998764 34444432 211       11223568899999999999999988888777


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      +...++||||+++++|.+++.         ....++.++++++++|   |+.|++|||+||+||++ +++.++|+|||++
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            778899999999999998775         3567899999999999   89999999999999999 6779999999998


Q ss_pred             ccc
Q 045539          765 KLL  767 (897)
Q Consensus       765 ~~~  767 (897)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=3.9e-16  Score=158.11  Aligned_cols=130  Identities=22%  Similarity=0.387  Sum_probs=106.4

Q ss_pred             eeecccceEEEEEEecCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .||+|++|.||+|.+. |..|++|+.....        .....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3799999999999854 7889999864321        112366789999999999887655555555666779999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      +|++|.+++.....        .++.+++.+++++   |+.|++|||++|+||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999987755321        7899999999999   899999999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=4.5e-17  Score=174.90  Aligned_cols=123  Identities=28%  Similarity=0.446  Sum_probs=107.6

Q ss_pred             CceEEEEEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      .+.|+.|++|...+|.+|+..+.  ...++.....++.|++.|++|      +|.+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            35789999999999999996543  567888899999999999988      7899999999999999999999999999


Q ss_pred             ccccCCCC----ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc
Q 045539          764 AKLLSGED----QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT  814 (897)
Q Consensus       764 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt  814 (897)
                      ........    .....+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            88765443    2233456679999999999999999999999999999999997

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=1.7e-16  Score=181.84  Aligned_cols=166  Identities=27%  Similarity=0.341  Sum_probs=121.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+|+.++.|..|+||.||.++++ ..+.+|.|+ .++.     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            468999999999999999999877 467888854 3221     11111  23333334333                  


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC----
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE----  770 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~----  770 (897)
                         |+-.+.++.-+ .++...        +.+++|+   |+.||+|||+||+|.+|+.-|.+|++|||+++.....    
T Consensus       136 ---gDc~tllk~~g-~lPvdm--------vla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPVDM--------VLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCC-CCcchh--------hHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               23333333322 233322        7789999   9999999999999999999999999999998653210    


Q ss_pred             ---------CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          771 ---------DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       771 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                               ........++||+.|+|||++....|+..+|.|++|+|+||.+.|..||...
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence                     0011223457999999999999999999999999999999999999999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=5.9e-15  Score=142.24  Aligned_cols=135  Identities=21%  Similarity=0.300  Sum_probs=115.8

Q ss_pred             cCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCC--CccceEeeeecCCCceEEEEEeccCC
Q 045539          621 ENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH--RNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      +.+.+|+|.++.||++...+ ..+++|+......  ...+.+|+.+++.++|  .++++++++...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999864 7899999876533  4578899999999986  58999999998888999999999988


Q ss_pred             ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          699 SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       699 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      .+...        +......++.+++++++++|..+..+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5567788999999999999765557899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7.5e-15  Score=147.13  Aligned_cols=136  Identities=24%  Similarity=0.264  Sum_probs=98.5

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHH--HHH----------------------HHHHHHHHHHhcCCC--cc
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER--ALK----------------------SFEDECEVMKRIRHR--NL  675 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~--~~~----------------------~~~~E~~~l~~l~h~--ni  675 (897)
                      .+.||+|+||.||+|...+|+.||||+++.....  ...                      ....|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998753211  111                      113566666666543  24


Q ss_pred             ceEeeeecCCCceEEEEEeccCCChhHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCC
Q 045539          676 VKIISSCSNDDFKALIMKYMPNGSLENC-LYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDED  753 (897)
Q Consensus       676 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~  753 (897)
                      .+.+++    ...++||||++++++... +....  .. .+...++.+++.++.++   |+ .||+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            445443    235899999999543221 11111  11 56788999999999999   77 9999999999999999 8


Q ss_pred             CcEEEeeccCccccC
Q 045539          754 MVAHISDFGIAKLLS  768 (897)
Q Consensus       754 ~~~kL~DFg~a~~~~  768 (897)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2.4e-16  Score=182.22  Aligned_cols=255  Identities=24%  Similarity=0.252  Sum_probs=196.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC--CceEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD--GMEVAVKVFHQQY--ERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  690 (897)
                      ...|...+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+.+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3467788889999999999886543  4456677665432  333455566888888887 9999999999999999999


Q ss_pred             EEEeccCCChhHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCcEeCCCCCCCeeeCCCC-cEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHFGH-STPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~  767 (897)
                      +++|..|+++.+-+ .......+......+..|+..++.|+   | ..++.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999998887 44333567777888999999999999   8 99999999999999999999 9999999999887


Q ss_pred             CC-CCceeeeecccc-CcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          768 SG-EDQLSIQIQTLA-TIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       768 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      .. .+.........| ++.|+|||...+ ....+..|+||.|+++..+++|..|++........+..|+.......    
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  251 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----  251 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc----
Confidence            76 455555556678 999999998777 45578889999999999999999999886655555455543321100    


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHH
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                                  ............++..+++..+| ..|.+.+++.
T Consensus       252 ------------~~~~~~~~~~~~~~l~k~l~~~~-~~r~s~~~~~  284 (601)
T KOG0590|consen  252 ------------QLPWNSISDQAHDLLHKILKENP-SNRLSIEELK  284 (601)
T ss_pred             ------------cCccccCChhhhhcccccccCCc-hhcccccccc
Confidence                        00011122334667778888889 9999887754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2.1e-14  Score=148.39  Aligned_cols=135  Identities=16%  Similarity=0.229  Sum_probs=105.8

Q ss_pred             CCeee-cccceEEEEEEecCCceEEEEEechhh-------------HHHHHHHHHHHHHHHhcCCCcc--ceEeeeecCC
Q 045539          622 NNLIG-IGSFGSIYVARLQDGMEVAVKVFHQQY-------------ERALKSFEDECEVMKRIRHRNL--VKIISSCSND  685 (897)
Q Consensus       622 ~~~lg-~G~~g~Vy~a~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  685 (897)
                      ...|| .|+.|+||.++.. +..+|||++....             .....++.+|++++.+++|+++  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999876 7889999885311             1223567889999999998775  6777764332


Q ss_pred             -C---ceEEEEEeccC-CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          686 -D---FKALIMKYMPN-GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       686 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                       .   ..++|||+++| .+|.+++....  ++..    .+.+++.++++|   |+.||+||||||+|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 68988876532  4443    367899999999   899999999999999999888999999


Q ss_pred             ccCccc
Q 045539          761 FGIAKL  766 (897)
Q Consensus       761 Fg~a~~  766 (897)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998865

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=9.1e-16  Score=164.59  Aligned_cols=177  Identities=33%  Similarity=0.516  Sum_probs=154.5

Q ss_pred             CccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccccccccee
Q 045539          337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVL  416 (897)
Q Consensus       337 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  416 (897)
                      .+..-...||+.|++.. +|..+..+..|+.+.|.+|.+. .+|..++++..|++|||+.|+++ .+|..++.++ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~e-lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFSE-LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhcccccccc-CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            35566778999999986 8888899999999999999998 78999999999999999999998 8888888875 8999


Q ss_pred             ccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcC
Q 045539          417 YLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS  496 (897)
Q Consensus       417 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~  496 (897)
                      -+++|+++ .+|..++.+..|..||.+.|.+.              ++|..++.+.+|+.|++..|++. .+|+.++.|+
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--------------slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp  212 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--------------SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP  212 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh--------------hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc
Confidence            99999998 58888888888887777666655              56889999999999999999998 6888888654


Q ss_pred             CCcEEeccCCccCCCCchhhhhhcccceEeccCCccccc
Q 045539          497 SLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE  535 (897)
Q Consensus       497 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  535 (897)
                       |..||+|.|+++ .+|-.|.+|..|++|-|.+|+|..+
T Consensus       213 -Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  213 -LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             -eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence             899999999998 8999999999999999999999753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=4.2e-13  Score=150.90  Aligned_cols=141  Identities=24%  Similarity=0.284  Sum_probs=100.4

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHH----------------------------------------HHHHH
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERA----------------------------------------LKSFE  661 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  661 (897)
                      .+.||.|++|.||+|+..+|+.||||+.+....+.                                        .-.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986432110                                        00244


Q ss_pred             HHHHHHHhcC----CCccceEeeee-cCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 045539          662 DECEVMKRIR----HRNLVKIISSC-SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL-ALEYLHFGHS  735 (897)
Q Consensus       662 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~Lh~~h~  735 (897)
                      +|++.+.+++    |.+-+.+-.++ ......++||||++|+++.++........   ....++.+++. .+..+   |.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---Hh
Confidence            5666666663    22223332222 22345789999999999988765322112   23456666665 35666   88


Q ss_pred             CCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       736 ~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      .|++|+|+||.||+++.++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999997765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.44  E-value=7.2e-14  Score=164.43  Aligned_cols=109  Identities=40%  Similarity=0.588  Sum_probs=74.0

Q ss_pred             cceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccC
Q 045539          450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF  529 (897)
Q Consensus       450 l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  529 (897)
                      +..|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            44666777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CcccccCCCC--CCCCCCCcccccchhhhhh
Q 045539          530 NKLEGEIPRG--GPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       530 N~l~~~~p~~--~~~~~~~~~~~~~N~~~c~  558 (897)
                      |+++|.+|..  ..+.++..+++.+|+.+|+
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~  530 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCG  530 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccC
Confidence            7777777653  1122334556667776665

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.40  E-value=2.1e-14  Score=154.24  Aligned_cols=191  Identities=27%  Similarity=0.416  Sum_probs=123.1

Q ss_pred             HHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccccc
Q 045539          318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGN  397 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  397 (897)
                      ...+++.|.+. .+|..+..+..|+.+.|..|.+.. +|..+.++..|+.|||+.|+++ ..|..+|.++ |+.|-+++|
T Consensus        78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN  153 (722)
T KOG0532|consen   78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN  153 (722)
T ss_pred             hhhhccccccc-cCchHHHHHHHHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence            34455555555 556666666666666677776664 6666777777777777777776 5666666553 666777777


Q ss_pred             ccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccc
Q 045539          398 KFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQM  477 (897)
Q Consensus       398 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L  477 (897)
                      +++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|             ++. .+|.++..| .|..|
T Consensus       154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn-------------~l~-~lp~El~~L-pLi~l  216 (722)
T KOG0532|consen  154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRN-------------HLE-DLPEELCSL-PLIRL  216 (722)
T ss_pred             ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhh-------------hhh-hCCHHHhCC-ceeee
Confidence            776 66777776677777777777776 36666676666664333333             333 235555533 46777


Q ss_pred             cccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcc---cceEeccCCc
Q 045539          478 FLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY---LKHLNLSFNK  531 (897)
Q Consensus       478 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~ls~N~  531 (897)
                      |+|.|+++ .||-.|.+|+.|++|-|.+|.|+ ..|..+...-.   .++|+..-++
T Consensus       217 DfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  217 DFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             ecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            77777777 67777888888888888888777 66666554322   3556655553

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=8.3e-13  Score=148.90  Aligned_cols=184  Identities=39%  Similarity=0.548  Sum_probs=148.0

Q ss_pred             ccCccCCcEEEccCCCCCCCccccccCcc-chhhhcccCcccccccchhhhcccccccccccccccccCCCccccccccc
Q 045539          335 VGNLGNLLVLELGGNNLTEPIPITFSQLQ-TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSL  413 (897)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  413 (897)
                      +..++.++.|++.+|+++. ++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|
T Consensus       112 ~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L  188 (394)
T COG4886         112 LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL  188 (394)
T ss_pred             hhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence            3445788999999999987 555666664 8999999999998 56677888999999999999998 677766688899


Q ss_pred             ceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCC
Q 045539          414 RVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFG  493 (897)
Q Consensus       414 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  493 (897)
                      +.|++++|+++ .+|........|+++++++|.+.              .++..+..+.++..|.+++|++. .++..++
T Consensus       189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--------------~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~  252 (394)
T COG4886         189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--------------ELLSSLSNLKNLSGLELSNNKLE-DLPESIG  252 (394)
T ss_pred             hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--------------ecchhhhhcccccccccCCceee-eccchhc
Confidence            99999999998 46766655666776666655311              35667888899999999999998 4588899


Q ss_pred             CcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCC
Q 045539          494 DLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG  539 (897)
Q Consensus       494 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  539 (897)
                      .+++|+.|++++|+++ .++. +..+.+++.|++++|.++..+|..
T Consensus       253 ~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         253 NLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             cccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence            9999999999999998 5555 888999999999999998777753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.5e-12  Score=143.41  Aligned_cols=199  Identities=24%  Similarity=0.286  Sum_probs=160.1

Q ss_pred             cCCCcCCeeec--ccceEEEEEEe---cCCceEEEEEechhhH--HHHHHHHHHHHHHHhcC-CCccceEeeeecCCCce
Q 045539          617 DRFSENNLIGI--GSFGSIYVARL---QDGMEVAVKVFHQQYE--RALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFK  688 (897)
Q Consensus       617 ~~y~~~~~lg~--G~~g~Vy~a~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  688 (897)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|.-+....  .....=.+|+...++++ |++.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35667788999  99999999976   3688899998443322  22233346777777775 99999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGI  763 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~  763 (897)
                      ++-+|++ +.++.++.+.....++....+.+..+..+    |+.++   |..+++|-|+||.||+...+ ...+++|||.
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCcce
Confidence            9999998 57888888777766888888999999988    99999   99999999999999999999 8999999999


Q ss_pred             ccccCCCCceee---eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          764 AKLLSGEDQLSI---QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       764 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                      ...+........   .....|...|++||. .++-++.++|||++|.++.+..++..+..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhccccc
Confidence            988765543221   222357788999996 45677889999999999999999877643

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.32  E-value=1.8e-12  Score=146.18  Aligned_cols=216  Identities=32%  Similarity=0.430  Sum_probs=147.5

Q ss_pred             cceeeeEeeCCCCeEE---EEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCC-CCcEEeccCccccCC
Q 045539           64 CSWIGITCDVNSHRVI---GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH-TLKLLYFSDNQLFGS  139 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~---~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~  139 (897)
                      +.+.+..+...  .+.   .+++..+.+... ...+..++.++.|++.+|.++ .+|...+.++ +|++|++++|++.. 
T Consensus        80 ~~~l~~~~~~~--~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-  154 (394)
T COG4886          80 ISSLDGSENLL--NLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-  154 (394)
T ss_pred             ccccccccccc--CCCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-
Confidence            55555555322  222   356666655322 233555677888888888887 6777777774 88888888888743 


Q ss_pred             ccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccc
Q 045539          140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLS  219 (897)
Q Consensus       140 ~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  219 (897)
                      +|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++.+.+ .+..+..|++|++++|.+. .++..+. .
T Consensus       155 l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~-~~~~~~~L~~l~~~~N~~~-~~~~~~~-~  230 (394)
T COG4886         155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPP-EIELLSALEELDLSNNSII-ELLSSLS-N  230 (394)
T ss_pred             hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCch-hhhhhhhhhhhhhcCCcce-ecchhhh-h
Confidence            3456777888888888888887 677777778888888888888887743 3345566888888888543 3443333 5


Q ss_pred             ccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecC
Q 045539          220 LPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTG  299 (897)
Q Consensus       220 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~  299 (897)
                      +.++..|.+.+|++. ..+..++.++.+++|++++|+++....                       +..+.+|+.|++++
T Consensus       231 ~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-----------------------~~~~~~l~~L~~s~  286 (394)
T COG4886         231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-----------------------LGSLTNLRELDLSG  286 (394)
T ss_pred             cccccccccCCceee-eccchhccccccceecccccccccccc-----------------------ccccCccCEEeccC
Confidence            677777778888775 336777778888888888888775433                       35667888888888


Q ss_pred             CCCCCCCCCcccC
Q 045539          300 NPLDGILPKSKGN  312 (897)
Q Consensus       300 N~l~~~~p~~~~~  312 (897)
                      |.+....|.....
T Consensus       287 n~~~~~~~~~~~~  299 (394)
T COG4886         287 NSLSNALPLIALL  299 (394)
T ss_pred             ccccccchhhhcc
Confidence            8887766654443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.4e-12  Score=129.79  Aligned_cols=204  Identities=21%  Similarity=0.255  Sum_probs=140.1

Q ss_pred             HHHHHHhcCCCccceEeeeecCCC-----ceEEEEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 045539          663 ECEVMKRIRHRNLVKIISSCSNDD-----FKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGH  734 (897)
Q Consensus       663 E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h  734 (897)
                      -..-+-++-|-|+|+++.|+.+..     ...+++|||..|++..++++..   ..+......+|+.||..||.|||. .
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence            344555667999999999986543     5678999999999999987543   557778889999999999999976 7


Q ss_pred             CCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC--CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHH
Q 045539          735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEM  812 (897)
Q Consensus       735 ~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~el  812 (897)
                      +..|+|+++..+-|++..+|-+|+.--.-.....  ............+-++|.|||+......+.++|||+||+...||
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            7899999999999999999988875211110000  00000111122467899999998887888899999999999999


Q ss_pred             HcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          813 FTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       813 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+...-......             ....+-+...+......          .-..++.+|++..| ..||+|.+++.
T Consensus       276 ailEiq~tnseS~-------------~~~ee~ia~~i~~len~----------lqr~~i~kcl~~eP-~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSESK-------------VEVEENIANVIIGLENG----------LQRGSITKCLEGEP-NGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcce-------------eehhhhhhhheeeccCc----------cccCcCcccccCCC-CCCcchhhhhc
Confidence            9887642221000             00111111111110000          01356779999999 99999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=5.5e-12  Score=143.08  Aligned_cols=145  Identities=20%  Similarity=0.249  Sum_probs=95.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHH----------------------------------HHHH-
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYER----------------------------------ALKS-  659 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-  659 (897)
                      ...|+. +.||+|++|.||+|+.++ |+.||||+.++...+                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999987 999999998754211                                  0111 


Q ss_pred             -----HHHHHHHHHhcC----CCccceEeeeecC-CCceEEEEEeccCCChhHhh--hcCCCCCCHHHHHHHHHHHHHH-
Q 045539          660 -----FEDECEVMKRIR----HRNLVKIISSCSN-DDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALA-  726 (897)
Q Consensus       660 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~-  726 (897)
                           +.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.+.-  ...+  .+..   .++...++. 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~  272 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVF  272 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHH
Confidence                 334554444443    3333333333322 34568999999999998742  2222  2222   233332222 


Q ss_pred             HHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccCccccCC
Q 045539          727 LEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLSG  769 (897)
Q Consensus       727 L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a~~~~~  769 (897)
                      +..+   ...|++|+|+||.||+++.++    .++++|||++.....
T Consensus       273 ~~Qi---f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQV---FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2333   678999999999999999888    999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=6.4e-11  Score=116.58  Aligned_cols=138  Identities=20%  Similarity=0.227  Sum_probs=101.3

Q ss_pred             CCeeecccceEEEEEEecC-------CceEEEEEechhh------H----------------HHHHHH----HHHHHHHH
Q 045539          622 NNLIGIGSFGSIYVARLQD-------GMEVAVKVFHQQY------E----------------RALKSF----EDECEVMK  668 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~-------~~~vavK~~~~~~------~----------------~~~~~~----~~E~~~l~  668 (897)
                      ...||.|.-+.||.|...+       +..+|||+++...      .                ...+.+    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997553       4789999875211      0                012223    38999999


Q ss_pred             hcC--CCccceEeeeecCCCceEEEEEeccCCChhH-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCC
Q 045539          669 RIR--HRNLVKIISSCSNDDFKALIMKYMPNGSLEN-CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKP  745 (897)
Q Consensus       669 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp  745 (897)
                      ++.  .-++++.+++    ...++||||+.+..+.. .+...  .++..+...+..+++.++..++  |+.|+||||+++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCH
Confidence            996  3566777765    45689999997653321 22221  2455567778899999999986  889999999999


Q ss_pred             CCeeeCCCCcEEEeeccCccccC
Q 045539          746 SNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       746 ~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      .||+++ ++.+.++|||.|....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.2e-11  Score=121.84  Aligned_cols=128  Identities=24%  Similarity=0.259  Sum_probs=96.2

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcc-ceEeeeecCCCceEEEEEeccCCCh
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL-VKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.++ .+++++..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            367899999999999876 78899999765432 12345789999999875444 45555443  345899999999888


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP-----IIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-----ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      .+.    .     .....++.+++++++.|   |+.+     ++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643    0     11234678899999999   6666     59999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.26  E-value=2e-13  Score=139.23  Aligned_cols=260  Identities=22%  Similarity=0.279  Sum_probs=147.9

Q ss_pred             CCCCCCCCCceecccCccccC----cCCccccCCCCCcEEeccCc---cccCCccc-------cccccccccEEEeeecC
Q 045539           94 PQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLYFSDN---QLFGSLSF-------FIFNVSSVTTIDLSING  159 (897)
Q Consensus        94 ~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~~~-------~~~~l~~L~~LdLs~N~  159 (897)
                      +.+....++++|+||+|.|..    .+-..+.+.++|+..++|+=   ++...+|.       .+..++.|++||||+|.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            345567778888888888752    34556667778888887763   22233333       33455677777777777


Q ss_pred             CCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccc
Q 045539          160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPS  239 (897)
Q Consensus       160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~  239 (897)
                      |.-.-++.|..                    -+..+++|++|+|.+|.+.-.--..+..   .|..|.  .|       .
T Consensus       104 ~G~~g~~~l~~--------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~~---al~~l~--~~-------k  151 (382)
T KOG1909|consen  104 FGPKGIRGLEE--------------------LLSSCTDLEELYLNNCGLGPEAGGRLGR---ALFELA--VN-------K  151 (382)
T ss_pred             cCccchHHHHH--------------------HHHhccCHHHHhhhcCCCChhHHHHHHH---HHHHHH--HH-------h
Confidence            76444444322                    1455677888888877775111111111   112121  11       2


Q ss_pred             cccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHH
Q 045539          240 SITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI  319 (897)
Q Consensus       240 ~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~  319 (897)
                      ..+.-++|+.+..+.|++.......+.                 ..+...+.|+.+.++.|.|..   ....        
T Consensus       152 k~~~~~~Lrv~i~~rNrlen~ga~~~A-----------------~~~~~~~~leevr~~qN~I~~---eG~~--------  203 (382)
T KOG1909|consen  152 KAASKPKLRVFICGRNRLENGGATALA-----------------EAFQSHPTLEEVRLSQNGIRP---EGVT--------  203 (382)
T ss_pred             ccCCCcceEEEEeeccccccccHHHHH-----------------HHHHhccccceEEEecccccC---chhH--------
Confidence            233456677777777766533222110                 123445677777777776652   1111        


Q ss_pred             HHhccCCCCCCcCccccCccCCcEEEccCCCCCCC----ccccccCccchhhhcccCcccccccchhhh-----cccccc
Q 045539          320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP----IPITFSQLQTLQALGLTRNKLAGPITDELC-----HLARLH  390 (897)
Q Consensus       320 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~  390 (897)
                                .+...|..+++|++|||.+|-++..    +...+..+++|+.|++++|.+...-..+|.     ..++|+
T Consensus       204 ----------al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~  273 (382)
T KOG1909|consen  204 ----------ALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLE  273 (382)
T ss_pred             ----------HHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCc
Confidence                      1224566777788888888877642    234456667777777777777754443332     246677


Q ss_pred             cccccccccccC----CCcccccccccceeccccccc
Q 045539          391 SLVLQGNKFSGS----IPSCLGNLTSLRVLYLGLNRF  423 (897)
Q Consensus       391 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l  423 (897)
                      .|.+.+|.|+..    +..++...+.|..|+|++|++
T Consensus       274 vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  274 VLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             eeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            777777777632    223344566677777777766

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.23  E-value=6.8e-11  Score=131.35  Aligned_cols=168  Identities=17%  Similarity=0.222  Sum_probs=128.1

Q ss_pred             EecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHH
Q 045539          637 RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR  716 (897)
Q Consensus       637 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  716 (897)
                      +..++.+|.|+.++...........+-++.++.++||+|+++++.++.++..|+|+|.+.  .|..++.+.+    ...+
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            344688888888775544445667788899999999999999999999999999999984  5666666533    5566


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCC
Q 045539          717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV  796 (897)
Q Consensus       717 ~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  796 (897)
                      .-.+.||+.||.+||  ++.+++|++|.-+-|+++..|..||++|..+........  ......--..|..|+...... 
T Consensus       107 ~~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            678899999999997  789999999999999999999999999998765432221  011111223466666433322 


Q ss_pred             CccchHHHHHHHHHHHHcCC
Q 045539          797 CTRGDVYSYGIMLMEMFTKK  816 (897)
Q Consensus       797 ~~~sDv~slGvil~elltg~  816 (897)
                       -..|.|.||++++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             2359999999999999993

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1.1e-10  Score=110.05  Aligned_cols=131  Identities=24%  Similarity=0.392  Sum_probs=99.8

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEe-chhh-----H--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVF-HQQY-----E--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~-~~~~-----~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+++|+-+.+|.+.+. |.++++|.- ++..     .  -...+..+|++++.+++--.|..-+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999876 555777743 2221     1  1235667899999999754444444445566677899999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ++|..|.+.+...        ...++..+-.-+.-|   |..||+|+|+.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888765        245677777778888   999999999999999998764 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=2e-10  Score=107.53  Aligned_cols=142  Identities=19%  Similarity=0.258  Sum_probs=106.9

Q ss_pred             cCCeeecccceEEEEEEecCCceEEEEE-echhh-------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          621 ENNLIGIGSFGSIYVARLQDGMEVAVKV-FHQQY-------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ....+-+|+-+.|+++.+. |+.++||. +.+..       .-..++..+|++.+.+++--.|.--.=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999987 78877774 32221       123567789999999997444443333455566668999


Q ss_pred             EeccC-CChhHhhhcCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEeeccCccc
Q 045539          693 KYMPN-GSLENCLYSGTCMLDIFQR-LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFGIAKL  766 (897)
Q Consensus       693 e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~  766 (897)
                      ||++| .++.+++......-...+. ...+.+|-+.+.-|   |..+|+|||+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4788887765533333333 78999999999999   999999999999999997655   568999999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=3e-12  Score=127.25  Aligned_cols=204  Identities=24%  Similarity=0.277  Sum_probs=105.3

Q ss_pred             ccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccC-CCCCCCccccccCccc
Q 045539          286 LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGG-NNLTEPIPITFSQLQT  364 (897)
Q Consensus       286 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~  364 (897)
                      +.-.++|+.+.+|.+.-..+.  .+..+.+.|+++.+.+..++.. |. +-....+..+.-+. .-.+|........++.
T Consensus       210 l~~f~~l~~~~~s~~~~~~i~--~~~~~kptl~t~~v~~s~~~~~-~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~  285 (490)
T KOG1259|consen  210 LNAFRNLKTLKFSALSTENIV--DIELLKPTLQTICVHNTTIQDV-PS-LLPETILADPSGSEPSTSNGSALVSADTWQE  285 (490)
T ss_pred             hHHhhhhheeeeeccchhhee--ceeecCchhheeeeeccccccc-cc-ccchhhhcCccCCCCCccCCceEEecchHhh
Confidence            344566677776666433221  1122233566666666555421 11 11111222111111 1122333333344556


Q ss_pred             hhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecC
Q 045539          365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS  444 (897)
Q Consensus       365 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  444 (897)
                      |++||||+|.|+ .+.+...-+|.++.|++|+|.|. .+ ..+..+++|+.||||+|.++. +..+-.++.++       
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI-------  354 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI-------  354 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhHh-hhhhHhhhcCE-------
Confidence            777777777776 55666666677777777777776 22 236666666667776666653 33333344444       


Q ss_pred             CcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCC-chhhhhhcccc
Q 045539          445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAI-PASLQKLLYLK  523 (897)
Q Consensus       445 N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~  523 (897)
                                                    +.|.|+.|.|..  -..+.++-+|..||+++|+|...- -..+++|+-|+
T Consensus       355 ------------------------------KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE  402 (490)
T KOG1259|consen  355 ------------------------------KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE  402 (490)
T ss_pred             ------------------------------eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHH
Confidence                                          444455554441  123455556666666666665211 23566677777


Q ss_pred             eEeccCCcccccC
Q 045539          524 HLNLSFNKLEGEI  536 (897)
Q Consensus       524 ~L~ls~N~l~~~~  536 (897)
                      .+.|.+|++.+.+
T Consensus       403 ~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  403 TLRLTGNPLAGSV  415 (490)
T ss_pred             HHhhcCCCccccc
Confidence            7777777776543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.19  E-value=5.4e-12  Score=142.39  Aligned_cols=220  Identities=25%  Similarity=0.315  Sum_probs=114.0

Q ss_pred             CCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccccccccccccccc
Q 045539          122 NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEI  201 (897)
Q Consensus       122 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  201 (897)
                      .+..++.+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+.+.+  +..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            34444445555555432 2223445555555555555555 333335566666666666666666543  4555666777


Q ss_pred             ccccccccccCCccccccccccceeeccccccccccc-ccccCCCcccEEEccccccccccCccccccccccccCCCCcc
Q 045539          202 YLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVP-SSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPEL  280 (897)
Q Consensus       202 ~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~  280 (897)
                      ++++|.|+ .+...-  .++.|+.+++++|++...-+ . ...+.+++.++++.|.+.....                  
T Consensus       146 ~l~~N~i~-~~~~~~--~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~------------------  203 (414)
T KOG0531|consen  146 NLSGNLIS-DISGLE--SLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG------------------  203 (414)
T ss_pred             eeccCcch-hccCCc--cchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc------------------
Confidence            77777665 322211  25666666666666654333 2 4566666667777666653322                  


Q ss_pred             cccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcccccc
Q 045539          281 SFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFS  360 (897)
Q Consensus       281 ~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  360 (897)
                           +..+..+..+++..|.++.+-+....... .|+.+++.+|.+... +..+..+.++..|++.+|++...  ..+.
T Consensus       204 -----~~~~~~l~~~~l~~n~i~~~~~l~~~~~~-~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~  274 (414)
T KOG0531|consen  204 -----LDLLKKLVLLSLLDNKISKLEGLNELVML-HLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLE  274 (414)
T ss_pred             -----hHHHHHHHHhhcccccceeccCcccchhH-HHHHHhcccCccccc-cccccccccccccchhhcccccc--cccc
Confidence                 22333444446666666543221111100 256666666666522 23445556666666666666542  2234


Q ss_pred             CccchhhhcccCcccc
Q 045539          361 QLQTLQALGLTRNKLA  376 (897)
Q Consensus       361 ~l~~L~~L~Ls~N~l~  376 (897)
                      ....+..+.+..|.+.
T Consensus       275 ~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  275 RLPKLSELWLNDNKLA  290 (414)
T ss_pred             ccchHHHhccCcchhc
Confidence            4445555555555544

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.18  E-value=8.6e-12  Score=140.77  Aligned_cols=106  Identities=34%  Similarity=0.409  Sum_probs=56.4

Q ss_pred             ccCccCCcEEEccCCCCCCCcc-ccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccc-
Q 045539          335 VGNLGNLLVLELGGNNLTEPIP-ITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS-  412 (897)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-  412 (897)
                      +..+++|+.+++++|+++.+.+ . ...+.+++.+++.+|.+..  .+.+..+..+..+++..|+++..-+  +..+.. 
T Consensus       158 ~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~  232 (414)
T KOG0531|consen  158 LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVML  232 (414)
T ss_pred             CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhH
Confidence            3346677777777777766443 2 4566677777777777652  2334444555555667777663221  222222 


Q ss_pred             -cceeccccccccCCccccccccccceEEeecCCc
Q 045539          413 -LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS  446 (897)
Q Consensus       413 -L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  446 (897)
                       |+.+++++|++.. ++..+..+..+..+++++|+
T Consensus       233 ~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~  266 (414)
T KOG0531|consen  233 HLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNR  266 (414)
T ss_pred             HHHHHhcccCcccc-ccccccccccccccchhhcc
Confidence             6666666666652 22333344444433333333

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=4.9e-12  Score=125.71  Aligned_cols=186  Identities=25%  Similarity=0.283  Sum_probs=131.2

Q ss_pred             CCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCc---c--------------------ccccccc
Q 045539           92 IPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL---S--------------------FFIFNVS  148 (897)
Q Consensus        92 ~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~--------------------~~~~~l~  148 (897)
                      +|-.+.-+.+|..+.+|++.-. .|-+....-+.|+.+...+..+....   |                    ..+....
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq  284 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ  284 (490)
T ss_pred             cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence            4445666788888888887543 23333334466777777766553211   1                    1223345


Q ss_pred             cccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeec
Q 045539          149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNL  228 (897)
Q Consensus       149 ~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L  228 (897)
                      .|+.||||+|.|+ .+..+..-+|+++.|++++|.|..+..  +..+++|++||||+|.++ .+. ++-..+-++++|.|
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~-Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECV-GWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhh-hhHhhhcCEeeeeh
Confidence            7899999999998 788888889999999999999988754  888999999999999987 332 23336778888888


Q ss_pred             ccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCC
Q 045539          229 GINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGI  305 (897)
Q Consensus       229 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~  305 (897)
                      +.|.|..  -+.+..+-+|.+||+++|+|.....                    ...++++|.|+.|.|.+|++.++
T Consensus       360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~lde--------------------V~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDE--------------------VNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhHhh--hhhhHhhhhheeccccccchhhHHH--------------------hcccccccHHHHHhhcCCCcccc
Confidence            8888853  3556677778888888888764321                    23467777777777777777754

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=5.9e-12  Score=131.89  Aligned_cols=137  Identities=23%  Similarity=0.254  Sum_probs=65.8

Q ss_pred             cCCCCCcEEeccCccccCCcc-ccccccccccEEEeeecCCCCCCC--ccccCccccccccccccccccccccc-ccccc
Q 045539          121 FNMHTLKLLYFSDNQLFGSLS-FFIFNVSSVTTIDLSINGLSGEMP--REIGNLPYLARLAFATNNLVGVAPVT-IFNMS  196 (897)
Q Consensus       121 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~LdLs~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~  196 (897)
                      .++.+|+...|.+........ .....|++++.||||+|-|..--|  .-...||+|+.|+|+.|++....... -..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            466777777777776543322 345566666777777666653111  22344566666666666554322111 12344


Q ss_pred             cccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       197 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      +|+.|.|+.|.++..--..+...+|+|+.|+|..|.....-......+..|+.|||++|++
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~l  258 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNL  258 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcc
Confidence            5555555555554211112222345555555555532222233333344444444444443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=5.8e-10  Score=115.01  Aligned_cols=142  Identities=18%  Similarity=0.216  Sum_probs=111.7

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhhH-HHHHHHHHHHHHHHhcCC--CccceEeeeecCC---CceEEEEEecc
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRH--RNLVKIISSCSND---DFKALIMKYMP  696 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  696 (897)
                      +.++.|..+.||+++..+|+.+++|+...... .....+.+|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999887778999999765432 134567899999999975  3467788877664   36789999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG-------------------------------------------  733 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-------------------------------------------  733 (897)
                      |.++.+.+..  ..++..+...++.+++++|++||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775532  2367778888899999999999731                                           


Q ss_pred             ----------CCCCcEeCCCCCCCeeeCC--CCcEEEeeccCccc
Q 045539          734 ----------HSTPIIHCDLKPSNVLLDE--DMVAHISDFGIAKL  766 (897)
Q Consensus       734 ----------h~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~  766 (897)
                                -...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0256799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=8.4e-11  Score=129.79  Aligned_cols=199  Identities=22%  Similarity=0.200  Sum_probs=150.3

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec--CCceEEEEEechhhHHHH--HHHHHHHHHHHhcC-CCccceEeeeecCCC
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ--DGMEVAVKVFHQQYERAL--KSFEDECEVMKRIR-HRNLVKIISSCSNDD  686 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  686 (897)
                      ......+|..+..||.|.|+.|+....+  ++..|++|...+......  ..-..|+-+...+. |.++++.+..+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3444668889999999999999998643  578899998765432211  12235666666664 889999888888777


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCcc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK  765 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~  765 (897)
                      ..|+--||+++++.+..... ...+++..++.+..|++.++.++   |++.++|+|+||+||++..+ +..++.|||.+.
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhcccccccc
Confidence            88899999999988776522 23477888899999999999999   99999999999999999876 788999999986


Q ss_pred             ccCCCCceeeeeccccCccc-CCcCccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 045539          766 LLSGEDQLSIQIQTLATIGY-MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP  818 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDv~slGvil~elltg~~p  818 (897)
                      .+.-    ........+..| .+|+......+..++|+||||..+.|.+++..-
T Consensus       416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ccce----ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            4221    111111223334 356666777888999999999999999998653

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.07  E-value=2.3e-11  Score=127.53  Aligned_cols=216  Identities=16%  Similarity=0.176  Sum_probs=116.2

Q ss_pred             CCCCCCceecccCccccCcCC--ccccCCCCCcEEeccCccccCC--ccccccccccccEEEeeecCCCCCCCccc-cCc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIP--SSIFNMHTLKLLYFSDNQLFGS--LSFFIFNVSSVTTIDLSINGLSGEMPREI-GNL  171 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~LdLs~N~l~~~~p~~l-~~l  171 (897)
                      .++++|+...|.+..+. ..+  .....|++++.||||+|-+...  +-.....|++|+.|+||.|++.-...... ..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            35666666666666554 222  2455666666666666655432  22334456666666666666653222221 245


Q ss_pred             ccccccccccccccccc-cccccccccccccccccccccccCCccccccccccceeecccccccccc-cccccCCCcccE
Q 045539          172 PYLARLAFATNNLVGVA-PVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV-PSSITNASKLSD  249 (897)
Q Consensus       172 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~  249 (897)
                      ++|+.|.|++|.++... ......+++|+.|+|..|..- .+...-..-+..|+.|||++|.+-... -...+.++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            66666666666665322 222345667777777777421 111111123456677777777664221 144566777777


Q ss_pred             EEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCC-CcccCchHHHHHHHhccCCCC
Q 045539          250 LELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP-KSKGNLSLSLEIILMDNCSIS  328 (897)
Q Consensus       250 L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~~L~~L~l~~n~l~  328 (897)
                      |+++.+.++.+.-..               ..-..-....++|++|+++.|++...-. ..+..+. +|+.|....|.++
T Consensus       276 Lnls~tgi~si~~~d---------------~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~-nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPD---------------VESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLE-NLKHLRITLNYLN  339 (505)
T ss_pred             hhccccCcchhcCCC---------------ccchhhhcccccceeeecccCccccccccchhhccc-hhhhhhccccccc
Confidence            777777665432110               0011113456778888888888764321 1222232 6777777777776


Q ss_pred             CC
Q 045539          329 GN  330 (897)
Q Consensus       329 ~~  330 (897)
                      ..
T Consensus       340 ~e  341 (505)
T KOG3207|consen  340 KE  341 (505)
T ss_pred             cc
Confidence            43

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=5.3e-11  Score=114.84  Aligned_cols=108  Identities=25%  Similarity=0.364  Sum_probs=27.1

Q ss_pred             CCCCCCceecccCccccCcCCcccc-CCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccc-cCcccc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREI-GNLPYL  174 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l-~~l~~L  174 (897)
                      .+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|....  .+..++.|++|++++|+|+ .++..+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            34445666777777666 332 344 4566666666666665432  3445556666666666665 333333 245555


Q ss_pred             ccccccccccccccc-cccccccccccccccccccc
Q 045539          175 ARLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       175 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  209 (897)
                      ++|+|++|+|..... ..++.+++|+.|+|.+|.++
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            555555555554321 23444555555555555554

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.05  E-value=5.9e-12  Score=128.58  Aligned_cols=159  Identities=25%  Similarity=0.316  Sum_probs=106.7

Q ss_pred             ccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHH
Q 045539          239 SSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE  318 (897)
Q Consensus       239 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~  318 (897)
                      +.+..+++|+.||||.|.|.-..+..|..+                 ++++.+|++|.|.+|.+.   |..-..+...|.
T Consensus        86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~l-----------------l~s~~~L~eL~L~N~Glg---~~ag~~l~~al~  145 (382)
T KOG1909|consen   86 KALLGCPKLQKLDLSDNAFGPKGIRGLEEL-----------------LSSCTDLEELYLNNCGLG---PEAGGRLGRALF  145 (382)
T ss_pred             HHHhcCCceeEeeccccccCccchHHHHHH-----------------HHhccCHHHHhhhcCCCC---hhHHHHHHHHHH
Confidence            445556678888888887765555444332                 456788888888888665   333334444555


Q ss_pred             HHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCc----cccccCccchhhhcccCcccccc----cchhhhcccccc
Q 045539          319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPI----PITFSQLQTLQALGLTRNKLAGP----ITDELCHLARLH  390 (897)
Q Consensus       319 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~  390 (897)
                      .|.  .++.       ...-++|+++..++|++..-.    ...|...+.|+.+.++.|.|...    ....|..+++|+
T Consensus       146 ~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~Le  216 (382)
T KOG1909|consen  146 ELA--VNKK-------AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLE  216 (382)
T ss_pred             HHH--HHhc-------cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcce
Confidence            555  2221       234568999999999987532    23466678889999999887632    234677788888


Q ss_pred             cccccccccccC----CCcccccccccceeccccccccCC
Q 045539          391 SLVLQGNKFSGS----IPSCLGNLTSLRVLYLGLNRFTSA  426 (897)
Q Consensus       391 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~  426 (897)
                      .|||.+|-|+..    +...++.+++|+.|++++|.+...
T Consensus       217 vLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~  256 (382)
T KOG1909|consen  217 VLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENE  256 (382)
T ss_pred             eeecccchhhhHHHHHHHHHhcccchheeecccccccccc
Confidence            888888888732    234566777888888888887643

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.04  E-value=5.9e-11  Score=114.50  Aligned_cols=123  Identities=24%  Similarity=0.292  Sum_probs=32.8

Q ss_pred             cCccccCcCCccccCCCCCcEEeccCccccCCcccccc-ccccccEEEeeecCCCCCCCccccCcccccccccccccccc
Q 045539          108 SHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVG  186 (897)
Q Consensus       108 s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  186 (897)
                      ..+-|. .+| .+.+..++++|+|++|+|..+-  .++ .+.+|+.||||+|.|+ .++ .+..+++|+.|++++|+|+.
T Consensus         5 t~~~i~-~~~-~~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~   78 (175)
T PF14580_consen    5 TANMIE-QIA-QYNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS   78 (175)
T ss_dssp             -----------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S
T ss_pred             cccccc-ccc-cccccccccccccccccccccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc
Confidence            334443 333 3455667788888888775432  233 4667777777777777 332 46666677777777777766


Q ss_pred             cccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccc
Q 045539          187 VAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF  260 (897)
Q Consensus       187 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  260 (897)
                      +.+.....+++|++|+|++|+|.. +.                       .-..++.+++|+.|+|.+|.++..
T Consensus        79 i~~~l~~~lp~L~~L~L~~N~I~~-l~-----------------------~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   79 ISEGLDKNLPNLQELYLSNNKISD-LN-----------------------ELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             -CHHHHHH-TT--EEE-TTS---S-CC-----------------------CCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             cccchHHhCCcCCEEECcCCcCCC-hH-----------------------HhHHHHcCCCcceeeccCCcccch
Confidence            543222346666666666666651 11                       113455667777777777776543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=2e-09  Score=105.84  Aligned_cols=127  Identities=24%  Similarity=0.268  Sum_probs=86.0

Q ss_pred             EEEEEEecCCceEEEEEechhh--------------------------HHHHHHHHHHHHHHHhcCCC--ccceEeeeec
Q 045539          632 SIYVARLQDGMEVAVKVFHQQY--------------------------ERALKSFEDECEVMKRIRHR--NLVKIISSCS  683 (897)
Q Consensus       632 ~Vy~a~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  683 (897)
                      .||.|...+|..+|+|+.+...                          .......++|++.|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999889999999974210                          11234567899999999855  567777553 


Q ss_pred             CCCceEEEEEecc--CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          684 NDDFKALIMKYMP--NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       684 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                         ..++||||++  |..+..+....   ++......++.+++..+..++  |+.||+|||+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               3479999998  65554433221   113345667888888666654  89999999999999999887 9999999


Q ss_pred             cCccccC
Q 045539          762 GIAKLLS  768 (897)
Q Consensus       762 g~a~~~~  768 (897)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.96  E-value=4.6e-10  Score=81.34  Aligned_cols=40  Identities=43%  Similarity=0.936  Sum_probs=30.1

Q ss_pred             hhHHHHHHHHHhccccCCCcccccCCCCC--CCCcceeeeEee
Q 045539           32 TTDQQALLALKAHISYDHTNLFARNWTSS--TSVCSWIGITCD   72 (897)
Q Consensus        32 ~~~~~aLl~~k~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~   72 (897)
                      ++|++||++||+++..+|.+.+. +|+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~-~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLS-SWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCT-T--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccc-cCCCcCCCCCeeeccEEeC
Confidence            57999999999999876766666 99976  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.96  E-value=8.6e-09  Score=108.09  Aligned_cols=192  Identities=12%  Similarity=0.139  Sum_probs=131.9

Q ss_pred             cCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeee------ec-CCCceEEEE
Q 045539          621 ENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISS------CS-NDDFKALIM  692 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~-~~~~~~lv~  692 (897)
                      ..+.||+|+.+.+|..-.  -...+.|+++........+   .++.|... .||-+-.-+.+      .. .+....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            357799999999997521  2335678887654332222   22233333 46644331211      11 223367888


Q ss_pred             EeccCC-ChhHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          693 KYMPNG-SLENCLYS-----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       693 e~~~~g-sL~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..+.+. ....++..     .-...+|....++++.++.+.+.|   |..|.+-||+.++|+|+.+++.+.|+|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEcccceee
Confidence            887765 22222221     115578999999999999999999   899999999999999999999999998654443


Q ss_pred             cCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcC-CCCCcccc
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTK-KKPTDEIF  823 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg-~~p~~~~~  823 (897)
                      .   .........+|...|.+||...     +-..+...|-|.+|+++++++.| +.||..+.
T Consensus       167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            2   2223345668999999999643     34557788999999999999886 99998753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=1.4e-08  Score=106.13  Aligned_cols=140  Identities=16%  Similarity=0.088  Sum_probs=101.6

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhhH-HHHH----------HHHHHHHHHHhcCCCc--cceEeeeecC-----
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE-RALK----------SFEDECEVMKRIRHRN--LVKIISSCSN-----  684 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~-~~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  684 (897)
                      +.+-......|+++++. |+.|.||+...... +..+          .+.+|.+.+.++...+  .++.+++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            45555555567777664 78999998753321 1111          3778999998885333  3344555532     


Q ss_pred             CCceEEEEEeccCC-ChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-------CCc
Q 045539          685 DDFKALIMKYMPNG-SLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-------DMV  755 (897)
Q Consensus       685 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-------~~~  755 (897)
                      ....++|||++++. +|.+++... ....+......++.+++..++.|   |+.||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCce
Confidence            23568999999886 899887532 23356677789999999999999   9999999999999999975       468


Q ss_pred             EEEeeccCccc
Q 045539          756 AHISDFGIAKL  766 (897)
Q Consensus       756 ~kL~DFg~a~~  766 (897)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.90  E-value=2.3e-09  Score=129.00  Aligned_cols=291  Identities=21%  Similarity=0.223  Sum_probs=172.0

Q ss_pred             CCCCCCceecccCccccCcCCccccCCCCCcEEeccCcc--ccCCccccccccccccEEEeeecCCCCCCCccccCcccc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ--LFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL  174 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L  174 (897)
                      .+....++..+-+|.+. .++.... .++|+.|-+..|.  +.......|..++.|++||||+|.=-+.+|+.+++|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            34467788888888876 4554433 3478888888886  656666678889999999999887777889999988888


Q ss_pred             cccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccc--cccccccccCCCcccEEEc
Q 045539          175 ARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSF--YGTVPSSITNASKLSDLEL  252 (897)
Q Consensus       175 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l--~~~~p~~l~~l~~L~~L~L  252 (897)
                      ++|+|++..++.+ |..+.++..|.+|++..+.-...+ ..+...+++|++|.+..-..  ....-..+.++.       
T Consensus       598 ryL~L~~t~I~~L-P~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le-------  668 (889)
T KOG4658|consen  598 RYLDLSDTGISHL-PSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSALSNDKLLLKELENLE-------  668 (889)
T ss_pred             hcccccCCCcccc-chHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccccccchhhHHhhhccc-------
Confidence            8888888888855 777888888888888877765333 34444566666666654431  111112222223       


Q ss_pred             cccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCC-CCCCcccCchHHHHHHHhccCCCCCCc
Q 045539          253 GVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG-ILPKSKGNLSLSLEIILMDNCSISGNI  331 (897)
Q Consensus       253 ~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~~L~~L~l~~n~l~~~~  331 (897)
                                                            +|+.+......... .-......+....+.+.+..+... ..
T Consensus       669 --------------------------------------~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~  709 (889)
T KOG4658|consen  669 --------------------------------------HLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TL  709 (889)
T ss_pred             --------------------------------------chhhheeecchhHhHhhhhhhHHHHHHhHhhhhcccccc-ee
Confidence                                                  33333222211100 000111112222333443333322 45


Q ss_pred             CccccCccCCcEEEccCCCCCCCccccccCcc------chhhhcccCcccccccchhhhcccccccccccccccccCCCc
Q 045539          332 PQVVGNLGNLLVLELGGNNLTEPIPITFSQLQ------TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS  405 (897)
Q Consensus       332 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  405 (897)
                      +..+..+.+|+.|.+.++.+..+...++....      ++..+...++... ..+.+.-..++|+.|.+........+.+
T Consensus       710 ~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~  788 (889)
T KOG4658|consen  710 ISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIP  788 (889)
T ss_pred             ecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCC
Confidence            56778899999999999998765444433322      2223222222211 1222333457888888888777766666


Q ss_pred             ccccccccceeccccccccCC-ccccccccccce
Q 045539          406 CLGNLTSLRVLYLGLNRFTSA-LPSTIWNLKDIL  438 (897)
Q Consensus       406 ~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~  438 (897)
                      ....+..++.+-+..+.+.+. .-.....++++.
T Consensus       789 ~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~  822 (889)
T KOG4658|consen  789 KLKALLELKELILPFNKLEGLRMLCSLGGLPQLY  822 (889)
T ss_pred             HHHHhhhcccEEecccccccceeeecCCCCceeE
Confidence            666666666666666666654 223333344443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.86  E-value=2.9e-09  Score=128.13  Aligned_cols=268  Identities=24%  Similarity=0.259  Sum_probs=152.9

Q ss_pred             CCceecccCcc--ccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc
Q 045539          101 SLQTLDLSHNK--LSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA  178 (897)
Q Consensus       101 ~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~  178 (897)
                      .|++|-+..|.  +....++.|..++.|++|||++|.=.+.+|..+++|-+|++|||++..++ .+|..+++|++|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            67788777775  44233344667888888888887766778888888888888888888888 7888888888888888


Q ss_pred             cccccccccccccccccccccccccccccccc--cCCccccccccccceeecccccccccccccccCCCcccEE----Ec
Q 045539          179 FATNNLVGVAPVTIFNMSALKEIYLLNNSLSG--SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL----EL  252 (897)
Q Consensus       179 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L----~L  252 (897)
                      +..+.-...+|.....|++|++|.+.......  ..-..+ ..+.+|+.+.......  .+-..+..++.|..+    .+
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el-~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~  701 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKEL-ENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI  701 (889)
T ss_pred             cccccccccccchhhhcccccEEEeeccccccchhhHHhh-hcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence            88876655556666778888888877665221  011111 1334444444432221  111122222332211    11


Q ss_pred             cccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCch-----HHHHHHHhccCCC
Q 045539          253 GVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS-----LSLEIILMDNCSI  327 (897)
Q Consensus       253 ~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-----~~L~~L~l~~n~l  327 (897)
                      ..+.                      .....+++..+.+|+.|.+.++.+..+.........     .++..+...++..
T Consensus       702 ~~~~----------------------~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~  759 (889)
T KOG4658|consen  702 EGCS----------------------KRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHM  759 (889)
T ss_pred             cccc----------------------cceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcccc
Confidence            1111                      111234567888899999999888654332211111     1233333333332


Q ss_pred             CCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccc-cchhhhccccccccccc
Q 045539          328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP-ITDELCHLARLHSLVLQ  395 (897)
Q Consensus       328 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~  395 (897)
                      - ..+.+..-.++|+.|++..+...+.+.+....+..++.+-+..+.+.+. .-.....++++..+.++
T Consensus       760 ~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  760 L-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             c-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence            2 1223334457888888888876665555555555565555666666544 22333344444443333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=4.8e-10  Score=129.79  Aligned_cols=205  Identities=23%  Similarity=0.269  Sum_probs=147.0

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      ...+.+.+.+-+-+|+++.++-++-. .|...+.|+.....   ....+....+-.+.-..++|-+++...-+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567777888999999999988633 34344444332211   111222223333333334566665555555667889


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +|++|..+++|...++..+ ..+.+........+..++++|   |...+.|+|++|.|++...++..++.|||......-
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999998887766 355556666777888999999   888899999999999999999999999984322110


Q ss_pred             -----------------------------CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          770 -----------------------------EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       770 -----------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                                                   .+.........||+.|.+||...+......+|.|+.|++++|.++|..||+
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                         000011234568999999999999999999999999999999999999998


Q ss_pred             cc
Q 045539          821 EI  822 (897)
Q Consensus       821 ~~  822 (897)
                      ..
T Consensus      1037 a~ 1038 (1205)
T KOG0606|consen 1037 AE 1038 (1205)
T ss_pred             Cc
Confidence            74

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=2.4e-08  Score=100.25  Aligned_cols=136  Identities=25%  Similarity=0.257  Sum_probs=102.9

Q ss_pred             CCcCCeeecccceEEEEEEecCCceEEEEEechhh----------------------HHHHHHHHHHHHHHHhcCCC--c
Q 045539          619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----------------------ERALKSFEDECEVMKRIRHR--N  674 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  674 (897)
                      +.+...||.|.-+.||.|..+.|.++|||.=+...                      .......++|.++|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44568899999999999999999999999632110                      11234567899999999754  6


Q ss_pred             cceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       675 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      +++.+++    +..++|||+++|-.|...-      ++.+....++..|++-++..   -..||||||+++-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecCC
Confidence            6666654    4568999999997775431      23445556677777777766   578999999999999999999


Q ss_pred             cEEEeeccCcccc
Q 045539          755 VAHISDFGIAKLL  767 (897)
Q Consensus       755 ~~kL~DFg~a~~~  767 (897)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=8.8e-08  Score=103.47  Aligned_cols=167  Identities=20%  Similarity=0.238  Sum_probs=127.6

Q ss_pred             ceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeec----CCCceEEEEEeccC-CChhHh
Q 045539          630 FGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS----NDDFKALIMKYMPN-GSLENC  703 (897)
Q Consensus       630 ~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~  703 (897)
                      -.+.|++... ||..|++|+++............-+++++++.|+|+|++.++|.    .+...++|++|+++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678999754 89999999996544333333445688999999999999999886    34467899999987 577775


Q ss_pred             hhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          704 LYSG--------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       704 l~~~--------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ....              +...++..++.++.|+..||.++   |+.|..-+-+.|.+|+++.+.+++|+.-|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4322              13467889999999999999999   899999999999999999999999988887665543


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCC
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP  818 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p  818 (897)
                      +..                |-+.   --.+-|.=.||.++..|.||..-
T Consensus       446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            320                1011   12356999999999999999553

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.78  E-value=3.5e-09  Score=83.98  Aligned_cols=61  Identities=36%  Similarity=0.422  Sum_probs=39.7

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      ++|++|++++|+|+...+..|.++++|++|++++|++....+..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566677777777654445666677777777777766666666666666666666666654

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.78  E-value=3e-09  Score=84.37  Aligned_cols=60  Identities=40%  Similarity=0.593  Sum_probs=38.0

Q ss_pred             ccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcc
Q 045539          473 NLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL  532 (897)
Q Consensus       473 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  532 (897)
                      +|++|++++|+|+...+..|.++++|++|++++|+|+...|..|..+++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            456666666666654445666666666666666666655555666666666666666654

...

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=2e-07  Score=91.94  Aligned_cols=137  Identities=15%  Similarity=0.113  Sum_probs=103.4

Q ss_pred             eecccceEEEEEEecCCceEEEEEechhh------HHHHHHHHHHHHHHHhcCC--CccceEeeeecC-----CCceEEE
Q 045539          625 IGIGSFGSIYVARLQDGMEVAVKVFHQQY------ERALKSFEDECEVMKRIRH--RNLVKIISSCSN-----DDFKALI  691 (897)
Q Consensus       625 lg~G~~g~Vy~a~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-----~~~~~lv  691 (897)
                      -|+||.+.|++.... |+.+-+|+-....      +-....|.+|...++++..  -.+.+++ ++..     ....++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367899999998776 4578888754211      2245788999999999963  2244544 3321     1245799


Q ss_pred             EEeccC-CChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc--EEEeeccCccc
Q 045539          692 MKYMPN-GSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHISDFGIAKL  766 (897)
Q Consensus       692 ~e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~  766 (897)
                      +|-++| .+|.+++.+.. .+.+...+..+..+++.+++-|   |+.|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998764 58998886643 3567888889999999999999   9999999999999999986666  99999987654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=7.5e-10  Score=122.62  Aligned_cols=181  Identities=28%  Similarity=0.286  Sum_probs=119.0

Q ss_pred             CccccCccCCcEEEccCCCCCCCccccccCc-cchhhhcccCccccc---ccch---hhhc---cccccccccccccccc
Q 045539          332 PQVVGNLGNLLVLELGGNNLTEPIPITFSQL-QTLQALGLTRNKLAG---PITD---ELCH---LARLHSLVLQGNKFSG  401 (897)
Q Consensus       332 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~---~~~~---~~~~---l~~L~~L~L~~N~l~~  401 (897)
                      |-.+..+.+|++|.|.++.|...  ..+..+ ..|++|- .+|.+..   .+..   .+++   ...|.+.+.+.|+++ 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            33455678899999999988641  112111 1233332 2233221   1111   1111   235778888999988 


Q ss_pred             CCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccC
Q 045539          402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEY  481 (897)
Q Consensus       402 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~  481 (897)
                      ..-..+.-++.|+.|+|++|+++...  .+..++.|++||++.|.|..+..+...+             + +|+.|++++
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~g-------------c-~L~~L~lrn  241 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVG-------------C-KLQLLNLRN  241 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhh-------------h-hheeeeecc
Confidence            66677778888999999999988532  6777888888888888777665444332             2 377888888


Q ss_pred             ceecccCCCCCCCcCCCcEEeccCCccCCCC-chhhhhhcccceEeccCCcccc
Q 045539          482 NRLEGSIPESFGDLSSLEVLDLSKNKISGAI-PASLQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       482 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~  534 (897)
                      |.++..  ..+.+|++|+.||||+|-|++-- -.-+..|..|..|+|.||++..
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            888732  45778888888888888877532 2335567788888888888864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=3.6e-10  Score=125.09  Aligned_cols=181  Identities=28%  Similarity=0.317  Sum_probs=133.8

Q ss_pred             CCCCCCCCCCceecccCccccCcCCccccCC-CCCcEEeccCcccc---CCccccccc------cccccEEEeeecCCCC
Q 045539           93 PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM-HTLKLLYFSDNQLF---GSLSFFIFN------VSSVTTIDLSINGLSG  162 (897)
Q Consensus        93 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~---~~~~~~~~~------l~~L~~LdLs~N~l~~  162 (897)
                      |-+|..+.+|++|.|.++.|+.  -..+..+ .+|+.|..++ .+.   ..+..-.+.      --.|.+.+.++|++. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            5568889999999999998863  1112222 3455554332 221   111111111      125888899999998 


Q ss_pred             CCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccccccccc
Q 045539          163 EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSIT  242 (897)
Q Consensus       163 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~  242 (897)
                      .+..++.-++.|++|+|++|+++...  .+..|+.|++|||+.|.+. .+|..-.... .|..|.+++|.++..  ..+.
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHH
Confidence            78888999999999999999999985  6899999999999999998 6775433333 499999999998643  5678


Q ss_pred             CCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCC
Q 045539          243 NASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       243 ~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~  303 (897)
                      ++.+|+.||+++|-|++.--                    +..+..+..|+.|+|.+|++-
T Consensus       252 ~LksL~~LDlsyNll~~hse--------------------L~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSE--------------------LEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhhccchhHhhhhcchh--------------------hhHHHHHHHHHHHhhcCCccc
Confidence            99999999999999875432                    234677888999999999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=1.7e-07  Score=94.81  Aligned_cols=105  Identities=25%  Similarity=0.298  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHhcCCC--ccceEeeeecCC----CceEEEEEeccCC-ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 045539          658 KSFEDECEVMKRIRHR--NLVKIISSCSND----DFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYL  730 (897)
Q Consensus       658 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L  730 (897)
                      .+..+|...+.++...  .+++.+++.+..    ...++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4677888888888532  345566665442    2458999999884 89998876433 56677889999999999999


Q ss_pred             HhcCCCCcEeCCCCCCCeeeCCCC---cEEEeeccCccc
Q 045539          731 HFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFGIAKL  766 (897)
Q Consensus       731 h~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~  766 (897)
                         |+.||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       135 ---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 ---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             ---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence               999999999999999999876   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=3e-07  Score=104.04  Aligned_cols=140  Identities=22%  Similarity=0.249  Sum_probs=96.2

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhhHH----------------------------------H------HHHHHH
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER----------------------------------A------LKSFED  662 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~----------------------------------~------~~~~~~  662 (897)
                      +-|+.++-|.||+|+.++|+.||||+.++...+                                  .      .-.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            678999999999999999999999997542100                                  0      111345


Q ss_pred             HHHHHHhcC-----CCccceEeee-ecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 045539          663 ECEVMKRIR-----HRNLVKIISS-CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA-LEYLHFGHS  735 (897)
Q Consensus       663 E~~~l~~l~-----h~niv~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~Lh~~h~  735 (897)
                      |+..+.+++     .|.+ ++=.+ ++-.....++|||++|-.+.+...-.....+.   ..++..++++ +..+   -.
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~---~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQL---LR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHH---Hh
Confidence            666666653     2332 22222 23345668999999999988874332233553   3344444443 3444   45


Q ss_pred             CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       736 ~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      .|++|.|.+|.||+++.+|.+.+.|||+.....+
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            7999999999999999999999999999877654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.56  E-value=1e-06  Score=87.97  Aligned_cols=157  Identities=21%  Similarity=0.241  Sum_probs=107.1

Q ss_pred             ccccCCHHHHHHHhcCCCcCCee---ecccceEEEEEEecCCceEEEEEechhhHH------------------------
Q 045539          603 AIRRFSYHELLRATDRFSENNLI---GIGSFGSIYVARLQDGMEVAVKVFHQQYER------------------------  655 (897)
Q Consensus       603 ~~~~~~~~~~~~~~~~y~~~~~l---g~G~~g~Vy~a~~~~~~~vavK~~~~~~~~------------------------  655 (897)
                      .+-..+.+.+....++..+.+..   +.|.-+.||+|...++..+|+|+++.....                        
T Consensus        31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l  110 (268)
T COG1718          31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL  110 (268)
T ss_pred             hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence            34445666777777777766654   467778999999888999999998643211                        


Q ss_pred             HHHHHHHHHHHHHhcC--CCccceEeeeecCCCceEEEEEeccCCC-hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045539          656 ALKSFEDECEVMKRIR--HRNLVKIISSCSNDDFKALIMKYMPNGS-LENCLYSGTCMLDIFQRLNIMIDVALALEYLHF  732 (897)
Q Consensus       656 ~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~  732 (897)
                      ...-..+|+.-|+++.  +-.+.+-+++.    ...+||||+.... -.-.|..-  .+...+...+..++++.+.-|. 
T Consensus       111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~-  183 (268)
T COG1718         111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLY-  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHH-
Confidence            0111346777777764  33444444443    3479999985541 11112221  2233367778888888888884 


Q ss_pred             cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       733 ~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                       +..++||+|++.-|||+. ++.+.++|||-|....
T Consensus       184 -~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 -KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             669999999999999999 8899999999887654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.54  E-value=8.1e-09  Score=103.26  Aligned_cols=64  Identities=19%  Similarity=0.166  Sum_probs=40.5

Q ss_pred             ccCCcEEEccCCCCCCCc-cccccCccchhhhcccCcccccc-cchhhhccccccccccccccccc
Q 045539          338 LGNLLVLELGGNNLTEPI-PITFSQLQTLQALGLTRNKLAGP-ITDELCHLARLHSLVLQGNKFSG  401 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~  401 (897)
                      ++++..+.+..|.+.... -..+..++.+..|+|+.|+|..- .-+++..+++|..|.+++|.+..
T Consensus       198 Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  198 FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            456777777788776432 23455666777777887777642 12456666677777777776653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	897
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-35
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-32
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		9e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-04
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		6e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  150 bits (378), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 90/254 (35%), Positives = 140/254 (55%), Gaps = 9/254 (3%)
Query: 604 IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK-SFED 662
           ++RFS  EL  A+D FS  N++G G FG +Y  RL DG  VAVK   ++  +  +  F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNI 719
           E E++    HRNL+++   C     + L+  YM NGS+ +CL         LD  +R  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
            +  A  L YLH      IIH D+K +N+LLDE+  A + DFG+AKL+  +D   +    
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAV 203
Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG---ELSLNRWINDL 836
             TIG++APEY + G+   + DV+ YG+ML+E+ T ++  D   +    ++ L  W+  L
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 837 LPVSVME-VIDTNL 849
           L    +E ++D +L
Sbjct: 264 LKEKKLEALVDVDL 277

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  146 bits (369), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 138/254 (54%), Gaps = 9/254 (3%)
Query: 604 IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK-SFED 662
           ++RFS  EL  A+D F   N++G G FG +Y  RL DG  VAVK   ++  +  +  F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNI 719
           E E++    HRNL+++   C     + L+  YM NGS+ +CL         LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
            +  A  L YLH      IIH D+K +N+LLDE+  A + DFG+AKL+  +D   +    
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAV 195
Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG---ELSLNRWINDL 836
              IG++APEY + G+   + DV+ YG+ML+E+ T ++  D   +    ++ L  W+  L
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 837 LPVSVME-VIDTNL 849
           L    +E ++D +L
Sbjct: 256 LKEKKLEALVDVDL 269

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  137 bits (344), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 156/551 (28%), Positives = 233/551 (42%), Gaps = 69/551 (12%)
Query: 69  ITCDVNSHRVIGL---NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT 125
           I+ DV+  R + L   ++SS N    IP  LG+ S+LQ LD+S NKLSG+   +I     
Sbjct: 187 ISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 245
Query: 126 LKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNL 184
           LKLL  S NQ  G +      + S+  + L+ N  +GE+P  + G    L  L  + N+ 
Sbjct: 246 LKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 303
Query: 185 VGVAPVTIFNMSALKEIYXXXXXXXXXXXXRIDLSLPNVETLNLGINSFYGTVPSSITN- 243
            G  P    + S L+ +                L +  ++ L+L  N F G +P S+TN 
Sbjct: 304 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 363
Query: 244 ASKLSDLELGVNLFSG-FIPNTFVN----MADNYLTSSTPELSFLSSLTNCKKLKVLILT 298
           ++ L  L+L  N FSG  +PN   N    + + YL ++        +L+NC +L  L L+
Sbjct: 364 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 423
Query: 299 GNPLDGILPKSKGNLSL-----------------------SLEIILMDNCSISGNIPQXX 335
            N L G +P S G+LS                        +LE +++D   ++G IP   
Sbjct: 424 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 483
Query: 336 XXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ 395
                           T  IP    +L+ L  L L+ N  +G I  EL     L  L L 
Sbjct: 484 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 543
Query: 396 GNKFSGSIPSCL--------------------------------GNLTSLR-VLYLGLNR 422
            N F+G+IP+ +                                GNL   + +    LNR
Sbjct: 544 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 603
Query: 423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
            ++  P  I +         + ++   ++ L+ S N LSG IP  IG +  L  + L +N
Sbjct: 604 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 663
Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGPF 542
            + GSIP+  GDL  L +LDLS NK+ G IP +            S N L G IP  G F
Sbjct: 664 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 723
Query: 543 ANLTAKSFMGN 553
                  F+ N
Sbjct: 724 ETFPPAKFLNN 734

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  136 bits (343), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 156/551 (28%), Positives = 233/551 (42%), Gaps = 69/551 (12%)
Query: 69  ITCDVNSHRVIGL---NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT 125
           I+ DV+  R + L   ++SS N    IP  LG+ S+LQ LD+S NKLSG+   +I     
Sbjct: 190 ISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 248
Query: 126 LKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNL 184
           LKLL  S NQ  G +      + S+  + L+ N  +GE+P  + G    L  L  + N+ 
Sbjct: 249 LKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF 306
Query: 185 VGVAPVTIFNMSALKEIYXXXXXXXXXXXXRIDLSLPNVETLNLGINSFYGTVPSSITN- 243
            G  P    + S L+ +                L +  ++ L+L  N F G +P S+TN 
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366
Query: 244 ASKLSDLELGVNLFSG-FIPNTFVN----MADNYLTSSTPELSFLSSLTNCKKLKVLILT 298
           ++ L  L+L  N FSG  +PN   N    + + YL ++        +L+NC +L  L L+
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 299 GNPLDGILPKSKGNLSL-----------------------SLEIILMDNCSISGNIPQXX 335
            N L G +P S G+LS                        +LE +++D   ++G IP   
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
Query: 336 XXXXXXXXXXXXXXXXTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ 395
                           T  IP    +L+ L  L L+ N  +G I  EL     L  L L 
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 396 GNKFSGSIPSCL--------------------------------GNLTSLR-VLYLGLNR 422
            N F+G+IP+ +                                GNL   + +    LNR
Sbjct: 547 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
            ++  P  I +         + ++   ++ L+ S N LSG IP  IG +  L  + L +N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGPF 542
            + GSIP+  GDL  L +LDLS NK+ G IP +            S N L G IP  G F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 543 ANLTAKSFMGN 553
                  F+ N
Sbjct: 727 ETFPPAKFLNN 737

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  134 bits (336), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 96/276 (34%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 587 WKSRTGPSNDGINSPQAIRRFSYH----ELLRATDRFSENNLIGIGSFGSIYVARLQDGM 642
           +   T   ND ++S   +   SY     +L  AT+ F    LIG G FG +Y   L+DG 
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 643 EVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
           +VA+K    +  + ++ FE E E +   RH +LV +I  C   +   LI KYM NG+L+ 
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 703 CLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS 759
            LY     T  +   QRL I I  A  L YLH   +  IIH D+K  N+LLDE+ V  I+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181
Query: 760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK-- 817
           DFGI+K  +  DQ  +      T+GY+ PEY  KGR+  + DVYS+G++L E+   +   
Sbjct: 182 DFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 818 ----PTDEIFIGELSLNRWINDLLPVSVMEVIDTNL 849
               P + + + E ++    N  L     +++D NL
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLE----QIVDPNL 273

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 141/276 (51%), Gaps = 20/276 (7%)
Query: 587 WKSRTGPSNDGINSPQAIRRFSYH----ELLRATDRFSENNLIGIGSFGSIYVARLQDGM 642
           +   T   ND ++S   +   SY     +L  AT+ F    LIG G FG +Y   L+DG 
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 643 EVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
           +VA+K    +  + ++ FE E E +   RH +LV +I  C   +   LI KYM NG+L+ 
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 703 CLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS 759
            LY     T  +   QRL I I  A  L YLH   +  IIH D+K  N+LLDE+ V  I+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181
Query: 760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK-- 817
           DFGI+K  +   Q  +      T+GY+ PEY  KGR+  + DVYS+G++L E+   +   
Sbjct: 182 DFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 818 ----PTDEIFIGELSLNRWINDLLPVSVMEVIDTNL 849
               P + + + E ++    N  L     +++D NL
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLE----QIVDPNL 273

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/228 (35%), Positives = 117/228 (51%), Gaps = 19/228 (8%)
Query: 607 FSYHELLRATDRFSEN------NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----ERA 656
           FS++EL   T+ F E       N +G G FG +Y   + +   VAVK          E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN---CLYSGTCMLDI 713
            + F+ E +VM + +H NLV+++   S+ D   L+  YMPNGSL +   CL  GT  L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
             R  I    A  + +LH  H    IH D+K +N+LLDE   A ISDFG+A+      Q 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
            +  + + T  YMAPE   +G +  + D+YS+G++L+E+ T     DE
Sbjct: 190 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/228 (35%), Positives = 117/228 (51%), Gaps = 19/228 (8%)
Query: 607 FSYHELLRATDRFSEN------NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----ERA 656
           FS++EL   T+ F E       N +G G FG +Y   + +   VAVK          E  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN---CLYSGTCMLDI 713
            + F+ E +VM + +H NLV+++   S+ D   L+  YMPNGSL +   CL  GT  L  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 126
Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
             R  I    A  + +LH  H    IH D+K +N+LLDE   A ISDFG+A+      Q 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
            +  + + T  YMAPE   +G +  + D+YS+G++L+E+ T     DE
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/228 (35%), Positives = 117/228 (51%), Gaps = 19/228 (8%)
Query: 607 FSYHELLRATDRFSEN------NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----ERA 656
           FS++EL   T+ F E       N +G G FG +Y   + +   VAVK          E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN---CLYSGTCMLDI 713
            + F+ E +VM + +H NLV+++   S+ D   L+  YMPNGSL +   CL  GT  L  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSW 132
Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
             R  I    A  + +LH  H    IH D+K +N+LLDE   A ISDFG+A+      Q 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
            +  + + T  YMAPE   +G +  + D+YS+G++L+E+ T     DE
Sbjct: 190 VMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/228 (33%), Positives = 112/228 (49%), Gaps = 19/228 (8%)
Query: 607 FSYHELLRATDRFSEN------NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----ERA 656
           FS++EL   T+ F E       N  G G FG +Y   + +   VAVK          E  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN---CLYSGTCMLDI 713
            + F+ E +V  + +H NLV+++   S+ D   L+  Y PNGSL +   CL  GT  L  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSW 123
Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
             R  I    A  + +LH  H    IH D+K +N+LLDE   A ISDFG+A+      Q 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
               + + T  Y APE   +G +  + D+YS+G++L+E+ T     DE
Sbjct: 181 VXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG+++ A    G +VAVK+  +Q  +   +  F  E  +MKR+RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +     +++ +Y+  GSL   L+       LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DLK  N+L+D+     + DFG+++L +             T  +MAPE         + 
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 801 DVYSYGIMLMEMFTKKKP 818
           DVYS+G++L E+ T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG+++ A    G +VAVK+  +Q  +   +  F  E  +MKR+RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +     +++ +Y+  GSL   L+       LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            +LK  N+L+D+     + DFG+++ L     LS +     T  +MAPE         + 
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSK-SAAGTPEWMAPEVLRDEPSNEKS 220
Query: 801 DVYSYGIMLMEMFTKKKP 818
           DVYS+G++L E+ T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 16/215 (7%)
Query: 613 LRATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFED 662
           +R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM 720
           E E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQT 779
             +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++   
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 129 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 127 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 128 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 121 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 126 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 618 RFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVM 667
           +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIG 784
            +EYL    +   IH DL   N+L++ +    I DFG+ K+L  + +   ++    + I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + APE  T+ +     DV+S+G++L E+FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 618 RFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVM 667
           +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIG 784
            +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    + I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + APE  T+ +     DV+S+G++L E+FT
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 618 RFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVM 667
           +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIG 784
            +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    + I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + APE  T+ +     DV+S+G++L E+FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 618 RFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVM 667
           +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIG 784
            +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    + I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + APE  T+ +     DV+S+G++L E+FT
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 618 RFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDECEVM 667
           +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E E++
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 668 KRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIG 784
            +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    + I 
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + APE  T+ +     DV+S+G++L E+FT
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+Y+P GSL + L      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTL 780
            +   +EYL    +   IH +L   N+L++ +    I DFG+ K+L  + +   ++    
Sbjct: 123 QICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 16/214 (7%)
Query: 614 RATDRFSENNL-----IGIGSFGSIYVAR---LQD--GMEVAVKVFHQQYERALKSFEDE 663
           R   +F E +L     +G G+FGS+ + R   LQD  G  VAVK      E  L+ FE E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E++K ++H N+VK    C +   +   LIM+++P GSL   L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTL 780
            +   +EYL    +   IH DL   N+L++ +    I DFG+ K+L   ++   ++    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + I + APE  T+ +     DV+S+G++L E+FT
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 601 PQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALK 658
           P+  R  SY+  + A++       IG GSFG++Y  +     +VAVK+           +
Sbjct: 21  PRGQRDSSYYWEIEASEVMLSTR-IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQ 77
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN 718
           +F +E  V+++ RH N++  +   + D+  A++ ++    SL   L+       +FQ ++
Sbjct: 78  AFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLID 136
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSI 775
           I    A  ++YLH   +  IIH D+K +N+ L E +   I DFG+A +    SG  Q+  
Sbjct: 137 IARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE- 192
Query: 776 QIQTLATIGYMAPE---YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
             Q   ++ +MAPE            + DVYSYGI+L E+ T + P   I
Sbjct: 193 --QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH   
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 126
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T+ 
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
             C   D+++ G ++ ++     P
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH   
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 127
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T+ 
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
             C   D+++ G ++ ++     P
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 125
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T+ 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
             C   D+++ G ++ ++     P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 211 EKSACKSSDLWALGCIIYQL 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 209 EKSACKSSDLWALGCIIYQL 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH   
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 124
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T+ 
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
             C   D+++ G ++ ++     P
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
            VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 131
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T+ 
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
             C   D+++ G ++ ++     P
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 209 EKSACKSSDLWALGCIIYQL 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 208 EKSACKSSDLWALGCIIYQL 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 205 EKSACKSSDLWALGCIIYQL 224

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T   L + Q +++   +A  + Y+        +H DL
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 448
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 449 SFGILLTELTTKGR 462

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 205 EKSACKSSDLWALGCIIYQL 224

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
             ++G G+FG +  A+ +   +VA+K    + ER  K+F  E   + R+ H N+VK+  +
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM---IDVALALEYLHFGHSTPI 738
           C N     L+M+Y   GSL N L+ G   L  +   + M   +  +  + YLH      +
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 739 IHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-----IGYMAPEYGT 792
           IH DLKP N+LL     V  I DFG A            IQT  T       +MAPE   
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSAAWMAPEVFE 177
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
                 + DV+S+GI+L E+ T++KP DEI
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
             ++G G+FG +  A+ +   +VA+K    + ER  K+F  E   + R+ H N+VK+  +
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM---IDVALALEYLHFGHSTPI 738
           C N     L+M+Y   GSL N L+ G   L  +   + M   +  +  + YLH      +
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 739 IHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-----IGYMAPEYGT 792
           IH DLKP N+LL     V  I DFG A            IQT  T       +MAPE   
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSAAWMAPEVFE 176
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
                 + DV+S+GI+L E+ T++KP DEI
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+     +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 213 EKSACKSSDLWALGCIIYQL 232

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T     + RL  ++D+A  +   + +      +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 365
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T   L + Q +++   +A  + Y+        +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 365
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF +  +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +   C   D+++ G ++ ++
Sbjct: 206 EKSACKSSDLWALGCIIYQL 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T     + RL  ++D+A  +   + +      +H DL
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDL 130
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 189
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 190 SFGILLTELTTKGR 203

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD M VAVK   +  E A + F+ E E++  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS--------------GTCMLDIFQRLNIMIDVA 724
              C+      ++ +YM +G L   L S                  L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             + YL   H    +H DL   N L+ + +V  I DFG+++ +   D   +  +T+  I 
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
           +M PE     +  T  DV+S+G++L E+FT  K
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T     + RL  ++D+A  +   + +      +H DL
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 365
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 622 NNLIGIGSFGSIYVARLQDGMEVAVKVFH----QQYERALKSFEDECEVMKRIRHRNLVK 677
             +IGIG FG +Y A    G EVAVK       +   + +++   E ++   ++H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           +   C  +    L+M++   G L   L       DI   +N  + +A  + YLH     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 738 IIHCDLKPSNVLLDEDM--------VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           IIH DLK SN+L+ + +        +  I+DFG+A+    E   + ++       +MAPE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPE 184
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                      DV+SYG++L E+ T + P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD M VAVK   +  E A + F+ E E++  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS--------------GTCMLDIFQRLNIMIDVA 724
              C+      ++ +YM +G L   L S                  L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             + YL   H    +H DL   N L+ + +V  I DFG+++ +   D   +  +T+  I 
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
           +M PE     +  T  DV+S+G++L E+FT  K
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 105/194 (54%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++++YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T     + RL  ++D+A  +   + +      +H DL
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDL 133
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 192
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 193 SFGILLTELTTKGR 206

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQ-------RLNIMIDVALALEY-LHFGHST 736
           +    ++M+YM  G          C+LD  +       RL  ++D+A  +   + +    
Sbjct: 85  EPI-YIVMEYMSKG----------CLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H DL+ +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRF 192
Query: 797 CTRGDVYSYGIMLMEMFTKKK 817
             + DV+S+GI+L E+ TK +
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD M VAVK   +  E A + F+ E E++  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS--------------GTCMLDIFQRLNIMIDVA 724
              C+      ++ +YM +G L   L S                  L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             + YL   H    +H DL   N L+ + +V  I DFG+++ +   D   +  +T+  I 
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
           +M PE     +  T  DV+S+G++L E+FT  K
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK+IRH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 74/240 (30%), Positives = 117/240 (48%), Gaps = 26/240 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD---GMEVAVKVFH---QQYERALKSFEDECEVMKRI 670
           +R+   + +G G   ++Y+A  +D    ++VA+K      ++ E  LK FE E     ++
Sbjct: 11  ERYKIVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEY 729
            H+N+V +I     DD   L+M+Y+   +L   + S G   +D        I     L+ 
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI-----LDG 123
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           +   H   I+H D+KP N+L+D +    I DFGIAK LS E  L+     L T+ Y +PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPE 182
Query: 790 Y--GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN---RWINDLLPVSVMEV 844
              G     CT  D+YS GI+L EM   + P    F GE +++   + I D +P    +V
Sbjct: 183 QAKGEATDECT--DIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDV 236

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 105/194 (54%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++++YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T   L + Q +++   +A  + Y+        +H DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 196
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 307
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+ +L+   +  + Q      I + APE    GR   + DV+
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 366
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 367 SFGILLTELTTKGR 380

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 625 IGIGSFGSIYVAR------LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        +D M VAVK        A K F+ E E++  ++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYS---------------GTCMLDIFQRLNIMIDV 723
              C + D   ++ +YM +G L   L +                   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           A  + YL   H    +H DL   N L+  +++  I DFG+++ +   D   +   T+  I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
            +M PE     +  T  DV+S+G++L E+FT  K
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L   T   L + Q +++   +A  + Y+        +H DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 196
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 191
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 186
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 129
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 188
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 189 SFGILLTELTTKGR 202

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 188
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 131
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 190
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 191 SFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 191
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +       D+++ G ++ ++
Sbjct: 208 EKSASKSSDLWALGCIIYQL 227

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VA+K   +    + +SF +E ++MK+++H  LV++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 685 DDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L  G    L +   +++   VA  + Y+        IH DL
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+   ++  I+DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 190
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 191 SFGILLTELVTKGR 204

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
              VK+  +  +D+     + Y  NG L   +       +   R     ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE  T
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +       D+++ G ++ ++
Sbjct: 208 EKSAXKSSDLWALGCIIYQL 227

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        QD + VAVK      + A K F  E E++  ++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSG------------TCMLDIFQRLNIMIDVALA 726
              C   D   ++ +YM +G L   L +                L   Q L+I   +A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           + YL   H    +H DL   N L+ E+++  I DFG+++ +   D   +   T+  I +M
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
            PE     +  T  DV+S G++L E+FT  K
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 213
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 214
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A +    SG  Q     Q   +I +MAPE      K   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 186
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 743 LKPSNVLLDEDMVAHISDFGIA---KLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A      SG  Q     Q   +I +MAPE      K   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 186
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 94  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 743 LKPSNVLLDEDMVAHISDFGIA---KLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A      SG  Q     Q   +I +MAPE      K   
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 206
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-LHFGHSTPIIHCDL 743
           +    ++ +YM  GSL + L      +  + RL  ++D+A  +   + +      +H DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
             +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + DV+
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 199
Query: 804 SYGIMLMEMFTKKK 817
           S+GI+L E+ TK +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 743 LKPSNVLLDEDMVAHISDFGIA---KLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED+   I DFG+A      SG  Q     Q   +I +MAPE      K   
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPY 214
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++        VA+K   +    + ++F  E +VMK++RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQ-------RLNIMIDVALALEY-LHFGHST 736
           +    ++ +YM  G          C+LD  +       RL  ++D+A  +   + +    
Sbjct: 85  EPI-YIVTEYMSKG----------CLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H DL+ +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRF 192
Query: 797 CTRGDVYSYGIMLMEMFTKKK 817
             + DV+S+GI+L E+ TK +
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 18/223 (8%)
Query: 611 ELLRATDRFSENN---LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEV 666
           +LL     + EN    ++G G++G +Y  R L + + +A+K   ++  R  +   +E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            K ++H+N+V+ + S S + F  + M+ +P GSL   L S    L   ++  I       
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQI 131
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIG 784
           LE L + H   I+H D+K  NVL++    V  ISDFG +K L+G   ++   +T   T+ 
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQ 188
Query: 785 YMAPEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKPTDEI 822
           YMAPE   KG    RG     D++S G  ++EM T K P  E+
Sbjct: 189 YMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG + + + +   +VAVK+  ++   +   F  E + M ++ H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
           +    ++ +Y+ NG L N L S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLA 131
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+D D+   +SDFG+ + +  +DQ    + T   + + APE     +  ++ DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 805 YGIMLMEMFT-KKKPTD 820
           +GI++ E+F+  K P D
Sbjct: 191 FGILMWEVFSLGKMPYD 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L++     ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 743 LKPSNVLLDEDMVAHISDFGIAKL---LSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED    I DFG+A +    SG  Q     Q   +I +MAPE          
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNPY 190
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNI 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG+A++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK      +   ++F  E  VM ++RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 685 DDFKALIM-KYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     I+ +YM  GSL + L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   + +  T+ DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 183 WSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK      +   ++F  E  VM ++RH NLV+++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 685 DDFKALIM-KYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     I+ +YM  GSL + L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   + +  T+ DV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 198 WSFGILLWEIYS 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEASVIHRDLA 130
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L++     ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 743 LKPSNVLLDEDMVAHISDFGIA---KLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED    I DFG+A      SG  Q     Q   +I +MAPE          
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNPY 202
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+D  +VAVKV      R       F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++   M     +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+L+       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA--DSGNSVXQTAAVIGTAQ 184
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 15/214 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D   +  ++G G++G +Y  R L + + +A+K   ++  R  +   +E  + K ++H+N+
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V+ + S S + F  + M+ +P GSL   L S    L   ++  I       LE L + H 
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHD 126
Query: 736 TPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYGTK 793
             I+H D+K  NVL++    V  ISDFG +K L+G   ++   +T   T+ YMAPE   K
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDK 183
Query: 794 GRVCTRG-----DVYSYGIMLMEMFTKKKPTDEI 822
           G    RG     D++S G  ++EM T K P  E+
Sbjct: 184 G---PRGYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK      +   ++F  E  VM ++RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 685 DDFKALIM-KYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     I+ +YM  GSL + L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   + +  T+ DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 370 WSFGILLWEIYS 381

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLA 781
           +A  ++YL        +H DL   N+L++ ++V  +SDFG++++L  + + +   +    
Sbjct: 156 IASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK      +   ++F  E  VM ++RH NLV+++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 685 DDFKALIM-KYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     I+ +YM  GSL + L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   +    T+ DV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E+++
Sbjct: 189 WSFGILLWEIYS 200

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 7   HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 127 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 24  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 143
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 144 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 5/192 (2%)
Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKIISSC 682
           IG G+FG ++  RL+ D   VAVK   +     LK+ F  E  ++K+  H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++M+ +  G     L +    L +   L ++ D A  +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E  V  ISDFG+++  +     +        + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+D  +VAVKV      R       F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++   M     +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 355 IPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLR 414
           IP   SQ++TL  L  + N L+G +   +  L  L  +   GN+ SG+IP   G+ + L 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 415 V-LYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKN 473
             + +  NR T  +P T  NL ++ F+D+S             RN L GD  +  G  KN
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLS-------------RNMLEGDASVLFGSDKN 222
Query: 474 LQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASXXXXXXXXXXXXSFNKLE 533
            Q++ L  N L   + +  G   +L  LDL  N+I G +P              SFN L 
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 534 GEIPRGGPFANLTAKSFMGNE 554
           GEIP+GG        ++  N+
Sbjct: 282 GEIPQGGNLQRFDVSAYANNK 302

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG+ ++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+D  +VAVKV      R       F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++   M     +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   ++   +   F +E EVM ++ H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 150
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 210 FGVLMWEVFSEGK 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L++     ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 743 LKPSNVLLDEDMVAHISDFGIA---KLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRV 796
           LK +N+ L ED    I DFG+A      SG  Q     Q   +I +MAPE          
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNPY 202
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTDEI 822
             + DVY++GI+L E+ T + P   I
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 5/192 (2%)
Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKIISSC 682
           IG G+FG ++  RL+ D   VAVK   +     LK+ F  E  ++K+  H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++M+ +  G     L +    L +   L ++ D A  +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E  V  ISDFG+++  +     +        + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 128
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 188 FGVLMWEVFSEGK 200

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 133
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 193 FGVLMWEVFSEGK 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 130
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 34  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ +YM NGSL++ L        + Q + ++  
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 153
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 154 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 8/202 (3%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 135
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S + + + T  +MAPE  T+   
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSEMVGTPYWMAPEVVTRKAY 193
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                L+ ++M +G L + L +   +      L + +DV   + YL       +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 131
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 805 YGIMLMEMFTKKK 817
           +G+++ E+F++ K
Sbjct: 191 FGVLMWEVFSEGK 203

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 121
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 180
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 71
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 127
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 186
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 10  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 66
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 67  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 122
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 181
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 19  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 75
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 76  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 131
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 190
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 191 AINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 121
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 180
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 14  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 71  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 126
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 185
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 186 AINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 18  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 74
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 75  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 130
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 131 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 189
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 11  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 67
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 68  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 123
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 182
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 121
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 180
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 71
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 127
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 186
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 17  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 73
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 74  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPE 188
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 135
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVVTRKAY 193
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 135
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 136
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH D+K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVVTRKAY 194
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 112/208 (53%), Gaps = 9/208 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 60
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 61  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 116
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 175
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
               G    + DV+S+GI+L E+ T  +
Sbjct: 176 AINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 608 SYHELLRATDRFSEN---------NLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY- 653
           +Y E  RA   F+            +IG G  G +   RL    Q  + VA+K     Y 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 654 ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI 713
           ER  + F  E  +M +  H N++++    +      ++ +YM NGSL+  L +      I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 714 FQRLNIMIDVALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-D 771
            Q + ++  V   + YL   G+    +H DL   NVL+D ++V  +SDFG++++L  + D
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      I + APE        +  DV+S+G+++ E+  
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 7   HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ + M NGSL++ L        + Q + ++  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 127 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 169
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 207 FGVLMWEIYSLGKMPYERF 225

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++    +  +VAVK   +    ++++F +E  +MK ++H  LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 685 DDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           ++   +I +YM  GSL + L S   G  +L   + ++    +A  + Y+        IH 
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +NVL+ E ++  I+DFG+A+++  +++ + +      I + APE    G    + D
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 802 VYSYGIMLMEMFTKKK 817
           V+S+GI+L E+ T  K
Sbjct: 194 VWSFGILLYEIVTYGK 209

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ + M NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLA 781
           +A  ++YL        +H DL   N+L++ ++V  +SDFG++++L  + + +   +    
Sbjct: 156 IASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 170
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 143
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 112/208 (53%), Gaps = 9/208 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G FG +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 61
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 62  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 117
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH +L+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE
Sbjct: 118 MAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 176
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
               G    + DV+S+GI+L E+ T  +
Sbjct: 177 AINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 608 SYHELLRATDRFSEN---------NLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY- 653
           +Y E  RA   F+            +IG G  G +   RL    Q  + VA+K     Y 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 654 ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI 713
           ER  + F  E  +M +  H N++++    +      ++ +YM NGSL+  L +      I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 714 FQRLNIMIDVALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
            Q + ++  V   + YL   G+    +H DL   NVL+D ++V  +SDFG++++L  ED 
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDD 204
Query: 773 LSIQIQTLA---TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                 T      I + APE        +  DV+S+G+++ E+  
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 138
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 198 FGVLMWEIYSLGKMPYERF 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 131
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 191 FGVLMWEIYSLGKMPYERF 209

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 192 FGVLMWEIYSLGKMPYERF 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 127
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 187 FGVLMWEIYSLGKMPYERF 205

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 149
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 610 HELLRATD--RFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFED 662
           HE  +  D    S + ++G G FG +   RL+      + VA+K     Y E+  + F  
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  +M +  H N++++    +      ++ + M NGSL++ L        + Q + ++  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 723 VALALEYL-HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TL 780
           +A  ++YL   G+    +H DL   N+L++ ++V  +SDFG++++L  + + +   +   
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I + +PE     +  +  DV+SYGI+L E+ +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +++ S  + +   + +  PE     +  ++ D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 207 FGVLMWEIYSLGKMPYERF 225

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 148
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 620 SENNLIGIGSFGSIYVARLQDG-----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHR 673
           +   +IG G FG +Y   L+       + VA+K     Y E+    F  E  +M +  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N++++    S      +I +YM NG+L+  L        + Q + ++  +A  ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPEYGT 792
            +   +H DL   N+L++ ++V  +SDFG++++L  + + +         I + APE  +
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 793 KGRVCTRGDVYSYGIMLMEMFT 814
             +  +  DV+S+GI++ E+ T
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 146
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+   +VAVKV      R       F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V + ++   +        ++M+Y+   +L + +++   M    + + ++ D   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIAD---AC 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
             + S    D   ++M+Y+  GSL + + + TCM D  Q   +  +   ALE+LH   S 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFLH---SN 136
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH ++K  N+LL  D    ++DFG    ++ E   S +   + T  +MAPE  T+   
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 194
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
             + D++S GIM +EM   + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +YV   +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    ++ +YMP G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 99  LEPPFYIVTEYMPYGNLLD--YLRECNREEVTAVVLLYMATQISSAMEYL---EKKNFIH 153
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ V  ++DFG+++L++G D  +        I + APE         + 
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 213 DVWAFGVLLWEIAT 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 102/191 (53%), Gaps = 7/191 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++A      +VAVK   +    ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHCDL 743
           +    +I ++M  GSL + L S        Q L  +ID +  + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+   +V  I+DFG+A+++  +++ + +      I + APE    G    + DV+
Sbjct: 311 RAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 804 SYGIMLMEMFT 814
           S+GI+LME+ T
Sbjct: 370 SFGILLMEIVT 380

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 57/191 (29%), Positives = 102/191 (53%), Gaps = 7/191 (3%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++A      +VAVK   +    ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHCDL 743
           +    +I ++M  GSL + L S        Q L  +ID +  + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+   +V  I+DFG+A+++  +++ + +      I + APE    G    + DV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 804 SYGIMLMEMFT 814
           S+GI+LME+ T
Sbjct: 197 SFGILLMEIVT 207

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+   +VAVKV      R       F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++   M     +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+   +VAVKV      R       F  E +    + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 672 HRNLVKIISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++   M     +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 143
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           + L+F H   IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 201
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE      V  R DVYS G +L E+ T + P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 58/205 (28%), Positives = 108/205 (52%), Gaps = 9/205 (4%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI 670
           E+ R T +  E   +G G  G +++       +VAVK   +Q   +  +F  E  +MK++
Sbjct: 9   EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EY 729
           +H+ LV++ +  + +    +I +YM NGSL + L + +    I   +N ++D+A  + E 
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEG 121
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + F      IH DL+ +N+L+ + +   I+DFG+A+L+   +  + +      I + APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPE 180
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFT 814
               G    + DV+S+GI+L E+ T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 625 IGIGSFGSIYVARLQD-----GMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG + + R        G +VAVK    +     +   + E E+++ + H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C+ D      LIM+++P+GSL+  L      +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 133
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVL++ +    I DFG+ K + + ++  +++    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 5/199 (2%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  ++   +   F +E +VM  + H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK 744
                +I +YM NG L N L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYS 804
             N L+++  V  +SDFG+++ +  +D+ +    +   + +  PE     +  ++ D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 805 YGIMLMEMFTKKKPTDEIF 823
           +G+++ E+++  K   E F
Sbjct: 192 FGVLMWEIYSLGKMPYERF 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 625 IGIGSFGSIYVARLQD-----GMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG + + R        G +VAVK    +     +   + E E+++ + H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C+ D      LIM+++P+GSL+  L      +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 145
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVL++ +    I DFG+ K + + ++  +++    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGME----VAVKVFHQQY-ERA 656
           +A+R F+  E+  +  +  E  +IG G FG +   RL+   +    VA+K     Y ER 
Sbjct: 4   EAVREFA-KEIDVSYVKIEE--VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ 60
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR 716
            + F  E  +M +  H N++++    +N     ++ ++M NG+L++ L        + Q 
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL 120
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           + ++  +A  + YL        +H DL   N+L++ ++V  +SDFG+++ L        +
Sbjct: 121 VGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 777 IQTLA---TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             +L     I + APE     +  +  D +SYGI++ E+ +
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 52/196 (26%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++    +  +VAVK   +    ++++F +E  +MK ++H  LV++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 685 DDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           ++   +I ++M  GSL + L S   G  +L   + ++    +A  + Y+        IH 
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +NVL+ E ++  I+DFG+A+++  +++ + +      I + APE    G    + +
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 802 VYSYGIMLMEMFTKKK 817
           V+S+GI+L E+ T  K
Sbjct: 193 VWSFGILLYEIVTYGK 208

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 610 HELLRATDRFSENNLIGIGSFG-SIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMK 668
           H + R +D      ++G G FG +I V   + G  + +K   +  E   ++F  E +VM+
Sbjct: 4   HRIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
            + H N++K I     D     I +Y+  G+L   + S        QR++   D+A  + 
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-------- 780
           YL   HS  IIH DL   N L+ E+    ++DFG+A+L+  E      +++L        
Sbjct: 123 YL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 781 -ATIG---YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
              +G   +MAPE         + DV+S+GI+L E+  +
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 156
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 210
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 149
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLV 676
           N +IG G FG +Y   L D     +  AVK  ++  +   +  F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 677 KIISSCSNDDFKALI-MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            ++  C   +   L+ + YM +G L N + + T    +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +  ++  S+  +T A   + +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T+ DV+S+G++L E+ T+  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 622 NNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
             +IG G FG +   RL+      + VA+K     Y E+  + F  E  +M +  H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL-HFGHS 735
            +    +      ++ +YM NGSL+  L        + Q + ++  ++  ++YL   G+ 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY- 145
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPEYGTKG 794
              +H DL   N+L++ ++V  +SDFG++++L  + + +   +     I + APE     
Sbjct: 146 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
           +  +  DV+SYGI++ E+ +
Sbjct: 203 KFTSASDVWSYGIVMWEVVS 222

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 27/232 (11%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVF-------HQQYERALKSFEDECEV 666
           A +       IG G FG ++  RL +D   VA+K           +     + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           M  + H N+VK+     N     ++M+++P G L + L      +    +L +M+D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 727 LEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHISDFGIAKLLSGEDQLSIQIQT-- 779
           +EY+    + PI+H DL+  N+    LDE+  + A ++DFG++       Q S+   +  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-------QQSVHSVSGL 186
Query: 780 LATIGYMAPE-YGTKGRVCT-RGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
           L    +MAPE  G +    T + D YS+ ++L  + T + P DE   G++  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 619 FSENNL-----IGIGSFGSIYVARLQD-----GMEVAVKVFHQQYERALKSFEDECEVMK 668
           F E +L     +G G+FGS+ + R        G  VAVK          + F+ E +++K
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 669 RIRHRNLVKI--ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            +    +VK   +S         L+M+Y+P+G L + L      LD  + L     +   
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGY 785
           +EYL    S   +H DL   N+L++ +    I+DFG+AKLL   +D   ++    + I +
Sbjct: 127 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            APE  +      + DV+S+G++L E+FT
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 108/219 (49%), Gaps = 12/219 (5%)
Query: 602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERA 656
           QA+R F+  E+  +  +  +  +IG+G FG +   RL+      + VA+K     Y ++ 
Sbjct: 17  QAVREFA-KEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR 716
            + F  E  +M +  H N++ +    +      +I +YM NGSL+  L        + Q 
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL 133
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           + ++  +   ++YL        +H DL   N+L++ ++V  +SDFG++++L  + + +  
Sbjct: 134 VGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 777 IQ-TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     I + APE     +  +  DV+SYGI++ E+ +
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 619 FSENNL-----IGIGSFGSIYVARLQD-----GMEVAVKVFHQQYERALKSFEDECEVMK 668
           F E +L     +G G+FGS+ + R        G  VAVK          + F+ E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 669 RIRHRNLVKI--ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            +    +VK   +S         L+M+Y+P+G L + L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGY 785
           +EYL    S   +H DL   N+L++ +    I+DFG+AKLL   +D   ++    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            APE  +      + DV+S+G++L E+FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 622 NNLIGIGSFGSIYVARLQDGME----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
             +IG G FG +   RL+   +    VA+K     Y ER  + F  E  +M +  H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++    +N     ++ ++M NG+L++ L        + Q + ++  +A  + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL---SGEDQLSIQIQTLATIGYMAPEYGTK 793
             +H DL   N+L++ ++V  +SDFG+++ L   S +   +  +     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 794 GRVCTRGDVYSYGIMLMEMFT 814
            +  +  D +SYGI++ E+ +
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 108/219 (49%), Gaps = 12/219 (5%)
Query: 602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERA 656
           QA+R F+  E+  +  +  +  +IG+G FG +   RL+      + VA+K     Y ++ 
Sbjct: 2   QAVREFA-KEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 58
Query: 657 LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR 716
            + F  E  +M +  H N++ +    +      +I +YM NGSL+  L        + Q 
Sbjct: 59  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL 118
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           + ++  +   ++YL        +H DL   N+L++ ++V  +SDFG++++L  + + +  
Sbjct: 119 VGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 777 IQ-TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     I + APE     +  +  DV+SYGI++ E+ +
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRN 674
           FS+   IG GSFG++Y AR +++   VA+K      +++ + ++D   E   ++++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYL 730
            ++       +    L+M+Y        CL S + +L++ ++    +++A     AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
            + HS  +IH D+K  N+LL E  +  + DFG A +++  +        + T  +MAPE 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEV 221
Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +G+   + DV+S GI  +E+  +K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 622 NNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
             +IG G FG +    L+      + VA+K     Y E+  + F  E  +M +  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            +    +      +I ++M NGSL++ L        + Q + ++  +A  ++YL      
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-----TIGYMAPEYG 791
             +H DL   N+L++ ++V  +SDFG+++ L  ED  S    T A      I + APE  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 792 TKGRVCTRGDVYSYGIMLMEMFT 814
              +  +  DV+SYGI++ E+ +
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 619 FSENNL-----IGIGSFGSIYVARLQD-----GMEVAVKVFHQQYERALKSFEDECEVMK 668
           F E +L     +G G+FGS+ + R        G  VAVK          + F+ E +++K
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 669 RIRHRNLVKI--ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            +    +VK   +S         L+M+Y+P+G L + L      LD  + L     +   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGY 785
           +EYL    S   +H DL   N+L++ +    I+DFG+AKLL   +D   ++    + I +
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            APE  +      + DV+S+G++L E+FT
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK---SFEDECEVMKRIRHRNLVKI 678
           + +G+G+FG + +   Q  G +VAVK+ ++Q  R+L      + E + +K  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
               S      ++M+Y+  G L    +   C     + +         L  + + H   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DLKP NVLLD  M A I+DFG++ ++S  + L     +  +  Y APE    GR+  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---DSCGSPNYAAPEV-ISGRLYA 188
Query: 799 --RGDVYSYGIMLMEMFTKKKPTDE 821
               D++S G++L  +     P D+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDEC---EVMKRIRHRNLVKI-- 678
           +G G FG +     QD G +VA+K   Q  E + K+ E  C   ++MK++ H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 679 ----ISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHF 732
               +   + +D   L M+Y   G L   L  +   C L       ++ D++ AL YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 733 GHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
                IIH DLKP N++L    + ++  I D G AK L   DQ  +  + + T+ Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPE 193
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              + +     D +S+G +  E  T  +P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDEC---EVMKRIRHRNLVKI-- 678
           +G G FG +     QD G +VA+K   Q  E + K+ E  C   ++MK++ H N+V    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 679 ----ISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHF 732
               +   + +D   L M+Y   G L   L  +   C L       ++ D++ AL YLH 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 139
Query: 733 GHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
                IIH DLKP N++L    + ++  I D G AK L   DQ  +  + + T+ Y+APE
Sbjct: 140 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPE 194
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              + +     D +S+G +  E  T  +P
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK---SFEDECEVMKRIRHRNLVKI 678
           + +G+G+FG + +   Q  G +VAVK+ ++Q  R+L      + E + +K  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
               S      ++M+Y+  G L    +   C     + +         L  + + H   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DLKP NVLLD  M A I+DFG++ ++S  + L     +  +  Y APE    GR+  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSCGSPNYAAPEV-ISGRLYA 188
Query: 799 --RGDVYSYGIMLMEMFTKKKPTDE 821
               D++S G++L  +     P D+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVF-------HQQYERALKSFEDECEV 666
           A +       IG G FG ++  RL +D   VA+K           +     + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           M  + H N+VK+     N     ++M+++P G L + L      +    +L +M+D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 727 LEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHISDFGIAKLLSGEDQLSIQIQT-- 779
           +EY+    + PI+H DL+  N+    LDE+  + A ++DFG +       Q S+   +  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-------QQSVHSVSGL 186
Query: 780 LATIGYMAPE-YGTKGRVCT-RGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
           L    +MAPE  G +    T + D YS+ ++L  + T + P DE   G++  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKIIS 680
           +G GSFG +++ R   +G   A+KV  ++    LK  E   DE  ++  + H  ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +  +     +IM Y+  G L + L       +   +     +V LALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DLKP N+LLD++    I+DFG AK +       +      T  Y+APE  +        
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 801 DVYSYGIMLMEMFTKKKP 818
           D +S+GI++ EM     P
Sbjct: 185 DWWSFGILIYEMLAGYTP 202

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I+++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 85  REPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I+++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 81  REPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 135
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 195 DVWAFGVLLWEIAT 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G FG +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 78  REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 132
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRN 674
           FS+   IG GSFG++Y AR +++   VA+K      +++ + ++D   E   ++++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL----ALEYL 730
            ++       +    L+M+Y        CL S + +L++ ++    +++A     AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
            + HS  +IH D+K  N+LL E  +  + DFG A +++  +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEV 182
Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +G+   + DV+S GI  +E+  +K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 622 NNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
             +IG+G FG +   RL+      + VA+K     Y ++  + F  E  +M +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            +    +      +I +YM NGSL+  L        + Q + ++  +   ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPEYGTKGR 795
             +H DL   N+L++ ++V  +SDFG++++L  + + +   +     I + APE     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 796 VCTRGDVYSYGIMLMEMFT 814
             +  DV+SYGI++ E+ +
Sbjct: 190 FTSASDVWSYGIVMWEVMS 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 96/191 (50%), Gaps = 17/191 (8%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++A      +VAVK   +    ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-EYLHFGHSTPIIHCDL 743
           +    +I ++M  GSL + L S        Q L  +ID +  + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+   +V  I+DFG+A+           +     I + APE    G    + DV+
Sbjct: 305 RAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 804 SYGIMLMEMFT 814
           S+GI+LME+ T
Sbjct: 354 SFGILLMEIVT 364

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I+++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I+++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I+++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 78  REPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 132
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 85  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 93  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 147
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 207 DVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 85  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 84  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 138
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 198 DVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 82  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 136
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 82  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 136
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 78  REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 132
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 85  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 684 NDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
            +    +I ++M  G+L + L       ++    L +   ++ A+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRN 382
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 803 YSYGIMLMEMFT 814
           +++G++L E+ T
Sbjct: 442 WAFGVLLWEIAT 453

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 619 FSENNL-----IGIGSFGSIYVAR------LQDGMEVAVKVFHQQYERALKS-FEDECEV 666
           +  NN+     IG G+FG ++ AR       +    VAVK+  ++    +++ F+ E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS-------------------- 706
           M    + N+VK++  C+      L+ +YM  G L   L S                    
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 707 ---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
              G   L   ++L I   VA  + YL        +H DL   N L+ E+MV  I+DFG+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++ +   D           I +M PE     R  T  DV++YG++L E+F+
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 684 NDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
            +    +I ++M  G+L + L       +     L +   ++ A+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRN 343
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + DV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 803 YSYGIMLMEMFT 814
           +++G++L E+ T
Sbjct: 403 WAFGVLLWEIAT 414

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 619 FSENNL-----IGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMK 668
           F E +L     +G G+FGS+ + R        G  VAVK          + F+ E +++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 669 RIRHRNLVKI--ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            +    +VK   +S         L+M+Y+P+G L + L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQTLATIGY 785
           +EYL    S   +H DL   N+L++ +    I+DFG+AKLL   +D   ++    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            APE  +      + DV+S+G++L E+FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCML 711
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L               ++    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 622 NNLIGIGSFGSIYVARLQ-DG--MEVAVKVFHQQYERA-LKSFEDECEVMKRI-RHRNLV 676
            ++IG G+FG +  AR++ DG  M+ A+K   +   +   + F  E EV+ ++  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLY---------------SGTCMLDIFQRLNIMI 721
            ++ +C +  +  L ++Y P+G+L + L                S    L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           DVA  ++YL        IH DL   N+L+ E+ VA I+DFG+++   G++    +     
Sbjct: 140 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + +MA E        T  DV+SYG++L E+ +
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQ--YER-ALKSFED 662
           F + E+LRA         IG GSFG + + +  D  ++ A+K  ++Q   ER  +++   
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E ++M+ + H  LV +  S  +++   +++  +  G L   L       +   +L  + +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICE 123
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA- 781
           + +AL+YL    +  IIH D+KP N+LLDE    HI+DF IA +L  E     QI T+A 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 782 TIGYMAPEY--GTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           T  YMAPE     KG   +   D +S G+   E+   ++P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 80  REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    +     L +   ++ A+EYL        IH
Sbjct: 85  REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 622 NNLIGIGSFGSIYVARLQ-DG--MEVAVKVFHQQYERA-LKSFEDECEVMKRI-RHRNLV 676
            ++IG G+FG +  AR++ DG  M+ A+K   +   +   + F  E EV+ ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLY---------------SGTCMLDIFQRLNIMI 721
            ++ +C +  +  L ++Y P+G+L + L                S    L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           DVA  ++YL        IH DL   N+L+ E+ VA I+DFG+++   G++    +     
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + +MA E        T  DV+SYG++L E+ +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 XXKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVF-------HQQYERALKSFEDECEV 666
           A +       IG G FG ++  RL +D   VA+K           +     + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           M  + H N+VK+     N     ++M+++P G L + L      +    +L +M+D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 727 LEYLHFGHSTPIIHCDLKPSNVL---LDED--MVAHISDFGIAKLLSGEDQLSIQIQT-- 779
           +EY+    + PI+H DL+  N+    LDE+  + A ++DF ++       Q S+   +  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-------QQSVHSVSGL 186
Query: 780 LATIGYMAPE-YGTKGRVCT-RGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
           L    +MAPE  G +    T + D YS+ ++L  + T + P DE   G++  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 141 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 81  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 135
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 195 DVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTC---MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            +    +I ++M  G+L +  Y   C    ++    L +   ++ A+EYL        IH
Sbjct: 82  REPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIH 136
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            DL   N L+ E+ +  ++DFG+++L++G D  +        I + APE     +   + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 801 DVYSYGIMLMEMFT 814
           DV+++G++L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 140 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 137 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------YSGTCMLDIFQRL 717
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L         YS     +  ++L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 718 N------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           +          VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     IG GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+YMP G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 XXKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     IG GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+YMP G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 608 SYHELLRATDRFSEN---------NLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY- 653
           +Y +  RA  +F++           +IG G FG +   RL+      + VA+K     Y 
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 654 ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI 713
           E+  + F  E  +M +  H N+V +    +      +++++M NG+L+  L        +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
            Q + ++  +A  + YL        +H DL   N+L++ ++V  +SDFG+++++  +D  
Sbjct: 145 IQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPE 200
Query: 774 SIQIQTLATI--GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++   T   I   + APE     +  +  DV+SYGI++ E+ +
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCML 711
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 258 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ--YERAL-KSFEDECEVMKRIRH 672
           + F   NL+G GSF  +Y A  +  G+EVA+K+  ++  Y+  + +  ++E ++  +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            +++++ +   + ++  L+++   NG +   L +        +  + M  +   + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH- 129
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  I+H DL  SN+LL  +M   I+DFG+A  L    +    +    T  Y++PE  T
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIAT 185
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
           +       DV+S G M   +   + P D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 40/262 (15%)
Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSI 633
           ++WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +
Sbjct: 14  VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKV 62
Query: 634 YVARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSC 682
             A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGAC 119
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH-------- 734
           ++     +I +Y   G L N L   + +L+      I    A   + LHF          
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 735 --STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S   IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MAPE   
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
Query: 793 KGRVCTRGDVYSYGIMLMEMFT 814
                 + DV+SYGI+L E+F+
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFS 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVARL----QDG----MEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A      +D      +VAVK+      E+ L     E E+M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCML 711
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L               ++    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G++L E+FT
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKNTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I+ Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 623 NLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
            +IG G FG +    L+      + VA+K     Y E+  + F  E  +M +  H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           +    +      +I ++M NGSL++ L        + Q + ++  +A  ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-----TIGYMAPEYGT 792
            +H  L   N+L++ ++V  +SDFG+++ L  ED  S    T A      I + APE   
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 793 KGRVCTRGDVYSYGIMLMEMFT 814
             +  +  DV+SYGI++ E+ +
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 201 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 199 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E  L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 618 RFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKS-FEDECEVMKRI 670
           RF E   +G   FG +Y   L      +    VA+K    + E  L+  F  E  +  R+
Sbjct: 29  RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 86
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-------------- 716
           +H N+V ++   + D   ++I  Y  +G L   L   +   D+                 
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 717 -LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
            ++++  +A  +EYL   H   ++H DL   NVL+ + +   ISD G+ + +   D   +
Sbjct: 147 FVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 203
Query: 776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +L  I +MAPE    G+     D++SYG++L E+F+
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +          DI        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 204 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK---SFEDECEVMKRIRHRNLVKI 678
           + +G+G+FG + V + +  G +VAVK+ ++Q  R+L        E + +K  RH +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
               S      ++M+Y+  G L + +      LD  +   +   +   ++Y H      +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H DLKP NVLLD  M A I+DFG++ ++S  + L     +  +  Y APE    GR+  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---XSCGSPNYAAPEV-ISGRLYA 193
Query: 799 --RGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
               D++S G++L  +     P D+  +  L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 622 NNLIGIGSFGSIYVARLQ-DG--MEVAVKVFHQQYERA-LKSFEDECEVMKRI-RHRNLV 676
            ++IG G+FG +  AR++ DG  M+ A+K   +   +   + F  E EV+ ++  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLY---------------SGTCMLDIFQRLNIMI 721
            ++ +C +  +  L ++Y P+G+L + L                S    L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           DVA  ++YL        IH +L   N+L+ E+ VA I+DFG+++   G++    +     
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + +MA E        T  DV+SYG++L E+ +
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA--------RLQDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A        + ++ + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG-----TCMLDI-------- 713
           K I +H+N++ ++ +C+ D    +I+ Y   G+L   L +          DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 714 -FQRL-NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
            F+ L +    +A  +EYL    S   IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFT 814
                      + +MAPE     RV T + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYG 791
             S  +I+ DLKP N+L+D+     ++DFG AK + G      +  TL  T  Y+APE  
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 196
Query: 792 TKGRVCTRGDVYSYGIMLMEM 812
                    D ++ G+++ EM
Sbjct: 197 LSKGYNKAVDWWALGVLIYEM 217

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYG 791
             S  +I+ DLKP N+L+D+     ++DFG AK + G      +  TL  T  Y+APE  
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 211
Query: 792 TKGRVCTRGDVYSYGIMLMEM 812
                    D ++ G+++ EM
Sbjct: 212 LSKGYNKAVDWWALGVLIYEM 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 618 RFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKS-FEDECEVMKRI 670
           RF E   +G   FG +Y   L      +    VA+K    + E  L+  F  E  +  R+
Sbjct: 12  RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 69
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-------------- 716
           +H N+V ++   + D   ++I  Y  +G L   L   +   D+                 
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 717 -LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
            ++++  +A  +EYL   H   ++H DL   NVL+ + +   ISD G+ + +   D   +
Sbjct: 130 FVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +L  I +MAPE    G+     D++SYG++L E+F+
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     IG GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 593 PSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ 651
           PS +  N  QA+ R     +L+ T+ F +  ++G G+FG++Y    + +G +V + V  +
Sbjct: 3   PSGEAPN--QALLR-----ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 54
Query: 652 QYERAL-----KSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
           +   A      K   DE  VM  + + ++ +++  C     + LIM+ MP G L + +  
Sbjct: 55  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE 113
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               +     LN  + +A  + YL       ++H DL   NVL+       I+DFG+AKL
Sbjct: 114 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 170
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIG 825
           L  E++          I +MA E         + DV+SYG+ + E+ T   KP D I   
Sbjct: 171 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 230
Query: 826 ELSLNRWINDLLPVSVMEVIDTNLL 850
           E+S      + LP   +  ID  ++
Sbjct: 231 EISSILEKGERLPQPPICTIDVYMI 255

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + + R +   +V       ++E   +S    F +E ++M       +V++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +  +D +  ++M+YMP G L N L S   + + + R     +V LAL+ +H   S   I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 195
Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-------GT 792
           H D+KP N+LLD+     ++DFG    ++ E  +      + T  Y++PE        G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 254
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
            GR C   D +S G+ L EM     P
Sbjct: 255 YGREC---DWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 624 LIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + + R +   +V       ++E   +S    F +E ++M       +V++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +  +D +  ++M+YMP G L N L S   + + + R     +V LAL+ +H   S   I
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 190
Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-------GT 792
           H D+KP N+LLD+     ++DFG    ++ E  +      + T  Y++PE        G 
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 249
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
            GR C   D +S G+ L EM     P
Sbjct: 250 YGREC---DWWSVGVFLYEMLVGDTP 272

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 115/232 (49%), Gaps = 15/232 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A     G +VAVK    + ++  +   +E  +M+   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   ++M+++  G+L + +      ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++    T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 804 SYGIMLMEMFTKKKPTDEIFIGELSLN--RWINDLLPVSVMEVID-TNLLRG 852
           S GIM++EM   + P    +  E  L   R I D LP  V ++   +++LRG
Sbjct: 226 SLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRG 273

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 625 IGIGSFG--SIYVARLQD---GMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG  S+Y     +   G  VAVK   +     L+S ++ E E+++ + H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +   K+  L+M+Y+P GSL +  Y     + + Q L     +   + YLH  H  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 131
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH  L   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 625 IGIGSFG--SIYVARLQD---GMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG  S+Y     +   G  VAVK   +     L+S ++ E E+++ + H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +   K+  L+M+Y+P GSL +  Y     + + Q L     +   + YLH  H  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 132
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH  L   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 595 NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE 654
            D IN  + +R       ++A D +    +IG G+FG + + R +   +V       ++E
Sbjct: 60  KDTINKIRDLR-------MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE 111
Query: 655 RALKS----FEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM 710
              +S    F +E ++M       +V++  +  +D +  ++M+YMP G L N L S   +
Sbjct: 112 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDV 170
Query: 711 LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
            + + R     +V LAL+ +H   S   IH D+KP N+LLD+     ++DFG    ++ E
Sbjct: 171 PEKWARF-YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 226
Query: 771 DQLSIQIQTLATIGYMAPEY-------GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +      + T  Y++PE        G  GR C   D +S G+ L EM     P
Sbjct: 227 GMVRCDT-AVGTPDYISPEVLKSQGGDGYYGREC---DWWSVGVFLYEMLVGDTP 277

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 204
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 205 SKGYNKAVDWWALGVLIYEM 224

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 623 NLIGIGSFGSIY----VARLQDGMEVAVKVFHQQYERALKSFEDECE--VMKRIRHRNLV 676
            ++G GSFG ++    V R   G   A+KV  +   +       + E  ++  + H  +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+  +   +    LI+ ++  G L   L S   M         + ++AL L++LH   S 
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---SL 149
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            II+ DLKP N+LLDE+    ++DFG++K     D          T+ YMAPE   +   
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGH 207
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
               D +SYG+++ EM T   P
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLP 229

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 40/262 (15%)
Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSI 633
           ++WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +
Sbjct: 14  VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKV 62
Query: 634 YVARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSC 682
             A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGAC 119
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH-------- 734
           ++     +I +Y   G L N L   + +L+      I        + LHF          
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAF 179
Query: 735 --STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S   IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MAPE   
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
Query: 793 KGRVCTRGDVYSYGIMLMEMFT 814
                 + DV+SYGI+L E+F+
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFS 261

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++ G   A KV   + E  L+ +  E E++    H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
           +D    +++++ P G+++        ML++ + L    I +     LE L+F HS  IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 741 CDLKPSNVLLDEDMVAHISDFGIA----KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            DLK  NVL+  +    ++DFG++    K L   D        + T  +MAPE      +
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF------IGTPYWMAPEV----VM 182
Query: 797 CT---------RGDVYSYGIMLMEMFTKKKPTDEI 822
           C          + D++S GI L+EM   + P  E+
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG+AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 19/242 (7%)
Query: 593 PSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVA-RLQDG----MEVAVK 647
           PS    N  Q +R     EL R         ++G G+FG++Y    + +G    + VA+K
Sbjct: 22  PSGTAPNQAQ-LRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIK 73
Query: 648 VFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
           + ++    +A   F DE  +M  + H +LV+++  C +   + L+ + MP+G L   ++ 
Sbjct: 74  ILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE 132
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               +     LN  + +A  + YL       ++H DL   NVL+       I+DFG+A+L
Sbjct: 133 HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 189
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIG 825
           L G+++          I +MA E     +   + DV+SYG+ + E+ T   KP D I   
Sbjct: 190 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 249
Query: 826 EL 827
           E+
Sbjct: 250 EI 251

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 248 IDVYMI 253

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 204
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 205 SKGYNKAVDWWALGVLIYEM 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 247 IDVYMI 252

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++ G   A KV   + E  L+ +  E E++    H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
           +D    +++++ P G+++        ML++ + L    I +     LE L+F HS  IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 741 CDLKPSNVLLDEDMVAHISDFGIA----KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            DLK  NVL+  +    ++DFG++    K L   D        + T  +MAPE      +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF------IGTPYWMAPEVV----M 190
Query: 797 CT---------RGDVYSYGIMLMEMFTKKKPTDEI 822
           C          + D++S GI L+EM   + P  E+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 232
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 233 SKGYNKAVDWWALGVLIYEM 252

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 249 IDVYMI 254

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 246
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 247 IDVYMI 252

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG+AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 625 IGIGSFG--SIYVARLQD---GMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG  S+Y     +   G  VAVK          +S ++ E ++++ + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 679 ISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +    +L  +M+Y+P GSL + L   +  + + Q L     +   + YLH  H  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH DL   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 214 FYYASDVWSFGVTLYELLT 232

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
            LIG G FG +Y  R     EVA+++    +  E  LK+F+ E    ++ RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +C +    A+I       +L + +     +LD+ +   I  ++   + YL   H+  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 741 CDLKPSNVLLDEDMVAHISDFG---IAKLLSG---EDQLSIQIQTLATIGYMAPEY---- 790
            DLK  NV  D   V  I+DFG   I+ +L     ED+L IQ   L    ++APE     
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQL 209
Query: 791 -----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                  K       DV++ G +  E+  ++ P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 622 NNLIGIGSFGSIY----VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLV 676
           + +IG G FG +Y    + + Q+ ++ A+K   +  E + +++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 677 KIIS-SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            +I      +    +++ YM +G L   + S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---E 142
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPEYGTK 793
              +H DL   N +LDE     ++DFG+A+ +   +  S+Q    A   + + A E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            R  T+ DV+S+G++L E+ T+  P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERAL--KSFEDECEVMKR 669
            ++ +++    L+G GS+G +   R +D G  VA+K F +  +  +  K    E +++K+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENC-LYSGTCMLDIFQRLNIMIDVALALE 728
           +RH NLV ++  C       L+ +++ +  L++  L+       + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            + F HS  IIH D+KP N+L+ +  V  + DFG A+ L+   +  +    +AT  Y AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193
Query: 789 E-------YGTKGRVCTRGDVYSYGIMLMEMF 813
           E       YG         DV++ G ++ EMF
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMF 219

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 625 IGIGSFG--SIYVARLQD---GMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG  S+Y     +   G  VAVK          +S ++ E ++++ + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 679 ISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +   K+L  +M+Y+P GSL + L   +  + + Q L     +   + YLH  H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH +L   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV----AVKVFHQQYERALKSFEDECE--VMKRIRHRNLV 676
            ++G GSFG +++ +   G +     A+KV  +   +       + E  ++  + H  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+  +   +    LI+ ++  G L   L S   M         + ++ALAL++LH   S 
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---SL 146
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            II+ DLKP N+LLDE+    ++DFG++K     D          T+ YMAPE   +   
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
               D +S+G+++ EM T   P
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLP 226

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 625 IGIGSFG--SIYVARLQD---GMEVAVKVFHQQYERALKS-FEDECEVMKRIRHRNLVKI 678
           +G G FG  S+Y     +   G  VAVK          +S ++ E ++++ + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 679 ISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +   K+L  +M+Y+P GSL + L   +  + + Q L     +   + YLH  H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQH-- 137
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH +L   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV----AVKVFHQQYERALKSFEDECE--VMKRIRHRNLV 676
            ++G GSFG +++ +   G +     A+KV  +   +       + E  ++  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+  +   +    LI+ ++  G L   L S   M         + ++ALAL++LH   S 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---SL 145
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            II+ DLKP N+LLDE+    ++DFG++K     D          T+ YMAPE   +   
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 797 CTRGDVYSYGIMLMEMFT 814
               D +S+G+++ EM T
Sbjct: 204 TQSADWWSFGVLMFEMLT 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV----AVKVFHQQYERALKSFEDECE--VMKRIRHRNLV 676
            ++G GSFG +++ +   G +     A+KV  +   +       + E  ++  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+  +   +    LI+ ++  G L   L S   M         + ++ALAL++LH   S 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---SL 145
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            II+ DLKP N+LLDE+    ++DFG++K     D          T+ YMAPE   +   
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
               D +S+G+++ EM T   P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLP 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 11/212 (5%)
Query: 623 NLIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLV 676
            ++G G+FG++Y    + +G    + VA+K+ ++    +A   F DE  +M  + H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +++  C +   + L+ + MP+G L   ++     +     LN  + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            ++H DL   NVL+       I+DFG+A+LL G+++          I +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 797 CTRGDVYSYGIMLMEMFT-KKKPTDEIFIGEL 827
             + DV+SYG+ + E+ T   KP D I   E+
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G GS+GS+Y A   + G  VA+K      E  L+    E  +M++    ++VK   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
            +    ++M+Y   GS+ + +      L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDV 802
           K  N+LL+ +  A ++DFG+A  L+  D ++ +   + T  +MAPE   + G  C   D+
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCV-ADI 208
Query: 803 YSYGIMLMEMFTKKKPTDEI 822
           +S GI  +EM   K P  +I
Sbjct: 209 WSLGITAIEMAEGKPPYADI 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 248 IDVYMI 253

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 248 IDVYMI 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 130
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E     ++ T   +  Y APE +  K      
Sbjct: 131 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 800 GDVYSYGIMLMEMFTKKKPTD 820
            DV+S G++L  + +   P D
Sbjct: 187 VDVWSLGVILYTLVSGSLPFD 207

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 133 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 249
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 250 IDVYMI 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 180
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 182
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E     ++ T   +  Y APE +  K      
Sbjct: 138 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            DV+S G++L  + +   P D   + EL
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L K+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEM 178
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E     ++ T   +  Y APE +  K      
Sbjct: 138 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            DV+S G++L  + +   P D   + EL
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKI 678
            +IG G+FG + + R +   +V       ++E   +S    F +E ++M       +V++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  +D +  ++M+YMP G L N L S   + + + +     +V LAL+ +H   S  +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGL 195
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-------G 791
           IH D+KP N+LLD+     ++DFG    +     +      + T  Y++PE        G
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVGTPDYISPEVLKSQGGDG 254
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             GR C   D +S G+ L EM     P
Sbjct: 255 YYGREC---DWWSVGVFLFEMLVGDTP 278

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAV++    Q    +L+    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGRVCTRG 800
           DLK  N+LLD DM   I+DFG +   +  ++L    +   +  Y APE +  K       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLD---EFCGSPPYAAPELFQGKKYDGPEV 194
Query: 801 DVYSYGIMLMEMFTKKKPTDEIFIGEL 827
           DV+S G++L  + +   P D   + EL
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 253 IDVYMI 258

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 37/230 (16%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR    F E  ++G G+FG +  AR   D    A+K      E+ L +   E  ++  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 672 H-------------RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQR 716
           H             RN VK +++        + M+Y  NG+L + ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSI 775
           L   I     LE L + HS  IIH DLKP N+ +DE     I DFG+AK +    D L +
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 776 QIQTL-----------ATIGYMAPEY--GTKGRVCTRGDVYSYGIMLMEM 812
             Q L            T  Y+A E   GT G    + D+YS GI+  EM
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEM 224

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+DE     ++DFG AK + G            T  Y+APE   
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 198
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 199 SKGYNKAVDWWALGVLIYEM 218

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 248 IDVYMI 253

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 135 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 251
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 252 IDVYMI 257

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALK-SFEDECEVMKRI- 670
           AT R+     IG+G++G++Y AR    G  VA+K V     E  L  S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 671 --RHRNLVKIISSCS-----------------NDDFKALIMKYMPNGSLENCLYSGTCML 711
              H N+V+++  C+                 + D +  + K  P G           + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG------LPAETIK 115
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           D+ ++          L  L F H+  I+H DLKP N+L+       ++DFG+A++ S + 
Sbjct: 116 DLMRQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 166
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            L+     + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 167 ALA---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 42/261 (16%)
Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSI 633
           ++WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +
Sbjct: 6   VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKV 54
Query: 634 YVARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSC 682
             A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C
Sbjct: 55  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGAC 111
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCM---------LDIFQRLNIMIDVALALEYLHFG 733
           ++     +I +Y   G L N L               L++   L+    VA  + +L   
Sbjct: 112 THGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-- 169
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
            S   IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MAPE    
Sbjct: 170 -SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 228
Query: 794 GRVCTRGDVYSYGIMLMEMFT 814
                + DV+SYGI+L E+F+
Sbjct: 229 CVYTVQSDVWSYGILLWEIFS 249

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 150
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG--IAKLLSGEDQLSIQIQTLATIGYMAP 788
           H   S  +IH D+KP N+LL       I+DFG  +    S  D L        T+ Y+ P
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL------CGTLDYLPP 201
Query: 789 EYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           E   +GR+   + D++S G++  E    K P
Sbjct: 202 EM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 249 IDVYMI 254

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 249 IDVYMI 254

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++  G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LIM+ MP G L + +      +     LN  + +A 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 253 IDVYMI 258

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 248
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 249 IDVYMI 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 623 NLIGIGSFGSIYVARL--QDG--MEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLV 676
            ++G G FGS+    L  +DG  ++VAVK        +R ++ F  E   MK   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 677 KIISSCSNDDFKAL-----IMKYMPNGSLEN-CLYS----GTCMLDIFQRLNIMIDVALA 726
           +++  C     + +     I+ +M  G L    LYS    G   + +   L  M+D+AL 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGY 785
           +EYL    +   +H DL   N +L +DM   ++DFG++ K+ SG+     +I  +  + +
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-VKW 215
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
           +A E        ++ DV+++G+ + E+ T+
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 154 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 270
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 271 IDVYMI 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGRVCTRG 800
           DLK  N+LLD DM   I+DFG +   +  ++L           Y APE +  K       
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEV 194
Query: 801 DVYSYGIMLMEMFTKKKPTDEIFIGEL 827
           DV+S G++L  + +   P D   + EL
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L K+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSI-----YVARLQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR 671
           R+++   IG G++G +     +V + +  ++      HQ Y +R L+    E +++ R R
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFR 99
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA--LEY 729
           H N++ I         +A+   Y+    +E  LY    +L   Q  N  I   L   L  
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILRG 156
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           L + HS  ++H DLKPSN+L++      I DFG+A++   E D      + +AT  Y AP
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 625 IGIGSFGSIY--VARL-QDGMEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLVKIIS 680
           +G G+FGS+   V R+ +  ++VA+KV  Q  E+A  +    E ++M ++ +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            C  +    L+M+    G L   L      + +     ++  V++ ++YL        +H
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTR 799
            DL   NVLL     A ISDFG++K L  +D   + +      + + APE     +  +R
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 800 GDVYSYGIMLMEMFT-KKKP 818
            DV+SYG+ + E  +  +KP
Sbjct: 194 SDVWSYGVTMWEALSYGQKP 213

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG +  V  ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L K+  S  ++    ++M+Y P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVA+K+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    LIM+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E  +  ++ T   +  Y APE +  K      
Sbjct: 136 DLKAENLLLDADMNIKIADFG----FSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 800 GDVYSYGIMLMEMFTKKKPTD 820
            DV+S G++L  + +   P D
Sbjct: 192 VDVWSLGVILYTLVSGSLPFD 212

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 613 LRATDRFSENNLIGIGSFG-SIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
            ++ +++     IG GSFG +I V   +DG +  +K  +  +   +  +    E  V+  
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALA 726
           ++H N+V+   S   +    ++M Y   G L   + +   +L  FQ    L+  + + LA
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLA 137
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           L+++H      I+H D+K  N+ L +D    + DFGIA++L+   +L+     + T  Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYL 192
Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           +PE         + D+++ G +L E+ T K
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 19/265 (7%)
Query: 593 PSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ 651
           PS +  N  QA+ R     +L+ T+ F +  ++G G+FG++Y    + +G +V + V   
Sbjct: 33  PSGEAPN--QALLR-----ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIM 84
Query: 652 QYERAL-----KSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
           +   A      K   DE  VM  + + ++ +++  C     + LI + MP G L + +  
Sbjct: 85  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE 143
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               +     LN  + +A  + YL       ++H DL   NVL+       I+DFG+AKL
Sbjct: 144 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 200
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIG 825
           L  E++          I +MA E         + DV+SYG+ + E+ T   KP D I   
Sbjct: 201 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 260
Query: 826 ELSLNRWINDLLPVSVMEVIDTNLL 850
           E+S      + LP   +  ID  ++
Sbjct: 261 EISSILEKGERLPQPPICTIDVYMI 285

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 232
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 233 SKGYNKAVDWWALGVLIYEM 252

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 139 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 255
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 256 IDVYMI 261

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 173
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 174 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 225
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 226 YRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 272

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPEYG 791
             S  +I+ DLKP N+L+D+     ++DFG AK + G      +   LA T  Y+APE  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEII 210
Query: 792 TKGRVCTRGDVYSYGIMLMEM 812
                    D ++ G+++ EM
Sbjct: 211 LSKGYNKAVDWWALGVLIYEM 231

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALK-SFEDECEVMKRI- 670
           AT R+     IG+G++G++Y AR    G  VA+K V     E  L  S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 671 --RHRNLVKIISSCS-----------------NDDFKALIMKYMPNGSLENCLYSGTCML 711
              H N+V+++  C+                 + D +  + K  P G           + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG------LPAETIK 115
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           D+ ++          L  L F H+  I+H DLKP N+L+       ++DFG+A++ S + 
Sbjct: 116 DLMRQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 166
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            L      + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 167 AL---FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H  +   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E  +  ++ T   +  Y APE +  K      
Sbjct: 139 DLKAENLLLDGDMNIKIADFG----FSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            DV+S G++L  + +   P D   + EL
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAV++    Q    +L+    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+M+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-YGTKGRVCTR 799
           DLK  N+LLD DM   I+DFG     S E     ++ T   +  Y APE +  K      
Sbjct: 138 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            DV+S G++L  + +   P D   + EL
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 206
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 207 SKGYNKAVDWWALGVLIYEM 226

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALK-SFEDECEVMKRI- 670
           AT R+     IG+G++G++Y AR    G  VA+K V     E  L  S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 671 --RHRNLVKIISSCS-----------------NDDFKALIMKYMPNGSLENCLYSGTCML 711
              H N+V+++  C+                 + D +  + K  P G           + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG------LPAETIK 115
Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           D+ ++          L  L F H+  I+H DLKP N+L+       ++DFG+A++ S + 
Sbjct: 116 DLMRQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 166
Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            L      + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 167 ALD---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 140
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 141 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 192
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 193 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQP----IFPGDSGVDQLVE 239

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 171
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 172 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 223
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 224 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S + +   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 169
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 221
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 222 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 169
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 221
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 222 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +AR +  G +VAVK+   + ++  +   +E  +M+  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             +   ++M+++  G+L + +      L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S +  +  +   + T  +MAPE  ++    T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 804 SYGIMLMEMFTKKKP 818
           S GIM++EM   + P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDEC 664
           Y + +   + F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E 
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEI 76
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            V+ +     + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++ 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 134
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             L+YLH   S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-----DTQIKRNTFVG 186
Query: 785 ---YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
              +MAPE   +    ++ D++S GI  +E+   + P  E+
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 42/261 (16%)
Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSI 633
           ++WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +
Sbjct: 14  VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKV 62
Query: 634 YVARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSC 682
             A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGAC 119
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCM---------LDIFQRLNIMIDVALALEYLHFG 733
           ++     +I +Y   G L N L               L++   L+    VA  + +L   
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-- 177
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
            S   IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MAPE    
Sbjct: 178 -SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 236
Query: 794 GRVCTRGDVYSYGIMLMEMFT 814
                + DV+SYGI+L E+F+
Sbjct: 237 CVYTVQSDVWSYGILLWEIFS 257

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 126 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 242
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 243 IDVYMI 248

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 12/224 (5%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELS 828
           MA E         + DV+SYG+ + E+ T   KP D I   E+S
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 163
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 164 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 215
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 216 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 262

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 214
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 215 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 266
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 267 YRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 313

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF--QRLNIMI-DVALAL 727
           RH N++++     +     LI++Y P G +    Y     L  F  QR    I ++A AL
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANAL 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
            Y H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 788 PEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           PE   +GR+   + D++S G++  E    K P
Sbjct: 180 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 84
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 143
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 144 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 195
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 196 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 242

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF--QRLNIMI-DVALAL 727
           RH N++++     +     LI++Y P G +    Y     L  F  QR    I ++A AL
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANAL 126
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
            Y H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLP 179
Query: 788 PEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           PE   +GR+   + D++S G++  E    K P
Sbjct: 180 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G        +T    G   PEY  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--------RTWXLCG--TPEYLA 206
Query: 793 KGRVCTRG-----DVYSYGIMLMEM 812
              + ++G     D ++ G+++ EM
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 95
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 154
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 155 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 206
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 207 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 253

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 147
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 148 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 199
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 200 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 89
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 148
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 149 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 200
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 201 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 247

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 147
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 148 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 199
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 200 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKR--IRHRNLVKIIS 680
            LIG G +G++Y   L D   VAVKVF        ++F +E  + +   + H N+ + I 
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFI- 73
Query: 681 SCSNDDFKA-------LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF- 732
              ++   A       L+M+Y PNGSL   L   T   D      +   V   L YLH  
Sbjct: 74  -VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTE 130
Query: 733 ----GHSTPII-HCDLKPSNVLLDEDMVAHISDFGIAKLLSGE------DQLSIQIQTLA 781
                H  P I H DL   NVL+  D    ISDFG++  L+G       ++ +  I  + 
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 782 TIGYMAPEYGTKGRVCTRG--------DVYSYGIMLMEMFTKKKPTDEIFIGE 826
           TI YMAPE   +G V  R         D+Y+ G++  E+F +     ++F GE
Sbjct: 191 TIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  + + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++++Y P G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 77
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 136
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 137 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 188
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 189 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 235

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVK-VFHQQYERALKSFEDECEVMKRIRHRN 674
           D +   +++G G+F  + +A  +   + VA+K +  +  E    S E+E  V+ +I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSL-----ENCLYSG-TCMLDIFQRLNIMIDVALALE 728
           +V +     +     LIM+ +  G L     E   Y+       IFQ L+       A++
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVK 130
Query: 729 YLHFGHSTPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H   I+H DLKP N+L   LDED    ISDFG++K+   ED  S+      T GY
Sbjct: 131 YL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE   +       D +S G++
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVARL--QDG--MEVAVKVFHQQY--ERALKSFEDE 663
            ++L    +F+   ++G G FGS+  A+L  +DG  ++VAVK+          ++ F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKA------LIMKYMPNGSLENCLYSGTCMLDIFQR- 716
              MK   H ++ K++        K       +I+ +M +G L   L +     + F   
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 717 ----LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
               +  M+D+A  +EYL    S   IH DL   N +L EDM   ++DFG+++ +   D 
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
                 +   + ++A E           DV+++G+ + E+ T+
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYG 791
             S  +I+ DLKP N+L+D+     ++DFG AK + G         TL  T  Y+APE  
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEII 231
Query: 792 TKGRVCTRGDVYSYGIMLMEM 812
                    D ++ G+++ EM
Sbjct: 232 LSKGYNKAVDWWALGVLIYEM 252

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVA+K+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    LIM+Y   G + + L +   M +   R      +  A++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPE-YGTKGRVC 797
           DLK  N+LLD DM   I+DFG +      ++ ++  +  A  G   Y APE +  K    
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 798 TRGDVYSYGIMLMEMFTKKKPTD 820
              DV+S G++L  + +   P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 253 IDVYMI 258

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR ++   + A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 118/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K+F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 118/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K+F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQP----IFPGDSGVDQLVE 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 247
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 248 IDVYMI 253

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 623 NLIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLV 676
            ++G G FG+++    + +G    + V +KV   +  R + ++  D    +  + H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +++  C     + L+ +Y+P GSL + +      L     LN  + +A  + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            ++H +L   NVLL       ++DFG+A LL  +D+  +  +    I +MA E    G+ 
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 797 CTRGDVYSYGIMLMEMFT 814
             + DV+SYG+ + E+ T
Sbjct: 213 THQSDVWSYGVTVWELMT 230

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 623 NLIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLV 676
            ++G G FG+++    + +G    + V +KV   +  R + ++  D    +  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +++  C     + L+ +Y+P GSL + +      L     LN  + +A  + YL      
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            ++H +L   NVLL       ++DFG+A LL  +D+  +  +    I +MA E    G+ 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 797 CTRGDVYSYGIMLMEMFT 814
             + DV+SYG+ + E+ T
Sbjct: 195 THQSDVWSYGVTVWELMT 212

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++  +  A KV   + E  L+ +  E +++    H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
            ++   +++++   G+++        ML++ + L    I +     L+ L++ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPEY----GTKG 794
            DLK  N+L   D    ++DFG+    S ++  +IQ +   + T  +MAPE      +K 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 795 RVCT-RGDVYSYGIMLMEMFTKKKPTDEI 822
           R    + DV+S GI L+EM   + P  E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 139
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 140 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 191
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 192 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 125
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 118/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K+F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 35/232 (15%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERALKSFED-ECEVMKRIRHRNLV 676
           +++  +IG GSFG +Y A+L D  E VA+K   Q      K F++ E ++M+++ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 677 KI----ISSCSNDD--FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALAL 727
           ++     SS    D  +  L++ Y+P        +   +   +  I+ +L  M  +  +L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSL 135
Query: 728 EYLH-FGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAK-LLSGEDQLSIQIQTLATIG 784
            Y+H FG    I H D+KP N+LLD D  V  + DFG AK L+ GE  +S     + +  
Sbjct: 136 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 187
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           Y APE  +G      +  DV+S G +L E+   +     IF G+  +++ + 
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 128
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 141
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 195 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 123
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 176
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 177 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++G G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 180
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 126
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 179
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG GS+G    + R  DG  +  K   +    E   +    E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 682 CSNDDFKAL--IMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHF---- 732
             +     L  +M+Y   G L + +  GT     LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
           GH+  ++H DLKP+NV LD      + DFG+A++L+ ++  + +   + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF--VGTPYYMSPEQMN 189
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +     + D++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG--IAKLLSGEDQLSIQIQTLATIGYMAP 788
           H   S  +IH D+KP N+LL       I+DFG  +    S  D L        T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPP 178
Query: 789 EYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           E   +GR+   + D++S G++  E    K P
Sbjct: 179 EM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+++D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIII 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 124
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 619 FSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ +     
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYG 791
           S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE  
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVI 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            +    ++ D++S GI  +E+   + P  E+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED--- 662
           F  H     +DR+    ++G GSFG + + + +  G E AVKV  +   R +K   D   
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKES 95
Query: 663 ---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
              E +++K++ H N++K+     +  +  L+ +    G L + + S       F  ++ 
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDA 151
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQ 776
              +   L  + + H   I+H DLKP N+LL+   +D    I DFG++       ++  +
Sbjct: 152 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 777 IQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIML 809
           I    T  Y+APE  +GT    C   DV+S G++L
Sbjct: 212 I---GTAYYIAPEVLHGTYDEKC---DVWSTGVIL 240

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 125
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG--IAKLLSGEDQLSIQIQTLATIGYMAP 788
           H   S  +IH D+KP N+LL       I+DFG  +    S  D L        T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC------GTLDYLPP 176
Query: 789 EYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           E   +GR+   + D++S G++  E    K P
Sbjct: 177 EM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED--- 662
           F  H     +DR+    ++G GSFG + + + +  G E AVKV  +   R +K   D   
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKES 96
Query: 663 ---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
              E +++K++ H N++K+     +  +  L+ +    G L + + S     ++     I
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARI 155
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQ 776
           +  V   + Y+H      I+H DLKP N+LL+   +D    I DFG++       ++  +
Sbjct: 156 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 777 IQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIML 809
           I    T  Y+APE  +GT    C   DV+S G++L
Sbjct: 213 I---GTAYYIAPEVLHGTYDEKC---DVWSTGVIL 241

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 619 FSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ +     
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 136
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYG 791
           S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE  
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-----DTQIKRNXFVGTPFWMAPEVI 191
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            +    ++ D++S GI  +E+   + P  E+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 623 NLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRI-RHRN 674
            ++G G+FG +       +++    ++VAVK+  ++ + + + +   E ++M ++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCL-------------YSGTCMLDIFQRLNIM- 720
           +V ++ +C+      LI +Y   G L N L             Y     L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 721 --------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
                     VA  +E+L F      +H DL   NVL+    V  I DFG+A+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             ++      + +MAPE   +G    + DV+SYGI+L E+F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDG-MEVAVKV-FHQQYER--ALKSFEDECEVMKRIRH 672
           D F     +G G FG++Y+AR +     VA+KV F  Q E+         E E+   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++ +   +     LI++Y P G L   L   +C  D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH- 140
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYG 791
                +IH D+KP N+LL       I+DFG +         S++ +T+  T+ Y+ PE  
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP-----SLRRKTMCGTLDYLPPEM- 192
Query: 792 TKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
            +GR+   + D++  G++  E+     P
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           F E  LIG G FG ++ A+ + DG    +K      E+A    E E + + ++ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY-------SGTCMLDIFQRLNIMIDVALALEYL 730
                   D+         + S   CL+        GT    I +R    +D  LALE  
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 731 H-------FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
                   + HS  +I+ DLKPSN+ L +     I DFG+   L  + +   + ++  T+
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSKGTL 185
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
            YM+PE  +        D+Y+ G++L E+ 
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 121
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 174
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 175 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++  +  A KV   + E  L+ +  E +++    H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
            ++   +++++   G+++        ML++ + L    I +     L+ L++ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPEY----GTKG 794
            DLK  N+L   D    ++DFG+    S ++   IQ +   + T  +MAPE      +K 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 795 RVCT-RGDVYSYGIMLMEMFTKKKPTDEI 822
           R    + DV+S GI L+EM   + P  E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG +Y A+ ++  +  A KV   + E  L+ +  E +++    H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMIDVALALEYLHFGHSTPIIH 740
            ++   +++++   G+++        ML++ + L    I +     L+ L++ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPEY----GTKG 794
            DLK  N+L   D    ++DFG+    S ++   IQ +   + T  +MAPE      +K 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 795 RVCT-RGDVYSYGIMLMEMFTKKKPTDEI 822
           R    + DV+S GI L+EM   + P  E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMK 668
           L   + F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           +     + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++   L+
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLD 118
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---Y 785
           YLH   S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +
Sbjct: 119 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-----DTQIKRNXFVGTPFW 170
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
           MAPE   +    ++ D++S GI  +E+   + P  E+
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED--- 662
           F  H     +DR+    ++G GSFG + + + +  G E AVKV  +   R +K   D   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKES 72
Query: 663 ---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
              E +++K++ H N++K+     +  +  L+ +    G L + + S       F  ++ 
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDA 128
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQ 776
              +   L  + + H   I+H DLKP N+LL+   +D    I DFG++       ++  +
Sbjct: 129 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 777 IQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIML 809
           I    T  Y+APE  +GT    C   DV+S G++L
Sbjct: 189 I---GTAYYIAPEVLHGTYDEKC---DVWSTGVIL 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCML---------DIFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    +          + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCML---------DIFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    +          + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++  G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 252
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 253 IDVYMI 258

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 601 PQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGME-VAVK-VFHQQYERALK 658
           P A+    + +     D +   +++G G+F  + +A  +   + VA+K +  +  E    
Sbjct: 2   PGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG 61
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL-----ENCLYSGTCMLD- 712
           S E+E  V+ +I+H N+V +     +     LIM+ +  G L     E   Y+       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSG 769
           IFQ L+       A++YL   H   I+H DLKP N+L   LDED    ISDFG++K+   
Sbjct: 122 IFQVLD-------AVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--- 168
Query: 770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM 808
           ED  S+      T GY+APE   +       D +S G++
Sbjct: 169 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 44/228 (19%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALK-----SFEDECEVMK 668
           AT R+     IG+G++G++Y AR    G  VA+K                S   E  +++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 669 RIR---HRNLVKIISSCS-----------------NDDFKALIMKYMPNGSLENCLYSGT 708
           R+    H N+V+++  C+                 + D +  + K  P G          
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG------LPAE 120
Query: 709 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
            + D+ ++          L  L F H+  I+H DLKP N+L+       ++DFG+A++ S
Sbjct: 121 TIKDLMRQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            +  L+     + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 172 YQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 129
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I+DFG     S     S +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEX 182
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR    + D++S G++  E    K P
Sbjct: 183 -IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ +M
Sbjct: 212 SKGYNKAVDWWALGVLIYQM 231

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 34/231 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED-ECEVMKRIRHRNLVK 677
           ++   +IG GSFG ++ A+L +  EVA+K   Q      K F++ E ++M+ ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 678 IIS-SCSNDD-----FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA----L 727
           + +   SN D     F  L+++Y+P       +Y  +      ++   M+ + L     L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAK-LLSGEDQLSIQIQTLATIGY 785
             L + HS  I H D+KP N+LLD    V  + DFG AK L++GE  +S     + +  Y
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----XICSRYY 207
Query: 786 MAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            APE  +G      T  D++S G ++ E+   +     +F GE  +++ + 
Sbjct: 208 RAPELIFGATN-YTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLVE 253

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 45/226 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+K+  +         + + AL 
Sbjct: 4   YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL- 60
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 120 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 168
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIML 809
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L
Sbjct: 169 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVIL 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 625 IGIGSFGSIY--VARLQDG-MEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRNLVKIIS 680
           +G G+FGS+   V R++   ++VA+KV  Q  E+A  +    E ++M ++ +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            C  +    L+M+    G L   L      + +     ++  V++ ++YL        +H
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 459
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTR 799
            +L   NVLL     A ISDFG++K L  +D   + +      + + APE     +  +R
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 800 GDVYSYGIMLMEMFT 814
            DV+SYG+ + E  +
Sbjct: 520 SDVWSYGVTMWEALS 534

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED--- 662
           F  H     +DR+    ++G GSFG + + + +  G E AVKV  ++  +     E    
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 81
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E +++K++ H N++K+     +  +  L+ +    G L + + S       F  ++    
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARI 137
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           +   L  + + H   I+H DLKP N+LL+   +D    I DFG++       ++  +I  
Sbjct: 138 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 195
Query: 780 LATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             T  Y+APE  +GT    C   DV+S G++L  + +   P
Sbjct: 196 -GTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLSGCPP 232

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL-----KSFEDECE 665
           +L+ T+ F +  ++  G+FG++Y    + +G +V + V  ++   A      K   DE  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I +
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           MA E         + DV+SYG+ + E+ T   KP D I   E+S      + LP   +  
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 845 IDTNLL 850
           ID  ++
Sbjct: 246 IDVYMI 251

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 45/226 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+K+  +         + + AL 
Sbjct: 4   YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL- 60
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 120 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 168
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIML 809
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L
Sbjct: 169 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVIL 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 114/227 (50%), Gaps = 45/227 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+K+  +         + + AL 
Sbjct: 3   YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL- 59
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 118
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 119 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 167
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIMLM 810
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L 
Sbjct: 168 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 619 FSENNLIGIGSFGSIYVA---RLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           F++   IG GSFG ++     R Q    VA+K+   ++ E  ++  + E  V+ +     
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           + K   S        +IM+Y+  GS  + L +G    D FQ   ++ ++   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH--- 137
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPEYG 791
           S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   +MAPE  
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----DTQIKRNTFVGTPFWMAPEVI 192
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            +    ++ D++S GI  +E+   + P  ++
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 615 ATDRFSENNLIGIGSFGSIY------VARLQDGMEVAVKVFHQQYE-RALKSFEDECEVM 667
           A ++ + +  +G GSFG +Y      V + +    VA+K  ++    R    F +E  VM
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD---------IFQRLN 718
           K     ++V+++   S      +IM+ M  G L++ L S    ++         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +  ++A  + YL+   +   +H DL   N  + ED    I DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            L  + +M+PE    G   T  DV+S+G++L E+ T
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR    F E  ++G G+FG +  AR   D    A+K      E+ L +   E  ++  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 672 H-------------RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQR 716
           H             RN VK +++        + M+Y  N +L + ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSI 775
           L   I     LE L + HS  IIH DLKP N+ +DE     I DFG+AK +    D L +
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 776 QIQTL-----------ATIGYMAPEY--GTKGRVCTRGDVYSYGIMLMEM 812
             Q L            T  Y+A E   GT G    + D+YS GI+  EM
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEM 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 45/226 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+K+  +         + + AL 
Sbjct: 4   YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL- 60
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 120 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 168
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIML 809
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L
Sbjct: 169 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVIL 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 45/226 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+K+  +         + + AL 
Sbjct: 10  YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL- 66
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 125
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 126 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 174
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIML 809
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L
Sbjct: 175 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVIL 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 623 NLIGIGSFGSIYVA-RLQDG----MEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLV 676
            ++G G+FG++Y    + DG    + VA+KV  +    +A K   DE  VM  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +++  C     + L+ + MP G L + +      L     LN  + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            ++H DL   NVL+       I+DFG+A+LL  ++           I +MA E   + R 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 797 CTRGDVYSYGIMLMEMFT-KKKPTDEIFIGEL 827
             + DV+SYG+ + E+ T   KP D I   E+
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 618 RFSENNLIGIGSFGSIYVARLQDGMEVA----VKVFHQQYER------ALKSFEDECEVM 667
           R+ + + +G G F ++Y AR ++  ++     +K+ H+   +      AL+    E +++
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR----EIKLL 66
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           + + H N++ ++ +  +    +L+  +M    LE  +   + +L        M+     L
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           EYLH      I+H DLKP+N+LLDE+ V  ++DFG+AK     ++       + T  Y A
Sbjct: 126 EYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYXHQVVTRWYRA 180
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTK 815
           PE     R+   G D+++ G +L E+  +
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   + Y E+    F  E  ++ +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED--- 662
           F  H     +DR+    ++G GSFG + + + +  G E AVKV  +   R +K   D   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKES 72
Query: 663 ---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
              E +++K++ H N+ K+     +  +  L+ +    G L + + S       F  ++ 
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDA 128
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQ 776
              +   L  + + H   I+H DLKP N+LL+   +D    I DFG++       +   +
Sbjct: 129 ARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK 188
Query: 777 IQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIML 809
           I    T  Y+APE  +GT    C   DV+S G++L
Sbjct: 189 I---GTAYYIAPEVLHGTYDEKC---DVWSTGVIL 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 623 NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVM-------KRIRHRN 674
            +IG GSFG + +AR + + +  AVKV  +   +A+   ++E  +M       K ++H  
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           LV +  S    D    ++ Y+  G L   L    C L+   R     ++A AL YLH   
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH--- 156
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  I++ DLKP N+LLD      ++DFG+ K     +  S       T  Y+APE   K 
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 795 RVCTRGDVYSYGIMLMEM 812
                 D +  G +L EM
Sbjct: 215 PYDRTVDWWCLGAVLYEM 232

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 606 RFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGME-VAVK-VFHQQYERALKSFEDE 663
           R+   E +R  D +   +++G G+F  + +A  +   + VA+K +  +  E    S E+E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL-----ENCLYSGTCMLD-IFQRL 717
             V+ +I+H N+V +     +     LIM+ +  G L     E   Y+       IFQ L
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSGEDQLS 774
           +       A++YL   H   I+H DLKP N+L   LDED    ISDFG++K+   ED  S
Sbjct: 127 D-------AVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM 808
           +      T GY+APE   +       D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRIRHRNLVKIIS 680
           +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              +     LI++Y P G++   L       D  +    + ++A AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQK-LSRFDEQRTATYITELANALSYCH---SKRVIH 135
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC-TR 799
            D+KP N+LL  +    I+DFG     S     S +     T+ Y+ PE   +GR+   +
Sbjct: 136 RDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM-IEGRMHDEK 190
Query: 800 GDVYSYGIMLMEMFTKKKP 818
            D++S G++  E      P
Sbjct: 191 VDLWSLGVLCYEFLVGMPP 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERA-LKSFEDECEVMKRIRHRN 674
           D F     +G G+FG ++ V     G+E  +K  ++   +  ++  E E EV+K + H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLH 731
           ++KI     +     ++M+    G L   + S               +M  +  AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             H   ++H DLKP N+L  +D   H    I DFG+A+L   ++  +       T  YMA
Sbjct: 142 SQH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHST---NAAGTALYMA 194
Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           PE   K  V  + D++S G+++  + T
Sbjct: 195 PEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 25/256 (9%)
Query: 597 GINSPQAIRRFSYHELLRAT---------DRFSENNLI--GIGSFGSIYVARLQD-GMEV 644
           G  SPQ   +   HE  RA           R   +N I  G GS G + +A ++  G  V
Sbjct: 120 GPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLV 179
Query: 645 AVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           AVK    + ++  +   +E  +M+  +H N+V++ +S    D   ++M+++  G+L + +
Sbjct: 180 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 239
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
                 ++  Q   + + V  AL  LH   +  +IH D+K  ++LL  D    +SDFG  
Sbjct: 240 TH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFI 824
             +S E  +  +   + T  +MAPE  ++       D++S GIM++EM   + P    + 
Sbjct: 295 AQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP----YF 348
Query: 825 GELSLN--RWINDLLP 838
            E  L   + I D LP
Sbjct: 349 NEPPLKAMKMIRDNLP 364

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 606 RFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGME-VAVK-VFHQQYERALKSFEDE 663
           R+   E +R  D +   +++G G+F  + +A  +   + VA+K +  +  E    S E+E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL-----ENCLYSGTCMLD-IFQRL 717
             V+ +I+H N+V +     +     LIM+ +  G L     E   Y+       IFQ L
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSGEDQLS 774
           +       A++YL   H   I+H DLKP N+L   LDED    ISDFG++K+   ED  S
Sbjct: 127 D-------AVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM 808
           +      T GY+APE   +       D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 126
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I++FG     S     S +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 179
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRI 670
           A + F     +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           RH N++++     +     LI++Y P G++   L       D  +    + ++A AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYC 127
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   S  +IH D+KP N+LL       I++FG     S     S +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 791 GTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
             +GR+   + D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYERA--LKSFEDECEVMKRIRHRNLVKIIS 680
           +G G FG++Y+AR  Q    +A+KV F  Q E+A        E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              +     LI++Y P G++   L       D  +    + ++A AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQK-LSRFDEQRTATYITELANALSYCH---SKRVIH 135
Query: 741 CDLKPSNVLLDEDMVAHISDFG--IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC- 797
            D+KP N+LL  +    I+DFG  +    S  D L        T+ Y+ PE   +GR+  
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEM-IEGRMHD 188
Query: 798 TRGDVYSYGIMLMEMFTKKKP 818
            + D++S G++  E      P
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPP 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 12/225 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG++  L  E    +  + + T  YM+PE    
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
                + D++S G+ L+EM   + P   + I EL L+  +N+  P
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPP 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-- 729
           H N++ I     ND  +A  ++ M +  L   L  G  +  + +  ++  D      Y  
Sbjct: 100 HENIIGI-----NDIIRAPTIEQMKDVYLVTHL-MGADLYKLLKTQHLSNDHICYFLYQI 153
Query: 730 ---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGY 785
              L + HS  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 786 MAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
            APE     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 19/234 (8%)
Query: 597 GINSPQAIRRFSYHELLRAT---------DRFSENNLI--GIGSFGSIYVARLQD-GMEV 644
           G  SPQ   +   HE  RA           R   +N I  G GS G + +A ++  G  V
Sbjct: 43  GPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLV 102
Query: 645 AVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           AVK    + ++  +   +E  +M+  +H N+V++ +S    D   ++M+++  G+L + +
Sbjct: 103 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 162
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
                 ++  Q   + + V  AL  LH   +  +IH D+K  ++LL  D    +SDFG  
Sbjct: 163 TH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +S E  +  +   + T  +MAPE  ++       D++S GIM++EM   + P
Sbjct: 218 AQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG GS+G    + R  DG  +  K   +    E   +    E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 682 CSNDDFKAL--IMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHF---- 732
             +     L  +M+Y   G L + +  GT     LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
           GH+  ++H DLKP+NV LD      + DFG+A++L+ +   +     + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGTPYYMSPEQMN 189
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +     + D++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 631 GSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-- 686
           G ++  R Q G ++ VKV   +    R  + F +EC  ++   H N++ ++ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 687 FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPII--HCDL 743
              LI  +MP GSL N L+ GT  ++D  Q +   +D+A  + +LH     P+I  H  L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPEYGTKGRVCTR--- 799
              +V++DEDM A IS          + + S Q    +    ++APE   K    T    
Sbjct: 140 NSRSVMIDEDMTARIS--------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRS 191
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
            D++S+ ++L E+ T++ P  ++   E+ +   +  L P
Sbjct: 192 ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 45/227 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+++  +         + + AL 
Sbjct: 129 YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL- 185
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 245 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 293
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIMLM 810
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L 
Sbjct: 294 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 335

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 48/267 (17%)
Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSI 633
           ++WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +
Sbjct: 14  VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKV 62
Query: 634 YVARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSC 682
             A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGAC 119
Query: 683 SNDDFKALIMKYMPNGSLENCL---------------YSGTCMLDIFQRLNIMIDVALAL 727
           ++     +I +Y   G L N L               ++    L     L+    VA  +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGM 179
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
            +L    S   IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MA
Sbjct: 180 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 236
Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           PE         + DV+SYGI+L E+F+
Sbjct: 237 PESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG GS+G    + R  DG  +  K   +    E   +    E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 682 CSNDDFKAL--IMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHF---- 732
             +     L  +M+Y   G L + +  GT     LD    L +M  + LAL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
           GH+  ++H DLKP+NV LD      + DFG+A++L+ +   +     + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF--VGTPYYMSPEQMN 189
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
           +     + D++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 45/227 (19%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQ---------QYERALK 658
           Y + LR  D +  +  +G G+ G + +A   +   +VA+++  +         + + AL 
Sbjct: 143 YPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL- 199
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLD 712
           + E E E++K++ H  ++KI +    +D+  ++++ M  G L         L   TC L 
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSG 769
            +Q L       LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L G
Sbjct: 259 FYQML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-G 307
Query: 770 EDQLSIQIQTL-ATIGYMAPE----YGTKGRVCTRG-DVYSYGIMLM 810
           E  L   ++TL  T  Y+APE     GT G    R  D +S G++L 
Sbjct: 308 ETSL---MRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 349

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           F E  LIG G FG ++ A+ + DG    ++      E+A    E E + + ++ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVH 69
Query: 678 IISSC----------SNDDFKALIMKYMPNGSLE------NCLY-------SGTCMLDIF 714
             + C          S+D  ++    Y P  S         CL+        GT    I 
Sbjct: 70  Y-NGCWDGFDYDPETSDDSLES--SDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 715 QRLNIMIDVALALEYLH-------FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
           +R    +D  LALE          + HS  +IH DLKPSN+ L +     I DFG+   L
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEM 812
             + +   + ++  T+ YM+PE  +        D+Y+ G++L E+
Sbjct: 187 KNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 10/212 (4%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           D +    +IG G+   +  A      E VA+K  + ++ + ++     E + M +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 675 LVKIISSCSNDDFKALIMKYMPNGS----LENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           +V   +S    D   L+MK +  GS    +++ +  G     +     I   +   LE L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSIQIQT--LATIGYMA 787
            + H    IH D+K  N+LL ED    I+DFG++  L+ G D    +++   + T  +MA
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 788 PEYGTKGRVCT-RGDVYSYGIMLMEMFTKKKP 818
           PE   + R    + D++S+GI  +E+ T   P
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIIS 680
           +G GSFG + +A     G +VA+K+ +++           E E   ++ +RH +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              + D   ++++Y  N   +  +          +R      +  A+EY H      I+H
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 135
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-GTKGRVCTR 799
            DLKP N+LLDE +   I+DFG++ +++  + L     +  +  Y APE    K      
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPE 192
Query: 800 GDVYSYGIMLMEMFTKKKPTDE 821
            DV+S G++L  M  ++ P D+
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDD 214

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIIS 680
           +G GSFG + +A     G +VA+K+ +++           E E   ++ +RH +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              + D   ++++Y  N   +  +          +R      +  A+EY H      I+H
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 130
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-GTKGRVCTR 799
            DLKP N+LLDE +   I+DFG++ +++  + L     +  +  Y APE    K      
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPE 187
Query: 800 GDVYSYGIMLMEMFTKKKPTDE 821
            DV+S G++L  M  ++ P D+
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDD 209

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 145 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIIS 680
           +G GSFG + +A     G +VA+K+ +++           E E   ++ +RH +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              + D   ++++Y  N   +  +          +R      +  A+EY H      I+H
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 136
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-GTKGRVCTR 799
            DLKP N+LLDE +   I+DFG++ +++  + L     +  +  Y APE    K      
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPE 193
Query: 800 GDVYSYGIMLMEMFTKKKPTDE 821
            DV+S G++L  M  ++ P D+
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDD 215

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 160 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 145 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIIS 680
           +G GSFG + +A     G +VA+K+ +++           E E   ++ +RH +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
              + D   ++++Y  N   +  +          +R      +  A+EY H      I+H
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 126
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-GTKGRVCTR 799
            DLKP N+LLDE +   I+DFG++ +++  + L     +  +  Y APE    K      
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVISGKLYAGPE 183
Query: 800 GDVYSYGIMLMEMFTKKKPTDE 821
            DV+S G++L  M  ++ P D+
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDD 205

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 85
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 146 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 242

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 76
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 137 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 233

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFE---DECEVMKRIRH 672
           D+F     +G GSFG + + + ++ G   A+K+  +Q    LK  E   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T   +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEALAPEIIL 211
Query: 793 KGRVCTRGDVYSYGIMLMEM 812
                   D ++ G+++ EM
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 87
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 148 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 244

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           D +    +IG G+   +  A      E VA+K  + ++ + ++     E + M +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 675 LVKIISSCSNDDFKALIMKYMPNGS----LENCLYSG---TCMLDIFQRLNIMIDVALAL 727
           +V   +S    D   L+MK +  GS    +++ +  G   + +LD      I+ +V   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS---IQIQTLATIG 784
           EYLH       IH D+K  N+LL ED    I+DFG++  L+    ++   ++   + T  
Sbjct: 130 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 785 YMAPEYGTKGRVCT-RGDVYSYGIMLMEMFTKKKP 818
           +MAPE   + R    + D++S+GI  +E+ T   P
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 117/246 (47%), Gaps = 29/246 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +++ +   IG GS+G ++  R +D G  VA+K F +  +  +  K    E  ++K+++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVAL-ALEY 729
           NLV ++          L+ +Y        C ++    LD +QR    +++  +    L+ 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           ++F H    IH D+KP N+L+ +  V  + DFG A+LL+G          +AT  Y +PE
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPE 172
Query: 790 -------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM 842
                  YG    V   G V++  +  + ++  K   D++++    + + + DL+P    
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL----IRKTLGDLIPRH-Q 227
Query: 843 EVIDTN 848
           +V  TN
Sbjct: 228 QVFSTN 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 81
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 236

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 138 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 138 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H +L   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H +L   N ++  D    I DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++M+ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A ++  G  VAVK    + ++  +   +E  +M+  +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
             D   ++M+++  G+L + +      ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++       D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 804 SYGIMLMEMFTKKKP 818
           S GIM++EM   + P
Sbjct: 212 SLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A ++  G  VAVK    + ++  +   +E  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN--IMIDVALA-LEYLHFGHSTPIIH 740
             D   ++M+++  G+L + +           R+N   +  V LA L+ L   H+  +IH
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 139
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++       
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 801 DVYSYGIMLMEMFTKKKP 818
           D++S GIM++EM   + P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A ++  G  VAVK    + ++  +   +E  +M+  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN--IMIDVALA-LEYLHFGHSTPIIH 740
             D   ++M+++  G+L + +           R+N   +  V LA L+ L   H+  +IH
Sbjct: 92  VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 143
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++       
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 801 DVYSYGIMLMEMFTKKKP 818
           D++S GIM++EM   + P
Sbjct: 202 DIWSLGIMVIEMVDGEPP 219

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           IG GS G + +A ++  G  VAVK    + ++  +   +E  +M+  +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN--IMIDVALA-LEYLHFGHSTPIIH 740
             D   ++M+++  G+L + +           R+N   +  V LA L+ L   H+  +IH
Sbjct: 97  VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 148
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            D+K  ++LL  D    +SDFG    +S E  +  +   + T  +MAPE  ++       
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 801 DVYSYGIMLMEMFTKKKP 818
           D++S GIM++EM   + P
Sbjct: 207 DIWSLGIMVIEMVDGEPP 224

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++M+ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA++      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 112/226 (49%), Gaps = 25/226 (11%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++ R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSL-ENCLYSGTCMLDIFQRL---NIMIDVALAL 727
           H N++ I     ND  +A  ++ M +  + ++ + +    L   Q L   +I   +   L
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQIL 138
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYM 786
             L + HS  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 787 APEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           APE     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 628 GSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV--MKRIRHRNLVKIISS---- 681
           G FG ++ A+L +   VAVK+F  Q +   +S+++E EV  +  ++H N+++ I +    
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-------GH 734
            S D    LI  +   GSL + L +     +  +  +I   +A  L YLH        GH
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEY--- 790
              I H D+K  NVLL  ++ A I+DFG+A K  +G+       Q + T  YMAPE    
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEG 207
Query: 791 --GTKGRVCTRGDVYSYGIMLMEMFTK----KKPTDEIFI 824
               +     R D+Y+ G++L E+ ++      P DE  +
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALK---SFEDECEVMKRIRHRNLVKIIS 680
           +G GSFG + +A   +   +VA+K   +Q  +        E E   +K +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
             +      ++++Y   G L + +     M +   R      +  A+EY H      I+H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-GTKGRVCTR 799
            DLKP N+LLD+++   I+DFG++ +++  + L     +  +  Y APE    K      
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVINGKLYAGPE 188
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            DV+S GI+L  M   + P D+ FI  L
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 55/272 (20%)
Query: 581 WKLIECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNL-----IGIGSFGSIYV 635
           WK+IE   S  G S   I+  Q      Y+E       F  NNL     +G G+FG +  
Sbjct: 1   WKIIE---SYEGNSYTFIDPTQ----LPYNEKWE----FPRNNLQFGKTLGAGAFGKVVE 49
Query: 636 ARL-----QDG-MEVAVKVF----HQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSN 684
           A       +D  ++VAVK+     H   + AL S   E ++M  + +H N+V ++ +C++
Sbjct: 50  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTH 106
Query: 685 DDFKALIMKYMPNGSLENCLY-SGTCML---------------------DIFQRLNIMID 722
                +I +Y   G L N L      ML                     ++   L+    
Sbjct: 107 GGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQ 166
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  + +L    S   IH D+   NVLL    VA I DFG+A+ +  +    ++      
Sbjct: 167 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 223
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+SYGI+L E+F+
Sbjct: 224 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 628 GSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS---CSN 684
           G FG ++ A+L +   VAVK+F  Q +++ +S E E      ++H NL++ I++    SN
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 685 DDFK-ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF--------GHS 735
            + +  LI  +   GSL + L       +  +  ++   ++  L YLH         GH 
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGNIITWN--ELCHVAETMSRGLSYLHEDVPWCRGEGHK 141
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEY---- 790
             I H D K  NVLL  D+ A ++DFG+A +   G+       Q + T  YMAPE     
Sbjct: 142 PSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAPEVLEGA 200
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
              +     R D+Y+ G++L E+ ++ K  D
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ ++ H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 641 GMEVAVKVFH--------QQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALI 691
           G E AVK+          +Q E   ++   E  +++++  H +++ +I S  +  F  L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD 751
              M  G L + L     + +   R +IM  +   LE + F H+  I+H DLKP N+LLD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR-SIMRSL---LEAVSFLHANNIVHRDLKPENILLD 234
Query: 752 EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           ++M   +SDFG +  L   ++L    +   T GY+APE
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPE 269

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ ++ H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           +G G +G ++    Q G  VAVK+F  + E   KS+  E E+   +  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 100
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH---FG-H 734
                 +    LI  Y   GSL + L   T  LD    L I++ +A  L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSI-QIQTLATIGYMAPEY- 790
             P I H DLK  N+L+ ++    I+D G+A + S   +QL +     + T  YMAPE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 791 -GTKGRVC----TRGDVYSYGIMLMEM 812
             T    C     R D++++G++L E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 239
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 619 FSENNLIGIGSFGSIY-VARLQDGMEVA---VKVFHQQYERALKSFEDECEVMKRIRHRN 674
           F     IG G F  +Y  A L DG+ VA   V++F     +A      E +++K++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY----- 729
           ++K  +S   D+   ++++    G L         M+  F++   +I      +Y     
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 730 --LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L   HS  ++H D+KP+NV +    V  + D G+ +  S +   +  +  + T  YM+
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMS 204
Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE   +     + D++S G +L EM   + P
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 105
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 163
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 625 IGIGSFGSIYVARLQDGME------VAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +D ++      VAVK  ++    R    F +E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYS---------GTCMLDIFQRLNIMIDVALALE 728
           ++   S      ++M+ M +G L++ L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL+   +   +H DL   N ++  D    I DFG+ + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEM 812
           E    G   T  D++S+G++L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + IG G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 85
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 140
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV---ATRWYRA 195
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 92
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 150
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 162 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 147 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 136
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++     +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT---GXVATRWYRAP 191
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 21/233 (9%)
Query: 594 SNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQ 652
           SN     P   R+     +    +R+   + +G G++GS+  A   + G+ VAVK   + 
Sbjct: 22  SNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 653 YE---RALKSFEDECEVMKRIRHRNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCL 704
           ++    A +++  E  ++K ++H N++ ++     + S ++F    ++ ++    L N +
Sbjct: 82  FQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 140
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
                  D  Q L   I     L  L + HS  IIH DLKPSN+ ++ED    I DFG+A
Sbjct: 141 KCQKLTDDHVQFLIYQI-----LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 195
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           +    E         +AT  Y APE         +  D++S G ++ E+ T +
Sbjct: 196 RHTDDE-----MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                + D++S G+ L+EM   + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 85
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 140
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV---ATRWYRA 195
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           +G G +G ++    Q G  VAVK+F  + E   KS+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH---FG-H 734
                 +    LI  Y   GSL + L   T  LD    L I++ +A  L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSI-QIQTLATIGYMAPEY- 790
             P I H DLK  N+L+ ++    I+D G+A + S   +QL +     + T  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 791 -GTKGRVC----TRGDVYSYGIMLMEM 812
             T    C     R D++++G++L E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK----SFEDECEVMKRIRHR 673
           F     +G G+F  + +A  +  G   AVK   +   +ALK    S E+E  V+++I+H 
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPK---KALKGKESSIENEIAVLRKIKHE 80
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+V +     + +   L+M+ +  G     L+        +   +    +   L+ +++ 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGE----LFDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 734 HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   I+H DLKP N+L    DE+    ISDFG++K+    D +S       T GY+APE 
Sbjct: 137 HRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST---ACGTPGYVAPEV 193
Query: 791 GTKGRVCTRGDVYSYGIM 808
             +       D +S G++
Sbjct: 194 LAQKPYSKAVDCWSIGVI 211

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 172 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 91
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 146
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV---ATRWYRA 201
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 77
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 132
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 187
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 132
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRAP 187
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 134
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y AP
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRAP 189
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           +G G +G ++    Q G  VAVK+F  + E   KS+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH---FG-H 734
                 +    LI  Y   GSL + L   T  LD    L I++ +A  L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSI-QIQTLATIGYMAPEY- 790
             P I H DLK  N+L+ ++    I+D G+A + S   +QL +     + T  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 791 -GTKGRVC----TRGDVYSYGIMLMEM 812
             T    C     R D++++G++L E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 77
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 132
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 187
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 67
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 125
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 85
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 140
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 195
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 620 SENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           S+  ++G G FG ++       G+++A K+   +  +  +  ++E  VM ++ H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  + +   L+M+Y+  G L + +   +  L     +  M  +   + ++   H   I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYI 208
Query: 739 IHCDLKPSNVL-LDEDMVA-HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           +H DLKP N+L ++ D     I DFG+A+     ++L +      T  ++APE      V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFV 265
Query: 797 CTRGDVYSYGIM 808
               D++S G++
Sbjct: 266 SFPTDMWSVGVI 277

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 72
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 130
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 625 IGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIMIDVALALE 728
            I        + ++++ M  G L++ L          S   MLD+   L++  D+A   +
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 172
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   H    IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 173 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 69
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 127
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKH 92
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 147
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 202
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 82
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 137
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYV---ATRWYRA 192
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N + S     D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+ +    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 143
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+  + E         +AT  Y AP
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRN 674
           +++ +   +G G++G +Y A+   G  VA+K      + E    +   E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V +I    ++    L+ ++M    L+  L      L   Q   I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--LATIGYMAPE--Y 790
              I+H DLKP N+L++ D    ++DFG+A+       + ++  T  + T+ Y AP+   
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFG----IPVRSYTHEVVTLWYRAPDVLM 192
Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKK 816
           G+K +  T  D++S G +  EM T K
Sbjct: 193 GSK-KYSTSVDIWSIGCIFAEMITGK 217

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 99
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 154
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 209
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 100
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 155
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 210
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 143
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+  + E         +AT  Y AP
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 142
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+  + E         +AT  Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 102/228 (44%), Gaps = 18/228 (7%)
Query: 592 GPSNDGINSPQAIRRFSYHELLRATDRFSEN----NLIGIGSFGSIY-VARLQDGMEVAV 646
           GP    +   Q + R S   ++ A+ +FS+N      +G G+F  +        G+E A 
Sbjct: 1   GPHMASMTGGQQMGRGSEF-MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 647 KVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           K+ + +    R  +  E E  + ++++H N+V++  S   + F  L+   +  G     L
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----L 115
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDF 761
           +      + +   +    +   LE + + HS  I+H +LKP N+LL    +     ++DF
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIML 809
           G+A  ++  +          T GY++PE   K       D+++ G++L
Sbjct: 176 GLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 92
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 147
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 202
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRN 674
           +++ +   +G G++G +Y A+   G  VA+K      + E    +   E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V +I    ++    L+ ++M    L+  L      L   Q   I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YGT 792
              I+H DLKP N+L++ D    ++DFG+A+       +      + T+ Y AP+   G+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGS 194
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKK 816
           K +  T  D++S G +  EM T K
Sbjct: 195 K-KYSTSVDIWSIGCIFAEMITGK 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 142
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 197
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 92
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 147
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 202
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 85
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 140
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 195
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 79
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 134
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 135 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 189
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 86
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 141
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYV---ATRWYRA 196
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 82
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 137
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 192
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE--DECEVMKRIRHRNLV 676
           F   +L+G G++G +  A  +   E+      + +++ L +     E +++K  +H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGH 734
            I +    D F+     Y+    ++  L+    T ML      +I   +   L  +   H
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQYFIYQTLRAVKVLH 129
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGED------QLSIQIQTLATIGYM 786
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D      Q S  ++ +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 787 APEYG-TKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   T  +     DV+S G +L E+F ++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   E+   E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   E+   E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 82
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 137
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 192
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G FG ++  + + G EVAVK+F  + ER   S+  E E+ + +  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 683 SNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF----GH 734
           + D+       L+  Y  +GSL + L   T  ++    + + +  A  L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 124
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQI-QTLATIGYMAPEYG 791
             P I H DLK  N+L+ ++    I+D G+A +  S  D + I     + T  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 792 TKG------RVCTRGDVYSYGIMLMEMFTK 815
                        R D+Y+ G++  E+  +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 82
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 137
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 192
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 103
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 158
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 213
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 11/216 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 150
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 204
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                + D++S G+ L+EM   + P       EL L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 147
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRAP 202
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 86
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 141
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 196
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVF----HQQY-ERALKSFEDECEVMKRIR 671
           R++  + IG G++G +  A    + + VA+K      HQ Y +R L+    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEY 729
           H N++ I         + +   Y+    +E  LY    T  L        +  +   L+Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAP 788
           +H   S  ++H DLKPSN+LL+      I DFG+A++   + D      + +AT  Y AP
Sbjct: 142 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           E     +  T+  D++S G +L EM + +     IF G+  L++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           +R T  F E  ++G G+F  +++ + +  G   A+K   +       S E+E  V+K+I+
Sbjct: 7   IRKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSL-ENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           H N+V +     +     L+M+ +  G L +  L  G     ++   +  + +   L  +
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAV 119
Query: 731 HFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
            + H   I+H DLKP N+L    +E+    I+DFG++K+    +Q  I      T GY+A
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 788 PEYGTKGRVCTRGDVYSYGIM 808
           PE   +       D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVI 196

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++ V+    G+ +A K+ H + + A++     E +V+       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L  +G     I  +++I   V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 142
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YM+PE    
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 196
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                + D++S G+ L+EM   + P
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 33/234 (14%)
Query: 625 IGIGSFGSI---YVARLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKI 678
           +G G++GS+   Y ARL+   +VAVK   + ++    A +++  E  ++K ++H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 679 IS----SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +     + S +DF  + +     G+  N +     + D     ++   V   L  L + H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD----EHVQFLVYQLLRGLKYIH 148
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  IIH DLKPSNV ++ED    I DFG+A+    +++++  +   AT  Y APE     
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYV---ATRWYRAPEIMLNW 203
Query: 795 RVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT 847
               +  D++S G ++ E+   K     +F G    + +I+ L    +MEV+ T
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKA----LFPG----SDYIDQL--KRIMEVVGT 247

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G  VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQI-----LR 132
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRAP 187
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRH 672
           TD +     +G G+F  +    ++  G E A K+ + +    R  +  E E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S S + F  L+   +  G     L+      + +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 733 GHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            H   I+H DLKP N+LL    +     ++DFG+A  + G+ Q         T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF--AGTPGYLSPE 176
Query: 790 YGTKGRVCTRGDVYSYGIML 809
              K       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 86
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 141
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 196
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE--DECEVMKRIRHRNLV 676
           F   +L+G G++G +  A  +   E+      + +++ L +     E +++K  +H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGH 734
            I +    D F+     Y+    ++  L+    T ML      +I   +   L  +   H
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQYFIYQTLRAVKVLH 129
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGED------QLSIQIQTLATIGYM 786
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D      Q S   + +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 787 APEYG-TKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   T  +     DV+S G +L E+F ++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 619 FSENNLI-----GIGSFGSIYVA-----RLQDGME-VAVKVFHQQYERA-LKSFEDECEV 666
           F   NL+     G G FG +  A     + + G   VAVK+  +    + L+    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------------- 704
           +K++ H +++K+  +CS D    LI++Y   GSL   L                      
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 705 -YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
            +     L +   ++    ++  ++YL       ++H DL   N+L+ E     ISDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++ +  ED    + Q    + +MA E        T+ DV+S+G++L E+ T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 619 FSENNLI-----GIGSFGSIYVA-----RLQDGME-VAVKVFHQQYERA-LKSFEDECEV 666
           F   NL+     G G FG +  A     + + G   VAVK+  +    + L+    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------------- 704
           +K++ H +++K+  +CS D    LI++Y   GSL   L                      
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 705 -YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
            +     L +   ++    ++  ++YL       ++H DL   N+L+ E     ISDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++ +  ED    + Q    + +MA E        T+ DV+S+G++L E+ T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 619 FSENNLI-----GIGSFGSIYVA-----RLQDGME-VAVKVFHQQYERA-LKSFEDECEV 666
           F   NL+     G G FG +  A     + + G   VAVK+  +    + L+    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL---------------------- 704
           +K++ H +++K+  +CS D    LI++Y   GSL   L                      
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 705 -YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
            +     L +   ++    ++  ++YL       ++H DL   N+L+ E     ISDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++ +  ED    + Q    + +MA E        T+ DV+S+G++L E+ T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSC 682
           IG G +G +++ + + G +VAVKVF    E    S+  E E+ + +  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA- 99
Query: 683 SNDDFKA--------LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-- 732
              D K         LI  Y  NGSL + L S T  LD    L +       L +LH   
Sbjct: 100 ---DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 733 --GHSTPII-HCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQT-LATIGYMA 787
                 P I H DLK  N+L+ ++    I+D G+A K +S  +++ I   T + T  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 788 PEYGTKG------RVCTRGDVYSYGIMLMEM 812
           PE   +       +     D+YS+G++L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFE-DECEVMKRI 670
           + ++ +F +   +G G++ ++Y       G+ VA+K      E    S    E  +MK +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC-------MLDIFQRLNIMIDV 723
           +H N+V++      ++   L+ ++M N  L+  + S T         L++ +     +  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL-- 117
Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-- 781
              L+ L F H   I+H DLKP N+L+++     + DFG+A+         I + T +  
Sbjct: 118 ---LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------AFGIPVNTFSSE 168
Query: 782 --TIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKK 816
             T+ Y AP+     R   T  D++S G +L EM T K
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRH 672
           TD +     +G G+F  +    ++  G E A K+ + +    R  +  E E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S S + F  L+   +  G     L+      + +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 733 GHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            H   I+H DLKP N+LL    +     ++DFG+A  + G+ Q         T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 790 YGTKGRVCTRGDVYSYGIML 809
              K       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE--DECEVMKRIRHRNLV 676
           F   +L+G G++G +  A  +   E+      + +++ L +     E +++K  +H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGH 734
            I +    D F+     Y+    ++  L+    T ML      +I   +   L  +   H
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQYFIYQTLRAVKVLH 129
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGED------QLSIQIQTLATIGYM 786
            + +IH DLKPSN+L++ +    + DFG+A+++  S  D      Q S   + +AT  Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 787 APEYG-TKGRVCTRGDVYSYGIMLMEMFTKK 816
           APE   T  +     DV+S G +L E+F ++
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 76
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 131
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 186
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 99
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 154
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 209
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I D+G+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 100
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 155
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 210
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 41/225 (18%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKR 669
           D +     IG G++G +  AR +  G +VA+K     ++      R L+    E +++K 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKH 110
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-LNIMIDVA--LA 726
            +H N++ I         K ++   +P G  ++       +LD+ +  L+ +I  +  L 
Sbjct: 111 FKHDNIIAI---------KDILRPTVPYGEFKSVY----VVLDLMESDLHQIIHSSQPLT 157
Query: 727 LEY-----------LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGEDQL 773
           LE+           L + HS  +IH DLKPSN+L++E+    I DFG+A+ L  S  +  
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 217
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKK 817
               + +AT  Y APE        T+  D++S G +  EM  +++
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
           TD +     IG G+F  +    +L  G E A K+ + +    R  +  E E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S S + F  L+   +  G     L+      + +   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 733 GHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            H   ++H DLKP N+LL    +     ++DFG+A  + G+ Q         T GY++PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              K       D+++ G++L  +     P
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR    F E  ++G G+FG +  AR   D    A+K   +  E  L +   E  ++  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 672 H-------------RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQR 716
           H             RN VK  ++        +  +Y  N +L + ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSI 775
           L   I     LE L + HS  IIH +LKP N+ +DE     I DFG+AK +    D L +
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 776 QIQTL-----------ATIGYMAPEY--GTKGRVCTRGDVYSYGIMLME 811
             Q L            T  Y+A E   GT G    + D YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGT-GHYNEKIDXYSLGIIFFE 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G++  A   + G +VA+K  ++ ++  L  K    E  ++K +RH N++ ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 682 CSND----DFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            + D    DF    L+M +M    L   +       D  Q L     V   L+ L + H+
Sbjct: 93  FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLRYIHA 146
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG- 794
             IIH DLKP N+ ++ED    I DFG+A+    E         + T  Y APE      
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVILNWM 201
Query: 795 RVCTRGDVYSYGIMLMEMFTKK 816
           R     D++S G ++ EM T K
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGK 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 41/225 (18%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKR 669
           D +     IG G++G +  AR +  G +VA+K     ++      R L+    E +++K 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKH 109
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR-LNIMIDVA--LA 726
            +H N++ I         K ++   +P G  ++       +LD+ +  L+ +I  +  L 
Sbjct: 110 FKHDNIIAI---------KDILRPTVPYGEFKSVY----VVLDLMESDLHQIIHSSQPLT 156
Query: 727 LEY-----------LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGEDQL 773
           LE+           L + HS  +IH DLKPSN+L++E+    I DFG+A+ L  S  +  
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 216
Query: 774 SIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKK 817
               + +AT  Y APE        T+  D++S G +  EM  +++
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G  VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 132
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++     +AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMA---GFVATRWYRAP 187
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 33/234 (14%)
Query: 625 IGIGSFGSI---YVARLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKI 678
           +G G++GS+   Y ARL+   +VAVK   + ++    A +++  E  ++K ++H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 679 IS----SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +     + S +DF  + +     G+  N +     + D     ++   V   L  L + H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD----EHVQFLVYQLLRGLKYIH 148
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  IIH DLKPSNV ++ED    I DFG+A+    +++++  +   AT  Y APE     
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYV---ATRWYRAPEIMLNW 203
Query: 795 RVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT 847
               +  D++S G ++ E+   K     +F G    + +I+ L    +MEV+ T
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKA----LFPG----SDYIDQL--KRIMEVVGT 247

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 33/234 (14%)
Query: 625 IGIGSFGSI---YVARLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKI 678
           +G G++GS+   Y ARL+   +VAVK   + ++    A +++  E  ++K ++H N++ +
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 679 IS----SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +     + S +DF  + +     G+  N +     + D     ++   V   L  L + H
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD----EHVQFLVYQLLRGLKYIH 140
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  IIH DLKPSNV ++ED    I DFG+A+    +++++  +   AT  Y APE     
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYV---ATRWYRAPEIMLNW 195
Query: 795 RVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT 847
               +  D++S G ++ E+   K     +F G    + +I+ L    +MEV+ T
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKA----LFPG----SDYIDQL--KRIMEVVGT 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 100
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 155
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    E         +AT  Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRA 210
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 72  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++     +AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMA---GFVATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++     +AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMA---GFVATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 29/244 (11%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFH-QQYERALKSFEDECEVM 667
           H  +   + F++ + IG GSFG +Y        EV A+K+   ++ E  ++  + E  V+
Sbjct: 12  HSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVL 71
Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            +     + +   S        +IM+Y+  GS  + L  G   L+      I+ ++   L
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGL 129
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           +YLH   S   IH D+K +NVLL E     ++DFG+A  L+       QI+    +G   
Sbjct: 130 DYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----DTQIKRNXFVGTPF 181
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV 844
           +MAPE   +     + D++S GI  +E+   + P               +DL P+ V+ +
Sbjct: 182 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFL 227
Query: 845 IDTN 848
           I  N
Sbjct: 228 IPKN 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 663 ECEVMKRIRHRNLVKIISSCS--NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM 720
           E  ++K++ H N+VK++      N+D   ++ + +  G +           D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            D+   +EYLH+     IIH D+KPSN+L+ ED    I+DFG++    G D L     T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 781 ATIGYMAPEYGTKGRVCTRG---DVYSYGIML 809
            T  +MAPE  ++ R    G   DV++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 86
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 141
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 196
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVAVK+    Q    +L+    E  + K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+ +Y   G + + L +     +   R      +  A++Y H      I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGRVCTRG 800
           DLK  N+LLD D    I+DFG +   +  ++L           Y APE +  K       
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEV 194
Query: 801 DVYSYGIMLMEMFTKKKPTDEIFIGEL 827
           DV+S G++L  + +   P D   + EL
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+     +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 90
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 145
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 146 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 200
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 614 RATDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRI 670
           R TD +     +G G+F  +    +     E A K+ + +    R  +  E E  + + +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           +H N+V++  S S + F  L+   +  G     L+      + +   +    +   LE +
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIHQILESV 143
Query: 731 HFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           +  H   I+H DLKP N+LL    +     ++DFG+A  + GE Q         T GY++
Sbjct: 144 NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF--AGTPGYLS 201
Query: 788 PEYGTKGRVCTRGDVYSYGIML 809
           PE   K       D+++ G++L
Sbjct: 202 PEVLRKDPYGKPVDIWACGVIL 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYER--ALKSFEDECEVMKRIRH 672
           D F     +G G FG++Y+AR  Q+   +A+KV F  Q E+         E E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++ +   +     L++++ P G L   L       D  +    M ++A AL   H+
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 130
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL------ATIGYM 786
            H   +IH D+KP N+L+       I+DFG           S+   +L       T+ Y+
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGELKIADFG----------WSVHAPSLRRRXMCGTLDYL 180
Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
            PE         + D++  G++  E      P D
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  +  ++ G+++AVK   + ++    A +++  E  ++K ++H
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 109
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 164
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DFG+A+    +D+++  +   AT  Y A
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV---ATRWYRA 219
Query: 788 PEYGTKG-RVCTRGDVYSYGIMLMEMFTKK 816
           PE            D++S G ++ E+ T +
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 622 NNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLV 676
           N ++G G FG +Y  V     G ++ V V   + +  L   + F  E  +MK + H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+I     +    +IM+  P G L + L      L +   +   + +  A+ YL    S 
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   N+L+       + DFG+++ +  ED     +  L  I +M+PE     R 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 797 CTRGDVYSYGIMLMEMFT-KKKP 818
            T  DV+ + + + E+ +  K+P
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 622 NNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLV 676
           N ++G G FG +Y  V     G ++ V V   + +  L   + F  E  +MK + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+I     +    +IM+  P G L + L      L +   +   + +  A+ YL    S 
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   N+L+       + DFG+++ +  ED     +  L  I +M+PE     R 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 797 CTRGDVYSYGIMLMEMFT-KKKP 818
            T  DV+ + + + E+ +  K+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
           L + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H N+VK++     ++   L+ +++   S++   +     L       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPE 176
Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G K    T  D++S G +  EM T++
Sbjct: 177 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  VM+++ +  +V++I  C  + +  L+M+    G L   L     + D    + ++  
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 477
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLA 781
           V++ ++YL     +  +H DL   NVLL     A ISDFG++K L + E+    Q     
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + + APE     +  ++ DV+S+G+++ E F+
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVAR-LQDGME-VAVK-VFHQQYERALK-SFEDECEVM 667
           L RA  ++     IG G++G ++ AR L++G   VA+K V  Q  E  +  S   E  V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 668 KRIR---HRNLVKIISSCS---NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           + +    H N+V++   C+    D    L + +      E+     T  LD      +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------EHVDQDLTTYLDKVPEPGVPT 119
Query: 722 DVALALEY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           +    + +     L F HS  ++H DLKP N+L+       ++DFG+A++ S +  L+  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-- 177
Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 178 -SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 622 NNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLV 676
           N ++G G FG +Y  V     G ++ V V   + +  L   + F  E  +MK + H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+I     +    +IM+  P G L + L      L +   +   + +  A+ YL    S 
Sbjct: 89  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   N+L+       + DFG+++ +  ED     +  L  I +M+PE     R 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 797 CTRGDVYSYGIMLMEMFT 814
            T  DV+ + + + E+ +
Sbjct: 204 TTASDVWMFAVCMWEILS 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 46/219 (21%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR +  G +VA+K    + E+      AL+    E ++++ ++H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRL-NIMIDVALA-------- 726
           +I  C          K  P    +  +Y     C  D+   L N+++   L+        
Sbjct: 82  LIEICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 727 -LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL--LSGEDQLSIQIQTLATI 783
            L  L++ H   I+H D+K +NVL+  D V  ++DFG+A+   L+   Q +     + T+
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 784 GYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTK 815
            Y  PE       YG         D++  G ++ EM+T+
Sbjct: 194 WYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTR 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  VM+++ +  +V++I  C  + +  L+M+    G L   L     + D    + ++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLA 781
           V++ ++YL     +  +H DL   NVLL     A ISDFG++K L + E+    Q     
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + + APE     +  ++ DV+S+G+++ E F+
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++   S++   +     L       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEIL 176
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 177 LGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
           L + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H N+VK++     ++   L+ +++   S++   +     L       I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPE 176
Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G K    T  D++S G +  EM T++
Sbjct: 177 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSI-YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRN 674
           D F   + +G G+ G +  V     G+ +A K+ H + + A++     E +V+       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLNIMIDVALALEYLHFG 733
           +V    +  +D   ++ M++M  GSL+  L     + + I  +++I +   LA  YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 133
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           H   I+H D+KPSN+L++      + DFG+    SG+   S+    + T  YMAPE    
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMAPERLQG 187
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                + D++S G+ L+E+   + P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 25/246 (10%)
Query: 595 NDGINSPQAIRRFSYHELLRATDRFSENNL-IGIGSFGSIYVARLQD---GMEVAVKVFH 650
           N+G+   + ++   Y    R    ++ + L +G GSFG ++  R++D   G + AVK   
Sbjct: 53  NEGVLLTEKLKPVDYE--YREEVHWATHQLRLGRGSFGEVH--RMEDKQTGFQCAVKKVR 108
Query: 651 QQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM 710
            +  RA     +E      +    +V +  +     +  + M+ +  GSL   +    C+
Sbjct: 109 LEVFRA-----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCL 163
Query: 711 LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-AHISDFGIAKLLS- 768
            +       +  +  ALE L + HS  I+H D+K  NVLL  D   A + DFG A  L  
Sbjct: 164 PED----RALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQP 219
Query: 769 ---GEDQLSIQIQTLATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKPTDEIFI 824
              G+D L+       T  +MAPE    GR C  + DV+S   M++ M     P  + F 
Sbjct: 220 DGLGKDLLTGDY-IPGTETHMAPEV-VLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFR 277
Query: 825 GELSLN 830
           G L L 
Sbjct: 278 GPLCLK 283

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 126
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 184
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 185 XK-YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 116/245 (47%), Gaps = 36/245 (14%)
Query: 618 RFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           R+ +   +G G  G ++ A   D    VA+K       +++K    E ++++R+ H N+V
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 677 KIIS------SCSNDDFKAL--------IMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           K+        S   DD  +L        + +YM    L N L  G  +L+   RL  M  
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LLEEHARL-FMYQ 128
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLL----SGEDQLSIQI 777
           +   L+Y+H   S  ++H DLKP+N+ ++ ED+V  I DFG+A+++    S +  LS   
Sbjct: 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS--- 182
Query: 778 QTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIG--ELSLNRWIN 834
           + L T  Y +P         T+  D+++ G +  EM T K     +F G  EL   + I 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQMQLIL 238
Query: 835 DLLPV 839
           + +PV
Sbjct: 239 ESIPV 243

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV--AVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           ++  N IG GS+G + +A +Q G  +  A K   + +   +  F+ E E+MK + H N++
Sbjct: 28  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLHFG 733
           ++  +  ++    L+M+    G     L+       +F+      IM DV  A+ Y    
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC--- 139
Query: 734 HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   + H DLKP N L      D    + DFG+A        +  ++    T  Y++P+ 
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 196
Query: 791 --GTKGRVCTRGDVYSYGIML 809
             G  G  C   D +S G+M+
Sbjct: 197 LEGLYGPEC---DEWSAGVMM 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE----DECEVMKRIRHRN 674
           F +  ++G G FG +   +++   ++      ++     +  E    +E ++++++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V +  +    D   L++  M  G L+  +Y  G       + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
               I++ DLKP N+LLD+     ISD G+A  +     +  ++    T+GYMAPE    
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKN 359
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            R     D ++ G +L EM   + P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHR 673
           +R+   + +G G++GS+  A   + G+ VAVK   + ++  +  K    E  ++K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 674 NLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 136
Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
            L + HS  IIH DLKPSN+ ++ED    I  FG+A+    +D+++  +   AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYV---ATRWYRAP 191
Query: 789 EYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           E         +  D++S G ++ E+ T +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVAR-LQDGME-VAVK-VFHQQYERALK-SFEDECEVM 667
           L RA  ++     IG G++G ++ AR L++G   VA+K V  Q  E  +  S   E  V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 668 KRIR---HRNLVKIISSCS---NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           + +    H N+V++   C+    D    L + +      E+     T  LD      +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------EHVDQDLTTYLDKVPEPGVPT 119
Query: 722 DVALALEY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           +    + +     L F HS  ++H DLKP N+L+       ++DFG+A++ S +  L+  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-- 177
Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 178 -SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----R 671
           F  + ++G GSFG +++A  +   +  A+K   +  +  L   + EC  V KR+      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWE 77
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYL 730
           H  L  +  +    +    +M+Y+  G L    +  +C   D+ +      ++ L L++L
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPE 789
           H   S  I++ DLK  N+LLD+D    I+DFG+ K  + G+ + +   +   T  Y+APE
Sbjct: 136 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---EFCGTPDYIAPE 189
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +     D +S+G++L EM   + P
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEV--AVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           ++  N IG GS+G + +A +Q G  +  A K   + +   +  F+ E E+MK + H N++
Sbjct: 11  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMIDVALALEYLHFG 733
           ++  +  ++    L+M+    G     L+       +F+      IM DV  A+ Y    
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC--- 122
Query: 734 HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   + H DLKP N L      D    + DFG+A        +  ++    T  Y++P+ 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 179
Query: 791 --GTKGRVCTRGDVYSYGIML 809
             G  G  C   D +S G+M+
Sbjct: 180 LEGLYGPEC---DEWSAGVMM 197

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR +  G +VA+K    + E+      AL+    E ++++ ++H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRL-NIMIDVALA-------- 726
           +I  C          K  P    +  +Y     C  D+   L N+++   L+        
Sbjct: 82  LIEICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 727 -LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL--LSGEDQLSIQIQTLATI 783
            L  L++ H   I+H D+K +NVL+  D V  ++DFG+A+   L+   Q +     + T+
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 784 GYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTK 815
            Y  PE     R      D++  G ++ EM+T+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL------ 727
           N+VK++     ++   L+ +++               L  F   + +  + L L      
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQD------------LKTFMDASALTGIPLPLIKSYLF 113
Query: 728 ---EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
              + L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ 
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLW 171
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           Y APE   G K    T  D++S G +  EM T++
Sbjct: 172 YRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
           L + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H N+VK++     ++   L+ +++   S++   +     L       I   +   L+ 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPE 175
Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G K    T  D++S G +  EM T++
Sbjct: 176 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
           L + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQG 118
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPE 176
Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G K    T  D++S G +  EM T++
Sbjct: 177 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-FHQQYER--ALKSFEDECEVMKRIRH 672
           D F     +G G FG++Y+AR  Q+   +A+KV F  Q E+         E E+   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++ +   +     L++++ P G L   L       D  +    M ++A AL   H+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 129
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL------ATIGYM 786
            H   +IH D+KP N+L+       I+DFG           S+   +L       T+ Y+
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFG----------WSVHAPSLRRRXMCGTLDYL 179
Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
            PE         + D++  G++  E      P D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKR 669
           L + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQG 119
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPE 177
Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G K    T  D++S G +  EM T++
Sbjct: 178 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 126
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 184
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 185 CK-YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I D G+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 XK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 625 IGIGSFGSIYVARLQD---GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G GSFG ++  R++D   G + AVK    +  RA     +E      +    +V +  +
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRA-----EELMACAGLTSPRIVPLYGA 153
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
                +  + M+ +  GSL   +    C+ +       +  +  ALE L + HS  I+H 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED----RALYYLGQALEGLEYLHSRRILHG 209
Query: 742 DLKPSNVLLDEDMV-AHISDFGIAKLLSGEDQLSIQIQT----LATIGYMAPEYGTKGRV 796
           D+K  NVLL  D   A + DFG A  L   D L   + T      T  +MAPE    GR 
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQ-PDGLGKSLLTGDYIPGTETHMAPEV-VLGRS 267
Query: 797 C-TRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN 830
           C  + DV+S   M++ M     P  + F G L L 
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L++ +   + +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEIL 175
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 176 LGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE----DECEVMKRIRHRN 674
           F +  ++G G FG +   +++   ++      ++     +  E    +E ++++++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFG 733
           +V +  +    D   L++  M  G L+  +Y  G       + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
               I++ DLKP N+LLD+     ISD G+A  +     +  ++    T+GYMAPE    
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKN 359
Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            R     D ++ G +L EM   + P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR +  G +VA+K    + E+      AL+    E ++++ ++H N+V 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRL-NIMIDVALA-------- 726
           +I  C          K  P    +  +Y     C  D+   L N+++   L+        
Sbjct: 81  LIEICRT--------KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 727 -LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL--LSGEDQLSIQIQTLATI 783
            L  L++ H   I+H D+K +NVL+  D V  ++DFG+A+   L+   Q +     + T+
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 784 GYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTK 815
            Y  PE     R      D++  G ++ EM+T+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLSFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 120
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEIL 178
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 179 LGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 178
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 179 CK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVAR-LQDGME-VAVK-VFHQQYERALK-SFEDECEVM 667
           L RA  ++     IG G++G ++ AR L++G   VA+K V  Q  E  +  S   E  V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 668 KRIR---HRNLVKIISSCS---NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           + +    H N+V++   C+    D    L + +      E+     T  LD      +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF------EHVDQDLTTYLDKVPEPGVPT 119
Query: 722 DVALALEY-----LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           +    + +     L F HS  ++H DLKP N+L+       ++DFG+A++ S +  L+  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-- 177
Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              + T+ Y APE   +    T  D++S G +  EMF +K
Sbjct: 178 -SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 119
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEIL 177
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 178 LGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I D G+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 121
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 179
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 180 CK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR +  G +VA+K    + E+      AL+    E ++++ ++H N+V 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRL-NIMIDVALA-------- 726
           +I  C          K  P    +  +Y     C  D+   L N+++   L+        
Sbjct: 82  LIEICRT--------KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 727 -LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL--LSGEDQLSIQIQTLATI 783
            L  L++ H   I+H D+K +NVL+  D V  ++DFG+A+   L+   Q +     + T+
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 784 GYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTK 815
            Y  PE     R      D++  G ++ EM+T+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 121
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 179
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 180 CK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 177 CK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 177 CK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 118
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEIL 176
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 177 LGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEIL 175
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 176 LGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 177 CK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 123
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 181
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 182 CK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISS- 681
           +G G +G ++   L  G  VAVK+F  + E   +S+  E E+   +  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 682 --CSNDDFK-ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH---FG-H 734
               N   +  LI  Y  +GSL + L   T  L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 735 STPII-HCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSI-QIQTLATIGYMAPEY- 790
             P I H D K  NVL+  ++   I+D G+A + S G D L I     + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 791 GTKGRV-CTRG----DVYSYGIMLMEMFTK 815
             + R  C       D++++G++L E+  +
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLG 178
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 179 CK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G+ G + +A +    E AV V     +RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G+ VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I D G+A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERAL---KSFEDECEVMKRIRHRNLVKIISS 681
           +G G++G + +A +    E AV V     +RA+   ++ + E  +   + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLH-------F 732
               + + L ++Y   G L             F R+  +I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            H   I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 793 KGRVCTRG-DVYSYGIMLMEMFTKKKPTDE 821
           +        DV+S GI+L  M   + P D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 177 CK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 8/207 (3%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           D F +  ++G G FG ++  +++  G   A K  +++  +  K ++    E +++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           R +V +  +        L+M  M  G +   +Y+       FQ    +   A  +  L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYG 791
            H   II+ DLKP NVLLD+D    ISD G+A +L +G+ +         T G+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    D ++ G+ L EM   + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 8/207 (3%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           D F +  ++G G FG ++  +++  G   A K  +++  +  K ++    E +++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           R +V +  +        L+M  M  G +   +Y+       FQ    +   A  +  L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYG 791
            H   II+ DLKP NVLLD+D    ISD G+A +L +G+ +         T G+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    D ++ G+ L EM   + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 178
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 179 CK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 8/207 (3%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           D F +  ++G G FG ++  +++  G   A K  +++  +  K ++    E +++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           R +V +  +        L+M  M  G +   +Y+       FQ    +   A  +  L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYG 791
            H   II+ DLKP NVLLD+D    ISD G+A +L +G+ +         T G+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    D ++ G+ L EM   + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIR 671
           + + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEIL 175
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            G K    T  D++S G +  EM T++
Sbjct: 176 LGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 663 ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           E  VM+++ +  +V++I  C  + +  L+M+    G L   L     + D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLA 781
           V++ ++YL     +  +H DL   NVLL     A ISDFG++K L + E+    Q     
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKP 818
            + + APE     +  ++ DV+S+G+++ E F+  +KP
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/209 (21%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
           +D +     +G G+F  +        G+E A K+ + +    R  +  E E  + ++++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S   + F  L+   +  G     L+      + +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 733 GHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            HS  I+H +LKP N+LL    +     ++DFG+A  ++  +          T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPE 177
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              K       D+++ G++L  +     P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/209 (21%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
           +D +     +G G+F  +        G+E A K+ + +    R  +  E E  + ++++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S   + F  L+   +  G     L+      + +   +    +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 733 GHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            HS  I+H +LKP N+LL    +     ++DFG+A  ++  +          T GY++PE
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPE 176
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              K       D+++ G++L  +     P
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 45/209 (21%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 616 TDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
           +D +     +G G+F  +        G+E A K+ + +    R  +  E E  + ++++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N+V++  S   + F  L+   +  G     L+      + +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 733 GHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            HS  I+H +LKP N+LL    +     ++DFG+A  ++  +          T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPE 177
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              K       D+++ G++L  +     P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+     +G G++G + + + +  G E A+K+  +          +  DE  V+K++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N++K+     +     L+M+    G L    +    +   F  ++  + +   L    
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 732 FGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           + H   I+H DLKP N+LL+    D +  I DFG++       ++    + L T  Y+AP
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK---ERLGTAYYIAP 192
Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E   K +   + DV+S G++L  +     P
Sbjct: 193 EVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL------ 727
           N+VK++     ++   L+ +++               L  F   + +  + L L      
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD------------LKTFMDASALTGIPLPLIKSYLF 109
Query: 728 ---EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
              + L F HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ 
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLW 167
Query: 785 YMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           Y APE   G K    T  D++S G +  EM T++
Sbjct: 168 YRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +  G  VA+K      + E    +   E  ++K + H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 122
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLG 180
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 181 CK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 613 LRATDRFSENNLIGIGSFG----SIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMK 668
           ++ TD +     IG+GS+      I+ A     ME AVK+     +++ +   +E E++ 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKII----DKSKRDPTEEIEILL 70
Query: 669 RI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           R  +H N++ +     +  +  ++ + M  G L + +       +  +   ++  +   +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTV 129
Query: 728 EYLHFGHSTPIIHCDLKPSNVL-LDED---MVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           EYLH   +  ++H DLKPSN+L +DE        I DFG AK L  E+ L   +    T 
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTA 184
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            ++APE   +       D++S G++L  M T   P
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 8/207 (3%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           D F +  ++G G FG ++  +++  G   A K  +++  +  K ++    E +++ ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           R +V +  +        L+M  M  G +   +Y+       FQ    +   A  +  L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQTLATIGYMAPEYG 791
            H   II+ DLKP NVLLD+D    ISD G+A +L +G+ +         T G+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    D ++ G+ L EM   + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 622 NNLIGIGSFGSIYVARLQD-GMEVAVKVFHQ-QYERALKSFEDECEVMKRIRHRNLVKI- 678
           ++++G G+  +++  R +  G   A+KVF+   + R +     E EV+K++ H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 679 -ISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            I   +    K LIM++ P GSL   L   S    L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RE 130
Query: 736 TPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
             I+H ++KP N++     D   V  ++DFG A+ L  ++Q    +    T  Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGTEEYLHPD 185

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 622 NNLIGIGSFGSIYVARLQD-GMEVAVKVFHQ-QYERALKSFEDECEVMKRIRHRNLVKI- 678
           ++++G G+  +++  R +  G   A+KVF+   + R +     E EV+K++ H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 679 -ISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
            I   +    K LIM++ P GSL   L   S    L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RE 130
Query: 736 TPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
             I+H ++KP N++     D   V  ++DFG A+ L  ++Q    +    T  Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPD 185

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 135
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 123
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALK---SFEDECEVMKRIR 671
           +DR+     +G G++G + + + +  G E A+K+  +          +  DE  V+K++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N++K+     +     L+M+    G L    +    +   F  ++  + +   L    
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 732 FGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           + H   I+H DLKP N+LL+    D +  I DFG++       ++    + L T  Y+AP
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK---ERLGTAYYIAP 175
Query: 789 EYGTKGRVCTRGDVYSYGIML 809
           E   K +   + DV+S G++L
Sbjct: 176 EVLRK-KYDEKCDVWSCGVIL 195

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 145
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 61/127 (48%), Gaps = 20/127 (15%)
Query: 707 GTCMLDIFQRLN----------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA 756
           GTC   + +R+           + + +  AL YL   H   +IH D+KPSN+LLDE    
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQI 164
Query: 757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY-----GTKGRVCTRGDVYSYGIMLME 811
            + DFGI+  L  +     + ++     YMAPE       TK     R DV+S GI L+E
Sbjct: 165 KLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 812 MFTKKKP 818
           + T + P
Sbjct: 222 LATGQFP 228

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 143
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 125
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 621 ENNLIGIGSFGSI----YVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIRHRNL 675
           E+  +G G+FG++    Y  +          + ++  + ALK     E  VM+++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L     + D    + ++  V++ ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
           +  +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 795 RVCTRGDVYSYGIMLMEMFT-KKKP 818
           +  ++ DV+S+G+++ E F+  +KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 617 DRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           +R+   + +G G++GS+  A   + G  VAVK   + ++    A +++  E  ++K ++H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 80
Query: 673 RNLVKIIS----SCSNDDF-KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++     + S ++F    ++ ++    L N +       D  Q L   I     L
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----L 135
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L + HS  IIH DLKPSN+ ++ED    I DF +A+    +D+++  +   AT  Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYV---ATRWYRA 190
Query: 788 PEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           PE         +  D++S G ++ E+ T +
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRHRNLVKI 678
            +IG G+FG + V +L++  +V A+K+ +  +  +RA  + F +E +V+     + +  +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  +D+   L+M Y   G L   L      L        + ++ +A++ +H  H    
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---Y 196
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIA-KLLS-GEDQLSIQIQTLATIGYMAPEY-----G 791
           +H D+KP N+L+D +    ++DFG   KL+  G  Q S+ +    T  Y++PE      G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV---GTPDYISPEILQAMEG 253
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            KGR     D +S G+ + EM   + P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 625 IGIGSFGSI----YVARLQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +    + A     + VAVK           A+  F  E   M  + HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +         K ++ +  P GSL + L  + G  +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKG 794
              IH DL   N+LL    +  I DFG+ + L   +D   +Q        + APE     
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D + +G+ L EMFT
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 622 NNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRN 674
           + ++G GSFG +++A  +   +  A+K   +  +  L   + EC  V KR+      H  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFG 733
           L  +  +    +    +M+Y+  G L    +  +C   D+ +      ++ L L++LH  
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLH-- 135
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSIQIQTLATIGYMAPEYGT 792
            S  I++ DLK  N+LLD+D    I+DFG+ K  + G+ + +       T  Y+APE   
Sbjct: 136 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---XFCGTPDYIAPEILL 191
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +     D +S+G++L EM   + P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           FS + +IG G FG +Y  R  D G   A+K   +   + +K  + E   +     R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALN---ERIMLS 243
Query: 678 IISS-------CSNDDFK-----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           ++S+       C +  F      + I+  M  G L   L       +   R     ++ L
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 302
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            LE++H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ T GY
Sbjct: 303 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 355
Query: 786 MAPEYGTKGRVC-TRGDVYSYGIMLMEM------FTKKKPTDEIFIGELSL 829
           MAPE   KG    +  D +S G ML ++      F + K  D+  I  ++L
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           FS + +IG G FG +Y  R  D G   A+K   +   + +K  + E   +     R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALN---ERIMLS 244
Query: 678 IISS-------CSNDDFK-----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           ++S+       C +  F      + I+  M  G L   L       +   R     ++ L
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            LE++H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ T GY
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 786 MAPEYGTKGRVC-TRGDVYSYGIMLMEM------FTKKKPTDEIFIGELSL 829
           MAPE   KG    +  D +S G ML ++      F + K  D+  I  ++L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 31/245 (12%)
Query: 592 GPSNDGIN-SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG--------M 642
           G S   +N  P+ IR   + ELLR         ++G G +G ++  R   G        M
Sbjct: 1   GSSETSVNRGPEKIRPECF-ELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAM 50
Query: 643 EVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
           +V  K    +  +     + E  +++ ++H  +V +I +        LI++Y+  G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 703 CL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF 761
            L   G  M D       + ++++AL +LH      II+ DLKP N++L+      ++DF
Sbjct: 111 QLEREGIFMEDT--ACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDF 165
Query: 762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
           G+ K        ++      TI YMAPE   +       D +S G ++ +M T   P   
Sbjct: 166 GLCK--ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--- 220
Query: 822 IFIGE 826
            F GE
Sbjct: 221 -FTGE 224

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 31/245 (12%)
Query: 592 GPSNDGIN-SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG--------M 642
           G S   +N  P+ IR   + ELLR         ++G G +G ++  R   G        M
Sbjct: 1   GSSETSVNRGPEKIRPECF-ELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAM 50
Query: 643 EVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
           +V  K    +  +     + E  +++ ++H  +V +I +        LI++Y+  G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 703 CL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF 761
            L   G  M D       + ++++AL +LH      II+ DLKP N++L+      ++DF
Sbjct: 111 QLEREGIFMEDT--ACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDF 165
Query: 762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
           G+ K        ++      TI YMAPE   +       D +S G ++ +M T   P   
Sbjct: 166 GLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--- 220
Query: 822 IFIGE 826
            F GE
Sbjct: 221 -FTGE 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 12/191 (6%)
Query: 625 IGIGSFGSIY-VARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G+F  +    ++  G E A K+ + +    R  +  E E  + + ++H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
            S +    LI   +  G     L+      + +   +    +   LE +   H   ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 742 DLKPSNVLLDEDM---VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           DLKP N+LL   +      ++DFG+A  + GE Q         T GY++PE   K     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 799 RGDVYSYGIML 809
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           FS + +IG G FG +Y  R  D G   A+K   +   + +K  + E   +     R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALN---ERIMLS 244
Query: 678 IISS-------CSNDDFK-----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           ++S+       C +  F      + I+  M  G L   L       +   R     ++ L
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            LE++H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ T GY
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 786 MAPEYGTKGRVC-TRGDVYSYGIMLMEM------FTKKKPTDEIFIGELSL 829
           MAPE   KG    +  D +S G ML ++      F + K  D+  I  ++L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK 677
           FS + +IG G FG +Y  R  D G   A+K   +   + +K  + E   +     R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALN---ERIMLS 244
Query: 678 IISS-------CSNDDFK-----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           ++S+       C +  F      + I+  M  G L   L       +   R     ++ L
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            LE++H   +  +++ DLKP+N+LLDE     ISD G+A   S +   +    ++ T GY
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 786 MAPEYGTKGRVC-TRGDVYSYGIMLMEM------FTKKKPTDEIFIGELSL 829
           MAPE   KG    +  D +S G ML ++      F + K  D+  I  ++L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV----AVKVFHQ----QYERALKSFEDECEVMKRIRHRN 674
            ++G G++G +++ R   G +     A+KV  +    Q  +  +    E +V++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 675 LVKIISSCSNDDFK-ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI---DVALALEYL 730
            +  +      + K  LI+ Y+  G L    ++     + F    + I   ++ LALE+L
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H      II+ D+K  N+LLD +    ++DFG++K     D+         TI YMAP+ 
Sbjct: 176 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDI 231
Query: 791 GTKGRVCTRG--DVYSYGIMLMEMFTKKKP 818
              G        D +S G+++ E+ T   P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAV--KV-FHQQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +   EV    K+    + E    +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 177
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 178 CK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAV--KV-FHQQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR +   EV    K+    + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++ +  L+  +   + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YG 791
           HS  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y APE   G
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 176
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKK 816
            K    T  D++S G +  EM T++
Sbjct: 177 CK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKS 659
           H+     +R S    +G G+FG +  A      +    M VAVK+     H     AL S
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------SG 707
              E +V+  +  H N+V ++ +C+      +I +Y   G L N L            S 
Sbjct: 99  ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 708 TCMLDIFQRLNIMIDVALALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
             M D    L++   ++ + +    + F  S   IH DL   N+LL    +  I DFG+A
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +  +    ++      + +MAPE           DV+SYGI L E+F+
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 9/195 (4%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D +  +  +G G+FG ++ V     G   A K     +E   ++   E + M  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V +  +  +D+   +I ++M  G L   +      +   + +  M  V   L ++H  + 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 736 TPIIHCDLKPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
              +H DLKP N++        +   DFG+   L  +  + +   T  T  + APE    
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 330
Query: 794 GRVCTRGDVYSYGIM 808
             V    D++S G++
Sbjct: 331 KPVGYYTDMWSVGVL 345

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 625 IGIGSFGSIYVARLQDGM-EVAVKVFHQ-QYERA--------LKSFEDEC----EVMKRI 670
           +G G++G + + + ++G  E A+KV  + Q+++         ++ F +E      ++K +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
            H N++K+     +  +  L+ ++   G L   + +     D     NIM  +   + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL 162
Query: 731 HFGHSTPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           H      I+H D+KP N+LL+     +   I DFG++   S + +L      L T  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIA 216
Query: 788 PEYGTKGRVCTRGDVYSYGIML 809
           PE   K +   + DV+S G+++
Sbjct: 217 PEV-LKKKYNEKCDVWSCGVIM 237

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKS 659
           H+     +R S    +G G+FG +  A      +    M VAVK+     H     AL S
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------SG 707
              E +V+  +  H N+V ++ +C+      +I +Y   G L N L            S 
Sbjct: 76  ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 708 TCMLDIFQRLNIMIDVALALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
             M D    L++   ++ + +    + F  S   IH DL   N+LL    +  I DFG+A
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +  +    ++      + +MAPE           DV+SYGI L E+F+
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKS 659
           H+     +R S    +G G+FG +  A      +    M VAVK+     H     AL S
Sbjct: 32  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 91
Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------SG 707
              E +V+  +  H N+V ++ +C+      +I +Y   G L N L            S 
Sbjct: 92  ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 148
Query: 708 TCMLDIFQRLNIMIDVALALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
             M D    L++   ++ + +    + F  S   IH DL   N+LL    +  I DFG+A
Sbjct: 149 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 208
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +  +    ++      + +MAPE           DV+SYGI L E+F+
Sbjct: 209 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 22/252 (8%)
Query: 589 SRTGPS---NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEV 644
            R GP    N+G+   + ++   Y E        +    +G GSFG ++  +  Q G + 
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 645 AVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           AVK    +  R      +E      +    +V +  +     +  + M+ +  GSL   +
Sbjct: 87  AVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGI 763
               C+ +       +  +  ALE L + H+  I+H D+K  NVLL  D   A + DFG 
Sbjct: 142 KQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 764 AKLLSGEDQLSIQIQT----LATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           A  L   D L   + T      T  +MAPE    G+ C  + D++S   M++ M     P
Sbjct: 198 ALCLQ-PDGLGKSLLTGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 819 TDEIFIGELSLN 830
             + F G L L 
Sbjct: 256 WTQYFRGPLCLK 267

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIR 671
           +R      IG G FG     IY++     M VA+K        +++  F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+  +    + DFG+++ +            L  I +MAPE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP-IKWMAPESI 184
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 9/195 (4%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D +  +  +G G+FG ++ V     G   A K     +E   ++   E + M  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V +  +  +D+   +I ++M  G L   +      +   + +  M  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 736 TPIIHCDLKPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
              +H DLKP N++        +   DFG+   L  +  + +   T  T  + APE    
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 224
Query: 794 GRVCTRGDVYSYGIM 808
             V    D++S G++
Sbjct: 225 KPVGYYTDMWSVGVL 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKS 659
           H+     +R S    +G G+FG +  A      +    M VAVK+     H     AL S
Sbjct: 34  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 93
Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------SG 707
              E +V+  +  H N+V ++ +C+      +I +Y   G L N L            S 
Sbjct: 94  ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 150
Query: 708 TCMLDIFQRLNIMIDVALALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
             M D    L++   ++ + +    + F  S   IH DL   N+LL    +  I DFG+A
Sbjct: 151 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +  +    ++      + +MAPE           DV+SYGI L E+F+
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSI-YVARLQDGMEVAVKVFHQQYERALKSFEDECEVM 667
           Y + +  +D +     IG+GS+            ME AVKV     +++ +   +E E++
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEIL 74
Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
            R  +H N++ +     +     L+ + M  G L + +       +      ++  +   
Sbjct: 75  LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKT 133
Query: 727 LEYLHFGHSTPIIHCDLKPSNVL-LDED---MVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           +EYLH   S  ++H DLKPSN+L +DE        I DFG AK L  E+ L   +    T
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL--LMTPCYT 188
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             ++APE   +       D++S GI+L  M     P
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 28/230 (12%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF----HQQYERALKS 659
           H+     +R S    +G G+FG +  A      +    M VAVK+     H     AL S
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------SG 707
              E +V+  +  H N+V ++ +C+      +I +Y   G L N L            S 
Sbjct: 99  ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 708 TCMLDIFQRLNIMIDVALALEY---LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
             M D    L++   ++ + +    + F  S   IH DL   N+LL    +  I DFG+A
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +  +    ++      + +MAPE           DV+SYGI L E+F+
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 22/252 (8%)
Query: 589 SRTGPS---NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEV 644
            R GP    N+G+   + ++   Y E        +    +G GSFG ++  +  Q G + 
Sbjct: 44  QRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 102
Query: 645 AVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           AVK    +  R      +E      +    +V +  +     +  + M+ +  GSL   +
Sbjct: 103 AVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 157
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGI 763
               C+ +       +  +  ALE L + H+  I+H D+K  NVLL  D   A + DFG 
Sbjct: 158 KQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 213
Query: 764 AKLLSGEDQLSIQIQT----LATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           A  L   D L   + T      T  +MAPE    G+ C  + D++S   M++ M     P
Sbjct: 214 ALCLQ-PDGLGKSLLTGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHP 271
Query: 819 TDEIFIGELSLN 830
             + F G L L 
Sbjct: 272 WTQYFRGPLCLK 283

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMS---ELK 84
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           ++  I H  N+V ++ +C+      + I+++   G+L   L S       ++  ++  D 
Sbjct: 85  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF 144
Query: 724 ALALEYL-----------HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
            L LE+L            F  S   IH DL   N+LL E  V  I DFG+A+ +  +  
Sbjct: 145 -LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 616 TDRFSENNLIGIGSFGSI-YVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHR 673
           +D +     IG+GS+            ME AVKV     +++ +   +E E++ R  +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N++ +     +     L+ + M  G L + +       +      ++  +   +EYLH  
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH-- 138
Query: 734 HSTPIIHCDLKPSNVL-LDED---MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
            S  ++H DLKPSN+L +DE        I DFG AK L  E+ L   +    T  ++APE
Sbjct: 139 -SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL--LMTPCYTANFVAPE 195
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              +       D++S GI+L  M     P
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 22/252 (8%)
Query: 589 SRTGPS---NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEV 644
            R GP    N+G+   + ++   Y E        +    +G GSFG ++  +  Q G + 
Sbjct: 42  QRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQC 100
Query: 645 AVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           AVK    +  R      +E      +    +V +  +     +  + M+ +  GSL   +
Sbjct: 101 AVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 155
Query: 705 YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGI 763
               C+ +       +  +  ALE L + H+  I+H D+K  NVLL  D   A + DFG 
Sbjct: 156 KQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 211
Query: 764 AKLLSGEDQLSIQIQT----LATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKP 818
           A  L   D L   + T      T  +MAPE    G+ C  + D++S   M++ M     P
Sbjct: 212 ALCLQ-PDGLGKSLLTGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHP 269
Query: 819 TDEIFIGELSLN 830
             + F G L L 
Sbjct: 270 WTQYFRGPLCLK 281

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 614 RATDRFSENNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI- 670
           R T  F E   IG G FGS++  V RL DG   A+K    + ++ L    DE   ++ + 
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 671 ------RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMI 721
                 +H ++V+  S+ + DD   +  +Y   GSL + +     ++  F+     ++++
Sbjct: 59  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 118
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLL 750
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 119 QVGRGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 610 HELLRATDRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDEC 664
           +E+ R  +R      IG G FG     IY++     M VA+K        +++  F  E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
             M++  H ++VK+I   + +    +IM+    G L + L      LD+   +     ++
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 121
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+  +    + DFG+++ +            L  I 
Sbjct: 122 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK 177
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
           +MAPE     R  +  DV+ +G+ + E+ 
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 614 RATDRFSENNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI- 670
           R T  F E   IG G FGS++  V RL DG   A+K    + ++ L    DE   ++ + 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 671 ------RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMI 721
                 +H ++V+  S+ + DD   +  +Y   GSL + +     ++  F+     ++++
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLL 750
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 44/206 (21%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFE-------------DECEVMKRIR 671
           +G G++G + + R         KV H   ERA+K                +E  V+K + 
Sbjct: 45  LGSGAYGEVLLCR--------DKVTH--VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNI-MIDVALALEYL 730
           H N++K+     +     L+M+         C   G    +I  R+    +D A+ ++ +
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVME---------CYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 731 HFG----HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
             G    H   I+H DLKP N+LL   ++D +  I DFG++ +   + ++    + L T 
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIML 809
            Y+APE   K +   + DV+S G++L
Sbjct: 203 YYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 614 RATDRFSENNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI- 670
           R T  F E   IG G FGS++  V RL DG   A+K    + ++ L    DE   ++ + 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 671 ------RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMI 721
                 +H ++V+  S+ + DD   +  +Y   GSL + +     ++  F+     ++++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLL 750
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFH-QQYERALKSFEDECEVMKRIRH---- 672
           F     +G G FG ++ A+ + D    A+K       E A +    E + + ++ H    
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 673 --------RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR---LNIMI 721
                   +N  + +   S   +  + M+     +L++ + +G C ++  +R   L+I +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFL 125
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            +A A+E+LH   S  ++H DLKPSN+    D V  + DFG+   +  +++    +  + 
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 782 TIG----------YMAPEYGTKGRVCTRGDVYSYGIMLMEM 812
                        YM+PE         + D++S G++L E+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 614 RATDRFSENNLIGIGSFGSIY--VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI- 670
           R T  F E   IG G FGS++  V RL DG   A+K    + ++ L    DE   ++ + 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 671 ------RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---NIMI 721
                 +H ++V+  S+ + DD   +  +Y   GSL + +     ++  F+     ++++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLL 750
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E+ V  I DFG+A+ +        +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE        T+ DV+SYG++L E+F+
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 31/185 (16%)
Query: 610 HELLRATDRFSENNLIGIGSFGSIYVARLQDGME---VAVKVFHQQYERALKSFED---- 662
           H   +  DR+   +LIG GS+G  +V    D +E   VA+K       + L+ FED    
Sbjct: 46  HSDWQIPDRYEIRHLIGTGSYG--HVCEAYDKLEKRVVAIK-------KILRVFEDLIDC 96
Query: 663 -----ECEVMKRIRHRNLVKIISSCSNDD---FKALIMKYMPNGSLENCLYSGTCMLDIF 714
                E  ++ R+ H ++VK++      D   F  L +      S    L+     L   
Sbjct: 97  KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL----SGE 770
               ++ ++ + ++Y+H   S  I+H DLKP+N L+++D    + DFG+A+ +    +G 
Sbjct: 157 HIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 771 DQLSI 775
            QL I
Sbjct: 214 SQLPI 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALK-SFEDECEVMKRIR 671
           +R      IG G FG     IY++     M VA+K        +++  F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+       + DFG+++ +            L  I +MAPE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESI 184
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR +    +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 83
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           ++  I H  N+V ++ +C+      + I+++   G+L   L S       ++    +   
Sbjct: 84  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD 143
Query: 724 ALALEYL-----------HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
            L LE+L            F  S   IH DL   N+LL E  V  I DFG+A+ +  +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDECEVMKRIR 671
           +R      IG G FG     IY++     M VA+K        +++  F  E   M++  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+  +    + DFG+++ +            L  I +MAPE  
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESI 564
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 610 HELLRATDRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALK-SFEDEC 664
           +E+ R  +R      IG G FG     IY++     + VA+K        +++  F  E 
Sbjct: 33  YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
             M++  H ++VK+I   + +    +IM+    G L + L      LD+   +     ++
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 149
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+  +    + DFG+++ +            L  I 
Sbjct: 150 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK 205
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
           +MAPE     R  +  DV+ +G+ + E+ 
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR +    +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMS---ELK 82
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCML----DIFQR--- 716
           ++  I H  N+V ++ +C+      + I+++   G+L   L S         D+++    
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 717 ----LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
               +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +  
Sbjct: 143 LEHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 614 RATDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRI 670
           R T+ +     +G G+F  +    ++  G E A  + + +    R  +  E E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           +H N+V++  S S +    LI   +  G     L+      + +   +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAV 123
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
              H   ++H +LKP N+LL   +      ++DFG+A  + GE Q         T GY++
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLS 181
Query: 788 PEYGTKGRVCTRGDVYSYGIML 809
           PE   K       D+++ G++L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVIL 203

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 631 GSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSND--D 686
           G ++  R Q G ++ VKV   +    R  + F +EC  ++   H N++ ++ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 687 FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPII--HCDL 743
              LI  + P GSL N L+ GT  ++D  Q +   +D A    +LH     P+I  H  L
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPEYGTKGRVCTR--- 799
              +V +DED  A IS          + + S Q         ++APE   K    T    
Sbjct: 140 NSRSVXIDEDXTARIS--------XADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRS 191
Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
            D +S+ ++L E+ T++ P  ++   E+     +  L P
Sbjct: 192 ADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRP 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQ---YERALKSFEDECEVMKR 669
           +  DRF    + G G+FG++ + + +  GM VA+K   Q      R L+  +D    +  
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAV 75
Query: 670 IRHRNLVKIIS-------SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL----N 718
           + H N+V++ S           D +  ++M+Y+P+ +L  C        + ++R      
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC------RNYYRRQVAPPP 128
Query: 719 IMIDVAL-----ALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQ 772
           I+I V L     ++  LH   S  + H D+KP NVL++E D    + DFG AK LS  + 
Sbjct: 129 ILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 773 LSIQIQTLATIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEM 812
               +  + +  Y APE  +G +    T  D++S G +  EM
Sbjct: 188 ---NVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEM 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDECEVMKRIR 671
           +R      IG G FG     IY++     + VA+K        +++  F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+  +    + DFG+++ +            L  I +MAPE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESI 184
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG G++G +Y A+   G   A+K     ++ E    +   E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                  L+ +++ +  L+  L      L+     + ++ +   + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YGTKGRVCTRG 800
           LKP N+L++ +    I+DFG+A+       +      + T+ Y AP+   G+K +  T  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTI 182
Query: 801 DVYSYGIMLMEM 812
           D++S G +  EM
Sbjct: 183 DIWSVGCIFAEM 194

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 610 HELLRATDRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALK-SFEDEC 664
           +E+ R  +R      IG G FG     IY++     + VA+K        +++  F  E 
Sbjct: 10  YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
             M++  H ++VK+I   + +    +IM+    G L + L      LD+   +     ++
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+  +    + DFG+++ +            L  I 
Sbjct: 127 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK 182
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
           +MAPE     R  +  DV+ +G+ + E+ 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 125
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 183
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 663 ECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR--LNI 719
           E ++++++  H N++++  +   + F  L+   M  G L + L     + +   R  +  
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           +++V  AL      H   I+H DLKP N+LLD+DM   ++DFG +  L   ++L    + 
Sbjct: 120 LLEVICAL------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 170
Query: 780 LATIGYMAPE 789
             T  Y+APE
Sbjct: 171 CGTPSYLAPE 180

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 663 ECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR--LNI 719
           E ++++++  H N++++  +   + F  L+   M  G L + L     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           +++V  AL      H   I+H DLKP N+LLD+DM   ++DFG +  L   ++L    + 
Sbjct: 133 LLEVICAL------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 183
Query: 780 LATIGYMAPE 789
             T  Y+APE
Sbjct: 184 CGTPSYLAPE 193

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 127
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 185
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG G++G +Y A+   G   A+K     ++ E    +   E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                  L+ +++ +  L+  L      L+     + ++ +   + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--GTKGRVCTRG 800
           LKP N+L++ +    I+DFG+A+       +      + T+ Y AP+   G+K +  T  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 801 DVYSYGIMLMEM 812
           D++S G +  EM
Sbjct: 183 DIWSVGCIFAEM 194

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 610 HELLRATDRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDEC 664
           +E+ R  +R      IG G FG     IY++     + VA+K        +++  F  E 
Sbjct: 8   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
             M++  H ++VK+I   + +    +IM+    G L + L      LD+   +     ++
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 124
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+  +    + DFG+++ +            L  I 
Sbjct: 125 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK 180
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
           +MAPE     R  +  DV+ +G+ + E+ 
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG G++G +Y A+   G   A+K     ++ E    +   E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                  L+ +++ +  L+  L      L+     + ++ +   + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--GTKGRVCTRG 800
           LKP N+L++ +    I+DFG+A+       +      + T+ Y AP+   G+K +  T  
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 801 DVYSYGIMLMEM 812
           D++S G +  EM
Sbjct: 183 DIWSVGCIFAEM 194

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 619 FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRN 674
           F    L+G G+FG + + R +  G   A+K+  ++    +  +     E  V++  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           L  +  +    D    +M+Y   G L   L       +   R     ++  ALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ D+K  N++LD+D    I+DFG+ K   G    +       T  Y+APE     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
                 D +  G+++ EM   + P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 625 IGIGSFGSI-YVARLQDGMEVAVK--VFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G F  +  V  L DG   A+K  + H+Q +R  +  + E ++ +   H N++++++ 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLVAY 94
Query: 682 CSNDDFKA----LIMKYMPNGSLEN---CLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           C  +        L++ +   G+L N    L      L   Q L +++ +   LE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-------ATIGYMA 787
           +    H DLKP+N+LL ++    + D G         + S Q  TL        TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 788 PEYGTKGRVCT---RGDVYSYGIMLMEMFTKKKPTDEIF 823
           PE  +    C    R DV+S G +L  M   + P D +F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++ E+  ++ + E    + +R
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSL-ENCLYSGTCMLD----IFQRLNIMIDVALA 726
           H N+V+           A++M+Y   G L E    +G    D     FQ+L         
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--------- 124
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIG 784
           +  + + H+  + H DLK  N LLD        I+DFG +K      Q       + T  
Sbjct: 125 ISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPK---SAVGTPA 181
Query: 785 YMAPEYGTKGRVCTR-GDVYSYGIMLMEMFTKKKPTDE 821
           Y+APE   K     +  DV+S G+ L  M     P ++
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 610 HELLRATDRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDEC 664
           +E+ R  +R      IG G FG     IY++     + VA+K        +++  F  E 
Sbjct: 7   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
             M++  H ++VK+I   + +    +IM+    G L + L      LD+   +     ++
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 123
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            AL YL    S   +H D+   NVL+  +    + DFG+++ +            L  I 
Sbjct: 124 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK 179
Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
           +MAPE     R  +  DV+ +G+ + E+ 
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDECEVMKRIR 671
           +R      IG G FG     IY++     M VA+K        +++  F  E   M++  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+       + DFG+++ +            L  I +MAPE  
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESI 564
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR +    +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMS---ELK 82
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCML----DIFQRLNI 719
           ++  I H  N+V ++ +C+      + I+++   G+L   L S         D+++    
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 720 M-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
           +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +  
Sbjct: 143 LEHLICYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 10/202 (4%)
Query: 617 DRFSENNLIGIGSFGS----IYVARLQDGMEVAVKVFHQQYERALKS-FEDECEVMKRIR 671
           +R      IG G FG     IY++     + VA+K        +++  F  E   M++  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + +    +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+  +    + DFG+++ +            L  I +MAPE  
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESI 181
Query: 792 TKGRVCTRGDVYSYGIMLMEMF 813
              R  +  DV+ +G+ + E+ 
Sbjct: 182 NFRRFTSASDVWMFGVCMWEIL 203

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 89/187 (47%), Gaps = 9/187 (4%)
Query: 625 IGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G+FG ++       G     K  +  Y     + ++E  +M ++ H  L+ +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +     LI++++  G L + + +    +   + +N M      L+++H  HS  I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHS--IVHLDI 175
Query: 744 KPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           KP N++ +    + +   DFG+A  L+ ++ + +   T AT  + APE   +  V    D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTD 232
Query: 802 VYSYGIM 808
           +++ G++
Sbjct: 233 MWAIGVL 239

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERAL--KSFEDECEVMKR 669
           ++  D +   +LIG GS+G +Y+A  ++  + VA+K  ++ +E  +  K    E  ++ R
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 670 IRHRNLVKIISSCSNDD---FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++   ++++      +D   F  L +      S    L+     L       I+ ++ L 
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
            +++H    + IIH DLKP+N LL++D    I DFG+A+ ++ +  + I
Sbjct: 144 EKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 67/131 (51%), Gaps = 14/131 (10%)
Query: 663 ECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQR--LNI 719
           E ++++++  H N++++  +   + F  L+   M  G L + L     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSIQIQ 778
           +++V  AL      H   I+H DLKP N+LLD+DM   ++DFG + +L  GE   S+   
Sbjct: 133 LLEVICAL------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV--- 183
Query: 779 TLATIGYMAPE 789
              T  Y+APE
Sbjct: 184 -CGTPSYLAPE 193

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 82/169 (48%), Gaps = 9/169 (5%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYERAL--KSFEDECEVMKR 669
           +   D +   +LIG GS+G +Y+A  ++  + VA+K  ++ +E  +  K    E  ++ R
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 670 IRHRNLVKIISSCSNDD---FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++   ++++      DD   F  L +      S    L+     L       I+ ++ L 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
             ++H    + IIH DLKP+N LL++D    + DFG+A+ ++ E   +I
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 16/216 (7%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++ E+   + + E    + +R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLR 73
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+           A++M+Y   G     L+   C    F            +  + 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + H+  + H DLK  N LLD        I DFG +K      Q      T+ T  Y+APE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 186
Query: 790 YGTK----GRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
              K    G+V    DV+S G+ L  M     P ++
Sbjct: 187 VLLKKEYDGKV---ADVWSCGVTLYVMLVGAYPFED 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVKII-- 679
           +G G++GS+  A   + G +VA+K   + ++  +  K    E  ++K ++H N++ ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 680 ----SSCSN-DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
               SS  N  DF  L+M +M    L+        M   F    I   V   L+ L + H
Sbjct: 92  FTPASSLRNFYDF-YLVMPFM-QTDLQKI------MGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  ++H DLKP N+ ++ED    I DFG+A+    E         + T  Y APE     
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW 198
Query: 795 RVCTRG-DVYSYGIMLMEMFTKK 816
               +  D++S G ++ EM T K
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 16/216 (7%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++ E+  ++ + E    + +R
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+           A++M+Y   G     L+   C    F            +  + 
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + H+  + H DLK  N LLD        I DFG +K      Q      T+ T  Y+APE
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 185
Query: 790 YGTK----GRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
              K    G+V    DV+S G+ L  M     P ++
Sbjct: 186 VLLKKEYDGKV---ADVWSCGVTLYVMLVGAYPFED 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERAL--KSFEDECEVMKRIRHRNLVKII-- 679
           +G G++GS+  A   + G +VA+K   + ++  +  K    E  ++K ++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 680 ----SSCSN-DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
               SS  N  DF  L+M +M    L+        M   F    I   V   L+ L + H
Sbjct: 110 FTPASSLRNFYDF-YLVMPFM-QTDLQKI------MGMEFSEEKIQYLVYQMLKGLKYIH 161
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  ++H DLKP N+ ++ED    I DFG+A+    E         + T  Y APE     
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW 216
Query: 795 RVCTRG-DVYSYGIMLMEMFTKK 816
               +  D++S G ++ EM T K
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 13/106 (12%)
Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ---- 772
           L+I I +A A+E+LH   S  ++H DLKPSN+    D V  + DFG+   +  +++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 773 ------LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEM 812
                  +     + T  YM+PE         + D++S G++L E+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           H D+KP N+L+  D  A++ DFGIA   + E +L+    T+ T+ Y APE  ++     R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 800 GDVYSYGIMLMEMFTKKKP--TDEIFIGELSLNRWI 833
            D+Y+   +L E  T   P   D++ +    +N+ I
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAI 251

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 43/246 (17%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDEC 664
           R   R+     +G G F   Y     D  EV A KV         HQ+     +    E 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-----EKMSTEI 93
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            + K + + ++V       +DDF  ++++     SL         + +   R   M    
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTI 152
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLAT 782
             ++YLH   +  +IH DLK  N+ L++DM   I DFG+A  +   GE + ++      T
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL----CGT 205
Query: 783 IGYMAPEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKPTD-----EIFI----GELS 828
             Y+APE      +C +G     D++S G +L  +   K P +     E +I     E S
Sbjct: 206 PNYIAPEV-----LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS 260
Query: 829 LNRWIN 834
           + R IN
Sbjct: 261 VPRHIN 266

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQY----ERAL--KSFEDECEVMKR 669
           D +     +G G F  +   R +  G E A K   ++      R +  +  E E  +++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD--IFQRLNIMIDVALAL 727
           IRH N++ +     N     LI++ +  G L + L     + +    Q L  ++D     
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG---- 141
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGEDQLSIQIQTLATI 783
             +H+ HS  I H DLKP N++L +  V +    + DFGIA  +   ++         T 
Sbjct: 142 --VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NIFGTP 196
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
            ++APE      +    D++S G++   + +   P    F+GE
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY----ERAL--KSFEDECEVMKR 669
           D +     +G G F  +   R +  G E A K   ++      R +  +  E E  +++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD--IFQRLNIMIDVALAL 727
           IRH N++ +     N     LI++ +  G L + L     + +    Q L  ++D     
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG---- 127
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGEDQLSIQIQTLATI 783
             +H+ HS  I H DLKP N++L +  V +    + DFGIA  +   ++         T 
Sbjct: 128 --VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NIFGTP 182
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
            ++APE      +    D++S G++   + +   P    F+GE
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY----ERAL--KSFEDECEVMKR 669
           D +     +G G F  +   R +  G E A K   ++      R +  +  E E  +++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD--IFQRLNIMIDVALAL 727
           IRH N++ +     N     LI++ +  G L + L     + +    Q L  ++D     
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG---- 120
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGEDQLSIQIQTLATI 783
             +H+ HS  I H DLKP N++L +  V +    + DFGIA  +   ++         T 
Sbjct: 121 --VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NIFGTP 175
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
            ++APE      +    D++S G++   + +   P    F+GE
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 214

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVM-KRI---- 670
           D F    ++G GSFG + +AR+++ G   AVKV  +     L+  + EC +  KRI    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLA 80
Query: 671 -RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
             H  L ++       D    +M+++  G L   +         F         A  +  
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISA 136
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L F H   II+ DLK  NVLLD +    ++DFG+ K   G            T  Y+APE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              +       D ++ G++L EM     P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 618 RFSENNLIGIGSFGSIYVARLQDGME-VAVKVFH--QQYERALKSFEDECEVMKRIRHRN 674
           ++ +   IG G++G+++ A+ ++  E VA+K        E    S   E  ++K ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V++     +D    L+ ++  +  L+   Y  +C  D+   +       L L+ L F H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKK--YFDSCNGDLDPEIVKSFLFQL-LKGLGFCH 118
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YGT 792
           S  ++H DLKP N+L++ +    ++DFG+A+       +      + T+ Y  P+  +G 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
           K    T  D++S G +  E+    +P
Sbjct: 177 K-LYSTSIDMWSAGCIFAELANAARP 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 73
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSG--------TCMLDIFQ 715
           ++  I H  N+V ++ +C+      + I+++   G+L   L S             D+++
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 716 RLNIM-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ + 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQDGME--VAVKVFHQQYERALKSFEDECEVMKRIRHR 673
           +D F   + +G G+   +Y  + Q G +   A+KV  +  ++  K    E  V+ R+ H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHP 108
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSL-----ENCLYSGTCMLDIFQRLNIMIDVALALE 728
           N++K+          +L+++ +  G L     E   YS     D  +++         LE
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI---------LE 159
Query: 729 YLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
            + + H   I+H DLKP N+L      D    I+DFG++K++  E Q+ ++     T GY
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGY 216
Query: 786 MAPEYGTKGRVCTRG---DVYSYGIM 808
            APE     R C  G   D++S GI+
Sbjct: 217 CAPEI---LRGCAYGPEVDMWSVGII 239

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 73
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKALIM------------------KYMPNGSLENCLYS 706
           ++  I H  N+V ++ +C+      +++                  +++P       LY 
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               L +   +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ 
Sbjct: 134 D--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 84
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKALIM------------------KYMPNGSLENCLYS 706
           ++  I H  N+V ++ +C+      +++                  +++P       LY 
Sbjct: 85  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               L +   +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ 
Sbjct: 145 D--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 82
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSG--------TCMLDIFQ 715
           ++  I H  N+V ++ +C+      + I+++   G+L   L S             D+++
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 716 RLNIM-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
            +R++   ++G GSFG +   + +    E AVKV ++     +   +   E E++K++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLNI-MIDVALALEYL 730
            N++K+            I++   +  +   LY+G  + D I +R      D A  ++ +
Sbjct: 81  PNIMKLFE----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 731 HFG----HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
             G    H   I+H DLKP N+LL   ++D    I DFG++       ++  +I    T 
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 784 GYMAPE--YGTKGRVCTRGDVYSYGIML 809
            Y+APE   GT    C   DV+S G++L
Sbjct: 188 YYIAPEVLRGTYDEKC---DVWSAGVIL 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 39/244 (15%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDEC 664
           R   R+     +G G F   Y     D  EV A KV         HQ+     +    E 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-----EKMSTEI 93
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            + K + + ++V       +DDF  ++++     SL         + +   R   M    
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTI 152
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             ++YLH   +  +IH DLK  N+ L++DM   I DFG+A  +  + +    +    T  
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPN 207
Query: 785 YMAPEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKPTD-----EIFI----GELSLN 830
           Y+APE      +C +G     D++S G +L  +   K P +     E +I     E S+ 
Sbjct: 208 YIAPEV-----LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 262
Query: 831 RWIN 834
           R IN
Sbjct: 263 RHIN 266

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 119
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSG--------TCMLDIFQ 715
           ++  I H  N+V ++ +C+      + I+++   G+L   L S             D+++
Sbjct: 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 716 RLNIM-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ + 
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 82
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSG--------TCMLDIFQ 715
           ++  I H  N+V ++ +C+      + I+++   G+L   L S             D+++
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 716 RLNIM-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 82
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSG--------TCMLDIFQ 715
           ++  I H  N+V ++ +C+      + I+++   G+L   L S             D+++
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 716 RLNIM-------IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               +         VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 39/244 (15%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDEC 664
           R   R+     +G G F   Y     D  EV A KV         HQ+     +    E 
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-----EKMSTEI 77
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            + K + + ++V       +DDF  ++++     SL         + +   R   M    
Sbjct: 78  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTI 136
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             ++YLH   +  +IH DLK  N+ L++DM   I DFG+A  +  + +    +    T  
Sbjct: 137 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPN 191
Query: 785 YMAPEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKPTD-----EIFI----GELSLN 830
           Y+APE      +C +G     D++S G +L  +   K P +     E +I     E S+ 
Sbjct: 192 YIAPEV-----LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 246
Query: 831 RWIN 834
           R IN
Sbjct: 247 RHIN 250

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 73
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKALIM------------------KYMPNGSLENCLYS 706
           ++  I H  N+V ++ +C+      +++                  +++P       LY 
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               L +   +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ 
Sbjct: 134 D--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 46/223 (20%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQDGME-VAVKVFHQQYER------ALKSFEDECEVMKR 669
           DR+     +G G++G +Y A      E VA+K    ++E       A++    E  ++K 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL-- 727
           ++HRN++++ S   ++    LI +Y  N              D+ + ++   DV++ +  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN--------------DLKKYMDKNPDVSMRVIK 135
Query: 728 EYLH-------FGHSTPIIHCDLKPSNVLL-----DEDMVAHISDFGIAKLLSGEDQLSI 775
            +L+       F HS   +H DLKP N+LL      E  V  I DFG+A+       + I
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPI 191
Query: 776 Q--IQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTK 815
           +     + T+ Y  PE     R   T  D++S   +  EM  K
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 39/244 (15%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDEC 664
           R   R+     +G G F   Y     D  EV A KV         HQ+     +    E 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-----EKMSTEI 93
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            + K + + ++V       +DDF  ++++     SL         + +   R   M    
Sbjct: 94  AIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTI 152
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             ++YLH   +  +IH DLK  N+ L++DM   I DFG+A  +  + +    +    T  
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL--CGTPN 207
Query: 785 YMAPEYGTKGRVCTRG-----DVYSYGIMLMEMFTKKKPTD-----EIFI----GELSLN 830
           Y+APE      +C +G     D++S G +L  +   K P +     E +I     E S+ 
Sbjct: 208 YIAPEV-----LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 262
Query: 831 RWIN 834
           R IN
Sbjct: 263 RHIN 266

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 617 DRFSENNLIGIGSFGSIYVA------RLQDGMEVAVKVF-----HQQYERALKSFEDECE 665
           DR      +G G+FG +  A      +      VAVK+      H ++ RAL S   E +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMS---ELK 73
Query: 666 VMKRIRHR-NLVKIISSCSNDDFKALIM------------------KYMPNGSLENCLYS 706
           ++  I H  N+V ++ +C+      +++                  +++P       LY 
Sbjct: 74  ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
               L +   +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ 
Sbjct: 134 D--FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  +     +      + +MAPE         + DV+S+G++L E+F+
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEV 666
           +  D +     +G G F  +   R +  G+E A K   ++  RA +        E E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++++ H N++ +     N     LI++ +  G L + L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLAT 782
           + YLH   +  I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGT 181
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
             ++APE      +    D++S G++   + +   P    F+G+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQ--YERALKSFEDECEVMKRI 670
            +R++   ++G GSFG   V + +D +   E AVKV ++     +   +   E E++K++
Sbjct: 21  AERYNIVCMLGKGSFGE--VLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLNI-MIDVALALE 728
            H N++K+            I++   +  +   LY+G  + D I +R      D A  ++
Sbjct: 79  DHPNIMKLFE----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 729 YLHFG----HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            +  G    H   I+H DLKP N+LL   ++D    I DFG++       ++  +I    
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---G 185
Query: 782 TIGYMAPEY--GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           T  Y+APE   GT    C   DV+S G++L  + +   P
Sbjct: 186 TAYYIAPEVLRGTYDEKC---DVWSAGVILYILLSGTPP 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 14/215 (6%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++     ++ + E    + +R
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+           A+IM+Y   G L    Y   C    F            L  + 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAK--LLSGEDQLSIQIQTLATIGYMA 787
           + HS  I H DLK  N LLD        I DFG +K  +L  + +      T+ T  Y+A
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIA 185
Query: 788 PEYGTKGRVCTR-GDVYSYGIMLMEMFTKKKPTDE 821
           PE   +     +  DV+S G+ L  M     P ++
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH 672
            +R++   ++G GSFG +   + +    E AVKV ++     +   +   E E++K++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLNI-MIDVALALEYL 730
            N++K+            I++   +  +   LY+G  + D I +R      D A  ++ +
Sbjct: 81  PNIMKLFE----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 731 HFG----HSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
             G    H   I+H DLKP N+LL   ++D    I DFG++       ++  +I    T 
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTA 187
Query: 784 GYMAPEY--GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            Y+APE   GT    C   DV+S G++L  + +   P
Sbjct: 188 YYIAPEVLRGTYDEKC---DVWSAGVILYILLSGTPP 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 33/245 (13%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 82
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL         + +   R  +   + L  +YLH   
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR 141
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLATIGYMAPEYGT 792
              +IH DLK  N+ L+ED+   I DFG+A  +   GE + ++      T  Y+APE  +
Sbjct: 142 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL----CGTPNYIAPEVLS 194
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVME 843
           K       DV+S G ++  +   K P +          I   E S+ + IN +    + +
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254
Query: 844 VIDTN 848
           ++ T+
Sbjct: 255 MLQTD 259

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 616 TDRFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKS--FED--------EC 664
           + ++S  + +G G+FG ++ A   +   EV VK   +  E+ L+    ED        E 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKK--EKVLEDCWIEDPKLGKVTLEI 80
Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            ++ R+ H N++K++    N  F  L+M+   +G            LD      I   + 
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
            A+ YL       IIH D+K  N+++ ED    + DFG A  L   ++  +      TI 
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIE 194
Query: 785 YMAPE 789
           Y APE
Sbjct: 195 YCAPE 199

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 619 FSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYERALKSFEDECEVMKRIRHR 673
           F   + +G GS+G ++  R  +DG   AVK     F    +RA K  E      K  +H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH-EKVGQHP 117
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
             V++  +        L  +       ++C   G  + +  Q    + D  LAL +LH  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEA-QVWGYLRDTLLALAHLH-- 174
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
            S  ++H D+KP+N+ L       + DFG+   L       +Q        YMAPE   +
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQ 229
Query: 794 GRVCTRGDVYSYGIMLMEM 812
           G   T  DV+S G+ ++E+
Sbjct: 230 GSYGTAADVFSLGLTILEV 248

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEV 666
           +  D +     +G G F  +   R +  G+E A K   ++  RA +        E E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++++ H N++ +     N     LI++ +  G L + L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLAT 782
           + YLH   +  I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGT 181
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIM 808
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 33/245 (13%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 78
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL         + +   R  +   + L  +YLH   
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR 137
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLATIGYMAPEYGT 792
              +IH DLK  N+ L+ED+   I DFG+A  +   GE + ++      T  Y+APE  +
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL----CGTPNYIAPEVLS 190
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVME 843
           K       DV+S G ++  +   K P +          I   E S+ + IN +    + +
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
Query: 844 VIDTN 848
           ++ T+
Sbjct: 251 MLQTD 255

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 33/245 (13%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 78
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL         + +   R  +   + L  +YLH   
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR 137
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLATIGYMAPEYGT 792
              +IH DLK  N+ L+ED+   I DFG+A  +   GE + ++      T  Y+APE  +
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL----CGTPNYIAPEVLS 190
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVME 843
           K       DV+S G ++  +   K P +          I   E S+ + IN +    + +
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
Query: 844 VIDTN 848
           ++ T+
Sbjct: 251 MLQTD 255

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 625 IGIGSFGSIYVA-RLQDGMEVAVKVFHQQYER---ALKSFEDECEVMKRIRHRNLVKIIS 680
           +G G++G ++ +   + G  VAVK     ++    A ++F +   + +   H N+V +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 681 --SCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGHST 736
                ND    L+  YM     E  L++     +L+   +  ++  +   ++YLH G   
Sbjct: 77  VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG--- 128
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG-------------------EDQLSIQI 777
            ++H D+KPSN+LL+ +    ++DFG+++                       +D   I  
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 778 QTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
             +AT  Y APE        T+G D++S G +L E+   K     IF G  ++N+
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFPGSSTMNQ 239

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 613 LRATDRFSENNLIGIGSFG----SIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMK 668
           ++ TD +     IG+GS+      I+ A      E AVK+     +++ +   +E E++ 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNXEFAVKII----DKSKRDPTEEIEILL 70
Query: 669 RI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           R  +H N++ +     +  +  ++ +    G L + +       +  +   ++  +   +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTV 129
Query: 728 EYLHFGHSTPIIHCDLKPSNVL-LDED---MVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           EYLH   +  ++H DLKPSN+L +DE        I DFG AK L  E+ L        T 
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LXTPCYTA 184
Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            ++APE   +       D++S G++L    T   P
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEV 666
           +  D +     +G G F  +   R +  G+E A K   ++  RA +        E E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++++ H N++ +     N     LI++ +  G L + L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLAT 782
           + YLH   +  I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGT 181
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIM 808
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 661 EDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-------- 712
           + E ++++R+RH+N+++++    N++ + + M       +E C+     MLD        
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM------VMEYCVCGMQEMLDSVPEKRFP 107
Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
           + Q       +   LEYLH   S  I+H D+KP N+LL       IS  G+A+ L
Sbjct: 108 VCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 618 RFSENNLIGIGSFGSIYVARLQDGME-VAVKVFH--QQYERALKSFEDECEVMKRIRHRN 674
           ++ +   IG G++G+++ A+ ++  E VA+K        E    S   E  ++K ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V++     +D    L+ ++  +  L+   Y  +C  D+   +       L L+ L F H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-DQDLKK--YFDSCNGDLDPEIVKSFLFQL-LKGLGFCH 118
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE--YGT 792
           S  ++H DLKP N+L++ +    +++FG+A+       +      + T+ Y  P+  +G 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
           K    T  D++S G +  E+    +P
Sbjct: 177 K-LYSTSIDMWSAGCIFAELANAGRP 201

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEV 666
           +  D +     +G G F  +   R +  G+E A K   ++  RA +        E E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++++ H N++ +     N     LI++ +  G L + L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLAT 782
           + YLH   +  I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGT 181
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIM 808
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 614 RATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEV 666
           +  D +     +G G F  +   R +  G+E A K   ++  RA +        E E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           ++++ H N++ +     N     LI++ +  G L + L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 727 LEYLHFGHSTPIIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLAT 782
           + YLH   +  I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGT 181
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIM 808
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 16/216 (7%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++ E+  ++ + E    + +R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+           A++M+Y   G     L+   C    F            +  + 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + H+  + H DLK  N LLD        I  FG +K      Q      T+ T  Y+APE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK---STVGTPAYIAPE 186
Query: 790 YGTK----GRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
              K    G+V    DV+S G+ L  M     P ++
Sbjct: 187 VLLKKEYDGKV---ADVWSCGVTLYVMLVGAYPFED 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            PE   K    +R             DV+S G +L  M   K P  +I      L+  I+
Sbjct: 180 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 238
Query: 835 --------DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM 886
                   D+    + +V+   L R  ++  +  E +    + + T    +   G   +M
Sbjct: 239 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 298
Query: 887 GWIFSAL 893
            ++   L
Sbjct: 299 KYVLGQL 305

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 10/213 (4%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           ++  +DR+     IG G+FG   + R +   E+    + ++ E+  ++ + E    + +R
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N+V+           A++M+Y   G     L+   C    F            +  + 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           + H+  + H DLK  N LLD        I  FG +K      Q      T+ T  Y+APE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK---DTVGTPAYIAPE 186
Query: 790 YGTKGRVCTR-GDVYSYGIMLMEMFTKKKPTDE 821
              K     +  DV+S G+ L  M     P ++
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +     +      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+S+G++L E+F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 9/200 (4%)
Query: 623 NLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRHRNLVKI 678
            L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH  L  +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             S    D    +M+Y   G L   L       +   R     ++  AL+YLH      +
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 273
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           ++ DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE         
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 331
Query: 799 RGDVYSYGIMLMEMFTKKKP 818
             D +  G+++ EM   + P
Sbjct: 332 AVDWWGLGVVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 617 DRFSENNLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           + F    L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L  +  S    D    +M+Y   G L   L       +   R     ++  AL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 265
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                +++ DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE   
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   D +  G+++ EM   + P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 103/243 (42%), Gaps = 29/243 (11%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 102
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL   L+     L   +    +  + L  +YLH   
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              +IH DLK  N+ L+ED+   I DFG+A  +  + +    +    T  Y+APE  +K 
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKK 216
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVMEVI 845
                 DV+S G ++  +   K P +          I   E S+ + IN +    + +++
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276
Query: 846 DTN 848
            T+
Sbjct: 277 QTD 279

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +     +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+S+G++L E+F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIF 823
            PE   K    +R             DV+S G +L  M   K P  +I 
Sbjct: 196 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +     +      
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+S+G++L E+F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            PE   K    +R             DV+S G +L  M   K P  +I      L+  I+
Sbjct: 177 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
Query: 835 --------DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM 886
                   D+    + +V+   L R  ++  +  E +    + + T    +   G   +M
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295
Query: 887 GWIFSAL 893
            ++   L
Sbjct: 296 KYVLGQL 302

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +     +      
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MAPE         + DV+S+G++L E+F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 29/243 (11%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 100
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL         + +   R  +   + L  +YLH   
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR 159
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              +IH DLK  N+ L+ED+   I DFG+A  +  + +    +    T  Y+APE  +K 
Sbjct: 160 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKK 214
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVMEVI 845
                 DV+S G ++  +   K P +          I   E S+ + IN +    + +++
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 274
Query: 846 DTN 848
            T+
Sbjct: 275 QTD 277

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 617 DRFSENNLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           + F    L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L  +  S    D    +M+Y   G L   L       +   R     ++  AL+YLH 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 125
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                +++ DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE   
Sbjct: 126 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   D +  G+++ EM   + P
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            PE   K    +R             DV+S G +L  M   K P  +I      L+  I+
Sbjct: 176 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 234
Query: 835 --------DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM 886
                   D+    + +V+   L R  ++  +  E +    + + T    +   G   +M
Sbjct: 235 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 294
Query: 887 GWIFSAL 893
            ++   L
Sbjct: 295 KYVLGQL 301

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 617 DRFSENNLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           + F    L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L  +  S    D    +M+Y   G L   L       +   R     ++  AL+YLH 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 127
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                +++ DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE   
Sbjct: 128 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   D +  G+++ EM   + P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           I + +  ALE+LH   S  +IH D+KPSNVL++      + DFGI+  L   D ++  I 
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDID 169
Query: 779 TLATIGYMA-----PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
                 YMA     PE   KG    + D++S GI ++E+   + P D
Sbjct: 170 A-GCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 617 DRFSENNLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           + F    L+G G+FG  I V     G   A+K+  ++   A         E  V++  RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L  +  S    D    +M+Y   G L   L       +   R     ++  AL+YLH 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 126
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                +++ DLK  N++LD+D    I+DFG+ K   G    +       T  Y+APE   
Sbjct: 127 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   D +  G+++ EM   + P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            PE   K    +R             DV+S G +L  M   K P  +I      L+  I+
Sbjct: 224 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 835 --------DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM 886
                   D+    + +V+   L R  ++  +  E +    + + T    +   G   +M
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 342
Query: 887 GWIFSAL 893
            ++   L
Sbjct: 343 KYVLGQL 349

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
           H   +  IIH D+KPSN+LLD      + DFGI+  L   D ++ + +      YMAPE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIA-KTRDAGCRPYMAPER 196
Query: 791 ----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                ++     R DV+S GI L E+ T + P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 625 IGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKRIRHRNLVK 677
           +G G F  +   R +  G+E A K   ++  RA +        E E  +++++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           +     N     LI++ +  G L + L     + +  +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 738 IIHCDLKPSNV-LLDEDM-VAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           I H DLKP N+ LLD+++ + HI   DFG+A  +  ED +  +     T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK-NIFGTPEFVAPEIVNY 192
Query: 794 GRVCTRGDVYSYGIM 808
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKV-----FHQQYERALKSFEDECEVMKRI 670
           D +    +IG G+F  +      + G + AVK+     F      + +  + E  +   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN--IMIDVALA-- 726
           +H ++V+++ + S+D    ++ ++M    L           +I +R +   +   A+A  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASH 134
Query: 727 -----LEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
                LE L + H   IIH D+KP NVLL   +      + DFG+A  L GE  L +   
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGL-VAGG 192
Query: 779 TLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMF--------TKKKPTDEIFIGELSLN 830
            + T  +MAPE   +       DV+  G++L  +         TK++  + I  G+  +N
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 831 --RW 832
             +W
Sbjct: 253 PRQW 256

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + +A  +   E+ A+K+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKK--DVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++ S     D    +M+Y+  G L   +Y     +  F+    +   A     L F H  
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDL---MYH-IQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMAPE---YG 791
            II+ DLK  NV+LD +    I+DFG+ K  ++ G        +   T  Y+APE   Y 
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG----VTTREFCGTPDYIAPEIIAYQ 195
Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
             G+     D ++YG++L EM   + P D
Sbjct: 196 PYGKSV---DWWAYGVLLYEMLAGQPPFD 221

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 29/243 (11%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVF--------HQQYERALKSFEDECEVMKRIRHRN 674
            +G G F   +     D  EV A K+         HQ+ + ++     E  + + + H++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAHQH 76
Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V       ++DF  ++++     SL         + +   R  +   + L  +YLH   
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH--- 132
Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              +IH DLK  N+ L+ED+   I DFG+A  +  + +    +    T  Y+APE  +K 
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKK 190
Query: 795 RVCTRGDVYSYGIMLMEMFTKKKPTD---------EIFIGELSLNRWINDLLPVSVMEVI 845
                 DV+S G ++  +   K P +          I   E S+ + IN +    + +++
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250
Query: 846 DTN 848
            T+
Sbjct: 251 QTD 253

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIF 823
            PE   K    +R             DV+S G +L  M   K P  +I 
Sbjct: 196 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 14/109 (12%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIF 823
            PE   K    +R             DV+S G +L  M   K P  +I 
Sbjct: 224 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+    + A+KV  ++    +  +   + E  V ++  +   +  +
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 680 SSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC   + +   +++Y+  G L   +     + +   R     +++LAL YLH      I
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 127
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           I+ DLK  NVLLD +    ++D+G+ K   G            T  Y+APE         
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 799 RGDVYSYGIMLMEMFTKKKPTD 820
             D ++ G+++ EM   + P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRHRNLVKI 678
            +IG G+FG + V ++++   + A+K+ +  +  +RA  + F +E +V+     + +  +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  +++   L+M Y   G L   L      L        + ++ LA++ +H  H    
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH---Y 212
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPE-------- 789
           +H D+KP NVLLD +    ++DFG    L   D  ++Q    + T  Y++PE        
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 270
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            G  G  C   D +S G+ + EM   + P
Sbjct: 271 MGKYGPEC---DWWSLGVCMYEMLYGETP 296

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 74/151 (49%), Gaps = 18/151 (11%)
Query: 690 LIMKYMPNGSLEN-CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV 748
           LI++Y   G + + CL     + ++    +++  +   LE +++ H   I+H DLKP N+
Sbjct: 106 LILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 749 LLDE-----DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           LL       D+   I DFG+++ +    +L    + + T  Y+APE      + T  D++
Sbjct: 163 LLSSIYPLGDI--KIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMW 217
Query: 804 SYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           + GI+   + T   P    F+GE +   ++N
Sbjct: 218 NIGIIAYMLLTHTSP----FVGEDNQETYLN 244

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 623 NLIGIGSFGSIYVARLQDGMEV-AVKVFH--QQYERALKS-FEDECEVMKRIRHRNLVKI 678
            +IG G+FG + V ++++   + A+K+ +  +  +RA  + F +E +V+     + +  +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  +++   L+M Y   G L   L      L        + ++ LA++ +H  H    
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH---Y 196
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ-TLATIGYMAPE-------- 789
           +H D+KP NVLLD +    ++DFG    L   D  ++Q    + T  Y++PE        
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 254
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            G  G  C   D +S G+ + EM   + P
Sbjct: 255 MGKYGPEC---DWWSLGVCMYEMLYGETP 280

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+    + A+KV  ++    +  +   + E  V ++  +   +  +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 680 SSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC   + +   +++Y+  G L   +     + +   R     +++LAL YLH      I
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           I+ DLK  NVLLD +    ++D+G+ K   G            T  Y+APE         
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 799 RGDVYSYGIMLMEMFTKKKPTD 820
             D ++ G+++ EM   + P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 625 IGIGSFGSIYV--ARLQDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISS 681
           +G G++ ++Y   ++L D + VA+K    ++E  A  +   E  ++K ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              +    L+ +Y+ +  L+   Y   C  +I    N+ + +   L  L + H   ++H 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQ--YLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT----LATIGYMAPE--YGTKGR 795
           DLKP N+L++E     ++DFG+A+        SI  +T    + T+ Y  P+   G+   
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWYRPPDILLGSTD- 177
Query: 796 VCTRGDVYSYGIMLMEMFTKK 816
             T+ D++  G +  EM T +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 618 RFSENNLIGIGSFGSIYVARLQDGME--VAVKVFHQQYE---RALKSFEDECEVMKRIRH 672
           R+     IG G+ G I VA     +E  VA+K   + ++    A +++  E  +MK + H
Sbjct: 25  RYQNLKPIGSGAQG-IVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 673 RNLVKIIS----SCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +N++ +++      S ++F+   ++M+ M + +L   +      LD  +   ++  + + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLVG 138
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           +++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y 
Sbjct: 139 IKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRYYR 192
Query: 787 APE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           APE     G K  V    D++S G+++ EM         +F G   +++W
Sbjct: 193 APEVILGMGYKENV----DIWSVGVIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 15/219 (6%)
Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQ---YERALKSFEDECEV 666
           E+    D F    +IG G+F  + V ++ Q G   A+K+ ++        +  F +E +V
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +     R + ++  +  ++++  L+M+Y   G L   L      +        + ++ +A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           ++ +H       +H D+KP N+LLD      ++DFG    L  +  +   +  + T  Y+
Sbjct: 175 IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYL 230
Query: 787 APE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +PE           G      D ++ G+   EMF  + P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 676 VKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + +++  +     ++F+   L+M+ M + +L   +      LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI---QMELDHERMSYLLYQMLXGIKH 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 195
Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
                G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 196 VILGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+    + A++V  ++    +  +   + E  V ++  +   +  +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 680 SSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC   + +   +++Y+  G L   +     + +   R     +++LAL YLH      I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 174
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           I+ DLK  NVLLD +    ++D+G+ K  L  G+   +       T  Y+APE       
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEILRGEDY 230
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTD 820
               D ++ G+++ EM   + P D
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           +IG GS+  + + RL+    + A+KV  ++    +  +   + E  V ++  +   +  +
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 680 SSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
            SC   + +   +++Y+  G L   +     + +   R     +++LAL YLH      I
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 142
Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
           I+ DLK  NVLLD +    ++D+G+ K  L  G+           T  Y+APE       
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGTPNYIAPEILRGEDY 198
Query: 797 CTRGDVYSYGIMLMEMFTKKKPTD 820
               D ++ G+++ EM   + P D
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI 777
            I + +  ALE+LH   S  +IH D+KPSNVL++      + DFGI+  L   D ++  I
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTI 212
Query: 778 QTLATIGYMAPEY-----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
                  YMAPE        KG    + D++S GI ++E+   + P D
Sbjct: 213 DA-GCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 592 GPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFH 650
           GP+N G +  Q       H+      R+    +IG GSFG +  A        VA+K+  
Sbjct: 74  GPNNGGYDDDQGSYVQVPHD--HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR 131
Query: 651 QQYERALKSFEDECEVMKRIRHR---NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG 707
            + +R  +   +E  +++ +R +   N + +I    N  F+  I   M    L   LY  
Sbjct: 132 NE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYE- 187
Query: 708 TCMLDIFQRLNIMIDVALA---LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS--DFG 762
               + FQ  ++ +    A   L+ L   H   IIHCDLKP N+LL +   + I   DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +       ++   IQ+     Y APE     R     D++S G +L E+ T
Sbjct: 248 SS--CYEHQRVYTXIQSRF---YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 16/230 (6%)
Query: 592 GPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFH 650
           GP+N G +  Q       H+      R+    +IG GSFG +  A        VA+K+  
Sbjct: 74  GPNNGGYDDDQGSYVQVPHD--HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR 131
Query: 651 QQYERALKSFEDECEVMKRIRHR---NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG 707
            + +R  +   +E  +++ +R +   N + +I    N  F+  I   M    L   LY  
Sbjct: 132 NE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYE- 187
Query: 708 TCMLDIFQRLNIMIDVALA---LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA 764
               + FQ  ++ +    A   L+ L   H   IIHCDLKP N+LL +   + I      
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                  ++   IQ+     Y APE     R     D++S G +L E+ T
Sbjct: 248 SSCYEHQRVYTXIQSRF---YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 676 VKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + +++  +     ++F+   L+M+ M + +L   +      LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI---QMELDHERMSYLLYQMLCGIKH 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 195
Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
                G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 196 VILGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 622 NNLIGIGSFGSIYVA-RLQDG-------MEVAVKVFHQQYERALKSFEDECEVMKRIRHR 673
           N  +G G+F  I+   R + G        EV +KV  + +    +SF +   +M ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +LV     C   D   L+ +++  GSL+  L      ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 734 HSTPIIHCDLKPSNVLL--DEDMVA------HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
               +IH ++   N+LL  +ED          +SD GI+  +  +D L         I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ERIPW 183
Query: 786 MAPEYGTKGR-VCTRGDVYSYGIMLMEM 812
           + PE     + +    D +S+G  L E+
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +APE      +    D++S G++   + +   P    F+G+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 22/187 (11%)
Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
           LE +H  H   I+H DLKP+N L+ + M+  I DFGIA  +  +    ++   +  + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 787 APEYGTKGRVCTR------------GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
            PE   K    +R             DV+S G +L  M   K P  +I      L+  I+
Sbjct: 224 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 835 --------DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM 886
                   D+    + +V+   L R  ++  +  E +    + + T    +   G   +M
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 342
Query: 887 GWIFSAL 893
            ++   L
Sbjct: 343 KYVLGQL 349

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 622 NNLIGIGSFGSIYVA-RLQDG-------MEVAVKVFHQQYERALKSFEDECEVMKRIRHR 673
           N  +G G+F  I+   R + G        EV +KV  + +    +SF +   +M ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +LV     C   D   L+ +++  GSL+  L      ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 734 HSTPIIHCDLKPSNVLL--DEDMVA------HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
               +IH ++   N+LL  +ED          +SD GI+  +  +D L         I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ERIPW 183
Query: 786 MAPEYGTKGR-VCTRGDVYSYGIMLMEM 812
           + PE     + +    D +S+G  L E+
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 676 VKIIS----SCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + +++      S ++F+   ++M+ M + +L   +      LD  +   ++  + + +++
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLVGIKH 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 195
Query: 790 Y----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
                G K  V    D++S G+++ EM         +F G   +++W
Sbjct: 196 VILGMGYKENV----DIWSVGVIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 78
Query: 676 VKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + +++  +     ++F+   L+M+ M + +L   +      LD  +   ++  +   +++
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI---QMELDHERMSYLLYQMLXGIKH 134
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 188
Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
                G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 189 VILGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL---ENCLY----SGTCML 711
            F++E +++  I++   +      +N D   +I +YM N S+   +   +    + TC +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 712 DIFQRLNIMIDVAL-ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
            I Q +  +I   L +  Y+H  +   I H D+KPSN+L+D++    +SDFG       E
Sbjct: 149 PI-QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFG-----ESE 200
Query: 771 DQLSIQIQ-TLATIGYMAPEYGTKGRVC--TRGDVYSYGIMLMEMF 813
             +  +I+ +  T  +M PE+ +        + D++S GI L  MF
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       +  ++    T  Y APE    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV---VTRYYRAPEVILG 199
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 200 MGYKENV----DIWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +APE      +    D++S G++   + +   P    F+G+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 182
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 182
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 622 NNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKII 679
           + L+G G++  +  A  LQ+G E AVK+  +Q   +      E E + + + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
               +D    L+ + +  GS+   +       +  +   ++ DVA AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 740 HCDLKPSNVLLDE-DMVA--HISDFGIAKLLSGEDQLS-IQIQTLAT----IGYMAPEY- 790
           H DLKP N+L +  + V+   I DF +   +   +  + I    L T      YMAPE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 791 ----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN 830
                       R D++S G++L  M +   P    F+G    +
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP----FVGHCGAD 233

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKS----FEDECEVMKRIRHRNLVKII- 679
           IG GSF ++Y   L     V V     Q  +  KS    F++E E +K ++H N+V+   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 680 ---SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI------DVALALEYL 730
              S+        L+ +   +G+L+         L  F+   I +       +   L++L
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKT-------YLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 731 HFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           H   + PIIH DLK  N+ +        I D G+A L     + S     + T  + APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPE 200
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
              + +     DVY++G   +E  T + P  E
Sbjct: 201 X-YEEKYDESVDVYAFGXCXLEXATSEYPYSE 231

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + +++  +     ++F+   L+M+ M + +L   +      LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI---QMELDHERMSYLLYQMLXGIKH 141
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 195
Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
                G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 196 VILGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 49/136 (36%), Positives = 67/136 (49%), Gaps = 17/136 (12%)
Query: 387 ARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWN-LKDILFIDVSS 444
           A    L LQ NK S S+PS     LT LR+LYL  N+  + LP+ I+  LK++  + V+ 
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTD 94
Query: 445 NSLNVL-IG----------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-F 492
           N L  L IG          L   RN L    P     L  L  + L YN L+ S+P+  F
Sbjct: 95  NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 493 GDLSSLEVLDLSKNKI 508
             L+SL+ L L  N++
Sbjct: 154 DKLTSLKELRLYNNQL 169

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +            +L+  + P  +LE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 86  I------------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-RMSYLL 132
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV---VTR 189
Query: 784 GYMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 190 YYRAPEVILGMGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED----ECEVM-KRIRHRNLVK 677
            ++G GS G++       G  VAVK       R L  F D    E +++ +   H N+++
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 91
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLH 731
              S + D F  + ++ + N +L++ + S         +   +  ++++  +A  + +LH
Sbjct: 92  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 732 FGHSTPIIHCDLKPSNVLLD-------------EDMVAHISDFGIAKLL-SGEDQLSIQI 777
              S  IIH DLKP N+L+              E++   ISDFG+ K L SG+      +
Sbjct: 151 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 778 QTLA-TIGYMAPEY---GTKGRVCTRGDVYSYGIMLMEMFTKKK 817
              + T G+ APE     TK R+    D++S G +   + +K K
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 41/241 (17%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED----ECEVM-KRIRHRNLVK 677
            ++G GS G++       G  VAVK       R L  F D    E +++ +   H N+++
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 91
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLH 731
              S + D F  + ++ + N +L++ + S         +   +  ++++  +A  + +LH
Sbjct: 92  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 732 FGHSTPIIHCDLKPSNVLLD-------------EDMVAHISDFGIAKLL-SGEDQLSIQI 777
              S  IIH DLKP N+L+              E++   ISDFG+ K L SG+      +
Sbjct: 151 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 778 QTLA-TIGYMAPEY---GTKGRVCTRGDVYSYGIMLMEMFTK-KKPTDEIFIGELSLNRW 832
              + T G+ APE     TK R+    D++S G +   + +K K P  + +  E ++ R 
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 833 I 833
           I
Sbjct: 268 I 268

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 237
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 238 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +APE      +    D++S G++   + +   P    F+G+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       +  ++    T  Y APE    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV---VTRYYRAPEVILG 199
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 200 MGYKENV----DLWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 200
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 201 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 192
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 193 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 198
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 199 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 193
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 194 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 199
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 200 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHR 673
           R+ +   IG G+ G +  A     G+ VAVK   + ++    A +++  E  ++K + H+
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 81
Query: 674 NLVKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           N++ +++  +     ++F+   L+M+ M + +L   ++     LD  +   ++  +   +
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGI 137
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           ++LH   S  IIH DLKPSN+++  D    I DFG+A+  S    ++  +    T  Y A
Sbjct: 138 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYV---VTRYYRA 191
Query: 788 PEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           PE     G K  V    D++S G ++ E+         IF G   +++W
Sbjct: 192 PEVILGMGYKENV----DIWSVGCIMGELVKGSV----IFQGTDHIDQW 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 237
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 238 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 200
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 201 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 193
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 194 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY--- 790
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 199
Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 200 MGYKENV----DIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 674 NLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           N++K+I +  +   K  AL+ +Y+ N   +  LY      DI  R   M ++  AL+Y H
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQ-LYQILTDFDI--RF-YMYELLKALDYCH 149
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVA-HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
              S  I+H D+KP NV++D       + D+G+A+      + ++++   A+  +  PE 
Sbjct: 150 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV---ASRYFKGPEL 203
Query: 791 GTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
               ++     D++S G ML  M  +++P
Sbjct: 204 LVDYQMYDYSLDMWSLGCMLASMIFRREP 232

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 20/232 (8%)
Query: 592 GPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFH 650
           GP+N G +  Q       H+      R+    +IG G FG +  A        VA+K+  
Sbjct: 74  GPNNGGYDDDQGSYVQVPHD--HVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR 131
Query: 651 QQYERALKSFEDECEVMKRIRHR---NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG 707
            + +R  +   +E  +++ +R +   N + +I    N  F+  I   M    L   LY  
Sbjct: 132 NE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYE- 187
Query: 708 TCMLDIFQRLNIMIDVALA---LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS--DFG 762
               + FQ  ++ +    A   L+ L   H   IIHCDLKP N+LL +   + I   DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            +          IQ +      Y APE     R     D++S G +L E+ T
Sbjct: 248 SSCYEHQRVYXXIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 623 NLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIIS 680
            L+G G++G +Y  R ++ G   A+KV     +   +  + E  ++K+   HRN+     
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYG 88
Query: 681 SCSN------DDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHF 732
           +         DD   L+M++   GS+ + +    G  + + +    I  ++   L +LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 146
Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT-LATIGYMAPEY- 790
                +IH D+K  NVLL E+    + DFG++  L   D+   +  T + T  +MAPE  
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 201
Query: 791 ----GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                       + D++S GI  +EM     P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 674 NLVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           N++K+I +  +   K  AL+ +Y+ N   +  LY      DI  R   M ++  AL+Y H
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQ-LYQILTDFDI--RF-YMYELLKALDYCH 154
Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVA-HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY 790
              S  I+H D+KP NV++D       + D+G+A+      + ++++   A+  +  PE 
Sbjct: 155 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV---ASRYFKGPEL 208
Query: 791 GTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
               ++     D++S G ML  M  +++P
Sbjct: 209 LVDYQMYDYSLDMWSLGCMLASMIFRREP 237

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +             L+  + P  SLE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLL 132
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+       ++ ++    T 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEV---VTR 189
Query: 784 GYMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 190 YYRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 60/252 (23%)
Query: 612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERAL-----KSFEDECE 665
           LL    ++     IG GS+G + VA       + A+K+ ++   R +     +  + E  
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL------YSGTCMLDIF----- 714
           +MK++ H N+ ++     ++ +  L+M+    G L + L       +G C +D+      
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 715 ------------------------QRL----NIMIDVALALEYLHFGHSTPIIHCDLKPS 746
                                   QR     NIM  +  AL YLH   +  I H D+KP 
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 747 NVLLDEDMVAHIS--DFGIA----KLLSGEDQLSIQIQTLATIGY-MAPEY--GTKGRVC 797
           N L   +    I   DFG++    KL +GE      + T A   Y +APE    T     
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 798 TRGDVYSYGIML 809
            + D +S G++L
Sbjct: 255 PKCDAWSAGVLL 266

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 44/228 (19%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED----ECEVM-KRIRHRNLVK 677
            ++G GS G++       G  VAVK       R L  F D    E +++ +   H N+++
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLH 731
              S + D F  + ++ + N +L++ + S         +   +  ++++  +A  + +LH
Sbjct: 74  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 732 FGHSTPIIHCDLKPSNVLLD-------------EDMVAHISDFGIAKLL-SGEDQLSIQI 777
              S  IIH DLKP N+L+              E++   ISDFG+ K L SG+      +
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 778 QTLA-TIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
              + T G+ APE         TK R+    D++S G +   + +K K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 204
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 205 MGYKENV----DLWSVGCIMGEMVCHKI----LFPGRDYIDQW 239

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE---YLHF 732
           +             L+  + P  SLE        M  +   L+ +I + L  E   YL +
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 733 G--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
                    HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 785 YMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE---YLHF 732
           +             L+  + P  SLE        M  +   L+ +I + L  E   YL +
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 733 G--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
                    HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 785 YMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR  +R+     IG GSFG IY+   +  G EVA+K+  +  +        E ++ K ++
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQ 62
Query: 672 HRNLVKIISSCSND-DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
               +  I  C  + D+  ++M+ +   SLE+     +    +   L +   +   +EY+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 731 HFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
              HS   IH D+KP N L+    +  + +I DFG+AK
Sbjct: 122 ---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---- 789
           HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y APE    
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILG 193
Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            G K  V    D++S G ++ EM   K     +F G   +++W
Sbjct: 194 MGYKENV----DLWSVGCIMGEMVCHKI----LFPGRDYIDQW 228

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR  +R+     IG GSFG IY+   +  G EVA+K+  +  +        E ++ K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQ 60
Query: 672 HRNLVKIISSCSND-DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
               +  I  C  + D+  ++M+ +   SLE+     +    +   L +   +   +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 731 HFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
              HS   IH D+KP N L+    +  + +I DFG+AK
Sbjct: 120 ---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 617 DRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALK------SFEDECEVMKR 669
           D +     +G G F  +   R +  G++ A K   ++  ++ +        E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI + +  G L + L     + +  +    +  +   + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           LH   S  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 183
Query: 786 MAPEYGTKGRVCTRGDVYSYGIM 808
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE---YLHF 732
           +             L+  + P  SLE        M  +   L+ +I + L  E   YL +
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 733 G--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
                    HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 785 YMAPEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 44/228 (19%)
Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFED----ECEVM-KRIRHRNLVK 677
            ++G GS G++       G  VAVK       R L  F D    E +++ +   H N+++
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVK-------RMLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLH 731
              S + D F  + ++ + N +L++ + S         +   +  ++++  +A  + +LH
Sbjct: 74  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 732 FGHSTPIIHCDLKPSNVLLD-------------EDMVAHISDFGIAKLL-SGEDQLSIQI 777
              S  IIH DLKP N+L+              E++   ISDFG+ K L SG+      +
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 778 QTLA-TIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
              + T G+ APE         TK R+    D++S G +   + +K K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 37/222 (16%)
Query: 661 EDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN-- 718
           + E  ++   RHRN++ +  S  + +   +I +++          SG   LDIF+R+N  
Sbjct: 49  KKEISILNIARHRNILHLHESFESMEELVMIFEFI----------SG---LDIFERINTS 95
Query: 719 --------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS--DFGIAKLLS 768
                   I+  V    E L F HS  I H D++P N++      + I   +FG A+ L 
Sbjct: 96  AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMF---------TKKKPT 819
             D   +         Y APE      V T  D++S G ++  +          T ++  
Sbjct: 156 PGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 820 DEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKE 861
           + I   E + +      + +  M+ +D  L++  +    A E
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + ++  +   E+ AVK+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++ S     D    +M+Y+  G L   +Y     +  F+  + +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT---LATIGYMAPE---Y 790
            II+ DLK  NV+LD +    I+DFG+ K     + +   + T     T  Y+APE   Y
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
              G+     D +++G++L EM   + P      DE+F
Sbjct: 517 QPYGKSV---DWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE---YLHF 732
           +             L+  + P  SLE        M  +   L+ +I + L  E   YL +
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 733 G--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
                    HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRY 190
Query: 785 YMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE--DQLSI 775
            I + +  ALE+LH   S  +IH D+KPSNVL++        DFGI+  L  +    +  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD 820
             +       + PE   KG    + D++S GI  +E+   + P D
Sbjct: 198 GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECE-VMKRI-----RHRNLV 676
           ++G GSFG + ++  +   E+ AVK+  +  +  ++  + EC  V KR+     +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++ S     D    +M+Y+  G L   +Y     +  F+  + +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT---LATIGYMAPE---Y 790
            II+ DLK  NV+LD +    I+DFG+ K     + +   + T     T  Y+APE   Y
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
              G+     D +++G++L EM   + P      DE+F
Sbjct: 196 QPYGKSV---DWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 613 LRATDRFSENNLIGIGSFGSIYV-ARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR  +++     IG GSFG IY+ A +  G EVA+K+  +  +        E +  K ++
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL--ECVKTKHPQLHIESKFYKMMQ 62
Query: 672 HRNLVKIISSCSND-DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
               +  I  C  + D+  ++M+ +   SLE+     +    +   L +   +   +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 731 HFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
              HS   IH D+KP N L+    +  + +I DFG+AK
Sbjct: 122 ---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 29  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 87
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +             L+  + P  SLE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 88  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLL 134
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+         + +  + T 
Sbjct: 135 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMVPFVVTR 191
Query: 784 GYMAPEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 192 YYRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 236

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV 748
           AL+ +++ N   +  LY      DI  R   M ++  AL+Y H   S  I+H D+KP NV
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLTDYDI--RF-YMYEILKALDYCH---SMGIMHRDVKPHNV 162
Query: 749 LLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYG 806
           L+D E     + D+G+A+      + ++++   A+  +  PE     ++     D++S G
Sbjct: 163 LIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 807 IMLMEMFTKKKP 818
            ML  M  +K+P
Sbjct: 220 CMLASMIFRKEP 231

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 45/94 (47%), Gaps = 14/94 (14%)
Query: 416 LYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ 475
           LYL  N+FT  +P  + N K +  ID+S+N ++ L   +FS              +  L 
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFS-------------NMTQLL 81
Query: 476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
            + L YNRL    P +F  L SL +L L  N IS
Sbjct: 82  TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS 115

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 618 RFSENNLIGIGSFGSIYVA--RLQDGMEVAVK-VFHQQYERALKSFEDECEVMKRIRHRN 674
           ++     I  G  G IY+A  R  +G  V +K + H     A      E + +  + H +
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 675 LVKIISSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           +V+I +   + D        ++M+Y+   SL+    S    L + + +  ++++  AL Y
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---SKGQKLPVAEAIAYLLEILPALSY 197
Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  +++ DLKP N++L E+ +  I D G    ++    L        T G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFGYL------YGTPGFQAPE 247
Query: 790 YGTKGRVCTRGDVYSYGIMLMEM 812
               G      D+Y+ G  L  +
Sbjct: 248 IVRTGPTVAT-DIYTVGRTLAAL 269

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 618 RFSENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHR 673
           R+ +   IG G+ G +  A     G+ VAVK   + ++    A +++  E  ++K + H+
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 83
Query: 674 NLVKIISSCSN----DDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           N++ +++  +     ++F+   L+M+ M + +L   ++     LD  +   ++  +   +
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGI 139
Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           ++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y A
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYV---VTRYYRA 193
Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
           PE           D++S G ++ E+         IF G   +++W
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKGCV----IFQGTDHIDQW 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 32/235 (13%)
Query: 615 ATDRFS---------ENNLIGIGSFGSIYVA-RLQDGMEVAVKVFHQQYERALKSFEDEC 664
           +TD FS         + +++G G+   +     L    E AVK+  +Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 665 EVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           E++ + + HRN++++I     +D   L+ + M  GS+ + ++      +  +   ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVA--HISDFGIAK--LLSGEDQLSIQIQ 778
           A AL++LH   +  I H DLKP N+L +  + V+   I DFG+     L+G+       +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 779 TLATIG---YMAPE----YGTKGRVC-TRGDVYSYGIMLMEMFTKKKPTDEIFIG 825
            L   G   YMAPE    +  +  +   R D++S G++L  + +   P    F+G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVG 228

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +             L+  + P  SLE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLL 132
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR 189
Query: 784 GYMAPEY----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 190 YYRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 86
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +             L+  + P  SLE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 87  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLL 133
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T 
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR 190
Query: 784 GYMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 191 YYRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 235

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 622 NNLIGIGSFGSIYVARLQDGM---EVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNL 675
            NL  IGS     V    D +    VA+K   + ++    A +++  E  +MK + H+N+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENC--LYSGTCMLD--IFQRLNIMIDVALALEYLH 731
           +             L+  + P  SLE    +Y    ++D  + Q + + +D    + YL 
Sbjct: 86  I------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLL 132
Query: 732 FG--------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           +         HS  IIH DLKPSN+++  D    I DFG+A+       ++  +    T 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR 189
Query: 784 GYMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
            Y APE     G K  V    D++S G ++ EM         +F G   +++W
Sbjct: 190 YYRAPEVILGMGYKENV----DIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVA--RLQDGMEVAVKVFHQQYERALKSFEDECEV 666
           Y  + + ++ F   + IG G+F S+Y+A  +LQ G E  + + H            E + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 667 MKRIRHRNLVKIISSC-SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           +     ++ V  +  C   +D   + M Y+ + S  + L S    L   +    M+++  
Sbjct: 73  LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFK 128
Query: 726 ALEYLH-FGHSTPIIHCDLKPSNVLLDEDMVAH-ISDFGIA-----------KLLSGEDQ 772
           AL+ +H FG    I+H D+KPSN L +  +  + + DFG+A           K +  E Q
Sbjct: 129 ALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 773 ------------LSIQIQT---LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
                       LS + Q      T G+ APE  TK    T   D++S G++ + + + +
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 817 KP 818
            P
Sbjct: 245 YP 246

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV 748
           AL+ +++ N   +  LY      DI  R   M ++  AL+Y H   S  I+H D+KP NV
Sbjct: 109 ALVFEHVNNTDFKQ-LYQTLTDYDI--RF-YMYEILKALDYCH---SMGIMHRDVKPHNV 161
Query: 749 LLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYG 806
           ++D E     + D+G+A+      + ++++   A+  +  PE     ++     D++S G
Sbjct: 162 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLG 218
Query: 807 IMLMEMFTKKKP 818
            ML  M  +K+P
Sbjct: 219 CMLASMIFRKEP 230

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNV 748
           AL+ +++ N   +  LY      DI  R   M ++  AL+Y H   S  I+H D+KP NV
Sbjct: 108 ALVFEHVNNTDFKQ-LYQTLTDYDI--RF-YMYEILKALDYCH---SMGIMHRDVKPHNV 160
Query: 749 LLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYG 806
           ++D E     + D+G+A+      + ++++   A+  +  PE     ++     D++S G
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLG 217
Query: 807 IMLMEMFTKKKP 818
            ML  M  +K+P
Sbjct: 218 CMLASMIFRKEP 229
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	897
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-125
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-113
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-109
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-106
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-81
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-55
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-80
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-64
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-74
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-62
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-40
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-73
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-72
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-70
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-64
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-50
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-49
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-64
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-60
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-45
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-41
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-51
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-48
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-23
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-44
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-19
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-08
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-07
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-11
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-27
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-07
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-10
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-06
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-07
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-16
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-05
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-05
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	7e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  395 bits (1016), Expect = e-125
 Identities = 145/494 (29%), Positives = 218/494 (44%), Gaps = 45/494 (9%)

Query: 81  LNISSFNLQGTIPPQL-GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS 139
           L+++     G IP  L G   +L  LDLS N   G +P    +   L+ L  S N   G 
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 140 LSF-FIFNVSSVTTIDLSINGLSGEMPREIGNL-PYLARLAFATNNLVGVAPVTIFN--M 195
           L    +  +  +  +DLS N  SGE+P  + NL   L  L  ++NN  G     +     
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
           + L+E+YL NN  +G +P  +  +   + +L+L  N   GT+PSS+ + SKL DL+L +N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTL-SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL 315
           +  G IP                       L   K L+ LIL  N L G +P    N + 
Sbjct: 453 MLEGEIP---------------------QELMYVKTLETLILDFNDLTGEIPSGLSNCT- 490

Query: 316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           +L  I + N  ++G IP+ +G L NL +L+L  N+ +  IP      ++L  L L  N  
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN--RFTSALPSTIWN 433
            G I   +       S  +  N  +G     + N    +  +   N   F       +  
Sbjct: 551 NGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606

Query: 434 LKDILFIDVSSN-----------SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
           L      +++S            +   ++ L+ S N LSG IP  IG +  L  + L +N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666

Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPF 542
            + GSIP+  GDL  L +LDLS NK+ G IP ++  L  L  ++LS N L G IP  G F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726

Query: 543 ANLTAKSFMGNELL 556
                  F+ N  L
Sbjct: 727 ETFPPAKFLNNPGL 740

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  362 bits (932), Expect = e-113
 Identities = 133/485 (27%), Positives = 209/485 (43%), Gaps = 37/485 (7%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD 133
           +   +  L+IS   L G     +   + L+ L++S N+  G IP     + +L+ L  ++
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278

Query: 134 NQLFGSLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPV-T 191
           N+  G +  F+     ++T +DLS N   G +P   G+   L  LA ++NN  G  P+ T
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

Query: 192 IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASK--LSD 249
           +  M  LK + L  N  SG LP  +     ++ TL+L  N+F G +  ++    K  L +
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 250 LELGVNLFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNP 301
           L L  N F+G IP T  N         + NYL+ + P     SSL +  KL+ L L  N 
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP-----SSLGSLSKLRDLKLWLNM 453

Query: 302 LDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQ 361
           L+G +P+    +  +LE +++D   ++G IP  + N  NL  + L  N LT  IP    +
Sbjct: 454 LEGEIPQELMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 362 LQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN 421
           L+ L  L L+ N  +G I  EL     L  L L  N F+G+IP+ +   +      +  N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568

Query: 422 RFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEY 481
                    I N         + N                G     +  L       +  
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNL-----------LEFQGIRSEQLNRLSTRNPCNITS 617

Query: 482 NRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGP 541
               G    +F +  S+  LD+S N +SG IP  +  + YL  LNL  N + G IP    
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE-- 675

Query: 542 FANLT 546
             +L 
Sbjct: 676 VGDLR 680

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  352 bits (905), Expect = e-109
 Identities = 137/462 (29%), Positives = 205/462 (44%), Gaps = 47/462 (10%)

Query: 81  LNISSFNLQGTIPPQL---GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLF 137
           L++S+ ++ G              L+ L +S NK+SG++   +     L+ L  S N   
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213

Query: 138 GSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA 197
             + F + + S++  +D+S N LSG+  R I     L  L  ++N  VG  P     + +
Sbjct: 214 TGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKS 270

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           L+ + L  N  +G +P  +  +   +  L+L  N FYG VP    + S L  L L  N F
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330

Query: 258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
           SG +P                      +L   + LKVL L+ N   G LP+S  NLS SL
Sbjct: 331 SGELPM--------------------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370

Query: 318 EIILMDNCSISGNIPQVVGN--LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
             + + + + SG I   +       L  L L  N  T  IP T S    L +L L+ N L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
           +G I   L  L++L  L L  N   G IP  L  + +L  L L  N  T  +PS + N  
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL 495
           +             L  ++ S N L+G+IP  IG L+NL  + L  N   G+IP   GD 
Sbjct: 491 N-------------LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

Query: 496 SSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            SL  LDL+ N  +G IPA++ K        ++ N + G+  
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRY 575

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  343 bits (883), Expect = e-106
 Identities = 139/531 (26%), Positives = 226/531 (42%), Gaps = 89/531 (16%)

Query: 23  VIAAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLN 82
             A+ + ++  +   L++ K  +  D   L   +W+S+ + C++ G+TC     +V  ++
Sbjct: 2   FQASPSQSLYREIHQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTCR--DDKVTSID 56

Query: 83  ISSFNLQ---GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS 139
           +SS  L      +   L +L+ L++L LS++ ++G++                    F  
Sbjct: 57  LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG------------------FKC 98

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK 199
            +       S+T++DLS N LSG +                          ++ + S LK
Sbjct: 99  SA-------SLTSLDLSRNSLSGPVT----------------------TLTSLGSCSGLK 129

Query: 200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSIT---NASKLSDLELGVNL 256
            + + +N+L         L L ++E L+L  NS  G             +L  L +  N 
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189

Query: 257 FSGFIPN------TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSK 310
            SG +         F++++ N  ++  P L       +C  L+ L ++GN L G   ++ 
Sbjct: 190 ISGDVDVSRCVNLEFLDVSSNNFSTGIPFLG------DCSALQHLDISGNKLSGDFSRAI 243

Query: 311 GNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPIT-FSQLQTLQALG 369
              +  L+++ + +    G IP     L +L  L L  N  T  IP        TL  L 
Sbjct: 244 STCT-ELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLD 300

Query: 370 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRFTSALP 428
           L+ N   G +       + L SL L  N FSG +P   L  +  L+VL L  N F+  LP
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 429 STIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG--LKNLQQMFLEYNRLEG 486
            ++ NL         S SL     L+ S NN SG I   +       LQ+++L+ N   G
Sbjct: 361 ESLTNL---------SASLLT---LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408

Query: 487 SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            IP +  + S L  L LS N +SG IP+SL  L  L+ L L  N LEGEIP
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  216 bits (552), Expect = 2e-59
 Identities = 92/334 (27%), Positives = 140/334 (41%), Gaps = 29/334 (8%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD 133
           N   ++ L++S   L GTIP  LG+LS L+ L L  N L G IP  +  + TL+ L    
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF 193
           N L G +   + N +++  I LS N L+GE+P+ IG L  LA L  + N+  G  P  + 
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELG 253
           +  +L  + L  N  +G++P+ +        +  +  N   G     I N     +    
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQ-----SGKIAANFIAGKRYVYIKNDGMKKECHGA 590

Query: 254 VNL--FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
            NL  F G                          L          +T     G    +  
Sbjct: 591 GNLLEFQGIRS---------------------EQLNRLSTRNPCNITSRVYGGHTSPTFD 629

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           N   S+  + M    +SG IP+ +G++  L +L LG N+++  IP     L+ L  L L+
Sbjct: 630 NNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
            NKL G I   +  L  L  + L  N  SG IP 
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  262 bits (673), Expect = 8e-81
 Identities = 83/276 (30%), Positives = 126/276 (45%), Gaps = 18/276 (6%)

Query: 284 SSLTNCKKLKVLILTGNPLDG--ILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL 341
            + T   ++  L L+G  L     +P S  NL     + +    ++ G IP  +  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 401
             L +   N++  IP   SQ++TL  L  + N L+G +   +  L  L  +   GN+ SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 402 SIPSCLGNLTSL-RVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNL 460
           +IP   G+ + L   + +  NR T  +P T  NL               L  ++ SRN L
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--------------LAFVDLSRNML 209

Query: 461 SGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL 520
            GD  +  G  KN Q++ L  N L   +    G   +L  LDL  N+I G +P  L +L 
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268

Query: 521 YLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
           +L  LN+SFN L GEIP+GG        ++  N+ L
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  192 bits (490), Expect = 4e-55
 Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 60/314 (19%)

Query: 33  TDQQALLALKAHISYDHTNLFARNWTSSTSVC--SWIGITCDV--NSHRVIGLNISSFNL 88
            D+QALL +K  +  + T L   +W  +T  C  +W+G+ CD    ++RV  L++S  NL
Sbjct: 6   QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 89  QGT---------------------------IPPQLGNLSSLQTLDLSHNKLSGNIPSSIF 121
                                         IPP +  L+ L  L ++H  +SG IP  + 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 122 NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLAR-LAFA 180
            + TL  L FS N L G+L   I ++ ++  I    N +SG +P   G+   L   +  +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182

Query: 181 TNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSS 240
            N L G  P T  N++ L  + L  N L G        S  N + ++L  NS    +   
Sbjct: 183 RNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLG-K 239

Query: 241 ITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGN 300
           +  +  L+ L+L  N   G +P                       LT  K L  L ++ N
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLP---------------------QGLTQLKFLHSLNVSFN 278

Query: 301 PLDGILPKSKGNLS 314
            L G +P+  GNL 
Sbjct: 279 NLCGEIPQG-GNLQ 291

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 16/54 (29%), Positives = 29/54 (53%), Gaps = 1/54 (1%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDN 134
           L++ +  + GT+P  L  L  L +L++S N L G IP    N+    +  +++N
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  272 bits (698), Expect = 1e-80
 Identities = 80/510 (15%), Positives = 165/510 (32%), Gaps = 74/510 (14%)

Query: 56  NWTSSTSVCSW---IGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKL 112
           NW  +  +  W    G++ + ++ RV GL++  F   G +P  +G L+ L+ L L  +  
Sbjct: 59  NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117

Query: 113 SGN----IPSSIFNMHTLKLLYFSDNQLFGSLSFFIF--NVSSVTTIDLSINGLSGEMPR 166
             N     P  I    + +           +   +    + S +    ++ +     + +
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

Query: 167 EIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETL 226
                    ++   +NN+  V    +  ++ L++ Y+ N+                 E  
Sbjct: 178 SSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENI------CEAWENE 230

Query: 227 NLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSL 286
           N      Y T      N   L+D+E+        +P                     + L
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP---------------------TFL 269

Query: 287 TNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
               +++++ +  N                                        + ++ +
Sbjct: 270 KALPEMQLINVACNRGISGEQ-----------------LKDDWQALADAPVGEKIQIIYI 312

Query: 347 GGNNLTE-PIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
           G NNL   P+  +  +++ L  L    N+L G +        +L SL L  N+ +    +
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPAN 371

Query: 406 CLGNLTSLRVLYLGLNRFTSALPST--IWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGD 463
             G    +  L    N+    +P+     ++  +  ID S N +  + G NF        
Sbjct: 372 FCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD------P 424

Query: 464 IPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG-------AIPASL 516
           +  T     N+  + L  N++     E F   S L  ++L  N ++            + 
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

Query: 517 QKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +    L  ++L FNKL   +        L 
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  226 bits (578), Expect = 6e-64
 Identities = 69/475 (14%), Positives = 142/475 (29%), Gaps = 80/475 (16%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
            N        T   +  NL  L  +++ +      +P+ +  +  ++L+  + N+     
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG---- 285

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNL-VGVAPVTIFNMSALK 199
                       I         +   +      +  +    NNL       ++  M  L 
Sbjct: 286 ------------ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 200 EIYLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
            +  L N L G LP+         + +LNL  N       +      ++ +L    N   
Sbjct: 334 MLECLYNQLEGKLPA---FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390

Query: 259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE 318
             IPN F                      +   +  +  + N +  +  K+         
Sbjct: 391 Y-IPNIF-------------------DAKSVSVMSAIDFSYNEIGSVDGKN--------- 421

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG- 377
                       +        N+  + L  N +++     FS    L ++ L  N L   
Sbjct: 422 ---------FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472

Query: 378 ------PITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPST 430
                    +   +   L S+ L+ NK +          L  L  + L  N F+   P+ 
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531

Query: 431 IWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE 490
             N   +    + +         +   N    + P  I    +L Q+ +  N +   + E
Sbjct: 532 PLNSSTLKGFGIRNQ-------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE 583

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANL 545
                 ++ VLD+  N       + +   +      L ++K + +I RG    ++
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DI-RGCDALDI 634

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  126 bits (319), Expect = 3e-30
 Identities = 29/254 (11%), Positives = 73/254 (28%), Gaps = 24/254 (9%)

Query: 325 CSISGNIPQV-VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP----I 379
             + G  P V + + G +  L L G   +  +P    QL  L+ L L  +          
Sbjct: 66  LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125

Query: 380 TDELCHLARLHSLVLQGNKFSGSIPSCLG--NLTSLRVLYLGLNRFTSALPSTIWNLKDI 437
              +               +  +        + + L    +  +    ++  +       
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185

Query: 438 LFIDVSSNSLNV----------LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGS 487
             I   SN++            L       +    +        +N      EY +   +
Sbjct: 186 TQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKT 240

Query: 488 IPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
               + +L  L  +++        +P  L+ L  ++ +N++ N+          +  L  
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 548 KSFMGNELLKMLLL 561
                   ++++ +
Sbjct: 301 APVGEK--IQIIYI 312

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  262 bits (671), Expect = 2e-76
 Identities = 106/492 (21%), Positives = 168/492 (34%), Gaps = 36/492 (7%)

Query: 81  LNISSFNLQGTIPP--QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFG 138
           L +S+  +Q        +   SSL+ L+LS N++    P     +  L  L+ ++ QL  
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 139 SLSFFIF---NVSSVTTIDLSINGLSGEMPREIGNLPY--LARLAFATNNLVGVAPVTIF 193
           SL+  +      +S+  + LS + LS         L +  L  L  + NNL  V   +  
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLG---------INSFYGTVPSSITNA 244
            +  L+  +L  N++       +   L NV  LNL          + S       S    
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 245 SKLSDLELGVNLFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLI 296
             L  L +  N   G   N F  +        ++++ +  T       SL +   L +L 
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILN 387

Query: 297 LTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIP-QVVGNLGNLLVLELGGNNLTEPI 355
           LT N +  I   +   L   LE++ +    I   +  Q    L N+  + L  N   +  
Sbjct: 388 LTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 356 PITFSQLQTLQALGLTRNKLAG--PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSL 413
             +F+ + +LQ L L R  L            L  L  L L  N  +      L  L  L
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506

Query: 414 RVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKN 473
            +L L  N                    +S      L  LN   N            L  
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSH-----LHILNLESNGFDEIPVEVFKDLFE 561

Query: 474 LQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY-LKHLNLSFNKL 532
           L+ + L  N L       F +  SL+ L+L KN I+             L  L++ FN  
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

Query: 533 EGEIPRGGPFAN 544
           +        F N
Sbjct: 622 DCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  257 bits (658), Expect = 1e-74
 Identities = 84/478 (17%), Positives = 158/478 (33%), Gaps = 39/478 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           LN++   L+          S L +LD+  N +S   P     +  LK+L    N+L    
Sbjct: 30  LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                  +++T + L  N +             L  L  + N L      T   +  L+E
Sbjct: 90  DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQE 149

Query: 201 IYLLNNSLSGSLPSRID-LSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
           + L NN +       +D  +  +++ L L  N      P       +L  L L       
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL-SLE 318
            +                              ++ L L+ + L      +   L   +L 
Sbjct: 210 SLTEKL------------------CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN----- 373
           ++ +   +++         L  L    L  NN+      +   L  ++ L L R+     
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 374 ----KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPS 429
                L          L  L  L ++ N   G   +    L +L+ L L  +        
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT------ 365

Query: 430 TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
           ++  L +  F+ ++ + L++   LN ++N +S         L +L+ + L  N +   + 
Sbjct: 366 SLRTLTNETFVSLAHSPLHI---LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 490 -ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            + +  L ++  + LS NK       S   +  L+ L L    L+       PF  L 
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  222 bits (567), Expect = 4e-62
 Identities = 101/475 (21%), Positives = 169/475 (35%), Gaps = 62/475 (13%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
            + S   L   +P  L   +++  L+L+HN+L     ++      L  L           
Sbjct: 9   ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSL----------- 54

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                        D+  N +S   P     LP L  L    N L  ++  T    + L E
Sbjct: 55  -------------DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTE 101

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF 260
           ++L++NS+     +       N+ TL+L  N    T   +      L +L L  N     
Sbjct: 102 LHLMSNSIQKIKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160

Query: 261 IPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII 320
                                    +     LK L L+ N +    P     +   L  +
Sbjct: 161 KSEEL-------------------DIFANSSLKKLELSSNQIKEFSPGCFHAIG-RLFGL 200

Query: 321 LMDNCSISGNIPQVVG---NLGNLLVLELGGNNLTEPIPITFSQLQ--TLQALGLTRNKL 375
            ++N  +  ++ + +       ++  L L  + L+     TF  L+   L  L L+ N L
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
                D    L +L    L+ N         L  L ++R L L  +    ++     +L 
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA--SLP 318

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGS--IPESFG 493
            I   D S   L  L  LN   N++ G       GL NL+ + L  +         E+F 
Sbjct: 319 KI--DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376

Query: 494 DL--SSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            L  S L +L+L+KNKIS     +   L +L+ L+L  N++  E+  G  +  L 
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-GQEWRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  156 bits (397), Expect = 7e-40
 Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 24/273 (8%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
            +V   +   L  +      +L  ++ ++ + +  +             L  L++G N +
Sbjct: 6   HEVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 411
           ++  P    +L  L+ L L  N+L+            L  L L  N       +      
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 412 SLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIG-------------LNFSRN 458
           +L  L L  N  +S    T   L+++  + +S+N +  L               L  S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 459 NLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGD---LSSLEVLDLSKNKISGAIPAS 515
            +    P     +  L  +FL   +L  S+ E        +S+  L LS +++S     +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 516 LQKLLY--LKHLNLSFNKLEGEIPRGGPFANLT 546
              L +  L  L+LS+N L         FA L 
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLP 272

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  243 bits (622), Expect = 2e-73
 Identities = 95/295 (32%), Positives = 141/295 (47%), Gaps = 14/295 (4%)

Query: 589 SRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKV 648
           S     +     P    R    +L  AT+ F    LIG G FG +Y   L+DG +VA+K 
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70

Query: 649 FHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY--- 705
              +  + ++ FE E E +   RH +LV +I  C   +   LI KYM NG+L+  LY   
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130

Query: 706 SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
             T  +   QRL I I  A  L YLH      IIH D+K  N+LLDE+ V  I+DFGI+K
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIF-I 824
             +  DQ  +      T+GY+ PEY  KGR+  + DVYS+G++L E+   +    +    
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247

Query: 825 GELSLNRWINDLLPVS-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIES 878
             ++L  W  +      + +++D N L  +      +   L    + A +C   S
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPN-LADK---IRPES--LRKFGDTAVKCLALS 296

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  238 bits (610), Expect = 9e-72
 Identities = 96/284 (33%), Positives = 150/284 (52%), Gaps = 23/284 (8%)

Query: 604 IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVF----HQQYERALKS 659
           ++RFS  EL  A+D FS  N++G G FG +Y  RL DG  VAVK       Q  E     
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ--- 73

Query: 660 FEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY---SGTCMLDIFQR 716
           F+ E E++    HRNL+++   C     + L+  YM NGS+ +CL         LD  +R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSI 775
             I +  A  L YLH      IIH D+K +N+LLDE+  A + DFG+AKL+  +D  ++ 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE---LSLNRW 832
            +    TIG++APEY + G+   + DV+ YG+ML+E+ T ++  D   +     + L  W
Sbjct: 194 AV--RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 833 INDLLPV-SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECT 875
           +  LL    +  ++D + L+G    +  +E  +  ++ +A  CT
Sbjct: 252 VKGLLKEKKLEALVDVD-LQGN---YKDEE--VEQLIQVALLCT 289

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  242 bits (619), Expect = 7e-70
 Identities = 89/475 (18%), Positives = 166/475 (34%), Gaps = 38/475 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL-FGS 139
           L ++   +Q         LSSLQ L      L+      I ++ TLK L  + N +    
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL----ARLAFATNNLVGVAPVTIFNM 195
           L  +  N++++  +DLS N +      ++  L  +      L  + N +  + P   F  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKE 199

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV------PSSITNASKLSD 249
             L ++ L NN  S ++       L  +E   L +  F           S++     L+ 
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 250 LEL---GVNLFSGFIPNTFVNMAD-NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGI 305
            E     ++ +   I + F  + + +  +  +  +  +   +     + L L        
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319

Query: 306 LPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT--EPIPITFSQLQ 363
                 +L        +   S  G       +L +L  L+L  N L+       +     
Sbjct: 320 PTLKLKSLKR------LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNR 422
           +L+ L L+ N +   ++     L +L  L  Q +        S   +L +L  L +    
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
              A       L  +  + ++ NS                 +P     L+NL  + L   
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENF------------LPDIFTELRNLTFLDLSQC 480

Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
           +LE   P +F  LSSL+VL++S N          + L  L+ L+ S N +     
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  222 bits (569), Expect = 6e-63
 Identities = 98/485 (20%), Positives = 169/485 (34%), Gaps = 42/485 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L++S   L+        +   LQ LDLS  ++      +  ++  L  L  + N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALK 199
                 +SS+  +      L+      IG+L  L  L  A N +        F N++ L+
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 200 EIYLLNNSLSGSLPSRID----LSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
            + L +N +     + +     + L N+ +L+L +N      P +     +L  L L  N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNL-SLDLSLNPMNFIQPGAFKE-IRLHKLTLRNN 210

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL 315
             S  +  T +         +  E+  L       +  +     + L+G+   +     L
Sbjct: 211 FDSLNVMKTCIQ------GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           +             +I  +   L N+    L    +       FS     Q L L   K 
Sbjct: 265 AY------LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR--FTSALPSTIWN 433
               T +L  L       L      G       +L SL  L L  N   F      + + 
Sbjct: 317 GQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 434 LKDILFIDVSSN----------SLNVLIGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYN 482
              + ++D+S N           L  L  L+F  +NL      ++   L+NL  + + + 
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAI-PASLQKLLYLKHLNLSFNKLEGEIPRGGP 541
               +    F  LSSLEVL ++ N       P    +L  L  L+LS  +LE   P    
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP--TA 489

Query: 542 FANLT 546
           F +L+
Sbjct: 490 FNSLS 494

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  212 bits (541), Expect = 4e-59
 Identities = 95/478 (19%), Positives = 162/478 (33%), Gaps = 41/478 (8%)

Query: 81  LNISSFNLQGT-IPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL----LYFSDNQ 135
           LN++   +Q   +P    NL++L+ LDLS NK+     + +  +H + L    L  S N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMPRE-IGNLPYLARLAFATNNLVGVAPVTIFN 194
           +   +    F    +  + L  N  S  + +  I  L  L               +  F+
Sbjct: 189 M-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 195 MSALK--------EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASK 246
            SAL+        E  L            +   L NV + +L   +         +    
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFG 305

Query: 247 LSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD--G 304
              LEL    F  F      ++    LT ++ +     S  +   L+ L L+ N L   G
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSL--KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363

Query: 305 ILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI-TFSQLQ 363
              +S    + SL+ + +    +   +      L  L  L+   +NL +      F  L+
Sbjct: 364 CCSQSDFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNR 422
            L  L ++              L+ L  L + GN F  +        L +L  L L   +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
                P+   +L               L  LN S NN           L +LQ +    N
Sbjct: 482 LEQLSPTAFNSLSS-------------LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 483 RLEGSIPESFGDL-SSLEVLDLSKNKISGAIPAS--LQKLLYLKHLNLSFNKLEGEIP 537
            +  S  +      SSL  L+L++N  +        LQ +   + L +   ++E   P
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (539), Expect = 7e-59
 Identities = 91/484 (18%), Positives = 162/484 (33%), Gaps = 45/484 (9%)

Query: 82  NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS 141
                N    IP  L    S + LDLS N L      S F+   L++L  S  ++     
Sbjct: 13  QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 142 FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEI 201
               ++S ++T+ L+ N +          L  L +L     NL  +    I ++  LKE+
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 202 YLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLS----DLELGVNLF 257
            + +N +          +L N+E L+L  N       + +    ++      L+L +N  
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 258 SGFIPNTFVNM-------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSK 310
           +   P  F  +        +N+ + +  +      L   +  ++++        +    K
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI-QGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 311 GNL----SLSLEIILMDNCSISGN-IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTL 365
             L    +L++E   +       + I  +   L N+    L    +       FS     
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGW 306

Query: 366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR--F 423
           Q L L   K     T +L  L       L      G       +L SL  L L  N   F
Sbjct: 307 QHLELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 424 TSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNR 483
                 + +                 L  L+ S N +   +     GL+ L+ +  +++ 
Sbjct: 362 KGCCSQSDFGTTS-------------LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407

Query: 484 LEGSIPES-FGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPF 542
           L+     S F  L +L  LD+S      A       L  L+ L ++ N  +        F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-F 466

Query: 543 ANLT 546
             L 
Sbjct: 467 TELR 470

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  161 bits (410), Expect = 8e-42
 Identities = 80/465 (17%), Positives = 149/465 (32%), Gaps = 87/465 (18%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFN------MHTLKLLYFSDN 134
           L++S   +   I P       L  L L +N  S N+  +         +H L L  F + 
Sbjct: 182 LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 135 QLFGSLSFFIF-NVSSVTTIDLSINGLS---GEMPREIGNLPYLARLAFATNNLVGVAPV 190
                        + ++T  +  +  L     ++      L  ++  +  +  +  V   
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300

Query: 191 TIFNMSALKEIYLLNNSLSGSLPSRI------------------DLSLPNVETLNLGIN- 231
           +       + + L+N         ++                  ++ LP++E L+L  N 
Sbjct: 301 S--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 232 -SFYGTVPSSITNASKLSDLELGVNLFSGFIPN-------TFVNMADNYLTSSTPELSFL 283
            SF G    S    + L  L+L  N       N         ++   + L   +      
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE----F 414

Query: 284 SSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNI-PQVVGNLGNLL 342
           S   + + L  L ++              LS SLE++ M   S   N  P +   L NL 
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
            L+L    L +  P  F+ L +LQ L ++ N      T     L  L  L    N    S
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 403 IPSCLGNL-TSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
               L +  +SL  L L                                     ++N+ +
Sbjct: 534 KKQELQHFPSSLAFLNL-------------------------------------TQNDFA 556

Query: 462 GDIPIT--IGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
                   +  +K+ +Q+ +E  R+E + P     +  +  L+++
Sbjct: 557 CTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  114 bits (288), Expect = 1e-26
 Identities = 43/230 (18%), Positives = 79/230 (34%), Gaps = 24/230 (10%)

Query: 77  RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL 136
             + L+ +  + +G         +SL+ LDLS N +   + S+   +  L+ L F  + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408

Query: 137 FGSLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-N 194
                F +F ++ ++  +D+S              L  L  L  A N+        IF  
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 195 MSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
           +  L  + L    L    P+  + SL +++ LN+  N+F+          + L  L+  +
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 255 NLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG 304
           N           +   +                    L  L LT N    
Sbjct: 528 NHIMTSKKQELQHFPSS--------------------LAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 7e-17
 Identities = 23/120 (19%), Positives = 40/120 (33%), Gaps = 2/120 (1%)

Query: 427 LPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG 486
           +P+  +   ++ F  +  N       L+ S N L      +      LQ + L    ++ 
Sbjct: 7   VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 487 SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
               ++  LS L  L L+ N I      +   L  L+ L      L        P  +L 
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN--FPIGHLK 124

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 3/102 (2%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFS 132
           +   +  LN+S  N           L+SLQ LD S N +  +    + +  + L  L  +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 133 DNQLFGS--LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLP 172
            N    +     F+  +     + + +  +    P +   +P
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  227 bits (581), Expect = 1e-64
 Identities = 93/495 (18%), Positives = 157/495 (31%), Gaps = 37/495 (7%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L  S   L          L +L  LDL+  ++      +  + H L  L  + N L    
Sbjct: 38  LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
              +    ++  +     G+S      + N   L  L   +N++  +     F    LK 
Sbjct: 98  ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKV 157

Query: 201 IYLLNNSLSGSLPSRID-LSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
           +   NN++       +  L      +LNL  N     +     +++    L  G      
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLL 216

Query: 260 FIPNTFVN----------MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKS 309
            I     N            D      +P +       +   ++ + L  +    I   +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS---VESINLQKHYFFNISSNT 273

Query: 310 KGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALG 369
               S  L+ + +    +S  +P  +  L  L  L L  N       I+ S   +L  L 
Sbjct: 274 FHCFS-GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331

Query: 370 LTRNKLAGPITDE-LCHLARLHSLVLQGNK--FSGSIPSCLGNLTSLRVLYLGLNRFTSA 426
           +  N     +    L +L  L  L L  +    S      L NL+ L+ L L  N   S 
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391

Query: 427 LPSTIWNLKDILFIDVSSNSLNVLIG------------LNFSRNNLSGDIPITIGGLKNL 474
                     +  +D++   L V               LN S + L         GL  L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451

Query: 475 QQMFLEYNRLEGSI---PESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK 531
           Q + L+ N           S   L  LE+L LS   +S     +   L  + H++LS N+
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511

Query: 532 LEGEIPRGGPFANLT 546
           L          ++L 
Sbjct: 512 LTSSSI--EALSHLK 524

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  220 bits (562), Expect = 5e-62
 Identities = 88/484 (18%), Positives = 163/484 (33%), Gaps = 38/484 (7%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L +++  L       L    +L+ L      +S      + N  TL+ LY   N +    
Sbjct: 86  LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFA-TNNLVGVAPVTIFNMSALK 199
               F    +  +D   N +      ++ +L     L+     N +       F+ +  +
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205

Query: 200 EIYLLNNSLSGSLPSRID-LSLPNVETLNLGINSFYGTVPSSITNASKLS--DLELGVNL 256
            +          +   +   ++ ++              P+      ++S   + L  + 
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

Query: 257 FSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK 308
           F     NTF              +L+         S L     LK L+L+ N  + +   
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSE------LPSGLVGLSTLKKLVLSANKFENLCQI 319

Query: 309 SKGNLSLSLEIILMDNCSISGNI-PQVVGNLGNLLVLELGGNNLT--EPIPITFSQLQTL 365
           S  N   SL  + +   +    +    + NL NL  L+L  +++   +   +    L  L
Sbjct: 320 SASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378

Query: 366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRFT 424
           Q+L L+ N+     T+      +L  L L   +       S   NL  L+VL L  +   
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438

Query: 425 SALPSTIWNLKDILFIDVSSNSLNVLIG--------------LNFSRNNLSGDIPITIGG 470
            +       L  +  +++  N                     L  S  +LS         
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498

Query: 471 LKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           LK +  + L +NRL  S  E+   L  +  L+L+ N IS  +P+ L  L   + +NL  N
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557

Query: 531 KLEG 534
            L+ 
Sbjct: 558 PLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  218 bits (557), Expect = 2e-61
 Identities = 95/479 (19%), Positives = 176/479 (36%), Gaps = 32/479 (6%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
            N  +  L   IP  L   +S + L+ S N L     ++   +  L  L  +  Q++   
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                +   + T+ L+ N L       +     L  L F    +  +  + + N   L+ 
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV--NLFS 258
           +YL +N +S S+          ++ L+   N+ +      +++  + ++L L +  N  +
Sbjct: 134 LYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 259 GFIPNTF-------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKS-K 310
           G  P  F       +N           +    S++ +   L +        + I P   +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS---LWLGTFEDMDDEDISPAVFE 249

Query: 311 GNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGL 370
           G   +S+E I +                  L  L+L   +L+E +P     L TL+ L L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVL 308

Query: 371 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPS 429
           + NK          +   L  L ++GN     + + CL NL +LR L L  +        
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD-------- 360

Query: 430 TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
              +++     ++   +L+ L  LN S N               L+ + L + RL+    
Sbjct: 361 ---DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417

Query: 490 ES-FGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG-GPFANLT 546
           +S F +L  L+VL+LS + +  +       L  L+HLNL  N       +       L 
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  187 bits (476), Expect = 2e-50
 Identities = 80/458 (17%), Positives = 155/458 (33%), Gaps = 61/458 (13%)

Query: 103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSG 162
           +T +  +  L+  IP ++                           +S   ++ S N L  
Sbjct: 15  KTYNCENLGLN-EIPGTLP--------------------------NSTECLEFSFNVLPT 47

Query: 163 EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPN 222
                   L  L  L      +  +   T  +   L  + L  N L   +          
Sbjct: 48  IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALSGPKA 106

Query: 223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM--------ADNYLT 274
           ++ L              + N   L  L LG N  S                   +N + 
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166

Query: 275 SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQV 334
             + E   +SSL     L  L L GN + GI      + ++   +      ++      +
Sbjct: 167 YLSKED--MSSLQQATNLS-LNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQNLLVIFKGL 222

Query: 335 VGN-LGNLLVLELGGNNLTEPIPITFSQLQ--TLQALGLTRNKLAGPITDELCHLARLHS 391
             + + +L +      +  +  P  F  L   +++++ L ++      ++     + L  
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282

Query: 392 LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI 451
           L L     S  +PS L  L++L+ L L  N+F +    +  N                L 
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS-------------LT 328

Query: 452 GLNFSRNNLSGDI-PITIGGLKNLQQMFLEYNRLEGS--IPESFGDLSSLEVLDLSKNKI 508
            L+   N    ++    +  L+NL+++ L ++ +E S        +LS L+ L+LS N+ 
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388

Query: 509 SGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
                 + ++   L+ L+L+F +L+       PF NL 
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  182 bits (465), Expect = 5e-49
 Identities = 80/481 (16%), Positives = 156/481 (32%), Gaps = 40/481 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL--LYFSDNQLFG 138
           L + S ++     P+      L+ LD  +N +       + ++       L  + N +  
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-A 192

Query: 139 SLSFFIFNVSSVTTIDLSINGLSGEMPREIG--NLPYLARLAFATNNLVGVAPVTIFNMS 196
            +    F+ +   +++         + + +    +  L    F   +   ++P     + 
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 197 A--LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
              ++ I L  +    ++ S        ++ L+L        +PS +   S L  L L  
Sbjct: 253 EMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310

Query: 255 NLFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGIL 306
           N F      +  N           N                N + L+ L L+ + ++   
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL----ENLENLRELDLSHDDIETSD 366

Query: 307 PKSKGNLSL-SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE-PIPITFSQLQT 364
             +    +L  L+ + +          +       L +L+L    L        F  L  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC---LGNLTSLRVLYLGLN 421
           L+ L L+ + L          L  L  L LQGN F          L  L  L +L L   
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486

Query: 422 RFTSALPSTIWNLKDILFIDVSSNSLNVLIG----------LNFSRNNLSGDIPITIGGL 471
             +S       +LK +  +D+S N L               LN + N++S  +P  +  L
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546

Query: 472 KNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK 531
              + + L  N L+ +      ++  LE    +  K+        +    L+ + LS   
Sbjct: 547 SQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602

Query: 532 L 532
           L
Sbjct: 603 L 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 27/129 (20%), Positives = 51/129 (39%), Gaps = 5/129 (3%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L +S  +L         +L  +  +DLSHN+L+ +   ++ ++  +  L  + N +   L
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIIL 539

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
              +  +S   TI+L  N L         N+ +L         L         N   L+ 
Sbjct: 540 PSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595

Query: 201 IYLLNNSLS 209
           + L + +LS
Sbjct: 596 VRLSDVTLS 604

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  232 bits (593), Expect = 2e-64
 Identities = 83/545 (15%), Positives = 172/545 (31%), Gaps = 91/545 (16%)

Query: 33  TDQQALLALKAHISYD---------HTNLFARNWTSSTSVCSWIGITCDV--NSHRVIGL 81
            D +AL A+   +            +  + + NW  +  +  W         N+ RV GL
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 82  NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS 141
           +++ F  +G +P  +G L+ L+ L    +  + +         T  +     +++     
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 142 -FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA------PVTIFN 194
             F+     +   DL  + ++     E+  +   +R++     +  +          I  
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446

Query: 195 MSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
           ++ L+ IY  N+  +    +            N      Y     S +N   L+D+EL  
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWE------DANSDYAKQYENEELSWSNLKDLTDVELYN 500

Query: 255 NLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS 314
                 +P                       L +  +L+ L +  N       + K + +
Sbjct: 501 CPNMTQLP---------------------DFLYDLPELQSLNIACNRGISA-AQLKADWT 538

Query: 315 LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE-PIPITFSQLQTLQALGLTRN 373
                           +         + +  +G NNL E P   +  ++  L  L    N
Sbjct: 539 ---------------RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583

Query: 374 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWN 433
           K+     +      +L  L L  N+              +  L    N+    +P+    
Sbjct: 584 KVRHL--EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF-- 638

Query: 434 LKDILFIDVSSNSLNVLIGLNFSRNNLSGDIP-----ITIGGLKNLQQMFLEYNRLEGSI 488
                    ++ S+ V+  ++FS N +  +       +      N   + L YN ++   
Sbjct: 639 ---------NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689

Query: 489 PESFGDLSSLEVLDLSKNKIS-------GAIPASLQKLLYLKHLNLSFNKLEGEIPRGGP 541
            E F   S +  + LS N ++            + +    L  ++L FNKL   +     
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748

Query: 542 FANLT 546
              L 
Sbjct: 749 ATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  220 bits (563), Expect = 2e-60
 Identities = 68/488 (13%), Positives = 148/488 (30%), Gaps = 73/488 (14%)

Query: 85  SFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFI 144
             N    I   +  L+ LQ +  +++  + +  +        +       + + +     
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSW 487

Query: 145 FNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA---------PVTIFNM 195
            N+  +T ++L       ++P  + +LP L  L  A N  +  A                
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547

Query: 196 SALKEIYLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
             ++  Y+  N+L    P+   L  +  +  L+   N        +     KL+DL+L  
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDY 604

Query: 255 NLFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGIL 306
           N       +             + N L       +      +   +  +  + N +    
Sbjct: 605 NQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN----AKSVYVMGSVDFSYNKIGSEG 660

Query: 307 PKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ 366
                ++                          N   + L  N + +     F+    + 
Sbjct: 661 RNISCSMDDY--------------------KGINASTVTLSYNEIQKFPTELFATGSPIS 700

Query: 367 ALGLTRNKL-------AGPITDELCHLARLHSLVLQGNKFSGSIPS--CLGNLTSLRVLY 417
            + L+ N +         P      +   L ++ L+ NK + S+        L  L  + 
Sbjct: 701 TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD 759

Query: 418 LGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQM 477
           +  N F+S  P+   N   +    +           +   N +    P  I    +L Q+
Sbjct: 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQ-------RDAEGNRILRQWPTGITTCPSLIQL 811

Query: 478 FLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            +  N +   + E       L +LD++ N        S+   +      L ++K + +I 
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ-DI- 866

Query: 538 RGGPFANL 545
           RG     +
Sbjct: 867 RGCDALGI 874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  117 bits (295), Expect = 4e-27
 Identities = 47/331 (14%), Positives = 91/331 (27%), Gaps = 30/331 (9%)

Query: 254 VNLFSGFIPNTFVNMADNYLTSSTPE-LSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN 312
             L +  +      + DN LT      +    +    K  K L      LDG   +    
Sbjct: 232 SELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSG 291

Query: 313 LSLSLEI-----ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQA 367
              +           +           + N G +  L L G      +P    QL  L+ 
Sbjct: 292 TINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKV 351

Query: 368 LGLTRNKLAGPITDELCH-------LARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL 420
           L    +                     R H + +   K        L     L+      
Sbjct: 352 LSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411

Query: 421 NRFTSALPSTIWNLKDILFIDVSSNSLNVL---IG-------LNFSRNNLSGDIPITIGG 470
                    +  +LKD   I   +N +  +   I        + F+ +  + D       
Sbjct: 412 PEMKPIKKDSRISLKD-TQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV--- 467

Query: 471 LKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
             + +    +Y +   +   S+ +L  L  ++L        +P  L  L  L+ LN++ N
Sbjct: 468 --DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

Query: 531 KLEGEIPRGGPFANLTAKSFMGNELLKMLLL 561
           +          +  L          +++  +
Sbjct: 526 RGISAAQLKADWTRLA-DDEDTGPKIQIFYM 555

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 14/92 (15%), Positives = 27/92 (29%)

Query: 480 EYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG 539
           E +           +   +  L L+     G +P ++ +L  LK L+   +         
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 540 GPFANLTAKSFMGNELLKMLLLVIILPLSTAL 571
           G        S      ++M    + L     L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  212 bits (543), Expect = 2e-62
 Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 27/288 (9%)

Query: 605 RRFSYHELLRATDRFSE------NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERA-- 656
             FS++EL   T+ F E       N +G G FG +Y   + +   VAVK      +    
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 657 --LKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY--SGTCMLD 712
              + F+ E +VM + +H NLV+++   S+ D   L+  YMPNGSL + L    GT  L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
              R  I    A  + +LH       IH D+K +N+LLDE   A ISDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
             +  + + T  YMAPE    G +  + D+YS+G++L+E+ T     DE       L   
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDI 246

Query: 833 INDLL--PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIES 878
             ++     ++ + ID  +   +     +    + ++ ++A++C  E 
Sbjct: 247 KEEIEDEEKTIEDYIDKKM--ND---ADSTS--VEAMYSVASQCLHEK 287

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  205 bits (524), Expect = 8e-57
 Identities = 88/474 (18%), Positives = 161/474 (33%), Gaps = 37/474 (7%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFG-S 139
           L ++   +Q   P     L+SL+ L     KL+      I  + TLK L  + N +    
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFA---TNNLVGVAPVTIFNMS 196
           L  +  N++++  +DLS N +      ++  L    ++  +   + N +       F   
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204

Query: 197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLS-------- 248
            L E+ L  N  S ++      +L  +    L +  F       I   S +         
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 249 DLELGVNLFSGFIPNTFVNMAD-NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP 307
           +  L            F  +A+ + ++ +   + +L  +    K + L +    L     
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF-- 322

Query: 308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQT--L 365
               +L   L+ + +     S  I      L +L  L+L  N L+     ++S L T  L
Sbjct: 323 -PTLDLP-FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378

Query: 366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRFT 424
           + L L+ N     ++     L  L  L  Q +        S   +L  L  L +      
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437

Query: 425 SALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIP-ITIGGLKNLQQMFLEYNR 483
                    L               L  L  + N+   +          NL  + L   +
Sbjct: 438 IDFDGIFLGLTS-------------LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484

Query: 484 LEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
           LE      F  L  L++L++S N +     +   +L  L  L+ SFN++E    
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  196 bits (501), Expect = 1e-53
 Identities = 85/468 (18%), Positives = 142/468 (30%), Gaps = 59/468 (12%)

Query: 81  LNISSFNLQG-TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL----LYFSDNQ 135
           LN++   +    +P    NL++L  +DLS+N +     + +  +         L  S N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMPRE-IGNLPYLARLAFATNNLVGVAPVTIFN 194
           +   +    F    +  + L  N  S  + +  + NL  L               + IF 
Sbjct: 193 I-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 195 MSA---LKEIYLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFYGTVPSSITNASKL 247
            S    L ++ +    L+ +     D+     L NV  ++L   S        +    K 
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309

Query: 248 SDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP 307
             L +       F       +    LT +  + S          L  L L+ N L     
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFL--KSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGC 367

Query: 308 KSKGNLSL-SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI-TFSQLQTL 365
            S  +L   SL  + +        +      L  L  L+   + L        F  L+ L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426

Query: 366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFT 424
             L ++              L  L++L + GN F  +  S    N T+L  L L      
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL------ 480

Query: 425 SALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRL 484
                                          S+  L          L  LQ + + +N L
Sbjct: 481 -------------------------------SKCQLEQISWGVFDTLHRLQLLNMSHNNL 509

Query: 485 EGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL 532
                  +  L SL  LD S N+I  +          L   NL+ N +
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  172 bits (437), Expect = 3e-45
 Identities = 93/468 (19%), Positives = 167/468 (35%), Gaps = 56/468 (11%)

Query: 90  GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSS 149
           G++ P +  + ++ T      KLS  +P  I +  + K +  S N L    S+   N S 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 150 VTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS 209
           +  +DLS   +     +    L +L+ L    N +   +P +   +++L+ +  +   L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 210 GSLPSRIDLSLPNVETLNLGINSFYG-TVPSSITNASKLSDLELGVNLFSGFIPNTFVNM 268
            SL S     L  ++ LN+  N  +   +P+  +N + L  ++L  N       N     
Sbjct: 118 -SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL--- 173

Query: 269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS 328
                        FL           L ++ NP+D I  ++   + L  E+ L  N + S
Sbjct: 174 ------------QFLRENPQ--VNLSLDMSLNPIDFIQDQAFQGIKL-HELTLRGNFNSS 218

Query: 329 GNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALG--------LTRNKLAGPIT 380
             +   + NL  L V  L      +   +   +   ++ L         LT         
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278

Query: 381 DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFI 440
            +   LA + ++ L G          +      + L +   +                  
Sbjct: 279 VKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ--------------- 321

Query: 441 DVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL--SSL 498
              +  L  L  L  + N  S  I      L +L  + L  N L  S   S+ DL  +SL
Sbjct: 322 -FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378

Query: 499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
             LDLS N     + A+   L  L+HL+   + L+  +     F +L 
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLE 424

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  159 bits (404), Expect = 5e-41
 Identities = 69/382 (18%), Positives = 136/382 (35%), Gaps = 23/382 (6%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGS 139
           L++S   +   I  Q      L  L L  N  S NI  +   N+  L +      +    
Sbjct: 186 LDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

Query: 140 LSFFIFNVS--------SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVT 191
            +  IF  S        ++    L+      +   +   L  ++ ++ A  ++  +    
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED-- 302

Query: 192 IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE 251
           +      + + ++   L    P+   L LP +++L L +N   G++         LS L+
Sbjct: 303 VPKHFKWQSLSIIRCQLK-QFPT---LDLPFLKSLTLTMNK--GSISFKKVALPSLSYLD 356

Query: 252 LGVNLFSGFIPNTFVNMADNYLTS---STPELSFLSS-LTNCKKLKVLILTGNPLDGILP 307
           L  N  S     ++ ++  N L     S      +S+     ++L+ L    + L  +  
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTE 416

Query: 308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIP-ITFSQLQTLQ 366
            S       L  + +   +   +   +   L +L  L++ GN+  +      F+    L 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 367 ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSA 426
            L L++ +L          L RL  L +  N       S    L SL  L    NR  ++
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 427 LPSTIWNLKDILFIDVSSNSLN 448
                   K + F ++++NS+ 
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 52/375 (13%), Positives = 111/375 (29%), Gaps = 26/375 (6%)

Query: 84  SSFNLQGTIPPQLGNLSSLQT--LDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS 141
              NL+   P  +  L  +      L++     +       +  +  +  +   +     
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED 302

Query: 142 FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEI 201
                     ++ +    L         +LP+L  L    N            + +L  +
Sbjct: 303 VP--KHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGSI--SFKKVALPSLSYL 355

Query: 202 YLLNNSLSGSLP-SRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF 260
            L  N+LS S   S  DL   ++  L+L  N     + ++     +L  L+   +     
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414

Query: 261 IPN---------TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
                        +++++                      L  L + GN        +  
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDG-----IFLGLTSLNTLKMAGNSFKDNTLSNVF 469

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
             + +L  + +  C +      V   L  L +L +  NNL       ++QL +L  L  +
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
            N++             L    L  N  +  I      L  ++     L        +T 
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATP 588

Query: 432 WNLKDILFIDVSSNS 446
             +   L +D ++++
Sbjct: 589 VEMNTSLVLDFNNST 603

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  105 bits (263), Expect = 2e-23
 Identities = 45/245 (18%), Positives = 85/245 (34%), Gaps = 22/245 (8%)

Query: 329 GNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR 388
           G++   +  + N+   +     L++ +P       + + + L+ N L    +    + + 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN 448
           L  L L   +           L  L  L L  N   S  P +   L              
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS------------ 105

Query: 449 VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVLDLSKNK 507
            L  L      L+      IG L  L+++ + +N +    +P  F +L++L  +DLS N 
Sbjct: 106 -LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164

Query: 508 ISGAIPASLQKL----LYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLLVI 563
           I       LQ L         L++S N ++    +      L   +  GN     ++   
Sbjct: 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTC 224

Query: 564 ILPLS 568
           +  L+
Sbjct: 225 LQNLA 229

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  196 bits (500), Expect = 2e-56
 Identities = 67/287 (23%), Positives = 110/287 (38%), Gaps = 22/287 (7%)

Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV 666
                L   +       +   G FG ++ A+L     VAVK+F  Q +++ +  E E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 667 MKRIRHRNLVKIISSCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           +  ++H N+++ I +            LI  +   GSL + L +    +   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAET 129

Query: 723 VALALEYLH------FGHSTP-IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
           +A  L YLH           P I H D+K  NVLL  ++ A I+DFG+A           
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 776 QIQTLATIGYMAPEY-----GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIG-ELSL 829
               + T  YMAPE        +     R D+Y+ G++L E+ ++    D       L  
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 830 NRWINDLLPVSVM-EVIDTNLLRGEERFFAAKEQILLSVLNLATECT 875
              I     +  M EV+     R   R +  K   +  +     EC 
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  188 bits (480), Expect = 9e-54
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 8/202 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG+++ A    G +VAVK+  +Q      +  F  E  +MKR+RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTC--MLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +     +++ +Y+  GSL   L+       LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            +LK  N+L+D+     + DFG+++L +     S       T  +MAPE         + 
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 801 DVYSYGIMLMEMFTKKKPTDEI 822
           DVYS+G++L E+ T ++P   +
Sbjct: 221 DVYSFGVILWELATLQQPWGNL 242

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (476), Expect = 2e-53
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     A++ ++    SL + L++     ++ + ++I    A  ++YLH   +  IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE---YGTKGRVCTR 799
           LK +N+ L ED    I DFG+A   S         Q   +I +MAPE            +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 800 GDVYSYGIMLMEMFTKKKP 818
            DVY++GI+L E+ T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  184 bits (468), Expect = 3e-52
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G+FG +  A+ +   +VA+K    + ER  K+F  E   + R+ H N+VK+  +C N
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 685 DDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
                L+M+Y   GSL N L+             ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 743 LKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           LKP N+LL     V  I DFG A  +     ++    + A   +MAPE         + D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAA---WMAPEVFEGSNYSEKCD 185

Query: 802 VYSYGIMLMEMFTKKKPTDEI 822
           V+S+GI+L E+ T++KP DEI
Sbjct: 186 VFSWGIILWEVITRRKPFDEI 206

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (459), Expect = 2e-51
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC 682
           +     G ++  R Q G ++ VKV   +    R  + F +EC  ++   H N++ ++ +C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 683 SN--DDFKALIMKYMPNGSLENCLYSGTCM-LDIFQRLNIMIDVALALEYLHFGHSTPII 739
            +       LI  +MP GSL N L+ GT   +D  Q +   +D+A  + +LH      I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YGTK 793
              L   +V++DEDM A IS   +                +    ++APE        T 
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTN 188

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
            R     D++S+ ++L E+ T++ P  ++
Sbjct: 189 RRSA---DMWSFAVLLWELVTREVPFADL 214

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  180 bits (460), Expect = 3e-51
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQ-------YERALKSFEDECEVMKRIRHRNLV 676
           IG G FG ++  RL  D   VA+K                 + F+ E  +M  + H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           K+     N     ++M+++P G L + L      +    +L +M+D+AL +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 737 PIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
           PI+H DL+  N+ L        + A ++DFG+++       +S  +       +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQ---WMAPETI 198

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
              +     + D YS+ ++L  + T + P DE 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  179 bits (455), Expect = 7e-51
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQ----YERALKSFEDECEVMKRIRHRNLVKIIS 680
           IGIG FG +Y A    G EVAVK           + +++   E ++   ++H N++ +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
            C  +    L+M++   G L   L      +     +N  + +A  + YLH     PIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 741 CDLKPSNVLLDEDMVAH--------ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            DLK SN+L+ + +           I+DFG+A+      ++S          +MAPE   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYAWMAPEVIR 187

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
                   DV+SYG++L E+ T + P   I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (456), Expect = 2e-50
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIIS 680
            LIG G FG +Y  R     EVA+++   +   E  LK+F+ E    ++ RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           +C +    A+I       +L + +     +LD+ +   I  ++   + YL   H+  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA---TIGYMAPE-------- 789
            DLK  NV  D   V  I+DFG+  +         + +       + ++APE        
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               K       DV++ G +  E+  ++ P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (446), Expect = 6e-49
 Identities = 67/238 (28%), Positives = 95/238 (39%), Gaps = 32/238 (13%)

Query: 607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV 666
            +  E     D      LIG G +G++Y   L D   VAVKVF     +   +F +E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 667 MK--RIRHRNLVKIISSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
            +   + H N+ + I               L+M+Y PNGSL   L   T   D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 720 MIDVALALEYLH-----FGHSTP-IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
              V   L YLH       H  P I H DL   NVL+  D    ISDFG++  L+G   +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 774 SIQIQTLA------TIGYMAPEY-------GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               +  A      TI YMAPE                + D+Y+ G++  E+F +   
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  180 bits (459), Expect = 2e-48
 Identities = 95/484 (19%), Positives = 172/484 (35%), Gaps = 42/484 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL-FGS 139
           L ++   +Q         LSSLQ L      L+      I ++ TLK L  + N +    
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL----ARLAFATNNLVGVAPVTIFNM 195
           L  +  N++++  +DLS N +      ++  L  +      L  + N +  + P   F  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKE 199

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
             L ++ L NN  S ++       L  +E   L +  F         N   L   +   +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF--------RNEGNLEKFDK--S 249

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL 315
              G    T       YL     ++  L +      +    L    ++ +   S      
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKDFSYNFGWQ 307

Query: 316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
            LE++                 L +L  L    N        +   L +L+ L L+RN L
Sbjct: 308 HLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGL 359

Query: 376 A--GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIW- 432
           +  G  +        L  L L  N    ++ S    L  L  L    +        +++ 
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 433 NLKDILFIDVSSNSLNV-----------LIGLNFSRNNLSGDI-PITIGGLKNLQQMFLE 480
           +L++++++D+S     V           L  L  + N+   +  P     L+NL  + L 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 481 YNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGG 540
             +LE   P +F  LSSL+VL+++ N++         +L  L+ + L  N  +   PR  
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538

Query: 541 PFAN 544
             + 
Sbjct: 539 YLSR 542

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  173 bits (441), Expect = 5e-46
 Identities = 104/498 (20%), Positives = 179/498 (35%), Gaps = 44/498 (8%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGS 139
           L++S   L+        +   LQ LDLS  ++   I    + ++  L  L  + N +  S
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QS 90

Query: 140 LSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSA 197
           L+   F  +SS+  +      L+      IG+L  L  L  A N +        F N++ 
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPN----VETLNLGINSFYGTVPSSITNASKLSDLELG 253
           L+ + L +N +  S+       L        +L+L +N     +        +L  L L 
Sbjct: 151 LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLR 208

Query: 254 VNLFSGFIPNTFVNMADNYLTSSTPELSF----------LSSLTNCKKLKVLILTGNPLD 303
            N  S  +  T +               F           S+L     L +       LD
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQ 363
             L       +    +      S++    +          LEL      +       +L+
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ---FPTLKLK 325

Query: 364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNK--FSGSIPSCLGNLTSLRVLYLGLN 421
           +L+ L  T NK     ++    L  L  L L  N   F G         TSL+ L L  N
Sbjct: 326 SLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 422 RFTSALPSTIWNLKDILFIDVSSNSLNV------------LIGLNFSRNNLSGDIPITIG 469
              + + S    L+ +  +D   ++L              LI L+ S  +          
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 470 GLKNLQQMFLEYNRLEGSI-PESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLS 528
           GL +L+ + +  N  + +  P+ F +L +L  LDLS+ ++    P +   L  L+ LN++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502

Query: 529 FNKLEGEIPRGGPFANLT 546
            N+L+  +P  G F  LT
Sbjct: 503 SNQLK-SVPD-GIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  155 bits (393), Expect = 8e-40
 Identities = 87/482 (18%), Positives = 165/482 (34%), Gaps = 45/482 (9%)

Query: 84  SSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF 143
              N    IP  L    S + LDLS N L      S F+   L++L  S  ++  ++   
Sbjct: 15  MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDG 70

Query: 144 IF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIY 202
            + ++S ++T+ L+ N +          L  L +L     NL  +    I ++  LKE+ 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLS----DLELGVNLFS 258
           + +N +          +L N+E L+L  N       + +    ++      L+L +N  +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 259 GFIPNTFVNM-------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
              P  F  +        +N+ + +  +      L   +  ++++        +    K 
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI-QGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 312 NL----SLSLEIILMDNCSISGN-IPQVVGNLGNLLVLELGGNNLTEPIPITF-SQLQTL 365
            L    +L++E   +       + I  +   L N+    L    +      ++    Q L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309

Query: 366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS 425
           + +     +           L  L  L    NK   +      +L SL  L L  N  + 
Sbjct: 310 ELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSF 361

Query: 426 ALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLE 485
                            S      L  L+ S N +   +     GL+ L+ +  +++ L+
Sbjct: 362 -----------KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409

Query: 486 GSIPES-FGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFAN 544
                S F  L +L  LD+S      A       L  L+ L ++ N  +        F  
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTE 468

Query: 545 LT 546
           L 
Sbjct: 469 LR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  103 bits (258), Expect = 6e-23
 Identities = 49/274 (17%), Positives = 97/274 (35%), Gaps = 28/274 (10%)

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           NL  S + + +    +         +   L VL+L    +       +  L  L  L LT
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS-ALPST 430
            N +          L+ L  LV      +      +G+L +L+ L +  N   S  LP  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 431 IWNLKDILFIDVSSNSLNVL---------------IGLNFSRNNLSGDIPITIGGLKNLQ 475
             NL ++  +D+SSN +  +               + L+ S N ++  I         L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203

Query: 476 QMFLEYNRLEGSIPE-SFGDLSSLEVLDLSK------NKISGAIPASLQKL--LYLKHLN 526
           ++ L  N    ++ +     L+ LEV  L          +     ++L+ L  L ++   
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 527 LSFNKLEGEIPRG--GPFANLTAKSFMGNELLKM 558
           L++     +          N+++ S +   + ++
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  171 bits (435), Expect = 1e-47
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 625 IGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G FG        + G  + +K   +  E   ++F  E +VM+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
            D     I +Y+  G+L   + S        QR++   D+A  + YL   HS  IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDL 134

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLS---------IQIQTLATIG---YMAPEYG 791
              N L+ E+    ++DFG+A+L+  E              + +    +G   +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                  + DV+S+GI+L E+  +   
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (431), Expect = 3e-47
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV--MKRIRHRNLVKIIS 680
             +G G +G ++    Q G  VAVK+F  + E+   S+  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 681 SCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH----- 731
           S       +    LI  Y   GSL + L   T  LD    L I++ +A  L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPE 789
                 I H DLK  N+L+ ++    I+D G+A + S               T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 790 ------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
                          R D++++G++L E+  +      +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  166 bits (422), Expect = 1e-45
 Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 26/272 (9%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV--MKRIRHRNLVKIIS 680
             IG G +G +++ + + G +VAVKVF    E    S+  E E+     +RH N++  I+
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98

Query: 681 SCSNDDFK----ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH----- 731
           +            LI  Y  NGSL + L S T  LD    L +       L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPE 789
                 I H DLK  N+L+ ++    I+D G+A     +             T  YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 790 ------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM- 842
                      +     D+YS+G++L E+  +      +   +L  +  +        M 
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 843 EVIDTNLLRGEERFFAAKEQILLSVLNLATEC 874
           E++    LR       + ++ L  +  L TEC
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  163 bits (414), Expect = 2e-44
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEV--MKRIRHRNLVKIIS 680
             IG G FG ++  + + G EVAVK+F  + ER   S+  E E+     +RH N++  I+
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103

Query: 681 SCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH----- 731
           + + D+       L+  Y  +GSL + L   T  + +   + + +  A  L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPE 789
                 I H DLK  N+L+ ++    I+D G+A                   T  YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 790 ------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI 822
                          R D+Y+ G++  E+  +       
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  167 bits (426), Expect = 3e-44
 Identities = 95/486 (19%), Positives = 182/486 (37%), Gaps = 48/486 (9%)

Query: 85  SFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSF 142
           SFN    I    L   ++LQ L L  ++++  I    F ++ +L+ L  SDN L  SLS 
Sbjct: 34  SFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL-SSLSS 91

Query: 143 FIF-NVSSVTTIDLSINGLSGEMPR-EIGNLPYLARLAFATNNLVGVAPVTIF-NMSALK 199
             F  +SS+  ++L  N            NL  L  L               F  +++L 
Sbjct: 92  SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN 151

Query: 200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
           E+ +   SL  +  S+   S+ ++  L L ++     +       S +  LEL     + 
Sbjct: 152 ELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

Query: 260 FIPNTFVNMA-------DNYLTSSTPELSF------LSSLTNCKKLKVLILTGNPLDGIL 306
           F  +               +  S   + SF      L  +    +++    T N L    
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270

Query: 307 PKSKGNLS-------LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITF 359
           P     +S       +++  + +    +  ++  V   L  +  + +  + +        
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330

Query: 360 SQLQTLQALGLTRNKL---AGPITDELCHLARLHSLVLQGNKFS--GSIPSCLGNLTSLR 414
             L++L+ L L+ N +       +        L +LVL  N           L  L +L 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 415 VLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV--------LIGLNFSRNNLSGDIPI 466
            L +  N F   +P +    + + F+++SS  + V        L  L+ S NNL     +
Sbjct: 391 SLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSL 448

Query: 467 TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLN 526
               L  LQ++++  N+L+ ++P++      L V+ +S+N++         +L  L+ + 
Sbjct: 449 ---FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503

Query: 527 LSFNKL 532
           L  N  
Sbjct: 504 LHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  129 bits (326), Expect = 1e-31
 Identities = 70/452 (15%), Positives = 148/452 (32%), Gaps = 70/452 (15%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSI 157
           +  +    D      + +IPS +                           +++ ++DLS 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLT--------------------------AAMKSLDLSF 35

Query: 158 NGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRID 217
           N ++     ++     L  L   ++ +  +     +++ +L+ + L +N LS SL S   
Sbjct: 36  NKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWF 94

Query: 218 LSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSST 277
             L +++ LNL  N +      ++   S   +L    NL         + + +    S  
Sbjct: 95  GPLSSLKYLNLMGNPY-----QTLGVTSLFPNL---TNL-------QTLRIGNVETFSEI 139

Query: 278 PELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN 337
             + F         L  L +    L     +S  ++   +  + +     +  +      
Sbjct: 140 RRIDFA----GLTSLNELEIKALSLRNYQSQSLKSIR-DIHHLTLHLSESAFLLEIFADI 194

Query: 338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGN 397
           L ++  LEL   NL           +    +     + +    +    L +L   +L   
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL--- 251

Query: 398 KFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSR 457
                       L+ +      LN      PS    + ++  ++  +     +  L+  +
Sbjct: 252 -----------ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT-----IRRLHIPQ 295

Query: 458 NNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAI---PA 514
             L  D+      L+ ++++ +E +++          L SLE LDLS+N +        A
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355

Query: 515 SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
                  L+ L LS N L      G     L 
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 40/236 (16%), Positives = 85/236 (36%), Gaps = 27/236 (11%)

Query: 80  GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQL-- 136
            L+I  F L   +      L  ++ + + ++K+   +P S   ++ +L+ L  S+N +  
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 137 -FGSLSFFIFNVSSVTTIDLSINGLS--GEMPREIGNLPYLARLAFATNNLVGVAPVTIF 193
            +   S       S+ T+ LS N L    +    +  L  L  L  + N    + P +  
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQ 407

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELG 253
               ++ + L +  +   + + I      +E L++  N+   +    +     L +L + 
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNL-DSFSLFLPR---LQELYIS 459

Query: 254 VNLFSGFIPNTF------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
            N        +       + ++ N L S                L+ + L  NP D
Sbjct: 460 RNKLKTLPDASLFPVLLVMKISRNQLKSVPD-----GIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.6 bits (194), Expect = 3e-15
 Identities = 48/328 (14%), Positives = 105/328 (32%), Gaps = 48/328 (14%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD 133
            + R   L   SFN    +   +  LS ++  D + N L    PS    +  L  +    
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV---- 283

Query: 134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF 193
                          ++  + +    L  ++      L  + R+    + +  V      
Sbjct: 284 ------------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331

Query: 194 NMSALKEIYLLNNSLS--GSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE 251
           ++ +L+ + L  N +       S    + P+++TL L  N               L  ++
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN--------------HLRSMQ 377

Query: 252 LGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
               +       T ++++ N          +       +K++ L L+   +  +      
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWP------EKMRFLNLSSTGIRVVKT---- 427

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
            +  +LE++ + N ++          L  L  L +  N L      +      L  + ++
Sbjct: 428 CIPQTLEVLDVSNNNLD----SFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKIS 481

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKF 399
           RN+L          L  L  + L  N +
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  163 bits (416), Expect = 1e-43
 Identities = 103/480 (21%), Positives = 176/480 (36%), Gaps = 70/480 (14%)

Query: 77  RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL 136
            +    I+       I      L+      L    ++  +     ++  +  L      +
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 137 FGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMS 196
             S+   +  ++++T I+ S N L+   P  + NL  L  +    N +  + P  + N++
Sbjct: 59  -KSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL 256
            L  + L NN ++   P +   +L N+  L L  N+   +  S+++  + L  L  G   
Sbjct: 113 NLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQ- 166

Query: 257 FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS 316
                                  ++ L  L N   L+ L ++ N +  I       L+ +
Sbjct: 167 -----------------------VTDLKPLANLTTLERLDISSNKVSDI--SVLAKLT-N 200

Query: 317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLA 376
           LE ++  N  IS   P  +G L NL  L L GN L +      + L  L  L L  N+++
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQIS 256

Query: 377 GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKD 436
                 L  L +L  L L  N+ S   P  L  LT+L  L L  N+      S I NLK+
Sbjct: 257 NLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKN 310

Query: 437 ILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS 496
                        L  L    NN+S   P  +  L  LQ++F   N++      S  +L+
Sbjct: 311 -------------LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLT 353

Query: 497 SLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
           ++  L    N+IS   P  L  L  +  L L+               ++          L
Sbjct: 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  151 bits (384), Expect = 3e-39
 Identities = 88/447 (19%), Positives = 173/447 (38%), Gaps = 67/447 (14%)

Query: 87  NLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFN 146
            L       +  L++L  ++ S+N+L+   P  + N+  L  +  ++NQ+       + N
Sbjct: 55  RLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110

Query: 147 VSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNN 206
           ++++T + L  N ++   P  + NL  L RL  ++N +  ++   +  +++L+++    N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS-FGN 165

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFV 266
            ++   P     +L  +E L++  N    +  S +   + L  L    N  S   P    
Sbjct: 166 QVTDLKPLA---NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP---- 216

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS 326
                              L     L  L L GN L  I   +  +L+ +L  + + N  
Sbjct: 217 -------------------LGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQ 254

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
           IS   P  +  L  L  L+LG N ++   P+  + L  L  L L  N+L       + +L
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTNLELNENQLEDIS--PISNL 308

Query: 387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS 446
             L  L L  N  S   P  + +LT L+ L+   N+ +    S++ NL +          
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTN---------- 354

Query: 447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
              +  L+   N +S   P  +  L  + Q+ L       +      ++S    +     
Sbjct: 355 ---INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409

Query: 507 KISGAIPASLQKLLYLKHLNLSFNKLE 533
            +    PA++         ++++N   
Sbjct: 410 ALI--APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  103 bits (258), Expect = 3e-23
 Identities = 63/301 (20%), Positives = 130/301 (43%), Gaps = 22/301 (7%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L+ISS  +  +    L  L++L++L  ++N++S   P  +  +  L  L  + NQL   +
Sbjct: 182 LDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-KDI 236

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                +++++T +DL+ N +S   P  +  L  L  L    N +  ++P  +  ++AL  
Sbjct: 237 GTL-ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF 260
           + L  N L    P     +L N+  L L  N+   +  S +++ +KL  L    N  S  
Sbjct: 292 LELNENQLEDISPIS---NLKNLTYLTLYFNNI--SDISPVSSLTKLQRLFFYNNKVSDV 346

Query: 261 IPNTFVNMAD-NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI 319
                 N+ + N+L++   ++S L+ L N  ++  L L            K N+S+   +
Sbjct: 347 SS--LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI 379
             +    I+   P  + + G+    ++  N  +    ++++       +G      +G +
Sbjct: 405 KNVTGALIA---PATISDGGSYTEPDITWNLPSYTNEVSYT-FSQPVTIGKGTTTFSGTV 460

Query: 380 T 380
           T
Sbjct: 461 T 461

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  169 bits (429), Expect = 2e-43
 Identities = 109/527 (20%), Positives = 189/527 (35%), Gaps = 70/527 (13%)

Query: 81  LNISSFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQL-F 137
           L + S     TI  +   NL +L+ LDL  +K+   +    F  +  L  L      L  
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSD 111

Query: 138 GSLSFFIF-NVSSVTTIDLSINGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTI--F 193
             L    F N+ ++T +DLS N +    +    G L  L  + F++N +  V    +   
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGI-----------------NSFYGT 236
               L    L  NSL   +       +     + L I                 N+   +
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231

Query: 237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTS---STPELSFLSSLT--NCKK 291
              S+  A  +     G +       NTF  +A + +     S   +  L+S      K 
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
           LKVL L  N ++ I  ++   L  +L+++ +    +          L  +  ++L  N++
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG---------- 401
                 TF  L+ LQ L L  N L       +  +  +  + L GNK             
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL 405

Query: 402 -----------SIPSCLGNLTSLRVLYLGLNRFTS-ALPSTIWNLKDILFIDVSSNSLNV 449
                       I   L  +  L++L L  NRF+S +   T      +  + +  N L +
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
                   +   G        L +LQ ++L +N L    P  F  L++L  L L+ N+++
Sbjct: 466 AWETELCWDVFEG--------LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 510 GAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
                 L     L+ L++S N+L    P    F +L+      N+ +
Sbjct: 518 VLSHNDLPAN--LEILDISRNQL--LAPNPDVFVSLSVLDITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  161 bits (409), Expect = 5e-41
 Identities = 92/539 (17%), Positives = 167/539 (30%), Gaps = 70/539 (12%)

Query: 64  CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-N 122
           CS+ G             N++       +P     L++ + L LS N +   + +S F  
Sbjct: 2   CSFDGRIAF-YRFC----NLTQ------VPQ---VLNTTERLLLSFNYIR-TVTASSFPF 46

Query: 123 MHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFAT 181
           +  L+LL         ++    F N+ ++  +DL  + +    P     L +L  L    
Sbjct: 47  LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106

Query: 182 NNL--VGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPS 239
             L    +      N+ AL  + L  N +           L ++++++   N  +     
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166

Query: 240 SITN--ASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLIL 297
            +       LS   L  N     +   +    + +       L    +            
Sbjct: 167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226

Query: 298 TGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLG--NLLVLELGGNNLTEPI 355
             +            L+  +        +I          L   ++  L+L    +    
Sbjct: 227 AIS----KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 356 PITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRV 415
              F  L+ L+ L L  NK+     +    L  L  L L  N       S    L  +  
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342

Query: 416 LYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIG----------------------- 452
           + L  N        T   L+ +  +D+  N+L  +                         
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLT 402

Query: 453 ---LNFSRNNLSG-DIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVLDLSKNK 507
              ++ S N L   DI   +  + +LQ + L  NR    S  ++  +  SLE L L +N 
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462

Query: 508 ISGAIPASL-----QKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLL 561
           +  A    L     + L +L+ L L+ N L           +L    F     L+ L L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN----------SLPPGVFSHLTALRGLSL 511

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 88.7 bits (220), Expect = 4e-18
 Identities = 51/275 (18%), Positives = 95/275 (34%), Gaps = 32/275 (11%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           LN++   +          L +LQ L+LS+N L     S+ + +  +  +    N +    
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF------- 193
                 +  + T+DL  N L+      I  +P +  +  + N LV +  + +        
Sbjct: 355 DQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLS 409

Query: 194 --------------NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPS 239
                          +  L+ + L  N  S     +     P++E L LG N       +
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469

Query: 240 SI-----TNASKLSDLELGVNLFSGFIPNTFVNMAD-NYLTSSTPELSFLSSLTNCKKLK 293
            +        S L  L L  N  +   P  F ++     L+ ++  L+ LS       L+
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLE 529

Query: 294 VLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS 328
           +L ++ N L    P    +LS+         C   
Sbjct: 530 ILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  149 bits (380), Expect = 7e-40
 Identities = 81/432 (18%), Positives = 155/432 (35%), Gaps = 87/432 (20%)

Query: 102 LQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLS 161
             TL      ++   P +  ++            +   ++     + S+T + ++   ++
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57

Query: 162 GEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLP 221
               + I  L  L  L    N +  ++P  + N+  L  +Y+  N +             
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI------------- 100

Query: 222 NVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELS 281
                         T  S++ N + L +L L                 ++ ++       
Sbjct: 101 --------------TDISALQNLTNLRELYLN----------------EDNISD------ 124

Query: 282 FLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL 341
            +S L N  K+  L L  N           N++  L  + +    +    P  + NL +L
Sbjct: 125 -ISPLANLTKMYSLNLGANHNLSD-LSPLSNMT-GLNYLTVTESKVKDVTP--IANLTDL 179

Query: 342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 401
             L L  N + +  P   + L +L       N++       + ++ RL+SL +  NK + 
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT--PVANMTRLNSLKIGNNKITD 235

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
             P  L NL+ L  L +G N+ +    + + +L               L  LN   N +S
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTK-------------LKMLNVGSNQIS 278

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY 521
            DI + +  L  L  +FL  N+L     E  G L++L  L LS+N I+   P  L  L  
Sbjct: 279 -DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 522 LKHLNLSFNKLE 533
           +   + +   ++
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  141 bits (359), Expect = 4e-37
 Identities = 77/364 (21%), Positives = 140/364 (38%), Gaps = 47/364 (12%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
              +  L   ++   P   D  L       L   S   T   +      ++ L +     
Sbjct: 2   AATLATLPAPINQIFP---DADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKV 56

Query: 258 S-----GFIPN-TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
           +      ++ N  ++N+  N +T        +S L+N  KL  L +  N +  I   +  
Sbjct: 57  ASIQGIEYLTNLEYLNLNGNQITD-------ISPLSNLVKLTNLYIGTNKITDI--SALQ 107

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           NL+ +L  + ++  +IS   P  + NL  +  L LG N+    +    S +  L  L +T
Sbjct: 108 NLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVT 163

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
            +K+       + +L  L+SL L  N+     P  L +LTSL      +N+ T    + +
Sbjct: 164 ESKVKDVT--PIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPV 217

Query: 432 WNLKDILFIDVSSNSLNVLIG---------LNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
            N+  +  + + +N +  L           L    N +S DI   +  L  L+ + +  N
Sbjct: 218 ANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSN 275

Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPF 542
           ++         +LS L  L L+ N++       +  L  L  L LS N +        P 
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR----PL 329

Query: 543 ANLT 546
           A+L+
Sbjct: 330 ASLS 333

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  137 bits (347), Expect = 2e-35
 Identities = 86/441 (19%), Positives = 161/441 (36%), Gaps = 109/441 (24%)

Query: 69  ITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 128
           I  D +    I   +   ++   +      L S+  L ++  K++      I  +  L+ 
Sbjct: 15  IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEY 70

Query: 129 LYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA 188
           L  + NQ+              T I              + NL  L  L   TN +  ++
Sbjct: 71  LNLNGNQI--------------TDIS------------PLSNLVKLTNLYIGTNKITDIS 104

Query: 189 PVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLS 248
              + N++ L+E+YL  +++S   P     +L  + +LNLG N    +  S ++N + L+
Sbjct: 105 A--LQNLTNLRELYLNEDNISDISPLA---NLTKMYSLNLGANHN-LSDLSPLSNMTGLN 158

Query: 249 DLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK 308
            L +  +                       ++  ++ + N   L  L L  N ++ I P 
Sbjct: 159 YLTVTES-----------------------KVKDVTPIANLTDLYSLSLNYNQIEDISP- 194

Query: 309 SKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQAL 368
                                     + +L +L       N +T+  P+  + +  L +L
Sbjct: 195 --------------------------LASLTSLHYFTAYVNQITDITPV--ANMTRLNSL 226

Query: 369 GLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP 428
            +  NK+       L +L++L  L +  N+ S    + + +LT L++L +G N+ +    
Sbjct: 227 KIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--I 280

Query: 429 STIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSI 488
           S + NL               L  L  + N L  +    IGGL NL  +FL  N +    
Sbjct: 281 SVLNNLSQ-------------LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327

Query: 489 PESFGDLSSLEVLDLSKNKIS 509
           P     LS ++  D +   I 
Sbjct: 328 P--LASLSKMDSADFANQVIK 346

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (355), Expect = 4e-37
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 622 NNLIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +  IG GSF ++Y     +  +EVA       +  +   + F++E E++K ++H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 679 ISSCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
             S  +         L+ + M +G+L+        ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 735 STPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           + PIIH DLK  N+ +        I D G+A L       ++      T  +MAPE   +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEE 204

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                  DVY++G+ ++EM T + P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (355), Expect = 3e-36
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 5/192 (2%)

Query: 625 IGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSC 682
           IG G+FG ++  RL+ D   VAVK   +         F  E  ++K+  H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +      ++M+ +  G     L +    L +   L ++ D A  +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E  V  ISDFG+++  +     +        + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 803 YSYGIMLMEMFT 814
           +S+GI+L E F+
Sbjct: 299 WSFGILLWETFS 310

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  143 bits (361), Expect = 4e-36
 Identities = 98/476 (20%), Positives = 179/476 (37%), Gaps = 43/476 (9%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGS 139
           LNIS   +       + +LS L+ L +SHN++   +  S+F     L+ L  S N+L   
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL-VK 83

Query: 140 LSFFIFNVSSVTTIDLSINGL-SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL 198
           +S       ++  +DLS N   +  + +E GN+  L  L  +T +L   + + I +++  
Sbjct: 84  ISCHPT--VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           K + +L  +            L +  T +L I          I + S  +   L ++   
Sbjct: 142 KVLLVLGETYGEKEDP---EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS--- 195

Query: 259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKL--KVLILTGNPLDGILPKSKGNLSLS 316
               N    + DN  +     L+ L +      L    +  T N    IL   +     +
Sbjct: 196 ----NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL---QLVWHTT 248

Query: 317 LEIILMDNCSISGNI-----PQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           +    + N  + G +          +L  L + ++  +    P    +     +     T
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
            +            ++    L    N  + ++    G+LT L  L L +N+    L    
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIA 367

Query: 432 WNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPE 490
                          +  L  L+ S+N++S D         K+L  + +  N L  +I  
Sbjct: 368 EMTT----------QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
                  ++VLDL  NKI  +IP  + KL  L+ LN++ N+L+  +P  G F  LT
Sbjct: 418 CL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  102 bits (255), Expect = 8e-23
 Identities = 69/389 (17%), Positives = 137/389 (35%), Gaps = 30/389 (7%)

Query: 85  SFNLQGTIPPQ--LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL-----F 137
           SFN    +P     GN+S L+ L LS   L  +    I +++  K+L             
Sbjct: 98  SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157

Query: 138 GSLSF---------FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA 188
             L           F  N      +D+S+  ++      I  +    + ++  + L  + 
Sbjct: 158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217

Query: 189 PVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNAS--K 246
                +   L  I    NS    L      ++      N+ +           +  S   
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277

Query: 247 LSDLELGVNLFSGFIPNTF---VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
           LS  ++  ++F       +    NM     T S   +  +   +       L  + N L 
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

Query: 304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVG---NLGNLLVLELGGNNLTE-PIPITF 359
             + ++ G+L+  LE +++    +   + ++      + +L  L++  N+++        
Sbjct: 338 DTVFENCGHLT-ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395

Query: 360 SQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLG 419
           S  ++L +L ++ N L   I   L    R+  L L  NK   SIP  +  L +L+ L + 
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452

Query: 420 LNRFTSALPSTIWNLKDILFIDVSSNSLN 448
            N+  S        L  +  I + +N  +
Sbjct: 453 SNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 62/402 (15%), Positives = 121/402 (30%), Gaps = 51/402 (12%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
              T +++S N +S     +I +L  L  L  + N +  +          L+ + L +N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           L   +         N++ L+L  N+F      ++    +  ++     L        F+ 
Sbjct: 81  LV-KISCH---PTVNLKHLDLSFNAF-----DALPICKEFGNM---SQL-------KFLG 121

Query: 268 MADNYLTSSTPE-LSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS-LSLEIILMDNC 325
           ++  +L  S+   ++ L+         +L+L     +   P+   + +  SL I+   N 
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKV-----LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
                +   V  + NL +  +             S L  LQ      N            
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN------------ 224

Query: 386 LARLHSLVLQGNKFSG-SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
                 L L   + +  S    L  +    V Y  ++         +    D    D S 
Sbjct: 225 ------LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK------LQGQLDFRDFDYSG 272

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
            SL  L       +              N+       +            +S    LD S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            N ++  +  +   L  L+ L L  N+L+           + 
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.9 bits (184), Expect = 4e-14
 Identities = 52/276 (18%), Positives = 97/276 (35%), Gaps = 24/276 (8%)

Query: 45  ISYDHTNLFARNWTSSTSVCSW---IGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLS- 100
           ++   TN    N T +    +W   I I   V    V   +IS+  LQG +  +  + S 
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272

Query: 101 ----SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS 156
               +L    +  +               + +  F+ +            +S    +D S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332

Query: 157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVT-IF-NMSALKEIYLLNNSLSGSLPS 214
            N L+  +    G+L  L  L    N L  ++ +  +   M +L+++ +  NS+S     
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

Query: 215 RIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTF-------VN 267
                  ++ +LN+  N    T+   +    ++  L+L  N                 +N
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELN 450

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
           +A N L  S P+  F         L+ + L  NP D
Sbjct: 451 VASNQLK-SVPDGIF----DRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 4/123 (3%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS 156
            + SLQ LD+S N +S +          +L  L  S N L     F       +  +DL 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL-TDTIFRCLP-PRIKVLDLH 429

Query: 157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
            N +   +P+++  L  L  L  A+N L  V       +++L++I+L  N    S P   
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 488

Query: 217 DLS 219
            LS
Sbjct: 489 YLS 491

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (346), Expect = 2e-34
 Identities = 92/470 (19%), Positives = 163/470 (34%), Gaps = 74/470 (15%)

Query: 81  LNISSFNLQGTIPPQLGNLS-------------SLQTLDLSHNKLSGNIPSSIFNMHTLK 127
              +    +   PP  G                    L+L++  LS ++P    +   L+
Sbjct: 39  YYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LE 94

Query: 128 LLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGV 187
            L  S N L   L     ++ S+   + ++  LS          P L  L  + N L  +
Sbjct: 95  SLVASCNSL-TELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLEKL 146

Query: 188 APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKL 247
               + N S LK I + NNSL   LP       P++E +  G N         + N   L
Sbjct: 147 PE--LQNSSFLKIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQL--EELPELQNLPFL 197

Query: 248 SDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP 307
           + +    N     +P+  +++    + +    L  L  L N   L  +    N L   LP
Sbjct: 198 TAIYADNNSLK-KLPDLPLSL--ESIVAGNNILEELPELQNLPFLTTIYADNNLL-KTLP 253

Query: 308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQA 367
               +L    E + + +  ++ ++P++  +L  L V E   + L+E  P        L  
Sbjct: 254 DLPPSL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYY 301

Query: 368 LGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL 427
           L  + N+    I         L  L +  NK    +P+    L     L    N     +
Sbjct: 302 LNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-V 352

Query: 428 PSTIWNLKDILFIDVSSNSLNVLIGL-----NFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
           P    NLK +    V  N L     +     +   N+   ++P       NL+Q+ +E N
Sbjct: 353 PELPQNLKQL---HVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ---NLKQLHVETN 406

Query: 483 RLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL 532
            L    P+      S+E L ++  ++      + +    L+      +  
Sbjct: 407 PLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  134 bits (340), Expect = 9e-34
 Identities = 78/448 (17%), Positives = 144/448 (32%), Gaps = 107/448 (23%)

Query: 91  TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSV 150
            +P +  N+ S      + ++   N P        + +    D                 
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQA 73

Query: 151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG 210
             ++L+  GLS  +P    +                           L+ +    NSL+ 
Sbjct: 74  HELELNNLGLS-SLPELPPH---------------------------LESLVASCNSLT- 104

Query: 211 SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN-TFVNMA 269
                                     +P    +   L      +   S   P   ++ ++
Sbjct: 105 -------------------------ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVS 139

Query: 270 DNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISG 329
           +N L         L  L N   LK++ +  N L   LP    +    LE I   N  +  
Sbjct: 140 NNQLEK-------LPELQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE- 186

Query: 330 NIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARL 389
            +P+ + NL  L  +    N+L +          +L+++    N L      EL +L  L
Sbjct: 187 ELPE-LQNLPFLTAIYADNNSLKK----LPDLPLSLESIVAGNNILEEL--PELQNLPFL 239

Query: 390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV 449
            ++    N    ++P    +L +L V    L      LP    +L  +   +   + L+ 
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSE 294

Query: 450 LIG----LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSK 505
           L      LN S N +   +        +L+++ +  N+L   +P        LE L  S 
Sbjct: 295 LPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASF 346

Query: 506 NKISGAIPASLQKLLYLKHLNLSFNKLE 533
           N ++  +P   Q    LK L++ +N L 
Sbjct: 347 NHLA-EVPELPQN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  109 bits (275), Expect = 2e-25
 Identities = 67/363 (18%), Positives = 127/363 (34%), Gaps = 60/363 (16%)

Query: 192 IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE 251
             + + L+E    +++L+  +P   + ++ +        + +    P       +++   
Sbjct: 7   NVSNTFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 252 LGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSL--------------TNCKKLKVLIL 297
           L   L         + + +  L+S       L SL               + K L V   
Sbjct: 65  LRDCLDRQA---HELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNN 121

Query: 298 TGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI 357
               L  + P         LE + + N  +   +P+ + N   L ++++  N+L + +P 
Sbjct: 122 NLKALSDLPP--------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LP- 169

Query: 358 TFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY 417
                 +L+ +    N+L      EL +L  L ++    N     +P    +L S   + 
Sbjct: 170 --DLPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLSLES---IV 221

Query: 418 LGLNRFTSALPSTIWNLKDILFIDVSSNSLNV-------LIGLNFSRNNLSGDIPITIGG 470
            G N         + NL  +  I   +N L         L  LN   N L+ D+P     
Sbjct: 222 AGNNILEE--LPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQS 278

Query: 471 LKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           L  L      ++ L    P       +L  L+ S N+I  ++         L+ LN+S N
Sbjct: 279 LTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPS---LEELNVSNN 327

Query: 531 KLE 533
           KL 
Sbjct: 328 KLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 90.4 bits (225), Expect = 4e-19
 Identities = 48/233 (20%), Positives = 84/233 (36%), Gaps = 31/233 (13%)

Query: 305 ILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQT 364
           I P++  N  L  E +   +      +P    N+ +        +      P    + + 
Sbjct: 3   INPRNVSNTFL-QEPLRHSSNLTE--MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59

Query: 365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT 424
           +    L             C   + H L L     S S+P    +L S   L    N  T
Sbjct: 60  MAVSRLRD-----------CLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT 104

Query: 425 SALPSTIWNLKDILFIDVSSNSLNVLIG----LNFSRNNLSGDIPITIGGLKNLQQMFLE 480
             LP    +LK +L  + +  +L+ L      L  S N L   +P  +     L+ + ++
Sbjct: 105 E-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVD 161

Query: 481 YNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE 533
            N L+  +P+      SLE +    N++   +P  LQ L +L  +    N L+
Sbjct: 162 NNSLK-KLPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 79.7 bits (197), Expect = 9e-16
 Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 14/170 (8%)

Query: 386 LARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
              L   +   +  +  +P    N+ S    Y   + +    P      +++    +   
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSK 505
                  L  +   LS  +P     L++L       N L   +PE    L SL V + + 
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 506 NKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNEL 555
             +S   P        L++L +S N+LE ++P     + L       N L
Sbjct: 124 KALSDLPPL-------LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSL 165

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.6 bits (132), Expect = 9e-08
 Identities = 22/113 (19%), Positives = 45/113 (39%), Gaps = 19/113 (16%)

Query: 438 LFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS- 496
           +FI+  + S   L       +NL+ ++P+    +K+  + +  ++  E + P   G+   
Sbjct: 1   MFINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59

Query: 497 ------------SLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
                           L+L+   +S ++P        L+ L  S N L  E+P
Sbjct: 60  MAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELP 107

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (334), Expect = 2e-34
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKII 679
           +G G+FGS+ + R        G  VAVK      E  L+ FE E E++K ++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 680 SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
             C +   +   LIM+Y+P GSL + L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 134

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT--IGYMAPEYGTKGR 795
            IH DL   N+L++ +    I DFG+ K+L  +D+   +++      I + APE  T+ +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G++L E+FT
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (336), Expect = 2e-34
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKII 679
           +G G+FGS+ + R        G  VAVK      E  L+ FE E E++K ++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 680 SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
             C +   +   LIM+Y+P GSL + L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 165

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            IH DL   N+L++ +    I DFG+ K+L   ++   ++    + I + APE  T+ + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 797 CTRGDVYSYGIMLMEMFT 814
               DV+S+G++L E+FT
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (336), Expect = 3e-34
 Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 27/236 (11%)

Query: 594 SNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ 652
            N+G+   + ++   Y E        +    +G GSFG ++  +  Q G + AVK    +
Sbjct: 36  DNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94

Query: 653 YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD 712
                    +E      +    +V +  +     +  + M+ +  GSL   +    C+  
Sbjct: 95  -----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL-P 148

Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGED 771
             + L  +      LEYL   H+  I+H D+K  NVLL  D   A + DFG A  L  + 
Sbjct: 149 EDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205

Query: 772 QLSIQIQTLATIG---YMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +      G   +MAPE         K       D++S   M++ M     P
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAK------VDIWSSCCMMLHMLNGCHP 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (332), Expect = 4e-34
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 13/210 (6%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            D   +  ++G G++G +Y  R L + + +A+K   ++  R  +   +E  + K ++H+N
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--NIMIDVALALEYLHF 732
           +V+ + S S + F  + M+ +P GSL   L S    L   ++        +   L+YL  
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL-- 138

Query: 733 GHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-- 789
            H   I+H D+K  NVL++    V  ISDFG +K L+G +  +       T+ YMAPE  
Sbjct: 139 -HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEII 195

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             G +G      D++S G  ++EM T K P
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKPP 224

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 4e-34
 Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 7/194 (3%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
             +G G FG +++        VA+K        + ++F  E +VMK++RH  LV++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 683 SNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           S +    ++ +YM  GSL + L       L + Q +++   +A  + Y+        +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 363

Query: 802 VYSYGIMLMEMFTK 815
           V+S+GI+L E+ TK
Sbjct: 364 VWSFGILLTELTTK 377

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (332), Expect = 4e-34
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 19/217 (8%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           +R+   + +G G   ++Y+A      ++VA+K         E  LK FE E     ++ H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           +N+V +I     DD   L+M+Y+   +L   + S    L +   +N    +   +++ H 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD 129

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPE 789
                I+H D+KP N+L+D +    I DFGIAK LS     +   QT   +G   Y +PE
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE----TSLTQTNHVLGTVQYFSPE 182

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
                      D+YS GI+L EM   + P    F GE
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (338), Expect = 5e-34
 Identities = 74/402 (18%), Positives = 125/402 (31%), Gaps = 53/402 (13%)

Query: 165 PREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVE 224
              +        +                 ++  K +   N+++   LP+ +  S   VE
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72

Query: 225 TLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLS 284
            LNL           +   A  +  L +G N      P+ F N+                
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---------------- 116

Query: 285 SLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVL 344
                  L VL+L  N L  +      N    L  + M N ++            +L  L
Sbjct: 117 -----PLLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNL 170

Query: 345 ELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 404
           +L  N LT    +  S + +L    ++ N L       L     +  L    N  +  + 
Sbjct: 171 QLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVR 221

Query: 405 SCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV-----------LIGL 453
                   L +L L  N  T    + + N   ++ +D+S N L             L  L
Sbjct: 222 G--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277

Query: 454 NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP 513
             S N L   + +    +  L+ + L +N L   +  +      LE L L  N I   + 
Sbjct: 278 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334

Query: 514 ASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNEL 555
            S      LK+L LS N  +        F N+   +    + 
Sbjct: 335 LST--HHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  122 bits (308), Expect = 5e-30
 Identities = 70/342 (20%), Positives = 127/342 (37%), Gaps = 35/342 (10%)

Query: 231 NSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM--------ADNYLTSSTPELSF 282
              Y  + S++       D+ + +     +     + +         ++ +      L  
Sbjct: 7   QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-- 64

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
              L + +++++L L    ++ I   +      +++ + M   +I    P V  N+  L 
Sbjct: 65  ---LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLT 120

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
           VL L  N+L+      F     L  L ++ N L     D       L +L L  N+ +  
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179

Query: 403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV--------LIGLN 454
           +   L  + SL    +  N  ++     +     +  +D S NS+NV        L  L 
Sbjct: 180 VD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVNVELTILK 232

Query: 455 FSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA 514
              NNL+ D    +     L ++ L YN LE  +   F  +  LE L +S N++  A+  
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289

Query: 515 SLQKLLYLKHLNLSFNKLEGEIPRG-GPFANLTAKSFMGNEL 555
             Q +  LK L+LS N L   + R    F  L       N +
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 7/120 (5%)

Query: 91  TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSS 149
           T    L N   L  +DLS+N+L   I    F  M  L+ LY S+N+L  +L+ +   + +
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPT 296

Query: 150 VTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS 209
           +  +DLS N L   + R       L  L    N++V +   T      LK + L +N   
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLST---HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 15/115 (13%), Positives = 36/115 (31%), Gaps = 2/115 (1%)

Query: 433 NLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF 492
              +   ID +     V   ++                L N + +  + + +        
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 493 GDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
                +E+L+L+  +I      +      ++ L + FN +   +P    F N+  
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP-HVFQNVPL 118

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (344), Expect = 7e-34
 Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 7/194 (3%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
             +G G FG +++        VA+K        + ++F  E +VMK++RH  LV++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 683 SNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           S +    ++ +YM  GSL + L       L + Q +++   +A  + Y+        +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +N+L+ E++V  ++DFG+A+L+   +  + Q      I + APE    GR   + D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 446

Query: 802 VYSYGIMLMEMFTK 815
           V+S+GI+L E+ TK
Sbjct: 447 VWSFGILLTELTTK 460

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  131 bits (331), Expect = 7e-34
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG + + R        G +VAVK    +     +   + E E+++ + H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C+ D      LIM+++P+GSL+  L      +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVL++ +    I DFG+ K + + ++  +++    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  131 bits (332), Expect = 9e-34
 Identities = 61/333 (18%), Positives = 108/333 (32%), Gaps = 34/333 (10%)

Query: 240 SITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTG 299
              ++S   +L    +       +        +  +            N    ++   TG
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQW-QRHYNADRNRWHSAWRQANSNNPQIETRTG 65

Query: 300 NPLDGILPKSKGNLSL-SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPIT 358
             L         + +      + + +  +    P     L +L  + +    L E +P T
Sbjct: 66  RAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDT 122

Query: 359 FSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN--------- 409
             Q   L+ L L RN L   +   +  L RL  L ++       +P  L +         
Sbjct: 123 MQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 410 LTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG 469
           L +L+ L L      S LP++I NL++             L  L    + LS  +   I 
Sbjct: 182 LVNLQSLRLEWTGIRS-LPASIANLQN-------------LKSLKIRNSPLSA-LGPAIH 226

Query: 470 GLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF 529
            L  L+++ L       + P  FG  + L+ L L        +P  + +L  L+ L+L  
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 530 NKLEGEIPRGGPFANLTA--KSFMGNELLKMLL 560
                 +P     A L A     +   L   L 
Sbjct: 287 CVNLSRLPSL--IAQLPANCIILVPPHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  123 bits (312), Expect = 4e-31
 Identities = 65/364 (17%), Positives = 111/364 (30%), Gaps = 50/364 (13%)

Query: 90  GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSS 149
           G+      + S  + L    +         +      +  Y +D   + S      N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQ---WQRHYNADRNRWHSAWRQA-NSNN 57

Query: 150 VTTIDLSINGLSGEMPREIGNL--PYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
                 +   L       + +   P    L   +  L    P   F +S L+ + +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAG 115

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           L   LP  +      +ETL L  N     +P+SI + ++L +L +        +P    +
Sbjct: 116 LM-ELPDTMQ-QFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
                                   L+ L L    +   LP S  NL  +L+ + + N  +
Sbjct: 173 ------------TDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQ-NLKSLKIRNSPL 218

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA 387
           S  +   + +L  L  L+L G       P                              A
Sbjct: 219 SA-LGPAIHHLPKLEELDLRGCTALRNYP------------------------PIFGGRA 253

Query: 388 RLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL 447
            L  L+L+      ++P  +  LT L  L L      S LPS I  L     I V  +  
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

Query: 448 NVLI 451
             L 
Sbjct: 314 AQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  120 bits (304), Expect = 4e-30
 Identities = 53/342 (15%), Positives = 104/342 (30%), Gaps = 48/342 (14%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L              L         D +    +        N +  ++   +   L  + 
Sbjct: 17  LYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKATA 72

Query: 141 -SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK 199
                        ++L    L  + P +   L +L  +      L+ + P T+   + L+
Sbjct: 73  DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLE 130

Query: 200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
            + L  N L  +LP+ I  SL  +  L++        +P  + +                
Sbjct: 131 TLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLAS---------------- 172

Query: 260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI 319
                                           L+ L L    +   LP S  NL  +L+ 
Sbjct: 173 --------------------TDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQ-NLKS 210

Query: 320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI 379
           + + N  +S  +   + +L  L  L+L G       P  F     L+ L L        +
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269

Query: 380 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN 421
             ++  L +L  L L+G      +PS +  L +  ++ +  +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  105 bits (265), Expect = 6e-25
 Identities = 53/304 (17%), Positives = 104/304 (34%), Gaps = 38/304 (12%)

Query: 93  PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL--LYFSDNQLFGSLSFFIFNVSSV 150
             +  N ++ Q    +   L       + +        L      L        F +S +
Sbjct: 49  AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHL 106

Query: 151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG 210
             + +   GL  E+P  +     L  L  A N L  + P +I +++ L+E+ +       
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELT 164

Query: 211 SLPSRI--------DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
            LP  +           L N+++L L       ++P+SI N   L  L++          
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR--------- 214

Query: 263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILM 322
                  ++ L++         ++ +  KL+ L L G       P   G  +  L+ +++
Sbjct: 215 -------NSPLSA------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLIL 260

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDE 382
            +CS    +P  +  L  L  L+L G      +P   +QL     + +  +  A      
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

Query: 383 LCHL 386
               
Sbjct: 321 PVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 36/192 (18%)

Query: 81  LNISSFNLQGTIPPQLGN---------LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYF 131
           L+I +      +P  L +         L +LQ+L L    +  ++P+SI N+  LK L  
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213

Query: 132 SDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVT 191
            ++ L                           +   I +LP L  L       +   P  
Sbjct: 214 RNSPLS-------------------------ALGPAIHHLPKLEELDLRGCTALRNYPPI 248

Query: 192 IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE 251
               + LK + L + S   +LP  I   L  +E L+L        +PS I        + 
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307

Query: 252 LGVNLFSGFIPN 263
           +  +L +    +
Sbjct: 308 VPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 28/141 (19%), Positives = 42/141 (29%), Gaps = 26/141 (18%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L I +  L   + P + +L  L+ LDL       N P        LK L   D     +L
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                                   P +I  L  L +L       +   P  I  + A   
Sbjct: 270 ------------------------PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305

Query: 201 IYLLNNSLSGSLPSRIDLSLP 221
           I +  + L   L     ++ P
Sbjct: 306 ILVPPH-LQAQLDQHRPVARP 325

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (327), Expect = 1e-33
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 11/193 (5%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHC 741
                L+ ++M +G L + L +   +      L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL   N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R  ++ D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 802 VYSYGIMLMEMFT 814
           V+S+G+++ E+F+
Sbjct: 188 VWSFGVLMWEVFS 200

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  131 bits (331), Expect = 1e-33
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 27/238 (11%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
            +     +G G F  + +   L DG   A+K      ++  +  + E ++ +   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 677 KIISSCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALALEY 729
           ++++ C  +        L++ +   G+L N +       +     Q L +++ +   LE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-------T 782
           +H   +    H DLKP+N+LL ++    + D G         + S Q  TL        T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 783 IGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
           I Y APE      +        R DV+S G +L  M   + P D +F    S+   + 
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  131 bits (331), Expect = 1e-33
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)

Query: 625 IGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKII 679
           +G G+FGS+ + R        G  VAVK          + F+ E +++K +    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 680 SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
                   ++  L+M+Y+P+G L + L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRR 147

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +H DL   N+L++ +    I+DFG+AKLL   +D   ++    + I + APE  +    
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207

Query: 797 CTRGDVYSYGIMLMEMFT 814
             + DV+S+G++L E+FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  129 bits (326), Expect = 1e-33
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG + + + +   +VAVK+  +    +   F  E + M ++ H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHC 741
           +    ++ +Y+ NG L N L S    L+  Q L +  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL   N L+D D+   +SDFG+ + +  +DQ    + T   + + APE     +  ++ D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 802 VYSYGIMLMEMFTK-KKP 818
           V+++GI++ E+F+  K P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  134 bits (339), Expect = 2e-33
 Identities = 50/195 (25%), Positives = 96/195 (49%), Gaps = 7/195 (3%)

Query: 623 NLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           + +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 682 CSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIH 740
           C+ +    +I ++M  G+L + L       +     L +   ++ A+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341

Query: 741 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG 800
            +L   N L+ E+ +  ++DFG+++L++  D  +        I + APE     +   + 
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 801 DVYSYGIMLMEMFTK 815
           DV+++G++L E+ T 
Sbjct: 401 DVWAFGVLLWEIATY 415

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (326), Expect = 2e-33
 Identities = 48/193 (24%), Positives = 96/193 (49%), Gaps = 11/193 (5%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +   + +   +VA+K+  +    +   F +E +VM  + H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHC 741
                +I +YM NG L N L          Q L +  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL   N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     +  ++ D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 802 VYSYGIMLMEMFT 814
           ++++G+++ E+++
Sbjct: 204 IWAFGVLMWEIYS 216

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (326), Expect = 2e-33
 Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 40/229 (17%)

Query: 614 RATDRFSENNLIGIGSFGSIY-VARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH 672
           R    F E  LIG G FG ++      DG    +K      E+A +    E + + ++ H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-------SGTCMLDIFQR--------- 716
            N+V         D+         + S   CL+        GT    I +R         
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 717 -LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI 775
            L +   +   ++Y+H   S  +I+ DLKPSN+ L +     I DFG+   L  + + + 
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 776 QIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              TL    YM+PE      YG +       D+Y+ G++L E+      
Sbjct: 181 SKGTLR---YMSPEQISSQDYGKE------VDLYALGLILAELLHVCDT 220

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (336), Expect = 3e-33
 Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
             +G G FG +++A      +VAVK        ++++F  E  VMK ++H  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 683 SNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           + +    +I ++M  GSL + L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGD 801
           DL+ +N+L+   +V  I+DFG+A+++   +  + +      I + APE    G    + D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSD 367

Query: 802 VYSYGIMLMEMFTK 815
           V+S+GI+LME+ T 
Sbjct: 368 VWSFGILLMEIVTY 381

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  129 bits (326), Expect = 3e-33
 Identities = 52/211 (24%), Positives = 78/211 (36%), Gaps = 29/211 (13%)

Query: 625 IGIGSFGSIYVARLQ----DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +            + VAVK           A+  F  E   M  + HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGH 734
           +         K ++ +  P GSL + L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG------YMAP 788
               IH DL   N+LL    +  I DFG+ + L   D        +          + AP
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-----HYVMQEHRKVPFAWCAP 193

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTK-KKP 818
           E           D + +G+ L EMFT  ++P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (337), Expect = 3e-33
 Identities = 78/359 (21%), Positives = 126/359 (35%), Gaps = 42/359 (11%)

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           + +         ++P  I         L+LG N           +   L +LEL  N+ S
Sbjct: 14  RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE 318
              P  F N+                       L+ L L  N L  I       LS +L 
Sbjct: 70  AVEPGAFNNL---------------------FNLRTLGLRSNRLKLIPLGVFTGLS-NLT 107

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP 378
            + +    I   +  +  +L NL  LE+G N+L       FS L +L+ L L +  L   
Sbjct: 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167

Query: 379 ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL 438
            T+ L HL  L  L L+    +         L  L+VL +    +   +           
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG---- 223

Query: 439 FIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL 498
                   LN L  L+ +  NL+    + +  L  L+ + L YN +         +L  L
Sbjct: 224 --------LN-LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274

Query: 499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG--GPFANLTAKSFMGNEL 555
           + + L   +++   P + + L YL+ LN+S N+L   +         NL       N L
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (312), Expect = 4e-30
 Identities = 72/364 (19%), Positives = 135/364 (37%), Gaps = 43/364 (11%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
           +    +          +P  I        L    N +  +      +   L+E+ L  N 
Sbjct: 11  AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           +S ++      +L N+ TL L  N          T  S L+ L++  N     +   F +
Sbjct: 68  VS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
           +                       LK L +  N L  I  ++   L+ SLE + ++ C++
Sbjct: 127 L---------------------YNLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKCNL 164

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA 387
           +    + + +L  L+VL L   N+      +F +L  L+ L ++       +T    +  
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224

Query: 388 RLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS 446
            L SL +     + ++P   + +L  LR L L  N  ++   S +  L  +  I +    
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283

Query: 447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSK 505
           L V+    F              GL  L+ + +  N+L  ++ ES F  + +LE L L  
Sbjct: 284 LAVVEPYAFR-------------GLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329

Query: 506 NKIS 509
           N ++
Sbjct: 330 NPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  119 bits (300), Expect = 1e-28
 Identities = 74/386 (19%), Positives = 138/386 (35%), Gaps = 86/386 (22%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
           +    +DL  N +      E  + P+L  L    N +  V P    N+  L+ + L +N 
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           L   +P  +   L N+  L++  N              K+  L              F +
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISEN--------------KIVILL----------DYMFQD 126

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
           +                       LK L +  N L  I  ++   L+ SLE + ++ C++
Sbjct: 127 L---------------------YNLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKCNL 164

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA 387
           +    + + +L  L+VL L   N+      +F +L  L+ L ++       +T    +  
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224

Query: 388 RLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS 446
            L SL +     + ++P   + +L  LR L L  N  ++                +  + 
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST----------------IEGSM 267

Query: 447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
           L+                      L  LQ++ L   +L    P +F  L+ L VL++S N
Sbjct: 268 LH---------------------ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306

Query: 507 KISGAIPASLQKLLYLKHLNLSFNKL 532
           +++    +    +  L+ L L  N L
Sbjct: 307 QLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  117 bits (294), Expect = 1e-27
 Identities = 63/345 (18%), Positives = 127/345 (36%), Gaps = 51/345 (14%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGS 139
           L++    ++     +  +   L+ L+L+ N +S  +    F N+  L+ L    N+L   
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL-KL 94

Query: 140 LSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL 198
           +   +F  +S++T +D+S N +   +     +L  L  L    N+LV ++      +++L
Sbjct: 95  IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           +++ L   +L+ S+P+     L  +  L L                              
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRL------------------------------ 183

Query: 259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE 318
                         + +         S     +LKVL ++  P    +  +     L+L 
Sbjct: 184 ----------RHLNINAIRDY-----SFKRLYRLKVLEISHWPYLDTMTPNCLYG-LNLT 227

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP 378
            + + +C+++      V +L  L  L L  N ++        +L  LQ + L   +LA  
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287

Query: 379 ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRF 423
                  L  L  L + GN+ +    S   ++ +L  L L  N  
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 4/176 (2%)

Query: 85  SFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSF 142
                 +IP + L +L  L  L L H  ++  I    F  ++ LK+L  S      +++ 
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTP 218

Query: 143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIY 202
                 ++T++ ++   L+      + +L YL  L  + N +  +    +  +  L+EI 
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           L+   L+  +       L  +  LN+  N       S   +   L  L L  N  +
Sbjct: 279 LVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 4e-33
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 17/215 (7%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQY-ERALKSFEDECE 665
            +         + +IG G FG +Y     D     ++ A+K   +    + +++F  E  
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 666 VMKRIRHRNLVKIISSCSNDD-FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
           +M+ + H N++ +I      +    +++ YM +G L   + S      +   ++  + VA
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134

Query: 725 LALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
             +EYL    F      +H DL   N +LDE     ++DFG+A+ +   +  S+Q    A
Sbjct: 135 RGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 782 T--IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              + + A E     R  T+ DV+S+G++L E+ T
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (327), Expect = 4e-33
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 625 IGIGSFGSIYVARLQDGME-----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG++Y        E     VA+K   +    +A K   DE  VM  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHS 735
           +  C     + LI + MP G L + +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
              +H DL   NVL+       I+DFG+AKLL  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 796 VCTRGDVYSYGIMLMEMFTK-KKP 818
              + DV+SYG+ + E+ T   KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (325), Expect = 5e-33
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVK---VFHQQYERALKSFEDECEVMKRIRH 672
             F     IG G F  +Y  A L DG+ VA+K   +F     +A      E +++K++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALALEY 729
            N++K  +S   D+   ++++    G L   +        +          + +  ALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAP 788
           +H   S  ++H D+KP+NV +    V  + D G+ +  S +   +    +L  T  YM+P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMSP 205

Query: 789 E------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E      Y  K       D++S G +L EM   + P
Sbjct: 206 ERIHENGYNFK------SDIWSLGCLLYEMAALQSP 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  128 bits (323), Expect = 6e-33
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 625 IGIGSFGSIYVARLQDG---MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIIS 680
           +G G+FGS+     +     ++VA+KV  Q   +   +    E ++M ++ +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTP 737
            C  +    L+M+    G L   L      + +     ++  V++ ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +H DL   NVLL     A ISDFG++K L + +   + +      + + APE     + 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 797 CTRGDVYSYGIMLMEMFTK-KKP 818
            +R DV+SYG+ + E  +  +KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (323), Expect = 6e-33
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHR 673
           + +     IG GS+G    + R  DG  +  K   +    E   +    E  +++ ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 674 NLVKIISSCSNDDFKAL--IMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALALE 728
           N+V+      +     L  +M+Y   G L + +  GT           L +M  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 729 YLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGY 785
             H        ++H DLKP+NV LD      + DFG+A++L+ +   +   +T   T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTFVGTPYY 182

Query: 786 MAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           M+PE      Y  K       D++S G +L E+     P
Sbjct: 183 MSPEQMNRMSYNEK------SDIWSLGCLLYELCALMPP 215

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  132 bits (334), Expect = 7e-33
 Identities = 58/413 (14%), Positives = 125/413 (30%), Gaps = 36/413 (8%)

Query: 139 SLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL 198
           ++     N +      ++ + L   +     +   +  L  + N L  ++   +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           + + L +N L  +L      SL  + TL+L  N         +     +  L    N  S
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 259 GFIPNTFVN-----MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNL 313
               +         +A+N +T                +++ L L  N +D +        
Sbjct: 113 RVSCSRGQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAELAAS 167

Query: 314 SLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
           S +LE + +    I  ++   V     L  L+L  N L   +   F     +  + L  N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNN 224

Query: 374 KLAGPITDELCHLARLHSLVLQGNKFS-GSIPSCLGNLTSLRVLYLGLNRFTSALPS--- 429
           KL   I   L     L    L+GN F  G++         ++ +     +  +       
Sbjct: 225 KLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283

Query: 430 ---TIWNLKDILFIDVSSNSLNVLIGLNFSRN-------NLSGDIPITIGGLKNLQQMFL 479
              T+ +       D+ +   + LI L    +       + +  +          +++  
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343

Query: 480 EYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL 532
              +    I +      +   L+  K  +   +    +    L          
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  115 bits (290), Expect = 3e-27
 Identities = 42/225 (18%), Positives = 87/225 (38%), Gaps = 21/225 (9%)

Query: 331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLH 390
           I ++  N     + ++  ++L + +         ++ L L+ N L+     +L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV- 449
            L L  N    ++   L +L++LR L L  N         +     I  +  ++N+++  
Sbjct: 62  LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRV 114

Query: 450 -------LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVL 501
                     +  + N ++    +  G    +Q + L+ N ++  +  E      +LE L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 502 DLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +L  N I   +   +     LK L+LS NKL   +     F +  
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE--FQSAA 214

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  115 bits (289), Expect = 4e-27
 Identities = 71/476 (14%), Positives = 143/476 (30%), Gaps = 61/476 (12%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           LN+SS  L       L +LS+L+TLDL++N +       +    +++ L+ ++N +   +
Sbjct: 63  LNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRV 114

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALK 199
           S           I L+ N ++     + G    +  L    N +  V    +  +   L+
Sbjct: 115 SCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
            + L  N +   +     +    ++TL+L  N     +     +A+ ++ +         
Sbjct: 173 HLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWI--------- 219

Query: 260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD-GILPKSKGNLSLSLE 318
                  ++ +N L      L F  +L +        L GN    G L            
Sbjct: 220 -------SLRNNKLVLIEKALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQT 266

Query: 319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP 378
           +       ++G   +         +   G     +   +       L AL    + L   
Sbjct: 267 VAKQTVKKLTGQNEE---ECTVPTLGHYGAYCCED---LPAPFADRLIALKRKEHAL--- 317

Query: 379 ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL 438
                        L  QG++    +     N    R +     ++ + +       +  +
Sbjct: 318 -------------LSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363

Query: 439 FIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL 498
            ++    +L+  +      +           G   LQ    E + L+             
Sbjct: 364 TLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMY 423

Query: 499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNE 554
                 +N           K   L   N    KL GE       AN T +  +  E
Sbjct: 424 VEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVRE 479

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 90.7 bits (225), Expect = 3e-19
 Identities = 53/415 (12%), Positives = 111/415 (26%), Gaps = 40/415 (9%)

Query: 85  SFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFI 144
           + N    +          + + L++NK++            ++ L    N++        
Sbjct: 107 ANNNISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-------- 156

Query: 145 FNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLL 204
                  T++               +   L  L    N +  V    +   + LK + L 
Sbjct: 157 ------DTVNF---------AELAASSDTLEHLNLQYNFIYDV-KGQVV-FAKLKTLDLS 199

Query: 205 NNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNT 264
           +N L+  +      S   V  ++L  N     +  ++  +  L   +L  N F       
Sbjct: 200 SNKLA-FMGPEFQ-SAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 265 FV--NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGN---PLDGILPKSKGNLSLSLEI 319
           F   N     +   T +     +   C    +          L          L      
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316

Query: 320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI 379
           +L    S +  +     N      ++         I     + Q    L   +  L   +
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376

Query: 380 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL-PSTIWNLKDIL 438
           ++     A L   + Q       +       + L++L   + R+              I 
Sbjct: 377 SNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIR 435

Query: 439 FIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFG 493
             D+  +    L   N     L+G+  +    L +      E    E ++    G
Sbjct: 436 DWDMYQHKETQLAEENARLKKLNGEADLA---LASANATLQELVVREQNLASQLG 487

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 12/60 (20%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 487 SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +I E   + +  ++  ++ + +  A+ +  Q    +K L+LS N L          A  T
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFT 58

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (327), Expect = 8e-33
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 23/213 (10%)

Query: 617 DRFSENNLIGIGSFGSIY-VARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHR 673
           +++     IG GSFG    V   +DG +  +K     +   +  +    E  V+  ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHF 732
           N+V+   S   +    ++M Y   G L   +      +    Q L+  + + LAL+++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE-- 789
                I+H D+K  N+ L +D    + DFGIA++L+   +L+   +    T  Y++PE  
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPYYLSPEIC 197

Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               Y  K       D+++ G +L E+ T K  
Sbjct: 198 ENKPYNNK------SDIWALGCVLYELCTLKHA 224

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (321), Expect = 2e-32
 Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 50/263 (19%)

Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR    F E  ++G G+FG +  AR   D    A+K   +  E  L +   E  ++  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60

Query: 672 HRNLVKIISSCSNDDFKA-------------LIMKYMPNGSLENCLYSGTCMLDIFQRLN 718
           H+ +V+  ++                     + M+Y  NG+L + ++S        +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +   +  AL Y+H   S  IIH DLKP N+ +DE     I DFG+AK +     +     
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 779 TLAT---------IG---YMAPE-------YGTKGRVCTRGDVYSYGIMLMEM------- 812
                        IG   Y+A E       Y  K       D+YS GI+  EM       
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK---I---DMYSLGIIFFEMIYPFSTG 231

Query: 813 FTKKKPTDEIFIGELSLNRWIND 835
             +     ++    +      +D
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDD 254

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (320), Expect = 2e-32
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 17/226 (7%)

Query: 600 SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQY-E 654
           +P+ ++   +  +  ++     N +IG G FG +Y   L D     +  AVK  ++    
Sbjct: 8   NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 67

Query: 655 RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDI 713
             +  F  E  +MK   H N++ ++  C   +   L ++ YM +G L N + + T    +
Sbjct: 68  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127

Query: 714 FQRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
              +   + VA  ++YL    F      +H DL   N +LDE     ++DFG+A+ +  +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

Query: 771 DQLSIQIQTLAT--IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  S+  +T A   + +MA E     +  T+ DV+S+G++L E+ T
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  127 bits (322), Expect = 2e-32
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 625 IGIGSFGSIYVARLQD-----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG + +          G  VAVK        +    ++ E ++++ + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 679 ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
              C +    +  L+M+Y+P GSL + L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             IH DL   NVLLD D +  I DFG+AK +  G +   ++    + + + APE   + +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 796 VCTRGDVYSYGIMLMEMFT 814
                DV+S+G+ L E+ T
Sbjct: 214 FYYASDVWSFGVTLYELLT 232

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (320), Expect = 3e-32
 Identities = 48/258 (18%), Positives = 92/258 (35%), Gaps = 27/258 (10%)

Query: 288 NCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELG 347
           N  + K+  +T + L   L   + +   +++ + +    +S      +     L +L L 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 348 GNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL 407
            N L E +      L TL+ L L  N +      EL     + +L    N  S  +    
Sbjct: 67  SNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC-- 116

Query: 408 GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV------------LIGLNF 455
                 + +YL  N+ T            + ++D+  N ++             L  LN 
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 456 SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS 515
             N +  D+   +     L+ + L  N+L   +   F   + +  + L  NK+   I  +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 516 LQKLLYLKHLNLSFNKLE 533
           L+    L+H +L  N   
Sbjct: 233 LRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (298), Expect = 2e-29
 Identities = 42/225 (18%), Positives = 85/225 (37%), Gaps = 21/225 (9%)

Query: 331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLH 390
           I ++  N     + ++  ++L + +         ++ L L+ N L+     +L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV- 449
            L L  N         L +L++LR L L  N         +     I  +  ++N+++  
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRV 114

Query: 450 -------LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVL 501
                     +  + N ++    +  G    +Q + L+ N ++  +  E      +LE L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 502 DLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +L  N I   +   +     LK L+LS NKL   +     F +  
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE--FQSAA 214

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  106 bits (266), Expect = 4e-25
 Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 39/318 (12%)

Query: 74  NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD 133
           N +R     ++  +L+  +     +  +++ LDLS N LS    + +     L+LL  S 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF 193
           N L+ +L     ++S++ T+DL+ N +      E+   P +  L  A NN+  V   +  
Sbjct: 68  NVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV-SCSRG 119

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG-TVPSSITNASKLSDLEL 252
                K IYL NN ++  L    +     V+ L+L +N            ++  L  L L
Sbjct: 120 --QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 253 GVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN 312
             N                        +  +       KLK L L+ N L  +      +
Sbjct: 177 QYN-----------------------FIYDVKGQVVFAKLKTLDLSSNKLAFM-GPEFQS 212

Query: 313 LSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE-PIPITFSQLQTLQALGLT 371
            +  +  I + N  +   I + +    NL   +L GN      +   FS+ Q +Q +   
Sbjct: 213 AA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

Query: 372 RNKLAGPITDELCHLARL 389
             K      +E C +  L
Sbjct: 271 TVKKLTGQNEEECTVPTL 288

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  105 bits (265), Expect = 4e-25
 Identities = 54/327 (16%), Positives = 104/327 (31%), Gaps = 47/327 (14%)

Query: 139 SLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL 198
           ++     N +      ++ + L   +     +   +  L  + N L  ++   +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
           + + L +N L  +L      SL  + TL+L  N         +     +  L    N  S
Sbjct: 61  ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

Query: 259 GFIPNTFVN-----MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNL 313
               +         +A+N +T                +++ L L  N +D +        
Sbjct: 113 RVSCSRGQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTV-------- 159

Query: 314 SLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
                           N  ++  +   L  L L  N + + +         L+ L L+ N
Sbjct: 160 ----------------NFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSN 201

Query: 374 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWN 433
           KLA  +  E    A +  + L+ NK    I   L    +L    L  N F        + 
Sbjct: 202 KLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFF 258

Query: 434 LKDILFIDVSSNSLNVLIGLNFSRNNL 460
            K+     V+  ++  L G N     +
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTV 285

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 13/60 (21%), Positives = 27/60 (45%), Gaps = 2/60 (3%)

Query: 487 SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +I E   + +  ++  ++ + +  A+ +  Q    +K L+LS N L  +I      A  T
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAAD-LAPFT 58

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (320), Expect = 3e-32
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 11/201 (5%)

Query: 625 IGIGSFGSIYVARLQDGME-----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G FG+++        E     V +KV   +   ++ ++  D    +  + H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
           +  C     + L+ +Y+P GSL + +      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           +H +L   NVLL       ++DFG+A LL  +D+  +  +    I +MA E    G+   
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 799 RGDVYSYGIMLMEMFTK-KKP 818
           + DV+SYG+ + E+ T   +P
Sbjct: 197 QSDVWSYGVTVWELMTFGAEP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (318), Expect = 4e-32
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 625 IGIGSFGSIYVARLQDG---MEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKII 679
           +G G+FG++     Q       VAVK+   +            E  VM+++ +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
             C  + +  L+M+    G L   L      +     + ++  V++ ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVLL     A ISDFG++K L + E+    Q      + + APE     +
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 796 VCTRGDVYSYGIMLMEMFTK-KKP 818
             ++ DV+S+G+++ E F+  +KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 5e-32
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 625 IGIGSFGSIYVARLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
           IG G  G +   RL+      + VA+K     Y ER  + F  E  +M +  H N++++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
              +      ++ +YM NGSL+  L +      I Q + ++  V   + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   NVL+D ++V  +SDFG++++L    D           I + APE      
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 796 VCTRGDVYSYGIMLMEMFTK-KKP 818
             +  DV+S+G+++ E+    ++P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  126 bits (319), Expect = 5e-32
 Identities = 59/230 (25%), Positives = 112/230 (48%), Gaps = 24/230 (10%)

Query: 602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG-----MEVAVKVFHQQY-ER 655
           QA+ +F+  E+  +     +  +IG G FG +Y   L+       + VA+K     Y E+
Sbjct: 32  QAVLKFTT-EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88

Query: 656 ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQ 715
               F  E  +M +  H N++++    S      +I +YM NG+L+  L        + Q
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 716 RLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
            + ++  +A  ++YL   ++      +H DL   N+L++ ++V  +SDFG++++L  ED 
Sbjct: 149 LVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVL--EDD 200

Query: 773 LSIQIQTLAT---IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKP 818
                 T      I + APE  +  +  +  DV+S+GI++ E+ T  ++P
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  127 bits (321), Expect = 5e-32
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 17/226 (7%)

Query: 600 SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQY-E 654
           +P+ ++   +  +  ++     N +IG G FG +Y   L D     +  AVK  ++    
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131

Query: 655 RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL-IMKYMPNGSLENCLYSGTCMLDI 713
             +  F  E  +MK   H N++ ++  C   +   L ++ YM +G L N + + T    +
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191

Query: 714 FQRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
              +   + VA  +++L    F      +H DL   N +LDE     ++DFG+A+ +  +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 771 DQLSIQIQTLAT--IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +  S+  +T A   + +MA E     +  T+ DV+S+G++L E+ T
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (333), Expect = 6e-32
 Identities = 53/252 (21%), Positives = 97/252 (38%), Gaps = 34/252 (13%)

Query: 624 LIGIGSFGSIYVA---RLQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
            I  G  G IY+A    + +G  V +K         A      E + +  + H ++V+I 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 680 SSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +   + D        ++M+Y+   SL+         L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +++ DLKP N++L E+ +  + D G    ++    L        T G+ APE     
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRINSFGYL------YGTPGFQAPEIVR-T 251

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG-- 852
                 D+Y+ G  L  +            G   ++    D   +   +     L R   
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGRLLRRAID 306

Query: 853 ---EERFFAAKE 861
               +RF  A+E
Sbjct: 307 PDPRQRFTTAEE 318

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (331), Expect = 6e-32
 Identities = 55/237 (23%), Positives = 106/237 (44%), Gaps = 18/237 (7%)

Query: 591 TGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG---MEVAVK 647
           T       + P+ ++      L R     ++  L G G+FGS+     +     ++VA+K
Sbjct: 312 TSVFESPFSDPEELKDKKL-FLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIK 369

Query: 648 VFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
           V  Q   +   +    E ++M ++ +  +V++I  C  +    L+M+    G L   L  
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVG 428

Query: 707 GTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
               + +     ++  V++ ++YL   +F      +H +L   NVLL     A ISDFG+
Sbjct: 429 KREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGL 482

Query: 764 AKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKP 818
           +K L + +   + +      + + APE     +  +R DV+SYG+ + E  +  +KP
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (314), Expect = 7e-32
 Identities = 53/192 (27%), Positives = 103/192 (53%), Gaps = 7/192 (3%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           +G G FG +++       +VAVK   Q    +  +F  E  +MK+++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 685 DDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL 743
           +    +I +YM NGSL + L + +   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVY 803
           + +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE    G    + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

Query: 804 SYGIMLMEMFTK 815
           S+GI+L E+ T 
Sbjct: 195 SFGILLTEIVTH 206

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (323), Expect = 1e-31
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 13/193 (6%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG + +   + G +VAVK          ++F  E  VM ++RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 685 DDFKA-LIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
           +     ++ +YM  GSL + L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   NVL+ ED VA +SDFG+ K     +  S Q      + + APE   + +  T+ DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 803 YSYGIMLMEMFTK 815
           +S+GI+L E+++ 
Sbjct: 370 WSFGILLWEIYSF 382

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (315), Expect = 1e-31
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 625 IGIGSFGSIYVARLQDG----MEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G FGS+    L+      ++VAVK        +R ++ F  E   MK   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 679 ISSCSNDDFKA-----LIMKYMPNGSL-----ENCLYSGTCMLDIFQRLNIMIDVALALE 728
           +  C     +      +I+ +M  G L      + L +G   + +   L  M+D+AL +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 729 YL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           YL   +F      +H DL   N +L +DM   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           +A E        ++ DV+++G+ + E+ T
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (313), Expect = 1e-31
 Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 7/192 (3%)

Query: 625 IGIGSFGSIYVARLQDG-MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS 683
           +G G +G +Y    +   + VAVK   +     ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 684 NDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD 742
            +    +I ++M  G+L + L       +     L +   ++ A+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRD 136

Query: 743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDV 802
           L   N L+ E+ +  ++DFG+++L++  D  +        I + APE     +   + DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 803 YSYGIMLMEMFT 814
           +++G++L E+ T
Sbjct: 196 WAFGVLLWEIAT 207

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (315), Expect = 1e-31
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 13/207 (6%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
           L+G G  G +Y A        VA+K+  +            + E     R++  ++V I 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
                D    + M+ +    L   L      L   + + I+  +  AL+  H        
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAG---AT 156

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTR 799
           H D+KP N+L+  D  A++ DFGIA   + +++L+    T+ T+ YMAPE  ++     R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 800 GDVYSYGIMLMEMFTKKKPTDEIFIGE 826
            D+Y+   +L E  T   P    + G+
Sbjct: 216 ADIYALTCVLYECLTGSPP----YQGD 238

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  126 bits (318), Expect = 1e-31
 Identities = 50/204 (24%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 625 IGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
           +G G FG +   RL+      + VA+K     Y E+  + F  E  +M +  H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
              +      ++ +YM NGSL++ L        + Q + ++  +A  ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEYGTKGR 795
             +H DL   N+L++ ++V  +SDFG+ ++L    +           I + +PE     +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 796 VCTRGDVYSYGIMLMEMFTK-KKP 818
             +  DV+SYGI+L E+ +  ++P
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (312), Expect = 1e-31
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 17/203 (8%)

Query: 625 IGIGSFGSIYVARLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
           +G G FG +Y     +     + VAVK   +       + F  E  +MK + H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
                +    +IM+  P G L + L      L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   N+L+       + DFG+++ +  ED       T   I +M+PE     R 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-VTRLPIKWMSPESINFRRF 191

Query: 797 CTRGDVYSYGIMLMEMFTK-KKP 818
            T  DV+ + + + E+ +  K+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (312), Expect = 2e-31
 Identities = 50/231 (21%), Positives = 96/231 (41%), Gaps = 35/231 (15%)

Query: 609 YHELLRATDRFSENNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQYERALKSF 660
           +H++      F+E   +G G+F  I+    ++          EV +KV  + +    +SF
Sbjct: 2   FHKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59

Query: 661 EDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIM 720
            +   +M ++ H++LV     C   D   L+ +++  GSL+  L      ++I  +L + 
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 721 IDVALALEYL---HFGHSTPIIHCDLKPSNVLLD--------EDMVAHISDFGIAKLLSG 769
             +A A+ +L           IH ++   N+LL               +SD GI+  +  
Sbjct: 120 KQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

Query: 770 EDQLSIQIQTLATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFTK-KKP 818
           +D L  +I       ++ PE     +      D +S+G  L E+ +   KP
Sbjct: 174 KDILQERIP------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (312), Expect = 3e-31
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 21/221 (9%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           DR+    ++G G    +++AR L+D  +VAVKV              F  E +    + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 673 RNLVKIISSCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
             +V +  +   +        ++M+Y+   +L + +++    +   + + ++ D   AL 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALN 130

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---Y 785
           + H      IIH D+KP+N+++       + DFGIA+ ++  D  +   QT A IG   Y
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQY 185

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           ++PE      V  R DVYS G +L E+ T + P    F G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  124 bits (313), Expect = 3e-31
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 625 IGIGSFGSIYVARLQDGME-----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG++Y        E     VA+K   +    +A K   DE  VM  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHS 735
           +  C     + LI + MP G L + +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
              +H DL   NVL+       I+DFG+AKLL  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 796 VCTRGDVYSYGIMLMEMFT 814
              + DV+SYG+ + E+ T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (308), Expect = 5e-31
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 17/203 (8%)

Query: 625 IGIGSFGSIYVARLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
           IG G FG ++           + VA+K       +   + F  E   M++  H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
              + +    +IM+    G L + L      LD+   +     ++ AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   NVL+  +    + DFG+++ +  +       +    I +MAPE     R 
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 797 CTRGDVYSYGIMLMEMFTK-KKP 818
            +  DV+ +G+ + E+     KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (311), Expect = 5e-31
 Identities = 53/235 (22%), Positives = 99/235 (42%), Gaps = 28/235 (11%)

Query: 600 SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG----MEVAVKVFHQQY-- 653
           S +   +     +     +F+   ++G G FGS+  A+L+      ++VAVK+       
Sbjct: 8   SDELKEKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65

Query: 654 ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA------LIMKYMPNGSLENCL--- 704
              ++ F  E   MK   H ++ K++        K       +I+ +M +G L   L   
Sbjct: 66  SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125

Query: 705 --YSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHIS 759
                   L +   +  M+D+A  +EYL   +F      IH DL   N +L EDM   ++
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVA 179

Query: 760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           DFG+++ +   D       +   + ++A E           DV+++G+ + E+ T
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  128 bits (322), Expect = 6e-31
 Identities = 93/457 (20%), Positives = 169/457 (36%), Gaps = 41/457 (8%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS 156
            LS L+ L LSHN++  ++   +F     L+ L  S N+L  ++S      +S+  +DLS
Sbjct: 74  FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISCCPM--ASLRHLDLS 129

Query: 157 INGLSGEMPR--EIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPS 214
            N     +P   E GNL  L  L  +      +  + + +   L    +L + +S  +  
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH---LHLSCILLDLVSYHIKG 185

Query: 215 RIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLT 274
               SL    T  L +     ++ S   N S  +   L ++           +     L 
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS------NIKLNDENCQRLM 239

Query: 275 SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQV 334
           +   EL+   +L N   L+ +  T      +    +      +E + + N +I+  I + 
Sbjct: 240 TFLSELTRGPTLLNVT-LQHIETTWKCSVKLF---QFFWPRPVEYLNIYNLTITERIDRE 295

Query: 335 VGN-----LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARL 389
                   L +L++  +            +S    +    L+ +             +  
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355

Query: 390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV 449
             L    N F+ S+      L  L+ L L  N   +         K++  ++    SLN 
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNS 414

Query: 450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
           L          S     T    +++  + L  N L GS+         ++VLDL  N+I 
Sbjct: 415 L---------NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463

Query: 510 GAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            +IP  +  L  L+ LN++ N+L+  +P  G F  LT
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 80.3 bits (198), Expect = 1e-15
 Identities = 69/407 (16%), Positives = 128/407 (31%), Gaps = 42/407 (10%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
              + +D S   L+  +P+++   P    L+ + N++  +    I  +S L+ + L +N 
Sbjct: 31  ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           +  SL   + L   ++E L++  N     +       + L  L+L  N F          
Sbjct: 88  IR-SLDFHVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFD--------- 134

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
                     P      +LT    L  L L+      +      +L LS  ++ + +  I
Sbjct: 135 --------VLPVCKEFGNLTK---LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG-------PIT 380
            G   + +    N  VL L  +  +         +  L  L L+  KL            
Sbjct: 184 KGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL 242

Query: 381 DELCHLARLHSLVLQGNKFS-GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF 439
            EL     L ++ LQ  + +               V YL +   T      I    D   
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT------ITERIDREE 296

Query: 440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE 499
              S  +L  L+  +                   +    L  +             SS  
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356

Query: 500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            L+ ++N  + ++      L  L+ L L  N L+          N++
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.1 bits (195), Expect = 2e-15
 Identities = 75/392 (19%), Positives = 136/392 (34%), Gaps = 64/392 (16%)

Query: 85  SFNLQGTIPP--QLGNLSSLQTLDLSHNKL-------------------------SGNIP 117
           SFN    +P   + GNL+ L  L LS  K                           G   
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188

Query: 118 SSIFNMHTLKL-LYFSDNQLFGSLSFFIFN-VSSVTTIDLSINGLSGEMPR----EIGNL 171
            S+   +T  L L F  N LF        N +  +   ++ +N  + +       E+   
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248

Query: 172 PYLARLAFATNNLVGVAPVTIFN---MSALKEIYLLNNSLSGSLPSRI----DLSLPNVE 224
           P L  +            V +F       ++ + + N +++  +        + +L ++ 
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308

Query: 225 TLNLGINSFYGTVPSSITNASKLSDLELGVN--------LFSGFIPNTFVNMADNYLTSS 276
             ++    F  +  +  +  ++++   L ++                TF+N   N  T S
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368

Query: 277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS---ISGNIPQ 333
             +    S+L     L+ LIL  N L     K          +  +D       S    +
Sbjct: 369 VFQGC--STLKR---LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422

Query: 334 VVGNLGNLLVLELGGNNLTEPIPITFSQL-QTLQALGLTRNKLAGPITDELCHLARLHSL 392
                 ++LVL L  N LT  +   F  L   ++ L L  N++   I  ++ HL  L  L
Sbjct: 423 TCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQEL 478

Query: 393 VLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRF 423
            +  N+   S+P      LTSL+ ++L  N +
Sbjct: 479 NVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 56/296 (18%), Positives = 95/296 (32%), Gaps = 32/296 (10%)

Query: 29  SNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCD---VNSHRVIGLNISS 85
           SNI  + +    L   +S         N T      +W              V  LNI +
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 86  FNLQGTIPPQLGN-----LSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGS 139
             +   I  +        L SL    + +         +++++   + +   S +     
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFI 344

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK 199
                 + SS T ++ + N  +  + +    L  L  L    N L             + 
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMS 403

Query: 200 EIYLLNNSLSGSLPSRIDLSL----PNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
            +  L+ SL+ SL S           ++  LNL  N   G+V   +    K+  L+L  N
Sbjct: 404 SLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNN 460

Query: 256 LFSGFIPNTF--------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
                IP           +N+A N L S  P+  F         L+ + L  NP D
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLKS-VPDGVF----DRLTSLQYIWLHDNPWD 510

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  128 bits (322), Expect = 8e-31
 Identities = 74/404 (18%), Positives = 127/404 (31%), Gaps = 53/404 (13%)

Query: 163 EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPN 222
            +   +        +                 ++  K +   N+++   LP+ +  S   
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSF 282
           VE LNL           +   A  +  L +G N      P+ F N+              
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV-------------- 122

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
                    L VL+L  N L  +      N    L  + M N ++            +L 
Sbjct: 123 -------PLLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQ 174

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
            L+L  N LT    +  S + +L    ++ N L+      L     +  L    N  +  
Sbjct: 175 NLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-V 225

Query: 403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV-----------LI 451
           +         L +L L  N  T    + + N   ++ +D+S N L             L 
Sbjct: 226 VRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA 511
            L  S N L   + +    +  L+ + L +N L   +  +      LE L L  N I   
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338

Query: 512 IPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNEL 555
           +  S      LK+L LS N  +        F N+   +    + 
Sbjct: 339 LKLST--HHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQ 379

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  126 bits (317), Expect = 3e-30
 Identities = 80/550 (14%), Positives = 173/550 (31%), Gaps = 38/550 (6%)

Query: 80  GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG 138
            ++I           +   L++ + +   ++ +   +P+++  +   ++LL  +D Q+  
Sbjct: 31  DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-E 88

Query: 139 SLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA 197
            +  + F    ++  + +  N +    P    N+P L  L    N+L  +      N   
Sbjct: 89  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           L  + + NN+L   +      +  +++ L L  N     V  S      L    +  NL 
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVDLS--LIPSLFHANVSYNLL 204

Query: 258 SGFIPNTFV---NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS 314
           S       V   + + N +      +          +L +L L  N L         N  
Sbjct: 205 STLAIPIAVEELDASHNSINVVRGPV--------NVELTILKLQHNNLTDT--AWLLNYP 254

Query: 315 LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNK 374
             L  + +    +   +      +  L  L +  N L   + +    + TL+ L L+ N 
Sbjct: 255 -GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH 312

Query: 375 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL 434
           L   +        RL +L L  N    ++   L    +L+ L L  N +       +   
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--F 366

Query: 435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGD 494
           +++    V     +  I           +         +    ++    +   +  + G 
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGLCCKESD---KPYLDRLLQYIALTSVVEKVQRAQGR 423

Query: 495 LSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNE 554
            S+ + ++  ++            L   + L    N+L  E+        LT +     +
Sbjct: 424 CSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ------QLTNEQIQQEQ 477

Query: 555 LLKMLLLVIILPLSTALIVVVTLTLKWKLIECWKSRTGPSNDGINSPQAIRRFSYHELLR 614
           LL+ L   I   L    +    L      +    +               RR       +
Sbjct: 478 LLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQK 537

Query: 615 ATDRFSENNL 624
            T+   + N+
Sbjct: 538 ETEDLEQENI 547

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 24/178 (13%), Positives = 59/178 (33%), Gaps = 15/178 (8%)

Query: 370 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPS 429
             R      I   L +    + + +               L + +++    +       +
Sbjct: 10  KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69

Query: 430 TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
            + + + +  ++++   +  +    F+                 +Q++++ +N +    P
Sbjct: 70  LLDSFRQVELLNLNDLQIEEIDTYAFA-------------YAHTIQKLYMGFNAIRYLPP 116

Query: 490 ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             F ++  L VL L +N +S            L  L++S N LE  I     F   T+
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQATTS 172

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  121 bits (306), Expect = 1e-30
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 13/218 (5%)

Query: 599 NSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALK 658
            S  A   F                 IG G FG + +   + G +VAVK          +
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--Q 59

Query: 659 SFEDECEVMKRIRHRNLVKIISSCSNDDFKALI-MKYMPNGSLENCLYS-GTCMLDIFQR 716
           +F  E  VM ++RH NLV+++     +     I  +YM  GSL + L S G  +L     
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           L   +DV  A+EYL        +H DL   NVL+ ED VA +SDFG+ K     +  S Q
Sbjct: 120 LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ 171

Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                 + + APE   + +  T+ DV+S+GI+L E+++
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 1e-30
 Identities = 47/233 (20%), Positives = 91/233 (39%), Gaps = 41/233 (17%)

Query: 614 RATDRFSENNLIGIGSFGSIY-VARLQDGMEVAVK-VFHQQYERALKSFEDECEVMKRIR 671
           R    F     +G G FG ++      D    A+K +     E A +    E + + ++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 672 HRNLVKIISSCSNDDFKA------------LIMKYMPNGSLENCL--YSGTCMLDIFQRL 717
           H  +V+  ++    +               + M+     +L++ +         +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI 777
           +I + +A A+E+LH   S  ++H DLKPSN+    D V  + DFG+   +  +++    +
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 778 QTLATIG----------YMAPE------YGTKGRVCTRGDVYSYGIMLMEMFT 814
             +              YM+PE      Y  K       D++S G++L E+  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK------VDIFSLGLILFELLY 225

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (308), Expect = 1e-30
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 22/214 (10%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRI 670
                F   + +G GS+G ++  R  +DG   AVK     +   +       E    +++
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 671 -RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
            +H   V++  +        L  +     SL+    +    L   Q    + D  LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH   S  ++H D+KP+N+ L       + DFG+   L       +Q        YMAPE
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226

Query: 790 -----YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                YGT        DV+S G+ ++E+    + 
Sbjct: 227 LLQGSYGTA------ADVFSLGLTILEVACNMEL 254

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (313), Expect = 2e-30
 Identities = 44/211 (20%), Positives = 90/211 (42%), Gaps = 17/211 (8%)

Query: 618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLV 676
            F   +++G G+ G+I    + D  +VAVK    +        + E ++++    H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           +   +  +  F+ + ++     +L+  +          + + ++      L +L   HS 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSL 137

Query: 737 PIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPEY 790
            I+H DLKP N+L+        + A ISDFG+ K L+       +   +  T G++APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                K       D++S G +   + ++   
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (305), Expect = 2e-30
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 30/214 (14%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKI 678
           +G G+FG +++A        +D M VAVK        A K F+ E E++  ++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCL---------------YSGTCMLDIFQRLNIMIDV 723
              C + D   ++ +YM +G L   L                     L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 724 ALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
           A  + YL   HF      +H DL   N L+  +++  I DFG+++ +   D   +   T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             I +M PE     +  T  DV+S+G++L E+FT
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 2e-30
 Identities = 48/247 (19%), Positives = 99/247 (40%), Gaps = 23/247 (9%)

Query: 588 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVK 647
           +      + G +        +   +      +S    IG G    ++    +     A+K
Sbjct: 27  RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86

Query: 648 V--FHQQYERALKSFEDECEVMKRIRHRNL--VKIISSCSNDDFKALIMKYMPNGSLENC 703
                +   + L S+ +E   + +++  +   +++      D +  ++M+   N  L + 
Sbjct: 87  YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145

Query: 704 LYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI 763
           L      +D ++R +   ++  A+  +H      I+H DLKP+N L+ + M+  + DFGI
Sbjct: 146 LKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGI 200

Query: 764 AKLLSGEDQLSIQIQTLA-TIGYMAPE-----------YGTKGRVCTRGDVYSYGIMLME 811
           A  +   D  S+   +    + YM PE             +K ++  + DV+S G +L  
Sbjct: 201 ANQMQ-PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259

Query: 812 MFTKKKP 818
           M   K P
Sbjct: 260 MTYGKTP 266

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (305), Expect = 3e-30
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNL--VKI 678
             IG G    ++    +     A+K     +   + L S+ +E   + +++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
                 D +  ++M+   N  L + L      +D ++R +   ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE-------- 789
           +H DLKP+N L+ + M+  + DFGIA  +   D  S+   +   T+ YM PE        
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 790 ---YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +K ++  + DV+S G +L  M   K P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (304), Expect = 6e-30
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKV--FHQQYERALKSFEDECEVMKRIRHRNL--VKI 678
             IG G    ++    +     A+K     +   + L S+ +E   + +++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
                 D +  ++M+   N  L + L      +D ++R +   ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE-------- 789
           +H DLKP+N L+ + M+  + DFGIA  +   D  S+   +   T+ YM PE        
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 790 ---YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                +K ++  + DV+S G +L  M   K P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  119 bits (300), Expect = 1e-29
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 19/206 (9%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G GSFG +Y    +          VA+K  ++    R    F +E  VMK     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 678 IISSCSNDDFKALIMKYMPNGSL---------ENCLYSGTCMLDIFQRLNIMIDVALALE 728
           ++   S      +IM+ M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           YL   ++   +H DL   N ++ ED    I DFG+ + +   D      + L  + +M+P
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFT 814
           E    G   T  DV+S+G++L E+ T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (313), Expect = 1e-29
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 17/203 (8%)

Query: 625 IGIGSFGSIYVARLQDG----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII 679
           IG G FG ++           M VA+K       +   + F  E   M++  H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL---HFGHST 736
              + +    +IM+    G L + L      LD+   +     ++ AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H D+   NVL+  +    + DFG+++ +          +    I +MAPE     R 
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFRRF 569

Query: 797 CTRGDVYSYGIMLMEMFTK-KKP 818
            +  DV+ +G+ + E+     KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (298), Expect = 3e-29
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL------YSGTCMLDIFQRLNIMIDVALALEYL- 730
            I        + ++M+ M  G L++ L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 731 --HFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
             HF      IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (298), Expect = 3e-29
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 31/240 (12%)

Query: 598 INSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDG------MEVAVKVFHQ 651
           I +PQ       H + R          +G G+FG +++A   +       M VAVK   +
Sbjct: 24  IENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 81

Query: 652 QYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL------- 704
             E A + F+ E E++  ++H+++V+    C+      ++ +YM +G L   L       
Sbjct: 82  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141

Query: 705 -------YSGTCMLDIFQRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDM 754
                        L + Q L +   VA  + YL   HF      +H DL   N L+ + +
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGL 195

Query: 755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           V  I DFG+++ +   D   +  +T+  I +M PE     +  T  DV+S+G++L E+FT
Sbjct: 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  116 bits (293), Expect = 6e-29
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G   FG +Y   L           VA+K    +      + F  E  +  R++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 678 IISSCSNDDFKALIMKYMPNGSL---------------ENCLYSGTCMLDIFQRLNIMID 722
           ++   + D   ++I  Y  +G L                +   +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 723 VALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           +A  +EYL   H       +H DL   NVL+ + +   ISD G+ + +   D   +   +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           L  I +MAPE    G+     D++SYG++L E+F+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (292), Expect = 1e-28
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 16/202 (7%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
                    IG GS G + +AR    G +VAVK+   + ++  +   +E  +M+  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V++  S    +   ++M+++  G+L + +      L+  Q   +   V  AL YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLH--- 158

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMAPEY 790
           +  +IH D+K  ++LL  D    +SDFG         Q+S  +    + +G   +MAPE 
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QISKDVPKRKSLVGTPYWMAPEV 212

Query: 791 GTKGRVCTRGDVYSYGIMLMEM 812
            ++    T  D++S GIM++EM
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEM 234

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (291), Expect = 1e-28
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
             +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V  + S    D   ++M+Y+  GSL + +      +D  Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--- 133

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMAPE- 789
           S  +IH D+K  N+LL  D    ++DFG         Q++ +    +T +G   +MAPE 
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QITPEQSKRSTMVGTPYWMAPEV 187

Query: 790 -----YGTKGRVCTRGDVYSYGIMLMEM 812
                YG K       D++S GIM +EM
Sbjct: 188 VTRKAYGPK------VDIWSLGIMAIEM 209

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (294), Expect = 2e-28
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G+FG +Y  ++         ++VAVK   +   E+    F  E  ++ +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL------YSGTCMLDIFQRLNIMIDVALALEYL- 730
            I        + ++++ M  G L++ L       S    L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 731 --HFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY 785
             HF      IH D+   N LL       VA I DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           M PE   +G   ++ D +S+G++L E+F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 2e-28
 Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 27/229 (11%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNL 675
           R     ++  G F  +Y A+ +  G E A+K      E   ++   E   MK++  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 676 VKIISSCS-------NDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDVALA 726
           V+  S+ S           + L++  +  G L   L        L     L I      A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA----- 781
           ++++H     PIIH DLK  N+LL       + DFG A  +S     S   Q  A     
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 782 -----TIGYMAPE----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
                T  Y  PE    Y     +  + D+++ G +L  +  ++ P ++
Sbjct: 208 ITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFED 255

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (289), Expect = 3e-28
 Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 28/215 (13%)

Query: 625 IGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLV 676
           +G G+FG +  A           M VAVK+          ++   E +V+  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCL-----------------YSGTCMLDIFQRLNI 719
            ++ +C+      +I +Y   G L N L                       LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
              VA  + +L    S   IH DL   N+LL    +  I DFG+A+ +  +    ++   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              + +MAPE           DV+SYGI L E+F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (287), Expect = 6e-28
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 26/221 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
             +  ++++G G+  +++  R  + G   A+KVF+   + R +     E EV+K++ H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 675 LVKI--ISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYL 730
           +VK+  I   +    K LIM++ P GSL   L        L   + L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 731 HFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGY 785
                  I+H ++KP N++     D   V  ++DFG A+ L  ++Q      +L  T  Y
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV----SLYGTEEY 181

Query: 786 MAPEYGTKGRVCTRG--------DVYSYGIMLMEMFTKKKP 818
           + P+   +  +            D++S G+      T   P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (286), Expect = 7e-28
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            + F     +G GS+GS+Y A   + G  VA+K      E  L+    E  +M++    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK   S   +    ++M+Y   GS+ + +      L   +   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMAPEY 790
               IH D+K  N+LL+ +  A ++DFG+A       QL+  +    T IG   +MAPE 
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG------QLTDTMAKRNTVIGTPFWMAPEV 196

Query: 791 GTKGRVCTRGDVYSYGIMLMEM 812
             +       D++S GI  +EM
Sbjct: 197 IQEIGYNCVADIWSLGITAIEM 218

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  116 bits (293), Expect = 1e-27
 Identities = 87/417 (20%), Positives = 141/417 (33%), Gaps = 69/417 (16%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNN 206
           + V  +DLS+N ++         L  L  L         V     F  +S+L  + L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFV 266
                L +     L N+E L L                  L    L  N F        +
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQC--------------NLDGAVLSGNFFKPLTSLEML 134

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS 326
            + DN +    P   F  ++       VL LT N +  I  +   N       +L     
Sbjct: 135 VLRDNNIKKIQPASFF-LNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLL----- 185

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
                      L ++ + ++    L         +  ++  L L+ N     +       
Sbjct: 186 ----------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235

Query: 387 ---ARLHSLVLQ--GNKFSGSIPSCLGNL----------TSLRVLYLGLNRFTSALPSTI 431
               ++ SL+L    N  S    +   +           + ++   L  ++  + L S  
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF 295

Query: 432 WNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE- 490
            +  D+  + ++ N +N +    F              GL +L ++ L  N L GSI   
Sbjct: 296 SHFTDLEQLTLAQNEINKIDDNAFW-------------GLTHLLKLNLSQNFL-GSIDSR 341

Query: 491 SFGDLSSLEVLDLSKNKISGAIPA-SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            F +L  LEVLDLS N I  A+   S   L  LK L L  N+L+  +P  G F  LT
Sbjct: 342 MFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD-GIFDRLT 395

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  113 bits (284), Expect = 1e-26
 Identities = 64/383 (16%), Positives = 123/383 (32%), Gaps = 31/383 (8%)

Query: 85  SFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSF 142
           S N    +       L  LQ L +        I ++ F  + +L +L    NQ    L  
Sbjct: 38  SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLET 96

Query: 143 FIF-NVSSVTTIDLSINGL-SGEMPREI-GNLPYLARLAFATNNLVGVAPVTIF-NMSAL 198
             F  ++++  + L+   L    +       L  L  L    NN+  + P + F NM   
Sbjct: 97  GAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRF 156

Query: 199 KEIYLLNNSLSGSLPSRI----------DLSLPNVETLNLGINSFYGTVPSSITNASKLS 248
             + L  N +  S+               L L ++   ++           +    + ++
Sbjct: 157 HVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

Query: 249 DLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK 308
            L+L  N F   +   F +        S    +  +  ++               G+   
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS 275

Query: 309 SKGNLSLSLEIILMDNC--SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ 366
                 LS       +   ++  ++     +  +L  L L  N + +     F  L  L 
Sbjct: 276 GVKTCDLS------KSKIFALLKSVFS---HFTDLEQLTLAQNEINKIDDNAFWGLTHLL 326

Query: 367 ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL-GNLTSLRVLYLGLNRFTS 425
            L L++N L    +    +L +L  L L  N    ++       L +L+ L L  N+  S
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS 385

Query: 426 ALPSTIWNLKDILFIDVSSNSLN 448
                   L  +  I + +N  +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  112 bits (281), Expect = 3e-26
 Identities = 79/437 (18%), Positives = 146/437 (33%), Gaps = 67/437 (15%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSIN 158
           + +  +DLS N ++    +S   +  L+ L          +    F  +SS+  + L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 159 GLSGEMPREI-GNLPYLARLAFATNNLVGVA-PVTIF-NMSALKEIYLLNNSLSGSLPSR 215
               ++       L  L  L     NL G       F  +++L+ + L +N++    P+ 
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 216 IDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTS 275
             L++     L+L  N         + N        L   L S     T  +M + +L  
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--RLSS----ITLQDMNEYWLGW 202

Query: 276 STPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV 335
                    +      +  L L+GN     + K   +  ++   I     S S N+    
Sbjct: 203 EKC-----GNPFKNTSITTLDLSGNGFKESMAKRFFDA-IAGTKIQSLILSNSYNMGSS- 255

Query: 336 GNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ 395
                      G  N  +P   TF  L+                       + + +  L 
Sbjct: 256 ----------FGHTNFKDPDNFTFKGLEA----------------------SGVKTCDLS 283

Query: 396 GNKFSGSIPSCL-GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLN 454
            +K   ++   +  + T L  L L  N       +  W L  +L +++S N L  +    
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342

Query: 455 FSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIP 513
           F               L  L+ + L YN +  ++ + SF  L +L+ L L  N++     
Sbjct: 343 FE-------------NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPD 388

Query: 514 ASLQKLLYLKHLNLSFN 530
               +L  L+ + L  N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 46/227 (20%), Positives = 76/227 (33%), Gaps = 43/227 (18%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELC-HLARLHSLVLQGNK 398
           ++  ++L  N++ E    +FS+LQ LQ L + +      I +     L+ L  L L  N+
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 399 FSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSR 457
           F   + +     L +L VL L       A+      L    F                  
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAV------LSGNFFK----------------- 126

Query: 458 NNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPASL 516
                        L +L+ + L  N ++   P S F ++    VLDL+ NK+       L
Sbjct: 127 ------------PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDL 174

Query: 517 QKL--LYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLL 561
                 +   L LS   L+               +   N  +  L L
Sbjct: 175 LNFQGKHFTLLRLSSITLQD--MNEYWLGWEKCGNPFKNTSITTLDL 219

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (297), Expect = 1e-27
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 33/225 (14%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ-YERALKSFEDECEVMKRIR 671
           +    +     +G G FG +        G +VA+K   Q+   +  + +  E ++MK++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 672 HRNLVKII------SSCSNDDFKALIMKYMPNGSLENCL--YSGTCMLDIFQRLNIMIDV 723
           H N+V            + +D   L M+Y   G L   L  +   C L       ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
           + AL YLH      IIH DLKP N++L    + ++  I D G AK L   +         
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC----TEF 183

Query: 781 A-TIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             T+ Y+APE      Y          D +S+G +  E  T  +P
Sbjct: 184 VGTLQYLAPELLEQKKYTVT------VDYWSFGTLAFECITGFRP 222

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (283), Expect = 3e-27
 Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 39/223 (17%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           IG G+FG ++ AR            VAVK+  ++        F+ E  +M    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCL-----------------------YSGTCMLDIF 714
           ++  C+      L+ +YM  G L   L                         G   L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 715 QRLNIMIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           ++L I   VA  + YL    F      +H DL   N L+ E+MV  I+DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      I +M PE     R  T  DV++YG++L E+F+
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (281), Expect = 4e-27
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVK 677
           +G G FG +  A             VAVK+  +      L+    E  V+K++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 678 IISSCSNDDFKALIMKYMPNGSL-----------------------ENCLYSGTCMLDIF 714
           +  +CS D    LI++Y   GSL                        +  +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 774
             ++    ++  ++YL       ++H DL   N+L+ E     ISDFG+++ +  ED   
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
            + Q    + +MA E        T+ DV+S+G++L E+ T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  112 bits (282), Expect = 4e-27
 Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 36/260 (13%)

Query: 579 LKWKLIECWKSRTGPSNDGINSPQAIRRFSYH---ELLRATDRFSENNLIGIGSFGSIYV 635
           ++WK+IE   S  G S   I+  Q      Y+   E  R  +       +G G+FG +  
Sbjct: 14  VRWKIIE---SYEGNSYTFIDPTQ----LPYNEKWEFPR--NNLQFGKTLGAGAFGKVVE 64

Query: 636 ARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF 687
           A           ++VAVK+          ++   E ++M  + +H N+V ++ +C++   
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124

Query: 688 KALIMKYMPNGSL-------------ENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
             +I +Y   G L             +               L+    VA  + +L   +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
               IH D+   NVLL    VA I DFG+A+ +  +    ++      + +MAPE     
Sbjct: 185 ---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 241

Query: 795 RVCTRGDVYSYGIMLMEMFT 814
               + DV+SYGI+L E+F+
Sbjct: 242 VYTVQSDVWSYGILLWEIFS 261

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (284), Expect = 5e-27
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 26/221 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
             +  ++++G G+  +++  R  + G   A+KVF+   + R +     E EV+K++ H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 675 LVKI--ISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYL 730
           +VK+  I   +    K LIM++ P GSL   L        L   + L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 731 HFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGY 785
                  I+H ++KP N++     D   V  ++DFG A+ L  ++Q      +L  T  Y
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEY 181

Query: 786 MAPEYGTKGRVCTRG--------DVYSYGIMLMEMFTKKKP 818
           + P+   +  +            D++S G+      T   P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (278), Expect = 7e-27
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 31/213 (14%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            + +     +G G+FG +Y A+  + G   A KV   + E  L+ +  E E++    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK++ +  +D    +++++ P G+++  +      L   Q   +   +  AL +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMAPE- 789
              IIH DLK  NVL+  +    ++DFG++       +    +Q   + IG   +MAPE 
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSA------KNLKTLQKRDSFIGTPYWMAPEV 188

Query: 790 ----------YGTKGRVCTRGDVYSYGIMLMEM 812
                     Y  K       D++S GI L+EM
Sbjct: 189 VMCETMKDTPYDYK------ADIWSLGITLIEM 215

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  111 bits (279), Expect = 1e-26
 Identities = 62/346 (17%), Positives = 116/346 (33%), Gaps = 60/346 (17%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           L+ +   +  L   +P  +    P+   L+L  N           N   L  L L  N  
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
           S   P  F  +                      KL+ L L+ N L  +       +  +L
Sbjct: 89  SKISPGAFAPL---------------------VKLERLYLSKNQLKELPE----KMPKTL 123

Query: 318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPI--PITFSQLQTLQALGLTRNKL 375
           + + +    I+     V   L  ++V+ELG N L         F  ++ L  + +    +
Sbjct: 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNL 434
              I   L     L  L L GNK +  + +  L  L +L  L L  N  ++    ++ N 
Sbjct: 184 TT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239

Query: 435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES--- 491
             +  + +++N L                +P  +   K +Q ++L  N +  +I  +   
Sbjct: 240 PHLRELHLNNNKLVK--------------VPGGLADHKYIQVVYLHNNNIS-AIGSNDFC 284

Query: 492 ----FGDLSSLEVLDLSKNKISGAI--PASLQKLLYLKHLNLSFNK 531
                   +S   + L  N +      P++ + +     + L   K
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 99.7 bits (249), Expect = 9e-23
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 22/236 (9%)

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           +L     ++ + N  I+        NL NL  L L  N +++  P  F+ L  L+ L L+
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
           +N+L   + +++     L  L +  N+ +    S    L  + V+ LG N   S+     
Sbjct: 109 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS----- 160

Query: 432 WNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE- 490
             +++  F       +  L  +  +  N++    I  G   +L ++ L+ N++   +   
Sbjct: 161 -GIENGAF-----QGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKIT-KVDAA 210

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           S   L++L  L LS N IS     SL    +L+ L+L+ NKL  ++P G   A+  
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG--LADHK 263

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 97.0 bits (242), Expect = 6e-22
 Identities = 65/386 (16%), Positives = 114/386 (29%), Gaps = 90/386 (23%)

Query: 101 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL 160
            L+ +  S   L   +P  +                                +DL  N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--------------------------PDTALLDLQNNKI 64

Query: 161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSL 220
           +     +  NL  L  L    N +  ++P     +  L+ +YL  N L   LP ++    
Sbjct: 65  TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM---P 120

Query: 221 PNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSST-PE 279
             ++ L +  N       S     +++  +ELG                 N L SS    
Sbjct: 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELG----------------TNPLKSSGIEN 164

Query: 280 LSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLG 339
            +F       KKL  + +    +  I                              G   
Sbjct: 165 GAF----QGMKKLSYIRIADTNITTIPQ----------------------------GLPP 192

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF 399
           +L  L L GN +T+    +   L  L  LGL+ N ++      L +   L  L L  NK 
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 400 SGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNN 459
              +P  L +   ++V+YL  N  ++   +                      G++   N 
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN-------TKKASYSGVSLFSNP 304

Query: 460 LSGDI--PITIGGLKNLQQMFLEYNR 483
           +      P T   +     + L   +
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 52/337 (15%), Positives = 109/337 (32%), Gaps = 73/337 (21%)

Query: 79  IGLNISSFNLQG----TIPP-QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFS 132
           +  + +  +LQ      I      NL +L TL L +NK+S  I    F  +  L+ LY S
Sbjct: 50  LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS 108

Query: 133 DNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTI 192
            NQL   L   +    ++  + +  N            +  + +  F             
Sbjct: 109 KNQL-KELPEKMP--KTLQELRVHEN-----------EITKVRKSVFN------------ 142

Query: 193 FNMSALKEIYLLNNSL-SGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNA--SKLSD 249
             ++ +  + L  N L S  + +     +  +  + +   +      ++I       L++
Sbjct: 143 -GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-----TTIPQGLPPSLTE 196

Query: 250 LELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKS 309
           L L  N  +     +   +                       L  L L+ N +  +   S
Sbjct: 197 LHLDGNKITKVDAASLKGL---------------------NNLAKLGLSFNSISAVDNGS 235

Query: 310 KGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE------PIPITFSQLQ 363
             N    L  + ++N  +   +P  + +   + V+ L  NN++         P   ++  
Sbjct: 236 LANTP-HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293

Query: 364 TLQALGLTRNKL-AGPITDEL-CHLARLHSLVLQGNK 398
           +   + L  N +    I       +    ++ L   K
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 16/137 (11%)

Query: 411 TSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG 470
               +L L  N+ T        NLK+             L  L    N +S   P     
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKN-------------LHTLILINNKISKISPGAFAP 98

Query: 471 LKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           L  L++++L  N+L+  +PE      +L+ L + +N+I+    +    L  +  + L  N
Sbjct: 99  LVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155

Query: 531 KLEGEIPRGGPFANLTA 547
            L+      G F  +  
Sbjct: 156 PLKSSGIENGAFQGMKK 172

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 5/91 (5%)

Query: 456 SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS 515
           S   L   +P  +    +   + L+ N++       F +L +L  L L  NKIS   P +
Sbjct: 39  SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95

Query: 516 LQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
              L+ L+ L LS N+L+ E+P       L 
Sbjct: 96  FAPLVKLERLYLSKNQLK-ELP-EKMPKTLQ 124

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 1e-26
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 625 IGIGSFGSIYVARLQD--------GMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRN 674
           +G G+FG + +A              +VAVK+      E+ L     E E+MK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSL---------------ENCLYSGTCMLDIFQRLNI 719
           ++ ++ +C+ D    +I++Y   G+L                N  ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
              VA  +EYL        IH DL   NVL+ ED V  I+DFG+A+ +   D        
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
              + +MAPE         + DV+S+G++L E+FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  110 bits (277), Expect = 1e-26
 Identities = 55/245 (22%), Positives = 84/245 (34%), Gaps = 18/245 (7%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS--GNIPQVVGNLGNLLVLELGGN 349
              L L  N L  +       L+  L  + + +  +S  G   Q      +L  L+L  N
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 350 NLTEPIPITFSQLQTLQALGLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPSCLG 408
            +   +   F  L+ L+ L    + L           L  L  L +       +      
Sbjct: 89  GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147

Query: 409 NLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITI 468
            L+SL VL +  N F       I+              L  L  L+ S+  L    P   
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFT------------ELRNLTFLDLSQCQLEQLSPTAF 195

Query: 469 GGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY-LKHLNL 527
             L +LQ + + +N         +  L+SL+VLD S N I  +    LQ     L  LNL
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 528 SFNKL 532
           + N  
Sbjct: 256 TQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 3e-23
 Identities = 47/211 (22%), Positives = 77/211 (36%), Gaps = 18/211 (8%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLA--GPITDELCHLARLHSLVLQGN 397
           +   LEL  N L       F +L  L  L L+ N L+  G  +        L  L L  N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 398 KFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSR 457
               ++ S    L  L  L    +        +++             SL  LI L+ S 
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL------------SLRNLIYLDISH 135

Query: 458 NNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIPASL 516
            +          GL +L+ + +  N  + +     F +L +L  LDLS+ ++    P + 
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 517 QKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             L  L+ LN+S N     +    P+  L +
Sbjct: 196 NSLSSLQVLNMSHNNFF-SLDT-FPYKCLNS 224

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 23/247 (9%)

Query: 91  TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQL-FGSLSFFIF-NV 147
           ++P  +   SS   L+L  NKL  ++P  +F  +  L  L  S N L F           
Sbjct: 21  SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNN 206
           +S+  +DLS NG+   M      L  L  L F  +NL  ++  ++F ++  L  + + + 
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSI-TNASKLSDLELGVNLFSGFIPNTF 265
                  + I   L ++E L +  NSF       I T    L+ L+L         P  F
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 266 --------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
                   +NM+ N   S                L+VL  + N +     +   +   SL
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDT-----FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250

Query: 318 EIILMDN 324
             + +  
Sbjct: 251 AFLNLTQ 257

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 8/179 (4%)

Query: 85  SFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFF 143
           SFN   T+      L  L+ LD  H+ L      S+F ++  L  L  S           
Sbjct: 86  SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNG 144

Query: 144 IF-NVSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEI 201
           IF  +SS+  + ++ N        +I   L  L  L  +   L  ++P    ++S+L+ +
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204

Query: 202 YLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSI--TNASKLSDLELGVNLFS 258
            + +N+   SL +     L +++ L+  +N    T          S L+ L L  N F+
Sbjct: 205 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 21/82 (25%), Positives = 44/82 (53%), Gaps = 7/82 (8%)

Query: 81  LNISSFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG 138
           L++S   L+  + P    +LSSLQ L++SHN    ++ +  +  +++L++L +S N +  
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-M 236

Query: 139 SLSFFIFN--VSSVTTIDLSIN 158
           +          SS+  ++L+ N
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQN 258

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  111 bits (279), Expect = 1e-26
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 33/220 (15%)

Query: 625 IGIGSFGSIYVARLQDG------MEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLV 676
           +G G+FG +  A           ++VAVK+  ++      ++   E ++M ++  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCL----------------------YSGTCMLDIF 714
            ++ +C+      LI +Y   G L N L                           +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 715 QRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 774
             L     VA  +E+L F      +H DL   NVL+    V  I DFG+A+ +  +    
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           ++      + +MAPE   +G    + DV+SYGI+L E+F+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (275), Expect = 1e-26
 Identities = 56/245 (22%), Positives = 98/245 (40%), Gaps = 39/245 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F     +G G FG++Y+AR  Q    +A+KV  +              E E+   +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++     +     LI++Y P G++   L   +   +       + ++A AL Y H 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHS 127

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-- 789
                +IH D+KP N+LL       I+DFG +       +       L  T+ Y+ PE  
Sbjct: 128 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TDLCGTLDYLPPEMI 179

Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE---------IFIGELSLNRWIN-- 834
               +  K       D++S G++  E    K P +          I   E +   ++   
Sbjct: 180 EGRMHDEK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233

Query: 835 --DLL 837
             DL+
Sbjct: 234 ARDLI 238

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 1e-26
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 38/232 (16%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH-QQYERALKSFEDECEVMKRI-RHRN 674
           +      ++G GS G++       G  VAVK       + AL     E +++     H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPN 70

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLE------NCLYSGTCMLDIFQRLNIMIDVALALE 728
           +++   S + D F  + ++   N +L+      N       +   +  ++++  +A  + 
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 729 YLHFGHSTPIIHCDLKPSNVLLD-------------EDMVAHISDFGIAKLL-SGEDQLS 774
           +L   HS  IIH DLKP N+L+              E++   ISDFG+ K L SG+    
Sbjct: 130 HL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 775 IQIQTLA-TIGYMAPEY--GTKGRVCTRG-----DVYSYGIMLMEMFTKKKP 818
             +   + T G+ APE    +      R      D++S G +   + +K K 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  109 bits (275), Expect = 1e-26
 Identities = 45/241 (18%), Positives = 87/241 (36%), Gaps = 54/241 (22%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV--FHQQYERALKSFEDECEVMKRI 670
           R T  F E   IG G FGS++      DG   A+K            ++   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 671 -RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF---QRLNIMIDVALA 726
            +H ++V+  S+ + DD   +  +Y   GSL + +     ++  F   +  ++++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDED-------------------MVAHISDFGIAKLL 767
           L Y+H   S  ++H D+KPSN+ +                      ++  I D G    +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 768 SGEDQLSIQIQTLATIG---YMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKK 817
           S               G   ++A E       +  K       D+++  + ++     + 
Sbjct: 185 S---------SPQVEEGDSRFLANEVLQENYTHLPK------ADIFALALTVVCAAGAEP 229

Query: 818 P 818
            
Sbjct: 230 L 230

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (277), Expect = 1e-26
 Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 27/214 (12%)

Query: 625 IGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLV 676
           +G G+FG +  A             VAVK+  +       ++   E +++  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 677 KIISSCSNDDFKA-LIMKYMPNGSL---------------ENCLYSGTCMLDIFQRLNIM 720
            ++ +C+       +I+++   G+L                         L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
             VA  +E+L        IH DL   N+LL E  V  I DFG+A+ +  +     +    
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             + +MAPE         + DV+S+G++L E+F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  110 bits (277), Expect = 2e-26
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQY-ERALKSFEDECEVM 667
           D+ +    +G G+FG + +A             + VAVK+      E+ L     E E+M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSL---------------ENCLYSGTCML 711
           K I +H+N++ ++ +C+ D    +I++Y   G+L                +        +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                ++    +A  +EYL        IH DL   NVL+ E+ V  I+DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                      + +MAPE         + DV+S+G+++ E+FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  110 bits (277), Expect = 2e-26
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 623 NLIGIGSFGSIYVARLQDG---MEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVK 677
           ++IG G+FG +  AR++     M+ A+K   +   +   + F  E EV+ ++  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 678 IISSCSNDDFKALIMKYMPNGSL---------------ENCLYSGTCMLDIFQRLNIMID 722
           ++ +C +  +  L ++Y P+G+L                    S    L   Q L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           VA  ++YL        IH DL   N+L+ E+ VA I+DFG+++   G++    +      
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
           + +MA E        T  DV+SYG++L E+ +
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  111 bits (279), Expect = 2e-26
 Identities = 40/287 (13%), Positives = 89/287 (31%), Gaps = 63/287 (21%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIR-------- 671
           ++G     +   A   + G    V V +        A+K  ++E   ++ +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 672 --------------HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD----- 712
                              K+I    ++    ++ ++     +++ L +   +L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 713 -----IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
                   RL + + V   L  LH      ++H  L+P +++LD+     ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 768 SGEDQLSIQIQTLATIGYMAPEY----------GTKGRVCTRGDVYSYGIMLMEMFTKKK 817
            G   +     +    G+  PE                +    D ++ G+ +  ++    
Sbjct: 262 -GASAV-----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 818 P---TDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG--EERFFAA 859
           P      +   E       N  +P  V  ++    LR   E+R    
Sbjct: 316 PNTDDAALGGSEWIFRSCKN--IPQPVRALL-EGFLRYPKEDRLLPL 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (284), Expect = 4e-26
 Identities = 76/342 (22%), Positives = 132/342 (38%), Gaps = 56/342 (16%)

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
           +    + +  + L+ +LP  +     ++ TL +  N+   ++P+       L  LE+  N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNL-TSLPALPPE---LRTLEVSGN 91

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL 315
             +  +P     +    L+  +  L+ L +L     L  L + GN L   LP     L  
Sbjct: 92  QLT-SLPVLPPGLL--ELSIFSNPLTHLPAL--PSGLCKLWIFGNQLTS-LPVLPPGLQ- 144

Query: 316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
             E+ + DN      +  +      L  L    N LT  +P+  S LQ L    ++ N+L
Sbjct: 145 --ELSVSDN-----QLASLPALPSELCKLWAYNNQLTS-LPMLPSGLQELS---VSDNQL 193

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
           A  +      L +L       N+ + S+P+    L  L V     NR TS LP     LK
Sbjct: 194 AS-LPTLPSELYKLW---AYNNRLT-SLPALPSGLKELIVSG---NRLTS-LPVLPSELK 244

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL 495
           +                L  S N L+  +P+   GL +L    +  N+L   +PES   L
Sbjct: 245 E----------------LMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHL 283

Query: 496 SSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
           SS   ++L  N +S     +L+++      +    + +    
Sbjct: 284 SSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  110 bits (276), Expect = 3e-25
 Identities = 75/390 (19%), Positives = 138/390 (35%), Gaps = 51/390 (13%)

Query: 99  LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN 158
            +    L++  + L+  +P  +     +  L   DN     L+        + T+++S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNN----LTSLPALPPELRTLEVSGN 91

Query: 159 GLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDL 218
            L+  +P     L  L+  +    +L  +        S L ++++  N L+ SLP     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPV---- 138

Query: 219 SLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN-TFVNMADNYLTSST 277
             P ++ L++  N    ++P+  +   KL      +            ++++DN L S  
Sbjct: 139 LPPGLQELSVSDNQL-ASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLP 197

Query: 278 PELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN 337
              S         +L  L    N L   LP     L    E+I+  N      +  +   
Sbjct: 198 TLPS---------ELYKLWAYNNRLTS-LPALPSGLK---ELIVSGN-----RLTSLPVL 239

Query: 338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGN 397
              L  L + GN LT  +P+  S L +L    + RN+L   + + L HL+   ++ L+GN
Sbjct: 240 PSELKELMVSGNRLTS-LPMLPSGLLSLS---VYRNQLTR-LPESLIHLSSETTVNLEGN 294

Query: 398 KFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSR 457
             S      L  +TS    Y G         ++       L +  +   +    G     
Sbjct: 295 PLSERTLQALREITSA-PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 458 NNLSGDIPITIGGLKNLQQMFLEYNRLEGS 487
           +          G   N     L  +RL  +
Sbjct: 354 DRWH-----MFGQEDNADAFSLFLDRLSET 378

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (276), Expect = 5e-26
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 625 IGIGSFGSIYVARLQD--------GMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRN 674
           +G G FG + +A             + VAVK+      E+ L     E E+MK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSL---------------ENCLYSGTCMLDIFQRLNI 719
           ++ ++ +C+ D    +I++Y   G+L                +        +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 720 MIDVALALEYL---HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
              +A  +EYL           IH DL   NVL+ E+ V  I+DFG+A+ ++  D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                 + +MAPE         + DV+S+G+++ E+FT
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (270), Expect = 8e-26
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIR 671
            + F++   IG GSFG ++     +    VA+K+     E A    ED   E  V+ +  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 78

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
              + K   S   D    +IM+Y+  GS  + L  G   LD  Q   I+ ++   L+YLH
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH 136

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMA 787
              S   IH D+K +NVLL E     ++DFG+A       QL+       T +G   +MA
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QLTDTQIKRNTFVGTPFWMA 187

Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE   +    ++ D++S GI  +E+   + P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 9e-26
 Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 39/233 (16%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFH-----------------QQYERALKSFEDECEVM 667
           +  G F  I +   +D    A+K +                     +     F++E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL-------NIM 720
             I++   +      +N D   +I +YM N S+         +   +           I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
             V  +  Y+H   +  I H D+KPSN+L+D++    +SDFG ++ +  +      I+  
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 781 A-TIGYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN 830
             T  +M PE           + D++S GI L  MF    P    F  ++SL 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (268), Expect = 1e-25
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 32/223 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEVMKRIRH 672
           D +    +IG G+   +  A       +VA+K      E+   S ++   E + M +  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLN------IMIDVAL 725
            N+V   +S    D   L+MK +  GS+ + + +           L+      I+ +V  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG- 784
            LEYLH       IH D+K  N+LL ED    I+DFG++  L+    ++        +G 
Sbjct: 133 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 785 --YMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             +MAPE       Y  K       D++S+GI  +E+ T   P
Sbjct: 190 PCWMAPEVMEQVRGYDFK------ADIWSFGITAIELATGAAP 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 5e-25
 Identities = 53/285 (18%), Positives = 95/285 (33%), Gaps = 86/285 (30%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK-VFHQQYERALKSFEDECEVMKRIR 671
           R    F     +G G FG ++ A+   D    A+K +     E A +    E + + ++ 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 672 HRNLVKIISSCSNDDFKAL----------------------------------------- 690
           H  +V+  ++      +                                           
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 691 IMKYMPNGSLENCLY-------SGTCMLDIFQR-----------LNIMIDVALALEYLHF 732
            +  +   S +  LY              + +R           L+I I +A A+E+L  
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL-- 180

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA----------T 782
            HS  ++H DLKPSN+    D V  + DFG+   +  +++    +  +           T
Sbjct: 181 -HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 783 IGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
             YM+PE      Y  K       D++S G++L E+        E
Sbjct: 240 KLYMSPEQIHGNNYSHK------VDIFSLGLILFELLYSFSTQME 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (267), Expect = 6e-25
 Identities = 41/210 (19%), Positives = 79/210 (37%), Gaps = 26/210 (12%)

Query: 626 GIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKIISSC 682
           G     ++ +AR    G  V V+           +   + E  V K   H N+V   ++ 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 683 SNDDFKALIMKYMPNGSLENCL-YSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
             D+   ++  +M  GS ++ +       ++      I+  V  AL+Y+H       +H 
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSIQIQTLATIG---YMAPE------- 789
            +K S++L+  D   ++S       +   G+ Q  +      ++    +++PE       
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            Y  K       D+YS GI   E+     P
Sbjct: 213 GYDAK------SDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (264), Expect = 9e-25
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV---FHQQYERALKSFEDECEVMKRIR 671
              FS+   IG GSFG++Y AR +++   VA+K      +Q     +    E   ++++R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N ++       +    L+M+Y   GS  + L      L   +   +       L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT-IG---YMA 787
              S  +IH D+K  N+LL E  +  + DFG A            +    + +G   +MA
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----------IMAPANSFVGTPYWMA 218

Query: 788 PE---------YGTKGRVCTRGDVYSYGIMLMEM 812
           PE         Y  K       DV+S GI  +E+
Sbjct: 219 PEVILAMDEGQYDGK------VDVWSLGITCIEL 246

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 1e-24
 Identities = 34/230 (14%), Positives = 74/230 (32%), Gaps = 36/230 (15%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR------LQDGMEVAVKVFHQQYERALKSFEDECEVMKR 669
           +     ++L+G G+F  +Y A        ++  +  +KV                E +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL----YSGTCMLDIFQRLNIMIDVAL 725
                 +K  S+    +   L+ +    G+L N +     +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH-----------ISDFGIAKLLSGEDQLS 774
            +E +   H   IIH D+KP N +L    +             + D G +  +    + +
Sbjct: 184 MIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 775 IQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           I      T G+   E      +  +       D +     +  M      
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYM 284

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  106 bits (267), Expect = 2e-24
 Identities = 58/240 (24%), Positives = 91/240 (37%), Gaps = 17/240 (7%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
            + L L  N +  I   +  +L   LE++ +   SI          L +L  LEL  N L
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNL 410
           T      F  L  L+ L L  N +    +     +  L  L L   K    I       L
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195

Query: 411 TSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG 470
            +L+ L LG+          + NL            L  L  L  S N+     P +  G
Sbjct: 196 FNLKYLNLGMCNIKD-----MPNLTP----------LVGLEELEMSGNHFPEIRPGSFHG 240

Query: 471 LKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           L +L+++++  +++      +F  L+SL  L+L+ N +S         L YL  L+L  N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  104 bits (261), Expect = 1e-23
 Identities = 60/229 (26%), Positives = 88/229 (38%), Gaps = 19/229 (8%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF 399
           N   L L  NN+      TF  L  L+ L L RN +          LA L++L L  N  
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 400 SGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN------------S 446
           +  IPS     L+ LR L+L  N   S        +  ++ +D+                
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
           L  L  LN    N+  D+P  +  L  L+++ +  N      P SF  LSSL+ L +  +
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252

Query: 507 KISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG--GPFANLTAKSFMGN 553
           ++S     +   L  L  LNL+ N L   +P     P   L       N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 58/277 (20%), Positives = 99/277 (35%), Gaps = 33/277 (11%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING 159
           +    +  +   LS  +P  I      + L   +N +                I      
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNI--------------QMIQ----- 91

Query: 160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLS 219
                     +L +L  L    N++  +       +++L  + L +N L+  +PS     
Sbjct: 92  -----ADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEY 145

Query: 220 LPNVETLNLGINSFYGTVPSSI-TNASKLSDLELG-VNLFSGFIPNTFVNMAD-NYLTSS 276
           L  +  L L  N    ++PS        L  L+LG +          F  + +  YL   
Sbjct: 146 LSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG 336
              +  + +LT    L+ L ++GN    I P S   LS SL+ + + N  +S        
Sbjct: 205 MCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLS-SLKKLWVMNSQVSLIERNAFD 263

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
            L +L+ L L  NNL+      F+ L+ L  L L  N
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.0 bits (208), Expect = 5e-17
 Identities = 53/261 (20%), Positives = 91/261 (34%), Gaps = 19/261 (7%)

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
           +   ++      LS  +P  I     N   LNL  N+       +  +   L  L+LG N
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 256 LFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP 307
                    F  +         DN+LT           L+    L+ L L  NP++ I  
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSK---LRELWLRNNPIESIPS 164

Query: 308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQA 367
            +   +   + + L +   +          L NL  L LG  N+ + +P   + L  L+ 
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEE 222

Query: 368 LGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL 427
           L ++ N            L+ L  L +  ++ S    +    L SL  L L  N  +S  
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282

Query: 428 PSTIWNLKDILFIDVSSNSLN 448
                 L+ ++ + +  N  N
Sbjct: 283 HDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 83.3 bits (206), Expect = 8e-17
 Identities = 49/269 (18%), Positives = 82/269 (30%), Gaps = 51/269 (18%)

Query: 85  SFNLQGTIPP-QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSF 142
             N    I      +L  L+ L L  N +   I    F  + +L  L   DN L      
Sbjct: 83  MENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL------ 135

Query: 143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIY 202
                   T I                 L  L  L    N +  +       + +L  + 
Sbjct: 136 --------TVIP----------SGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
           L        +       L N++ LNLG+ +       ++T    L +LE+  N F    P
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFPEIRP 235

Query: 263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILM 322
            +F  +                       LK L +  + +  I   +   L+ SL  + +
Sbjct: 236 GSFHGL---------------------SSLKKLWVMNSQVSLIERNAFDGLA-SLVELNL 273

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNL 351
            + ++S     +   L  L+ L L  N  
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 6/95 (6%)

Query: 94  PQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NVSSVT 151
           P L  L  L+ L++S N     I    F  + +LK L+  ++Q+   +    F  ++S+ 
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLV 269

Query: 152 TIDLSINGLSGEMPREI-GNLPYLARLAFATNNLV 185
            ++L+ N LS  +P ++   L YL  L    N   
Sbjct: 270 ELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  103 bits (259), Expect = 2e-24
 Identities = 52/232 (22%), Positives = 106/232 (45%), Gaps = 32/232 (13%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQ---QYERALKSFEDECEVMKRIRHRNLVKII 679
           L+G GSF  +Y A  +  G+EVA+K+  +        ++  ++E ++  +++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
           +   + ++  L+++   NG +   L +        +  + M  +   + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE------YGT 792
           H DL  SN+LL  +M   I+DFG+A  L    +      TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTPNYISPEIATRSAHGL 191

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKPTDE---------IFIGELSLNRWIND 835
           +       DV+S G M   +   + P D          + + +  +  +++ 
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 39/245 (15%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           D F     +G G FG++Y+AR  Q+   +A+KV  +     E        E E+   +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++ +   +     L++++ P G L   L       +       M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHE 132

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPE-- 789
                +IH D+KP N+L+       I+DFG +       +     +T+  T+ Y+ PE  
Sbjct: 133 RK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-----RTMCGTLDYLPPEMI 184

Query: 790 ----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE---------IFIGELSLNRWIN-- 834
               +  K       D++  G++  E      P D          I   +L    +++  
Sbjct: 185 EGKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 238

Query: 835 --DLL 837
             DL+
Sbjct: 239 SKDLI 243

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 5e-24
 Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 39/235 (16%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
            +G G F   +           A K+  +         +    E  + + + H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPII 739
               ++DF  ++++     SL         + +   R   +  + L  +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI-G---YMAPE------ 789
           H DLK  N+ L+ED+   I DFG+A  +  + +          + G   Y+APE      
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTPNYIAPEVLSKKG 191

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE---------IFIGELSLNRWIND 835
           +  +       DV+S G ++  +   K P +          I   E S+ + IN 
Sbjct: 192 HSFE------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (262), Expect = 6e-24
 Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 19/229 (8%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF 399
           N  +L L  N +      +F  L+ L+ L L+RN +          LA L++L L  N+ 
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 400 SGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN------------S 446
           + +IP+     L+ L+ L+L  N   S        +  +  +D+                
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
           L+ L  LN +  NL  +IP  +  L  L ++ L  N L    P SF  L  L+ L + ++
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 507 KISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG--GPFANLTAKSFMGN 553
           +I      +   L  L  +NL+ N L   +P     P  +L       N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 58/277 (20%), Positives = 102/277 (36%), Gaps = 33/277 (11%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING 159
           +    +      L   +P  I                           ++   ++L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--------------------------TNTRLLNLHENQ 75

Query: 160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLS 219
           +         +L +L  L  + N++  +       ++ L  + L +N L+ ++P+   + 
Sbjct: 76  IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVY 134

Query: 220 LPNVETLNLGINSFYGTVPSSI-TNASKLSDLELG-VNLFSGFIPNTFVNMAD-NYLTSS 276
           L  ++ L L  N    ++PS        L  L+LG +   S      F  +++  YL  +
Sbjct: 135 LSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG 336
              L  + +LT   KL  L L+GN L  I P S   L   L+ + M    I         
Sbjct: 194 MCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLM-HLQKLWMIQSQIQVIERNAFD 252

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
           NL +L+ + L  NNLT      F+ L  L+ + L  N
Sbjct: 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 5e-17
 Identities = 58/261 (22%), Positives = 87/261 (33%), Gaps = 19/261 (7%)

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
           +   ++  +  +L   +P  I     N   LNL  N       +S  +   L  L+L  N
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 256 LFSGFIPNTFVNM--------ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILP 307
                    F  +         DN LT+          L+    LK L L  NP++ I  
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGA--FVYLSK---LKELWLRNNPIESIPS 153

Query: 308 KSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQA 367
            +   +     + L +   +S         L NL  L L   NL E IP   + L  L  
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDE 211

Query: 368 LGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL 427
           L L+ N L+         L  L  L +  ++      +   NL SL  + L  N  T   
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271

Query: 428 PSTIWNLKDILFIDVSSNSLN 448
                 L  +  I +  N  N
Sbjct: 272 HDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 50/231 (21%), Positives = 82/231 (35%), Gaps = 22/231 (9%)

Query: 85  SFNLQGTIPP-QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSF 142
             N    I      +L  L+ L LS N +   I    F  +  L  L   DN+L  ++  
Sbjct: 72  HENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL-TTIPN 129

Query: 143 FIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKE 200
             F  +S +  + L  N +          +P L RL       +       F  +S L+ 
Sbjct: 130 GAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY 189

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGF 260
           + L   +L   +P+     L  ++ L+L  N      P S      L  L +  +     
Sbjct: 190 LNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246

Query: 261 IPNTF--------VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
             N F        +N+A N LT    +L   + L +   L+ + L  NP +
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDL--FTPLHH---LERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 26/143 (18%), Positives = 53/143 (37%), Gaps = 21/143 (14%)

Query: 405 SCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDI 464
           SC    + +  +   L      + +    L      ++  N + ++   +F         
Sbjct: 40  SCSNQFSKVICVRKNLREVPDGISTNTRLL------NLHENQIQIIKVNSFK-------- 85

Query: 465 PITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKH 524
                 L++L+ + L  N +      +F  L++L  L+L  N+++     +   L  LK 
Sbjct: 86  -----HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKE 140

Query: 525 LNLSFNKLEGEIPRGGPFANLTA 547
           L L  N +E  IP    F  + +
Sbjct: 141 LWLRNNPIE-SIPSYA-FNRIPS 161

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (256), Expect = 9e-24
 Identities = 46/246 (18%), Positives = 89/246 (36%), Gaps = 42/246 (17%)

Query: 587 WKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVA 645
                    + +  P++ RR+      R          +G G F   +           A
Sbjct: 23  AAPPAKEIPEVLVDPRSRRRY---VRGR---------FLGKGGFAKCFEISDADTKEVFA 70

Query: 646 VKVFHQ---QYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLEN 702
            K+  +         +    E  + + + H+++V       ++DF  ++++     SL  
Sbjct: 71  GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 130

Query: 703 CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG 762
                  + +   R   +  + L  +YLH      +IH DLK  N+ L+ED+   I DFG
Sbjct: 131 LHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFG 186

Query: 763 IAKLLSGEDQLSIQIQTLATI-G---YMAPE------YGTKGRVCTRGDVYSYGIMLMEM 812
           +A  +  + +          + G   Y+APE      +  +       DV+S G ++  +
Sbjct: 187 LATKVEYDGER------KKVLCGTPNYIAPEVLSKKGHSFE------VDVWSIGCIMYTL 234

Query: 813 FTKKKP 818
              K P
Sbjct: 235 LVGKPP 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (255), Expect = 9e-24
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 50/217 (23%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
              F    ++G G+F  +++ +    G   A+K   +       S E+E  V+K+I+H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIMID 722
           +V +     +     L+M+ +  G L             F R+             ++  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQ 114

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           V  A++YL   H   I+H DLKP N+L    +E+    I+DFG++K+          + T
Sbjct: 115 VLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMST 166

Query: 780 LA-TIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
              T GY+APE      Y          D +S G++ 
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (261), Expect = 1e-23
 Identities = 69/455 (15%), Positives = 147/455 (32%), Gaps = 79/455 (17%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
              ++F +Q T       L++L +LD  ++ ++    + I  +  L  L  + N +    
Sbjct: 23  EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI---T 77

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
           +  +   +++T +    N L+     ++  L  L  L   TN L     + +     L  
Sbjct: 78  TLDLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTY 131

Query: 201 IYLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
           +    N+L     + ID+S    +  L+  +N         +T  ++L+ L+   N  + 
Sbjct: 132 LNCARNTL-----TEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITE 184

Query: 260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI 319
                                     ++  K L  L    N +  +           L  
Sbjct: 185 L------------------------DVSQNKLLNRLNCDTNNITKL---DLNQNI-QLTF 216

Query: 320 ILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPI 379
           +   +  ++  I   V  L  L   +   N LTE   +  S L  L  L   +  L   +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDL---L 267

Query: 380 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF 439
             +L H  +L     +G +    +   + + T L +L       T               
Sbjct: 268 EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE-------------- 311

Query: 440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE 499
           +D+S N    L+ L  +   L+ ++   +     L+ +      ++       G + +L 
Sbjct: 312 LDLSQNPK--LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALN 364

Query: 500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG 534
               ++ +       +L        ++       G
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  100 bits (250), Expect = 2e-22
 Identities = 68/457 (14%), Positives = 148/457 (32%), Gaps = 56/457 (12%)

Query: 126 LKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLV 185
                 +  ++  + +     ++++T++D   + ++      I  L  L +L   +NN+ 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 186 GVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFYGTVPSSITNA 244
               + +   + L  +   +N L     + +D++ L  +  LN   N         ++  
Sbjct: 78  T---LDLSQNTNLTYLACDSNKL-----TNLDVTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 245 SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG 304
             L+ L    N  +    +    +    L     +      +T   +L  L  + N +  
Sbjct: 127 PLLTYLNCARNTLTEIDVSHNTQL--TELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE 184

Query: 305 ILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQT 364
           +           L  +  D  +I+  +   +     L  L+   N LTE   I  + L  
Sbjct: 185 L---DVSQNK-LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQ 234

Query: 365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT 424
           L     + N L      ++  L++L +L          I   L + T L           
Sbjct: 235 LTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE----- 283

Query: 425 SALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRL 484
                     + I  +DV+ N+   L  L+     ++    + +     L  ++L    L
Sbjct: 284 --------GCRKIKELDVTHNTQ--LYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL 330

Query: 485 EGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFAN 544
              +       + L+ L      I      S+ K+  L +   +  +    +P+     N
Sbjct: 331 T-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNN 384

Query: 545 LTAKSFMGNELLKMLLLVIILPLSTALIVVVTLTLKW 581
               +   + L +    + I P    +    T T+ W
Sbjct: 385 SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITW 421

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 23/178 (12%), Positives = 58/178 (32%), Gaps = 19/178 (10%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           +   +   +      + + + L  LD     ++  +   +     L  LY ++ +L    
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL---T 331

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
              + + + + ++      +  +    +G +P L     A                 + +
Sbjct: 332 ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT-----------ITMPK 378

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS 258
             L NNSL+ ++   +     N   +  G    Y    ++IT  +  +D       F+
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFT 436

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (251), Expect = 2e-23
 Identities = 55/221 (24%), Positives = 81/221 (36%), Gaps = 16/221 (7%)

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
            +  + + I +    IS           NL +L L  N L       F+ L  L+ L L+
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 372 RNKLAGPITDE-LCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPS 429
            N     +       L RLH+L L        +       L +L+ LYL  N   + LP 
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPD 146

Query: 430 TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
             +              L  L  L    N +S        GL +L ++ L  NR+    P
Sbjct: 147 DTFR------------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 490 ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
            +F DL  L  L L  N +S     +L  L  L++L L+ N
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 57/224 (25%), Positives = 83/224 (37%), Gaps = 24/224 (10%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
           ++   IP           + L GN ++     +F   + L  L L  N LA         
Sbjct: 25  AVPVGIPA------ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78

Query: 386 LARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
           LA L  L L  N    S+       L  L  L+L         P     L  + ++ +  
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDL 503
           N+L  L    F               L NL  +FL  NR+  S+PE +F  L SL+ L L
Sbjct: 139 NALQALPDDTFR-------------DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLL 184

Query: 504 SKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
            +N+++   P + + L  L  L L  N L   +P     A L A
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA-LAPLRA 226

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 19/215 (8%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSI 157
           ++ Q + L  N++S ++P++ F     L +L+   N L   +    F  ++ +  +DLS 
Sbjct: 32  AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89

Query: 158 NGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
           N     +       L  L  L      L  + P     ++AL+ +YL +N+L  +LP   
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 217 DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM-------- 268
              L N+  L L  N        +      L  L L  N  +   P+ F ++        
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
             N L++   E      L   + L+ L L  NP  
Sbjct: 209 FANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 49/247 (19%), Positives = 84/247 (34%), Gaps = 31/247 (12%)

Query: 205 NNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNT 264
              L  ++P  I       + + L  N       +S      L+ L L  N+ +      
Sbjct: 20  QQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 265 FVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNP-LDGILPKSKGNLSLSLEIILMD 323
           F  +                       L+ L L+ N  L  + P +   L   L  + +D
Sbjct: 76  FTGL---------------------ALLEQLDLSDNAQLRSVDPATFHGLG-RLHTLHLD 113

Query: 324 NCSISGNIPQVV-GNLGNLLVLELGGNNLTEPIPI-TFSQLQTLQALGLTRNKLAGPITD 381
            C +   +   +   L  L  L L  N L   +P  TF  L  L  L L  N+++     
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPER 171

Query: 382 ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFID 441
               L  L  L+L  N+ +   P    +L  L  LYL  N  ++     +  L+ + ++ 
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231

Query: 442 VSSNSLN 448
           ++ N   
Sbjct: 232 LNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 22/226 (9%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
           ++   I L  N +S            L  L   +N L  +       ++ L+++ L +N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
              S+       L  + TL+L                  L +L  G+  F G     ++ 
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRC--------------GLQELGPGL--FRGLAALQYLY 135

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSI 327
           + DN L +   +        +   L  L L GN +  +  ++   L  SL+ +L+    +
Sbjct: 136 LQDNALQALPDDT-----FRDLGNLTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRV 189

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
           +   P    +LG L+ L L  NNL+       + L+ LQ L L  N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 5/98 (5%)

Query: 91  TIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NV 147
            +P     +L +L  L L  N++S ++P   F  +H+L  L    N++   +    F ++
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV-AHVHPHAFRDL 200

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLV 185
             + T+ L  N LS      +  L  L  L    N  V
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  103 bits (259), Expect = 3e-23
 Identities = 57/264 (21%), Positives = 101/264 (38%), Gaps = 56/264 (21%)

Query: 588 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAV 646
           +       D   +P          L   ++ +     +G G++G + + R     +E A+
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 647 KVF--HQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           K+         +     +E  V+K + H N++K+     +     L+M+    G L    
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---- 123

Query: 705 YSGTCMLDIFQRL------------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-- 750
                    F  +             I+  V   + YLH  +   I+H DLKP N+LL  
Sbjct: 124 ---------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLES 171

Query: 751 -DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-----YGTKGRVCTRGDVYS 804
            ++D +  I DFG++ +   + ++    + L T  Y+APE     Y  K   C   DV+S
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPEVLRKKYDEK---C---DVWS 222

Query: 805 YGIMLMEMFTKKKP-----TDEIF 823
            G++L  +     P       EI 
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEIL 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  100 bits (251), Expect = 3e-23
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 52/209 (24%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSC 682
           +G GSF         +     AVK+  +   R   + + E   +K    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIMIDVALALEYL 730
            +     L+M+ +  G L             F+R+             IM  +  A+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 731 HFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYM 786
           H      ++H DLKP N+L    ++++   I DFG A+L   ++Q    ++T   T+ Y 
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP---LKTPCFTLHYA 176

Query: 787 APE------YGTKGRVCTRGDVYSYGIML 809
           APE      Y      C   D++S G++L
Sbjct: 177 APELLNQNGYDES---C---DLWSLGVIL 199

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (250), Expect = 4e-23
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 46/203 (22%)

Query: 614 RATDRFSEN----NLIGIGSFGSIYVAR-LQDGMEVAVKVF---------HQQYERALKS 659
            +T  F EN     ++G G    +          E AVK+           ++ +   ++
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 660 FEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL- 717
              E ++++++  H N++++  +   + F  L+   M  G L             F  L 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116

Query: 718 -----------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
                       IM  +   +  LH  +   I+H DLKP N+LLD+DM   ++DFG +  
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 767 LSGEDQLSIQIQTLATIGYMAPE 789
           L   ++L    +   T  Y+APE
Sbjct: 174 LDPGEKLR---EVCGTPSYLAPE 193

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =   99 bits (249), Expect = 9e-23
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRN 674
           D F + + +G G+ G ++       G+ +A K+ H +           E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V    +  +D   ++ M++M  GSL+  +      +       + I V   L YL   H
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-----TIGYMAPE 789
              I+H D+KPSN+L++      + DFG++  L         I ++A     T  YM+PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------IDSMANSFVGTRSYMSPE 200

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    + D++S G+ L+EM   + P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 9e-23
 Identities = 27/233 (11%), Positives = 62/233 (26%), Gaps = 47/233 (20%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKII 679
            + +G    +++ R ++   + A+KVF          L+   +      R+   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 680 SSC----------------------SNDDFKA----LIMKYM-----PNGSLENCLYSGT 708
                                      DD+      L+M           S  + +Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 709 CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
               I     +   +      L    S  ++H    P N+ +  D    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG---DVYSYGIMLMEMFTKKKP 818
              ++  +    +     AP         T     + +  G+ +  ++    P
Sbjct: 243 ---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 46/215 (21%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
              ++  N IG GS+G + +A      +  A K   + +   +  F+ E E+MK + H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIMID 722
           ++++  +  ++    L+M+    G L             F+R+             IM D
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKD 114

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           V  A+ Y H  +   + H DLKP N L      D    + DFG+A        +      
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TK 168

Query: 780 LATIGYMAPE-----YGTKGRVCTRGDVYSYGIML 809
           + T  Y++P+     YG +   C   D +S G+M+
Sbjct: 169 VGTPYYVSPQVLEGLYGPE---C---DEWSAGVMM 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 48/217 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRH 672
            +R++   ++G GSFG +   +      E AVKV +      +   +   E E++K++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIM 720
            N++K+     +     ++ +    G L             F  +             I+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARII 127

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQI 777
             V   + Y+   H   I+H DLKP N+LL   ++D    I DFG++       ++    
Sbjct: 128 KQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--- 181

Query: 778 QTLATIGYMAPE-----YGTKGRVCTRGDVYSYGIML 809
             + T  Y+APE     Y  K   C   DV+S G++L
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEK---C---DVWSAGVIL 212

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 23/236 (9%)

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
            +S    ++ + N  IS         L +L  L L  N +++     FS L+ LQ L ++
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
           +N L   I   L   + L  L +  N+           L ++  + +G N   ++     
Sbjct: 111 KNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS----- 162

Query: 432 WNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE- 490
              +   F  +       L  L  S   L+G   I     + L ++ L++N+++ +I   
Sbjct: 163 -GFEPGAFDGLK------LNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELE 211

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
                S L  L L  N+I      SL  L  L+ L+L  NKL   +P G    +L 
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG--LPDLK 264

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 52/291 (17%), Positives = 104/291 (35%), Gaps = 35/291 (12%)

Query: 264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMD 323
           T +++ +N ++               + L  L+L  N +  I  K+   L   L+ + + 
Sbjct: 57  TLLDLQNNDISELRK-----DDFKGLQHLYALVLVNNKISKIHEKAFSPLR-KLQKLYIS 110

Query: 324 NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLA-GPITDE 382
              +   IP       +L+ L +  N + +     FS L+ +  + +  N L        
Sbjct: 111 KNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDV 442
                +L+ L +   K +  IP       +L  L+L  N+        I  ++       
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK--------IQAIELEDL--- 213

Query: 443 SSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD 502
                + L  L    N +      ++  L  L+++ L+ N+L   +P    DL  L+V+ 
Sbjct: 214 --LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270

Query: 503 LSKNKISGAIPAS-------LQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           L  N I+  +  +         K  Y   ++L  N +     +   F  +T
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 62/361 (17%), Positives = 113/361 (31%), Gaps = 65/361 (18%)

Query: 149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSL 208
            +  +  S  GL   +P+EI   P    L    N++  +       +  L  + L+NN +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 209 SGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM 268
           S  +  +    L  ++ L +  N     +P ++   S L +L +  N         F  +
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146

Query: 269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS 328
                                + +  + + GNPL+    +      L L  + +    ++
Sbjct: 147 ---------------------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

Query: 329 GNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR 388
             IP+       L  L L  N +         +   L  LGL  N++       L  L  
Sbjct: 186 -GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN 448
           L  L L  NK S  +P+ L +L  L+V+YL  N  T    +    +   +          
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV---------- 291

Query: 449 VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSI--PESFGDLSSLEVLDLSKN 506
                                       + L  N +      P +F  ++    +     
Sbjct: 292 ---------------------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

Query: 507 K 507
           K
Sbjct: 331 K 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 60/352 (17%), Positives = 98/352 (27%), Gaps = 80/352 (22%)

Query: 79  IGLNISSFNLQG----TIPP-QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFS 132
           I  + +  +LQ      +       L  L  L L +NK+S  I    F  +  L+ LY S
Sbjct: 52  ISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYIS 110

Query: 133 DNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTI 192
            N L                I  ++                L  L    N +  V     
Sbjct: 111 KNHL--------------VEIPPNL-------------PSSLVELRIHDNRIRKVPKGVF 143

Query: 193 FNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL 252
             +  +  I +  N L  S           +  L +        +P  +     L++L L
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDLP--ETLNELHL 200

Query: 253 GVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN 312
             N                                   KL  L L  N +  I   S   
Sbjct: 201 DHNKIQAIELEDL---------------------LRYSKLYRLGLGHNQIRMIENGSLSF 239

Query: 313 LSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTR 372
           L  +L  + +DN  +S  +P  + +L  L V+ L  NN+T+     F  +          
Sbjct: 240 LP-TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV------ 291

Query: 373 NKLAGPITDELCHLARLHSLVLQGNKFSGSI--PSCLGNLTSLRVLYLGLNR 422
                         A  + + L  N        P+    +T    +  G  +
Sbjct: 292 ------------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 25/91 (27%), Positives = 36/91 (39%), Gaps = 5/91 (5%)

Query: 456 SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS 515
           S   L   +P  I    +   + L+ N +     + F  L  L  L L  NKIS     +
Sbjct: 41  SDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97

Query: 516 LQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
              L  L+ L +S N L  EIP     ++L 
Sbjct: 98  FSPLRKLQKLYISKNHLV-EIPPNL-PSSLV 126

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 2e-22
 Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 60/264 (22%)

Query: 592 GPS---NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK 647
           GP    +    +P    + S       +DR+    ++G GSFG + + +    G E AVK
Sbjct: 1   GPGSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK 57

Query: 648 VF---HQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           V      + +   +S   E +++K++ H N++K+     +  +  L+ +    G L    
Sbjct: 58  VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---- 113

Query: 705 YSGTCMLDIFQRL------------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-- 750
                    F  +             I+  V   + Y+H      I+H DLKP N+LL  
Sbjct: 114 ---------FDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLES 161

Query: 751 -DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-----YGTKGRVCTRGDVYS 804
             +D    I DFG++       ++      + T  Y+APE     Y  K   C   DV+S
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHGTYDEK---C---DVWS 212

Query: 805 YGIMLMEMFTKKKP-----TDEIF 823
            G++L  + +   P       +I 
Sbjct: 213 TGVILYILLSGCPPFNGANEYDIL 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 65/261 (24%)

Query: 588 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSEN----NLIGIGSFGSIYVAR-LQDGM 642
            +   P        Q++          A   F +     ++IG G    +        G 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 643 EVAVKVF--------HQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMK 693
           E AVK+          +Q E   ++   E  +++++  H +++ +I S  +  F  L+  
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 694 YMPNGSLENCLYSGTCMLDIFQRL------------NIMIDVALALEYLHFGHSTPIIHC 741
            M  G L             F  L            +IM  +  A+ +LH  +   I+H 
Sbjct: 181 LMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHR 224

Query: 742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE----------- 789
           DLKP N+LLD++M   +SDFG +  L   ++L      L  T GY+APE           
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR----ELCGTPGYLAPEILKCSMDETHP 280

Query: 790 -YGTKGRVCTRGDVYSYGIML 809
            YG +       D+++ G++L
Sbjct: 281 GYGKE---V---DLWACGVIL 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 58/228 (25%)

Query: 611 ELLRATDRFSEN----NLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECE 665
           +L R + +F++       IG+GS+            ME AVK+     +++ +   +E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIE 67

Query: 666 VMKR-IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------- 717
           ++ R  +H N++ +     +  +  ++ + M  G L               ++       
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFS 114

Query: 718 -----NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLS 768
                 ++  +   +EYLH   +  ++H DLKPSN+L            I DFG AK L 
Sbjct: 115 EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 769 GEDQLSIQIQTLA-TIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
            E+ L   + T   T  ++APE      Y      C   D++S G++L
Sbjct: 172 AENGL---LMTPCYTANFVAPEVLERQGYDAA---C---DIWSLGVLL 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 64/237 (27%)

Query: 615 ATDRFSEN---------NLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDEC 664
           +TD FS           +++G G+   +     L    E AVK+  +Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 665 EVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------ 717
           E++ + + HRN++++I     +D   L+ + M  GS+                +      
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108

Query: 718 ------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLS 768
                  ++ DVA AL++LH   +  I H DLKP N+L    ++     I DF +   + 
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 769 -GEDQLSIQIQTLATI----GYMAPE-----------YGTKGRVCTRGDVYSYGIML 809
              D   I    L T      YMAPE           Y  +   C   D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR---C---DLWSLGVIL 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 52/246 (21%), Positives = 102/246 (41%), Gaps = 54/246 (21%)

Query: 592 GPSNDGINSPQAIRRFSYHELLRATDRFSEN----NLIGIGSFGSIYVAR-LQDGMEVAV 646
           GP    +   Q + R S   ++ A+ +FS+N      +G G+F  +        G+E A 
Sbjct: 1   GPHMASMTGGQQMGRGS-EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59

Query: 647 KVFH--QQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCL 704
           K+ +  +   R  +  E E  + ++++H N+V++  S   + F  L+   +  G L    
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---- 115

Query: 705 YSGTCMLDIFQRL------------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-- 750
                    F+ +            + +  +  ++ Y    HS  I+H +LKP N+LL  
Sbjct: 116 ---------FEDIVAREFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLAS 163

Query: 751 -DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YGTKGRVCTRGDVY 803
             +     ++DFG+A  ++  +          T GY++PE      Y          D++
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKP------VDIW 214

Query: 804 SYGIML 809
           + G++L
Sbjct: 215 ACGVIL 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 2e-22
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 48/217 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRH 672
            +R++   ++G GSFG +   +      E AVKV        +   +   E E++K++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIM 720
            N++K+     +     ++ +    G L             F  +             I+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARII 127

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQI 777
             V   + Y+H  +   I+H DLKP N+LL   ++D    I DFG++       ++    
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--- 181

Query: 778 QTLATIGYMAPE-----YGTKGRVCTRGDVYSYGIML 809
             + T  Y+APE     Y  K   C   DV+S G++L
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEK---C---DVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  100 bits (251), Expect = 3e-22
 Identities = 53/245 (21%), Positives = 101/245 (41%), Gaps = 63/245 (25%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-------------FHQQYERALKSFE 661
            + + +   +G G++G + + +      E A+KV              ++  E+  +   
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 662 DECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---- 717
           +E  ++K + H N++K+     +  +  L+ ++   G L             F+++    
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRH 141

Query: 718 --------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKL 766
                   NIM  +   + YLH  +   I+H D+KP N+LL   +  +   I DFG++  
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 767 LSGEDQLSIQIQTLATIGYMAPE-----YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE 821
            S + +L      L T  Y+APE     Y  K   C   DV+S G+++  +     P   
Sbjct: 199 FSKDYKLR---DRLGTAYYIAPEVLKKKYNEK---C---DVWSCGVIMYILLCGYPP--- 246

Query: 822 IFIGE 826
            F G+
Sbjct: 247 -FGGQ 250

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.1 bits (245), Expect = 4e-22
 Identities = 49/222 (22%), Positives = 85/222 (38%), Gaps = 49/222 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV-----FHQQYERALKSFEDECEVMKR 669
            D +    +IG G F  +      + G + AVK+     F      + +  + E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSL---------ENCLYS----GTCMLDIFQR 716
           ++H ++V+++ + S+D    ++ ++M    L            +YS       M  I + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 773
                    AL Y    H   IIH D+KP  VLL   +      +  FG+A  L     +
Sbjct: 142 ---------ALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189

Query: 774 SIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
           +     + T  +MAPE      YG         DV+  G++L
Sbjct: 190 AGGR--VGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.7 bits (249), Expect = 4e-22
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 50/219 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRH 672
           T+ +     +G G+F  +     +  G E A  +    +   R  +  E E  + + ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIM 720
            N+V++  S S +    LI   +  G L             F+ +            + +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCI 116

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQI 777
             +  A+ +    H   ++H +LKP N+LL    +     ++DFG+A  + GE Q     
Sbjct: 117 QQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---W 170

Query: 778 QTLA-TIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
              A T GY++PE      YG         D+++ G++L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.5 bits (246), Expect = 4e-22
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 25/216 (11%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEV 666
           E+LRA         IG GSFG + + +  D  ++ A+K  ++Q             E ++
Sbjct: 18  EILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68

Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           M+ + H  LV +  S  +++   +++  +  G L   L       +   +L I  ++ +A
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMA 127

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGY 785
           L+YL    +  IIH D+KP N+LLDE    HI+DF IA +L  E Q++    T+A T  Y
Sbjct: 128 LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT----TMAGTKPY 180

Query: 786 MAPE--YGTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           MAPE     KG   +   D +S G+   E+   ++P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.9 bits (242), Expect = 5e-22
 Identities = 63/241 (26%), Positives = 100/241 (41%), Gaps = 35/241 (14%)

Query: 591 TGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVF 649
                 G  S Q  +        R  D F    ++G GSF ++ +AR      E A+K+ 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKIL 63

Query: 650 HQQYERALKSFE---DECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
            +++            E +VM R+ H   VK+  +  +D+     + Y  NG L      
Sbjct: 64  EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL------ 117

Query: 707 GTCMLDIFQRLN----IMIDVA--------LALEYLHFGHSTPIIHCDLKPSNVLLDEDM 754
                   + +                    ALEYLH      IIH DLKP N+LL+EDM
Sbjct: 118 -------LKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDM 167

Query: 755 VAHISDFGIAKLLSGEDQLSIQIQTL-ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMF 813
              I+DFG AK+LS E +   +  +   T  Y++PE  T+   C   D+++ G ++ ++ 
Sbjct: 168 HIQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

Query: 814 T 814
            
Sbjct: 227 A 227

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 44/218 (20%), Positives = 89/218 (40%), Gaps = 49/218 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRH 672
           +D +     +G G+F  +        G+E A K+ +  +   R  +  E E  + ++++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIM 720
            N+V++  S   + F  L+   +  G L             F+ +            + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCI 111

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQI 777
             +  ++ Y    HS  I+H +LKP N+LL    +     ++DFG+A  ++  +      
Sbjct: 112 QQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165

Query: 778 QTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
               T GY++PE      Y          D+++ G++L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKP---V---DIWACGVIL 197

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.4 bits (242), Expect = 9e-22
 Identities = 37/278 (13%), Positives = 88/278 (31%), Gaps = 62/278 (22%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFH---QQYERALKSFEDECEVMKRIR-------- 671
           ++G     +   A   + G    V V +   +    A+K  ++E   ++ +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 672 -----------------HRNLVKIISSCSNDDFKALIMKYM-PNGSLENCL------YSG 707
                             + ++++     +    +    Y     +L+          S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 708 TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 767
              L    RL + + V   L  LH      ++H  L+P +++LD+     ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 768 SGEDQLSIQIQTLATIGYMAPEY-----------GTKGRVCTRGDVYSYGIMLMEMFTKK 816
               +   ++ +  + G+  PE              +  +    D ++ G+++  ++   
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 817 KP---TDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR 851
            P      +   E       N  +P  V  ++    LR
Sbjct: 311 LPITKDAALGGSEWIFRSCKN--IPQPVRALL-EGFLR 345

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 99.3 bits (247), Expect = 1e-21
 Identities = 50/283 (17%), Positives = 97/283 (34%), Gaps = 37/283 (13%)

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS 326
           N   N ++ +  +       +   K +   L G   +  +   K  L      + ++  +
Sbjct: 16  NSFYNTISGTYADY-----FSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLN 70

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
           +S ++P  +     + VLE+  N L   +P   + L+ L       N+L+  + +    L
Sbjct: 71  LS-SLPDNLPP--QITVLEITQNALIS-LPELPASLEYLD---ACDNRLST-LPELPASL 122

Query: 387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS 446
             L    +  N+ +  +P     L  +       N+ T  LP    +L+ +    V +N 
Sbjct: 123 KHLD---VDNNQLT-MLPELPALLEYI---NADNNQLTM-LPELPTSLEVL---SVRNNQ 171

Query: 447 LNV-------LIGLNFSRNNLSGDIPITIGGLKNLQQMF----LEYNRLEGSIPESFGDL 495
           L         L  L+ S N L   +P       + ++         NR+   IPE+   L
Sbjct: 172 LTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229

Query: 496 SSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPR 538
                + L  N +S  I  SL +       +           +
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 83.1 bits (205), Expect = 1e-16
 Identities = 65/479 (13%), Positives = 135/479 (28%), Gaps = 114/479 (23%)

Query: 91  TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF----NMHTLKLLYFSDNQLFGSLSFFIFN 146
           +I   + N  SL + +  +N +S    +  F          L   + N+    L   + N
Sbjct: 2   SIMLPINNNFSL-SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59

Query: 147 VSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNN 206
               + + L+   LS  +P  +                             +  + +  N
Sbjct: 60  --QFSELQLNRLNLS-SLPDNLP--------------------------PQITVLEITQN 90

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFV 266
           +L  SLP        ++E L+   N    T+P    +   L                   
Sbjct: 91  ALI-SLPE----LPASLEYLDACDNRL-STLPELPASLKHL------------------- 125

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS 326
           ++ +N LT      +          L+ +    N L   LP+                  
Sbjct: 126 DVDNNQLTMLPELPA---------LLEYINADNNQLTM-LPEL----------------- 158

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
                        +L VL +  N LT  +P      ++L+AL ++ N L   +       
Sbjct: 159 -----------PTSLEVLSVRNNQLTF-LP---ELPESLEALDVSTNLLES-LPAVPVRN 202

Query: 387 ARLHS----LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDV 442
                       + N+ +  IP  + +L     + L  N  +S +  ++           
Sbjct: 203 HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261

Query: 443 SSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD 502
                ++  G   + +    D             +   ++  E     +    + L+ L 
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFE-HEEHANTFSAFLDRLS 320

Query: 503 LSKNKISGA-----IPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
            + +  + +     + A L+KL     L      +  +             + +   LL
Sbjct: 321 DTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 79.2 bits (195), Expect = 2e-15
 Identities = 67/456 (14%), Positives = 124/456 (27%), Gaps = 110/456 (24%)

Query: 81  LNISSFNL-QGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS 139
             +   N  +     +   ++    L L+   LS ++P ++     + +L  + N L   
Sbjct: 39  QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL--- 92

Query: 140 LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK 199
                                   +P    +L YL                         
Sbjct: 93  ----------------------ISLPELPASLEYL------------------------- 105

Query: 200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
                +N LS +LP        +++ L++  N     +P        +            
Sbjct: 106 --DACDNRLS-TLPE----LPASLKHLDVDNNQL-TMLPELPALLEYI------------ 145

Query: 260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEI 319
                  N  +N LT      +          L+VL +  N L   LP+   +    LE 
Sbjct: 146 -------NADNNQLTMLPELPT---------SLEVLSVRNNQL-TFLPELPES----LEA 184

Query: 320 ILMDNCSISGNIPQVVGNLGNL----LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           + +    +  ++P V     +     +      N +T  IP     L     + L  N L
Sbjct: 185 LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFTSALPSTIWN- 433
           +  I + L               FS S       +      +         +  S IW+ 
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHA 302

Query: 434 LKDILFIDVSSNSLNVLIGLNFSRNN--LSGDIPITIGGLKNLQQMFLEYNRLEGSIPES 491
            +     +  S  L+ L     +RN       +   +  L    ++  +   +     ES
Sbjct: 303 FEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATES 362

Query: 492 FGD-----LSSLEVLDLSKNKISGAIPASLQKLLYL 522
             D      ++L    L      G        LL L
Sbjct: 363 CEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHR 673
              F    L+G G++G +Y  R ++ G   A+KV     +   +  + E  ++K+   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHR 81

Query: 674 NLVKIISS------CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMI 721
           N+     +         DD   L+M++   GS+ + +            L       I  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEEWIAYICR 136

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           ++   L +LH      +IH D+K  NVLL E+    + DFG++       QL   +    
Sbjct: 137 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QLDRTVGRRN 187

Query: 782 T-IG---YMAPEYGTKGRVCTRG-----DVYSYGIMLMEM 812
           T IG   +MAPE                D++S GI  +EM
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 49/223 (21%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVF--------------------------HQQYERA 656
            IG GS+G + +A    D    A+KV                             Q    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 657 LKSFEDECEVMKRIRHRNLVKIIS--SCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-- 712
           ++    E  ++K++ H N+VK++      N+D   ++ + +  G +           D  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 713 --IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 770
              FQ      D+   +EYL   H   IIH D+KPSN+L+ ED    I+DFG++    G 
Sbjct: 140 RFYFQ------DLIKGIEYL---HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 771 DQLSIQIQTLA-TIGYMAPE---YGTKGRVCTRGDVYSYGIML 809
           D L   +     T  +MAPE      K       DV++ G+ L
Sbjct: 191 DAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 50/232 (21%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED----ECEVMKRIRHRNLVK- 677
           L+G GS+G +      +     AVK+  ++  R + + E     E ++++R+RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 678 --IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD--------------IFQRLNIMI 721
             ++ +        ++M+Y   G  E        MLD               F +L   I
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE--------MLDSVPEKRFPVCQAHGYFCQL---I 119

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
           D    LEYLH   S  I+H D+KP N+LL       IS  G+A+ L           T  
Sbjct: 120 D---GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD----TCR 169

Query: 782 TI----GYMAPE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
           T      +  PE   G       + D++S G+ L  + T   P +   I +L
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 51/220 (23%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHR 673
            D F     +G G+FG +++      G+E  +K  +  + +  ++  E E EV+K + H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL---------------- 717
           N++KI     +     ++M+    G L              +R+                
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL-------------LERIVSAQARGKALSEGYVA 127

Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLS 774
            +M  +  AL Y H  H   ++H DLKP N+L           I DFG+A+L   ++  +
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 775 IQIQTLATIGYMAPE-----YGTKGRVCTRGDVYSYGIML 809
                  T  YMAPE        K   C   D++S G+++
Sbjct: 185 ---NAAGTALYMAPEVFKRDVTFK---C---DIWSAGVVM 215

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 51/244 (20%)

Query: 589 SRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK 647
           S T  +  G  S               +D F   + +G G+   +Y  +        A+K
Sbjct: 25  SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84

Query: 648 VFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG 707
           V  +  ++  K    E  V+ R+ H N++K+          +L+++ +  G L       
Sbjct: 85  VLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL------- 135

Query: 708 TCMLDIFQRL------------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DE 752
                 F R+            + +  +  A+ YL   H   I+H DLKP N+L      
Sbjct: 136 ------FDRIVEKGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAP 186

Query: 753 DMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE------YGTKGRVCTRGDVYSY 805
           D    I+DFG++K++  +  +     T+  T GY APE      YG +       D++S 
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMK----TVCGTPGYCAPEILRGCAYGPE---V---DMWSV 236

Query: 806 GIML 809
           GI+ 
Sbjct: 237 GIIT 240

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 24/202 (11%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERA-LKSFEDECEV-MKRIRHRNLVKIISS 681
           +G G++G +   R +  G  +AVK           K    + ++ M+ +     V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHS 735
              +    + M+ M + SL+        ++D  Q +       I + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE----Y 790
             +IH D+KPSNVL++      + DFGI+  L       +     A    YMAPE     
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPE 184

Query: 791 GTKGRVCTRGDVYSYGIMLMEM 812
             +     + D++S GI ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 71/266 (26%)

Query: 588 KSRTGPSNDGIN-SPQAIRRFSYHELLRATDRFSENNL---------IGIGSFGSIYVAR 637
           K R   +N  I  S    + F + +L           L         +G G+ G + +A 
Sbjct: 96  KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155

Query: 638 -LQDGMEVAVKVFH--------QQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK 688
             +   +VA+++           +      + E E E++K++ H  ++KI +    +D+ 
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY- 214

Query: 689 ALIMKYMPNGSLENCLYSGTCMLDIFQRL------------NIMIDVALALEYLHFGHST 736
            ++++ M  G L             F ++                 + LA++YLH     
Sbjct: 215 YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---EN 258

Query: 737 PIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE--- 789
            IIH DLKP NVLL   +ED +  I+DFG +K+L     +     TL  T  Y+APE   
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR----TLCGTPTYLAPEVLV 314

Query: 790 ------YGTKGRVCTRGDVYSYGIML 809
                 Y     V    D +S G++L
Sbjct: 315 SVGTAGYNRA--V----DCWSLGVIL 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.9 bits (234), Expect = 7e-21
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 61/228 (26%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--------QQYERALKSFEDECEV 666
            D +  +  +G G+ G + +A   +   +VA+K+           +      + E E E+
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--------- 717
           +K++ H  ++KI +    +D+  ++++ M  G L             F ++         
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 114

Query: 718 ---NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGED 771
                   + LA++YLH      IIH DLKP NVLL   +ED +  I+DFG +K+L    
Sbjct: 115 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171

Query: 772 QLSIQIQTLA-TIGYMAPE---------YGTKGRVCTRGDVYSYGIML 809
            +     TL  T  Y+APE         Y     V    D +S G++L
Sbjct: 172 LMR----TLCGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.6 bits (233), Expect = 1e-20
 Identities = 51/252 (20%), Positives = 93/252 (36%), Gaps = 11/252 (4%)

Query: 284 SSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLV 343
           S L  C  L+ L+LT N ++ I   S  +L  SLE + +    +S         L +L  
Sbjct: 70  SDLQRCVNLQALVLTSNGINTIEEDSFSSLG-SLEHLDLSYNYLSNLSSSWFKPLSSLTF 128

Query: 344 LELGGNNLTE-PIPITFSQLQTLQALGLTRNKLAGPITDE-LCHLARLHSLVLQGNKFSG 401
           L L GN          FS L  LQ L +        I  +    L  L  L +  +    
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
             P  L ++ ++  L L + +    L   +     +  +++    L+      F  + LS
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD-----TFHFSELS 243

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS-LQKLL 520
                ++      + + +    L   + +    +S L  L+ S+N++   +P     +L 
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301

Query: 521 YLKHLNLSFNKL 532
            L+ + L  N  
Sbjct: 302 SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.3 bits (227), Expect = 6e-20
 Identities = 47/265 (17%), Positives = 95/265 (35%), Gaps = 27/265 (10%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
           +K L L+ N +  I          +L+ +++ +  I+        +LG+L  L+L  N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPS-CLGN 409
           +      F  L +L  L L  N       T    HL +L  L +        I       
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172

Query: 410 LTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG 469
           LT L  L +  +   S  P ++ +++++  + +      +L+ +                
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD------------- 219

Query: 470 GLKNLQQMFLEYNRLEG----SIPE----SFGDLSSLEVLDLSKNKISGAIPASLQKLLY 521
              +++ + L    L+      +      S     +   + ++   +   +   L ++  
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278

Query: 522 LKHLNLSFNKLEGEIPRGGPFANLT 546
           L  L  S N+L+  +P G  F  LT
Sbjct: 279 LLELEFSRNQLKS-VPDGI-FDRLT 301

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 53/265 (20%), Positives = 94/265 (35%), Gaps = 26/265 (9%)

Query: 325 CSISGN----IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPIT 380
           C  S      IP   G    +  L+L  N +T        +   LQAL LT N +     
Sbjct: 36  CKGSSGSLNSIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93

Query: 381 DELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF 439
           D    L  L  L L  N  S ++ S     L+SL  L L  N + +   +++++      
Sbjct: 94  DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS------ 146

Query: 440 IDVSSNSLNVLIGLNFSRNNLSGDIPI-TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL 498
                  L  L  L     +    I      GL  L+++ ++ + L+   P+S   + ++
Sbjct: 147 ------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200

Query: 499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG----EIPRGGPFANLTAKSFMGNE 554
             L L   +    +   +     ++ L L    L+     E+   G   +L  K    N 
Sbjct: 201 SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-GETNSLIKKFTFRNV 259

Query: 555 LLKMLLLVIILPLSTALIVVVTLTL 579
            +    L  ++ L   +  ++ L  
Sbjct: 260 KITDESLFQVMKLLNQISGLLELEF 284

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 46/269 (17%), Positives = 97/269 (36%), Gaps = 22/269 (8%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSI 157
            ++++LDLS+N+++  I +S       L+ L  + N +  ++    F ++ S+  +DLS 
Sbjct: 52  EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSY 109

Query: 158 NGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNNSLSGSLPSRI 216
           N LS         L  L  L    N    +   ++F +++ L+ + + N      +  + 
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 217 DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN--------LFSGFIPNTFVNM 268
              L  +E L +  +      P S+ +   +S L L +                   + +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 269 ADNYLT----SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDN 324
            D  L     S        +SL      + + +T   L  ++          L  +    
Sbjct: 230 RDTDLDTFHFSELSTGET-NSLIKKFTFRNVKITDESLFQVMKLLNQI--SGLLELEFSR 286

Query: 325 CSISGNIPQ-VVGNLGNLLVLELGGNNLT 352
             +  ++P  +   L +L  + L  N   
Sbjct: 287 NQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 53/313 (16%), Positives = 105/313 (33%), Gaps = 55/313 (17%)

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
            A+K + L NN ++  + +       N++ L L  N               ++ +E    
Sbjct: 52  EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN--------------GINTIEEDS- 95

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL 315
            FS       ++++ NYL++ +              L  L L GNP   +   S  +   
Sbjct: 96  -FSSLGSLEHLDLSYNYLSNLSSSW-----FKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149

Query: 316 SLEIILMDNCSISGNIP-QVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNK 374
            L+I+ + N      I  +    L  L  LE+  ++L    P +   +Q +  L L   +
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209

Query: 375 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL 434
                             +L                +S+  L L      +   S +   
Sbjct: 210 HI----------------LLLEIFVD--------VTSSVECLELRDTDLDTFHFSELSTG 245

Query: 435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FG 493
           +    I            +  +  +L   +   +  +  L ++    N+L+ S+P+  F 
Sbjct: 246 ETNSLIK-----KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298

Query: 494 DLSSLEVLDLSKN 506
            L+SL+ + L  N
Sbjct: 299 RLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 56/374 (14%), Positives = 113/374 (30%), Gaps = 81/374 (21%)

Query: 83  ISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSF 142
           I S + + +      +         S   L+ +IPS +     +K L  S+N++      
Sbjct: 14  IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRI------ 64

Query: 143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIY 202
                   T I             ++     L  L   +N +  +   +  ++ +L+ + 
Sbjct: 65  --------TYIS----------NSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
           L  N LS +L S     L ++  LNL  N +      ++   S          LFS    
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY-----KTLGETS----------LFSHLTK 150

Query: 263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILM 322
              + + +    +      F + LT    L+ L +  + L    P               
Sbjct: 151 LQILRVGNMDTFTKIQRKDF-AGLTF---LEELEIDASDLQSYEP--------------- 191

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGP---- 378
                     + + ++ N+  L L        + I      +++ L L    L       
Sbjct: 192 ----------KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 379 ----ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL 434
                T+ L       ++ +        +   L  ++ L  L    N+  S        L
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300

Query: 435 KDILFIDVSSNSLN 448
             +  I + +N  +
Sbjct: 301 TSLQKIWLHTNPWD 314

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 45/213 (21%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECE--------VMKRIRHRNL 675
           IG G++GS+        G  +AVK             E E +        VM+      +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIR------STVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEY 729
           V+   +   +    + M+ M + S +           +   +       I +    AL +
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA---TIG-- 784
           L       IIH D+KPSN+LLD      + DFGI+  L         + ++A     G  
Sbjct: 141 LKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---------VDSIAKTRDAGCR 189

Query: 785 -YMAPE----YGTKGRVCTRGDVYSYGIMLMEM 812
            YMAPE      ++     R DV+S GI L E+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 29/204 (14%), Positives = 55/204 (26%), Gaps = 43/204 (21%)

Query: 624 LIGIGSFGSIYVARLQD---GMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVK 677
             G       + A   D     +VA+     Q    +  L+        + RI    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 678 IISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP 737
           ++          ++ +++  GSL+    +          +  M  +A A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 738 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVC 797
           +      PS V +  D        G                 LA    M           
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD-------AN 180

Query: 798 TRGDVYSYGIMLMEMFTKKKPTDE 821
            + D+   G  L  +   + P  E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.8 bits (228), Expect = 4e-20
 Identities = 56/251 (22%), Positives = 94/251 (37%), Gaps = 66/251 (26%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF-----HQQYERALKSFEDECEVMKR 669
             ++     IG GS+G + VA   Q     A+K+       Q   + ++  + E  +MK+
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSL------ENCLYSGTCMLDIFQRL------ 717
           + H N+ ++     ++ +  L+M+    G L           +G C +D+ +        
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 718 ---------------------------NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL 750
                                      NIM  +  AL YLH      I H D+KP N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201

Query: 751 --DEDMVAHISDFGIAKLLSGEDQLSIQI-QTLA-TIGYMAPE--------YGTKGRVCT 798
             ++     + DFG++K     +        T A T  ++APE        YG K   C 
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK---C- 257

Query: 799 RGDVYSYGIML 809
             D +S G++L
Sbjct: 258 --DAWSAGVLL 266

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 31/230 (13%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKV--------FHQQYERALKSFEDECEVMKRIRHRNL 675
           +G G+FG ++ A   +   EV VK              +  L     E  ++ R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 676 VKIISSCSNDDFKALIM-KYMPNGSLENCLYSGTCMLD-----IFQRLNIMIDVALALEY 729
           +K++    N  F  L+M K+     L   +     + +     IF++L        A+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL------VSAVGY 145

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           L       IIH D+K  N+++ ED    + DFG A  L              TI Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPE 199

Query: 790 -YGTKGRVCTRGDVYSYGIMLMEMFTKKKP---TDEIFIGELSLNRWIND 835
                       +++S G+ L  +  ++ P    +E     +     ++ 
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 38/220 (17%), Positives = 70/220 (31%), Gaps = 29/220 (13%)

Query: 318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG 377
           E   +     + NIP         L   LG ++      IT +Q+ +L  + L       
Sbjct: 4   EQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN--- 55

Query: 378 PITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
            +TD   + +   +  L +     +   P  +  L++L  L +     TS     +  L 
Sbjct: 56  -VTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL 495
                         L  L+ S +     I   I  L  +  + L YN     I      L
Sbjct: 113 S-------------LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158

Query: 496 SSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE 535
             L+ L++  + +       ++    L  L      + G+
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 35/224 (15%), Positives = 67/224 (29%), Gaps = 48/224 (21%)

Query: 287 TNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
           +  K     +L  +    I   ++  ++ SL  I + N +++      +    N+  L +
Sbjct: 20  STFKAYLNGLLGQSSTANI---TEAQMN-SLTYITLANINVTDLTG--IEYAHNIKDLTI 73

Query: 347 GGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 406
              + T   PI  S L  L+ L +    +       L  L  L  L +  +    SI + 
Sbjct: 74  NNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 407 LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPI 466
           +  L  +  + L                                     S N    DI  
Sbjct: 132 INTLPKVNSIDL-------------------------------------SYNGAITDIM- 153

Query: 467 TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG 510
            +  L  L+ + ++++ +         D   L  L      I G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 25/147 (17%), Positives = 58/147 (39%), Gaps = 17/147 (11%)

Query: 409 NLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIG---------LNFSRNN 459
              +     LG +   +   +    +  + +I +++ ++  L G         L  +  +
Sbjct: 21  TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIH 77

Query: 460 LSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKL 519
            + +    I GL NL+++ +    +      +   L+SL +LD+S +    +I   +  L
Sbjct: 78  AT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLT 546
             +  ++LS+N    +I    P   L 
Sbjct: 136 PKVNSIDLSYNGAITDIM---PLKTLP 159

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 30/209 (14%), Positives = 72/209 (34%), Gaps = 53/209 (25%)

Query: 97  GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS 156
             ++SL  + L++  ++ ++ + I   H +K L  ++                       
Sbjct: 41  AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH--------------------- 77

Query: 157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
               +      I  L  L RL     ++       +  +++L  + + +++   S+ ++I
Sbjct: 78  ATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 217 DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSS 276
           + +LP V +++L  N        +IT+   L  L     L         +N+  + +   
Sbjct: 133 N-TLPKVNSIDLSYNG-------AITDIMPLKTL---PEL-------KSLNIQFDGVHD- 173

Query: 277 TPELSFLSSLTNCKKLKVLILTGNPLDGI 305
                    + +  KL  L      + G 
Sbjct: 174 ------YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 3/115 (2%)

Query: 96  LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL 155
           +  LS+L+ L +    ++ +   ++  + +L LL  S +    S+   I  +  V +IDL
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG 210
           S NG   ++   +  LP L  L    + +     +   +   L ++Y  + ++ G
Sbjct: 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 18/140 (12%), Positives = 50/140 (35%), Gaps = 14/140 (10%)

Query: 96  LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL 155
           +    +++ L +++   + N  + I  +  L+ L      +       +  ++S+T +D+
Sbjct: 62  IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSR 215
           S +     +  +I  LP +  +  + N  +      +  +  LK + +  + +       
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH------ 172

Query: 216 IDLS----LPNVETLNLGIN 231
            D       P +  L     
Sbjct: 173 -DYRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 31/256 (12%), Positives = 69/256 (26%), Gaps = 82/256 (32%)

Query: 172 PYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGIN 231
                           A +T   M++L  I L N ++                       
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV----------------------- 56

Query: 232 SFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKK 291
                  + +T      ++               + + + + T+        + ++    
Sbjct: 57  -------TDLTGIEYAHNI-------------KDLTINNIHATN-------YNPISGLSN 89

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
           L+ L + G                           ++ +    +  L +L +L++  +  
Sbjct: 90  LERLRIMGKD-------------------------VTSDKIPNLSGLTSLTLLDISHSAH 124

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGN 409
            + I    + L  + ++ L+ N     ITD   L  L  L SL +Q +         + +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGA---ITDIMPLKTLPELKSLNIQFDGVHDYRG--IED 179

Query: 410 LTSLRVLYLGLNRFTS 425
              L  LY        
Sbjct: 180 FPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 20/104 (19%), Positives = 44/104 (42%), Gaps = 3/104 (2%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L I   ++     P L  L+SL  LD+SH+    +I + I  +  +  +  S N     +
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNL 184
              +  +  + ++++  +G+       I + P L +L   +  +
Sbjct: 153 M-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 19/143 (13%), Positives = 48/143 (33%), Gaps = 7/143 (4%)

Query: 167 EIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETL 226
               +  L  +  A  N+  +  +       +K++ + N   +   P      L N+E L
Sbjct: 39  TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNPIS---GLSNLERL 93

Query: 227 NLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD-NYLT-SSTPELSFLS 284
            +           +++  + L+ L++  +     I      +   N +  S    ++ + 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 285 SLTNCKKLKVLILTGNPLDGILP 307
            L    +LK L +  + +     
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG 176

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.1 bits (229), Expect = 6e-20
 Identities = 42/207 (20%), Positives = 84/207 (40%), Gaps = 29/207 (14%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            D +     +G G+FG ++       G     K  +  Y     + ++E  +M ++ H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSL------ENCLYS----GTCMLDIFQRLNIMIDVA 724
           L+ +  +  +     LI++++  G L      E+   S       M    +         
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE--------- 160

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
             L+++H      I+H D+KP N++    +     I DFG+A  L+ ++ +     T AT
Sbjct: 161 -GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTAT 213

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIML 809
             + APE   +  V    D+++ G++ 
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLG 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.0 bits (229), Expect = 6e-20
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 52/235 (22%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
              ++   +IG GSFG ++ A+L +  EVA+K   Q      +    E ++M+ ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 676 VK----IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL---- 725
           V       S+    D     L+++Y+P    E  +Y        + +L   + + L    
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYR---ASRHYAKLKQTMPMLLIKLY 146

Query: 726 ------ALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQ 778
                 +L Y+H   S  I H D+KP N+LLD    V  + DFG AK+L   +     I 
Sbjct: 147 MYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

Query: 779 TLATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +     Y APE       Y T        D++S G ++ E+    +P   +F GE
Sbjct: 204 SRY---YRAPELIFGATNYTTN------IDIWSTGCVMAELMQ-GQP---LFPGE 245

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.6 bits (228), Expect = 6e-20
 Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 24/218 (11%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVK--VFHQQYERALKSFED---------EC 664
              ++    I  GS+G++      +G+ VA+K         R +    D         E 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 665 EVMKRIRHRNLVK---IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNI 719
            ++    H N++    I             L+ + M    L   ++    ++        
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
           M  + L L  LH      ++H DL P N+LL ++    I DF +A+  + +   +     
Sbjct: 140 MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---HY 193

Query: 780 LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
           +    Y APE   + +  T+  D++S G ++ EMF +K
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 44/217 (20%), Positives = 88/217 (40%), Gaps = 37/217 (17%)

Query: 593 PSNDGINSPQAIRRFSYHELLRATDRFSEN------NLIGIGSFGSIYVAR-LQDGMEVA 645
            S   ++ P     F +  +       +         ++G G FG ++       G+++A
Sbjct: 59  TSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA 118

Query: 646 VKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL----- 700
            K+   +  +  +  ++E  VM ++ H NL+++  +  + +   L+M+Y+  G L     
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 701 -ENCLYS----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DE 752
            E+   +       M  I +           + ++   H   I+H DLKP N+L    D 
Sbjct: 179 DESYNLTELDTILFMKQICE----------GIRHM---HQMYILHLDLKPENILCVNRDA 225

Query: 753 DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
             +  I DFG+A+     ++L        T  ++APE
Sbjct: 226 KQIK-IIDFGLARRYKPREKLK---VNFGTPEFLAPE 258

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 25/215 (11%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF 399
           +   L+L  N L      +F     LQ L L+R ++          L+ L +L+L GN  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 400 SGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLN-FSR 457
             S+       L+SL+ L        S     I +LK +  ++V+ N +        FS 
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS- 146

Query: 458 NNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEV----LDLSKNKISGAI 512
                        L NL+ + L  N+++ SI       L  + +    LDLS N ++  I
Sbjct: 147 ------------NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 513 PASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
                K + LK L L  N+L+  +P G  F  LT+
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGI-FDRLTS 225

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 40/200 (20%), Positives = 67/200 (33%), Gaps = 21/200 (10%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
           +   L VL+L    +       +  L  L  L LT N +          L+ L  LV   
Sbjct: 50  SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109

Query: 397 NKFSGSIPSCL-GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNF 455
              + S+ +   G+L +L+ L +  N   S             F     ++L  L  L+ 
Sbjct: 110 TNLA-SLENFPIGHLKTLKELNVAHNLIQS-FKL------PEYF-----SNLTNLEHLDL 156

Query: 456 SRNNLSGDIPI-TIGGLKNLQ----QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG 510
           S N +   I    +  L  +      + L  N +   I         L+ L L  N++  
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS 214

Query: 511 AIPASLQKLLYLKHLNLSFN 530
                  +L  L+ + L  N
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 26/223 (11%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIP-QVVGNLGNLLVLELGGNN 350
            K L L+ NPL  +   S  +    L+++ +  C I   I      +L +L  L L GN 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 351 LTEPIPITFSQLQTLQALGLTRNKL----AGPITDELCHLARLHSLVLQGNKFSGSIPS- 405
           +       FS L +LQ L      L      PI     HL  L  L +  N    S    
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIG----HLKTLKELNVAHNLIQ-SFKLP 142

Query: 406 -CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDI 464
               NLT+L  L L  N+  S   + +  L  +  +++S         L+ S N ++  I
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---------LDLSLNPMN-FI 192

Query: 465 PITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKN 506
                    L+++ L+ N+L+ S+P+  F  L+SL+ + L  N
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 14/214 (6%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSI 157
            S + LDLS N L  ++ S  F +   L++L  S  ++  ++    + ++S ++T+ L+ 
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85

Query: 158 NGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
           N +   +       L  L +L     NL  +    I ++  LKE+ + +N +  S     
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143

Query: 217 DLS-LPNVETLNLGINSFYGTVPSSITNASKL----SDLELGVNLFSGFIPNTFVNMADN 271
             S L N+E L+L  N       + +    ++      L+L +N  +   P  F  +   
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLK 203

Query: 272 YLTSSTPELSFLSS--LTNCKKLKVLILTGNPLD 303
            L   T +L  +          L+ + L  NP D
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 37/251 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDEC--------EVM 667
           + FS + +IG G FG +Y  R  D  ++ A+K   +  +R      +           ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK--KRIKMKQGETLALNERIMLSLV 246

Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
                  +V +  +    D  + I+  M  G L   L       +   R     ++ L L
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGL 305

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYM 786
           E++H   +  +++ DLKP+N+LLDE     ISD G+A   S +     +      T GYM
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYM 357

Query: 787 APEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI 845
           APE   KG       D +S G ML ++     P    F    + ++             I
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK-----------HEI 402

Query: 846 DTNLLRGEERF 856
           D   L      
Sbjct: 403 DRMTLTMAVEL 413

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 50/270 (18%), Positives = 95/270 (35%), Gaps = 28/270 (10%)

Query: 278 PELSFLSSLTNCKKLKVLILTGNPL-DGILPKSKGNLSLS-LEIILMDNCSISGNIPQVV 335
            +L   + +     LK L +    +   IL  +   L +S L+ + ++N  ++G  P  +
Sbjct: 56  ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115

Query: 336 GNLGNLLVLELGGNNLTEPIPITFS------QLQTLQALGLTRNKLAGPITDELCHLARL 389
                  +  L   N++      +           L+ L + +        +++     L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175

Query: 390 HSLVLQGNKFSGSIP----SCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
            +L L  N   G        C     +L+VL L      +        L         + 
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET-PSGVCSAL---------AA 225

Query: 446 SLNVLIGLNFSRNNLSGDIP-ITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
           +   L GL+ S N+L       +      L  + L +  L+  +P+     + L VLDLS
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLS 282

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEG 534
            N++    P S  +L  + +L+L  N    
Sbjct: 283 YNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 44/236 (18%), Positives = 78/236 (33%), Gaps = 30/236 (12%)

Query: 333 QVVGNLGNLLVLELGGNNLTEPIPIT-FSQLQTLQALGLTRNKLAGPITDELCHL---AR 388
           ++ G   +L  L    +   +    T   +  +L+ L +   ++   I      +   + 
Sbjct: 37  ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96

Query: 389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI------WNLKDILFIDV 442
           L  L L+  + +G+ P  L   T   +  L L   + A           W    +  + +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 443 SSNSLNVLIG-----------LNFSRNNLSGDIPITI----GGLKNLQQMFLEYNRLE-- 485
           +                    L+ S N   G+  +           LQ + L    +E  
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 486 -GSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY-LKHLNLSFNKLEGEIPRG 539
            G           L+ LDLS N +  A  A        L  LNLSF  L+ ++P+G
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 50/271 (18%), Positives = 78/271 (28%), Gaps = 20/271 (7%)

Query: 286 LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQ---VVGNLGNLL 342
               + L+ L+   +    +   +    SLSL+ + +    I   I      V  +  L 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 343 VLELGGNNLT--EPIPITFSQLQTLQALGLTRNKLAGPITD----ELCHLARLHSLVLQG 396
            L L    +T   P P+  +    L  L L     A         +      L  L +  
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFS 456
                     +    +L  L L  N                        +L VL   N  
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF------PTLQVLALRNAG 212

Query: 457 RNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIPAS 515
               SG           LQ + L +N L  +    S    S L  L+LS   +       
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL 272

Query: 516 LQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
             K   L  L+LS+N+L+   P       + 
Sbjct: 273 PAK---LSVLDLSYNRLD-RNPSPDELPQVG 299

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.4 bits (180), Expect = 4e-14
 Identities = 41/236 (17%), Positives = 67/236 (28%), Gaps = 23/236 (9%)

Query: 273 LTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLS-LSLEIILMDNCSISGNI 331
               +  L     +     L+ L L    + G  P      +   L I+ + N S +   
Sbjct: 78  ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD 137

Query: 332 PQVVG----NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG--PITDELC- 384
             +          L VL +   +              L  L L+ N   G   +   LC 
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

Query: 385 -HLARLHSLVLQGNKF---SGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI-WNLKDILF 439
                L  L L+       SG   +       L+ L L  N    A  +        +  
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 440 IDVSSNSLNVLIG--------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGS 487
           +++S   L  +          L+ S N L    P     L  +  + L+ N    S
Sbjct: 258 LNLSFTGLKQVPKGLPAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 42/305 (13%), Positives = 85/305 (27%), Gaps = 49/305 (16%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSS---IFNMHTLKLLYFSDNQLF 137
           L              +    SL+ L +   ++   I      +  +  L+ L   + ++ 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 138 GSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA 197
           G+    +   +      L++  +S                         +A +  +    
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSW------------------ATRDAWLAELQQWLKPG 150

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           LK + +       +         P + TL+L  N               L +  L   L 
Sbjct: 151 LKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPE-------------LGERGLISALC 196

Query: 258 SGFIPN-TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS 316
               P    + + +  + + +   S L       +L+ L L+ N L         +    
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 317 LEIILMDNC---SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN 373
           L  + +       +   +P        L VL+L  N L    P    +L  +  L L  N
Sbjct: 255 LNSLNLSFTGLKQVPKGLPA------KLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGN 306

Query: 374 KLAGP 378
                
Sbjct: 307 PFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 44/315 (13%), Positives = 83/315 (26%), Gaps = 49/315 (15%)

Query: 95  QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL---SFFIFNVSSVT 151
             G  S    L     +      + I    +LK L     ++   +   +  +  +S + 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 152 TIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG- 210
            + L    ++G  P  +                             L  + L N S +  
Sbjct: 99  ELTLENLEVTGTAPPPLLEA----------------------TGPDLNILNLRNVSWATR 136

Query: 211 --SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM 268
              L        P ++ L++            +     LS L+L  N   G         
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL----- 191

Query: 269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS 328
                                + L +         G+           L+ + + + S+ 
Sbjct: 192 ---------ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV-QLQGLDLSHNSLR 241

Query: 329 GNIPQVV-GNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLA 387
                        L  L L    L +      ++L  L    L+ N+L          L 
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD---LSYNRLDR--NPSPDELP 296

Query: 388 RLHSLVLQGNKFSGS 402
           ++ +L L+GN F  S
Sbjct: 297 QVGNLSLKGNPFLDS 311

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 42/217 (19%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKS---FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + + R +   +V A+K+  +           F +E ++M       +V++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LALEYLH 731
            +  +D +  ++M+YMP G L          +++    ++    A        LAL+ +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAIH 185

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIGYMAP 788
              S   IH D+KP N+LLD+    H+  +DFG    ++ E    ++  T   T  Y++P
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISP 238

Query: 789 E-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E        G  GR C   D +S G+ L EM     P
Sbjct: 239 EVLKSQGGDGYYGREC---DWWSVGVFLYEMLVGDTP 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 40/223 (17%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED---ECEV-MKRIR 671
           +       +G G+ G ++  R  + G  +AVK          +  +    + +V +K   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHD 82

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLN----------IMI 721
              +V+   +   +    + M+ M           GTC   + +R+           + +
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELM-----------GTCAEKLKKRMQGPIPERILGKMTV 131

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            +  AL YL   H   +IH D+KPSN+LLDE     + DFGI+  L             A
Sbjct: 132 AIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSA 185

Query: 782 -TIGYMAPE-----YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
               YMAPE       TK     R DV+S GI L+E+ T + P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 89.8 bits (223), Expect = 5e-19
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 39/229 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
              +++  +IG GSFG +Y A+L D G  VA+K   Q      +    E ++M+++ H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 675 LVKII------SSCSNDDFKALIMKYMP---NGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           +V++           ++ +  L++ Y+P        +   +   +  I+ +L  M  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFR 167

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
           +L Y+H   S  I H D+KP N+LLD D  V  + DFG AK L   +     I    +  
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRY 221

Query: 785 YMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           Y APE       Y +        DV+S G +L E+    +P   IF G+
Sbjct: 222 YRAPELIFGATDYTSS------IDVWSAGCVLAELLL-GQP---IFPGD 260

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 56/213 (26%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKII-- 679
           ++G+G  G +      + G + A+K+ +            E +   +     ++V I+  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90

Query: 680 --SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLN----------IMIDVALA 726
             +         +IM+ M  G L             I +R +          IM D+  A
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-T 782
           +++LH   S  I H D+KP N+L    ++D V  ++DFG AK  +        +QT   T
Sbjct: 141 IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYT 192

Query: 783 IGYMAPE------YGTKGRVCTRGDVYSYGIML 809
             Y+APE      Y      C   D++S G+++
Sbjct: 193 PYYVAPEVLGPEKYDKS---C---DMWSLGVIM 219

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.9 bits (225), Expect = 5e-19
 Identities = 64/252 (25%), Positives = 102/252 (40%), Gaps = 34/252 (13%)

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
           +       +     L    +   + ++   L+ S++ I+ +N  I  ++ Q +  L N+ 
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 68

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD--ELCHLARLHSLVLQGNKFS 400
            L L GN LT+  P+  + L+ L  L L  NK    I D   L  L +L SL L+ N  S
Sbjct: 69  KLFLNGNKLTDIKPL--TNLKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLEHNGIS 122

Query: 401 GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNL 460
             I   L +L  L  LYLG N            + DI  +      L  L  L+   N +
Sbjct: 123 -DING-LVHLPQLESLYLGNN-----------KITDITVLS----RLTKLDTLSLEDNQI 165

Query: 461 SGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL 520
           S DI   + GL  LQ ++L  N +  S   +   L +L+VL+L   +           L+
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 521 YLKHLNLSFNKL 532
               +  +   L
Sbjct: 222 VPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.2 bits (210), Expect = 4e-17
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 318 EIILMDNCSISGNIPQVVG--NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           E I +        I Q+         +   L   ++T+ +    ++L ++  +    +  
Sbjct: 3   ETITVST-----PIKQIFPDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSD- 54

Query: 376 AGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWN 433
              I     + +L  +  L L GNK +  I   L NL +L  L+L  N+        + +
Sbjct: 55  ---IKSVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKD-----LSS 104

Query: 434 LKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFG 493
           LKD          L  L  L+   N +S DI   +  L  L+ ++L  N++  +      
Sbjct: 105 LKD----------LKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLS 150

Query: 494 DLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE 533
            L+ L+ L L  N+IS  +P  L  L  L++L LS N + 
Sbjct: 151 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 75.9 bits (186), Expect = 2e-14
 Identities = 61/303 (20%), Positives = 107/303 (35%), Gaps = 33/303 (10%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           + E   ++  +    P   D +       NL   S   T   +    + +  +    +  
Sbjct: 1   MGETITVSTPIKQIFP---DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDI 55

Query: 258 S-----GFIPN-TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
                  ++PN T + +  N LT        +  LTN K L  L L  N +  +      
Sbjct: 56  KSVQGIQYLPNVTKLFLNGNKLTD-------IKPLTNLKNLGWLFLDENKIKDLSSLK-- 106

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           +L   L+ + +++  IS +I   + +L  L  L LG N +T+   +  S+L  L  L L 
Sbjct: 107 DLK-KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLE 161

Query: 372 RNKLAGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPS 429
            N+    I+D   L  L +L +L L  N  S  +   L  L +L VL L      +   +
Sbjct: 162 DNQ----ISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPIN 215

Query: 430 TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
              NL     +  +  SL     ++   +    ++   +    N            G   
Sbjct: 216 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275

Query: 490 ESF 492
             F
Sbjct: 276 ARF 278

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.4 bits (182), Expect = 7e-14
 Identities = 51/284 (17%), Positives = 107/284 (37%), Gaps = 39/284 (13%)

Query: 96  LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL 155
               +     +L    ++  +  +   ++++  +  +++ +  S+   I  + +VT + L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFL 72

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSR 215
           + N L+   P  + NL  L  L    N +  ++ +   ++  LK + L +N +S      
Sbjct: 73  NGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS------ 122

Query: 216 IDLS----LPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL------FSGFIPNTF 265
            D++    LP +E+L LG N    T  + ++  +KL  L L  N        +G      
Sbjct: 123 -DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 179

Query: 266 VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDN- 324
           + ++ N+++        L +L   K L VL L            + NL +   +   D  
Sbjct: 180 LYLSKNHISD-------LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232

Query: 325 ----CSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQT 364
                 IS +      N+   L       +     P+T  + + 
Sbjct: 233 LVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 15/89 (16%), Positives = 34/89 (38%), Gaps = 5/89 (5%)

Query: 470 GLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF 529
                 +  L+   +  ++     +L+S++ +  + + I       +Q L  +  L L+ 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74

Query: 530 NKLEGEIPRGGPFANLTAKSFMGNELLKM 558
           NKL  +I       NL       N++  +
Sbjct: 75  NKLT-DIKPLTNLKNLGWLFLDENKIKDL 102

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.2 bits (224), Expect = 6e-19
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 33/229 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEV-AVKVF-------HQQYERALKSFEDECEVMK 668
           D F +  ++G G FG ++  +++   ++ A K          + Y+ A+     E +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILA 240

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF--QRLNIMI-DVAL 725
           ++  R +V +  +        L+M  M  G +   +Y+       F   R       +  
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIG 784
            LE+LH      II+ DLKP NVLLD+D    ISD G+A  L        + +  A T G
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT---KTKGYAGTPG 354

Query: 785 YMAPEYGTKGRVCTRG-DVYSYGIMLMEMFT---------KKKPTDEIF 823
           +MAPE    G       D ++ G+ L EM           +K    E+ 
Sbjct: 355 FMAPEL-LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.3 bits (224), Expect = 7e-19
 Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 35/210 (16%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            D +  +  +G G+FG ++       G   A K     +E   ++   E + M  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL-------------NIMI 721
           LV +  +  +D+   +I ++M  G L             F+++               M 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMR 262

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQT 779
            V   L ++H  +    +H DLKP N++        +   DFG+   L  +  + +   T
Sbjct: 263 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---T 316

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIML 809
             T  + APE      V    D++S G++ 
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 55/212 (25%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKII--- 679
           +G+G  G +      +   + A+K+              E E+  R  +  ++V+I+   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124

Query: 680 -SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLD-IFQRLN----------IMIDVALAL 727
            +  +      ++M+ +  G L             I  R +          IM  +  A+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 728 EYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TI 783
           +YLH   S  I H D+KP N+L      + +  ++DFG AK  +  + L     T   T 
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCYTP 227

Query: 784 GYMAPE------YGTKGRVCTRGDVYSYGIML 809
            Y+APE      Y      C   D++S G+++
Sbjct: 228 YYVAPEVLGPEKYDKS---C---DMWSLGVIM 253

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
            +G G++G + +A        VAVK+   ++     ++ + E  + K + H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGHST 736
               + + L ++Y   G L + +     M        F +L   +     + YLH     
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH---GI 124

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGR 795
            I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE    +  
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 796 VCTRGDVYSYGIMLMEMFTKKKPTDE 821
                DV+S GI+L  M   + P D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.9 bits (223), Expect = 1e-18
 Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 49/264 (18%)

Query: 590 RTGPSNDGINSPQAIRRFSYHELLRAT---DRFSENNLIGIGSFGSIYVARLQDGMEV-A 645
              P  D ++S    R   +  L R     + F +  ++G G FG +   +++   ++ A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 646 VKVFHQQYERALKSFEDEC-----EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSL 700
            K   +  +R  K   +       ++++++  R +V +  +    D   L++  M  G L
Sbjct: 214 CKKLEK--KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271

Query: 701 ENCLYSGTCMLDIFQRLNIMID----------VALALEYLHFGHSTPIIHCDLKPSNVLL 750
                       I+                  +   LE LH      I++ DLKP N+LL
Sbjct: 272 ---------KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILL 319

Query: 751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPEYGTKGRVCTRG-DVYSYGIM 808
           D+     ISD G+A  +         I+    T+GYMAPE   K    T   D ++ G +
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEV-VKNERYTFSPDWWALGCL 374

Query: 809 LMEMFT---------KKKPTDEIF 823
           L EM           KK   +E+ 
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVE 398

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.3 bits (219), Expect = 2e-18
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 45/220 (20%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKS---FEDECEVMKRIRHRNLVKII 679
           +IG G+FG + V +L++  +V A+K+ ++           F +E +V+     + +  + 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID----------VALALEY 729
            +  +D+   L+M Y   G L   L           +    +           + +A++ 
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIGYM 786
           +H       +H D+KP N+L+D +   HI  +DFG    L  +   ++Q      T  Y+
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYI 243

Query: 787 APE--------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +PE         G  G  C   D +S G+ + EM   + P
Sbjct: 244 SPEILQAMEGGKGRYGPEC---DWWSLGVCMYEMLYGETP 280

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 46/223 (20%), Positives = 78/223 (34%), Gaps = 54/223 (24%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH------QQYERALKSFEDECEVMK 668
            D +     +G G F  +   R    G E A K          +   + +  E E  +++
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL----------- 717
            IRH N++ +     N     LI++ +  G L             F  L           
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEA 110

Query: 718 -NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 772
              +  +   + YLH      I H DLKP N++L      +    + DFGIA  +   ++
Sbjct: 111 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

Query: 773 LSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
                    T  ++APE       G +       D++S G++ 
Sbjct: 168 FK---NIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 53/217 (24%), Positives = 77/217 (35%), Gaps = 53/217 (24%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG-PITDELC 384
           ++  ++P       +  +L L  N L      T      L  L L R +L    +   L 
Sbjct: 24  ALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP 77

Query: 385 HLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
            L  L    L  N+   S+P     L +L VL +  NR TS LP                
Sbjct: 78  VLGTLD---LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGA------------- 119

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDL 503
                                    GL  LQ+++L+ N L+ ++P         LE L L
Sbjct: 120 ----------LR-------------GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155

Query: 504 SKNKISGAIPASL-QKLLYLKHLNLSFNKLEGEIPRG 539
           + N ++  +PA L   L  L  L L  N L   IP+G
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 32/163 (19%), Positives = 63/163 (38%), Gaps = 23/163 (14%)

Query: 386 LARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
           +A    +       + ++P          +L+L  N   +   +T+     +  +++   
Sbjct: 9   VASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSK 505
            L  L                  G L  L  + L +N+L+ S+P     L +L VLD+S 
Sbjct: 66  ELTKLQ---------------VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109

Query: 506 NKISGAIPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
           N+++ ++P    + L  L+ L L  N+L+  +P G        
Sbjct: 110 NRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL-LTPTPK 149

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 47/229 (20%), Positives = 74/229 (32%), Gaps = 35/229 (15%)

Query: 220 LPNVETLNLGINSFYGTVPSSI-TNASKLSDLELGVNLFSGFIPNTFVNMAD-NYLTSST 277
           + +   +N    +    +P  +  + + L    L  NL   F   T +       L    
Sbjct: 9   VASHLEVNCDKRNL-TALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 278 PELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN 337
            EL+ L        L  L L+ N L                           ++P +   
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQ--------------------------SLPLLGQT 98

Query: 338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGN 397
           L  L VL++  N LT         L  LQ L L  N+L       L    +L  L L  N
Sbjct: 99  LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158

Query: 398 KFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
             +  +P+  L  L +L  L L  N   + +P   +    + F  +  N
Sbjct: 159 NLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 50/206 (24%), Positives = 75/206 (36%), Gaps = 30/206 (14%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN 158
                L LS N L      +       L  L     +L   L      +  + T+DLS N
Sbjct: 31  KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHN 87

Query: 159 GLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNNSLSGSLPSRID 217
            L   +P     LP L  L  + N L  + P+     +  L+E+YL  N L  +LP  + 
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLTSL-PLGALRGLGELQELYLKGNELK-TLPPGLL 144

Query: 218 LSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSST 277
              P +E L+L  N               L++L  G+   +G      + + +N L  + 
Sbjct: 145 TPTPKLEKLSLANN--------------NLTELPAGL--LNGLENLDTLLLQENSLY-TI 187

Query: 278 PELSFLSSLTNCKKLKVLILTGNPLD 303
           P+  F S       L    L GNP  
Sbjct: 188 PKGFFGS-----HLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 10/174 (5%)

Query: 85  SFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF 143
           S NL  T     L   + L  L+L   +L+  +      +  L  L  S NQL  SL   
Sbjct: 39  SENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLL 95

Query: 144 IFNVSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIF-NMSALKEI 201
              + ++T +D+S N L+  +P      L  L  L    N L  + P  +      L+++
Sbjct: 96  GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTL-PPGLLTPTPKLEKL 153

Query: 202 YLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
            L NN+L+  LP+ +   L N++TL L  NS Y T+P     +  L    L  N
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 36/236 (15%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLS 156
            ++S   ++     L+  +P  +       +L+ S+N L  + S       + +T ++L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLD 63

Query: 157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
              L+    +  G LP L  L  + N L  + P+    + AL  + +  N L+ SLP   
Sbjct: 64  RAELT--KLQVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 217 DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSS 276
              L  ++ L L  N              +L  L  G+   +       +++A+N LT  
Sbjct: 120 LRGLGELQELYLKGN--------------ELKTLPPGL--LTPTPKLEKLSLANNNLT-E 162

Query: 277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDN-----CSI 327
            P     + L N   L  L+L  N L  I     G+  L     L  N     C I
Sbjct: 163 LPAGLL-NGLEN---LDTLLLQENSLYTIPKGFFGSHLLP-FAFLHGNPWLCNCEI 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 60/243 (24%), Positives = 87/243 (35%), Gaps = 37/243 (15%)

Query: 591 TGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF 649
             P   G      +     ++ ++          IG G+FG   + R       VAVK  
Sbjct: 3   RAPVTTGPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYI 53

Query: 650 HQQYERALKSFED---ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS 706
               ER     E+   E    + +RH N+V+           A+IM+Y   G L   + +
Sbjct: 54  ----ERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN 109

Query: 707 GTCM-----LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH--IS 759
                       FQ+L   +     + Y H   S  I H DLK  N LLD        I 
Sbjct: 110 AGRFSEDEARFFFQQL---LS---GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKIC 160

Query: 760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           DFG +K      Q    + T A   Y+APE    +       DV+S G+ L  M     P
Sbjct: 161 DFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

Query: 819 TDE 821
            ++
Sbjct: 218 FED 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 54/223 (24%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED------ECEVMK 668
            D +     +G G F  +   R    G+E A K   ++  RA +          E  +++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL----------- 717
           ++ H N++ +     N     LI++ +  G L             F  L           
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 718 -NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 772
            + +  +   + YLH      I H DLKP N++L           + DFG+A  +    +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 773 LSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
                    T  ++APE       G +       D++S G++ 
Sbjct: 175 FK---NIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 51/224 (22%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQY--ERA-LKSFEDECEVMKRIRHRNLVKII 679
           +IG G+F  + V +++   +V A+K+ ++    +R  +  F +E +V+     R + ++ 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID----------VALALEY 729
            +  ++++  L+M+Y   G L   L           +    I           + +A++ 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDS 177

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTLATIG--- 784
           +H       +H D+KP N+LLD     HI  +DFG    L  +      +++L  +G   
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG----TVRSLVAVGTPD 228

Query: 785 YMAPE----------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           Y++PE           G+ G  C   D ++ G+   EMF  + P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPEC---DWWALGVFAYEMFYGQTP 269

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.9 bits (213), Expect = 6e-18
 Identities = 43/223 (19%), Positives = 77/223 (34%), Gaps = 54/223 (24%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH------QQYERALKSFEDECEVMK 668
            D +     +G G F  +   R    G+E A K          +     +  E E  +++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL----------- 717
           ++ H N++ +     N     LI++ +  G L             F  L           
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 718 -NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 772
            + +  +   + YLH      I H DLKP N++L           + DFG+A  +    +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 773 LSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
                    T  ++APE       G +       D++S G++ 
Sbjct: 175 FK---NIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 208

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 41/210 (19%), Positives = 78/210 (37%), Gaps = 36/210 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            +++     +G G FG ++             K    +        + E  ++   RHRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRN 62

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL-------------NIMI 721
           ++ +  S  + +   +I +++                DIF+R+             + + 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVH 109

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
            V  AL++LH  +   I H D++P N++          I +FG A+ L   D   +    
Sbjct: 110 QVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---L 163

Query: 780 LATIGYMAPEYGTKGRVCTRGDVYSYGIML 809
                Y APE      V T  D++S G ++
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 33/246 (13%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
             R+     IG G+ G +  A        VA+K     F  Q    RA +    E  +MK
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 669 RIRHRNLVKI----ISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
            + H+N++ +        S ++F+   ++M+ M   +L   +      LD  +   ++  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME---LDHERMSYLLYQ 135

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           +   +++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T
Sbjct: 136 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VT 189

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--INDLLPVS 840
             Y APE           D++S G ++ EM         +F G   +++W  + + L   
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNKVIEQLGTP 245

Query: 841 VMEVID 846
             E + 
Sbjct: 246 CPEFMK 251

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 17/219 (7%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFH-QQYERALKSFEDECEVMKRIRHRNLVKIISS 681
            +G G++G + +A        VAVK+   ++     ++ + E  + K + H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGHST 736
               + + L ++Y   G L + +     M        F +L   +     + YLH     
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH---GI 124

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGR 795
            I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE    +  
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 796 VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN 834
                DV+S GI+L  M   + P D+        + W  
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 50/259 (19%), Positives = 101/259 (38%), Gaps = 26/259 (10%)

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
           +           +    + +   + ++  +L   +  +      ++  I   V  L NL+
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVTQA--DLD-GITTLSAFGTGVT-TIE-GVQYLNNLI 66

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 402
            LEL  N +T+  P     L  +  L L+ N L       +  L  + +L L   + +  
Sbjct: 67  GLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDV 122

Query: 403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN---------SLNVLIGL 453
            P  L  L++L+VLYL LN+ T+   S +  L ++ ++ + +          +L+ L  L
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 454 NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP 513
               N +S DI   +  L NL ++ L+ N++         + S+L ++ L+   I+    
Sbjct: 179 KADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPV 234

Query: 514 ASLQKLLYLKHLNLSFNKL 532
                L+    +       
Sbjct: 235 FYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD--ELCHLARLHSLVL 394
            L N + +  G +N+T+ +    + L  +  L          +T    + +L  L  L L
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTG----VTTIEGVQYLNNLIGLEL 70

Query: 395 QGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN--------- 445
           + N+ +  + + L NLT +  L L  N   +   S I  L+ I  +D++S          
Sbjct: 71  KDNQIT-DL-APLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSK 505
            L+ L  L    N ++ +I   + GL NLQ + +   ++   +     +LS L  L    
Sbjct: 127 GLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADD 182

Query: 506 NKISGAIPASLQKLLYLKHLNLSFNKLE 533
           NKIS   P  L  L  L  ++L  N++ 
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 57/302 (18%), Positives = 114/302 (37%), Gaps = 39/302 (12%)

Query: 69  ITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 128
           I  D      I +     N+  T+     +L  + TL      ++  I   +  ++ L  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIG 67

Query: 129 LYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA 188
           L   DNQ+   L+    N++ +T ++LS N L       I  L  +  L   +  +  V 
Sbjct: 68  LELKDNQI-TDLAPL-KNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 189 PVTIFNMSALKEIYLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFYGTVPSSITNA 244
           P+    +S L+ +YL  N ++       ++S    L N++ L++G      +  + + N 
Sbjct: 124 PLA--GLSNLQVLYLDLNQIT-------NISPLAGLTNLQYLSIGNAQV--SDLTPLANL 172

Query: 245 SKLSDLELGVNL------FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILT 298
           SKL+ L+   N        +       V++ +N ++        +S L N   L ++ LT
Sbjct: 173 SKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVTLT 225

Query: 299 GNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPIT 358
              +         NL +   +       I+   P  + + G      L  N  +    ++
Sbjct: 226 NQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNLTSFINNVS 282

Query: 359 FS 360
           ++
Sbjct: 283 YT 284

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 37/188 (19%), Positives = 76/188 (40%), Gaps = 29/188 (15%)

Query: 350 NLTEPIPIT----FSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
           ++T+P  I        L     +   ++ +   +T     L  + +L   G   + +I  
Sbjct: 2   SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG 58

Query: 406 CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIP 465
            +  L +L  L L  N            + D+  +     +L  +  L  S N L  ++ 
Sbjct: 59  -VQYLNNLIGLELKDN-----------QITDLAPLK----NLTKITELELSGNPLK-NVS 101

Query: 466 ITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL 525
             I GL++++ + L   ++  +       LS+L+VL L  N+I+   P  L  L  L++L
Sbjct: 102 -AIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156

Query: 526 NLSFNKLE 533
           ++   ++ 
Sbjct: 157 SIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 10/97 (10%)

Query: 450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS 509
            I +   ++N++    +T   L  +  +      +  +I E    L++L  L+L  N+I+
Sbjct: 21  AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQIT 76

Query: 510 GAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
              P  L+ L  +  L LS N L+  +      A L 
Sbjct: 77  DLAP--LKNLTKITELELSGNPLK-NVS---AIAGLQ 107

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKIISS 681
           IG G+F  + +AR +  G EVA+K+    Q    +L+    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 682 CSNDDFKALIMKYMPNGSLENCLYSGTCMLD-----IFQRLNIMIDVALALEYLHFGHST 736
              +    LIM+Y   G + + L +   M +      F+++        A++Y H     
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH---QK 133

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTKGR 795
            I+H DLK  N+LLD DM   I+DFG +   +   +L           Y APE +  K  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---YAAPELFQGKKY 190

Query: 796 VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
                DV+S G++L  + +   P D   + EL
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 45/223 (20%), Positives = 78/223 (34%), Gaps = 54/223 (24%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH------QQYERALKSFEDECEVMK 668
            D +     +G G F  +   R    G++ A K          +   + +  E E  ++K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL----------- 717
            I+H N++ +     N     LI++ +  G L             F  L           
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEEEA 116

Query: 718 -NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 772
              +  +   + YLH      I H DLKP N++L           I DFG+A  +   ++
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 773 LSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIML 809
                    T  ++APE       G +       D++S G++ 
Sbjct: 174 FK---NIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 23/214 (10%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK---VF-HQQY-ERALKSFEDECEVMKR 669
             R++  + IG G++G +  A    + + VA+K    F HQ Y +R L+    E +++ R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81

Query: 670 IRHRNLVK---IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            RH N++    II + + +  K   ++   M    L   L +     D       +  + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC--YFLYQIL 138

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI-QTLATI 783
             L+Y+H   S  ++H DLKPSN+LL+      I DFG+A++   +   +  + + +AT 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 784 GYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
            Y APE     +  T+  D++S G +L EM + +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVK-VF-HQQYE-RALKSFEDECEVMKRIR 671
            DRF    + G G+FG++ + + +  GM VA+K V    ++  R L+      + +  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAVLH 77

Query: 672 HRNLVK---IISSCSNDDFK----ALIMKYMP---NGSLENCLYSGTCMLDIFQRLNIMI 721
           H N+V+      +    D +     ++M+Y+P   +    N          I  ++  + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            +  ++  LH   S  + H D+KP NVL++  D    + DFG AK LS  +     I   
Sbjct: 137 QLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI--- 192

Query: 781 ATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
            +  Y APE       Y T        D++S G +  EM    +P   IF G+
Sbjct: 193 CSRYYRAPELIFGNQHYTTA------VDIWSVGCIFAEMML-GEP---IFRGD 235

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 40/239 (16%), Positives = 80/239 (33%), Gaps = 21/239 (8%)

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI-TFSQLQTLQALGL 370
           +L  +   +      +           G+L  +E+  N++ E I    FS L  L  + +
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 371 TR-NKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALP 428
            + N L     +   +L  L  L++        +P     +     +L +  N     + 
Sbjct: 87  EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 429 STIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSI 488
                     F+ +S       + L  ++N +         G +  +    + N LE   
Sbjct: 146 RN-------SFVGLSFE----SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194

Query: 489 PESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
            + F   S   +LD+S+ +I       L+ L  L+  +    K   ++P       L A
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP---TLEKLVA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.8 bits (202), Expect = 9e-17
 Identities = 50/245 (20%), Positives = 80/245 (32%), Gaps = 26/245 (10%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIP-QVVGNLGNLLVLEL-GGN 349
              L      L  I   +       LE I +    +   I   V  NL  L  + +   N
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 350 NLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLG 408
           NL    P  F  L  LQ L ++   +         H  +   L +Q N    +I      
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 409 NLTS-LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPIT 467
            L+    +L+L  N       S     +              L  LN S NN   ++P  
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQ--------------LDELNLSDNNNLEELPND 196

Query: 468 I-GGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL 525
           +  G      + +   R+  S+P     +L  L        K    +P +L+KL+ L   
Sbjct: 197 VFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEA 251

Query: 526 NLSFN 530
           +L++ 
Sbjct: 252 SLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.9 bits (179), Expect = 7e-14
 Identities = 49/302 (16%), Positives = 101/302 (33%), Gaps = 30/302 (9%)

Query: 149 SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSL 208
           S        + ++ E+P ++        L F    L  +          L++I +  N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 209 SGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM 268
              + + +  +LP +  + +               A+ L  +      F       ++ +
Sbjct: 67  LEVIEADVFSNLPKLHEIRI-------------EKANNLLYINPEA--FQNLPNLQYLLI 111

Query: 269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNP-LDGILPKSKGNLSLSLEIILMDNCSI 327
           ++  +    P++  + SL    +  +L +  N  +  I   S   LS    I+ ++   I
Sbjct: 112 SNTGIKHL-PDVHKIHSL----QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166

Query: 328 SGNIPQVVGNLGNLLVLELGGNNLTEPIPI-TFSQLQTLQALGLTRNKLAGPITDELCHL 386
              I     N   L  L L  NN  E +P   F        L ++R ++    +  L +L
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225

Query: 387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNS 446
            +L +      K    +P+ L  L +L    L       A  +    + ++  I   S  
Sbjct: 226 KKLRARSTYNLK---KLPT-LEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSIL 281

Query: 447 LN 448
             
Sbjct: 282 RQ 283

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 33/225 (14%), Positives = 63/225 (28%), Gaps = 8/225 (3%)

Query: 81  LNISSFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG 138
           L      L+  I          L+ +++S N +   I + +F N+  L  +         
Sbjct: 35  LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93

Query: 139 SLSFFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFN--M 195
            ++   F N+ ++  + +S  G+         +      L    N  +       F    
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153

Query: 196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
                ++L  N +   + +         E      N+           AS    L++   
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212

Query: 256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGN 300
                      N+       ST  L  L +L     L    LT  
Sbjct: 213 RIHSLPSYGLENLKKLRAR-STYNLKKLPTLEKLVALMEASLTYP 256

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.5 bits (209), Expect = 4e-17
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 37/273 (13%)

Query: 593 PSNDGINSPQAIRRFSYHELLRAT----DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK 647
             +  ++  +   +F   E+  +T     R+     IG G+ G +  A        VA+K
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93

Query: 648 ----VFHQQYE--RALKSFEDECEVMKRIRHRNLVKII----SSCSNDDFKA--LIMKYM 695
                F  Q    RA +    E  +MK + H+N++ ++       + ++F+   L+M+ M
Sbjct: 94  KLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149

Query: 696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV 755
              +L   +      LD  +   ++  +   +++LH   S  IIH DLKPSN+++  D  
Sbjct: 150 DA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

Query: 756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK 815
             I DFG+A+       ++     + T  Y APE           D++S G ++ EM   
Sbjct: 203 LKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

Query: 816 KKPTDEIFIGELSLNRW--INDLLPVSVMEVID 846
           K     +F G   +++W  + + L     E + 
Sbjct: 260 K----ILFPGRDYIDQWNKVIEQLGTPCPEFMK 288

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 25/208 (12%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
           +I  NIP       +   L+L  N L+      F +L  L+ L L  NKL          
Sbjct: 30  AIPSNIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE 83

Query: 386 LARLHSLVLQGNKFSGSIPSCL-GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
           L  L +L +  NK   ++P  +   L +L  L L  N+  S LP  +++           
Sbjct: 84  LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFD----------- 130

Query: 445 NSLNVLIGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLD 502
            SL  L  L+   N L   +P  +   L +L+++ L  N+L+  +PE  F  L+ L+ L 
Sbjct: 131 -SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187

Query: 503 LSKNKISGAIPASLQKLLYLKHLNLSFN 530
           L  N++      +   L  LK L L  N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 21/160 (13%)

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVL 450
            L LQ NK S         LT LR+LYL  N+  + LP+ I       F       L  L
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGI-------F-----KELKNL 87

Query: 451 IGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKI 508
             L  + N L   +PI +   L NL ++ L+ N+L+ S+P   F  L+ L  L L  N++
Sbjct: 88  ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145

Query: 509 SGAIPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             ++P  +  KL  LK L L  N+L+  +P G  F  LT 
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA-FDKLTE 182

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 24/156 (15%)

Query: 395 QGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLN 454
              K + +IPS        + L L  N+ +S LPS         F     + L  L  L 
Sbjct: 24  SSKKLT-AIPS--NIPADTKKLDLQSNKLSS-LPSKA-------F-----HRLTKLRLLY 67

Query: 455 FSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAI 512
            + N L   +P  I   LKNL+ +++  N+L+ ++P   F  L +L  L L +N++  ++
Sbjct: 68  LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SL 124

Query: 513 PASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
           P  +   L  L +L+L +N+L+  +P+G  F  LT+
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKLTS 158

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 41/246 (16%)

Query: 62  SVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF 121
            VC     +C+ N + V   + SS  L   IP      +  + LDL  NKLS ++PS  F
Sbjct: 10  GVC-----SCNNNKNSV---DCSSKKLT-AIPS--NIPADTKKLDLQSNKLS-SLPSKAF 57

Query: 122 -NMHTLKLLYFSDNQLFGSLSFFIFN-VSSVTTIDLSINGLSGEMPREI-GNLPYLARLA 178
             +  L+LLY +DN+L  +L   IF  + ++ T+ ++ N L   +P  +   L  LA L 
Sbjct: 58  HRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELR 115

Query: 179 FATNNLVGVAPVTIF-NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV 237
              N L  + P  +F +++ L  + L  N L  SLP  +   L +++ L L  N      
Sbjct: 116 LDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNN------ 167

Query: 238 PSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLIL 297
                   +L  +  G   F        + + +N L    PE +F     + +KLK+L L
Sbjct: 168 --------QLKRVPEGA--FDKLTELKTLKLDNNQLK-RVPEGAF----DSLEKLKMLQL 212

Query: 298 TGNPLD 303
             NP D
Sbjct: 213 QENPWD 218

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 33/241 (13%)

Query: 594 SNDGINSPQAIRRFSYHELLRA----TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKV 648
           ++   +  Q    F   EL +      +R+   + +G G++GS+  A   + G+ VAVK 
Sbjct: 2   AHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 61

Query: 649 FHQQYE------RALKSFEDECEVMKRIRHRNLVKI----ISSCSNDDFKA--LIMKYMP 696
             + ++      R  +    E  ++K ++H N++ +      + S ++F    L+   M 
Sbjct: 62  LSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 117

Query: 697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA 756
              L N +       D  Q   ++  +   L+Y+H   S  IIH DLKPSN+ ++ED   
Sbjct: 118 A-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171

Query: 757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTK 815
            I DFG+A+  + E         +AT  Y APE         +  D++S G ++ E+ T 
Sbjct: 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

Query: 816 K 816
           +
Sbjct: 227 R 227

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.9 bits (205), Expect = 6e-17
 Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 63/257 (24%)

Query: 616 TDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
           + ++S    +G GSFG +      + G   A+K   Q      +    E ++MK + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 675 LVKIIS---SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY-- 729
           ++K++    +  +++ K        N               +    +    + + +EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 730 --------------------------------LHFGHSTPIIHCDLKPSNVLLD-EDMVA 756
                                           + F HS  I H D+KP N+L++ +D   
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-------YGTKGRVCTRGDVYSYGIML 809
            + DFG AK L   +     +  + +  Y APE       Y          D++S G + 
Sbjct: 182 KLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPS------IDLWSIGCVF 232

Query: 810 MEMFTKKKPTDEIFIGE 826
            E+    KP   +F GE
Sbjct: 233 GELIL-GKP---LFSGE 245

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 28/217 (12%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED------ECEVMKRIRHRNLV 676
            +G+G+FG + +      G +VAVK+ ++Q    ++S +       E + +K  RH +++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM-----LDIFQRLNIMIDVALALEYLH 731
           K+    S      ++M+Y+  G L + +     +       +FQ++   +    A++Y H
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LS---AVDYCH 128

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-Y 790
                 ++H DLKP NVLLD  M A I+DFG++ ++S  + L     +     Y APE  
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---YAAPEVI 182

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
             +       D++S G++L  +     P D+  +  L
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 49/228 (21%), Positives = 89/228 (39%), Gaps = 27/228 (11%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVK------VFHQQYERALKSFEDECEVMKRIR----H 672
           L+G G FG+++    L D ++VA+K      V          +   E  ++ ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 673 RNLVKIISSCSNDDFKALIMKY-MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
             +++++      +   L+++  +P   L + +     + +   R      V  A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 732 FGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE 789
              S  ++H D+K  N+L+D     A + DFG   LL  E            T  Y  PE
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYTDFDGTRVYSPPE 208

Query: 790 Y-GTKGRVCTRGDVYSYGIMLMEMFTKKKP---TDEIFIGELSLNRWI 833
           +            V+S GI+L +M     P     EI   EL     +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 34/252 (13%)

Query: 283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL 342
           + S     +     L    +   + +++ N   S++ I+ +N  I  ++ Q +  L N+ 
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNELN---SIDQIIANNSDIK-SV-QGIQYLPNVT 71

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD--ELCHLARLHSLVLQGNKFS 400
            L L GN LT+  P+  + L+ L  L L  NK    + D   L  L +L SL L+ N  S
Sbjct: 72  KLFLNGNKLTDIKPL--ANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 401 GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNL 460
             I   L +L  L  LYLG N            + DI  +      L  L  L+   N +
Sbjct: 126 -DING-LVHLPQLESLYLGNN-----------KITDITVLS----RLTKLDTLSLEDNQI 168

Query: 461 SGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL 520
           S DI   + GL  LQ ++L  N +   +  +   L +L+VL+L   +           L+
Sbjct: 169 S-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 521 YLKHLNLSFNKL 532
               +  +   L
Sbjct: 225 VPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 45/288 (15%), Positives = 109/288 (37%), Gaps = 49/288 (17%)

Query: 69  ITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 128
           I  D      I  N+   ++   +      L+S+  +  +++ +  ++   I  +  +  
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72

Query: 129 LYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA 188
           L+ + N+L  +    + N+ ++  + L  N +       + +L  L  L+   N +  + 
Sbjct: 73  LFLNGNKL--TDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDIN 128

Query: 189 PVTIFNMSALKEIYLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFYGTVPSSITNA 244
            +   ++  L+ +YL NN ++       D++    L  ++TL+L  N       S I   
Sbjct: 129 GLV--HLPQLESLYLGNNKIT-------DITVLSRLTKLDTLSLEDNQI-----SDIVPL 174

Query: 245 SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG 304
           + L+ L+              + ++ N+++        L +L   K L VL L       
Sbjct: 175 AGLTKLQ-------------NLYLSKNHISD-------LRALAGLKNLDVLELFSQECLN 214

Query: 305 ILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT 352
                + NL +   +   D   ++   P+++ + G+     +  +   
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT---PEIISDDGDYEKPNVKWHLPE 259

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 25/226 (11%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVK------VFHQQYERALKSFEDECEVMKRIRHR--N 674
           L+G G FGS+Y    + D + VA+K      +              E  ++K++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 675 LVKIISSCSNDDFKALIMKY-MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           +++++      D   LI++   P   L + +     + +   R +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166

Query: 734 HSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPEY- 790
            +  ++H D+K  N+L+D +     + DFG   LL               T  Y  PE+ 
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 220

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKP---TDEIFIGELSLNRWI 833
                      V+S GI+L +M     P    +EI  G++   + +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 53/215 (24%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
            +G GSFG + + + ++     A+K+  +Q    LK  E   +E  +++ +    LVK+ 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 680 SSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMIDVALA 726
            S  ++    ++M+Y+  G +           E     Y+                + L 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA--------------QIVLT 153

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
            EYLH   S  +I+ DLKP N+L+D+     ++DFG AK + G         TL  T   
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLCGTPEA 204

Query: 786 MAPE------YGTKGRVCTRGDVYSYGIMLMEMFT 814
           +APE      Y     V    D ++ G+++ EM  
Sbjct: 205 LAPEIILSKGYNKA--V----DWWALGVLIYEMAA 233

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 57/217 (26%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
            +G GSFG +++ R +      A+KV  ++    LK  E   DE  ++  + H  ++++ 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 680 SSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMIDVALA 726
            +  +     +IM Y+  G L                 Y+               +V LA
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--------------EVCLA 118

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATI 783
           LEYLH   S  II+ DLKP N+LLD++   HI  +DFG AK +           TL  T 
Sbjct: 119 LEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPDVT------YTLCGTP 167

Query: 784 GYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFT 814
            Y+APE      Y     +    D +S+GI++ EM  
Sbjct: 168 DYIAPEVVSTKPYNKS--I----DWWSFGILIYEMLA 198

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 41/212 (19%), Positives = 74/212 (34%), Gaps = 52/212 (24%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR-NLVKIIS 680
           +G G F  +        G E A K     ++ +        E  V++  +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL--------------NIMIDVALA 726
              N     LI++Y   G +             F                  ++  +   
Sbjct: 97  VYENTSEIILILEYAAGGEI-------------FSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           + YLH  +   I+H DLKP N+LL          I DFG+++ +    +L    + + T 
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTP 197

Query: 784 GYMAPE------YGTKGRVCTRGDVYSYGIML 809
            Y+APE        T        D+++ GI+ 
Sbjct: 198 EYLAPEILNYDPITTA------TDMWNIGIIA 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 49/220 (22%), Positives = 101/220 (45%), Gaps = 25/220 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKR 669
            ++ +   IG G++G+++ A+  +    VA+K      +       AL+    E  ++K 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           ++H+N+V++     +D    L+ ++     L+    S    LD     + +  +   L +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAP 788
            H   S  ++H DLKP N+L++ +    +++FG+A+      +  S ++ TL    Y  P
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---WYRPP 170

Query: 789 E--YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE 826
           +  +G K    T  D++S G +  E+    +P   +F G 
Sbjct: 171 DVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 38/255 (14%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK--VFHQQYE--RALKSFEDECEVMKRI 670
             R+ +   +G G  G ++ A        VA+K  V         AL+    E ++++R+
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRL 65

Query: 671 RHRNLVKII------------SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQR 716
            H N+VK+                S  +  +  ++ +YM    L N L  G  + +  + 
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR- 123

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSI 775
              M  +   L+Y+H   S  ++H DLKP+N+ ++ ED+V  I DFG+A+++        
Sbjct: 124 -LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 776 QI-QTLATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW- 832
            + + L T  Y +P         T+  D+++ G +  EM T K     +F G   L +  
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELEQMQ 235

Query: 833 -INDLLPVSVMEVID 846
            I + +PV   E   
Sbjct: 236 LILESIPVVHEEDRQ 250

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 46/253 (18%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
              +     +G G++GS+  A   + G +VA+K     F  +    RA +    E  ++K
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 669 RIRHRNLVKI----ISSCSNDDFKA--LIMKYMP---NGSLENCLYSGTCMLDIFQRLNI 719
            ++H N++ +      + S  +F    L+M +M       +            ++Q L  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 720 MIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT 779
                  L+Y+H   S  ++H DLKP N+ ++ED    I DFG+A+    E        T
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-------MT 181

Query: 780 --LATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--IN 834
             + T  Y APE         +  D++S G ++ EM T K     +F G+  L++   I 
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQLTQIL 237

Query: 835 DLLPVSVMEVIDT 847
            +  V   E +  
Sbjct: 238 KVTGVPGTEFVQK 250

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.2 bits (198), Expect = 7e-16
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 28/217 (12%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKII 679
            +G+G+FG + V +    G +VAVK+ ++Q       +     E + +K  RH +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 680 SSCSNDDFKALIMKYMPNGSLENCLYSGTCM-----LDIFQRLNIMIDVALALEYLHFGH 734
              S      ++M+Y+  G L + +     +       +FQ++   +     ++Y H   
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LS---GVDYCH--- 133

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG---YMAPE-Y 790
              ++H DLKP NVLLD  M A I+DFG++ ++S  + L    +T  + G   Y APE  
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL----RT--SCGSPNYAAPEVI 187

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
             +       D++S G++L  +     P D+  +  L
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER------ALKSFEDECEVM 667
              +++ +   +G G++G +Y A+   G  VA+K      E       A++    E  ++
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLL 73

Query: 668 KRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           K + H N+V +I    ++    L+ ++M    L+  L      L   Q    +  +   +
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYM 786
            + H      I+H DLKP N+L++ D    ++DFG+A+      +  + ++ TL    Y 
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL---WYR 186

Query: 787 APE--YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           AP+   G+K +  T  D++S G +  EM T K
Sbjct: 187 APDVLMGSK-KYSTSVDIWSIGCIFAEMITGK 217

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 48/243 (19%), Positives = 96/243 (39%), Gaps = 42/243 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
            D +   +LIG GS+G +Y+A        VA+K    +F    +  R L+    E  ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILN 80

Query: 669 RIRHRNLVK---IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           R++   +++   +I       F    ++++   +  L+    +   + +   +  I+ ++
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNL 138

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
            L   ++H    + IIH DLKP+N LL++D    + DFG+A+ ++ E   +I        
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 784 GYMAPEYGTKGR----VCTR-----------------GDVYSYGIMLMEMFTKKKPTDEI 822
                    K +    V TR                  D++S G +  E+    +     
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 823 FIG 825
              
Sbjct: 256 PTN 258

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 48/250 (19%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK---VFHQQYE--RALKSFEDECEVMKR 669
           +  F   +L+G G++G +  A     G  VA+K    F +     R L+    E +++K 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKH 65

Query: 670 IRHRNLVK---IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLN------ 718
            +H N++    I    S ++F    +I + M    L   + +        Q L+      
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--------QMLSDDHIQY 116

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
            +     A++ LH    + +IH DLKPSN+L++ +    + DFG+A+++      + +  
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 779 TL--------ATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSL 829
                     AT  Y APE        +R  DV+S G +L E+F ++     IF G    
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP----IFPGRDYR 229

Query: 830 NRW--INDLL 837
           ++   I  ++
Sbjct: 230 HQLLLIFGII 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 44/224 (19%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFE---DECEVMKRIRHRNLVKII 679
           L+G G+FG + + + +      A+K+  ++   A         E  V++  RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 680 SSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMIDVALA 726
            S    D    +M+Y   G L           E+    Y                ++  A
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIVSA 260

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
           L+YLH   +  +++ DLK  N++LD+D    I+DFG+ K    +       +T   T  Y
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEY 315

Query: 786 MAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
           +APE   +     R  D +  G+++ EM   + P      +++F
Sbjct: 316 LAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 5/157 (3%)

Query: 658 KSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL 717
           K +     V  + R  ++    SS S+   +   +  +        LY     L +   +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF--LTLEHLI 196

Query: 718 NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI 777
                VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +     + 
Sbjct: 197 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
                + +MAPE         + DV+S+G++L E+F+
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEV 666
           ++ +++    L+G GS+G +   R    G  VA+K F +  +       A++    E ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77

Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALA 726
           +K++RH NLV ++  C       L+ +++ + ++ + L      LD       +  +   
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGY 785
           + + H   S  IIH D+KP N+L+ +  V  + DFG A+ L+   +    ++ T     Y
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW---Y 190

Query: 786 MAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            APE       YG    V    DV++ G ++ EMF  +
Sbjct: 191 RAPELLVGDVKYGKA--V----DVWAIGCLVTEMFMGE 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 5e-15
 Identities = 50/242 (20%), Positives = 100/242 (41%), Gaps = 47/242 (19%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
            DR+   +LIG GS+G +  A    +   VA+K    VF    +  R L+    E  ++ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107

Query: 669 RIRHRNLVK---IISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDV 723
           R+ H ++VK   I+     + F    ++++   +   +    +   + ++  +  ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
            + ++Y+H   S  I+H DLKP+N L+++D    + DFG+A+ +   +  + Q+      
Sbjct: 166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 784 GYMAPEYGTKGR---------VCTR-----------------GDVYSYGIMLMEMFTKKK 817
             M        +         V TR                  DV+S G +  E+    K
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 818 PT 819
             
Sbjct: 283 EN 284

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 38/218 (17%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEVMKR 669
           +++ +   IG GS+G ++  R    G  VA+K F +  +       AL+    E  ++K+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           ++H NLV ++          L+ +Y  + ++ + L      +      +I      A+ +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL----ATIGY 785
            H       IH D+KP N+L+ +  V  + DFG A+       L+          AT  Y
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR------LLTGPSDYYDDEVATRWY 168

Query: 786 MAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            +PE       YG    V    DV++ G +  E+ +  
Sbjct: 169 RSPELLVGDTQYGPP--V----DVWAIGCVFAELLSGV 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 75.2 bits (186), Expect = 6e-15
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER------ALKSFEDECEVMKRI 670
           +++     IG G++G +Y A+   G   A+K    + E        ++    E  ++K +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           +H N+VK+           L+ +++    L+  L      L+     + ++ +   + Y 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAPE 789
           H      ++H DLKP N+L++ +    I+DFG+A+      +  + +I TL    Y AP+
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL---WYRAPD 170

Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G+K +  T  D++S G +  EM    
Sbjct: 171 VLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 36/230 (15%), Positives = 79/230 (34%), Gaps = 22/230 (9%)

Query: 324 NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL 383
             +   +I ++     +   L+L   +L       FS L  +  + ++ +     +    
Sbjct: 17  RVT-CKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS 75

Query: 384 -CHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFID 441
             +L+++  + ++  +    I    L  L  L+ L +                 D+  + 
Sbjct: 76  FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM--------FPDLTKV- 126

Query: 442 VSSNSLNVLIGLNFSRNNLSGDIPI-TIGGLKN-LQQMFLEYNRLEGSIPESFGDLSSLE 499
               S ++   L  + N     IP+    GL N    + L  N    S+     + + L+
Sbjct: 127 ---YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182

Query: 500 VLDLSKNKISGAIPA-SLQKLL-YLKHLNLSFNKLEGEIPRGGPFANLTA 547
            + L+KNK    I   +   +      L++S   +   +P  G   +L  
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG-LEHLKE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 47/197 (23%), Positives = 74/197 (37%), Gaps = 12/197 (6%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGS 139
             ++  ++Q  IP       S QTL L    L   IPS  F N+  +  +Y S +     
Sbjct: 16  FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70

Query: 140 LSFFIF-NVSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVT-IFNMS 196
           L    F N+S VT I++        +  +    LP L  L      L     +T +++  
Sbjct: 71  LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTD 130

Query: 197 ALKEIYLLNNSLSGSLPSRIDLSLPNV-ETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
               + + +N    S+P      L N   TL L  N F  +V     N +KL  + L  N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKN 189

Query: 256 LFSGFIP-NTFVNMADN 271
            +   I  + F  +   
Sbjct: 190 KYLTVIDKDAFGGVYSG 206

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 27/169 (15%), Positives = 46/169 (27%), Gaps = 21/169 (12%)

Query: 382 ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFID 441
             C   +     +        IPS      S + L L      +       NL +I  I 
Sbjct: 6   PPCECHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61

Query: 442 VSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSSLEV 500
           VS +              L      +   L  +  + +   R    I  ++  +L  L+ 
Sbjct: 62  VSID------------VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109

Query: 501 LDLSKNKISGAIPA--SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
           L +    +    P    +        L ++ N     IP    F  L  
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV-NAFQGLCN 156

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 35/232 (15%), Positives = 67/232 (28%), Gaps = 19/232 (8%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
                  ++   +   +P      P    L     +L  +      N+  +  IY+  + 
Sbjct: 11  HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSI-TNASKLSDLELGVNLFSGFIPNTFV 266
               L S    +L  V  + +        +          L  L +       F   T V
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126

Query: 267 ---------NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
                     + DN   +S P  +F   L N  +   L L  N    +   +     L  
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAF-QGLCN--ETLTLKLYNNGFTSVQGYAFNGTKL-D 182

Query: 318 EIILMDNCSISGNIPQVVGNLGNLL-VLELGGNNLTEPIPITFSQLQTLQAL 368
            + L  N  ++       G + +   +L++   ++T         L+ L A 
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 25/159 (15%), Positives = 51/159 (32%), Gaps = 9/159 (5%)

Query: 81  LNISSFNLQGTIPPQL-GNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQL-- 136
           + +S       +      NLS +  +++ + +    I       +  LK L   +  L  
Sbjct: 60  IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119

Query: 137 FGSLSFFIFNVSSVTTIDLSINGLSGEMPREI--GNLPYLARLAFATNNLVGVAPVTIFN 194
           F  L+   ++      ++++ N     +P     G       L    N    V     FN
Sbjct: 120 FPDLTKV-YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSV-QGYAFN 177

Query: 195 MSALKEIYLLNNSLSGSLPSRIDLSLPNV-ETLNLGINS 232
            + L  +YL  N     +       + +    L++   S
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 29/217 (13%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED------ECEVMKRIRHRNLV 676
            +G GSFG + +A   +   +VA+K   +Q    LK  +       E   +K +RH +++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM-----LDIFQRLNIMIDVALALEYLH 731
           K+    +      ++++Y   G L + +     M        FQ++   I    A+EY H
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI---IC---AIEYCH 125

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-Y 790
                 I+H DLKP N+LLD+++   I+DFG++ +++  + L     +     Y APE  
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---YAAPEVI 179

Query: 791 GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
             K       DV+S GI+L  M   + P D+ FI  L
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 29/215 (13%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
              + +   +G G++G++  A   + G +VA+K     F  +    RA +    E  ++K
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLK 79

Query: 669 RIRHRNLVKII----SSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
            +RH N++ ++       + DDF    L+M +M    L   +       D  Q   ++  
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--LVYQ 136

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           +   L Y+H   +  IIH DLKP N+ ++ED    I DFG+A+    + +++     + T
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT---GYVVT 188

Query: 783 IGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
             Y APE        T+  D++S G ++ EM T K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 35/172 (20%), Positives = 66/172 (38%), Gaps = 44/172 (25%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRN 674
           D    + ++G+G  G +      +   + A+K+              E E+  R  +  +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72

Query: 675 LVKII----SSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRL------------- 717
           +V+I+    +  +      ++M+ +  G L             F R+             
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREA 119

Query: 718 -NIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
             IM  +  A++YLH   S  I H D+KP N+L      + +  ++DFG AK
Sbjct: 120 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 52/227 (22%), Positives = 101/227 (44%), Gaps = 38/227 (16%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER------ALKSFEDECEV 666
               ++ +   IG G+FG ++ AR  + G +VA+K    + E+      AL+    E ++
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69

Query: 667 MKRIRHRNLVK---IISSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLN 718
           ++ ++H N+V    I  + ++   +      L+  +  +  L   L +      + +   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 719 IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQ 778
           +M  +   L Y+H      I+H D+K +NVL+  D V  ++DFG+A+  S          
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 779 T--LATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           T  + T+ Y  PE       YG    +    D++  G ++ EM+T+ 
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPP--I----DLWGAGCIMAEMWTRS 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 53/228 (23%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDEC-----EVMKRIRHRNLVK 677
           L+G G+FG + + R +      A+K+  +  E  +   E         V++  RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 678 IISSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMIDVA 724
           +  +    D    +M+Y   G L           E     Y                ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-A 781
            ALEYL   HS  +++ D+K  N++LD+D   HI  +DFG+ K    +       +T   
Sbjct: 116 SALEYL---HSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATM---KTFCG 167

Query: 782 TIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
           T  Y+APE   +     R  D +  G+++ EM   + P      + +F
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 44/209 (21%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYE-----RALKSFEDECEVMKRI 670
           + + + + +G G++ ++Y  +       VA+K    ++E      A++    E  ++K +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
           +H N+V +      +    L+ +Y+    L+  L     ++++      +  +   L Y 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAPE 789
           H      ++H DLKP N+L++E     ++DFG+A+  S   +    ++ TL    Y  P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---WYRPPD 170

Query: 790 --YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              G+     T+ D++  G +  EM T +
Sbjct: 171 ILLGST-DYSTQIDMWGVGCIFYEMATGR 198

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 79/242 (32%)

Query: 624 LIGIGSFGSIYVARLQDGMEV----AVKVF-----------HQQYERALKSFEDECEVMK 668
           ++G GSFG +++ +   G +     A+KV              + ER         +++ 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER---------DILV 81

Query: 669 RIRHRNLVKIISSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQ 715
            + H  +VK+  +   +    LI+ ++  G L           E     Y          
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-------- 133

Query: 716 RLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQL 773
                 ++ALAL++LH   S  II+ DLKP N+LLDE+   HI  +DFG++K     ++ 
Sbjct: 134 ------ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK 182

Query: 774 SIQIQTL-ATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDE 821
           +    +   T+ YMAPE      +          D +S+G+++ EM T   P       E
Sbjct: 183 A---YSFCGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKE 233

Query: 822 IF 823
             
Sbjct: 234 TM 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.9 bits (181), Expect = 1e-13
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 57/269 (21%)

Query: 585 ECWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEV 644
           +  +    P     N+          + ++ TD F+   ++G GSFG + ++  +   E+
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDEL 368

Query: 645 -AVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLVKIISSCSNDDFKALIMKYMPN 697
            AVK+  +  +  ++  + EC ++ KR+     +   L ++ S     D    +M+Y+  
Sbjct: 369 YAVKILKK--DVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426

Query: 698 GSLENCLYSGTCMLDIFQRLNIMI---------DVALALEYLHFGHSTPIIHCDLKPSNV 748
           G L         M  I Q++             ++A+ L +L    S  II+ DLK  NV
Sbjct: 427 GDL---------MYHI-QQVGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNV 473

Query: 749 LLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE------YGTKGRVCTR 799
           +LD +   HI  +DFG+ K    +   +   +T   T  Y+APE      YG    V   
Sbjct: 474 MLDSE--GHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAYQPYGKS--V--- 523

Query: 800 GDVYSYGIMLMEMFTKKKP-----TDEIF 823
            D +++G++L EM   + P      DE+F
Sbjct: 524 -DWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 33/223 (14%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFED------- 662
           ++     R+ + + +G G F ++Y AR       VA+K     +       +D       
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR---SEAKDGINRTAL 60

Query: 663 -ECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
            E ++++ + H N++ ++ +  +    +L+  +M    LE  +   + +L        M+
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYML 119

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTL 780
                LEYLH  H   I+H DLKP+N+LLDE+ V  ++DFG+AK     ++  + Q+ T 
Sbjct: 120 MTLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176

Query: 781 ATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
               Y APE       YG    V    D+++ G +L E+  + 
Sbjct: 177 ---WYRAPELLFGARMYGVG--V----DMWAVGCILAELLLRV 210

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 50/231 (21%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR--LQDGMEVAVKVFHQQYER------------ALKS 659
           RA  ++     IG G++G ++ AR     G  VA+K    Q                L+ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 660 FEDECEVMKRIRHRNLVK---IISSCSNDDFKA--LIMKYMPN---GSLENCLYSGTCML 711
                  ++   H N+V+   + +    D      L+ +++       L+         +
Sbjct: 68  -------LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGV 117

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                 ++M  +   L++LH   S  ++H DLKP N+L+       ++DFG+A++ S + 
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 772 QLSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            L+  + TL    Y APE      Y T   V    D++S G +  EMF +K
Sbjct: 175 ALTSVVVTL---WYRAPEVLLQSSYATP--V----DLWSVGCIFAEMFRRK 216

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 46/233 (19%), Positives = 92/233 (39%), Gaps = 46/233 (19%)

Query: 614 RATDRFS-ENNLIGIGSFGSIYVARLQD---GMEVAVKVFHQQYERALKSFEDECEVMKR 669
           R  D F  E   +G G++G +Y A+ +D     + A+K           S   E  +++ 
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRE 74

Query: 670 IRHRNLVK---IISSCSND-----------DFKALIMKYMPNGSLENCLYSGTCMLDIFQ 715
           ++H N++    +  S ++            D   + +K+                L    
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHI-IKFHRASKANK----KPVQLPRGM 129

Query: 716 RLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGED 771
             +++  +   + YLH   +  ++H DLKP+N+L+  +        I+D G A+L +   
Sbjct: 130 VKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186

Query: 772 Q-LSIQIQTLATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           + L+     + T  Y APE       Y     +    D+++ G +  E+ T +
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKA--I----DIWAIGCIFAELLTSE 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 48/231 (20%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEV------ 666
            AT R+     IG+G++G++Y AR    G  VA+K                  +      
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-----GGGGGLPISTVR 60

Query: 667 -------MKRIRHRNLVK---IISSCSNDDFKA--LIMKYMPN---GSLENCLYSGTCML 711
                  ++   H N+V+   + ++   D      L+ +++       L+         L
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGL 117

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                 ++M      L++LH   +  I+H DLKP N+L+       ++DFG+A++ S + 
Sbjct: 118 PAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 772 QLSIQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
            L+  + TL    Y APE      Y T   V    D++S G +  EMF +K
Sbjct: 175 ALTPVVVTL---WYRAPEVLLQSTYATP--V----DMWSVGCIFAEMFRRK 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 50/231 (21%), Positives = 97/231 (41%), Gaps = 40/231 (17%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK----VFHQQYE--RALKSFEDECEVMK 668
             ++     +G G++G ++ +   + G  VAVK     F    +  R  +    E  ++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63

Query: 669 RIR-HRNLVKIISSCSNDDFKA--LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
            +  H N+V +++    D+ +   L+  YM    L   + +        Q   ++  +  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ--YVVYQLIK 120

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL----- 780
            ++YLH   S  ++H D+KPSN+LL+ +    ++DFG+++      +++  I        
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 781 --------------ATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKK 816
                         AT  Y APE        T+G D++S G +L E+   K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 57/232 (24%)

Query: 624 LIGIGSFGSIYVARLQDGMEV----AVKVFH----QQYERALKSFEDECEVMKRIRHRNL 675
           ++G G +G ++  R   G       A+KV       +  +     + E  +++ ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 676 VKIISSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMID 722
           V +I +        LI++Y+  G L           E+  C Y                +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA--------------E 129

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL 780
           +++AL +LH      II+ DLKP N++L+     H+  +DFG+ K    +  ++    T 
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVT---HTF 181

Query: 781 A-TIGYMAPEYGTK---GRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
             TI YMAPE   +    R     D +S G ++ +M T   P       +  
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV---DWWSLGALMYDMLTGAPPFTGENRKKTI 230

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 34/222 (15%)

Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER-----ALKSFEDECEV 666
           + ++ +F +   +G G++ ++Y       G+ VA+K      E      A++    E  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISL 56

Query: 667 MKRIRHRNLVKIISSCSNDDFKALIMKYMPN---GSLENCLYSGT-CMLDIFQRLNIMID 722
           MK ++H N+V++      ++   L+ ++M N     +++     T   L++         
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSIQIQTLA 781
           +   L + H      I+H DLKP N+L+++     + DFG+A+         S ++ TL 
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL- 172

Query: 782 TIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
              Y AP+       Y T   +    D++S G +L EM T K
Sbjct: 173 --WYRAPDVLMGSRTYSTS--I----DIWSCGCILAEMITGK 206

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 35/159 (22%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH-RNLVKIISSC 682
           IG G+FG + + + L     VA+K+   +          E    K++     + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 683 SNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQR----------LNIMIDVALALEYLH 731
               + A++++ +  G SLE          D+F            L I I +   +EY+H
Sbjct: 75  PCGKYNAMVLELL--GPSLE----------DLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 732 FGHSTPIIHCDLKPSNVLL-----DEDMVAHISDFGIAK 765
              S  +I+ D+KP N L+         V HI DF +AK
Sbjct: 123 ---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 69.6 bits (171), Expect = 7e-13
 Identities = 45/221 (20%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQ-QYERALKSFEDECEVMKRIR-H 672
            D +     +G G +  ++ A  + +  +V VK+    + ++  +    E ++++ +R  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGG 90

Query: 673 RNLVKII----SSCSNDDFKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVAL 725
            N++ +        S     AL+ +++ N   +    + T       +++ L        
Sbjct: 91  PNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK------- 141

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
           AL+Y H   S  I+H D+KP NV++D E     + D+G+A+      + ++++   A+  
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRY 195

Query: 785 YMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +  PE       Y          D++S G ML  M  +K+P
Sbjct: 196 FKGPELLVDYQMYDYS------LDMWSLGCMLASMIFRKEP 230

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.4 bits (173), Expect = 8e-13
 Identities = 79/472 (16%), Positives = 154/472 (32%), Gaps = 101/472 (21%)

Query: 100 SSLQTLDLSHNKLSGN-IPSSIFNMHTLKLLYFSDNQL----FGSLSFFIFNVSSVTTID 154
             +Q+LD+   +LS       +  +   +++   D  L       +S  +    ++  ++
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 155 LSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS----G 210
           L  N L       +            T +              ++++ L N  L+    G
Sbjct: 63  LRSNELGDVGVHCVLQ-------GLQTPS------------CKIQKLSLQNCCLTGAGCG 103

Query: 211 SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD 270
            L S    +LP ++ L+L  N               L +  L             + +  
Sbjct: 104 VL-SSTLRTLPTLQELHLSDNLL------GDAGLQLLCEGLLDPQC-----RLEKLQLEY 151

Query: 271 NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG----ILPKSKGNLSLSLEIILMDNCS 326
             L++++ E    S L      K L ++ N ++     +L +   +    LE + +++C 
Sbjct: 152 CSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL----AGPITDE 382
           ++        +L  ++                 +   +L+ L L  NKL       +   
Sbjct: 211 VT---SDNCRDLCGIV-----------------ASKASLRELALGSNKLGDVGMAELCPG 250

Query: 383 LCH-LARLHSLVLQGNKFS----GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKD- 436
           L H  +RL +L +     +    G +   L    SL+ L L  N            L D 
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN-----------ELGDE 299

Query: 437 --ILFIDVSSNSLNVLIGLNFSRNNLSGD----IPITIGGLKNLQQMFLEYNRLEGSIPE 490
              L  +        L  L     + +          +   + L ++ +  NRLE +   
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359

Query: 491 SFGDL-----SSLEVLDLSKNKIS----GAIPASLQKLLYLKHLNLSFNKLE 533
                     S L VL L+   +S     ++ A+L     L+ L+LS N L 
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 85/478 (17%), Positives = 148/478 (30%), Gaps = 87/478 (18%)

Query: 96  LGNLSSLQTLDLSHNKLS----GNIPSSIFNMHTLKLLYFSDNQLFGS-----LSFFIFN 146
           L  L   Q + L    L+     +I S++     L  L    N+L        L      
Sbjct: 24  LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83

Query: 147 VSSVTTIDLSINGLSGE----MPREIGNLPYLARLAFATNNLVGVAPVTIFNM-----SA 197
              +  + L    L+G     +   +  LP L  L  + N L       +          
Sbjct: 84  SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143

Query: 198 LKEIYLLNNSLSGSLPSRIDLSL---PNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
           L+++ L   SLS +    +   L   P+ + L +  N         +    K S  +L  
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL-- 201

Query: 255 NLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPL--DGI--LPKSK 310
                      + +    +TS          + +   L+ L L  N L   G+  L    
Sbjct: 202 ---------EALKLESCGVTSDNCR-DLCGIVASKASLRELALGSNKLGDVGMAELCPGL 251

Query: 311 GNLSLSLEIILMDNCSIS----GNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQL---- 362
            + S  L  + +  C I+    G++ +V+    +L  L L GN L +       +     
Sbjct: 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311

Query: 363 -QTLQALGLTRNKL----AGPITDELCHLARLHSLVLQGNKFSGSIPSCLG-----NLTS 412
              L++L +             +  L     L  L +  N+   +    L        + 
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371

Query: 413 LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLK 472
           LRVL+L     + +   +  +L   L     +N    L  L+ S N L         G+ 
Sbjct: 372 LRVLWLADCDVSDS---SCSSLAATL----LANH--SLRELDLSNNCLGDA------GIL 416

Query: 473 NLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL----YLKHLN 526
            L +   +                 LE L L     S  +   LQ L      L+ ++
Sbjct: 417 QLVESVRQPG-------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.0 bits (172), Expect = 9e-13
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVMKR------IRHRNLV 676
           +IG GSFG + +AR +      AVKV   Q +  LK  E++  + +R      ++H  LV
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 677 KIISSCSNDDFKALIMKYMPNGSL-----------EN--CLYSGTCMLDIFQRLNIMIDV 723
            +  S    D    ++ Y+  G L           E     Y+               ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 724 ALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL- 780
           A AL YLH   S  I++ DLKP N+LLD     HI  +DFG+ K     +  +    T  
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTT---STFC 200

Query: 781 ATIGYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
            T  Y+APE     +   R  D +  G +L EM     P     T E++
Sbjct: 201 GTPEYLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.6 bits (171), Expect = 9e-13
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 44/224 (19%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLV 676
           ++G GSFG + +AR+++  ++ AVKV  +  +  L+  + EC +  KRI      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKK--DVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LALE 728
           ++       D    +M+++  G L         M  I +        A         AL 
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDL---------MFHIQKSRRFDEARARFYAAEIISALM 138

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
           +L   H   II+ DLK  NVLLD +   H   +DFG+ K        +    T   T  Y
Sbjct: 139 FL---HDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTT---ATFCGTPDY 190

Query: 786 MAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
           +APE   +  +     D ++ G++L EM     P      D++F
Sbjct: 191 IAPEI-LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 13/147 (8%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH-RNLVKIISSC 682
           IG GSFG IY+   +  G EVA+K+   + +        E ++ K ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 683 SNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
           +  D+  ++M+ +  G SLE+     +    +   L +   +   +EY+H   S   IH 
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129

Query: 742 DLKPSNVLL---DEDMVAHISDFGIAK 765
           D+KP N L+    +  + +I DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 40/240 (16%)

Query: 599 NSPQAIRRFSYHEL--LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYER 655
              Q     S        + DR+     +G G++G +Y A        VA+K    ++E 
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73

Query: 656 ------ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC 709
                 A++    E  ++K ++HRN++++ S   ++    LI +Y  N  L+  +     
Sbjct: 74  EGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP- 127

Query: 710 MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH-----ISDFGIA 764
            + +    + +  +   + + H   S   +H DLKP N+LL     +      I DFG+A
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

Query: 765 KLLSGEDQ-LSIQIQTLATIGYMAPE-------YGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           +      +  + +I TL    Y  PE       Y T   V    D++S   +  EM  K 
Sbjct: 185 RAFGIPIRQFTHEIITL---WYRPPEILLGSRHYSTS--V----DIWSIACIWAEMLMKT 235

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 29/207 (14%)

Query: 344 LELGGNNLTEPIPITFSQLQTLQALGLTRNKL-AGPITDELCHLARLHSLVLQGNKFSGS 402
             L   ++T+ +    ++L ++  +    + + +        +L  +  L L GNK    
Sbjct: 24  ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ---YLPNVRYLALGGNKLH-D 77

Query: 403 IPSCLGNLTSLRVLYLGLNRFTSALPSTIWN-LKDILFIDVSSNSLNVLIGLNFSRNNLS 461
           I + L  LT+L  L L  N+  S LP+ +++ L ++  + +  N L  L    F +    
Sbjct: 78  ISA-LKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDK---- 131

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPASL-QKL 519
                    L NL  + L +N+L+ S+P+  F  L++L  LDLS N++  ++P  +  KL
Sbjct: 132 ---------LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLT 546
             LK L L  N+L+  +P G  F  LT
Sbjct: 181 TQLKDLRLYQNQLKS-VPDGV-FDRLT 205

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 28/133 (21%), Positives = 50/133 (37%), Gaps = 23/133 (17%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
             P             L     T    +    L  I  I  +++ +  + G         
Sbjct: 12  IFPD--DAFAETIKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSVQG--------- 58

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL-QKLL 520
                 I  L N++ + L  N+L   I  +  +L++L  L L+ N++  ++P  +  KL 
Sbjct: 59  ------IQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLT 109

Query: 521 YLKHLNLSFNKLE 533
            LK L L  N+L+
Sbjct: 110 NLKELVLVENQLQ 122

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 54/229 (23%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLV 676
           ++G GSFG + ++  +   E+ AVK+  +  +  ++  + EC ++ KR+     +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LALE 728
           ++ S     D    +M+Y+  G L         M  I Q        A        + L 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
           +L    S  II+ DLK  NV+LD +   HI  +DFG+ K    +   +   +T   T  Y
Sbjct: 136 FL---QSKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTT---KTFCGTPDY 187

Query: 786 MAPE------YGTKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIF 823
           +APE      YG    V    D +++G++L EM   + P      DE+F
Sbjct: 188 IAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 41/215 (19%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM--KRI-----RHRNL 675
           +IG GS+  + + RL+    + A+KV  +  E      + +  V   K +      H  L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKK--ELVNDDEDIDW-VQTEKHVFEQASNHPFL 72

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LAL 727
           V + S    +     +++Y+  G L         M  + ++  +  + A        LAL
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDL---------MFHMQRQRKLPEEHARFYSAEISLAL 123

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIG 784
            YL   H   II+ DLK  NVLLD +   HI  +D+G+ K        +    T   T  
Sbjct: 124 NYL---HERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTT---STFCGTPN 175

Query: 785 YMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           Y+APE   +G       D ++ G+++ EM   + P
Sbjct: 176 YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 56/226 (24%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRHRNLVKIIS 680
            +G G F ++++A+ + +   VA+K+    + Y  A    EDE ++++R+   +  K   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTK--- 79

Query: 681 SCSNDDFKALIMKYMPNGSLENCLYSGTCM--------LDIFQRLN------------IM 720
              +      I+K + + + +        M        L    +              I 
Sbjct: 80  --EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH------ISDFGIAKLLSGEDQLS 774
             + L L+Y+H      IIH D+KP NVL++            I+D G A     ++  +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYT 193

Query: 775 IQIQTLATIGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFT 814
             IQT     Y +PE      +G         D++S   ++ E+ T
Sbjct: 194 NSIQTRE---YRSPEVLLGAPWGCG------ADIWSTACLIFELIT 230

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 39/214 (18%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM-KRI-----RHRNLV 676
           +IG GS+  + + RL+    + A++V  +  E      + +     K +      H  LV
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKK--ELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LALE 728
            + S    +     +++Y+  G L         M  + ++  +  + A        LAL 
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL---------MFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSIQIQTL-ATIGY 785
           YL   H   II+ DLK  NVLLD +   HI  +D+G+ K        +    T   T  Y
Sbjct: 168 YL---HERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTT---STFCGTPNY 219

Query: 786 MAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           +APE   +G       D ++ G+++ EM   + P
Sbjct: 220 IAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 48/226 (21%)

Query: 624 LIGIGSFGSIYVARLQDGMEV-AVKVFHQQYERALKSFEDECEVM--KRI-----RHRNL 675
           ++G GSFG +++A  +   +  A+K   +  +  L   + EC  M  KR+      H  L
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVEC-TMVEKRVLSLAWEHPFL 80

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LAL 727
             +  +    +    +M+Y+  G L         M  I       +  A        L L
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDL---------MYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKL-LSGEDQLSIQIQTL-ATI 783
           ++L   HS  I++ DLK  N+LLD+D   HI  +DFG+ K  + G+ + +    T   T 
Sbjct: 132 QFL---HSKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTN----TFCGTP 182

Query: 784 GYMAPEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP-----TDEIF 823
            Y+APE    G+      D +S+G++L EM   + P      +E+F
Sbjct: 183 DYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 624 LIGIGSFGSIYVARLQDGMEV----AVKVFHQ----QYERALKSFEDECEVMKRIRHRN- 674
           ++G G++G +++ R   G +     A+KV  +    Q  +  +    E +V++ IR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA--------LA 726
           LV +  +   +    LI+ Y+  G L            + QR                LA
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL---------FTHLSQRERFTEHEVQIYVGEIVLA 171

Query: 727 LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKL-LSGEDQLSIQIQTLA-T 782
           LE+L   H   II+ D+K  N+LLD +   H+  +DFG++K  ++ E + +        T
Sbjct: 172 LEHL---HKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERA---YDFCGT 223

Query: 783 IGYMAPE------YGTKGRVCTRGDVYSYGIMLMEMFT 814
           I YMAP+       G    V    D +S G+++ E+ T
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLT 257

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 17/150 (11%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH-RNLVKIISSC 682
           IG GSFG I+    L +  +VA+K   ++ +       DE    K +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 683 SNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
                  L++  +  G SLE+ L        +         +   ++ +H      +++ 
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130

Query: 742 DLKPSNVLL------DEDMVAHISDFGIAK 765
           D+KP N L+      + +M+ ++ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 67.2 bits (163), Expect = 2e-11
 Identities = 88/530 (16%), Positives = 160/530 (30%), Gaps = 147/530 (27%)

Query: 358 TFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY 417
            ++  Q      ++R +    +   L  L    ++++ G   SG   + +          
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK--TWVALDV-CLS-- 173

Query: 418 LGLNRFTSALPSTI-W-NLK------DILFIDVSSNSLNVLIGLNF-SRNNLSGDIPITI 468
               +    +   I W NLK       +L +      L   I  N+ SR++ S +I + I
Sbjct: 174 ---YKVQCKMDFKIFWLNLKNCNSPETVLEM---LQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 469 GGLKNLQQMFLEYNRLEGS-----------IPESFGDLSSLEVLDLSKNK-ISGAIPASL 516
             ++   +  L+    E                +F +LS  ++L  ++ K ++  + A+ 
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NLSC-KILLTTRFKQVTDFLSAAT 285

Query: 517 QKLLYLKH-----------------LNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKML 559
              + L H                 L+     L  E+    P                  
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-----------------R 328

Query: 560 LLVIILPLSTALIVVVTLTLK-WKLIECWKSRTGPSNDGIN--SPQAIRRFSYHELLRAT 616
            L II       I     T   WK + C K  T   +  +N   P   R+  +  L  + 
Sbjct: 329 RLSII----AESIRDGLATWDNWKHVNCDKLTTIIESS-LNVLEPAEYRKM-FDRL--SV 380

Query: 617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVF----------------HQQYERALKS 659
             F  +  I       I+   +  D M V  K+                    Y      
Sbjct: 381 --FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438

Query: 660 FEDECEVMKR-IRHRNLVKIISSCSNDDFKALIMKYMPN--GS-LENCLYSGTCMLDIFQ 715
            E+E  + +  + H N+ K  +  S+D     + +Y  +  G  L+N  +     + +F+
Sbjct: 439 LENEYALHRSIVDHYNIPK--TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE--RMTLFR 494

Query: 716 RLNIMIDVALALEYLHFG-------HSTPIIHCDLKPSNVLLD---------------ED 753
            +           +L F        H +   +      N L                 E 
Sbjct: 495 MV-----------FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543

Query: 754 MVAHISDFGIAKLLSGEDQLSIQIQT-LATIGYMAPE---YGTKGRVCTR 799
           +V  I DF    L   E+ L     T L  I  MA +   +    +   R
Sbjct: 544 LVNAILDF----LPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 3e-08
 Identities = 87/494 (17%), Positives = 151/494 (30%), Gaps = 130/494 (26%)

Query: 86  FNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH--------TLKLLYFSDNQLF 137
           +N          N+S LQ        L    P+    +          + L      ++ 
Sbjct: 120 YNDNQVFAK--YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 138 GSLSFFIF--NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA-PVTIFN 194
             + F IF  N+ +  + +  +  L          L Y     + + +       + I +
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQ--------KLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 195 MSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV 254
           + A     L +      L     L L NV+      N+F  +    +T   K       V
Sbjct: 230 IQAELRRLLKSKPYENCL-----LVLLNVQNAKA-WNAFNLSCKILLTTRFK------QV 277

Query: 255 NLFSGFIPNTFVNMADNYLTSSTPE-LSFLSSLTNCK--KLKVLILTGNPL--------- 302
             F      T +++  + +T +  E  S L    +C+   L   +LT NP          
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 303 -DGI----------LPKSKGNLSLSLEII-------LMDNCSI---SGNIP--------- 332
            DG+            K    +  SL ++       + D  S+   S +IP         
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397

Query: 333 --------QVVGNLGNLLVLELGGNNLTEPIP-ITFS---QLQTLQAL------------ 368
                    VV  L    ++E      T  IP I      +L+   AL            
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457

Query: 369 GLTRNKLAGPITDE--LCHLARLH-SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS 425
               + L  P  D+    H+   H   +    + +             R+++L   RF  
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMT-----------LFRMVFLDF-RFLE 504

Query: 426 A---LPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
                 ST WN         S + LN L  L F +  +  + P     +  +   FL   
Sbjct: 505 QKIRHDSTAWN--------ASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD-FLP-- 553

Query: 483 RLEGSIPES-FGDL 495
           ++E ++  S + DL
Sbjct: 554 KIEENLICSKYTDL 567

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 25/163 (15%)

Query: 392 LVLQGNKFSGSIPS--CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV 449
           L L  N  S  + +      LT+L  L L  N            + ++ ++D+SSN L+ 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102

Query: 450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKI 508
           L    FS              L+ L+ + L  N +   +   +F D++ L+ L LS+N+I
Sbjct: 103 LDEFLFS-------------DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148

Query: 509 SGAIPA----SLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
           S   P        KL  L  L+LS NKL+ ++P       L A
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL-TDLQKLPA 188

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 43/211 (20%), Positives = 71/211 (33%), Gaps = 51/211 (24%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTE-PIPITFSQLQTLQALGLTRNKLAGPITDELC 384
           ++  ++P          +L+L  NNL+      T ++L  L +L L+ N L    ++   
Sbjct: 32  NVPQSLPS------YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFV 85

Query: 385 HLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVS 443
            +  L  L L  N    ++      +L +L VL L  N         I  +    F    
Sbjct: 86  PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH--------IVVVDRNAF---- 132

Query: 444 SNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE----SFGDLSSLE 499
                                      +  LQ+++L  N++    P         L  L 
Sbjct: 133 -------------------------EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166

Query: 500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           +LDLS NK+       LQKL       L  +
Sbjct: 167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 34/142 (23%), Positives = 57/142 (40%), Gaps = 23/142 (16%)

Query: 402 SIPSCLGNL-TSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNL 460
           ++P    +L +   +L L  N  +             L  + +   L  L  L  S N+L
Sbjct: 32  NVPQ---SLPSYTALLDLSHNNLSR------------LRAEWTPTRLTNLHSLLLSHNHL 76

Query: 461 SGDIPI-TIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSSLEVLDLSKNKISGAIPA-SLQ 517
           +  I       + NL+ + L  N L  ++    F DL +LEVL L  N I   +   + +
Sbjct: 77  N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133

Query: 518 KLLYLKHLNLSFNKLEGEIPRG 539
            +  L+ L LS N++    P  
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVE 154

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 10/155 (6%)

Query: 85  SFNLQGTIPPQ--LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLS 141
           S N    +  +     L++L +L LSHN L+  I S  F  +  L+ L  S N L  +L 
Sbjct: 47  SHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL-HTLD 104

Query: 142 FFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP---VTIFNMSA 197
            F+F ++ ++  + L  N +         ++  L +L  + N +             +  
Sbjct: 105 EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINS 232
           L  + L +N L   LP      LP      L +++
Sbjct: 165 LMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 41/159 (25%), Positives = 62/159 (38%), Gaps = 9/159 (5%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSI 157
           S    LDLSHN LS          +  L  L  S N L   +S   F  V ++  +DLS 
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSS 97

Query: 158 NGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
           N L   +   +  +L  L  L    N++V V      +M+ L+++YL  N +S   P  +
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 217 ---DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL 252
                 LP +  L+L  N       + +          L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 34/137 (24%), Positives = 63/137 (45%), Gaps = 13/137 (9%)

Query: 81  LNISSFNLQGTIPPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFG 138
           L +S  +L   I  +    + +L+ LDLS N L   +   +F ++  L++L   +N +  
Sbjct: 69  LLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-V 125

Query: 139 SLSFFIF-NVSSVTTIDLSINGLSGEMPREI----GNLPYLARLAFATNNLVGVAPVTIF 193
            +    F +++ +  + LS N +S   P E+      LP L  L  ++N L  +    + 
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ 184

Query: 194 NMSALKE--IYLLNNSL 208
            + A  +  +YL NN L
Sbjct: 185 KLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 40/225 (17%), Positives = 76/225 (33%), Gaps = 56/225 (24%)

Query: 151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNNSLS 209
             +  S   L   +P+ +    Y A L  + NNL  +        ++ L  + L +N L+
Sbjct: 21  NILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 210 GSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMA 269
             + S   + +PN+  L+L  N               L  L+             F ++ 
Sbjct: 78  -FISSEAFVPVPNLRYLDLSSN--------------HLHTLD----------EFLFSDLQ 112

Query: 270 DNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISG 329
                                 L+VL+L  N +  +   +  +++  L+ + +    IS 
Sbjct: 113 ---------------------ALEVLLLYNNHIVVVDRNAFEDMA-QLQKLYLSQNQIS- 149

Query: 330 NIP----QVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGL 370
             P    +    L  L++L+L  N L +       +L      GL
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 29/166 (17%), Positives = 64/166 (38%), Gaps = 31/166 (18%)

Query: 625 IGIGSFGSIYVAR---------LQDGMEVAVKV-------FHQQ--YERALKSFEDECEV 666
               + G +Y A               + ++K+       F++Q  ++RA K  +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 667 -MKRIRHRNLVKIISSCSN-DDFKALIMKYMPNG-SLENCL-YSGTCMLDIFQRLNIMID 722
            +       +   +    + D ++ L++  +  G SL++ L  S   +L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
           +  ALE+LH       +H ++   N+ +   D+  V  ++ +G A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 4e-11
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 13/147 (8%)

Query: 625 IGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV-KIISSC 682
           IG GSFG IY+   +Q   EVA+K+ + + +        E ++ + ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 683 SNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC 741
              D+  L+M  +  G SLE+     +  L +   L +   +   +E++H       +H 
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127

Query: 742 DLKPSNVLLDEDMVAH---ISDFGIAK 765
           D+KP N L+     A+   I DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 5e-11
 Identities = 55/293 (18%), Positives = 84/293 (28%), Gaps = 30/293 (10%)

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS 326
           + A   +   TP+     S      L    L                    E +L+ +  
Sbjct: 279 DEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP 338

Query: 327 ISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHL 386
                 +       L   EL     T  +       + LQ L          I   +  L
Sbjct: 339 ECW--CRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRAL 395

Query: 387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR--FTSALPSTIWNLKDILFIDVSS 444
             L         FS      L  +  +R  YL   R  F            D+  + ++ 
Sbjct: 396 DPLLYEKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
             L VL  L                 L  +  + L +NRL  ++P +   L  LEVL  S
Sbjct: 451 KDLTVLCHL---------------EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEG--EIPRGGPFANLTAKSFMGNEL 555
            N +   +   +  L  L+ L L  N+L+    I        L   +  GN L
Sbjct: 495 DNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 1e-10
 Identities = 42/261 (16%), Positives = 83/261 (31%), Gaps = 27/261 (10%)

Query: 264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL-SLEIILM 322
           T  +     +        +       ++L    L+      +  + +    L  LE    
Sbjct: 323 TGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENK 382

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDE 382
                   + + +  L          + L    P+  + L  L++  L  N +       
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSV------L 436

Query: 383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDV 442
               A +  L L     +  +   L  L  +  L L  NR  + LP  +  L+ +  +  
Sbjct: 437 KMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQA 493

Query: 443 SSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVL 501
           S N+L           N+ G     +  L  LQ++ L  NRL+  +  +       L +L
Sbjct: 494 SDNALE----------NVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538

Query: 502 DLSKNKISGAIPASLQKLLYL 522
           +L  N +        ++L  +
Sbjct: 539 NLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.2 bits (145), Expect = 2e-09
 Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 34/182 (18%)

Query: 48  DHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDL 107
           D       +   S  +     +  +    RV+ L     +   T+   L  L  +  LDL
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA----HKDLTVLCHLEQLLLVTHLDL 470

Query: 108 SHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPRE 167
           SHN+L   +P ++  +  L++L  SDN L                +D             
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNAL--------------ENVD------------G 503

Query: 168 IGNLPYLARLAFATNNLVGVAPV-TIFNMSALKEIYLLNNSLSG--SLPSRIDLSLPNVE 224
           + NLP L  L    N L   A +  + +   L  + L  NSL     +  R+   LP+V 
Sbjct: 504 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563

Query: 225 TL 226
           ++
Sbjct: 564 SI 565

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 21/160 (13%)

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWN-LKDILFIDVSSNSLNV 449
            L LQ    +    +    LT L  L L  N+  + L + +++ L ++  + +++N L  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS 97

Query: 450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKI 508
           L    F               L  L +++L  N+L+ S+P   F  L+ L+ L L+ N++
Sbjct: 98  LPLGVFDH-------------LTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143

Query: 509 SGAIPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             +IPA    KL  L+ L+LS N+L+  +P G  F  L  
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGA-FDRLGK 180

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 54/207 (26%), Positives = 80/207 (38%), Gaps = 47/207 (22%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
           S+   IP       +   L+L    L      TF  L  L  L L  N+L          
Sbjct: 28  SVPSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81

Query: 386 LARLHSLVLQGNKFSGSIPSCL-GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
           L  L +L L  N+ + S+P  +  +LT L  LYLG N+  S LPS +             
Sbjct: 82  LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGV------------- 126

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDL 503
                     F R             L  L+++ L  N+L+ SIP   F  L++L+ L L
Sbjct: 127 ----------FDR-------------LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162

Query: 504 SKNKISGAIPASLQKLLYLKHLNLSFN 530
           S N++      +  +L  L+ + L  N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 18/163 (11%)

Query: 151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFN-MSALKEIYLLNNSLS 209
             +DL   GL+         L  L  L    N L  +    +F+ ++ L  + L NN L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLA 96

Query: 210 GSLPSRIDLSLPNVETLNLGINSFYGTVPSSI-TNASKLSDLELGVN--------LFSGF 260
            SLP  +   L  ++ L LG N    ++PS +    +KL +L L  N         F   
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154

Query: 261 IPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
                ++++ N L S  P  +F        KL+ + L GN  D
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAF----DRLGKLQTITLFGNQFD 192

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 20/148 (13%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
            IP  +        L L  N FT    + I+              L  L  +NFS N ++
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFK------------KLPQLRKINFSNNKIT 70

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPA-SLQKL 519
                   G   + ++ L  NRLE ++    F  L SL+ L L  N+I+  +   S   L
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             ++ L+L  N++   +  G  F  L +
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGA-FDTLHS 154

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 25/113 (22%), Positives = 48/113 (42%), Gaps = 2/113 (1%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
            L  L  +    N +T+     F     +  + LT N+L          L  L +L+L+ 
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114

Query: 397 NKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN 448
           N+ +  + +     L+S+R+L L  N+ T+  P     L  +  +++ +N  N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 25/126 (19%), Positives = 52/126 (41%), Gaps = 6/126 (4%)

Query: 85  SFNLQGTIPPQ--LGNLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLYFSDNQLFGSLS 141
           + N    +        L  L+ ++ S+NK++ +I    F     +  +  + N+L  ++ 
Sbjct: 40  NNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-ENVQ 97

Query: 142 FFIF-NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
             +F  + S+ T+ L  N ++         L  +  L+   N +  VAP     + +L  
Sbjct: 98  HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157

Query: 201 IYLLNN 206
           + LL N
Sbjct: 158 LNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 35/170 (20%), Positives = 56/170 (32%), Gaps = 40/170 (23%)

Query: 363 QTLQALGLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN 421
           Q    L L  N+      T     L +L  +    NK +          + +  + L  N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 422 RFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEY 481
           R  + +   +                       F              GL++L+ + L  
Sbjct: 92  RLEN-VQHKM-----------------------FK-------------GLESLKTLMLRS 114

Query: 482 NRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN 530
           NR+   +   SF  LSS+ +L L  N+I+   P +   L  L  LNL  N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 31/136 (22%), Positives = 60/136 (44%), Gaps = 4/136 (2%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGSLSFFIFN-VSSVTTIDLSI 157
                L L++N+ +    + IF     L+ + FS+N++   +    F   S V  I L+ 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTS 90

Query: 158 NGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRID 217
           N L     +    L  L  L   +N +  V   +   +S+++ + L +N ++ ++     
Sbjct: 91  NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149

Query: 218 LSLPNVETLNLGINSF 233
            +L ++ TLNL  N F
Sbjct: 150 DTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 31/157 (19%), Positives = 52/157 (33%), Gaps = 23/157 (14%)

Query: 148 SSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNN 206
                + L+ N  +      I   LP L ++ F+ N +  +        S + EI L +N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFV 266
            L  ++  ++   L +++TL L  N        S    S +  L L  N  +   P  F 
Sbjct: 92  RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
            +                       L  L L  NP +
Sbjct: 151 TL---------------------HSLSTLNLLANPFN 166

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 34/174 (19%), Positives = 67/174 (38%), Gaps = 48/174 (27%)

Query: 624 LIGIGSFGSIYVA-RLQDGMEVAVKVF------HQQ--YE-RALKSFEDECEVMKRIRHR 673
            IG G FG IY+A       + A  V       +     E +  +    +  + K I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 674 NLVKI---------ISSCSNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQR------- 716
            L  +         ++      ++ ++M+ +  G  L+           I  +       
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ----------KISGQNGTFKKS 151

Query: 717 --LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
             L + I +   LEY+H       +H D+K +N+LL   + D V +++D+G++ 
Sbjct: 152 TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 47/175 (26%)

Query: 624 LIGIGSFGSIYVAR------LQDGMEVAVKVFHQQ-----YE-RALKSFEDECEVMKRIR 671
            IG G FG IY+A       +       VKV          E +  +      ++ K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 672 HRNLVKI---------ISSCSNDDFKALIMKYMPNG-SLENCLYSG--------TCMLDI 713
            R L  +         +   +   ++ +IM     G  L+    +            L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 765
            +    ++D+   LEY+   H    +H D+K SN+LL   + D V ++ D+G+A 
Sbjct: 160 -R----ILDI---LEYI---HEHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 31/141 (21%), Positives = 57/141 (40%), Gaps = 17/141 (12%)

Query: 392 LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI 451
           + L+ N      P        LR + L  N+ +  L           F       L  L 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDA-------F-----QGLRSLN 83

Query: 452 GLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKIS 509
            L    N ++ ++P ++  GL +LQ + L  N++   +   +F DL +L +L L  NK+ 
Sbjct: 84  SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 510 GAIPASLQKLLYLKHLNLSFN 530
                +   L  ++ ++L+ N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 25/112 (22%), Positives = 52/112 (46%), Gaps = 6/112 (5%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDL 155
               L+ +DLS+N++S  +    F  + +L  L    N++   L   +F  + S+  + L
Sbjct: 54  PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLL 111

Query: 156 SINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNN 206
           + N ++  +  +   +L  L  L+   N L  +A  T   + A++ ++L  N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 21/148 (14%)

Query: 402 SIPSCLGNL-TSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNL 460
            IP+   NL  ++  + L  N      P      K +  ID+S+N ++ L    F     
Sbjct: 25  EIPT---NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---- 77

Query: 461 SGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPASLQKL 519
                    GL++L  + L  N++   +P+S F  L SL++L L+ NKI+     + Q L
Sbjct: 78  ---------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDL 127

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLTA 547
             L  L+L  NKL+  I +G  F+ L A
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGT-FSPLRA 153

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 45/182 (24%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
            I  N+P+       +  + L  N +    P  FS  + L+ + L+ N+++    D    
Sbjct: 25  EIPTNLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG 78

Query: 386 LARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
           L  L+SLVL GNK +  +P      L SL++L L  N+    L                 
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDA------------- 123

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
                     F               L NL  + L  N+L+     +F  L +++ + L+
Sbjct: 124 ----------FQD-------------LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160

Query: 505 KN 506
           +N
Sbjct: 161 QN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 29/137 (21%), Positives = 61/137 (44%), Gaps = 7/137 (5%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGSLSFFIFN-VSSVTTIDLSI 157
            ++  + L  N +   IP   F+ +  L+ +  S+NQ+   L+   F  + S+ ++ L  
Sbjct: 32  ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYG 89

Query: 158 NGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
           N ++ E+P+ +   L  L  L    N +  +      ++  L  + L +N L  ++    
Sbjct: 90  NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

Query: 217 DLSLPNVETLNLGINSF 233
              L  ++T++L  N F
Sbjct: 148 FSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 33/159 (20%), Positives = 60/159 (37%), Gaps = 8/159 (5%)

Query: 101 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSING 159
           S   +D     L+  IP+++    T+  +    N +   +    F     +  IDLS N 
Sbjct: 12  SNNIVDCRGKGLT-EIPTNLPE--TITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQ 67

Query: 160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNNSLSGSLPSRIDL 218
           +S   P     L  L  L    N +  + P ++F  + +L+ + L  N ++  L      
Sbjct: 68  ISELAPDAFQGLRSLNSLVLYGNKITEL-PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125

Query: 219 SLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
            L N+  L+L  N        + +    +  + L  N F
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 29/156 (18%), Positives = 59/156 (37%), Gaps = 22/156 (14%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
            ++T I L  N +    P        L R+  + N +  +AP     + +L  + L  N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 208 LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVN 267
           ++  LP  +   L +++ L L  N              K++ L +    F        ++
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNAN--------------KINCLRVDA--FQDLHNLNLLS 134

Query: 268 MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
           + DN L +   + +F    +  + ++ + L  NP  
Sbjct: 135 LYDNKLQT-IAKGTF----SPLRAIQTMHLAQNPFI 165

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 64/253 (25%), Positives = 100/253 (39%), Gaps = 56/253 (22%)

Query: 589 SRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVK 647
              GP+N G +  Q       H+ +    R+    +IG GSFG +  A   +    VA+K
Sbjct: 71  MTGGPNNGGYDDDQGSYVQVPHDHV--AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK 128

Query: 648 V------FHQQYERALKSFEDECEVMKRIRHR---NLVKIISSCSNDDFKA---LIMKYM 695
           +      FH+Q   A +    E  +++ +R +   N + +I    N  F+    +  +  
Sbjct: 129 MVRNEKRFHRQ---AAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE-- 179

Query: 696 PNGSLENCLYSGTCMLDIFQRLN------IMIDVALALEYLHFGHSTPIIHCDLKPSNVL 749
               L   LY        FQ  +          +   L+ LH      IIHCDLKP N+L
Sbjct: 180 ---LLSMNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENIL 232

Query: 750 LDEDMVAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YGTKGRVCTRGD 801
           L +   + I   DFG +       ++   IQ+     Y APE      YG         D
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRF---YRAPEVILGARYGMP---I---D 281

Query: 802 VYSYGIMLMEMFT 814
           ++S G +L E+ T
Sbjct: 282 MWSLGCILAELLT 294

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 48/269 (17%), Positives = 94/269 (34%), Gaps = 48/269 (17%)

Query: 96  LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL 155
              L++    +L    ++     S   +  ++     ++ +  SL+  +   +++  + L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHL 70

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSR 215
           S N +S      + +L  L  L+   N L  +        + L  ++L NN L       
Sbjct: 71  SHNQIS--DLSPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELR------ 119

Query: 216 IDLS----LPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADN 271
            D      L N+E L++  N        SI     LS LE              +++  N
Sbjct: 120 -DTDSLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLE-------------VLDLHGN 160

Query: 272 YLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNI 331
            +T+          LT  KK+  + LTG        K +  L ++  +   D   IS   
Sbjct: 161 EITN-------TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--- 210

Query: 332 PQVVGNLGNLLVLELGGNNLTEPIPITFS 360
           P  + N G+ +   +          +++ 
Sbjct: 211 PYYISNGGSYVDGCVLWELPVYTDEVSYK 239

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 14/169 (8%)

Query: 279 ELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL 338
            ++ L S      ++      + +  +          +L+ + + +  IS ++  +  +L
Sbjct: 30  SVTDLVSQKELSGVQNFNGDNSNIQSLAGMQF---FTNLKELHLSHNQIS-DLSPL-KDL 84

Query: 339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNK 398
             L  L +  N L     +       L  L L  N+L    TD L HL  L  L ++ NK
Sbjct: 85  TKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNK 139

Query: 399 FSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL 447
              SI   LG L+ L VL L  N  T+     +  LK + +ID++    
Sbjct: 140 LK-SI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 22/142 (15%), Positives = 49/142 (34%), Gaps = 24/142 (16%)

Query: 392 LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI 451
            + +    +  +      L +     LG    T     +   L  +   +  ++++  L 
Sbjct: 2   SIQRPTPIN-QV-FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLA 57

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA 511
           G+                   NL+++ L +N++   +     DL+ LE L +++N++   
Sbjct: 58  GMQ---------------FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL 100

Query: 512 IPASLQKLLYLKHLNLSFNKLE 533
                     L  L L  N+L 
Sbjct: 101 NGIP---SACLSRLFLDNNELR 119

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 44/256 (17%), Positives = 83/256 (32%), Gaps = 35/256 (13%)

Query: 315 LSLEIILMDNCSISG----NIPQVVGNLGNLLVLELGGNNLTEP----IPITFSQLQTLQ 366
            S+E   +   +I+     ++  V+    ++  + L GN +       +    +  + L+
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 367 ALGLTRNKL----------AGPITDELCHLARLHSLVLQGNKFSG----SIPSCLGNLTS 412
               +                 +   L    +LH++ L  N F       +   L   T 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 413 LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGD----IPITI 468
           L  LYL  N       + I      L ++  + +   L  +   RN L          T 
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 469 GGLKNLQQMFLEYNRL-----EGSIPESFGDLSSLEVLDLSKNKISG----AIPASLQKL 519
              + L  + +  N +     E  + E       L+VLDL  N  +     A+  +L+  
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 520 LYLKHLNLSFNKLEGE 535
             L+ L L+   L   
Sbjct: 244 PNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 50/309 (16%), Positives = 91/309 (29%), Gaps = 77/309 (24%)

Query: 283 LSSLTNCKKLKVLILTGNPLD-----GILPKSKGNLSLSLEIILMDNC--SISGNIPQVV 335
            + L     +K ++L+GN +       +         L       D     +   IP+ +
Sbjct: 25  FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE-IAEFSDIFTGRVKDEIPEAL 83

Query: 336 GNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL----AGPITDELCHLARLHS 391
             L   L                  +   L  + L+ N        P+ D L     L  
Sbjct: 84  RLLLQAL-----------------LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 126

Query: 392 LVLQGNKFS-------------GSIPSCLGNLTSLRVLYLGLNRFT----SALPSTIWNL 434
           L L  N                 ++     N   LR +  G NR           T  + 
Sbjct: 127 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 186

Query: 435 KDILFIDVSSNSL----------------NVLIGLNFSRNNLSGD----IPITIGGLKNL 474
           + +  + +  N +                  L  L+   N  +      + I +    NL
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246

Query: 475 QQMFLEYNRL--EG--SIPESFGDLS--SLEVLDLSKNKISG----AIPASLQ-KLLYLK 523
           +++ L    L   G  ++ ++F  L    L+ L L  N+I       +   +  K+  L 
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 306

Query: 524 HLNLSFNKL 532
            L L+ N+ 
Sbjct: 307 FLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 51/350 (14%), Positives = 109/350 (31%), Gaps = 81/350 (23%)

Query: 96  LGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLYFSDNQL----FGSLSFFIFNV 147
           +   S ++   L  + ++     ++ + +    ++K +  S N +       LS  I + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 148 SSVTTIDLS---INGLSGEMPREIGNL-------PYLARLAFATNNL--VGVAPVT--IF 193
             +   + S      +  E+P  +  L       P L  +  + N        P+   + 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 194 NMSALKEIYLLNNS------------LSGSLPSRIDLSLPNVETLNLGINSFY--GTVP- 238
             + L+ +YL NN             L     ++   + P + ++  G N          
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 239 -SSITNASKLSDLELGVN----------LFSGFIPNTFV---NMADNYLTSS-TPELSFL 283
             +  +   L  +++  N          L  G      +   ++ DN  T   +  L+  
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA-- 237

Query: 284 SSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLV 343
            +L +   L+ L L    L      ++G  ++      ++N                L  
Sbjct: 238 IALKSWPNLRELGLNDCLL-----SARGAAAVVDAFSKLENIG--------------LQT 278

Query: 344 LELGGNNLTEPIPITFSQ-----LQTLQALGLTRNKL--AGPITDELCHL 386
           L L  N +      T        +  L  L L  N+      + DE+  +
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 328

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 33/159 (20%), Positives = 57/159 (35%), Gaps = 28/159 (17%)

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVL 450
            L          + + L  L + + L L  N         I +L          + +  L
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-----ISSL----------SGMENL 72

Query: 451 IGLNFSRNNLSGDIPITIGGL----KNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
             L+  RN +       I  L      L+++++ YN++  S+      L +L VL +S N
Sbjct: 73  RILSLGRNLIK-----KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNN 125

Query: 507 KISGAIP-ASLQKLLYLKHLNLSFNKLEGEIPRGGPFAN 544
           KI+       L  L  L+ L L+ N L  +       + 
Sbjct: 126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 35/168 (20%), Positives = 57/168 (33%), Gaps = 22/168 (13%)

Query: 368 LGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL 427
           L      +   +   L  L     L L  N     I S L  + +LR+L LG N      
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-- 84

Query: 428 PSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLE-- 485
                       I+      + L  L  S N ++  +   I  L NL+ +++  N++   
Sbjct: 85  ------------IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNW 130

Query: 486 GSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE 533
           G I +    L  LE L L+ N +      +     Y   +      L+
Sbjct: 131 GEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 26/119 (21%), Positives = 47/119 (39%), Gaps = 12/119 (10%)

Query: 92  IPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVT 151
           +   L  L + + L LS N +   I SS+  M  L++L    N +   +        ++ 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLE 96

Query: 152 TIDLSING---LSGEMPREIGNLPYLARLAFATNNLVGVAPV-TIFNMSALKEIYLLNN 206
            + +S N    LSG     I  L  L  L  + N +     +  +  +  L+++ L  N
Sbjct: 97  ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 60/260 (23%), Positives = 91/260 (35%), Gaps = 66/260 (25%)

Query: 588 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAV 646
           K      NDG +           E     DR+  ++LIG GSFG +  A    +   VA+
Sbjct: 27  KKERKVYNDGYDDDNYDYIVKNGEKW--MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAI 84

Query: 647 KV------FHQQYERALKSFEDECEVMKRIRHR------NLVKIISSCSNDDFKALIMKY 694
           K+      F  Q   A      E  +++ +          +V +       +   L+ + 
Sbjct: 85  KIIKNKKAFLNQ---AQI----EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE- 136

Query: 695 MPNGSLENCLYSGTCMLDIFQRLN------------IMIDVALALEYLHFGHSTPIIHCD 742
                L   LY          R                  +  AL +L     + IIHCD
Sbjct: 137 ----MLSYNLYD-------LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCD 184

Query: 743 LKPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLSIQIQTLATIGYMAPE------YGTKG 794
           LKP N+LL     + I   DFG +  L    ++   IQ+     Y +PE      Y    
Sbjct: 185 LKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRF---YRSPEVLLGMPYDLA- 238

Query: 795 RVCTRGDVYSYGIMLMEMFT 814
                 D++S G +L+EM T
Sbjct: 239 --I---DMWSLGCILVEMHT 253

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 4e-09
 Identities = 32/212 (15%), Positives = 63/212 (29%), Gaps = 57/212 (26%)

Query: 602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKV--------FHQQY 653
           +    FS+      T++      IG G FG ++     D   VA+K+         +  +
Sbjct: 8   KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63

Query: 654 ERALKSFEDECEVMKRI---------RHRNLVKIISSC---------------------- 682
           ++  +    E  + K +         R    + + S                        
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 683 --------SNDDFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
                     DD   +++++   G  LE        +  +    +I+  +  +L      
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAE-- 178

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK 765
            S    H DL   NVLL +  +  +      K
Sbjct: 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 6/107 (5%)

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSSLEVLDLSKNKISG 510
           GL  +R+    D    + G +NL ++++E  +    +       L  L  L + K+ +  
Sbjct: 12  GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 511 AIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFM--GNEL 555
             P +      L  LNLSFN LE  +        L+ +  +  GN L
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 23/131 (17%), Positives = 39/131 (29%), Gaps = 37/131 (28%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
                L    +L  LY+   +    L                                  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELR------------------------------- 50

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY 521
                 + GL  L+ + +  + L    P++F     L  L+LS N +  ++     + L 
Sbjct: 51  -----DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS 104

Query: 522 LKHLNLSFNKL 532
           L+ L LS N L
Sbjct: 105 LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 8e-06
 Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 26/119 (21%)

Query: 91  TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSS 149
                L    +L  L + + +   ++       +  L+ L    + L             
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL------------- 68

Query: 150 VTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSL 208
              +           P      P L+RL  + N L  ++  T+  +S L+E+ L  N L
Sbjct: 69  -RFVA----------PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 2e-05
 Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 1/78 (1%)

Query: 385 HLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVS 443
               L  L ++  +    +    L  L  LR L +  +      P        +  +++S
Sbjct: 29  GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88

Query: 444 SNSLNVLIGLNFSRNNLS 461
            N+L  L        +L 
Sbjct: 89  FNALESLSWKTVQGLSLQ 106

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 2/96 (2%)

Query: 330 NIPQVVGNLGNLLVLELGGNNLTEPIP-ITFSQLQTLQALGLTRNKLAGPITDELCHLAR 388
           +    +    NL  L +      + +       L  L+ L + ++ L     D      R
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT 424
           L  L L  N    S+        SL+ L L  N   
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 26/128 (20%), Positives = 36/128 (28%), Gaps = 8/128 (6%)

Query: 280 LSFLSSLTNCKKLKVLILTGNP-LDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL 338
           L  L  L   + L  L +     L  +  +    L   L  + +    +    P      
Sbjct: 21  LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG-ELRNLTIVKSGLRFVAPDAFHFT 79

Query: 339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNK 398
             L  L L  N L      T   L +LQ L L+ N L        C L  L     +G  
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL-----HCSCALRWLQRWEEEGLG 133

Query: 399 FSGSIPSC 406
                   
Sbjct: 134 GVPEQKLQ 141

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 22/147 (14%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVL-IGLNFSRNNL 460
           S+P+  G  T+ ++LYL  N+ T   P    +L ++  + + SN L  L +G+ F     
Sbjct: 33  SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV-FDS--- 86

Query: 461 SGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPASLQKL 519
                     L  L  + L  N+L   +P + F  L  L+ L +  NK++  +P  +++L
Sbjct: 87  ----------LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERL 134

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLT 546
            +L HL L  N+L+  IP G  F  L+
Sbjct: 135 THLTHLALDQNQLKS-IPHGA-FDRLS 159

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 7/112 (6%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGSLSFFIFN-VSSVTTIDL 155
           +L +L+ L L  N+L   +P  +F+  T L +L    NQL   L   +F+ +  +  + +
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFM 119

Query: 156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNN 206
             N L+ E+PR I  L +L  LA   N L  + P   F  +S+L   YL  N
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSI-PHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 42/164 (25%), Positives = 63/164 (38%), Gaps = 34/164 (20%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL----AGPITD 381
           S+   IP       N  +L L  N +T+  P  F  L  L+ L L  N+L     G + D
Sbjct: 33  SVPAGIPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFD 85

Query: 382 ELCHLARLHSLVLQGNKFSGSIPSCLG---NLTSLRVLYLGLNRFTSALPSTIWNLKDIL 438
               L +L  L L  N+ +  +PS       L  L+ L++  N+ T  LP  I  L  + 
Sbjct: 86  ---SLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLT 138

Query: 439 FIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
            + +  N L  +    F R             L +L   +L  N
Sbjct: 139 HLALDQNQLKSIPHGAFDR-------------LSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 46/147 (31%), Positives = 63/147 (42%), Gaps = 22/147 (14%)

Query: 364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG---NLTSLRVLYLGL 420
             Q L L  N++          L  L  L L  N+   ++P   G   +LT L VL LG 
Sbjct: 41  NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSLTQLTVLDLGT 97

Query: 421 NRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLE 480
           N+ T  LPS +       F     + L  L  L    N L+  +P  I  L +L  + L+
Sbjct: 98  NQLTV-LPSAV-------F-----DRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALD 143

Query: 481 YNRLEGSIPE-SFGDLSSLEVLDLSKN 506
            N+L+ SIP  +F  LSSL    L  N
Sbjct: 144 QNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 36/157 (22%), Positives = 59/157 (37%), Gaps = 25/157 (15%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFN-MSALKEIYLLNN 206
           ++   + L  N ++   P    +L  L  L   +N L  + PV +F+ ++ L  + L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL-PVGVFDSLTQLTVLDLGTN 98

Query: 207 SLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFV 266
            L+  LPS +   L +++ L +  N     +P  I   + L+ L L  N           
Sbjct: 99  QLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-------- 148

Query: 267 NMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD 303
                    S P  +F         L    L GNP D
Sbjct: 149 ---------SIPHGAF----DRLSSLTHAYLFGNPWD 172

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 54.2 bits (129), Expect = 9e-08
 Identities = 27/168 (16%), Positives = 53/168 (31%), Gaps = 13/168 (7%)

Query: 362 LQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG--NLTSLRVLYLG 419
           L  +  L   + K    ++        L SL +       S+   +   +L +L  L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 420 LNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG---LKNLQQ 476
           +          +   + +     S +    L  L          +         L  L+ 
Sbjct: 228 VGVEDYGFDGDMNVFRPLF----SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLET 283

Query: 477 MFLEYNRL--EG--SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL 520
           M +    L  EG   + +    +  L+ +++  N +S  +   LQK L
Sbjct: 284 MDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 21/147 (14%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
           S+P+  G       L L  N   S        L  +  + +  N L  L    F++    
Sbjct: 21  SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK---- 74

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGAIPASL-QKL 519
                    L +L  + L  N+L+ S+P   F  L+ L+ L L+ N++  ++P  +  KL
Sbjct: 75  ---------LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL 123

Query: 520 LYLKHLNLSFNKLEGEIPRGGPFANLT 546
             LK L L  N+L+  +P G  F  LT
Sbjct: 124 TQLKDLRLYQNQLKS-VPDGV-FDRLT 148

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 41/148 (27%), Positives = 57/148 (38%), Gaps = 23/148 (15%)

Query: 364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRF 423
               L L  N L          L  L  L L GNK           LTSL  L L  N+ 
Sbjct: 29  QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88

Query: 424 TSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG----LKNLQQMFL 479
            S LP+ ++            + L  L  L  + N L   +P    G    L  L+ + L
Sbjct: 89  QS-LPNGVF------------DKLTQLKELALNTNQLQS-LP---DGVFDKLTQLKDLRL 131

Query: 480 EYNRLEGSIPE-SFGDLSSLEVLDLSKN 506
             N+L+ S+P+  F  L+SL+ + L  N
Sbjct: 132 YQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 8/130 (6%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGS 139
           L++ + +L+         L+SL  L L  NKL  ++P+ +FN  T L  L  S NQL  S
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL-QS 90

Query: 140 LSFFIFN-VSSVTTIDLSINGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIF-NMS 196
           L   +F+ ++ +  + L+ N L   +P  +   L  L  L    N L  V P  +F  ++
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSV-PDGVFDRLT 148

Query: 197 ALKEIYLLNN 206
           +L+ I+L +N
Sbjct: 149 SLQYIWLHDN 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 53/272 (19%), Positives = 89/272 (32%), Gaps = 92/272 (33%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRH 672
             R+     +G G F +++++  +Q    VA+KV    + Y        DE  ++K +R+
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92

Query: 673 RNLVKIISSCSNDDFKALIMKYM-------PNGSLENCL---YSGTCMLDIFQRLN---- 718
            +         ND  + ++++ +        NG+   C+     G  +L    + N    
Sbjct: 93  SD--------PNDPNREMVVQLLDDFKISGVNGTHI-CMVFEVLGHHLLKWIIKSNYQGL 143

Query: 719 -------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLL--------------------- 750
                  I+  V   L+YLH      IIH D+KP N+LL                     
Sbjct: 144 PLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 751 ----------------------------DEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
                                        E +   I+D G A  +       IQ     T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----T 256

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT 814
             Y + E        T  D++S   M  E+ T
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGA 511
           L    N  +  +P  +   K+L  + L  NR+  ++   SF +++ L  L LS N++   
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 512 IPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           IP      L  L+ L+L  N +   +P G  F +L+
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVPEGA-FNDLS 126

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 41/134 (30%), Positives = 58/134 (43%), Gaps = 26/134 (19%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
            +P   G    +  LYL  N+FT  +P  + N K +  ID+S+N ++ L   +FS     
Sbjct: 24  VLPK--GIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSN---- 76

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIP----ASL 516
                    +  L  + L YNRL   IP  +F  L SL +L L  N IS  +P      L
Sbjct: 77  ---------MTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125

Query: 517 QKLLYLKHLNLSFN 530
                L HL +  N
Sbjct: 126 SA---LSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 14/98 (14%)

Query: 331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL----AGPITDELCHL 386
           +P+ + N  +L +++L  N ++     +FS +  L  L L+ N+L         D    L
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPR-TFD---GL 101

Query: 387 ARLHSLVLQGNKFSGSIPSCLG---NLTSLRVLYLGLN 421
             L  L L GN  S  +P   G   +L++L  L +G N
Sbjct: 102 KSLRLLSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 475 QQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG 534
            +++L+ N+    +P+   +   L ++DLS N+IS     S   +  L  L LS+N+L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 535 EIPRGGPFANLT 546
            IP    F  L 
Sbjct: 92  CIPP-RTFDGLK 102

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 28/123 (22%)

Query: 86  FNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFI 144
            N    +P +L N   L  +DLS+N++S  + +  F NM  L  L  S N+L   +    
Sbjct: 40  GNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPPRT 97

Query: 145 FN-VSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYL 203
           F+ + S+  + L  N +S  +P            AF              ++SAL  + +
Sbjct: 98  FDGLKSLRLLSLHGNDIS-VVPEG----------AFN-------------DLSALSHLAI 133

Query: 204 LNN 206
             N
Sbjct: 134 GAN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 7/97 (7%)

Query: 453 LNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISG 510
           L  + N L       + G L +L ++ L+ N+L   I  + F   S ++ L L +NKI  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91

Query: 511 AIPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
            I   +   L  LK LNL  N++   +  G  F +L 
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISC-VMPGS-FEHLN 126

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 19/74 (25%), Positives = 34/74 (45%), Gaps = 5/74 (6%)

Query: 475 QQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKNKISGAIPASL-QKLLYLKHLNLSFNKL 532
            ++ L  N L     +  FG L  L  L+L +N+++  I  +  +   +++ L L  NK+
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 533 EGEIPRGGPFANLT 546
           + EI     F  L 
Sbjct: 91  K-EISN-KMFLGLH 102

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 20/120 (16%)

Query: 391 SLVLQGNKFSGSIPSC--LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN 448
            L+L  N+    I S    G L  L  L L  N+ T  +           F        +
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNA-------F-----EGAS 78

Query: 449 VLIGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGSIPE-SFGDLSSLEVLDLSKN 506
            +  L    N +  +I   +  GL  L+ + L  N++   +   SF  L+SL  L+L+ N
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 6/91 (6%)

Query: 334 VVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLV 393
           + G L +L+ LEL  N LT   P  F     +Q L L  NK+          L +L +L 
Sbjct: 49  LFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108

Query: 394 LQGNKFSGSIPSCLG---NLTSLRVLYLGLN 421
           L  N+ S  +    G   +L SL  L L  N
Sbjct: 109 LYDNQIS-CVMP--GSFEHLNSLTSLNLASN 136

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 45/246 (18%), Positives = 81/246 (32%), Gaps = 66/246 (26%)

Query: 610 HELLRATDRFSENNLIGIGSFGSIYVA--RLQDGMEVAVKVF--HQQYERALKSFEDECE 665
            + L   +R+     +G G+FG +       +   +VA+K+     +Y  A +    E  
Sbjct: 14  GDWL--QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR---LEIN 68

Query: 666 VMKRIRHR------NLVKIISSCSNDDFKA---LIMKYMPNGSLENCLYSGTCMLDI--- 713
           V+K+I+ +        V +       +F     +  +      L    +      +    
Sbjct: 69  VLKKIKEKDKENKFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTF------EFLKE 114

Query: 714 --FQRLNIMIDVALA---LEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 768
             FQ   +     +A      L F H   + H DLKP N+L        + +   +    
Sbjct: 115 NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174

Query: 769 GEDQLSIQI----------QTLATI----GYMAPE------YGTKGRVCTRGDVYSYGIM 808
                SI++          +   TI     Y  PE      +      C   DV+S G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQP---C---DVWSIGCI 228

Query: 809 LMEMFT 814
           L E + 
Sbjct: 229 LFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.2 bits (118), Expect = 4e-06
 Identities = 51/248 (20%), Positives = 88/248 (35%), Gaps = 76/248 (30%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVF--HQQYERALKSFEDECEVMKRIRH 672
            + F     +G G+FG + + + + +    AVKV    ++Y R+ K    E +++K+I++
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK---IEADILKKIQN 90

Query: 673 R-----NLVKIISSCSNDDFKA---LIMKYMPNGSLENCLYSGTCMLDIFQRLN------ 718
                 N+VK         +     LI +      L   LY            N      
Sbjct: 91  DDINNNNIVKYHGKF---MYYDHMCLIFE-----PLGPSLYE-------IITRNNYNGFH 135

Query: 719 ------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
                   I++  AL YL       + H DLKP N+LLD+                 + Q
Sbjct: 136 IEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 773 L------SIQI----------QTLATI----GYMAPE------YGTKGRVCTRGDVYSYG 806
           +       I++              +I     Y APE      +          D++S+G
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVS---S---DMWSFG 246

Query: 807 IMLMEMFT 814
            +L E++T
Sbjct: 247 CVLAELYT 254

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 21/101 (20%), Positives = 35/101 (34%), Gaps = 4/101 (3%)

Query: 457 RNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL 516
           R      I      L     +    N +   + + F  L  L+ L ++ N+I        
Sbjct: 27  RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLD 84

Query: 517 QKLLYLKHLNLSFNKLE--GEIPRGGPFANLTAKSFMGNEL 555
           Q L  L  L L+ N L   G++       +LT    + N +
Sbjct: 85  QALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 19/100 (19%), Positives = 32/100 (32%), Gaps = 5/100 (5%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
           N      L+L G  +   I    + L    A+  + N++   +      L RL +L++  
Sbjct: 17  NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73

Query: 397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKD 436
           N+           L  L  L L  N         +  L  
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLAS 111

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 22/130 (16%), Positives = 38/130 (29%), Gaps = 17/130 (13%)

Query: 381 DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFI 440
            +  +  R   L L+G K    I +    L     +    N         +         
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-----LDGF------ 60

Query: 441 DVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLE 499
                 L  L  L  + N +          L +L ++ L  N L      +    L SL 
Sbjct: 61  ----PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 500 VLDLSKNKIS 509
            L + +N ++
Sbjct: 117 YLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.0 bits (94), Expect = 9e-04
 Identities = 28/139 (20%), Positives = 45/139 (32%), Gaps = 29/139 (20%)

Query: 94  PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTI 153
            Q  N    + LDL   K+   I +    +     + FSDN++                 
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 55

Query: 154 DLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLP 213
              ++G           L  L  L    N +  +       +  L E+ L NNSL   L 
Sbjct: 56  --KLDGFP--------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELG 104

Query: 214 SRIDLS-LPNVETLNLGIN 231
               L+ L ++  L +  N
Sbjct: 105 DLDPLASLKSLTYLCILRN 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 7/113 (6%)

Query: 288 NCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS--GNIPQVVGNLGNLLVLE 345
               +K L+L  +  +    +   +    LE +   N  ++   N+P     L  L  LE
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70

Query: 346 LGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPIT-DELCHLARLHSLVLQGN 397
           L  N ++  + +   +   L  L L+ NK+    T + L  L  L SL L   
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 33/135 (24%), Positives = 52/135 (38%), Gaps = 19/135 (14%)

Query: 379 ITDELCH--LARLHSLVLQGNKFS-GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
           I  EL +   + +  LVL  ++ + G +         L  L       TS     I NL 
Sbjct: 7   IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-----IANLP 61

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGD 494
                      LN L  L  S N +SG + +      NL  + L  N+++  S  E    
Sbjct: 62  ----------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK 111

Query: 495 LSSLEVLDLSKNKIS 509
           L +L+ LDL   +++
Sbjct: 112 LENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 5/105 (4%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAI 512
           L+ SR+N  G +       + L+ +      L  SI  +   L+ L+ L+LS N++SG +
Sbjct: 24  LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80

Query: 513 PASLQKLLYLKHLNLSFNKLE--GEIPRGGPFANLTAKSFMGNEL 555
               +K   L HLNLS NK++    I       NL +      E+
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 20/120 (16%)

Query: 194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE-- 251
             S +KE+ L N+  +      +      +E L+           +SI N  KL+ L+  
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69

Query: 252 -LGVNLFSGFIPN--------TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPL 302
            L  N  SG +          T +N++ N +     +LS +  L   + LK L L    +
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.4 bits (116), Expect = 6e-06
 Identities = 47/253 (18%), Positives = 86/253 (33%), Gaps = 72/253 (28%)

Query: 606 RFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVF--HQQYERALKS 659
                ++L  + R+   + +G G+FG   V    D    G  VAVK+     +Y  A + 
Sbjct: 5   ICQSGDVL--SARYEIVDTLGEGAFGK--VVECIDHKAGGRHVAVKIVKNVDRYCEAAR- 59

Query: 660 FEDECEVMKRIRHR------NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDI 713
              E +V++ +           V+++      +    I        L    Y        
Sbjct: 60  --SEIQVLEHLNTTDPNSTFRCVQMLEWF---EHHGHICIVFEL--LGLSTYD------- 105

Query: 714 FQRLN------------IMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF 761
           F + N            +   +  ++ +LH   S  + H DLKP N+L  +       + 
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP 162

Query: 762 GIAKLLSGEDQLSIQI----------QTLATI----GYMAPE------YGTKGRVCTRGD 801
            I +         I++          +  +T+     Y APE      +      C   D
Sbjct: 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQP---C---D 216

Query: 802 VYSYGIMLMEMFT 814
           V+S G +L+E + 
Sbjct: 217 VWSIGCILIEYYL 229

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES-FGDLSSLEVLDLSKNKISGA 511
           L    N L          L  L ++ L  N+++ S+P+  F  L+ L +L L +NK+  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 512 IPASL-QKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
           +P  +  KL  LK L L  N+L+  +P G  F  LT
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKS-VPDGI-FDRLT 124

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 14/110 (12%)

Query: 343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKL----AGPITDELCHLARLHSLVLQGNK 398
            LEL  N L       F +L  L  L L++N++     G + D+L  L  L+   L  NK
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG-VFDKLTKLTILY---LHENK 87

Query: 399 FSGSIPSCLG---NLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN 445
              S+P+  G    LT L+ L L  N+  S        L  +  I + +N
Sbjct: 88  LQ-SLPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 8/111 (7%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLYFSDNQLFGSLSFFIFN-VSSVTTIDLSI 157
           SS   L+L  NKL  ++P  +F+  T L  L  S NQ+  SL   +F+ ++ +T + L  
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHE 85

Query: 158 NGLSGEMPREI-GNLPYLARLAFATNNLVGVAPVTIF-NMSALKEIYLLNN 206
           N L   +P  +   L  L  LA  TN L  V P  IF  +++L++I+L  N
Sbjct: 86  NKLQ-SLPNGVFDKLTQLKELALDTNQLKSV-PDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 4/73 (5%)

Query: 475 QQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL-QKLLYLKHLNLSFNKLE 533
            ++ LE N+L+      F  L+ L  L LS+N+I  ++P  +  KL  L  L L  NKL+
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 534 GEIPRGGPFANLT 546
             +P  G F  LT
Sbjct: 90  -SLPN-GVFDKLT 100

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 67/462 (14%), Positives = 136/462 (29%), Gaps = 73/462 (15%)

Query: 98  NLSSLQTLDLSHNKLSGNIPSSIF--NMHTLKLLYFSDNQLFG--SLSFFIFNVSSVTTI 153
           NL  L+++      +S      +       L+ L       F    L   + +   + T+
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169

Query: 154 DLSINGLSGEMPREIG----NLPYLARLAFATNNLVGVAPVTIF----NMSALKEIYLLN 205
            +  +  S +  + +     +   L  L F       ++P  +     N  +L  + +  
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKV-- 227

Query: 206 NSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTF 265
                        +  N+E    G  +    +P    N      L               
Sbjct: 228 GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR----------LGL 277

Query: 266 VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNC 325
             M  N +    P            +++ L L    L+     +      +LE++   N 
Sbjct: 278 SYMGPNEMPILFP---------FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNV 328

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQL--QTLQALGLTRNKLAGPITDEL 383
                +  +      L  L +      + +      +  + L AL             + 
Sbjct: 329 IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA------------QG 376

Query: 384 CHLARLHSLVLQGNKFS----GSIPSCLGNLTSLRVLYL-GLNRFT-----SALPSTIWN 433
           C    L  + +  +  +     SI + L NL   R++ L    R T     + + S +  
Sbjct: 377 CQ--ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434

Query: 434 LKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG-GLKNLQQMFLEYNRL-EGSIPES 491
            K +                      L+      IG    N++ M L Y    +  + E 
Sbjct: 435 CKKLRRFAFYLRQ-----------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483

Query: 492 FGDLSSLEVLDLSKNKIS-GAIPASLQKLLYLKHLNLSFNKL 532
                +L+ L++     S  AI A++ KL  L++L +   + 
Sbjct: 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 31/135 (22%), Positives = 49/135 (36%), Gaps = 10/135 (7%)

Query: 288 NCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSIS--GNIPQVVGNLGNLLVLE 345
               ++ L+L     +    +      ++LE + + N  +    N+P     L  L  LE
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77

Query: 346 LGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPIT-DELCHLARLHSLVLQGN---KFSG 401
           L  N +   + +   +L  L  L L+ NKL    T + L  L  L SL L        + 
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137

Query: 402 SIPSCLGNLTSLRVL 416
              S    L  L  L
Sbjct: 138 YRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 4/101 (3%)

Query: 457 RNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL 516
             +  G I        NL+ + L    L  S+  +   L  L+ L+LS+N+I G +    
Sbjct: 34  CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLA 91

Query: 517 QKLLYLKHLNLSFNKLE--GEIPRGGPFANLTAKSFMGNEL 555
           +KL  L HLNLS NKL+    +        L +      E+
Sbjct: 92  EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 30/109 (27%), Positives = 43/109 (39%), Gaps = 3/109 (2%)

Query: 318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG 377
           E++L +  S  G I  +     NL  L L    L   +     +L  L+ L L+ N++ G
Sbjct: 28  ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENRIFG 85

Query: 378 PITDELCHLARLHSLVLQGNKFSG-SIPSCLGNLTSLRVLYLGLNRFTS 425
            +      L  L  L L GNK    S    L  L  L+ L L     T+
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 11/93 (11%)

Query: 87  NLQGTIPPQLGNLSSLQTLDLSHNKLS--GNIPSSIFNMHTLKLLYFSDNQLFGSLSFFI 144
           +  G I        +L+ L L +  L    N+P     +  LK L  S+N++FG L    
Sbjct: 36  SNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLA 91

Query: 145 FNVSSVTTIDLSINGLSGEMPREIGNLPYLARL 177
             + ++T ++LS N L      +I  L  L +L
Sbjct: 92  EKLPNLTHLNLSGNKLK-----DISTLEPLKKL 119

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 25/95 (26%), Positives = 37/95 (38%), Gaps = 5/95 (5%)

Query: 342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 401
           LVL+   +N  + I    ++   L+ L L    L       L  L +L  L L  N+  G
Sbjct: 29  LVLDNCKSNDGK-IEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFG 85

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKD 436
            +      L +L  L L  N+      ST+  LK 
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKK 118

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 27/75 (36%), Positives = 41/75 (54%), Gaps = 4/75 (5%)

Query: 473 NLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL-QKLLYLKHLNLSFNK 531
             Q ++L  N++    P  F  L+ L  LDL  N+++  +PA +  KL  L  L+L+ N+
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89

Query: 532 LEGEIPRGGPFANLT 546
           L+  IPRG  F NL 
Sbjct: 90  LKS-IPRGA-FDNLK 102

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 4/75 (5%)

Query: 473 NLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL-QKLLYLKHLNLSFNK 531
           + Q+++L  N++    P  F  L +L+ L  + NK++ AIP  +  KL  L  L+L+ N 
Sbjct: 34  DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92

Query: 532 LEGEIPRGGPFANLT 546
           L+  IPRG  F NL 
Sbjct: 93  LKS-IPRGA-FDNLK 105

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 63/410 (15%), Positives = 117/410 (28%), Gaps = 100/410 (24%)

Query: 148 SSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNS 207
             VT++DLS+N L      E+         AFA               +++  + L  NS
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQ-------AFANTP------------ASVTSLNLSGNS 62

Query: 208 LS----GSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN 263
           L       L   +     NV +LNL  N         +          +           
Sbjct: 63  LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI----------- 111

Query: 264 TFVNMADNYLTSSTPELSFLSSLTNC-KKLKVLILTGNPLDGILPKSKGNLSLSLEIILM 322
           T +++  N  +S +    F  + +N    +  L L GN L       K +  L  +I+  
Sbjct: 112 TVLDLGWNDFSSKSSS-EFKQAFSNLPASITSLNLRGNDLG-----IKSSDELI-QILAA 164

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQL-----QTLQALGLTRNKL-- 375
              +              +  L L GNNL        ++       ++ +L L+ N L  
Sbjct: 165 IPAN--------------VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210

Query: 376 --AGPITDELCHL-ARLHSLVLQGNKFSGS----IPSCLGNLTSLRVLYLGLNRFTSALP 428
                +      +   + SL L  N   G     +     +L  L+ +YL  +   +   
Sbjct: 211 KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSK 270

Query: 429 STIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSI 488
                L           ++  +I ++ +   +             +  +  E +      
Sbjct: 271 EQCKALGAAF------PNIQKIILVDKNGKEIHPS------HSIPISNLIRELS------ 312

Query: 489 PESFGDLSSLEVLDLSKNKISGA-----IPASLQKLLYLKHLNLSFNKLE 533
                     +V  L    +  A         L     L+    +   L 
Sbjct: 313 -------GKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 52/335 (15%), Positives = 108/335 (32%), Gaps = 62/335 (18%)

Query: 286 LTNCKKLKVLILTGNPL--DGILPKSKG--NLSLSLEIILMDNCSISGNIPQVVG----- 336
            +    +  L L+ N L     +   +   N   S+  + +   S+       +      
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQL-----QTLQALGLTRNKL----AGPITDELCHL- 386
              N+  L L GN L+        +       T+  L L  N      +        +L 
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 387 ARLHSLVLQGNKFSG----SIPSCLGNL-TSLRVLYLGLNRFT--------SALPSTIWN 433
           A + SL L+GN         +   L  +  ++  L L  N             L S   +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 434 LKDILFIDVSSNSL----------------NVLIGLNFSRNNLSGD----IPITIGGLKN 473
           +  +   D+S+N L                N ++ LN   N L G     + +    LK+
Sbjct: 198 VTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 474 LQQMFLEYNRLEG-------SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLN 526
           LQ ++L+Y+ ++        ++  +F ++  + ++D +  +I  +    +  L+      
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314

Query: 527 LSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLL 561
                L  +            +     + L+  + 
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQ 349

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 31/171 (18%), Positives = 64/171 (37%), Gaps = 34/171 (19%)

Query: 610 HELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH----------QQYERALKS 659
           H L+R+    +   L+G G   +++    +   E  VK             ++ +     
Sbjct: 83  HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLH 142

Query: 660 F--------EDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCML 711
           F         +E   +++++   + K+ +   N    A++M+ +    L          +
Sbjct: 143 FSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYR------VRV 192

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG 762
           +    +  MI     LE +   +   I+H DL   NVL+ E+ +  I DF 
Sbjct: 193 ENPDEVLDMI-----LEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFP 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	897
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.59
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.5
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.46
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.46
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.29
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.21
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.02
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.88
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.79
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.79
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.65
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.57
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.02
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.83
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.61
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.39
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.31
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.14
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.13
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.12
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.8
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.63
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.6
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.48
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.5
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.64

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1e-75  Score=715.75  Aligned_cols=529  Identities=31%  Similarity=0.478  Sum_probs=425.8

Q ss_pred             HHhhcCChhHHHHHHHHHhccccCCCcccccCCCCCCCCcceeeeEeeCCCCeEEEEEeeccccccc---CC--------
Q 045539           25 AAAASNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGT---IP--------   93 (897)
Q Consensus        25 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~--------   93 (897)
                      ++++.+.++|++||++||+++. ||. .++ +|+.+++||+|+||+|+  ++||++|||+++++.|.   +|        
T Consensus         4 ~~~~~~~~~~~~all~~k~~~~-~~~-~l~-~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~   78 (768)
T 3rgz_A            4 ASPSQSLYREIHQLISFKDVLP-DKN-LLP-DWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG   78 (768)
T ss_dssp             ----CCHHHHHHHHHHHHTTCS-CTT-SST-TCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred             CccccCCHHHHHHHHHHHhhCC-Ccc-ccc-CCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence            4455567889999999999997 676 665 99988999999999998  68999999999999887   43        


Q ss_pred             ---------------CCCCCCCCCceecccCccccCcCCc--cccCCCCCcEEeccCccccCCccccc------------
Q 045539           94 ---------------PQLGNLSSLQTLDLSHNKLSGNIPS--SIFNMHTLKLLYFSDNQLFGSLSFFI------------  144 (897)
Q Consensus        94 ---------------~~l~~l~~L~~L~Ls~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~------------  144 (897)
                                     +.++++++|++|||++|.++|.+|.  .++++++|++|+|++|.+.+.+|..+            
T Consensus        79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  158 (768)
T 3rgz_A           79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL  158 (768)
T ss_dssp             CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred             ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence                           5788889999999999999988888  88888888888888888776655432            


Q ss_pred             --------------------------------------cccccccEEEeeecCCCCCCCccccCcccccccccccccccc
Q 045539          145 --------------------------------------FNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVG  186 (897)
Q Consensus       145 --------------------------------------~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  186 (897)
                                                            ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++
T Consensus       159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~  237 (768)
T 3rgz_A          159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG  237 (768)
T ss_dssp             CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred             CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence                                                  2345566666666666665665 7778888888888888887


Q ss_pred             cccccccccccccccccccccccc----------------------cCCccccccccccceeecccccccccccccccCC
Q 045539          187 VAPVTIFNMSALKEIYLLNNSLSG----------------------SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNA  244 (897)
Q Consensus       187 ~~~~~~~~l~~L~~L~L~~N~l~~----------------------~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  244 (897)
                      ..|..+.++++|++|+|++|++++                      .+|..++..+++|++|+|++|.+++.+|..|+++
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l  317 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC  317 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence            777777777777777776666654                      4444444334666666777776666666666677


Q ss_pred             CcccEEEccccccccccCcc-ccc--------cccccccCCCCcc-c-------------------ccccccc--cCCCc
Q 045539          245 SKLSDLELGVNLFSGFIPNT-FVN--------MADNYLTSSTPEL-S-------------------FLSSLTN--CKKLK  293 (897)
Q Consensus       245 ~~L~~L~L~~N~l~~~~~~~-f~~--------l~~~~l~~~~~~~-~-------------------~l~~l~~--l~~L~  293 (897)
                      ++|++|+|++|.+++.+|.. |..        +..|.+.+..+.. .                   .+..+..  +++|+
T Consensus       318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  397 (768)
T 3rgz_A          318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ  397 (768)
T ss_dssp             TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred             CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence            77777777777666555543 322        2233333221110 0                   0111112  55677


Q ss_pred             EEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCc
Q 045539          294 VLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN  373 (897)
Q Consensus       294 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  373 (897)
                      +|++++|++++.+|..+..++ +|++|++++|.+++.+|..++.+++|++|++++|++++.+|..|..+++|++|+|++|
T Consensus       398 ~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  476 (768)
T 3rgz_A          398 ELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN  476 (768)
T ss_dssp             EEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             EEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence            777777777777777777776 7888888888888888888888888888888888888888888888889999999999


Q ss_pred             ccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCccc-----
Q 045539          374 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN-----  448 (897)
Q Consensus       374 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----  448 (897)
                      ++++.+|..+..+++|++|+|++|++++.+|..++++++|+.|++++|++++.+|..+.++++|++|++++|.+.     
T Consensus       477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~  556 (768)
T 3rgz_A          477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA  556 (768)
T ss_dssp             CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred             cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence            998888888988999999999999999888998999999999999999999889999999999999999888653     


Q ss_pred             ----------------------------------------------------------------------------ccce
Q 045539          449 ----------------------------------------------------------------------------VLIG  452 (897)
Q Consensus       449 ----------------------------------------------------------------------------~l~~  452 (897)
                                                                                                  .|+.
T Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~  636 (768)
T 3rgz_A          557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF  636 (768)
T ss_dssp             GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred             HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence                                                                                        3667


Q ss_pred             eecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcc
Q 045539          453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL  532 (897)
Q Consensus       453 l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  532 (897)
                      |||++|+++|.+|..++.+++|+.|+|++|+++|.+|..|+++++|++||||+|+++|.+|..+..+++|++|||++|+|
T Consensus       637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l  716 (768)
T 3rgz_A          637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL  716 (768)
T ss_dssp             EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred             EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCcccccchhhhhhhh
Q 045539          533 EGEIPRGGPFANLTAKSFMGNELLKMLL  560 (897)
Q Consensus       533 ~~~~p~~~~~~~~~~~~~~~N~~~c~~~  560 (897)
                      +|.||.++++.++...+|.|||++||.+
T Consensus       717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          717 SGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             EEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             cccCCCchhhccCCHHHhcCCchhcCCC
Confidence            9999999999999999999999999964

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.8e-59  Score=554.40  Aligned_cols=457  Identities=20%  Similarity=0.261  Sum_probs=287.9

Q ss_pred             ChhHHHHHHHHHhccccCCCc-------ccccCCCCCCCCcce---eeeEeeCCCCeEEEEEeecccccccCCCCCCCCC
Q 045539           31 ITTDQQALLALKAHISYDHTN-------LFARNWTSSTSVCSW---IGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLS  100 (897)
Q Consensus        31 ~~~~~~aLl~~k~~~~~~~~~-------~~~~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~  100 (897)
                      ...|++||.+||.++..+...       .. .+|+.+++||.|   .||+|+.. |||++|+|++++++|.+|+++++|+
T Consensus        28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~-~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           28 YIKDYLALKEIWDALNGKNWSQQGFGTQPG-ANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHHTTGGGCCCCC-------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             HHHHHHHHHHHHHHcCCCCcccCCcCCccC-CCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence            357999999999998543221       11 279988999999   99999865 8999999999999999999999999


Q ss_pred             CCceecccCccc------cC---------------------------cCCcccc-------------------CCCCCcE
Q 045539          101 SLQTLDLSHNKL------SG---------------------------NIPSSIF-------------------NMHTLKL  128 (897)
Q Consensus       101 ~L~~L~Ls~n~l------~~---------------------------~~p~~~~-------------------~l~~L~~  128 (897)
                      +|++|||++|.+      .|                           .+|..+.                   ....++.
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~  185 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD  185 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred             cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence            999999999965      11                           1111111                   0011111


Q ss_pred             Eecc--CccccCCccccccccccccEEEeeecCCCCC-----------------CCcccc--Cccccccccccccccccc
Q 045539          129 LYFS--DNQLFGSLSFFIFNVSSVTTIDLSINGLSGE-----------------MPREIG--NLPYLARLAFATNNLVGV  187 (897)
Q Consensus       129 L~Ls--~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~-----------------~p~~l~--~l~~L~~L~L~~N~l~~~  187 (897)
                      +.+.  .|++++ +|..++++++|++|||++|++++.                 +|..++  ++++|++|+|++|++.+.
T Consensus       186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~  264 (636)
T 4eco_A          186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK  264 (636)
T ss_dssp             TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred             hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence            1111  345555 455555555555555555555543                 555555  555555555555555555


Q ss_pred             cccccccccccccccccccc-ccc-cCCccccc-----cccccceeecccccccccccc--cccCCCcccEEEccccccc
Q 045539          188 APVTIFNMSALKEIYLLNNS-LSG-SLPSRIDL-----SLPNVETLNLGINSFYGTVPS--SITNASKLSDLELGVNLFS  258 (897)
Q Consensus       188 ~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~-----~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~  258 (897)
                      +|..|+++++|++|+|++|+ ++| .+|..++.     .+++|++|+|++|+++ .+|.  .++++++|++|++++|.++
T Consensus       265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~  343 (636)
T 4eco_A          265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE  343 (636)
T ss_dssp             CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred             ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc
Confidence            55555555555555555555 554 45544431     1255555555555555 4555  5555555555555555555


Q ss_pred             cccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCc
Q 045539          259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL  338 (897)
Q Consensus       259 ~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l  338 (897)
                      |.+| .                     +..+++|++|+|++|+++ .+|..+..+..+|++|++++|.++ .+|..+..+
T Consensus       344 g~ip-~---------------------~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~  399 (636)
T 4eco_A          344 GKLP-A---------------------FGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK  399 (636)
T ss_dssp             EECC-C---------------------CEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT
T ss_pred             cchh-h---------------------hCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc
Confidence            4444 2                     233445555555555555 444445555422555555555555 455555554


Q ss_pred             c--CCcEEEccCCCCCCCcccccc-------CccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccc
Q 045539          339 G--NLLVLELGGNNLTEPIPITFS-------QLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN  409 (897)
Q Consensus       339 ~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  409 (897)
                      +  +|++|++++|++++.+|..|.       .+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus       400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~  478 (636)
T 4eco_A          400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLK  478 (636)
T ss_dssp             CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSE
T ss_pred             ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhc
Confidence            3  677777777777777777776       6667777777777777443344555777777777777777 45543322


Q ss_pred             -c-------cccceeccccccccCCcccccc--ccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccc
Q 045539          410 -L-------TSLRVLYLGLNRFTSALPSTIW--NLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFL  479 (897)
Q Consensus       410 -l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~l  479 (897)
                       .       ++|+.|+|++|+++ .+|..+.  .+++|+             .|+|++|++++ +|..++.+++|+.|+|
T Consensus       479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~-------------~L~Ls~N~l~~-ip~~~~~l~~L~~L~L  543 (636)
T 4eco_A          479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLV-------------GIDLSYNSFSK-FPTQPLNSSTLKGFGI  543 (636)
T ss_dssp             ETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCC-------------EEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred             cccccccccCCccEEECcCCcCC-ccChhhhhccCCCcC-------------EEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence             2       27777777777777 4666665  666666             44455555555 6777777777777777


Q ss_pred             ------cCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccc
Q 045539          480 ------EYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       480 ------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  534 (897)
                            ++|++.+.+|..++++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++..
T Consensus       544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence                  45667777777777777777777777777 47777655  677777777777654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.6e-58  Score=559.13  Aligned_cols=451  Identities=19%  Similarity=0.249  Sum_probs=255.1

Q ss_pred             cCChhHHHHHHHHHhccccCCCcccccCCCCCC-----CC--cce------------eeeEeeCCCCeEEEEEeeccccc
Q 045539           29 SNITTDQQALLALKAHISYDHTNLFARNWTSST-----SV--CSW------------IGITCDVNSHRVIGLNISSFNLQ   89 (897)
Q Consensus        29 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~   89 (897)
                      ++..+|++||++||+++. +|      +|+.+.     +|  |+|            .||+|+. ++||++|+|+++++.
T Consensus       265 ~~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~  336 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK  336 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred             ccchHHHHHHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence            344679999999999994 43      676443     45  999            9999986 689999999999999


Q ss_pred             ccCCCCCCCCCCCceecc-cCccccCcCCccc------------------------------------------------
Q 045539           90 GTIPPQLGNLSSLQTLDL-SHNKLSGNIPSSI------------------------------------------------  120 (897)
Q Consensus        90 g~~~~~l~~l~~L~~L~L-s~n~l~~~~p~~~------------------------------------------------  120 (897)
                      |.+|++|++|++|++||| ++|.++|..|...                                                
T Consensus       337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            999999999999999999 8888776522110                                                


Q ss_pred             ---cCCCCCcEEeccC--ccccCCccccccccccccEEEeeecCCCC-----------------CCCcccc--Ccccccc
Q 045539          121 ---FNMHTLKLLYFSD--NQLFGSLSFFIFNVSSVTTIDLSINGLSG-----------------EMPREIG--NLPYLAR  176 (897)
Q Consensus       121 ---~~l~~L~~L~Ls~--N~l~~~~~~~~~~l~~L~~LdLs~N~l~~-----------------~~p~~l~--~l~~L~~  176 (897)
                         .+...++.+.+..  |++.+ +|..+.++++|++|+|++|+|++                 .+|..++  ++++|++
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~  495 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD  495 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence               1111222233322  55555 45555555555555555555554                 2555555  5555555


Q ss_pred             ccccccccccccccccccccccccccccccc-ccc-cCCcccc------ccccccceeecccccccccccc--cccCCCc
Q 045539          177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNS-LSG-SLPSRID------LSLPNVETLNLGINSFYGTVPS--SITNASK  246 (897)
Q Consensus       177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~------~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~  246 (897)
                      |+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+.      ..+++|++|+|++|.++ .+|.  .+.++++
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~  574 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK  574 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence            5555555555555555555555555555555 554 4554332      12235555555555555 4555  5555555


Q ss_pred             ccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCC
Q 045539          247 LSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCS  326 (897)
Q Consensus       247 L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~  326 (897)
                      |+.|+|++|.++ .+| .                     +.++++|+.|+|++|++. .+|..+..++.+|+.|++++|.
T Consensus       575 L~~L~Ls~N~l~-~lp-~---------------------~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~  630 (876)
T 4ecn_A          575 LGLLDCVHNKVR-HLE-A---------------------FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK  630 (876)
T ss_dssp             CCEEECTTSCCC-BCC-C---------------------CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred             CCEEECCCCCcc-cch-h---------------------hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence            555555555555 222 1                     234455555555555555 4455555554225555555555


Q ss_pred             CCCCcCccccCccC--CcEEEccCCCCCCCccccc---c--CccchhhhcccCcccccccchhhhccccccccccccccc
Q 045539          327 ISGNIPQVVGNLGN--LLVLELGGNNLTEPIPITF---S--QLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF  399 (897)
Q Consensus       327 l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  399 (897)
                      ++ .+|..+..++.  |+.|+|++|++++.+|...   .  .+++|+.|+|++|+++...+..+..+++|+.|+|++|++
T Consensus       631 L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L  709 (876)
T 4ecn_A          631 LK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM  709 (876)
T ss_dssp             CC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCC
T ss_pred             CC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcC
Confidence            55 44555544433  5555555555555443221   1  223555555555555532222233455555555555555


Q ss_pred             ccCCCccccc--------ccccceeccccccccCCcccccc--ccccceEEeecCCcccccceeecccCcCCCCCccccc
Q 045539          400 SGSIPSCLGN--------LTSLRVLYLGLNRFTSALPSTIW--NLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG  469 (897)
Q Consensus       400 ~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~  469 (897)
                      + .+|..+..        +++|+.|+|++|+++ .+|..+.  .+++|+             .|+|++|++++ +|..++
T Consensus       710 ~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~-------------~L~Ls~N~L~~-lp~~l~  773 (876)
T 4ecn_A          710 T-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS-------------NMDVSYNCFSS-FPTQPL  773 (876)
T ss_dssp             S-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCC-------------EEECCSSCCSS-CCCGGG
T ss_pred             C-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcC-------------EEEeCCCCCCc-cchhhh
Confidence            5 34433222        225555555555555 3455444  455554             33333344443 455555


Q ss_pred             CCcccccccccC------ceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          470 GLKNLQQMFLEY------NRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       470 ~l~~L~~L~ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      .+++|+.|+|++      |++.+.+|..|.++++|+.|+|++|+| +.+|..+.  ++|+.|||++|++.
T Consensus       774 ~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~  840 (876)
T 4ecn_A          774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNI  840 (876)
T ss_dssp             GCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTC
T ss_pred             cCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCC
Confidence            555555555544      555555555555555555555555555 35555543  35555555555554

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=8.1e-58  Score=557.86  Aligned_cols=455  Identities=35%  Similarity=0.494  Sum_probs=394.7

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++..|+|++|++++.+|. ++++++|++|+|++|.+++.+|..|+++++|++|+|++|++.+.+|..  .+++|++|+|
T Consensus       200 ~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L  276 (768)
T 3rgz_A          200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL  276 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEEC
T ss_pred             CcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEEC
Confidence            3567788888888877776 888888888888888888888888888888888888888888777765  7888888888


Q ss_pred             eecCCCCCCCccccCc-ccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccc
Q 045539          156 SINGLSGEMPREIGNL-PYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFY  234 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~  234 (897)
                      ++|++++.+|..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|+++|.+|...+..+++|++|+|++|.++
T Consensus       277 ~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~  356 (768)
T 3rgz_A          277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS  356 (768)
T ss_dssp             CSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE
T ss_pred             cCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC
Confidence            8888888888888775 999999999999999989999999999999999999998899886668899999999999999


Q ss_pred             ccccccccCCC-cccEEEccccccccccCccccc-----cccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCC
Q 045539          235 GTVPSSITNAS-KLSDLELGVNLFSGFIPNTFVN-----MADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPK  308 (897)
Q Consensus       235 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~f~~-----l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~  308 (897)
                      +.+|..+.+++ +|+.|++++|.+++.+|..+..     +....+..+.........+.++++|++|+|++|++++.+|.
T Consensus       357 ~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~  436 (768)
T 3rgz_A          357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS  436 (768)
T ss_dssp             ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred             ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH
Confidence            89999998887 8999999999998877766533     32233333222223345688899999999999999999999


Q ss_pred             cccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccc
Q 045539          309 SKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR  388 (897)
Q Consensus       309 ~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  388 (897)
                      .+..++ +|+.|++++|.+++.+|..+..+++|++|++++|++++.+|..|.++++|++|+|++|++++.+|.+++.+++
T Consensus       437 ~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  515 (768)
T 3rgz_A          437 SLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN  515 (768)
T ss_dssp             GGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             HHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCC
Confidence            999887 8999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccCCCcccccccccceeccccccccCCcccccc------------------------------------
Q 045539          389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIW------------------------------------  432 (897)
Q Consensus       389 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~------------------------------------  432 (897)
                      |++|+|++|+++|.+|..++++++|+.|++++|+++|.+|..++                                    
T Consensus       516 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (768)
T 3rgz_A          516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE  595 (768)
T ss_dssp             CCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEE
T ss_pred             CCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999887776543                                    


Q ss_pred             ----------------------------------ccccceEEeecCCccc-----------ccceeecccCcCCCCCccc
Q 045539          433 ----------------------------------NLKDILFIDVSSNSLN-----------VLIGLNFSRNNLSGDIPIT  467 (897)
Q Consensus       433 ----------------------------------~l~~L~~L~ls~N~l~-----------~l~~l~ls~n~l~~~~p~~  467 (897)
                                                        .+++|++||+++|+++           .|+.|+|++|+++|.+|..
T Consensus       596 ~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~  675 (768)
T 3rgz_A          596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE  675 (768)
T ss_dssp             CTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred             cccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH
Confidence                                              3567899999999874           4788999999999999999


Q ss_pred             ccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCc-cccc
Q 045539          468 IGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK-LEGE  535 (897)
Q Consensus       468 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~  535 (897)
                      ++.+++|+.|+|++|+++|.+|..++++++|++||||+|+|+|.+|.. ..+..+....+.+|+ |+|.
T Consensus       676 l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             GGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred             HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence            999999999999999999999999999999999999999999999974 445566667788886 6764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.9e-54  Score=516.18  Aligned_cols=478  Identities=20%  Similarity=0.199  Sum_probs=384.2

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      ..++.|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++.+..|..|.++++|++|+|
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            35778888888888777888888888888888888888777888888888888888888888888888888888888888


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccc--eeecccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVE--TLNLGINSF  233 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~--~L~L~~N~l  233 (897)
                      ++|++++..|..++++++|++|++++|+++++.+..+.++++|++|++++|++++ ++...+..+++|+  .|++++|.+
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE-ECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc-cChhhhhhhcccceeEEecCCCcc
Confidence            8888886557778888888888888888888665556668888888888888874 4333344677777  788888888


Q ss_pred             cccccccccCCCcccEEEccccccc--------------------------cccCccccc-----cccccccCCCCcccc
Q 045539          234 YGTVPSSITNASKLSDLELGVNLFS--------------------------GFIPNTFVN-----MADNYLTSSTPELSF  282 (897)
Q Consensus       234 ~~~~p~~l~~l~~L~~L~L~~N~l~--------------------------~~~~~~f~~-----l~~~~l~~~~~~~~~  282 (897)
                      ++..|..+.. .+|+.|++++|...                          ...+..|..     +....++.+......
T Consensus       192 ~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~  270 (606)
T 3t6q_A          192 AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS  270 (606)
T ss_dssp             CEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred             CccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence            8776666554 56777777766410                          000111111     111111111111111


Q ss_pred             cccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccc-cccC
Q 045539          283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI-TFSQ  361 (897)
Q Consensus       283 l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~  361 (897)
                      ...+.++++|++|++++|+++ .+|..+..++ +|++|++++|.+++..|..+..+++|++|++++|.+.+.+|. .+..
T Consensus       271 ~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  348 (606)
T 3t6q_A          271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN  348 (606)
T ss_dssp             TTTTTTCTTCSEEECTTSCCS-CCCSSCCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTT
T ss_pred             HHHhccccCCCEEeccCCccC-CCChhhcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhc
Confidence            223678899999999999998 5677888887 899999999999988899999999999999999999865554 5889


Q ss_pred             ccchhhhcccCccccccc--chhhhcccccccccccccccccCCCcccccccccceeccccccccCCcccc-ccccccce
Q 045539          362 LQTLQALGLTRNKLAGPI--TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPST-IWNLKDIL  438 (897)
Q Consensus       362 l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~  438 (897)
                      +++|++|++++|++++..  +..+..+++|++|++++|++++..|..++++++|+.|++++|++++..|.. +..+++|+
T Consensus       349 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  428 (606)
T 3t6q_A          349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK  428 (606)
T ss_dssp             CTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCC
T ss_pred             cCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCC
Confidence            999999999999998766  778999999999999999999888999999999999999999998876654 88999999


Q ss_pred             EEeecCCccc-----------ccceeecccCcCCCC---CcccccCCcccccccccCceecccCCCCCCCcCCCcEEecc
Q 045539          439 FIDVSSNSLN-----------VLIGLNFSRNNLSGD---IPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS  504 (897)
Q Consensus       439 ~L~ls~N~l~-----------~l~~l~ls~n~l~~~---~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls  504 (897)
                      +|++++|.+.           .|+.|++++|++++.   .+..+..+++|++|++++|++++..|..|.++++|+.|+|+
T Consensus       429 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  508 (606)
T 3t6q_A          429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS  508 (606)
T ss_dssp             EEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             EEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECC
Confidence            9999999753           578899999999873   34678999999999999999999999999999999999999


Q ss_pred             CCccCCCCchhhhhhcccceEeccCCcccccCCCC-CCCCCCCcccccchhhhhh
Q 045539          505 KNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG-GPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       505 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~  558 (897)
                      +|++++..|..+.+++.| .|+|++|++++.+|.. +.+.++..+.+.|||+.|.
T Consensus       509 ~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             SSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             CCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            999999999999999999 9999999999887753 3467788889999998875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2e-53  Score=514.36  Aligned_cols=483  Identities=22%  Similarity=0.231  Sum_probs=301.3

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .+++.|+|++|++++..+.+++++++|++|||++|.+++..|..|+++++|++|+|++|++.+.++..|.++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            47899999999999877788999999999999999999988999999999999999999999888888999999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccc-ccccccceeeccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRID-LSLPNVETLNLGINSFY  234 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~l~~L~~L~L~~N~l~  234 (897)
                      ++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|++++..+..+. ..+++|++|++++|.++
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~  184 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK  184 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence            99999977778899999999999999999999999999999999999999999855444332 24578899999999888


Q ss_pred             ccccccccCC---------------------------CcccEEEccccccccccCccccccc-----cccccCCCCcccc
Q 045539          235 GTVPSSITNA---------------------------SKLSDLELGVNLFSGFIPNTFVNMA-----DNYLTSSTPELSF  282 (897)
Q Consensus       235 ~~~p~~l~~l---------------------------~~L~~L~L~~N~l~~~~~~~f~~l~-----~~~l~~~~~~~~~  282 (897)
                      +..|..+..+                           ++|+.|++++|.+++..|..|..+.     ...++.+......
T Consensus       185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~  264 (680)
T 1ziw_A          185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG  264 (680)
T ss_dssp             CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred             ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence            8777766554                           4456666667777766666664432     2222222222222


Q ss_pred             cccccccCCCcEEEecCCCCCCCCCCcccCch--------------------------------HHHHHHHhccCCCCCC
Q 045539          283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLS--------------------------------LSLEIILMDNCSISGN  330 (897)
Q Consensus       283 l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--------------------------------~~L~~L~l~~n~l~~~  330 (897)
                      ...+..+++|++|++++|++.+..|..+..+.                                .+|++|++++|.+++.
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~  344 (680)
T 1ziw_A          265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI  344 (680)
T ss_dssp             TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred             cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence            23456667777777777777666655444433                                1344444444444444


Q ss_pred             cCccccCccCCcEEEccCCCCCCC--ccccccCc--cchhhhcccCcccccccchhhhcccccccccccccccccCCC-c
Q 045539          331 IPQVVGNLGNLLVLELGGNNLTEP--IPITFSQL--QTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-S  405 (897)
Q Consensus       331 ~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~  405 (897)
                      .+..|.++++|++|++++|.++..  .+..|..+  ++|+.|++++|++++..|..|..+++|++|+|++|++++.+| .
T Consensus       345 ~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  424 (680)
T 1ziw_A          345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ  424 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred             ChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence            444444444444444443332110  00111111  133333344444554555556666666666666666655444 4


Q ss_pred             ccccccccceeccccccccCCccccccccccceEEeecCCcc-------------cccceeecccCcCCCCCcccccCCc
Q 045539          406 CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSL-------------NVLIGLNFSRNNLSGDIPITIGGLK  472 (897)
Q Consensus       406 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l-------------~~l~~l~ls~n~l~~~~p~~~~~l~  472 (897)
                      .+.++++|+.|++++|++++..+..|..+++|+.|++++|.+             +.|+.|++++|++++..|..++.++
T Consensus       425 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~  504 (680)
T 1ziw_A          425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE  504 (680)
T ss_dssp             GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc
Confidence            555566666666666665555455555555555555555433             1244455555555544444444455


Q ss_pred             ccccccccCceecc--------------------------------cCCCCCCCcCCCcEEeccCCccCCCCchhhhhhc
Q 045539          473 NLQQMFLEYNRLEG--------------------------------SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL  520 (897)
Q Consensus       473 ~L~~L~ls~N~l~~--------------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  520 (897)
                      +|++|++++|++++                                ..+..|.++++|+.|+|++|+|++..+..+..++
T Consensus       505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~  584 (680)
T 1ziw_A          505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV  584 (680)
T ss_dssp             TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCC
Confidence            55555555554443                                2223345555555555555555533333444455


Q ss_pred             ccceEeccCCcccccCCCCC--CCCCCCcccccchhhhhh
Q 045539          521 YLKHLNLSFNKLEGEIPRGG--PFANLTAKSFMGNELLKM  558 (897)
Q Consensus       521 ~L~~L~ls~N~l~~~~p~~~--~~~~~~~~~~~~N~~~c~  558 (897)
                      +|+.|+|++|++++.+|...  .+.++..+.+.|||+.|.
T Consensus       585 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            55555555555554433211  234444555555555553

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-53  Score=520.56  Aligned_cols=481  Identities=20%  Similarity=0.226  Sum_probs=399.9

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcC-CccccCCCCCcEEeccCccccCCccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNI-PSSIFNMHTLKLLYFSDNQLFGSLSF  142 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~  142 (897)
                      |.|.+|.+  ...+++.|||++|.+++..|.+|+++++|++|||++|.+.+.+ |..|+++++|++|+|++|++.+..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            67888887  4568999999999999999999999999999999999776666 78899999999999999999999999


Q ss_pred             cccccccccEEEeeecCCCCCCCcc--ccCccccccccccccccccccc-ccccccccccccccccccccccCCcccccc
Q 045539          143 FIFNVSSVTTIDLSINGLSGEMPRE--IGNLPYLARLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLSGSLPSRIDLS  219 (897)
Q Consensus       143 ~~~~l~~L~~LdLs~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  219 (897)
                      .|.++++|++|+|++|.+++.+|..  |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+. .
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~-~  170 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE-P  170 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH-H
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc-c
Confidence            9999999999999999999877766  9999999999999999998865 5799999999999999999977776654 4


Q ss_pred             c--cccceeecccccccccccccccCCCc------ccEEEccccccccccCcccccccc------cccc---------CC
Q 045539          220 L--PNVETLNLGINSFYGTVPSSITNASK------LSDLELGVNLFSGFIPNTFVNMAD------NYLT---------SS  276 (897)
Q Consensus       220 l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~~~~f~~l~~------~~l~---------~~  276 (897)
                      +  ++|+.|+|++|.+.+..|..+..+++      |+.|++++|.+++..+..+.....      ..+.         ..
T Consensus       171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence            4  89999999999999999988887776      999999999998888776654211      0000         00


Q ss_pred             CCccccccccccc--CCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCC
Q 045539          277 TPELSFLSSLTNC--KKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP  354 (897)
Q Consensus       277 ~~~~~~l~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  354 (897)
                      .........+.++  ++|+.|+|++|.+.+..|..+..++ +|+.|++++|++++..|..|..+++|++|+|++|++++.
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  329 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL  329 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc
Confidence            0000011123333  6788888888888888888888777 788888888888888888888888888888888888888


Q ss_pred             ccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecccccccc----------
Q 045539          355 IPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT----------  424 (897)
Q Consensus       355 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~----------  424 (897)
                      .|..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|.+++ ++.    +++|+.|++++|+++          
T Consensus       330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~----~~~L~~L~l~~N~l~~l~~~~~~l~  404 (844)
T 3j0a_A          330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHF----IPSIPDIFLSGNKLVTLPKINLTAN  404 (844)
T ss_dssp             CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSS----CCSCSEEEEESCCCCCCCCCCTTCC
T ss_pred             CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccC----CCCcchhccCCCCcccccccccccc
Confidence            88888888888888888888887777788888888888888888874 222    455555555555554          


Q ss_pred             ----------CCc-cccccccccceEEeecCCccc------------ccceeecccCcCC-----CCCcccccCCccccc
Q 045539          425 ----------SAL-PSTIWNLKDILFIDVSSNSLN------------VLIGLNFSRNNLS-----GDIPITIGGLKNLQQ  476 (897)
Q Consensus       425 ----------~~~-p~~~~~l~~L~~L~ls~N~l~------------~l~~l~ls~n~l~-----~~~p~~~~~l~~L~~  476 (897)
                                +.. +..+.++++|+.|++++|+++            .|+.|+|++|.++     +..|..|..+++|+.
T Consensus       405 ~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~  484 (844)
T 3j0a_A          405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV  484 (844)
T ss_dssp             EEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEEC
T ss_pred             eeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccE
Confidence                      321 122457889999999999875            4778999999997     555677999999999


Q ss_pred             ccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhhh
Q 045539          477 MFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL  556 (897)
Q Consensus       477 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~  556 (897)
                      |+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|+|++|++++.+|.  .+.++..+.+.|||+.
T Consensus       485 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~  560 (844)
T 3j0a_A          485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFI  560 (844)
T ss_dssp             CCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCC
T ss_pred             EECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcc
Confidence            99999999999999999999999999999999987777666  8999999999999999986  4678888999999988


Q ss_pred             h
Q 045539          557 K  557 (897)
Q Consensus       557 c  557 (897)
                      |
T Consensus       561 C  561 (844)
T 3j0a_A          561 C  561 (844)
T ss_dssp             C
T ss_pred             c
Confidence            8

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.4e-52  Score=500.02  Aligned_cols=472  Identities=20%  Similarity=0.190  Sum_probs=403.4

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .+++.|+|++|++++..+.+++++++|++|||++|++++..|..|+++++|++|+|++|++.+..|..|.++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            57899999999999988889999999999999999999888999999999999999999999999999999999999999


Q ss_pred             eecCCCCCCCccccCccccccccccccccccc-ccccccccccccccccccccccccCCccccccccccc----eeeccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGV-APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVE----TLNLGI  230 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~----~L~L~~  230 (897)
                      ++|++++..|..|+++++|++|++++|++++. .|..|+++++|++|+|++|++++..|..+ ..+++|+    +|++++
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL-QFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT-HHHHHCTTCCCEEECTT
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh-hhhhccccccceeeccC
Confidence            99999977778999999999999999999974 58999999999999999999996555444 3566655    799999


Q ss_pred             ccccccccccccCCCcccEEEcccccccc-ccCccccccccc-----------------------------------ccc
Q 045539          231 NSFYGTVPSSITNASKLSDLELGVNLFSG-FIPNTFVNMADN-----------------------------------YLT  274 (897)
Q Consensus       231 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~f~~l~~~-----------------------------------~l~  274 (897)
                      |.+++..+..+... +|+.|++++|.+++ ..|..+.++...                                   .+.
T Consensus       191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  269 (606)
T 3vq2_A          191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT  269 (606)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred             CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence            99997666666655 99999999998863 333333322211                                   110


Q ss_pred             CCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCC
Q 045539          275 SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP  354 (897)
Q Consensus       275 ~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  354 (897)
                      ....-......+..+++|+.|++++|.+..+ | .+..+. +|+.|++++|.+ +.+| .+ .+++|++|++++|+..+.
T Consensus       270 ~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l-~-~l~~~~-~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~  343 (606)
T 3vq2_A          270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYL-E-DVPKHF-KWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSIS  343 (606)
T ss_dssp             CCTTCCGGGGSCGGGTTCSEEEEESCCCCCC-C-CCCTTC-CCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEE
T ss_pred             ccccccccccccccCCCCCEEEecCccchhh-h-hccccc-cCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccc
Confidence            1111112223377889999999999999764 4 677666 899999999999 6777 45 999999999999966543


Q ss_pred             ccccccCccchhhhcccCcccccc--cchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcc-ccc
Q 045539          355 IPITFSQLQTLQALGLTRNKLAGP--ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP-STI  431 (897)
Q Consensus       355 ~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~  431 (897)
                        ..+..+++|++|++++|++++.  +|..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..| ..+
T Consensus       344 --~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  420 (606)
T 3vq2_A          344 --FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF  420 (606)
T ss_dssp             --CCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTT
T ss_pred             --hhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhh
Confidence              3678999999999999999976  3889999999999999999998 477899999999999999999998877 689


Q ss_pred             cccccceEEeecCCcc-----------cccceeecccCcCCC-CCcccccCCcccccccccCceecccCCCCCCCcCCCc
Q 045539          432 WNLKDILFIDVSSNSL-----------NVLIGLNFSRNNLSG-DIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE  499 (897)
Q Consensus       432 ~~l~~L~~L~ls~N~l-----------~~l~~l~ls~n~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  499 (897)
                      ..+++|++|++++|.+           +.|+.|++++|++++ .+|..++.+++|++|++++|++++..|..|.++++|+
T Consensus       421 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  500 (606)
T 3vq2_A          421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ  500 (606)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC
Confidence            9999999999999975           358899999999998 4799999999999999999999999999999999999


Q ss_pred             EEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCC-CCCcccccchhhhhh
Q 045539          500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFA-NLTAKSFMGNELLKM  558 (897)
Q Consensus       500 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~~~~~~~~~N~~~c~  558 (897)
                      +|+|++|++++.+|..+..+++|+.|+|++|+++..++....+. ++..+.+.|||+.|.
T Consensus       501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence            99999999999999999999999999999999995444334454 478889999999885

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1e-51  Score=492.67  Aligned_cols=438  Identities=22%  Similarity=0.240  Sum_probs=388.6

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++..|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++.+..+..+.++++|++|+|
T Consensus        57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L  136 (606)
T 3t6q_A           57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL  136 (606)
T ss_dssp             TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred             ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence            36789999999999999999999999999999999999899999999999999999999999988899999999999999


Q ss_pred             eecCCCCCCCccccCccccccccccccccccccccccccccccc--ccccccccccccCCcccccc--------------
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK--EIYLLNNSLSGSLPSRIDLS--------------  219 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~p~~~~~~--------------  219 (897)
                      ++|++++..+..+..+++|++|++++|+++++.|..|+++++|+  +|++++|++++..|..+...              
T Consensus       137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~  216 (606)
T 3t6q_A          137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL  216 (606)
T ss_dssp             CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHH
T ss_pred             CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHH
Confidence            99999974445555699999999999999999999999999999  89999999996555443210              


Q ss_pred             ----------------------------------c--cccceeecccccccccccccccCCCcccEEEccccccccccCc
Q 045539          220 ----------------------------------L--PNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN  263 (897)
Q Consensus       220 ----------------------------------l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  263 (897)
                                                        +  .+|+.|++++|.+++..+..|.++++|++|++++|.++.. |.
T Consensus       217 ~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l-p~  295 (606)
T 3t6q_A          217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PS  295 (606)
T ss_dssp             HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC-CS
T ss_pred             HHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC-Ch
Confidence                                              0  1566777777777766666677777777777777777632 32


Q ss_pred             cccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCc-cccCccCCc
Q 045539          264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQ-VVGNLGNLL  342 (897)
Q Consensus       264 ~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~-~~~~l~~L~  342 (897)
                                           .+.++++|++|++++|++.+..|..+..++ +|++|++++|.+.+.+|. .+..+++|+
T Consensus       296 ---------------------~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~  353 (606)
T 3t6q_A          296 ---------------------GLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLR  353 (606)
T ss_dssp             ---------------------SCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCC
T ss_pred             ---------------------hhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCC
Confidence                                 356789999999999999998888888887 899999999999876654 599999999


Q ss_pred             EEEccCCCCCCCc--cccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcc-cccccccceeccc
Q 045539          343 VLELGGNNLTEPI--PITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLG  419 (897)
Q Consensus       343 ~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~  419 (897)
                      +|++++|++++..  +..+..+++|++|++++|++.+..|..|..+++|++|++++|++++..|.. +.++++|+.|+++
T Consensus       354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  433 (606)
T 3t6q_A          354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS  433 (606)
T ss_dssp             EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred             EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence            9999999999866  778999999999999999999988999999999999999999999876654 8999999999999


Q ss_pred             cccccCCccccccccccceEEeecCCccc--------------ccceeecccCcCCCCCcccccCCcccccccccCceec
Q 045539          420 LNRFTSALPSTIWNLKDILFIDVSSNSLN--------------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLE  485 (897)
Q Consensus       420 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--------------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~  485 (897)
                      +|.+++..|..+..+++|++|++++|.++              .|+.|++++|++++.+|..++.+++|++|+|++|+++
T Consensus       434 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             TCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            99999989999999999999999999763              4788999999999999999999999999999999999


Q ss_pred             ccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCC
Q 045539          486 GSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       486 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      +..|..|.++++| .|+|++|++++.+|..+..+++|+.|++++|++.+..+
T Consensus       514 ~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             GGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             cCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            9999999999999 99999999999999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-52  Score=443.43  Aligned_cols=254  Identities=27%  Similarity=0.434  Sum_probs=211.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999864      478899999987766677889999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          691 IMKYMPNGSLENCLYSGT------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      |||||++|+|.++++..+            ..+++.++..|+.||++||+||   |+++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            4689999999999999999999   7899999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||......            
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------------  237 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------------  237 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence            99999987655444444444569999999999999999999999999999999999 89999763211            


Q ss_pred             CchHHHHhhhh-hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTN-LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                        ++...+... ....+       +.+..++.+++.+||+.|| ++|||++||.+.|++
T Consensus       238 --~~~~~i~~~~~~~~p-------~~~~~~~~~li~~cl~~dP-~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          238 --EVIECITQGRVLQRP-------RTCPQEVYELMLGCWQREP-HMRKNIKGIHTLLQN  286 (299)
T ss_dssp             --HHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHcCCCCCCC-------ccchHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence              111111111 11111       1234568899999999999 999999999988853

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.8e-50  Score=488.42  Aligned_cols=462  Identities=23%  Similarity=0.244  Sum_probs=361.7

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +++.|+|++|.+++..|.+++++++|++|+|++|++++..+..|+++++|++|+|++|++.+..+..|.++++|++|||+
T Consensus        50 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  129 (680)
T 1ziw_A           50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS  129 (680)
T ss_dssp             TCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECC
T ss_pred             cCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECC
Confidence            57788888888888778888888888888888888885555568888888888888888887777888888888888888


Q ss_pred             ecCCCCCCCccccCccccccccccccccccccccccc--ccccccccccccccccccCCccc------------------
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF--NMSALKEIYLLNNSLSGSLPSRI------------------  216 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~------------------  216 (897)
                      +|.+++..|..++++++|++|++++|++++..+..+.  ++++|++|++++|++++..|..+                  
T Consensus       130 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~  209 (680)
T 1ziw_A          130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP  209 (680)
T ss_dssp             SSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHH
T ss_pred             CCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccCh
Confidence            8888877778888888888888888888877776554  44777777777777765444321                  


Q ss_pred             --------------------------------cccc--cccceeecccccccccccccccCCCcccEEEccccccccccC
Q 045539          217 --------------------------------DLSL--PNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       217 --------------------------------~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  262 (897)
                                                      +..+  ++|++|+|++|.+++..|..|..+++|++|++++|.+++..|
T Consensus       210 ~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  289 (680)
T 1ziw_A          210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS  289 (680)
T ss_dssp             HHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECT
T ss_pred             hhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccCh
Confidence                                            1122  237777777777777777777777777777777777777766


Q ss_pred             cccccccc---ccccCCCCc----ccccc-----cccccCCCcEEEecCCCCCCCCCCcccCch----------------
Q 045539          263 NTFVNMAD---NYLTSSTPE----LSFLS-----SLTNCKKLKVLILTGNPLDGILPKSKGNLS----------------  314 (897)
Q Consensus       263 ~~f~~l~~---~~l~~~~~~----~~~l~-----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~----------------  314 (897)
                      ..|..+..   ..+......    ...++     .+..+++|++|++++|++.++.|..+..++                
T Consensus       290 ~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~  369 (680)
T 1ziw_A          290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT  369 (680)
T ss_dssp             TTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCE
T ss_pred             hhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhh
Confidence            66544321   111110000    00011     456778888888888888887776665554                


Q ss_pred             -----------HHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcc-ccccCccchhhhcccCcccccccchh
Q 045539          315 -----------LSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIP-ITFSQLQTLQALGLTRNKLAGPITDE  382 (897)
Q Consensus       315 -----------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~  382 (897)
                                 .+|+.|++++|++++..|.+|..+++|++|++++|++++.+| ..|.++++|++|++++|++.+..+..
T Consensus       370 l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  449 (680)
T 1ziw_A          370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS  449 (680)
T ss_dssp             ECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTT
T ss_pred             cchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhh
Confidence                       134455556677777778888888888888888888876444 67888888888888888888888888


Q ss_pred             hhcccccccccccccccc--cCCCcccccccccceeccccccccCCccccccccccceEEeecCCccc------------
Q 045539          383 LCHLARLHSLVLQGNKFS--GSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN------------  448 (897)
Q Consensus       383 ~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~------------  448 (897)
                      |..+++|+.|++++|.++  +.+|..+.++++|+.|++++|++++..|..+..+++|++|++++|.++            
T Consensus       450 ~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  529 (680)
T 1ziw_A          450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI  529 (680)
T ss_dssp             TTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCC
T ss_pred             hhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcc
Confidence            888888999999988886  578899999999999999999999888888999999999999999764            


Q ss_pred             -------ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhh-hhc
Q 045539          449 -------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQ-KLL  520 (897)
Q Consensus       449 -------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~  520 (897)
                             .|+.|+|++|+++...+..|+++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..|..+. .++
T Consensus       530 ~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  609 (680)
T 1ziw_A          530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR  609 (680)
T ss_dssp             CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHT
T ss_pred             hhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhccccc
Confidence                   467899999999965556799999999999999999987777789999999999999999988888888 899


Q ss_pred             ccceEeccCCcccccCCC
Q 045539          521 YLKHLNLSFNKLEGEIPR  538 (897)
Q Consensus       521 ~L~~L~ls~N~l~~~~p~  538 (897)
                      +|+.|+|++|++.+..+.
T Consensus       610 ~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          610 NLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCSEEECTTCCCCBCCCC
T ss_pred             ccCEEEccCCCcccCCcc
Confidence            999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=444.14  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46778899999999999999864      478899999987766677889999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          691 IMKYMPNGSLENCLYSGT--------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      |||||++|+|.++++...              .++++.++..|+.||++||+||   |+++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcE
Confidence            999999999999987542              3589999999999999999999   78999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhh
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIND  835 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  835 (897)
                      ||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||......  .       
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~-------  268 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--E-------  268 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--H-------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--H-------
Confidence            9999999987755544444456679999999999999999999999999999999999 89999763211  1       


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           +...+........+      +.+..++.+++.+||+.|| ++|||++||+++|++
T Consensus       269 -----~~~~i~~g~~~~~p------~~~~~~~~~li~~cl~~dP-~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          269 -----AIDCITQGRELERP------RACPPEVYAIMRGCWQREP-QQRHSIKDVHARLQA  316 (329)
T ss_dssp             -----HHHHHHHTCCCCCC------TTCCHHHHHHHHHHCCSST-TTSCCHHHHHHHHHH
T ss_pred             -----HHHHHHcCCCCCCc------ccccHHHHHHHHHHcCcCh-hHCcCHHHHHHHHHH
Confidence                 11111111100110      1234568899999999999 999999999998853

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-51  Score=435.13  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=201.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|.+.++||+|+||+||+|++.  ..||||+++..  ..+..+.|.+|++++++++|||||+++|++.+ +..|+|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467888999999999999999876  36999998643  24556789999999999999999999999865 46799999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ||++|+|.+++......+++.++..|+.|||+||+||   |+++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999987777799999999999999999999   7899999999999999999999999999999876544433


Q ss_pred             eeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          774 SIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .......||+.|||||++.   .+.++.++|||||||++|||+||+.||....... ..            ...+.....
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~------------~~~~~~~~~  255 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QI------------IFMVGRGYA  255 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HH------------HHHHHTTCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HH------------HHHHhcCCC
Confidence            3445668999999999874   3468999999999999999999999997532110 11            111111110


Q ss_pred             c-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          851 R-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       851 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . ...   .....+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       256 ~p~~~---~~~~~~~~~l~~li~~cl~~dP-~~RPs~~ei~~~Le  296 (307)
T 3omv_A          256 SPDLS---KLYKNCPKAMKRLVADCVKKVK-EERPLFPQILSSIE  296 (307)
T ss_dssp             CCCST---TSCTTSCHHHHHHHHHHTCSSS-TTSCCHHHHHHHHH
T ss_pred             CCCcc---cccccchHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            0 000   0011234568899999999999 99999999998874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-51  Score=437.59  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=209.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      +++++.+.||+|+||+||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35667789999999999999863      46889999997543 334578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC
Q 045539          690 LIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM  754 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~  754 (897)
                      +|||||++|+|.+++....               ..+++.++..|+.|||+||+||   |+++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCC
Confidence            9999999999999996532               3589999999999999999999   789999999999999999999


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHh
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~  833 (897)
                      .+||+|||+|+.....+.........||+.|||||++.++.++.++|||||||++|||+| |+.||......  .     
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~-----  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--D-----  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--H-----
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--H-----
Confidence            999999999987654444334455679999999999999999999999999999999999 89999763211  1     


Q ss_pred             hhcCCchHHHHhhhh-hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          834 NDLLPVSVMEVIDTN-LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             +.+.+... ....+       +.++.++.+++.+||+.|| ++|||++||+++|++
T Consensus       256 -------~~~~i~~~~~~~~p-------~~~~~~~~~li~~C~~~dP-~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          256 -------VVEMIRNRQVLPCP-------DDCPAWVYALMIECWNEFP-SRRPRFKDIHSRLRA  303 (308)
T ss_dssp             -------HHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             -------HHHHHHcCCCCCCc-------ccchHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHh
Confidence                   11111111 11111       2344568899999999999 999999999999975

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.9e-51  Score=480.83  Aligned_cols=459  Identities=21%  Similarity=0.258  Sum_probs=309.5

Q ss_pred             CcceeeeEeeCCC-----------CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEec
Q 045539           63 VCSWIGITCDVNS-----------HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYF  131 (897)
Q Consensus        63 ~c~w~gv~c~~~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  131 (897)
                      .|.|.|| |+...           .+++.|+|++|++++..|.+++++++|++|+|++|++++..|..|+++++|++|+|
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            5999999 97431           36888999999999888888999999999999999999888888999999999999


Q ss_pred             cCccccCCccccccccccccEEEeeecCCCC-CCCccccCccccccccccccc-cccccccccccccccccccccccccc
Q 045539          132 SDNQLFGSLSFFIFNVSSVTTIDLSINGLSG-EMPREIGNLPYLARLAFATNN-LVGVAPVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       132 s~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~-~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                      ++|++.+.++..|+++++|++|+|++|++++ .+|..++++++|++|++++|+ +..+.+..|.++++|++|++++|+++
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence            9999998888889999999999999999986 457788999999999999998 55565578899999999999999998


Q ss_pred             ccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccccc--Ccc----cccc-----ccccccCCCC
Q 045539          210 GSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFI--PNT----FVNM-----ADNYLTSSTP  278 (897)
Q Consensus       210 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--~~~----f~~l-----~~~~l~~~~~  278 (897)
                      +.+|..+. .+++|++|++++|.+.......+..+++|++|++++|.+++..  |..    ...+     ..|.+....+
T Consensus       162 ~~~~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  240 (549)
T 2z81_A          162 NYQSQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF  240 (549)
T ss_dssp             EECTTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred             ccChhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence            77777665 6888899999888876443334456888999999999888752  111    1111     1111111000


Q ss_pred             cccccccccccCCCcEEEecCCCCCCCCC------CcccCchHHHHHHHhccCCCCCC-----cCccccCccCCcEEEcc
Q 045539          279 ELSFLSSLTNCKKLKVLILTGNPLDGILP------KSKGNLSLSLEIILMDNCSISGN-----IPQVVGNLGNLLVLELG  347 (897)
Q Consensus       279 ~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p------~~~~~l~~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~L~  347 (897)
                      . .....+..+++|+.|++++|.+.+...      ..+..+. +++.|.+.++.+...     ++..+...++|+.|+++
T Consensus       241 ~-~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~  318 (549)
T 2z81_A          241 N-ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG-KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE  318 (549)
T ss_dssp             H-HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT-TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEE
T ss_pred             H-HHHHHhhhhccccccccccccccccccccccchhhhhhhc-ccccccccccccchhhhcccchhhhhhcccceEEEec
Confidence            0 011223456677777777776655311      1112222 455566666655431     12223345678888888


Q ss_pred             CCCCCCCccccc-cCccchhhhcccCcccccccch---hhhcccccccccccccccccCCC--cccccccccceeccccc
Q 045539          348 GNNLTEPIPITF-SQLQTLQALGLTRNKLAGPITD---ELCHLARLHSLVLQGNKFSGSIP--SCLGNLTSLRVLYLGLN  421 (897)
Q Consensus       348 ~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N  421 (897)
                      +|+++. +|..+ ..+++|++|+|++|++++.+|.   .+..+++|++|+|++|++++..+  ..+..+++|++|++++|
T Consensus       319 ~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N  397 (549)
T 2z81_A          319 NSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN  397 (549)
T ss_dssp             SSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTC
T ss_pred             cCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCC
Confidence            888875 44443 5678888888888888876643   36677888888888888875432  45777888888888888


Q ss_pred             cccCCccccccccccceEEeecCCccc--------ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCC
Q 045539          422 RFTSALPSTIWNLKDILFIDVSSNSLN--------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFG  493 (897)
Q Consensus       422 ~l~~~~p~~~~~l~~L~~L~ls~N~l~--------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  493 (897)
                      +++ .+|..+..+++|++|++++|.++        .|+.|++++|++++.+    ..+++|++|+|++|+|+ .+|. ..
T Consensus       398 ~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~  470 (549)
T 2z81_A          398 TFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-AS  470 (549)
T ss_dssp             CCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GG
T ss_pred             CCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cc
Confidence            887 47777777788887777777663        3444455555444422    24444555555555554 3443 23


Q ss_pred             CcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          494 DLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       494 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      .+++|++|||++|+|++.+|..+..+++|+.|+|++|++.
T Consensus       471 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  510 (549)
T 2z81_A          471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD  510 (549)
T ss_dssp             GCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBC
T ss_pred             cCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCcc
Confidence            4445555555555555444444445555555555555443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.2e-51  Score=432.46  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=209.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|++++++++|||||++++++++++..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999875 69999999997653   23457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999997654 599999999999999999999   89999999999999999999999999999999876554


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||.....                 .+++...+..
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------------~~~~~~i~~~  249 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------GLIFAKIIKL  249 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHT
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHcC
Confidence            44445567899999999999999999999999999999999999999975211                 1111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHH
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                      .+. .+   +.+..++.+++.+|++.|| ++|||++|++
T Consensus       250 ~~~-~p---~~~s~~~~dli~~lL~~dp-~~R~t~~e~~  283 (311)
T 4aw0_A          250 EYD-FP---EKFFPKARDLVEKLLVLDA-TKRLGCEEME  283 (311)
T ss_dssp             CCC-CC---TTCCHHHHHHHHHHSCSSG-GGSTTSGGGT
T ss_pred             CCC-CC---cccCHHHHHHHHHHccCCH-hHCcChHHHc
Confidence            110 00   1123457899999999999 9999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-50  Score=437.73  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=208.0

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.|+..++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999876 69999999997665555567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +||+|.+++...  .+++.++..++.||+.||+||   |++||+||||||+|||++.+|.+||+|||+|+.......  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999875  489999999999999999999   899999999999999999999999999999987654322  2


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+....+.        .+      
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~--------~~------  290 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--------RL------  290 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC--------CC------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--------CC------
Confidence            3456899999999999999999999999999999999999999975211  1111111111110        00      


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        .....+..++.+++.+||+.|| ++|||++|+++
T Consensus       291 --~~~~~~s~~~~dli~~~L~~dP-~~R~ta~e~l~  323 (346)
T 4fih_A          291 --KNLHKVSPSLKGFLDRLLVRDP-AQRATAAELLK  323 (346)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             --CccccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence              0011233457899999999999 99999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8e-51  Score=439.47  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++++..  ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999875 69999999997542  445678999999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+||+|.+++.... ..+++.++..|+.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997544 4579999999999999999999   89999999999999999999999999999998764221


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....                 .+++...+..
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------------~~~~~~i~~~  240 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----------------KNLVLKIISG  240 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHHHHHT
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------------HHHHHHHHcC
Confidence              122345799999999999999999999999999999999999999975211                 1111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .++..   ...+..++.+++.+||+.|| ++|||++|+++
T Consensus       241 ~~~~~---~~~~s~~~~~li~~~L~~dP-~~R~s~~e~l~  276 (350)
T 4b9d_A          241 SFPPV---SLHYSYDLRSLVSQLFKRNP-RDRPSVNSILE  276 (350)
T ss_dssp             CCCCC---CTTSCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             CCCCC---CccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            11000   01223457899999999999 99999999976

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.2e-50  Score=478.65  Aligned_cols=452  Identities=19%  Similarity=0.169  Sum_probs=384.4

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++..|+|++|++++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|++|++.+..+..++++++|++|+|
T Consensus        56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  135 (606)
T 3vq2_A           56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV  135 (606)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred             ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence            46889999999999988999999999999999999999888999999999999999999999999899999999999999


Q ss_pred             eecCCCC-CCCccccCccccccccccccccccccccccccccccc----ccccccccccccCCccccccccccceeeccc
Q 045539          156 SINGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK----EIYLLNNSLSGSLPSRIDLSLPNVETLNLGI  230 (897)
Q Consensus       156 s~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~  230 (897)
                      ++|.+++ .+|..|+++++|++|++++|+++++.+..|+.+++|+    +|++++|+++ .+|...+.. .+|+.|++++
T Consensus       136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~-~~L~~L~L~~  213 (606)
T 3vq2_A          136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG-IKLHELTLRG  213 (606)
T ss_dssp             CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCC-EECTTTTTT-CEEEEEEEES
T ss_pred             CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcc-eeCcccccC-ceeeeeeccC
Confidence            9999986 6799999999999999999999999999999998876    7999999998 667666644 4899999999


Q ss_pred             cccc-ccccccccCCCcccEEEc---------------------------------cccccccccCcccccccc-ccccC
Q 045539          231 NSFY-GTVPSSITNASKLSDLEL---------------------------------GVNLFSGFIPNTFVNMAD-NYLTS  275 (897)
Q Consensus       231 N~l~-~~~p~~l~~l~~L~~L~L---------------------------------~~N~l~~~~~~~f~~l~~-~~l~~  275 (897)
                      |.+. +..|..+.++++|+.+++                                 ..|.+++..|. |..+.. ..+..
T Consensus       214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l  292 (606)
T 3vq2_A          214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL  292 (606)
T ss_dssp             CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred             CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence            9886 455666777777766665                                 44455555554 332221 01111


Q ss_pred             CCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCc
Q 045539          276 STPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPI  355 (897)
Q Consensus       276 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  355 (897)
                      .......++.+..+++|++|++++|++ +.+| .+ .++ +|+.|++++|...+..  .+..+++|++|++++|++++..
T Consensus       293 ~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~  366 (606)
T 3vq2_A          293 AGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFP-TL-DLP-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG  366 (606)
T ss_dssp             ESCCCCCCCCCCTTCCCSEEEEESCCC-SSCC-CC-CCS-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEE
T ss_pred             cCccchhhhhccccccCCEEEcccccC-cccc-cC-CCC-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCc
Confidence            111122233577888999999999999 5667 44 565 8899999999665544  6778999999999999998753


Q ss_pred             --cccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCC-cccccccccceeccccccccCCcccccc
Q 045539          356 --PITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRFTSALPSTIW  432 (897)
Q Consensus       356 --~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~  432 (897)
                        |..+..+++|++|++++|++++ +|..+..+++|++|++++|++++..| ..+.++++|+.|++++|.+++..|..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence              7788899999999999999885 66888899999999999999998777 6888999999999999999988899999


Q ss_pred             ccccceEEeecCCccc------------ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcE
Q 045539          433 NLKDILFIDVSSNSLN------------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEV  500 (897)
Q Consensus       433 ~l~~L~~L~ls~N~l~------------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  500 (897)
                      ++++|++|++++|.+.            .|+.|++++|++++.+|..++.+++|++|++++|++++.+|..|.++++|+.
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  525 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST  525 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence            9999999999998653            4778999999999999999999999999999999999999999999999999


Q ss_pred             EeccCCccCCCCchhhhhhc-ccceEeccCCcccccCCC
Q 045539          501 LDLSKNKISGAIPASLQKLL-YLKHLNLSFNKLEGEIPR  538 (897)
Q Consensus       501 L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~  538 (897)
                      |||++|+|+ .+|..+..++ +|+.|++++|++.+..+.
T Consensus       526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999999999 7888899997 599999999999886653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=486.41  Aligned_cols=450  Identities=23%  Similarity=0.198  Sum_probs=370.3

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCc-cccccccccccEEEeeecC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL-SFFIFNVSSVTTIDLSING  159 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~LdLs~N~  159 (897)
                      .|.++++++ .+|.   ..++|++|||++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.
T Consensus         9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A            9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            456778888 5666   4689999999999999989999999999999999999766665 8889999999999999999


Q ss_pred             CCCCCCccccCccccccccccccccccccccc--ccccccccccccccccccccCCccccccccccceeecccccccccc
Q 045539          160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVT--IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV  237 (897)
Q Consensus       160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  237 (897)
                      +.+..|..|+++++|++|+|++|.+++..|..  |.++++|++|+|++|++++..+...+..+++|++|+|++|.+++..
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~  164 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC  164 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence            99888999999999999999999999866654  9999999999999999997766666679999999999999999999


Q ss_pred             cccccCC--CcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccC---
Q 045539          238 PSSITNA--SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN---  312 (897)
Q Consensus       238 p~~l~~l--~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~---  312 (897)
                      +..+..+  ++|+.|+++.|.+.+..|..+.....              .+.+ .+|++|++++|++.+..|..+..   
T Consensus       165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~--------------~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~l~  229 (844)
T 3j0a_A          165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN--------------PFRN-MVLEILDVSGNGWTVDITGNFSNAIS  229 (844)
T ss_dssp             SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC--------------TTTT-CCBSEEBCSSCCSSTTTTSGGGGTSC
T ss_pred             HHHcccccCCccceEECCCCccccccccchhhcCC--------------cccc-CceeEEecCCCcCchhHHHHHHhhcC
Confidence            9999988  89999999999999877765422110              0111 24777777777666555543332   


Q ss_pred             ---------------------------------c-hHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcccc
Q 045539          313 ---------------------------------L-SLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPIT  358 (897)
Q Consensus       313 ---------------------------------l-~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  358 (897)
                                                       + ..+|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..
T Consensus       230 ~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  309 (844)
T 3j0a_A          230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA  309 (844)
T ss_dssp             SCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTT
T ss_pred             cccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHH
Confidence                                             1 136888899999999888899999999999999999999888888


Q ss_pred             ccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccce
Q 045539          359 FSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDIL  438 (897)
Q Consensus       359 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  438 (897)
                      |.++++|++|+|++|++++..|..|..+++|++|++++|++++..+..|.++++|+.|+|++|.+++. +.    +++|+
T Consensus       310 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~~----~~~L~  384 (844)
T 3j0a_A          310 FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-HF----IPSIP  384 (844)
T ss_dssp             TTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-SS----CCSCS
T ss_pred             hcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-cC----CCCcc
Confidence            99999999999999999988888999999999999999999877778889999999999999998852 22    45555


Q ss_pred             EEeecCCcc--------------------------------cccceeecccCcCCCCCcc-cccCCcccccccccCceec
Q 045539          439 FIDVSSNSL--------------------------------NVLIGLNFSRNNLSGDIPI-TIGGLKNLQQMFLEYNRLE  485 (897)
Q Consensus       439 ~L~ls~N~l--------------------------------~~l~~l~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~l~  485 (897)
                      .|++++|++                                +.|+.|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus       385 ~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~  464 (844)
T 3j0a_A          385 DIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ  464 (844)
T ss_dssp             EEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCS
T ss_pred             hhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccc
Confidence            555555533                                3456677777777765443 3556788888888888886


Q ss_pred             -----ccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhh
Q 045539          486 -----GSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNEL  555 (897)
Q Consensus       486 -----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~  555 (897)
                           +..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++.+|...+ .++..+.+.+|..
T Consensus       465 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l  538 (844)
T 3j0a_A          465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQL  538 (844)
T ss_dssp             SSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECC
T ss_pred             cccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcC
Confidence                 44556789999999999999999998899999999999999999999987766444 6777788888854

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=438.87  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=207.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.|+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999876 69999999997665555567889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +||+|.+++....  +++.++..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            9999999997654  89999999999999999999   889999999999999999999999999999987654322  2


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....  ......+....+.        .+.     
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~--------~~~-----  368 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--------RLK-----  368 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC--------CCS-----
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--------CCc-----
Confidence            3456799999999999999999999999999999999999999975211  1111111111110        000     


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         ....+..++.+++.+||+.|| ++|||++|+++
T Consensus       369 ---~~~~~s~~~~dli~~~L~~dP-~~R~ta~ell~  400 (423)
T 4fie_A          369 ---NLHKVSPSLKGFLDRLLVRDP-AQRATAAELLK  400 (423)
T ss_dssp             ---CTTSSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence               011223457899999999999 99999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.6e-50  Score=430.45  Aligned_cols=250  Identities=21%  Similarity=0.208  Sum_probs=201.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .+.|+..++||+|+||+||+|++. +|+.||||+++...     ...+|+.++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888899999999999999875 69999999997642     224799999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||++.+| .+||+|||+|+........
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999997654 599999999999999999999   899999999999999999988 6999999999877543221


Q ss_pred             e---eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          774 S---IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       774 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .   .....+||+.|||||++.+..++.++||||+||++|||+||+.||......+ ..........+          ..
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~----------~~  276 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPP----------IR  276 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCG----------GG
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCC----------ch
Confidence            1   1233579999999999999999999999999999999999999997633221 11111111000          00


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhc
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSAL  893 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L  893 (897)
                      .-+       ..+...+.+++.+||+.|| ++|||++|+++.|
T Consensus       277 ~~~-------~~~s~~~~~li~~~L~~dP-~~R~sa~el~~~l  311 (336)
T 4g3f_A          277 EIP-------PSCAPLTAQAIQEGLRKEP-VHRASAMELRRKV  311 (336)
T ss_dssp             GSC-------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHH
T ss_pred             hcC-------ccCCHHHHHHHHHHccCCH-hHCcCHHHHHHHH
Confidence            000       1233457899999999999 9999999998875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-49  Score=463.69  Aligned_cols=459  Identities=19%  Similarity=0.177  Sum_probs=346.1

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++..|+|++|++++..+.+|+++++|++|||++|++++..|..|+++++|++|+|++|++.+..+..|.++++|++|++
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            46889999999999888889999999999999999999888889999999999999999999999999999999999999


Q ss_pred             eecCCCCCCCccccCccccccccccccccccc-ccccccccccccccccccccccccCCcccccccccc----ceeeccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGV-APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV----ETLNLGI  230 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L----~~L~L~~  230 (897)
                      ++|++++..+..|+++++|++|++++|+++++ .|..|+++++|++|++++|++++ ++...+..+++|    +.|++++
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE-ECGGGGHHHHTCTTCCCEEECTT
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce-ecHHHccchhccchhhhhcccCC
Confidence            99999965556799999999999999999985 58899999999999999999985 444444467777    8999999


Q ss_pred             ccccccccccccCCCcccEEEccccccccc-cCcccccccc-----------------------------------cccc
Q 045539          231 NSFYGTVPSSITNASKLSDLELGVNLFSGF-IPNTFVNMAD-----------------------------------NYLT  274 (897)
Q Consensus       231 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~f~~l~~-----------------------------------~~l~  274 (897)
                      |.+++..|..+..+ +|+.|++++|..... .+..+..+..                                   ..+.
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            99998888888776 899999998843211 1111111100                                   0000


Q ss_pred             CC-CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCC
Q 045539          275 SS-TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE  353 (897)
Q Consensus       275 ~~-~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  353 (897)
                      .. .........+..+++|++|++++|++.+ +|..+..+  +|+.|++.+|.++ .+|.  ..+++|+.|++++|.+.+
T Consensus       266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~  339 (570)
T 2z63_A          266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN  339 (570)
T ss_dssp             ETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCC
T ss_pred             cchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccc
Confidence            00 0000111235566777777777777764 55555555  6777777777777 3443  456777777777777766


Q ss_pred             CccccccCccchhhhcccCccccccc--chhhhcccccccccccccccccCCCcccccccccceeccccccccCCcc-cc
Q 045539          354 PIPITFSQLQTLQALGLTRNKLAGPI--TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP-ST  430 (897)
Q Consensus       354 ~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~  430 (897)
                      ..+.  ..+++|++|++++|++++..  +..+..+++|++|++++|++++..+. +..+++|+.|++++|.+++..| ..
T Consensus       340 ~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~  416 (570)
T 2z63_A          340 AFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSV  416 (570)
T ss_dssp             BCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCT
T ss_pred             cccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhh
Confidence            5443  56777777777777777543  56677777777777777777744333 7777777777777777776555 45


Q ss_pred             ccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceec-ccCCCCCCCcCCCcEEeccCCccC
Q 045539          431 IWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLE-GSIPESFGDLSSLEVLDLSKNKIS  509 (897)
Q Consensus       431 ~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~  509 (897)
                      +..+++|+             .|++++|.+++.+|..+..+++|++|++++|+++ +.+|..+..+++|++|+|++|+++
T Consensus       417 ~~~l~~L~-------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~  483 (570)
T 2z63_A          417 FLSLRNLI-------------YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE  483 (570)
T ss_dssp             TTTCTTCC-------------EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC
T ss_pred             hhcCCCCC-------------EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccc
Confidence            66666666             5556666666677778888888888888888887 567888888888888888888888


Q ss_pred             CCCchhhhhhcccceEeccCCcccccCCCC-CCCCCCCcccccchhhhhh
Q 045539          510 GAIPASLQKLLYLKHLNLSFNKLEGEIPRG-GPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       510 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~  558 (897)
                      +..|..+..+++|+.|+|++|++++.+|.. ..++++..+.+.+|+..|.
T Consensus       484 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  533 (570)
T 2z63_A          484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  533 (570)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence            777888888888888888888888776652 4566777778888887765

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-48  Score=411.63  Aligned_cols=244  Identities=23%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC----CCceEEEE
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN----DDFKALIM  692 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  692 (897)
                      +..+.||+|+||+||+|.+. +++.||+|++....  ....+.|.+|++++++++|||||+++++|.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999876 58999999987543  3456789999999999999999999999864    35689999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeC-CCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~  769 (897)
                      |||+||+|.+++.... .+++..+..++.||+.||+||   |++|  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997654 589999999999999999999   6666  99999999999998 478999999999986543


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .    .....+||+.|||||++.+ .++.++|||||||++|||+||+.||....... .+.+.+......          
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~~----------  248 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKP----------  248 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCC----------
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCCC----------
Confidence            2    2235679999999998764 69999999999999999999999996521110 111111110000          


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ...+      .....++.+++.+||+.|| ++|||++|+++
T Consensus       249 -~~~~------~~~~~~~~~li~~~L~~dP-~~R~s~~e~l~  282 (290)
T 3fpq_A          249 -ASFD------KVAIPEVKEIIEGCIRQNK-DERYSIKDLLN  282 (290)
T ss_dssp             -GGGG------GCCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             -CCCC------ccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence             0000      1122347889999999999 99999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-48  Score=410.37  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=189.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++++..   ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999875 69999999997543   23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+ +|+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 689999987765 599999999999999999999   88999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....     .            ++......
T Consensus       167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~------------~~~~~i~~  226 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----P------------VLFKNISN  226 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H------------HHHHHHHH
T ss_pred             ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----H------------HHHHHHHc
Confidence               2334679999999999988776 5899999999999999999999975211     1            11111111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+. .+   +.+..++.+++.+|++.|| ++|||++|+++
T Consensus       227 ~~~~-~p---~~~s~~~~~li~~~L~~dP-~~R~s~~eil~  262 (275)
T 3hyh_A          227 GVYT-LP---KFLSPGAAGLIKRMLIVNP-LNRISIHEIMQ  262 (275)
T ss_dssp             TCCC-CC---TTSCHHHHHHHHHHSCSSG-GGSCCHHHHHH
T ss_pred             CCCC-CC---CCCCHHHHHHHHHHccCCh-hHCcCHHHHHc
Confidence            1000 00   1123457889999999999 99999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5.1e-49  Score=469.20  Aligned_cols=421  Identities=19%  Similarity=0.262  Sum_probs=355.6

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccc------cC---------------------------Cccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL------FG---------------------------SLSFFIFN  146 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~---------------------------~~~~~~~~  146 (897)
                      .+++.|+|++|+++|.+|.+|++|++|++|+|++|.+      .+                           .++..+..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~  160 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD  160 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence            4789999999999999999999999999999999976      22                           11111111


Q ss_pred             -cccccEEEee--------------------ecCCCCCCCccccCccccccccccccccccc-----------------c
Q 045539          147 -VSSVTTIDLS--------------------INGLSGEMPREIGNLPYLARLAFATNNLVGV-----------------A  188 (897)
Q Consensus       147 -l~~L~~LdLs--------------------~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~  188 (897)
                       +..+..+++.                    +|+++| +|..|+++++|++|+|++|++++.                 +
T Consensus       161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i  239 (636)
T 4eco_A          161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK  239 (636)
T ss_dssp             HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence             1111112222                    678888 999999999999999999999995                 7


Q ss_pred             ccccc--ccccccccccccccccccCCccccccccccceeeccccc-ccc-cccccccCC------CcccEEEccccccc
Q 045539          189 PVTIF--NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINS-FYG-TVPSSITNA------SKLSDLELGVNLFS  258 (897)
Q Consensus       189 ~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~  258 (897)
                      |..++  ++++|++|+|++|++.|.+|..+. .+++|++|+|++|+ +++ .+|..++++      ++|++|+|++|.++
T Consensus       240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             chhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            99999  999999999999999999997776 89999999999999 998 899999887      99999999999999


Q ss_pred             cccCc--cccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCcccc
Q 045539          259 GFIPN--TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG  336 (897)
Q Consensus       259 ~~~~~--~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~  336 (897)
                       .+|.  .                     ++++++|++|++++|+++|.+| .+..++ +|++|++++|+++ .+|..+.
T Consensus       319 -~ip~~~~---------------------l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~  373 (636)
T 4eco_A          319 -TFPVETS---------------------LQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFC  373 (636)
T ss_dssp             -SCCCHHH---------------------HTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSE
T ss_pred             -ccCchhh---------------------hccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhh
Confidence             5554  3                     4678999999999999998899 888887 8999999999999 8888899


Q ss_pred             CccC-CcEEEccCCCCCCCccccccCcc--chhhhcccCcccccccchhhh-------cccccccccccccccccCCCc-
Q 045539          337 NLGN-LLVLELGGNNLTEPIPITFSQLQ--TLQALGLTRNKLAGPITDELC-------HLARLHSLVLQGNKFSGSIPS-  405 (897)
Q Consensus       337 ~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~-  405 (897)
                      .+++ |++|++++|+++ .+|..+..++  +|+.|++++|++++.+|..+.       .+++|++|+|++|+++ .+|. 
T Consensus       374 ~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~  451 (636)
T 4eco_A          374 GFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKE  451 (636)
T ss_dssp             EECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTH
T ss_pred             hhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHH
Confidence            9999 999999999999 5788887765  899999999999999999888       8889999999999999 4555 


Q ss_pred             ccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccccc--CCcccccccccCce
Q 045539          406 CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG--GLKNLQQMFLEYNR  483 (897)
Q Consensus       406 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~--~l~~L~~L~ls~N~  483 (897)
                      .+..+++|+.|+|++|+++ .+|..+.....     -....++.|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+
T Consensus       452 ~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~-----~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~  524 (636)
T 4eco_A          452 LFSTGSPLSSINLMGNMLT-EIPKNSLKDEN-----ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS  524 (636)
T ss_dssp             HHHTTCCCSEEECCSSCCS-BCCSSSSEETT-----EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred             HHccCCCCCEEECCCCCCC-CcCHHHhcccc-----ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence            4567999999999999999 56654433210     00001123336667777777 6788887  99999999999999


Q ss_pred             ecccCCCCCCCcCCCcEEec------cCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhhhh
Q 045539          484 LEGSIPESFGDLSSLEVLDL------SKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLK  557 (897)
Q Consensus       484 l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c  557 (897)
                      +++ +|..+.++++|+.|+|      ++|++.+.+|.++..+++|+.|+|++|++ +.+|.. ..+++..+.+.+|+..|
T Consensus       525 l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCE
T ss_pred             CCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcc
Confidence            997 9999999999999999      56889999999999999999999999999 788875 33788899999999887


Q ss_pred             hh
Q 045539          558 ML  559 (897)
Q Consensus       558 ~~  559 (897)
                      ..
T Consensus       602 ~~  603 (636)
T 4eco_A          602 ID  603 (636)
T ss_dssp             EE
T ss_pred             cc
Confidence            43

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.8e-49  Score=421.37  Aligned_cols=272  Identities=23%  Similarity=0.282  Sum_probs=202.4

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----ceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----FKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  692 (897)
                      ++|.+.++||+|+||+||+|++. |+.||||+++..... ....+.|+..+.+++|||||+++++|.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            46888899999999999999985 899999999765332 233445666777889999999999997653    579999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG-----HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-----h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      ||+++|+|.++++...  +++.++.+++.|+++||+|||..     |+.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998764  89999999999999999999642     3559999999999999999999999999999876


Q ss_pred             CCCCcee--eeeccccCcccCCcCccCCC------CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          768 SGEDQLS--IQIQTLATIGYMAPEYGTKG------RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       768 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      .......  ......||+.|||||++.+.      .++.++|||||||++|||+||..||.........+..........
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443321  22345799999999987654      467899999999999999999988765332222211111110000


Q ss_pred             -hHH-HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          840 -SVM-EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       840 -~~~-~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                       ... .+....+....+.... ..++...+.+++.+||+.|| ++||||+||+++|+
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~-~~~~~~~l~~li~~cl~~dP-~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANG-AARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGG-SSHHHHHHHHHHHTTCCSSG-GGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCcccc-chHHHHHHHHHHHHHcccCH-hHCcCHHHHHHHHH
Confidence             111 1222222222221111 12445678899999999999 99999999999885

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-49  Score=430.49  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=215.0

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhh-HHHHHHHHHHHHHHHhcCC-CccceE
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRH-RNLVKI  678 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l  678 (897)
                      +..++++...++|++.+.||+|+||+||+|++..      ++.||||+++... ....+.+.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4455666667899999999999999999998642      3679999997543 3445789999999999975 899999


Q ss_pred             eeeecC-CCceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCC
Q 045539          679 ISSCSN-DDFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCD  742 (897)
Q Consensus       679 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~D  742 (897)
                      +|+|.+ ++..|+|||||++|+|.++++...               ..+++.++..++.|||+||+||   |+++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCc
Confidence            999865 457899999999999999997532               3489999999999999999999   889999999


Q ss_pred             CCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcc
Q 045539          743 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDE  821 (897)
Q Consensus       743 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~  821 (897)
                      |||+|||+++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987765555445556679999999999999999999999999999999998 8999976


Q ss_pred             cccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          822 IFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       822 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+ .            +...+........+      +.+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       291 ~~~~~-~------------~~~~i~~g~~~~~p------~~~~~~~~~li~~c~~~dP-~~RPt~~eil~~L~  343 (353)
T 4ase_A          291 VKIDE-E------------FCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEP-SQRPTFSELVEHLG  343 (353)
T ss_dssp             CCCSH-H------------HHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCHHH-H------------HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCcCh-hHCcCHHHHHHHHH
Confidence            32111 1            11122111111111      1233457899999999999 99999999999875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=457.63  Aligned_cols=464  Identities=22%  Similarity=0.252  Sum_probs=362.7

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      ++-++.+++ .+|..+.  +++++|||++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            344455565 5776653  5899999999999988888999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCcccccccccccccccccccccccccccccccccccccccc-cCCccccccccccceeecccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG-SLPSRIDLSLPNVETLNLGINSFYGTVPS  239 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~~p~  239 (897)
                      ++..|..|+++++|++|++++|+++++.+..++++++|++|++++|++++ .+|..+. .+++|++|++++|.+++..+.
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGG-GCTTCCEEECTTSCCCEECGG
T ss_pred             CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhc-ccCCCCEEeCcCCccceecHH
Confidence            98778999999999999999999999988789999999999999999986 4677655 799999999999999998899


Q ss_pred             cccCCCcc----cEEEccccccccccCccccccc--cccccCCCCcc-cccccccccCCCcEEEecCCCCC------CCC
Q 045539          240 SITNASKL----SDLELGVNLFSGFIPNTFVNMA--DNYLTSSTPEL-SFLSSLTNCKKLKVLILTGNPLD------GIL  306 (897)
Q Consensus       240 ~l~~l~~L----~~L~L~~N~l~~~~~~~f~~l~--~~~l~~~~~~~-~~l~~l~~l~~L~~L~Ls~N~l~------~~~  306 (897)
                      .++.+++|    +.|++++|.+++..+..|....  ...+..+.... .....+.++++++.+.+.-+.+.      ...
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  247 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  247 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence            99999999    8999999999999887764321  11111110000 00011222233332222211111      111


Q ss_pred             CCcccCch-HHHHHHHhccC-CCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhh
Q 045539          307 PKSKGNLS-LSLEIILMDNC-SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELC  384 (897)
Q Consensus       307 p~~~~~l~-~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  384 (897)
                      ...+..+. .+++.+.+..+ .+.+..|..+..+++|++|++++|.+++ +|..+..+ +|++|++++|++. .+|.  .
T Consensus       248 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~--~  322 (570)
T 2z63_A          248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPT--L  322 (570)
T ss_dssp             TTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCB--C
T ss_pred             hhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCc--c
Confidence            11111111 01334444555 5667778888888888888888888885 67777777 8888888888887 4554  4


Q ss_pred             cccccccccccccccccCCCcccccccccceeccccccccCCc--cccccccccceEEeecCCcc----------cccce
Q 045539          385 HLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL--PSTIWNLKDILFIDVSSNSL----------NVLIG  452 (897)
Q Consensus       385 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ls~N~l----------~~l~~  452 (897)
                      .+++|++|++++|.+.+..+.  ..+++|+.|++++|++++..  |..+..+++|++|++++|.+          +.|+.
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~  400 (570)
T 2z63_A          323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEH  400 (570)
T ss_dssp             BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCE
T ss_pred             cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCE
Confidence            677888888888888766555  67888888888888887654  67788888888888888864          35778


Q ss_pred             eecccCcCCCCCc-ccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccC-CCCchhhhhhcccceEeccCC
Q 045539          453 LNFSRNNLSGDIP-ITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS-GAIPASLQKLLYLKHLNLSFN  530 (897)
Q Consensus       453 l~ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N  530 (897)
                      |++++|.+++..| ..+..+++|++|++++|++++..|..|.++++|++|+|++|+++ +.+|..+..+++|+.|+|++|
T Consensus       401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n  480 (570)
T 2z63_A          401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  480 (570)
T ss_dssp             EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence            9999999988776 57899999999999999999999999999999999999999998 679999999999999999999


Q ss_pred             cccccCCCC-CCCCCCCcccccchhh
Q 045539          531 KLEGEIPRG-GPFANLTAKSFMGNEL  555 (897)
Q Consensus       531 ~l~~~~p~~-~~~~~~~~~~~~~N~~  555 (897)
                      ++++.+|.. ..++++..+.+.+|..
T Consensus       481 ~l~~~~~~~~~~l~~L~~L~l~~n~l  506 (570)
T 2z63_A          481 QLEQLSPTAFNSLSSLQVLNMASNQL  506 (570)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             ccccCChhhhhcccCCCEEeCCCCcC
Confidence            999987753 4577888888888853

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-49  Score=420.35  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=192.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec----CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|++.+.||+|+||+||+|+..    +++.||+|++++..  .....++.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999753    47889999987542  1223467889999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 599999999999999999999   8999999999999999999999999999999865432


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .  ......+||+.|||||++.+..++.++||||+||++|||+||+.||.....                 .+++.....
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------------~~~~~~i~~  240 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----------------KETMTMILK  240 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHH
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----------------HHHHHHHHc
Confidence            2  223456799999999999999999999999999999999999999975211                 111111111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      ..+. .+   +.+..++.+++.+||+.|| ++|||+
T Consensus       241 ~~~~-~p---~~~s~~~~~li~~~L~~dP-~~R~ta  271 (304)
T 3ubd_A          241 AKLG-MP---QFLSPEAQSLLRMLFKRNP-ANRLGA  271 (304)
T ss_dssp             CCCC-CC---TTSCHHHHHHHHHHTCSSG-GGSTTC
T ss_pred             CCCC-CC---CcCCHHHHHHHHHHcccCH-HHCCCC
Confidence            1110 00   1123457899999999999 999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-47  Score=405.82  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=189.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  686 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999875 69999999987543 344578899999999999999999999986543       


Q ss_pred             -----ceEEEEEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEe
Q 045539          687 -----FKALIMKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS  759 (897)
Q Consensus       687 -----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~  759 (897)
                           ..|+||||+++|+|.+++....  ...++..+..++.||++||+||   |++||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEc
Confidence                 3689999999999999998764  3356677889999999999999   88999999999999999999999999


Q ss_pred             eccCccccCCCCce----------eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccch
Q 045539          760 DFGIAKLLSGEDQL----------SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL  829 (897)
Q Consensus       760 DFg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~  829 (897)
                      |||+|+........          ...+..+||+.|||||++.+..++.++|||||||++|||++   ||......    
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----
Confidence            99999876543221          11234579999999999999999999999999999999996   77542110    


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                  ...+........+   +...+......+++.+||+.|| ++|||++|+++
T Consensus       234 ------------~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP-~~Rps~~eil~  279 (299)
T 4g31_A          234 ------------VRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSP-MERPEAINIIE  279 (299)
T ss_dssp             ------------HHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             ------------HHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence                        0111111111111   1122233446789999999999 99999999987

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.6e-47  Score=461.26  Aligned_cols=418  Identities=20%  Similarity=0.251  Sum_probs=349.8

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEec-cCccccCCcccccc---------------------------------
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYF-SDNQLFGSLSFFIF---------------------------------  145 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~~~~~~---------------------------------  145 (897)
                      ..++.|+|++|+++|.+|++|++|++|++|+| ++|.+.|..+....                                 
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57999999999999999999999999999999 99988776432211                                 


Q ss_pred             ------------------ccccccEEEee--ecCCCCCCCccccCcccccccccccccccc-----------------cc
Q 045539          146 ------------------NVSSVTTIDLS--INGLSGEMPREIGNLPYLARLAFATNNLVG-----------------VA  188 (897)
Q Consensus       146 ------------------~l~~L~~LdLs--~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------~~  188 (897)
                                        ....++.+.++  .|++++ +|..|++|++|++|+|++|++++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                              11122333333  488887 99999999999999999999999                 37


Q ss_pred             ccccc--ccccccccccccccccccCCccccccccccceeeccccc-ccc-cccccccCCC-------cccEEEcccccc
Q 045539          189 PVTIF--NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINS-FYG-TVPSSITNAS-------KLSDLELGVNLF  257 (897)
Q Consensus       189 ~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l  257 (897)
                      |..++  ++++|++|+|++|++.+.+|..+. .+++|++|+|++|+ +++ .+|..+++++       +|+.|+|++|.+
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~-~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGG-GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHh-CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            88877  999999999999999999997665 89999999999998 998 8998777776       999999999999


Q ss_pred             ccccCc--cccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccc
Q 045539          258 SGFIPN--TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV  335 (897)
Q Consensus       258 ~~~~~~--~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~  335 (897)
                      + .+|.  .                     +.++++|++|+|++|+++ .+| .+..++ +|+.|++++|+++ .+|..+
T Consensus       561 ~-~ip~~~~---------------------l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l  614 (876)
T 4ecn_A          561 E-EFPASAS---------------------LQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDF  614 (876)
T ss_dssp             C-BCCCHHH---------------------HTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTS
T ss_pred             C-ccCChhh---------------------hhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHH
Confidence            9 5554  3                     467899999999999999 777 888887 8999999999999 889899


Q ss_pred             cCccC-CcEEEccCCCCCCCccccccCccc--hhhhcccCcccccccchhh---h--cccccccccccccccccCCCccc
Q 045539          336 GNLGN-LLVLELGGNNLTEPIPITFSQLQT--LQALGLTRNKLAGPITDEL---C--HLARLHSLVLQGNKFSGSIPSCL  407 (897)
Q Consensus       336 ~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~p~~~  407 (897)
                      ..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|+++ .+|..+
T Consensus       615 ~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~  692 (876)
T 4ecn_A          615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTEL  692 (876)
T ss_dssp             CEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHH
T ss_pred             hhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHH
Confidence            99999 999999999999 57888887765  9999999999998776433   2  3458999999999999 666655


Q ss_pred             -ccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccccc--CCcccccccccCcee
Q 045539          408 -GNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG--GLKNLQQMFLEYNRL  484 (897)
Q Consensus       408 -~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~--~l~~L~~L~ls~N~l  484 (897)
                       ..+++|+.|+|++|+++ .+|..+.....-     ....++.|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|
T Consensus       693 ~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~-----~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L  765 (876)
T 4ecn_A          693 FATGSPISTIILSNNLMT-SIPENSLKPKDG-----NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF  765 (876)
T ss_dssp             HHTTCCCSEEECCSCCCS-CCCTTSSSCTTS-----CCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCC
T ss_pred             HccCCCCCEEECCCCcCC-ccChHHhccccc-----cccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCC
Confidence             58999999999999999 566655432200     0001123336667777777 6788887  999999999999999


Q ss_pred             cccCCCCCCCcCCCcEEeccC------CccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhhhh
Q 045539          485 EGSIPESFGDLSSLEVLDLSK------NKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLK  557 (897)
Q Consensus       485 ~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c  557 (897)
                      ++ +|..+..+++|+.|+|++      |++.+.+|..+.++++|+.|+|++|++ +.+|.. ..+++..+.+.+|+...
T Consensus       766 ~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          766 SS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNIS  841 (876)
T ss_dssp             SS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCE
T ss_pred             Cc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCc
Confidence            97 899999999999999976      889999999999999999999999999 788875 34688888999998643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.1e-47  Score=452.05  Aligned_cols=444  Identities=19%  Similarity=0.207  Sum_probs=354.6

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      .|.++++++ .+|+.+.  ++|++|||++|++++..|..|+++++|++|+|++|++.+..|..|.++++|++|||++|++
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            688899988 7888765  8999999999999988899999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCccccccccccccccccc-ccccccccccccccccccccccccCCccccccccccceeecccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGV-APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPS  239 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~  239 (897)
                      ++..|..|+++++|++|+|++|+++++ .|..++++++|++|++++|++.+.+|...+..+++|++|++++|.+++..|.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            987777899999999999999999975 4678999999999999999976788877777899999999999999999999


Q ss_pred             cccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCC--CCcccCchHHH
Q 045539          240 SITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGIL--PKSKGNLSLSL  317 (897)
Q Consensus       240 ~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~~L  317 (897)
                      .+..+++|++|+++.|.+...... +                    +..+++|++|++++|++++..  |..+.....+|
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~~~~~-~--------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L  225 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAFLLEI-F--------------------ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM  225 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTTHHHH-H--------------------HHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCC
T ss_pred             hhhccccCceEecccCcccccchh-h--------------------HhhcccccEEEccCCccccccccccchhhhhhcc
Confidence            999999999999999987643322 1                    234567777777777776642  22222222245


Q ss_pred             HHHHhccCCCCCCcC----ccccCccCCcEEEccCCCCCCC-----------------------------------cccc
Q 045539          318 EIILMDNCSISGNIP----QVVGNLGNLLVLELGGNNLTEP-----------------------------------IPIT  358 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~-----------------------------------~~~~  358 (897)
                      +.|++++|.+++..+    ..+..+++|+.|++++|.+.+.                                   .+..
T Consensus       226 ~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~  305 (549)
T 2z81_A          226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV  305 (549)
T ss_dssp             CEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHH
T ss_pred             cceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhh
Confidence            555555555544322    2223344444444444443331                                   0111


Q ss_pred             ccCccchhhhcccCcccccccchhh-hcccccccccccccccccCCC---cccccccccceeccccccccCCcc--cccc
Q 045539          359 FSQLQTLQALGLTRNKLAGPITDEL-CHLARLHSLVLQGNKFSGSIP---SCLGNLTSLRVLYLGLNRFTSALP--STIW  432 (897)
Q Consensus       359 ~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~  432 (897)
                      +....+|+.|++++|++. .+|..+ ..+++|++|+|++|++++.+|   ..++.+++|+.|++++|++++..+  ..+.
T Consensus       306 ~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  384 (549)
T 2z81_A          306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL  384 (549)
T ss_dssp             HHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGG
T ss_pred             hhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhh
Confidence            223457889999999987 566655 579999999999999998764   457889999999999999987543  5688


Q ss_pred             ccccceEEeecCCccc----------ccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEe
Q 045539          433 NLKDILFIDVSSNSLN----------VLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD  502 (897)
Q Consensus       433 ~l~~L~~L~ls~N~l~----------~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  502 (897)
                      .+++|++|++++|+++          .|+.|++++|++++ +|..+.  ++|++|++++|+|++.+    ..+++|++|+
T Consensus       385 ~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~  457 (549)
T 2z81_A          385 TLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELY  457 (549)
T ss_dssp             GCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEE
T ss_pred             cCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEE
Confidence            9999999999999764          47789999999874 444432  68999999999999743    5789999999


Q ss_pred             ccCCccCCCCchhhhhhcccceEeccCCcccccCCC-CCCCCCCCcccccchhhhhh
Q 045539          503 LSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPR-GGPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       503 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~N~~~c~  558 (897)
                      |++|+|+ .+|. ...+++|+.|+|++|++++.+|. .+.+.++..+.+.+|++.|.
T Consensus       458 Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          458 ISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            9999999 7887 57899999999999999998886 35678888899999998876

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.5e-48  Score=449.43  Aligned_cols=448  Identities=20%  Similarity=0.198  Sum_probs=304.6

Q ss_pred             EEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecC
Q 045539           80 GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING  159 (897)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~  159 (897)
                      .+|+++++++ .+|..+.  ++|++|||++|.+++..|..|.++++|++|+|++|++.+..|..|.++++|++|||++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            5788888888 5777666  788888888888887777788888888888888888888888888888888888888888


Q ss_pred             CCCCCCccccCccccccccccccccccc-ccccccccccccccccccccccccCCcccccccccc--ceeecccccc--c
Q 045539          160 LSGEMPREIGNLPYLARLAFATNNLVGV-APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV--ETLNLGINSF--Y  234 (897)
Q Consensus       160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L--~~L~L~~N~l--~  234 (897)
                      ++ .+|..  .+++|++|+|++|+++++ .|..|+++++|++|+|++|++++.    .+..+++|  ++|+|++|.+  .
T Consensus        81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS----SVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG----GGGGGTTSCEEEEEEEECTTTTS
T ss_pred             ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh----hccccccceeeEEEeeccccccc
Confidence            88 57766  788888888888888874 577888888888888888888742    23356666  8888888888  7


Q ss_pred             ccccccccCCC-cccEEEccccccccccCcc-cccc---ccccccCCC------CcccccccccccCCCcEEEecCCCCC
Q 045539          235 GTVPSSITNAS-KLSDLELGVNLFSGFIPNT-FVNM---ADNYLTSST------PELSFLSSLTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       235 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~-f~~l---~~~~l~~~~------~~~~~l~~l~~l~~L~~L~Ls~N~l~  303 (897)
                      +..|..+..+. +...+++++|.+.+.++.. +..+   ....++.+.      .-...++.+..+++|+.|++++|.+.
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~  233 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT  233 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccC
Confidence            77777777655 3445566666665544432 1111   111111100      00011123455666666666666655


Q ss_pred             CCCCCcccCc--hHHHHHHHhccCCCCCCcCccc-----cCccCCcEEEccCCCCCCCcc-ccccCc---cchhhhcccC
Q 045539          304 GILPKSKGNL--SLSLEIILMDNCSISGNIPQVV-----GNLGNLLVLELGGNNLTEPIP-ITFSQL---QTLQALGLTR  372 (897)
Q Consensus       304 ~~~p~~~~~l--~~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~  372 (897)
                      +..+..+...  ..+|++|++++|+++|.+|..+     +.+++|+.+++++|.+ . +| ..+..+   .+|+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~-~p~~~~~~~~~~~~L~~L~l~~  311 (520)
T 2z7x_B          234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-G-FPQSYIYEIFSNMNIKNFTVSG  311 (520)
T ss_dssp             HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-C-SCTHHHHHHHHTCCCSEEEEES
T ss_pred             HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-e-cchhhhhcccccCceeEEEcCC
Confidence            3211111000  0135555666666665666555     5666666666666666 2 33 333333   4466666666


Q ss_pred             cccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccC--CccccccccccceEEeecCCccccc
Q 045539          373 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS--ALPSTIWNLKDILFIDVSSNSLNVL  450 (897)
Q Consensus       373 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~l  450 (897)
                      |++....  .+..+++|++|++++|++++.+|..++++++|+.|++++|++++  .+|..+..+++|+            
T Consensus       312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~------------  377 (520)
T 2z7x_B          312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ------------  377 (520)
T ss_dssp             SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCC------------
T ss_pred             Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCC------------
Confidence            6654322  11455666666666666665566666666666666666666654  3445555555555            


Q ss_pred             ceeecccCcCCCCCccc-ccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccC
Q 045539          451 IGLNFSRNNLSGDIPIT-IGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF  529 (897)
Q Consensus       451 ~~l~ls~n~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  529 (897)
                       .|++++|++++.+|.. +..+++|++|++++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus       378 -~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~  453 (520)
T 2z7x_B          378 -QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS  453 (520)
T ss_dssp             -EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred             -EEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCC
Confidence             6677777777756654 88899999999999999988888775  79999999999999 8999888999999999999


Q ss_pred             CcccccCCC--CCCCCCCCcccccchhhhhh
Q 045539          530 NKLEGEIPR--GGPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       530 N~l~~~~p~--~~~~~~~~~~~~~~N~~~c~  558 (897)
                      |++++ +|.  ...+.++..+.+.+|+..|.
T Consensus       454 N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          454 NQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             SCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence            99995 554  34577888889999998875

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=442.08  Aligned_cols=415  Identities=22%  Similarity=0.282  Sum_probs=342.2

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .+++.|+|++|++++..|.+++++++|++|+|++|++++..|..|+++++|++|+|++|++.. +|..  .+++|++|||
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEec
Confidence            578999999999998888899999999999999999998889999999999999999999985 5554  8999999999


Q ss_pred             eecCCCC-CCCccccCcccccccccccccccccccccccccccc--cccccccccc--cccCCccccc------------
Q 045539          156 SINGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL--KEIYLLNNSL--SGSLPSRIDL------------  218 (897)
Q Consensus       156 s~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~------------  218 (897)
                      ++|++++ .+|..|+++++|++|++++|++++.   .+.++++|  ++|++++|++  ++..|..+..            
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  174 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT  174 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccchh---hccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence            9999997 5789999999999999999999873   57778888  9999999999  6666655432            


Q ss_pred             -------------cccccceeeccccc-------ccccccccccCCCcccEEEccccccccccCccccccccccccCCCC
Q 045539          219 -------------SLPNVETLNLGINS-------FYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTP  278 (897)
Q Consensus       219 -------------~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~  278 (897)
                                   .+++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+++..+..+.            
T Consensus       175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~------------  241 (520)
T 2z7x_B          175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRIL------------  241 (520)
T ss_dssp             SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHH------------
T ss_pred             Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHH------------
Confidence                         35566666666665       555544 566666666666666666543322110            


Q ss_pred             cccccccccccCCCcEEEecCCCCCCCCCCcc-----cCchHHHHHHHhccCCCCCCcC-ccccCc---cCCcEEEccCC
Q 045539          279 ELSFLSSLTNCKKLKVLILTGNPLDGILPKSK-----GNLSLSLEIILMDNCSISGNIP-QVVGNL---GNLLVLELGGN  349 (897)
Q Consensus       279 ~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~~L~~L~l~~n~l~~~~p-~~~~~l---~~L~~L~L~~N  349 (897)
                            ....+++|++|++++|++.+.+|..+     ..+. +|+.+++++|.+  .+| ..+..+   .+|+.|++++|
T Consensus       242 ------~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n  312 (520)
T 2z7x_B          242 ------QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGT  312 (520)
T ss_dssp             ------HHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCC-EEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESS
T ss_pred             ------HHhhhCcccEEEeecccccCccccchhhcccccCc-eeEeccccccce--ecchhhhhcccccCceeEEEcCCC
Confidence                  01124689999999999999899888     7776 889999999999  455 555555   67999999999


Q ss_pred             CCCCCccccccCccchhhhcccCcccccccchhhhccccccccccccccccc--CCCcccccccccceeccccccccCCc
Q 045539          350 NLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG--SIPSCLGNLTSLRVLYLGLNRFTSAL  427 (897)
Q Consensus       350 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~  427 (897)
                      .+.+..  .+..+++|++|++++|++++.+|..+..+++|++|+|++|++++  .+|..++++++|+.|++++|++++.+
T Consensus       313 ~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l  390 (520)
T 2z7x_B          313 RMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE  390 (520)
T ss_dssp             CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCG
T ss_pred             cccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccc
Confidence            987643  23688999999999999999899999999999999999999996  56678999999999999999999856


Q ss_pred             cc-cccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCC
Q 045539          428 PS-TIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN  506 (897)
Q Consensus       428 p~-~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  506 (897)
                      |. .+..+++|+             .|++++|++++.+|..+.  ++|+.|++++|+++ .+|..+..+++|++|+|++|
T Consensus       391 ~~~~~~~l~~L~-------------~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N  454 (520)
T 2z7x_B          391 KKGDCSWTKSLL-------------SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN  454 (520)
T ss_dssp             GGCSCCCCTTCC-------------EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred             ccchhccCccCC-------------EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence            65 477777777             555666666677777665  79999999999999 78988889999999999999


Q ss_pred             ccCCCCchh-hhhhcccceEeccCCcccccCC
Q 045539          507 KISGAIPAS-LQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       507 ~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      +|+ .+|.. +..+++|+.|+|++|++++..+
T Consensus       455 ~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          455 QLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            999 56665 8999999999999999987544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.4e-44  Score=431.59  Aligned_cols=471  Identities=20%  Similarity=0.184  Sum_probs=330.2

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      .++.|||++|++++..+.+|+++++|++|||++|+|++..|.+|.+|++|++|+|++|+|++.++..|.++++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            57788888888887667788888888888888888887777778888888888888888888777888888888888888


Q ss_pred             ecCCCCCCCccccCccccccccccccccccc-ccccccccccccccccccccccccCCcccccccccc----ceeecccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGV-APVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV----ETLNLGIN  231 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L----~~L~L~~N  231 (897)
                      +|++++..+..|+++++|++|+|++|++++. .|..++++++|++|+|++|++++..|..+ ..+.++    ..++++.|
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG-HHHHTCTTCCCEEECTTC
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc-cchhhhhhhhhhhhcccC
Confidence            8888866666788888888888888888764 46677888888888888888875444433 233333    35778888


Q ss_pred             cccccccccccCCCcccEEEccccccccccC-ccccccccc--------------cccCC--------------------
Q 045539          232 SFYGTVPSSITNASKLSDLELGVNLFSGFIP-NTFVNMADN--------------YLTSS--------------------  276 (897)
Q Consensus       232 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~~--------------~l~~~--------------------  276 (897)
                      .+....+..+ ....++.+++.+|......+ ..+..+...              .+...                    
T Consensus       212 ~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          212 PMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             cccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            8875444443 44456777777775432211 111111000              00000                    


Q ss_pred             --CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCC
Q 045539          277 --TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP  354 (897)
Q Consensus       277 --~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  354 (897)
                        .........+..+.+++.+++.+|.+..+.+.  .... .++.|.+.+|.+.+..+.   .+..|+.+++++|.+...
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~--~~~~-~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~  364 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNF-GWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA  364 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGG--GSCC-CCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB
T ss_pred             hcccccchhhhhhhhccccccccccccccccccc--ccch-hhhhhhcccccccCcCcc---cchhhhhcccccccCCCC
Confidence              00000111234455666666666665543221  1111 456667777776654433   345677777777776542


Q ss_pred             ccccccCccchhhhcccCccccc--ccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcc-ccc
Q 045539          355 IPITFSQLQTLQALGLTRNKLAG--PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP-STI  431 (897)
Q Consensus       355 ~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~  431 (897)
                        ..+..+++|+.|++++|.+..  ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.++++.|......+ ..+
T Consensus       365 --~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~  441 (635)
T 4g8a_A          365 --FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF  441 (635)
T ss_dssp             --CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTT
T ss_pred             --cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccc
Confidence              234466777777777777653  34555666677777777777776 345566677777777777766654433 446


Q ss_pred             cccccceEEeecCCccc-----------ccceeecccCcC-CCCCcccccCCcccccccccCceecccCCCCCCCcCCCc
Q 045539          432 WNLKDILFIDVSSNSLN-----------VLIGLNFSRNNL-SGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLE  499 (897)
Q Consensus       432 ~~l~~L~~L~ls~N~l~-----------~l~~l~ls~n~l-~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  499 (897)
                      ..+.+++.++++.|.+.           .++.|++++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|+
T Consensus       442 ~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~  521 (635)
T 4g8a_A          442 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  521 (635)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence            66777777777777543           356788888874 445788999999999999999999999999999999999


Q ss_pred             EEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCC-CC-CCCCcccccchhhhhh
Q 045539          500 VLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGG-PF-ANLTAKSFMGNELLKM  558 (897)
Q Consensus       500 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~-~~~~~~~~~~N~~~c~  558 (897)
                      +|+|++|+|++..|..+..+++|+.|+|++|++++.+|..- .+ .+++.+.+.|||+.|.
T Consensus       522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            99999999998889999999999999999999999988642 33 5678889999998874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.7e-44  Score=412.89  Aligned_cols=399  Identities=20%  Similarity=0.220  Sum_probs=314.2

Q ss_pred             CCcceee--eEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCC
Q 045539           62 SVCSWIG--ITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS  139 (897)
Q Consensus        62 ~~c~w~g--v~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  139 (897)
                      ..|.|.+  |.|+.            ++++ .+|. +  .++|++|||++|.+++..|..|+++++|++|+|++|.+.+.
T Consensus         6 ~~c~~~~~~~~c~~------------~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~   69 (455)
T 3v47_A            6 SECSVIGYNAICIN------------RGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV   69 (455)
T ss_dssp             -CCEEETTEEECCS------------SCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred             ceeEEEccccCcCC------------CCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence            4577766  66653            3344 4565 3  27899999999999988899999999999999999998755


Q ss_pred             c-cccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccccc--ccccccccccccccccccccCCccc
Q 045539          140 L-SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVT--IFNMSALKEIYLLNNSLSGSLPSRI  216 (897)
Q Consensus       140 ~-~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~~~  216 (897)
                      + +..|.++++|++|||++|++++..|..|+++++|++|+|++|++++..+..  |.++++|++|+|++|++++..|..+
T Consensus        70 i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  149 (455)
T 3v47_A           70 IRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF  149 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG
T ss_pred             ECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccc
Confidence            4 677999999999999999999888999999999999999999998855554  8899999999999999987777776


Q ss_pred             cccccccceeecccccccccccccccCC--CcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcE
Q 045539          217 DLSLPNVETLNLGINSFYGTVPSSITNA--SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKV  294 (897)
Q Consensus       217 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~  294 (897)
                      +..+++|++|+|++|.+++..+..+..+  .+|+.|++++|.+.+..+..+..             .....+..+++|++
T Consensus       150 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~-------------~~~~~~~~~~~L~~  216 (455)
T 3v47_A          150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW-------------EKCGNPFKNTSITT  216 (455)
T ss_dssp             GGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH-------------HHHCCTTTTCEEEE
T ss_pred             cCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc-------------cccccccccceeee
Confidence            6788899999999999988888888776  68888888888887765543210             11122345677888


Q ss_pred             EEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcc
Q 045539          295 LILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNK  374 (897)
Q Consensus       295 L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  374 (897)
                      |++++|++.+..|..+...                      ...++|+.|++++|.+.+..              +..+.
T Consensus       217 L~Ls~n~l~~~~~~~~~~~----------------------~~~~~L~~L~l~~~~~~~~~--------------~~~~~  260 (455)
T 3v47_A          217 LDLSGNGFKESMAKRFFDA----------------------IAGTKIQSLILSNSYNMGSS--------------FGHTN  260 (455)
T ss_dssp             EECTTSCCCHHHHHHHHHH----------------------TTTCCEEEEECTTCTTTSCC--------------TTCCS
T ss_pred             EecCCCcccccchhhhhcc----------------------ccccceeeEeeccccccccc--------------cchhh
Confidence            8888888776543322211                      12367888888888766521              12222


Q ss_pred             cccccchhhhcc--cccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccce
Q 045539          375 LAGPITDELCHL--ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIG  452 (897)
Q Consensus       375 l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~  452 (897)
                      +.+..+..+..+  ++|++|++++|++++.+|..++.+++|+.|++++|++++..|..|.++++|+             .
T Consensus       261 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-------------~  327 (455)
T 3v47_A          261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL-------------K  327 (455)
T ss_dssp             SCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-------------E
T ss_pred             hccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCC-------------E
Confidence            333333333333  6899999999999988899999999999999999999988888898888888             4


Q ss_pred             eecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcc
Q 045539          453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL  532 (897)
Q Consensus       453 l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  532 (897)
                      |+|++|++++..|..++.+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++
T Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  407 (455)
T 3v47_A          328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  407 (455)
T ss_dssp             EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence            55555666666788899999999999999999988899999999999999999999977677789999999999999999


Q ss_pred             cccCCC
Q 045539          533 EGEIPR  538 (897)
Q Consensus       533 ~~~~p~  538 (897)
                      ++.+|.
T Consensus       408 ~~~~~~  413 (455)
T 3v47_A          408 DCSCPR  413 (455)
T ss_dssp             CCCTTT
T ss_pred             ccCCCc
Confidence            998875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.3e-44  Score=392.72  Aligned_cols=224  Identities=29%  Similarity=0.547  Sum_probs=176.7

Q ss_pred             cCChhHHHHHHHHHhccccCCCcccccCCCCCCCCcc--eeeeEeeCCC--CeEEEEEeecccccc--cCCCCCCCCCCC
Q 045539           29 SNITTDQQALLALKAHISYDHTNLFARNWTSSTSVCS--WIGITCDVNS--HRVIGLNISSFNLQG--TIPPQLGNLSSL  102 (897)
Q Consensus        29 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L  102 (897)
                      .|.++|++||++||+++. ||. .++ +|..+++||+  |.||+|+..+  ++|+.|+|++++++|  .+|++++++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l~-~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-ccc-CCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            588999999999999995 555 555 9988889998  9999998765  899999999999999  999999999999


Q ss_pred             ceecccC-ccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccc
Q 045539          103 QTLDLSH-NKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFAT  181 (897)
Q Consensus       103 ~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~  181 (897)
                      ++|+|++ |.+++.+|..|+++++|++|+|++|++.+.+|..+.++++|++|||++|++++.+|..|+.+++|++|+|++
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  158 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence            9999995 999999999999999999999999999888888888899999999999988888888888888888888888


Q ss_pred             ccccccccccccccc-cccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          182 NNLVGVAPVTIFNMS-ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       182 N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      |++++..|..+++++ +|++|+|++|++++.+|..+. .++ |++|+|++|.+++..|..+..+++|+.|+|++|.+
T Consensus       159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~-~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (313)
T 1ogq_A          159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG-GCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHh-CCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCce
Confidence            888877777777776 777777777777665555443 222 44555555544444444444444444444444443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=400.30  Aligned_cols=269  Identities=22%  Similarity=0.239  Sum_probs=200.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC------CC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN------DD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  686 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            368999999999999999999875 69999999997543  3445678899999999999999999998753      46


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+|||||+ |+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999995 67999887654 699999999999999999999   899999999999999999999999999999987


Q ss_pred             cCCCCc--eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC--Cc--
Q 045539          767 LSGEDQ--LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL--PV--  839 (897)
Q Consensus       767 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~--  839 (897)
                      +.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+........  +.  
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence            643221  1223456899999999987764 5699999999999999999999999753111 01111111000  00  


Q ss_pred             -------hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 -------SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 -------~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                             .....+...-...+............++.+++.+||..|| ++|||++|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP-~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP-SARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCCh-hHCcCHHHHhc
Confidence                   0111111000000000000001123457899999999999 99999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-44  Score=396.08  Aligned_cols=199  Identities=24%  Similarity=0.342  Sum_probs=170.4

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCce
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  688 (897)
                      +..++|++.+.||+|+||+||+|+.+    +++.||+|++.+...  ..++.+|+++++.+ +||||+++++++.+++..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45688999999999999999999753    467899999875432  35678899999998 599999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCcccc
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLL  767 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~  767 (897)
                      |+||||+++|+|.+++.    .+++.++..++.|++.||+||   |++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999884    389999999999999999999   89999999999999999876 79999999999765


Q ss_pred             CCCCc--------------------------eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          768 SGEDQ--------------------------LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       768 ~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                      .....                          .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                          0112345799999999988765 58999999999999999999999996


Q ss_pred             c
Q 045539          821 E  821 (897)
Q Consensus       821 ~  821 (897)
                      .
T Consensus       249 ~  249 (361)
T 4f9c_A          249 K  249 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.9e-44  Score=419.87  Aligned_cols=449  Identities=19%  Similarity=0.164  Sum_probs=292.3

Q ss_pred             EEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeec
Q 045539           79 IGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN  158 (897)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N  158 (897)
                      ..+|++++++++ +|..+.  ++|++|||++|.+++..|..|+++++|++|+|++|++.+..|..|.++++|++|||++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            567888888884 777664  78888888888888777778888888888888888888888888888888888888888


Q ss_pred             CCCCCCCccccCcccccccccccccccccc-cccccccccccccccccccccccCCcccccccccc--ceeecccccc--
Q 045539          159 GLSGEMPREIGNLPYLARLAFATNNLVGVA-PVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV--ETLNLGINSF--  233 (897)
Q Consensus       159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L--~~L~L~~N~l--  233 (897)
                      +++ .+|..  .+++|++|+|++|+++++. |..|+++++|++|+|++|++++..    +..+++|  ++|+|++|.+  
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD----LLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT----TGGGTTSCEEEEEEEESSCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc----hhhhhhceeeEEEeecccccc
Confidence            888 67766  7888888888888888854 578888888888888888887421    2234455  8888888888  


Q ss_pred             cccccccccCCC-cccEEEccccccccccCcccc----ccccccccCCCC----cccccccccccCCCcEEEecCCCCCC
Q 045539          234 YGTVPSSITNAS-KLSDLELGVNLFSGFIPNTFV----NMADNYLTSSTP----ELSFLSSLTNCKKLKVLILTGNPLDG  304 (897)
Q Consensus       234 ~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~f~----~l~~~~l~~~~~----~~~~l~~l~~l~~L~~L~Ls~N~l~~  304 (897)
                      ++..|..+..+. ..-.+++++|.+.+.++....    .+....++.+..    -...+..+.++++|+.|+++++.+.+
T Consensus       184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~  263 (562)
T 3a79_B          184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW  263 (562)
T ss_dssp             CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred             cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence            777777777654 122456677776655443210    000000000000    00011123344445555554444432


Q ss_pred             CCCCcc---cCchHHHHHHHhccCCCCCCcCccc-----cCccCCcEEEccCCCCCCCcc-ccccCc---cchhhhcccC
Q 045539          305 ILPKSK---GNLSLSLEIILMDNCSISGNIPQVV-----GNLGNLLVLELGGNNLTEPIP-ITFSQL---QTLQALGLTR  372 (897)
Q Consensus       305 ~~p~~~---~~l~~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~  372 (897)
                      .....+   .... +|++|++++|.++|.+|..+     ..+++|+.++++.|.+ . +| ..+..+   .+|+.|++++
T Consensus       264 ~~~~~~~~~~~~~-~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~-~p~~~~~~~~~~~~L~~L~l~~  340 (562)
T 3a79_B          264 KCSVKLFQFFWPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-L-FSKEALYSVFAEMNIKMLSISD  340 (562)
T ss_dssp             HHHHHHHHHHTTS-SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-S-SCHHHHHHHHHTCCCSEEEEES
T ss_pred             HHHHHHHHhhhcc-cccEEEEeccEeeccccchhhhcccccchheehhhccccee-e-cChhhhhhhhccCcceEEEccC
Confidence            100000   0000 34445555555555555544     4455555555555554 1 22 222221   3455555555


Q ss_pred             cccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCC--ccccccccccceEEeecCCccccc
Q 045539          373 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSA--LPSTIWNLKDILFIDVSSNSLNVL  450 (897)
Q Consensus       373 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~l  450 (897)
                      |++....  ....+++|++|++++|++++.+|..++++++|+.|++++|++++.  +|..+.++++|+            
T Consensus       341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~------------  406 (562)
T 3a79_B          341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE------------  406 (562)
T ss_dssp             SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC------------
T ss_pred             CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC------------
Confidence            5554221  113455566666666666655556666666666666666666542  234455555555            


Q ss_pred             ceeecccCcCCCCCcc-cccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccC
Q 045539          451 IGLNFSRNNLSGDIPI-TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF  529 (897)
Q Consensus       451 ~~l~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  529 (897)
                       .|++++|++++.+|. .+..+++|++|++++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus       407 -~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~  482 (562)
T 3a79_B          407 -TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS  482 (562)
T ss_dssp             -EEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCS
T ss_pred             -EEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCC
Confidence             667777777775555 488899999999999999988887765  78999999999998 7888888999999999999


Q ss_pred             CcccccCCC-CCCCCCCCcccccchhhhhh
Q 045539          530 NKLEGEIPR-GGPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       530 N~l~~~~p~-~~~~~~~~~~~~~~N~~~c~  558 (897)
                      |++++.++. ...++++..+.+.+|++.|.
T Consensus       483 N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          483 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             SCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            999954443 45677888889999998875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.5e-44  Score=414.89  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=209.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999875 6999999999876666667889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC--CcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED--MVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~--~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+||+|.+++......+++.++..++.||+.||+||   |++||+||||||+|||++.+  +.+||+|||+|+.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999987666799999999999999999999   89999999999999999854  8999999999998764432


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......  .....           +....... 
T Consensus       313 ---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~-----------i~~~~~~~-  375 (573)
T 3uto_A          313 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRN-----------VKSCDWNM-  375 (573)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH-----------HHTTCCCC-
T ss_pred             ---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH-----------HHhCCCCC-
Confidence               23457999999999999999999999999999999999999999752111  11111           11100000 


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.   .....+..++.+++.+||+.|| ++|||++|+++
T Consensus       376 ~~---~~~~~~s~~~~dli~~~L~~dp-~~R~t~~e~l~  410 (573)
T 3uto_A          376 DD---SAFSGISEDGKDFIRKLLLADP-NTRMTIHQALE  410 (573)
T ss_dssp             CS---GGGTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             Cc---ccccCCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            00   0011223457889999999999 99999999987

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.1e-44  Score=422.31  Aligned_cols=431  Identities=22%  Similarity=0.266  Sum_probs=333.3

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .+++.|+|++|++++..|.+++++++|++|+|++|++++..|..|+++++|++|+|++|+|.. +|..  .+++|++|||
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEEC
Confidence            578999999999998888899999999999999999998889999999999999999999985 4544  8999999999


Q ss_pred             eecCCCC-CCCccccCcccccccccccccccccccccccccccc--cccccccccc--cccCCcccccccc-ccceeecc
Q 045539          156 SINGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL--KEIYLLNNSL--SGSLPSRIDLSLP-NVETLNLG  229 (897)
Q Consensus       156 s~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~~l~-~L~~L~L~  229 (897)
                      ++|++++ .+|..|+++++|++|+|++|++++.   .+.++++|  ++|++++|++  ++..|..+.. +. ..-.++++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~-l~~~~l~l~l~  204 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLVFH  204 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEE-CCEEEEEEEEC
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccc-cCcceEEEEec
Confidence            9999996 4578999999999999999999874   45556666  9999999999  7777766542 21 12255777


Q ss_pred             cccccccccc-cccCCCcccEEEccccc-----cccccCc-------cccccccccccCCCCcccccccccccCCCcEEE
Q 045539          230 INSFYGTVPS-SITNASKLSDLELGVNL-----FSGFIPN-------TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLI  296 (897)
Q Consensus       230 ~N~l~~~~p~-~l~~l~~L~~L~L~~N~-----l~~~~~~-------~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~  296 (897)
                      +|.+.+.++. .+..+++|+.|++++|.     +.+.++.       ....+..+.++...  ...+......++|++|+
T Consensus       205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~--~~~~~~~~~~~~L~~L~  282 (562)
T 3a79_B          205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC--SVKLFQFFWPRPVEYLN  282 (562)
T ss_dssp             SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHH--HHHHHHHHTTSSEEEEE
T ss_pred             CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHH--HHHHHHhhhcccccEEE
Confidence            7777665543 45567777777777764     1111110       00111111111100  00001112335899999


Q ss_pred             ecCCCCCCCCCCcc-----cCchHHHHHHHhccCCCCCCcC-ccccCc---cCCcEEEccCCCCCCCccccccCccchhh
Q 045539          297 LTGNPLDGILPKSK-----GNLSLSLEIILMDNCSISGNIP-QVVGNL---GNLLVLELGGNNLTEPIPITFSQLQTLQA  367 (897)
Q Consensus       297 Ls~N~l~~~~p~~~-----~~l~~~L~~L~l~~n~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  367 (897)
                      +++|+++|.+|..+     ..+. .|+.+++..|.+  .+| ..+..+   .+|++|++++|.+....  ....+++|++
T Consensus       283 l~~n~l~~~ip~~~~~~~~~~L~-~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~  357 (562)
T 3a79_B          283 IYNLTITERIDREEFTYSETALK-SLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTF  357 (562)
T ss_dssp             EEEEEECSCCCCCCCCCCSCSCC-EEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCE
T ss_pred             EeccEeeccccchhhhcccccch-heehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceE
Confidence            99999999888877     5554 555666666666  333 233222   67999999999987532  2368899999


Q ss_pred             hcccCcccccccchhhhcccccccccccccccccC--CCcccccccccceeccccccccCCccc-cccccccceEEeecC
Q 045539          368 LGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS--IPSCLGNLTSLRVLYLGLNRFTSALPS-TIWNLKDILFIDVSS  444 (897)
Q Consensus       368 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~  444 (897)
                      |++++|++++.+|..+..+++|++|+|++|++++.  +|..++++++|+.|++++|++++.+|. .+..+++|+      
T Consensus       358 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~------  431 (562)
T 3a79_B          358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL------  431 (562)
T ss_dssp             EECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC------
T ss_pred             EECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC------
Confidence            99999999999999999999999999999999963  356799999999999999999985554 577777777      


Q ss_pred             CcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchh-hhhhcccc
Q 045539          445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS-LQKLLYLK  523 (897)
Q Consensus       445 N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~  523 (897)
                             .|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|+
T Consensus       432 -------~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~  500 (562)
T 3a79_B          432 -------VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQ  500 (562)
T ss_dssp             -------EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCC
T ss_pred             -------EEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCC
Confidence                   555666666667776655  79999999999999 78888889999999999999999 67766 99999999


Q ss_pred             eEeccCCcccccCC
Q 045539          524 HLNLSFNKLEGEIP  537 (897)
Q Consensus       524 ~L~ls~N~l~~~~p  537 (897)
                      .|+|++|++.+..|
T Consensus       501 ~L~l~~N~~~c~c~  514 (562)
T 3a79_B          501 YIWLHDNPWDCTCP  514 (562)
T ss_dssp             CEECCSCCBCCCHH
T ss_pred             EEEecCCCcCCCcc
Confidence            99999999987655

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.4e-43  Score=402.02  Aligned_cols=249  Identities=22%  Similarity=0.253  Sum_probs=198.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHH---HHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFE---DECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.+..-   .....+.   .++++++.++|||||+++++|++++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999876 699999999975431   1122333   446667777899999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |+||||++||+|.+++...+ .+++..+..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+...
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999997654 599999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ...    ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.......              ..++...
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--------------~~~i~~~  405 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------------KHEIDRM  405 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--------------HHHHHHH
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHh
Confidence            432    234689999999999865 579999999999999999999999997632221              1111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .....+. .+   ..+..++.+++.+|++.|| ++|++     ++||.+
T Consensus       406 i~~~~~~-~p---~~~S~~a~dLI~~lL~~dP-~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          406 TLTMAVE-LP---DSFSPELRSLLEGLLQRDV-NRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHCCCC-CC---TTSCHHHHHHHHHHTCSCG-GGCTTCSSSTHHHHTT
T ss_pred             hcCCCCC-CC---ccCCHHHHHHHHHHccCCH-hHCCCCCCCCHHHHhc
Confidence            1111100 00   1123457899999999999 99998     566543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.2e-43  Score=418.25  Aligned_cols=450  Identities=18%  Similarity=0.171  Sum_probs=351.1

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +...|||++|++++..+.+|.+|++|++|+|++|+|++..|..|.+|++|++|+|++|++++..+..|+++++|++|+|+
T Consensus        77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls  156 (635)
T 4g8a_A           77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  156 (635)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence            57889999999998888899999999999999999997777889999999999999999999999999999999999999


Q ss_pred             ecCCCC-CCCccccCccccccccccccccccccccccccccccc----ccccccccccccCCccccccccccceeecccc
Q 045539          157 INGLSG-EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK----EIYLLNNSLSGSLPSRIDLSLPNVETLNLGIN  231 (897)
Q Consensus       157 ~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N  231 (897)
                      +|++++ .+|..++.+++|++|+|++|+++++.+..|..+.+++    .++++.|.++ .++...+ ....++.+++.+|
T Consensus       157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n  234 (635)
T 4g8a_A          157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNN  234 (635)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESC
T ss_pred             cCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCcccc-cchhhhhhhhhcc
Confidence            999986 4688899999999999999999999999998887765    5778999998 5555554 3446677888877


Q ss_pred             ccccc-ccccccCCCcccEEEccccccc------cccCccc---------------------------ccccc-ccccCC
Q 045539          232 SFYGT-VPSSITNASKLSDLELGVNLFS------GFIPNTF---------------------------VNMAD-NYLTSS  276 (897)
Q Consensus       232 ~l~~~-~p~~l~~l~~L~~L~L~~N~l~------~~~~~~f---------------------------~~l~~-~~l~~~  276 (897)
                      ..... .+..+..++.++...+..+...      ......+                           ..+.. ..+...
T Consensus       235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~  314 (635)
T 4g8a_A          235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV  314 (635)
T ss_dssp             CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred             cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence            65432 2334555555555544322211      1111111                           00000 011111


Q ss_pred             CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCC--C
Q 045539          277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE--P  354 (897)
Q Consensus       277 ~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~  354 (897)
                      ......+..+....+|+.|++++|.+.+..+..+.    .++.+.+.+|.+....  ....+++|+.|++++|.+..  .
T Consensus       315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~----~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~  388 (635)
T 4g8a_A          315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK----SLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGC  388 (635)
T ss_dssp             SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCT----TCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEE
T ss_pred             ccccccccccccchhhhhhhcccccccCcCcccch----hhhhcccccccCCCCc--ccccccccccchhhccccccccc
Confidence            12222334466678899999999998876655443    4556777777766433  34578889999999998864  3


Q ss_pred             ccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCC-cccccccccceeccccccccCCccccccc
Q 045539          355 IPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSLRVLYLGLNRFTSALPSTIWN  433 (897)
Q Consensus       355 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  433 (897)
                      .+..+..+.+|+.|+++.|.+.. .+..+..+++|+.+++++|+.....+ ..+..+++++.++++.|.+++..|..+..
T Consensus       389 ~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~  467 (635)
T 4g8a_A          389 CSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  467 (635)
T ss_dssp             CCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             cccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence            44556677888888888888774 45567778888888888887765554 45778888888888888888888888888


Q ss_pred             cccceEEeecCCcc------------cccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEE
Q 045539          434 LKDILFIDVSSNSL------------NVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVL  501 (897)
Q Consensus       434 l~~L~~L~ls~N~l------------~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L  501 (897)
                      +++++.|++++|.+            +.|+.|+|++|+|++.+|..|+++++|++|+|++|+|++..|..|.++++|++|
T Consensus       468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L  547 (635)
T 4g8a_A          468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  547 (635)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred             chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence            88888888888752            357789999999999999999999999999999999999889999999999999


Q ss_pred             eccCCccCCCCchhhhhh-cccceEeccCCccccc
Q 045539          502 DLSKNKISGAIPASLQKL-LYLKHLNLSFNKLEGE  535 (897)
Q Consensus       502 ~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~  535 (897)
                      ||++|+|++..|..+..+ ++|+.|+|++|++.+.
T Consensus       548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            999999999999999998 6899999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.8e-43  Score=381.32  Aligned_cols=286  Identities=33%  Similarity=0.550  Sum_probs=234.0

Q ss_pred             cccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEee
Q 045539          602 QAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIIS  680 (897)
Q Consensus       602 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~  680 (897)
                      ...+.|++.++..+.++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            446789999999999999999999999999999999888999999998755322 2346889999999999999999999


Q ss_pred             eecCCCceEEEEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEE
Q 045539          681 SCSNDDFKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  757 (897)
Q Consensus       681 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~k  757 (897)
                      ++.+++..++||||+++++|.+++....   ..+++..+..++.|++.||+|||..+..||+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999998654   3589999999999999999999554444999999999999999999999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccc---cCccchhHHhh
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIF---IGELSLNRWIN  834 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~---~~~~~~~~~~~  834 (897)
                      |+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||+...   .......+|+.
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999987653332 23344569999999999988889999999999999999999999997432   22334455554


Q ss_pred             hcCCch-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          835 DLLPVS-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       835 ~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...... ...+.+..+.....      .+....+.+++.+||+.|| ++|||++||+++|++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP-~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYK------DEEVEQLIQVALLCTQSSP-MERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCC------HHHHHHHHHHHHHHTCSCG-GGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhccccC------HHHHHHHHHHHHHHhCcCC-ccCCCHHHHHHHhcC
Confidence            443332 33333333332222      2445678999999999999 999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.7e-43  Score=382.24  Aligned_cols=280  Identities=34%  Similarity=0.550  Sum_probs=224.7

Q ss_pred             ccCCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          605 RRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       605 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      .++++.++..++++|+..+.||+|+||.||+|++.+|+.||+|++........+.+.+|++++++++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34555566678899999999999999999999988899999999876655566789999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      ++..++||||+++++|.+++....   ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999987654   3589999999999999999999   7899999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc-cchhHHhhhcC-Cc
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE-LSLNRWINDLL-PV  839 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~-~~  839 (897)
                      |++................||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....|..... ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99987543333333344568999999999888899999999999999999999999997643322 22233321111 11


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....+++.+....      ..+...++.+++.+||+.|| ++|||++||++.|+
T Consensus       264 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~  311 (321)
T 2qkw_B          264 QLEQIVDPNLADKI------RPESLRKFGDTAVKCLALSS-EDRPSMGDVLWKLE  311 (321)
T ss_dssp             CCCSSSSSSCTTCS------CHHHHHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             cHHHhcChhhcccc------CHHHHHHHHHHHHHHcCCCc-ccCcCHHHHHHHHH
Confidence            11122222221111      12455678999999999999 99999999999886

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.5e-43  Score=397.04  Aligned_cols=376  Identities=25%  Similarity=0.302  Sum_probs=219.2

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCC-------------cEEeccCccccCCccc
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTL-------------KLLYFSDNQLFGSLSF  142 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~~~  142 (897)
                      .++..++++++++ |.+|++++++++|++|+|++|+++|.+|.+++++++|             ++|++++|.+++.+. 
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~-   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE-   88 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS-
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC-
Confidence            4678899999999 8999999999999999999999999999999998875             777787777765332 


Q ss_pred             cccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccc
Q 045539          143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPN  222 (897)
Q Consensus       143 ~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~  222 (897)
                      .   .++|++|++++|++++ +|..   +++|++|++++|+++++...    .++|++|++++|++++ +|.  +..+++
T Consensus        89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~-lp~--~~~l~~  154 (454)
T 1jl5_A           89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEK-LPE--LQNSSF  154 (454)
T ss_dssp             C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSS-CCC--CTTCTT
T ss_pred             C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCC-Ccc--cCCCCC
Confidence            1   3577777888777775 6643   36777777777777765321    1577777777777774 663  446777


Q ss_pred             cceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCC
Q 045539          223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPL  302 (897)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l  302 (897)
                      |++|++++|++++ +|..+   ++|++|++++|.+++. |.                      +.++++|++|++++|++
T Consensus       155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~~----------------------~~~l~~L~~L~l~~N~l  207 (454)
T 1jl5_A          155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-PE----------------------LQNLPFLTAIYADNNSL  207 (454)
T ss_dssp             CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-CC----------------------CTTCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-cc----------------------ccCCCCCCEEECCCCcC
Confidence            7777777777764 45433   4777777777777653 21                      45667778888888877


Q ss_pred             CCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchh
Q 045539          303 DGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDE  382 (897)
Q Consensus       303 ~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  382 (897)
                      +++ |...    .+|++|++++|.++ .+|. ++.+++|++|++++|++++ +|..   .++|+.|++++|++++ +|..
T Consensus       208 ~~l-~~~~----~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~  275 (454)
T 1jl5_A          208 KKL-PDLP----LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL  275 (454)
T ss_dssp             SSC-CCCC----TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC
T ss_pred             CcC-CCCc----CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc
Confidence            752 3222    14556666666665 3442 5666666666666666655 3322   2456666666666654 3332


Q ss_pred             hhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCC
Q 045539          383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSG  462 (897)
Q Consensus       383 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~  462 (897)
                         +++|++|++++|++++ +|..   .++|+.|++++|++++ ++    .++            +.|+.|++++|++++
T Consensus       276 ---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~------------~~L~~L~Ls~N~l~~  331 (454)
T 1jl5_A          276 ---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLP------------PSLEELNVSNNKLIE  331 (454)
T ss_dssp             ---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCC------------TTCCEEECCSSCCSC
T ss_pred             ---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCc------------CcCCEEECCCCcccc
Confidence               2556666666666654 2211   1455666666666553 11    111            134567777777775


Q ss_pred             CCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCC--CCchhhhhh-------------cccceEec
Q 045539          463 DIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG--AIPASLQKL-------------LYLKHLNL  527 (897)
Q Consensus       463 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~l  527 (897)
                       +|..   +++|++|++++|+++ .+|.   .+++|++|+|++|++++  .+|.++..+             ++|+.|++
T Consensus       332 -lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~l  403 (454)
T 1jl5_A          332 -LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHV  403 (454)
T ss_dssp             -CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------
T ss_pred             -cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEEC
Confidence             5554   578899999999998 4676   46889999999999998  788888877             78999999


Q ss_pred             cCCcccc--cCCC
Q 045539          528 SFNKLEG--EIPR  538 (897)
Q Consensus       528 s~N~l~~--~~p~  538 (897)
                      ++|++++  .+|.
T Consensus       404 s~N~l~~~~~iP~  416 (454)
T 1jl5_A          404 ETNPLREFPDIPE  416 (454)
T ss_dssp             -------------
T ss_pred             CCCcCCccccchh
Confidence            9999987  6664

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.7e-42  Score=396.29  Aligned_cols=388  Identities=18%  Similarity=0.184  Sum_probs=293.8

Q ss_pred             CCCCCCCCcceeeeEeeCC-CCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcC-CccccCCCCCcEEeccC
Q 045539           56 NWTSSTSVCSWIGITCDVN-SHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNI-PSSIFNMHTLKLLYFSD  133 (897)
Q Consensus        56 ~w~~~~~~c~w~gv~c~~~-~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~  133 (897)
                      .|....-.|++.|++.-+. ..+++.|+|++|++++..|.+++++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus         9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A            9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            3433333477777765432 357999999999999988999999999999999999998665 56799999999999999


Q ss_pred             ccccCCccccccccccccEEEeeecCCCCCCCcc--ccCccccccccccccccccccccc-ccccccccccccccccccc
Q 045539          134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPRE--IGNLPYLARLAFATNNLVGVAPVT-IFNMSALKEIYLLNNSLSG  210 (897)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~  210 (897)
                      |++.+..|..|.++++|++|+|++|++++.+|..  |+++++|++|+|++|++++..|.. +.++++|++|++++|++++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            9999999999999999999999999999866655  999999999999999999998876 8999999999999999997


Q ss_pred             cCCccccc-cccccceeeccccccccccccc--------ccCCCcccEEEccccccccccCccccccccccccCCCCccc
Q 045539          211 SLPSRIDL-SLPNVETLNLGINSFYGTVPSS--------ITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELS  281 (897)
Q Consensus       211 ~~p~~~~~-~l~~L~~L~L~~N~l~~~~p~~--------l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~  281 (897)
                      ..|..+.. ...+|+.|++++|.+.+..+..        +..+++|++|++++|.+++..|..|...             
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~-------------  235 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-------------  235 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH-------------
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcc-------------
Confidence            76765542 2378999999999998766554        3467899999999999999888765321             


Q ss_pred             ccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCc--cCCcEEEccCCCCCCCccccc
Q 045539          282 FLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL--GNLLVLELGGNNLTEPIPITF  359 (897)
Q Consensus       282 ~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~  359 (897)
                           ...++|+.|++++|.+.+...               ..+.+.+..+..+..+  ++|++|++++|++        
T Consensus       236 -----~~~~~L~~L~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l--------  287 (455)
T 3v47_A          236 -----IAGTKIQSLILSNSYNMGSSF---------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKI--------  287 (455)
T ss_dssp             -----TTTCCEEEEECTTCTTTSCCT---------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCC--------
T ss_pred             -----ccccceeeEeecccccccccc---------------chhhhccCcccccccccccCceEEEecCccc--------
Confidence                 234789999999998765311               1222222222223222  3455555555544        


Q ss_pred             cCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceE
Q 045539          360 SQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF  439 (897)
Q Consensus       360 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  439 (897)
                                      .+..|..+..+++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..+.++++|+ 
T Consensus       288 ----------------~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-  350 (455)
T 3v47_A          288 ----------------FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE-  350 (455)
T ss_dssp             ----------------CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCC-
T ss_pred             ----------------cccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCC-
Confidence                            444455555555555555555556555555666666666666666666655566666666666 


Q ss_pred             EeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCc
Q 045539          440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP  513 (897)
Q Consensus       440 L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  513 (897)
                                  .|+|++|++++..|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus       351 ------------~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          351 ------------VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             ------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ------------EEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence                        34444444555567778888899999999999997667778999999999999999998887

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.7e-42  Score=393.33  Aligned_cols=370  Identities=26%  Similarity=0.329  Sum_probs=267.5

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCC-------------ceecccCccccCcCCccccCCCCCcEEeccCccccCCcccc
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSL-------------QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF  143 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L-------------~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  143 (897)
                      +...|+++++++.|.+|++++++++|             ++|++++|++++ +|..   .++|++|++++|++.+ +|..
T Consensus        35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~  109 (454)
T 1jl5_A           35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL  109 (454)
T ss_dssp             CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC
T ss_pred             chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc
Confidence            45668899999999999999999875             999999999985 5542   3789999999999988 5543


Q ss_pred             ccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccccccc
Q 045539          144 IFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV  223 (897)
Q Consensus       144 ~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L  223 (897)
                         +++|++|++++|++++ +|..   .++|++|++++|+++++ | .|+++++|++|++++|+++ .+|..    .++|
T Consensus       110 ---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L  175 (454)
T 1jl5_A          110 ---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSL  175 (454)
T ss_dssp             ---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCS-CCCCC----CTTC
T ss_pred             ---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCc-ccCCC----cccc
Confidence               4899999999999985 4432   27999999999999985 5 5999999999999999999 47754    3599


Q ss_pred             ceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCC
Q 045539          224 ETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       224 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~  303 (897)
                      ++|++++|.+++ +| .++++++|++|++++|.+++...                         ..++|++|++++|+++
T Consensus       176 ~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-------------------------~~~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          176 EFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-------------------------LPLSLESIVAGNNILE  228 (454)
T ss_dssp             CEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-------------------------CCTTCCEEECCSSCCS
T ss_pred             cEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-------------------------CcCcccEEECcCCcCC
Confidence            999999999987 56 69999999999999999986322                         1258999999999999


Q ss_pred             CCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhh
Q 045539          304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL  383 (897)
Q Consensus       304 ~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  383 (897)
                       .+| .+..++ +|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|+.|++++|++++. |.. 
T Consensus       229 -~lp-~~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~-  295 (454)
T 1jl5_A          229 -ELP-ELQNLP-FLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL-  295 (454)
T ss_dssp             -SCC-CCTTCT-TCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC-
T ss_pred             -ccc-ccCCCC-CCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc-
Confidence             456 477777 89999999999996 4443   4799999999999998 5543   37899999999999972 221 


Q ss_pred             hcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCC
Q 045539          384 CHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGD  463 (897)
Q Consensus       384 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~  463 (897)
                        .++|++|++++|++++ ++..   .++|+.|++++|++++ +|..   +++|++|++++             |+++ .
T Consensus       296 --~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~-------------N~l~-~  351 (454)
T 1jl5_A          296 --PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASF-------------NHLA-E  351 (454)
T ss_dssp             --CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS-------------SCCS-C
T ss_pred             --CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCC-------------Cccc-c
Confidence              2689999999999985 3321   2589999999999997 6654   45666555554             4454 2


Q ss_pred             CcccccCCcccccccccCceecc--cCCCCCCCc-------------CCCcEEeccCCccCC--CCchhhhhhcccceEe
Q 045539          464 IPITIGGLKNLQQMFLEYNRLEG--SIPESFGDL-------------SSLEVLDLSKNKISG--AIPASLQKLLYLKHLN  526 (897)
Q Consensus       464 ~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l-------------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~  526 (897)
                      +|.   .+++|++|++++|++++  .+|.+++.+             ++|+.||+++|++++  .+|.+      ++.|.
T Consensus       352 lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~s------l~~L~  422 (454)
T 1jl5_A          352 VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPES------VEDLR  422 (454)
T ss_dssp             CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------------------
T ss_pred             ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhh------Hhhee
Confidence            444   35778888888888877  677777777             899999999999997  67765      55667


Q ss_pred             ccCCcccccCCC
Q 045539          527 LSFNKLEGEIPR  538 (897)
Q Consensus       527 ls~N~l~~~~p~  538 (897)
                      +.+|.+.+.+|.
T Consensus       423 ~~~~~~~~~~~~  434 (454)
T 1jl5_A          423 MNSERVVDPYEF  434 (454)
T ss_dssp             ------------
T ss_pred             CcCcccCCcccc
Confidence            889998887764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-41  Score=365.95  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=206.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999864 6899999999766555567789999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++....  +++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            99999999998764  89999999999999999999   889999999999999999999999999999987654332  


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........         .... .+ 
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~---------~~~~-~~-  239 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGT---------PELQ-NP-  239 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCS---------CCCS-CG-
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC---------CCCC-Cc-
Confidence            2334579999999999999999999999999999999999999996521110 0000000000         0000 01 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                            +.....+.+++.+||+.|| ++|||++|+++
T Consensus       240 ------~~~~~~~~~li~~~l~~dp-~~Rps~~ell~  269 (297)
T 3fxz_A          240 ------EKLSAIFRDFLNRCLEMDV-EKRGSAKELLQ  269 (297)
T ss_dssp             ------GGSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             ------cccCHHHHHHHHHHccCCh-hHCcCHHHHhh
Confidence                  1223457899999999999 99999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-41  Score=371.98  Aligned_cols=271  Identities=23%  Similarity=0.286  Sum_probs=208.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----ceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----FKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  691 (897)
                      .++|++.+.||+|+||+||+|++. ++.||||++...... .....+|+.++++++||||+++++++.++.    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999877 799999999765332 345567999999999999999999997754    36999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST----------PIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~----------~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      |||+++|+|.+++....  +++..+..++.|++.||+||   |+.          ||+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999998754  89999999999999999999   777          9999999999999999999999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCcc-chhHHhhh
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL-SLNRWIND  835 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~-~~~~~~~~  835 (897)
                      |+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||........ .+......
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987765443333344579999999998876     3567789999999999999999999976433221 11111111


Q ss_pred             cCCc-hHHHHh-hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          836 LLPV-SVMEVI-DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       836 ~~~~-~~~~~i-~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .... ...+.+ ...........+ .......++.+++.+||+.|| ++|||++||+++|++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP-~~Rps~~ell~~L~~  315 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDA-EARLSAGCVGERITQ  315 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccc-cccchHHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            1111 111111 111111111111 112344568999999999999 999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=364.85  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=211.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|.+.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            468999999999999999999875 5899999998766666778899999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999988666799999999999999999999   88999999999999999999999999999998764332211


Q ss_pred             ------------eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH
Q 045539          775 ------------IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       775 ------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                                  ......||+.|+|||++.+..++.++||||||+++|||++|..|+..........        .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------~~~~~  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------GLNVR  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------SBCHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------hhhhh
Confidence                        1114569999999999999999999999999999999999999987532221110        01111


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...+.....          .+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       238 ~~~~~~~~~----------~~~~~l~~li~~~l~~dP-~~Rps~~~l~~~L~  278 (310)
T 3s95_A          238 GFLDRYCPP----------NCPPSFFPITVRCCDLDP-EKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHHHHTCCT----------TCCTTHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ccccccCCC----------CCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            222211111          122347889999999999 99999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-40  Score=359.46  Aligned_cols=279  Identities=30%  Similarity=0.453  Sum_probs=226.4

Q ss_pred             ccccCCHHHHHHHhcCCCcC------CeeecccceEEEEEEecCCceEEEEEechhh----HHHHHHHHHHHHHHHhcCC
Q 045539          603 AIRRFSYHELLRATDRFSEN------NLIGIGSFGSIYVARLQDGMEVAVKVFHQQY----ERALKSFEDECEVMKRIRH  672 (897)
Q Consensus       603 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h  672 (897)
                      ....|++.++..++++|...      +.||+|+||.||+|+. +++.||+|++....    ....+.+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45779999999999999877      8999999999999987 48899999986432    3345788999999999999


Q ss_pred             CccceEeeeecCCCceEEEEEeccCCChhHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSG--TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       673 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      |||+++++++.+++..++||||+++++|.+++...  ...+++..+..++.|++.||+||   |++||+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998643  24589999999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchh
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN  830 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~  830 (897)
                      +.++.+||+|||.+................||+.|+|||...+ .++.++||||||+++|+|++|+.||....... ...
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence            9999999999999987654443333445579999999998764 58899999999999999999999997643221 122


Q ss_pred             HHhhh--cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          831 RWIND--LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       831 ~~~~~--~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+...  .....+.+.+++.+...+       ......+.+++.+||+.|| ++|||++||++.|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p-~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMNDAD-------STSVEAMYSVASQCLHEKK-NKRPDIKKVQQLLQE  303 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSCCC-------HHHHHHHHHHHHHHTCSST-TTSCCHHHHHHHHHH
T ss_pred             HHHHHhhhhhhhhhhhccccccccc-------hHHHHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHH
Confidence            22111  111224444444433222       2345668899999999999 999999999998863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-41  Score=365.39  Aligned_cols=251  Identities=18%  Similarity=0.242  Sum_probs=208.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            578999999999999999999876 58899999987543 3346788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC--CCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.  ++.+||+|||++........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999999999987766799999999999999999999   8899999999999999987  78999999999987754432


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++||||+||++|+|++|..||......                 +.+.......
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------------~~~~~i~~~~  219 (321)
T 1tki_A          160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----------------QIIENIMNAE  219 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------------HHHHHHHHTC
T ss_pred             ---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----------------HHHHHHHcCC
Confidence               23456899999999998888999999999999999999999999752111                 1111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +............++.+++.+|+..|| ++|||++|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp-~~Rpt~~e~l~  257 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKER-KSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence            110111122344568899999999999 99999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.8e-41  Score=373.58  Aligned_cols=256  Identities=24%  Similarity=0.419  Sum_probs=208.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|++.+.||+|+||.||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999752        35679999997553 34567899999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..|+||||+++|+|.+++....               ..+++.++..++.||+.||+||   |++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEE
Confidence            99999999999999999987653               3478999999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  . 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~-  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E-  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H-
Confidence            9999999999999987654433233334457889999999988899999999999999999999 99998763211  1 


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                 ....+........+      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       314 -----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 -----------LFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVP-SQRPTFKQLVEDLDR  361 (370)
T ss_dssp             -----------HHHHHHTTCCCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             -----------HHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence                       11111111110000      1223457899999999999 999999999998863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.7e-41  Score=381.63  Aligned_cols=359  Identities=18%  Similarity=0.181  Sum_probs=231.3

Q ss_pred             CCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcc
Q 045539           93 PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLP  172 (897)
Q Consensus        93 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~  172 (897)
                      +.+++++++|++|||++|.+++ +| .++.+++|++|+|++|++.+. +  ++.+++|++|+|++|++++ +|  +++++
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~  106 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLT  106 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred             ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCC
Confidence            3344555555555555555553 23 455555555555555555543 2  5555555555555555554 22  55555


Q ss_pred             cccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEc
Q 045539          173 YLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL  252 (897)
Q Consensus       173 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  252 (897)
                      +|++|++++|+++++ |  ++++++|++|++++|++++ ++   ...+++|++|++++|...+.+  .+..+++|+.|++
T Consensus       107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l  177 (457)
T 3bz5_A          107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC  177 (457)
T ss_dssp             TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred             cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence            555555555555554 2  5555555555555555553 22   224555555555555433333  3455555555555


Q ss_pred             cccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcC
Q 045539          253 GVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIP  332 (897)
Q Consensus       253 ~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p  332 (897)
                      ++|++++. |                       +..+++|+.|++++|++++.   .+..++ +|+.|++++|++++ +|
T Consensus       178 s~n~l~~l-~-----------------------l~~l~~L~~L~l~~N~l~~~---~l~~l~-~L~~L~Ls~N~l~~-ip  228 (457)
T 3bz5_A          178 SFNKITEL-D-----------------------VSQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLTE-ID  228 (457)
T ss_dssp             CSSCCCCC-C-----------------------CTTCTTCCEEECCSSCCSCC---CCTTCT-TCSEEECCSSCCSC-CC
T ss_pred             CCCcccee-c-----------------------cccCCCCCEEECcCCcCCee---ccccCC-CCCEEECcCCcccc-cC
Confidence            55555542 1                       23445555555555555543   122222 33344444444443 23


Q ss_pred             ccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccc
Q 045539          333 QVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS  412 (897)
Q Consensus       333 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  412 (897)
                        ++.+++|++|++++|++++..   ++.+++|+.|++++|              +|+.|++++|++.+.+|  ++.+++
T Consensus       229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~  287 (457)
T 3bz5_A          229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRK  287 (457)
T ss_dssp             --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTT
T ss_pred             --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cccccc
Confidence              556677777777777777743   345556666666655              45668999999888877  578899


Q ss_pred             cceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCC
Q 045539          413 LRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF  492 (897)
Q Consensus       413 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  492 (897)
                      |+.|++++|.+.+.+|.   ...+|+.|++++|  +.|+.|++++|++++. +  ++.+++|+.|++++|+|++      
T Consensus       288 L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~--~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~------  353 (457)
T 3bz5_A          288 IKELDVTHNTQLYLLDC---QAAGITELDLSQN--PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD------  353 (457)
T ss_dssp             CCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC--TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB------
T ss_pred             CCEEECCCCcccceecc---CCCcceEechhhc--ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC------
Confidence            99999999998888885   4567788888887  5788999999999984 3  8999999999999999996      


Q ss_pred             CCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCC
Q 045539          493 GDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRG  539 (897)
Q Consensus       493 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  539 (897)
                        ++.|+.|++++|+++|.     .++..|..+++++|+|+|.||..
T Consensus       354 --l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 --FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             --CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             --ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence              25677889999999976     46778899999999999999963

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.3e-41  Score=364.55  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=213.9

Q ss_pred             ccCCHHHHHHHhcC----------CCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCC
Q 045539          605 RRFSYHELLRATDR----------FSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR  673 (897)
Q Consensus       605 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  673 (897)
                      ..++++++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888888764          677789999999999999876 6999999999866555567889999999999999


Q ss_pred             ccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC
Q 045539          674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED  753 (897)
Q Consensus       674 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~  753 (897)
                      ||+++++++..++..++||||+++++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998764  489999999999999999999   78999999999999999999


Q ss_pred             CcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh
Q 045539          754 MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI  833 (897)
Q Consensus       754 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~  833 (897)
                      +.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....+
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~  253 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL  253 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            9999999999987653322  223457999999999999999999999999999999999999999752111  111111


Q ss_pred             hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          834 NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       834 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....+.        .+..        .......+.+++.+||+.|| ++|||++|+++.
T Consensus       254 ~~~~~~--------~~~~--------~~~~~~~l~~li~~~l~~dp-~~Rps~~ell~h  295 (321)
T 2c30_A          254 RDSPPP--------KLKN--------SHKVSPVLRDFLERMLVRDP-QERATAQELLDH  295 (321)
T ss_dssp             HHSSCC--------CCTT--------GGGSCHHHHHHHHHHSCSST-TTSCCHHHHHTS
T ss_pred             hcCCCC--------CcCc--------cccCCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            110000        0000        01123457889999999999 999999999873

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-40  Score=363.94  Aligned_cols=248  Identities=24%  Similarity=0.310  Sum_probs=204.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999987 479999999987543  345677889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++...+ .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            9999999999987654 489999999999999999999   889999999999999999999999999999987654322


Q ss_pred             eeeeeccccCcccCCcCccCCCCCC-ccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVC-TRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                         .....||+.|+|||++.+..+. +++||||+||++|||++|+.||.....                 .++.......
T Consensus       170 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------------~~~~~~i~~~  229 (328)
T 3fe3_A          170 ---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----------------KELRERVLRG  229 (328)
T ss_dssp             ---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHC
T ss_pred             ---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhC
Confidence               2345799999999998877764 899999999999999999999976211                 1111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+.. +   .....++.+++.+|++.|| ++|||++|+++.
T Consensus       230 ~~~~-p---~~~s~~~~~li~~~L~~dP-~~R~t~~eil~h  265 (328)
T 3fe3_A          230 KYRI-P---FYMSTDCENLLKRFLVLNP-IKRGTLEQIMKD  265 (328)
T ss_dssp             CCCC-C---TTSCHHHHHHHHHHCCSST-TTSCCHHHHTTC
T ss_pred             CCCC-C---CCCCHHHHHHHHHHCCCCh-hHCcCHHHHhcC
Confidence            1100 0   0122447789999999999 999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-40  Score=365.79  Aligned_cols=252  Identities=18%  Similarity=0.251  Sum_probs=206.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH------HHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++++....      ..+.+.+|+.++++++||||+++++++.+++.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3568999999999999999999876 6899999998754321      34678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccC
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGI  763 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~  763 (897)
                      .|+||||+++|+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999997654 589999999999999999999   789999999999999998776    799999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      +........   .....||+.|+|||++.+..++.++||||+||++|+|++|..||......                 +
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----------------~  225 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----------------E  225 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------------H
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----------------H
Confidence            987654322   23456999999999999889999999999999999999999999752111                 1


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.......+.............+.+++.+|+..|| ++|||++|+++
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~t~~e~l~  272 (361)
T 2yab_A          226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKET-RKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSST-TTSCCHHHHHT
T ss_pred             HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCCh-hHCcCHHHHhc
Confidence            111111111100011112334567899999999999 99999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=365.22  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++.    .+..||||+++.. .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999874    3456999999764 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987766799999999999999999999   8899999999999999999999999999999876543


Q ss_pred             Cc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      .. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .            ....+...
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~------------~~~~~~~~  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--D------------VISSVEEG  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--H------------HHHHHHTT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--H------------HHHHHHcC
Confidence            22 122233456788999999988899999999999999999999 99999653111  0            11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......      ..+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       271 ~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~eil~~L~  309 (325)
T 3kul_A          271 YRLPAP------MGCPHALHQLMLDCWHKDR-AQRPRFSQIVSVLD  309 (325)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCCC------CCcCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            110000      1233458899999999999 99999999999885

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-40  Score=362.79  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=205.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999876 68999999986443 2334678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987654 589999999999999999999   8899999999999999999999999999999876543333


Q ss_pred             eeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+.......            .
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------~  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------N  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------------T
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------------C
Confidence            33345679999999999877665 7899999999999999999999976433222222222111100            0


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +      ......++.+++.+|++.|| ++|||++|+++.
T Consensus       230 ~------~~~~~~~~~~li~~~L~~dP-~~R~t~~eil~h  262 (323)
T 3tki_A          230 P------WKKIDSAPLALLHKILVENP-SARITIPDIKKD  262 (323)
T ss_dssp             T------GGGSCHHHHHHHHHHSCSST-TTSCCHHHHTTC
T ss_pred             c------cccCCHHHHHHHHHHccCCh-hhCcCHHHHhhC
Confidence            0      01223456789999999999 999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.4e-41  Score=362.32  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ...++|++.+.||+|+||+||+|++. |+.||||++....  ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            34578999999999999999999874 8899999986543  34457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          692 MKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      |||+++++|.+++....  ..+++..+..++.|++.||+||   |++|  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999998754  2489999999999999999999   7888  999999999999999999999999999765


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+           ...
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~-----------~~~  254 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAV-----------GFK  254 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHH-----------HHS
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-----------Hhc
Confidence            4321  2223456899999999999999999999999999999999999999763111  000000           000


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......+      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       255 ~~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rps~~~ll~~L~  294 (309)
T 3p86_A          255 CKRLEIP------RNLNPQVAAIIEGCWTNEP-WKRPSFATIMDLLR  294 (309)
T ss_dssp             CCCCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCCCC------ccCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence            0000000      1123457899999999999 99999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-40  Score=353.04  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=209.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            568999999999999999999998888999999975532 2366889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........ ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence            99999999987766799999999999999999999   889999999999999999999999999999987654332 23


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....+|+.|+|||...+..++.++||||+|+++|||++ |+.||.......  ..           ..+........+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~-----------~~~~~~~~~~~~~  228 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VV-----------LKVSQGHRLYRPH  228 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH-----------HHHHTTCCCCCCT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HH-----------HHHHcCCCCCCCC
Confidence            334456788999999988889999999999999999999 999987532110  00           0011000000010


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             .....+.+++.+||+.|| ++|||++|+++.|++
T Consensus       229 -------~~~~~l~~li~~~l~~~p-~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          229 -------LASDTIYQIMYSCWHELP-EKRPTFQQLLSSIEP  261 (268)
T ss_dssp             -------TSCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHGG
T ss_pred             -------cChHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence                   112357899999999999 999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-40  Score=357.31  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=203.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999865 6899999998532   244567889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999987654 589999999999999999999   88999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      . .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ..+.+....+. ...        
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~-~~~--------  234 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSVPN-VTT--------  234 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-HHHHHSSCCCC-HHH--------
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhccCCC-cch--------
Confidence            1 223345699999999999988999999999999999999999999976311100 00011111110 000        


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-CHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGA-DMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-t~~evl~~L~~  895 (897)
                            .........+.+++.+|++.|| ++|| +++++.+.|++
T Consensus       235 ------~~~~~~~~~l~~li~~~l~~dp-~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          235 ------DVRKDIPQSLSNVILRATEKDK-ANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             ------HSCTTSCHHHHHHHHHHSCSSG-GGSCSSHHHHHHHHHT
T ss_pred             ------hcccCCCHHHHHHHHHHhcCCH-hHccccHHHHHHHHHH
Confidence                  0011234568899999999999 9999 88888887754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-40  Score=354.53  Aligned_cols=254  Identities=23%  Similarity=0.393  Sum_probs=208.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            468999999999999999999998889999999976532 2367889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            99999999988777799999999999999999999   88999999999999999999999999999998664322 112


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....+|+.|+|||...+..++.++||||+|+++|||++ |+.||......  ..            .+.+........+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~------------~~~~~~~~~~~~~  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EV------------VEDISTGFRLYKP  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH------------HHHHHTTCCCCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HH------------HHHHhcCccCCCC
Confidence            233456788999999988899999999999999999999 99998753111  11            1111111010000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ......+.+++.+||+.|| ++|||++|+++.|++
T Consensus       230 ------~~~~~~~~~li~~~l~~~p-~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          230 ------RLASTHVYQIMNHCWRERP-EDRPAFSRLLRQLAE  263 (269)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ------CcCCHHHHHHHHHHccCCc-ccCcCHHHHHHHHHH
Confidence                  0112457899999999999 999999999998863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-41  Score=375.75  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=208.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3568999999999999999999986 68999999987543 334567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999987666799999999999999999999   889999999999999999999999999999986543221


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........+++.|+|||.+..+.++.++|||||||++|||++ |..||......  .            ..+.+......
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~------------~~~~~~~~~~~  334 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--Q------------TREFVEKGGRL  334 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--H------------HHHHHHTTCCC
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H------------HHHHHHcCCCC
Confidence            111112235778999999988889999999999999999998 99998763211  1            11112111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..+      +.+..++.+++.+||+.|| ++|||++||++.|++
T Consensus       335 ~~~------~~~~~~l~~li~~cl~~dP-~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          335 PCP------ELCPDAVFRLMEQCWAYEP-GQRPSFSTIYQELQS  371 (377)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHHH
Confidence            110      1223457899999999999 999999999998853

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-40  Score=364.68  Aligned_cols=252  Identities=19%  Similarity=0.237  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER-----ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|++.+.||+|+||.||+|... +|+.||||++......     ..+.+.+|++++++++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999875 6899999998754321     3577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc---EEEeeccC
Q 045539          690 LIMKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHISDFGI  763 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~---~kL~DFg~  763 (897)
                      +||||+++++|.+++...   ...+++..+..++.||+.||+||   |++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877543   23589999999999999999999   8899999999999999986654   99999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      +........  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ..            ...
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~------------~~~  243 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RL------------FEG  243 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HH------------HHH
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HH------------HHH
Confidence            987654322  22345799999999999988999999999999999999999999975210  00            011


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.......    ..........++.+++.+||+.|| ++|||+.|+++
T Consensus       244 i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP-~~R~s~~e~l~  286 (351)
T 3c0i_A          244 IIKGKYKM----NPRQWSHISESAKDLVRRMLMLDP-AERITVYEALN  286 (351)
T ss_dssp             HHHTCCCC----CHHHHTTSCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             HHcCCCCC----CccccccCCHHHHHHHHHHCCCCh-hHCcCHHHHhc
Confidence            11111111    111122334568899999999999 99999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.2e-40  Score=356.08  Aligned_cols=268  Identities=19%  Similarity=0.257  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|++.+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            578999999999999999999998899999999875432  234678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ +|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9974 88888877776799999999999999999999   889999999999999999999999999999987643322 


Q ss_pred             eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh---hcCCchHHH------
Q 045539          774 SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN---DLLPVSVME------  843 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~------  843 (897)
                       ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......   ...+.....      
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccch
Confidence             2334568999999998765 568999999999999999999999997633221 1111111   000000000      


Q ss_pred             Hhhhhhcchhh-hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEE-RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ........... ...........++.+++.+|++.|| ++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP-NKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCT-TTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCCh-hHCCCHHHHhc
Confidence            00000000000 0001111223467899999999999 99999999987

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=367.75  Aligned_cols=253  Identities=18%  Similarity=0.243  Sum_probs=207.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+++..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999876 6899999999866555567889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC--CCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~~~~~~  772 (897)
                      +++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.  ++.+||+|||++........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999999999987766799999999999999999999   8899999999999999974  57899999999987754432


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ....           .+........
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~-----------~i~~~~~~~~  270 (387)
T 1kob_A          207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQ-----------NVKRCDWEFD  270 (387)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH-----------HHHHCCCCCC
T ss_pred             ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHhCCCCCC
Confidence               22346999999999999999999999999999999999999999752111  0000           0000000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .    ........++.+++.+||+.|| ++|||++|+++.
T Consensus       271 ~----~~~~~~s~~~~~li~~~L~~dP-~~Rpt~~ell~h  305 (387)
T 1kob_A          271 E----DAFSSVSPEAKDFIKNLLQKEP-RKRLTVHDALEH  305 (387)
T ss_dssp             S----STTTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHTS
T ss_pred             c----cccccCCHHHHHHHHHHcCCCh-hHCcCHHHHhhC
Confidence            0    0001223457899999999999 999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.3e-41  Score=362.71  Aligned_cols=270  Identities=26%  Similarity=0.408  Sum_probs=207.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  688 (897)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999984     2588999999987766667889999999999999999999999854  3568


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999988776799999999999999999999   78999999999999999999999999999998765


Q ss_pred             CCCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch--HHHHh
Q 045539          769 GEDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS--VMEVI  845 (897)
Q Consensus       769 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~i  845 (897)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......   ..+.........  .....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            43221 2223345778899999998889999999999999999999999998753211   111111111110  11111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      +.......   .+....+..++.+++.+||+.|| ++|||++|++++|++
T Consensus       243 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp-~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          243 ELLKNNGR---LPRPDGCPDEIYMIMTECWNNNV-NQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHHHHHH
T ss_pred             HHHhccCc---CCCCcCcCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHHH
Confidence            11110000   00011234568899999999999 999999999998853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-40  Score=369.66  Aligned_cols=255  Identities=24%  Similarity=0.458  Sum_probs=197.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            458999999999999999999865    47789999997543 4455789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999988777799999999999999999999   7899999999999999999999999999999876533


Q ss_pred             Ccee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......              .....+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------------~~~~~i~~~  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVDEG  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------------HHHHHHHTT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcC
Confidence            2211 1122345778999999988899999999999999999998 99999653111              111122211


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......      ..+..++.+++.+||+.|| ++||+++||++.|+
T Consensus       267 ~~~~~~------~~~~~~l~~li~~cl~~dp-~~RPs~~~i~~~L~  305 (373)
T 2qol_A          267 YRLPPP------MDCPAALYQLMLDCWQKDR-NNRPKFEQIVSILD  305 (373)
T ss_dssp             EECCCC------TTCBHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCCC------ccccHHHHHHHHHHhCcCh-hhCcCHHHHHHHHH
Confidence            111111      1233558899999999999 99999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=373.46  Aligned_cols=255  Identities=19%  Similarity=0.257  Sum_probs=205.1

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34678999999999999999999765 68999999986543  3445778999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~  767 (897)
                      ||||+++|+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++   .++.+||+|||++...
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999988765 589999999999999999999   889999999999999998   5678999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .....  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......  ....           .+...
T Consensus       164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~-----------~i~~~  228 (444)
T 3soa_A          164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQ-----------QIKAG  228 (444)
T ss_dssp             CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-----------HHHHT
T ss_pred             cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHH-----------HHHhC
Confidence            54322  223457999999999999989999999999999999999999999652111  0100           11110


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ... .+.   +....+..++.+++.+|++.|| ++|||++|+++.
T Consensus       229 ~~~-~~~---~~~~~~s~~~~~li~~~L~~dP-~~Rpta~e~L~h  268 (444)
T 3soa_A          229 AYD-FPS---PEWDTVTPEAKDLINKMLTINP-SKRITAAEALKH  268 (444)
T ss_dssp             CCC-CCT---TTTTTSCHHHHHHHHHHSCSST-TTSCCHHHHHHS
T ss_pred             CCC-CCc---cccccCCHHHHHHHHHHcCCCh-hHCCCHHHHhcC
Confidence            000 000   0011223457899999999999 999999999873

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-40  Score=364.71  Aligned_cols=254  Identities=18%  Similarity=0.299  Sum_probs=205.5

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999875 68999999997542  3455778999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~~  767 (897)
                      ||||+++++|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++   .+||+|||++...
T Consensus       106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999999887654 589999999999999999999   889999999999999998654   5999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  .....           +...
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~-----------i~~~  245 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ-----------IKAG  245 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----------HHHT
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-----------HHhC
Confidence            53322   23457999999999999889999999999999999999999999752111  11111           1110


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ... .+.   +....+..++.+++.+||+.|| ++|||++|+++.
T Consensus       246 ~~~-~~~---~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 AYD-YPS---PEWDTVTPEAKSLIDSMLTVNP-KKRITADQALKV  285 (362)
T ss_dssp             CCC-CCT---TGGGGSCHHHHHHHHHHSCSSG-GGSCCHHHHTTS
T ss_pred             CCC-CCc---ccccCCCHHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            000 000   0011223457899999999999 999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-40  Score=369.29  Aligned_cols=269  Identities=22%  Similarity=0.324  Sum_probs=215.0

Q ss_pred             cccCCHHHHHHHhcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCcc
Q 045539          604 IRRFSYHELLRATDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNL  675 (897)
Q Consensus       604 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni  675 (897)
                      ...+...++....++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            34456666777789999999999999999999973      246889999997643 34457889999999999 79999


Q ss_pred             ceEeeeecCCC-ceEEEEEeccCCChhHhhhcCCC---------------------------------------------
Q 045539          676 VKIISSCSNDD-FKALIMKYMPNGSLENCLYSGTC---------------------------------------------  709 (897)
Q Consensus       676 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  709 (897)
                      +++++++.+.+ ..++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999987754 48999999999999999876532                                             


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          710 --------------------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       710 --------------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                                          .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                188999999999999999999   889999999999999999999999999999987655


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .            ....+...
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~------------~~~~~~~~  312 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E------------FCRRLKEG  312 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H------------HHHHHHHT
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-H------------HHHHHHcC
Confidence            444444555678999999999988899999999999999999998 999997632211 1            11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .....+      .....++.+++.+||+.|| ++|||++||++.|++
T Consensus       313 ~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          313 TRMRAP------DYTTPEMYQTMLDCWHGEP-SQRPTFSELVEHLGN  352 (359)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCCCC------CCCCHHHHHHHHHHccCCh-hhCCCHHHHHHHHHH
Confidence            100000      0122457889999999999 999999999998863

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=358.33  Aligned_cols=252  Identities=19%  Similarity=0.253  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH------HHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|++++++++||||+++++++.+++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999876 689999999875432      1357789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a  764 (897)
                      ++||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999987654 589999999999999999999   889999999999999999887    8999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ...           ..+
T Consensus       166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~-----------~~~  229 (326)
T 2y0a_A          166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL-----------ANV  229 (326)
T ss_dssp             EECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH-----------HHH
T ss_pred             eECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHH-----------HHH
Confidence            87653322   23456999999999999889999999999999999999999999652111  000           000


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..... ..+   ..........+.+++.+|++.|| ++|||++|+++.
T Consensus       230 ~~~~~-~~~---~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 SAVNY-EFE---DEYFSNTSALAKDFIRRLLVKDP-KKRMTIQDSLQH  272 (326)
T ss_dssp             HHTCC-CCC---HHHHTTSCHHHHHHHHHHSCSSG-GGSCCHHHHHHS
T ss_pred             HhcCC-CcC---ccccccCCHHHHHHHHHHccCCh-hhCCCHHHHhcC
Confidence            00000 000   01112233457899999999999 999999999873

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.7e-40  Score=357.71  Aligned_cols=249  Identities=21%  Similarity=0.259  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999876 68999999997653   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999887654 589999999999999999999   78999999999999999999999999999998643222


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...           ..+...... 
T Consensus       160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~-----------~~i~~~~~~-  223 (337)
T 1o6l_A          160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF-----------ELILMEEIR-  223 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-----------HHHHHCCCC-
T ss_pred             C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHH-----------HHHHcCCCC-
Confidence            1  223457999999999999999999999999999999999999999752111  000           011111110 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                      .+.       ....++.+++.+|++.|| ++||     +++|+++.
T Consensus       224 ~p~-------~~s~~~~~li~~lL~~dP-~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 FPR-------TLSPEAKSLLAGLLKKDP-KQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSST-TTSTTCSTTTHHHHHTS
T ss_pred             CCC-------CCCHHHHHHHHHHhhcCH-HHhcCCCCCCHHHHHcC
Confidence            010       123457889999999999 9999     89998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-40  Score=373.83  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=206.5

Q ss_pred             HHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCC
Q 045539          610 HELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSND  685 (897)
Q Consensus       610 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  685 (897)
                      .++....++|++.+.||+|+||.||+|+.. +++.||+|++++...   ...+.+.+|+.+++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455789999999999999999999876 588999999976432   1234578899999999999999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      +..|+||||++||+|.+++....  +++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            99999999999999999997654  89999999999999999999   88999999999999999999999999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCC----CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchH
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGR----VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      ...... ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....                 
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------------  278 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------------  278 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------
T ss_pred             eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----------------
Confidence            765433 22334567999999999876554    78999999999999999999999975211                 


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCC--CCCHHHHHhh
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGN--GADMGWIFSA  892 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~--RPt~~evl~~  892 (897)
                      .+.....+.......++.......++.+++.+|++.+| ++  ||+++||++.
T Consensus       279 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~-~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          279 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDRE-VRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGG-GCTTSSCHHHHHTS
T ss_pred             hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChh-hhCCCCCHHHHhcC
Confidence            11111111100000000001223457899999999888 88  9999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.4e-41  Score=378.31  Aligned_cols=262  Identities=18%  Similarity=0.229  Sum_probs=207.9

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH---HHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER---ALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      +.++....++|++.++||+|+||+||+|+.. +++.||+|++++....   ..+.+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4445555789999999999999999999876 4889999999764322   22347899999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..|+||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999987666799999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      +....... .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||......     +.       
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~-------  289 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ET-------  289 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH-------
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HH-------
Confidence            87654332 2333467999999999876     567899999999999999999999999752111     00       


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCC--CCCHHHHHh
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGN--GADMGWIFS  891 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~--RPt~~evl~  891 (897)
                       ...++........+.   .......++.+++.+|+..+| ++  ||+++|+++
T Consensus       290 -~~~i~~~~~~~~~p~---~~~~~s~~~~dLi~~lL~~~~-~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 -YGKIMNHKERFQFPT---QVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKK  338 (437)
T ss_dssp             -HHHHHTHHHHCCCCS---SCCCSCHHHHHHHHTTSSCGG-GCTTTTTTHHHHT
T ss_pred             -HHhhhhccccccCCc---ccccCCHHHHHHHHHHhcccc-cccCCCCHHHHhC
Confidence             111111100000000   001123457889999998888 77  999999876

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.5e-39  Score=369.96  Aligned_cols=346  Identities=28%  Similarity=0.419  Sum_probs=225.1

Q ss_pred             CCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc
Q 045539           99 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA  178 (897)
Q Consensus        99 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~  178 (897)
                      +++|+.|++++|.++ .+|. +..+++|++|+|++|++.+..+  +.++++|++|++++|++++..|  ++++++|++|+
T Consensus        45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            445555555555555 3442 5555556666666665555443  5555566666666666553322  55666666666


Q ss_pred             cccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccc
Q 045539          179 FATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS  258 (897)
Q Consensus       179 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  258 (897)
                      +++|+++++.+  +.++++|++|++++|++++ ++.  ...+++|++|+++ |.+.+..  .+.++++|+.|++++|.++
T Consensus       119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISA--LSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS  190 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CGG--GTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Chh--hccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence            66666655543  5666666666666666652 332  2355666666664 3343322  2667777777777777665


Q ss_pred             cccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCc
Q 045539          259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL  338 (897)
Q Consensus       259 ~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l  338 (897)
                      +..                       .+..+++|++|++++|++.+..|                           ++.+
T Consensus       191 ~~~-----------------------~l~~l~~L~~L~l~~n~l~~~~~---------------------------~~~l  220 (466)
T 1o6v_A          191 DIS-----------------------VLAKLTNLESLIATNNQISDITP---------------------------LGIL  220 (466)
T ss_dssp             CCG-----------------------GGGGCTTCSEEECCSSCCCCCGG---------------------------GGGC
T ss_pred             CCh-----------------------hhccCCCCCEEEecCCccccccc---------------------------cccc
Confidence            431                       14566777777777777664321                           3456


Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      ++|++|++++|++++.  ..+..+++|+.|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|++
T Consensus       221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L  294 (466)
T 1o6v_A          221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL  294 (466)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence            6777777777777763  356677777777777777776544  6777778888888887775433  777788888888


Q ss_pred             ccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCC
Q 045539          419 GLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL  498 (897)
Q Consensus       419 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L  498 (897)
                      ++|++++..|  +..+++|+             .|++++|++++..|  ++.+++|+.|++++|++++.  ..+.++++|
T Consensus       295 ~~n~l~~~~~--~~~l~~L~-------------~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L  355 (466)
T 1o6v_A          295 NENQLEDISP--ISNLKNLT-------------YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNI  355 (466)
T ss_dssp             CSSCCSCCGG--GGGCTTCS-------------EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             CCCcccCchh--hcCCCCCC-------------EEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCC
Confidence            8888876443  56666666             44445555555544  67788888888888888864  468888888


Q ss_pred             cEEeccCCccCCCCchhhhhhcccceEeccCCccccc
Q 045539          499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE  535 (897)
Q Consensus       499 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  535 (897)
                      +.|++++|++++..|  +..+++|+.|++++|++++.
T Consensus       356 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             CEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            888888888887766  78888888888888888874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=367.25  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=209.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|.+.+.||+|+||.||+|++.        .++.||+|+++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999852        24579999997653 34557889999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+||   |++||+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEEE
Confidence            99999999999999999997654               3589999999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......  . 
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~-  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E-  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H-
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence            9999999999999987654443333444567889999999999999999999999999999999 99998753111  1 


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                                 ..+.+.........      ..+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       302 -----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~  348 (382)
T 3tt0_A          302 -----------LFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVP-SQRPTFKQLVEDLD  348 (382)
T ss_dssp             -----------HHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             -----------HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence                       11111111111110      1223457899999999999 99999999999885

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-39  Score=352.45  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHh--cCCCccceEeeeecC----CCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKR--IRHRNLVKIISSCSN----DDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  689 (897)
                      .++|++.+.||+|+||+||+|++ +|+.||||++....   .+.+.+|.+++..  ++||||+++++++.+    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            57899999999999999999988 58999999987653   2445566677666  789999999998643    35689


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      +||||+++|+|.+++...  .+++..+..++.|++.||+|||.     .+++||+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  48999999999999999999941     11899999999999999999999999999999


Q ss_pred             cccCCCCceee--eeccccCcccCCcCccCCC------CCCccchHHHHHHHHHHHHcC----------CCCCcccccCc
Q 045539          765 KLLSGEDQLSI--QIQTLATIGYMAPEYGTKG------RVCTRGDVYSYGIMLMEMFTK----------KKPTDEIFIGE  826 (897)
Q Consensus       765 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvil~elltg----------~~p~~~~~~~~  826 (897)
                      +..........  .....||+.|+|||++.+.      .+++++|||||||++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            87654333211  2234799999999988776      456799999999999999999          77776543322


Q ss_pred             cchhHHhhhcCCchHHHHhhh-hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          827 LSLNRWINDLLPVSVMEVIDT-NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~-~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ........         .+.. ......+.. ........++.+++.+||+.|| ++|||++||++.|++
T Consensus       241 ~~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP-~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          241 PSFEDMRK---------VVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNP-SARLTALRIKKTLTK  299 (301)
T ss_dssp             CCHHHHHH---------HHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHCCSSG-GGSCCHHHHHHHHHH
T ss_pred             cchhhhhH---------HHhccCCCCCCChh-hccCccHHHHHHHHHHHhhcCh-hhCCCHHHHHHHHhc
Confidence            22211111         1100 000000000 0012345678999999999999 999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4e-40  Score=363.37  Aligned_cols=258  Identities=27%  Similarity=0.392  Sum_probs=209.0

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  686 (897)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34679999999999999999999875      34889999997653 344678999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCC
Q 045539          687 FKALIMKYMPNGSLENCLYSGT-----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDL  743 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dl  743 (897)
                      ..++||||+++++|.+++....                       ..+++.+++.++.|+++||+||   |++||+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCC
Confidence            9999999999999999987642                       4689999999999999999999   8899999999


Q ss_pred             CCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCccc
Q 045539          744 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEI  822 (897)
Q Consensus       744 kp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~  822 (897)
                      ||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987654333333344568999999999888889999999999999999999 99999753


Q ss_pred             ccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          823 FIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...  ....           .+.+......+       ..+..++.+++.+||+.|| ++|||++||++.|++
T Consensus       281 ~~~--~~~~-----------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p-~~Rps~~~~~~~L~~  332 (343)
T 1luf_A          281 AHE--EVIY-----------YVRDGNILACP-------ENCPLELYNLMRLCWSKLP-ADRPSFCSIHRILQR  332 (343)
T ss_dssp             CHH--HHHH-----------HHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ChH--HHHH-----------HHhCCCcCCCC-------CCCCHHHHHHHHHHcccCc-ccCCCHHHHHHHHHH
Confidence            111  1111           11111111111       1223457899999999999 999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.3e-40  Score=359.49  Aligned_cols=257  Identities=18%  Similarity=0.198  Sum_probs=206.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++.+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46899999999999999999986 4689999999875432  24678999999999 89999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc-----EEEeeccCccccC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-----AHISDFGIAKLLS  768 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~-----~kL~DFg~a~~~~  768 (897)
                      |+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.     +||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 9999999987666799999999999999999999   7889999999999999998887     9999999998765


Q ss_pred             CCCcee-----eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          769 GEDQLS-----IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       769 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .            ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~------------~~~  227 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--T------------LKE  227 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--S------------HHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--c------------HHH
Confidence            433211     123557999999999999999999999999999999999999999763211  1            111


Q ss_pred             HhhhhhcchhhhhHHHH-HHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          844 VIDTNLLRGEERFFAAK-EQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+............... ...+ ++.+++..||+.|| .+||++++|.+.|+
T Consensus       228 ~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p-~~RP~~~~l~~~l~  277 (330)
T 2izr_A          228 RYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDF-FEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCT-TCCCCHHHHHHHHH
T ss_pred             HHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCC-CCCCCHHHHHHHHH
Confidence            11111100000000000 1122 68999999999999 99999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.1e-40  Score=353.67  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=205.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..++|++.+.||+|+||.||+|++.+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3578999999999999999999999888999999985532 236788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........ .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            999999999987666799999999999999999999   889999999999999999999999999999987643221 1


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                      ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......              ...+.+........
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------------~~~~~~~~~~~~~~  242 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------------ETAEHIAQGLRLYR  242 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------------HHHHHHHTTCCCCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------------HHHHHHhcccCCCC
Confidence            1223456788999999988889999999999999999998 99999763211              01111111111111


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +      ......+.+++.+||+.|| ++|||++|+++.|+
T Consensus       243 ~------~~~~~~l~~li~~~l~~~p-~~Rps~~~ll~~L~  276 (283)
T 3gen_A          243 P------HLASEKVYTIMYSCWHEKA-DERPTFKILLSNIL  276 (283)
T ss_dssp             C------TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHH
T ss_pred             C------CcCCHHHHHHHHHHccCCh-hHCcCHHHHHHHHH
Confidence            1      0112457899999999999 99999999999885

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4e-40  Score=360.38  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCce----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGME----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.++... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            467999999999999999999864 3443    5888775433 344578899999999999999999999998765 78


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +|+||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999988777799999999999999999999   788999999999999999999999999999988765


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .            ....+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~------------~~~~~~~~  235 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E------------ISSILEKG  235 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G------------HHHHHHTT
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--H------------HHHHHHcC
Confidence            544444445567889999999999999999999999999999999 99999763211  1            12222211


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       236 ~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rps~~ell~~l~  274 (327)
T 3poz_A          236 ERLPQP------PICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCCC------TTBCHHHHHHHHHHTCSCG-GGSCCHHHHHHHHH
T ss_pred             CCCCCC------ccCCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHH
Confidence            111110      1123457889999999999 99999999998874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=364.21  Aligned_cols=247  Identities=19%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             cCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccCCC
Q 045539          621 ENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      ..+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3578999999999999865 689999999987655566789999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee--CCCCcEEEeeccCccccCCCCceeeee
Q 045539          700 LENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       700 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll--~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      |.+++......+++.++..++.|++.||+||   |++||+||||||+||++  +.++.+||+|||+++.......   ..
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence            9999887766799999999999999999999   88999999999999999  6778999999999987654332   22


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhH
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFF  857 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  857 (897)
                      ...||+.|+|||++....++.++|||||||++|||++|+.||...... ..+            ..++.........   
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~------------~~i~~~~~~~~~~---  310 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETL------------NNILACRWDLEDE---  310 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH------------HHHHHTCCCSCSG---
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHH------------HHHHhccCCCChh---
Confidence            346999999999998889999999999999999999999999753111 011            1111111100000   


Q ss_pred             HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          858 AAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       858 ~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       .......++.+++.+|++.|| ++|||++|+++
T Consensus       311 -~~~~~~~~~~~li~~~L~~dp-~~Rps~~e~l~  342 (373)
T 2x4f_A          311 -EFQDISEEAKEFISKLLIKEK-SWRISASEALK  342 (373)
T ss_dssp             -GGTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             -hhccCCHHHHHHHHHHcCCCh-hhCCCHHHHhc
Confidence             001223457899999999999 99999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.4e-40  Score=355.82  Aligned_cols=257  Identities=24%  Similarity=0.367  Sum_probs=211.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++.+++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            56899999999999999999975      246889999997553 34457889999999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          688 KALIMKYMPNGSLENCLYSGTC-----------------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      .++||||+++|+|.+++.....                 .+++.++..++.|++.||+||   |++||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEE
Confidence            9999999999999999876542                 489999999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence            9999999999999987765544444445567889999999888899999999999999999999 999987632111   


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                .....+.........      .....++.+++.+|++.|| ++|||++|+++.|++
T Consensus       256 ----------~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~~  304 (313)
T 1t46_A          256 ----------KFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADP-LKRPTFKQIVQLIEK  304 (313)
T ss_dssp             ----------HHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ----------HHHHHhccCCCCCCc------ccCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHHH
Confidence                      111122211111110      1123457899999999999 999999999998863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.6e-40  Score=355.91  Aligned_cols=256  Identities=23%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|.+.+.||+|+||.||+|+.      .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            57899999999999999999975      235789999997543 44567889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCC
Q 045539          689 ALIMKYMPNGSLENCLYSGT-----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKP  745 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp  745 (897)
                      ++||||+++++|.+++....                       ..+++.++..++.|+++||+||   |++||+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccch
Confidence            99999999999999987643                       2388999999999999999999   789999999999


Q ss_pred             CCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCccccc
Q 045539          746 SNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFI  824 (897)
Q Consensus       746 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~  824 (897)
                      +||+++.++.+||+|||++................+|+.|+|||...+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755444333444567889999999888889999999999999999999 9999975321


Q ss_pred             CccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          825 GELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .  .            ..+.+.........      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       259 ~--~------------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp-~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          259 E--R------------LFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQEP-DKRPVFADISKDLEK  308 (314)
T ss_dssp             G--G------------HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             H--H------------HHHHhhcCCcCCCC------ccCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            1  1            11111111100000      1223457899999999999 999999999998853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.7e-40  Score=360.14  Aligned_cols=249  Identities=21%  Similarity=0.275  Sum_probs=198.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  689 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|.++++.+ +||||+++++++.+++..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999876 58999999998653   33456778999999998 6999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999987654 589999999999999999999   889999999999999999999999999999985432


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..           ...+.....
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~-----------~~~i~~~~~  241 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DL-----------FEAILNDEV  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH-----------HHHHHHCCC
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HH-----------HHHHHcCCC
Confidence            22  2234557999999999998888999999999999999999999999752111  00           011111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH------HHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM------GWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~------~evl~  891 (897)
                      . .+.       .....+.+++.+|++.|| ++||++      +|+++
T Consensus       242 ~-~p~-------~~~~~~~~li~~lL~~dP-~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 V-YPT-------WLHEDATGILKSFMTKNP-TMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C-CCT-------TSCHHHHHHHHHHTCSSG-GGSTTSGGGTCTHHHHT
T ss_pred             C-CCC-------CCCHHHHHHHHHHhhhCH-HHccCCcccCCHHHHhh
Confidence            0 010       122447889999999999 999998      66654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=367.87  Aligned_cols=255  Identities=22%  Similarity=0.356  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec------CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++.+++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999843      4678999998643 244456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEe
Q 045539          689 ALIMKYMPNGSLENCLYSGT------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHIS  759 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~  759 (897)
                      ++||||+++|+|.+++....      ..+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999987643      4589999999999999999999   889999999999999999555   59999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......  .          
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~----------  294 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--E----------  294 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H----------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H----------
Confidence            9999976533222222334568999999999988899999999999999999998 99999763111  1          


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                        ..+.+.........      ..+...+.+++.+||+.|| ++|||++||++.|+
T Consensus       295 --~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rps~~eil~~l~  341 (367)
T 3l9p_A          295 --VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQP-EDRPNFAIILERIE  341 (367)
T ss_dssp             --HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             --HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence              11111111111111      1223457899999999999 99999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=352.28  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--------------------------HHHHHHHHHHHHHH
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--------------------------RALKSFEDECEVMK  668 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  668 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999865 689999999864421                          12356889999999


Q ss_pred             hcCCCccceEeeeecC--CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCC
Q 045539          669 RIRHRNLVKIISSCSN--DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPS  746 (897)
Q Consensus       669 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~  746 (897)
                      +++||||+++++++.+  ++..|+||||+++++|.+++..  ..+++.++..++.|++.||+||   |++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHH
Confidence            9999999999999976  5688999999999999887554  3589999999999999999999   7889999999999


Q ss_pred             CeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCC---CCccchHHHHHHHHHHHHcCCCCCcccc
Q 045539          747 NVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR---VCTRGDVYSYGIMLMEMFTKKKPTDEIF  823 (897)
Q Consensus       747 NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvil~elltg~~p~~~~~  823 (897)
                      ||+++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999987654332  233457999999999987654   4788999999999999999999997521


Q ss_pred             cCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          824 IGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..  ....           .+....... +.     ......++.+++.+||+.|| ++|||++|+++
T Consensus       245 ~~--~~~~-----------~~~~~~~~~-~~-----~~~~~~~l~~li~~~l~~dp-~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IM--CLHS-----------KIKSQALEF-PD-----QPDIAEDLKDLITRMLDKNP-ESRIVVPEIKL  292 (298)
T ss_dssp             HH--HHHH-----------HHHHCCCCC-CS-----SSCCCHHHHHHHHHHTCSCT-TTSCCHHHHTT
T ss_pred             HH--HHHH-----------HHhcccCCC-CC-----ccccCHHHHHHHHHHhhcCh-hhCCCHHHHhc
Confidence            10  0000           000000000 00     01123457899999999999 99999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-39  Score=350.50  Aligned_cols=259  Identities=14%  Similarity=0.151  Sum_probs=207.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....  .+.+.+|+++++++ +|++++++++++.++...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46899999999999999999986 4689999999865432  24678899999999 69999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc-----EEEeeccCccccC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-----AHISDFGIAKLLS  768 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~-----~kL~DFg~a~~~~  768 (897)
                      |+ +++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 9999999987766799999999999999999999   8999999999999999987776     9999999998765


Q ss_pred             CCCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          769 GEDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       769 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....     .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ...        ...
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~--------~~~  232 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQK--------YER  232 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHH--------HHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHH--------HHH
Confidence            43321     122345699999999999999999999999999999999999999976321110  000        011


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +..........   .....+..++.+++.+||+.|| ++|||+++|++.|+
T Consensus       233 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp-~~RP~~~~l~~~l~  279 (298)
T 1csn_A          233 IGEKKQSTPLR---ELCAGFPEEFYKYMHYARNLAF-DATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHHHHHSCHH---HHTTTSCHHHHHHHHHHHHCCT-TCCCCHHHHHHHHH
T ss_pred             HHhhccCccHH---HHHhhCcHHHHHHHHHHhcCCc-ccCCCHHHHHHHHH
Confidence            11111100000   0111234568899999999999 99999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=368.52  Aligned_cols=261  Identities=18%  Similarity=0.260  Sum_probs=206.9

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      +.+.....++|++.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|.+++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4444555789999999999999999999875 69999999997643   2233557899999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..|+||||+++|+|.+++...+..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            9999999999999999999987655699999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccC-------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGT-------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||......     +.     
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~-----  278 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ET-----  278 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH-----
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HH-----
Confidence            87654332 2223457999999999876       457899999999999999999999999752111     00     


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCC---CCHHHHHh
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNG---ADMGWIFS  891 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~R---Pt~~evl~  891 (897)
                         ...++........   .........++.+++.+|+. +| ++|   |+++|+++
T Consensus       279 ---~~~i~~~~~~~~~---p~~~~~~s~~~~dli~~lL~-~p-~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          279 ---YGKIVHYKEHLSL---PLVDEGVPEEARDFIQRLLC-PP-ETRLGRGGAGDFRT  327 (412)
T ss_dssp             ---HHHHHTHHHHCCC---C----CCCHHHHHHHHTTSS-CG-GGCTTTTTHHHHHT
T ss_pred             ---HHHHHhcccCcCC---CccccCCCHHHHHHHHHHcC-Ch-hhcCCCCCHHHHhc
Confidence               0111110000000   00011234567899999998 99 887   68999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-40  Score=360.37  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=208.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDD  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  686 (897)
                      ..++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++.+++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999986      246689999997543 33457889999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCC
Q 045539          687 FKALIMKYMPNGSLENCLYSGTC----------------------MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLK  744 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlk  744 (897)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|++.||+||   |++||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCC
Confidence            99999999999999999976542                      378999999999999999999   88999999999


Q ss_pred             CCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccc
Q 045539          745 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIF  823 (897)
Q Consensus       745 p~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~  823 (897)
                      |+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987655444444445567899999999888899999999999999999998 999997632


Q ss_pred             cCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          824 IGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       824 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .. ..            ....+........+      .....++.+++.+||+.|| ++|||++|+++.|+
T Consensus       280 ~~-~~------------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          280 VD-AN------------FYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDS-RKRPSFPNLTSFLG  330 (344)
T ss_dssp             CS-HH------------HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             cH-HH------------HHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCc-hhCcCHHHHHHHHH
Confidence            11 11            11112111111110      0123457889999999999 99999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-39  Score=354.92  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=199.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      ..++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999886 79999999987433 334578899999999999999999999885433      


Q ss_pred             ---------------------------------------------------ceEEEEEeccCCChhHhhhcCC--CCCCH
Q 045539          687 ---------------------------------------------------FKALIMKYMPNGSLENCLYSGT--CMLDI  713 (897)
Q Consensus       687 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~~~~  713 (897)
                                                                         ..++||||+++++|.+++....  ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3799999999999999998755  34566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce----------eeeeccccCc
Q 045539          714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL----------SIQIQTLATI  783 (897)
Q Consensus       714 ~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~----------~~~~~~~gt~  783 (897)
                      ..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77899999999999999   8899999999999999999999999999999877543221          1223456999


Q ss_pred             ccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHH
Q 045539          784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQI  863 (897)
Q Consensus       784 ~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~  863 (897)
                      .|+|||++.+..++.++|||||||++|||++|..|+....                   +..........+   ......
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~~~~~---~~~~~~  298 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRNLKFP---LLFTQK  298 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHTTCCC---HHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhccCCC---cccccC
Confidence            9999999988899999999999999999999987754310                   111111111111   112233


Q ss_pred             HHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          864 LLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       864 ~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..++.+++.+||+.|| ++|||++|+++.
T Consensus       299 ~~~~~~li~~~l~~~p-~~Rps~~~~l~~  326 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSP-TERPEATDIIEN  326 (332)
T ss_dssp             CHHHHHHHHHHHCSSG-GGSCCHHHHHHS
T ss_pred             ChhHHHHHHHHccCCC-CcCCCHHHHhhc
Confidence            4456889999999999 999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-39  Score=350.49  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=200.2

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||.||+|+..+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999988899999999864432  2346788999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +++ +|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 99998887666799999999999999999999   78999999999999999999999999999998764322  1


Q ss_pred             eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc---CCchHHHH-----h
Q 045539          775 IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL---LPVSVMEV-----I  845 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~-----i  845 (897)
                      ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...+.....   ........     .
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence            2234568999999998865 458999999999999999999999997532111 111111100   00000000     0


Q ss_pred             hhhhcchhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          846 DTNLLRGEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       846 ~~~l~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ++......+. ..........++.+++.+|++.|| ++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP-NQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCc-ccCCCHHHHhcC
Confidence            0000000000 000001123457899999999999 999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-39  Score=344.61  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=205.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3568999999999999999999876 477899999987665566789999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||.+......
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999887654 489999999999999999999   88999999999999999   78889999999999876543


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      ..   .....||+.|+|||++.+ .++.++||||||+++|||++|+.||......                 +.......
T Consensus       163 ~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------------~~~~~~~~  221 (277)
T 3f3z_A          163 KM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----------------EVMLKIRE  221 (277)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHH
T ss_pred             cc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-----------------HHHHHHHh
Confidence            32   234568999999998765 4899999999999999999999999763211                 11111110


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...............++.+++.+|++.|| ++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp-~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GTFTFPEKDWLNVSPQAESLIRRLLTKSP-KQRITSLQALE  261 (277)
T ss_dssp             CCCCCCHHHHTTSCHHHHHHHHHHTCSST-TTSCCHHHHTT
T ss_pred             CCCCCCchhhhcCCHHHHHHHHHHccCCh-hhCcCHHHHhc
Confidence            10000011111234568899999999999 99999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-39  Score=349.84  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=203.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++++...   ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468999999999999999999876 689999999986532   2356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998754 589999999999999999999   8999999999999999999999999999999875432 


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..           ...++..... 
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~-----------~~~i~~~~~~-  221 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT-----------YEKILNAELR-  221 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-----------HHHHHHCCCC-
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH-----------HHHHHhCCCC-
Confidence                23457999999999999999999999999999999999999999752111  00           1111111111 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      .+.       ....++.+++.+|++.|| ++||     +++|+++
T Consensus       222 ~p~-------~~~~~~~~li~~lL~~dp-~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 FPP-------FFNEDVKDLLSRLITRDL-SQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSCT-TTCTTSSTTTTHHHHT
T ss_pred             CCC-------CCCHHHHHHHHHHhccCH-HHcCCCcCCCHHHHhc
Confidence            010       122457899999999999 9999     8888874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.4e-40  Score=351.83  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=193.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|++.  ..||+|+++...  ....+.+.+|++++++++||||+++++++. .+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            568999999999999999999865  359999986432  445678999999999999999999999764 456899999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            9999999999987777799999999999999999999   8899999999999999999999999999999866533333


Q ss_pred             eeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh-h
Q 045539          774 SIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN-L  849 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l  849 (897)
                      .......||+.|+|||++.   ...++.++||||||+++|||++|+.||....... .            ..+.+... .
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~------------~~~~~~~~~~  243 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-Q------------IIEMVGRGSL  243 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-H------------HHHHHHHTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-H------------HHHHhccccc
Confidence            3334456899999999876   6678889999999999999999999997632111 1            11111111 0


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .......   ...+..++.+++.+||+.|| ++|||++|++++|++
T Consensus       244 ~~~~~~~---~~~~~~~l~~li~~~l~~~p-~~Rps~~ell~~L~~  285 (289)
T 3og7_A          244 SPDLSKV---RSNCPKRMKRLMAECLKKKR-DERPSFPRILAEIEE  285 (289)
T ss_dssp             CCCTTSS---CTTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             Ccchhhc---cccCCHHHHHHHHHHccCCh-hhCCCHHHHHHHHHH
Confidence            0000000   01223458899999999999 999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=352.30  Aligned_cols=272  Identities=20%  Similarity=0.283  Sum_probs=206.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--ceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--FKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  691 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            468999999999999999999876 58999999997543 334567789999999999999999999987655  77999


Q ss_pred             EEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----CCCCcEEEeeccCcc
Q 045539          692 MKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAK  765 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~  765 (897)
                      |||+++++|.+++....  ..+++.++..++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999997654  2389999999999999999999   88999999999999999    788899999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccC--------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc---chhHHhh
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGT--------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL---SLNRWIN  834 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~---~~~~~~~  834 (897)
                      .......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||........   .......
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7654332   23456999999999865        57889999999999999999999999975322111   1111111


Q ss_pred             hcCCchH---HHHhhhhh--cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          835 DLLPVSV---MEVIDTNL--LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       835 ~~~~~~~---~~~i~~~l--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...+...   ........  ....+......+.....+.+++.+|++.|| ++|||++|+++...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP-~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ-EKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT-TTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh-hhhccHHHhhhccH
Confidence            1000000   00000000  000000001113445668899999999999 99999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-40  Score=357.90  Aligned_cols=246  Identities=22%  Similarity=0.342  Sum_probs=200.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|++ .+|+.||+|++.....   ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999987 4689999999976532   2245788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+ +|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 788888876654 589999999999999999999   78899999999999999999999999999998765432


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .   .....||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........  .+.+            .....
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i------------~~~~~  225 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKV------------NSCVY  225 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCC------------CSSCC
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHH------------HcCCC
Confidence            2   234569999999999887776 7899999999999999999999976321110  0000            00000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+.       ....++.+++.+|++.|| ++|||++|+++
T Consensus       226 ~~p~-------~~s~~~~~li~~~L~~dP-~~Rpt~~eil~  258 (336)
T 3h4j_B          226 VMPD-------FLSPGAQSLIRRMIVADP-MQRITIQEIRR  258 (336)
T ss_dssp             CCCT-------TSCHHHHHHHHTTSCSSG-GGSCCHHHHTT
T ss_pred             CCcc-------cCCHHHHHHHHHHcCCCh-hHCcCHHHHHh
Confidence            0000       112346789999999999 99999999976

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.7e-40  Score=357.32  Aligned_cols=254  Identities=21%  Similarity=0.332  Sum_probs=194.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF----  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  687 (897)
                      .++|++.+.||+|+||.||+|++ .+++.||+|+++...   ....+.+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            56899999999999999999986 468999999997542   3445678999999999999999999999876544    


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999987654 589999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCCCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          768 SGEDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       768 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......                 +...
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----------------~~~~  229 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----------------SVAY  229 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHH
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------------HHHH
Confidence            533221 2223456899999999998889999999999999999999999999753211                 0111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...................++.+++.+||+.|| ++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP-~~R~~~~~~l~  273 (311)
T 3ork_A          230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNP-ENRYQTAAEMR  273 (311)
T ss_dssp             HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSG-GGSCSSHHHHH
T ss_pred             HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCH-hhChhhHHHHH
Confidence            111110000001111234567899999999999 99997777654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=349.56  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=195.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|++. ++.||+|++....  ..+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            357889999999999999999886 7899999987543  34678999999999999999999999874  479999999


Q ss_pred             cCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc-EEEeeccCccccCCCCc
Q 045539          696 PNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV-AHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       696 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~-~kL~DFg~a~~~~~~~~  772 (897)
                      ++++|.+++....  ..+++..+..++.|+++||+|||..|.+||+||||||+||+++.++. +||+|||.+......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            9999999998665  34788999999999999999996655599999999999999988876 799999999765422  


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||...............           .......
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~~~~~~~  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-----------NGTRPPL  225 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-----------TTCCCCC
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-----------cCCCCCc
Confidence               12345899999999999989999999999999999999999999753221111000000           0000000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .       ..+...+.+++.+||+.|| ++|||++|+++.|+
T Consensus       226 ~-------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~  259 (307)
T 2eva_A          226 I-------KNLPKPIESLMTRCWSKDP-SQRPSMEEIVKIMT  259 (307)
T ss_dssp             B-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             c-------cccCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHH
Confidence            0       1123457889999999999 99999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-39  Score=361.63  Aligned_cols=264  Identities=17%  Similarity=0.179  Sum_probs=204.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC------CceEEEEEechhhHHH-----------HHHHHHHHHHHHhcCCCccceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQYERA-----------LKSFEDECEVMKRIRHRNLVKI  678 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  678 (897)
                      .++|++.+.||+|+||.||+|++..      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            5689999999999999999998754      4789999986543211           1223456667788889999999


Q ss_pred             eeeecCC----CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--C
Q 045539          679 ISSCSND----DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--E  752 (897)
Q Consensus       679 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~  752 (897)
                      ++++...    ...|+||||+ +++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecCC
Confidence            9998664    4589999999 9999999988767799999999999999999999   788999999999999998  8


Q ss_pred             CCcEEEeeccCccccCCCCcee-----eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          753 DMVAHISDFGIAKLLSGEDQLS-----IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       753 ~~~~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~  268 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-P  268 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-H
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-H
Confidence            8999999999998764322111     112345999999999999999999999999999999999999999863222 1


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...............+++++.+..         ..+..++.+++..||+.|| ++||++++|++.|+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p-~~RP~~~~l~~~l~  325 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPA---------ANAPGEIAKYMETVKLLDY-TEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCT---------TCCCHHHHHHHHHHHTCCT-TCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhccc---------ccCHHHHHHHHHHHhcCCC-CCCCCHHHHHHHHH
Confidence            222222222222233444433311         1123568899999999999 99999999999875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-38  Score=366.56  Aligned_cols=347  Identities=23%  Similarity=0.359  Sum_probs=294.0

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +++.|+++++++.. +| .+..+++|++|||++|.+++..|  ++++++|++|++++|++.+..+  +.++++|++|+|+
T Consensus        47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  120 (466)
T 1o6v_A           47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF  120 (466)
T ss_dssp             TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence            57889999999874 55 48899999999999999996544  9999999999999999988776  9999999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      +|.+++. |. ++++++|++|++++|+++++.  .+.++++|++|+++ |.+.+. +.  +..+++|++|++++|.+++.
T Consensus       121 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~-~~--~~~l~~L~~L~l~~n~l~~~  192 (466)
T 1o6v_A          121 NNQITDI-DP-LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL-KP--LANLTTLERLDISSNKVSDI  192 (466)
T ss_dssp             SSCCCCC-GG-GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC-GG--GTTCTTCCEEECCSSCCCCC
T ss_pred             CCCCCCC-hH-HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc-hh--hccCCCCCEEECcCCcCCCC
Confidence            9999954 43 999999999999999999874  48999999999997 566533 32  45889999999999999764


Q ss_pred             ccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHH
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS  316 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~  316 (897)
                        ..+..+++|++|++++|.+++..|                       ++.+++|++|++++|+++++           
T Consensus       193 --~~l~~l~~L~~L~l~~n~l~~~~~-----------------------~~~l~~L~~L~l~~n~l~~~-----------  236 (466)
T 1o6v_A          193 --SVLAKLTNLESLIATNNQISDITP-----------------------LGILTNLDELSLNGNQLKDI-----------  236 (466)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG-----------------------GGGCTTCCEEECCSSCCCCC-----------
T ss_pred             --hhhccCCCCCEEEecCCccccccc-----------------------ccccCCCCEEECCCCCcccc-----------
Confidence              458999999999999999987654                       35678999999999998753           


Q ss_pred             HHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccc
Q 045539          317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG  396 (897)
Q Consensus       317 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  396 (897)
                                      ..+..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|++++
T Consensus       237 ----------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~  296 (466)
T 1o6v_A          237 ----------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE  296 (466)
T ss_dssp             ----------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred             ----------------hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCC
Confidence                            235678899999999999998665  8899999999999999997554  88899999999999


Q ss_pred             cccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccccc
Q 045539          397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQ  476 (897)
Q Consensus       397 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~  476 (897)
                      |++++..|  ++.+++|+.|++++|++++..|  +..+++|+.|+++             +|++++.  ..++.+++|+.
T Consensus       297 n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~-------------~n~l~~~--~~l~~l~~L~~  357 (466)
T 1o6v_A          297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY-------------NNKVSDV--SSLANLTNINW  357 (466)
T ss_dssp             SCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC-------------SSCCCCC--GGGTTCTTCCE
T ss_pred             CcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC-------------CCccCCc--hhhccCCCCCE
Confidence            99996544  8899999999999999998666  6778888855554             4555543  46888999999


Q ss_pred             ccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchh
Q 045539          477 MFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPAS  515 (897)
Q Consensus       477 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  515 (897)
                      |++++|++++..|  +..+++|+.|++++|++++ +|..
T Consensus       358 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             EECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             EeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence            9999999998777  8999999999999999996 4543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-39  Score=356.26  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=202.0

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCce
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  688 (897)
                      ...++|.+.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+..|.++++.+ +||||+++++++.+++..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34679999999999999999999876 58999999998653   23456678899999987 899999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |+||||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999987644 589999999999999999999   78999999999999999999999999999998643


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.+           ....
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i-----------~~~~  234 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSI-----------RMDN  234 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-----------HHCC
T ss_pred             cCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-----------HhCC
Confidence            2221  234567999999999999999999999999999999999999999752111  111111           0000


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHH-HHH
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMG-WIF  890 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~-evl  890 (897)
                      .  ..+      .....++.+++.+|++.|| ++||++. |+.
T Consensus       235 ~--~~p------~~~s~~~~~li~~lL~~dp-~~R~~~~~~i~  268 (345)
T 1xjd_A          235 P--FYP------RWLEKEAKDLLVKLFVREP-EKRLGVRGDIR  268 (345)
T ss_dssp             C--CCC------TTSCHHHHHHHHHHSCSSG-GGSBTTBSCGG
T ss_pred             C--CCC------cccCHHHHHHHHHHhcCCH-hHcCCChHHHH
Confidence            0  000      0122457889999999999 9999997 554

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-39  Score=356.52  Aligned_cols=256  Identities=24%  Similarity=0.424  Sum_probs=190.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecC-C---ceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQD-G---MEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-~---~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      ..++|++.+.||+|+||.||+|++.. +   ..||+|+++...  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35689999999999999999998663 3   279999987542  34467889999999999999999999999877655


Q ss_pred             ------EEEEEeccCCChhHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEE
Q 045539          689 ------ALIMKYMPNGSLENCLYSGT-----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  757 (897)
Q Consensus       689 ------~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~k  757 (897)
                            ++||||+++++|.+++....     ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999886432     2589999999999999999999   889999999999999999999999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhc
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......  .....    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~----  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY----  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH----
Confidence            999999987654443333444567889999999988899999999999999999999 89998763211  11111    


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                             +........+       .....++.+++.+||+.|| ++|||++|+++.|+
T Consensus       252 -------~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~l~  294 (323)
T 3qup_A          252 -------LIGGNRLKQP-------PECMEEVYDLMYQCWSADP-KQRPSFTCLRMELE  294 (323)
T ss_dssp             -------HHTTCCCCCC-------TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHH
T ss_pred             -------HhcCCCCCCC-------CccCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence                   1111101111       1223457899999999999 99999999998875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-39  Score=358.23  Aligned_cols=211  Identities=26%  Similarity=0.340  Sum_probs=185.0

Q ss_pred             ccccccCCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-----CCc
Q 045539          601 PQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-----HRN  674 (897)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~n  674 (897)
                      ......+++.+.....++|++.+.||+|+||.||+|++. +++.||||+++.. ....+.+..|++++++++     |||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            345666777777777899999999999999999999874 6899999999753 333466778999999997     999


Q ss_pred             cceEeeeecCCCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-
Q 045539          675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-  752 (897)
Q Consensus       675 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-  752 (897)
                      |+++++++...+..++||||+ +++|.+++.... ..+++.++..++.|++.||+||   |++||+||||||+||+++. 
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCT
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEccc
Confidence            999999999999999999999 999999987655 4589999999999999999999   8899999999999999975 


Q ss_pred             ------------------------CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHH
Q 045539          753 ------------------------DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIM  808 (897)
Q Consensus       753 ------------------------~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvi  808 (897)
                                              ++.+||+|||+|.......     ....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    7899999999998654322     24568999999999999999999999999999


Q ss_pred             HHHHHcCCCCCcc
Q 045539          809 LMEMFTKKKPTDE  821 (897)
Q Consensus       809 l~elltg~~p~~~  821 (897)
                      +|||++|+.||..
T Consensus       249 l~ell~g~~pf~~  261 (360)
T 3llt_A          249 LAELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHHSSCSCCC
T ss_pred             HHHHHHCCCCCCC
Confidence            9999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-39  Score=352.54  Aligned_cols=250  Identities=20%  Similarity=0.231  Sum_probs=182.6

Q ss_pred             CCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEeccCCC
Q 045539          622 NNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      .+.||+|+||.||+|.+. +|+.||||++.+..   ...+.+|+.++++++ ||||+++++++.+++..|+||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999876 68999999997543   356678999999997 9999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEeeccCccccCCCCceeee
Q 045539          700 LENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       700 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      |.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+|||+++.......  ..
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            999998764 589999999999999999999   889999999999999997665   899999999986643322  22


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......          ......+++.......+...
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL----------TCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCCC
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc----------ccccHHHHHHHHHcCCCCCC
Confidence            34568999999999999999999999999999999999999997632210          00111222222222221111


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .........++.+++.+|++.|| ++|||++|+++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP-~~Rpt~~ell~  270 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDP-NKRLKMSGLRY  270 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCT-TTCCCTTTSTT
T ss_pred             cccccCCCHHHHHHHHHHCCCCh-hHCCCHHHHhc
Confidence            12223445668899999999999 99999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.5e-40  Score=359.55  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=209.3

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEecC-C-----ceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecC
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQD-G-----MEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSN  684 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  684 (897)
                      ....++|++.+.||+|+||.||+|.+.. +     +.||+|++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3446789999999999999999998642 2     479999987553 34457889999999999 89999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC
Q 045539          685 DDFKALIMKYMPNGSLENCLYSG-------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD  751 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~  751 (897)
                      ++..++||||+++|+|.+++...             ...+++..+..++.|++.||+||   |++||+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEEC
Confidence            99999999999999999998653             23579999999999999999999   788999999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchh
Q 045539          752 EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLN  830 (897)
Q Consensus       752 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~  830 (897)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||....... .  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~--  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-K--  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-H--
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-H--
Confidence            999999999999987654444334444567889999999888889999999999999999999 999987632111 1  


Q ss_pred             HHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          831 RWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       831 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                ....+........+      ......+.+++.+||+.|| ++|||++||++.|++
T Consensus       276 ----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          276 ----------FYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEP-THRPTFQQICSFLQE  323 (333)
T ss_dssp             ----------HHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ----------HHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccCh-hhCcCHHHHHHHHHH
Confidence                      11111111111100      0112457889999999999 999999999998863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.6e-39  Score=348.14  Aligned_cols=268  Identities=18%  Similarity=0.221  Sum_probs=200.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            58999999999999999999876 58999999987443  2344678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++ ++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 66666665556799999999999999999999   88899999999999999999999999999998764322  


Q ss_pred             eeeeccccCcccCCcCccCCCC-CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc---hHHHHh---h
Q 045539          774 SIQIQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV---SVMEVI---D  846 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~i---~  846 (897)
                      .......||+.|+|||++.+.. ++.++||||+||++|||++|..||....................   ......   +
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2223456899999999887665 79999999999999999999888643221111111111100000   000000   0


Q ss_pred             hh---hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TN---LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~---l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..   .................++.+++.+|++.|| ++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP-VQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccCh-hhCCCHHHHhc
Confidence            00   0000000000001223457899999999999 99999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-39  Score=357.07  Aligned_cols=260  Identities=20%  Similarity=0.289  Sum_probs=201.6

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|++....     ....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34567789999999999999999999875 68899999987653     2345788999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 045539          685 DDFKALIMKYMPNGSLENCLYSG---------------------------------------TCMLDIFQRLNIMIDVAL  725 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~  725 (897)
                      ++..++||||+++|+|.+++...                                       ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988521                                       112357778899999999


Q ss_pred             HHHHHHhcCCCCcEeCCCCCCCeeeCCCC--cEEEeeccCccccCCCC--ceeeeeccccCcccCCcCccCC--CCCCcc
Q 045539          726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDM--VAHISDFGIAKLLSGED--QLSIQIQTLATIGYMAPEYGTK--GRVCTR  799 (897)
Q Consensus       726 ~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~--~~kL~DFg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  799 (897)
                      ||+||   |++||+||||||+||+++.++  .+||+|||++.......  .........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999   788999999999999998776  89999999998654322  1122345579999999998764  678999


Q ss_pred             chHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCC
Q 045539          800 GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESR  879 (897)
Q Consensus       800 sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  879 (897)
                      +|||||||++|||++|+.||......+ .            ...++........+    ........+.+++.+|++.||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~-~------------~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD-T------------ISQVLNKKLCFENP----NYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH-H------------HHHHHHCCCCTTSG----GGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH-H------------HHHHHhcccccCCc----ccccCCHHHHHHHHHHcCCCh
Confidence            999999999999999999997532110 0            11111111111100    011223457899999999999


Q ss_pred             CCCCCCHHHHHh
Q 045539          880 DGNGADMGWIFS  891 (897)
Q Consensus       880 ~~~RPt~~evl~  891 (897)
                       ++|||+.|+++
T Consensus       320 -~~Rps~~~~l~  330 (345)
T 3hko_A          320 -DERFDAMRALQ  330 (345)
T ss_dssp             -TTSCCHHHHHH
T ss_pred             -hHCCCHHHHhc
Confidence             99999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=353.52  Aligned_cols=246  Identities=20%  Similarity=0.216  Sum_probs=194.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.++||+|+||+||+|++. +|+.||||++....  .........|+..+.++ +||||++++++|.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999876 69999999986432  23334455566666555 899999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 7799998877666799999999999999999999   78899999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                         ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    ...            .+.......
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~------------~~~~~~~~~  271 (311)
T 3p1a_A          212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQ------------QLRQGYLPP  271 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHH------------HHTTTCCCH
T ss_pred             ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHH------------HHhccCCCc
Confidence               2234569999999998765 78999999999999999999977664311    011            111111100


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                            ........++.+++.+|++.|| ++|||++|+++.
T Consensus       272 ------~~~~~~~~~l~~li~~~L~~dP-~~Rpt~~ell~h  305 (311)
T 3p1a_A          272 ------EFTAGLSSELRSVLVMMLEPDP-KLRATAEALLAL  305 (311)
T ss_dssp             ------HHHTTSCHHHHHHHHHHSCSST-TTSCCHHHHHTS
T ss_pred             ------ccccCCCHHHHHHHHHHcCCCh-hhCcCHHHHHhC
Confidence                  0111234568899999999999 999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.1e-39  Score=346.83  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=194.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|.+..    +..||+|+++... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            5689999999999999999998642    4579999987543 344578899999999999999999999985 456899


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            9999999999999987766799999999999999999999   7899999999999999999999999999999876533


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .. .......+++.|+|||+.....++.++||||||+++|||++ |..||......  .....+.           ....
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~-----------~~~~  235 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE-----------NGER  235 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH-----------TTCC
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHH-----------cCCC
Confidence            22 12233456789999999888889999999999999999997 99999763221  1111111           1000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...+       ..+...+.+++.+||+.|| ++|||++|+++.|++
T Consensus       236 ~~~~-------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 LPMP-------PNCPPTLYSLMTKCWAYDP-SRRPRFTELKAQLST  273 (281)
T ss_dssp             CCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCC-------CCCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            0001       1223457899999999999 999999999998853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=358.24  Aligned_cols=252  Identities=20%  Similarity=0.268  Sum_probs=189.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999876 58899999997653  33678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~~~~~~  770 (897)
                      |+++++|.+++.... .+++.++..++.|++.||+||   |+.||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999987654 589999999999999999999   7889999999999999975   889999999999876432


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............            .....
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------------~~~~~  269 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------------NCEYY  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------------TTCCC
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------------hCCCc
Confidence            2   22345689999999999998999999999999999999999999965322111111111            11000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...    +.......++.+++.+|++.|| ++|||++|+++.
T Consensus       270 ~~~----~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 FIS----PWWDEVSLNAKDLVRKLIVLDP-KKRLTTFQALQH  306 (349)
T ss_dssp             CCT----TTTTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHHS
T ss_pred             cCC----chhhhCCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence            000    0001223457899999999999 999999999873

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=357.39  Aligned_cols=252  Identities=20%  Similarity=0.304  Sum_probs=196.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCC--CccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRH--RNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++|  |||+++++++.+++..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999998643  24455788999999999986  9999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      || +.+++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++ ++.+||+|||++.......
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 56889999998754 589999999999999999999   788999999999999997 5789999999998775444


Q ss_pred             ceeeeeccccCcccCCcCccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          772 QLSIQIQTLATIGYMAPEYGTK-----------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........            
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------  229 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------  229 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH------------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH------------
Confidence            3333445679999999998753           67899999999999999999999999753211111            


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....++.......+.      ....++.+++.+||+.|| ++|||++|+++.
T Consensus       230 ~~~~~~~~~~~~~~~------~~~~~l~~li~~~L~~dp-~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 LHAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDP-KQRISIPELLAH  274 (343)
T ss_dssp             HHHHHCTTSCCCCCC------CSCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             HHHHhcCCcccCCcc------cCCHHHHHHHHHHcCCCh-hHCCCHHHHHhC
Confidence            112222111111110      112347889999999999 999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-39  Score=354.65  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=207.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|++.+.||+|+||.||+|++.        +++.||+|+++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            578999999999999999999863        46789999997543 34567889999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..++||||+++++|.+++....               ..+++.++..++.|++.||+||   |++||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEEE
Confidence            99999999999999999997654               2488999999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  . 
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~-  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E-  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H-
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H-
Confidence            9999999999999987765444333444567889999999888889999999999999999999 99998753111  1 


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                                 ....+.........      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       268 -----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~  314 (334)
T 2pvf_A          268 -----------LFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVP-SQRPTFKQLVEDLD  314 (334)
T ss_dssp             -----------HHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             -----------HHHHHhcCCCCCCC------ccCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence                       11111111100000      1223457899999999999 99999999999885

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.5e-40  Score=358.03  Aligned_cols=267  Identities=23%  Similarity=0.315  Sum_probs=211.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeec--CCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS--NDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     358899999998776666788999999999999999999999885  55678


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999987655699999999999999999999   78999999999999999999999999999998775


Q ss_pred             CCCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH---
Q 045539          769 GEDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV---  844 (897)
Q Consensus       769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  844 (897)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........  ..+...........+   
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHHHHHHH
Confidence            443322 22334578889999999888899999999999999999999999865321100  000000001111111   


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +........      ...+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       257 ~~~~~~~~~------~~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~  299 (327)
T 3lxl_A          257 LEEGQRLPA------PPACPAEVHELMKLCWAPSP-QDRPSFSALGPQLD  299 (327)
T ss_dssp             HHTTCCCCC------CTTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             hhcccCCCC------CCcccHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            111111111      11234568899999999999 99999999998885

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.2e-39  Score=359.05  Aligned_cols=272  Identities=17%  Similarity=0.250  Sum_probs=204.9

Q ss_pred             hcCCCcCCeeecc--cceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIG--SFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G--~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            5689999999999  99999999876 69999999997553  4456788899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          691 IMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999987652 4589999999999999999999   889999999999999999999999999998865432


Q ss_pred             CCce-----eeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch--
Q 045539          770 EDQL-----SIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS--  840 (897)
Q Consensus       770 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  840 (897)
                      ....     .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ..........+..  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HHHHC----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCcccc
Confidence            2111     11123468999999999877  678999999999999999999999997632221 1111111100000  


Q ss_pred             ---------------------HHHHhhhhhcc---hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 ---------------------VMEVIDTNLLR---GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ---------------------~~~~i~~~l~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                                           ..+.+......   ......+.......++.+++.+||+.|| ++|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP-DARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCT-TTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCc-ccCCCHHHHhcC
Confidence                                 00000000000   0000001112334568899999999999 999999999853

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.4e-39  Score=343.68  Aligned_cols=252  Identities=18%  Similarity=0.299  Sum_probs=204.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999875 58999999987543  345577889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc---EEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~---~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887654 589999999999999999999   8899999999999999986655   99999999987653


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......  .....           +.....
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~-----------~~~~~~  224 (284)
T 3kk8_A          161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ-----------IKAGAY  224 (284)
T ss_dssp             SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----------HHHTCC
T ss_pred             Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHH-----------HHhccc
Confidence            322   23456899999999999999999999999999999999999999652111  00000           011000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      . .+.   +.......++.+++.+|++.|| ++|||++|+++.
T Consensus       225 ~-~~~---~~~~~~~~~~~~li~~~l~~dp-~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 D-YPS---PEWDTVTPEAKSLIDSMLTVNP-KKRITADQALKV  262 (284)
T ss_dssp             C-CCT---TTTTTSCHHHHHHHHHHSCSST-TTSCCHHHHTTS
T ss_pred             c-CCc---hhhcccCHHHHHHHHHHcccCh-hhCCCHHHHhcC
Confidence            0 000   0001223457899999999999 999999999873

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-38  Score=340.38  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=207.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3568999999999999999999876 68999999987543 334578899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999987653 589999999999999999999   789999999999999999999999999999987643332


Q ss_pred             eeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........|++.|+|||...+..+ +.++||||||+++|||++|+.||............+......            .
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------~  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------L  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT------------S
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc------------c
Confidence            223345578999999999877665 789999999999999999999997643322222222211100            0


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..      .......+.+++.+|++.|| ++|||++|+++
T Consensus       229 ~~------~~~~~~~~~~li~~~l~~~p-~~Rps~~~il~  261 (276)
T 2yex_A          229 NP------WKKIDSAPLALLHKILVENP-SARITIPDIKK  261 (276)
T ss_dssp             TT------GGGSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             Cc------hhhcCHHHHHHHHHHCCCCc-hhCCCHHHHhc
Confidence            00      01123457889999999999 99999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=355.60  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=202.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999876 58899999997653   23356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999988754 589999999999999999999   88999999999999999999999999999998765332


Q ss_pred             ceeeeeccccCcccCCcCccCC---CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          772 QLSIQIQTLATIGYMAPEYGTK---GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                         ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......  ...         ....+...
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~---------~~~~~~~~  235 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKE---------IVHTFETT  235 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHH---------HHHHHHHC
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHH---------HHHHHhhc
Confidence               2335679999999998763   458999999999999999999999997522111  110         11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-HHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-MGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-~~evl~  891 (897)
                      ....+.       ....++.+++.+||+.|| ++||+ +++|.+
T Consensus       236 ~~~~p~-------~~s~~~~~li~~lL~~dP-~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 VVTYPS-------AWSQEMVSLLKKLLEPNP-DQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCCT-------TSCHHHHHHHHHHSCSSG-GGSCCSHHHHHT
T ss_pred             ccCCCC-------cCCHHHHHHHHHHhcCCH-hHhcccHHHHHc
Confidence            111111       123457899999999999 99998 676654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-39  Score=345.89  Aligned_cols=254  Identities=22%  Similarity=0.378  Sum_probs=207.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            468899999999999999999998889999999986532 2367889999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+....... ...
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            99999999988766789999999999999999999   88999999999999999999999999999998664321 111


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      .....+++.|+|||+..+..++.++||||+|+++|||++ |+.||......  ...+.            +........+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~------------i~~~~~~~~~  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED------------ISTGFRLYKP  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH------------HHTTCCCCCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHH------------HhcCCcCCCC
Confidence            223456788999999888889999999999999999999 89998752111  01111            1110000000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ......+.+++.+||+.|| ++|||++|+++.|++
T Consensus       228 ------~~~~~~l~~li~~~l~~~p-~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          228 ------RLASTHVYQIMNHCWRERP-EDRPAFSRLLRQLAE  261 (267)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ------ccCcHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence                  0112457889999999999 999999999998853

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-39  Score=344.37  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=193.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH----HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE----RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|++. |+.||+|+++....    ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999976 89999999875432    2356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---cEeCCCCCCCeeeCC--------CCcEEEee
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP---IIHCDLKPSNVLLDE--------DMVAHISD  760 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~---ivH~Dlkp~NIll~~--------~~~~kL~D  760 (897)
                      |||+++++|.+++...  .+++..+..++.|++.||+||   |++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998654  489999999999999999999   6666   999999999999986        67899999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      ||.+........    ....||+.|+|||...+..++.++||||||+++|+|++|+.||........             
T Consensus       160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------  222 (271)
T 3dtc_A          160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------------  222 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------------
T ss_pred             CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------
Confidence            999986543322    234689999999998888899999999999999999999999976321100             


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .............+      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       223 ~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          223 AYGVAMNKLALPIP------STCPEPFAKLMEDCWNPDP-HSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHHHTSCCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHC
T ss_pred             HHhhhcCCCCCCCC------cccCHHHHHHHHHHhcCCc-ccCcCHHHHHHHHhc
Confidence            00111111110000      1223457899999999999 999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.9e-39  Score=353.29  Aligned_cols=245  Identities=21%  Similarity=0.270  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.+...   ...+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999876 689999999976532   3456788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            99999999999987654 489999999999999999999   88999999999999999999999999999998764322


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..           ...+...... 
T Consensus       196 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~-----------~~~i~~~~~~-  256 (350)
T 1rdq_E          196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QI-----------YEKIVSGKVR-  256 (350)
T ss_dssp             -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH-----------HHHHHHCCCC-
T ss_pred             -----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HH-----------HHHHHcCCCC-
Confidence                 2456899999999999999999999999999999999999999752110  00           0111111110 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .+.       ....++.+++.+|++.|| ++||+     ++||++
T Consensus       257 ~p~-------~~~~~~~~li~~lL~~dp-~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FPS-------HFSSDLKDLLRNLLQVDL-TKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCT-------TCCHHHHHHHHHHSCSCT-TTCTTSSTTTTHHHHT
T ss_pred             CCC-------CCCHHHHHHHHHHhhcCH-HhccCCccCCHHHHHh
Confidence            010       123457899999999999 99998     777764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.6e-40  Score=353.81  Aligned_cols=270  Identities=22%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--Cc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  687 (897)
                      .++|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     368999999997543 23457789999999999999999999999876  66


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .++||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            8999999999999999976666799999999999999999999   8899999999999999999999999999999877


Q ss_pred             CCCCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch-HHHHh
Q 045539          768 SGEDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS-VMEVI  845 (897)
Q Consensus       768 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~i  845 (897)
                      ...... .......||..|+|||++.+..++.++||||+|+++|||++|..|+......   ............ ...+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHH
Confidence            544332 2233456888899999998888999999999999999999999986542111   001111111111 11111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .........   +....+..++.+++.+||+.|| ++|||++|++++|++
T Consensus       254 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 NTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQP-SNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHHH
T ss_pred             HHHhccCCC---CCCCCCCHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHH
Confidence            111100000   0001233568899999999999 999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.1e-39  Score=349.68  Aligned_cols=252  Identities=17%  Similarity=0.252  Sum_probs=205.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH------HHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER------ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            568999999999999999999876 6899999998754321      357789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a  764 (897)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 589999999999999999999   789999999999999999887    7999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......  ...           ..+
T Consensus       167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~-----------~~i  230 (321)
T 2a2a_A          167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL-----------ANI  230 (321)
T ss_dssp             EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH-----------HHH
T ss_pred             eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHH-----------HHH
Confidence            87654322   23456899999999999889999999999999999999999999652111  000           001


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ... ....+   ..........+.+++.+|++.|| ++|||++|+++.
T Consensus       231 ~~~-~~~~~---~~~~~~~~~~~~~li~~~l~~dp-~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSV-SYDFD---EEFFSHTSELAKDFIRKLLVKET-RKRLTIQEALRH  273 (321)
T ss_dssp             HTT-CCCCC---HHHHTTCCHHHHHHHHTTSCSST-TTSCCHHHHHHS
T ss_pred             Hhc-ccccC---hhhhcccCHHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            000 00000   01111233457899999999999 999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6e-40  Score=375.24  Aligned_cols=257  Identities=24%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++...++|++.+.||+|+||.||+|++.+++.||||+++... ...+.+.+|++++++++||||+++++++. ++..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567899999999999999999999888999999998643 34578899999999999999999999987 5678999


Q ss_pred             EEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999997543 3588999999999999999999   7899999999999999999999999999999876432


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      . ........++..|+|||++..+.++.++|||||||++|||++ |+.||......              .....+....
T Consensus       338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------------~~~~~i~~~~  402 (454)
T 1qcf_A          338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------------EVIRALERGY  402 (454)
T ss_dssp             H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------------HHHHHHHHTC
T ss_pred             c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCC
Confidence            1 111223346788999999988899999999999999999999 99999753111              1111111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....+      ..+..++.+++.+||+.|| ++|||+++|++.|++
T Consensus       403 ~~~~~------~~~~~~l~~li~~cl~~dp-~~RPt~~~i~~~L~~  441 (454)
T 1qcf_A          403 RMPRP------ENCPEELYNIMMRCWKNRP-EERPTFEYIQSVLDD  441 (454)
T ss_dssp             CCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             CCCCC------CCCCHHHHHHHHHHccCCh-hHCcCHHHHHHHHHH
Confidence            10000      1234568899999999999 999999999998865

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.3e-40  Score=357.01  Aligned_cols=265  Identities=23%  Similarity=0.351  Sum_probs=211.9

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEe
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKII  679 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  679 (897)
                      +..+++....++|++.+.||+|+||.||+|++.      +++.||+|++.... ......+.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334445556789999999999999999999754      36789999987543 34456788999999999999999999


Q ss_pred             eeecCCCceEEEEEeccCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          680 SSCSNDDFKALIMKYMPNGSLENCLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       680 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +++.+++..++||||+++++|.+++....         ..+++..+..++.|++.||+||   |++||+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEE
Confidence            99999999999999999999999986532         3468999999999999999999   78899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  ..
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~  249 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV  249 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence            9999999999999986654333222333456889999999888889999999999999999999 88998652111  11


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+           .+........+       ..+...+.+++.+||+.|| ++|||++|+++.|++
T Consensus       250 ~~-----------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp-~~Rps~~e~l~~L~~  296 (322)
T 1p4o_A          250 LR-----------FVMEGGLLDKP-------DNCPDMLFELMRMCWQYNP-KMRPSFLEIISSIKE  296 (322)
T ss_dssp             HH-----------HHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHGG
T ss_pred             HH-----------HHHcCCcCCCC-------CCCCHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHH
Confidence            11           11111111111       1223457899999999999 999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.9e-39  Score=342.77  Aligned_cols=252  Identities=25%  Similarity=0.405  Sum_probs=202.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-------HHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-------RALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....       ...+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            468999999999999999999875 689999999864321       11267899999999999999999999997765 


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCc-----EEEee
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMV-----AHISD  760 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~-----~kL~D  760 (897)
                       ++||||+++++|.+++......+++..+..++.|++.||+||   |++|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999999988777899999999999999999999   7888  999999999999988776     99999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCcc--CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYG--TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      ||+++.....     .....||+.|+|||++  ....++.++||||+|+++|||++|+.||.............+     
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----  242 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----  242 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-----
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-----
Confidence            9999754321     2345799999999987  455678999999999999999999999976322211111111     


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ..........      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       243 ------~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 ------REEGLRPTIP------EDCPPRLRNVIELCWSGDP-KKRPHFSYIVKELSE  286 (287)
T ss_dssp             ------HHSCCCCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             ------hccCCCCCCC------cccCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHHh
Confidence                  1111111000      1223457899999999999 999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.5e-40  Score=357.58  Aligned_cols=254  Identities=21%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCce----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGME----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357999999999999999999865 4554    7777765332 223356678999999999999999999986 45688


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999987766789999999999999999999   788999999999999999999999999999998765


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........||..|+|||++.+..++.++||||||+++|||++ |+.||......  .            ..+.+...
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~------------~~~~~~~~  233 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--E------------VPDLLEKG  233 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--H------------HHHHHHTT
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--H------------HHHHHHcC
Confidence            544444445668889999999988899999999999999999999 99999763211  1            11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....+      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       234 ~~~~~~------~~~~~~~~~li~~~l~~dp-~~Rps~~el~~~l~  272 (325)
T 3kex_A          234 ERLAQP------QICTIDVYMVMVKCWMIDE-NIRPTFKELANEFT  272 (325)
T ss_dssp             CBCCCC------TTBCTTTTHHHHHHTCSCT-TTSCCHHHHHHHHH
T ss_pred             CCCCCC------CcCcHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            110000      0112346789999999999 99999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.1e-39  Score=359.12  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=197.5

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcC--CCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIR--HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999998644  2445678899999999997  599999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      | +.+++|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++ ++.+||+|||+++.......
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999998765 588999999999999999999   899999999999999995 57999999999987654433


Q ss_pred             eeeeeccccCcccCCcCccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchH
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-----------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........            .
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------------~  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------L  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------------H
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH------------H
Confidence            333345679999999998754           46889999999999999999999999753211111            1


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..+++.......+.      ....++.+++.+||+.|| ++|||++|+++.
T Consensus       278 ~~~~~~~~~~~~~~------~~~~~~~~li~~~L~~dP-~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDP-KQRISIPELLAH  321 (390)
T ss_dssp             HHHHCTTSCCCCCC------CSCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             HHHhCccccCCCCc------cchHHHHHHHHHHcccCh-hhCCCHHHHhhC
Confidence            12222211111110      012347899999999999 999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.3e-39  Score=357.84  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|..+++++ +||||+++++++.+++..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999876 58899999998653   23345678899999887 79999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999887654 589999999999999999999   8899999999999999999999999999999863322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...     ........+.+...-.
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-----~~~~~~~~~~i~~~~~  279 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVILEKQI  279 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------CCHHHHHHHHHHCCC
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-----hhhHHHHHHHHhcccc
Confidence            2  12345679999999999999999999999999999999999999996422111000     0000001111111100


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      ..+.       ....++.+++.+||+.|| ++||++
T Consensus       280 ~~p~-------~~s~~~~~li~~lL~~dP-~~R~~~  307 (396)
T 4dc2_A          280 RIPR-------SLSVKAASVLKSFLNKDP-KERLGC  307 (396)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSCT-TTSTTC
T ss_pred             CCCC-------cCCHHHHHHHHHHhcCCH-hHcCCC
Confidence            1111       123457899999999999 999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.9e-39  Score=352.07  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             cCCHHHHHHHhcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccce
Q 045539          606 RFSYHELLRATDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVK  677 (897)
Q Consensus       606 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~  677 (897)
                      .+...++....++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345556666678999999999999999999974      346889999997643 33456789999999999 6999999


Q ss_pred             EeeeecCCC-ceEEEEEeccCCChhHhhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCcEeC
Q 045539          678 IISSCSNDD-FKALIMKYMPNGSLENCLYSGTCM---------------LDIFQRLNIMIDVALALEYLHFGHSTPIIHC  741 (897)
Q Consensus       678 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~  741 (897)
                      +++++...+ ..++||||+++++|.+++......               +++..+..++.|++.||+||   |++||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCcccc
Confidence            999987654 589999999999999999876432               78999999999999999999   78999999


Q ss_pred             CCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCc
Q 045539          742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTD  820 (897)
Q Consensus       742 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~  820 (897)
                      ||||+||+++.++.+||+|||.+................||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987655444444445568899999999988899999999999999999998 999987


Q ss_pred             ccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          821 EIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...... ..            ...+.........      .....++.+++.+||+.|| ++|||++||++.|+
T Consensus       253 ~~~~~~-~~------------~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~  306 (316)
T 2xir_A          253 GVKIDE-EF------------CRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEP-SQRPTFSELVEHLG  306 (316)
T ss_dssp             TCCCSH-HH------------HHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ccchhH-HH------------HHHhccCccCCCC------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            632111 11            1111111000000      0122457889999999999 99999999999885

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-39  Score=359.90  Aligned_cols=254  Identities=26%  Similarity=0.278  Sum_probs=197.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHH-HHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEV-MKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|..+ ++.++||||+++++++.+++..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999876 58899999997653   2234556677776 467899999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||++||+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987654 588999999999999999999   8899999999999999999999999999999864322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     +.        ...++.....
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~--------~~~i~~~~~~  257 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EM--------YDNILNKPLQ  257 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----HH--------HHHHHHSCCC
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HH--------HHHHHhcccC
Confidence            2  1234567999999999999999999999999999999999999999752111     00        1111111111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCCCC
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDPNP  897 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~~~  897 (897)
                      -..        .....+.+++.+|++.|| ++||++.+.++++.++|
T Consensus       258 ~~~--------~~~~~~~~li~~lL~~dp-~~R~~~~~~~~~i~~h~  295 (373)
T 2r5t_A          258 LKP--------NITNSARHLLEGLLQKDR-TKRLGAKDDFMEIKSHV  295 (373)
T ss_dssp             CCS--------SSCHHHHHHHHHHTCSSG-GGSTTTTTTHHHHHTSG
T ss_pred             CCC--------CCCHHHHHHHHHHcccCH-HhCCCCCCCHHHHhCCc
Confidence            000        122457889999999999 99999976666666554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.4e-39  Score=350.11  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=193.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEe----cCCceEEEEEechhh----HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY----ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|++++..    ......+.+|++++++++||||+++++++.+++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    468999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987654 588999999999999999999   7889999999999999999999999999998764


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..        ...+...
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~--------~~~i~~~  236 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KT--------IDKILKC  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HH--------HHHHHHT
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HH--------HHHHHhC
Confidence            3222  1233457999999999998889999999999999999999999999752111     00        1111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      ... .+.       ....++.+++.+||+.|| ++||     +++|+++
T Consensus       237 ~~~-~p~-------~~~~~~~~li~~~L~~dp-~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KLN-LPP-------YLTQEARDLLKKLLKRNA-ASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCC-CCT-------TSCHHHHHHHHHHSCSCG-GGSTTSSTTTHHHHHH
T ss_pred             CCC-CCC-------CCCHHHHHHHHHHHhcCH-hhccCCCCCCHHHHHc
Confidence            111 011       123457899999999999 9999     7778765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.8e-39  Score=349.01  Aligned_cols=258  Identities=20%  Similarity=0.274  Sum_probs=187.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            568999999999999999999875 589999999875432 234677899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          694 YMPNGSLENCLYSGT-----CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |++ ++|.+++....     ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 58988876432     3589999999999999999999   78999999999999999999999999999998764


Q ss_pred             CCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--c---------
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--L---------  836 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--~---------  836 (897)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ........  .         
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence            3221  1234568999999998866 468999999999999999999999997532111 11111100  0         


Q ss_pred             -------------CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          837 -------------LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       837 -------------~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                   .+....+.+.+....          ....++.+++.+|++.|| ++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~l~~li~~~L~~dP-~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKE----------PLDGNLMDFLHGLLQLNP-DMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSS----------CCCHHHHHHHHHHSCSSG-GGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccc----------cCCHHHHHHHHHHCCCCc-ccCCCHHHHhC
Confidence                         000011111111111          123458899999999999 99999999976

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=350.96  Aligned_cols=265  Identities=25%  Similarity=0.357  Sum_probs=199.4

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc--CCCccceEeeeecCC---
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI--RHRNLVKIISSCSND---  685 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~---  685 (897)
                      .-....++|++.+.||+|+||.||+|++. |+.||||++.....   ..+.+|.+++...  +||||+++++++.+.   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445679999999999999999999886 89999999875432   3344555666555  899999999999776   


Q ss_pred             -CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CcEeCCCCCCCeeeCCCCcE
Q 045539          686 -DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST--------PIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       686 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~--------~ivH~Dlkp~NIll~~~~~~  756 (897)
                       ...++||||+++|+|.+++....  +++..+..++.|++.||+||   |++        ||+||||||+||+++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHL---HTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHH---HHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             67899999999999999997754  89999999999999999999   555        99999999999999999999


Q ss_pred             EEeeccCccccCCCCcee--eeeccccCcccCCcCccCCCCCCcc------chHHHHHHHHHHHHcC----------CCC
Q 045539          757 HISDFGIAKLLSGEDQLS--IQIQTLATIGYMAPEYGTKGRVCTR------GDVYSYGIMLMEMFTK----------KKP  818 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~slGvil~elltg----------~~p  818 (897)
                      ||+|||++..........  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997664332211  1124469999999999877766655      9999999999999999          445


Q ss_pred             CcccccCccchhHHhhhcCCchHHHHhh-hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          819 TDEIFIGELSLNRWINDLLPVSVMEVID-TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       819 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      |............         ..+.+. .......+... ...++..++.+++.+||+.|| ++|||++||++.|++
T Consensus       262 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          262 YHDLVPSDPSYED---------MREIVCIKKLRPSFPNRW-SSDECLRQMGKLMTECWAHNP-ASRLTALRVKKTLAK  328 (337)
T ss_dssp             TTTTSCSSCCHHH---------HHHHHTTSCCCCCCCGGG-GGSHHHHHHHHHHHHHSCSSG-GGSCCHHHHHHHHHH
T ss_pred             HhhhcCCCCchhh---------hHHHHhhhccCccccccc-hhhHHHHHHHHHHHHhhhhCh-hhCCCHHHHHHHHHH
Confidence            5432222111111         111111 11111111111 112456778999999999999 999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.7e-39  Score=373.33  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=209.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|++.. ++.||||+++... ...+.+.+|++++++++||||++++++|.+++..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            35678999999999999999998874 8899999997543 235778999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            999999999997643 5689999999999999999999   88999999999999999999999999999998765332 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........+++.|+|||++....++.++|||||||++|||++ |+.||......              ...+.+......
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------------~~~~~~~~~~~~  438 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYELLEKDYRM  438 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------------GHHHHHHTTCCC
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCCCC
Confidence            222233456788999999988889999999999999999999 99998763211              111222221111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..+      ..+..++.+++.+||+.|| ++|||++||++.|++
T Consensus       439 ~~~------~~~~~~l~~li~~cl~~dP-~~RPs~~el~~~L~~  475 (495)
T 1opk_A          439 ERP------EGCPEKVYELMRACWQWNP-SDRPSFAEIHQAFET  475 (495)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             CCC------CCCCHHHHHHHHHHcCcCh-hHCcCHHHHHHHHHH
Confidence            111      1233457899999999999 999999999998864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=341.76  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=185.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999874 689999999975532   2347789999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999988767799999999999999999999   78999999999999999999999999999998764322


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  ......||+.|+|||...+..++.++||||||+++|||++|+.||.......     ...        ........ 
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~--------~~~~~~~~-  230 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLN--------KVVLADYE-  230 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCCC-
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHH--------HHhhcccC-
Confidence            1  1223568999999999988889999999999999999999999997532111     000        00000000 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.       ....++.+++.+|++.|| ++|||++|+++
T Consensus       231 ~~~-------~~~~~~~~li~~~l~~dp-~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPS-------FLSIEAKDLIHQLLRRNP-ADRLSLSSVLD  262 (278)
T ss_dssp             CCT-------TSCHHHHHHHHHHSCSSG-GGSCCHHHHTT
T ss_pred             Ccc-------ccCHHHHHHHHHHcccCH-hhCCCHHHHhc
Confidence            000       122357889999999999 99999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-39  Score=349.68  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=210.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4678999999999999999999876 48899999987543 345778899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999997643 5689999999999999999999   788999999999999999999999999999987654332


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                       .......+|+.|+|||...+..++.++||||||+++|+|++ |..||......  .            ..+.+......
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~------------~~~~~~~~~~~  231 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q------------VYELLEKDYRM  231 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G------------HHHHHHTTCCC
T ss_pred             -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H------------HHHHHhccCCC
Confidence             33344567889999999988899999999999999999999 99998753211  1            11222211111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...      ..+..++.+++.+|++.|| ++|||++|+++.|+
T Consensus       232 ~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          232 ERP------EGCPEKVYELMRACWQWNP-SDRPSFAEIHQAFE  267 (288)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHhCCCh-hhCcCHHHHHHHHH
Confidence            111      1223457899999999999 99999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-38  Score=355.67  Aligned_cols=271  Identities=20%  Similarity=0.274  Sum_probs=193.4

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCC--c
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIR-HRNLVKIISSCSNDD--F  687 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  687 (897)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++++. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            45679999999999999999999865 6899999998643  2344567889999999997 999999999996543  7


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||++ ++|.+++...  .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+|+..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 6899988775  489999999999999999999   8899999999999999999999999999999865


Q ss_pred             CCCC-------------------ceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          768 SGED-------------------QLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       768 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ....                   .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            3211                   1112334579999999998876 67899999999999999999999999753211 1


Q ss_pred             chhHHhhhc-----------CCchHHHHhhhhh------cchhhhhHHHHH----------HHHHHHHHHHhHccCCCCC
Q 045539          828 SLNRWINDL-----------LPVSVMEVIDTNL------LRGEERFFAAKE----------QILLSVLNLATECTIESRD  880 (897)
Q Consensus       828 ~~~~~~~~~-----------~~~~~~~~i~~~l------~~~~~~~~~~~~----------~~~~~l~~l~~~cl~~dP~  880 (897)
                      .+...+...           ........++...      .......++...          .+..++.+++.+||+.|| 
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP-  317 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP-  317 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG-
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc-
Confidence            111111100           0000111111000      000000011111          223468899999999999 


Q ss_pred             CCCCCHHHHHhh
Q 045539          881 GNGADMGWIFSA  892 (897)
Q Consensus       881 ~~RPt~~evl~~  892 (897)
                      ++|||++|+++.
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-38  Score=349.92  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++..   ....+.+.+|..+++++ +||||+++++++.+++..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999876 58999999997653   34456788999999988 79999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999987654 589999999999999999999   8899999999999999999999999999999864322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........     ........+.+...-.
T Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~i~~~~~  236 (345)
T 3a8x_A          164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVILEKQI  236 (345)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHHHHHHHHCCC
T ss_pred             CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-----cccHHHHHHHHHcCCC
Confidence            21  2334579999999999999999999999999999999999999996521110000     0000001111111100


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      .-+.       ....++.+++.+||+.|| ++||++
T Consensus       237 ~~p~-------~~s~~~~~li~~lL~~dP-~~R~~~  264 (345)
T 3a8x_A          237 RIPR-------SLSVKAASVLKSFLNKDP-KERLGC  264 (345)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSST-TTSTTC
T ss_pred             CCCC-------CCCHHHHHHHHHHhcCCH-hHCCCC
Confidence            0111       123457889999999999 999996

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-38  Score=359.49  Aligned_cols=201  Identities=23%  Similarity=0.387  Sum_probs=169.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----Cc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  687 (897)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++...  ....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            569999999999999999999875 58899999997532  34557889999999999999999999999766     57


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||++ ++|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999985 69999987654 589999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCce--------------------eeeeccccCcccCCcCcc-CCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          768 SGEDQL--------------------SIQIQTLATIGYMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       768 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ......                    ......+||+.|+|||++ ....++.++||||+||++|||++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            533221                    123456799999999975 566799999999999999999997766643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.9e-39  Score=351.80  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=201.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  689 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|.++++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999876 48899999998653   23456778899999988 7999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||++||+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987654 489999999999999999999   889999999999999999999999999999986432


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..           ...+.....
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~-----------~~~i~~~~~  238 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL-----------FQSIMEHNV  238 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH-----------HHHHHHCCC
T ss_pred             CCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HH-----------HHHHHhCCC
Confidence            221  233457999999999999999999999999999999999999999752111  00           011111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      . .+       .....++.+++.+|++.|| ++||+     ++|+++
T Consensus       239 ~-~p-------~~~s~~~~~li~~lL~~dP-~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 A-YP-------KSMSKEAVAICKGLMTKHP-GKRLGCGPEGERDIKE  276 (353)
T ss_dssp             C-CC-------TTSCHHHHHHHHHHTCSCT-TSCTTCSTTHHHHHHT
T ss_pred             C-CC-------CCCCHHHHHHHHHHhhcCH-HHcCCCCCCCHHHHhc
Confidence            0 01       0123457899999999999 99995     466654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-39  Score=352.27  Aligned_cols=267  Identities=22%  Similarity=0.370  Sum_probs=206.6

Q ss_pred             cCC-CcCCeeecccceEEEEEEec-----CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCc
Q 045539          617 DRF-SENNLIGIGSFGSIYVARLQ-----DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDF  687 (897)
Q Consensus       617 ~~y-~~~~~lg~G~~g~Vy~a~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  687 (897)
                      ++| ++.+.||+|+||.||++.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            345 89999999999999988642     58899999998653 3456788999999999999999999999976  457


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .++||||+++++|.+++....  +++.++..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||.+...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            899999999999999998765  89999999999999999999   8899999999999999999999999999999887


Q ss_pred             CCCCce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC-chHHHHh
Q 045539          768 SGEDQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP-VSVMEVI  845 (897)
Q Consensus       768 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~i  845 (897)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++|+.||............+...... ....+.+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            644332 22334467888999999988889999999999999999999999987532111000000000000 0111222


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .........      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       265 ~~~~~~~~~------~~~~~~l~~li~~~l~~dP-~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          265 ERGERLPRP------DKCPAEVYHLMKNCWETEA-SFRPTFENLIPILKT  307 (318)
T ss_dssp             HTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             hcccCCCCC------ccccHHHHHHHHHHcCCCc-ccCcCHHHHHHHHHH
Confidence            211111111      1234568899999999999 999999999998853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.2e-39  Score=350.09  Aligned_cols=269  Identities=19%  Similarity=0.239  Sum_probs=200.3

Q ss_pred             hcCCCcC-CeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSEN-NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678874 78999999999999865 6899999999766545567888999999995 6999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc---EEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~---~kL~DFg~a~~~~~  769 (897)
                      ||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999987654 589999999999999999999   7889999999999999998775   99999999876542


Q ss_pred             CCc-----eeeeeccccCcccCCcCccCC-----CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          770 EDQ-----LSIQIQTLATIGYMAPEYGTK-----GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       770 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      ...     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+..   |.......
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~  243 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---WDRGEACP  243 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---C----CCH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---ccccccch
Confidence            211     111223458999999998764     56789999999999999999999999764322211   10000000


Q ss_pred             h-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          840 S-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       840 ~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      . ...+.....................++.+++.+|++.|| ++|||++|+++.
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA-KQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSST-TTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCCh-hhCCCHHHHhcC
Confidence            0 111111111111110011112344568899999999999 999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=353.57  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCce----EEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGME----VAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999864 4554    4666664332 334578899999999999999999999998765 78


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +|+||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999988777799999999999999999999   789999999999999999999999999999987754


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .            ....+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~------------~~~~~~~~  235 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E------------ISSILEKG  235 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G------------HHHHHHTT
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--H------------HHHHHHcC
Confidence            443333444567889999999988899999999999999999999 99999763221  1            11222211


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       236 ~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~  274 (327)
T 3lzb_A          236 ERLPQP------PICTIDVYMIMRKCWMIDA-DSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCCC------TTBCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCCC------ccCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHH
Confidence            111110      1123457889999999999 99999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.1e-39  Score=356.80  Aligned_cols=253  Identities=23%  Similarity=0.250  Sum_probs=192.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            568999999999999999999876 689999999875432 235678999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc--EEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~~~~~~~  772 (897)
                      +++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.  +||+|||+++...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999987644 589999999999999999999   8899999999999999987765  9999999997543221 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCcc-chHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTR-GDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                        ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||....... ..            ...+......
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~------------~~~~~~~~~~  237 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DY------------RKTIQRILSV  237 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CH------------HHHHHHHHTT
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HH------------HHHHHHHhcC
Confidence              2234569999999999877777655 899999999999999999997632211 11            1111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...  .+.......++.+++.+||+.|| ++|||++|+++.
T Consensus       238 ~~~--~~~~~~~s~~~~~li~~~L~~dP-~~Rps~~ell~h  275 (361)
T 3uc3_A          238 KYS--IPDDIRISPECCHLISRIFVADP-ATRISIPEIKTH  275 (361)
T ss_dssp             CCC--CCTTSCCCHHHHHHHHHHSCSCT-TTSCCHHHHHTS
T ss_pred             CCC--CCCcCCCCHHHHHHHHHHccCCh-hHCcCHHHHHhC
Confidence            000  00000122457899999999999 999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.2e-39  Score=341.12  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC--CceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND--DFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|++. ++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            468999999999999999999986 8999999987543  34557899999999999999999999999877  788999


Q ss_pred             EEeccCCChhHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTC-MLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |||+++++|.+++..... .+++.++..++.|++.||+||   |++|  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987653 589999999999999999999   8888  9999999999999999999999999876533


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCc---cchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCT---RGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ..       ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||........             .....
T Consensus       165 ~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~  224 (271)
T 3kmu_A          165 SP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------------GMKVA  224 (271)
T ss_dssp             CT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------------HHHHH
T ss_pred             cc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------------HHHHH
Confidence            22       345899999999987655544   79999999999999999999975321110             01111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ........+      ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       225 ~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          225 LEGLRPTIP------PGISPHVSKLMKICMNEDP-AKRPKFDMIVPILEK  267 (271)
T ss_dssp             HSCCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             hcCCCCCCC------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence            111110000      1123457899999999999 999999999998863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-39  Score=346.26  Aligned_cols=253  Identities=23%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..++|++.+.||+|+||.||+|+..+++.||+|+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            457899999999999999999998888899999987543 234678899999999999999999999875 458999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++.... ..+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||.+....... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            99999999987543 2589999999999999999999   88999999999999999999999999999998765332 2


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||......  ...            ..+.......
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~------------~~~~~~~~~~  230 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI------------QNLERGYRMV  230 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH------------HHHHTTCCCC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHH------------HHHhcccCCC
Confidence            22233456789999999888889999999999999999999 89998752111  111            1111110000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ..      ..+..++.+++.+|++.|| ++|||++++++.|+
T Consensus       231 ~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          231 RP------DNCPEELYQLMRLCWKERP-EDRPTFDYLRSVLE  265 (279)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             Cc------ccccHHHHHHHHHHhccCh-hhCCCHHHHHHHHH
Confidence            00      1123457899999999999 99999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-38  Score=359.88  Aligned_cols=247  Identities=24%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999876 799999999976532   2356789999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999987654 589999999999999999999   89999999999999999999999999999998765432


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......  ...           ..+.+... 
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~-----------~~i~~~~~-  233 (476)
T 2y94_A          171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLF-----------KKICDGIF-  233 (476)
T ss_dssp             C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHH-----------HHHHTTCC-
T ss_pred             c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHH-----------HHHhcCCc-
Confidence            2   234569999999999887765 78999999999999999999999752111  111           11111111 


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+.       ....++.+++.+||+.|| ++|||++|+++
T Consensus       234 ~~p~-------~~s~~~~~Li~~~L~~dP-~~Rpt~~eil~  266 (476)
T 2y94_A          234 YTPQ-------YLNPSVISLLKHMLQVDP-MKRATIKDIRE  266 (476)
T ss_dssp             CCCT-------TCCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             CCCc-------cCCHHHHHHHHHHcCCCc-hhCcCHHHHHh
Confidence            1111       122347889999999999 99999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.2e-39  Score=365.15  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-ceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-FKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|++. |+.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..|+||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            468889999999999999999886 7899999998653  3467899999999999999999999986654 78999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            99999999998654 3479999999999999999999   8899999999999999999999999999999854322   


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .            ....+.......
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~------------~~~~i~~~~~~~  406 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D------------VVPRVEKGYKMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--T------------HHHHHHTTCCCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H------------HHHHHHcCCCCC
Confidence              112357889999999999999999999999999999998 99999763211  1            111111111100


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       407 ~p------~~~~~~l~~li~~cl~~dp-~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          407 AP------DGCPPAVYDVMKNCWHLDA-ATRPTFLQLREQLE  441 (450)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CC------CcCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHH
Confidence            10      1233567899999999999 99999999999885

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-38  Score=351.14  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=206.9

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhc-CCCccceE
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--------ERALKSFEDECEVMKRI-RHRNLVKI  678 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l  678 (897)
                      ........++|++.+.||+|+||.||+|+.. +|+.||||+++...        ....+.+.+|+++++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556678999999999999999999876 69999999986432        22356788999999999 79999999


Q ss_pred             eeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       679 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      ++++...+..|+||||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999987653 589999999999999999999   7889999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccC------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW  832 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~  832 (897)
                      +|||++........   .....||+.|+|||++.      ...++.++|||||||++|||++|+.||......  .... 
T Consensus       242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~-  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLR-  315 (365)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-
T ss_pred             EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHH-
Confidence            99999987654332   23457999999999864      336889999999999999999999999652110  0000 


Q ss_pred             hhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          833 INDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       833 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                .+.......    ..+........+.+++.+|++.|| ++|||++|+++
T Consensus       316 ----------~i~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP-~~Rps~~ell~  359 (365)
T 2y7j_A          316 ----------MIMEGQYQF----SSPEWDDRSSTVKDLISRLLQVDP-EARLTAEQALQ  359 (365)
T ss_dssp             ----------HHHHTCCCC----CHHHHSSSCHHHHHHHHHHSCSST-TTSCCHHHHHH
T ss_pred             ----------HHHhCCCCC----CCcccccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence                      111100000    011112234557899999999999 99999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.5e-39  Score=347.01  Aligned_cols=256  Identities=22%  Similarity=0.273  Sum_probs=197.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            578999999999999999999876 68999999997543   33457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999987654 589999999999999999999   88999999999999999999999999999997664332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      . .......|++.|+|||++.+..++.++||||||+++|||++|+.||......  .....+....+.            
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~------------  253 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR------------  253 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC------------
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC------------
Confidence            1 2223456899999999999999999999999999999999999999763211  111111111100            


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-CHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGA-DMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-t~~evl~~L~~  895 (897)
                      ..    .....+..++.+++.+||+.|| ++|| +++++++.|++
T Consensus       254 ~~----~~~~~~~~~l~~li~~~l~~dP-~~Rp~s~~~l~~~l~~  293 (309)
T 2h34_A          254 PS----TVRPGIPVAFDAVIARGMAKNP-EDRYVTCGDLSAAAHA  293 (309)
T ss_dssp             GG----GTSTTCCTHHHHHHHHHTCSSG-GGSCSSHHHHHHHHHH
T ss_pred             cc----ccCCCCCHHHHHHHHHhccCCH-HHHHHhHHHHHHHHHH
Confidence            00    0001223457889999999999 9999 99999998753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.8e-39  Score=346.41  Aligned_cols=249  Identities=20%  Similarity=0.309  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-C-------ceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-G-------MEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      .++|.+.+.||+|+||.||+|+... +       +.||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999997653 3       4699999987766667889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc--------EEEe
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--------AHIS  759 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~--------~kL~  759 (897)
                      .++||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999988776699999999999999999999   8899999999999999988876        9999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||.+......      ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+....... ..         
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~---------  227 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RK---------  227 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH---------
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HH---------
Confidence            99998765322      23458899999998877 678999999999999999999655543311110 00         


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         .......... +.       ....++.+++.+||+.|| ++|||++|+++.|++
T Consensus       228 ---~~~~~~~~~~-~~-------~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          228 ---LQFYEDRHQL-PA-------PKAAELANLINNCMDYEP-DHRPSFRAIIRDLNS  272 (289)
T ss_dssp             ---HHHHHTTCCC-CC-------CSSCTTHHHHHHHSCSSG-GGSCCHHHHHHHHHT
T ss_pred             ---HHHhhccCCC-CC-------CCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence               0000000000 00       012347889999999999 999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.7e-39  Score=342.06  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=201.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++..    +..||+|+++... ....+.+.+|++++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            5689999999999999999998642    3459999987652 34567899999999999999999999998764 5689


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999999987666799999999999999999999   8899999999999999999999999999999876533


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .. .......+++.|+|||+..+..++.++||||||+++|||++ |+.||......  .....            +....
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~------------~~~~~  231 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGV------------LEKGD  231 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHH------------HHHTC
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHH------------HhcCC
Confidence            22 12234457889999999988889999999999999999998 99999753211  11111            11110


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+      ..+...+.+++.+||+.|| ++|||++|+++.|+
T Consensus       232 ~~~~~------~~~~~~l~~li~~~l~~~p-~~Rps~~ell~~L~  269 (281)
T 3cc6_A          232 RLPKP------DLCPPVLYTLMTRCWDYDP-SDRPRFTELVCSLS  269 (281)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCC------CCCCHHHHHHHHHHccCCc-hhCcCHHHHHHHHH
Confidence            00000      0123457899999999999 99999999999885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=354.63  Aligned_cols=261  Identities=18%  Similarity=0.199  Sum_probs=197.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhhHH-----------HHHHHHHHHHHHHhcCCCccceEee
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQYER-----------ALKSFEDECEVMKRIRHRNLVKIIS  680 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  680 (897)
                      .++|++.+.||+|+||.||+|+..    ++..||+|++......           ..+.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999875    5788999998643211           1234667889999999999999999


Q ss_pred             eecC----CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC--
Q 045539          681 SCSN----DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM--  754 (897)
Q Consensus       681 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~--  754 (897)
                      ++.+    +...|+||||+ +++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCC
Confidence            9877    77899999999 999999988765 689999999999999999999   788999999999999998877  


Q ss_pred             cEEEeeccCccccCCCCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccch
Q 045539          755 VAHISDFGIAKLLSGEDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL  829 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~  829 (897)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211     11134468999999999998899999999999999999999999996532221111


Q ss_pred             hHHh---hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWI---NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~---~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....   ....+.....    ...         ......++.+++.+||+.|| ++|||++||++.|++
T Consensus       271 ~~~~~~~~~~~~~~~~~----~~~---------~~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLK----WAP---------SGSSCCEIAQFLVCAHSLAY-DEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHHHHHHHTTTHHHHH----HSC---------TTSCCHHHHHHHHHHHTCCT-TCCCCHHHHHHHHCT
T ss_pred             HHHHHhhcccccHHHHh----hcc---------ccccHHHHHHHHHHHhhcCc-ccCCCHHHHHHHHhc
Confidence            1110   0001100000    000         00233468999999999999 999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=342.45  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             hcCCCcCC-eeecccceEEEEEEec---CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENN-LIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            34666666 9999999999999754   57889999997643 34567889999999999999999999999 4556899


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999987766799999999999999999999   8899999999999999999999999999999877543


Q ss_pred             Ccee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      .... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  ...            ..+...
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~------------~~i~~~  229 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM------------AFIEQG  229 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH------------HHHHTT
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH------------HHHhcC
Confidence            3221 1223356889999999888889999999999999999998 99999753211  111            111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .....+      ..+..++.+++.+||+.|| ++||+++|+++.|+
T Consensus       230 ~~~~~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~l~  268 (287)
T 1u59_A          230 KRMECP------PECPPELYALMSDCWIYKW-EDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHH
T ss_pred             CcCCCC------CCcCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            000000      1223458899999999999 99999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=348.55  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=198.8

Q ss_pred             cCCCcCCeeecccceEEEEEEecC-----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQD-----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|+..+.||+|+||.||+|+...     +..||+|+++... ......+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999997652     2459999997543 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999988766799999999999999999999   7889999999999999999999999999999876533


Q ss_pred             Cce-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          771 DQL-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       771 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .            ..+.+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~------------~~~~~~~~  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E------------VMKAINDG  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H------------HHHHHHTT
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--H------------HHHHHHCC
Confidence            221 11223346788999999988899999999999999999999 99999652111  0            11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......      ..+..++.+++.+||+.|| ++||+++|+++.|+
T Consensus       267 ~~~~~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          267 FRLPTP------MDCPSAIYQLMMQCWQQER-ARRPKFADIVSILD  305 (333)
T ss_dssp             CCCCCC------TTCBHHHHHHHHHHTCSST-TTSCCHHHHHHHHH
T ss_pred             CcCCCc------ccCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            000000      1223457899999999999 99999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.5e-38  Score=338.07  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            578999999999999999999876 578899999875432   2356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999999999987654 489999999999999999999   89999999999999999999999999999986543222


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                          .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||......  .            ....+......
T Consensus       164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~------------~~~~~~~~~~~  225 (279)
T 3fdn_A          164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--E------------TYKRISRVEFT  225 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H------------HHHHHHHTCCC
T ss_pred             ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--H------------HHHHHHhCCCC
Confidence                23456899999999999989999999999999999999999999752111  0            00111100000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+.       .....+.+++.+|++.|| ++|||++|+++.
T Consensus       226 ~~~-------~~~~~~~~li~~~l~~~p-~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPD-------FVTEGARDLISRLLKHNP-SQRPMLREVLEH  258 (279)
T ss_dssp             CCT-------TSCHHHHHHHHHHCCSSG-GGSCCHHHHHHC
T ss_pred             CCC-------cCCHHHHHHHHHHhccCh-hhCCCHHHHhhC
Confidence            010       122457889999999999 999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-38  Score=351.51  Aligned_cols=247  Identities=25%  Similarity=0.334  Sum_probs=199.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688999999999999999986 47899999998643   234457789999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||++ |++.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++...... 
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            99997 688888765556799999999999999999999   7889999999999999999999999999999875432 


Q ss_pred             ceeeeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          772 QLSIQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                           ....||+.|+|||++   ..+.++.++|||||||++|||++|+.||....... ..........+         .
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~---------~  272 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------A  272 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------C
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------C
Confidence                 234699999999986   35778999999999999999999999986521110 00011100000         0


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...         ......+.+++.+||+.|| ++|||++|+++.
T Consensus       273 ~~~---------~~~~~~l~~li~~~l~~dP-~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 LQS---------GHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKH  306 (348)
T ss_dssp             CCC---------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHTTC
T ss_pred             CCC---------CCCCHHHHHHHHHHcccCh-hhCcCHHHHhhC
Confidence            000         0122347889999999999 999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-38  Score=339.34  Aligned_cols=251  Identities=19%  Similarity=0.268  Sum_probs=201.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH------HHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++....      ...+.+.+|++++++++||||+++++++.+++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999876 689999999875421      1357789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a  764 (897)
                      ++||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999987644 589999999999999999999   789999999999999998877    8999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ........   .....|++.|+|||++....++.++||||||+++|+|++|+.||......  ...           ..+
T Consensus       160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-----------~~~  223 (283)
T 3bhy_A          160 HKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETL-----------TNI  223 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH-----------HHH
T ss_pred             eeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHH-----------HHh
Confidence            87643322   23446899999999999889999999999999999999999999752111  000           000


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..... ...   ..........+.+++.+|++.|| ++|||++|+++
T Consensus       224 ~~~~~-~~~---~~~~~~~~~~~~~li~~~l~~dp-~~Rps~~~~l~  265 (283)
T 3bhy_A          224 SAVNY-DFD---EEYFSNTSELAKDFIRRLLVKDP-KRRMTIAQSLE  265 (283)
T ss_dssp             HTTCC-CCC---HHHHTTCCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             Hhccc-CCc---chhcccCCHHHHHHHHHHccCCH-hHCcCHHHHHh
Confidence            00000 000   11112234557899999999999 99999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-38  Score=344.68  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=201.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3568999999999999999999876 689999999986554445678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||.+......
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999887654 589999999999999999999   78999999999999999   78889999999998764322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .    .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......  ...+.+           ......
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i-----------~~~~~~  225 (304)
T 2jam_A          163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKI-----------KEGYYE  225 (304)
T ss_dssp             T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH-----------HHCCCC
T ss_pred             c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-----------HcCCCC
Confidence            1    22346899999999999999999999999999999999999999752111  111111           110000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ...    +.......++.+++.+|++.|| ++|||++|+++
T Consensus       226 ~~~----~~~~~~~~~~~~li~~~l~~dp-~~Rps~~~~l~  261 (304)
T 2jam_A          226 FES----PFWDDISESAKDFICHLLEKDP-NERYTCEKALS  261 (304)
T ss_dssp             CCT----TTTTTSCHHHHHHHHHHHCSST-TTSCCHHHHHT
T ss_pred             CCc----cccccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence            000    0001223457899999999999 99999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5e-39  Score=367.17  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=201.5

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            456899999999999999999999888889999998643 234678999999999999999999999976 678999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++|+|.+++.... ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997532 4589999999999999999999   88999999999999999999999999999998765322 1


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      .......++..|+|||.+..+.++.++|||||||++|||++ |+.||......              ...+.+.......
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------------~~~~~i~~~~~~~  401 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------------EVLDQVERGYRMP  401 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------HHHHHHHTTCCCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCCCCC
Confidence            22233457889999999988899999999999999999999 99998753211              0111111111100


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .+      ..+...+.+++.+||+.|| ++|||+++|++.|++
T Consensus       402 ~~------~~~~~~l~~li~~cl~~dP-~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          402 CP------PECPESLHDLMCQCWRKEP-EERPTFEYLQAFLED  437 (452)
T ss_dssp             CC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             CC------CCCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            00      1234567899999999999 999999999998864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-38  Score=345.47  Aligned_cols=258  Identities=22%  Similarity=0.397  Sum_probs=194.6

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec----CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC-
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDD-  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  686 (897)
                      ...++|.+.+.||+|+||.||+|+..    +++.||+|+++..  .....+.+.+|++++++++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578999999999999999999754    3457999998754  2445577899999999999999999999997655 


Q ss_pred             ----ceEEEEEeccCCChhHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEE
Q 045539          687 ----FKALIMKYMPNGSLENCLYS-----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAH  757 (897)
Q Consensus       687 ----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~k  757 (897)
                          ..++||||+++++|.+++..     ....+++..++.++.|+++||+||   |++||+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEE
Confidence                35999999999999999843     235689999999999999999999   889999999999999999999999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhc
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      |+|||++................+++.|+|||...+..++.++||||||+++|||++ |..||......  .....+   
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~---  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL---  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH---
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH---
Confidence            999999987654433333344567889999999988899999999999999999999 88898653211  111111   


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                              ........+       ..+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       263 --------~~~~~~~~~-------~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          263 --------LHGHRLKQP-------EDCLDELYEIMYSCWRTDP-LDRPTFSVLRLQLEK  305 (313)
T ss_dssp             --------HTTCCCCCB-------TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHHH
T ss_pred             --------HcCCCCCCC-------ccccHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence                    111000111       1223457899999999999 999999999998853

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=342.95  Aligned_cols=268  Identities=22%  Similarity=0.261  Sum_probs=199.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            368999999999999999999876 58999999886443  334567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus        82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            9999999998876554 589999999999999999999   889999999999999999999999999999987653322


Q ss_pred             eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh---cCCchHHHHhhhh
Q 045539          773 LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND---LLPVSVMEVIDTN  848 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~  848 (897)
                        ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+  ....+..   .............
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhcccccccccccccc
Confidence              2234568999999998765 678999999999999999999999997632211  1111100   0000000100000


Q ss_pred             -h-----cchh---hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          849 -L-----LRGE---ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       849 -l-----~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       .     ...+   .............+.+++.+||+.|| ++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP-TERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSST-TTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCCh-hhcCCHHHHhcC
Confidence             0     0000   00000111234557899999999999 999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.6e-38  Score=346.70  Aligned_cols=272  Identities=23%  Similarity=0.332  Sum_probs=209.6

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHh--cCCCccceEeeeecC
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKR--IRHRNLVKIISSCSN  684 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  684 (897)
                      .++..-....++|++.+.||+|+||.||+|++. |+.||||++....   .+.+.+|+++++.  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            334444556789999999999999999999885 8999999997543   3566788888888  689999999999987


Q ss_pred             CC----ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEeCCCCCCCeeeCCCCc
Q 045539          685 DD----FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       685 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      .+    ..++||||+++|+|.+++....  +++.++..++.|++.||+|||.     .|++||+||||||+||+++.++.
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            76    7899999999999999998754  8999999999999999999941     11899999999999999999999


Q ss_pred             EEEeeccCccccCCCCcee--eeeccccCcccCCcCccCCC------CCCccchHHHHHHHHHHHHcC----------CC
Q 045539          756 AHISDFGIAKLLSGEDQLS--IQIQTLATIGYMAPEYGTKG------RVCTRGDVYSYGIMLMEMFTK----------KK  817 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvil~elltg----------~~  817 (897)
                      +||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765443321  12345689999999987765      334789999999999999999          66


Q ss_pred             CCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          818 PTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       818 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ||............+..        .+....+....+.++. ..++...+.+++.+||+.|| ++|||++||++.|+
T Consensus       266 p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp-~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRK--------VVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANG-AARLTALRIKKTLS  332 (342)
T ss_dssp             TTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCGGGG-TSHHHHHHHHHHHHHCCSSG-GGSCCHHHHHHHHH
T ss_pred             CccccCcCcccHHHHHH--------HHHHHHhCCCCccccc-chhHHHHHHHHHHHHhccCh-hhCCCHHHHHHHHH
Confidence            77653332222222211        1111112111111111 12445678999999999999 99999999999885

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=347.66  Aligned_cols=258  Identities=21%  Similarity=0.265  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeec----CCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS----NDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999987 468999999987665666788999999999999999999999986    3457899


Q ss_pred             EEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      ||||+++++|.+++..   ....+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999998875   345689999999999999999999   7889999999999999999999999999998764


Q ss_pred             CCCCcee-------eeeccccCcccCCcCccCCCC---CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          768 SGEDQLS-------IQIQTLATIGYMAPEYGTKGR---VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       768 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      .......       ......||+.|+|||++....   ++.++||||||+++|||++|+.||................  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            3111000       011235799999999876543   6889999999999999999999997633222221111111  


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                .......      .....++.+++.+||+.|| ++|||++|+++.|++
T Consensus       263 ----------~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~L~~  303 (317)
T 2buj_A          263 ----------QLSIPQS------PRHSSALWQLLNSMMTVDP-HQRPHIPLLLSQLEA  303 (317)
T ss_dssp             ----------C--CCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ----------cCCCCcc------ccCCHHHHHHHHHHhhcCh-hhCCCHHHHHHHhhh
Confidence                      1000000      1123458899999999999 999999999999854

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=344.25  Aligned_cols=269  Identities=22%  Similarity=0.283  Sum_probs=197.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-----HHHHHHHHHHHHHHHhcC---CCccceEeeeecCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIR---HRNLVKIISSCSND  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  685 (897)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|+++...     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4679999999999999999999864 68999999986432     111245567777777765   99999999999765


Q ss_pred             C-----ceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEe
Q 045539          686 D-----FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHIS  759 (897)
Q Consensus       686 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~  759 (897)
                      .     ..++||||++ ++|.+++.... ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999996 59999987765 3489999999999999999999   88999999999999999999999999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc--C
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL--L  837 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~  837 (897)
                      |||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........  .
T Consensus       163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            9999987643322   234578999999999988899999999999999999999999997532111 111111000  0


Q ss_pred             Cch-HH---HHhhhhhcch-hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          838 PVS-VM---EVIDTNLLRG-EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       838 ~~~-~~---~~i~~~l~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.. ..   .......... +........+...++.+++.+|++.|| ++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP-HKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCC-ccCCCHHHHhcC
Confidence            000 00   0000000000 000001111234567899999999999 999999999863

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.2e-38  Score=377.65  Aligned_cols=370  Identities=18%  Similarity=0.180  Sum_probs=215.2

Q ss_pred             cCCCCCCCCcc----eeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEe
Q 045539           55 RNWTSSTSVCS----WIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLY  130 (897)
Q Consensus        55 ~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  130 (897)
                      ++|..+.+||.    |.++.|+.   ++   +-.....  ..+..-..+++++.|++++|.+++..+..|.++++|++|+
T Consensus        10 ~~~~~~~~C~~~~~~~~c~~~~~---~i---~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~   81 (597)
T 3oja_B           10 KPRQPEYKCIDSNLQYDCVFYDV---HI---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN   81 (597)
T ss_dssp             -CCCSEECCCCC--CCSEEECSC---EE---CSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEE
T ss_pred             cCCCCCCcCcccCcCceeEecCc---ee---ccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEE
Confidence            48988888874    76666642   11   1111111  1111122467788888888888755555677888888888


Q ss_pred             ccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccc
Q 045539          131 FSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSG  210 (897)
Q Consensus       131 Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  210 (897)
                      |++|.+.+.++..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++++++..|.++++|++|+|++|.++ 
T Consensus        82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~-  160 (597)
T 3oja_B           82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-  160 (597)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred             CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC-
Confidence            8888887777777777777777777777777666666666666666666666666555555555555555555555554 


Q ss_pred             cCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccC
Q 045539          211 SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCK  290 (897)
Q Consensus       211 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~  290 (897)
                                              +..|..|.++++|++|+|++|.+++..                        +..++
T Consensus       161 ------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~------------------------~~~l~  192 (597)
T 3oja_B          161 ------------------------RIEDDTFQATTSLQNLQLSSNRLTHVD------------------------LSLIP  192 (597)
T ss_dssp             ------------------------BCCTTTTTTCTTCCEEECTTSCCSBCC------------------------GGGCT
T ss_pred             ------------------------CCChhhhhcCCcCcEEECcCCCCCCcC------------------------hhhhh
Confidence                                    444445555556666666666555432                        13345


Q ss_pred             CCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcc
Q 045539          291 KLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGL  370 (897)
Q Consensus       291 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  370 (897)
                      +|+.|++++|.+++.                              ...++|+.|++++|.++...+. +  .++|+.|+|
T Consensus       193 ~L~~L~l~~n~l~~l------------------------------~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L  239 (597)
T 3oja_B          193 SLFHANVSYNLLSTL------------------------------AIPIAVEELDASHNSINVVRGP-V--NVELTILKL  239 (597)
T ss_dssp             TCSEEECCSSCCSEE------------------------------ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEEC
T ss_pred             hhhhhhcccCccccc------------------------------cCCchhheeeccCCcccccccc-c--CCCCCEEEC
Confidence            666666666655421                              1223566666666666542221 1  134455555


Q ss_pred             cCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCccccc
Q 045539          371 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVL  450 (897)
Q Consensus       371 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l  450 (897)
                      ++|++++  +..+..+++|++|+|++|.+++.+|..|+++++|+.|+|++|.+++ +                       
T Consensus       240 ~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l-----------------------  293 (597)
T 3oja_B          240 QHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-L-----------------------  293 (597)
T ss_dssp             CSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-E-----------------------
T ss_pred             CCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-C-----------------------
Confidence            5555443  2334445555555555555555445555555555555555555443 2                       


Q ss_pred             ceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCC
Q 045539          451 IGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN  530 (897)
Q Consensus       451 ~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  530 (897)
                                    |..++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++. |  +..+++|+.|+|++|
T Consensus       294 --------------~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N  355 (597)
T 3oja_B          294 --------------NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHN  355 (597)
T ss_dssp             --------------ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSS
T ss_pred             --------------CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCC
Confidence                          333444556666666666666 4566666667777777777777643 2  455667777777777


Q ss_pred             cccccCCCCCCCCCCCcccccchhhhhhh
Q 045539          531 KLEGEIPRGGPFANLTAKSFMGNELLKML  559 (897)
Q Consensus       531 ~l~~~~p~~~~~~~~~~~~~~~N~~~c~~  559 (897)
                      ++++..+. ..+..+....+.+++..|+.
T Consensus       356 ~~~~~~~~-~~~~~~~~~~~~~~~~~C~~  383 (597)
T 3oja_B          356 DWDCNSLR-ALFRNVARPAVDDADQHCKI  383 (597)
T ss_dssp             CEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred             CCCChhHH-HHHHHHhhhccccccccCCc
Confidence            77654322 23445555566777777754

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-38  Score=357.23  Aligned_cols=372  Identities=17%  Similarity=0.158  Sum_probs=202.6

Q ss_pred             cCCCCCCCCcc-eeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccC
Q 045539           55 RNWTSSTSVCS-WIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSD  133 (897)
Q Consensus        55 ~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~  133 (897)
                      ++|..+.+||. |.+..|.....+     +............-..++++++|++++|.++...+..|.++++|++|+|++
T Consensus         4 ~~~~~~~~C~~~~~~~~c~~~~~~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~   78 (390)
T 3o6n_A            4 KPRQPEYKCIDSNLQYDCVFYDVH-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND   78 (390)
T ss_dssp             ---CCEECBCC------EEEESCE-----ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTT
T ss_pred             CCCCCccceehhhhhhccceeeee-----eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCC
Confidence            38988888875 555555422212     222222222222233568888888888888754444578888888888888


Q ss_pred             ccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCC
Q 045539          134 NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLP  213 (897)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  213 (897)
                      |++.+..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++.+.+..|.++++|++|++++|+++    
T Consensus        79 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~----  154 (390)
T 3o6n_A           79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE----  154 (390)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC----
T ss_pred             CcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC----
Confidence            8887777777777777777777777777666666666666666666666666555444555555555555555554    


Q ss_pred             ccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCc
Q 045539          214 SRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLK  293 (897)
Q Consensus       214 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~  293 (897)
                                           +..|..+..+++|++|++++|.+++..                        +..+++|+
T Consensus       155 ---------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~------------------------~~~l~~L~  189 (390)
T 3o6n_A          155 ---------------------RIEDDTFQATTSLQNLQLSSNRLTHVD------------------------LSLIPSLF  189 (390)
T ss_dssp             ---------------------BCCTTTTSSCTTCCEEECCSSCCSBCC------------------------GGGCTTCS
T ss_pred             ---------------------ccChhhccCCCCCCEEECCCCcCCccc------------------------cccccccc
Confidence                                 444444555555666666655554331                        23345666


Q ss_pred             EEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCc
Q 045539          294 VLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRN  373 (897)
Q Consensus       294 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  373 (897)
                      .|++++|.+++.                              ...++|++|++++|+++.. |..  ..++|+.|++++|
T Consensus       190 ~L~l~~n~l~~~------------------------------~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n  236 (390)
T 3o6n_A          190 HANVSYNLLSTL------------------------------AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHN  236 (390)
T ss_dssp             EEECCSSCCSEE------------------------------ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSS
T ss_pred             eeeccccccccc------------------------------CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCC
Confidence            666666655421                              1223566666666666543 221  1244555555555


Q ss_pred             ccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCccccccee
Q 045539          374 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGL  453 (897)
Q Consensus       374 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l  453 (897)
                      ++++.  ..+..+++|++|+|++|++++..|..|.++++|+.|++++|++++ +|.                        
T Consensus       237 ~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~------------------------  289 (390)
T 3o6n_A          237 NLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNL------------------------  289 (390)
T ss_dssp             CCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EEC------------------------
T ss_pred             CCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCc------------------------
Confidence            55432  344455555555555555555555555555555555555555543 222                        


Q ss_pred             ecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          454 NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       454 ~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                                   .+..+++|++|++++|+++ .+|..+..+++|+.|+|++|+|++ +|  +..+++|+.|++++|+++
T Consensus       290 -------------~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~  352 (390)
T 3o6n_A          290 -------------YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWD  352 (390)
T ss_dssp             -------------SSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEE
T ss_pred             -------------ccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCcc
Confidence                         2334445555555555555 344445555555666666665552 22  445555666666666655


Q ss_pred             ccCCCCCCCCCCCcccccchhhhhh
Q 045539          534 GEIPRGGPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       534 ~~~p~~~~~~~~~~~~~~~N~~~c~  558 (897)
                      +.-.. ..+..+....+.+++..|.
T Consensus       353 ~~~~~-~~~~~~~~~~~~~~~~~c~  376 (390)
T 3o6n_A          353 CNSLR-ALFRNVARPAVDDADQHCK  376 (390)
T ss_dssp             HHHHH-HHTTTCCTTTBCCCCSCCC
T ss_pred             chhHH-HHHHHHHhhcccccCceec
Confidence            43111 1223333344555555554

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=352.56  Aligned_cols=272  Identities=24%  Similarity=0.289  Sum_probs=194.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee-----cCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC-----SNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-----~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+. +++.||||++....... ...+.|+..+..++||||+++++++     ......++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            46899999999999999999987 48999999997553321 1223344444558899999999744     33446789


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CcEeCCCCCCCeeeCCCCcEEEeec
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST---------PIIHCDLKPSNVLLDEDMVAHISDF  761 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~---------~ivH~Dlkp~NIll~~~~~~kL~DF  761 (897)
                      ||||+++|+|.+++....  .++..+..++.|++.||+||   |+.         ||+||||||+||+++.++.+||+||
T Consensus        90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            999999999999997765  58899999999999999999   666         9999999999999999999999999


Q ss_pred             cCccccCCCCc------eeeeeccccCcccCCcCccCC-------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccc
Q 045539          762 GIAKLLSGEDQ------LSIQIQTLATIGYMAPEYGTK-------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS  828 (897)
Q Consensus       762 g~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~  828 (897)
                      |+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||.........
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987653221      112234469999999998876       45678999999999999999998776442211111


Q ss_pred             hhHHhh--hcCCc--hHHHHhh-hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          829 LNRWIN--DLLPV--SVMEVID-TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       829 ~~~~~~--~~~~~--~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...+..  ...+.  .....+. .......+...........++.+++.+||+.|| ++|||++|++++|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP-~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA-EARLTAQXAEERMAE  315 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG-GGSCCHHHHHHHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh-hhCcchHHHHHHHHH
Confidence            001100  00010  0111111 111111111111112345568999999999999 999999999998853

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-38  Score=341.95  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=201.6

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee-cCCCceEEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC-SNDDFKALI  691 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv  691 (897)
                      ...++|++.+.||+|+||.||+|+. .+++.||+|++.....  .+.+.+|++++++++|++++..++++ .+++..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3467999999999999999999986 4689999998764432  24578899999999988777666655 677788999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~  768 (897)
                      |||+ +++|.+++......+++.++..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999986666799999999999999999999   88999999999999999   788999999999998765


Q ss_pred             CCCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          769 GEDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       769 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....     .......||+.|+|||...+..++.++|||||||++|||++|+.||.........          .....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~  229 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------QKYER  229 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----------SHHHH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh----------hhhhh
Confidence            43321     1223456899999999999999999999999999999999999999763222110          01111


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      +.........+   ........++.+++.+||+.|| ++|||++||++.|++
T Consensus       230 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p-~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          230 ISEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRF-DDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HHHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCT-TCCCCHHHHHHHHHH
T ss_pred             hhcccccchhh---hhhccCCHHHHHHHHHHHhcCC-CCCCCHHHHHHHHHH
Confidence            11111111110   0001223568899999999999 999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-38  Score=342.35  Aligned_cols=256  Identities=22%  Similarity=0.381  Sum_probs=200.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeee-cCCCceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSC-SNDDFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  689 (897)
                      ..+|++.+.||+|+||.||+|++.+    +..||+|++.... ....+.+.+|++++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578889999999999999998642    2358999987533 34567889999999999999999999985 5566889


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999988777789999999999999999999   889999999999999999999999999999987653


Q ss_pred             CCc--eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcC-CCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          770 EDQ--LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTK-KKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       770 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ...  ........+|+.|+|||...+..++.++||||+|+++|||++| ..||......  .....+           ..
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~-----------~~  247 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL-----------LQ  247 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH-----------HT
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH-----------hc
Confidence            322  1223344678899999999888999999999999999999995 5555442111  111111           11


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ......+.       .+..++.+++.+||+.|| ++|||++|++++|++
T Consensus       248 ~~~~~~~~-------~~~~~l~~li~~~l~~~p-~~Rps~~ell~~L~~  288 (298)
T 3f66_A          248 GRRLLQPE-------YCPDPLYEVMLKCWHPKA-EMRPSFSELVSRISA  288 (298)
T ss_dssp             TCCCCCCT-------TCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCCCCCc-------cCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence            00000010       122457899999999999 999999999998863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-38  Score=341.54  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=196.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            468999999999999999999875 68999999987654 2345788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCcccc
Q 045539          694 YMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLL  767 (897)
Q Consensus       694 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~  767 (897)
                      |+++++|.+++...   ...+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543   25689999999999999999999   88999999999999999   45678999999999865


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||......+  .........         .
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~---------~  242 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKE---------P  242 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCC---------C
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCC---------c
Confidence            4332   223456899999999875 568899999999999999999999997632110  000000000         0


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .....       ......++.+++.+|++.|| ++|||++|+++
T Consensus       243 ~~~~~-------~~~~~~~~~~li~~~L~~dP-~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAVE-------CRPLTPQAVDLLKQMLTKDP-ERRPSAAQVLH  278 (285)
T ss_dssp             CCCC---------CCCCHHHHHHHHHHTCSCT-TTSCCHHHHHT
T ss_pred             ccccc-------cCcCCHHHHHHHHHHccCCh-hhCcCHHHHhc
Confidence            00000       00122457889999999999 99999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=351.24  Aligned_cols=266  Identities=18%  Similarity=0.258  Sum_probs=196.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH-HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER-ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999876 6899999998754322 122455799999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++ ++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 589999888777799999999999999999999   88999999999999999999999999999998654322  2


Q ss_pred             eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc----CCchHHHHhhh--
Q 045539          775 IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL----LPVSVMEVIDT--  847 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~--  847 (897)
                      ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......  .....+...    .+.........  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcchh
Confidence            2234568999999998766 56899999999999999999999999763211  111111100    00000000000  


Q ss_pred             ----hhcc-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          848 ----NLLR-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       848 ----~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          .... ..............++.+++.+|++.|| ++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEG-RNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSG-GGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCc-ccCCCHHHHhc
Confidence                0000 0000011112234567899999999999 99999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.1e-38  Score=359.80  Aligned_cols=265  Identities=21%  Similarity=0.198  Sum_probs=195.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCC------C
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSND------D  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  686 (897)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+++.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999865 6899999999754  234567888999999999999999999999654      3


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||++++ +.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            569999999764 6555543   388999999999999999999   888999999999999999999999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh----------c
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND----------L  836 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~  836 (897)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...+..          .
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred             cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence            64332   233457999999999999999999999999999999999999999753111 011111110          0


Q ss_pred             CCchHHHHhhhhhcc---hhh---------hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          837 LPVSVMEVIDTNLLR---GEE---------RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~---~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ........+......   ..+         ...........++.+++.+|++.|| ++|||++|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP-~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP-AKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST-TTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCCh-hhCCCHHHHhcC
Confidence            000111111100000   000         0001112234568999999999999 999999999863

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-38  Score=357.87  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=193.7

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34679999999999999999999865 58999999987542        1122357899999999999999999999865


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEEEeec
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAHISDF  761 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~kL~DF  761 (897)
                      + ..|+||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+||
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             C-ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeec
Confidence            4 5789999999999999887654 589999999999999999999   788999999999999997544   5999999


Q ss_pred             cCccccCCCCceeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          762 GIAKLLSGEDQLSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       762 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |+++......   ......||+.|+|||++.   ...++.++|||||||++|||++|+.||....... .....+     
T Consensus       287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i-----  357 (419)
T 3i6u_A          287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQI-----  357 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHH-----
T ss_pred             ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHH-----
Confidence            9998765322   223457999999999875   3677889999999999999999999997632221 111111     


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                             .......   ..........++.+++.+|++.|| ++|||++|+++.
T Consensus       358 -------~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP-~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 -------TSGKYNF---IPEVWAEVSEKALDLVKKLLVVDP-KARFTTEEALRH  400 (419)
T ss_dssp             -------HTTCCCC---CHHHHTTSCHHHHHHHHHHSCSST-TTSCCHHHHHHS
T ss_pred             -------hcCCCCC---CchhhcccCHHHHHHHHHHccCCh-hHCcCHHHHhCC
Confidence                   1110000   011112334568899999999999 999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=8.6e-38  Score=356.44  Aligned_cols=346  Identities=17%  Similarity=0.180  Sum_probs=271.2

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++..|+++++++++. | .++.+++|++|+|++|++++ +|  ++++++|++|+|++|++.+. +  +.++++|++|+|
T Consensus        42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L  113 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC  113 (457)
T ss_dssp             TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence            3688999999999974 5 79999999999999999996 44  99999999999999999886 3  899999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      ++|++++ +|  ++.+++|++|++++|+++++ +  ++++++|++|++++|+..+.++   +..+++|++|++++|++++
T Consensus       114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~  184 (457)
T 3bz5_A          114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE  184 (457)
T ss_dssp             CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce
Confidence            9999996 55  99999999999999999997 3  8899999999999997666764   3478999999999999997


Q ss_pred             cccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchH
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL  315 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (897)
                       +|  +..+++|+.|++++|.+++. +                       +..+++|++|++++|+++++ |  +..++ 
T Consensus       185 -l~--l~~l~~L~~L~l~~N~l~~~-~-----------------------l~~l~~L~~L~Ls~N~l~~i-p--~~~l~-  233 (457)
T 3bz5_A          185 -LD--VSQNKLLNRLNCDTNNITKL-D-----------------------LNQNIQLTFLDCSSNKLTEI-D--VTPLT-  233 (457)
T ss_dssp             -CC--CTTCTTCCEEECCSSCCSCC-C-----------------------CTTCTTCSEEECCSSCCSCC-C--CTTCT-
T ss_pred             -ec--cccCCCCCEEECcCCcCCee-c-----------------------cccCCCCCEEECcCCccccc-C--ccccC-
Confidence             44  88999999999999999865 1                       46789999999999999984 5  66666 


Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      +|+.|++++|++++..+   +.+++|+.|++++|+              |+.|++++|++.+.+|  +..+++|+.|+++
T Consensus       234 ~L~~L~l~~N~l~~~~~---~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls  294 (457)
T 3bz5_A          234 QLTYFDCSVNPLTELDV---STLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVT  294 (457)
T ss_dssp             TCSEEECCSSCCSCCCC---TTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCT
T ss_pred             CCCEEEeeCCcCCCcCH---HHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECC
Confidence            89999999999998754   455666666666553              3344555555554444  2344555555555


Q ss_pred             ccccccCCCc--------ccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccc
Q 045539          396 GNKFSGSIPS--------CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPIT  467 (897)
Q Consensus       396 ~N~l~~~~p~--------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~  467 (897)
                      +|++.+.+|.        .++++++|+.|++++|++++. +  +..+++|+.|++++|++             ++     
T Consensus       295 ~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l-------------~~-----  353 (457)
T 3bz5_A          295 HNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHI-------------QD-----  353 (457)
T ss_dssp             TCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCC-------------CB-----
T ss_pred             CCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCC-------------CC-----
Confidence            5554444432        134447899999999999984 3  78888888655555544             43     


Q ss_pred             ccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhh
Q 045539          468 IGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQ  517 (897)
Q Consensus       468 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  517 (897)
                         ++.|..|++++|+++|.     +++..|+.+++++|+++|.+|..+.
T Consensus       354 ---l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          354 ---FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             ---CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             ---ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence               24567777888888775     3566777788888888888876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-39  Score=353.78  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++.+...    ...+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999876 689999999976532    234688888888 6999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC----CcEEEeeccCccccC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED----MVAHISDFGIAKLLS  768 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~~  768 (897)
                      ||+++|+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||++.++    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999987654 589999999999999999999   88999999999999998533    359999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .            ..+++...
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~------------~~~~~~~i  235 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--T------------PEEILARI  235 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--C------------HHHHHHHH
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--C------------HHHHHHHH
Confidence            4322  223457899999999988878899999999999999999999999752111  1            11111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....+............++.+++.+|++.|| ++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~t~~~il~  277 (342)
T 2qr7_A          236 GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP-HQRLTAALVLR  277 (342)
T ss_dssp             HHCCCCCCSTTTTTSCHHHHHHHHHHTCSST-TTSCCHHHHTT
T ss_pred             ccCCcccCccccccCCHHHHHHHHHHCCCCh-hHCcCHHHHhc
Confidence            1110000000001223457899999999999 99999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=351.61  Aligned_cols=248  Identities=16%  Similarity=0.135  Sum_probs=199.3

Q ss_pred             HhcCCCcCCeeecccceEEEEEE------ecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC---CCccceEeeeecCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVAR------LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR---HRNLVKIISSCSND  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  685 (897)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|+++...   ...+.+|++++++++   |+||+++++++..+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999994      3468999999997653   345677888888887   99999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---------
Q 045539          686 DFKALIMKYMPNGSLENCLYS----GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---------  752 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---------  752 (897)
                      +..|+||||+++|+|.+++..    ....+++..+..++.|++.||+||   |++||+||||||+||+++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999874    335699999999999999999999   8899999999999999998         


Q ss_pred             --CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchh
Q 045539          753 --DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN  830 (897)
Q Consensus       753 --~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~  830 (897)
                        ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....+.... 
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-  295 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP-  295 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE-
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee-
Confidence              89999999999976543333344456679999999999999999999999999999999999999996543221110 


Q ss_pred             HHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCC-CCHHHHHhhcC
Q 045539          831 RWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNG-ADMGWIFSALD  894 (897)
Q Consensus       831 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~R-Pt~~evl~~L~  894 (897)
                                     .......+         ....+.+++..|++.+| .+| |+++++.+.|+
T Consensus       296 ---------------~~~~~~~~---------~~~~~~~~~~~~l~~~p-~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          296 ---------------EGLFRRLP---------HLDMWNEFFHVMLNIPD-CHHLPSLDLLRQKLK  335 (365)
T ss_dssp             ---------------CSCCTTCS---------SHHHHHHHHHHHHCCCC-TTCCCCHHHHHHHHH
T ss_pred             ---------------chhccccC---------cHHHHHHHHHHHcCCCC-CCcchHHHHHHHHHH
Confidence                           00000001         01235677888999999 777 57777766654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-38  Score=361.52  Aligned_cols=195  Identities=24%  Similarity=0.389  Sum_probs=155.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC-----CCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN-----DDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  687 (897)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....  ....+++.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999865 68999999986532  3455788999999999999999999999843     357


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 578998887654 589999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCce-------------------------eeeeccccCcccCCcCcc-CCCCCCccchHHHHHHHHHHHHcC
Q 045539          768 SGEDQL-------------------------SIQIQTLATIGYMAPEYG-TKGRVCTRGDVYSYGIMLMEMFTK  815 (897)
Q Consensus       768 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvil~elltg  815 (897)
                      ......                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            422210                         123445789999999975 566799999999999999999994

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=341.74  Aligned_cols=255  Identities=20%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             CCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce-EEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK-ALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  691 (897)
                      .|...+.||+|+||+||+|++.+    +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            55667899999999999998542    2369999987543 34567889999999999999999999999776655 999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+.+++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999988777789999999999999999999   78899999999999999999999999999998654322


Q ss_pred             c--eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          772 Q--LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       772 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .  ........+++.|+|||...+..++.++||||||+++|+|++|..|+...... ....            ..+....
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~------------~~~~~~~  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLT------------HFLAQGR  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHH------------HHHHTTC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHH------------HHhhcCC
Confidence            1  11223446789999999999999999999999999999999966665432111 1111            1111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ....+      ......+.+++.+|++.|| ++|||++|++++|++
T Consensus       246 ~~~~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          246 RLPQP------EYCPDSLYQVMQQCWEADP-AVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCCC------ccchHHHHHHHHHHccCCh-hhCcCHHHHHHHHHH
Confidence            10000      0122457899999999999 999999999998853

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-38  Score=356.68  Aligned_cols=251  Identities=18%  Similarity=0.228  Sum_probs=191.1

Q ss_pred             hcCCCcC-CeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHh-cCCCccceEeeeecC----CCce
Q 045539          616 TDRFSEN-NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKR-IRHRNLVKIISSCSN----DDFK  688 (897)
Q Consensus       616 ~~~y~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  688 (897)
                      .++|.+. +.||+|+||.||+|++. +|+.||||+++..     ..+.+|++++.+ .+||||+++++++..    ++..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567766 68999999999999876 6899999998743     356678888754 479999999998865    5678


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a  764 (897)
                      |+||||+++|+|.+++.... ..+++.++..++.||+.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998754 4689999999999999999999   7899999999999999997   789999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH-
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME-  843 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  843 (897)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........          ..... 
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------~~~~~~  278 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTR  278 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----------CSHHHH
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----------HHHHHH
Confidence            8654322   223456899999999999999999999999999999999999999763221110          00111 


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.........    .....+..++.+++.+||+.|| ++|||++|+++.
T Consensus       279 i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP-~~Rpt~~eil~h  322 (400)
T 1nxk_A          279 IRMGQYEFPN----PEWSEVSEEVKMLIRNLLKTEP-TQRMTITEFMNH  322 (400)
T ss_dssp             HHHTCCCCCT----TTTTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHHS
T ss_pred             HHcCcccCCC----cccccCCHHHHHHHHHHCCCCh-hHCcCHHHHhcC
Confidence            1110000000    0011233457899999999999 999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=351.48  Aligned_cols=267  Identities=26%  Similarity=0.394  Sum_probs=209.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-----cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--ce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-----QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--FK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  688 (897)
                      .++|++.+.||+|+||.||+|++     .+|+.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45789999999999999999984     368999999998766666788999999999999999999999986654  78


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999988776799999999999999999999   78999999999999999999999999999998775


Q ss_pred             CCCceee-eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc-----hHH
Q 045539          769 GEDQLSI-QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV-----SVM  842 (897)
Q Consensus       769 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~  842 (897)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......   ..+........     .+.
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            4433221 22345678899999988888999999999999999999999997642110   11111110000     011


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      +.+........      ...+..++.+++.+||+.|| ++|||++||+++|++
T Consensus       274 ~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP-~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          274 ELLKNNGRLPR------PDGCPDEIYMIMTECWNNNV-NQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHHHHHH
T ss_pred             HHhhcCCCCCC------CCcccHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence            11111111000      01234568899999999999 999999999998863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-38  Score=345.10  Aligned_cols=257  Identities=21%  Similarity=0.335  Sum_probs=195.2

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++..   .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3568999999999999999999864 6899999998752   24456788999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      ||||+++++|.+++..   ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998864   335689999999999999999999   8899999999999999999999999999999866


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      .....  ......|++.|+|||++.+..++.++||||||+++|||++|+.||.............+..           .
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~  253 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-----------C  253 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-----------T
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-----------c
Confidence            43221  2234468999999999998899999999999999999999999996532111111111100           0


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .......      .....++.+++.+||+.|| ++|||++||++.|+
T Consensus       254 ~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~il~~l~  293 (310)
T 2wqm_A          254 DYPPLPS------DHYSEELRQLVNMCINPDP-EKRPDVTYVYDVAK  293 (310)
T ss_dssp             CSCCCCT------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             cCCCCcc------cccCHHHHHHHHHHcCCCh-hhCCCHHHHHHHHH
Confidence            0000000      1123457899999999999 99999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-38  Score=364.88  Aligned_cols=252  Identities=20%  Similarity=0.267  Sum_probs=202.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..++|++.+.||+|+||+||+|+.. +++.||||++.+..  ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3568999999999999999999876 68999999997543  23457788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~  768 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++   .++.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999887654 589999999999999999999   889999999999999995   45689999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......                 +++...
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------------~~~~~i  234 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----------------DILKRV  234 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHH
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHH
Confidence            332   2234579999999998765 5899999999999999999999999752111                 111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ....+....+....+..++.+++.+||+.|| ++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp-~~R~t~~~~l~h  277 (486)
T 3mwu_A          235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHP-SLRITATQCLEH  277 (486)
T ss_dssp             HHTCCCSCSGGGGGSCHHHHHHHHHHTCSST-TTSCCHHHHHHC
T ss_pred             HhCCCCCCCcccCCCCHHHHHHHHHHcCCCh-hhCcCHHHHhcC
Confidence            1110000001111233457899999999999 999999999873

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.5e-38  Score=363.51  Aligned_cols=251  Identities=20%  Similarity=0.297  Sum_probs=202.2

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH-------------HHHHHHHHHHHHHHhcCCCccceEee
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-------------RALKSFEDECEVMKRIRHRNLVKIIS  680 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  680 (897)
                      ..++|.+.+.||+|+||+||+|+.. +++.||+|++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999876 588999999875421             23567889999999999999999999


Q ss_pred             eecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC---cEE
Q 045539          681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM---VAH  757 (897)
Q Consensus       681 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~---~~k  757 (897)
                      ++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999887654 589999999999999999999   889999999999999998775   699


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      |+|||++........   .....||+.|+|||++. +.++.++||||+||++|+|++|+.||.....             
T Consensus       190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------  252 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------------  252 (504)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------
T ss_pred             EEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------------
Confidence            999999987654322   23456999999999876 4689999999999999999999999976211             


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          .+++.......+....+....+..++.+++.+|++.|| ++|||++|+++
T Consensus       253 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp-~~R~t~~e~l~  301 (504)
T 3q5i_A          253 ----QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDY-NKRCTAEEALN  301 (504)
T ss_dssp             ----HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             ----HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCCh-hHCCCHHHHhc
Confidence                11111111111111112223344568899999999999 99999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-39  Score=350.18  Aligned_cols=243  Identities=22%  Similarity=0.307  Sum_probs=201.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--------HHHHHHHHHHHHHHhcCCCccceEeeeecCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--------RALKSFEDECEVMKRIRHRNLVKIISSCSND  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  685 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++....        ...+.+.+|++++++++||||+++++++.++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999865 689999999875421        1234567899999999999999999999999


Q ss_pred             CceEEEEEeccCC-ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          686 DFKALIMKYMPNG-SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       686 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887664 589999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      ........   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                  
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------  236 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------  236 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred             eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence            87654332   223569999999999887776 88999999999999999999999752111                  


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                       .........        ....++.+++.+||+.|| ++|||++|+++.
T Consensus       237 -~~~~~~~~~--------~~~~~l~~li~~~L~~dP-~~Rps~~ell~h  275 (335)
T 3dls_A          237 -VEAAIHPPY--------LVSKELMSLVSGLLQPVP-ERRTTLEKLVTD  275 (335)
T ss_dssp             -TTTCCCCSS--------CCCHHHHHHHHHHTCSSG-GGSCCHHHHHHC
T ss_pred             -HhhccCCCc--------ccCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence             000000000        012347899999999999 999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-38  Score=340.05  Aligned_cols=259  Identities=20%  Similarity=0.262  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee-cCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC-SNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....  .+.+.+|++++++++|++++..++++ .+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999986 4799999999865432  24678999999999988876666555 66778899999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+ +++|.+++......+++.++..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||.+......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 9999999986666799999999999999999999   88999999999999999   48889999999999876543


Q ss_pred             Ccee-----eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          771 DQLS-----IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       771 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ....     ......||+.|+|||+..+..++.++|||||||++|||++|+.||.........          .....+.
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~  231 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------QKYERIS  231 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----------SHHHHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh----------hhhhhhc
Confidence            3211     123456999999999999999999999999999999999999999763221100          0111111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ........+   ........++.+++.+||+.|| ++|||++||++.|+
T Consensus       232 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          232 EKKMSTPIE---VLCKGYPSEFATYLNFCRSLRF-DDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCT-TCCCCHHHHHHHHH
T ss_pred             ccccCCchH---HHHhhCCHHHHHHHHHHHhcCc-CcCCCHHHHHHHHH
Confidence            111111110   0001233568899999999999 99999999999885

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-39  Score=359.72  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--ceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--FKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            468999999999999999999876 58999999997543 234567789999999999999999999997655  77999


Q ss_pred             EEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----CCCCcEEEeeccCcc
Q 045539          692 MKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAHISDFGIAK  765 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~  765 (897)
                      |||+++++|.+++....  ..+++..+..++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999987654  2389999999999999999999   88999999999999999    788889999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCC--------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccc---hhHHhh
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTK--------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS---LNRWIN  834 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~---~~~~~~  834 (897)
                      .......   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........   ..+...
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            7654322   224569999999998654        56788999999999999999999999753221111   111111


Q ss_pred             hcCCchHHHHhhhhh------cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          835 DLLPVSVMEVIDTNL------LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . .+......+....      ....+....-.+.....+.+++.+||+.|| ++|||++|+++.++
T Consensus       242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP-~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ-EKCWGFDQFFAETS  305 (396)
T ss_dssp             S-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT-TTSCCHHHHHHHHH
T ss_pred             C-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh-hhhccHHHHHHHHH
Confidence            1 1100000000000      000000000113445668899999999999 99999999988764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=363.65  Aligned_cols=346  Identities=20%  Similarity=0.188  Sum_probs=196.8

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.++.++++++ .+|..+.  ++|++|+|++|++.+..+..|.++++|++|+|++|.++                     
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~---------------------   69 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS---------------------   69 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC---------------------
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccC---------------------
Confidence            35666666666 5555443  45666666666555544444444444444444444444                     


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccC
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  262 (897)
                         ++.|..|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..+
T Consensus        70 ---~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  145 (477)
T 2id5_A           70 ---AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH  145 (477)
T ss_dssp             ---EECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT
T ss_pred             ---EeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh
Confidence               444444445555555555555554 3444333344455555555555555555555666666666666665555444


Q ss_pred             ccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCc
Q 045539          263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLL  342 (897)
Q Consensus       263 ~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~  342 (897)
                      ..                     +.++++|++|+|++|+++++                         .+..|..+++|+
T Consensus       146 ~~---------------------~~~l~~L~~L~l~~n~l~~~-------------------------~~~~l~~l~~L~  179 (477)
T 2id5_A          146 RA---------------------FSGLNSLEQLTLEKCNLTSI-------------------------PTEALSHLHGLI  179 (477)
T ss_dssp             TS---------------------STTCTTCCEEEEESCCCSSC-------------------------CHHHHTTCTTCC
T ss_pred             hh---------------------ccCCCCCCEEECCCCcCccc-------------------------ChhHhcccCCCc
Confidence            32                     23444555555555544421                         122344555555


Q ss_pred             EEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecccccc
Q 045539          343 VLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNR  422 (897)
Q Consensus       343 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  422 (897)
                      .|++++|++++..+..|..+++|+.|++                        ++|.+.+.+|.......+|+.|++++|+
T Consensus       180 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l------------------------~~~~~~~~~~~~~~~~~~L~~L~l~~n~  235 (477)
T 2id5_A          180 VLRLRHLNINAIRDYSFKRLYRLKVLEI------------------------SHWPYLDTMTPNCLYGLNLTSLSITHCN  235 (477)
T ss_dssp             EEEEESCCCCEECTTCSCSCTTCCEEEE------------------------ECCTTCCEECTTTTTTCCCSEEEEESSC
T ss_pred             EEeCCCCcCcEeChhhcccCcccceeeC------------------------CCCccccccCcccccCccccEEECcCCc
Confidence            6666655555544444555555555544                        4444444444444444456666666666


Q ss_pred             ccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEe
Q 045539          423 FTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLD  502 (897)
Q Consensus       423 l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~  502 (897)
                      +++..+..+..+++|+.             |+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+
T Consensus       236 l~~~~~~~~~~l~~L~~-------------L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  302 (477)
T 2id5_A          236 LTAVPYLAVRHLVYLRF-------------LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN  302 (477)
T ss_dssp             CCSCCHHHHTTCTTCCE-------------EECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred             ccccCHHHhcCccccCe-------------eECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence            65433345555555553             33333344444456677778888888888888887788888888888888


Q ss_pred             ccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhhhhhh
Q 045539          503 LSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKML  559 (897)
Q Consensus       503 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~  559 (897)
                      |++|+|++..+..|..+++|+.|+|++|++.+..+....+.......+.++...|..
T Consensus       303 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~  359 (477)
T 2id5_A          303 VSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT  359 (477)
T ss_dssp             CCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred             CCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence            888888876667778888888888888888765432111222233456666666653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-38  Score=347.98  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=201.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++... .......+.+|+.++++++||||+++++++.+++..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            57899999999999999999984      24778999998643 244556788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEe
Q 045539          689 ALIMKYMPNGSLENCLYSGT------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHIS  759 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~  759 (897)
                      |+||||+++++|.+++....      ..+++.++..++.|++.||+||   |++||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      3589999999999999999999   8899999999999999984   4469999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||.+................||+.|+|||++.+..++.++||||||+++|||++ |+.||......  ...+.      
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~------  257 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEF------  257 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHH------
Confidence            9999986644433333345568999999999888889999999999999999998 99998752111  11111      


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                            +.........      ..+...+.+++.+||+.|| ++|||++|+++.|+
T Consensus       258 ------~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          258 ------VTSGGRMDPP------KNCPGPVYRIMTQCWQHQP-EDRPNFAIILERIE  300 (327)
T ss_dssp             ------HHTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ------HhcCCCCCCC------CCCCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHH
Confidence                  1111000000      1123457899999999999 99999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.5e-38  Score=364.55  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=201.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++.+...   ...+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            468899999999999999999876 699999999976532   2346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |||++||+|.+++....   ..+++..+..++.||+.||+||   |++||+||||||+||+++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987543   4689999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......        ..+....
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~--------~~i~~~~  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELK--------QRVLEQA  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHH--------HHHHHCC
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHH--------HHHhhcc
Confidence            4322  1234579999999999999999999999999999999999999997632110 111110        0111111


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      . ..+       ......+.+++.+|++.|| ++||++
T Consensus       410 ~-~~p-------~~~s~~~~~li~~lL~~dP-~~R~~~  438 (543)
T 3c4z_A          410 V-TYP-------DKFSPASKDFCEALLQKDP-EKRLGF  438 (543)
T ss_dssp             C-CCC-------TTSCHHHHHHHHHHSCSSG-GGSCCC
T ss_pred             c-CCC-------cccCHHHHHHHHHhccCCH-hHCCCC
Confidence            1 011       1223457889999999999 999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=354.32  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=191.8

Q ss_pred             CCCcCCeeecccceEEEEEEec--CC--ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeec-CCCceEEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ--DG--MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCS-NDDFKALI  691 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  691 (897)
                      .|...+.||+|+||.||+|++.  ++  ..||+|.++... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5677889999999999999864  22  458999986432 345678999999999999999999999864 45688999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999999988777789999999999999999999   88999999999999999999999999999998664332


Q ss_pred             ce--eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          772 QL--SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       772 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ..  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .....+..           ..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~-----------~~  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ-----------GR  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHT-----------TC
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHc-----------CC
Confidence            21  12233457889999999988899999999999999999999 67777653211  11111111           00


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+       ..+...+.+++.+||+.|| ++|||++|+++.|+
T Consensus       314 ~~~~p-------~~~~~~l~~li~~cl~~dp-~~RPs~~ell~~L~  351 (373)
T 3c1x_A          314 RLLQP-------EYCPDPLYEVMLKCWHPKA-EMRPSFSELVSRIS  351 (373)
T ss_dssp             CCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCC-------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHH
Confidence            00001       1123457899999999999 99999999999885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3e-38  Score=364.53  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.+..   ......+.+|++++++++||||+++++++.+++..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999875 69999999997653   22346688999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |||++||+|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987654 4589999999999999999999   7889999999999999999999999999999876543


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...         .+...+...-.
T Consensus       340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~---------~i~~~i~~~~~  406 (576)
T 2acx_A          340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE---------EVERLVKEVPE  406 (576)
T ss_dssp             CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHH---------HHHHHHHHCCC
T ss_pred             cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHH---------HHHHHhhcccc
Confidence            32   234579999999999999899999999999999999999999997632111 000         01111111000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      ..+       .....++.+++.+|++.|| ++||     +++||++
T Consensus       407 ~~p-------~~~s~~~~dLI~~lL~~dP-~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYS-------ERFSPQARSLCSQLLCKDP-AERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCC-------TTSCHHHHHHHHHHTCSSG-GGSTTCSSSHHHHHHT
T ss_pred             cCC-------ccCCHHHHHHHHHhccCCH-HHcCCCCCCCHHHHHh
Confidence            000       1123457899999999999 9999     7888875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-38  Score=362.66  Aligned_cols=248  Identities=22%  Similarity=0.267  Sum_probs=194.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+++++.++||||+++++++.+++..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999999865 68999999998653   23446678899999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |+ +||+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999887654 589999999999999999999   76 89999999999999999999999999999864322


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+           .+..... 
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~-----------~i~~~~~-  366 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE-----------LILMEEI-  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----------HHHHCCC-
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH-----------HHHhCCC-
Confidence            2  2234567999999999999999999999999999999999999999652111  0000           1111110 


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      ..+.       ....++.+++.+||+.|| ++||     +++|+++
T Consensus       367 ~~p~-------~~~~~~~~li~~~L~~dP-~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 RFPR-------TLGPEAKSLLSGLLKKDP-KQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSST-TTSTTCSTTTHHHHHT
T ss_pred             CCCc-------cCCHHHHHHHHHHcccCH-HHhCCCCCCCHHHHHh
Confidence            0010       123457899999999999 9999     9999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-38  Score=342.09  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=201.9

Q ss_pred             HhcCCCcCC-eeecccceEEEEEEec---CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          615 ATDRFSENN-LIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       615 ~~~~y~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      ..++|.+.+ .||+|+||.||+|.+.   +++.||||+++...  ....+.+.+|++++++++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            356788888 9999999999999643   46889999997553  23357889999999999999999999999 55678


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999998754 589999999999999999999   78899999999999999999999999999998765


Q ss_pred             CCCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  ..            .+.+.
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~------------~~~~~  234 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV------------TAMLE  234 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH------------HHHHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH------------HHHHH
Confidence            443322 1223346788999999888889999999999999999999 99999763211  11            11111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .......+      ..+..++.+++.+||+.|| ++|||++||++.|++
T Consensus       235 ~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          235 KGERMGCP------AGCPREMYDLMNLCWTYDV-ENRPGFAAVELRLRN  276 (291)
T ss_dssp             TTCCCCCC------TTCCHHHHHHHHHHTCSST-TTSCCHHHHHHHHHH
T ss_pred             cCCCCCCC------CCCCHHHHHHHHHHcCCCh-hhCcCHHHHHHHHHH
Confidence            11000000      1223458899999999999 999999999998863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.7e-38  Score=336.66  Aligned_cols=249  Identities=19%  Similarity=0.273  Sum_probs=204.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999876 58899999987542   34567788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887643 589999999999999999999   78899999999999999999999999999998764322


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  ......||+.|+|||+..+..++.++||||||+++|+|++|+.||......+     .        ...+..... .
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~--------~~~~~~~~~-~  233 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----T--------YLRIKKNEY-S  233 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H--------HHHHHTTCC-C
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H--------HHHHhhccC-C
Confidence            2  1234568999999999988889999999999999999999999997532110     0        001111000 0


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+.       .....+.+++.+|++.|| ++|||++|+++.
T Consensus       234 ~~~-------~~~~~~~~li~~~l~~~p-~~Rps~~~ll~~  266 (294)
T 2rku_A          234 IPK-------HINPVAASLIQKMLQTDP-TARPTINELLND  266 (294)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSG-GGSCCGGGGGGS
T ss_pred             Ccc-------ccCHHHHHHHHHHcccCh-hhCcCHHHHhhC
Confidence            000       122347889999999999 999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-38  Score=346.27  Aligned_cols=259  Identities=18%  Similarity=0.249  Sum_probs=203.1

Q ss_pred             HHHHHHhcCCCcC-CeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcC-CCccceEeeeecC
Q 045539          610 HELLRATDRFSEN-NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIR-HRNLVKIISSCSN  684 (897)
Q Consensus       610 ~~~~~~~~~y~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  684 (897)
                      .......++|.+. +.||+|+||.||+|... +|+.||+|+++...  ......+.+|+.++++++ ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344566788887 89999999999999876 68999999987543  223567889999999995 6999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEee
Q 045539          685 DDFKALIMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISD  760 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~D  760 (897)
                      ++..++||||+++++|.+++... ...+++.++..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999998654 35689999999999999999999   8899999999999999987   78999999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCch
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS  840 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  840 (897)
                      ||++........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+  .           
T Consensus       178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~-----------  241 (327)
T 3lm5_A          178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--T-----------  241 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H-----------
T ss_pred             CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H-----------
Confidence            999987653322   234569999999999999999999999999999999999999996521110  0           


Q ss_pred             HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          841 VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       841 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...+...... .+.   .........+.+++.+|++.|| ++|||++|+++.
T Consensus       242 ~~~i~~~~~~-~~~---~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~~ll~h  288 (327)
T 3lm5_A          242 YLNISQVNVD-YSE---ETFSSVSQLATDFIQSLLVKNP-EKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHTCCC-CCT---TTTTTSCHHHHHHHHHHSCSSG-GGSCCHHHHTTC
T ss_pred             HHHHHhcccc-cCc---hhhcccCHHHHHHHHHHcCCCh-hhCcCHHHHhCC
Confidence            0001100000 000   0001223457889999999999 999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-38  Score=344.17  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3568999999999999999999876 589999999987665566788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence            9999999999877556699999999999999999999   78899999999999999999999999999875432111  


Q ss_pred             eeeeccccCcccCCcCcc-----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          774 SIQIQTLATIGYMAPEYG-----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      .......||+.|+|||++     ....++.++||||||+++|+|++|+.||....... ..........+         .
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~  241 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP---------T  241 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------C
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc---------c
Confidence            112234689999999987     46778999999999999999999999997632110 00001000000         0


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .. .+       .....++.+++.+||+.|| ++|||++|+++
T Consensus       242 ~~-~~-------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LL-TP-------SKWSVEFRDFLKIALDKNP-ETRPSAAQLLE  275 (302)
T ss_dssp             CS-SG-------GGSCHHHHHHHHHHSCSCT-TTSCCHHHHTT
T ss_pred             cC-Cc-------cccCHHHHHHHHHHcccCh-hhCCCHHHHhc
Confidence            00 00       1123457899999999999 99999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.3e-38  Score=343.77  Aligned_cols=263  Identities=20%  Similarity=0.258  Sum_probs=201.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecC--CCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSN--DDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   .+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            368999999999999999999864 68999999987543   357889999999997 9999999999987  6678999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGE  770 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~  770 (897)
                      |||+++++|.+++..    +++.++..++.|++.||+||   |++||+||||||+||+++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998753    78999999999999999999   889999999999999999776 8999999999876543


Q ss_pred             CceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh--
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT--  847 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--  847 (897)
                      ..   .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.......-.....+.++.  
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            32   234568999999998776 678999999999999999999999995432221111111111111111111111  


Q ss_pred             -------------hhcchhhhh--HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 -------------NLLRGEERF--FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 -------------~l~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                                   .........  .........++.+++.+|++.|| ++|||++|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH-QSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSG-GGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCc-ccCCCHHHHhcC
Confidence                         100000000  00001134568899999999999 999999999873

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-38  Score=348.88  Aligned_cols=271  Identities=21%  Similarity=0.248  Sum_probs=198.2

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER-----ALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      ...++|++.+.||+|+||.||+|++. +|+.||+|+++.....     ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            44678999999999999999999876 5899999998753221     12467899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .++||||+++ +|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999975 89988887776789999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC---chHHH
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP---VSVME  843 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  843 (897)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+.+.......   ....+
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSS
T ss_pred             cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhh
Confidence            43322  22345689999999988654 5789999999999999999999998753211 111111110000   00000


Q ss_pred             ---Hhhhhhcch-hhhh-HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 ---VIDTNLLRG-EERF-FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ---~i~~~l~~~-~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ..+...... +... .........++.+++.+|++.|| ++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP-CARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSST-TTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccCh-hhCCCHHHHhcC
Confidence               000000000 0000 00011223568899999999999 999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-38  Score=348.61  Aligned_cols=260  Identities=22%  Similarity=0.271  Sum_probs=194.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+++.+|++++++++||||+++++++..++      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            568999999999999999999875 69999999985432  344577889999999999999999999997653      


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||+ +++|.+++...  .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999998874  489999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-----------
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-----------  834 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-----------  834 (897)
                      ....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....           
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            5432     234568999999998766 67899999999999999999999999753211 01111111           


Q ss_pred             hcCCchHHHHhhhhh---cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          835 DLLPVSVMEVIDTNL---LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..........+...-   .......   .......+.+++.+|++.|| ++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~mL~~dP-~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLVLDA-EQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSCSST-TTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHH---CCCCCHHHHHHHHHHccCCh-hHCCCHHHHhc
Confidence            000001111111000   0000000   01223457899999999999 99999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.3e-38  Score=364.12  Aligned_cols=250  Identities=20%  Similarity=0.314  Sum_probs=197.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++..  ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            458999999999999999999876 68899999987543  223567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC---CcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~a~~~~~  769 (897)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++..   +.+||+|||++.....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999998887654 589999999999999999999   88999999999999999764   4599999999987654


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...   .....||+.|+|||++. +.++.++||||+||++|+|++|+.||......  ....           .+.....
T Consensus       192 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~-----------~i~~~~~  254 (494)
T 3lij_A          192 QKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILR-----------KVEKGKY  254 (494)
T ss_dssp             TBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----------HHHHTCC
T ss_pred             Ccc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHhCCC
Confidence            322   23456999999999876 56899999999999999999999999763111  0101           1111000


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....    +....+...+.+++.+||+.|| ++|||++|+++
T Consensus       255 ~~~~----~~~~~~s~~~~~li~~~L~~dp-~~R~s~~e~l~  291 (494)
T 3lij_A          255 TFDS----PEWKNVSEGAKDLIKQMLQFDS-QRRISAQQALE  291 (494)
T ss_dssp             CCCS----GGGTTSCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             CCCc----hhcccCCHHHHHHHHHHCCCCh-hhCccHHHHhc
Confidence            0000    0011233457899999999999 99999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-37  Score=346.60  Aligned_cols=277  Identities=19%  Similarity=0.217  Sum_probs=204.4

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh-----------HHHHHHHHHHHHHHHhcCCCcc
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY-----------ERALKSFEDECEVMKRIRHRNL  675 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni  675 (897)
                      ....++....++|++.+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34667888899999999999999999999998889999999985421           2234788999999999999999


Q ss_pred             ceEeeeec-----CCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          676 VKIISSCS-----NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       676 v~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +++++++.     .....|+||||++ |+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEE
Confidence            99999983     3446899999997 688888887776799999999999999999999   78899999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~  243 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQL  243 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence            999999999999997543322   2234568999999998776 67899999999999999999999999763211 011


Q ss_pred             hHHhhhcC-----------CchHHHHhhhhhcchhhhhH-HHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          830 NRWINDLL-----------PVSVMEVIDTNLLRGEERFF-AAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       830 ~~~~~~~~-----------~~~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ........           .....+.+.......+.... .........+.+++.+|++.|| ++|||++|+++.
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~h  317 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP-QRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG-GGSCCHHHHHTS
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh-hhCCCHHHHHcC
Confidence            11111000           01111112111111111111 1111224558899999999999 999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-37  Score=332.28  Aligned_cols=247  Identities=23%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC----CCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN----DDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  689 (897)
                      ..|.+.+.||+|+||.||+|... ++..||+|++....  ....+.+.+|++++++++||||+++++++..    +...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            35788889999999999999875 58889999987543  4456788999999999999999999998854    45689


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeC-CCCcEEEeeccCccc
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHISDFGIAKL  766 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~  766 (897)
                      +||||+++++|.+++.... .+++..+..++.|++.||+||   |+.|  |+||||||+||+++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999997643 589999999999999999999   7777  99999999999998 789999999999976


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      .....    .....||+.|+|||++. +.++.++||||+|+++|+|++|+.||..................+        
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------  248 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------
T ss_pred             ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--------
Confidence            54332    22356899999999876 468999999999999999999999997532111111000000000        


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          ....      .....++.+++.+||+.|| ++|||++|+++
T Consensus       249 ----~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~  282 (290)
T 1t4h_A          249 ----ASFD------KVAIPEVKEIIEGCIRQNK-DERYSIKDLLN  282 (290)
T ss_dssp             ----GGGG------GCCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             ----cccC------CCCCHHHHHHHHHHccCCh-hhCCCHHHHhh
Confidence                0000      0112357899999999999 99999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.1e-38  Score=366.18  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=203.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999876 68999999986542   23457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~  768 (897)
                      |||+.+++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||++....
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999887654 589999999999999999999   88999999999999999   567899999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....   .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......  .....           +....
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~-----------i~~~~  243 (484)
T 3nyv_A          181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKK-----------VEKGK  243 (484)
T ss_dssp             CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----------HHHCC
T ss_pred             cccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-----------HHcCC
Confidence            4332   234569999999998765 6899999999999999999999999762111  11111           11100


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....    .+....+..++.+++.+|++.|| ++|||++|+++
T Consensus       244 ~~~~----~~~~~~~s~~~~~li~~~L~~dp-~~R~s~~e~l~  281 (484)
T 3nyv_A          244 YTFE----LPQWKKVSESAKDLIRKMLTYVP-SMRISARDALD  281 (484)
T ss_dssp             CCCC----SGGGGGSCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             CCCC----CcccccCCHHHHHHHHHHCCCCh-hHCcCHHHHhh
Confidence            0000    01111233457899999999999 99999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-37  Score=333.20  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999876 578899999875432   2346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999987654 589999999999999999999   89999999999999999999999999999987654322


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                          .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......  ..           ...+...... 
T Consensus       169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~-----------~~~~~~~~~~-  230 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ET-----------HRRIVNVDLK-  230 (284)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-----------HHHHHTTCCC-
T ss_pred             ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HH-----------HHHHhccccC-
Confidence                23456899999999999989999999999999999999999999752111  00           0111111110 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .+.       ....++.+++.+|++.|| ++|||++|+++
T Consensus       231 ~~~-------~~~~~~~~li~~~l~~~p-~~Rps~~~ll~  262 (284)
T 2vgo_A          231 FPP-------FLSDGSKDLISKLLRYHP-PQRLPLKGVME  262 (284)
T ss_dssp             CCT-------TSCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             CCC-------cCCHHHHHHHHHHhhcCH-hhCCCHHHHhh
Confidence            000       122457889999999999 99999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.2e-38  Score=335.69  Aligned_cols=245  Identities=18%  Similarity=0.262  Sum_probs=198.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999876 69999999987532  33456788899999999 89999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC--------------
Q 045539          691 IMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED--------------  753 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~--------------  753 (897)
                      ||||+++++|.+++....   ..+++.++..++.|++.||+||   |++||+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999987642   4589999999999999999999   88999999999999999844              


Q ss_pred             -----CcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          754 -----MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       754 -----~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                           ..+||+|||.+.......      ...||+.|+|||++.+. .+++++|||||||++|||++|..|+...    .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence                 479999999998765332      23589999999988765 5678999999999999999998876431    0


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..            ..+........+.       ....++.+++.+||+.|| ++|||++|+++.
T Consensus       236 ~~------------~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp-~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 QW------------HEIRQGRLPRIPQ-------VLSQEFTELLKVMIHPDP-ERRPSAMALVKH  280 (289)
T ss_dssp             HH------------HHHHTTCCCCCSS-------CCCHHHHHHHHHHTCSSG-GGSCCHHHHHTC
T ss_pred             HH------------HHHHcCCCCCCCc-------ccCHHHHHHHHHHhCCCc-ccCCCHHHHhhC
Confidence            11            1111111111110       122457899999999999 999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.5e-38  Score=343.16  Aligned_cols=267  Identities=23%  Similarity=0.319  Sum_probs=200.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999876 58999999986432  334567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++++|.++..... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999988765544 589999999999999999999   889999999999999999999999999999986643322


Q ss_pred             eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh--cCCchHHHHhhhh-
Q 045539          773 LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND--LLPVSVMEVIDTN-  848 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~-  848 (897)
                        ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ........  ............. 
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhcc
Confidence              22345689999999988765 78999999999999999999999997632111 11111100  0011111111100 


Q ss_pred             ---------hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 ---------LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 ---------l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                               +.... ............+.+++.+||+.|| ++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP-~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKERE-PLERRYPKLSEVVIDLAKKCLHIDP-DKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCC-CHHHHSTTSCHHHHHHHHHHTCSSG-GGSCCGGGGGG
T ss_pred             ccccccCccccccc-hhhhcccchhHHHHHHHHHHhccCc-ccCCCHHHHhc
Confidence                     00000 0001111334568999999999999 99999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.5e-38  Score=342.76  Aligned_cols=249  Identities=19%  Similarity=0.271  Sum_probs=204.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            568999999999999999999876 58899999987542   34567788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887643 589999999999999999999   78899999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+     .        ...+...... 
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~--------~~~~~~~~~~-  259 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----T--------YLRIKKNEYS-  259 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H--------HHHHHHTCCC-
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----H--------HHHHhcCCCC-
Confidence            2  2234568999999999988889999999999999999999999997521110     0        0001110000 


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .+.       .....+.+++.+||+.|| ++|||++|+++.
T Consensus       260 ~~~-------~~~~~~~~li~~~l~~dp-~~Rps~~ell~~  292 (335)
T 2owb_A          260 IPK-------HINPVAASLIQKMLQTDP-TARPTINELLND  292 (335)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSG-GGSCCGGGGGGS
T ss_pred             CCc-------cCCHHHHHHHHHHccCCh-hHCcCHHHHhcC
Confidence            000       122347789999999999 999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=348.67  Aligned_cols=252  Identities=21%  Similarity=0.257  Sum_probs=185.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeee--------cC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSC--------SN  684 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~--------~~  684 (897)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++        ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3468999999999999999999875 68999999987666666778899999999996 99999999998        34


Q ss_pred             CCceEEEEEeccCCChhHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeCCCCcEEEee
Q 045539          685 DDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                      ....++||||++ |+|.+++..  ....+++.++..++.|++.||+||   |+.|  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEec
Confidence            456799999995 789888764  334699999999999999999999   7788  99999999999999999999999


Q ss_pred             ccCccccCCCCcee----------eeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          761 FGIAKLLSGEDQLS----------IQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       761 Fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ||++..........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||......  
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--  259 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--  259 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence            99998765432211          11134589999999987   5677899999999999999999999999752111  


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                         +            ++.........      ......+.+++.+||+.|| ++|||++|+++.|+
T Consensus       260 ---~------------~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 ---R------------IVNGKYSIPPH------DTQYTVFHSLIRAMLQVNP-EERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---------------------CCCCTT------CCSSGGGHHHHHHHSCSSG-GGSCCHHHHHHHHH
T ss_pred             ---H------------hhcCcccCCcc------cccchHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence               0            11111100000      0111236789999999999 99999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.6e-38  Score=337.02  Aligned_cols=252  Identities=20%  Similarity=0.282  Sum_probs=203.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---------HHHHHHHHHHHHHHHhcC-CCccceEeeeec
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---------ERALKSFEDECEVMKRIR-HRNLVKIISSCS  683 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  683 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999876 68999999986432         234567889999999996 999999999999


Q ss_pred             CCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       684 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      +++..++||||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999987653 589999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccC------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGT------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +........   .....|++.|+|||++.      ...++.++||||||+++|||++|+.||......  ...+      
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~------  239 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLR------  239 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH------
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHH------
Confidence            987654322   23456899999999863      556889999999999999999999999652111  0000      


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           .+.........    +.......++.+++.+|++.|| ++|||++|+++
T Consensus       240 -----~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~  283 (298)
T 1phk_A          240 -----MIMSGNYQFGS----PEWDDYSDTVKDLVSRFLVVQP-QKRYTAEEALA  283 (298)
T ss_dssp             -----HHHHTCCCCCT----TTGGGSCHHHHHHHHHHCCSSG-GGSCCHHHHTT
T ss_pred             -----HHhcCCcccCc----ccccccCHHHHHHHHHHccCCc-ccCCCHHHHHh
Confidence                 11111100000    0011233457899999999999 99999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=352.19  Aligned_cols=259  Identities=12%  Similarity=0.120  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC---------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccce---------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD---------GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVK---------  677 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  677 (897)
                      .++|++.+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998763         789999998755     46788999999999999988         


Q ss_pred             ------EeeeecC-CCceEEEEEeccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCee
Q 045539          678 ------IISSCSN-DDFKALIMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVL  749 (897)
Q Consensus       678 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIl  749 (897)
                            +++++.. ++..|+||||+ +++|.+++... ...+++.++..++.|++.||+||   |++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEE
Confidence                  5566654 67889999999 99999999875 35699999999999999999999   7889999999999999


Q ss_pred             eCCCC--cEEEeeccCccccCCCCcee-----eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          750 LDEDM--VAHISDFGIAKLLSGEDQLS-----IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       750 l~~~~--~~kL~DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      ++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998764322111     113347899999999999989999999999999999999999999864


Q ss_pred             ccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          823 FIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       823 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .............         +......... ..........++.+++.+||+.|| ++|||++||++.|+
T Consensus       272 ~~~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp-~~Rps~~~l~~~L~  332 (352)
T 2jii_A          272 LPNTEDIMKQKQK---------FVDKPGPFVG-PCGHWIRPSETLQKYLKVVMALTY-EEKPPYAMLRNNLE  332 (352)
T ss_dssp             TTCHHHHHHHHHH---------HHHSCCCEEC-TTSCEECCCHHHHHHHHHHHTCCT-TCCCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHh---------ccCChhhhhh-hccccCCCcHHHHHHHHHHHhCCh-hhCCCHHHHHHHHH
Confidence            3221111111100         0000000000 000000112458899999999999 99999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-37  Score=336.67  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .+.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999865 68999999987543 3345788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+........ 
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999998764  489999999999999999999   789999999999999999999999999999987653321 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......  .....+....+        ..+..  
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~--  241 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNP--------PTLEG--  241 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC--------CCCCS--
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCC--------CCCcc--
Confidence             223456899999999999999999999999999999999999998753111  01111110000        00111  


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                              .....+.+++.+||+.|| ++|||++|+++.
T Consensus       242 --------~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 --------NYSKPLKEFVEACLNKEP-SFRPTAKELLKH  271 (303)
T ss_dssp             --------SCCHHHHHHHHHHCCSSG-GGSCCHHHHTTC
T ss_pred             --------ccCHHHHHHHHHHcCCCh-hhCcCHHHHhhC
Confidence                    122457899999999999 999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-37  Score=330.56  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=195.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|.+.+.||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999876 699999999976532   2356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 489999999999999999999   78999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                         ......|++.|+|||...+..+ +.++||||||+++|+|++|+.||......  ..            .+.+.....
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~------------~~~~~~~~~  228 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TL------------FKKIRGGVF  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH------------HHHHHHCCC
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HH------------HHHhhcCcc
Confidence               1234468999999999887765 68999999999999999999999752111  00            111111110


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..+.       .....+.+++.+|++.|| ++|||++|+++.
T Consensus       229 ~~~~-------~~~~~l~~li~~~l~~~p-~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YIPE-------YLNRSVATLLMHMLQVDP-LKRATIKDIREH  262 (276)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSSG-GGSCCHHHHHHS
T ss_pred             cCch-------hcCHHHHHHHHHHccCCh-hhCCCHHHHHhC
Confidence            0010       122457889999999999 999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=334.18  Aligned_cols=252  Identities=20%  Similarity=0.256  Sum_probs=197.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH----HHHHHHHHHHHHHHhcCCCccceEeeee--cCCCc
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE----RALKSFEDECEVMKRIRHRNLVKIISSC--SNDDF  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~  687 (897)
                      ..++|++.+.||+|+||.||+|... +++.||+|+++....    ...+.+.+|++++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4579999999999999999999875 688999999976532    3457889999999999999999999998  45568


Q ss_pred             eEEEEEeccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          688 KALIMKYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      .++||||++++ +.+++... ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 66666543 35689999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCC--CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGR--VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ..............||+.|+|||+..+..  ++.++||||||+++|||++|+.||......     +         ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~---------~~~~  224 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----K---------LFEN  224 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----H---------HHHH
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----H---------HHHH
Confidence            65433333344556999999999876543  478999999999999999999999752110     0         0111


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.......+       ..+...+.+++.+|++.|| ++|||++|+++.
T Consensus       225 i~~~~~~~~-------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~~  264 (305)
T 2wtk_C          225 IGKGSYAIP-------GDCGPPLSDLLKGMLEYEP-AKRFSIRQIRQH  264 (305)
T ss_dssp             HHHCCCCCC-------SSSCHHHHHHHHHHTCSST-TTSCCHHHHHHS
T ss_pred             HhcCCCCCC-------CccCHHHHHHHHHHccCCh-hhCCCHHHHhcC
Confidence            111000000       0123457889999999999 999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=341.62  Aligned_cols=251  Identities=25%  Similarity=0.300  Sum_probs=199.3

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999876 58999999987543  23678899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||.+........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            9999999999875555699999999999999999999   889999999999999999999999999999987653321 


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......|++.|+|||+..+..++.++||||||+++|+|++|+.||.......  ....+....+        .... .+
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------~~~~-~~  248 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPP--------PTFR-KP  248 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC--------CCCS-SG
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCC--------cccC-Cc
Confidence             2234568999999999998899999999999999999999999997531110  0000000000        0000 00


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                             ......+.+++.+||+.|| ++|||++|+++
T Consensus       249 -------~~~~~~l~~li~~~l~~dp-~~Rpt~~~ll~  278 (314)
T 3com_A          249 -------ELWSDNFTDFVKQCLVKSP-EQRATATQLLQ  278 (314)
T ss_dssp             -------GGSCHHHHHHHHHHTCSCT-TTSCCHHHHTT
T ss_pred             -------ccCCHHHHHHHHHHccCCh-hhCcCHHHHHh
Confidence                   1123457899999999999 99999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=369.95  Aligned_cols=255  Identities=24%  Similarity=0.428  Sum_probs=206.5

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ...++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..|+|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3457899999999999999999999888889999998643 234678999999999999999999999976 67899999


Q ss_pred             eccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++|+|.+++.... ..+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            999999999997532 4589999999999999999999   88999999999999999999999999999998764221 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      ........++..|+|||++..+.++.++|||||||++|||++ |+.||......              +..+.+......
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------------~~~~~i~~~~~~  483 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------------EVLDQVERGYRM  483 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------------HHHHHHHTTCCC
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCCCC
Confidence            111223456788999999888899999999999999999999 99998753211              111111111110


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...      ..+..++.+++.+||+.|| ++|||+++|++.|++
T Consensus       484 ~~~------~~~~~~l~~li~~cl~~dP-~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          484 PCP------PECPESLHDLMCQCWRKEP-EERPTFEYLQAFLED  520 (535)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             CCC------CCCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence            000      1233457899999999999 999999999998864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-37  Score=335.33  Aligned_cols=250  Identities=21%  Similarity=0.251  Sum_probs=185.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...  ....+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            578999999999999999999874 68999999997542  223344555666688889999999999999999999999


Q ss_pred             EeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          693 KYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       693 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ||++ ++|.+++..   ....+++..+..++.|++.||+||   |++ ||+||||||+||+++.++.+||+|||.+....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588776653   345699999999999999999999   777 99999999999999999999999999998764


Q ss_pred             CCCceeeeeccccCcccCCcCcc----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYG----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ....   .....||+.|+|||++    .+..++.++||||+|+++|||++|+.||...........            ..
T Consensus       162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~  226 (290)
T 3fme_A          162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK------------QV  226 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH------------HH
T ss_pred             cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH------------HH
Confidence            3322   2234689999999985    566789999999999999999999999975211111111            11


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.......+.      .....++.+++.+|++.|| ++|||++|+++
T Consensus       227 ~~~~~~~~~~------~~~~~~~~~li~~~l~~~p-~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPSPQLPA------DKFSAEFVDFTSQCLKKNS-KERPTYPELMQ  266 (290)
T ss_dssp             HHSCCCCCCT------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHTT
T ss_pred             hccCCCCccc------ccCCHHHHHHHHHHhhcCh-hhCcCHHHHHh
Confidence            1111111110      1123457899999999999 99999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=370.88  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             CCCcCC-eeecccceEEEEEEec---CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          618 RFSENN-LIGIGSFGSIYVARLQ---DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       618 ~y~~~~-~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +|.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.+ +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999764   46679999997643 2346789999999999999999999999976 5689999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++......+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999987777799999999999999999999   789999999999999999999999999999987653322


Q ss_pred             e-eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          773 L-SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       773 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      . .......+++.|+|||++....++.++|||||||++|||++ |+.||......  .            ..+.+.....
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~------------~~~~i~~~~~  557 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--E------------VMAFIEQGKR  557 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--H------------HHHHHHTTCC
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--H------------HHHHHHcCCC
Confidence            1 11222345689999999988899999999999999999998 99999763211  1            1111211111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ...+      ..+..++.+++.+||+.|| ++||++++|++.|+.
T Consensus       558 ~~~p------~~~~~~l~~li~~cl~~dP-~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          558 MECP------PECPPELYALMSDCWIYKW-EDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCCC------TTCCHHHHHHHHHTTCSST-TTSCCHHHHHHHHHH
T ss_pred             CCCC------CcCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence            0000      1234568899999999999 999999999998853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-38  Score=342.52  Aligned_cols=267  Identities=20%  Similarity=0.214  Sum_probs=193.1

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ...++|++.+.||+|+||+||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            45679999999999999999999865 68999999987543  2234567899999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee-----CCCCcEEEeeccCcc
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL-----DEDMVAHISDFGIAK  765 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll-----~~~~~~kL~DFg~a~  765 (897)
                      ||||++ ++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++     +.++.+||+|||++.
T Consensus       111 v~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999997 59999987765 489999999999999999999   78999999999999999     455569999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-cCCch--H
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-LLPVS--V  841 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~  841 (897)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ........ ..+..  .
T Consensus       186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhh
Confidence            764322  222345689999999988764 48999999999999999999999997532111 11111100 00000  0


Q ss_pred             HH---------HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          842 ME---------VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       842 ~~---------~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..         ...........  .........++.+++.+|++.|| ++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLK--RVLGALLDDEGLDLLTAMLEMDP-VKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHH--HHHGGGSCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHh--hhcccccCHHHHHHHHHHccCCh-hhCCCHHHHhC
Confidence            00         00000000000  00001123557899999999999 99999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=334.55  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=196.4

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      +|.....||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555669999999999999864 688999999976655556788999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCccccCCCCce
Q 045539          697 NGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       697 ~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++|.+++....  ...++..+..++.|++.||+||   |++||+||||||+||+++. ++.+||+|||.+........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            999999987653  3467888999999999999999   7899999999999999987 89999999999987643221 


Q ss_pred             eeeeccccCcccCCcCccCCCC--CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          774 SIQIQTLATIGYMAPEYGTKGR--VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                       ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||............            ........
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~~~~~~  245 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK------------VGMFKVHP  245 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH------------HHHHCCCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh------------hccccccc
Confidence             223456899999999876543  789999999999999999999999752111100000            00000000


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+      .....++.+++.+||+.|| ++|||++|+++
T Consensus       246 ~~~------~~~~~~~~~li~~~l~~dp-~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIP------ESMSAEAKAFILKCFEPDP-DKRACANDLLV  278 (295)
T ss_dssp             CCC------TTSCHHHHHHHHHTTCSST-TTSCCHHHHHT
T ss_pred             ccc------ccCCHHHHHHHHHHccCCh-hhCCCHHHHhc
Confidence            000      1123457889999999999 99999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-38  Score=346.91  Aligned_cols=263  Identities=23%  Similarity=0.280  Sum_probs=184.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC------C
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND------D  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  686 (897)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            579999999999999999999864 68999999986532  34457788999999999999999999998654      5


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+|||++ +++|.+++...  .+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 78999988764  489999999999999999999   889999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-----------
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-----------  834 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-----------  834 (897)
                      ....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....           
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            5422     234578999999998776 67899999999999999999999999753211 01111111           


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHH-HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFA-AKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..........+.. +...+...+. ........+.+++.+|++.|| ++|||++|+++.
T Consensus       256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP-~~R~t~~e~L~h  312 (367)
T 2fst_X          256 KISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAH  312 (367)
T ss_dssp             TCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHTS
T ss_pred             HhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc-ccCcCHHHHhcC
Confidence            0001111111111 1111100011 111223557899999999999 999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-38  Score=341.67  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=195.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--CCc--eEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--DGM--EVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            468999999999999999999853  233  68999987542   344678899999999999999999999998765 7


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999987666699999999999999999999   78899999999999999999999999999998775


Q ss_pred             CCCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          769 GEDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       769 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ...... ......+|+.|+|||+..+..++.++||||||+++|||++ |+.||......  ....           .+..
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~-----------~~~~  239 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILH-----------KIDK  239 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH-----------HHHT
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHH-----------HHHc
Confidence            443322 2233457889999999888888999999999999999999 99999753111  0000           0100


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .......      ...+..++.+++.+||+.|| ++|||++|+++.|++
T Consensus       240 ~~~~~~~------~~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~l~~  281 (291)
T 1u46_A          240 EGERLPR------PEDCPQDIYNVMVQCWAHKP-EDRPTFVALRDFLLE  281 (291)
T ss_dssp             SCCCCCC------CTTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             cCCCCCC------CcCcCHHHHHHHHHHccCCc-ccCcCHHHHHHHHHH
Confidence            0000000      01223458899999999999 999999999998853

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-38  Score=337.65  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC-CCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-DDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. |+.||+|+++...  ..+.+.+|++++++++||||+++++++.+ ++..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            578999999999999999999876 8999999987543  34678899999999999999999998754 4578999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            99999999987654 2378899999999999999999   88999999999999999999999999999987654321  


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         ....+++.|+|||...+..++.++||||||+++|||++ |+.||......  .....            +.......
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~------------~~~~~~~~  234 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR------------VEKGYKMD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH------------HTTTCCCC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HhcCCCCC
Confidence               22357889999999988889999999999999999998 99998753211  11111            11110000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      ..      ......+.+++.+||+.|| ++|||++|+++.|++
T Consensus       235 ~~------~~~~~~l~~li~~~l~~~p-~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          235 AP------DGCPPAVYEVMKNCWHLDA-AMRPSFLQLREQLEH  270 (278)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             Cc------ccCCHHHHHHHHHHhcCCh-hhCCCHHHHHHHHHH
Confidence            00      1123457899999999999 999999999998853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-38  Score=337.55  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=201.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeee--cCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSC--SNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++  ..++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999876 68999999987432  34567889999999999999999999987  44678899


Q ss_pred             EEEeccCCChhHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          691 IMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVALALEYLHFGHSTP-----IIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~-----ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+||   |+.|     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532   4589999999999999999999   6666     9999999999999999999999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                      .+........  ......|++.|+|||+..+..++.++||||||+++|+|++|+.||......  .....+         
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i---------  228 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI---------  228 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---------
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHH---------
Confidence            9987643321  122346899999999998888999999999999999999999999763111  111111         


Q ss_pred             HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          843 EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       843 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                        ........+       .....++.+++.+||+.|| ++|||++||++.+.
T Consensus       229 --~~~~~~~~~-------~~~~~~l~~li~~~l~~~p-~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          229 --REGKFRRIP-------YRYSDELNEIITRMLNLKD-YHRPSVEEILENPL  270 (279)
T ss_dssp             --HHTCCCCCC-------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHTSTT
T ss_pred             --hhcccccCC-------cccCHHHHHHHHHHcCCCc-ccCCCHHHHHhChh
Confidence              111000001       0123457899999999999 99999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.1e-38  Score=346.94  Aligned_cols=270  Identities=20%  Similarity=0.264  Sum_probs=200.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecC--------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSN--------  684 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  684 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.....  .....+.+|++++++++||||+++++++.+        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999874 689999999864432  223567789999999999999999999876        


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..++||||+++ ++.+.+......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999975 78777777666799999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCc--eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh---hcCC
Q 045539          765 KLLSGEDQ--LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN---DLLP  838 (897)
Q Consensus       765 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~  838 (897)
                      ........  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .....+.   ...+
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSIT  249 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence            87642221  122234568999999998765 56799999999999999999999999763211  1111110   0011


Q ss_pred             chH-HH-----Hhhhh--hcchhhhhHHHHH--HHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 VSV-ME-----VIDTN--LLRGEERFFAAKE--QILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ~~~-~~-----~i~~~--l~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ... ..     ..+..  .............  .....+.+++.+|++.|| ++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP-AQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG-GGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh-hhCCCHHHHhCC
Confidence            100 00     00000  0000000000000  112457899999999999 999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-37  Score=355.13  Aligned_cols=259  Identities=20%  Similarity=0.259  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-cCCceEEEEEechhhHHHHHHHHHHHHHHHhcCC-CccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH-RNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|++ .+++.||||++......  +.+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999986 46899999987654322  457789999999986 566667777788889999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee---CCCCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+ +++|.+++......+++.+++.|+.||+.||+||   |++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999987666799999999999999999999   88999999999999999   58889999999999876543


Q ss_pred             Cce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          771 DQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       771 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....        ...+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~--------~~~i~  229 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQK--------YEKIS  229 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHH--------HHHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHH--------HHHHh
Confidence            321     11225579999999999999999999999999999999999999997632221  0000        11111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...+....+   .....+..++.+++..||+.|| ++||++++|++.|+
T Consensus       230 ~~~~~~~~~---~l~~~~p~~l~~li~~cl~~dP-~~RPs~~el~~~L~  274 (483)
T 3sv0_A          230 EKKVATSIE---ALCRGYPTEFASYFHYCRSLRF-DDKPDYSYLKRLFR  274 (483)
T ss_dssp             HHHHHSCHH---HHHTTSCHHHHHHHHHHHTCCT-TCCCCHHHHHHHHH
T ss_pred             hccccccHH---HHhcCCcHHHHHHHHHHhcCCh-hhCcCHHHHHHHHH
Confidence            111111110   0111234568999999999999 99999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-38  Score=356.15  Aligned_cols=240  Identities=15%  Similarity=0.179  Sum_probs=186.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh---hHHHHHHHHHHHH---HHHhcCCCccceEe-------ee
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ---YERALKSFEDECE---VMKRIRHRNLVKII-------SS  681 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  681 (897)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467899999999999999999864 6999999998743   2345678899995   55555799999998       55


Q ss_pred             ecCCC-----------------ceEEEEEeccCCChhHhhhcCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 045539          682 CSNDD-----------------FKALIMKYMPNGSLENCLYSGTC------MLDIFQRLNIMIDVALALEYLHFGHSTPI  738 (897)
Q Consensus       682 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~L~~Lh~~h~~~i  738 (897)
                      +.+++                 ..|+||||+ +|+|.+++.....      .+++..+..++.||+.||+||   |++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence            55443                 378999999 6899999876432      233578889999999999999   78999


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-----------CCCccchHHHHHH
Q 045539          739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-----------RVCTRGDVYSYGI  807 (897)
Q Consensus       739 vH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGv  807 (897)
                      +||||||+||+++.++.+||+|||+|+....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2334567 999999998877           8999999999999


Q ss_pred             HHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHH
Q 045539          808 MLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMG  887 (897)
Q Consensus       808 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~  887 (897)
                      ++|||++|+.||.......  ....+           .. .. .          .+..++.+++.+||+.|| ++|||++
T Consensus       302 il~elltg~~Pf~~~~~~~--~~~~~-----------~~-~~-~----------~~~~~~~~li~~~L~~dp-~~Rpt~~  355 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG--GSEWI-----------FR-SC-K----------NIPQPVRALLEGFLRYPK-EDRLLPL  355 (377)
T ss_dssp             HHHHHHHSSCCC------C--CSGGG-----------GS-SC-C----------CCCHHHHHHHHHHTCSSG-GGCCCHH
T ss_pred             HHHHHHHCCCCCccccccc--chhhh-----------hh-hc-c----------CCCHHHHHHHHHHcCCCc-hhCCCHH
Confidence            9999999999997632111  00000           00 00 0          112347889999999999 9999999


Q ss_pred             HHHh
Q 045539          888 WIFS  891 (897)
Q Consensus       888 evl~  891 (897)
                      |+++
T Consensus       356 e~l~  359 (377)
T 3byv_A          356 QAME  359 (377)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.1e-38  Score=349.60  Aligned_cols=263  Identities=22%  Similarity=0.335  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999876 68999999987542 3445788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++++|.+++.... .+++..+..++.|++.||+||   |+. ||+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999987654 589999999999999999999   664 9999999999999999999999999998765322  


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh-------------------
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI-------------------  833 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~-------------------  833 (897)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+                   
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccCCCCCCCcccCC
Confidence              12345689999999999999999999999999999999999999975321110  0000                   


Q ss_pred             --------hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          834 --------NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       834 --------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                              ....+....+.++...........  ......++.+++.+||+.|| ++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNP-AERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSST-TTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcCh-hhCCCHHHHhh
Confidence                    000001112222221111111000  01123468899999999999 99999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5e-38  Score=343.95  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=199.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCce--EEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGME--VAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|+.. +|..  ||+|+++... ....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999865 4664  4999887532 33456788999999999 89999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          691 IMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      ||||+++++|.+++....               ..+++.++..++.|++.||+||   |++||+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCe
Confidence            999999999999987653               4689999999999999999999   8899999999999999999999


Q ss_pred             EEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhh
Q 045539          756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWIN  834 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~  834 (897)
                      +||+|||+++.....   .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......  ..     
T Consensus       181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~-----  250 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL-----  250 (327)
T ss_dssp             EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH-----
T ss_pred             EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HH-----
Confidence            999999998743211   11223356889999999888889999999999999999998 99999753111  01     


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                             .+.+.........      ..+..++.+++.+||+.|| ++|||++|+++.|+
T Consensus       251 -------~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~~L~  296 (327)
T 1fvr_A          251 -------YEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKP-YERPSFAQILVSLN  296 (327)
T ss_dssp             -------HHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             -------HHHhhcCCCCCCC------CCCCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence                   1111111000000      0123457899999999999 99999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-38  Score=340.70  Aligned_cols=262  Identities=24%  Similarity=0.320  Sum_probs=185.2

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999865 68999999987543 334567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          693 KYMPNGSLENCLYS-------GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       693 e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ||+++++|.+++..       ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864       234589999999999999999999   78899999999999999999999999999987


Q ss_pred             ccCCCCc---eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchH
Q 045539          766 LLSGEDQ---LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSV  841 (897)
Q Consensus       766 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  841 (897)
                      .......   ........||+.|+|||+..+ ..++.++||||||+++|||++|+.||........ .........+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  248 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDPPSLE  248 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHTSSCCCTT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhccCCCccc
Confidence            6643221   111234468999999998765 5688999999999999999999999976322111 1111111110000


Q ss_pred             HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          842 MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       842 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....+.....          ....++.+++.+||+.|| ++|||++|+++
T Consensus       249 ~~~~~~~~~~----------~~~~~~~~li~~~l~~dp-~~Rps~~~ll~  287 (303)
T 2vwi_A          249 TGVQDKEMLK----------KYGKSFRKMISLCLQKDP-EKRPTAAELLR  287 (303)
T ss_dssp             C-----CCCC----------CCCHHHHHHHHHHCCSSG-GGSCCHHHHHT
T ss_pred             cccccchhhh----------hhhHHHHHHHHHHccCCh-hhCcCHHHHhh
Confidence            0001111111          112357889999999999 99999999987

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=358.14  Aligned_cols=313  Identities=20%  Similarity=0.178  Sum_probs=247.2

Q ss_pred             ccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCC
Q 045539           86 FNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMP  165 (897)
Q Consensus        86 ~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p  165 (897)
                      ++++ .+|..+.  +++++|||++|++++..|..|.++++|++|+|++|++.+..|..|.++++|++|+|++|++++..+
T Consensus        21 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   97 (477)
T 2id5_A           21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL   97 (477)
T ss_dssp             CCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCT
T ss_pred             CCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCc
Confidence            3444 5666553  588999999999998888899999999999999999998889999999999999999999986555


Q ss_pred             ccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCC
Q 045539          166 REIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNAS  245 (897)
Q Consensus       166 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  245 (897)
                      ..|+++++|++|+|++|+++++.+..|.++++|++|+|++|++++..| ..+..+++|++|+|++|.+++..+..+.+++
T Consensus        98 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~  176 (477)
T 2id5_A           98 GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH-RAFSGLNSLEQLTLEKCNLTSIPTEALSHLH  176 (477)
T ss_dssp             TSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT-TSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred             ccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh-hhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence            678899999999999999999988899999999999999999984444 4455789999999999999887777889999


Q ss_pred             cccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccC
Q 045539          246 KLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNC  325 (897)
Q Consensus       246 ~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n  325 (897)
                      +|+.|+|++|.+.+..+..                     +..+++|++|++++|++.+.+|...               
T Consensus       177 ~L~~L~l~~n~i~~~~~~~---------------------~~~l~~L~~L~l~~~~~~~~~~~~~---------------  220 (477)
T 2id5_A          177 GLIVLRLRHLNINAIRDYS---------------------FKRLYRLKVLEISHWPYLDTMTPNC---------------  220 (477)
T ss_dssp             TCCEEEEESCCCCEECTTC---------------------SCSCTTCCEEEEECCTTCCEECTTT---------------
T ss_pred             CCcEEeCCCCcCcEeChhh---------------------cccCcccceeeCCCCccccccCccc---------------
Confidence            9999999999988776654                     4567889999999988766544332               


Q ss_pred             CCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCc
Q 045539          326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS  405 (897)
Q Consensus       326 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  405 (897)
                                ....+|++|++++|+++++.+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|.
T Consensus       221 ----------~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  290 (477)
T 2id5_A          221 ----------LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY  290 (477)
T ss_dssp             ----------TTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred             ----------ccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence                      2233677777777777765556677777777777777777766666777777777777777777777777


Q ss_pred             ccccccccceeccccccccCCccccccccccceEEeecCCccc
Q 045539          406 CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN  448 (897)
Q Consensus       406 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  448 (897)
                      .|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus       291 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          291 AFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             TBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             HhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence            7777777777777777777666666777777776666666554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-37  Score=346.27  Aligned_cols=269  Identities=20%  Similarity=0.228  Sum_probs=201.5

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----C
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----D  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  686 (897)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34568999999999999999999865 68899999987433 34457889999999999999999999998654     4


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||++ ++|.+++....  +++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+..
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            6899999996 58999887754  89999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCCcee-eeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchH---
Q 045539          767 LSGEDQLS-IQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSV---  841 (897)
Q Consensus       767 ~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  841 (897)
                      ........ ......||+.|+|||++. ...++.++||||+||++|||++|+.||......  .....+........   
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQED  255 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSCCHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCCCHHH
Confidence            64322111 123457999999999754 455899999999999999999999999763211  11111111100000   


Q ss_pred             ---------HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          842 ---------MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       842 ---------~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                               ........................++.+++.+|++.|| ++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCCh-hhCCCHHHHhc
Confidence                     00000000000000000011223567899999999999 99999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-37  Score=340.12  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=197.1

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCccceEeeeecCC
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIRHRNLVKIISSCSND  685 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  685 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4568999999999999999999875 58899999986432        12234578999999999999999999999776


Q ss_pred             CceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc---EEEeecc
Q 045539          686 DFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHISDFG  762 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~---~kL~DFg  762 (897)
                      + .|+||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999887654 589999999999999999999   7899999999999999987654   9999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCcc---CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYG---TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV  839 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  839 (897)
                      ++.......   ......||+.|+|||++   ....++.++|||||||++|+|++|+.||....... .....+..    
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~----  234 (322)
T 2ycf_A          163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITS----  234 (322)
T ss_dssp             TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHH----
T ss_pred             cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHh----
Confidence            998764322   12234689999999985   35678999999999999999999999997532221 11111111    


Q ss_pred             hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                              ......   .........++.+++.+|++.|| ++|||++|+++
T Consensus       235 --------~~~~~~---~~~~~~~~~~~~~li~~~l~~dP-~~Rps~~~~l~  274 (322)
T 2ycf_A          235 --------GKYNFI---PEVWAEVSEKALDLVKKLLVVDP-KARFTTEEALR  274 (322)
T ss_dssp             --------TCCCCC---HHHHTTSCHHHHHHHHHHSCSST-TTSCCHHHHHT
T ss_pred             --------CccccC---chhhhhcCHHHHHHHHHHcccCH-hhCCCHHHHhh
Confidence                    000000   01112234568899999999999 99999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.4e-38  Score=335.82  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=200.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC---------
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN---------  684 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  684 (897)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4568999999999999999999876 79999999987543    346789999999999999999998854         


Q ss_pred             -------CCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          685 -------DDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       685 -------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                             ....++||||+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCCE
Confidence                   445799999999999999997543 5689999999999999999999   78899999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      ||+|||.+........   .....||+.|+|||++.+..++.++||||||+++|||++|..|+....       ..    
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~----  227 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KF----  227 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HH----
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HH----
Confidence            9999999987654322   234468999999999988889999999999999999999999875411       00    


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                          ...+....+...          ....+.+++.+||+.|| ++|||++|+++.|+
T Consensus       228 ----~~~~~~~~~~~~----------~~~~~~~li~~~l~~dp-~~Rps~~e~l~~l~  270 (284)
T 2a19_B          228 ----FTDLRDGIISDI----------FDKKEKTLLQKLLSKKP-EDRPNTSEILRTLT  270 (284)
T ss_dssp             ----HHHHHTTCCCTT----------SCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ----HHHhhccccccc----------CCHHHHHHHHHHccCCh-hhCcCHHHHHHHHH
Confidence                011111111111          12346789999999999 99999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.4e-37  Score=342.27  Aligned_cols=262  Identities=21%  Similarity=0.224  Sum_probs=192.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999865 68999999987532  344577889999999999999999999997654      


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||+++ +|.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            67999999964 78887753   388999999999999999999   789999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc----------
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL----------  836 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~----------  836 (897)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...+...          
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHH
Confidence            54321   223456899999999999889999999999999999999999999753211 0111111000          


Q ss_pred             CCchHH---------------HHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          837 LPVSVM---------------EVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       837 ~~~~~~---------------~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ......               ..........   ..........++.+++.+|++.|| ++|||++|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~mL~~dP-~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPA---DSEHNKLKASQARDLLSKMLVIDA-SKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCC---SSHHHHHHHHHHHHHHHHHSCSSG-GGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcc---cccccccccHHHHHHHHHHCcCCh-hhCCCHHHHhCC
Confidence            000000               0000000000   011122335678999999999999 999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=337.30  Aligned_cols=267  Identities=22%  Similarity=0.284  Sum_probs=195.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeec-----------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCS-----------  683 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  683 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999876 48999999998666666788999999999999999999999873           


Q ss_pred             ---CCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEe
Q 045539          684 ---NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHIS  759 (897)
Q Consensus       684 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~  759 (897)
                         +....++||||++ ++|.+++..+  .+++..+..++.|++.||+||   |++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 6999998764  489999999999999999999   789999999999999997 56799999


Q ss_pred             eccCccccCCCCc-eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          760 DFGIAKLLSGEDQ-LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       760 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      |||.+........ ........+|..|+|||.... ..++.++||||||+++|||++|+.||......  .....+....
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~  241 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESI  241 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc
Confidence            9999987643211 112234457999999997654 67899999999999999999999999763211  1111111111


Q ss_pred             Cch----HHHHhh-------hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          838 PVS----VMEVID-------TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       838 ~~~----~~~~i~-------~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +..    ..++..       ...................++.+++.+|++.|| ++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG-GGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc-cccCCHHHHhC
Confidence            110    011100       000000000001111234668999999999999 99999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-37  Score=336.94  Aligned_cols=261  Identities=19%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             CCHHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcC--CCccceEeeee
Q 045539          607 FSYHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIR--HRNLVKIISSC  682 (897)
Q Consensus       607 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~  682 (897)
                      +.++.+....++|++.+.||+|+||.||+|...+++.||+|++...  .....+.+.+|++++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3333444456789999999999999999999888999999998643  2445678899999999997  59999999999


Q ss_pred             cCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          683 SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       683 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                      .+++..++||| +.+++|.+++.... .+++.++..++.|+++||+||   |++||+||||||+||++++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 56889999998765 589999999999999999999   7889999999999999964 899999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTK-----------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR  831 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~  831 (897)
                      ++................||+.|+|||++..           ..++.++||||||+++|||++|+.||.........   
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---  248 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---  248 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---
Confidence            9987654433223334568999999998765           47888999999999999999999999753211111   


Q ss_pred             HhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          832 WINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       832 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               ....++.......+.      ....++.+++.+||+.|| ++|||++|+++.
T Consensus       249 ---------~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp-~~Rps~~ell~h  293 (313)
T 3cek_A          249 ---------LHAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDP-KQRISIPELLAH  293 (313)
T ss_dssp             ---------HHHHHCTTSCCCCCC------CSCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             ---------HHHHHhcccccCCcc------cchHHHHHHHHHHccCCc-ccCcCHHHHhcC
Confidence                     111222111111110      112357889999999999 999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.7e-37  Score=341.35  Aligned_cols=263  Identities=20%  Similarity=0.263  Sum_probs=204.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHH-----------------HHHHHHHHHHHHhcCCCccceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERA-----------------LKSFEDECEVMKRIRHRNLVKI  678 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  678 (897)
                      .++|++.+.||+|+||.||+|+. +|+.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 89999999997654321                 1788999999999999999999


Q ss_pred             eeeecCCCceEEEEEeccCCChhHh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeee
Q 045539          679 ISSCSNDDFKALIMKYMPNGSLENC------LYSG-TCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLL  750 (897)
Q Consensus       679 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll  750 (897)
                      ++++.+++..++||||+++++|.++      +... ...+++..+..++.|++.||+||   |+ +||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5543 35699999999999999999999   76 999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-CCCc-cchHHHHHHHHHHHHcCCCCCcccccCccc
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCT-RGDVYSYGIMLMEMFTKKKPTDEIFIGELS  828 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~slGvil~elltg~~p~~~~~~~~~~  828 (897)
                      +.++.+||+|||.+......    ......|++.|+|||+..+. .++. ++||||||+++|||++|+.||....... .
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-E  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-H
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-H
Confidence            99999999999999876433    23455799999999998877 6666 9999999999999999999997632211 1


Q ss_pred             hhHHhhhc---CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          829 LNRWINDL---LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       829 ~~~~~~~~---~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..+.+...   .+...............   .........++.+++.+||+.|| ++|||++|+++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP-~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKS---TCSNNFLSNEDIDFLKLFLRKNP-AERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC-----------CCCHHHHHHHHHHCCSSG-GGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhcccccccc---ccchhhcCHHHHHHHHHHccCCh-hhCCCHHHHhc
Confidence            11111110   01000000000000000   00012234567899999999999 99999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-37  Score=368.15  Aligned_cols=244  Identities=20%  Similarity=0.246  Sum_probs=200.4

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  689 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++++..   ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3578999999999999999999876 58899999998653   23346678899999988 6999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999988754 589999999999999999999   889999999999999999999999999999986432


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....                 .++....+
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----------------~~~~~~i~  555 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------------DELFQSIM  555 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred             CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHH
Confidence            222  23456799999999999999999999999999999999999999976211                 11111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCH
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADM  886 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~  886 (897)
                      ..... .+   .....++.+++.+|++.|| ++||++
T Consensus       556 ~~~~~-~p---~~~s~~~~~li~~lL~~dP-~~R~~~  587 (674)
T 3pfq_A          556 EHNVA-YP---KSMSKEAVAICKGLMTKHP-GKRLGC  587 (674)
T ss_dssp             SSCCC-CC---TTSCHHHHHHHHHHSCSSS-TTCTTC
T ss_pred             hCCCC-CC---ccCCHHHHHHHHHHccCCH-HHCCCC
Confidence            11110 00   1223457899999999999 999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-37  Score=341.63  Aligned_cols=263  Identities=21%  Similarity=0.243  Sum_probs=197.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK----  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  688 (897)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999865 68999999997542  34457888999999999999999999999877654    


Q ss_pred             --EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          689 --ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       689 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                        ++||||++ ++|.+++..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 688877643   389999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh----------
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND----------  835 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~----------  835 (897)
                      ....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+......          
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHHH
Confidence            5422     234568999999998876 67899999999999999999999999753211 011111100          


Q ss_pred             cCCch-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          836 LLPVS-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       836 ~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..... ....+.....................+.+++.+|++.|| ++|||++|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT-TTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh-hhcCCHHHHhcC
Confidence            00000 111111111100000011111234568899999999999 999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-37  Score=348.39  Aligned_cols=197  Identities=22%  Similarity=0.307  Sum_probs=172.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc------CCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI------RHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  688 (897)
                      ..+|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            468999999999999999999765 5899999999764 33346677888888887      477999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc--EEEeeccCcc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV--AHISDFGIAK  765 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~  765 (897)
                      ++||||+. ++|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.  +||+|||+|.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 68988887654 4589999999999999999999   7889999999999999999887  9999999997


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCccc
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEI  822 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~  822 (897)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            65432     22456899999999999989999999999999999999999999763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-37  Score=335.08  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=193.0

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC---------
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN---------  684 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  684 (897)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++... ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999875 6899999998754 3445788999999999999999999998754         


Q ss_pred             ----CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          685 ----DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       685 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                          .+..|+||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEee
Confidence                4567999999999999999987766788999999999999999999   788999999999999999999999999


Q ss_pred             ccCccccCCCCc------------eeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          761 FGIAKLLSGEDQ------------LSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       761 Fg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ||.+........            ........||+.|+|||++.+. .++.++|||||||++|||++   ||....... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-  235 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-  235 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-
Confidence            999986542210            1122345689999999988754 68999999999999999998   554311110 


Q ss_pred             chhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          828 SLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       828 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+            .......+...   .......+.+++.+||+.|| ++|||++|+++.
T Consensus       236 ~~~~~~------------~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp-~~Rps~~~ll~h  284 (303)
T 1zy4_A          236 NILKKL------------RSVSIEFPPDF---DDNKMKVEKKIIRLLIDHDP-NKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHH------------HSTTCCCCTTC---CTTTSHHHHHHHHHHTCSSG-GGSCCHHHHHHS
T ss_pred             HHHHhc------------cccccccCccc---cccchHHHHHHHHHHHhcCc-ccCcCHHHHhCC
Confidence            000000            00000000000   01223447889999999999 999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-37  Score=367.84  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=195.9

Q ss_pred             CeeecccceEEEEEEec---CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999986532  345789999999999999999999999975 457899999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce-eee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SIQ  776 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~  776 (897)
                      |+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++........ ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 589999999999999999999   7899999999999999999999999999999876543321 222


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....+|+.|+|||++....++.++|||||||++|||++ |+.||......              ...+.+........+ 
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------------~~~~~i~~~~~~~~p-  594 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------EVTAMLEKGERMGCP-  594 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------HHHHHHHTTCCCCCC-
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCCCCCCC-
Confidence            33456789999999988899999999999999999998 99999763211              111222211111111 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           ..+..++.+++.+||+.|| ++|||+++|+++|++
T Consensus       595 -----~~~~~~l~~li~~cl~~dP-~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          595 -----AGCPREMYDLMNLCWTYDV-ENRPGFAAVELRLRN  628 (635)
T ss_dssp             -----TTCCHHHHHHHHHHTCSST-TTSCCHHHHHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHcCCCH-hHCcCHHHHHHHHHH
Confidence                 1233568899999999999 999999999998863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-38  Score=346.95  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEe----cCCceEEEEEechhh----HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY----ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  686 (897)
                      .++|++.+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|+++++++ +||||+++++++.+++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999987    368999999986432    12335567899999999 6999999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999987654 589999999999999999999   789999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ..            .++
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~------------~~~  274 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQ------------AEI  274 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CH------------HHH
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hH------------HHH
Confidence            542221 12234579999999999875  457899999999999999999999997532111 11            111


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHhh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFSA  892 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~~  892 (897)
                      ........+. ..   ......+.+++.+||+.|| ++||     |++|+++.
T Consensus       275 ~~~~~~~~~~-~~---~~~~~~~~~li~~~L~~dP-~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          275 SRRILKSEPP-YP---QEMSALAKDLIQRLLMKDP-KKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHCCCC-CC---TTSCHHHHHHHHHHTCSSG-GGSTTSSTTTHHHHHTS
T ss_pred             HHHHhccCCC-CC---cccCHHHHHHHHHHhhhCH-HHhcCCCCCCHHHHHcC
Confidence            1111111000 00   1223457889999999999 9999     99999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.8e-37  Score=341.83  Aligned_cols=200  Identities=25%  Similarity=0.318  Sum_probs=172.9

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CC-----ccceEeeeecCCC
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HR-----NLVKIISSCSNDD  686 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  686 (897)
                      ...++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+++++.++ |+     +|+++++++..++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            44679999999999999999999876 6889999999754 333466778999998885 55     4999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCCcEEEeeccC
Q 045539          687 FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHISDFGI  763 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~  763 (897)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||. |+.||+||||||+||+++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999996 59999887664 568999999999999999999953 478999999999999994  577899999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9876432     2245689999999999999999999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.6e-37  Score=343.84  Aligned_cols=257  Identities=20%  Similarity=0.232  Sum_probs=198.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC--------CCccceEeeeec---
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR--------HRNLVKIISSCS---  683 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  683 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999865 6889999999754 334567889999999996        788999999987   


Q ss_pred             -CCCceEEEEEeccCCChhHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCC------
Q 045539          684 -NDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDM------  754 (897)
Q Consensus       684 -~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~------  754 (897)
                       ++...++||||+ ++++.+++. .....+++..+..++.||+.||+||   |++ ||+||||||+||+++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhh
Confidence             567889999999 455555554 4335699999999999999999999   777 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeeccCccccCCCCceeeeeccccCcccCCcCcc
Q 045539          755 -------------------------------------------VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG  791 (897)
Q Consensus       755 -------------------------------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  791 (897)
                                                                 .+||+|||.+......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999876432     2345689999999999


Q ss_pred             CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccc----hhHHhhh---cCCch------------------------
Q 045539          792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS----LNRWIND---LLPVS------------------------  840 (897)
Q Consensus       792 ~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~----~~~~~~~---~~~~~------------------------  840 (897)
                      .+..++.++|||||||++|||++|+.||.........    ....+..   ..+..                        
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            8889999999999999999999999999753322110    0000000   00100                        


Q ss_pred             ----HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          841 ----VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       841 ----~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          ..+.+....        ....+....+.+++.+||+.|| ++|||++|+++
T Consensus       346 ~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKY--------EWSQEEAAGFTDFLLPMLELIP-EKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTS--------CCCHHHHHHHHHHHGGGGCSSG-GGSCCHHHHHT
T ss_pred             CCcchhHhhhhhc--------ccchhhHHHHHHHHHHHhccCh-hhcCCHHHHhh
Confidence                000000000        0112445678999999999999 99999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-36  Score=334.75  Aligned_cols=265  Identities=17%  Similarity=0.237  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEe-c-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCC------ccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL-Q-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR------NLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|.. . +++.||+|+++.. ....+.+.+|+++++.++|+      +++++++++.+++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986 3 6889999999754 33456788999999999765      49999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC--------------
Q 045539          688 KALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE--------------  752 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~--------------  752 (897)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999887665 4689999999999999999999   7899999999999999987              


Q ss_pred             -----CCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          753 -----DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       753 -----~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                           ++.+||+|||.+......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 668999999999865432     2245689999999999988999999999999999999999999975321110


Q ss_pred             -chhHHhhhcCCchHHHH-----------------------hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCC
Q 045539          828 -SLNRWINDLLPVSVMEV-----------------------IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNG  883 (897)
Q Consensus       828 -~~~~~~~~~~~~~~~~~-----------------------i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~R  883 (897)
                       ..........+.....-                       +........ ...........++.+++.+||+.|| ++|
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP-~~R  320 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQDVEHERLFDLIQKMLEYDP-AKR  320 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHHHHTCSST-TTS
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-hhcccchhhHHHHHHHHHHHhCcCc-ccc
Confidence             00000111111111000                       000000000 0000011234668999999999999 999


Q ss_pred             CCHHHHHhh
Q 045539          884 ADMGWIFSA  892 (897)
Q Consensus       884 Pt~~evl~~  892 (897)
                      ||++|+++.
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-37  Score=347.34  Aligned_cols=254  Identities=12%  Similarity=0.078  Sum_probs=181.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhc--CCCccceEe-------eee
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRI--RHRNLVKII-------SSC  682 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  682 (897)
                      ..+|...+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346889999999999999999875 68999999998643   34456778886555555  599988755       333


Q ss_pred             cCC-----------------CceEEEEEeccCCChhHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCcE
Q 045539          683 SND-----------------DFKALIMKYMPNGSLENCLYSGTCMLDIFQR------LNIMIDVALALEYLHFGHSTPII  739 (897)
Q Consensus       683 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~Lh~~h~~~iv  739 (897)
                      ..+                 ...|+||||++ ++|.+++......+++..+      ..++.|++.||+||   |++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCc
Confidence            222                 33799999998 8999999875444555566      77889999999999   889999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCC
Q 045539          740 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKK  817 (897)
Q Consensus       740 H~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~  817 (897)
                      ||||||+||+++.++.+||+|||+|+....     ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987542     1224567899999999877  678999999999999999999999


Q ss_pred             CCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          818 PTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       818 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ||..........  +.....    .........      ++....+...+.+++.+||+.|| ++|||++|+++
T Consensus       292 Pf~~~~~~~~~~--~~~~~~----~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS--WKRPSL----RVPGTDSLA------FGSCTPLPDFVKTLIGRFLNFDR-RRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC--CCBCCT----TSCCCCSCC------CTTSSCCCHHHHHHHHHHTCSST-TTCCCHHHHTT
T ss_pred             CCCCcCcccccc--hhhhhh----hhccccccc------hhhccCCCHHHHHHHHHHcCCCh-hhCCCHHHHhc
Confidence            998743221110  000000    000000000      00001223457899999999999 99999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-37  Score=331.45  Aligned_cols=251  Identities=20%  Similarity=0.273  Sum_probs=200.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4578999999999999999999876 68999999987543  23457788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC---CcEEEeeccCccccC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLS  768 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~a~~~~  768 (897)
                      |||+++++|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.+   +.+||+|||.+....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999886554 589999999999999999999   78999999999999999754   479999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ....   .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......  ....           .+....
T Consensus       176 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~-----------~~~~~~  238 (287)
T 2wei_A          176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK-----------RVETGK  238 (287)
T ss_dssp             CCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----------HHHHCC
T ss_pred             CCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHcCC
Confidence            3322   123458999999998765 4899999999999999999999999753111  1101           011100


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .....    +.......++.+++.+|++.|| ++|||++|+++
T Consensus       239 ~~~~~----~~~~~~~~~~~~li~~~l~~dp-~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFDL----PQWRTISDDAKDLIRKMLTFHP-SLRITATQCLE  276 (287)
T ss_dssp             CCCCS----GGGTTSCHHHHHHHHHHTCSSG-GGSCCHHHHHH
T ss_pred             CCCCc----hhhhhcCHHHHHHHHHHcccCh-hhCcCHHHHhc
Confidence            00000    0011223457899999999999 99999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-37  Score=343.29  Aligned_cols=264  Identities=21%  Similarity=0.248  Sum_probs=193.6

Q ss_pred             HHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC-------
Q 045539          613 LRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-------  684 (897)
Q Consensus       613 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  684 (897)
                      ....++|++.+.||+|+||.||+|+.. +|+.||+|++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345679999999999999999999864 699999999865422    23479999999999999999999833       


Q ss_pred             -------------------------------CCceEEEEEeccCCChhHhhhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 045539          685 -------------------------------DDFKALIMKYMPNGSLENCLYS---GTCMLDIFQRLNIMIDVALALEYL  730 (897)
Q Consensus       685 -------------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L  730 (897)
                                                     +...++||||++ ++|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 577776653   335699999999999999999999


Q ss_pred             HhcCCCCcEeCCCCCCCeeeC-CCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHH
Q 045539          731 HFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIM  808 (897)
Q Consensus       731 h~~h~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvi  808 (897)
                         |++||+||||||+||+++ .++.+||+|||+|+.......   .....||+.|+|||++.+. .++.++||||+||+
T Consensus       158 ---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 ---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             ---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             ---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence               899999999999999997 688999999999987654332   2345689999999987664 58999999999999


Q ss_pred             HHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh--hh--------h-cchhhhhHHHHHHHHHHHHHHHhHccCC
Q 045539          809 LMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID--TN--------L-LRGEERFFAAKEQILLSVLNLATECTIE  877 (897)
Q Consensus       809 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~--------l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~  877 (897)
                      +|||++|+.||...... ..+.+.+...-......+..  +.        . ......  ...+....++.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK--ILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHH--HSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHh--hCCCCCCHHHHHHHHHHccC
Confidence            99999999999763211 11111111111111111100  00        0 000000  00011234578999999999


Q ss_pred             CCCCCCCCHHHHHh
Q 045539          878 SRDGNGADMGWIFS  891 (897)
Q Consensus       878 dP~~~RPt~~evl~  891 (897)
                      || ++|||+.|+++
T Consensus       309 dP-~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EP-DLRINPYEAMA  321 (383)
T ss_dssp             SG-GGSCCHHHHHT
T ss_pred             Ch-hhCCCHHHHhc
Confidence            99 99999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=342.29  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             ccCCHHHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 045539          605 RRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSC  682 (897)
Q Consensus       605 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  682 (897)
                      ..+.+.++....++|++.+.||+|+||.||+|++. +|+.||+|++.... ...+.+.+|+++++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            33444455556789999999999999999999874 68999999986542 2346788999999999 799999999999


Q ss_pred             cC------CCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc
Q 045539          683 SN------DDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV  755 (897)
Q Consensus       683 ~~------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~  755 (897)
                      ..      .+..++||||+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCC
Confidence            76      467899999999999999987653 4689999999999999999999   7889999999999999999999


Q ss_pred             EEEeeccCccccCCCCceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchh
Q 045539          756 AHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN  830 (897)
Q Consensus       756 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~  830 (897)
                      +||+|||++.......  .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.......  ..
T Consensus       168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~  243 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL  243 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH
T ss_pred             EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH
Confidence            9999999998654322  1223456899999999876     5678999999999999999999999996521110  00


Q ss_pred             HHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          831 RWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       831 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                                 ..+..........      ......+.+++.+||..|| ++|||++|+++
T Consensus       244 -----------~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~  286 (326)
T 2x7f_A          244 -----------FLIPRNPAPRLKS------KKWSKKFQSFIESCLVKNH-SQRPATEQLMK  286 (326)
T ss_dssp             -----------HHHHHSCCCCCSC------SCSCHHHHHHHHHHCCSSG-GGSCCHHHHHT
T ss_pred             -----------HHhhcCccccCCc------cccCHHHHHHHHHHhccCh-hhCCCHHHHhh
Confidence                       0000000000000      0112457899999999999 99999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.5e-37  Score=339.04  Aligned_cols=268  Identities=20%  Similarity=0.245  Sum_probs=199.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----Cce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  688 (897)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            568999999999999999999876 68999999986432 34456788999999999999999999988654     678


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 6899988774  489999999999999999999   78999999999999999999999999999998765


Q ss_pred             CCCcee--------eeeccccCcccCCcCccC-CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh---h-
Q 045539          769 GEDQLS--------IQIQTLATIGYMAPEYGT-KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN---D-  835 (897)
Q Consensus       769 ~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~---~-  835 (897)
                      ......        ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .......   . 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            322111        112346899999999764 4678999999999999999999999997632110 0000000   0 


Q ss_pred             --------cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          836 --------LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       836 --------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                              .......+.+....................++.+++.+||+.|| ++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc-ccCCCHHHHhc
Confidence                    00000111111100000000001111334567899999999999 99999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-36  Score=334.99  Aligned_cols=274  Identities=21%  Similarity=0.250  Sum_probs=188.4

Q ss_pred             HHHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC--
Q 045539          610 HELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD--  686 (897)
Q Consensus       610 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  686 (897)
                      .+.....++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677899999999999999999999875 68999999886542 22245567888889999999999999985433  


Q ss_pred             -----ceEEEEEeccCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEE
Q 045539          687 -----FKALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAH  757 (897)
Q Consensus       687 -----~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~k  757 (897)
                           ..++||||++++ +.+.+.   .....+++..+..++.|++.||+|||. |++||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 378999999864 444332   234568999999999999999999942 3999999999999999996 89999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      |+|||++........   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence            999999987654332   2345689999999987654 4899999999999999999999999763211 1111111110


Q ss_pred             C--CchHHHHhhhhhcc---------hhhh-hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          837 L--PVSVMEVIDTNLLR---------GEER-FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       837 ~--~~~~~~~i~~~l~~---------~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .  +......+.+....         .... ..........++.+++.+||+.|| ++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP-EERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG-GGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc-cccCCHHHHhc
Confidence            0  00111111100000         0000 000000124568899999999999 99999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=342.13  Aligned_cols=200  Identities=23%  Similarity=0.313  Sum_probs=154.1

Q ss_pred             hcCCCc-CCeeecccceEEEEEEec---CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeee--cCCCceE
Q 045539          616 TDRFSE-NNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSC--SNDDFKA  689 (897)
Q Consensus       616 ~~~y~~-~~~lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~  689 (897)
                      .+.|++ .++||+|+||.||+|++.   +++.||+|++.....  .+.+.+|++++++++||||+++++++  ..+...|
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345665 568999999999999865   578899999875422  24677899999999999999999999  4577899


Q ss_pred             EEEEeccCCChhHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----CCCCcEE
Q 045539          690 LIMKYMPNGSLENCLYSG--------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----DEDMVAH  757 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----~~~~~~k  757 (897)
                      +||||++ ++|.+++...        ...+++..+..++.||+.||+||   |++||+||||||+||++    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 5777766422        13489999999999999999999   88999999999999999    6778999


Q ss_pred             EeeccCccccCCCCc-eeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          758 ISDFGIAKLLSGEDQ-LSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       758 L~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                      |+|||+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999999987653221 122334578999999998876 4589999999999999999999999965

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=335.38  Aligned_cols=263  Identities=21%  Similarity=0.256  Sum_probs=195.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc-----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-----  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  687 (897)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999875 68999999986532  3345778899999999999999999999987654     


Q ss_pred             -eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          688 -KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       688 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                       .|+||||++ ++|.+++..   .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 688887643   389999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh-----------
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN-----------  834 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~-----------  834 (897)
                      ....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.....           
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            5422     234568999999998776 678999999999999999999999997532110 0111110           


Q ss_pred             hcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          835 DLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       835 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ..........+...-................++.+++.+|++.|| ++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp-~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT-TTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc-ccCCCHHHHhcC
Confidence            000000111111000000000000001234568899999999999 999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.2e-37  Score=363.43  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             HhcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|+++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            35688999999999999999998642    4679999987543 3445788999999999999999999999854 5689


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999999987766799999999999999999999   788999999999999999999999999999987653


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN  848 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  848 (897)
                      ... .......+|+.|+|||++....++.++|||||||++|||++ |..||......  .....+.           ...
T Consensus       544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~-----------~~~  609 (656)
T 2j0j_A          544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE-----------NGE  609 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH-----------HTC
T ss_pred             Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH-----------cCC
Confidence            322 22233457789999999988899999999999999999997 99998753211  1111111           000


Q ss_pred             hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          849 LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       849 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+       ..+...+.+++.+||+.|| ++|||++|+++.|+
T Consensus       610 ~~~~~-------~~~~~~l~~li~~~l~~dP-~~RPs~~el~~~L~  647 (656)
T 2j0j_A          610 RLPMP-------PNCPPTLYSLMTKCWAYDP-SRRPRFTELKAQLS  647 (656)
T ss_dssp             CCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCC-------ccccHHHHHHHHHHcCCCh-hHCcCHHHHHHHHH
Confidence            00001       1223457899999999999 99999999999885

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-36  Score=340.94  Aligned_cols=265  Identities=22%  Similarity=0.265  Sum_probs=192.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCC------CceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSND------DFKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  689 (897)
                      ..+|++.+.||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457999999999999999999987777799998864421    223699999999999999999998443      3478


Q ss_pred             EEEEeccCCChhHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEeeccCccc
Q 045539          690 LIMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKL  766 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~  766 (897)
                      +||||++++.+.....  .....+++..+..++.|+++||+||   |++||+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754443321  2234689999999999999999999   889999999999999998 799999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH--H
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM--E  843 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  843 (897)
                      ......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.+.+...-.....  .
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            643322   2345689999999987654 5899999999999999999999999763211 1111111111111000  0


Q ss_pred             Hhhhhh-cchh----hhhHHH--HHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          844 VIDTNL-LRGE----ERFFAA--KEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       844 ~i~~~l-~~~~----~~~~~~--~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...+.. ....    ...+..  ......++.+++.+||+.|| ++|||+.|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG-GGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCCh-hhCCCHHHHhcC
Confidence            000000 0000    000000  00123468899999999999 999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-36  Score=342.70  Aligned_cols=263  Identities=23%  Similarity=0.275  Sum_probs=191.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC------CCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN------DDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  688 (897)
                      ..+|+..+.||+|+||.||+|++. +|+.||||++....    +...+|++++++++||||++++++|..      ....
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            347999999999999999999876 58999999986542    223479999999999999999998843      2246


Q ss_pred             EEEEEeccCCChhHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-CcEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLY---SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a  764 (897)
                      ++||||+++ ++.+.+.   .....+++..+..++.||++||+||   |++||+||||||+||+++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999975 5555443   2345689999999999999999999   89999999999999999955 57899999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.+...-......
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence            87643322   2345689999999988654 7899999999999999999999999763211 11222221111110000


Q ss_pred             H--hhhhhcc-hh----hhhHHHH--HHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 V--IDTNLLR-GE----ERFFAAK--EQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~--i~~~l~~-~~----~~~~~~~--~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +  ..+.... ..    ...+...  .....++.+++.+||+.|| ++|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP-~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh-hHCCCHHHHhC
Confidence            0  0000000 00    0000000  1123457899999999999 99999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.2e-36  Score=333.73  Aligned_cols=264  Identities=17%  Similarity=0.221  Sum_probs=198.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CC-ceEEEEEechhhHHHHHHHHHHHHHHHhcCCCc------cceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DG-MEVAVKVFHQQYERALKSFEDECEVMKRIRHRN------LVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999875 34 68999999754 334567888999999998665      8999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee----------------
Q 045539          688 KALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL----------------  750 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll----------------  750 (897)
                      .++||||+ ++++.+++.... ..+++.++..++.||+.||+||   |++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 556666665443 5689999999999999999999   88999999999999999                


Q ss_pred             ---CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          751 ---DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       751 ---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                         +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               567899999999998654322     245689999999999999999999999999999999999999976321110


Q ss_pred             -chhHHhhhcCCchHHHHh-----------------------hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCC
Q 045539          828 -SLNRWINDLLPVSVMEVI-----------------------DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNG  883 (897)
Q Consensus       828 -~~~~~~~~~~~~~~~~~i-----------------------~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~R  883 (897)
                       ..........+.......                       ........ ...........++.+++.+||+.|| ++|
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP-~~R  325 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK-SYMLQDSLEHVQLFDLMRRMLEFDP-AQR  325 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHHHHTCSST-TTS
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccc-ccccccchhHHHHHHHHHHHhcCCh-hhC
Confidence             000001111111110000                       00000000 0000001223468899999999999 999


Q ss_pred             CCHHHHHh
Q 045539          884 ADMGWIFS  891 (897)
Q Consensus       884 Pt~~evl~  891 (897)
                      ||++|+++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.6e-38  Score=340.55  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=198.9

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      +....++|++.+.||+|+||.||+|++.  ..||+|+++...  ....+.+.+|++++++++||||+++++++.+++..+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            3344678999999999999999999876  359999987432  222356778999999999999999999999999999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++ ++.+||+|||++.....
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999999999988776799999999999999999999   788999999999999998 67999999999876532


Q ss_pred             CCc---eeeeeccccCcccCCcCccCC---------CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC
Q 045539          770 EDQ---LSIQIQTLATIGYMAPEYGTK---------GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       770 ~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      ...   ........|++.|+|||++..         ..++.++||||||+++|||++|+.||......  .....+....
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~  259 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMGTGM  259 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHHTTC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccCC
Confidence            111   111223458999999998754         45788999999999999999999999753211  0000000000


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                              .+....         .....++.+++.+||+.|| ++|||++|++++|++
T Consensus       260 --------~~~~~~---------~~~~~~l~~li~~~l~~~p-~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          260 --------KPNLSQ---------IGMGKEISDILLFCWAFEQ-EERPTFTKLMDMLEK  299 (319)
T ss_dssp             --------CCCCCC---------SSCCTTHHHHHHHHHCSST-TTSCCHHHHHHHHTT
T ss_pred             --------CCCCCc---------CCCCHHHHHHHHHHhcCCh-hhCcCHHHHHHHHHH
Confidence                    000000         0112347899999999999 999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-36  Score=333.70  Aligned_cols=252  Identities=19%  Similarity=0.220  Sum_probs=172.5

Q ss_pred             HhcCCCcCC-eeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC----CCce
Q 045539          615 ATDRFSENN-LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN----DDFK  688 (897)
Q Consensus       615 ~~~~y~~~~-~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  688 (897)
                      ..++|.+.+ .||+|+||.||+|+.. +|+.||+|++......    ..+....++.++||||+++++++..    +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356899855 6999999999999876 6899999998754221    1222334566789999999999865    4568


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a  764 (897)
                      ++||||+++|+|.+++.... ..+++.++..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998764 4699999999999999999999   7889999999999999976   456999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      .......    .....||+.|+|||++....++.++||||||+++|+|++|+.||..........          .....
T Consensus       179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~  244 (336)
T 3fhr_A          179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRR  244 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHh
Confidence            8654322    234568999999999988899999999999999999999999997632221100          00000


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.......+   .+....+..++.+++.+|++.|| ++|||++|+++
T Consensus       245 ~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP-~~Rpt~~ell~  287 (336)
T 3fhr_A          245 IRLGQYGFP---NPEWSEVSEDAKQLIRLLLKTDP-TERLTITQFMN  287 (336)
T ss_dssp             ------CCC---TTTSTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHH
T ss_pred             hhccccccC---chhhccCCHHHHHHHHHHCCCCh-hHCcCHHHHhc
Confidence            000000000   00001223457899999999999 99999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.5e-36  Score=328.40  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=198.4

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEe--cCCceEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCccceEeeeec---
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARL--QDGMEVAVKVFHQQYE--RALKSFEDECEVMKRI---RHRNLVKIISSCS---  683 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  683 (897)
                      ++.++|++.+.||+|+||.||+|+.  .+|+.||+|+++....  .....+.+|+++++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3567999999999999999999987  3588999999864321  1123456777777766   8999999999986   


Q ss_pred             --CCCceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          684 --NDDFKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       684 --~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                        .....++||||++ ++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEec
Confidence              5677899999997 69999887654 4589999999999999999999   889999999999999999999999999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-----
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-----  835 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-----  835 (897)
                      ||.+.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........     
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence            99997654222   1234568999999999998899999999999999999999999997632110 11111100     


Q ss_pred             --cCCchH---HHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          836 --LLPVSV---MEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       836 --~~~~~~---~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                        .++...   ..............   ........+.+++.+||+.|| ++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP-~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEK---FVTDIDELGKDLLLKCLTFNP-AKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGG---TCCSCCHHHHHHHHHHSCSST-TTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhh---ccccCCHHHHHHHHHHcCCCc-ccCCCHHHHhc
Confidence              000000   00000000000000   001223457899999999999 99999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.7e-36  Score=342.69  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=185.9

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+++++++ +||||+++++++.+++..|+||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4556678899999999987766779999999987543   24567899999987 7999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC-------------CcE
Q 045539          696 PNGSLENCLYSGTCM------LDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED-------------MVA  756 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~-------------~~~  756 (897)
                      + |+|.+++......      .++..+..++.||+.||+||   |++||+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999765421      12334578999999999999   78999999999999999654             489


Q ss_pred             EEeeccCccccCCCCcee--eeeccccCcccCCcCccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCcccccCc
Q 045539          757 HISDFGIAKLLSGEDQLS--IQIQTLATIGYMAPEYGTK-------GRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGE  826 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~  826 (897)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998775432211  1234579999999998765       678999999999999999999 999997532111


Q ss_pred             cchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          827 LSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       827 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                         ...........       ... ..     .......++.+++.+|++.|| ++|||++||++
T Consensus       248 ---~~i~~~~~~~~-------~~~-~~-----~~~~~~~~~~~li~~~L~~dP-~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SNIIRGIFSLD-------EMK-CL-----HDRSLIAEATDLISQMIDHDP-LKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHHHTCCCCC-------CCT-TC-----CCHHHHHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             ---HHHhcCCCCcc-------ccc-cc-----ccccchHHHHHHHHHHhhCCh-hhCCCHHHHHh
Confidence               11111111000       000 00     011334568899999999999 99999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=342.57  Aligned_cols=250  Identities=19%  Similarity=0.279  Sum_probs=187.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+++..|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457889999999999997766566799999999875432   2356799999999 799999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-----CCcEEEeeccCccccCC
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSG  769 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-----~~~~kL~DFg~a~~~~~  769 (897)
                      ++ |+|.+++..........++..++.||+.||+||   |++||+||||||+||+++.     ...+||+|||+|+....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 699999987765566667789999999999999   8899999999999999953     33688999999987653


Q ss_pred             CCc-eeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          770 EDQ-LSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       770 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||......   ...           ..
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~-----------~~  241 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QAN-----------IL  241 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHH-----------HH
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHH-----------HH
Confidence            321 12234467999999999987   4567889999999999999999 89998642111   000           00


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..........    ........+.+++.+||+.|| ++|||++||++
T Consensus       242 ~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP-~~Rps~~evl~  283 (432)
T 3p23_A          242 LGACSLDCLH----PEKHEDVIARELIEKMIAMDP-QKRPSAKHVLK  283 (432)
T ss_dssp             TTCCCCTTSC----TTCHHHHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             hccCCccccC----ccccccHHHHHHHHHHHhCCH-hhCCCHHHHHh
Confidence            1000000000    001122346789999999999 99999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-36  Score=331.21  Aligned_cols=253  Identities=24%  Similarity=0.281  Sum_probs=175.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHH-HHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECE-VMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|+..+.||+|+||.||+|... +|+.||||+++... ......+.+|+. +++.++||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999875 68999999987542 233445555665 677789999999999999999999999


Q ss_pred             EeccCCChhHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          693 KYMPNGSLENCLYS----GTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       693 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      ||+++ +|.+++..    ....+++..+..++.|++.||+||   |+. ||+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 77776652    235689999999999999999999   677 9999999999999999999999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCcc----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYG----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||..................+     
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  248 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-----  248 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC-----
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC-----
Confidence            43321   2234689999999997    46678999999999999999999999997532111000000000000     


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                          .+.....      .....++.+++.+||+.|| ++|||++|+++
T Consensus       249 ----~~~~~~~------~~~~~~l~~li~~~l~~dp-~~Rps~~ell~  285 (327)
T 3aln_A          249 ----QLSNSEE------REFSPSFINFVNLCLTKDE-SKRPKYKELLK  285 (327)
T ss_dssp             ----CCCCCSS------CCCCHHHHHHHHHHTCSSG-GGSCCHHHHTT
T ss_pred             ----CCCCccc------ccCCHHHHHHHHHHhhCCh-hhCcCHHHHHh
Confidence                0000000      0122457899999999999 99999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.8e-36  Score=333.53  Aligned_cols=265  Identities=18%  Similarity=0.271  Sum_probs=197.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-----------CCccceEeeeec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-----------HRNLVKIISSCS  683 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  683 (897)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999864 68999999997542 33467788999999886           899999999987


Q ss_pred             CCC----ceEEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeC------
Q 045539          684 NDD----FKALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLD------  751 (897)
Q Consensus       684 ~~~----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~------  751 (897)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+||   |++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCc
Confidence            544    789999999 899999987643 4589999999999999999999   777 999999999999994      


Q ss_pred             CCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc----
Q 045539          752 EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL----  827 (897)
Q Consensus       752 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~----  827 (897)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........    
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999876432     2234689999999999888999999999999999999999999975321110    


Q ss_pred             -chhHHhh--hcCCchHHH-------Hhhh-----hh--------cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC
Q 045539          828 -SLNRWIN--DLLPVSVME-------VIDT-----NL--------LRGEERFFAAKEQILLSVLNLATECTIESRDGNGA  884 (897)
Q Consensus       828 -~~~~~~~--~~~~~~~~~-------~i~~-----~l--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP  884 (897)
                       .....+.  ...+.....       ....     .+        ................++.+++.+||+.|| ++||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP-~~Rp  326 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP-RKRA  326 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST-TTCB
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc-cccC
Confidence             0111110  001100000       0000     00        000000000112455678999999999999 9999


Q ss_pred             CHHHHHh
Q 045539          885 DMGWIFS  891 (897)
Q Consensus       885 t~~evl~  891 (897)
                      |++|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=328.84  Aligned_cols=246  Identities=20%  Similarity=0.303  Sum_probs=190.3

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH------HHHHHHHHHHHHHHhc----CCCccceEe
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKRI----RHRNLVKII  679 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  679 (897)
                      +.....++|++.+.||+|+||.||+|+.. +++.||+|++.....      .....+.+|+++++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34455689999999999999999999864 688999999865432      1234456799999999    899999999


Q ss_pred             eeecCCCceEEEEEe-ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEE
Q 045539          680 SSCSNDDFKALIMKY-MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAH  757 (897)
Q Consensus       680 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~k  757 (897)
                      +++.+.+..++|||| +.+++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999987654 589999999999999999999   788999999999999999 889999


Q ss_pred             EeeccCccccCCCCceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc
Q 045539          758 ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL  836 (897)
Q Consensus       758 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~  836 (897)
                      |+|||.+.......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....             
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------  243 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------  243 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence            99999998765432    234568999999998776665 458999999999999999999997521             


Q ss_pred             CCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          837 LPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       837 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                            +.......- +       .....++.+++.+||+.|| ++|||++|+++.
T Consensus       244 ------~~~~~~~~~-~-------~~~~~~~~~li~~~l~~~p-~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 ------EILEAELHF-P-------AHVSPDCCALIRRCLAPKP-SSRPSLEEILLD  284 (312)
T ss_dssp             ------HHHHTCCCC-C-------TTSCHHHHHHHHHHTCSST-TTSCCHHHHHHS
T ss_pred             ------HHhhhccCC-c-------ccCCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence                  011111100 0       0122347889999999999 999999999873

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=328.92  Aligned_cols=251  Identities=22%  Similarity=0.275  Sum_probs=179.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .++|+..+.||+|+||.||+|++. +|+.||||++....  ....+.+.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            568999999999999999999876 68999999987543  223344555666788889999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||+ ++.+..+.......+++..+..++.|++.||+||   |++ ||+||||||+||+++.++.+||+|||.+.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5666666554445689999999999999999999   664 99999999999999999999999999997654322


Q ss_pred             ceeeeeccccCcccCCcCccC-----CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          772 QLSIQIQTLATIGYMAPEYGT-----KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                         ......||+.|+|||++.     ...++.++||||||+++|||++|+.||..................+        
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--------  248 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--------
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--------
Confidence               123446899999999874     5678899999999999999999999997521111111111100000        


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ....        ......++.+++.+||+.|| ++|||++|+++
T Consensus       249 -~~~~--------~~~~~~~l~~li~~~l~~dp-~~Rps~~~ll~  283 (318)
T 2dyl_A          249 -LLPG--------HMGFSGDFQSFVKDCLTKDH-RKRPKYNKLLE  283 (318)
T ss_dssp             -CCCS--------SSCCCHHHHHHHHHHTCSCT-TTSCCHHHHTT
T ss_pred             -CCCc--------cCCCCHHHHHHHHHHccCCh-hHCcCHHHHhh
Confidence             0000        00122457899999999999 99999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-36  Score=331.92  Aligned_cols=246  Identities=20%  Similarity=0.240  Sum_probs=198.6

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHH------HHHHHHHHHHHHHhcC--CCccceEeee
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER------ALKSFEDECEVMKRIR--HRNLVKIISS  681 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~  681 (897)
                      +.....++|++.+.||+|+||.||+|+.. +++.||||++......      ..+.+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            33445678999999999999999999864 6899999998765321      2245678999999996  5999999999


Q ss_pred             ecCCCceEEEEEeccC-CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC-CCCcEEEe
Q 045539          682 CSNDDFKALIMKYMPN-GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHIS  759 (897)
Q Consensus       682 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~-~~~~~kL~  759 (897)
                      +.+++..++|||++.+ ++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++ +++.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999976 89999987654 589999999999999999999   889999999999999999 78999999


Q ss_pred             eccCccccCCCCceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          760 DFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       760 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      |||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       ....... 
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~-  260 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV-  260 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC-
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc-
Confidence            999998765332    223568999999998876665 688999999999999999999996521       0000000 


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                               ....          ....++.+++.+||+.|| ++|||++|+++.
T Consensus       261 ---------~~~~----------~~~~~~~~li~~~l~~dp-~~Rps~~~ll~h  294 (320)
T 3a99_A          261 ---------FFRQ----------RVSSECQHLIRWCLALRP-SDRPTFEEIQNH  294 (320)
T ss_dssp             ---------CCSS----------CCCHHHHHHHHHHTCSSG-GGSCCHHHHHTS
T ss_pred             ---------cccc----------cCCHHHHHHHHHHccCCh-hhCcCHHHHhcC
Confidence                     0000          112357889999999999 999999999873

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.5e-35  Score=323.38  Aligned_cols=280  Identities=20%  Similarity=0.246  Sum_probs=215.7

Q ss_pred             cCChhHHHHHHHHHhccccCCCcccccCC----CCCCCCcceeeeEee--------CCCCeEEEEEeecccccccCCCCC
Q 045539           29 SNITTDQQALLALKAHISYDHTNLFARNW----TSSTSVCSWIGITCD--------VNSHRVIGLNISSFNLQGTIPPQL   96 (897)
Q Consensus        29 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~--------~~~~~v~~l~l~~~~l~g~~~~~l   96 (897)
                      ++..+|++||++||+++..|+.+... +|    ..+.++|.|.||+|+        ....+|+.|+|++++++ .+|+.+
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~-~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHH-HHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhh-hhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            45678999999999999778777665 89    456789999999995        23468999999999998 889999


Q ss_pred             CCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLAR  176 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~  176 (897)
                      +++++|++|+|++|.++ .+|..++++++|++|+|++|++. .+|..+.++++|++|+|++|++.+.+|..++..     
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~-----  173 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-----  173 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-----
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-----
Confidence            99999999999999999 89999999999999999999998 778889999999999999999998999876541     


Q ss_pred             cccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc
Q 045539          177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL  256 (897)
Q Consensus       177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  256 (897)
                                ..+..|.++++|++|+|++|+++ .+|..+. .+++|++|+|++|.+++ +|..+..+++|++|+|++|.
T Consensus       174 ----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~-~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~  240 (328)
T 4fcg_A          174 ----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT  240 (328)
T ss_dssp             ----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGG-GCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred             ----------cchhhhccCCCCCEEECcCCCcC-cchHhhc-CCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence                      01223555666666666666666 6665543 56667777777777663 45567777777777777777


Q ss_pred             cccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCcccc
Q 045539          257 FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG  336 (897)
Q Consensus       257 l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~  336 (897)
                      +.+.+|..                     +.++++|++|+|++|++.+.+                         |..+.
T Consensus       241 ~~~~~p~~---------------------~~~l~~L~~L~L~~n~~~~~~-------------------------p~~~~  274 (328)
T 4fcg_A          241 ALRNYPPI---------------------FGGRAPLKRLILKDCSNLLTL-------------------------PLDIH  274 (328)
T ss_dssp             TCCBCCCC---------------------TTCCCCCCEEECTTCTTCCBC-------------------------CTTGG
T ss_pred             chhhhHHH---------------------hcCCCCCCEEECCCCCchhhc-------------------------chhhh
Confidence            77666654                     355677777777777666543                         34455


Q ss_pred             CccCCcEEEccCCCCCCCccccccCccchhhhcccCcccc
Q 045539          337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLA  376 (897)
Q Consensus       337 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  376 (897)
                      .+++|++|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus       275 ~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            6677777777777777777777777777777777766655

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.8e-36  Score=348.35  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=195.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecC------CCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSN------DDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  687 (897)
                      .++|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999875 6899999998754 34456788999999999999999999999865      678


Q ss_pred             eEEEEEeccCCChhHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCc---EEEeecc
Q 045539          688 KALIMKYMPNGSLENCLYSGT--CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMV---AHISDFG  762 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~---~kL~DFg  762 (897)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+||   |+.||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998654  3588899999999999999999   7899999999999999987664   9999999


Q ss_pred             CccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHH
Q 045539          763 IAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM  842 (897)
Q Consensus       763 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  842 (897)
                      .+........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||....    ....|..........
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC-----
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccch
Confidence            9987654322   234579999999999999999999999999999999999999996521    111111110000000


Q ss_pred             HH-hhhhhc------chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHH
Q 045539          843 EV-IDTNLL------RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       843 ~~-i~~~l~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                      .. ......      ...+............+.+++.+|+..|| ++|||++|++
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP-~kRPTa~elL  296 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ-RQRGTDPQNP  296 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC-C---CCTTCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCH-hhCcCHHHHh
Confidence            00 000000      00000000001234568899999999999 9999998754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.6e-34  Score=317.35  Aligned_cols=306  Identities=24%  Similarity=0.375  Sum_probs=180.9

Q ss_pred             CCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLAR  176 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~  176 (897)
                      ..+++|++|++++|.++ .+| .+..+++|++|++++|++.+..+  +.++++|++|+|++|.+++ +| .+.++++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred             hhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence            45677788888888776 344 37777888888888887766544  7777777777777777763 33 5677777777


Q ss_pred             cccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc
Q 045539          177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL  256 (897)
Q Consensus       177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  256 (897)
                      |++++|++++..+  +.++++|++|++++|.....++.                          +..+++|++|++++|.
T Consensus       115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~--------------------------~~~l~~L~~L~l~~~~  166 (347)
T 4fmz_A          115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP--------------------------LSNMTGLNYLTVTESK  166 (347)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG--------------------------GTTCTTCCEEECCSSC
T ss_pred             EECcCCcccCchh--hccCCceeEEECCCCCCcccccc--------------------------hhhCCCCcEEEecCCC
Confidence            7777777766544  66666666666666644423222                          3344444444444444


Q ss_pred             cccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCcccc
Q 045539          257 FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVG  336 (897)
Q Consensus       257 l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~  336 (897)
                      +.+..+                       +..+++|++|++++|++.+..                          . +.
T Consensus       167 ~~~~~~-----------------------~~~l~~L~~L~l~~n~l~~~~--------------------------~-~~  196 (347)
T 4fmz_A          167 VKDVTP-----------------------IANLTDLYSLSLNYNQIEDIS--------------------------P-LA  196 (347)
T ss_dssp             CCCCGG-----------------------GGGCTTCSEEECTTSCCCCCG--------------------------G-GG
T ss_pred             cCCchh-----------------------hccCCCCCEEEccCCcccccc--------------------------c-cc
Confidence            432221                       234445555555555444220                          0 33


Q ss_pred             CccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccccccccee
Q 045539          337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVL  416 (897)
Q Consensus       337 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  416 (897)
                      .+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|++|++++|++++.  +.+..+++|+.|
T Consensus       197 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L  270 (347)
T 4fmz_A          197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKML  270 (347)
T ss_dssp             GCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred             CCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEE
Confidence            44455555555555554333  4555555555555555553322  55555666666666666532  345566666666


Q ss_pred             ccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcC
Q 045539          417 YLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS  496 (897)
Q Consensus       417 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~  496 (897)
                      ++++|++++.  ..+..+++|+             .|++++|++++..|..++.+++|++|++++|++++..|  +..++
T Consensus       271 ~l~~n~l~~~--~~~~~l~~L~-------------~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~  333 (347)
T 4fmz_A          271 NVGSNQISDI--SVLNNLSQLN-------------SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS  333 (347)
T ss_dssp             ECCSSCCCCC--GGGGGCTTCS-------------EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCT
T ss_pred             EccCCccCCC--hhhcCCCCCC-------------EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhh
Confidence            6666666643  2355555555             44445555555566667777777777888887776555  77778


Q ss_pred             CCcEEeccCCccC
Q 045539          497 SLEVLDLSKNKIS  509 (897)
Q Consensus       497 ~L~~L~Ls~N~l~  509 (897)
                      +|+.|++++|.|+
T Consensus       334 ~L~~L~l~~N~i~  346 (347)
T 4fmz_A          334 KMDSADFANQVIK  346 (347)
T ss_dssp             TCSEESSSCC---
T ss_pred             ccceeehhhhccc
Confidence            8888888888775

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.3e-34  Score=317.80  Aligned_cols=307  Identities=24%  Similarity=0.368  Sum_probs=225.3

Q ss_pred             ccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccccccccccccc
Q 045539          120 IFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK  199 (897)
Q Consensus       120 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  199 (897)
                      +..+++|++|++++|.+... + .+..+++|++|++++|++++ +|. +..+++|++|++++|+++.+  ..+.++    
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l----  109 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--SALQNL----  109 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTC----
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--hHHcCC----
Confidence            45667777777777766543 2 25566666666666666653 333 55555555555555555543  124444    


Q ss_pred             ccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCc
Q 045539          200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPE  279 (897)
Q Consensus       200 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~  279 (897)
                                           ++|++|++++|.+.+..+  +..+++|+.|++++|......+                 
T Consensus       110 ---------------------~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-----------------  149 (347)
T 4fmz_A          110 ---------------------TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-----------------  149 (347)
T ss_dssp             ---------------------TTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-----------------
T ss_pred             ---------------------CcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-----------------
Confidence                                 445555555555443322  6677888888888885443332                 


Q ss_pred             ccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccc
Q 045539          280 LSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITF  359 (897)
Q Consensus       280 ~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  359 (897)
                           .+..+++|++|++++|++.+..                           .+..+++|++|++++|++++..+  +
T Consensus       150 -----~~~~l~~L~~L~l~~~~~~~~~---------------------------~~~~l~~L~~L~l~~n~l~~~~~--~  195 (347)
T 4fmz_A          150 -----PLSNMTGLNYLTVTESKVKDVT---------------------------PIANLTDLYSLSLNYNQIEDISP--L  195 (347)
T ss_dssp             -----GGTTCTTCCEEECCSSCCCCCG---------------------------GGGGCTTCSEEECTTSCCCCCGG--G
T ss_pred             -----chhhCCCCcEEEecCCCcCCch---------------------------hhccCCCCCEEEccCCccccccc--c
Confidence                 2567889999999999887531                           16678899999999999998544  8


Q ss_pred             cCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceE
Q 045539          360 SQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF  439 (897)
Q Consensus       360 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  439 (897)
                      ..+++|+.|++++|++.+..+  +..+++|++|++++|++++..+  +..+++|+.|++++|.+++.  ..+..+++|++
T Consensus       196 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~  269 (347)
T 4fmz_A          196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKM  269 (347)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred             cCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCE
Confidence            899999999999999996555  8889999999999999985444  88999999999999999863  45777888885


Q ss_pred             EeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhh
Q 045539          440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKL  519 (897)
Q Consensus       440 L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  519 (897)
                      |++++|.             +++.  +.+..+++|+.|++++|++++..|..++.+++|++|+|++|++++..|  +..+
T Consensus       270 L~l~~n~-------------l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l  332 (347)
T 4fmz_A          270 LNVGSNQ-------------ISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL  332 (347)
T ss_dssp             EECCSSC-------------CCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGC
T ss_pred             EEccCCc-------------cCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhh
Confidence            5555554             4432  357889999999999999998888889999999999999999997666  8899


Q ss_pred             cccceEeccCCccc
Q 045539          520 LYLKHLNLSFNKLE  533 (897)
Q Consensus       520 ~~L~~L~ls~N~l~  533 (897)
                      ++|+.|++++|+++
T Consensus       333 ~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          333 SKMDSADFANQVIK  346 (347)
T ss_dssp             TTCSEESSSCC---
T ss_pred             hccceeehhhhccc
Confidence            99999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.4e-35  Score=314.20  Aligned_cols=227  Identities=13%  Similarity=0.095  Sum_probs=181.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            368999999999999999999876 48999999997543   34457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||++|++|.+++..+   ....++..++.|++.||+||   |++||+||||||+||+++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            9999999999998653   35667899999999999999   88999999999999999999999998543         


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccc--hhHHhhhcCCchHHHHhhhhh
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELS--LNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l  849 (897)
                                   |++       .++.++|||||||++|||++|+.||.........  .........+ ...       
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~-------  226 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPA-------  226 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC-CHH-------
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC-Chh-------
Confidence                         333       3678999999999999999999999863222100  0000000000 000       


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                              .....+..++.+++.+||+.|| ++| |++|+++.|++
T Consensus       227 --------~~~~~~~~~l~~li~~~l~~dP-~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          227 --------DIDRDIPFQISAVAARSVQGDG-GIR-SASTLLNLMQQ  262 (286)
T ss_dssp             --------HHCTTSCHHHHHHHHHHHCTTS-SCC-CHHHHHHHHHH
T ss_pred             --------hcccCCCHHHHHHHHHHcccCC-ccC-CHHHHHHHHHH
Confidence                    0011233457899999999999 999 99999998853

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=7.7e-36  Score=323.78  Aligned_cols=256  Identities=32%  Similarity=0.518  Sum_probs=236.0

Q ss_pred             CCCcEEEecCCCCCC--CCCCcccCchHHHHHHHhcc-CCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchh
Q 045539          290 KKLKVLILTGNPLDG--ILPKSKGNLSLSLEIILMDN-CSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ  366 (897)
Q Consensus       290 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  366 (897)
                      .+++.|+|++|++++  .+|..+..++ +|++|++++ |.+++.+|..|+++++|++|+|++|++++.+|..|.++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            579999999999999  8899999887 899999994 999999999999999999999999999988999999999999


Q ss_pred             hhcccCcccccccchhhhcccccccccccccccccCCCccccccc-ccceeccccccccCCccccccccccceEEeecCC
Q 045539          367 ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT-SLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       367 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      +|+|++|++++.+|..+..+++|++|+|++|++++.+|..+++++ +|+.|++++|++++.+|..+..++ |+       
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~-------  200 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA-------  200 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CS-------
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-cc-------
Confidence            999999999999999999999999999999999999999999998 899999999999988998888775 66       


Q ss_pred             cccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       446 ~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                            .|++++|++++.+|..++.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|+|.+|.++..+++|+.|
T Consensus       201 ------~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  273 (313)
T 1ogq_A          201 ------FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL  273 (313)
T ss_dssp             ------EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred             ------EEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEE
Confidence                  666677777778899999999999999999999987776 8899999999999999999999999999999999


Q ss_pred             eccCCcccccCCCCCCCCCCCcccccchhhhhhhhh
Q 045539          526 NLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLL  561 (897)
Q Consensus       526 ~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~l  561 (897)
                      +|++|+++|.+|..+.+++++.+.+.||+++|+.++
T Consensus       274 ~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             ECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             ECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            999999999999998899999999999999998643

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-34  Score=342.87  Aligned_cols=309  Identities=18%  Similarity=0.187  Sum_probs=230.7

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      .+..++++++.+.+..+..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+|..|+++++|++|+|+
T Consensus        52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  131 (597)
T 3oja_B           52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE  131 (597)
T ss_dssp             CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence            45678899998886555567899999999999999998888899999999999999999999999999999999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      +|.+++..+..|+++++|++|+|++|.++++.|..|.++++|++|+|++|.+++ ++.   ..+++|+.|++++|.+++.
T Consensus       132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~---~~l~~L~~L~l~~n~l~~l  207 (597)
T 3oja_B          132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL---SLIPSLFHANVSYNLLSTL  207 (597)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CCG---GGCTTCSEEECCSSCCSEE
T ss_pred             CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cCh---hhhhhhhhhhcccCccccc
Confidence            999996555567999999999999999999999999999999999999999984 331   2345555555555555421


Q ss_pred             ccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHH
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS  316 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~  316 (897)
                           ...                                             ++|+.|++++|.+....+         
T Consensus       208 -----~~~---------------------------------------------~~L~~L~ls~n~l~~~~~---------  228 (597)
T 3oja_B          208 -----AIP---------------------------------------------IAVEELDASHNSINVVRG---------  228 (597)
T ss_dssp             -----ECC---------------------------------------------TTCSEEECCSSCCCEEEC---------
T ss_pred             -----cCC---------------------------------------------chhheeeccCCccccccc---------
Confidence                 122                                             345555555555542211         


Q ss_pred             HHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccc
Q 045539          317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG  396 (897)
Q Consensus       317 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  396 (897)
                                       .  ..++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+++.+|..|..+++|++|+|++
T Consensus       229 -----------------~--~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  287 (597)
T 3oja_B          229 -----------------P--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN  287 (597)
T ss_dssp             -----------------S--CCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTT
T ss_pred             -----------------c--cCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCC
Confidence                             0  013566666666666652  5566666777777777777766677777777777777777


Q ss_pred             cccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccccc
Q 045539          397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQ  476 (897)
Q Consensus       397 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~  476 (897)
                      |++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|++++|.+.             +. |  ++.+++|+.
T Consensus       288 N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~-------------~~-~--~~~~~~L~~  349 (597)
T 3oja_B          288 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-------------TL-K--LSTHHTLKN  349 (597)
T ss_dssp             SCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-------------CC-C--CCTTCCCSE
T ss_pred             CCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC-------------Cc-C--hhhcCCCCE
Confidence            77774 5666667777888888888877 46666777777775555554443             22 2  556788888


Q ss_pred             ccccCceeccc
Q 045539          477 MFLEYNRLEGS  487 (897)
Q Consensus       477 L~ls~N~l~~~  487 (897)
                      |++++|.+++.
T Consensus       350 L~l~~N~~~~~  360 (597)
T 3oja_B          350 LTLSHNDWDCN  360 (597)
T ss_dssp             EECCSSCEEHH
T ss_pred             EEeeCCCCCCh
Confidence            99999998864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-34  Score=324.62  Aligned_cols=308  Identities=19%  Similarity=0.188  Sum_probs=207.3

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      .+..++++++.++...+..+..+++|++|+|++|.+++..|..|+++++|++|+|++|++.+.+|..+.++++|++|+|+
T Consensus        46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  125 (390)
T 3o6n_A           46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE  125 (390)
T ss_dssp             CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence            56789999999885444457899999999999999998888899999999999999999999999999999999999999


Q ss_pred             ecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccc
Q 045539          157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT  236 (897)
Q Consensus       157 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~  236 (897)
                      +|+++...+..|+++++|++|++++|+++++.+..|.++++|++|++++|++++ ++.   ..+++|+.|++++|.+++.
T Consensus       126 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~---~~l~~L~~L~l~~n~l~~~  201 (390)
T 3o6n_A          126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL---SLIPSLFHANVSYNLLSTL  201 (390)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CCG---GGCTTCSEEECCSSCCSEE
T ss_pred             CCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc-ccc---ccccccceeeccccccccc
Confidence            999994444457999999999999999999999999999999999999999983 331   2456666666666665431


Q ss_pred             ccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHH
Q 045539          237 VPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS  316 (897)
Q Consensus       237 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~  316 (897)
                           ...++|+.|++++|.++.....                        .                            
T Consensus       202 -----~~~~~L~~L~l~~n~l~~~~~~------------------------~----------------------------  224 (390)
T 3o6n_A          202 -----AIPIAVEELDASHNSINVVRGP------------------------V----------------------------  224 (390)
T ss_dssp             -----ECCSSCSEEECCSSCCCEEECC------------------------C----------------------------
T ss_pred             -----CCCCcceEEECCCCeeeecccc------------------------c----------------------------
Confidence                 2233455555555544433111                        1                            


Q ss_pred             HHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccc
Q 045539          317 LEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG  396 (897)
Q Consensus       317 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  396 (897)
                                           .++|+.|++++|++++.  ..+..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus       225 ---------------------~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  281 (390)
T 3o6n_A          225 ---------------------NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN  281 (390)
T ss_dssp             ---------------------CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCS
T ss_pred             ---------------------cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCC
Confidence                                 13445555555555442  3444455555555555555544455555555555555555


Q ss_pred             cccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccccc
Q 045539          397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQ  476 (897)
Q Consensus       397 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~  476 (897)
                      |++++ +|..+..+++|+.|++++|+++ .+|..+..+++|++|++++|.++.             . |  +..+++|+.
T Consensus       282 n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-------------~-~--~~~~~~L~~  343 (390)
T 3o6n_A          282 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-------------L-K--LSTHHTLKN  343 (390)
T ss_dssp             SCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-------------C-C--CCTTCCCSE
T ss_pred             CcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-------------e-C--chhhccCCE
Confidence            55552 3444455555666666666555 244445555555544444433321             1 1  445566666


Q ss_pred             ccccCceecc
Q 045539          477 MFLEYNRLEG  486 (897)
Q Consensus       477 L~ls~N~l~~  486 (897)
                      |++++|++++
T Consensus       344 L~l~~N~~~~  353 (390)
T 3o6n_A          344 LTLSHNDWDC  353 (390)
T ss_dssp             EECCSSCEEH
T ss_pred             EEcCCCCccc
Confidence            6666666664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-34  Score=311.36  Aligned_cols=230  Identities=18%  Similarity=0.232  Sum_probs=179.0

Q ss_pred             hcCCCcC-CeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHH-HhcCCCccceEeeeecC----CCce
Q 045539          616 TDRFSEN-NLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVM-KRIRHRNLVKIISSCSN----DDFK  688 (897)
Q Consensus       616 ~~~y~~~-~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  688 (897)
                      .++|.+. +.||+|+||.||+|... +++.||+|+++..     ..+.+|++++ +..+||||+++++++..    +...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4677777 78999999999999874 6899999998754     4566788888 55589999999999876    6788


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a  764 (897)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 4689999999999999999999   8899999999999999997   789999999998


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ....                        +..++.++||||+||++|||++|+.||.........  ....          
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~----------  211 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMK----------  211 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSC----------
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HHHH----------
Confidence            6532                        234678999999999999999999999653211100  0000          


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ....................++.+++.+||+.|| ++|||++|+++
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP-~~Rps~~e~l~  256 (299)
T 3m2w_A          212 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP-TQRMTITEFMN  256 (299)
T ss_dssp             -CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             -HHHhhccccCCchhcccCCHHHHHHHHHHcccCh-hhCCCHHHHhc
Confidence             0000000000011112334568899999999999 99999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-34  Score=348.34  Aligned_cols=236  Identities=21%  Similarity=0.291  Sum_probs=189.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec--CCceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc-----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ--DGMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF-----  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  687 (897)
                      .++|++.+.||+|+||.||+|++.  +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999875  5899999998643 23455678899999999999999999999987655     


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||++|++|.+++..   .+++.++..++.||+.||+||   |++||+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999987755   589999999999999999999   78999999999999999886 8999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ...      ....||+.|+|||++.++. +.++|||||||++|+|++|..||........          +..       
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~-------  287 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PED-------  287 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTT-------
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------ccc-------
Confidence            533      3456999999999876554 8899999999999999999988765322110          000       


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-HHHHHhhc
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-MGWIFSAL  893 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-~~evl~~L  893 (897)
                          .+      .......+.+++.+||+.|| ++||+ ++++.+.|
T Consensus       288 ----~~------~~~~~~~l~~li~~~l~~dP-~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          288 ----DP------VLKTYDSYGRLLRRAIDPDP-RQRFTTAEEMSAQL  323 (681)
T ss_dssp             ----CH------HHHHCHHHHHHHHHHTCSSG-GGSCSSHHHHHHHH
T ss_pred             ----cc------ccccCHHHHHHHhhhccCCh-hhCCCHHHHHHHHH
Confidence                00      01122457889999999999 99996 44444433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.6e-35  Score=319.14  Aligned_cols=242  Identities=17%  Similarity=0.168  Sum_probs=182.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcC----------------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIR----------------  671 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~----------------  671 (897)
                      .++|++.+.||+|+||+||+|++ +|+.||||+++...        ....+.+.+|+++++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999988 58999999997542        223467889999999886                


Q ss_pred             ----------CCccceEeeeecC-------------CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 045539          672 ----------HRNLVKIISSCSN-------------DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE  728 (897)
Q Consensus       672 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~  728 (897)
                                ||||+++++++.+             ++..|+||||+++|++.+.+..  ..+++.++..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                      4555555555543             7789999999999977666644  34899999999999999999


Q ss_pred             HHHhcC-CCCcEeCCCCCCCeeeCCCC--------------------cEEEeeccCccccCCCCceeeeeccccCcccCC
Q 045539          729 YLHFGH-STPIIHCDLKPSNVLLDEDM--------------------VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA  787 (897)
Q Consensus       729 ~Lh~~h-~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~a  787 (897)
                      ||   | ++||+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|
T Consensus       176 ~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            99   7 89999999999999999887                    9999999999876432       2369999999


Q ss_pred             cCccCCCCCCccchHHHHHHH-HHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHH
Q 045539          788 PEYGTKGRVCTRGDVYSYGIM-LMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLS  866 (897)
Q Consensus       788 PE~~~~~~~~~~sDv~slGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  866 (897)
                      ||++.+.. +.++||||+|++ .+++++|..||...        .|...    ....+.... ................+
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHY----LTDKMLKQM-TFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHH----HHHHHHHTC-CCSSCCCSHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhH----HHHhhhhhh-ccCcccchhhhhhcCHH
Confidence            99987666 899999998777 78899999998541        01000    001111110 00111111223456677


Q ss_pred             HHHHHhHccCCCCCCCCCCHHHHH
Q 045539          867 VLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       867 l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                      +.+++.+|++.|      |++|++
T Consensus       312 ~~dli~~~L~~d------sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS------SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS------SHHHHH
T ss_pred             HHHHHHHHhccC------CHHHHH
Confidence            899999999765      689888

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-34  Score=327.07  Aligned_cols=240  Identities=15%  Similarity=0.114  Sum_probs=179.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCC-CccceEe-----------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH-RNLVKII-----------  679 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~-----------  679 (897)
                      ...|...+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|+.+++.++| ++...+.           
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345778899999999999999855 69999999987332   2335778999999999987 3222111           


Q ss_pred             ----------eeecC-----CCceEEEEEeccCCChhHhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 045539          680 ----------SSCSN-----DDFKALIMKYMPNGSLENCLY------SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI  738 (897)
Q Consensus       680 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~i  738 (897)
                                .++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+||   |++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCc
Confidence                      11111     12356777765 789998884      2234578889999999999999999   88999


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCcc----------CCCCCCccchHHHHHHH
Q 045539          739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG----------TKGRVCTRGDVYSYGIM  808 (897)
Q Consensus       739 vH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~slGvi  808 (897)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998865322     334567 999999988          66678899999999999


Q ss_pred             HHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHH
Q 045539          809 LMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGW  888 (897)
Q Consensus       809 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~e  888 (897)
                      +|||++|+.||........                 ....+....        .+..++.+++.+||+.|| ++|||+.|
T Consensus       307 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~~~--------~~~~~~~~li~~~l~~dP-~~Rpt~~~  360 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-----------------SEWIFRSCK--------NIPQPVRALLEGFLRYPK-EDRLLPLQ  360 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-----------------SGGGGSSCC--------CCCHHHHHHHHHHTCSSG-GGSCCHHH
T ss_pred             HHHHHHCCCCCCCcchhhh-----------------HHHHHhhcc--------cCCHHHHHHHHHHccCCh-hhCcCHHH
Confidence            9999999999976322110                 001111000        112457899999999999 99999988


Q ss_pred             HHh
Q 045539          889 IFS  891 (897)
Q Consensus       889 vl~  891 (897)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            865

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=9.2e-33  Score=302.73  Aligned_cols=294  Identities=21%  Similarity=0.275  Sum_probs=175.8

Q ss_pred             CCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccc
Q 045539          101 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFA  180 (897)
Q Consensus       101 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~  180 (897)
                      +|+.+++++|.++ .+|..+.  ++|++|+|++|++.+..                        |..|+++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~------------------------~~~~~~l~~L~~L~L~   86 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELR------------------------KDDFKGLQHLYALVLV   86 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEEC------------------------TTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccC------------------------HhHhhCCCCCcEEECC
Confidence            5666666666665 4555443  45555555555544443                        4445555555555555


Q ss_pred             cccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc-
Q 045539          181 TNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG-  259 (897)
Q Consensus       181 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-  259 (897)
                      +|+++++.|..|.++++|++|+|++|+++ .+|..++   ++|++|++++|.+++..+..|.++++|+.|++++|.++. 
T Consensus        87 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~  162 (332)
T 2ft3_A           87 NNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS  162 (332)
T ss_dssp             SSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG
T ss_pred             CCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC
Confidence            55555555555666666666666666665 5555543   566777777777665555567777777777777777653 


Q ss_pred             -ccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCc
Q 045539          260 -FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL  338 (897)
Q Consensus       260 -~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l  338 (897)
                       ..+..                     +..+ +|++|++++|+++++ |                         ..+.  
T Consensus       163 ~~~~~~---------------------~~~l-~L~~L~l~~n~l~~l-~-------------------------~~~~--  192 (332)
T 2ft3_A          163 GFEPGA---------------------FDGL-KLNYLRISEAKLTGI-P-------------------------KDLP--  192 (332)
T ss_dssp             GSCTTS---------------------SCSC-CCSCCBCCSSBCSSC-C-------------------------SSSC--
T ss_pred             CCCccc---------------------ccCC-ccCEEECcCCCCCcc-C-------------------------cccc--
Confidence             33322                     2333 666666666666542 1                         1111  


Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      ++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus       193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l  271 (332)
T 2ft3_A          193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL  271 (332)
T ss_dssp             SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence            46777777777777766677777777777777777777666667777777777777777777 66666777777777777


Q ss_pred             ccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceec--ccCCCCCCCcC
Q 045539          419 GLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLE--GSIPESFGDLS  496 (897)
Q Consensus       419 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~~l~  496 (897)
                      ++|++++..+..|....-                               -.....|+.|++++|.+.  +..|..|..++
T Consensus       272 ~~N~l~~~~~~~~~~~~~-------------------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~  320 (332)
T 2ft3_A          272 HTNNITKVGVNDFCPVGF-------------------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVT  320 (332)
T ss_dssp             CSSCCCBCCTTSSSCSSC-------------------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBC
T ss_pred             CCCCCCccChhHcccccc-------------------------------ccccccccceEeecCcccccccCcccccccc
Confidence            777777654444443210                               001234555555555554  44555566666


Q ss_pred             CCcEEeccCCc
Q 045539          497 SLEVLDLSKNK  507 (897)
Q Consensus       497 ~L~~L~Ls~N~  507 (897)
                      +|+.|+|++|+
T Consensus       321 ~L~~l~l~~n~  331 (332)
T 2ft3_A          321 DRLAIQFGNYK  331 (332)
T ss_dssp             CSTTEEC----
T ss_pred             hhhhhhccccc
Confidence            66666666653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.1e-32  Score=302.24  Aligned_cols=288  Identities=24%  Similarity=0.273  Sum_probs=210.7

Q ss_pred             cccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCC
Q 045539          197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSS  276 (897)
Q Consensus       197 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~  276 (897)
                      +++.+++++|.++ .+|..++   ++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..            
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------   97 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA------------   97 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG------------
T ss_pred             cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhH------------
Confidence            4566666666665 5555443   45666666666666655666666666777777666666655543            


Q ss_pred             CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCC--CC
Q 045539          277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT--EP  354 (897)
Q Consensus       277 ~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~  354 (897)
                               +.++++|++|+|++|+++. +|..+.   .+|++|++++|.+++..+..|..+++|++|++++|.++  +.
T Consensus        98 ---------~~~l~~L~~L~L~~n~l~~-l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  164 (332)
T 2ft3_A           98 ---------FSPLRKLQKLYISKNHLVE-IPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF  164 (332)
T ss_dssp             ---------STTCTTCCEEECCSSCCCS-CCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGS
T ss_pred             ---------hhCcCCCCEEECCCCcCCc-cCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCC
Confidence                     3455666677777766663 333332   25666666666666666677888999999999999986  36


Q ss_pred             ccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcccccccc
Q 045539          355 IPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL  434 (897)
Q Consensus       355 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  434 (897)
                      .+..|..+ +|+.|++++|++++ +|..+.  ++|++|++++|++++..|..+.++++|+.|++++|++++..+..+..+
T Consensus       165 ~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  240 (332)
T 2ft3_A          165 EPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL  240 (332)
T ss_dssp             CTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred             CcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence            77888888 89999999999985 555443  789999999999998777889999999999999999998777788888


Q ss_pred             ccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCc------CCCcEEeccCCcc
Q 045539          435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDL------SSLEVLDLSKNKI  508 (897)
Q Consensus       435 ~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l  508 (897)
                      ++|++|++++|             +++ .+|..+..+++|++|++++|++++..+..|...      .+|+.|++++|.+
T Consensus       241 ~~L~~L~L~~N-------------~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~  306 (332)
T 2ft3_A          241 PTLRELHLDNN-------------KLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV  306 (332)
T ss_dssp             TTCCEEECCSS-------------CCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred             CCCCEEECCCC-------------cCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence            88885555544             444 567788889999999999999987777777653      6788999999988


Q ss_pred             C--CCCchhhhhhcccceEeccCCc
Q 045539          509 S--GAIPASLQKLLYLKHLNLSFNK  531 (897)
Q Consensus       509 ~--~~~p~~~~~l~~L~~L~ls~N~  531 (897)
                      .  +..|..+..+++|+.+++++|+
T Consensus       307 ~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          307 PYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccCcccccccchhhhhhccccc
Confidence            7  5777888889999999998885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.4e-32  Score=297.99  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=167.9

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAF  179 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L  179 (897)
                      .+|+.++++++.++ .+|..+.  ++|++|+|++|++.+..+..|.++++|++|+|++|+++                  
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~------------------   89 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS------------------   89 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC------------------
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC------------------
Confidence            35677777777766 4555443  45666666666655555545555555555555555555                  


Q ss_pred             ccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc
Q 045539          180 ATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                            ++.|..|.++++|++|+|++|+++ .+|..++   ++|++|++++|.+++..+..+.++++|+.|++++|.+..
T Consensus        90 ------~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A           90 ------KISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             ------CBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             ------eeCHHHhcCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence                  444444555555555555555555 4554443   567777777777776666677778888888888887753


Q ss_pred             --ccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccC
Q 045539          260 --FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN  337 (897)
Q Consensus       260 --~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~  337 (897)
                        ..+.                     .+.++++|++|++++|+++.+ |.                         .+  
T Consensus       160 ~~~~~~---------------------~~~~l~~L~~L~l~~n~l~~l-~~-------------------------~~--  190 (330)
T 1xku_A          160 SGIENG---------------------AFQGMKKLSYIRIADTNITTI-PQ-------------------------GL--  190 (330)
T ss_dssp             GGBCTT---------------------GGGGCTTCCEEECCSSCCCSC-CS-------------------------SC--
T ss_pred             cCcChh---------------------hccCCCCcCEEECCCCccccC-Cc-------------------------cc--
Confidence              3332                     245677888888888877642 21                         11  


Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceec
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY  417 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  417 (897)
                      .++|++|++++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus       191 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~  269 (330)
T 1xku_A          191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  269 (330)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence            157788888888888777777888888888888888887776777777888888888888887 6777777888888888


Q ss_pred             cccccccCCcccccc
Q 045539          418 LGLNRFTSALPSTIW  432 (897)
Q Consensus       418 L~~N~l~~~~p~~~~  432 (897)
                      +++|++++..+..|.
T Consensus       270 l~~N~i~~~~~~~f~  284 (330)
T 1xku_A          270 LHNNNISAIGSNDFC  284 (330)
T ss_dssp             CCSSCCCCCCTTSSS
T ss_pred             CCCCcCCccChhhcC
Confidence            888888765555554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=3.4e-32  Score=298.03  Aligned_cols=270  Identities=21%  Similarity=0.236  Sum_probs=193.3

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF  143 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  143 (897)
                      |+|+.+.|+            +++++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|++.+..|..
T Consensus        31 c~l~~l~~~------------~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~   95 (330)
T 1xku_A           31 CHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   95 (330)
T ss_dssp             EETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             CCCeEEEec------------CCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH
Confidence            566666554            44555 5666554  68999999999999877779999999999999999999999999


Q ss_pred             ccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccccccc
Q 045539          144 IFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV  223 (897)
Q Consensus       144 ~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L  223 (897)
                      |.++++|++|+|++|+++ .+|..+.  ++|++|++++|+++++.+..|.++++|++|++++|+++..            
T Consensus        96 ~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------  160 (330)
T 1xku_A           96 FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS------------  160 (330)
T ss_dssp             TTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG------------
T ss_pred             hcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCcc------------
Confidence            999999999999999998 6777665  7889999999998888888888888888888888877521            


Q ss_pred             ceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCC
Q 045539          224 ETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       224 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~  303 (897)
                                 +..+..+.++++|++|++++|.++.....                        -.++|++|++++|+++
T Consensus       161 -----------~~~~~~~~~l~~L~~L~l~~n~l~~l~~~------------------------~~~~L~~L~l~~n~l~  205 (330)
T 1xku_A          161 -----------GIENGAFQGMKKLSYIRIADTNITTIPQG------------------------LPPSLTELHLDGNKIT  205 (330)
T ss_dssp             -----------GBCTTGGGGCTTCCEEECCSSCCCSCCSS------------------------CCTTCSEEECTTSCCC
T ss_pred             -----------CcChhhccCCCCcCEEECCCCccccCCcc------------------------ccccCCEEECCCCcCC
Confidence                       13334455555566666666655532211                        0145666666666655


Q ss_pred             CCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhh
Q 045539          304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL  383 (897)
Q Consensus       304 ~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  383 (897)
                      +.                         .|..|..+++|++|++++|++++..+..|..+++|++|+|++|+++ .+|..+
T Consensus       206 ~~-------------------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  259 (330)
T 1xku_A          206 KV-------------------------DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL  259 (330)
T ss_dssp             EE-------------------------CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred             cc-------------------------CHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence            32                         2344556667777777777777666666777777777777777777 566667


Q ss_pred             hcccccccccccccccccCCCcccccc------cccceecccccccc
Q 045539          384 CHLARLHSLVLQGNKFSGSIPSCLGNL------TSLRVLYLGLNRFT  424 (897)
Q Consensus       384 ~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~  424 (897)
                      ..+++|++|++++|+|++..+..|...      +.|+.|++++|.+.
T Consensus       260 ~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~  306 (330)
T 1xku_A          260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  306 (330)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence            777777777777777776555555432      44555555555553

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=1.1e-36  Score=350.13  Aligned_cols=287  Identities=19%  Similarity=0.196  Sum_probs=134.4

Q ss_pred             CCceecccCccccCcCCcc-ccCCCCCcEEeccCccccC----CccccccccccccEEEeeecCCCCCCCccc-cCcc--
Q 045539          101 SLQTLDLSHNKLSGNIPSS-IFNMHTLKLLYFSDNQLFG----SLSFFIFNVSSVTTIDLSINGLSGEMPREI-GNLP--  172 (897)
Q Consensus       101 ~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l-~~l~--  172 (897)
                      +|++|||++|+++...... +..+++|++|+|++|++.+    .++..+..+++|++|||++|.+....+..+ ..++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            3444444444443221111 3344444444444444432    123333444444444444444433222221 1222  


Q ss_pred             --cccccccccccccc----cccccccccccccccccccccccccCCccc----cccccccceeeccccccccc----cc
Q 045539          173 --YLARLAFATNNLVG----VAPVTIFNMSALKEIYLLNNSLSGSLPSRI----DLSLPNVETLNLGINSFYGT----VP  238 (897)
Q Consensus       173 --~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~~l~~L~~L~L~~N~l~~~----~p  238 (897)
                        +|++|+|++|+++.    ..+..+.++++|++|+|++|++++..+..+    ....++|++|+|++|.+++.    ++
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              35555555555442    224445555555555555555543222211    11234566666666655542    24


Q ss_pred             ccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccc-cccCCCcEEEecCCCCCCCCCCcccCchHHH
Q 045539          239 SSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSL-TNCKKLKVLILTGNPLDGILPKSKGNLSLSL  317 (897)
Q Consensus       239 ~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L  317 (897)
                      ..+..+++|++|++++|.++...+..+..                 .+ ...++|++|++++|++++..          .
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~-----------------~l~~~~~~L~~L~L~~n~l~~~~----------~  216 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQ-----------------GLKDSPCQLEALKLESCGVTSDN----------C  216 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHH-----------------HHHHSCCCCCEEECTTSCCBTTH----------H
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHH-----------------HHhcCCCCceEEEccCCCCcHHH----------H
Confidence            45555667777777777665443322210                 01 12346666666666655320          0


Q ss_pred             HHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCc-----cccccCccchhhhcccCcccccc----cchhhhcccc
Q 045539          318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPI-----PITFSQLQTLQALGLTRNKLAGP----ITDELCHLAR  388 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~  388 (897)
                      +           .++..+..+++|++|++++|++++..     +..+..+++|++|+|++|++++.    ++..+..+++
T Consensus       217 ~-----------~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~  285 (461)
T 1z7x_W          217 R-----------DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES  285 (461)
T ss_dssp             H-----------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTT
T ss_pred             H-----------HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCC
Confidence            0           12334455666666666666665422     22233455666666666666543    3444555566


Q ss_pred             cccccccccccccCCCcccccc-----cccceeccccccccC
Q 045539          389 LHSLVLQGNKFSGSIPSCLGNL-----TSLRVLYLGLNRFTS  425 (897)
Q Consensus       389 L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~  425 (897)
                      |++|+|++|++++..+..+...     ++|+.|++++|.+++
T Consensus       286 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~  327 (461)
T 1z7x_W          286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA  327 (461)
T ss_dssp             CCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred             cceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCch
Confidence            6666666666554333333221     355555555555543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2e-35  Score=339.66  Aligned_cols=360  Identities=21%  Similarity=0.205  Sum_probs=235.2

Q ss_pred             CCCcEEeccCccccCCcccc-ccccccccEEEeeecCCCC----CCCccccCccccccccccccccccccccccc-ccc-
Q 045539          124 HTLKLLYFSDNQLFGSLSFF-IFNVSSVTTIDLSINGLSG----EMPREIGNLPYLARLAFATNNLVGVAPVTIF-NMS-  196 (897)
Q Consensus       124 ~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~LdLs~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~l~-  196 (897)
                      ++|++|+|++|++....... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|++++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            56788888888887654333 7778888888888888874    3456677778888888888887765544433 344 


Q ss_pred             ---cccccccccccccc----cCCccccccccccceeeccccccccccccccc-----CCCcccEEEccccccccccCcc
Q 045539          197 ---ALKEIYLLNNSLSG----SLPSRIDLSLPNVETLNLGINSFYGTVPSSIT-----NASKLSDLELGVNLFSGFIPNT  264 (897)
Q Consensus       197 ---~L~~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~~~~  264 (897)
                         +|++|+|++|+++.    .+|..+ ..+++|++|+|++|.+++..+..+.     ..++|++|+|++|.+++.....
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l-~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTL-RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHT-TSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHH-ccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence               57777777777763    233333 2566777777777776554443332     2446777777777666543222


Q ss_pred             ccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccc-cCccCCcE
Q 045539          265 FVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV-GNLGNLLV  343 (897)
Q Consensus       265 f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~  343 (897)
                      +.                 ..+..+++|++|++++|++.+..+.          .+           ...+ ...++|++
T Consensus       162 l~-----------------~~l~~~~~L~~L~L~~n~i~~~~~~----------~l-----------~~~l~~~~~~L~~  203 (461)
T 1z7x_W          162 LA-----------------SVLRAKPDFKELTVSNNDINEAGVR----------VL-----------CQGLKDSPCQLEA  203 (461)
T ss_dssp             HH-----------------HHHHHCTTCCEEECCSSBCHHHHHH----------HH-----------HHHHHHSCCCCCE
T ss_pred             HH-----------------HHHhhCCCCCEEECcCCCcchHHHH----------HH-----------HHHHhcCCCCceE
Confidence            11                 1234556677777776665432110          00           0011 12446777


Q ss_pred             EEccCCCCCCC----ccccccCccchhhhcccCcccccccchh-----hhcccccccccccccccccC----CCcccccc
Q 045539          344 LELGGNNLTEP----IPITFSQLQTLQALGLTRNKLAGPITDE-----LCHLARLHSLVLQGNKFSGS----IPSCLGNL  410 (897)
Q Consensus       344 L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~----~p~~~~~l  410 (897)
                      |++++|.+++.    ++..+..+++|++|+|++|++++.....     +..+++|++|++++|++++.    ++..+.++
T Consensus       204 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~  283 (461)
T 1z7x_W          204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK  283 (461)
T ss_dssp             EECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             EEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC
Confidence            77777777664    3555666677777777777766533222     22356777777777777643    45556666


Q ss_pred             cccceeccccccccCCcccccccc-----ccceEEeecCCcccccceeecccCcCCCC----CcccccCCcccccccccC
Q 045539          411 TSLRVLYLGLNRFTSALPSTIWNL-----KDILFIDVSSNSLNVLIGLNFSRNNLSGD----IPITIGGLKNLQQMFLEY  481 (897)
Q Consensus       411 ~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~ls~N~l~~l~~l~ls~n~l~~~----~p~~~~~l~~L~~L~ls~  481 (897)
                      ++|+.|++++|.+++..+..+...     ++|+             .|++++|.+++.    +|..+..+++|++|++++
T Consensus       284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~-------------~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~  350 (461)
T 1z7x_W          284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLE-------------SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN  350 (461)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCC-------------EEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCS
T ss_pred             CCcceEECCCCCCchHHHHHHHHHhccCCccce-------------eeEcCCCCCchHHHHHHHHHHhhCCCccEEEccC
Confidence            777777777777665433333322     3444             666666666655    566778889999999999


Q ss_pred             ceecccCCCCCCC-----cCCCcEEeccCCccCC----CCchhhhhhcccceEeccCCccccc
Q 045539          482 NRLEGSIPESFGD-----LSSLEVLDLSKNKISG----AIPASLQKLLYLKHLNLSFNKLEGE  535 (897)
Q Consensus       482 N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~  535 (897)
                      |++++..+..+..     .++|++|+|++|++++    .+|..+..+++|++|+|++|++++.
T Consensus       351 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             CccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            9998765555543     6799999999999986    7899999999999999999999864

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.9e-32  Score=301.45  Aligned_cols=294  Identities=20%  Similarity=0.222  Sum_probs=218.6

Q ss_pred             CCCCCCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccc
Q 045539           57 WTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL  136 (897)
Q Consensus        57 w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  136 (897)
                      |.....+|.|.|+ |+          .++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus        23 ~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   88 (353)
T 2z80_A           23 SNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI   88 (353)
T ss_dssp             ----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             CCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCcc
Confidence            3334567999998 76          3556666 6777665  5899999999999977777899999999999999999


Q ss_pred             cCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccc-ccccccccccccccccccccccCCcc
Q 045539          137 FGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLSGSLPSR  215 (897)
Q Consensus       137 ~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~  215 (897)
                      .+..+..|.++++|++|||++|++++..+..|+++++|++|+|++|+++++.+ ..+.++++|++|++++|...+.++..
T Consensus        89 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  168 (353)
T 2z80_A           89 NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK  168 (353)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT
T ss_pred             CccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHH
Confidence            99889999999999999999999995444558999999999999999998766 57889999999999998533366655


Q ss_pred             ccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEE
Q 045539          216 IDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVL  295 (897)
Q Consensus       216 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L  295 (897)
                      .+..+++|++|++++|.+++..|..+..+++|++|++++|.++...+..                     +..+++|++|
T Consensus       169 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~---------------------~~~~~~L~~L  227 (353)
T 2z80_A          169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF---------------------VDVTSSVECL  227 (353)
T ss_dssp             TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH---------------------HHHTTTEEEE
T ss_pred             HccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh---------------------hhhcccccEE
Confidence            5567888899999999888888888888888888888888876443322                     2346788888


Q ss_pred             EecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCccc
Q 045539          296 ILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL  375 (897)
Q Consensus       296 ~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  375 (897)
                      ++++|++++..+..+..                      ....+.++.++|++|.+++                   |.+
T Consensus       228 ~L~~n~l~~~~~~~l~~----------------------~~~~~~l~~l~L~~~~l~~-------------------~~l  266 (353)
T 2z80_A          228 ELRDTDLDTFHFSELST----------------------GETNSLIKKFTFRNVKITD-------------------ESL  266 (353)
T ss_dssp             EEESCBCTTCCCC----------------------------CCCCCCEEEEESCBCCH-------------------HHH
T ss_pred             ECCCCcccccccccccc----------------------ccccchhhccccccccccC-------------------cch
Confidence            88888887654332211                      1223445566665555443                   222


Q ss_pred             ccccchhhhcccccccccccccccccCCCcc-cccccccceeccccccccCCcc
Q 045539          376 AGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSLRVLYLGLNRFTSALP  428 (897)
Q Consensus       376 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p  428 (897)
                      . .+|+.+..+++|++|+|++|+++ .+|.. |.++++|+.|++++|++++..|
T Consensus       267 ~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          267 F-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             H-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             h-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            2 35666777777888888888887 44544 5778888888888888776544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.5e-30  Score=281.60  Aligned_cols=283  Identities=23%  Similarity=0.274  Sum_probs=202.3

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCC--cc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGS--LS  141 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~  141 (897)
                      |.|.+|.|+..            +++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|++...  .+
T Consensus         7 C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~   71 (306)
T 2z66_A            7 CSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS   71 (306)
T ss_dssp             EETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred             eCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence            89999998643            343 5666543  6899999999999855455689999999999999998743  36


Q ss_pred             ccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccc-ccccccccccccccccccccccCCccccccc
Q 045539          142 FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLSGSLPSRIDLSL  220 (897)
Q Consensus       142 ~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l  220 (897)
                      ..+.++++|++|+|++|.+. .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|++++..|.. +..+
T Consensus        72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l  149 (306)
T 2z66_A           72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI-FNGL  149 (306)
T ss_dssp             HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTT-TTTC
T ss_pred             cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhh-cccC
Confidence            67778899999999999988 577778888888888888888888765 56778888888888888887444433 3467


Q ss_pred             cccceeecccccccc-cccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecC
Q 045539          221 PNVETLNLGINSFYG-TVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTG  299 (897)
Q Consensus       221 ~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~  299 (897)
                      ++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..|..                     +.++++|++|+|++
T Consensus       150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~---------------------~~~l~~L~~L~L~~  208 (306)
T 2z66_A          150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA---------------------FNSLSSLQVLNMSH  208 (306)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT---------------------TTTCTTCCEEECTT
T ss_pred             cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHH---------------------hcCCCCCCEEECCC
Confidence            777777777777765 56777777777777777777777665543                     34556677777777


Q ss_pred             CCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCcc-chhhhcccCcccccc
Q 045539          300 NPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQ-TLQALGLTRNKLAGP  378 (897)
Q Consensus       300 N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~  378 (897)
                      |++++.                         .+..+..+++|++|++++|++++..|..+..++ +|++|+|++|.+++.
T Consensus       209 N~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          209 NNFFSL-------------------------DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             SCCSBC-------------------------CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             CccCcc-------------------------ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            766543                         233456677778888888887777777777774 777777777777754


Q ss_pred             cc--hhhhcccccccccccccccccCCCccccc
Q 045539          379 IT--DELCHLARLHSLVLQGNKFSGSIPSCLGN  409 (897)
Q Consensus       379 ~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  409 (897)
                      .+  .....+...+.+.+..+.+....|..+.+
T Consensus       264 c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g  296 (306)
T 2z66_A          264 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQG  296 (306)
T ss_dssp             GGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred             cChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence            32  11223444555566666666666665544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=1.6e-30  Score=304.94  Aligned_cols=293  Identities=23%  Similarity=0.260  Sum_probs=203.6

Q ss_pred             cccccCCCCCCCCcceeeeEee------CCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCC
Q 045539           51 NLFARNWTSSTSVCSWIGITCD------VNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH  124 (897)
Q Consensus        51 ~~~~~~w~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~  124 (897)
                      ..+. +|..+.+||.|+|..|.      .....++.|++++++++ .+|..+.  ++|++|+|++|+|+ .+|.   .++
T Consensus        10 ~~w~-~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~   81 (622)
T 3g06_A           10 AVWS-AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP   81 (622)
T ss_dssp             CHHH-HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred             HHHH-HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence            3344 88888889999775432      12234788999999988 7888776  79999999999998 5665   578


Q ss_pred             CCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccc
Q 045539          125 TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLL  204 (897)
Q Consensus       125 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  204 (897)
                      +|++|+|++|+|++..+    .+++|++|+|++|++++ +|.   .+++|+.|++++|+++++.+    .+++|++|+|+
T Consensus        82 ~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls  149 (622)
T 3g06_A           82 ELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVS  149 (622)
T ss_dssp             TCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECC
T ss_pred             CCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEECc
Confidence            89999999998875433    67888899999998884 555   56778888888888887633    24778888888


Q ss_pred             cccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccc
Q 045539          205 NNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLS  284 (897)
Q Consensus       205 ~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~  284 (897)
                      +|+++ .+|.    .+++|+.|++++|.+++ +|   ..+++|+.|++++|.++++.+                      
T Consensus       150 ~N~l~-~l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----------------------  198 (622)
T 3g06_A          150 DNQLA-SLPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----------------------  198 (622)
T ss_dssp             SSCCS-CCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----------------------
T ss_pred             CCcCC-CcCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----------------------
Confidence            88887 4553    24567777777777764 34   345667777777777664321                      


Q ss_pred             cccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccc
Q 045539          285 SLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQT  364 (897)
Q Consensus       285 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  364 (897)
                         .+++|+.|++++|.++.+                          |.   .+++|+.|+|++|+|++ +|   ..+++
T Consensus       199 ---~~~~L~~L~L~~N~l~~l--------------------------~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~  242 (622)
T 3g06_A          199 ---LPSELYKLWAYNNRLTSL--------------------------PA---LPSGLKELIVSGNRLTS-LP---VLPSE  242 (622)
T ss_dssp             ---CCTTCCEEECCSSCCSSC--------------------------CC---CCTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred             ---ccchhhEEECcCCccccc--------------------------CC---CCCCCCEEEccCCccCc-CC---CCCCc
Confidence               125666677776666532                          11   13567777777777776 44   34566


Q ss_pred             hhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccc
Q 045539          365 LQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK  435 (897)
Q Consensus       365 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  435 (897)
                      |+.|+|++|+|++ +|.   .+++|++|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..++
T Consensus       243 L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          243 LKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            7777777777773 444   4566777777777777 5677777777777777777777766666555443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=4.4e-32  Score=296.00  Aligned_cols=289  Identities=18%  Similarity=0.252  Sum_probs=165.6

Q ss_pred             HhccccCCCcccccCCCC--CCCCcceeeeEeeCCCCeEEEEEeecccccccCCCCC--CCCCCCceecccCccccCcCC
Q 045539           42 KAHISYDHTNLFARNWTS--STSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQL--GNLSSLQTLDLSHNKLSGNIP  117 (897)
Q Consensus        42 k~~~~~~~~~~~~~~w~~--~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~Ls~n~l~~~~p  117 (897)
                      |+++ .|+..++. .|..  ..++|.|.++-|.............+.... .++..+  ...++++.|+|++|+++ .+|
T Consensus        22 ~~~~-~~~~~aLl-~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp   97 (328)
T 4fcg_A           22 STAL-RPYHDVLS-QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFP   97 (328)
T ss_dssp             -CCC-CCHHHHHH-HHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred             cccC-chHHHHHH-HHHHhccCCchhhhhhhcccccccccccccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcC
Confidence            3444 35555665 7875  357899999888432210000011111110 111111  13467788888888887 677


Q ss_pred             ccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccccccccccc
Q 045539          118 SSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA  197 (897)
Q Consensus       118 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  197 (897)
                      ..++++++|++|+|++|++. .+|..+.++++|++|+|++|+++ .+|..|++                        +++
T Consensus        98 ~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~------------------------l~~  151 (328)
T 4fcg_A           98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS------------------------LNR  151 (328)
T ss_dssp             SCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGG------------------------CTT
T ss_pred             hhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhc------------------------CcC
Confidence            77777888888877777776 56666666777777777777666 55555544                        455


Q ss_pred             ccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCC
Q 045539          198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSST  277 (897)
Q Consensus       198 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~  277 (897)
                      |++|+|++|++.+.+|..+..                ...+..+.++++|++|+|++|.++ .+|..             
T Consensus       152 L~~L~L~~n~~~~~~p~~~~~----------------~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-------------  201 (328)
T 4fcg_A          152 LRELSIRACPELTELPEPLAS----------------TDASGEHQGLVNLQSLRLEWTGIR-SLPAS-------------  201 (328)
T ss_dssp             CCEEEEEEETTCCCCCSCSEE----------------EC-CCCEEESTTCCEEEEEEECCC-CCCGG-------------
T ss_pred             CCEEECCCCCCccccChhHhh----------------ccchhhhccCCCCCEEECcCCCcC-cchHh-------------
Confidence            555555555555555544321                011233455566666666666655 22322             


Q ss_pred             CcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccc
Q 045539          278 PELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPI  357 (897)
Q Consensus       278 ~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  357 (897)
                              +.++++|++|+|++|+++++                          |..++.+++|++|+|++|++.+.+|.
T Consensus       202 --------l~~l~~L~~L~L~~N~l~~l--------------------------~~~l~~l~~L~~L~Ls~n~~~~~~p~  247 (328)
T 4fcg_A          202 --------IANLQNLKSLKIRNSPLSAL--------------------------GPAIHHLPKLEELDLRGCTALRNYPP  247 (328)
T ss_dssp             --------GGGCTTCCEEEEESSCCCCC--------------------------CGGGGGCTTCCEEECTTCTTCCBCCC
T ss_pred             --------hcCCCCCCEEEccCCCCCcC--------------------------chhhccCCCCCEEECcCCcchhhhHH
Confidence                    34455666666666655531                          22345566666666666666666666


Q ss_pred             cccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecccccccc
Q 045539          358 TFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFT  424 (897)
Q Consensus       358 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  424 (897)
                      .|.++++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus       248 ~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            6666666666666666666666666666666666666666666666666666666666666655443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.3e-30  Score=284.96  Aligned_cols=277  Identities=18%  Similarity=0.202  Sum_probs=210.7

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAF  179 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L  179 (897)
                      +.....|+++|+++ .+|..+.  ++|++|+|++|++.+..+..+.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (353)
T 2z80_A           31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL  107 (353)
T ss_dssp             CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence            33445788999998 7887766  58999999999999888889999999999999999999877888999999999999


Q ss_pred             ccccccccccccccccccccccccccccccccCCc-cccccccccceeecccc-cccccccccccCCCcccEEEcccccc
Q 045539          180 ATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPS-RIDLSLPNVETLNLGIN-SFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      ++|+++++.+..|.++++|++|+|++|+++ .+|. ..+..+++|++|++++| .+....+..+.++++|++|++++|.+
T Consensus       108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             CSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            999999988877999999999999999998 6776 56667888899999888 46666677888888888888888888


Q ss_pred             ccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccC
Q 045539          258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN  337 (897)
Q Consensus       258 ~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~  337 (897)
                      ++..|..                     +.++++|++|++++|++...                         .+..+..
T Consensus       187 ~~~~~~~---------------------l~~l~~L~~L~l~~n~l~~~-------------------------~~~~~~~  220 (353)
T 2z80_A          187 QSYEPKS---------------------LKSIQNVSHLILHMKQHILL-------------------------LEIFVDV  220 (353)
T ss_dssp             CEECTTT---------------------TTTCSEEEEEEEECSCSTTH-------------------------HHHHHHH
T ss_pred             CccCHHH---------------------HhccccCCeecCCCCccccc-------------------------hhhhhhh
Confidence            7776654                     35567788888888776522                         1112344


Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccccccccc----CCCccccccccc
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG----SIPSCLGNLTSL  413 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L  413 (897)
                      +++|++|++++|++++..+..+...                     ...+.++.++|++|.+++    .+|..+.++++|
T Consensus       221 ~~~L~~L~L~~n~l~~~~~~~l~~~---------------------~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L  279 (353)
T 2z80_A          221 TSSVECLELRDTDLDTFHFSELSTG---------------------ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL  279 (353)
T ss_dssp             TTTEEEEEEESCBCTTCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTC
T ss_pred             cccccEEECCCCccccccccccccc---------------------cccchhhccccccccccCcchhhhHHHHhcccCC
Confidence            6778888888888877544433221                     112233334444444433    577889999999


Q ss_pred             ceeccccccccCCcccc-ccccccceEEeecCCccc
Q 045539          414 RVLYLGLNRFTSALPST-IWNLKDILFIDVSSNSLN  448 (897)
Q Consensus       414 ~~L~L~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~  448 (897)
                      +.|++++|+++. +|.. |..+++|++|++++|.+.
T Consensus       280 ~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             CEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCcc
Confidence            999999999995 5554 688999997777666654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.9e-33  Score=332.34  Aligned_cols=434  Identities=15%  Similarity=0.089  Sum_probs=277.0

Q ss_pred             CcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccc---cCcCCcccc------------CCCCCc
Q 045539           63 VCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKL---SGNIPSSIF------------NMHTLK  127 (897)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~  127 (897)
                      |++|.++.+..  .+.  +.+.. .....++..+..+++|++|+|+++..   .+.+|..++            ++++|+
T Consensus        41 ck~W~~~~~~~--~~~--l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSET--REH--VTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHH--CCE--EEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhcc--ccE--EEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            55899995432  122  22222 23333444566788899999987532   234554444            789999


Q ss_pred             EEeccCccccCCcccccccc--ccccEEEeeecC-CCC-CCCccccCccccccccccccccccc----cccccccccccc
Q 045539          128 LLYFSDNQLFGSLSFFIFNV--SSVTTIDLSING-LSG-EMPREIGNLPYLARLAFATNNLVGV----APVTIFNMSALK  199 (897)
Q Consensus       128 ~L~Ls~N~l~~~~~~~~~~l--~~L~~LdLs~N~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~  199 (897)
                      +|+|++|.+.+..+..+...  .+|++|+|++|. ++. .++....++++|++|+|++|.+++.    .+..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999998887777777764  459999999886 211 1222334788999999999988766    334556788999


Q ss_pred             ccccccccccc----cCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccC
Q 045539          200 EIYLLNNSLSG----SLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTS  275 (897)
Q Consensus       200 ~L~L~~N~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~  275 (897)
                      +|++++|.+++    .++. +...+++|++|+|++|.+.+ +|..+.++++|++|+++++......+.            
T Consensus       196 ~L~L~~n~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~------------  261 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLET-IARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPE------------  261 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHH-HHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTT------------
T ss_pred             EEEeeccCCCccCHHHHHH-HHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHH------------
Confidence            99999999872    2222 23367899999999998875 678888999999999986432211111            


Q ss_pred             CCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcC-ccccCccCCcEEEccCCCCCC-
Q 045539          276 STPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIP-QVVGNLGNLLVLELGGNNLTE-  353 (897)
Q Consensus       276 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~-  353 (897)
                            ....+..+++|+.|+++++.. +.+|..+..++ +|++|++++|.+++... ..+..+++|++|+++ |.+++ 
T Consensus       262 ------~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~  332 (592)
T 3ogk_B          262 ------KYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR  332 (592)
T ss_dssp             ------SSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH
T ss_pred             ------HHHHhhccccccccCccccch-hHHHHHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH
Confidence                  112356778888888887533 23344444443 56666666666554332 335666777777776 33322 


Q ss_pred             CccccccCccchhhhccc-----------Ccccccccc-hhhhcccccccccccccccccCCCccccc-ccccceeccc-
Q 045539          354 PIPITFSQLQTLQALGLT-----------RNKLAGPIT-DELCHLARLHSLVLQGNKFSGSIPSCLGN-LTSLRVLYLG-  419 (897)
Q Consensus       354 ~~~~~~~~l~~L~~L~Ls-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~-  419 (897)
                      .++..+..+++|++|+|+           .|.+++... ..+..+++|++|+++.|++++..+..++. +++|+.|+++ 
T Consensus       333 ~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~  412 (592)
T 3ogk_B          333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL  412 (592)
T ss_dssp             HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEE
T ss_pred             HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEee
Confidence            223333456667777776           245554322 22334667777777667776655555544 6667777774 


Q ss_pred             ---cccccCC-----ccccccccccceEEeecCCcccccceeecccCcCCCCCcccccC-CcccccccccCceecc-cCC
Q 045539          420 ---LNRFTSA-----LPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGG-LKNLQQMFLEYNRLEG-SIP  489 (897)
Q Consensus       420 ---~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~-l~~L~~L~ls~N~l~~-~~p  489 (897)
                         .|.+++.     ++..+.++++|+.|+++++           .+.+++..+..++. +++|++|++++|++++ .++
T Consensus       413 ~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~-----------~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~  481 (592)
T 3ogk_B          413 LDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR-----------QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM  481 (592)
T ss_dssp             CSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECC-----------GGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred             cCCCccccCchHHHHHHHHHHhCCCCCEEEEecC-----------CCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence               5556542     3333455666665544321           12244444444443 7889999999999876 345


Q ss_pred             CCCCCcCCCcEEeccCCccCCC-CchhhhhhcccceEeccCCccccc
Q 045539          490 ESFGDLSSLEVLDLSKNKISGA-IPASLQKLLYLKHLNLSFNKLEGE  535 (897)
Q Consensus       490 ~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~  535 (897)
                      ..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.
T Consensus       482 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            5567788999999999998754 445556789999999999997753

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.1e-31  Score=287.58  Aligned_cols=251  Identities=18%  Similarity=0.159  Sum_probs=170.1

Q ss_pred             CCCCCceecccCccccCcCCccccCCCCCcEEeccCcccc-CCcccccc-------ccccccEEEeeecCCCCCCCccc-
Q 045539           98 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLF-GSLSFFIF-------NVSSVTTIDLSINGLSGEMPREI-  168 (897)
Q Consensus        98 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~LdLs~N~l~~~~p~~l-  168 (897)
                      ..++|++|++++|.+  .+|..+...  |++|+|++|++. ..+|..+.       ++++|++|+|++|++++.+|..+ 
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  116 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL  116 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence            345666777777776  566655544  667777777763 34454444       56677777777777776677665 


Q ss_pred             -cCccccccccccccccccccccccccc-----ccccccccccccccccCCccccccccccceeeccccccccc--cccc
Q 045539          169 -GNLPYLARLAFATNNLVGVAPVTIFNM-----SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT--VPSS  240 (897)
Q Consensus       169 -~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~--~p~~  240 (897)
                       +.+++|++|+|++|++++. |..+.++     ++|++|+|++|++++ ++...+..+++|++|+|++|++.+.  .|..
T Consensus       117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCC-CCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCcc-chHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence             6777777777777777776 6666666     677777777777763 3333334677777777777776654  2334


Q ss_pred             c--cCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHH
Q 045539          241 I--TNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLE  318 (897)
Q Consensus       241 l--~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~  318 (897)
                      +  ..+++|++|+|++|++++......                  ..+.++++|++|+|++|++++..|.          
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------~~~~~l~~L~~L~Ls~N~l~~~~~~----------  246 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPSGVCS------------------ALAAARVQLQGLDLSHNSLRDAAGA----------  246 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHHHHHH------------------HHHHTTCCCSEEECTTSCCCSSCCC----------
T ss_pred             HHhccCCCCCEEECCCCcCcchHHHHH------------------HHHhcCCCCCEEECCCCcCCcccch----------
Confidence            4  778888888888888874221100                  0134668888888888888865431          


Q ss_pred             HHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccc
Q 045539          319 IILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNK  398 (897)
Q Consensus       319 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  398 (897)
                                    ..+..+++|++|+|++|+|+. +|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|+
T Consensus       247 --------------~~~~~l~~L~~L~Ls~N~l~~-ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~  307 (312)
T 1wwl_A          247 --------------PSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNP  307 (312)
T ss_dssp             --------------SCCCCCTTCCEEECTTSCCSS-CCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCT
T ss_pred             --------------hhhhhcCCCCEEECCCCccCh-hhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCC
Confidence                          224456788888888888884 666665  7888888888888865 55 7888888888888888


Q ss_pred             ccc
Q 045539          399 FSG  401 (897)
Q Consensus       399 l~~  401 (897)
                      +++
T Consensus       308 l~~  310 (312)
T 1wwl_A          308 FLD  310 (312)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            874

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.7e-29  Score=273.38  Aligned_cols=276  Identities=22%  Similarity=0.243  Sum_probs=194.2

Q ss_pred             cccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccccc--CccccccccccccCC
Q 045539          199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFI--PNTFVNMADNYLTSS  276 (897)
Q Consensus       199 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--~~~f~~l~~~~l~~~  276 (897)
                      +.++++++.++ .+|..+.   ++|++|+|++|.++...+..|.++++|++|+|++|.++...  +..            
T Consensus        10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------------   73 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS------------   73 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHH------------
T ss_pred             CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccc------------
Confidence            35566666665 5665443   46677777777776444445677777777777777765332  221            


Q ss_pred             CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcc
Q 045539          277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIP  356 (897)
Q Consensus       277 ~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  356 (897)
                               +..+++|++|+|++|++.+                          +|..+..+++|++|++++|++++..+
T Consensus        74 ---------~~~~~~L~~L~Ls~n~i~~--------------------------l~~~~~~l~~L~~L~l~~n~l~~~~~  118 (306)
T 2z66_A           74 ---------DFGTTSLKYLDLSFNGVIT--------------------------MSSNFLGLEQLEHLDFQHSNLKQMSE  118 (306)
T ss_dssp             ---------HHSCSCCCEEECCSCSEEE--------------------------EEEEEETCTTCCEEECTTSEEESSTT
T ss_pred             ---------cccccccCEEECCCCcccc--------------------------ChhhcCCCCCCCEEECCCCccccccc
Confidence                     2345677777777776652                          33446667778888888887776554


Q ss_pred             -ccccCccchhhhcccCcccccccchhhhccccccccccccccccc-CCCcccccccccceeccccccccCCcccccccc
Q 045539          357 -ITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG-SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL  434 (897)
Q Consensus       357 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  434 (897)
                       ..+..+++|++|++++|++.+..+..+..+++|++|++++|++++ .+|..+..+++|+.|++++|++++..|..+..+
T Consensus       119 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  198 (306)
T 2z66_A          119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  198 (306)
T ss_dssp             TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCC
Confidence             567777788888888888777777777778888888888888876 567788888888888888888887777778777


Q ss_pred             ccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcC-CCcEEeccCCccCCCCc
Q 045539          435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS-SLEVLDLSKNKISGAIP  513 (897)
Q Consensus       435 ~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p  513 (897)
                      ++|+.             |+|++|++++..+..+..+++|++|++++|++++..|..+..++ +|++|+|++|.+++.-+
T Consensus       199 ~~L~~-------------L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~  265 (306)
T 2z66_A          199 SSLQV-------------LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  265 (306)
T ss_dssp             TTCCE-------------EECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred             CCCCE-------------EECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence            77774             44444555555566778888999999999999988888888884 89999999999986532


Q ss_pred             --hhhhhhcccceEeccCCcccccCCC
Q 045539          514 --ASLQKLLYLKHLNLSFNKLEGEIPR  538 (897)
Q Consensus       514 --~~~~~l~~L~~L~ls~N~l~~~~p~  538 (897)
                        ....-+...+.+.+..|.+.+..|.
T Consensus       266 ~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          266 HQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             GHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             hHHHHHHHHhhhhhhccccccccCCch
Confidence              2223344555666777777777665

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=5.9e-29  Score=284.46  Aligned_cols=173  Identities=20%  Similarity=0.207  Sum_probs=116.3

Q ss_pred             cccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCC
Q 045539           85 SFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEM  164 (897)
Q Consensus        85 ~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~  164 (897)
                      +.+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|.+..+..|.++++|++|+|++|++++..
T Consensus        63 ~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~  139 (452)
T 3zyi_A           63 RRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIP  139 (452)
T ss_dssp             SSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCC
T ss_pred             CCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccC
Confidence            34444 4665554  57888888888888777778888888888888888887777777888888888888888887655


Q ss_pred             CccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCC
Q 045539          165 PREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNA  244 (897)
Q Consensus       165 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  244 (897)
                      +..|+++++|++|+|++|+++.+.+..|.++++|++|+|++|...+.++...+..+++|++|+|++|.+++. | .+..+
T Consensus       140 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l  217 (452)
T 3zyi_A          140 SGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPL  217 (452)
T ss_dssp             TTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTC
T ss_pred             hhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-ccccc
Confidence            566777777888887777777777777777777777777775444455555555555555555555555432 2 34444


Q ss_pred             CcccEEEccccccccccC
Q 045539          245 SKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       245 ~~L~~L~L~~N~l~~~~~  262 (897)
                      ++|+.|+|++|.+++..|
T Consensus       218 ~~L~~L~Ls~N~l~~~~~  235 (452)
T 3zyi_A          218 VGLEELEMSGNHFPEIRP  235 (452)
T ss_dssp             TTCCEEECTTSCCSEECG
T ss_pred             ccccEEECcCCcCcccCc
Confidence            444444444444444333

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.5e-28  Score=278.30  Aligned_cols=174  Identities=20%  Similarity=0.229  Sum_probs=136.3

Q ss_pred             ecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCC
Q 045539           84 SSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGE  163 (897)
Q Consensus        84 ~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~  163 (897)
                      ++.+++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|++++.
T Consensus        51 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~  127 (440)
T 3zyj_A           51 VRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI  127 (440)
T ss_dssp             CSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSC
T ss_pred             CCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCee
Confidence            344555 6777665  7899999999999988889999999999999999999998889999999999999999999966


Q ss_pred             CCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccC
Q 045539          164 MPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITN  243 (897)
Q Consensus       164 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  243 (897)
                      .+..|..+++|++|+|++|+++.+.+..|.++++|++|+|++|...+.++...+..+++|++|+|++|.++. +| .+..
T Consensus       128 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~  205 (440)
T 3zyj_A          128 PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTP  205 (440)
T ss_dssp             CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTT
T ss_pred             CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCC
Confidence            666799999999999999999988888888899999999988655556666666666666666666666652 22 3445


Q ss_pred             CCcccEEEccccccccccC
Q 045539          244 ASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       244 l~~L~~L~L~~N~l~~~~~  262 (897)
                      +++|+.|+|++|.+++..|
T Consensus       206 l~~L~~L~Ls~N~l~~~~~  224 (440)
T 3zyj_A          206 LIKLDELDLSGNHLSAIRP  224 (440)
T ss_dssp             CSSCCEEECTTSCCCEECT
T ss_pred             CcccCEEECCCCccCccCh
Confidence            5555555555555544444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.5e-30  Score=282.31  Aligned_cols=256  Identities=19%  Similarity=0.177  Sum_probs=203.0

Q ss_pred             ccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC-CCCCCcccc-------Cccccccccccccccccccc
Q 045539          118 SSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL-SGEMPREIG-------NLPYLARLAFATNNLVGVAP  189 (897)
Q Consensus       118 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l-~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~~  189 (897)
                      +.++..++|++|++++|++  .+|..+...  |+.|+|++|.+ .+.+|..+.       ++++|++|+|++|++++..|
T Consensus        37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  112 (312)
T 1wwl_A           37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP  112 (312)
T ss_dssp             EEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred             EEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence            3567788999999999999  677766655  99999999999 556787776       89999999999999999888


Q ss_pred             ccc--cccccccccccccccccccCCccccccc-----cccceeecccccccccccccccCCCcccEEEccccccccccC
Q 045539          190 VTI--FNMSALKEIYLLNNSLSGSLPSRIDLSL-----PNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       190 ~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  262 (897)
                      ..+  .++++|++|+|++|++++. |..+. .+     ++|++|+|++|++.+..|..|+++++|++|+|++|++.+..+
T Consensus       113 ~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~-~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  190 (312)
T 1wwl_A          113 PPLLEATGPDLNILNLRNVSWATR-DAWLA-ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG  190 (312)
T ss_dssp             CCSSSCCSCCCSEEEEESCBCSSS-SSHHH-HHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH
T ss_pred             HHHHHhcCCCccEEEccCCCCcch-hHHHH-HHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH
Confidence            876  8999999999999999965 65443 44     899999999999999988999999999999999999876522


Q ss_pred             --ccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccC
Q 045539          263 --NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGN  340 (897)
Q Consensus       263 --~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~  340 (897)
                        ..+                   .+.++++|++|+|++|++++..     .                 .....+..+++
T Consensus       191 ~~~~~-------------------~~~~l~~L~~L~L~~N~l~~~~-----~-----------------~~~~~~~~l~~  229 (312)
T 1wwl_A          191 LISAL-------------------CPLKFPTLQVLALRNAGMETPS-----G-----------------VCSALAAARVQ  229 (312)
T ss_dssp             HHHHS-------------------CTTSCTTCCEEECTTSCCCCHH-----H-----------------HHHHHHHTTCC
T ss_pred             HHHHH-------------------HhccCCCCCEEECCCCcCcchH-----H-----------------HHHHHHhcCCC
Confidence              111                   1267789999999999887420     0                 11123456788


Q ss_pred             CcEEEccCCCCCCCcc-ccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccc
Q 045539          341 LLVLELGGNNLTEPIP-ITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLG  419 (897)
Q Consensus       341 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  419 (897)
                      |++|++++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.|+++
T Consensus       230 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~  304 (312)
T 1wwl_A          230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLK  304 (312)
T ss_dssp             CSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECT
T ss_pred             CCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEecc
Confidence            9999999999988764 45666788888888888887 5666555  6777777777777754 55 7777777777777


Q ss_pred             cccccC
Q 045539          420 LNRFTS  425 (897)
Q Consensus       420 ~N~l~~  425 (897)
                      +|++++
T Consensus       305 ~N~l~~  310 (312)
T 1wwl_A          305 GNPFLD  310 (312)
T ss_dssp             TCTTTC
T ss_pred             CCCCCC
Confidence            777764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=1.3e-29  Score=291.64  Aligned_cols=148  Identities=18%  Similarity=0.121  Sum_probs=91.3

Q ss_pred             chhhhcccCcccccccchhhhcccccccccccccccccCCCcccc-cccccceeccccccccCCccccccccccceEEee
Q 045539          364 TLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG-NLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDV  442 (897)
Q Consensus       364 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  442 (897)
                      +|+.|+|++|++++..|..+..+++|++|+|++|++++.+|..+. .+++|+.|+|++|.+++. |. ...+++|+    
T Consensus       121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~----  194 (487)
T 3oja_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLK----  194 (487)
T ss_dssp             SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCC----
T ss_pred             CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCC----
Confidence            344444444444444444444444444455555555444444443 455555555555555543 11 11244444    


Q ss_pred             cCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccC-CCCchhhhhhcc
Q 045539          443 SSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKIS-GAIPASLQKLLY  521 (897)
Q Consensus       443 s~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~  521 (897)
                               .|+|++|.+++ +|+.++.+++|+.|+|++|+|++ +|..+..+++|+.|++++|.++ +.+|..+..++.
T Consensus       195 ---------~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~  263 (487)
T 3oja_A          195 ---------TLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR  263 (487)
T ss_dssp             ---------EEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHH
T ss_pred             ---------EEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCC
Confidence                     33344444443 34447778888888888888885 7888889999999999999998 778888999999


Q ss_pred             cceEecc
Q 045539          522 LKHLNLS  528 (897)
Q Consensus       522 L~~L~ls  528 (897)
                      |+.++++
T Consensus       264 L~~l~~~  270 (487)
T 3oja_A          264 VQTVAKQ  270 (487)
T ss_dssp             HHHHHHH
T ss_pred             CcEEecc
Confidence            9888886

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.9e-28  Score=262.22  Aligned_cols=179  Identities=22%  Similarity=0.231  Sum_probs=132.3

Q ss_pred             EEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeec
Q 045539           79 IGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN  158 (897)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N  158 (897)
                      +.++.++++++ .+|..+  .++|++|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45667777777 566544  578999999999999777788999999999999999998888888999999999999999


Q ss_pred             C-CCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccc
Q 045539          159 G-LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV  237 (897)
Q Consensus       159 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  237 (897)
                      . +....|..|..+++|++|++++|+++++.|..|.++++|++|++++|+++ .+|...+..+++|++|+|++|++++..
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccC
Confidence            7 77655788888888888888888888887877888888888888888776 444444445555666666665555444


Q ss_pred             cccccCCCcccEEEcccccccccc
Q 045539          238 PSSITNASKLSDLELGVNLFSGFI  261 (897)
Q Consensus       238 p~~l~~l~~L~~L~L~~N~l~~~~  261 (897)
                      +..+..+++|++|++++|.+++..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~  193 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVH  193 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             HHHhcCccccCEEECCCCcccccC
Confidence            444555555555555555444433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=2.1e-28  Score=279.99  Aligned_cols=246  Identities=22%  Similarity=0.240  Sum_probs=165.5

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.++.+++.++ .+|..+.  ++|++|+|++|+|.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            45677778887 6776665  67888888888888777777777888888888888777666677777777777777777


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc-ccccc
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL-FSGFI  261 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~  261 (897)
                      +++.+.+..|.++++|++|+|++|+++ .+|..                        .|.++++|++|+|++|. +....
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~------------------------~~~~l~~L~~L~l~~~~~l~~i~  188 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY------------------------AFNRVPSLMRLDLGELKKLEYIS  188 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCC-EECTT------------------------TTTTCTTCCEEECCCCTTCCEEC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcc-eeCHh------------------------HHhcCCcccEEeCCCCCCccccC
Confidence            777666666666666666666666665 44443                        44455555555555532 22222


Q ss_pred             CccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCC
Q 045539          262 PNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL  341 (897)
Q Consensus       262 ~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L  341 (897)
                      +.                     .+.++++|++|+|++|+++++ |                          .+..+++|
T Consensus       189 ~~---------------------~~~~l~~L~~L~L~~n~l~~~-~--------------------------~~~~l~~L  220 (452)
T 3zyi_A          189 EG---------------------AFEGLFNLKYLNLGMCNIKDM-P--------------------------NLTPLVGL  220 (452)
T ss_dssp             TT---------------------TTTTCTTCCEEECTTSCCSSC-C--------------------------CCTTCTTC
T ss_pred             hh---------------------hccCCCCCCEEECCCCccccc-c--------------------------cccccccc
Confidence            21                     134556666666666666532 1                          14456677


Q ss_pred             cEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccc
Q 045539          342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN  421 (897)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  421 (897)
                      ++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus       221 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  300 (452)
T 3zyi_A          221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN  300 (452)
T ss_dssp             CEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSS
T ss_pred             cEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCC
Confidence            77777777777766777777777777777777777666667777777777777777777666666677777777777777


Q ss_pred             ccc
Q 045539          422 RFT  424 (897)
Q Consensus       422 ~l~  424 (897)
                      .+.
T Consensus       301 p~~  303 (452)
T 3zyi_A          301 PWN  303 (452)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            665

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.5e-28  Score=261.36  Aligned_cols=255  Identities=21%  Similarity=0.225  Sum_probs=189.5

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      ++++.+++.++ .+|..+  .++|++|+|++|++.+..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            68899999998 677655  478999999999999888888999999999999999999777888999999999999999


Q ss_pred             c-ccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccccc
Q 045539          183 N-LVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFI  261 (897)
Q Consensus       183 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  261 (897)
                      + ++.+.|..|.++++|++|++++|++++ ++...+..+++|++|+|++|.+++..+..+..+++|++|+|++|.+++..
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            7 888888888888889999888888884 44444446778888888888887666666777777888877777777655


Q ss_pred             CccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCC
Q 045539          262 PNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL  341 (897)
Q Consensus       262 ~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L  341 (897)
                      +..                     +.++++|++|+|++|++++.                         .|..|..+++|
T Consensus       170 ~~~---------------------~~~l~~L~~L~l~~n~l~~~-------------------------~~~~~~~l~~L  203 (285)
T 1ozn_A          170 ERA---------------------FRGLHSLDRLLLHQNRVAHV-------------------------HPHAFRDLGRL  203 (285)
T ss_dssp             TTT---------------------TTTCTTCCEEECCSSCCCEE-------------------------CTTTTTTCTTC
T ss_pred             HHH---------------------hcCccccCEEECCCCccccc-------------------------CHhHccCcccc
Confidence            543                     34566777777777766543                         34455566677


Q ss_pred             cEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccc
Q 045539          342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG  408 (897)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  408 (897)
                      +.|++++|++++..+..|..+++|+.|+|++|.+....+.. .....++.+..+.|.+....|..+.
T Consensus       204 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             cEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence            77777777777766666777777777777777776543321 1223455556666666666666554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=2.6e-28  Score=278.12  Aligned_cols=246  Identities=23%  Similarity=0.258  Sum_probs=164.3

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.++.++++++ .+|..+.  +++++|+|++|++.+..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            46788888888 7887666  67888999998888777777777777777777777777655566777777777777777


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc-ccccc
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL-FSGFI  261 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~  261 (897)
                      +++.+.+..|.++++|++|+|++|+++ .+|.                        ..|.++++|++|+|++|. +....
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~------------------------~~~~~l~~L~~L~l~~~~~l~~i~  177 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS------------------------YAFNRIPSLRRLDLGELKRLSYIS  177 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCC-EECT------------------------TTTTTCTTCCEEECCCCTTCCEEC
T ss_pred             cCCeeCHhHhhccccCceeeCCCCccc-ccCH------------------------HHhhhCcccCEeCCCCCCCcceeC
Confidence            666666666666666666666666665 3333                        344555555555555532 22222


Q ss_pred             CccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCC
Q 045539          262 PNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL  341 (897)
Q Consensus       262 ~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L  341 (897)
                      +..                     +.++++|++|+|++|+++.+                          | .+..+++|
T Consensus       178 ~~~---------------------~~~l~~L~~L~L~~n~l~~~--------------------------~-~~~~l~~L  209 (440)
T 3zyj_A          178 EGA---------------------FEGLSNLRYLNLAMCNLREI--------------------------P-NLTPLIKL  209 (440)
T ss_dssp             TTT---------------------TTTCSSCCEEECTTSCCSSC--------------------------C-CCTTCSSC
T ss_pred             cch---------------------hhcccccCeecCCCCcCccc--------------------------c-ccCCCccc
Confidence            211                     34556666666666666522                          1 14456677


Q ss_pred             cEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccc
Q 045539          342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN  421 (897)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  421 (897)
                      ++|+|++|+++++.|..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus       210 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  289 (440)
T 3zyj_A          210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN  289 (440)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSS
T ss_pred             CEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCC
Confidence            77777777777766777777777777777777777666666777777777777777777666666677777777777777


Q ss_pred             ccc
Q 045539          422 RFT  424 (897)
Q Consensus       422 ~l~  424 (897)
                      .+.
T Consensus       290 p~~  292 (440)
T 3zyj_A          290 PWN  292 (440)
T ss_dssp             CEE
T ss_pred             Ccc
Confidence            665

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6.4e-30  Score=277.91  Aligned_cols=256  Identities=18%  Similarity=0.155  Sum_probs=131.2

Q ss_pred             eecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccc
Q 045539          104 TLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNN  183 (897)
Q Consensus       104 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~  183 (897)
                      .++++.+.+...++..+..+++|++|+|++|++.+..|..|.++++|++|+|++|++++..|  ++.+++|++|+|++|+
T Consensus        14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~   91 (317)
T 3o53_A           14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY   91 (317)
T ss_dssp             EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred             EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence            34444444443333333344455555555555555444555555555555555555543322  5555555555555555


Q ss_pred             ccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCc
Q 045539          184 LVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN  263 (897)
Q Consensus       184 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  263 (897)
                      ++++.+     .++|++|++++|++++..+.    .+++|++|++++|++++..+..+..+++|++|+|++|.+++..+.
T Consensus        92 l~~l~~-----~~~L~~L~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  162 (317)
T 3o53_A           92 VQELLV-----GPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA  162 (317)
T ss_dssp             EEEEEE-----CTTCCEEECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred             cccccC-----CCCcCEEECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence            554422     25556666666655532221    235566666666666655555666666666666666666655444


Q ss_pred             cccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcE
Q 045539          264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLV  343 (897)
Q Consensus       264 ~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  343 (897)
                      .+                    ...+++|++|+|++|++++..+                           ...+++|++
T Consensus       163 ~~--------------------~~~l~~L~~L~L~~N~l~~~~~---------------------------~~~l~~L~~  195 (317)
T 3o53_A          163 EL--------------------AASSDTLEHLNLQYNFIYDVKG---------------------------QVVFAKLKT  195 (317)
T ss_dssp             GG--------------------GGGTTTCCEEECTTSCCCEEEC---------------------------CCCCTTCCE
T ss_pred             HH--------------------hhccCcCCEEECCCCcCccccc---------------------------ccccccCCE
Confidence            32                    1245566666666666653310                           112445555


Q ss_pred             EEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccc-cCCCcccccccccceeccc
Q 045539          344 LELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFS-GSIPSCLGNLTSLRVLYLG  419 (897)
Q Consensus       344 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~  419 (897)
                      |+|++|++++ +|..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++ +.+|..+..+++|+.|+++
T Consensus       196 L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             EECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             EECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            5555555554 2223555555555555555555 24444555555555555555555 4444555555555555555

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=4.4e-29  Score=271.28  Aligned_cols=161  Identities=20%  Similarity=0.142  Sum_probs=104.3

Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhh-cccccccccccccccccCCCccccccccccee
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELC-HLARLHSLVLQGNKFSGSIPSCLGNLTSLRVL  416 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  416 (897)
                      +++|++|++++|++++..+..|..+++|++|+|++|++++..+..+. .+++|++|+|++|+++                
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~----------------  182 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY----------------  182 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC----------------
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc----------------
Confidence            34566666666666655555555555555555555555544444432 3444555555555444                


Q ss_pred             ccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcC
Q 045539          417 YLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS  496 (897)
Q Consensus       417 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~  496 (897)
                              +. |. ...+++|+             .|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..++
T Consensus       183 --------~~-~~-~~~l~~L~-------------~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~  237 (317)
T 3o53_A          183 --------DV-KG-QVVFAKLK-------------TLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ  237 (317)
T ss_dssp             --------EE-EC-CCCCTTCC-------------EEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred             --------cc-cc-ccccccCC-------------EEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence                    32 11 11234444             33333333332 3444777888888999999998 5788899999


Q ss_pred             CCcEEeccCCccC-CCCchhhhhhcccceEecc-CCcccccCCCC
Q 045539          497 SLEVLDLSKNKIS-GAIPASLQKLLYLKHLNLS-FNKLEGEIPRG  539 (897)
Q Consensus       497 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls-~N~l~~~~p~~  539 (897)
                      +|+.|+|++|.++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus       238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            9999999999998 7889999999999999999 55677777754

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=1.1e-31  Score=318.84  Aligned_cols=415  Identities=14%  Similarity=0.062  Sum_probs=289.5

Q ss_pred             eEEEEEeecccc---cccCCCCCC------------CCCCCceecccCccccCcCCccccCC--CCCcEEeccCcc-ccC
Q 045539           77 RVIGLNISSFNL---QGTIPPQLG------------NLSSLQTLDLSHNKLSGNIPSSIFNM--HTLKLLYFSDNQ-LFG  138 (897)
Q Consensus        77 ~v~~l~l~~~~l---~g~~~~~l~------------~l~~L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~  138 (897)
                      ++..|+|+++..   .|.+|..++            .+++|++|+|++|.+++..+..++.+  .+|++|+|++|. +..
T Consensus        74 ~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~  153 (592)
T 3ogk_B           74 NLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTT  153 (592)
T ss_dssp             TCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEH
T ss_pred             CCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCH
Confidence            477888876432   245565555            68899999999998887767777664  449999999886 211


Q ss_pred             -CccccccccccccEEEeeecCCCCC----CCccccCcccccccccccccccc----ccccccccccccccccccccccc
Q 045539          139 -SLSFFIFNVSSVTTIDLSINGLSGE----MPREIGNLPYLARLAFATNNLVG----VAPVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       139 -~~~~~~~~l~~L~~LdLs~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                       .++....++++|++|+|++|.+++.    ++..+..+++|++|++++|.+++    ..+..+.++++|++|+|++|.+.
T Consensus       154 ~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~  233 (592)
T 3ogk_B          154 DGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL  233 (592)
T ss_dssp             HHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG
T ss_pred             HHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH
Confidence             1233345788999999999988765    33445678899999999999873    33445667889999999999887


Q ss_pred             ccCCccccccccccceeeccccccc---ccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccc
Q 045539          210 GSLPSRIDLSLPNVETLNLGINSFY---GTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSL  286 (897)
Q Consensus       210 ~~~p~~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l  286 (897)
                      + +|.. +..+++|+.|+++.+...   +..+..+..+++|+.|+++++... .+|.                     .+
T Consensus       234 ~-l~~~-~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~---------------------~~  289 (592)
T 3ogk_B          234 E-LVGF-FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPI---------------------LF  289 (592)
T ss_dssp             G-GHHH-HHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGG---------------------GG
T ss_pred             H-HHHH-HhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHH---------------------HH
Confidence            4 5533 447789999998864332   344567778888888888875322 2222                     13


Q ss_pred             cccCCCcEEEecCCCCCCCCCC-cccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccC-----------CCCCCC
Q 045539          287 TNCKKLKVLILTGNPLDGILPK-SKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGG-----------NNLTEP  354 (897)
Q Consensus       287 ~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~-----------N~l~~~  354 (897)
                      ..+++|++|+|++|.+++.... .+..++ +|+.|++.++...+.++..+..+++|++|++++           |.+++.
T Consensus       290 ~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~-~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~  368 (592)
T 3ogk_B          290 PFAAQIRKLDLLYALLETEDHCTLIQKCP-NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR  368 (592)
T ss_dssp             GGGGGCCEEEETTCCCCHHHHHHHHTTCT-TCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH
T ss_pred             hhcCCCcEEecCCCcCCHHHHHHHHHhCc-CCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH
Confidence            5677888888888886543321 123343 677777774333334455557789999999993           677653


Q ss_pred             cc-ccccCccchhhhcccCcccccccchhhhc-cccccccccc----ccccccC-----CCcccccccccceecccccc-
Q 045539          355 IP-ITFSQLQTLQALGLTRNKLAGPITDELCH-LARLHSLVLQ----GNKFSGS-----IPSCLGNLTSLRVLYLGLNR-  422 (897)
Q Consensus       355 ~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~-  422 (897)
                      .. ..+..+++|++|+++.|++++..+..+.. +++|+.|+++    .|++++.     ++..+.++++|+.|++++|. 
T Consensus       369 ~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~  448 (592)
T 3ogk_B          369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG  448 (592)
T ss_dssp             HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGG
T ss_pred             HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCC
Confidence            22 23456899999999999999888888776 8999999996    7788853     33346779999999998543 


Q ss_pred             -ccCCccccccc-cccceEEeecCCcccccceeecccCcCCC-CCcccccCCcccccccccCceeccc-CCCCCCCcCCC
Q 045539          423 -FTSALPSTIWN-LKDILFIDVSSNSLNVLIGLNFSRNNLSG-DIPITIGGLKNLQQMFLEYNRLEGS-IPESFGDLSSL  498 (897)
Q Consensus       423 -l~~~~p~~~~~-l~~L~~L~ls~N~l~~l~~l~ls~n~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L  498 (897)
                       +++..+..+.. +++|++|++             ++|++++ .++..+..+++|++|++++|.+++. ++..+..+++|
T Consensus       449 ~l~~~~~~~~~~~~~~L~~L~L-------------~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L  515 (592)
T 3ogk_B          449 GLTDLGLSYIGQYSPNVRWMLL-------------GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL  515 (592)
T ss_dssp             GCCHHHHHHHHHSCTTCCEEEE-------------CSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred             CccHHHHHHHHHhCccceEeec-------------cCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence             66655555543 667775554             5555554 3455567889999999999998754 44445678999


Q ss_pred             cEEeccCCccCCCCchhh-hhhcccceEeccC
Q 045539          499 EVLDLSKNKISGAIPASL-QKLLYLKHLNLSF  529 (897)
Q Consensus       499 ~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~  529 (897)
                      ++|+|++|++++.-...+ ..++.+....+..
T Consensus       516 ~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~  547 (592)
T 3ogk_B          516 RYLWVQGYRASMTGQDLMQMARPYWNIELIPS  547 (592)
T ss_dssp             CEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred             CeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence            999999999986533333 3456665554443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.1e-27  Score=280.81  Aligned_cols=149  Identities=29%  Similarity=0.340  Sum_probs=94.8

Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      ++|+.|++++|++++ +|   ..+++|+.|+|++|++++ +|..   +++|+.|++++|+++ .+|..   +++|+.|++
T Consensus       161 ~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~L  228 (622)
T 3g06_A          161 SELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIV  228 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEEC
T ss_pred             CCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEc
Confidence            345666666666665 33   334556666666666653 2321   356666777777776 44432   356777777


Q ss_pred             ccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCC
Q 045539          419 GLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL  498 (897)
Q Consensus       419 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L  498 (897)
                      ++|++++ +|   ..+++|+.             |+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..|.++++|
T Consensus       229 s~N~L~~-lp---~~l~~L~~-------------L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L  286 (622)
T 3g06_A          229 SGNRLTS-LP---VLPSELKE-------------LMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSE  286 (622)
T ss_dssp             CSSCCSC-CC---CCCTTCCE-------------EECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTT
T ss_pred             cCCccCc-CC---CCCCcCcE-------------EECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhcccc
Confidence            7777775 44   23345553             344444444 2344   4577888888888888 678888888888


Q ss_pred             cEEeccCCccCCCCchhhhhhcc
Q 045539          499 EVLDLSKNKISGAIPASLQKLLY  521 (897)
Q Consensus       499 ~~L~Ls~N~l~~~~p~~~~~l~~  521 (897)
                      +.|+|++|.+++.+|..+..++.
T Consensus       287 ~~L~L~~N~l~~~~~~~l~~L~~  309 (622)
T 3g06_A          287 TTVNLEGNPLSERTLQALREITS  309 (622)
T ss_dssp             CEEECCSCCCCHHHHHHHHHHHH
T ss_pred             CEEEecCCCCCCcCHHHHHhccc
Confidence            88888888888888887777653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.5e-29  Score=293.05  Aligned_cols=186  Identities=17%  Similarity=0.119  Sum_probs=132.6

Q ss_pred             eeecccceEEEEEEe-cCCceEEEEEechh----------hHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEE
Q 045539          624 LIGIGSFGSIYVARL-QDGMEVAVKVFHQQ----------YERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       624 ~lg~G~~g~Vy~a~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ..+.|++|.+..++. -.|+.||+|++.+.          .....+.|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            345666666666542 35899999998643          233457799999999999 599999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||++|++|.+++...+ +++..   +|+.||+.||+|+   |++|||||||||+|||++++|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999998765 46654   5889999999999   89999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPT  819 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~  819 (897)
                        ......+||+.|+|||++.+ .+..++|+||+|++.+++.++..|+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              22345679999999998765 5677899999999998887765554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=2.2e-27  Score=251.70  Aligned_cols=220  Identities=25%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             CCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCc
Q 045539           61 TSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL  140 (897)
Q Consensus        61 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  140 (897)
                      .++|.|.|+.|+.. +.+..+++++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++....
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            46899999999754 24567999999998 5787665  68999999999999777779999999999999999999888


Q ss_pred             cccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccc
Q 045539          141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSL  220 (897)
Q Consensus       141 ~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l  220 (897)
                      +..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+|...+..+
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l  156 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL  156 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCC
Confidence            888999999999999999999777778899999999999999999999999999999999999999998 6777777789


Q ss_pred             cccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCC
Q 045539          221 PNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGN  300 (897)
Q Consensus       221 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N  300 (897)
                      ++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..                     +..+++|+.|+|++|
T Consensus       157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------~~~l~~L~~L~l~~N  215 (270)
T 2o6q_A          157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA---------------------FDSLEKLKMLQLQEN  215 (270)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTT---------------------TTTCTTCCEEECCSS
T ss_pred             cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHH---------------------hccccCCCEEEecCC
Confidence            99999999999999888888999999999999999999776654                     356789999999999


Q ss_pred             CCCCCC
Q 045539          301 PLDGIL  306 (897)
Q Consensus       301 ~l~~~~  306 (897)
                      ++....
T Consensus       216 ~~~c~c  221 (270)
T 2o6q_A          216 PWDCTC  221 (270)
T ss_dssp             CBCCSS
T ss_pred             CeeCCC
Confidence            987543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=1.3e-27  Score=274.79  Aligned_cols=238  Identities=21%  Similarity=0.210  Sum_probs=134.0

Q ss_pred             CCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccc
Q 045539           98 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARL  177 (897)
Q Consensus        98 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L  177 (897)
                      ..++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+|  +..+++|++|||++|.|+                
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~----------------   93 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ----------------   93 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE----------------
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC----------------
Confidence            33466666666666665555666666666666666666654443  555555555555555554                


Q ss_pred             ccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          178 AFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       178 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                              ++.+     .++|++|++++|.+++..+.    .+++|++|+|++|.+++..|..++++++|+.|+|++|.+
T Consensus        94 --------~l~~-----~~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (487)
T 3oja_A           94 --------ELLV-----GPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (487)
T ss_dssp             --------EEEE-----CTTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC
T ss_pred             --------CCCC-----CCCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC
Confidence                    3322     14455555555555432221    234556666666666655566666666666666666666


Q ss_pred             ccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccC
Q 045539          258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN  337 (897)
Q Consensus       258 ~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~  337 (897)
                      ++.+|..|                    ...+++|++|+|++|.+++..+                           +..
T Consensus       157 ~~~~~~~l--------------------~~~l~~L~~L~Ls~N~l~~~~~---------------------------~~~  189 (487)
T 3oja_A          157 DTVNFAEL--------------------AASSDTLEHLNLQYNFIYDVKG---------------------------QVV  189 (487)
T ss_dssp             CEEEGGGG--------------------GGGTTTCCEEECTTSCCCEEEC---------------------------CCC
T ss_pred             CCcChHHH--------------------hhhCCcccEEecCCCccccccc---------------------------ccc
Confidence            66555433                    1245666666666666654311                           123


Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccc-cCCCccccccccccee
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFS-GSIPSCLGNLTSLRVL  416 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L  416 (897)
                      +++|++|+|++|+|+++ |..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.+
T Consensus       190 l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l  267 (487)
T 3oja_A          190 FAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV  267 (487)
T ss_dssp             CTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHH
T ss_pred             CCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEE
Confidence            45566666666666653 3335566666666666666663 4555566666666666666665 4555556666666666


Q ss_pred             ccc
Q 045539          417 YLG  419 (897)
Q Consensus       417 ~L~  419 (897)
                      +++
T Consensus       268 ~~~  270 (487)
T 3oja_A          268 AKQ  270 (487)
T ss_dssp             HHH
T ss_pred             ecc
Confidence            664

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=1.4e-30  Score=309.27  Aligned_cols=187  Identities=15%  Similarity=0.150  Sum_probs=123.6

Q ss_pred             CcceeeeEeeCCCCeEEEEEeecccccccCC-CCCCCCCCCceecccCccccC---cCCc------------cccCCCCC
Q 045539           63 VCSWIGITCDVNSHRVIGLNISSFNLQGTIP-PQLGNLSSLQTLDLSHNKLSG---NIPS------------SIFNMHTL  126 (897)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~Ls~n~l~~---~~p~------------~~~~l~~L  126 (897)
                      |++|.++..    .....+++....  +..| ..+..+++|++|+|+++....   ..|.            ....+++|
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            557888822    123345554332  1222 235567889999998875321   2221            23467889


Q ss_pred             cEEeccCccccCCcccccc-ccccccEEEeeec-CCCCC-CCccccCccccccccccccccccccccccc----cccccc
Q 045539          127 KLLYFSDNQLFGSLSFFIF-NVSSVTTIDLSIN-GLSGE-MPREIGNLPYLARLAFATNNLVGVAPVTIF----NMSALK  199 (897)
Q Consensus       127 ~~L~Ls~N~l~~~~~~~~~-~l~~L~~LdLs~N-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~  199 (897)
                      ++|+|++|.+.+..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            9999999988877766665 6889999999988 55432 344455788999999999988876555444    566899


Q ss_pred             cccccccc--ccccCCccccccccccceeecccccccccccccccCCCcccEEEcccc
Q 045539          200 EIYLLNNS--LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN  255 (897)
Q Consensus       200 ~L~L~~N~--l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  255 (897)
                      +|++++|.  ++......+...+++|++|+|++|...+.++..+.++++|+.|+++.+
T Consensus       188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~  245 (594)
T 2p1m_B          188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY  245 (594)
T ss_dssp             EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred             EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence            99999886  221111222234688999999888333347788888889999986554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=1.7e-25  Score=238.09  Aligned_cols=208  Identities=20%  Similarity=0.214  Sum_probs=165.5

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      ++++|++++|++++..+..|.++++|++|++++|+++++.+..|.++++|++|+|++|++++..+..|..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            44555555555555556677888899999999999988777788899999999999999988888888899999999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCC-ccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSA-LPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNL  474 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L  474 (897)
                      +|++++..+..++++++|++|++++|++++. +|..+.++++|++|+             +++|++++..+..+..+++|
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~-------------Ls~N~l~~~~~~~~~~l~~L  175 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD-------------LSSNKIQSIYCTDLRVLHQM  175 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE-------------CCSSCCCEECGGGGHHHHTC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE-------------CCCCCCCcCCHHHhhhhhhc
Confidence            9999877776788999999999999998864 588888888888444             44455555556677777777


Q ss_pred             c----cccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCC
Q 045539          475 Q----QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       475 ~----~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      +    .|++++|++++..+..+. ..+|+.|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus       176 ~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          176 PLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             TTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             cccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            7    788999999865555554 4589999999999997666677889999999999999987554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=7.5e-29  Score=294.48  Aligned_cols=382  Identities=13%  Similarity=0.145  Sum_probs=228.1

Q ss_pred             eEEEEEeecccccc---cCCCC------------CCCCCCCceecccCccccCcCCcccc-CCCCCcEEeccCc-cccCC
Q 045539           77 RVIGLNISSFNLQG---TIPPQ------------LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDN-QLFGS  139 (897)
Q Consensus        77 ~v~~l~l~~~~l~g---~~~~~------------l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~  139 (897)
                      ++..|+++++....   ..|..            ...+++|++|+|++|.+++..+..+. ++++|++|+|++| .+...
T Consensus        67 ~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~  146 (594)
T 2p1m_B           67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD  146 (594)
T ss_dssp             TCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHH
T ss_pred             CceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHH
Confidence            47788888765322   22222            23578999999999999877777776 7899999999999 55433


Q ss_pred             -ccccccccccccEEEeeecCCCCCCCcccc----Cccccccccccccc--cccc-ccccccccccccccccccc-cccc
Q 045539          140 -LSFFIFNVSSVTTIDLSINGLSGEMPREIG----NLPYLARLAFATNN--LVGV-APVTIFNMSALKEIYLLNN-SLSG  210 (897)
Q Consensus       140 -~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~----~l~~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L~L~~N-~l~~  210 (897)
                       ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  +... .+..+.++++|++|+|++| .++ 
T Consensus       147 ~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-  225 (594)
T 2p1m_B          147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-  225 (594)
T ss_dssp             HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-
T ss_pred             HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-
Confidence             455566899999999999998876655444    67799999999997  3211 1222345799999999998 444 


Q ss_pred             cCCccccccccccceeeccc-------ccccccccccccCCCcccEE-EccccccccccCccccccccccccCCCCcccc
Q 045539          211 SLPSRIDLSLPNVETLNLGI-------NSFYGTVPSSITNASKLSDL-ELGVNLFSGFIPNTFVNMADNYLTSSTPELSF  282 (897)
Q Consensus       211 ~~p~~~~~~l~~L~~L~L~~-------N~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~  282 (897)
                      .+|..+ ..+++|+.|+++.       |.+.+ ++..+.++++|+.| .+...... .++.                   
T Consensus       226 ~l~~~~-~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~-------------------  283 (594)
T 2p1m_B          226 KLATLL-QRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPA-------------------  283 (594)
T ss_dssp             HHHHHH-HHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGG-------------------
T ss_pred             HHHHHH-hcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHH-------------------
Confidence            354443 3688999999544       44544 44577888999988 33322211 1111                   


Q ss_pred             cccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCC-ccccccC
Q 045539          283 LSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEP-IPITFSQ  361 (897)
Q Consensus       283 l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~  361 (897)
                        .+..+++|++|+|++|.+++..                        ++..+..+++|++|++++| ++.. ++.....
T Consensus       284 --~~~~~~~L~~L~L~~~~l~~~~------------------------l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~  336 (594)
T 2p1m_B          284 --VYSVCSRLTTLNLSYATVQSYD------------------------LVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST  336 (594)
T ss_dssp             --GHHHHTTCCEEECTTCCCCHHH------------------------HHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred             --HHHhhCCCCEEEccCCCCCHHH------------------------HHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence              1346788999999999865321                        1122345667777777776 3321 1222234


Q ss_pred             ccchhhhcc---------cCcccccccchhhh-cccccccccccccccccCCCcccc-cccccceeccc--c----cccc
Q 045539          362 LQTLQALGL---------TRNKLAGPITDELC-HLARLHSLVLQGNKFSGSIPSCLG-NLTSLRVLYLG--L----NRFT  424 (897)
Q Consensus       362 l~~L~~L~L---------s~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~  424 (897)
                      +++|++|++         +.|.+++.....+. .+++|++|+++.|++++..+..+. .+++|+.|+++  +    |.++
T Consensus       337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~  416 (594)
T 2p1m_B          337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT  416 (594)
T ss_dssp             CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred             CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence            666777766         33455543333333 367777777777777655554454 46777777777  3    4454


Q ss_pred             CC-----ccccccccccceEEeecCCc-----------ccccceeecccCcCCCCCcccc-cCCcccccccccCceeccc
Q 045539          425 SA-----LPSTIWNLKDILFIDVSSNS-----------LNVLIGLNFSRNNLSGDIPITI-GGLKNLQQMFLEYNRLEGS  487 (897)
Q Consensus       425 ~~-----~p~~~~~l~~L~~L~ls~N~-----------l~~l~~l~ls~n~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~  487 (897)
                      +.     ++..+..+++|+.|+++++-           ++.|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.
T Consensus       417 ~~~~~~~~~~l~~~~~~L~~L~L~~~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~  496 (594)
T 2p1m_B          417 LEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK  496 (594)
T ss_dssp             CCCTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred             CCchhhHHHHHHhhCCCccEEeecCcccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence            21     12224556666655554410           1223344444444433333332 3345555555555555332


Q ss_pred             CCC-CCCCcCCCcEEeccCCcc
Q 045539          488 IPE-SFGDLSSLEVLDLSKNKI  508 (897)
Q Consensus       488 ~p~-~~~~l~~L~~L~Ls~N~l  508 (897)
                      .+. .+..+++|+.|++++|++
T Consensus       497 ~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          497 ALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHHHhCCCCCEEeeeCCCC
Confidence            221 223345555555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=7.2e-25  Score=233.18  Aligned_cols=220  Identities=20%  Similarity=0.233  Sum_probs=126.1

Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      ++..+. .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|+++ .++...+..+++|++|+|++|.+++
T Consensus        15 ~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~   90 (276)
T 2z62_A           15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS   90 (276)
T ss_dssp             TTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCE
T ss_pred             cCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCc
Confidence            333443 4444433  34555666666665555555556666666666666655 3333333355555555555565555


Q ss_pred             cccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchH
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL  315 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (897)
                      ..+..|.++++|++|++++|.+++..+..                     +.++++|++|++++|++++.          
T Consensus        91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------~~~l~~L~~L~l~~n~l~~~----------  139 (276)
T 2z62_A           91 LALGAFSGLSSLQKLVAVETNLASLENFP---------------------IGHLKTLKELNVAHNLIQSF----------  139 (276)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCCSTTCC---------------------CTTCTTCCEEECCSSCCCCC----------
T ss_pred             cChhhhcCCccccEEECCCCCccccCchh---------------------cccCCCCCEEECcCCcccee----------
Confidence            55556666666666666666665544422                     34556666666666665532          


Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchh----hhcccCcccccccchhhhccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ----ALGLTRNKLAGPITDELCHLARLHS  391 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~  391 (897)
                                    .+|..++.+++|++|++++|++++..+..|..+++|+    .|++++|++++..+..+. ..+|++
T Consensus       140 --------------~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~  204 (276)
T 2z62_A          140 --------------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKE  204 (276)
T ss_dssp             --------------CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEE
T ss_pred             --------------cCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccE
Confidence                          1344556666777777777777666566666666655    556666666644443333 235666


Q ss_pred             ccccccccccCCCcccccccccceeccccccccC
Q 045539          392 LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS  425 (897)
Q Consensus       392 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  425 (897)
                      |+|++|++++..+..+.++++|+.|++++|++++
T Consensus       205 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             EECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             EECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            6666666665444555666666666666666664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=6.3e-25  Score=230.01  Aligned_cols=193  Identities=22%  Similarity=0.245  Sum_probs=175.9

Q ss_pred             CCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcc
Q 045539           62 SVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS  141 (897)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  141 (897)
                      +||.|.|++|...   ...+++++++++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++.+..+
T Consensus         3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            5899999999643   235789999998 6787765  699999999999999888899999999999999999999999


Q ss_pred             ccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccccc
Q 045539          142 FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLP  221 (897)
Q Consensus       142 ~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~  221 (897)
                      ..|.++++|++|+|++|++++..+..|+.+++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+|...+..++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~  155 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT  155 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC-ccCHHHcCcCc
Confidence            99999999999999999999777788999999999999999999999888999999999999999999 66766666899


Q ss_pred             ccceeecccccccccccccccCCCcccEEEcccccccccc
Q 045539          222 NVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFI  261 (897)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  261 (897)
                      +|++|+|++|++++..+..+..+++|+.|+|++|.+++..
T Consensus       156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  195 (251)
T 3m19_A          156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR  195 (251)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred             CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence            9999999999999888889999999999999999998653

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.6e-25  Score=235.86  Aligned_cols=159  Identities=26%  Similarity=0.266  Sum_probs=78.0

Q ss_pred             cCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceE
Q 045539          360 SQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILF  439 (897)
Q Consensus       360 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  439 (897)
                      ..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+++++|++|++++|++++..+..+..+++|+ 
T Consensus        82 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-  160 (272)
T 3rfs_A           82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT-  160 (272)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-
T ss_pred             cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC-
Confidence            3333333333333333333333333444444444444444433333344444444444444444443333344444444 


Q ss_pred             EeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhh
Q 045539          440 IDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKL  519 (897)
Q Consensus       440 L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  519 (897)
                                  .|++++|++++..|..++.+++|++|++++|++++..|..|..+++|+.|+|++|.+++..|      
T Consensus       161 ------------~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------  222 (272)
T 3rfs_A          161 ------------ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------  222 (272)
T ss_dssp             ------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------
T ss_pred             ------------EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------
Confidence                        22333333333334445556666666666666666555556666666666666666654432      


Q ss_pred             cccceEeccCCcccccCCC
Q 045539          520 LYLKHLNLSFNKLEGEIPR  538 (897)
Q Consensus       520 ~~L~~L~ls~N~l~~~~p~  538 (897)
                       +|+.|+++.|+++|.+|.
T Consensus       223 -~l~~l~~~~n~~~g~ip~  240 (272)
T 3rfs_A          223 -GIRYLSEWINKHSGVVRN  240 (272)
T ss_dssp             -TTHHHHHHHHHTGGGBBC
T ss_pred             -HHHHHHHHHHhCCCcccC
Confidence             455666666666666664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=4.1e-24  Score=226.46  Aligned_cols=205  Identities=23%  Similarity=0.276  Sum_probs=162.0

Q ss_pred             CCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhc
Q 045539          290 KKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALG  369 (897)
Q Consensus       290 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  369 (897)
                      .+.+.+++++|+++.+ |.                         .+.  ++|++|+|++|+++++.+..|.++++|++|+
T Consensus        16 ~~~~~l~~~~~~l~~i-p~-------------------------~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~   67 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTAI-PS-------------------------NIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY   67 (270)
T ss_dssp             TTTTEEECTTSCCSSC-CS-------------------------CCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEE
T ss_pred             CCCCEEEccCCCCCcc-CC-------------------------CCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEE
Confidence            3578899999888743 32                         121  4678888888888887777888888888888


Q ss_pred             ccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccc
Q 045539          370 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV  449 (897)
Q Consensus       370 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  449 (897)
                      |++|+++...+..|..+++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|         
T Consensus        68 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---------  138 (270)
T 2o6q_A           68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---------  138 (270)
T ss_dssp             CCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE---------
T ss_pred             CCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE---------
Confidence            88888886666667788888888888888887666777888888888888888888777777888877744         


Q ss_pred             cceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccC
Q 045539          450 LIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF  529 (897)
Q Consensus       450 l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  529 (897)
                          +|++|++++..+..++.+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++
T Consensus       139 ----~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  214 (270)
T 2o6q_A          139 ----SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE  214 (270)
T ss_dssp             ----ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ----ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecC
Confidence                4445555555556688889999999999999977777788999999999999999976666788899999999999


Q ss_pred             Cccccc
Q 045539          530 NKLEGE  535 (897)
Q Consensus       530 N~l~~~  535 (897)
                      |++.+.
T Consensus       215 N~~~c~  220 (270)
T 2o6q_A          215 NPWDCT  220 (270)
T ss_dssp             SCBCCS
T ss_pred             CCeeCC
Confidence            988654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.1e-25  Score=258.46  Aligned_cols=188  Identities=19%  Similarity=0.192  Sum_probs=145.4

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhh--------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      .+...+.||+|+||.||+|+.. ++.+++|+.....        ....+++.+|++++++++||||+++..++...+..|
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             cCCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            3345679999999999999554 7889999864221        123466899999999999999996666665677789


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++++|.+++..         +..++.|+++||+||   |++||+||||||+||+++.  .+||+|||+|+....
T Consensus       416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999999876         557999999999999   8899999999999999998  999999999998754


Q ss_pred             CCcee-----eeeccccCcccCCcCccCC--CCCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          770 EDQLS-----IQIQTLATIGYMAPEYGTK--GRVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       770 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                      .....     ......||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211     1134579999999999876  567888999999999999888877764

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=3e-24  Score=229.47  Aligned_cols=203  Identities=23%  Similarity=0.220  Sum_probs=142.4

Q ss_pred             ccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccch
Q 045539          286 LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTL  365 (897)
Q Consensus       286 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  365 (897)
                      +.++++++++++++|.++.+ |                         ..+.  ++++.|+|++|++++..+..|.++++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~~i-p-------------------------~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L   57 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTAL-P-------------------------PDLP--KDTTILHLSENLLYTFSLATLMPYTRL   57 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSC-C-------------------------SCCC--TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred             ccccCCccEEECCCCCCCcC-C-------------------------CCCC--CCCCEEEcCCCcCCccCHHHhhcCCCC
Confidence            56677888888888887743 2                         1111  467777777777777667777777777


Q ss_pred             hhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCC
Q 045539          366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       366 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      ++|+|++|++++..+.  ..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..|..|.++++|+       
T Consensus        58 ~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~-------  127 (290)
T 1p9a_G           58 TQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ-------  127 (290)
T ss_dssp             CEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC-------
T ss_pred             CEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCC-------
Confidence            7777777777753332  56777777777777777 6677777777777777777777766666677777766       


Q ss_pred             cccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       446 ~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                            .|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|
T Consensus       128 ------~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l  200 (290)
T 1p9a_G          128 ------ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA  200 (290)
T ss_dssp             ------EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred             ------EEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeE
Confidence                  3444444455455566677777777777777777555556677777888888888777 677777777777777


Q ss_pred             eccCCccc
Q 045539          526 NLSFNKLE  533 (897)
Q Consensus       526 ~ls~N~l~  533 (897)
                      +|++|++.
T Consensus       201 ~L~~Np~~  208 (290)
T 1p9a_G          201 FLHGNPWL  208 (290)
T ss_dssp             ECCSCCBC
T ss_pred             EeCCCCcc
Confidence            77777764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=3.8e-24  Score=226.92  Aligned_cols=211  Identities=19%  Similarity=0.247  Sum_probs=165.7

Q ss_pred             CCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccc
Q 045539           96 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLA  175 (897)
Q Consensus        96 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~  175 (897)
                      +..+++|+.|++++|.++ .++ .++.+++|++|+|++|++.+.  ..+..+++|++|+|++|.+++..|..|+++++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  112 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK  112 (272)
T ss_dssp             HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence            456778888888888887 333 578888888888888888763  3677888888888888888876667778888888


Q ss_pred             ccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccc
Q 045539          176 RLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN  255 (897)
Q Consensus       176 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  255 (897)
                      +|+|++|+++++.+..|.++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|++|++++|
T Consensus       113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECCCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            8888888888887777888888888888888887 566665567888888888888888777777888899999999999


Q ss_pred             ccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccc
Q 045539          256 LFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVV  335 (897)
Q Consensus       256 ~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~  335 (897)
                      .+++..+..                     +..+++|++|++++|++.+..|        .++.+.+..|.++|.+|..+
T Consensus       192 ~l~~~~~~~---------------------~~~l~~L~~L~l~~N~~~~~~~--------~l~~l~~~~n~~~g~ip~~~  242 (272)
T 3rfs_A          192 QLKSVPDGV---------------------FDRLTSLQYIWLHDNPWDCTCP--------GIRYLSEWINKHSGVVRNSA  242 (272)
T ss_dssp             CCSCCCTTT---------------------TTTCTTCCEEECCSSCBCCCTT--------TTHHHHHHHHHTGGGBBCTT
T ss_pred             cCCccCHHH---------------------HhCCcCCCEEEccCCCccccCc--------HHHHHHHHHHhCCCcccCcc
Confidence            888776654                     3567889999999998876544        46677777777777777766


Q ss_pred             cCccC
Q 045539          336 GNLGN  340 (897)
Q Consensus       336 ~~l~~  340 (897)
                      +.+..
T Consensus       243 ~~~~~  247 (272)
T 3rfs_A          243 GSVAP  247 (272)
T ss_dssp             SCBCG
T ss_pred             cccCC
Confidence            65544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=5.3e-24  Score=221.27  Aligned_cols=198  Identities=14%  Similarity=0.126  Sum_probs=178.7

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCcc-ccCcCCccccCCCCCcEEeccC-ccccCCccccccccccccEE
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNK-LSGNIPSSIFNMHTLKLLYFSD-NQLFGSLSFFIFNVSSVTTI  153 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L  153 (897)
                      ..+..|++++|++++..+.+++++++|++|+|++|+ +++..+..|.++++|++|+|++ |++.+..+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            468999999999998777799999999999999997 8866677899999999999999 99998888999999999999


Q ss_pred             EeeecCCCCCCCccccCccccc---ccccccc-ccccccccccccccccc-ccccccccccccCCccccccccccceeec
Q 045539          154 DLSINGLSGEMPREIGNLPYLA---RLAFATN-NLVGVAPVTIFNMSALK-EIYLLNNSLSGSLPSRIDLSLPNVETLNL  228 (897)
Q Consensus       154 dLs~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~l~~L~~L~L  228 (897)
                      +|++|++++ +|. |+.+++|+   +|++++| +++++.+..|.++++|+ +|++++|+++ .+|...+.. ++|+.|+|
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L  186 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYL  186 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEEC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEc
Confidence            999999995 777 88999998   9999999 99999999999999999 9999999999 889888755 89999999


Q ss_pred             cccc-ccccccccccCC-CcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCC
Q 045539          229 GINS-FYGTVPSSITNA-SKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNP  301 (897)
Q Consensus       229 ~~N~-l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~  301 (897)
                      ++|+ +++..+..|..+ ++|+.|++++|++++..+.                        .+++|+.|+++++.
T Consensus       187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~------------------------~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK------------------------GLEHLKELIARNTW  237 (239)
T ss_dssp             TTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT------------------------TCTTCSEEECTTC-
T ss_pred             CCCCCcccCCHHHhhccccCCcEEECCCCccccCChh------------------------HhccCceeeccCcc
Confidence            9995 987778889999 9999999999999876553                        35788899988763

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=3.4e-26  Score=253.39  Aligned_cols=130  Identities=19%  Similarity=0.139  Sum_probs=84.4

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCC----ccccCCC-CCcEEeccCccccCCcccccccc-----ccc
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIP----SSIFNMH-TLKLLYFSDNQLFGSLSFFIFNV-----SSV  150 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~L  150 (897)
                      .+++.++++|.+|..+...++|++|||++|.+++..+    ..|.+++ +|++|+|++|++.+..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4566777777777666666667777777777775555    5666676 67777777777776666666664     677


Q ss_pred             cEEEeeecCCCCCCCccccC----c-ccccccccccccccccccccccc-----cccccccccccccccc
Q 045539          151 TTIDLSINGLSGEMPREIGN----L-PYLARLAFATNNLVGVAPVTIFN-----MSALKEIYLLNNSLSG  210 (897)
Q Consensus       151 ~~LdLs~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~  210 (897)
                      ++|||++|++++..+..++.    + ++|++|+|++|++++..+..+..     .++|++|+|++|++++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  152 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI  152 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence            77777777776655554333    2 66666777777666665544433     2466666666666653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=1.6e-25  Score=247.99  Aligned_cols=270  Identities=17%  Similarity=0.122  Sum_probs=173.8

Q ss_pred             eecccCccccCcCCccccCCCCCcEEeccCccccCCcc----ccccccc-cccEEEeeecCCCCCCCccccCc-----cc
Q 045539          104 TLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS----FFIFNVS-SVTTIDLSINGLSGEMPREIGNL-----PY  173 (897)
Q Consensus       104 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~LdLs~N~l~~~~p~~l~~l-----~~  173 (897)
                      .++|++|+++|.+|..+...++|++|+|++|++.+..+    ..+.+++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            46889999999999888888889999999999988877    7778888 89999999999998777777776     88


Q ss_pred             cccccccccccccccccccccc-----ccccccccccccccccCCccccc---c-ccccceeecccccccccc----ccc
Q 045539          174 LARLAFATNNLVGVAPVTIFNM-----SALKEIYLLNNSLSGSLPSRIDL---S-LPNVETLNLGINSFYGTV----PSS  240 (897)
Q Consensus       174 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~---~-l~~L~~L~L~~N~l~~~~----p~~  240 (897)
                      |++|+|++|++++..+..+...     ++|++|+|++|++++..+..+..   . .++|++|+|++|.+++..    +..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            9999999999988877755544     78888888888887544333221   1 247777777777776433    333


Q ss_pred             ccCCC-cccEEEccccccccccCccccccccccccCCCCccccccccccc-CCCcEEEecCCCCCCCCCCcccCchHHHH
Q 045539          241 ITNAS-KLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNC-KKLKVLILTGNPLDGILPKSKGNLSLSLE  318 (897)
Q Consensus       241 l~~l~-~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~  318 (897)
                      +..++ +|++|+|++|.+++..+..+..                 .+..+ ++|++|+|++|++++....          
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~-----------------~l~~~~~~L~~L~Ls~N~i~~~~~~----------  214 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAK-----------------FLASIPASVTSLDLSANLLGLKSYA----------  214 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHH-----------------HHHTSCTTCCEEECTTSCGGGSCHH----------
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHH-----------------HHHhCCCCCCEEECCCCCCChhHHH----------
Confidence            34444 7777777777776655543321                 13334 3677777777766532110          


Q ss_pred             HHHhccCCCCCCcCccccC-ccCCcEEEccCCCCCCCcc----ccccCccchhhhcccCcccccccchhhhccccccccc
Q 045539          319 IILMDNCSISGNIPQVVGN-LGNLLVLELGGNNLTEPIP----ITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLV  393 (897)
Q Consensus       319 ~L~l~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  393 (897)
                                 .++..+.. .++|++|+|++|++++..+    ..+..+++|++|+|++|++.+..+..+.         
T Consensus       215 -----------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~---------  274 (362)
T 3goz_A          215 -----------ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK---------  274 (362)
T ss_dssp             -----------HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHH---------
T ss_pred             -----------HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHH---------
Confidence                       12223333 2466777777777666443    2234445555555555554432222111         


Q ss_pred             ccccccccCCCcccccccccceeccccccccCCcc
Q 045539          394 LQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP  428 (897)
Q Consensus       394 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  428 (897)
                              .++..+.++++|+.|++++|++....+
T Consensus       275 --------~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          275 --------ALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             --------HHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             --------HHHHHhccCCceEEEecCCCcCCCcch
Confidence                    122345566666667777666655433

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=8.8e-24  Score=225.86  Aligned_cols=205  Identities=25%  Similarity=0.212  Sum_probs=177.1

Q ss_pred             ccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccc
Q 045539          335 VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLR  414 (897)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  414 (897)
                      ++++++++++++++|.++. +|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|++++..+.  +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            6788999999999999997 454443  6899999999999998899999999999999999999965443  7899999


Q ss_pred             eeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCC
Q 045539          415 VLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGD  494 (897)
Q Consensus       415 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  494 (897)
                      .|++++|+++ .+|..+..+++|+             .|+|++|++++..|..|..+++|++|+|++|+|++..+..|..
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~-------------~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  146 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALT-------------VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP  146 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCC-------------EEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred             EEECCCCcCC-cCchhhccCCCCC-------------EEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhccc
Confidence            9999999998 5788888888888             5555666666666788999999999999999999887888999


Q ss_pred             cCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCCcccccchhhhhh
Q 045539          495 LSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELLKM  558 (897)
Q Consensus       495 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~  558 (897)
                      +++|+.|+|++|+|++..+..+..+++|+.|+|++|+++..++......++..+.+.|||+.|.
T Consensus       147 l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence            9999999999999996666678899999999999999996555445566788889999999885

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=1.1e-25  Score=251.78  Aligned_cols=257  Identities=19%  Similarity=0.239  Sum_probs=180.3

Q ss_pred             cccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCC---CCCCCcccC
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD---GILPKSKGN  312 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~  312 (897)
                      .++..+..+++|+.|+|++|.++...+..+.                 ..+..+++|++|+|++|.+.   +.+|..   
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~-----------------~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~---   82 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLS-----------------ENIASKKDLEIAEFSDIFTGRVKDEIPEA---   82 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHH-----------------HTTTTCTTCCEEECCSCCTTSCGGGSHHH---
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHH-----------------HHHHhCCCccEEeCcccccCccccchhHH---
Confidence            3455566677777777777777655443321                 12456777888888776443   222221   


Q ss_pred             chHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCC----CccccccCccchhhhcccCcccccccchhhhc---
Q 045539          313 LSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTE----PIPITFSQLQTLQALGLTRNKLAGPITDELCH---  385 (897)
Q Consensus       313 l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~---  385 (897)
                          ++.+           ...+..+++|++|+|++|++++    .+|..+..+++|++|+|++|++++..+..+..   
T Consensus        83 ----~~~l-----------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  147 (386)
T 2ca6_A           83 ----LRLL-----------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ  147 (386)
T ss_dssp             ----HHHH-----------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             ----HHHH-----------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHH
Confidence                1111           1345677888888888888887    46667778888888888888887544444443   


Q ss_pred             -c---------cccccccccccccc-cCCC---cccccccccceeccccccccC-----CccccccccccceEEeecCCc
Q 045539          386 -L---------ARLHSLVLQGNKFS-GSIP---SCLGNLTSLRVLYLGLNRFTS-----ALPSTIWNLKDILFIDVSSNS  446 (897)
Q Consensus       386 -l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~ls~N~  446 (897)
                       +         ++|++|+|++|+++ +.+|   ..+..+++|+.|++++|+++.     ..|..+..+++|+.|++++|.
T Consensus       148 ~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~  227 (386)
T 2ca6_A          148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT  227 (386)
T ss_dssp             HHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred             HHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCC
Confidence             3         88999999999987 3444   456778889999999998872     344477778888855555444


Q ss_pred             ccccceeecccCcCCCCCcccccCCcccccccccCceeccc----CCCCC--CCcCCCcEEeccCCccCC----CCchhh
Q 045539          447 LNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGS----IPESF--GDLSSLEVLDLSKNKISG----AIPASL  516 (897)
Q Consensus       447 l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~  516 (897)
                      ++.--         .+.+|..+..+++|++|+|++|++++.    +|..+  +.+++|+.|+|++|+|++    .+|..+
T Consensus       228 l~~~g---------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l  298 (386)
T 2ca6_A          228 FTHLG---------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI  298 (386)
T ss_dssp             CHHHH---------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred             CCcHH---------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence            32100         045677888899999999999999875    56666  448999999999999997    488888


Q ss_pred             -hhhcccceEeccCCcccccC
Q 045539          517 -QKLLYLKHLNLSFNKLEGEI  536 (897)
Q Consensus       517 -~~l~~L~~L~ls~N~l~~~~  536 (897)
                       .++++|+.|+|++|++++..
T Consensus       299 ~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          299 DEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHCTTCCEEECTTSBSCTTS
T ss_pred             HhcCCCceEEEccCCcCCcch
Confidence             66899999999999987543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=1.5e-25  Score=245.95  Aligned_cols=189  Identities=15%  Similarity=0.210  Sum_probs=125.6

Q ss_pred             CCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCC--CCCceecccCccccCcCCccccCCCCCcEEeccCccccC
Q 045539           61 TSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNL--SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFG  138 (897)
Q Consensus        61 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  138 (897)
                      .-|.+|.++.|+.  ..+..++++++++.   +..++.+  ++++.|++++|.+++..|. +.++++|++|+|++|.+.+
T Consensus        34 ~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           34 GVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            3466899998863  34677888888776   3456666  7888899998888876655 6678888888888888876


Q ss_pred             C-ccccccccccccEEEeeecCCCCCCCccccCcccccccccccc-ccccc-ccccccccccccccccccc-ccccc-CC
Q 045539          139 S-LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN-NLVGV-APVTIFNMSALKEIYLLNN-SLSGS-LP  213 (897)
Q Consensus       139 ~-~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p  213 (897)
                      . ++..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. .+..+.++++|++|++++| .+++. ++
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~  187 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ  187 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence            5 7777888888888888888887777777777888888888887 56652 4555666777777777777 66532 22


Q ss_pred             cccccccc-ccceeecccc--ccc-ccccccccCCCcccEEEccccc
Q 045539          214 SRIDLSLP-NVETLNLGIN--SFY-GTVPSSITNASKLSDLELGVNL  256 (897)
Q Consensus       214 ~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~L~~N~  256 (897)
                      ..+ ..++ +|++|+|++|  .++ +.+|..+..+++|++|++++|.
T Consensus       188 ~~~-~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~  233 (336)
T 2ast_B          188 VAV-AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV  233 (336)
T ss_dssp             HHH-HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred             HHH-HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence            222 2344 5555555555  232 2333333444444444444443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=1.9e-25  Score=249.96  Aligned_cols=94  Identities=26%  Similarity=0.348  Sum_probs=51.0

Q ss_pred             cccCccCCcEEEccCCCCC----CCccccccCccchhhhcccCcccccc----cchhhhc--cccccccccccccccc--
Q 045539          334 VVGNLGNLLVLELGGNNLT----EPIPITFSQLQTLQALGLTRNKLAGP----ITDELCH--LARLHSLVLQGNKFSG--  401 (897)
Q Consensus       334 ~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~--l~~L~~L~L~~N~l~~--  401 (897)
                      .+..+++|++|+|++|.++    +.+|..+..+++|++|+|++|++++.    ++..+..  +++|++|+|++|++++  
T Consensus       211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g  290 (386)
T 2ca6_A          211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA  290 (386)
T ss_dssp             TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH
T ss_pred             HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHH
Confidence            3445555666666666654    33445555555555555555555543    3344422  5566666666666654  


Q ss_pred             --CCCccc-ccccccceeccccccccCCc
Q 045539          402 --SIPSCL-GNLTSLRVLYLGLNRFTSAL  427 (897)
Q Consensus       402 --~~p~~~-~~l~~L~~L~L~~N~l~~~~  427 (897)
                        .+|..+ .++++|+.|++++|++++..
T Consensus       291 ~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          291 VRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence              255444 44566666666666665443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=6.8e-23  Score=212.87  Aligned_cols=187  Identities=24%  Similarity=0.269  Sum_probs=156.1

Q ss_pred             cCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCcc-ccCCccccccccccccEEEeee-cCCCCCCCccc
Q 045539           91 TIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ-LFGSLSFFIFNVSSVTTIDLSI-NGLSGEMPREI  168 (897)
Q Consensus        91 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~LdLs~-N~l~~~~p~~l  168 (897)
                      .+|. +.  ++|++|+|++|++++..+..|+++++|++|++++|+ +....+..|.++++|++|+|++ |++++..+..|
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            5666 43  389999999999997777789999999999999997 8888888999999999999999 99997666789


Q ss_pred             cCccccccccccccccccccccccccccccc---ccccccc-cccccCCccccccccccc-eeecccccccccccccccC
Q 045539          169 GNLPYLARLAFATNNLVGVAPVTIFNMSALK---EIYLLNN-SLSGSLPSRIDLSLPNVE-TLNLGINSFYGTVPSSITN  243 (897)
Q Consensus       169 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~  243 (897)
                      .++++|++|++++|+++++ |. |.++++|+   +|++++| +++ .+|...+..+++|+ +|++++|+++ .+|.....
T Consensus       102 ~~l~~L~~L~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~  177 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN  177 (239)
T ss_dssp             ECCTTCCEEEEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCC-EECTTTTT
T ss_pred             CCCCCCCEEeCCCCCCccc-cc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCc-ccCHhhcC
Confidence            9999999999999999985 44 88888888   9999999 887 67777677889999 9999999998 45544333


Q ss_pred             CCcccEEEccccc-cccccCccccccccccccCCCCccccccccccc-CCCcEEEecCCCCCCC
Q 045539          244 ASKLSDLELGVNL-FSGFIPNTFVNMADNYLTSSTPELSFLSSLTNC-KKLKVLILTGNPLDGI  305 (897)
Q Consensus       244 l~~L~~L~L~~N~-l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l-~~L~~L~Ls~N~l~~~  305 (897)
                      .++|+.|+|++|+ +++..+..|                     .++ ++|++|++++|+++++
T Consensus       178 ~~~L~~L~L~~n~~l~~i~~~~~---------------------~~l~~~L~~L~l~~N~l~~l  220 (239)
T 2xwt_C          178 GTKLDAVYLNKNKYLTVIDKDAF---------------------GGVYSGPSLLDVSQTSVTAL  220 (239)
T ss_dssp             TCEEEEEECTTCTTCCEECTTTT---------------------TTCSBCCSEEECTTCCCCCC
T ss_pred             CCCCCEEEcCCCCCcccCCHHHh---------------------hccccCCcEEECCCCccccC
Confidence            3889999999995 887766543                     566 7899999999888753

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=3.2e-23  Score=224.30  Aligned_cols=158  Identities=18%  Similarity=0.216  Sum_probs=80.4

Q ss_pred             CCCceecccCccccCcCCccc--cCCCCCcEEeccCccccCCcc----ccccccccccEEEeeecCCCCCCCccccCccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSI--FNMHTLKLLYFSDNQLFGSLS----FFIFNVSSVTTIDLSINGLSGEMPREIGNLPY  173 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~  173 (897)
                      ++|++|+|++|.+++..|..+  .++++|++|+|++|++.+..+    ..+..+++|++|+|++|++.+..|..|+.+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            445555555555555555555  555555555555555554333    22334555555555555555544555555555


Q ss_pred             cccccccccccccc---cc-ccccccccccccccccccccccCCc---cccccccccceeecccccccccccccccCC--
Q 045539          174 LARLAFATNNLVGV---AP-VTIFNMSALKEIYLLNNSLSGSLPS---RIDLSLPNVETLNLGINSFYGTVPSSITNA--  244 (897)
Q Consensus       174 L~~L~L~~N~l~~~---~~-~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--  244 (897)
                      |++|+|++|++.+.   .+ ..+.++++|++|+|++|+++ .++.   .++..+++|++|+|++|++++..|..+..+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            55555555554431   11 11245555555555555554 2222   122344555555555555555555444444  


Q ss_pred             -CcccEEEccccccc
Q 045539          245 -SKLSDLELGVNLFS  258 (897)
Q Consensus       245 -~~L~~L~L~~N~l~  258 (897)
                       ++|++|+|++|+++
T Consensus       250 ~~~L~~L~Ls~N~l~  264 (310)
T 4glp_A          250 SSALNSLNLSFAGLE  264 (310)
T ss_dssp             CTTCCCEECCSSCCC
T ss_pred             cCcCCEEECCCCCCC
Confidence             35555555555555

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=1.5e-22  Score=211.89  Aligned_cols=183  Identities=21%  Similarity=0.237  Sum_probs=139.7

Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      .+.++++++++.++. +|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|+.|+|
T Consensus        14 ~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            356678888888876 444443  46778888888888777777888888888888888888777777888888888888


Q ss_pred             ccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCC
Q 045539          419 GLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL  498 (897)
Q Consensus       419 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L  498 (897)
                      ++|++++..+..|..+++|+             .|+|++|++++..+..|+.+++|++|+|++|+|++..|..|..+++|
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~-------------~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  157 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLD-------------KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL  157 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCC-------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CCCcccccChhHhcccCCCC-------------EEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCC
Confidence            88888876667777777777             44444555555556667788888888888888887666678888888


Q ss_pred             cEEeccCCccCCCCchhhhhhcccceEeccCCcccccCC
Q 045539          499 EVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       499 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      ++|+|++|+|++..|..+..+++|+.|+|++|++++..+
T Consensus       158 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred             CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence            888888888887777788888888888888888876533

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=5.9e-23  Score=222.20  Aligned_cols=190  Identities=21%  Similarity=0.200  Sum_probs=108.9

Q ss_pred             cCCcEEEccCCCCCCCccccc--cCccchhhhcccCcccccccc----hhhhcccccccccccccccccCCCcccccccc
Q 045539          339 GNLLVLELGGNNLTEPIPITF--SQLQTLQALGLTRNKLAGPIT----DELCHLARLHSLVLQGNKFSGSIPSCLGNLTS  412 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  412 (897)
                      ++|++|++++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..+++|++|+|++|++++..|..++++++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            446666666666666666655  666666666666666665433    23345666666666666666555566666666


Q ss_pred             cceeccccccccCC--c--cccccccccceEEeecCCccc--------------ccceeecccCcCCCCCcccccCC---
Q 045539          413 LRVLYLGLNRFTSA--L--PSTIWNLKDILFIDVSSNSLN--------------VLIGLNFSRNNLSGDIPITIGGL---  471 (897)
Q Consensus       413 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~ls~N~l~--------------~l~~l~ls~n~l~~~~p~~~~~l---  471 (897)
                      |++|+|++|++.+.  +  +..+..+++|++|++++|+++              .|+.|+|++|++++.+|..++.+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            66666666665432  1  122345555665555554442              22355555555555555555554   


Q ss_pred             cccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          472 KNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       472 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      ++|++|+|++|+|+ .+|..+.  ++|+.|||++|+|++. |. +..+++|+.|+|++|+++
T Consensus       251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            46666666666666 4555553  5666666666666632 32 455566666666666654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=4.8e-24  Score=233.82  Aligned_cols=149  Identities=21%  Similarity=0.199  Sum_probs=81.1

Q ss_pred             CceecccCccccCcCCccccCC--CCCcEEeccCccccCCccccccccccccEEEeeecCCCCC-CCccccCcccccccc
Q 045539          102 LQTLDLSHNKLSGNIPSSIFNM--HTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGE-MPREIGNLPYLARLA  178 (897)
Q Consensus       102 L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~-~p~~l~~l~~L~~L~  178 (897)
                      ++.||+++|.+.   |..+..+  +++++|++++|.+.+.++. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            566777777665   4556665  6677777777766655544 33566666666666666543 555556666666666


Q ss_pred             cccccccccccccccccccccccccccc-ccccc-CCccccccccccceeecccc-ccccc-ccccccCCC-cccEEEcc
Q 045539          179 FATNNLVGVAPVTIFNMSALKEIYLLNN-SLSGS-LPSRIDLSLPNVETLNLGIN-SFYGT-VPSSITNAS-KLSDLELG  253 (897)
Q Consensus       179 L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~L~  253 (897)
                      |++|++++..+..++++++|++|+|++| .+++. ++. ....+++|++|+|++| .+++. ++..+..++ +|++|+++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~-~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT-LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHH-HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHH-HHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            6666666555555555666666666655 34431 221 1223444444444444 44432 233344444 44444444


Q ss_pred             cc
Q 045539          254 VN  255 (897)
Q Consensus       254 ~N  255 (897)
                      +|
T Consensus       204 ~~  205 (336)
T 2ast_B          204 GY  205 (336)
T ss_dssp             SC
T ss_pred             CC
Confidence            44

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=2.8e-22  Score=220.70  Aligned_cols=125  Identities=18%  Similarity=0.171  Sum_probs=76.1

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcc-c
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS-F  142 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~  142 (897)
                      |+|..|.|+            +++++ .+|..+  .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.++ .
T Consensus         9 C~~~~v~C~------------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~   73 (350)
T 4ay9_X            9 CSNRVFLCQ------------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   73 (350)
T ss_dssp             EETTEEEEE------------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred             eeCCEEEec------------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence            677777775            34455 567665  3678888888888885445578888888888888887755443 4


Q ss_pred             cccccccccE-EEeeecCCCCCCCccccCccccccccccccccccccccccccccccccccc
Q 045539          143 FIFNVSSVTT-IDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYL  203 (897)
Q Consensus       143 ~~~~l~~L~~-LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  203 (897)
                      .|.++++|+. +++++|++++..|..|..+++|++|++++|+++.+.+..+....++..|++
T Consensus        74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l  135 (350)
T 4ay9_X           74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI  135 (350)
T ss_dssp             SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred             HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence            5566665543 455556666444555555555555555555555444444444444444444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=8.7e-23  Score=224.81  Aligned_cols=241  Identities=16%  Similarity=0.130  Sum_probs=156.2

Q ss_pred             cEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccce-eecc
Q 045539          151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVET-LNLG  229 (897)
Q Consensus       151 ~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~-L~L~  229 (897)
                      ++++.++|+++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|...+..++++.+ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            45666677776 6676552  567777888888877777778888888888888888776777777777777654 5666


Q ss_pred             cccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecC-CCCCCCCCC
Q 045539          230 INSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTG-NPLDGILPK  308 (897)
Q Consensus       230 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~-N~l~~~~p~  308 (897)
                      .|+++...|..|.++++|++|++++|++++..+..+                     ....++..|++.+ |++..+.+.
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~---------------------~~~~~l~~l~l~~~~~i~~l~~~  147 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK---------------------IHSLQKVLLDIQDNINIHTIERN  147 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT---------------------CCBSSCEEEEEESCTTCCEECTT
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhh---------------------cccchhhhhhhcccccccccccc
Confidence            788887777888888888888888888877665443                     2345677777765 345433222


Q ss_pred             cccCchHHHHHHHhccCCCCCCcCccccCc-cCCcEEEccCCCCCCCccccccCccchhhhcccC-cccccccchhhhcc
Q 045539          309 SKGNLSLSLEIILMDNCSISGNIPQVVGNL-GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTR-NKLAGPITDELCHL  386 (897)
Q Consensus       309 ~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l  386 (897)
                                               .|..+ ..++.|+|++|+|+.+.+..| ...+|++|++++ |+++...++.|..+
T Consensus       148 -------------------------~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l  201 (350)
T 4ay9_X          148 -------------------------SFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGA  201 (350)
T ss_dssp             -------------------------SSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTE
T ss_pred             -------------------------chhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccC
Confidence                                     23333 246677777777776433333 445677777764 45554444566777


Q ss_pred             cccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCC
Q 045539          387 ARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       387 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      ++|++|+|++|+|+...+..+.++++|+.+++.  .++ .+| .+.++++|+.++++++
T Consensus       202 ~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          202 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             ECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCH
T ss_pred             cccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCC
Confidence            777777777777774444445555555554442  233 344 3566677776666543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=4.2e-23  Score=238.91  Aligned_cols=205  Identities=21%  Similarity=0.320  Sum_probs=168.0

Q ss_pred             CCCCCCCCc-----ceeee-EeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEE
Q 045539           56 NWTSSTSVC-----SWIGI-TCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLL  129 (897)
Q Consensus        56 ~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  129 (897)
                      +|..+.++|     .|.|+ .|..  ++++.|+|+++++++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L  105 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYL  105 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence            676666677     79999 7864  479999999999997 888774  89999999999999 678   567999999


Q ss_pred             eccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccccccccccccccccccccccccccccccc
Q 045539          130 YFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       130 ~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                      +|++|+|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|+++.+    .+++|++|+|++|+|+
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCC
Confidence            999999988 555 655  99999999999996 777   68999999999999998643    6789999999999999


Q ss_pred             ccCCccccccccccceeecccccccccccccccCCCcc-------cEEEccccccccccCccccccccccccCCCCcccc
Q 045539          210 GSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKL-------SDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSF  282 (897)
Q Consensus       210 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~  282 (897)
                      + +|. +.   ++|+.|+|++|.|+ .+|. +..  +|       +.|+|++|+|+.+ |..                  
T Consensus       174 ~-lp~-l~---~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~l-p~~------------------  225 (571)
T 3cvr_A          174 F-LPE-LP---ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHI-PEN------------------  225 (571)
T ss_dssp             C-CCC-CC---TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCC-CGG------------------
T ss_pred             C-cch-hh---CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceec-CHH------------------
Confidence            5 887 43   89999999999998 6666 654  77       9999999999854 332                  


Q ss_pred             cccccccCCCcEEEecCCCCCCCCCCcccC
Q 045539          283 LSSLTNCKKLKVLILTGNPLDGILPKSKGN  312 (897)
Q Consensus       283 l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  312 (897)
                         +..+++|++|+|++|++++.+|..+..
T Consensus       226 ---l~~l~~L~~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          226 ---ILSLDPTCTIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             ---GGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred             ---HhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence               345789999999999998776654443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3.1e-22  Score=216.02  Aligned_cols=196  Identities=24%  Similarity=0.385  Sum_probs=158.0

Q ss_pred             ccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccch
Q 045539          286 LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTL  365 (897)
Q Consensus       286 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  365 (897)
                      ...+++|++|++++|.+...                          | .+..+++|++|++++|++++..+  +..+++|
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l--------------------------~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L   87 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTTI--------------------------E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKI   87 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCCC--------------------------T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSC
T ss_pred             HHHcCCcCEEEeeCCCccCc--------------------------h-hhhccCCCCEEEccCCcCCCChh--HccCCCC
Confidence            45678899999999988742                          2 35678899999999999988555  8899999


Q ss_pred             hhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCC
Q 045539          366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       366 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      ++|+|++|++++.  ..+..+++|++|++++|++++ +|. +..+++|+.|++++|++++..+  +..+++|++|++++ 
T Consensus        88 ~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~-  160 (308)
T 1h6u_A           88 TELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN-  160 (308)
T ss_dssp             CEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS-
T ss_pred             CEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccC-
Confidence            9999999999864  368889999999999999985 443 8899999999999999987544  77777777555544 


Q ss_pred             cccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       446 ~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                                  |++++. +. +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..  .+..+++|+.|
T Consensus       161 ------------n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L  222 (308)
T 1h6u_A          161 ------------AQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIV  222 (308)
T ss_dssp             ------------SCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEE
T ss_pred             ------------CcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEE
Confidence                        444443 33 7889999999999999986443  889999999999999998544  38899999999


Q ss_pred             eccCCccccc
Q 045539          526 NLSFNKLEGE  535 (897)
Q Consensus       526 ~ls~N~l~~~  535 (897)
                      +|++|++++.
T Consensus       223 ~l~~N~i~~~  232 (308)
T 1h6u_A          223 TLTNQTITNQ  232 (308)
T ss_dssp             EEEEEEEECC
T ss_pred             EccCCeeecC
Confidence            9999999863

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=4e-22  Score=215.16  Aligned_cols=212  Identities=22%  Similarity=0.345  Sum_probs=107.0

Q ss_pred             ccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEE
Q 045539          172 PYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE  251 (897)
Q Consensus       172 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  251 (897)
                      .++..+.+..+.+++...  +..+++|++|++++|.++ .+|.  +..+++|++|+|++|.+++..+  +..+++|++|+
T Consensus        19 ~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~~--~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cchh--hhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            334444455555444322  345556666666666655 3442  2245566666666666554333  55666666666


Q ss_pred             ccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCc
Q 045539          252 LGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNI  331 (897)
Q Consensus       252 L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~  331 (897)
                      |++|.+++..                       .+..+++|++|+|++|+++++.                         
T Consensus        92 L~~n~l~~~~-----------------------~~~~l~~L~~L~l~~n~l~~~~-------------------------  123 (308)
T 1h6u_A           92 LSGNPLKNVS-----------------------AIAGLQSIKTLDLTSTQITDVT-------------------------  123 (308)
T ss_dssp             CCSCCCSCCG-----------------------GGTTCTTCCEEECTTSCCCCCG-------------------------
T ss_pred             ccCCcCCCch-----------------------hhcCCCCCCEEECCCCCCCCch-------------------------
Confidence            6666555421                       1345556666666666555320                         


Q ss_pred             CccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccccc
Q 045539          332 PQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT  411 (897)
Q Consensus       332 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  411 (897)
                        .+..+++|++|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|++++|++++..+  +..++
T Consensus       124 --~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~  195 (308)
T 1h6u_A          124 --PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLP  195 (308)
T ss_dssp             --GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCT
T ss_pred             --hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCC
Confidence              13444555555555555554332  4555555555555555553222  4555555555555555553222  45555


Q ss_pred             ccceeccccccccCCccccccccccceEEeecCCccc
Q 045539          412 SLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLN  448 (897)
Q Consensus       412 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  448 (897)
                      +|+.|++++|++++..|  +..+++|+.|++++|.++
T Consensus       196 ~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             TCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             CCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence            55555555555554322  444555554444444443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=2.1e-22  Score=204.35  Aligned_cols=183  Identities=23%  Similarity=0.276  Sum_probs=128.3

Q ss_pred             CcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccc
Q 045539           63 VCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSF  142 (897)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  142 (897)
                      .|+|.+|.|+..            +++ .+|..+  .++|++|+|++|++++..+..|.++++|++|+|++|++.+..+.
T Consensus         6 ~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (208)
T 2o6s_A            6 SCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG   70 (208)
T ss_dssp             EEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             EECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence            389999999743            222 344333  34677777777777765555677777777777777777766666


Q ss_pred             cccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccc
Q 045539          143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPN  222 (897)
Q Consensus       143 ~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~  222 (897)
                      .|.++++|++|+|++|++++..+..|+++++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+|...+..+++
T Consensus        71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~  149 (208)
T 2o6s_A           71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTS  149 (208)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTT
T ss_pred             hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccCCC
Confidence            6777777777777777777555555677777777777777777776666777777777777777777 455555556777


Q ss_pred             cceeecccccccccccccccCCCcccEEEccccccccccCcccccc
Q 045539          223 VETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM  268 (897)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l  268 (897)
                      |++|+|++|.+.+       .+++|++|+++.|.++|.+|..+..+
T Consensus       150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l  188 (208)
T 2o6s_A          150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV  188 (208)
T ss_dssp             CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred             ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence            7777777776653       34567777777777777777766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.7e-22  Score=214.35  Aligned_cols=153  Identities=17%  Similarity=0.145  Sum_probs=122.3

Q ss_pred             HHHHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH------------------HHHHHHHHHHHHHHhc
Q 045539          609 YHELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE------------------RALKSFEDECEVMKRI  670 (897)
Q Consensus       609 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  670 (897)
                      ...+......|.+.+.||+|+||.||+|++.+|+.||+|+++....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3344455567778899999999999999987799999999864321                  2356788999999999


Q ss_pred             CCCccceEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       671 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +  | +++++++.. +..|+||||++|++|.+ +..       .+...++.|++.||+||   |++||+||||||+||++
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEE
Confidence            9  4 666665543 56699999999999988 422       23457999999999999   89999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccC
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT  792 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  792 (897)
                      + ++.+||+|||+|+.               +..|.|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9 99999999999863               34478888753

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.2e-20  Score=191.43  Aligned_cols=181  Identities=22%  Similarity=0.245  Sum_probs=115.6

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.++++++.++ .+|..+  .++|++|+|++|++.+..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            46777888887 566544  357888888888887777777777888888888888887555555677777777777777


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccC
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP  262 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  262 (897)
                      +++++.+..|.++++|++|+|++|+++ .+|.                        ..+..+++|++|+|++|.+++..+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~------------------------~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD------------------------GVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-CCCT------------------------TTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCc-ccCH------------------------hHhccCCcCCEEECCCCccceeCH
Confidence            777666666666666666666666665 3333                        334445555555555555554433


Q ss_pred             ccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccC
Q 045539          263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGN  340 (897)
Q Consensus       263 ~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~  340 (897)
                      ..                     +..+++|++|++++|++.+..|        +++.|.+..|+++|.+|..++.++.
T Consensus       142 ~~---------------------~~~l~~L~~L~l~~N~~~~~~~--------~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          142 GV---------------------FDRLTSLQYIWLHDNPWDCTCP--------GIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TT---------------------TTTCTTCCEEECCSCCBCCCTT--------TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HH---------------------hccCCCccEEEecCCCeecCCC--------CHHHHHHHHHhCCceeeccCccccC
Confidence            22                     2345566666666665554332        4566666666666666666655544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=2.6e-21  Score=223.92  Aligned_cols=190  Identities=24%  Similarity=0.310  Sum_probs=123.8

Q ss_pred             CCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhc
Q 045539          290 KKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALG  369 (897)
Q Consensus       290 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  369 (897)
                      .+|+.|+|++|++++ +|..+.   .+|++|++++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|+.|+
T Consensus        59 ~~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~  126 (571)
T 3cvr_A           59 NQFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLD  126 (571)
T ss_dssp             TTCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEE
T ss_pred             CCccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEE
Confidence            489999999999987 555443   25777777777777 445   346677777777777776 454 554  677777


Q ss_pred             ccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccc
Q 045539          370 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNV  449 (897)
Q Consensus       370 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  449 (897)
                      |++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|++++ +|. +.  ++|++|++++     
T Consensus       127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~-----  189 (571)
T 3cvr_A          127 VDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST-----  189 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS-----
T ss_pred             CCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC-----
Confidence            77777775 444   46677777777777774 554   45677777777777765 555 43  5555444333     


Q ss_pred             cceeecccCcCCCCCcccccCCccc-------ccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcc
Q 045539          450 LIGLNFSRNNLSGDIPITIGGLKNL-------QQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY  521 (897)
Q Consensus       450 l~~l~ls~n~l~~~~p~~~~~l~~L-------~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  521 (897)
                              |+|+ .+|. +..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus       190 --------N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          190 --------NLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             --------SCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             --------CCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence                    3333 3343 332  44       77777777777 46766667777777777777777777777766654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=1.2e-20  Score=194.28  Aligned_cols=162  Identities=23%  Similarity=0.252  Sum_probs=118.8

Q ss_pred             CCCCCCCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCcc
Q 045539           56 NWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ  135 (897)
Q Consensus        56 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  135 (897)
                      -|..++..|+|.+|.|+..            +++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        11 ~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~   75 (229)
T 3e6j_A           11 AACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ   75 (229)
T ss_dssp             CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence            3445778899999999642            233 5676554  889999999999998888899999999999999999


Q ss_pred             ccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcc
Q 045539          136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSR  215 (897)
Q Consensus       136 l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  215 (897)
                      |....+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+++.+ |..+.++++|++|+|++|+++ .+|..
T Consensus        76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~L~~N~l~-~~~~~  153 (229)
T 3e6j_A           76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLALDQNQLK-SIPHG  153 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSC-CTTGGGCTTCSEEECCSSCCC-CCCTT
T ss_pred             CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccccc-CcccccCCCCCEEECCCCcCC-ccCHH
Confidence            9777777788888888888888888866566677777777777777777744 555666677777777776666 44444


Q ss_pred             ccccccccceeeccccccc
Q 045539          216 IDLSLPNVETLNLGINSFY  234 (897)
Q Consensus       216 ~~~~l~~L~~L~L~~N~l~  234 (897)
                      .+..+++|+.|+|++|.+.
T Consensus       154 ~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             TTTTCTTCCEEECTTSCBC
T ss_pred             HHhCCCCCCEEEeeCCCcc
Confidence            4444455555555555444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=1.2e-21  Score=235.34  Aligned_cols=240  Identities=20%  Similarity=0.184  Sum_probs=89.6

Q ss_pred             CChhHHHHHHHHHhccccCCCcccccCCC-CCCCCcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceeccc
Q 045539           30 NITTDQQALLALKAHISYDHTNLFARNWT-SSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLS  108 (897)
Q Consensus        30 ~~~~~~~aLl~~k~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls  108 (897)
                      ....++++|+++..+.......... .|. ..+.++.|.+++++.  .+|+.|+|.++++.+ ++..     .|+.++|+
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls  199 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQ-QPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQA-----LLQHKKLS  199 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccC-CCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhh-----HhhcCccC
Confidence            4467889999998877433333222 564 345578999998864  678999998888875 3333     34555666


Q ss_pred             CccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccc
Q 045539          109 HNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVA  188 (897)
Q Consensus       109 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  188 (897)
                      +|.|.+.              +++.|++. .++..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+
T Consensus       200 ~~~i~~~--------------~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~l  262 (727)
T 4b8c_D          200 QYSIDED--------------DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-EL  262 (727)
T ss_dssp             -------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CC
T ss_pred             cccccCc--------------ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-cc
Confidence            6655421              23333332 34444555555555555555555 55555555555555555555555 33


Q ss_pred             cccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCcccccc
Q 045539          189 PVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNM  268 (897)
Q Consensus       189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l  268 (897)
                      |..|+++++|++|+|++|+|+ .+|..+. .+++|++|+|++|.|+ .+|..|+++                        
T Consensus       263 p~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~L~~N~l~-~lp~~~~~l------------------------  315 (727)
T 4b8c_D          263 PAEIKNLSNLRVLDLSHNRLT-SLPAELG-SCFQLKYFYFFDNMVT-TLPWEFGNL------------------------  315 (727)
T ss_dssp             CGGGGGGTTCCEEECTTSCCS-SCCSSGG-GGTTCSEEECCSSCCC-CCCSSTTSC------------------------
T ss_pred             ChhhhCCCCCCEEeCcCCcCC-ccChhhc-CCCCCCEEECCCCCCC-ccChhhhcC------------------------
Confidence            445555555555555555555 4444432 3444444444444443 334444444                        


Q ss_pred             ccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccC
Q 045539          269 ADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGG  348 (897)
Q Consensus       269 ~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~  348 (897)
                                           ++|++|+|++|+|++.+|..+..+......+++.+|.+++.+|..      |..|+++.
T Consensus       316 ---------------------~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~  368 (727)
T 4b8c_D          316 ---------------------CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINT  368 (727)
T ss_dssp             ---------------------TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------
T ss_pred             ---------------------CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeec
Confidence                                 455555555555555555555444434556778888888877754      45566666


Q ss_pred             C
Q 045539          349 N  349 (897)
Q Consensus       349 N  349 (897)
                      |
T Consensus       369 n  369 (727)
T 4b8c_D          369 D  369 (727)
T ss_dssp             -
T ss_pred             c
Confidence            6

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=2.1e-20  Score=218.84  Aligned_cols=193  Identities=27%  Similarity=0.322  Sum_probs=122.1

Q ss_pred             cccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEE
Q 045539          171 LPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL  250 (897)
Q Consensus       171 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  250 (897)
                      +.++..+.+..+.+..+.+  +..+++|+.|+|++|.++ .+|.  +..+++|+.|+|++|.+.+..|  +..+++|+.|
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L   92 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence            4455556666666665543  456666677777776665 4442  2356666677777766665444  6667777777


Q ss_pred             EccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCC
Q 045539          251 ELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN  330 (897)
Q Consensus       251 ~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~  330 (897)
                      +|++|.+++..                       .+..+++|+.|+|++|++.++                         
T Consensus        93 ~Ls~N~l~~l~-----------------------~l~~l~~L~~L~Ls~N~l~~l-------------------------  124 (605)
T 1m9s_A           93 FLDENKIKDLS-----------------------SLKDLKKLKSLSLEHNGISDI-------------------------  124 (605)
T ss_dssp             ECCSSCCCCCT-----------------------TSTTCTTCCEEECTTSCCCCC-------------------------
T ss_pred             ECcCCCCCCCh-----------------------hhccCCCCCEEEecCCCCCCC-------------------------
Confidence            77777665421                       245666777777777766532                         


Q ss_pred             cCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccc
Q 045539          331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL  410 (897)
Q Consensus       331 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  410 (897)
                        ..+..+++|+.|+|++|+++++  ..|..+++|+.|+|++|+|.+..|  +..+++|+.|+|++|+|++.  ..+..+
T Consensus       125 --~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l  196 (605)
T 1m9s_A          125 --NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGL  196 (605)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTC
T ss_pred             --ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccC
Confidence              1245566677777777777664  456667777777777777765554  66677777777777777643  346677


Q ss_pred             cccceeccccccccCC
Q 045539          411 TSLRVLYLGLNRFTSA  426 (897)
Q Consensus       411 ~~L~~L~L~~N~l~~~  426 (897)
                      ++|+.|+|++|++++.
T Consensus       197 ~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          197 KNLDVLELFSQECLNK  212 (605)
T ss_dssp             TTCSEEECCSEEEECC
T ss_pred             CCCCEEEccCCcCcCC
Confidence            7777777777777653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=5.5e-20  Score=196.57  Aligned_cols=191  Identities=23%  Similarity=0.277  Sum_probs=158.8

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      .+..+.+..+.+++..+  +..+++|+.|++++|.+++. + .+..+++|++|+|++|++++..+  +..+++|++|+++
T Consensus        25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~   98 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence            56666777777775443  46789999999999999875 3 48889999999999999997655  8999999999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      +|++++ +| .+..+++|+.|++++|++++.  ..+..+++|++|++++|             ++++.  ..++.+++|+
T Consensus        99 ~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n-------------~l~~~--~~l~~l~~L~  159 (291)
T 1h6t_A           99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNN-------------KITDI--TVLSRLTKLD  159 (291)
T ss_dssp             SSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSS-------------CCCCC--GGGGGCTTCS
T ss_pred             CCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCC-------------cCCcc--hhhccCCCCC
Confidence            999985 44 489999999999999999863  46778888885555555             44443  4688899999


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccccc
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGE  535 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  535 (897)
                      .|++++|++++..|  +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++..
T Consensus       160 ~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             EEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence            99999999997555  9999999999999999984 55 489999999999999999863

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=4.8e-22  Score=231.49  Aligned_cols=233  Identities=18%  Similarity=0.193  Sum_probs=148.9

Q ss_pred             ceeeeEeeCCCCeEEEEEeeccccccc---------------------CC-------CCCCCCCCCceecccCccccCcC
Q 045539           65 SWIGITCDVNSHRVIGLNISSFNLQGT---------------------IP-------PQLGNLSSLQTLDLSHNKLSGNI  116 (897)
Q Consensus        65 ~w~gv~c~~~~~~v~~l~l~~~~l~g~---------------------~~-------~~l~~l~~L~~L~Ls~n~l~~~~  116 (897)
                      .|..+.|+...++|..+++..-.+.-.                     .|       ..+..+++|+.|+|++|+++ .+
T Consensus       286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L  364 (567)
T 1dce_A          286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL  364 (567)
T ss_dssp             CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred             eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence            588777776667777777754332110                     00       01356778888888888886 67


Q ss_pred             CccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc-ccccccccccccccccc
Q 045539          117 PSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA-FATNNLVGVAPVTIFNM  195 (897)
Q Consensus       117 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~-L~~N~l~~~~~~~~~~l  195 (897)
                      |.++++|++|++|++++|......+..+           ..+.+.+.+|..++++++|+.|+ ++.|.+           
T Consensus       365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-----------  422 (567)
T 1dce_A          365 QSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKAVDPMRAAYL-----------  422 (567)
T ss_dssp             HHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHHHCGGGHHHH-----------
T ss_pred             HHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhcccCcchhhccc-----------
Confidence            8888888888888886664211111111           12234557788888888888888 666643           


Q ss_pred             ccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccC
Q 045539          196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTS  275 (897)
Q Consensus       196 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~  275 (897)
                      .+|+.+.+++|.++ .+|.      ..|+.|+|++|.+++ +|. ++.+++|+.|+|++|.|+ .+|..           
T Consensus       423 ~~L~~l~l~~n~i~-~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~-----------  481 (567)
T 1dce_A          423 DDLRSKFLLENSVL-KMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA-----------  481 (567)
T ss_dssp             HHHHHHHHHHHHHH-HHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG-----------
T ss_pred             chhhhhhhhccccc-ccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh-----------
Confidence            46778888888887 3332      358899999999986 565 888888888888888877 33432           


Q ss_pred             CCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCc
Q 045539          276 STPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPI  355 (897)
Q Consensus       276 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  355 (897)
                                ++++++|++|+|++|+|+++                          | .++.+++|++|+|++|+|++..
T Consensus       482 ----------~~~l~~L~~L~Ls~N~l~~l--------------------------p-~l~~l~~L~~L~Ls~N~l~~~~  524 (567)
T 1dce_A          482 ----------LAALRCLEVLQASDNALENV--------------------------D-GVANLPRLQELLLCNNRLQQSA  524 (567)
T ss_dssp             ----------GGGCTTCCEEECCSSCCCCC--------------------------G-GGTTCSSCCEEECCSSCCCSSS
T ss_pred             ----------hhcCCCCCEEECCCCCCCCC--------------------------c-ccCCCCCCcEEECCCCCCCCCC
Confidence                      34556666666666665531                          2 3445556666666666666554


Q ss_pred             -cccccCccchhhhcccCcccccc
Q 045539          356 -PITFSQLQTLQALGLTRNKLAGP  378 (897)
Q Consensus       356 -~~~~~~l~~L~~L~Ls~N~l~~~  378 (897)
                       |..|+.+++|+.|+|++|++++.
T Consensus       525 ~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          525 AIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             TTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CcHHHhcCCCCCEEEecCCcCCCC
Confidence             55555555555555555555543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=1.3e-19  Score=185.04  Aligned_cols=154  Identities=19%  Similarity=0.239  Sum_probs=115.3

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF  143 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  143 (897)
                      |.|..|.|+            +++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|.+..|..
T Consensus        11 C~~~~v~c~------------~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~   75 (220)
T 2v9t_B           11 CSNNIVDCR------------GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA   75 (220)
T ss_dssp             EETTEEECT------------TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred             ECCCEEEcC------------CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence            667766664            34455 5676654  68999999999999777778999999999999999998888888


Q ss_pred             ccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccccccc
Q 045539          144 IFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV  223 (897)
Q Consensus       144 ~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L  223 (897)
                      |.++++|++|+|++|+|++..+..|..+++|++|+|++|+++++.|..|.++++|++|+|++|+++ .++...+..+++|
T Consensus        76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L  154 (220)
T 2v9t_B           76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI  154 (220)
T ss_dssp             TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTC
T ss_pred             hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-EECHHHHhCCCCC
Confidence            888888999999988888544555778888888888888888887777777777777777777776 3443333344555


Q ss_pred             ceeecccccc
Q 045539          224 ETLNLGINSF  233 (897)
Q Consensus       224 ~~L~L~~N~l  233 (897)
                      ++|+|++|.+
T Consensus       155 ~~L~L~~N~~  164 (220)
T 2v9t_B          155 QTMHLAQNPF  164 (220)
T ss_dssp             CEEECCSSCE
T ss_pred             CEEEeCCCCc
Confidence            5555555544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=7.1e-20  Score=202.36  Aligned_cols=176  Identities=27%  Similarity=0.248  Sum_probs=156.2

Q ss_pred             EEEeecccccccCCCCCCCCCCCceecccCccccCcCCcccc-CCCCCcEEeccCccccCCccccccccccccEEEeeec
Q 045539           80 GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN  158 (897)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N  158 (897)
                      .+++++++++ .+|..+.  ..++.|+|++|+|++..+..|. ++++|++|+|++|+|.+..+..|.++++|++|||++|
T Consensus        22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            3566677777 4777664  4689999999999988888887 9999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccc---ccccccceeecccccccc
Q 045539          159 GLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRID---LSLPNVETLNLGINSFYG  235 (897)
Q Consensus       159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~~l~~L~~L~L~~N~l~~  235 (897)
                      +|++..+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..++   ..+++|+.|+|++|+|++
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            999777778999999999999999999999999999999999999999999 6888776   468999999999999997


Q ss_pred             cccccccCCCc--ccEEEcccccccc
Q 045539          236 TVPSSITNASK--LSDLELGVNLFSG  259 (897)
Q Consensus       236 ~~p~~l~~l~~--L~~L~L~~N~l~~  259 (897)
                      ..+..+..++.  |+.|+|++|.+..
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             cCHHHhhhccHhhcceEEecCCCccC
Confidence            77788888887  4899999999873

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=1.1e-19  Score=194.34  Aligned_cols=192  Identities=27%  Similarity=0.327  Sum_probs=117.0

Q ss_pred             cccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEE
Q 045539          171 LPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL  250 (897)
Q Consensus       171 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  250 (897)
                      +.++..+.+..+.+++..+  +..+++|++|++++|.++ .++.  ...+++|++|+|++|++++..+  +..+++|++|
T Consensus        23 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L   95 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL   95 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence            3445555566666655433  346666777777777666 3433  2346666667777666665443  6667777777


Q ss_pred             EccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCC
Q 045539          251 ELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN  330 (897)
Q Consensus       251 ~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~  330 (897)
                      ++++|.+++..                       .+..+++|++|++++|+++++                         
T Consensus        96 ~l~~n~l~~~~-----------------------~l~~l~~L~~L~L~~n~i~~~-------------------------  127 (291)
T 1h6t_A           96 FLDENKVKDLS-----------------------SLKDLKKLKSLSLEHNGISDI-------------------------  127 (291)
T ss_dssp             ECCSSCCCCGG-----------------------GGTTCTTCCEEECTTSCCCCC-------------------------
T ss_pred             ECCCCcCCCCh-----------------------hhccCCCCCEEECCCCcCCCC-------------------------
Confidence            77777665421                       135566677777777766532                         


Q ss_pred             cCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccc
Q 045539          331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL  410 (897)
Q Consensus       331 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  410 (897)
                        ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++..+  +..+++|++|++++|++++ +| .+..+
T Consensus       128 --~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l  199 (291)
T 1h6t_A          128 --NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGL  199 (291)
T ss_dssp             --GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTC
T ss_pred             --hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccC
Confidence              1244566677777777776664  456666666666666666665443  6666666666666666663 33 26666


Q ss_pred             cccceeccccccccC
Q 045539          411 TSLRVLYLGLNRFTS  425 (897)
Q Consensus       411 ~~L~~L~L~~N~l~~  425 (897)
                      ++|+.|++++|+++.
T Consensus       200 ~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          200 KNLDVLELFSQECLN  214 (291)
T ss_dssp             TTCSEEEEEEEEEEC
T ss_pred             CCCCEEECcCCcccC
Confidence            666666666666654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=2.6e-21  Score=225.36  Aligned_cols=104  Identities=24%  Similarity=0.252  Sum_probs=64.3

Q ss_pred             ccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCC-Cccccccccc
Q 045539          335 VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI-PSCLGNLTSL  413 (897)
Q Consensus       335 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L  413 (897)
                      |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.. |..++++++|
T Consensus       459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L  535 (567)
T 1dce_A          459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL  535 (567)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence            455566666666666666 355666666666666666666664 44 5666666666666666666554 6666667777


Q ss_pred             ceeccccccccCCcccc---ccccccceEEe
Q 045539          414 RVLYLGLNRFTSALPST---IWNLKDILFID  441 (897)
Q Consensus       414 ~~L~L~~N~l~~~~p~~---~~~l~~L~~L~  441 (897)
                      +.|+|++|++++.+|..   +..+++|+.|+
T Consensus       536 ~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          536 VLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             CEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            77777777766544321   22355666553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.79  E-value=1.1e-19  Score=200.87  Aligned_cols=176  Identities=25%  Similarity=0.259  Sum_probs=128.7

Q ss_pred             cEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhh-cccccccccccccccccCCCcccccccccceecccc
Q 045539          342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELC-HLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL  420 (897)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  420 (897)
                      +.+++++|+++. +|..+.  +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            577888888876 454443  3477788888888877677676 788888888888888876667788888888888888


Q ss_pred             ccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCC---CCcCC
Q 045539          421 NRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF---GDLSS  497 (897)
Q Consensus       421 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~  497 (897)
                      |++++..+..|..+++|++             |+|++|+|++..|..|..+++|+.|+|++|+|++..+..|   ..+++
T Consensus        98 N~l~~~~~~~~~~l~~L~~-------------L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~  164 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEV-------------LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK  164 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCE-------------EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTT
T ss_pred             CcCCcCCHHHhCCCcCCCE-------------EECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc
Confidence            8888766667777777774             4444445555567778888888888888888885433334   56888


Q ss_pred             CcEEeccCCccCCCCchhhhhhccc--ceEeccCCccc
Q 045539          498 LEVLDLSKNKISGAIPASLQKLLYL--KHLNLSFNKLE  533 (897)
Q Consensus       498 L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~ls~N~l~  533 (897)
                      |+.|||++|+|++..+..+..++.+  +.|+|++|++.
T Consensus       165 L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            9999999999986666777777763  77787777775

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=1.8e-19  Score=184.08  Aligned_cols=153  Identities=24%  Similarity=0.321  Sum_probs=87.4

Q ss_pred             cEEEccCCCCCCCccccccCccchhhhcccCcccccccc-hhhhcccccccccccccccccCCCcccccccccceecccc
Q 045539          342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPIT-DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL  420 (897)
Q Consensus       342 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  420 (897)
                      +.+++++|.+++ +|..+.  ..+++|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            477777777776 444432  234566666666665433 3355555555666665555554444555555555555555


Q ss_pred             ccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcE
Q 045539          421 NRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEV  500 (897)
Q Consensus       421 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  500 (897)
                      |++++..                                     |..|+.+++|++|+|++|+|++..|..|.++++|++
T Consensus        91 N~l~~~~-------------------------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (220)
T 2v70_A           91 NRLENVQ-------------------------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL  133 (220)
T ss_dssp             SCCCCCC-------------------------------------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE
T ss_pred             CccCccC-------------------------------------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE
Confidence            5555444                                     444455555555555555555555555666666666


Q ss_pred             EeccCCccCCCCchhhhhhcccceEeccCCcccc
Q 045539          501 LDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       501 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  534 (897)
                      |+|++|+|++..|..|..+++|+.|+|++|++.+
T Consensus       134 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          134 LSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             EECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             EECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            6666666665555566666666666666665554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=3.2e-19  Score=208.87  Aligned_cols=192  Identities=22%  Similarity=0.272  Sum_probs=159.3

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      .+..+.+..+.+++..+  +..+++|+.|++++|.++.+ + .+..+++|+.|+|++|++++..+  +..+++|+.|+|+
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            56677777787776554  56789999999999999874 3 58899999999999999997655  8899999999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      +|++++ +| .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|             ++++.  ..++.+++|+
T Consensus        96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N-------------~l~~l--~~l~~l~~L~  156 (605)
T 1m9s_A           96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNN-------------KITDI--TVLSRLTKLD  156 (605)
T ss_dssp             SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSS-------------CCCCC--GGGGSCTTCS
T ss_pred             CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCC-------------ccCCc--hhhcccCCCC
Confidence            999985 44 789999999999999999863  45778888885555554             44443  5688899999


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccC
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEI  536 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  536 (897)
                      .|+|++|+|++..|  +..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|++++..
T Consensus       157 ~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCC
T ss_pred             EEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCc
Confidence            99999999997666  9999999999999999985 4 46899999999999999998753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=4.1e-19  Score=181.44  Aligned_cols=153  Identities=19%  Similarity=0.193  Sum_probs=141.0

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            57899999998 6787766  78999999999999999999999999999999999999888999999999999999999


Q ss_pred             cccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                      +|+.+.+..|.++++|++|+|++|+++ .++...+..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCC-EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            999998888999999999999999999 4555556689999999999999999888899999999999999999864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=5e-19  Score=180.76  Aligned_cols=156  Identities=22%  Similarity=0.280  Sum_probs=126.4

Q ss_pred             HHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcc-ccccCccchhhhcccCcccccccchhhhcccccccccccc
Q 045539          318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIP-ITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG  396 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  396 (897)
                      +.+++++|.++. +|..+.  ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            367889999985 565553  467899999999998755 5689999999999999999988888999999999999999


Q ss_pred             cccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCccccc
Q 045539          397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQ  476 (897)
Q Consensus       397 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~  476 (897)
                      |++++..|..|.++++|+.|+|++|++++..|..                                     |..+++|++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------------~~~l~~L~~  133 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS-------------------------------------FIGLSSVRL  133 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTS-------------------------------------STTCTTCSE
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhH-------------------------------------cCCCccCCE
Confidence            9999888888999999998888888887654444                                     445566666


Q ss_pred             ccccCceecccCCCCCCCcCCCcEEeccCCccCCCCc
Q 045539          477 MFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP  513 (897)
Q Consensus       477 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  513 (897)
                      |+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus       134 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          134 LSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             EECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             EECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            6677777776667777778888888888888776544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=1.3e-19  Score=217.62  Aligned_cols=208  Identities=20%  Similarity=0.181  Sum_probs=125.6

Q ss_pred             CcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhccc
Q 045539          292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT  371 (897)
Q Consensus       292 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  371 (897)
                      |+.++|+.|.|.               .+.+..|.+. ..++.+..+++|+.|+|++|.++. +|..+.++++|++|+|+
T Consensus       193 l~~l~Ls~~~i~---------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls  255 (727)
T 4b8c_D          193 LQHKKLSQYSID---------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLN  255 (727)
T ss_dssp             ---------------------------------------------CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCT
T ss_pred             hhcCccCccccc---------------Ccccccccee-cChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEee
Confidence            455666666544               3344455555 668889999999999999999995 66667799999999999


Q ss_pred             CcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccc
Q 045539          372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI  451 (897)
Q Consensus       372 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~  451 (897)
                      +|+|+ .+|..|+.+++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..|+++++|+             
T Consensus       256 ~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~-------------  319 (727)
T 4b8c_D          256 GNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQ-------------  319 (727)
T ss_dssp             TSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCC-------------
T ss_pred             CCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCcc-------------
Confidence            99999 88999999999999999999999 78999999999999999999998 6788899998888             


Q ss_pred             eeecccCcCCCCCcccccCCcc-cccccccCceecccCCCCCCCcCCCcEEeccCC--------ccCCCCchhhhhhccc
Q 045539          452 GLNFSRNNLSGDIPITIGGLKN-LQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN--------KISGAIPASLQKLLYL  522 (897)
Q Consensus       452 ~l~ls~n~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L  522 (897)
                      .|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..      |+.|++++|        .|.+..+..+..+..+
T Consensus       320 ~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~  393 (727)
T 4b8c_D          320 FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKR  393 (727)
T ss_dssp             CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------------------
T ss_pred             EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhccccc
Confidence            6666777777888888766533 345889999999988864      566777777        4555556666777778


Q ss_pred             ceEeccCCcccccCCC
Q 045539          523 KHLNLSFNKLEGEIPR  538 (897)
Q Consensus       523 ~~L~ls~N~l~~~~p~  538 (897)
                      ....+++|-+.+....
T Consensus       394 ~~~~ls~Nil~~~~~~  409 (727)
T 4b8c_D          394 TFTVLSYNTLCQHYAT  409 (727)
T ss_dssp             --------CCCGGGCC
T ss_pred             ceeeeeccccccccCc
Confidence            8889999988765443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=1.1e-18  Score=179.35  Aligned_cols=153  Identities=23%  Similarity=0.292  Sum_probs=84.6

Q ss_pred             CcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecccc
Q 045539          341 LLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL  420 (897)
Q Consensus       341 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  420 (897)
                      -+.+++++++++. +|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            4567777777765 443332  5566666666666665566666666666666666666544444455566666666666


Q ss_pred             ccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcE
Q 045539          421 NRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEV  500 (897)
Q Consensus       421 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  500 (897)
                      |++++..+..|.                                     .+++|++|+|++|+|+ .+|..+..+++|++
T Consensus        98 N~l~~l~~~~~~-------------------------------------~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  139 (229)
T 3e6j_A           98 NQLTVLPSAVFD-------------------------------------RLVHLKELFMCCNKLT-ELPRGIERLTHLTH  139 (229)
T ss_dssp             SCCCCCCTTTTT-------------------------------------TCTTCCEEECCSSCCC-SCCTTGGGCTTCSE
T ss_pred             CcCCccChhHhC-------------------------------------cchhhCeEeccCCccc-ccCcccccCCCCCE
Confidence            655544444444                                     4444445555555554 34555555555555


Q ss_pred             EeccCCccCCCCchhhhhhcccceEeccCCcccc
Q 045539          501 LDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       501 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  534 (897)
                      |+|++|+|++..+..+..+++|+.|+|++|++.+
T Consensus       140 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             EECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            5555555554434445555555555555555443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=1e-18  Score=183.65  Aligned_cols=171  Identities=20%  Similarity=0.291  Sum_probs=107.3

Q ss_pred             CcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccE
Q 045539          170 NLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSD  249 (897)
Q Consensus       170 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  249 (897)
                      ++.++..+++++|.++++.  .+..+++|++|++++|+++ .+| . ...+++|++|+|++|++++..+  +.++++|++
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-G-MQFFTNLKELHLSHNQISDLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-H-HhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence            4566666677777766654  4666777777777777776 455 2 2356666666776666665443  666677777


Q ss_pred             EEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCC
Q 045539          250 LELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISG  329 (897)
Q Consensus       250 L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~  329 (897)
                      |+|++|++++..+                       +.. ++|++|+|++|+++++                        
T Consensus        90 L~L~~N~l~~l~~-----------------------~~~-~~L~~L~L~~N~l~~~------------------------  121 (263)
T 1xeu_A           90 LSVNRNRLKNLNG-----------------------IPS-ACLSRLFLDNNELRDT------------------------  121 (263)
T ss_dssp             EECCSSCCSCCTT-----------------------CCC-SSCCEEECCSSCCSBS------------------------
T ss_pred             EECCCCccCCcCc-----------------------ccc-CcccEEEccCCccCCC------------------------
Confidence            7777776665322                       112 5666666666666532                        


Q ss_pred             CcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccC
Q 045539          330 NIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS  402 (897)
Q Consensus       330 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  402 (897)
                         ..+..+++|++|++++|++++. + .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       122 ---~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          122 ---DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             ---GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ---hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence               1255666777777777777664 2 466667777777777777654  5566666777777777776644

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=7.8e-19  Score=184.01  Aligned_cols=137  Identities=20%  Similarity=0.254  Sum_probs=107.7

Q ss_pred             CCCcCCeeecccceEEEEEEe-cCCce--EEEEEechhhH------------------------HHHHHHHHHHHHHHhc
Q 045539          618 RFSENNLIGIGSFGSIYVARL-QDGME--VAVKVFHQQYE------------------------RALKSFEDECEVMKRI  670 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l  670 (897)
                      -|.+.+.||+|+||.||+|.+ .+|+.  ||||+++....                        .....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            366789999999999999988 67999  99998754311                        1124678999999999


Q ss_pred             CCCcc--ceEeeeecCCCceEEEEEeccC-C----ChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCcEeCC
Q 045539          671 RHRNL--VKIISSCSNDDFKALIMKYMPN-G----SLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH-STPIIHCD  742 (897)
Q Consensus       671 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h-~~~ivH~D  742 (897)
                      .|+++  +.++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|++||   | +.||+|||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEeCC
Confidence            88754  444443    356899999942 3    67665432    22446778999999999999   7 99999999


Q ss_pred             CCCCCeeeCCCCcEEEeeccCcccc
Q 045539          743 LKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       743 lkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=1.8e-18  Score=173.47  Aligned_cols=155  Identities=16%  Similarity=0.193  Sum_probs=126.5

Q ss_pred             CCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccc
Q 045539           96 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLA  175 (897)
Q Consensus        96 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~  175 (897)
                      .+.+++|++|++++|.++ .+| .+..+++|++|++++|.+..  +..+..+++|++|++++|++++..|..|+.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            356788889999999888 666 68888999999999986643  34788888999999999999877888899999999


Q ss_pred             cccccccccccccccccccccccccccccccc-ccccCCccccccccccceeecccccccccccccccCCCcccEEEccc
Q 045539          176 RLAFATNNLVGVAPVTIFNMSALKEIYLLNNS-LSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGV  254 (897)
Q Consensus       176 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  254 (897)
                      +|++++|++++..|..+.++++|++|+|++|+ ++ .+|  .+..+++|++|++++|.+++. + .+..+++|++|++++
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~--~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~  190 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM--PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFS  190 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG--GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECB
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH--hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeC
Confidence            99999999998888888999999999999998 54 666  244788999999999999763 3 788999999999999


Q ss_pred             ccccc
Q 045539          255 NLFSG  259 (897)
Q Consensus       255 N~l~~  259 (897)
                      |+|.+
T Consensus       191 N~i~~  195 (197)
T 4ezg_A          191 QTIGG  195 (197)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            98764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=2.7e-18  Score=172.26  Aligned_cols=105  Identities=18%  Similarity=0.280  Sum_probs=72.9

Q ss_pred             cccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccccccc
Q 045539          334 VVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSL  413 (897)
Q Consensus       334 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  413 (897)
                      ..+.+++|+.|++++|.++. +| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..|..++.+++|
T Consensus        39 ~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             ChhhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            34677888888888888885 44 57777888888888886652  3366677777777777777776666777777777


Q ss_pred             ceeccccccccCCccccccccccceEEee
Q 045539          414 RVLYLGLNRFTSALPSTIWNLKDILFIDV  442 (897)
Q Consensus       414 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  442 (897)
                      ++|++++|++++..|..+..+++|++|++
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  143 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDL  143 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence            77777777776655555555555553333

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=3.9e-18  Score=179.24  Aligned_cols=168  Identities=17%  Similarity=0.265  Sum_probs=117.2

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      .+..+++++|.+++..  .+..+++|++|++++|+++.+ + .+..+++|++|+|++|++++..+  +..+++|++|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            6778888888887544  578889999999999999874 4 67888888888888888886544  7888888888888


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      +|++++ +|... . ++|+.|++++|++++. + .+..+++|++|++++|+             +++. | .++.+++|+
T Consensus        94 ~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~-------------i~~~-~-~l~~l~~L~  153 (263)
T 1xeu_A           94 RNRLKN-LNGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNK-------------LKSI-V-MLGFLSKLE  153 (263)
T ss_dssp             SSCCSC-CTTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSC-------------CCBC-G-GGGGCTTCC
T ss_pred             CCccCC-cCccc-c-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCc-------------CCCC-h-HHccCCCCC
Confidence            888874 44322 2 7788888888877753 2 46666666644444333             3322 2 456666777


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCccCCC
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA  511 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  511 (897)
                      .|++++|++++.  ..+..+++|+.|++++|++++.
T Consensus       154 ~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          154 VLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             EEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             EEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            777777777654  5566666677777777766643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.71  E-value=8.2e-19  Score=191.27  Aligned_cols=101  Identities=21%  Similarity=0.160  Sum_probs=64.2

Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccc-cccccccccccCCCccccccccccee
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLH-SLVLQGNKFSGSIPSCLGNLTSLRVL  416 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L  416 (897)
                      +++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++...+.+|.++++|+ .+++.+ +++...+.+|.++++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            566777777777776666666677777777777666 5555555666666666 666666 5554445666666666666


Q ss_pred             ccccccccCCccccccccccceEE
Q 045539          417 YLGLNRFTSALPSTIWNLKDILFI  440 (897)
Q Consensus       417 ~L~~N~l~~~~p~~~~~l~~L~~L  440 (897)
                      +++.|+++...+..|.++++|+.+
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEE
T ss_pred             EeCCCccCccchhhhcCCcchhhh
Confidence            666666665555556666555544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=1.7e-17  Score=165.53  Aligned_cols=131  Identities=19%  Similarity=0.180  Sum_probs=116.1

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCc-cccCCCCCcEEeccCccccCCccccccccccccEEEeeecC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPS-SIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING  159 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~  159 (897)
                      +++++++++ .+|..+..  +|++|+|++|+|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        13 l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   89 (192)
T 1w8a_A           13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             EECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence            445566674 68877654  999999999999976664 48999999999999999999999999999999999999999


Q ss_pred             CCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCc
Q 045539          160 LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPS  214 (897)
Q Consensus       160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  214 (897)
                      |++..|..|.++++|++|+|++|+++++.|..|..+++|++|+|++|.+++..+.
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            9988888899999999999999999999999999999999999999999876553

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=5.6e-18  Score=169.00  Aligned_cols=130  Identities=24%  Similarity=0.297  Sum_probs=59.4

Q ss_pred             hhhcccCcccccccchhhhcccccccccccccccccCCCc-ccccccccceeccccccccCCccccccccccceEEeecC
Q 045539          366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS  444 (897)
Q Consensus       366 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  444 (897)
                      +.+++++|+++ .+|..+.  .+|++|++++|+|++..+. .|+++++|++|+|++|++++..|..|.++++|+      
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~------   81 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ------   81 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC------
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC------
Confidence            44555555554 3333332  1455555555555533332 244555555555555555544444444444444      


Q ss_pred             CcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCC
Q 045539          445 NSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA  511 (897)
Q Consensus       445 N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  511 (897)
                             .|+|++|+|++..|..|+.+++|++|+|++|+|++.+|..|..+++|++|+|++|.+++.
T Consensus        82 -------~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           82 -------ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             -------EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             -------EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence                   222233333333344444444444444444444444444444444444444444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=2.5e-18  Score=187.46  Aligned_cols=289  Identities=13%  Similarity=0.097  Sum_probs=173.4

Q ss_pred             ccCCCCCCC--CCCCceecccCccccCcCCccccC-CCCCcEEeccCcccc--CCccccccccccccEEEeeecCCCCCC
Q 045539           90 GTIPPQLGN--LSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLYFSDNQLF--GSLSFFIFNVSSVTTIDLSINGLSGEM  164 (897)
Q Consensus        90 g~~~~~l~~--l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~LdLs~N~l~~~~  164 (897)
                      |+++..+..  +.+++.|.++++ +.+.--..+.. +++|++|||++|++.  ...+..+   +.+..+++..|.+.   
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---   85 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---   85 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---
T ss_pred             CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---
Confidence            344444443  677888888764 22111122333 677888888888776  2222222   22445555555322   


Q ss_pred             CccccC--------cccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccc---
Q 045539          165 PREIGN--------LPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSF---  233 (897)
Q Consensus       165 p~~l~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l---  233 (897)
                      +..|.+        +++|+.|+|.+ .++.+.+.+|.+|++|++|++++|.++ .++...|....++..+.++.+..   
T Consensus        86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~  163 (329)
T 3sb4_A           86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRF  163 (329)
T ss_dssp             TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHT
T ss_pred             HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhc
Confidence            234555        77777777777 777777777777777777777777776 66666666666666555554321   


Q ss_pred             -cccccccccCCCccc-EEEccccccccccCcccc-------ccccccccCCCCcccccccc-cccCCCcEEEecCCCCC
Q 045539          234 -YGTVPSSITNASKLS-DLELGVNLFSGFIPNTFV-------NMADNYLTSSTPELSFLSSL-TNCKKLKVLILTGNPLD  303 (897)
Q Consensus       234 -~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~f~-------~l~~~~l~~~~~~~~~l~~l-~~l~~L~~L~Ls~N~l~  303 (897)
                       .......|.++..|+ .+.+....-   ++..+.       ++....+...... .....+ ..+++|+.++|++|+++
T Consensus       164 ~~~i~~~~f~~~~~L~~~i~~~~~~~---l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~  239 (329)
T 3sb4_A          164 KNRWEHFAFIEGEPLETTIQVGAMGK---LEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNAT  239 (329)
T ss_dssp             STTTTTSCEEESCCCEEEEEECTTCC---HHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCC
T ss_pred             cccccccccccccccceeEEecCCCc---HHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcc
Confidence             112233344444544 333322110   000000       0000000000000 000000 12556666666665554


Q ss_pred             CCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchh-hhcccCcccccccchh
Q 045539          304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ-ALGLTRNKLAGPITDE  382 (897)
Q Consensus       304 ~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~  382 (897)
                                               .+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ +++...+.+
T Consensus       240 -------------------------~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~a  292 (329)
T 3sb4_A          240 -------------------------TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGA  292 (329)
T ss_dssp             -------------------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTT
T ss_pred             -------------------------eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhh
Confidence                                     345567888999999999998 8888888999999999 999998 787777889


Q ss_pred             hhcccccccccccccccccCCCcccccccccceecc
Q 045539          383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       383 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      |.++++|+.|++++|+++...+.+|.++++|+.++.
T Consensus       293 F~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          293 FMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             TTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             hhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            999999999999999999777789999999998874

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=9e-17  Score=158.09  Aligned_cols=135  Identities=27%  Similarity=0.312  Sum_probs=110.6

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF  143 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  143 (897)
                      |+|.+|.|+..            +++ .+|..+  .++|++|+|++|++++..+..|+++++|++|+|++|++.+..+..
T Consensus         7 C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            7 CSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             EETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             eCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence            78998888642            344 455444  378999999999999777777899999999999999998888888


Q ss_pred             ccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCC
Q 045539          144 IFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLP  213 (897)
Q Consensus       144 ~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  213 (897)
                      +.++++|++|+|++|++++..+..|..+++|++|+|++|+++++.+..+.++++|++|+|++|.+++..|
T Consensus        72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8899999999999999997666678888888888888888888877777888888888888888875433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=8.5e-17  Score=156.79  Aligned_cols=108  Identities=20%  Similarity=0.306  Sum_probs=52.8

Q ss_pred             CCCceecccCcccc-CcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc
Q 045539          100 SSLQTLDLSHNKLS-GNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA  178 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~  178 (897)
                      ++|++|+|++|.++ +.+|..+..+++|++|+|++|++.+.  ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 44454455555555555555554443  4444455555555555555544444444445555555


Q ss_pred             ccccccccccc-cccccccccccccccccccc
Q 045539          179 FATNNLVGVAP-VTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       179 L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  209 (897)
                      |++|+++++.+ ..+.++++|++|++++|.++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            55555444321 34444444444444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=6.8e-17  Score=157.47  Aligned_cols=136  Identities=20%  Similarity=0.254  Sum_probs=124.2

Q ss_pred             CeEEEEEeeccccc-ccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEE
Q 045539           76 HRVIGLNISSFNLQ-GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTID  154 (897)
Q Consensus        76 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ld  154 (897)
                      .++..|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|+|++|++.+.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56889999999998 89999999999999999999999965  7899999999999999999998899999999999999


Q ss_pred             eeecCCCCCCC--ccccCccccccccccccccccccc---ccccccccccccccccccccccCCcc
Q 045539          155 LSINGLSGEMP--REIGNLPYLARLAFATNNLVGVAP---VTIFNMSALKEIYLLNNSLSGSLPSR  215 (897)
Q Consensus       155 Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~  215 (897)
                      |++|++++ +|  ..++.+++|++|++++|++++..+   ..+..+++|++|++++|.+. ++|..
T Consensus       102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~  165 (168)
T 2ell_A          102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS  165 (168)
T ss_dssp             CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred             ccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence            99999995 44  789999999999999999999876   57899999999999999987 55543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=1.1e-16  Score=152.52  Aligned_cols=108  Identities=19%  Similarity=0.258  Sum_probs=63.1

Q ss_pred             CCCceecccCcccc-CcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc
Q 045539          100 SSLQTLDLSHNKLS-GNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA  178 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~  178 (897)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|++.+.  ..+..+++|++|+|++|++++.+|..++.+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            55666666666665 55565566666666666666666544  4555566666666666666554555555556666666


Q ss_pred             ccccccccc-cccccccccccccccccccccc
Q 045539          179 FATNNLVGV-APVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       179 L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                      +++|+++++ .+..+.++++|++|++++|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            666665554 2345555555555555555555

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=1.1e-16  Score=173.66  Aligned_cols=138  Identities=17%  Similarity=0.206  Sum_probs=101.4

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhH----------------------HHHHHHHHHHHHHHhcCCCc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYE----------------------RALKSFEDECEVMKRIRHRN  674 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n  674 (897)
                      .-|++.+.||+|++|.||+|...+|+.||||+++....                      .......+|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34899999999999999999999999999998753210                      00111235666666665443


Q ss_pred             cc--eEeeeecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC
Q 045539          675 LV--KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE  752 (897)
Q Consensus       675 iv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~  752 (897)
                      +.  ..+++    ...++||||++|++|.++...       .....++.|++.++.+|   |+.|||||||||.|||+++
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRL---AKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeC
Confidence            32  22222    123799999999998765322       23456889999999999   7889999999999999987


Q ss_pred             CC----------cEEEeeccCccccC
Q 045539          753 DM----------VAHISDFGIAKLLS  768 (897)
Q Consensus       753 ~~----------~~kL~DFg~a~~~~  768 (897)
                      ++          .+.|+||+-+....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCcccccccccceEEEEeCCcccCC
Confidence            76          48999999876544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=5.8e-16  Score=154.32  Aligned_cols=125  Identities=24%  Similarity=0.294  Sum_probs=105.0

Q ss_pred             EEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539           81 LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus        81 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      +++++++++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus        15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l   90 (193)
T 2wfh_A           15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL   90 (193)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence            445566666 5776654  68999999999998 7888899999999999999999888888899999999999999999


Q ss_pred             CCCCCccccCccccccccccccccccccccccccccccccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                      ++..|..|..+++|++|+|++|+|+.+.+..|.++++|+.|+|++|.+.
T Consensus        91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            8777778888888888888888888887777888888888888888776

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=1.2e-16  Score=152.27  Aligned_cols=128  Identities=17%  Similarity=0.187  Sum_probs=117.4

Q ss_pred             CeEEEEEeeccccc-ccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEE
Q 045539           76 HRVIGLNISSFNLQ-GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTID  154 (897)
Q Consensus        76 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ld  154 (897)
                      .++..|++++++++ +.+|..++.+++|++|+|++|.+++.  ..++++++|++|+|++|++.+.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            46889999999998 89999999999999999999999965  7899999999999999999998999999999999999


Q ss_pred             eeecCCCCC-CCccccCccccccccccccccccccc---cccccccccccccccc
Q 045539          155 LSINGLSGE-MPREIGNLPYLARLAFATNNLVGVAP---VTIFNMSALKEIYLLN  205 (897)
Q Consensus       155 Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~  205 (897)
                      +++|++++. .|..++.+++|++|++++|++++..+   ..+..+++|++|++++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999999963 34889999999999999999999877   6789999999999874

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=1.3e-15  Score=151.85  Aligned_cols=128  Identities=27%  Similarity=0.390  Sum_probs=96.6

Q ss_pred             ccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccccc
Q 045539          390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG  469 (897)
Q Consensus       390 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~  469 (897)
                      +.+++++|+++ .+|..+.  ++|+.|++++|.++ .+|..|.++++|+             .|+|++|+|++..|..|.
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~-------------~L~Ls~N~i~~i~~~~f~   75 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLT-------------LIDLSNNRISTLSNQSFS   75 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCC-------------EEECCSSCCCCCCTTTTT
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCC-------------EEECCCCcCCEeCHhHcc
Confidence            45777777777 5665543  46788888888887 4667777777776             444555555556667788


Q ss_pred             CCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccc
Q 045539          470 GLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       470 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  534 (897)
                      ++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus        76 ~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           76 NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            88888888888888888777788888888888888888886555678888888888888888764

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.60  E-value=1.8e-15  Score=148.68  Aligned_cols=132  Identities=20%  Similarity=0.277  Sum_probs=78.5

Q ss_pred             ccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCccccc
Q 045539          390 HSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIG  469 (897)
Q Consensus       390 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~  469 (897)
                      +.+++++|+++ .+|..+.  ++|+.|++++|++++..+..+..+++|+             .|++++|++++..+..++
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~-------------~L~l~~n~l~~~~~~~~~   73 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLT-------------KLSLSQNQIQSLPDGVFD   73 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCS-------------EEECCSSCCCCCCTTTTT
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCccccc-------------EEECCCCcceEeChhHcc
Confidence            44555555555 3443332  4566666666666654444555555555             333333344434444556


Q ss_pred             CCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCC
Q 045539          470 GLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP  537 (897)
Q Consensus       470 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  537 (897)
                      .+++|++|++++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus        74 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           74 KLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            66777777777777776555566777777777777777775544455667777777777777665443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=2.2e-17  Score=165.74  Aligned_cols=155  Identities=18%  Similarity=0.230  Sum_probs=109.8

Q ss_pred             CCCCCCceecccCccccCcCCc------cccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccC
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPS------SIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGN  170 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~  170 (897)
                      .....++.++++.+.++|.+|.      .|+++++|++|+|++|++.+ +| .+.++++|++|+|++|+++ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3455666777777777766665      67777777777777777766 44 6777777777777777777 56777777


Q ss_pred             cccccccccccccccccccccccccccccccccccccccccCCc-cccccccccceeeccccccccccccc---------
Q 045539          171 LPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPS-RIDLSLPNVETLNLGINSFYGTVPSS---------  240 (897)
Q Consensus       171 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~L~~N~l~~~~p~~---------  240 (897)
                      +++|++|+|++|+++++ | .+.++++|++|++++|+++ .++. .....+++|++|++++|.+++.+|..         
T Consensus        92 ~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           92 ADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             CCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            77777777777777775 3 4777778888888888777 3332 23346778888888888887666653         


Q ss_pred             -ccCCCcccEEEcccccccc
Q 045539          241 -ITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       241 -l~~l~~L~~L~L~~N~l~~  259 (897)
                       +..+++|+.||  +|.++.
T Consensus       169 ~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGTT
T ss_pred             HHHhCCCcEEEC--CcccCH
Confidence             78888999887  666553

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.59  E-value=6.9e-15  Score=163.67  Aligned_cols=113  Identities=12%  Similarity=0.104  Sum_probs=60.9

Q ss_pred             ccccCccCCcEEEccCCCCC-----CCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccc
Q 045539          333 QVVGNLGNLLVLELGGNNLT-----EPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL  407 (897)
Q Consensus       333 ~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  407 (897)
                      .+|.++++|+.+++.+|.+.     .+.+..|.++++|+.++|. +.++.....+|.++++|+.++|..| ++..-+.+|
T Consensus       265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF  342 (401)
T 4fdw_A          265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAF  342 (401)
T ss_dssp             TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSS
T ss_pred             hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhC
Confidence            34555555555555555443     3344555555555555555 3344444555556666666666433 443445556


Q ss_pred             ccccccceeccccccccCCccccccccc-cceEEeecCCccc
Q 045539          408 GNLTSLRVLYLGLNRFTSALPSTIWNLK-DILFIDVSSNSLN  448 (897)
Q Consensus       408 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~  448 (897)
                      .++ +|+.+++++|.+....+..|.+++ +++.|.+..+.+.
T Consensus       343 ~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          343 NNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             SSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            666 666666666665554555555553 4555555555443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.56  E-value=1.8e-14  Score=160.19  Aligned_cols=269  Identities=11%  Similarity=0.118  Sum_probs=138.3

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccc
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAF  179 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L  179 (897)
                      ..++.+.+.+ .++..-+.+|.++ +|+.+.|.+| +..+....|.++ +|+.+++.. .++..-+..|.++++|+.++|
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            4455555542 3443334455553 5666666555 544455555553 466666553 344333445555555555555


Q ss_pred             ccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccccc
Q 045539          180 ATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                      .+|+++.+...+|. +++|+++.|.++ ++ .|+...|..+++|+.+++..| ++..-...|.+ ++|+.+.|. |.++.
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~  261 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN  261 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence            55555555555554 355555555533 43 455555555555555555543 33333444444 455555552 33333


Q ss_pred             ccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCcc
Q 045539          260 FIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLG  339 (897)
Q Consensus       260 ~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~  339 (897)
                      +...+                     +.++++|+.+++.+|.+..                    +.+....+.+|.+++
T Consensus       262 I~~~a---------------------F~~c~~L~~l~l~~~~~~~--------------------~~~~~I~~~aF~~c~  300 (401)
T 4fdw_A          262 IASRA---------------------FYYCPELAEVTTYGSTFND--------------------DPEAMIHPYCLEGCP  300 (401)
T ss_dssp             ECTTT---------------------TTTCTTCCEEEEESSCCCC--------------------CTTCEECTTTTTTCT
T ss_pred             EChhH---------------------hhCCCCCCEEEeCCccccC--------------------CcccEECHHHhhCCc
Confidence            33332                     2445555555555554431                    111123344556666


Q ss_pred             CCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCccccccc-ccceecc
Q 045539          340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT-SLRVLYL  418 (897)
Q Consensus       340 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L  418 (897)
                      +|+.++|. +.++.+...+|.++++|+.+.|..| ++.....+|.++ +|+.+++++|.+....+..|.+++ .++.|++
T Consensus       301 ~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~v  377 (401)
T 4fdw_A          301 KLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRV  377 (401)
T ss_dssp             TCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEE
T ss_pred             cCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEe
Confidence            66666666 3355555556666666666666433 444445556666 666666666666544445555553 4556666


Q ss_pred             ccccc
Q 045539          419 GLNRF  423 (897)
Q Consensus       419 ~~N~l  423 (897)
                      ..+.+
T Consensus       378 p~~~~  382 (401)
T 4fdw_A          378 PAESV  382 (401)
T ss_dssp             CGGGH
T ss_pred             CHHHH
Confidence            55544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=3.8e-17  Score=163.95  Aligned_cols=151  Identities=23%  Similarity=0.286  Sum_probs=94.8

Q ss_pred             cchhhhcccCcccccccch------hhhcccccccccccccccccCCCcccccccccceeccccccccCCcccccccccc
Q 045539          363 QTLQALGLTRNKLAGPITD------ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKD  436 (897)
Q Consensus       363 ~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  436 (897)
                      ..++.++++.|.+.+.+|.      .+..+++|++|+|++|++++ +| .+.++++|+.|++++|+++ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            3444444444544444443      66667777777777777764 55 6666777777777777776 45666666666


Q ss_pred             ceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCC-CCCCCcCCCcEEeccCCccCCCCch-
Q 045539          437 ILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSSLEVLDLSKNKISGAIPA-  514 (897)
Q Consensus       437 L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-  514 (897)
                      |++|++++|.             +++ +| .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|. 
T Consensus        95 L~~L~L~~N~-------------l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~  159 (198)
T 1ds9_A           95 LEELWISYNQ-------------IAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN  159 (198)
T ss_dssp             CSEEEEEEEE-------------CCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTT
T ss_pred             CCEEECcCCc-------------CCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccc
Confidence            6644444433             332 23 46667777777777777774222 3577777888888888887765554 


Q ss_pred             ---------hhhhhcccceEeccCCccc
Q 045539          515 ---------SLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       515 ---------~~~~l~~L~~L~ls~N~l~  533 (897)
                               .+..+++|+.||  +|+++
T Consensus       160 ~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          160 NATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             TTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             cchHHHHHHHHHhCCCcEEEC--CcccC
Confidence                     277778888776  66654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=2.6e-15  Score=147.40  Aligned_cols=134  Identities=19%  Similarity=0.119  Sum_probs=63.2

Q ss_pred             CCCCCCCceecccCccccCcCCccccCCC-CCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccc
Q 045539           96 LGNLSSLQTLDLSHNKLSGNIPSSIFNMH-TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL  174 (897)
Q Consensus        96 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L  174 (897)
                      +.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|++.+.  ..+..+++|++|+|++|+++             
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-------------   77 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-------------   77 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-------------
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-------------
Confidence            344555555555555555 2332 33332 555555555555432  33444444444444444444             


Q ss_pred             cccccccccccccccccccccccccccccccccccccCCc-cccccccccceeecccccccccccc----cccCCCcccE
Q 045539          175 ARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPS-RIDLSLPNVETLNLGINSFYGTVPS----SITNASKLSD  249 (897)
Q Consensus       175 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~  249 (897)
                                 ++.+..+.++++|++|+|++|+++ .+|. ..+..+++|++|++++|.++ .+|.    .+..+++|+.
T Consensus        78 -----------~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~  144 (176)
T 1a9n_A           78 -----------RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV  144 (176)
T ss_dssp             -----------EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred             -----------ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence                       433333344444444444444443 3332 11224445555555555554 2333    2556666677


Q ss_pred             EEcccccccc
Q 045539          250 LELGVNLFSG  259 (897)
Q Consensus       250 L~L~~N~l~~  259 (897)
                      ||++.|.+..
T Consensus       145 Ld~~~n~~~~  154 (176)
T 1a9n_A          145 LDFQKVKLKE  154 (176)
T ss_dssp             ETTEECCHHH
T ss_pred             eCCCcCCHHH
Confidence            7776666543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.50  E-value=7.7e-15  Score=143.99  Aligned_cols=133  Identities=20%  Similarity=0.205  Sum_probs=83.1

Q ss_pred             hhcccccccccccccccccCCCccccccc-ccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCC
Q 045539          383 LCHLARLHSLVLQGNKFSGSIPSCLGNLT-SLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS  461 (897)
Q Consensus       383 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~  461 (897)
                      +..+.+|+.|++++|+++ .+|. +..+. +|+.|++++|.+++.  ..+..+++|++             |++++|+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~-------------L~Ls~N~l~   77 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKT-------------LLVNNNRIC   77 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCE-------------EECCSSCCC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCE-------------EECCCCccc
Confidence            334455666666666665 3333 33333 666666666666643  44555555553             333333444


Q ss_pred             CCCcccccCCcccccccccCceecccCCC--CCCCcCCCcEEeccCCccCCCCchh----hhhhcccceEeccCCcccc
Q 045539          462 GDIPITIGGLKNLQQMFLEYNRLEGSIPE--SFGDLSSLEVLDLSKNKISGAIPAS----LQKLLYLKHLNLSFNKLEG  534 (897)
Q Consensus       462 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~  534 (897)
                      +..|..++.+++|++|++++|+++ .+|.  .+..+++|+.|++++|.++ .+|..    +..+++|+.||+++|....
T Consensus        78 ~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           78 RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            333334467777777777777775 4555  6778888888888888887 56664    7888888888888887653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.46  E-value=7.1e-14  Score=136.05  Aligned_cols=105  Identities=20%  Similarity=0.190  Sum_probs=81.4

Q ss_pred             EEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecC
Q 045539           80 GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING  159 (897)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~  159 (897)
                      .+++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|.+..+..|.++++|++|+|++|+
T Consensus        13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            3555666776 4776663  788888888888887778888888888888888888887777777888888888888888


Q ss_pred             CCCCCCccccCccccccccccccccccc
Q 045539          160 LSGEMPREIGNLPYLARLAFATNNLVGV  187 (897)
Q Consensus       160 l~~~~p~~l~~l~~L~~L~L~~N~l~~~  187 (897)
                      |++..+..|.++++|++|+|++|+++..
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            8865555677777777777777777654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.46  E-value=3.2e-13  Score=150.85  Aligned_cols=153  Identities=8%  Similarity=0.034  Sum_probs=74.8

Q ss_pred             CCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcc
Q 045539           93 PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLP  172 (897)
Q Consensus        93 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~  172 (897)
                      ..+|.++++|+.++|.. .++..-..+|.++++|+.++|.++ +.......|.++.+|+.+.+..+ +.......|.+..
T Consensus        64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~  140 (394)
T 4fs7_A           64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred             HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence            34566667777777653 355344456666777777766544 44444555666666665555433 2212233344433


Q ss_pred             cccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEc
Q 045539          173 YLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL  252 (897)
Q Consensus       173 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  252 (897)
                      .+......  .+..+...+|.++++|+.+.+.++. . .++...|..+++|+.+++..| ++......|.+++.|+.+.+
T Consensus       141 ~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~  215 (394)
T 4fs7_A          141 FKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-E-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEF  215 (394)
T ss_dssp             CSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-C-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCC
T ss_pred             ccccccCc--cccccchhhhcccCCCcEEecCCcc-c-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeec
Confidence            32222221  2222334455555555555554432 2 345555555555555555444 33233344444444444444


Q ss_pred             c
Q 045539          253 G  253 (897)
Q Consensus       253 ~  253 (897)
                      .
T Consensus       216 ~  216 (394)
T 4fs7_A          216 P  216 (394)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.44  E-value=5.5e-13  Score=148.89  Aligned_cols=336  Identities=11%  Similarity=0.041  Sum_probs=219.8

Q ss_pred             cccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccc
Q 045539          111 KLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPV  190 (897)
Q Consensus       111 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  190 (897)
                      .++..-..+|.++++|+.+.|..+ +..+...+|.++++|+.++|..+ ++..-...|.++++|+.+.+..+ +..+...
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            355455678999999999999854 77777889999999999999865 55344567889999999887754 6777777


Q ss_pred             cccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCcccccccc
Q 045539          191 TIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD  270 (897)
Q Consensus       191 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~  270 (897)
                      +|.++..++........   .+....|..+++|+.+.+.++. .......|.++++|+.+++..| ++.+...+|     
T Consensus       135 aF~~~~~~~~~~~~~~~---~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F-----  204 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGVT---VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCF-----  204 (394)
T ss_dssp             TTTTCCCSEEECCTTCC---EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTT-----
T ss_pred             eeecccccccccCcccc---ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhh-----
Confidence            88887655544443332   4566777788999999998664 4455678899999999999876 444444433     


Q ss_pred             ccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCC
Q 045539          271 NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNN  350 (897)
Q Consensus       271 ~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~  350 (897)
                                      .++..|+.+.+..+...                           +.+.+....+|+.+.+..+ 
T Consensus       205 ----------------~~~~~L~~i~~~~~~~~---------------------------i~~~~~~~~~l~~i~ip~~-  240 (394)
T 4fs7_A          205 ----------------AECILLENMEFPNSLYY---------------------------LGDFALSKTGVKNIIIPDS-  240 (394)
T ss_dssp             ----------------TTCTTCCBCCCCTTCCE---------------------------ECTTTTTTCCCCEEEECTT-
T ss_pred             ----------------ccccccceeecCCCceE---------------------------eehhhcccCCCceEEECCC-
Confidence                            45566666555544221                           1111222345555555432 


Q ss_pred             CCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcccc
Q 045539          351 LTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPST  430 (897)
Q Consensus       351 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  430 (897)
                      ++.+....|.++..|+.+.+..+... .....|.....++.+....+.+.   ...|..+.+|+.+.+..+ ++..-..+
T Consensus       241 ~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~a  315 (394)
T 4fs7_A          241 FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEA  315 (394)
T ss_dssp             CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTT
T ss_pred             ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhh
Confidence            33334455666666666666655433 44455666666666666555432   245666777777777654 55444556


Q ss_pred             ccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCC
Q 045539          431 IWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG  510 (897)
Q Consensus       431 ~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  510 (897)
                      |.++.+|+.+++..+              ++..-..+|.++.+|+.+.+..| ++..-...|.++.+|+.+++..| ++ 
T Consensus       316 F~~c~~L~~i~lp~~--------------v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-  378 (394)
T 4fs7_A          316 FESCTSLVSIDLPYL--------------VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-  378 (394)
T ss_dssp             TTTCTTCCEECCCTT--------------CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-
T ss_pred             hcCCCCCCEEEeCCc--------------ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-
Confidence            777777775555322              22223456778888888888777 66555678888899999988765 33 


Q ss_pred             CCchhhhhhcccceE
Q 045539          511 AIPASLQKLLYLKHL  525 (897)
Q Consensus       511 ~~p~~~~~l~~L~~L  525 (897)
                      .+...|.++++|+.+
T Consensus       379 ~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          379 QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             GGGGGBCTTCEEEEE
T ss_pred             EhhheecCCCCCcEE
Confidence            445677778777764

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=1.5e-13  Score=134.30  Aligned_cols=106  Identities=22%  Similarity=0.253  Sum_probs=84.3

Q ss_pred             EEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeec
Q 045539           79 IGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN  158 (897)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N  158 (897)
                      +.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|++.++..|.++++|++|||++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            35778888885 6777665  88899999999998888888888999999999998888877777788888888888888


Q ss_pred             CCCCCCCccccCccccccccccccccccc
Q 045539          159 GLSGEMPREIGNLPYLARLAFATNNLVGV  187 (897)
Q Consensus       159 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  187 (897)
                      +|++..+..|..+++|++|+|++|++...
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            88855445577777777777777777654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.43  E-value=2.7e-13  Score=131.93  Aligned_cols=107  Identities=27%  Similarity=0.337  Sum_probs=98.6

Q ss_pred             CceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccccccc
Q 045539          102 LQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFAT  181 (897)
Q Consensus       102 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~  181 (897)
                      .+.|++++|+++ .+|..+.  ++|++|+|++|+|.+..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            478999999998 6887774  8999999999999999999999999999999999999977777789999999999999


Q ss_pred             cccccccccccccccccccccccccccccc
Q 045539          182 NNLVGVAPVTIFNMSALKEIYLLNNSLSGS  211 (897)
Q Consensus       182 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  211 (897)
                      |+|+++.+..|.++++|++|+|++|.++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            999999988999999999999999999843

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=3.8e-13  Score=131.37  Aligned_cols=104  Identities=19%  Similarity=0.278  Sum_probs=97.0

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|.+.+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68999999997 7888775  89999999999999999999999999999999999999765666899999999999999


Q ss_pred             ccccccccccccccccccccccccccc
Q 045539          183 NLVGVAPVTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  209 (897)
                      +|+++.+..|.++++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            999998888999999999999999998

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=8.1e-13  Score=144.93  Aligned_cols=110  Identities=17%  Similarity=0.166  Sum_probs=94.3

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccC-ccccCcCCccccCCCCCcEEeccCccccCCccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSH-NKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSF  142 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  142 (897)
                      |.|.+|.|+..           |+|+ .+|. |..+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++.+|.
T Consensus         8 C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            88888887532           1566 4888 99999999999996 999988888999999999999999999999999


Q ss_pred             cccccccccEEEeeecCCCCCCCccccCccccccccccccccccc
Q 045539          143 FIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGV  187 (897)
Q Consensus       143 ~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  187 (897)
                      .|.++++|++|||++|+|++..+..|..++ |+.|+|++|.+...
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            999999999999999999965555566665 99999999988754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=2.4e-14  Score=157.75  Aligned_cols=14  Identities=21%  Similarity=0.304  Sum_probs=8.1

Q ss_pred             ccccEEEeeecCCC
Q 045539          148 SSVTTIDLSINGLS  161 (897)
Q Consensus       148 ~~L~~LdLs~N~l~  161 (897)
                      ++|+.|+|++|.++
T Consensus        72 ~~L~~L~Ls~n~l~   85 (372)
T 3un9_A           72 SSLRQLNLAGVRMT   85 (372)
T ss_dssp             TTCCEEECTTSCCC
T ss_pred             hhCCEEEecCCCCC
Confidence            44556666666555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.29  E-value=1.8e-12  Score=142.10  Aligned_cols=105  Identities=21%  Similarity=0.250  Sum_probs=94.6

Q ss_pred             ceecccCc-cccCcCCccccCCCCCcEEeccC-ccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccc
Q 045539          103 QTLDLSHN-KLSGNIPSSIFNMHTLKLLYFSD-NQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFA  180 (897)
Q Consensus       103 ~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~  180 (897)
                      ..++++++ +|+ .+|. |..+++|++|+|++ |+|.+.++..|.++++|++|+|++|+|++..|..|++|++|++|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35788888 898 5888 99999999999996 99999999999999999999999999998888899999999999999


Q ss_pred             cccccccccccccccccccccccccccccc
Q 045539          181 TNNLVGVAPVTIFNMSALKEIYLLNNSLSG  210 (897)
Q Consensus       181 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  210 (897)
                      +|+|+++.+..|..++ |+.|+|++|.+..
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            9999998887777776 9999999999873

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.28  E-value=3.8e-14  Score=156.11  Aligned_cols=88  Identities=23%  Similarity=0.204  Sum_probs=57.3

Q ss_pred             ccCCcEEEccCCCCCCCccccccCc-----cchhhhcccCcccccccchhhh-cccccccccccccccccCCCcccc---
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQL-----QTLQALGLTRNKLAGPITDELC-HLARLHSLVLQGNKFSGSIPSCLG---  408 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~---  408 (897)
                      +++|+.|+|++|.++......+...     ++|++|+|++|.++......+. .+++|++|+|++|+|+......++   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            4678899999999886544444433     6788888888888754444433 456777788888777644333332   


Q ss_pred             --cccccceeccccccccC
Q 045539          409 --NLTSLRVLYLGLNRFTS  425 (897)
Q Consensus       409 --~l~~L~~L~L~~N~l~~  425 (897)
                        ..++|+.|+|++|.++.
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~  169 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTA  169 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHH
T ss_pred             HhcCCccceeeCCCCCCCh
Confidence              34556666666666653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=6e-12  Score=132.07  Aligned_cols=147  Identities=16%  Similarity=0.133  Sum_probs=116.5

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEE
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  690 (897)
                      +....+.|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++.+.+..|+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3455678988888999999999999865 6899999987532222346889999999995 6778899999988889999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG-------------------------------------  733 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~-------------------------------------  733 (897)
                      ||||++|.++.+....      ......++.+++++++.||..                                     
T Consensus        88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876321      123347889999999999751                                     


Q ss_pred             -------------------CCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          734 -------------------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       734 -------------------h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                                         +..+++|||++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               11568999999999999876666799999765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.21  E-value=6.5e-11  Score=132.02  Aligned_cols=130  Identities=11%  Similarity=0.114  Sum_probs=63.9

Q ss_pred             ccccCCC-CCcEEeccCccccCCccccccccccccEEEeeecC---CCCCCCccccCccccccccccccccccccccccc
Q 045539          118 SSIFNMH-TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING---LSGEMPREIGNLPYLARLAFATNNLVGVAPVTIF  193 (897)
Q Consensus       118 ~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  193 (897)
                      .+|.++. .|+.+.+.++ ++.+...+|.++++|+.+.++.|.   ++..-...|.++.+|+.+.+..+ ++.+...+|.
T Consensus        57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence            3454442 3555555443 444445555555555555555543   33222344555555555555433 4455555566


Q ss_pred             ccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcc
Q 045539          194 NMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELG  253 (897)
Q Consensus       194 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  253 (897)
                      ++.+|+.+.+..+ +. .++...+....+|+.+.+..+ ++..-...|.+ .+|+.+.+.
T Consensus       135 ~c~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip  190 (394)
T 4gt6_A          135 HCEELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP  190 (394)
T ss_dssp             TCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred             hhcccccccccce-ee-eecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence            6666666666433 22 455555555555555555443 22222333332 445555544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.17  E-value=1.9e-10  Score=128.28  Aligned_cols=124  Identities=12%  Similarity=0.129  Sum_probs=89.9

Q ss_pred             cCCccccccccc-cccEEEeeecCCCCCCCccccCccccccccccccc---ccccccccccccccccccccccccccccC
Q 045539          137 FGSLSFFIFNVS-SVTTIDLSINGLSGEMPREIGNLPYLARLAFATNN---LVGVAPVTIFNMSALKEIYLLNNSLSGSL  212 (897)
Q Consensus       137 ~~~~~~~~~~l~-~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  212 (897)
                      +.+...+|.+++ .|+.+.+..+ ++..-...|.++++|+.+.+..|.   ++.+...+|.++.+|+.+.+.++ ++ .+
T Consensus        52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I  128 (394)
T 4gt6_A           52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EI  128 (394)
T ss_dssp             EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EE
T ss_pred             eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-ee
Confidence            344556777774 5899998754 664556778899999999988774   77788888999999998888755 44 67


Q ss_pred             CccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccc
Q 045539          213 PSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTF  265 (897)
Q Consensus       213 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f  265 (897)
                      +...+....+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.+...+|
T Consensus       129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF  179 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAF  179 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred             hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccc
Confidence            7777778888888888754 34455667788888888888654 443333333

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=6.9e-11  Score=123.76  Aligned_cols=139  Identities=15%  Similarity=0.099  Sum_probs=102.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCc--cceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN--LVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e  693 (897)
                      ...|.+....+.|..+.||++...+|+.+++|+....   ....+.+|+++++.+.+.+  +.+++++...++..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3445543333466679999998777889999997654   2245678999999986444  5668888888888999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH---------------------------------------  734 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h---------------------------------------  734 (897)
                      |++|.++.  ...    .+   ...++.++++.++.||...                                       
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99999884  211    12   2357788888888885321                                       


Q ss_pred             ----------------CCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          735 ----------------STPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       735 ----------------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                                      ..+++|||++|.||++++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998776677999998753

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.02  E-value=1.5e-12  Score=134.42  Aligned_cols=147  Identities=18%  Similarity=0.179  Sum_probs=82.1

Q ss_pred             CcceeeeEeeCCCCeEEEEEeec---ccccccCCC-CCCCCCCCceecccCccccCcCCc-cccCCCCCcE--EeccCcc
Q 045539           63 VCSWIGITCDVNSHRVIGLNISS---FNLQGTIPP-QLGNLSSLQTLDLSHNKLSGNIPS-SIFNMHTLKL--LYFSDNQ  135 (897)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~--L~Ls~N~  135 (897)
                      .|+|.|+.|+.+..+|+.+-..+   ..+.|.+++ .+..++.  .|...+|.-++.++- .|...+.|+.  ++++.|+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            69999999998777887666555   344555542 2222222  233334443333322 1444455554  5666664


Q ss_pred             cc---CCccccccccccccEEEeeecCCCC--CCCccccCcccccccccccccccccccccccccc--cccccccccccc
Q 045539          136 LF---GSLSFFIFNVSSVTTIDLSINGLSG--EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMS--ALKEIYLLNNSL  208 (897)
Q Consensus       136 l~---~~~~~~~~~l~~L~~LdLs~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l  208 (897)
                      ..   +..+....++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            32   2222223456677777777777775  3345556677777777777777665  1233333  666666666666


Q ss_pred             cccCC
Q 045539          209 SGSLP  213 (897)
Q Consensus       209 ~~~~p  213 (897)
                      .+.+|
T Consensus       233 ~~~~~  237 (267)
T 3rw6_A          233 CDTFR  237 (267)
T ss_dssp             GGGCS
T ss_pred             ccccC
Confidence            65554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=7.4e-11  Score=128.62  Aligned_cols=182  Identities=14%  Similarity=0.196  Sum_probs=127.7

Q ss_pred             CCeEEEEEeecccccc-c-------CCCCCCCCCCCceecccCcccc---------CcCCccccCCCCCcEEeccCcccc
Q 045539           75 SHRVIGLNISSFNLQG-T-------IPPQLGNLSSLQTLDLSHNKLS---------GNIPSSIFNMHTLKLLYFSDNQLF  137 (897)
Q Consensus        75 ~~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~Ls~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~  137 (897)
                      ..+|++|.+...+..| .       +..++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-.
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            4568888887666553 2       2455677899999999765431         234455678899999999988311


Q ss_pred             CCccccccccccccEEEeeecCCCCCCCcccc--Cccccccccccc--cccc------ccccccc--ccccccccccccc
Q 045539          138 GSLSFFIFNVSSVTTIDLSINGLSGEMPREIG--NLPYLARLAFAT--NNLV------GVAPVTI--FNMSALKEIYLLN  205 (897)
Q Consensus       138 ~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~--~l~~L~~L~L~~--N~l~------~~~~~~~--~~l~~L~~L~L~~  205 (897)
                       .++. + .+++|++|+|+.|.+.......+.  .+++|++|+|+.  |...      .+.+ .+  ..+++|++|+|++
T Consensus       186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~-~l~~~~~p~Lr~L~L~~  261 (362)
T 2ra8_A          186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP-LFSKDRFPNLKWLGIVD  261 (362)
T ss_dssp             -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG-GSCTTTCTTCCEEEEES
T ss_pred             -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH-HHhcCCCCCcCEEeCCC
Confidence             2222 3 388999999999987644334444  789999999863  2221      1111 22  3578999999999


Q ss_pred             ccccccCCcccc--ccccccceeeccccccccc----ccccccCCCcccEEEccccccccc
Q 045539          206 NSLSGSLPSRID--LSLPNVETLNLGINSFYGT----VPSSITNASKLSDLELGVNLFSGF  260 (897)
Q Consensus       206 N~l~~~~p~~~~--~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~  260 (897)
                      |.+++..+..++  ..+++|++|+|+.|.+.+.    ++..+.++++|+.|+|++|.++..
T Consensus       262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             CCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence            999854433332  2578999999999999874    455556789999999999988754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=6.1e-10  Score=119.36  Aligned_cols=185  Identities=17%  Similarity=0.177  Sum_probs=125.6

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCc--cceEeeeecCCC---ceEEEEEec
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRN--LVKIISSCSNDD---FKALIMKYM  695 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  695 (897)
                      .+.++.|....||++.    ..+++|+....  .....+.+|+++++.+. +..  +.+++.....++   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4668999999999873    56999986543  33467889999999884 322  455665554433   458999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG------------------------------------------  733 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~------------------------------------------  733 (897)
                      +|.++.+....   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988754332   367778888899999999888741                                          


Q ss_pred             -------------CCCCcEeCCCCCCCeeeCC--CCcEEEeeccCccccCCCCceeeeeccccCccc---CCcCccCC--
Q 045539          734 -------------HSTPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQLSIQIQTLATIGY---MAPEYGTK--  793 (897)
Q Consensus       734 -------------h~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~--  793 (897)
                                   ....++|+|++|.||++++  ...+.++||+.+..-.+.....      ....+   ..|+....  
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHHHHH
Confidence                         1145899999999999998  5568899999886543211100      00111   22221100  


Q ss_pred             ---C---------CCCccchHHHHHHHHHHHHcCCCCCcc
Q 045539          794 ---G---------RVCTRGDVYSYGIMLMEMFTKKKPTDE  821 (897)
Q Consensus       794 ---~---------~~~~~sDv~slGvil~elltg~~p~~~  821 (897)
                         +         ......+.|++|.++|++.+|+.+|-.
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence               0         011235899999999999999887643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=2e-09  Score=118.34  Aligned_cols=142  Identities=15%  Similarity=0.197  Sum_probs=108.0

Q ss_pred             cCCeeecccceEEEEEEecCCceEEEEEec--hhh-HHHHHHHHHHHHHHHhcC--CCccceEeeeecCC---CceEEEE
Q 045539          621 ENNLIGIGSFGSIYVARLQDGMEVAVKVFH--QQY-ERALKSFEDECEVMKRIR--HRNLVKIISSCSND---DFKALIM  692 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  692 (897)
                      ..+.++.|.++.||+++.. +..+++|+..  ... ......+.+|+++++.+.  +..++++++++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4577899999999999876 4678899876  332 122356788999999997  45688999988776   4589999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH--------------------------------------  734 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h--------------------------------------  734 (897)
                      ||++|..+.+...   ..++..++..++.+++++|+.||...                                      
T Consensus       121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999988754211   23678888999999999999998520                                      


Q ss_pred             -----------------CCCcEeCCCCCCCeeeCCCCc--EEEeeccCccc
Q 045539          735 -----------------STPIIHCDLKPSNVLLDEDMV--AHISDFGIAKL  766 (897)
Q Consensus       735 -----------------~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~  766 (897)
                                       ..+++|||++|.||+++.++.  +.++||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             357999999999999997753  68999998865

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.88  E-value=6e-10  Score=121.41  Aligned_cols=186  Identities=15%  Similarity=0.174  Sum_probs=128.9

Q ss_pred             CCCCceecccCccccC-c-------CCccccCCCCCcEEeccCcccc---------CCccccccccccccEEEeeecCCC
Q 045539           99 LSSLQTLDLSHNKLSG-N-------IPSSIFNMHTLKLLYFSDNQLF---------GSLSFFIFNVSSVTTIDLSINGLS  161 (897)
Q Consensus        99 l~~L~~L~Ls~n~l~~-~-------~p~~~~~l~~L~~L~Ls~N~l~---------~~~~~~~~~l~~L~~LdLs~N~l~  161 (897)
                      +..++.|.+......| .       +..++..+++|+.|.+.++...         +.+...+..+++|+.|+|++|.-.
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            3467778777655542 1       2344667899999999776431         235566778899999999998422


Q ss_pred             CCCCccccCccccccccccccccccccccccc--cccccccccccc--cccccc-----CCcccc-ccccccceeecccc
Q 045539          162 GEMPREIGNLPYLARLAFATNNLVGVAPVTIF--NMSALKEIYLLN--NSLSGS-----LPSRID-LSLPNVETLNLGIN  231 (897)
Q Consensus       162 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~~-~~l~~L~~L~L~~N  231 (897)
                       .++. +. +++|++|+|..+.+.......+.  .+++|++|+|+.  |...+.     +...+. ..+|+|++|+|++|
T Consensus       186 -~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~  262 (362)
T 2ra8_A          186 -SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA  262 (362)
T ss_dssp             -BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred             -eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence             3343 43 89999999999988765544454  789999999863  222222     111111 24799999999999


Q ss_pred             ccccccccccc---CCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCC
Q 045539          232 SFYGTVPSSIT---NASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDG  304 (897)
Q Consensus       232 ~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~  304 (897)
                      .+.+..+..+.   .+++|++|+|+.|.+.+.....+                 ...+.++++|+.|+|++|.++.
T Consensus       263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L-----------------~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL-----------------LDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             TTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHH-----------------HTTHHHHTTCSEEECCSBBCCH
T ss_pred             CCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHH-----------------HhhcccCCcceEEECCCCcCCH
Confidence            99765544443   58899999999999886543322                 1224567999999999998874

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.79  E-value=5.6e-08  Score=107.56  Aligned_cols=58  Identities=0%  Similarity=-0.069  Sum_probs=33.0

Q ss_pred             CCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee
Q 045539           96 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS  156 (897)
Q Consensus        96 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs  156 (897)
                      +..-.+|+.+.+.. .++..-..+|.++++|+.++|..+ +..+....|.++ +|+.+.+.
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~   99 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGM   99 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEEC
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECC
Confidence            34445666666653 354344556777777777777544 555555556555 45555544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.79  E-value=6.6e-08  Score=107.01  Aligned_cols=129  Identities=7%  Similarity=-0.002  Sum_probs=82.4

Q ss_pred             cccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccc
Q 045539          119 SIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL  198 (897)
Q Consensus       119 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  198 (897)
                      .+....+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++..-...|.+. +|+.+.+.. .++.+...+|.+. +|
T Consensus        41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DL  115 (379)
T ss_dssp             TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CC
T ss_pred             ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-Cc
Confidence            4666788999888754 66677788999999999999754 553334566665 577766654 3666666666654 68


Q ss_pred             cccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc
Q 045539          199 KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL  256 (897)
Q Consensus       199 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  256 (897)
                      +++.+.++ ++ .+....+.. .+++.+.+..+ ++......|.++.+++...+..+.
T Consensus       116 ~~i~lp~~-~~-~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~  169 (379)
T 4h09_A          116 DDFEFPGA-TT-EIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNN  169 (379)
T ss_dssp             SEEECCTT-CC-EECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTC
T ss_pred             ccccCCCc-cc-ccccccccc-ceeeeeeccce-eeccccchhccccccccccccccc
Confidence            88887654 22 444444433 34555555433 333445566667777777666544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.57  E-value=1.5e-09  Score=106.84  Aligned_cols=119  Identities=10%  Similarity=0.087  Sum_probs=76.5

Q ss_pred             cCCCCCCCCCCCceecccCc-cccC----cCCccccCCCCCcEEeccCccccCCc----cccccccccccEEEeeecCCC
Q 045539           91 TIPPQLGNLSSLQTLDLSHN-KLSG----NIPSSIFNMHTLKLLYFSDNQLFGSL----SFFIFNVSSVTTIDLSINGLS  161 (897)
Q Consensus        91 ~~~~~l~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~LdLs~N~l~  161 (897)
                      .+...+...++|++|+|++| .+..    .+...+...++|++|+|++|+|....    ...+...++|++|+|++|.|.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34455677888999999998 8863    24455667788999999999886533    344555577888888888877


Q ss_pred             CC----CCccccCccccccccc--ccccccccccc----ccccccccccccccccccc
Q 045539          162 GE----MPREIGNLPYLARLAF--ATNNLVGVAPV----TIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       162 ~~----~p~~l~~l~~L~~L~L--~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~  209 (897)
                      ..    +...+...+.|++|+|  ++|.|+.....    .+...++|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            42    2344555566777777  66666654322    2233355555555555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=1.2e-08  Score=105.21  Aligned_cols=61  Identities=20%  Similarity=0.248  Sum_probs=39.4

Q ss_pred             CcccccCCcccccccccCceecccCCCCCCCcC--CCcEEeccCCccCCCCch-------hhhhhcccceEe
Q 045539          464 IPITIGGLKNLQQMFLEYNRLEGSIPESFGDLS--SLEVLDLSKNKISGAIPA-------SLQKLLYLKHLN  526 (897)
Q Consensus       464 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~  526 (897)
                      +|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+++.+|.       .+..+++|+.||
T Consensus       188 l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          188 MSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             chhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            445556667777777777777653  3344444  777888888887766652       356677777765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=1.1e-06  Score=93.68  Aligned_cols=136  Identities=15%  Similarity=0.132  Sum_probs=99.2

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCC---ccceEeeeec-CCCceEEEEEeccC
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR---NLVKIISSCS-NDDFKALIMKYMPN  697 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  697 (897)
                      .+.++.|....||+.    |+.+++|+...  ......+.+|+++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999998    57899998643  23346788999999999742   3566777663 45678899999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG--------------------------------------------  733 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~--------------------------------------------  733 (897)
                      .++.+....   .++..+...++.++++.|+.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            988763221   145556666677777777666632                                            


Q ss_pred             -------------CCCCcEeCCCCCCCeeeCC---CCc-EEEeeccCccc
Q 045539          734 -------------HSTPIIHCDLKPSNVLLDE---DMV-AHISDFGIAKL  766 (897)
Q Consensus       734 -------------h~~~ivH~Dlkp~NIll~~---~~~-~kL~DFg~a~~  766 (897)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2335699999999999987   455 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.45  E-value=1.2e-06  Score=91.67  Aligned_cols=136  Identities=20%  Similarity=0.160  Sum_probs=100.3

Q ss_pred             Ceeecccce-EEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEEEeccCCC
Q 045539          623 NLIGIGSFG-SIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       623 ~~lg~G~~g-~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      +.+..|..+ .||+.... +++.+++|+-....   ...+.+|++.++.+. +--+.++++++.+++..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345556655 69998765 46789999876442   345778999998885 3347788999999999999999999998


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 045539          700 LENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG----------------------------------------------  733 (897)
Q Consensus       700 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~----------------------------------------------  733 (897)
                      +.+......     .....+..+++..|+.||..                                              
T Consensus       107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            877654321     23345667777777777631                                              


Q ss_pred             ---------CCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          734 ---------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       734 ---------h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                               +...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     122379999999999999887778999998753

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.26  E-value=7.6e-08  Score=94.52  Aligned_cols=94  Identities=20%  Similarity=0.233  Sum_probs=66.7

Q ss_pred             CccccCccCCcEEEccCC-CCCCC----ccccccCccchhhhcccCccccccc----chhhhcccccccccccccccccC
Q 045539          332 PQVVGNLGNLLVLELGGN-NLTEP----IPITFSQLQTLQALGLTRNKLAGPI----TDELCHLARLHSLVLQGNKFSGS  402 (897)
Q Consensus       332 p~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~  402 (897)
                      ...+...++|++|+|++| .++..    +...+...++|++|+|++|+|....    .+.+...++|++|+|++|.|+..
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            345677889999999999 88753    2344556678889999999887533    33444557788888888888743


Q ss_pred             ----CCcccccccccceecc--ccccccC
Q 045539          403 ----IPSCLGNLTSLRVLYL--GLNRFTS  425 (897)
Q Consensus       403 ----~p~~~~~l~~L~~L~L--~~N~l~~  425 (897)
                          +...+...++|++|+|  ++|.++.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence                3445566677788888  6777764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=1.2e-06  Score=95.79  Aligned_cols=81  Identities=7%  Similarity=0.072  Sum_probs=57.7

Q ss_pred             CCee-ecccceEEEEEEec-------CCceEEEEEechhhH---HHHHHHHHHHHHHHhcC-C--CccceEeeeecCC--
Q 045539          622 NNLI-GIGSFGSIYVARLQ-------DGMEVAVKVFHQQYE---RALKSFEDECEVMKRIR-H--RNLVKIISSCSND--  685 (897)
Q Consensus       622 ~~~l-g~G~~g~Vy~a~~~-------~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  685 (897)
                      .+.| +.|....+|+....       +++.+++|+......   .....+.+|+++++.+. +  -.+.+++.++.++  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998754       267899998754320   01245678888888885 3  3577888887665  


Q ss_pred             -CceEEEEEeccCCChhH
Q 045539          686 -DFKALIMKYMPNGSLEN  702 (897)
Q Consensus       686 -~~~~lv~e~~~~gsL~~  702 (897)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.02  E-value=1.5e-05  Score=88.53  Aligned_cols=75  Identities=12%  Similarity=0.099  Sum_probs=50.2

Q ss_pred             CCeeecccceEEEEEEec-CCceEEEEEechhhH-------HHHHHHHHHHHHHHhcCC--C-ccceEeeeecCCCceEE
Q 045539          622 NNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE-------RALKSFEDECEVMKRIRH--R-NLVKIISSCSNDDFKAL  690 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  690 (897)
                      .+.+|.|..+.||+++.. +++.|++|.......       ...+++..|+++++.+..  | .+++++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467899999999999754 468899998653211       123456779999988742  3 344666543  345689


Q ss_pred             EEEeccCC
Q 045539          691 IMKYMPNG  698 (897)
Q Consensus       691 v~e~~~~g  698 (897)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=2.2e-05  Score=85.08  Aligned_cols=138  Identities=14%  Similarity=0.142  Sum_probs=80.1

Q ss_pred             CeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC--CCccceEeee------ecCCCceEEEEEe
Q 045539          623 NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR--HRNLVKIISS------CSNDDFKALIMKY  694 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~------~~~~~~~~lv~e~  694 (897)
                      +.++.|..+.||++...+| .+++|+.....    ..+..|+++++.+.  .-.+++++..      ...++..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4466677899999987654 59999987532    23344555555553  1123444431      1345678899999


Q ss_pred             ccCCChh-----H---------hhhc--C----C-------CCCCHHHH-------------------------------
Q 045539          695 MPNGSLE-----N---------CLYS--G----T-------CMLDIFQR-------------------------------  716 (897)
Q Consensus       695 ~~~gsL~-----~---------~l~~--~----~-------~~~~~~~~-------------------------------  716 (897)
                      ++|.++.     +         .++.  .    .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987542     0         1111  0    0       00122110                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          717 LNIMIDVALALEYLHF----------GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       717 ~~i~~~i~~~L~~Lh~----------~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ..+..++..++++|+.          ....+++|||+++.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345566642          135789999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.83  E-value=8.5e-05  Score=78.79  Aligned_cols=136  Identities=13%  Similarity=0.103  Sum_probs=92.3

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC---CCccceEeeeecCCCceEEEEEeccCC
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR---HRNLVKIISSCSNDDFKALIMKYMPNG  698 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  698 (897)
                      .+.|+.|....+|+.... ++.+++|+....   ....+..|++.++.+.   ...++++++++..++..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999999864 678999987644   2456788999998884   356888999888888899999999987


Q ss_pred             ChhH-----------hhhcCCC---------------------CCCHHHHH---HHH----------------HHHHHHH
Q 045539          699 SLEN-----------CLYSGTC---------------------MLDIFQRL---NIM----------------IDVALAL  727 (897)
Q Consensus       699 sL~~-----------~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~L  727 (897)
                      .+..           .++....                     .-+|....   ++.                ..+...+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222110                     11343321   111                1112122


Q ss_pred             -HHHHh-cCCCCcEeCCCCCCCeeeCCCCcEEEeecc
Q 045539          728 -EYLHF-GHSTPIIHCDLKPSNVLLDEDMVAHISDFG  762 (897)
Q Consensus       728 -~~Lh~-~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg  762 (897)
                       ..|.. .....++|+|+.+.|++++.++ +.++||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23311 1256799999999999999887 8899974

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=3.3e-06  Score=80.64  Aligned_cols=59  Identities=5%  Similarity=0.019  Sum_probs=32.1

Q ss_pred             CCCceecccCccccCcCCccccCCCCCcEEeccCcc-ccCCcccccccc----ccccEEEeeec
Q 045539          100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQ-LFGSLSFFIFNV----SSVTTIDLSIN  158 (897)
Q Consensus       100 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~LdLs~N  158 (897)
                      -.|++|||+++.++..--..+.++++|++|+|++|. +++..-..++.+    ++|++|||++|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C  124 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC  124 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence            357777777776664434445666666666666663 443333333332    24555555554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.72  E-value=6.4e-06  Score=78.62  Aligned_cols=83  Identities=11%  Similarity=0.148  Sum_probs=46.1

Q ss_pred             CCcEEeccCccccCCccccccccccccEEEeeecC-CCCCCCccccCc----ccccccccccc-cccccccccccccccc
Q 045539          125 TLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING-LSGEMPREIGNL----PYLARLAFATN-NLVGVAPVTIFNMSAL  198 (897)
Q Consensus       125 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~-l~~~~p~~l~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~L  198 (897)
                      +|++|||+++.++...-..+.++++|++|+|++|. ++..--..++.+    ++|++|+|++| +|+...-..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            46666666666655555555566666666666663 443222234443    24666666665 3555444455566666


Q ss_pred             ccccccccc
Q 045539          199 KEIYLLNNS  207 (897)
Q Consensus       199 ~~L~L~~N~  207 (897)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.61  E-value=0.00016  Score=76.27  Aligned_cols=79  Identities=14%  Similarity=0.119  Sum_probs=58.4

Q ss_pred             CCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCC---CccceEeeeecCCCceEEEEEe
Q 045539          618 RFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRH---RNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      +....+.+|.|..+.||+.+..+|+.|++|+...........+..|++.|+.+..   -.+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            4455678999999999999999999999998764433333467889999998852   2355666543    24789999


Q ss_pred             ccCCCh
Q 045539          695 MPNGSL  700 (897)
Q Consensus       695 ~~~gsL  700 (897)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00014  Score=77.91  Aligned_cols=158  Identities=14%  Similarity=0.176  Sum_probs=91.0

Q ss_pred             ccCCHHHHHHHhcCCCcC-----CeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCc--cce
Q 045539          605 RRFSYHELLRATDRFSEN-----NLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN--LVK  677 (897)
Q Consensus       605 ~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  677 (897)
                      ..++.+++.....+|...     +.|+.|....+|+....+| .+++|+.....  ....+..|+++++.+....  +.+
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            345677777777777652     3466788899999987655 68899887531  1234556777777774222  333


Q ss_pred             Eeeee------cCCCceEEEEEeccCCChhH-----h---------hhcC--C--CC----CC---HHHHHH--------
Q 045539          678 IISSC------SNDDFKALIMKYMPNGSLEN-----C---------LYSG--T--CM----LD---IFQRLN--------  718 (897)
Q Consensus       678 l~~~~------~~~~~~~lv~e~~~~gsL~~-----~---------l~~~--~--~~----~~---~~~~~~--------  718 (897)
                      ++...      ...+..+++|+|++|..+..     +         ++..  .  ..    ..   |.....        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            43221      12356789999999865421     0         1110  0  00    11   111000        


Q ss_pred             ----HHHHHHHHHHHHHh----cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          719 ----IMIDVALALEYLHF----GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       719 ----i~~~i~~~L~~Lh~----~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                          +...+.+.++++..    ....+++|+|+.+.||+++++..+.++||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                01113344555532    124579999999999999887666899999765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.54  E-value=0.00018  Score=80.23  Aligned_cols=79  Identities=15%  Similarity=0.183  Sum_probs=49.4

Q ss_pred             CCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeecccc--CcccCCcCccCCC---CCCccchHHHHHHH
Q 045539          734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA--TIGYMAPEYGTKG---RVCTRGDVYSYGIM  808 (897)
Q Consensus       734 h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDv~slGvi  808 (897)
                      +...++|||++|.||+++.++ ++++||+.+..-.+.....   ...+  ...|.+|+.....   ......++.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG---AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH---HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH---HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence            578899999999999998776 9999999887532111000   0001  1345666543211   12234566688888


Q ss_pred             HHHHHcCC
Q 045539          809 LMEMFTKK  816 (897)
Q Consensus       809 l~elltg~  816 (897)
                      +|+.+++.
T Consensus       306 ~~~~y~~~  313 (420)
T 2pyw_A          306 TWNLFNKR  313 (420)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88877653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.44  E-value=0.00028  Score=76.01  Aligned_cols=140  Identities=11%  Similarity=0.081  Sum_probs=75.4

Q ss_pred             CeeecccceE-EEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-C-CccceEeeeecCCCceEEEEEeccCCC
Q 045539          623 NLIGIGSFGS-IYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-H-RNLVKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       623 ~~lg~G~~g~-Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      +.++.|+... +|+....+|+.+++|.......   ..+..|+++++.+. + -.+.+++.+..+.+  +++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565555554 6677654467788887554321   23345677777664 2 23566776644443  78999997766


Q ss_pred             hhHhhhcCC-------------------------CCCCHHHHH-------HH-------------HHHHHHHHHHHH---
Q 045539          700 LENCLYSGT-------------------------CMLDIFQRL-------NI-------------MIDVALALEYLH---  731 (897)
Q Consensus       700 L~~~l~~~~-------------------------~~~~~~~~~-------~i-------------~~~i~~~L~~Lh---  731 (897)
                      +.+++....                         ..++.....       .+             ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332110                         112211100       00             001111122221   


Q ss_pred             hcCCCCcEeCCCCCCCeeeCCC----CcEEEeeccCcccc
Q 045539          732 FGHSTPIIHCDLKPSNVLLDED----MVAHISDFGIAKLL  767 (897)
Q Consensus       732 ~~h~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~  767 (897)
                      ..+...++|||+.+.||+++.+    +.+.++||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1245689999999999999874    68999999988653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.39  E-value=0.00065  Score=72.89  Aligned_cols=159  Identities=11%  Similarity=0.105  Sum_probs=92.5

Q ss_pred             cccCCHHHHHHHhcCCCc-----CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCC--ccc
Q 045539          604 IRRFSYHELLRATDRFSE-----NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHR--NLV  676 (897)
Q Consensus       604 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv  676 (897)
                      ....+.+++....+.|..     .+.++ |....||++...+|+.+++|+..... .....+..|..+++.+...  .++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            344566666666665543     23466 88889999987778889999986431 1224566788888777522  244


Q ss_pred             eEeee-----ecCCCceEEEEEeccCCChh-----Hh---------hhc----C----CCCCCHHHH-------------
Q 045539          677 KIISS-----CSNDDFKALIMKYMPNGSLE-----NC---------LYS----G----TCMLDIFQR-------------  716 (897)
Q Consensus       677 ~l~~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~----~----~~~~~~~~~-------------  716 (897)
                      +++..     ...++..+++|||++|.++.     .+         ++.    .    ....++...             
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44443     12245568899999886542     11         110    0    011222211             


Q ss_pred             ---------HHHHHHHHHHHHHHHh-cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          717 ---------LNIMIDVALALEYLHF-GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       717 ---------~~i~~~i~~~L~~Lh~-~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                               ...+.+++..++.... .....++|||+++.||+++ + .+.++||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     0111122222222210 1356789999999999999 4 899999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.31  E-value=0.00054  Score=74.66  Aligned_cols=140  Identities=12%  Similarity=0.125  Sum_probs=85.0

Q ss_pred             CCeeecccceEEEEEEec--------CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          622 NNLIGIGSFGSIYVARLQ--------DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .+.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356778888999999865        2578999986432 122345568999998885 3334677777764    2999


Q ss_pred             EeccCCChhHh-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 045539          693 KYMPNGSLENC-----------------LYSGT----CMLD--IFQRLNIMIDVAL-------------------ALEYL  730 (897)
Q Consensus       693 e~~~~gsL~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~L~~L  730 (897)
                      ||++|.++..-                 ++.-.    ....  +.++.++..++..                   .++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998765321                 11111    1122  3445555544322                   12222


Q ss_pred             H-----hcCCCCcEeCCCCCCCeeeCCC----CcEEEeeccCccc
Q 045539          731 H-----FGHSTPIIHCDLKPSNVLLDED----MVAHISDFGIAKL  766 (897)
Q Consensus       731 h-----~~h~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~  766 (897)
                      .     ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     1234578999999999999876    7899999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.00066  Score=71.90  Aligned_cols=128  Identities=13%  Similarity=0.122  Sum_probs=77.1

Q ss_pred             CCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcc-ceEeeeecCCCceEEEEEec-cCCC
Q 045539          622 NNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL-VKIISSCSNDDFKALIMKYM-PNGS  699 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  699 (897)
                      .+.|+.|....+|++     +.+++|+........ ....+|+.+++.+....+ .++++++.  +..++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence            678999999999998     569999876532211 122468888877752222 56666543  3347899999 6655


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 045539          700 LENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-----------------------------------------------  732 (897)
Q Consensus       700 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----------------------------------------------  732 (897)
                      +...-...        ...+..++++.|+.+|.                                               
T Consensus        95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l  166 (301)
T 3dxq_A           95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL  166 (301)
T ss_dssp             CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred             CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence            53210000        00112222222222221                                               


Q ss_pred             ---cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          733 ---GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       733 ---~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                         .....++|+|+.|.||+ ..++.+.++||..+..
T Consensus       167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence               13345899999999999 5566789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.14  E-value=0.00051  Score=76.62  Aligned_cols=73  Identities=16%  Similarity=0.238  Sum_probs=50.8

Q ss_pred             CCeeecccceEEEEEEecC--------CceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          622 NNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .+.|+.|....||++...+        ++.|++|+......  ...+.+|..+++.+. +.-.+++++.+.+    .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4678889999999998753        57899999854211  134457888888885 3334677776653    3899


Q ss_pred             EeccCCCh
Q 045539          693 KYMPNGSL  700 (897)
Q Consensus       693 e~~~~gsL  700 (897)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.13  E-value=2.5e-05  Score=76.02  Aligned_cols=88  Identities=11%  Similarity=0.123  Sum_probs=54.3

Q ss_pred             CCCCCCCCCceecccCc-cccC----cCCccccCCCCCcEEeccCccccCCc----cccccccccccEEEeeecCCCCCC
Q 045539           94 PQLGNLSSLQTLDLSHN-KLSG----NIPSSIFNMHTLKLLYFSDNQLFGSL----SFFIFNVSSVTTIDLSINGLSGEM  164 (897)
Q Consensus        94 ~~l~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~LdLs~N~l~~~~  164 (897)
                      ..+.+-+.|++|+|++| +|..    .+-+.+..-+.|++|+|++|+|....    ...+..-+.|++|+|++|.|...-
T Consensus        35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G  114 (197)
T 1pgv_A           35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL  114 (197)
T ss_dssp             HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred             HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence            33455678888888885 7752    24455666678888888888886443    334445567788888888776422


Q ss_pred             C----ccccCccccccccccc
Q 045539          165 P----REIGNLPYLARLAFAT  181 (897)
Q Consensus       165 p----~~l~~l~~L~~L~L~~  181 (897)
                      -    ..+..-+.|++|+|++
T Consensus       115 a~ala~aL~~N~tL~~L~L~n  135 (197)
T 1pgv_A          115 LARLLRSTLVTQSIVEFKADN  135 (197)
T ss_dssp             HHHHHHHTTTTCCCSEEECCC
T ss_pred             HHHHHHHHhhCCceeEEECCC
Confidence            1    2233334455555553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.12  E-value=0.00074  Score=75.65  Aligned_cols=74  Identities=15%  Similarity=0.188  Sum_probs=49.4

Q ss_pred             CCeeecccceEEEEEEecC-CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcc-ceEeeeecCCCceEEEEEeccCCC
Q 045539          622 NNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL-VKIISSCSNDDFKALIMKYMPNGS  699 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  699 (897)
                      .+.|+.|-...+|++...+ ++.|++|+......... ...+|..+++.+...++ +++++++..    ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4678889999999998775 57899998754321111 11578899998874444 577777742    35999998865


Q ss_pred             h
Q 045539          700 L  700 (897)
Q Consensus       700 L  700 (897)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.83  E-value=0.0018  Score=70.65  Aligned_cols=74  Identities=14%  Similarity=0.226  Sum_probs=45.9

Q ss_pred             CCeeecccceEEEEEEecC---------CceEEEEEechhhHHHHHHHHHHHHHHHhcCCCc-cceEeeeecCCCceEEE
Q 045539          622 NNLIGIGSFGSIYVARLQD---------GMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN-LVKIISSCSNDDFKALI  691 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  691 (897)
                      .+.++.|....+|++...+         ++.+++|+........ .....|.++++.+...+ +.++++...    .++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3567888889999998654         2689999876532211 12357888888875323 456665542    3689


Q ss_pred             EEeccCCCh
Q 045539          692 MKYMPNGSL  700 (897)
Q Consensus       692 ~e~~~~gsL  700 (897)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.80  E-value=0.0018  Score=69.66  Aligned_cols=66  Identities=11%  Similarity=0.118  Sum_probs=43.7

Q ss_pred             ccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC---CCccceEeee------ecCCCceEEEEEeccCC
Q 045539          628 GSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR---HRNLVKIISS------CSNDDFKALIMKYMPNG  698 (897)
Q Consensus       628 G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~g  698 (897)
                      |....||+....+| .+++|+......      ..|+++++.+.   -|.+++.+..      ...++..+++|+|++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33689999988777 899998765431      34566666553   2324555432      23356789999999987


Q ss_pred             Ch
Q 045539          699 SL  700 (897)
Q Consensus       699 sL  700 (897)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.67  E-value=0.0019  Score=58.54  Aligned_cols=56  Identities=23%  Similarity=0.256  Sum_probs=37.4

Q ss_pred             cccccCceec-ccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCccc
Q 045539          476 QMFLEYNRLE-GSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLE  533 (897)
Q Consensus       476 ~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  533 (897)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4556666665 23554432  36788888888888555666777888888877777664

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.63  E-value=0.0058  Score=59.56  Aligned_cols=105  Identities=12%  Similarity=0.017  Sum_probs=70.7

Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeeee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQI  777 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~  777 (897)
                      -+|.+.+...+.++++++++.++.|.+.+|...-.  ++.-..+=+.|..|++..+|.+...+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            38999999988899999999999999999877621  11111333456889999999888764 1111            


Q ss_pred             ccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCc
Q 045539          778 QTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTD  820 (897)
Q Consensus       778 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~  820 (897)
                        .....+.|||... ...+.+.=|||+|+++|..+--..|-+
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence              0123466888753 355678899999999999998666543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.60  E-value=0.00022  Score=69.29  Aligned_cols=14  Identities=43%  Similarity=0.430  Sum_probs=6.8

Q ss_pred             cCCcEEEccCCCCC
Q 045539          339 GNLLVLELGGNNLT  352 (897)
Q Consensus       339 ~~L~~L~L~~N~l~  352 (897)
                      +.|++|+|++|.|+
T Consensus        98 ~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           98 PSLRVLNVESNFLT  111 (197)
T ss_dssp             SSCCEEECCSSBCC
T ss_pred             CccCeEecCCCcCC
Confidence            34445555555444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.48  E-value=0.003  Score=57.21  Aligned_cols=55  Identities=16%  Similarity=0.208  Sum_probs=31.7

Q ss_pred             EEEeeccccc-ccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccc
Q 045539           80 GLNISSFNLQ-GTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL  136 (897)
Q Consensus        80 ~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  136 (897)
                      .++-++++|+ ..+|..+.  .+|++|||++|+|+...+..|..+++|++|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            3555666665 34554332  3466666666666654455556666666666666644

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.50  E-value=0.035  Score=61.13  Aligned_cols=74  Identities=12%  Similarity=0.200  Sum_probs=49.7

Q ss_pred             CCeeecccceEEEEEEecC--------CceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          622 NNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      .+.+..|-...+|+....+        ++.|++|+........ -...+|.++++.+. +.-..++++.+.    .+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567788889999998763        5789999875432211 12256888888875 333456666443    27899


Q ss_pred             EeccCCCh
Q 045539          693 KYMPNGSL  700 (897)
Q Consensus       693 e~~~~gsL  700 (897)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.00  E-value=0.1  Score=57.36  Aligned_cols=30  Identities=27%  Similarity=0.375  Sum_probs=25.2

Q ss_pred             CcEeCCCCCCCeee------CCCCcEEEeeccCccc
Q 045539          737 PIIHCDLKPSNVLL------DEDMVAHISDFGIAKL  766 (897)
Q Consensus       737 ~ivH~Dlkp~NIll------~~~~~~kL~DFg~a~~  766 (897)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566899999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.64  E-value=1.9  Score=41.91  Aligned_cols=122  Identities=13%  Similarity=0.190  Sum_probs=80.5

Q ss_pred             CCCccceEeeeecCCCceEEEEEecc-CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCee
Q 045539          671 RHRNLVKIISSCSNDDFKALIMKYMP-NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVL  749 (897)
Q Consensus       671 ~h~niv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIl  749 (897)
                      .||+.++. .+-.+++.+.+.++.-+ +-++.. +    ...+...+++++..|+....++     ..=+|--++|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~-----~~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVN-----RTRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGG-----GSSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHh-----cCceEEEEecceEE
Confidence            48888866 45556665555555433 223333 2    2367889999999998877554     23478889999999


Q ss_pred             eCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCcc
Q 045539          750 LDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL  827 (897)
Q Consensus       750 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~  827 (897)
                      ++.++.+++.-.|....+                   +|.     ..+...=.-.+=+++..+++++..|++-..+..
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l  165 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL  165 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence            999999999877754322                   222     112222234567889999999999987655533

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	897
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-49
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-23
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.003
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-56
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 11/235 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRN 674
            + +    IG GSFG++Y  +     +VAVK+ +      + L++F++E  V+++ RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           ++  +   +     A++ ++    SL + L+      ++ + ++I    A  ++YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY---G 791
              IIH DLK +N+ L ED+   I DFG+A + S         Q   +I +MAPE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID 846
            K     + DVY++GI+L E+ T + P   I   +  +       L   + +V  
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (477), Expect = 4e-54
 Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 20/232 (8%)

Query: 604 IRRFSYHELLRATDRFSEN---------NLIGIGSFGSIYVARL----QDGMEVAVKVFH 650
           I  F++ +   A   F++           +IG G FG +    L    +  + VA+K   
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 651 QQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTC 709
             Y E+  + F  E  +M +  H N++ +    +      +I ++M NGSL++ L     
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 710 MLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 769
              + Q + ++  +A  ++YL   +    +H DL   N+L++ ++V  +SDFG+++ L  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 770 EDQLSIQIQTL---ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +         L     I + APE     +  +  DV+SYGI++ E+ +  + 
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 5e-52
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 9/206 (4%)

Query: 615 ATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRH 672
             D F + + +G G+ G ++       G+ +A K+ H +           E +V+     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             +V    +  +D   ++ M++M  GSL+  L      +       + I V   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR- 121

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
                I+H D+KPSN+L++      + DFG++  L      S     + T  YM+PE   
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQ 176

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                 + D++S G+ L+EM   + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-51
 Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 7/206 (3%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +       +G G FG +++       +VAVK   Q    +  +F  E  +MK+++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           ++ +  + +    +I +YM NGSL + L +     L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
              IH DL+ +N+L+ + +   I+DFG+A+L+  +++ + +      I + APE    G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 796 VCTRGDVYSYGIMLMEMFTKKKPTDE 821
              + DV+S+GI+L E+ T  +    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYP 212

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 5e-51
 Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 5/202 (2%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
              +    IG G FG +++    +  +VA+K   +    + + F +E EVM ++ H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++   C       L+ ++M +G L + L +   +      L + +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEA 120

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            +IH DL   N L+ E+ V  +SDFG+ + +  +DQ +    T   + + +PE  +  R 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
            ++ DV+S+G+++ E+F++ K 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI 201

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 6e-50
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 10/214 (4%)

Query: 611 ELLRATDRFS-ENNLIGIGSFGSIYVARLQ---DGMEVAVKVFHQQYERA-LKSFEDECE 665
           +L    D     +  +G G+FGS+     +     ++VA+KV  Q  E+A  +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 666 VMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           +M ++ +  +V++I  C  +    L+M+    G L   L      + +     ++  V++
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIG 784
            ++YL        +H DL   NVLL     A ISDFG++K L  +D            + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           + APE     +  +R DV+SYG+ + E  +  + 
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-49
 Identities = 55/223 (24%), Positives = 109/223 (48%), Gaps = 7/223 (3%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           +       +G G FG +++        VA+K        + ++F  E +VMK++RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIF-QRLNIMIDVALALEYLHFGHS 735
           ++ +  S +    ++ +YM  GSL + L   T       Q +++   +A  + Y+   + 
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGR 795
              +H DL+ +N+L+ E++V  ++DFG+A+L+  +++ + +      I + APE    GR
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 796 VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
              + DV+S+GI+L E+ TK +      +    L++       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-49
 Identities = 48/202 (23%), Positives = 97/202 (48%), Gaps = 5/202 (2%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
              +    +G G FG +   + +   +VA+K+  +    +   F +E +VM  + H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
           ++   C+      +I +YM NG L N L          Q L +  DV  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
             +H DL   N L+++  V  +SDFG+++ +  +D+ +  + +   + +  PE     + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 797 CTRGDVYSYGIMLMEMFTKKKP 818
            ++ D++++G+++ E+++  K 
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKM 200

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 5e-48
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
            D +     +G G+FG +Y A+  +  +  A KV   + E  L+ +  E +++    H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK++ +   ++   +++++   G+++  +      L   Q   +      AL YL   H
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---H 127

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY---- 790
              IIH DLK  N+L   D    ++DFG++   +   Q         T  +MAPE     
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCE 185

Query: 791 -GTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                    + DV+S GI L+EM   + P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (433), Expect = 5e-48
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 17/230 (7%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQ---QYERALKSFEDECEVMKRIR 671
              FS+   IG GSFG++Y AR +++   VA+K       Q     +    E   ++++R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H N ++       +    L+M+Y    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEY- 790
              S  +IH D+K  N+LL E  +  + DFG A +++  +        + T  +MAPE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVI 183

Query: 791 --GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
               +G+   + DV+S GI  +E+  +K P   +       +   N+   
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-48
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRI 670
           RA D +     IG GS+G     R   DG  +  K        E   +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 671 RHRNLVKIISSC--SNDDFKALIMKYMPNGSLENCLYSGT---CMLDIFQRLNIMIDVAL 725
           +H N+V+         +    ++M+Y   G L + +  GT     LD    L +M  + L
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 726 ALEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI 783
           AL+  H        ++H DLKP+NV LD      + DFG+A++L+ +   +       T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TP 178

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            YM+PE   +     + D++S G +L E+     P
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 8/204 (3%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRN 674
             +++    IG G+ G++Y A  +  G EVA++  + Q +   +   +E  VM+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +V  + S    D   ++M+Y+  GSL + +       D  Q   +  +   ALE+L   H
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFL---H 133

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
           S  +IH D+K  N+LL  D    ++DFG    ++ E      +    T  +MAPE  T+ 
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRK 191

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
               + D++S GIM +EM   + P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 11/204 (5%)

Query: 621 ENNLIGIGSFGSIYVARLQD---GMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNL 675
           E+  +G G+FG++     Q       VAVK+   +            E  VM+++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V++I  C  + +  L+M+    G L   L      +     + ++  V++ ++YL   + 
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE-DQLSIQIQTLATIGYMAPEYGTKG 794
              +H DL   NVLL     A ISDFG++K L  + +    Q      + + APE     
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
           +  ++ DV+S+G+++ E F+  + 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK 209

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-47
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 13/204 (6%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
                   IG G FG + +     G +VAVK      +   ++F  E  VM ++RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 677 KIISSCSNDDFK-ALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +++     +     ++ +YM  GSL + L S G  +L     L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
               +H DL   NVL+ ED VA +SDFG+ K  S     S Q      + + APE   + 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175

Query: 795 RVCTRGDVYSYGIMLMEMFTKKKP 818
           +  T+ DV+S+GI+L E+++  + 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV 199

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-47
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 7/238 (2%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRN 674
           + +     +G G++G + +A        VAVK+   +      ++ + E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK        + + L ++Y   G L + +      +           +   + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH--- 120

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKG 794
              I H D+KP N+LLDE     ISDFG+A +    ++  +  +   T+ Y+APE   + 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 795 RVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR 851
                  DV+S GI+L  M   + P D+        + W      ++  + ID+  L 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 4e-47
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 16/241 (6%)

Query: 618 RFSE-NNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHR 673
           RF + +  IG GSF ++Y     +  +EVA      +   +   + F++E E++K ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 674 NLVKIISSC----SNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           N+V+   S            L+ + M +G+L+  L      + I    +    +   L++
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQF 127

Query: 730 LHFGHSTPIIHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAP 788
           LH   + PIIH DLK  N+ +        I D G+A L       ++    + T  +MAP
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMAP 182

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTN 848
           E   + +     DVY++G+ ++EM T + P  E         R  + + P S  +V    
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 849 L 849
           +
Sbjct: 242 V 242

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-47
 Identities = 50/237 (21%), Positives = 103/237 (43%), Gaps = 10/237 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDG-----MEVAVKVFHQQY-ERALKSFEDECEVMKRI 670
              +   +IG G FG +Y   L+       + VA+K     Y E+    F  E  +M + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 671 RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYL 730
            H N++++    S      +I +YM NG+L+  L        + Q + ++  +A     +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA---AGM 123

Query: 731 HFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYMAPE 789
            +  +   +H DL   N+L++ ++V  +SDFG++++L  + + +         I + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID 846
             +  +  +  DV+S+GI++ E+ T  +           +    +     + M+   
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (422), Expect = 9e-47
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 7/216 (3%)

Query: 605 RRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQYERALKSFEDE 663
              +Y +        +  + +G G +G +Y    +   + VAVK   +     ++ F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 664 CEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-SGTCMLDIFQRLNIMID 722
             VMK I+H NLV+++  C+ +    +I ++M  G+L + L       +     L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLAT 782
           ++ A+EYL        IH DL   N L+ E+ +  ++DFG+++L++G D  +        
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 179

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           I + APE     +   + DV+++G++L E+ T    
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-46
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 8/209 (3%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKR 669
           +  + F    ++G GSF ++ +AR L    E A+K+  +++   E  +     E +VM R
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + H   VK+  +  +D+     + Y  NG L   +       D         ++  ALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           LH      IIH DLKP N+LL+EDM   I+DFG AK+LS E + +     + T  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 790 YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
             T+   C   D+++ G ++ ++     P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-46
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 12/206 (5%)

Query: 617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F     +G G FG++Y+AR  Q    +A+KV  +              E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
            N++++     +     LI++Y P G++   L   +   D  +    + ++A AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +IH D+KP N+LL       I+DFG +       + ++      T+ Y+ PE   
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                 + D++S G++  E    K P
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP 203

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (420), Expect = 8e-46
 Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 9/205 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D +  +  +G G+FG ++       G   A K     +E   ++   E + M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           V +  +  +D+   +I ++M  G L   +      +   + +  M  V   L ++H  + 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144

Query: 736 TPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
              +H DLKP N++          + DFG+   L  +  + +   T     + APE    
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG 199

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
             V    D++S G++   + +   P
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP 224

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 66/269 (24%), Positives = 108/269 (40%), Gaps = 22/269 (8%)

Query: 625 IGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN 684
           IG G FG ++  +   G EVAVK+F  + ER+    E E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 685 DDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH-----FGHS 735
           D+       L+  Y  +GSL + L   T  + +   + + +  A  L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 736 TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLA-TIGYMAPEY--- 790
             I H DLK  N+L+ ++    I+D G+A    S  D + I       T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 791 ---GTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVM-EVID 846
                      R D+Y+ G++  E+  +          +L     +     V  M +V+ 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 847 TNLLRGEERFFAAKEQILLSVLNLATECT 875
              LR          + L  +  +  EC 
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECW 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-45
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 33/232 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQD------GMEVAVKVFHQQY-ERALKSFEDECEVMKR 669
           +      ++G G+FG +  A           ++VAVK+  ++      ++   E ++M +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 670 I-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS---------------------- 706
           +  H N+V ++ +C+      LI +Y   G L N L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
              +L     L     VA  +E+L        +H DL   NVL+    V  I DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +  +    ++      + +MAPE   +G    + DV+SYGI+L E+F+    
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 6e-45
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 33/232 (14%)

Query: 617 DRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKR 669
           +       IG G+FG ++ AR       +    VAVK+  ++        F+ E  +M  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYS----------------------- 706
             + N+VK++  C+      L+ +YM  G L   L S                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 707 GTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 766
           G   L   ++L I   VA  + YL        +H DL   N L+ E+MV  I+DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 767 LSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +   D           I +M PE     R  T  DV++YG++L E+F+    
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-44
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 11/214 (5%)

Query: 611 ELLRATDRFSENNLIGIGSFGSIYVARLQD-----GMEVAVKVFHQ-QYERALKSFEDEC 664
            +L+ T+ F +  ++G G+FG++Y            + VA+K   +    +A K   DE 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 665 EVMKRIRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVA 724
            VM  + + ++ +++  C     + LI + MP G L + +      +     LN  + +A
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 725 LALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIG 784
             + YL       ++H DL   NVL+       I+DFG+AKLL  E++          I 
Sbjct: 122 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 785 YMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +MA E         + DV+SYG+ + E+ T    
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (411), Expect = 2e-44
 Identities = 42/205 (20%), Positives = 91/205 (44%), Gaps = 9/205 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           D +     +G G+FG ++       G     K  +  Y     + ++E  +M ++ H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           + +  +  +     LI++++  G L + + +    +   + +N M      L+++   H 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145

Query: 736 TPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
             I+H D+KP N++ +  +     I DFG+A  L+ ++ +     T AT  + APE   +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDR 202

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
             V    D+++ G++   + +   P
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 57/246 (23%), Positives = 111/246 (45%), Gaps = 15/246 (6%)

Query: 600 SPQAIRRFSYHELLRATDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-E 654
           +P+ ++   +  +  ++     N +IG G FG +Y   L D     +  AVK  ++    
Sbjct: 10  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69

Query: 655 RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA-LIMKYMPNGSLENCLYSGTCMLDI 713
             +  F  E  +MK   H N++ ++  C   +    +++ YM +G L N + + T    +
Sbjct: 70  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 129

Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
              +   + VA  +    F  S   +H DL   N +LDE     ++DFG+A+ +  ++  
Sbjct: 130 KDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 774 SIQIQT--LATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
           S+  +T     + +MA E     +  T+ DV+S+G++L E+ T+  P       +++   
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFD 242

Query: 832 WINDLL 837
               LL
Sbjct: 243 ITVYLL 248

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-43
 Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 28/260 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQ-QYERALKSFEDECEVMKR 669
           +R S    +G G+FG +  A           M VAVK+     +    ++   E +V+  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 670 I-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY-----------------SGTCML 711
           +  H N+V ++ +C+      +I +Y   G L N L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
           D+   L+    VA  + +L    S   IH DL   N+LL    +  I DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNR 831
              ++      + +MAPE           DV+SYGI L E+F+           +    +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 832 WINDLLPVSVMEVIDTNLLR 851
            I +   +   E     +  
Sbjct: 260 MIKEGFRMLSPEHAPAEMYD 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 7e-43
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 10/207 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIR 671
           +R      IG G FG ++           + VA+K       +   + F  E   M++  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H ++VK+I   + ++   +IM+    G L + L      LD+   +     ++ AL YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
              S   +H D+   NVL+  +    + DFG+++ +            L  I +MAPE  
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 181

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              R  +  DV+ +G+ + E+      
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVK 208

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 26/222 (11%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDG---MEVAVKVFHQQYER-ALKSFEDECEVMKRI-R 671
           +     ++IG G+FG +  AR++     M+ A+K   +   +   + F  E EV+ ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM---------------LDIFQR 716
           H N++ ++ +C +  +  L ++Y P+G+L + L     +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 717 LNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ 776
           L+   DVA  ++YL        IH DL   N+L+ E+ VA I+DFG+++      + +  
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-- 184

Query: 777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                 + +MA E        T  DV+SYG++L E+ +    
Sbjct: 185 -MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (386), Expect = 4e-42
 Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 25/275 (9%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIR 671
           +DR+    ++G G    +++AR L+   +VAVKV              F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 672 HRNLVKIISSCSNDDFKA----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           H  +V +  +   +        ++M+Y+   +L + +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-TIGYM 786
            + H      IIH D+KP+N+++       + DFGIA+ ++       Q   +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 787 APEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP---------TDEIFIGELSLNRWINDLL 837
           +PE      V  R DVYS G +L E+ T + P           +    +       ++ L
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 838 PVSVMEVIDTNL-LRGEERFFAAKE--QILLSVLN 869
              +  V+   L    E R+  A E    L+ V N
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-42
 Identities = 52/210 (24%), Positives = 78/210 (37%), Gaps = 12/210 (5%)

Query: 617 DRFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQQY---ERALKSFEDECEVMKR 669
                   +G GSFG +            + VAVK           A+  F  E   M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           + HRNL+++         K ++ +  P GSL + L        +       + VA  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAP 788
           L    S   IH DL   N+LL    +  I DFG+ + L   +D   +Q        + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 789 EYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           E           D + +G+ L EMFT  + 
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 53/238 (22%), Positives = 100/238 (42%), Gaps = 19/238 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKR 669
           ++ + +  +G GSFG +Y          +    VA+K  ++    R    F +E  VMK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLY---------SGTCMLDIFQRLNIM 720
               ++V+++   S      +IM+ M  G L++ L                 + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 721 IDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            ++A  + YL+   +   +H DL   N ++ ED    I DFG+ + +   D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP 838
             + +M+PE    G   T  DV+S+G++L E+ T  +   +    E  L   +   L 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (371), Expect = 1e-39
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 623 NLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKI 678
             +G GSFG +++ R   +G   A+KV  ++     + ++   DE  ++  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 679 ISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPI 738
             +  +     +IM Y+  G L + L                 +V LALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 739 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCT 798
           I+ DLKP N+LLD++    I+DFG AK +                 Y+APE  +      
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT-----PDYIAPEVVSTKPYNK 180

Query: 799 RGDVYSYGIMLMEMFTKKKP 818
             D +S+GI++ EM     P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 28/227 (12%)

Query: 617 DRFSENNLIGIGSFGSIYVARL--------QDGMEVAVKVFHQQY-ERALKSFEDECEVM 667
           DR      +G G+FG + +A              +VAVK+      E+ L     E E+M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 668 KRI-RHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCM---------------L 711
           K I +H+N++ ++ +C+ D    +I++Y   G+L   L +                   L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 712 DIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 771
                ++    VA  +EYL    S   IH DL   NVL+ ED V  I+DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                      + +MAPE         + DV+S+G++L E+FT    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 6/205 (2%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHR 673
            D +   +++G G+F  + +A   +    VA+K   ++  E    S E+E  V+ +I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+V +     +     LIM+ +  G L + +              ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
                           LDED    ISDFG++K+      LS    T    GY+APE   +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP---GYVAPEVLAQ 183

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
                  D +S G++   +     P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 57/258 (22%), Positives = 107/258 (41%), Gaps = 16/258 (6%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKR-IR 671
           + F  + ++G GSFG +++A   +     A+K   +     +  ++    E  V+     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
           H  L  +  +    +    +M+Y+  G L   + S     D+ +      ++ L L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
                 I++ DLK  N+LLD+D    I+DFG+ K     D  +       T  Y+APE  
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175

Query: 792 TKGRVCTRGDVYSYGIMLMEMFTKKKP-----TDEIFIGELSLNRWINDLLPVSVMEVID 846
              +     D +S+G++L EM   + P      +E+F      N +    L     +++ 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235

Query: 847 TNLLRGEERFFAAKEQIL 864
              +R  E+    +  I 
Sbjct: 236 KLFVREPEKRLGVRGDIR 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (371), Expect = 4e-39
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 16/213 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH------QQYERALKSFEDECEVMKR 669
           + FS + +IG G FG +Y  R    G   A+K         +Q E    +      ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
                +V +  +    D  + I+  M  G L   L       +         ++ L LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE 789
           +H   +  +++ DLKP+N+LLDE     ISD G+A   S          ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPE 175

Query: 790 YGTKGRVCT-RGDVYSYGIMLMEMFTKKKPTDE 821
              KG       D +S G ML ++     P  +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-39
 Identities = 40/205 (19%), Positives = 83/205 (40%), Gaps = 10/205 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
           +++     +G G FG ++             K    +        + E  ++   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           + +  S  + +   +I +++    +   + +    L+  + ++ +  V  AL++L   HS
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HS 120

Query: 736 TPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
             I H D++P N++      +   I +FG A+ L   D   +         Y APE    
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQH 177

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
             V T  D++S G ++  + +   P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 44/216 (20%), Positives = 86/216 (39%), Gaps = 18/216 (8%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH---------QQYERALKSFEDECEV 666
           + +    ++G G    +          E AVK+           ++ +   ++   E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 667 MKRIR-HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVAL 725
           ++++  H N++++  +   + F  L+   M  G L + L      L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121

Query: 726 ALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT---LAT 782
            +  LH      I+H DLKP N+LLD+DM   ++DFG +  L   ++L     T   LA 
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 783 IGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
                             D++S G+++  +     P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 9/209 (4%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQ-QYERALKSFEDECEVMKRIRHR 673
             R++  + IG G++G +  A    + + VA+K     +++   +    E +++ R RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYS--GTCMLDIFQRLNIMIDVALALEYLH 731
           N++ I         + +   Y+    +   LY    T  L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 732 FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSIQIQTLATIGYMAPEY 790
              S  ++H DLKPSN+LL+      I DFG+A++     D      + +AT  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 791 GTKGRVCTR-GDVYSYGIMLMEMFTKKKP 818
               +  T+  D++S G +L EM + +  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 14/224 (6%)

Query: 613 LRATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR 671
           LR  +R+     IG GSFG IY+   +  G EVA+K+   + +        E ++ K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60

Query: 672 HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLH 731
               +  I  C  +    +++  +   SLE+     +    +   L +   +   +EY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 732 FGHSTPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA-----TI 783
             +    IH D+KP N L     +  + +I DFG+AK                     T 
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 784 GYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL 827
            Y +           R D+ S G +LM       P   +     
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 7e-37
 Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 18/213 (8%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH------QQYERALKSFEDECEVMKR 669
           D +     +G G F  +   R    G++ A K          +   + +  E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 670 IRHRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEY 729
           I+H N++ +     N     LI++ +  G L + L     + +       +  +      
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-ATEFLKQILNG--- 125

Query: 730 LHFGHSTPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSIQIQTLATIGY 785
           +++ HS  I H DLKP N++L +  V      I DFG+A  +   ++         T  +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEF 182

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           +APE      +    D++S G++   + +   P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 9/206 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
           + F +   IG G++G +Y AR    G  VA+K      + E    +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+VK++     ++   L+ +++     +    S    + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGT 792
            S  ++H DLKP N+L++ +    ++DFG+A+      +       + T+ Y APE    
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                T  D++S G +  EM T++  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 9/205 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHRN 674
           +++     IG G++G +Y A+   G   A+K     ++ E    +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 675 LVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGH 734
           +VK+           L+ +++ +  L+  L      L+     + ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 735 STPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPE-YGTK 793
              ++H DLKP N+L++ +    I+DFG+A+      +       + T+ Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGS 175

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  T  D++S G +  EM      
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 3e-36
 Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 21/235 (8%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY------ERALKSFEDECEVMKR 669
            ++    L+G G FGS+Y    + D + VA+K   +                 E  ++K+
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 670 IR--HRNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           +      +++++      D   LI++            +    L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
            +    H+  ++H D+K  N+L+D +     + DFG   LL              T  Y 
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYS 176

Query: 787 APEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP---TDEIFIGELSLNRWINDLL 837
            PE+    R   R   V+S GI+L +M     P    +EI  G++   + ++   
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-35
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 623 NLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY-----ERALKSFEDECEVMKRIRHRNLV 676
           + +G G F ++Y AR       VA+K     +     +   ++   E ++++ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 677 KIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHST 736
            ++ +  +    +L+  +M        +   + +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 737 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV 796
            I+H DLKP+N+LLDE+ V  ++DFG+AK     ++       + T  Y APE     R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177

Query: 797 CT-RGDVYSYGIMLMEMFTKKKP 818
                D+++ G +L E+  +   
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 42/205 (20%), Positives = 83/205 (40%), Gaps = 21/205 (10%)

Query: 624 LIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISS 681
           ++G+G  G +      +   + A+K+              E E+  R  +  ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 682 C----SNDDFKALIMKYMPNGSLENCLYS-GTCMLDIFQRLNIMIDVALALEYLHFGHST 736
                +      ++M+ +  G L + +   G       +   IM  +  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 737 PIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
            I H D+KP N+L      + +  ++DFG AK  +  +          T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187

Query: 794 GRVCTRGDVYSYGIMLMEMFTKKKP 818
            +     D++S G+++  +     P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 7e-35
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 18/217 (8%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR--LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKR 669
           RA  ++     IG G++G ++ AR     G  VA+K    Q   E    S   E  V++ 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 670 I---RHRNLVKIISSCSNDDFKA-----LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           +    H N+V++   C+           L+ +++               +      ++M 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLA 781
            +   L++LH   S  ++H DLKP N+L+       ++DFG+A++ S +  L+  + TL 
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL- 179

Query: 782 TIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
              Y APE   +    T  D++S G +  EMF +K  
Sbjct: 180 --WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-34
 Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 27/259 (10%)

Query: 617 DRFSENNLIGIGSFGSIYVAR------LQDGMEVAVKVFHQQY-ERALKSFEDECEVMKR 669
           DR      +G G+FG +  A             VAVK+  +       ++   E +++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 670 IRHRNLVKII--SSCSNDDFKALIMKYMPNGSLENCLYS---------------GTCMLD 712
           I H   V  +  +         +I+++   G+L   L S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 713 IFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 772
           +   +     VA  +E+L    S   IH DL   N+LL E  V  I DFG+A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW 832
              +      + +MAPE         + DV+S+G++L E+F+           +    R 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 833 INDLLPVSVMEVIDTNLLR 851
           + +   +   +     + +
Sbjct: 250 LKEGTRMRAPDYTTPEMYQ 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 10/206 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           + F    L+G G+FG + + R    G   A+K+  ++    +  +     E  V++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             L  +  +    D    +M+Y   G L   L     +    +      ++  AL    +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSAL---EY 120

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
            HS  +++ D+K  N++LD+D    I+DFG+ K    +           T  Y+APE   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLE 178

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP 818
                   D +  G+++ EM   + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-34
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 21/213 (9%)

Query: 617 DRFSENNLIGIGSFGSIYVARL-QDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
             +++  +IG GSFG +Y A+L   G  VA+K   Q           E ++M+++ H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75

Query: 676 VKIISSC------SNDDFKALIMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALAL 727
           V++           ++ +  L++ Y+P        +       L +      M  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSIQIQTLATIGYM 786
            Y+H   S  I H D+KP N+LLD D  V  + DFG AK L   +     +  + +  Y 
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYR 189

Query: 787 APEYGTKGRVCTRG-DVYSYGIMLMEMFTKKKP 818
           APE        T   DV+S G +L E+   +  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 35/211 (16%), Positives = 69/211 (32%), Gaps = 16/211 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL 675
             +     IG GSFG I+    L +  +VA+K   ++ +       DE    K +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 676 VKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS 735
           +  +     +    +++  +   SLE+ L        +         +   ++ +   H 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HE 119

Query: 736 TPIIHCDLKPSNVLLDEDMVAH-----ISDFGIAKLLSGEDQLSIQIQTLA-----TIGY 785
             +++ D+KP N L+      +     + DFG+ K                     T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 786 MAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK 816
           M+           R D+ + G + M      
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGS 210

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 38/206 (18%), Positives = 91/206 (44%), Gaps = 10/206 (4%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRIRHR 673
            ++ +   IG G++G+++ A+  +    VA+K        E    S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 674 NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG 733
           N+V++     +D    L+ ++      +        + D     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120

Query: 734 HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTK 793
           +   ++H DLKP N+L++ +    +++FG+A+      +       + T+ Y  P+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175

Query: 794 GRVCTRG-DVYSYGIMLMEMFTKKKP 818
            ++ +   D++S G +  E+    +P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRP 201

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (328), Expect = 1e-33
 Identities = 54/261 (20%), Positives = 105/261 (40%), Gaps = 22/261 (8%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRH 672
           D+F     +G GSFG + + +  + G   A+K+  +Q     + ++   +E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 673 RNLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
             LVK+  S  ++    ++M+Y+  G + + L                  + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 733 GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGT 792
             S  +I+ DLKP N+L+D+     ++DFG AK + G            T   +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEALAPEIIL 211

Query: 793 KGRVCTRGDVYSYGIMLMEMFTKKKP---------TDEIFIGELSLNRWINDLLPVSVME 843
                   D ++ G+++ EM     P          ++I  G++      +  L   +  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

Query: 844 VIDTNLLRGEERFFAAKEQIL 864
           ++  +L +           I 
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIK 292

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-33
 Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 18/219 (8%)

Query: 614 RATDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFH--QQYERALKSFEDECEVMKRI 670
               ++ +   IG G+FG ++ AR  + G +VA+K      + E    +   E ++++ +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 671 RHRNLVKIISSCSNDDFKA--------LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMID 722
           +H N+V +I  C               L+  +  +               + +   +M  
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 125

Query: 723 VALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQT--L 780
           +   L  L++ H   I+H D+K +NVL+  D V  ++DFG+A+  S          T  +
Sbjct: 126 L---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 781 ATIGYMAPEYGTKGRVCT-RGDVYSYGIMLMEMFTKKKP 818
            T+ Y  PE     R      D++  G ++ EM+T+   
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVARL----QDGMEVAVKVFHQ----QYERALKSFEDECEVMK 668
           + F    ++G G++G +++ R       G   A+KV  +    Q  +  +    E +V++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 669 RIRHR-NLVKIISSCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            IR    LV +  +   +    LI+ Y+  G L   L       +      + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
             L   H   II+ D+K  N+LLD +    ++DFG++K    ++          TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMA 198

Query: 788 PE--YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           P+   G         D +S G+++ E+ T   P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 50/246 (20%), Positives = 106/246 (43%), Gaps = 19/246 (7%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRN 674
           D +     +G G +  ++ A  + +  +V VK+     +   K  + E ++++ +R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91

Query: 675 LVKIISSCSNDDFK--ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF 732
           ++ +     +   +  AL+ +++ N   +    +    L  +     M ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 733 GHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYG 791
             S  I+H D+KP NV++D E     + D+G+A+      + ++++ +     +  PE  
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELL 201

Query: 792 TKGRVCTRG-DVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL 850
              ++     D++S G ML  M  +K+P          L R    L    + + ID   +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 851 RGEERF 856
             + RF
Sbjct: 262 ELDPRF 267

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-29
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 25/226 (11%)

Query: 607 FSYHELLRAT----DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKS 659
           F   E+ +        + +   +G G++G++  A   + G +VA+K  ++ +  E   K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 660 FEDECEVMKRIRHRNLVKIISSCSNDDFKA------LIMKYMPNGSLENCLYSGTCMLDI 713
              E  ++K +RH N++ ++   + D+         L+M +M     +   +     L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGE 120

Query: 714 FQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 773
            +   ++  +   L Y+H   +  IIH DLKP N+ ++ED    I DFG+A+    E   
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177

Query: 774 SIQIQTLATIGYMAPE-YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
            +  +      Y APE      R     D++S G ++ EM T K  
Sbjct: 178 YVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 9e-29
 Identities = 46/247 (18%), Positives = 97/247 (39%), Gaps = 24/247 (9%)

Query: 618 RFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV 676
           R+     +G G F ++++A+ + +   VA+K+     +   ++ EDE ++++R+   +  
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72

Query: 677 KIISSCSNDDFK---------------ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMI 721
           K  S  +N   K                ++ + +    L          + +     I  
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 722 DVALALEYLHFGHSTPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSIQIQTL 780
            + L L+Y+H      IIH D+KP NVL++  D   ++    IA L +          ++
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 781 ATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVS 840
            T  Y +PE           D++S   ++ E+ T        F  +   +   +D     
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQ 246

Query: 841 VMEVIDT 847
           ++E++  
Sbjct: 247 IIELLGE 253

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-28
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 19/211 (9%)

Query: 617 DRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHR 673
            R+     IG G+ G +  A        VA+K   + +  +   K    E  +MK + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 674 NLVKIISSCSNDDFK------ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
           N++ +++  +            L+M+ M     +         LD  +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGI 132

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           ++LH   S  IIH DLKPSN+++  D    I DFG+A+       ++  +    T  Y A
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRA 186

Query: 788 PEYGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE           D++S G ++ EM   K  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 3e-28
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 19/212 (8%)

Query: 616 TDRFSENNLIGIGSFGSIYVAR-LQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRH 672
            +R+   + +G G++GS+  A   + G+ VAVK   + +      K    E  ++K ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 673 RNLVKIISSCS-----NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALAL 727
            N++ ++   +      +     ++ ++    L N +              ++  +   L
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHVQFLIYQILRGL 134

Query: 728 EYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMA 787
           +Y+   HS  IIH DLKPSN+ ++ED    I DFG+A+    E         +AT  Y A
Sbjct: 135 KYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186

Query: 788 PE-YGTKGRVCTRGDVYSYGIMLMEMFTKKKP 818
           PE            D++S G ++ E+ T +  
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  100 bits (249), Expect = 1e-23
 Identities = 75/350 (21%), Positives = 120/350 (34%), Gaps = 59/350 (16%)

Query: 33  TDQQALLALKAHISYDHTNLFARNWTSSTSVC--SWIGITCDVNS--HRVIGLNISSFNL 88
            D+QALL +K  +    T     +W  +T  C  +W+G+ CD ++  +RV  L++S  NL
Sbjct: 6   QDKQALLQIKKDLGNPTT---LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 89  QG--TIPPQLGNLSSLQTLDLSHN-KLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIF 145
                IP  L NL  L  L +     L G IP +I  +  L                   
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH------------------ 104

Query: 146 NVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLN 205
                  + ++   +SG +P  +  +  L  L F+ N L G  P +I ++  L  I    
Sbjct: 105 ------YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 206 NSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTF 265
           N +SG++P           ++ +  N   G +P +  N +          L         
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 266 VNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNC 325
            +     +  +   L+F        K                            + + N 
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNL------------------------NGLDLRNN 254

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
            I G +PQ +  L  L  L +  NNL   IP     LQ         NK 
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.6 bits (192), Expect = 3e-16
 Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 16/275 (5%)

Query: 284 SSLTNCKKLKVLILTGNPLDGI--LPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNL 341
            + T   ++  L L+G  L     +P S  NL     + +    ++ G IP  +  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 342 LVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 401
             L +   N++  IP   SQ++TL  L  + N L+G +   +  L  L  +   GN+ SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
           +IP   G+ + L           +      +   ++ F+D+S N L     + F  +   
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN- 222

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLY 521
                         Q                G   +L  LDL  N+I G +P  L +L +
Sbjct: 223 -------------TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 522 LKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
           L  LN+SFN L GEIP+GG        ++  N+ L
Sbjct: 270 LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 4e-10
 Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 28/286 (9%)

Query: 146 NVSSVTTIDLSINGLSG--EMPREIGNLPYLARLAFATN-NLVGVAPVTIFNMSALKEIY 202
               V  +DLS   L     +P  + NLPYL  L      NLVG  P  I  ++ L  +Y
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 203 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIP 262
           + + ++SG+        +  + TL+   N+  GT+P SI++   L  +    N  SG IP
Sbjct: 108 ITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 263 NTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILM 322
           +++ +                      K    + ++ N L G +P +  NL+L+   +  
Sbjct: 167 DSYGSF--------------------SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR 206

Query: 323 DNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDE 382
           +      ++          + L                 L  L    L  N++ G +   
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD---LRNNRIYGTLPQG 263

Query: 383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALP 428
           L  L  LHSL +  N   G IP   GNL    V     N+     P
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 50/255 (19%), Positives = 91/255 (35%), Gaps = 8/255 (3%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLS-LPNVETLNL-GINSFYGTVPSSITNASKLSDLELGVN 255
           +  + L   +L    P    L+ LP +  L + GIN+  G +P +I   ++L  L +   
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 256 LFSGFIPNTFVNMAD---NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGN 312
             SG IP+    +        + +    +   S+++   L  +   GN + G +P S G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 313 LSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTR 372
            S     + +    ++G IP    NL    V         +   +  S   T +      
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 373 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIW 432
           +         L        L  + N+  G++P  L  L  L  L +  N     +P    
Sbjct: 232 SLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288

Query: 433 NLKDILFIDVSSNSL 447
           NL+       ++N  
Sbjct: 289 NLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSIN- 158
            +L  LDL +N++ G +P  +  +  L  L  S N L G +     N+        + N 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302

Query: 159 GLSG 162
            L G
Sbjct: 303 CLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 64/279 (22%), Positives = 89/279 (31%), Gaps = 22/279 (7%)

Query: 217 DLSLPNVETLNLGINSFYG--TVPSSITNASKLSDLELG--VNLFSGFIPNTFVN--MAD 270
           D     V  L+L   +      +PSS+ N   L+ L +G   NL     P       +  
Sbjct: 46  DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105

Query: 271 NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN 330
            Y+T +    +    L+  K L  L  + N L G LP S  +L   + I    N  ISG 
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR-ISGA 164

Query: 331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLH 390
           IP   G+   L        N      I  +      A       +       L    +  
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRL-TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 391 SLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVL 450
             +             +G   +L  L L  NR    LP  +  LK              L
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-------------L 270

Query: 451 IGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
             LN S NNL G+IP   G L+         N+     P
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.2 bits (87), Expect = 0.003
 Identities = 15/37 (40%), Positives = 18/37 (48%), Gaps = 1/37 (2%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIP 117
           LN+S  NL G IP Q GNL        ++NK     P
Sbjct: 273 LNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 99.3 bits (246), Expect = 9e-23
 Identities = 77/385 (20%), Positives = 135/385 (35%), Gaps = 45/385 (11%)

Query: 170 NLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLG 229
            L    +      N+     V+  ++  +  +      +  S+   ++  L N+  +N  
Sbjct: 20  ALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK-SIDG-VE-YLNNLTQINFS 74

Query: 230 INSFYGTVPSSITNASKLSDLELGVN---------------LFSGFIPNTFVNMADNYLT 274
            N      P  + N +KL D+ +  N                 + F            LT
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 275 SSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQV 334
           +        +++++   L  L        G        L+    +  +D  S   +   V
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 335 VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVL 394
           +  L NL  L    N +++  P+       L  L L  N+L       L  L  L  L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDL 248

Query: 395 QGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN--------- 445
             N+ S   P  L  LT L  L LG N+ ++  P  +  L  +  ++++ N         
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS 304

Query: 446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSK 505
           +L  L  L    NN+S   P+    L  LQ++F   N++      S  +L+++  L    
Sbjct: 305 NLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 506 NKISGAIPASLQKLLYLKHLNLSFN 530
           N+IS   P  L  L  +  L L+  
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 84.7 bits (208), Expect = 5e-18
 Identities = 70/338 (20%), Positives = 123/338 (36%), Gaps = 28/338 (8%)

Query: 96  LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL 155
           +  L++L  ++ S+N+L+   P  + N+  L  +  ++NQ+            +  T+  
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 156 SINGLSGEMPR------------EIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYL 203
           +       +               I ++  L+ L        G     +  ++ L  +  
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 204 LNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPN 263
           L+ S +      +   L N+E+L    N      P  I   + L +L L  N     I  
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGT 236

Query: 264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMD 323
                    L  +  ++S L+ L+   KL  L L  N +  I P     L+    +  ++
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLE 291

Query: 324 NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL 383
                      + NL NL  L L  NN+++  P   S L  LQ L    NK++      L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSL 347

Query: 384 CHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLN 421
            +L  ++ L    N+ S   P  L NLT +  L L   
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.7 bits (190), Expect = 9e-16
 Identities = 74/411 (18%), Positives = 144/411 (35%), Gaps = 45/411 (10%)

Query: 72  DVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYF 131
           D      +   +   N+  T+     +L  + TL      +  +I   +  ++ L  + F
Sbjct: 18  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINF 73

Query: 132 SDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVT 191
           S+NQL         N++ +  I ++ N ++   P           L              
Sbjct: 74  SNNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDP 127

Query: 192 IFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLE 251
           + N++ L  + L +N++S         SL  +   N   +       +++      S+  
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187

Query: 252 LGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKG 311
             +++ +       +   +N ++  TP             L  L L GN L  I   +  
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITPL-------GILTNLDELSLNGNQLKDI--GTLA 238

Query: 312 NLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLT 371
           +L+ +L  + + N  IS   P  +  L  L  L+LG N ++   P+      T       
Sbjct: 239 SLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----E 291

Query: 372 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTI 431
            N+        + +L  L  L L  N  S   P  + +LT L+ L+   N+ +    S++
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 432 WNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYN 482
            NL +             +  L+   N +S   P  +  L  + Q+ L   
Sbjct: 348 ANLTN-------------INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.3 bits (150), Expect = 1e-10
 Identities = 40/212 (18%), Positives = 81/212 (38%), Gaps = 15/212 (7%)

Query: 44  HISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQ 103
                         +   +      IT       +  L+++   L+      L +L++L 
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLT 244

Query: 104 TLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGE 163
            LDL++N++S   P  +  +  L  L    NQ+            +   ++ +      E
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL----E 298

Query: 164 MPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV 223
               I NL  L  L    NN+  ++P  + +++ L+ ++  NN +S    S +  +L N+
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA-NLTNI 353

Query: 224 ETLNLGINSFYGTVPSSITNASKLSDLELGVN 255
             L+ G N      P  + N ++++ L L   
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 7e-06
 Identities = 45/273 (16%), Positives = 86/273 (31%), Gaps = 33/273 (12%)

Query: 287 TNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLEL 346
           T   +    +L    +   + ++  +    +  +  D   I  +I  V   L NL  +  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLD---QVTTLQADRLGIK-SIDGV-EYLNNLTQINF 73

Query: 347 GGNNLTEPIPIT-FSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 405
             N LT+  P+   ++L  +         +             L +  +       ++ +
Sbjct: 74  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 406 CLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN-------------------- 445
                 S   +              +     +  +   +N                    
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 446 -SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLS 504
             L  L  L  + N +S   P+ I    NL ++ L  N+L+     +   L++L  LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 505 KNKISGAIPASLQKLLYLKHLNLSFNKLEGEIP 537
            N+IS   P  L  L  L  L L  N++    P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.4 bits (88), Expect = 0.003
 Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 8/83 (9%)

Query: 459 NLSGDIPITI----GGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA 514
            ++ D PI        L    +  L    +  ++ ++  DL  +  L   +  I      
Sbjct: 5   TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--D 60

Query: 515 SLQKLLYLKHLNLSFNKLEGEIP 537
            ++ L  L  +N S N+L    P
Sbjct: 61  GVEYLNNLTQINFSNNQLTDITP 83

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 32/204 (15%), Positives = 67/204 (32%), Gaps = 33/204 (16%)

Query: 623 NLIGIGSFGSIYVARLQDGMEVAVKVFH----------QQYERALKSFEDECEVMKRIRH 672
            L+G G   +++    +   E  VK             ++ +     F        R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 673 RNLVKIISSCSNDDF----KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALE 728
           R L K+        +     A++M+ +               + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRVENPDEVLDMILEEVA 117

Query: 729 YLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATI-GYMA 787
                +   I+H DL   NVL+ E+ +  I DF  +  +  E    I  + +  I  Y +
Sbjct: 118 KF---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 788 PEYGTKGRVCTRGDVYSYGIMLME 811
             Y T+       D+ S    +++
Sbjct: 174 RTYRTE------KDINSAIDRILQ 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.2 bits (204), Expect = 8e-18
 Identities = 53/256 (20%), Positives = 89/256 (34%), Gaps = 17/256 (6%)

Query: 292 LKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNL 351
             +L L  N +  I      NL  +L  +++ N  IS   P     L  L  L L  N L
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 352 TEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 411
            E        LQ L+       K+   + + L  +  +  L     K SG        + 
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150

Query: 412 SLRVLYLGLNRFTSALPSTIWNLKDI--------LFIDVSSNSLNVLIGLNFSRNNLSGD 463
            L  + +     T+       +L ++             S   LN L  L  S N++S  
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210

Query: 464 IPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG------AIPASLQ 517
              ++    +L+++ L  N+L   +P    D   ++V+ L  N IS         P    
Sbjct: 211 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269

Query: 518 KLLYLKHLNLSFNKLE 533
           K      ++L  N ++
Sbjct: 270 KKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 7e-16
 Identities = 53/320 (16%), Positives = 103/320 (32%), Gaps = 37/320 (11%)

Query: 64  CSWIGITCDVNSHRVI---------GLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSG 114
           C    + C       +          L++ +  +         NL +L TL L +NK+S 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 115 NIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL 174
             P +   +  L+ LY S NQL          +  +   +  I  +   +   +  +  +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 175 ARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFY 234
             L        G+       M  L  I + + +++ ++P  +    P++  L+L  N   
Sbjct: 130 -ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKIT 184

Query: 235 GTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD--NYLTSSTPELSFLSSLTNCKKL 292
               +S+   + L+ L L  N  S     +  N         ++   +     L + K +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244

Query: 293 KVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT 352
           +V+ L  N +  I                          P       +   + L  N + 
Sbjct: 245 QVVYLHNNNISAIGSNDF-------------------CPPGYNTKKASYSGVSLFSNPVQ 285

Query: 353 --EPIPITFSQLQTLQALGL 370
             E  P TF  +    A+ L
Sbjct: 286 YWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 1e-15
 Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 17/195 (8%)

Query: 340 NLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKF 399
           +  +L+L  N +TE     F  L+ L  L L  NK++         L +L  L L  N+ 
Sbjct: 32  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 400 SGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNN 459
                     L  LRV    + +              +     +  +  +++ L  +   
Sbjct: 92  KELPEKMPKTLQELRVHENEITK--------------VRKSVFNGLNQMIVVELGTNPLK 137

Query: 460 LSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKL 519
            SG       G+K L  + +    +  +IP+      SL  L L  NKI+    ASL+ L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194

Query: 520 LYLKHLNLSFNKLEG 534
             L  L LSFN +  
Sbjct: 195 NNLAKLGLSFNSISA 209

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.3 bits (181), Expect = 7e-15
 Identities = 54/340 (15%), Positives = 100/340 (29%), Gaps = 56/340 (16%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
           L+ +   +  L   +P  +    P+   L+L  N           N   L  L L  N  
Sbjct: 12  LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 258 SGFIPNTFVNMAD-NYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLS 316
           S   P  F  +     L  S  +L  L         + L +  N +  +       L+  
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQM 126

Query: 317 LEIILMD-NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL 375
           + + L       SG        +  L  + +   N+T         L  L          
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH--------- 177

Query: 376 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLK 435
                             L GNK +    + L  L +L  L L  N  ++    ++ N  
Sbjct: 178 ------------------LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219

Query: 436 DILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF--- 492
            +  + +++N L                +P  +   K +Q ++L  N +       F   
Sbjct: 220 HLRELHLNNNKLV--------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265

Query: 493 ---GDLSSLEVLDLSKNKIS--GAIPASLQKLLYLKHLNL 527
                 +S   + L  N +      P++ + +     + L
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.8 bits (120), Expect = 4e-07
 Identities = 21/84 (25%), Positives = 34/84 (40%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAI 512
           L+   N ++         LKNL  + L  N++    P +F  L  LE L LSKN++    
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95

Query: 513 PASLQKLLYLKHLNLSFNKLEGEI 536
               + L  L+       K+   +
Sbjct: 96  EKMPKTLQELRVHENEITKVRKSV 119

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.0 bits (118), Expect = 6e-07
 Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 3/83 (3%)

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGA 511
            +  S   L   +P  +    +   + L+ N++       F +L +L  L L  NKIS  
Sbjct: 14  VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 512 IPASLQKLLYLKHLNLSFNKLEG 534
            P +   L+ L+ L LS N+L+ 
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKE 93

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (184), Expect = 2e-15
 Identities = 62/258 (24%), Positives = 91/258 (35%), Gaps = 20/258 (7%)

Query: 264 TFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMD 323
             + +  N ++          S   C+ L +L L  N L  I   +   L+L  ++ L D
Sbjct: 35  QRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89

Query: 324 NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL 383
           N  +    P     LG L  L L    L E  P  F  L  LQ L L  N L     D  
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149

Query: 384 CHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVS 443
             L  L  L L GN+ S         L SL  L L  NR     P    +L  ++ + + 
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 444 SN-----------SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESF 492
           +N            L  L  L  + N    D          LQ+     + +  S+P+  
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR- 267

Query: 493 GDLSSLEVLDLSKNKISG 510
             L+  ++  L+ N + G
Sbjct: 268 --LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (154), Expect = 1e-11
 Identities = 57/246 (23%), Positives = 88/246 (35%), Gaps = 16/246 (6%)

Query: 324 NCSISG--NIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD 381
           +C   G   +P  +        + L GN ++     +F   + L  L L  N LA     
Sbjct: 17  SCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 382 ELCHLARLHSLVLQGNKFSGSI-PSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFI 440
               LA L  L L  N    S+ P+    L  L  L+L         P     L  + ++
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 441 DVSSNSLNVLIG-----------LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP 489
            +  N+L  L             L    N +S        GL +L ++ L  NR+    P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 490 ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKS 549
            +F DL  L  L L  N +S     +L  L  L++L L+ N    +      +A L    
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 550 FMGNEL 555
              +E+
Sbjct: 255 GSSSEV 260

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.9 bits (138), Expect = 1e-09
 Identities = 33/179 (18%), Positives = 63/179 (35%), Gaps = 5/179 (2%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L++    LQ   P     L++LQ L L  N L      +  ++  L  L+   N++    
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169

Query: 141 SFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKE 200
                 + S+  + L  N ++   P    +L  L  L    NNL  +    +  + AL+ 
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229

Query: 201 IYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSG 259
           + L +N       +R   +   ++      +    ++P  +          L  N   G
Sbjct: 230 LRLNDNPWVCDCRARPLWA--WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (137), Expect = 1e-09
 Identities = 37/206 (17%), Positives = 62/206 (30%), Gaps = 12/206 (5%)

Query: 335 VGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVL 394
           V  + + L +     NLT  +P    +      L L+ N L       L    RL  L L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 395 QGNKFSGSIP-SCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI-- 451
              + +       L  L +L + +  L        +        +  +  ++     +  
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 452 -----GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKN 506
                 L    N L    P  +     L+++ L  N L          L +L+ L L +N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 507 KISGAIPASLQKLLYLKHLNLSFNKL 532
            +   IP        L    L  N  
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 6e-07
 Identities = 42/209 (20%), Positives = 74/209 (35%), Gaps = 6/209 (2%)

Query: 191 TIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL 250
            +  +++  E+     +L+ +LP  +     +   L+L  N  Y    +++   ++L+ L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 251 ELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSK 310
            L     +    +  + +      S     S          L VL ++ N L  +   + 
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 311 GNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGL 370
             L    E+ L  N  +    P ++     L  L L  NNLTE      + L+ L  L L
Sbjct: 121 RGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 371 TRNKLAGPITDELCHLARLHSLVLQGNKF 399
             N L   I         L    L GN +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 42/209 (20%), Positives = 68/209 (32%), Gaps = 27/209 (12%)

Query: 71  CDV-NSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLL 129
           C+V      + +N    NL   +PP L        L LS N L     +++     L  L
Sbjct: 4   CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 130 YFSDNQLFGSLSFFIFNVSSVTTIDLSIN---------------------GLSGEMPREI 168
                +L          V     +  +                        L+      +
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 169 GNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNL 228
             L  L  L    N L  + P  +     L+++ L NN+L+      ++  L N++TL L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDTLLL 179

Query: 229 GINSFYGTVPSSITNASKLSDLELGVNLF 257
             NS Y T+P     +  L    L  N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 5e-06
 Identities = 17/93 (18%), Positives = 30/93 (32%), Gaps = 1/93 (1%)

Query: 44  HISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQ 103
            +         +      +    +       + ++  L++++ NL       L  L +L 
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 104 TLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQL 136
           TL L  N L   IP   F  H L   +   N  
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 37/209 (17%), Positives = 65/209 (31%), Gaps = 9/209 (4%)

Query: 97  GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS 156
             ++S   ++     L+  +P  +       +L+ S+N L+      +   + +T ++L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 157 INGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRI 216
                    +  G LP L  L  + N L  +  +     +        N     SLP   
Sbjct: 64  --RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT--SLPLGA 119

Query: 217 DLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMAD--NYLT 274
              L  ++ L L  N      P  +T   KL  L L  N  +         + +    L 
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 275 SSTPELSFLSSLTNCKKLKVLILTGNPLD 303
                 +          L    L GNP  
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 1e-04
 Identities = 12/62 (19%), Positives = 24/62 (38%), Gaps = 3/62 (4%)

Query: 467 TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLN 526
            +  + +  ++  +   L  ++P          +L LS+N +     A+L     L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 527 LS 528
           L 
Sbjct: 62  LD 63

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 1e-08
 Identities = 37/219 (16%), Positives = 71/219 (32%), Gaps = 37/219 (16%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
            L N + +  G +N+T+ +  T + L  +  L      +     + + +L  L  L L+ 
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFS 456
           N+ +    + L NLT +  L L  N   +            L +  +  +    +    +
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 457 RNNLSGDI---------------------------PITIGGLKNLQQMFLEYNRLEGSIP 489
              L  D+                              +  L  L  +  + N++    P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 490 ESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLS 528
                L +L  + L  N+IS   P  L     L  + L+
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 14/78 (17%), Positives = 29/78 (37%), Gaps = 4/78 (5%)

Query: 56  NWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGN 115
               S        +T   N  ++  L      +    P  L +L +L  + L +N++S  
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210

Query: 116 IPSSIFNMHTLKLLYFSD 133
            P  + N   L ++  ++
Sbjct: 211 SP--LANTSNLFIVTLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 5e-08
 Identities = 40/195 (20%), Positives = 74/195 (37%), Gaps = 11/195 (5%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
                +   L   ++T+ +  T ++L ++  +    + +       + +L  +  L L G
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77

Query: 397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSAL-PSTIWNLKDILFIDVSSNSLNVLIGLNF 455
           NK +      L NL +L  L+L  N+         +  LK +       + +N L+ L  
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 456 SRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE--SFGDLSSLEVLDLSKNKISGAIP 513
             +   G+  IT   + +        +  +  I +      L+ L+ L LSKN IS    
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--L 193

Query: 514 ASLQKLLYLKHLNLS 528
            +L  L  L  L L 
Sbjct: 194 RALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 6e-05
 Identities = 40/210 (19%), Positives = 76/210 (36%), Gaps = 18/210 (8%)

Query: 346 LGGNNLTEPIPITF----SQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 401
           LG   +T P PI                L +  +   +T     L  +  ++   +    
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60

Query: 402 SIPSCLGNLTSLRVLYLGLNRFT-----SALPSTIWNLKDILFIDVSSNSLNVLIGLNFS 456
                +  L ++  L+L  N+ T     + L +  W   D   +   S+  ++    + S
Sbjct: 61  VQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118

Query: 457 RNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASL 516
             +        +  L  L+ ++L  N+   +       L+ L+ L L  N+IS  +P  L
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNK--ITDITVLSRLTKLDTLSLEDNQISDIVP--L 174

Query: 517 QKLLYLKHLNLSFNKLEGEIPRGGPFANLT 546
             L  L++L LS N +  ++       NL 
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLRALAGLKNLD 203

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 6e-07
 Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 9/84 (10%)

Query: 454 NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP 513
            +  N  S +I        +L+++ +  N+L   +P        LE L  S N ++  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320

Query: 514 ASLQKLLYLKHLNLSFNKLEGEIP 537
              Q L   K L++ +N L  E P
Sbjct: 321 ELPQNL---KQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 63/324 (19%), Positives = 102/324 (31%), Gaps = 16/324 (4%)

Query: 198 LKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF 257
             E+ L N  LS SLP       P++E+L    NS    +P    +   L      +   
Sbjct: 40  AHELELNNLGLS-SLPE----LPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 93

Query: 258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL 317
           S   P        N      PEL   S L         +     L   L       +   
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAG 377
           E+  + N      I     +L  L  L L   ++     I     +      LT      
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 378 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDI 437
            +   L  L      +   + +   +P    +LT L V     +  +   P+  +     
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 438 LFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSS 497
             I    +    L  LN S N L  ++P        L+++   +N L   +PE      +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPEL---PQN 325

Query: 498 LEVLDLSKNKISG--AIPASLQKL 519
           L+ L +  N +     IP S++ L
Sbjct: 326 LKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 19/111 (17%), Positives = 35/111 (31%), Gaps = 9/111 (8%)

Query: 64  CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 123
              +          +             I        SL+ L++S+NKL   +P+     
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR- 305

Query: 124 HTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYL 174
             L+ L  S N L   +        ++  + +  N L  E P    ++  L
Sbjct: 306 --LERLIASFNHL-AEVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 9/94 (9%)

Query: 322 MDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITD 381
               + S  I  +     +L  L +  N L E +P    +L+ L     + N LA  + +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAE-VPE 321

Query: 382 ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRV 415
              +L +LH   ++ N      P    ++  LR+
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 3e-05
 Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 22/107 (20%)

Query: 394 LQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGL 453
              N  S  I S      SL  L +  N+    LP+    L+                 L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER----------------L 309

Query: 454 NFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEV 500
             S N+L+ ++P      +NL+Q+ +EYN L    P+    +  L +
Sbjct: 310 IASFNHLA-EVP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 9e-05
 Identities = 23/81 (28%), Positives = 30/81 (37%), Gaps = 7/81 (8%)

Query: 475 QQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEG 534
                  N     I        SLE L++S NK+   +PA   +   L+ L  SFN L  
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA- 317

Query: 535 EIPRGGPFANLTAKSFMGNEL 555
           E+P      NL       N L
Sbjct: 318 EVPEL--PQNLKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 10/89 (11%)

Query: 349 NNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG 408
           N  +  I        +L+ L ++ NKL     +      RL  L+   N  +  +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL----IELPALPPRLERLIASFNHLA-EVPELPQ 324

Query: 409 NLTSLRVLYLGLNRFTS--ALPSTIWNLK 435
           NL     L++  N       +P ++ +L+
Sbjct: 325 NLKQ---LHVEYNPLREFPDIPESVEDLR 350

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 7e-07
 Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 11/93 (11%)

Query: 446 SLNVLIGLNFSRNNLS-GDIPITIGGLKNLQQMFLEYNRLEG----SIPESFGDLSSLEV 500
           SL+ +  L+     LS       +  L+  Q + L+   L       I  +     +L  
Sbjct: 1   SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 501 LDLSKNKISGAIPASLQKLL-----YLKHLNLS 528
           L+L  N++       + + L      ++ L+L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 473 NLQQMFLEYNRL-EGSIPESFGDLSSLEVLDLSKNKISG----AIPASLQKLLYLKHLNL 527
           ++Q + ++   L +    E    L   +V+ L    ++      I ++L+    L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 528 SFNKLEGEIPR 538
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 9/76 (11%)

Query: 472 KNLQQMFLEYNRLEG----SIPESFGDLSSLEVLDLSKNKISGAIPASLQKLL-----YL 522
             L+ ++L    +      S+  +     SL  LDLS N +  A    L + +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 523 KHLNLSFNKLEGEIPR 538
           + L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 11/76 (14%), Positives = 28/76 (36%), Gaps = 5/76 (6%)

Query: 101 SLQTLDLSHNKLSGNIPSSIF-NMHTLKLLYFSDNQL----FGSLSFFIFNVSSVTTIDL 155
            +Q+LD+   +LS    + +   +   +++   D  L       +S  +    ++  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 156 SINGLSGEMPREIGNL 171
             N L       +   
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 18/88 (20%), Positives = 31/88 (35%), Gaps = 9/88 (10%)

Query: 445 NSLNVLIGLNFSRNNLSGD----IPITIGGLKNLQQMFLEYNRLEGSIPESFGD-----L 495
              +VL  L  +  ++S      +  T+    +L+++ L  N L  +      +      
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 496 SSLEVLDLSKNKISGAIPASLQKLLYLK 523
             LE L L     S  +   LQ L   K
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/90 (16%), Positives = 26/90 (28%), Gaps = 5/90 (5%)

Query: 81  LNISSFNLQGTIPPQL-GNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLYFSDNQ 135
           L+I    L      +L   L   Q + L    L+     +I S++     L  L    N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 136 LFGSLSFFIFNVSSVTTIDLSINGLSGEMP 165
           L       +       +  +    L     
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 14/72 (19%), Positives = 24/72 (33%), Gaps = 5/72 (6%)

Query: 365 LQALGLTRNKLAGPITDELC-HLARLHSLVLQGNKFSG----SIPSCLGNLTSLRVLYLG 419
           +Q+L +   +L+     EL   L +   + L     +      I S L    +L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 420 LNRFTSALPSTI 431
            N         +
Sbjct: 64  SNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 17/88 (19%), Positives = 27/88 (30%), Gaps = 12/88 (13%)

Query: 389 LHSLVLQGNKFSG----SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSS 444
           L  L L     S     S+ + L    SLR L L  N    A    +        ++   
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL--------VESVR 422

Query: 445 NSLNVLIGLNFSRNNLSGDIPITIGGLK 472
               +L  L       S ++   +  L+
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 17/132 (12%), Positives = 33/132 (25%), Gaps = 23/132 (17%)

Query: 44  HISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGT----IPPQLGNL 99
             +     L   N     +    +          +  L ++  ++  +    +   L   
Sbjct: 337 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 396

Query: 100 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSING 159
            SL+ LDLS+N L       +                             +  + L    
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVES-------------------VRQPGCLLEQLVLYDIY 437

Query: 160 LSGEMPREIGNL 171
            S EM   +  L
Sbjct: 438 WSEEMEDRLQAL 449

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 38/192 (19%), Positives = 72/192 (37%), Gaps = 11/192 (5%)

Query: 337 NLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQG 396
            L   +   LG  N+T+ +  + + L  +  L   R  +     D + +L  L  +    
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71

Query: 397 NKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFS 456
           N+ +    + L NLT L  + +  N+     P         L +  +  +    +    +
Sbjct: 72  NQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 457 RNNLSG---DIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIP 513
            N L      I              L ++  + +  +   +L++LE LD+S NK+S    
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--I 187

Query: 514 ASLQKLLYLKHL 525
           + L KL  L+ L
Sbjct: 188 SVLAKLTNLESL 199

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 4e-06
 Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
           L+++  +L  T+   L  L  +  LDLSHN+L    P ++  +  L++L  SDN L    
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 141 SFFIFNVSSVTTIDLSINGL-SGEMPREIGNLPYLARLAFATNNLVGV 187
                    +  + L  N L      + + + P L  L    N+L   
Sbjct: 60  GVANLPR--LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 8e-05
 Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 21/132 (15%)

Query: 392 LVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLI 451
           L L     +  +   L  L  +  L L  NR  +  P+ +  L+ +  +  S N+L  + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEG-SIPESFGDLSSLEVLDLSKNKISG 510
           G+                    LQ++ L  NRL+  +  +       L +L+L  N +  
Sbjct: 60  GVANLPR---------------LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

Query: 511 --AIPASLQKLL 520
              I   L ++L
Sbjct: 105 EEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 8e-04
 Identities = 22/106 (20%), Positives = 36/106 (33%), Gaps = 26/106 (24%)

Query: 453 LNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSL-------------- 498
           L+ +  +L+  +   +  L  +  + L +NRL   +P +   L  L              
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD 59

Query: 499 --------EVLDLSKNKI-SGAIPASLQKLLYLKHLNLSFNKLEGE 535
                   + L L  N++   A    L     L  LNL  N L  E
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 34/238 (14%), Positives = 82/238 (34%), Gaps = 26/238 (10%)

Query: 324 NCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKL-AGPITDE 382
             ++  ++   + + G ++      + + +P+   FS  + +Q + L+ + +    +   
Sbjct: 9   GKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGI 66

Query: 383 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY---------------------LGLN 421
           L   ++L +L L+G + S  I + L   ++L  L                      L   
Sbjct: 67  LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126

Query: 422 RFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEY 481
             +     T  +++  +     + +   L G   +    S    +       +     + 
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK-SDLSTLVRRCPNLVHLDLSDS 185

Query: 482 NRLEGSIPESFGDLSSLEVLDLSK-NKISGAIPASLQKLLYLKHLNLSFNKLEGEIPR 538
             L+    + F  L+ L+ L LS+   I       L ++  LK L +     +G +  
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 5e-05
 Identities = 37/252 (14%), Positives = 75/252 (29%), Gaps = 15/252 (5%)

Query: 290 KKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN-IPQVVGNLGNLLVLELGG 348
           + +       + +D  L +        ++ + + N  I  + +  ++     L  L L G
Sbjct: 23  QGVIAFRCPRSFMDQPLAEHFS--PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80

Query: 349 NNLTEPIPITFSQLQTLQAL--GLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 406
             L++PI  T ++   L  L            +   L   +RL  L L            
Sbjct: 81  LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140

Query: 407 LGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPI 466
           +       V ++        L     NL+      +     N++         L  D   
Sbjct: 141 V------AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194

Query: 467 TIGGLKNLQQMFLEY-NRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL 525
               L  LQ + L     +        G++ +L+ L +      G +    +    L HL
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LPHL 251

Query: 526 NLSFNKLEGEIP 537
            ++ +       
Sbjct: 252 QINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 37/281 (13%), Positives = 83/281 (29%), Gaps = 19/281 (6%)

Query: 103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSG 162
           QTLDL+   L  ++   + +   +       + +   L    F+   V  +DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEV 60

Query: 163 E-MPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEI------YLLNNSLSGSLPSR 215
             +   +     L  L+     L      T+   S L  +           +L   L S 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 216 IDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLEL-----GVNLFSGFIPNTFVNMAD 270
             L   N+               + ++      +L         +  S  +      +  
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 271 NYLTSSTPELSFLSSLTNCKKLKVLILTG-NPLDGILPKSKGNLSLSLEIILMDNCSISG 329
           +   S   +            L+ L L+    +        G +  +L+ + +      G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP-TLKTLQVFGIVPDG 239

Query: 330 NIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGL 370
            +  +   L +   L++  ++ T     T    +  +  G+
Sbjct: 240 TLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGI 277

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)

Query: 402 SIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLS 461
            +   +          L L    S               D    + N+ + LN  R++++
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRS---------------DPDLVAQNIDVVLN-RRSSMA 54

Query: 462 GDIPITIGGLKNLQQMFLEYNRLEG--SIPESFGDLSSLEVLDLSKNKISGAIPASLQKL 519
             + I    +  L  + L  NRL     +        +L++L+LS N++         K 
Sbjct: 55  ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114

Query: 520 LYLKHLNLSFNKLEGEIP 537
           L L+ L L  N L     
Sbjct: 115 LKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 11/144 (7%)

Query: 92  IPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVT 151
           +   +          L    L       +   +   +L    + +  +L     N+  + 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELL 68

Query: 152 TIDLSINGLSG--EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLS 209
           +++LS N L    +M   +   P L  L  + N L     +       L+E++L  NSLS
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 210 GSLP------SRIDLSLPNVETLN 227
            +        S I    P +  L+
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLD 152

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 3e-05
 Identities = 28/221 (12%), Positives = 64/221 (28%), Gaps = 21/221 (9%)

Query: 326 SISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCH 385
            I  ++P+      N + L      L       FS    L+ + +++N +   I  ++  
Sbjct: 22  EIPSDLPR------NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75

Query: 386 LARLHSLVLQGNKFSGSIPSCL---------------GNLTSLRVLYLGLNRFTSALPST 430
                  +      +    +                   +  L  ++   +     L   
Sbjct: 76  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 431 IWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPE 490
                  +  +         + L  ++N +         G +  +    + N LE    +
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNK 531
            F   S   +LD+S+ +I       L+ L  L+  +    K
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 15/98 (15%), Positives = 29/98 (29%), Gaps = 1/98 (1%)

Query: 44  HISYDHTNLFARNWTSSTSVCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQ-LGNLSSL 102
             +      F                 C  N  ++  LN+S  N    +P       S  
Sbjct: 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 203

Query: 103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL 140
             LD+S  ++       + N+  L+     + +   +L
Sbjct: 204 VILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 241

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 9e-05
 Identities = 23/137 (16%), Positives = 45/137 (32%), Gaps = 6/137 (4%)

Query: 94  PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTI 153
            Q  N    + LDL   K+   I +    +     + FSDN++          +  + T+
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68

Query: 154 DLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLP 213
            ++ N +          LP L  L    N+LV +  +             +  +   +  
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 214 ---SRIDLSLPNVETLN 227
                +   +P V  L+
Sbjct: 129 HYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 9e-04
 Identities = 9/42 (21%), Positives = 15/42 (35%), Gaps = 1/42 (2%)

Query: 491 SFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKL 532
            + +      LDL   KI   I      L     ++ S N++
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 16/90 (17%), Positives = 29/90 (32%), Gaps = 11/90 (12%)

Query: 475 QQMFLEYNRLEGSIPESFGD------LSSLEVLDLSKNKISGAIPASL-----QKLLYLK 523
           +++ L    L      +  D         L+ L L  N+I      +L     +K+  L 
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305

Query: 524 HLNLSFNKLEGEIPRGGPFANLTAKSFMGN 553
            L L+ N+   E         + +    G 
Sbjct: 306 FLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 11/61 (18%), Positives = 25/61 (40%), Gaps = 4/61 (6%)

Query: 81  LNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGN----IPSSIFNMHTLKLLYFSDNQL 136
           L+  +   + ++   L    S++ + LS N +       +  +I +   L++  FSD   
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 137 F 137
            
Sbjct: 72  G 72

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 13/86 (15%)

Query: 454 NFSRNNLSGDIPITIG------GLKNLQQMFLEYNRLEGSIPESFGD-----LSSLEVLD 502
             +   LS      +           LQ + L+YN +E     +        +  L  L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 503 LSKNKIS--GAIPASLQKLLYLKHLN 526
           L+ N+ S    +   ++++   +   
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 12/89 (13%), Positives = 28/89 (31%), Gaps = 5/89 (5%)

Query: 472 KNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISG----AIPASLQKLLYLKHLNL 527
           K+L+   +     + S+     +  S++ + LS N I       +  ++     L+    
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 528 SFNKLEGEIPRGGPFANLTAKSFMGNELL 556
           S                L  ++ +    L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 33/202 (16%), Positives = 61/202 (30%), Gaps = 21/202 (10%)

Query: 64  CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 123
           C    + C     + I  +I                     L L+ N+L       +F  
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPL---------------HTTELLLNDNELGRISSDGLFGR 52

Query: 124 HT-LKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN 182
              L  L    NQL G         S +  + L  N +     +    L  L  L    N
Sbjct: 53  LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112

Query: 183 NLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSIT 242
            +  V P +  ++++L  + L +N  + +               +L   +     PS + 
Sbjct: 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLR--KKSLNGGAARCGAPSKVR 170

Query: 243 NASKLSDLELGVNLFSGFIPNT 264
           +   +   +L  + F     N+
Sbjct: 171 D---VQIKDLPHSEFKCSSENS 189

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.001
 Identities = 26/106 (24%), Positives = 42/106 (39%), Gaps = 2/106 (1%)

Query: 452 GLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSSLEVLDLSKNKISG 510
           GL  +R+    D    + G +NL ++++E  +    +       L  L  L + K+ +  
Sbjct: 12  GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 511 AIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLTAKSFMGNELL 556
             P +      L  LNLSFN LE    +     +L      GN L 
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	897
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.47
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.41
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.3
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.29
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.51
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.54
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.5
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.34
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.79
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.59
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.55

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=415.91  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... .+..+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999875 69999999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++|+|.+++.... .+++.++..++.|+++||+||   |++||+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999987654 699999999999999999999   8899999999999999999999999999999877544444


Q ss_pred             eeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+...            .....
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~------------~~~~~  227 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------KTYLN  227 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT------------CTTST
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------CCCCC
Confidence            44456689999999999877765 678999999999999999999997633222111111111            00000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +      ...+..++.+++.+||+.|| ++|||++|+++
T Consensus       228 ~------~~~~s~~~~~li~~~L~~dP-~~R~t~~eil~  259 (271)
T d1nvra_         228 P------WKKIDSAPLALLHKILVENP-SARITIPDIKK  259 (271)
T ss_dssp             T------GGGSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             c------cccCCHHHHHHHHHHcCCCh-hHCcCHHHHhc
Confidence            0      01223456789999999999 99999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=416.64  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=200.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechh--hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQ--YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999875  36999998643  24456789999999999999999999999865 46799999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+++|+|.+++......+++.++..++.||++||+||   |++|||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999987766799999999999999999999   7899999999999999999999999999999876544443


Q ss_pred             eeeeccccCcccCCcCccCC---CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          774 SIQIQTLATIGYMAPEYGTK---GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .......||+.|+|||++..   +.++.++|||||||++|||+||+.||....... .            ....+.....
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~------------~~~~~~~~~~  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-Q------------IIFMVGRGYL  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-H------------HHHHHHHTSC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-H------------HHHHHhcCCC
Confidence            44455679999999998753   457999999999999999999999997632111 1            1111111110


Q ss_pred             c-hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          851 R-GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       851 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . ...   .....+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       228 ~p~~~---~~~~~~~~~l~~li~~cl~~dp-~~RPt~~~il~~Le  268 (276)
T d1uwha_         228 SPDLS---KVRSNCPKAMKRLMAECLKKKR-DERPLFPQILASIE  268 (276)
T ss_dssp             CCCGG---GSCTTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCcch---hccccchHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            0 000   0001233568899999999999 99999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=415.96  Aligned_cols=249  Identities=25%  Similarity=0.341  Sum_probs=207.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999865 69999999998665555678999999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      +||+|.+++..+  .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.......  .
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            999999988765  489999999999999999999   889999999999999999999999999999987654332  2


Q ss_pred             eeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          776 QIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........+         .+ ..+  
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~---------~~-~~~--  239 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP---------EL-QNP--  239 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC---------CC-SSG--
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC---------CC-CCc--
Confidence            345579999999999999999999999999999999999999997521110 01111110000         00 001  


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           +.+..++.+++.+||+.|| ++|||++|+++
T Consensus       240 -----~~~s~~~~~li~~~L~~dP-~~R~s~~eil~  269 (293)
T d1yhwa1         240 -----EKLSAIFRDFLNRCLDMDV-EKRGSAKELLQ  269 (293)
T ss_dssp             -----GGSCHHHHHHHHHHTCSST-TTSCCHHHHTT
T ss_pred             -----ccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence                 1233457899999999999 99999999976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=406.14  Aligned_cols=245  Identities=22%  Similarity=0.327  Sum_probs=204.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999876 68999999987543   233577899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|+|.+++.... .+++.++..++.||++||+||   |++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999987654 589999999999999999999   88999999999999999999999999999998764332 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......                 ++........
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----------------~~~~~i~~~~  220 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----------------ETYKRISRVE  220 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----------------HHHHHHHTTC
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCC
Confidence               23457999999999999999999999999999999999999999752111                 1111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +. .+   +.+..++.+++.+||+.|| ++|||++|+++
T Consensus       221 ~~-~p---~~~s~~~~~li~~~L~~dp-~~R~t~~eil~  254 (263)
T d2j4za1         221 FT-FP---DFVTEGARDLISRLLKHNP-SQRPMLREVLE  254 (263)
T ss_dssp             CC-CC---TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             CC-CC---ccCCHHHHHHHHHHccCCH-hHCcCHHHHHc
Confidence            00 00   1123457889999999999 99999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-49  Score=411.25  Aligned_cols=253  Identities=23%  Similarity=0.376  Sum_probs=198.3

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|+..+.||+|+||+||+|++.+++.||||+++... ...+.+.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888999999987543 234678999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +|+|.+++......+++..+..++.|+++||+||   |+++|+||||||+||++++++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            9999999988777799999999999999999999   889999999999999999999999999999987654332 223


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERF  856 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  856 (897)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+..|+...... ....            +.+........+  
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~------------~~i~~~~~~~~p--  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVV------------EDISTGFRLYKP--  224 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHH------------HHHHHTCCCCCC--
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHH------------HHHHhcCCCCCc--
Confidence            3456899999999999999999999999999999999965544321111 1111            111111111111  


Q ss_pred             HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          857 FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       857 ~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                          ..+..++.+++.+||+.|| ++|||++||+++|+
T Consensus       225 ----~~~~~~l~~li~~cl~~~p-~~Rps~~~il~~L~  257 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERP-EDRPAFSRLLRQLA  257 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHccCCH-hHCcCHHHHHHHHH
Confidence                1123457899999999999 99999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=416.62  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=205.6

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      +.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            47899999999999999999875 68999999998765566678899999999999999999999999999999999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceee
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSI  775 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~  775 (897)
                      ++|+|.+++......+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            99999999876666799999999999999999999   88999999999999999999999999999997653211  12


Q ss_pred             eeccccCcccCCcCcc-----CCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhc
Q 045539          776 QIQTLATIGYMAPEYG-----TKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLL  850 (897)
Q Consensus       776 ~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  850 (897)
                      .....||+.|+|||++     ....++.++|||||||++|||+||+.||......+ .+.+......+         .+.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~---------~~~  236 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP---------TLA  236 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC---------CCS
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC---------CCC
Confidence            2345799999999986     35568999999999999999999999997632111 11111111000         000


Q ss_pred             chhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          851 RGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       851 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       .+       ..+..++.+++.+||+.|| ++|||++|+++
T Consensus       237 -~~-------~~~s~~~~~li~~~L~~dp-~~R~t~~ell~  268 (288)
T d2jfla1         237 -QP-------SRWSSNFKDFLKKCLEKNV-DARWTTSQLLQ  268 (288)
T ss_dssp             -SG-------GGSCHHHHHHHHHHSCSST-TTSCCHHHHTT
T ss_pred             -cc-------ccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence             01       1223457899999999999 99999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=412.85  Aligned_cols=248  Identities=26%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999875 68999999997543   234577899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||++||+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+|+.......
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 599999999999999999999   899999999999999999999999999999988764444


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....                 .++........
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------~~~~~~i~~~~  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------YLIFQKIIKLE  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHTTC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----------------HHHHHHHHcCC
Confidence            4444556799999999999999999999999999999999999999975211                 11111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHH
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIF  890 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl  890 (897)
                      +. .+   +....++.+++.+||+.|| ++|||++|++
T Consensus       227 ~~-~p---~~~s~~~~~li~~~L~~dP-~~R~t~~e~~  259 (288)
T d1uu3a_         227 YD-FP---EKFFPKARDLVEKLLVLDA-TKRLGCEEME  259 (288)
T ss_dssp             CC-CC---TTCCHHHHHHHHTTSCSSG-GGSTTSGGGT
T ss_pred             CC-CC---ccCCHHHHHHHHHHccCCH-hHCcCHHHHc
Confidence            10 00   1123457899999999999 9999999964

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-48  Score=414.68  Aligned_cols=254  Identities=23%  Similarity=0.434  Sum_probs=196.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CC---ceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DG---MEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|++.+.||+|+||+||+|+++ ++   ..||||++... .....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45667789999999999999875 23   35889987654 344567899999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++......+++.++..++.||++||+||   |++||+||||||+|||++.++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999888777799999999999999999999   78999999999999999999999999999998765433


Q ss_pred             cee---eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          772 QLS---IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       772 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ...   ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......  .            +...+..
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~------------~~~~i~~  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--D------------VINAIEQ  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H------------HHHHHHT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--H------------HHHHHHc
Confidence            221   1223457899999999999999999999999999999998 89998763211  1            1111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ......+      ..+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       249 ~~~~~~~------~~~~~~l~~li~~cl~~~P-~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         249 DYRLPPP------MDCPSALHQLMLDCWQKDR-NHRPKFGQIVNTLD  288 (299)
T ss_dssp             TCCCCCC------TTCCHHHHHHHHHHTCSST-TTSCCHHHHHHHHH
T ss_pred             CCCCCCC------ccchHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            1111111      1234568899999999999 99999999998875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-49  Score=415.62  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=210.4

Q ss_pred             HHhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          614 RATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       614 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ...++|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|++++++++|||||+++++|.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34578999999999999999999876 58899999987553 33567899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSG-TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      ||+++|+|.+++... ...+++..+..++.||++||+||   |++||+||||||+|||+++++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999998754 35689999999999999999999   78899999999999999999999999999998775433


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      . .......|++.|+|||++.++.++.++|||||||++|||++|..|+...... .            ...+.+......
T Consensus       170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~------------~~~~~i~~~~~~  235 (287)
T d1opja_         170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S------------QVYELLEKDYRM  235 (287)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H------------HHHHHHHTTCCC
T ss_pred             c-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-H------------HHHHHHhcCCCC
Confidence            2 3344556899999999999999999999999999999999987776442111 1            112222222111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ..+      +.+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       236 ~~~------~~~~~~l~~li~~cl~~dP-~~Rps~~ei~~~L~  271 (287)
T d1opja_         236 ERP------EGCPEKVYELMRACWQWNP-SDRPSFAEIHQAFE  271 (287)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCC------ccchHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            111      1233468899999999999 99999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=400.55  Aligned_cols=252  Identities=22%  Similarity=0.387  Sum_probs=211.4

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEecc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMP  696 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  696 (897)
                      ++|+..+.||+|+||+||+|++++++.||||++++... ..+.+.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999998888999999986532 34678999999999999999999999999999999999999


Q ss_pred             CCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCceeee
Q 045539          697 NGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQ  776 (897)
Q Consensus       697 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~  776 (897)
                      +|++.+++......+++..+..++.|+++||+||   |++||+||||||+||++++++.+||+|||+|+....... ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence            9999999887777799999999999999999999   789999999999999999999999999999987654332 233


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......  ...            ..+........+ 
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~------------~~i~~~~~~~~p-  223 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA------------EHIAQGLRLYRP-  223 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH------------HHHHTTCCCCCC-
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHH------------HHHHhCCCCCCc-
Confidence            44678999999999999999999999999999999998 89998763211  111            111111111111 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           ..+..++.+++.+||+.|| ++|||++|+++.|.
T Consensus       224 -----~~~~~~l~~li~~cl~~dP-~~RPt~~eil~~L~  256 (258)
T d1k2pa_         224 -----HLASEKVYTIMYSCWHEKA-DERPTFKILLSNIL  256 (258)
T ss_dssp             -----TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHH
T ss_pred             -----ccccHHHHHHHHHHccCCH-hHCcCHHHHHHHhh
Confidence                 1223458899999999999 99999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=409.76  Aligned_cols=254  Identities=23%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46899999999999999999999888999999997543 334679999999999999999999998865 4578999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++|+|.+++.... ..+++.++..|+.||++||+||   |+++|+||||||+||++++++.+||+|||+|+...... ..
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            9999999775543 3589999999999999999999   78999999999999999999999999999998875432 23


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ...            ...+........+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~------------~~~i~~~~~~~~p  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEV------------IQNLERGYRMVRP  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHH------------HHHHHTTCCCCCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHH------------HHHHHhcCCCCCc
Confidence            334557899999999998889999999999999999999976665432111 011            1111111111000


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                            ..+..++.+++.+||+.|| ++|||++||++.|++
T Consensus       233 ------~~~~~~l~~li~~cl~~~P-~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 ------DNCPEELYQLMRLCWKERP-EDRPTFDYLRSVLED  266 (272)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ------ccChHHHHHHHHHHcCCCH-hHCcCHHHHHHHhhh
Confidence                  1233457899999999999 999999999998863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=405.05  Aligned_cols=253  Identities=22%  Similarity=0.323  Sum_probs=191.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC--CCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN--DDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  690 (897)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++....  ....+.+.+|++++++++|||||++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999875 68999999986543  3456778999999999999999999999854  456899


Q ss_pred             EEEeccCCChhHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          691 IMKYMPNGSLENCLYSG---TCMLDIFQRLNIMIDVALALEYLHFGH--STPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~Lh~~h--~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||..+  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999988642   356999999999999999999995322  2359999999999999999999999999998


Q ss_pred             ccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          766 LLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       766 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      .......  ......||+.|+|||++.+..+++++|||||||++|||+||+.||......  ....           .+.
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~-----------~i~  227 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG-----------KIR  227 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-----------HHH
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHH-----------HHH
Confidence            8653322  234567999999999999999999999999999999999999999752111  1111           111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .......+.       ....++.+++.+||+.|| ++|||++|+++
T Consensus       228 ~~~~~~~~~-------~~s~~l~~li~~~L~~dp-~~Rps~~ell~  265 (269)
T d2java1         228 EGKFRRIPY-------RYSDELNEIITRMLNLKD-YHRPSVEEILE  265 (269)
T ss_dssp             HTCCCCCCT-------TSCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             cCCCCCCCc-------ccCHHHHHHHHHHcCCCh-hHCcCHHHHHh
Confidence            111111111       123457899999999999 99999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-47  Score=415.42  Aligned_cols=253  Identities=19%  Similarity=0.248  Sum_probs=209.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999875 6999999999876666678899999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ++||+|.+++......+++.++..++.||+.||+||   |++||+||||||+|||++  .++.+||+|||+|+.......
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999977666799999999999999999999   889999999999999996  457899999999988754433


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...           ..+........
T Consensus       182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~-----------~~i~~~~~~~~  245 (350)
T d1koaa2         182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETL-----------RNVKSCDWNMD  245 (350)
T ss_dssp             ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-----------HHHHHTCCCSC
T ss_pred             ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHH-----------HHHHhCCCCCC
Confidence               23457999999999999999999999999999999999999999752111  100           11111100000


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .    .....+..++.+++.+||+.|| ++|||++|+++.
T Consensus       246 ~----~~~~~~s~~~~~li~~~L~~dP-~~R~t~~eil~h  280 (350)
T d1koaa2         246 D----SAFSGISEDGKDFIRKLLLADP-NTRMTIHQALEH  280 (350)
T ss_dssp             C----GGGGGCCHHHHHHHHHHCCSSG-GGSCCHHHHHHS
T ss_pred             c----ccccCCCHHHHHHHHHHccCCh-hHCcCHHHHhcC
Confidence            0    0001223457899999999999 999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.1e-47  Score=414.26  Aligned_cols=253  Identities=18%  Similarity=0.230  Sum_probs=210.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999875 6999999999876655667889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC--CCCcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ++||+|.+++......+++.++..|+.||+.||+||   |++||+||||||+|||++  .++.+||+|||+|+.......
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            999999998887776799999999999999999999   889999999999999998  678999999999998765432


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++||||+||++|||+||+.||......                 +.+.......
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----------------~~~~~i~~~~  244 (352)
T d1koba_         185 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----------------ETLQNVKRCD  244 (352)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------------HHHHHHHHCC
T ss_pred             ---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence               23456999999999999999999999999999999999999999752111                 1111111100


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      +.........+..++.+++.+||+.|| ++|||++|+++.
T Consensus       245 ~~~~~~~~~~~s~~~~~li~~~L~~dp-~~R~s~~eil~H  283 (352)
T d1koba_         245 WEFDEDAFSSVSPEAKDFIKNLLQKEP-RKRLTVHDALEH  283 (352)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHTS
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCCh-hHCcCHHHHhcC
Confidence            000000001223457899999999999 999999999873

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-47  Score=409.45  Aligned_cols=253  Identities=23%  Similarity=0.279  Sum_probs=190.7

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ..++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567999999999999999999876 68999999987543 333467889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~~  769 (897)
                      ||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+||++.   +++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999997654 599999999999999999999   889999999999999994   578999999999987643


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..   ......||+.|+|||++.+..+++++||||+||++|||++|+.||......                 ++.....
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----------------~~~~~i~  222 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----------------KLFEQIL  222 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHHHHH
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----------------HHHHHHh
Confidence            32   223457999999999999999999999999999999999999999752111                 1111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      ...+....+....+..++.+++.+||+.|| ++|||++|+++.
T Consensus       223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~s~~eil~h  264 (307)
T d1a06a_         223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDP-EKRFTCEQALQH  264 (307)
T ss_dssp             TTCCCCCTTTTTTSCHHHHHHHHHHSCSSG-GGSCCHHHHHHS
T ss_pred             ccCCCCCCccccCCCHHHHHHHHHHccCCH-hHCcCHHHHhcC
Confidence            111000000011233457899999999999 999999999873

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=402.09  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             cCCCcCCe-eecccceEEEEEEec---CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNL-IGIGSFGSIYVARLQ---DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~-lg~G~~g~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++... ....+.|.+|++++++++|||||+++|++.++ ..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            45666674 999999999999764   35579999987543 44567899999999999999999999999754 57899


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999877767799999999999999999999   78999999999999999999999999999998876543


Q ss_pred             cee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          772 QLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       772 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||.....  ...            ...+....
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~------------~~~i~~~~  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV------------MAFIEQGK  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHH------------HHHHHTTC
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHH------------HHHHHcCC
Confidence            322 2234468999999999998999999999999999999998 8999976321  111            11111111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+      +.+..++.+++.+||+.|| ++|||+.+|.++|+
T Consensus       230 ~~~~p------~~~~~~l~~li~~cl~~~p-~~RPs~~~i~~~L~  267 (285)
T d1u59a_         230 RMECP------PECPPELYALMSDCWIYKW-EDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCCCC------TTCCHHHHHHHHHTTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCC------CcCCHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            11110      1234567899999999999 99999999998875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=393.27  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             CcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC----CCceEEEE
Q 045539          620 SENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN----DDFKALIM  692 (897)
Q Consensus       620 ~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  692 (897)
                      +..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999876 68899999987543  4456789999999999999999999999854    45679999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEeCCCCCCCeeeC-CCCcEEEeeccCccccCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTP--IIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~  769 (897)
                      ||+++|+|.+++.... .+++..+..++.||++||+||   |+++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999987654 589999999999999999999   6776  99999999999996 578999999999986543


Q ss_pred             CCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          770 EDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       770 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..    .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ...+.+......          
T Consensus       168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~~----------  231 (270)
T d1t4ha_         168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKP----------  231 (270)
T ss_dssp             TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCC----------
T ss_pred             Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCCC----------
Confidence            22    234579999999998765 69999999999999999999999997521111 111111110000          


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ....      .....++.+++.+||++|| ++|||++|+++
T Consensus       232 -~~~~------~~~~~~~~~li~~~l~~dp-~~R~s~~ell~  265 (270)
T d1t4ha_         232 -ASFD------KVAIPEVKEIIEGCIRQNK-DERYSIKDLLN  265 (270)
T ss_dssp             -GGGG------GCCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             -cccC------ccCCHHHHHHHHHHccCCH-hHCcCHHHHhC
Confidence             0000      1122347889999999999 99999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=401.61  Aligned_cols=255  Identities=24%  Similarity=0.419  Sum_probs=200.1

Q ss_pred             cCCCcCCeeecccceEEEEEEecCC-----ceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDG-----MEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      +.|+..++||+|+||+||+|.+++.     ..||||+++... ....+.|.+|++++++++|||||+++|++.+++..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999987632     469999987543 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+.++++.+++......+++.++..++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999999888777899999999999999999999   8899999999999999999999999999999876543


Q ss_pred             Cc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|..|+...... .            .+.+.+....
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~------------~~~~~i~~~~  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-H------------EVMKAINDGF  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-H------------HHHHHHHTTC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-H------------HHHHHHhccC
Confidence            22 22233456899999999999999999999999999999999976665432111 1            1111222111


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+      ..+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       231 ~~~~~------~~~~~~l~~li~~cl~~~p-~~RPt~~eil~~L~  268 (283)
T d1mqba_         231 RLPTP------MDCPSAIYQLMMQCWQQER-ARRPKFADIVSILD  268 (283)
T ss_dssp             CCCCC------TTCBHHHHHHHHHHTCSST-TTSCCHHHHHHHHH
T ss_pred             CCCCc------hhhHHHHHHHHHHHCcCCH-hHCcCHHHHHHHHH
Confidence            11111      1234568899999999999 99999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=410.28  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=207.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC-C-----ceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD-G-----MEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|++.... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999998652 2     369999986543 33456788999999998 79999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCC
Q 045539          688 KALIMKYMPNGSLENCLYSGT----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKP  745 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp  745 (897)
                      .|+||||+++|+|.+++....                      ..+++..+..++.||++||+||   |++||+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCch
Confidence            999999999999999997653                      2478999999999999999999   789999999999


Q ss_pred             CCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCccccc
Q 045539          746 SNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFI  824 (897)
Q Consensus       746 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~  824 (897)
                      +||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765555444556678999999999999999999999999999999998 8999976322


Q ss_pred             CccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          825 GELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . ..            +..++........+      ..+..++.+++.+||+.|| ++|||++||++.|.
T Consensus       273 ~-~~------------~~~~~~~~~~~~~p------~~~~~~l~~li~~cl~~dP-~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D-AN------------FYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDS-RKRPSFPNLTSFLG  322 (325)
T ss_dssp             S-HH------------HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             H-HH------------HHHHHhcCCCCCCC------CcCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHh
Confidence            1 11            12222221111111      1233468899999999999 99999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=411.37  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999875 68999999987543 3345788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHS-TPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~-~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+||   |+ +||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yL---H~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            999999999987654 589999999999999999999   54 589999999999999999999999999998764321 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHH--h-----------------
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRW--I-----------------  833 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~--~-----------------  833 (897)
                         ....+||+.|+|||++.+..+++++||||+||++|||++|+.||.............  .                 
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence               234579999999999999999999999999999999999999996532111000000  0                 


Q ss_pred             ------hhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          834 ------NDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       834 ------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                            ....+....+..+......++....  .....++.+++.+||+.|| ++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP-~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNP-AERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCCh-hHCcCHHHHhh
Confidence                  0000001111111111111100000  0112457899999999999 99999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=397.16  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             CeeecccceEEEEEEecC---CceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEeccC
Q 045539          623 NLIGIGSFGSIYVARLQD---GMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYMPN  697 (897)
Q Consensus       623 ~~lg~G~~g~Vy~a~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  697 (897)
                      +.||+|+||+||+|.+++   ++.||||+++...  ....+.+.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999997653   5679999987543  23457899999999999999999999999654 57899999999


Q ss_pred             CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee-ee
Q 045539          698 GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-IQ  776 (897)
Q Consensus       698 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~-~~  776 (897)
                      |+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+......... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999988765 589999999999999999999   78999999999999999999999999999998765443322 23


Q ss_pred             eccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhhh
Q 045539          777 IQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEER  855 (897)
Q Consensus       777 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  855 (897)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .            +...+........+ 
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~------------~~~~i~~~~~~~~p-  232 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E------------VTAMLEKGERMGCP-  232 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H------------HHHHHHTTCCCCCC-
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--H------------HHHHHHcCCCCCCC-
Confidence            34568999999999999999999999999999999998 89999763111  1            11112111111110 


Q ss_pred             hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          856 FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       856 ~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                           ..+..++.+++.+||+.|| ++|||++||.++|+
T Consensus       233 -----~~~~~~~~~li~~cl~~dp-~~RPs~~~i~~~L~  265 (277)
T d1xbba_         233 -----AGCPREMYDLMNLCWTYDV-ENRPGFAAVELRLR  265 (277)
T ss_dssp             -----TTCCHHHHHHHHHHTCSST-TTSCCHHHHHHHHH
T ss_pred             -----cccCHHHHHHHHHHcCCCH-hHCcCHHHHHHHhh
Confidence                 1234567899999999999 99999999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=398.65  Aligned_cols=251  Identities=19%  Similarity=0.245  Sum_probs=206.1

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh------HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY------ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++++..      ....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999875 69999999986432      12357889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC----cEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM----VAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a  764 (897)
                      |+||||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987654 599999999999999999999   899999999999999998776    5999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      ........   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......                 +.
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----------------~~  224 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----------------ET  224 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HH
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----------------HH
Confidence            87653322   23456899999999999999999999999999999999999999752111                 11


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.......+............++.+++.+||+.|| ++|||++|+++
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~s~~eil~  270 (293)
T d1jksa_         225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP-KKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            11111111110111112334567899999999999 99999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-47  Score=403.02  Aligned_cols=245  Identities=23%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      +.|+..+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999865 68999999986432   344577899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+++|++..++..+. .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|......  
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            9999999987665543 589999999999999999999   8899999999999999999999999999999865432  


Q ss_pred             eeeeeccccCcccCCcCccC---CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          773 LSIQIQTLATIGYMAPEYGT---KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                          ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||......+ .+            ..+.....
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~------------~~i~~~~~  231 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL------------YHIAQNES  231 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH------------HHHHHSCC
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HH------------HHHHhCCC
Confidence                2456999999999875   3568999999999999999999999997521110 01            11111100


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .....      .....++.+++.+||+.|| ++|||++|+++
T Consensus       232 ~~~~~------~~~s~~~~~li~~~L~~dP-~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PALQS------GHWSEYFRNFVDSCLQKIP-QDRPTSEVLLK  266 (309)
T ss_dssp             CCCSC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHTT
T ss_pred             CCCCC------CCCCHHHHHHHHHHCcCCh-hHCcCHHHHHh
Confidence            00000      1123457899999999999 99999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-47  Score=399.46  Aligned_cols=254  Identities=24%  Similarity=0.424  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEec
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKYM  695 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  695 (897)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888899999997553 334679999999999999999999999965 4578999999


Q ss_pred             cCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          696 PNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++|+|..++.... ..+++.++..++.||+.||+||   |++||+||||||+||++++++.+||+|||+|+....... .
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            9999998876543 4689999999999999999999   789999999999999999999999999999987643322 2


Q ss_pred             eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchhh
Q 045539          775 IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEE  854 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  854 (897)
                      ......||+.|+|||++..+.++.++|||||||++|||++|..|+...... ..            ....+........ 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~------------~~~~i~~~~~~~~-  235 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE------------VLDQVERGYRMPC-  235 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH------------HHHHHHTTCCCCC-
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HH------------HHHHHHhcCCCCC-
Confidence            334457899999999999999999999999999999999977766542111 11            1111111111111 


Q ss_pred             hhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          855 RFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       855 ~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                           ...+..++.+++.+||+.|| ++|||+++|+++|++
T Consensus       236 -----~~~~~~~l~~li~~cl~~dP-~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         236 -----PPECPESLHDLMCQCWRKEP-EERPTFEYLQAFLED  270 (285)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHT
T ss_pred             -----CcccCHHHHHHHHHHcccCH-hHCcCHHHHHHHHhh
Confidence                 11234568899999999999 999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=397.01  Aligned_cols=251  Identities=18%  Similarity=0.241  Sum_probs=207.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++....+ ...+.+|++++++++|||||++++++++++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            578999999999999999999875 6899999999865433 45688999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCC--CcEEEeeccCccccCCCCc
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDED--MVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~--~~~kL~DFg~a~~~~~~~~  772 (897)
                      ++||+|.+++...+..+++.++..++.||+.||+||   |++||+||||||+||+++.+  +.+||+|||++........
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999999999987766799999999999999999999   88999999999999999854  4899999999987654332


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....+|+.|+|||...+..++.++||||+||++|+|++|+.||.....                 .+++...+...
T Consensus       160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----------------~~~~~~i~~~~  219 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------------QQIIENIMNAE  219 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHTC
T ss_pred             ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence               2345689999999999999999999999999999999999999976211                 11111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +.-.......+..++.+++.+|++.|| ++|||++|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp-~~R~s~~eil~  257 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKER-KSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSG-GGSCCHHHHHH
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            110011112234557899999999999 99999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-46  Score=399.23  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=209.4

Q ss_pred             HHHHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecC
Q 045539          612 LLRATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSN  684 (897)
Q Consensus       612 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  684 (897)
                      ++...++|++.+.||+|+||+||+|++.      +++.||||+++... .+..+.+.+|++++++++||||++++++|.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334678999999999999999999864      35789999997543 3345789999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeC
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGT-----------------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHC  741 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~  741 (897)
                      ++..++||||+++|+|.+++....                       ..+++..+..++.|++.||+||   |+++||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEee
Confidence            999999999999999999986532                       2478999999999999999999   89999999


Q ss_pred             CCCCCCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCC-CCCc
Q 045539          742 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK-KPTD  820 (897)
Q Consensus       742 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~-~p~~  820 (897)
                      ||||+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998775544444445567899999999999999999999999999999999996 5665


Q ss_pred             ccccCccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          821 EIFIGELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       821 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .....  ....           .+.+......+       +.++.++.+++.+||+.|| ++||||.||+++|++
T Consensus       245 ~~~~~--e~~~-----------~v~~~~~~~~p-------~~~~~~~~~li~~cl~~~P-~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         245 GMAHE--EVIY-----------YVRDGNILACP-------ENCPLELYNLMRLCWSKLP-ADRPSFCSIHRILQR  298 (301)
T ss_dssp             TSCHH--HHHH-----------HHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCHH--HHHH-----------HHHcCCCCCCC-------ccchHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence            42111  1111           11111111111       1233468899999999999 999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=395.46  Aligned_cols=248  Identities=21%  Similarity=0.274  Sum_probs=205.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467999999999999999999875 69999999998653   23457788999999999999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||++||+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999988755 589999999999999999999   89999999999999999999999999999998764332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......                 ++.......
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----------------~~~~~i~~~  220 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------RLFELILME  220 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHHC
T ss_pred             c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----------------HHHHHHhcC
Confidence            2  234567999999999999999999999999999999999999999763111                 111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .+. .+   ..+..++.+++.+||++|| ++||+     ++|+++
T Consensus       221 ~~~-~p---~~~s~~~~dli~~~L~~dP-~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 EIR-FP---RTLSPEAKSLLAGLLKKDP-KQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCC-CC---TTSCHHHHHHHHHHTCSST-TTSTTCSTTTHHHHHT
T ss_pred             CCC-CC---ccCCHHHHHHHHhhccCCc-hhhcccccccHHHHHc
Confidence            110 00   1123456889999999999 99995     778765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-45  Score=392.76  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999875 69999999997653   234578899999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||++||++.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999887765 478889999999999999999   8999999999999999999999999999999876533  


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....                 .++..+.+...
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----------------~~~~~~i~~~~  217 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------------MKTYEKILNAE  217 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHCC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----------------HHHHHHHHcCC
Confidence               2346799999999999999999999999999999999999999975211                 11111111111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      .. .+   .....++.+++.+|++.|| ++||     |++|+++
T Consensus       218 ~~-~p---~~~s~~~~~li~~~L~~dp-~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 LR-FP---PFFNEDVKDLLSRLITRDL-SQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CC-CC---TTSCHHHHHHHHHHTCSCT-TTCTTSSTTTTHHHHT
T ss_pred             CC-CC---CCCCHHHHHHHHHHhhhCH-HhccccchhhHHHHHc
Confidence            10 00   0123457889999999999 9996     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-46  Score=392.94  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----c
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----F  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  687 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            468999999999999999999864 69999999997543   344578999999999999999999999986543    4


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||++|++|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+||+++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 589999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCc-eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhh
Q 045539          768 SGEDQ-LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVID  846 (897)
Q Consensus       768 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  846 (897)
                      ..... ........||+.|+|||++.+..+++++||||+||++|||+||+.||......                 +.+.
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----------------~~~~  224 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----------------SVAY  224 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHH
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----------------HHHH
Confidence            43222 22334557999999999999999999999999999999999999999752111                 1111


Q ss_pred             hhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-CHHHHHhhcC
Q 045539          847 TNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-DMGWIFSALD  894 (897)
Q Consensus       847 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-t~~evl~~L~  894 (897)
                      ..+...+.........+..++.+++.+|+++|| ++|| |++|+.+.|.
T Consensus       225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp-~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNP-ENRYQTAAEMRADLV  272 (277)
T ss_dssp             HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSG-GGSCSSHHHHHHHHH
T ss_pred             HHHhcCCCCCchhccCCCHHHHHHHHHHccCCH-hHCHhHHHHHHHHHH
Confidence            111111100000011233567899999999999 9999 8999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-45  Score=385.93  Aligned_cols=252  Identities=20%  Similarity=0.274  Sum_probs=204.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---------HHHHHHHHHHHHHHHhcC-CCccceEeeeecC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---------ERALKSFEDECEVMKRIR-HRNLVKIISSCSN  684 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  684 (897)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++++..         ....+.+.+|++++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999874 68999999986432         223457889999999997 9999999999999


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..|+||||+++|+|.+++...+ .+++.++..++.||++||+||   |++||+||||||+||+++.++.+||+|||+|
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999999997654 589999999999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccC------CCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGT------KGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      +.......   .....||+.|+|||++.      ...++.++||||+||++|||++|+.||......+ ..         
T Consensus       158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~---------  224 (277)
T d1phka_         158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-ML---------  224 (277)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH---------
T ss_pred             eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HH---------
Confidence            88754322   23467999999999763      3457889999999999999999999997632110 00         


Q ss_pred             chHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 VSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ..+........    .+....+..++.+++.+||++|| ++|||++||++.
T Consensus       225 ---~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~~p-~~R~s~~eil~h  270 (277)
T d1phka_         225 ---RMIMSGNYQFG----SPEWDDYSDTVKDLVSRFLVVQP-QKRYTAEEALAH  270 (277)
T ss_dssp             ---HHHHHTCCCCC----TTTGGGSCHHHHHHHHHHCCSSG-GGSCCHHHHTTS
T ss_pred             ---HHHHhCCCCCC----CcccccCCHHHHHHHHHHccCCh-hHCcCHHHHHcC
Confidence               11111111000    00111233457899999999999 999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=397.62  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCc----eEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGM----EVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      ++|++.++||+|+||+||+|++. +|+    +||+|+++... .+..+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999865 344    58888886443 34567899999999999999999999999875 5678


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      +|||+.+++|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999999888877899999999999999999999   7889999999999999999999999999999987655


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |+.||+.....              .+...+....
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------------~~~~~i~~~~  230 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------------EISSILEKGE  230 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------------GHHHHHHHTC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------------HHHHHHHcCC
Confidence            44444445578999999999999999999999999999999999 78888753211              1222222211


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ....+      +.+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       231 ~~~~p------~~~~~~~~~li~~cl~~dP-~~RPs~~eil~~l~  268 (317)
T d1xkka_         231 RLPQP------PICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFS  268 (317)
T ss_dssp             CCCCC------TTBCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCCC------cccCHHHHHHHHHhCCCCh-hhCcCHHHHHHHHH
Confidence            11111      1233457899999999999 99999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=390.29  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC----CceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  690 (897)
                      .++|++.+.||+|+||.||+|++..    +..||||+++... ....+.+.+|++++++++||||+++++++.+ +..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4689999999999999999998642    4568999886543 4446789999999999999999999999964 57899


Q ss_pred             EEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCC
Q 045539          691 IMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       691 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~  770 (897)
                      ||||+++|++.+++......+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998887777799999999999999999999   8999999999999999999999999999999876533


Q ss_pred             CceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhh
Q 045539          771 DQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNL  849 (897)
Q Consensus       771 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  849 (897)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++ |..||......  .....+.....           
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~-----------  227 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER-----------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC-----------
T ss_pred             cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence            22 23344568999999999999999999999999999999998 88898763221  11111111000           


Q ss_pred             cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          850 LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       850 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...+       ..+..++.+++.+||+.|| ++|||++||++.|+
T Consensus       228 ~~~~-------~~~~~~~~~li~~cl~~dp-~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         228 LPMP-------PNCPPTLYSLMTKCWAYDP-SRRPRFTELKAQLS  264 (273)
T ss_dssp             CCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CCCC-------CCCCHHHHHHHHHHcCCCH-hHCcCHHHHHHHHH
Confidence            0001       1233568899999999999 99999999998875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=391.88  Aligned_cols=273  Identities=23%  Similarity=0.277  Sum_probs=202.5

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----ceEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----FKALI  691 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  691 (897)
                      ..+|...+.||+|+||.||+|++. |+.||||+++..... ....+.|+..+.+++||||+++++++.+++    ..|+|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            356888899999999999999875 899999999755322 222344555666789999999999997543    57999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHF-----GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~-----~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      |||+++|+|.+++++..  +++.++..++.|++.||+|+|.     .|++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999998764  8999999999999999999974     2568999999999999999999999999999987


Q ss_pred             cCCCCcee--eeeccccCcccCCcCccCCC------CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC
Q 045539          767 LSGEDQLS--IQIQTLATIGYMAPEYGTKG------RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP  838 (897)
Q Consensus       767 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  838 (897)
                      ........  ......||+.|+|||++.+.      .++.++|||||||++|||+||..||...................
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            75433221  23346799999999987654      36789999999999999999998876533222211111111111


Q ss_pred             c-h-HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          839 V-S-VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       839 ~-~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . . .....+..++...+.+.. ..+....+.+++.+||+.|| ++|||+.||+++|+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp-~~Rps~~ei~~~L~  293 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANG-AARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSG-GGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccC-ChHHHHHHHHHHHHHcccCH-hHCcCHHHHHHHHH
Confidence            0 1 112222222222221111 12345668899999999999 99999999999885

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=392.00  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             cCCCcCCeeecccceEEEEEEec--CC--ceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ--DG--MEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  689 (897)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||++++..   .+..+.|.+|++++++++||||++++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            57999999999999999999754  22  368999987542   33457899999999999999999999999764 678


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      +||||+++|++.+++......+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999998887766799999999999999999999   789999999999999999999999999999998754


Q ss_pred             CCcee-eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          770 EDQLS-IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       770 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||......  .....           +...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~-----------i~~~  230 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHK-----------IDKE  230 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-----------HHTS
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHH-----------HHhC
Confidence            43322 2234457889999999999999999999999999999998 89999752111  11111           1111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                      .....      ..+.+..++.+++.+||+.|| ++|||++||.+.|++
T Consensus       231 ~~~~~------~~~~~~~~l~~li~~cl~~dp-~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         231 GERLP------RPEDCPQDIYNVMVQCWAHKP-EDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCCCC------CCTTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             CCCCC------CcccccHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHh
Confidence            11000      011223457899999999999 999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=385.63  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC-CCceEEEEEe
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN-DDFKALIMKY  694 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  694 (897)
                      .++|++.+.||+|+||.||+|+++ |+.||||+++...  ..+.+.+|++++++++||||++++|+|.+ .+..|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            357888999999999999999986 7899999997543  34678999999999999999999999854 5668999999


Q ss_pred             ccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          695 MPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       695 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      +++|+|.+++.... ..+++..++.|+.||+.||+||   |+.+|+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999987643 4589999999999999999999   7899999999999999999999999999999865432   


Q ss_pred             eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          774 SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                        .....+|+.|+|||++.++.+++++|||||||++|||+| |+.||.....  .+....+..            .....
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~------------~~~~~  220 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK------------GYKMD  220 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTT------------TCCCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc------------CCCCC
Confidence              223457899999999988999999999999999999998 6777765211  122222211            11111


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      .+      ..+..++.+++.+||+.|| ++|||++||+++|+
T Consensus       221 ~~------~~~~~~~~~li~~cl~~dP-~~Rps~~~l~~~L~  255 (262)
T d1byga_         221 AP------DGCPPAVYEVMKNCWHLDA-AMRPSFLQLREQLE  255 (262)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             CC------ccCCHHHHHHHHHHcccCH-hHCcCHHHHHHHHH
Confidence            11      1223457899999999999 99999999999885

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=391.58  Aligned_cols=262  Identities=22%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             HHHHHHhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeee
Q 045539          610 HELLRATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISS  681 (897)
Q Consensus       610 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~  681 (897)
                      .+++...++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            333334578999999999999999999853      34689999987543 34456778888888887 58999999998


Q ss_pred             ecC-CCceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCC
Q 045539          682 CSN-DDFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKP  745 (897)
Q Consensus       682 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp  745 (897)
                      +.+ ++..++||||+++|+|.+++....               ..+++.++..++.||++||+||   |++||+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcCCc
Confidence            765 456899999999999999987542               3488999999999999999999   889999999999


Q ss_pred             CCeeeCCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCC-CCCccccc
Q 045539          746 SNVLLDEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK-KPTDEIFI  824 (897)
Q Consensus       746 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~-~p~~~~~~  824 (897)
                      +|||+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998765544444444567999999999999999999999999999999999975 56654211


Q ss_pred             CccchhHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          825 GELSLNRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       825 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      . ..+.            ..+........+      +.+..++.+++.+||+.|| ++|||++||+++|+
T Consensus       243 ~-~~~~------------~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP-~~Rpt~~eil~~L~  292 (299)
T d1ywna1         243 D-EEFC------------RRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEP-SQRPTFSELVEHLG  292 (299)
T ss_dssp             S-HHHH------------HHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             H-HHHH------------HHHhcCCCCCCC------ccCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHH
Confidence            1 1111            111111111110      1123457899999999999 99999999999885

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=391.17  Aligned_cols=251  Identities=18%  Similarity=0.220  Sum_probs=198.6

Q ss_pred             hcCCCcCC-eeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhc-CCCccceEeeeecC----CCce
Q 045539          616 TDRFSENN-LIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRI-RHRNLVKIISSCSN----DDFK  688 (897)
Q Consensus       616 ~~~y~~~~-~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  688 (897)
                      .++|.+.. .||+|+||+||+|++. +|+.||||+++..     +.+.+|++++.++ +|||||+++++|++    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898764 6999999999999874 6899999999754     4567899987665 79999999999865    4678


Q ss_pred             EEEEEeccCCChhHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC---CCcEEEeeccCc
Q 045539          689 ALIMKYMPNGSLENCLYSGT-CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE---DMVAHISDFGIA  764 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a  764 (897)
                      |+|||||+||+|.+++...+ ..+++.++..++.||+.||+||   |++||+||||||+||+++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998754 5699999999999999999999   8999999999999999985   567999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      +.......   .....||+.|+|||++.+..++.++||||+||++|+|+||+.||.......  ....           +
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~-----------~  225 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPG-----------M  225 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHH-----------H
Confidence            87654332   234579999999999999999999999999999999999999997632111  0000           0


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ........+....+....+..++.+++.+|++.|| ++|||++|+++
T Consensus       226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~s~~eil~  271 (335)
T d2ozaa1         226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP-TQRMTITEFMN  271 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSST-TTSCCHHHHHH
T ss_pred             HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCCh-hHCcCHHHHHc
Confidence            00001111000001122344568899999999999 99999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=389.29  Aligned_cols=258  Identities=23%  Similarity=0.343  Sum_probs=211.7

Q ss_pred             hcCCCcCCeeecccceEEEEEEe------cCCceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARL------QDGMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  687 (897)
                      .++|++.++||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +|||||+++++|.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            47899999999999999999975      246789999997543 34456789999999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          688 KALIMKYMPNGSLENCLYSGT-----------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      .++||||+++|+|.+++....                 ..+++..+..++.||++|++||   |++||+||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccccccccc
Confidence            999999999999999987543                 3588999999999999999999   88999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchh
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLN  830 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~  830 (897)
                      +.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+..|+.........  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            999999999999999876555555556678999999999999999999999999999999999955554432222111  


Q ss_pred             HHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          831 RWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       831 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                +.+++........+      +....++.+++.+||+.|| ++|||++||+++|++
T Consensus       257 ----------~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP-~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 ----------FYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADP-LKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ----------HHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             ----------HHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence                      22233222221111      1223458899999999999 999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-44  Score=392.93  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=203.5

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.+..   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999875 69999999997543   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCc
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ  772 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~  772 (897)
                      ||+.+|+|.+++...+ .+++.++..++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+...... 
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999987654 589999999999999999999   88999999999999999999999999999998875332 


Q ss_pred             eeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcch
Q 045539          773 LSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRG  852 (897)
Q Consensus       773 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  852 (897)
                          ....||+.|+|||++.+..++.++||||+||++|||+||+.||.....  .....           .+..... ..
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~-----------~i~~~~~-~~  257 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYE-----------KIVSGKV-RF  257 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH-----------HHHHCCC-CC
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHH-----------HHhcCCC-CC
Confidence                245699999999999999999999999999999999999999975211  01100           1111111 01


Q ss_pred             hhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          853 EERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       853 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      +.       .+..++.+++.+|++.|| ++|+     |++|+++
T Consensus       258 p~-------~~s~~~~~li~~~L~~dP-~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 PS-------HFSSDLKDLLRNLLQVDL-TKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CT-------TCCHHHHHHHHHHSCSCT-TTCTTSSTTTTHHHHT
T ss_pred             Cc-------cCCHHHHHHHHHHhhhCH-HhccccccccHHHHHc
Confidence            11       123457899999999999 9994     8888875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.3e-44  Score=387.73  Aligned_cols=223  Identities=30%  Similarity=0.565  Sum_probs=171.2

Q ss_pred             CChhHHHHHHHHHhccccCCCcccccCCCCCCCCc--ceeeeEeeCCC--CeEEEEEeecccccc--cCCCCCCCCCCCc
Q 045539           30 NITTDQQALLALKAHISYDHTNLFARNWTSSTSVC--SWIGITCDVNS--HRVIGLNISSFNLQG--TIPPQLGNLSSLQ  103 (897)
Q Consensus        30 ~~~~~~~aLl~~k~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~  103 (897)
                      |.++|++||++||++++ ||. .++ +|..++|||  +|+||+|+..+  +||++|||+++++.|  .+|+++++|++|+
T Consensus         3 c~~~e~~aLl~~k~~~~-~~~-~l~-sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             SCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCHHHHHHHHHHHHHCC-CCC-cCC-CCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            88999999999999996 443 465 898889999  59999998754  489999999999998  5899999999999


Q ss_pred             eecccC-ccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          104 TLDLSH-NKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       104 ~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      +|||++ |+++|.+|.+|++|++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..++++++|+.+++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            999987 8999999999999999999999999999988888889999999999999888888888888888888888888


Q ss_pred             cccccccccccccccc-cccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          183 NLVGVAPVTIFNMSAL-KEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       183 ~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      ++.+.+|..+..+.++ +.+++++|++++..|..+. .+ ....+++++|.+.+.+|..+..+++|+.+++++|.+
T Consensus       160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~-~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l  233 (313)
T d1ogqa_         160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG-GC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccc-cc-cccccccccccccccccccccccccccccccccccc
Confidence            8887777777766664 6666666666655554432 11 222344444444444444444444444443333333

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-45  Score=388.30  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEecC--------CceEEEEEechhh-HHHHHHHHHHHHHHHhc-CCCccceEeeeecCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQY-ERALKSFEDECEVMKRI-RHRNLVKIISSCSND  685 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  685 (897)
                      .++|++.+.||+|+||.||+|+...        +..||||+++... ......+.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4689999999999999999997532        3479999997654 34457788999999888 799999999999999


Q ss_pred             CceEEEEEeccCCChhHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeee
Q 045539          686 DFKALIMKYMPNGSLENCLYSGT---------------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLL  750 (897)
Q Consensus       686 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll  750 (897)
                      +..++||||+++|+|.+++....               ..+++.++..++.||+.||+||   |+++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeecccceee
Confidence            99999999999999999997553               3589999999999999999999   89999999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHc-CCCCCcccccCccch
Q 045539          751 DEDMVAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFT-KKKPTDEIFIGELSL  829 (897)
Q Consensus       751 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~ellt-g~~p~~~~~~~~~~~  829 (897)
                      +.++.+||+|||.++...............||+.|+|||.+.++.+++++|||||||++|||++ |+.||......  . 
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~-  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E-  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H-
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--H-
Confidence            9999999999999987765444444455678999999999999999999999999999999998 68887652211  1 


Q ss_pred             hHHhhhcCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          830 NRWINDLLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       830 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                                 +.+.+........+      ..+..++.+++.+||+.|| ++||||+||++.|++
T Consensus       246 -----------~~~~i~~~~~~~~p------~~~~~~l~~li~~cl~~dP-~~Rps~~eil~~L~~  293 (299)
T d1fgka_         246 -----------LFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVP-SQRPTFKQLVEDLDR  293 (299)
T ss_dssp             -----------HHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             -----------HHHHHHcCCCCCCC------ccchHHHHHHHHHHccCCH-hHCcCHHHHHHHHHH
Confidence                       11111111111111      1223458899999999999 999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=387.34  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh---HHHHHHHHHHHHHHH-hcCCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY---ERALKSFEDECEVMK-RIRHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++..   ....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999876 69999999997643   233456667777765 68999999999999999999999


Q ss_pred             EEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCC
Q 045539          692 MKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED  771 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~  771 (897)
                      |||+++|+|.+++.... .+++.++..++.||+.||+||   |++||+||||||+|||+++++.+||+|||.|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997655 589999999999999999999   88999999999999999999999999999998664332


Q ss_pred             ceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcc
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLR  851 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  851 (897)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......                 ++.......
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----------------~~~~~i~~~  218 (320)
T d1xjda_         158 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----------------ELFHSIRMD  218 (320)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHHC
T ss_pred             c--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHcC
Confidence            2  234467999999999999999999999999999999999999999752111                 111111111


Q ss_pred             hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHH-HHHh
Q 045539          852 GEERFFAAKEQILLSVLNLATECTIESRDGNGADMG-WIFS  891 (897)
Q Consensus       852 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~-evl~  891 (897)
                      .+. .+   ..+..++.+++.+||+.|| ++|||+. |+++
T Consensus       219 ~~~-~p---~~~s~~~~dli~~~L~~dP-~~R~s~~~~l~~  254 (320)
T d1xjda_         219 NPF-YP---RWLEKEAKDLLVKLFVREP-EKRLGVRGDIRQ  254 (320)
T ss_dssp             CCC-CC---TTSCHHHHHHHHHHSCSSG-GGSBTTBSCGGG
T ss_pred             CCC-CC---ccCCHHHHHHHHHhcccCC-CCCcCHHHHHHh
Confidence            110 00   1123457899999999999 9999995 6653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.2e-44  Score=390.32  Aligned_cols=249  Identities=22%  Similarity=0.252  Sum_probs=197.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH---HHHHHHH---HHHHHHHhcCCCccceEeeeecCCCce
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE---RALKSFE---DECEVMKRIRHRNLVKIISSCSNDDFK  688 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  688 (897)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.+...   .....+.   +|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999876 699999999875431   1223333   446677777899999999999999999


Q ss_pred             EEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccC
Q 045539          689 ALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS  768 (897)
Q Consensus       689 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~  768 (897)
                      |+||||++||+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999987654 588999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhh
Q 045539          769 GEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDT  847 (897)
Q Consensus       769 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  847 (897)
                      ...    .....||+.|+|||++.. ..+++++||||+||++|||+||+.||.......  .            .++...
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~------------~~~~~~  220 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--K------------HEIDRM  220 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--H------------HHHHHH
T ss_pred             CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--H------------HHHHHh
Confidence            432    234579999999998865 568999999999999999999999997632211  1            111111


Q ss_pred             hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCC-----HHHHHh
Q 045539          848 NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGAD-----MGWIFS  891 (897)
Q Consensus       848 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt-----~~evl~  891 (897)
                      .....+. .+   ..+..++.+++.+||+.|| ++|||     ++|+++
T Consensus       221 ~~~~~~~-~~---~~~s~~~~~li~~~L~~dP-~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 TLTMAVE-LP---DSFSPELRSLLEGLLQRDV-NRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSSCCCC-CC---SSSCHHHHHHHHHHTCSST-TTSTTTSSSTHHHHHT
T ss_pred             cccCCCC-CC---CCCCHHHHHHHHHHcccCH-HHhCCCcccCHHHHHc
Confidence            1111110 00   0123457899999999999 99999     677764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-44  Score=381.56  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             CCeeecccceEEEEEEecC----CceEEEEEechh-hHHHHHHHHHHHHHHHhcCCCccceEeeeecC-CCceEEEEEec
Q 045539          622 NNLIGIGSFGSIYVARLQD----GMEVAVKVFHQQ-YERALKSFEDECEVMKRIRHRNLVKIISSCSN-DDFKALIMKYM  695 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  695 (897)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998753    235899998743 34556889999999999999999999999865 56789999999


Q ss_pred             cCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee-
Q 045539          696 PNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-  774 (897)
Q Consensus       696 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~-  774 (897)
                      ++|+|.+++.......++..+..++.|+++||.|+   |+++|+||||||+|||+++++.+||+|||+++......... 
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999988877788999999999999999999   89999999999999999999999999999998765432211 


Q ss_pred             -eeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHhhhhhcchh
Q 045539          775 -IQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVIDTNLLRGE  853 (897)
Q Consensus       775 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  853 (897)
                       ......||+.|+|||.+..+.++.++||||||+++|||+||+.||....... +...++......           ..+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~-----------~~p  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL-----------LQP  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-----------CCC
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCC-----------CCc
Confidence             2233468999999999999999999999999999999999888876532211 111111110000           001


Q ss_pred             hhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          854 ERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       854 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                             +.+..++.+++.+||+.|| ++|||+.||++.|++
T Consensus       257 -------~~~~~~l~~li~~cl~~dP-~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         257 -------EYCPDPLYEVMLKCWHPKA-EMRPSFSELVSRISA  290 (311)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHHH
T ss_pred             -------ccCcHHHHHHHHHHcCCCH-hHCcCHHHHHHHHHH
Confidence                   1123457899999999999 999999999998853

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=385.79  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=208.9

Q ss_pred             HhcCCCcCCeeecccceEEEEEEec------CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCc
Q 045539          615 ATDRFSENNLIGIGSFGSIYVARLQ------DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDF  687 (897)
Q Consensus       615 ~~~~y~~~~~lg~G~~g~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  687 (897)
                      ..++|++.+.||+|+||+||+|.+.      +++.||||+++... .+....+.+|++++++++||||++++++|..++.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3578999999999999999999763      35789999997543 3445678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEE
Q 045539          688 KALIMKYMPNGSLENCLYSGT---------CMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHI  758 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL  758 (897)
                      .++||||+++|+|.+++....         ..+++..+..++.|+++||.||   |+++|+||||||+|||+++++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCCceEEE
Confidence            999999999999999876432         3468999999999999999999   7889999999999999999999999


Q ss_pred             eeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCC-CCCcccccCccchhHHhhhcC
Q 045539          759 SDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKK-KPTDEIFIGELSLNRWINDLL  837 (897)
Q Consensus       759 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~  837 (897)
                      +|||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||. .||.....     .+.     
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~-----  244 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV-----  244 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH-----
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHH-----
Confidence            9999998775544444444556899999999999999999999999999999999985 56654211     111     


Q ss_pred             CchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcCC
Q 045539          838 PVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALDP  895 (897)
Q Consensus       838 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~~  895 (897)
                         ...+.+......+       ..+..++.+++.+||+.|| ++|||++||+++|++
T Consensus       245 ---~~~i~~~~~~~~p-------~~~~~~l~~li~~cl~~~P-~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         245 ---LRFVMEGGLLDKP-------DNCPDMLFELMRMCWQYNP-KMRPSFLEIISSIKE  291 (308)
T ss_dssp             ---HHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHGG
T ss_pred             ---HHHHHhCCCCCCc-------ccchHHHHHHHHHHcCCCh-hHCcCHHHHHHHHHH
Confidence               1111111111111       1233468999999999999 999999999999876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=382.02  Aligned_cols=269  Identities=20%  Similarity=0.256  Sum_probs=200.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH--HHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE--RALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999874 699999999975432  235788899999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      |+.++.+..........+++.++..++.|++.||+||   |++|||||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            9976555544445556799999999999999999999   889999999999999999999999999999987654332 


Q ss_pred             eeeeccccCcccCCcCccCCCC-CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcC-Cch--HHHHh--hh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLL-PVS--VMEVI--DT  847 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~i--~~  847 (897)
                       ......||+.|+|||...... ++.++||||+||++|+|++|+.||......+ .+........ +.+  .....  ..
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccc
Confidence             233457999999999866554 5889999999999999999999997532111 1111111000 000  00000  00


Q ss_pred             ---hh-cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          848 ---NL-LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       848 ---~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         .. ................++.+++.+|++.|| ++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP-~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP-NKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSST-TTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCCh-hHCcCHHHHhCC
Confidence               00 000000011111233567899999999999 999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=381.54  Aligned_cols=269  Identities=20%  Similarity=0.216  Sum_probs=196.3

Q ss_pred             cCCeeecccceEEEEEEec-CCceEEEEEechhhHH-----HHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          621 ENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYER-----ALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       621 ~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ..++||+|+||+||+|++. +|+.||||+++.....     ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999875 6899999998754321     234688999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      ++++++..+... ...+++.++..++.||+.||+||   |++||+||||||+||+++.++.+||+|||.|+.......  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            988877765543 44688999999999999999999   899999999999999999999999999999987654322  


Q ss_pred             eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhc-------CCchHHHHhh
Q 045539          775 IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDL-------LPVSVMEVID  846 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~  846 (897)
                      ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ .+.......       ++........
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence            2234579999999998765 457999999999999999999999996532111 011110000       0000000000


Q ss_pred             hhhcchhhhh-HHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh--cCCCC
Q 045539          847 TNLLRGEERF-FAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA--LDPNP  897 (897)
Q Consensus       847 ~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~--L~~~~  897 (897)
                      ......+... .........++.+++.+|++.|| ++||||+|+++.  +++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP-~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP-CARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSST-TTSCCHHHHHTSGGGTSSS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCCh-hhCcCHHHHhCCHhhCCCC
Confidence            0000000000 00001223457899999999999 999999999973  55543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-44  Score=382.85  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCc--eEEEEEechh-hHHHHHHHHHHHHHHHhc-CCCccceEeeeecCCCceEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGM--EVAVKVFHQQ-YERALKSFEDECEVMKRI-RHRNLVKIISSCSNDDFKALI  691 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  691 (897)
                      ++|++.+.||+|+||+||+|++. +|.  .||||+++.. ..+..+.+.+|+++++++ +|||||+++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999876 344  4778887543 234556899999999999 699999999999999999999


Q ss_pred             EEeccCCChhHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcE
Q 045539          692 MKYMPNGSLENCLYSG---------------TCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVA  756 (897)
Q Consensus       692 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~  756 (897)
                      |||+++|+|.++++..               ...+++.++..++.||++||+|+   |++||+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCce
Confidence            9999999999998754               25689999999999999999999   88999999999999999999999


Q ss_pred             EEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCC-CCcccccCccchhHHhhh
Q 045539          757 HISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKK-PTDEIFIGELSLNRWIND  835 (897)
Q Consensus       757 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~-p~~~~~~~~~~~~~~~~~  835 (897)
                      ||+|||+|+......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||....  ...+      
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~------  235 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAEL------  235 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH------
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHH------
Confidence            999999997653221   1223468999999999999999999999999999999999765 564421  1111      


Q ss_pred             cCCchHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          836 LLPVSVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       836 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                            .+.+........+      ..+..++.+++.+||+.|| ++||||+||++.|+
T Consensus       236 ------~~~i~~~~~~~~~------~~~~~~~~~li~~cl~~dP-~~RPs~~eil~~L~  281 (309)
T d1fvra_         236 ------YEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKP-YERPSFAQILVSLN  281 (309)
T ss_dssp             ------HHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSG-GGSCCHHHHHHHHH
T ss_pred             ------HHHHHhcCCCCCC------ccCCHHHHHHHHHHcCCCh-hHCcCHHHHHHHHH
Confidence                  1111111000000      1233468899999999999 99999999998874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=373.80  Aligned_cols=240  Identities=20%  Similarity=0.254  Sum_probs=195.0

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhH------HHHHHHHHHHHHHHhcC--CCccceEeeeecCCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYE------RALKSFEDECEVMKRIR--HRNLVKIISSCSNDD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  686 (897)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++++...      ...+++.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999875 689999999875431      11234678999999997  899999999999999


Q ss_pred             ceEEEEEeccC-CChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-CCcEEEeeccCc
Q 045539          687 FKALIMKYMPN-GSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-DMVAHISDFGIA  764 (897)
Q Consensus       687 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a  764 (897)
                      ..|+||||+.+ +++.+++..+. .+++.++..++.|+++||+||   |++||+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57777776544 589999999999999999999   8999999999999999985 579999999999


Q ss_pred             cccCCCCceeeeeccccCcccCCcCccCCCCC-CccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          765 KLLSGEDQLSIQIQTLATIGYMAPEYGTKGRV-CTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       765 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      +......    .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....       +            
T Consensus       159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~------------  215 (273)
T d1xwsa_         159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E------------  215 (273)
T ss_dssp             EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H------------
T ss_pred             eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------H------------
Confidence            8754322    234679999999999876655 677899999999999999999997521       0            


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      +...... .+.       .+..++.+++.+||+.|| ++|||++|+++
T Consensus       216 i~~~~~~-~~~-------~~s~~~~~li~~~L~~dp-~~R~s~~eil~  254 (273)
T d1xwsa_         216 IIRGQVF-FRQ-------RVSSECQHLIRWCLALRP-SDRPTFEEIQN  254 (273)
T ss_dssp             HHHCCCC-CSS-------CCCHHHHHHHHHHTCSSG-GGSCCHHHHHT
T ss_pred             HhhcccC-CCC-------CCCHHHHHHHHHHccCCH-hHCcCHHHHhc
Confidence            1110000 000       112347889999999999 99999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.7e-43  Score=374.68  Aligned_cols=267  Identities=18%  Similarity=0.241  Sum_probs=199.0

Q ss_pred             cCCCcCCeeecccceEEEEEEecCCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEEe
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMKY  694 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  694 (897)
                      ++|++.+.||+|+||+||+|++++|+.||||+++...  ....+++.+|+.++++++||||+++++++.+++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999986543  23357889999999999999999999999999999999999


Q ss_pred             ccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCcee
Q 045539          695 MPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS  774 (897)
Q Consensus       695 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~  774 (897)
                      +.++.+..+... ...+++..+..++.||+.||+||   |++||+||||||+||+++.++.+|++|||.|........  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            987766665544 45699999999999999999999   789999999999999999999999999999987653322  


Q ss_pred             eeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC---chHHHHhh----
Q 045539          775 IQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP---VSVMEVID----  846 (897)
Q Consensus       775 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~i~----  846 (897)
                      ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ...+.......   ........    
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhc
Confidence            2234468999999998765 456899999999999999999999997532111 11111110000   00000000    


Q ss_pred             -hhh-cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 -TNL-LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 -~~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                       ... ...........+.....+.+++.+|++.|| ++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP-~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP-NQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST-TTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence             000 000000000011123457899999999999 99999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-43  Score=375.18  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=197.4

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-C-CceEEEEEechhhH--HHHHHHHHHHHHHHhc---CCCccceEeeeec-----
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-D-GMEVAVKVFHQQYE--RALKSFEDECEVMKRI---RHRNLVKIISSCS-----  683 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  683 (897)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+.+++.+   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            579999999999999999999874 4 66799999865421  1223456777777766   7999999999984     


Q ss_pred             CCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccC
Q 045539          684 NDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGI  763 (897)
Q Consensus       684 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~  763 (897)
                      .....+++|||++++.+..........+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence            34578999999999888766666666799999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-------c
Q 045539          764 AKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-------L  836 (897)
Q Consensus       764 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~  836 (897)
                      ++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+......       .
T Consensus       163 ~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         163 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             hhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhc
Confidence            87654322   234567999999999999999999999999999999999999999753211 111111110       0


Q ss_pred             CCch---HHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          837 LPVS---VMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       837 ~~~~---~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ++..   ................   .......+.+++.+|++.|| ++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~~dP-~~R~sa~e~L~  292 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKF---VTDIDELGKDLLLKCLTFNP-AKRISAYSALS  292 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGT---CCSCCHHHHHHHHHHSCSST-TTSCCHHHHHT
T ss_pred             ccccccchhhhhccccccchhhc---cccCCHHHHHHHHHHCcCCh-hHCcCHHHHhc
Confidence            0000   0000000000000000   01123456789999999999 99999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=370.63  Aligned_cols=270  Identities=20%  Similarity=0.235  Sum_probs=196.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh-HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC----ceE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY-ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD----FKA  689 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  689 (897)
                      +++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            468999999999999999999864 79999999997543 445678899999999999999999999986553    234


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCC
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG  769 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~  769 (897)
                      ++++|+.+|+|.+++..+.  +++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            5556677999999997754  89999999999999999999   889999999999999999999999999999986543


Q ss_pred             CCce-eeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhh-cCCc-------
Q 045539          770 EDQL-SIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIND-LLPV-------  839 (897)
Q Consensus       770 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-------  839 (897)
                      .... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ....... ..+.       
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhhh
Confidence            2221 12234568999999998744 5678999999999999999999999975321111 0000000 0000       


Q ss_pred             ---hHHHHhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          840 ---SVMEVIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       840 ---~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                         ..........................++.+++.+|++.|| ++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP-~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSST-TTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCCh-hHCcCHHHHhcC
Confidence               0011110000000000001111223457899999999999 999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=368.68  Aligned_cols=261  Identities=23%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCC------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDD------  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  686 (897)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999875 69999999997532  345678899999999999999999999997654      


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..|+||||+ +.+|..+....  .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+|++|||.|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 67888877654  499999999999999999999   899999999999999999999999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh--hcCCc----
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN--DLLPV----  839 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~----  839 (897)
                      ....     .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....  ...+.    
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence            6533     234579999999998765 45689999999999999999999999753111 11111111  00000    


Q ss_pred             ----hHHHHhhhhh----cchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          840 ----SVMEVIDTNL----LRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       840 ----~~~~~i~~~l----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                          .........+    ........   ......+.+++.+|+..|| ++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~mL~~dP-~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASIL---TNASPLAVNLLEKMLVLDA-EQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTC---TTCCHHHHHHHHHHSCSST-TTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchHHhc---cCCCHHHHHHHHHHCcCCh-hHCcCHHHHhcC
Confidence                0000000000    00000000   1122356789999999999 999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-41  Score=361.89  Aligned_cols=259  Identities=20%  Similarity=0.241  Sum_probs=197.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccc-eEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLV-KIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+.+|++++++++|++++ .+.+++.+++..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            468999999999999999999874 689999999875432  24578899999999876655 55566678888999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeC---CCCcEEEeeccCccccCCC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGE  770 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~~~  770 (897)
                      |+ ++++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++   .+..+|++|||+|+.....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 5677777766666799999999999999999999   889999999999999986   4457999999999887543


Q ss_pred             Cce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHHh
Q 045539          771 DQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEVI  845 (897)
Q Consensus       771 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  845 (897)
                      ...     .......||+.|+|||...+..+++++|||||||++|||+||+.||..........          ......
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~----------~~~~~~  229 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------KYERIS  229 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------------HHHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH----------HHHHhh
Confidence            321     12334579999999999999999999999999999999999999997632221100          000111


Q ss_pred             hhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          846 DTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       846 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      ...+....+   .....++.++.+++..||+.|| ++||+++++.+.|+
T Consensus       230 ~~~~~~~~~---~~~~~~p~~~~~li~~cl~~~p-~~RP~~~~i~~~l~  274 (299)
T d1ckia_         230 EKKMSTPIE---VLCKGYPSEFATYLNFCRSLRF-DDKPDYSYLRQLFR  274 (299)
T ss_dssp             HHHHHSCHH---HHTTTSCHHHHHHHHHHHHSCT-TCCCCHHHHHHHHH
T ss_pred             cccCCCChh---HhccCCCHHHHHHHHHHccCCh-hHCcCHHHHHHHHH
Confidence            111111110   0011234568899999999999 99999998877664

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.4e-41  Score=357.15  Aligned_cols=259  Identities=14%  Similarity=0.156  Sum_probs=203.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCC-CccceEeeeecCCCceEEEEE
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRH-RNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  693 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999865 689999999865432  2456789999999975 899999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCC-----CCcEEEeeccCccccC
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLS  768 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~-----~~~~kL~DFg~a~~~~  768 (897)
                      |+ +++|.+++......++..++..++.|++.||+||   |++||+||||||+||+++.     ++.+||+|||+|+...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 7899999887777799999999999999999999   8999999999999999974     5689999999998765


Q ss_pred             CCCce-----eeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHH
Q 045539          769 GEDQL-----SIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVME  843 (897)
Q Consensus       769 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  843 (897)
                      .....     .......||+.|+|||++.+..+++++|||||||++|||+||+.||........  ...        ...
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--~~~--------~~~  227 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQK--------YER  227 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHH--------HHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH--HHH--------HHH
Confidence            33221     122345799999999999999999999999999999999999999975322211  000        001


Q ss_pred             HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhhcC
Q 045539          844 VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSALD  894 (897)
Q Consensus       844 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~L~  894 (897)
                      +.........+   .....++.++.+++..|+..+| ++||+++.+.+.|+
T Consensus       228 i~~~~~~~~~~---~l~~~~p~~l~~ii~~~~~~~~-~~rP~y~~l~~~l~  274 (293)
T d1csna_         228 IGEKKQSTPLR---ELCAGFPEEFYKYMHYARNLAF-DATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHHHSCHH---HHTTTSCHHHHHHHHHHHHCCT-TCCCCHHHHHHHHH
T ss_pred             HHhccCCCChH---HhcCCCCHHHHHHHHHHhcCCc-ccCcCHHHHHHHHH
Confidence            11111000000   0001233568899999999999 99999888776653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=360.18  Aligned_cols=271  Identities=20%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC--------
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN--------  684 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  684 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999875 79999999986542  2345678899999999999999999998854        


Q ss_pred             CCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCc
Q 045539          685 DDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIA  764 (897)
Q Consensus       685 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a  764 (897)
                      ++..|+||||++++.+.... .....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+|++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34679999999877665443 4445689999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCce--eeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCcc--chhHHhhhcCC-
Q 045539          765 KLLSGEDQL--SIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGEL--SLNRWINDLLP-  838 (897)
Q Consensus       765 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~-  838 (897)
                      .........  .......||+.|+|||++.+. .+++++||||+||++|||++|+.||........  ...+......+ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            776533221  122234699999999987654 689999999999999999999999975321100  00111100000 


Q ss_pred             -------chHHHHhhhh--hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          839 -------VSVMEVIDTN--LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       839 -------~~~~~~i~~~--l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                             ......+...  ........+.. ......+.+++.+||+.|| ++||||+|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP-~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKA-YVRDPYALDLIDKLLVLDP-AQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHH-HHCCHHHHHHHHHHSCSST-TTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhcc-ccCCHHHHHHHHHHCcCCh-hHCcCHHHHHcC
Confidence                   0011111100  00011111111 1112356789999999999 999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=364.41  Aligned_cols=261  Identities=23%  Similarity=0.261  Sum_probs=190.6

Q ss_pred             CCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCccceEeeeecC------CCceEE
Q 045539          618 RFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNLVKIISSCSN------DDFKAL  690 (897)
Q Consensus       618 ~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  690 (897)
                      +|+..++||+|+||+||+|++. +|+.||||+++...    ....+|++++++++||||++++++|..      ..+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888999999999999999875 69999999997543    223479999999999999999999843      335789


Q ss_pred             EEEeccCCChhHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCcccc
Q 045539          691 IMKYMPNGSLENCLY--SGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLL  767 (897)
Q Consensus       691 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~  767 (897)
                      ||||++++.+.....  .....+++.++..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998765444332  2345699999999999999999999   899999999999999999775 8999999999876


Q ss_pred             CCCCceeeeeccccCcccCCcCccCC-CCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc--h-HHH
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTK-GRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV--S-VME  843 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~  843 (897)
                      .....   .....||+.|+|||...+ ..++.++||||+||++|||++|+.||...... ..+.......-..  . ...
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence            54332   234579999999997654 57899999999999999999999999753211 1111111100000  0 000


Q ss_pred             Hhhh-------hhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          844 VIDT-------NLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       844 ~i~~-------~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ....       .....+... ........++.+++.+|++.|| ++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP-~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTP-TARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            0000       000000000 0000123457889999999999 99999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=358.85  Aligned_cols=268  Identities=17%  Similarity=0.209  Sum_probs=202.2

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCCCceEEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSNDDFKALIMK  693 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  693 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999875 68999999986443  3456788999999999999999999999999999999999


Q ss_pred             eccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccccCCCCce
Q 045539          694 YMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL  773 (897)
Q Consensus       694 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~  773 (897)
                      ++.++++..++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99999988877655 4689999999999999999999   889999999999999999999999999999987654332 


Q ss_pred             eeeeccccCcccCCcCccCCCC-CCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCC---ch---HHHHhh
Q 045539          774 SIQIQTLATIGYMAPEYGTKGR-VCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLP---VS---VMEVID  846 (897)
Q Consensus       774 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~i~  846 (897)
                       ......+++.|+|||.+.... ++.++||||+||++|||++|+.||..................+   ..   .....+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             223345788999999876654 6899999999999999999999975422111111111100000   00   000000


Q ss_pred             hh---hcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          847 TN---LLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       847 ~~---l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      ..   ..................+.+++.+|++.|| ++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP-~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP-VQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG-GGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence            00   0000000000001122457789999999999 99999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.3e-40  Score=359.38  Aligned_cols=260  Identities=19%  Similarity=0.257  Sum_probs=195.3

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecC--CCceEEEE
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSN--DDFKALIM  692 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  692 (897)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++...   .+++.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999874 68999999987543   356789999999996 9999999999864  45689999


Q ss_pred             EeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC-cEEEeeccCccccCCCC
Q 045539          693 KYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGED  771 (897)
Q Consensus       693 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~  771 (897)
                      ||+++++|.++.    ..+++.++..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997764    2489999999999999999999   899999999999999998655 69999999998765433


Q ss_pred             ceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCc-----------
Q 045539          772 QLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPV-----------  839 (897)
Q Consensus       772 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  839 (897)
                      .   .....+|+.|+|||...+. .++.++||||+||++|||++|+.||............ +......           
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR-IAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH-HHHHHCHHHHHHHHHHTT
T ss_pred             c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH-HHHHHCCchhhhhhhhcc
Confidence            2   2345689999999987654 5799999999999999999999999653211110000 0000000           


Q ss_pred             -----hHHHHhhhhhcchhhh--hHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          840 -----SVMEVIDTNLLRGEER--FFAAKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       840 -----~~~~~i~~~l~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                           ................  .......+..++.+++.+|++.|| ++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP-~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH-QSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh-hHCcCHHHHhc
Confidence                 0000000000000000  000011223457899999999999 99999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-40  Score=360.73  Aligned_cols=261  Identities=21%  Similarity=0.221  Sum_probs=190.8

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecC------CCc
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSN------DDF  687 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  687 (897)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999876 69999999997543  3445678999999999999999999999853      467


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .|+||||+.++.+..+ .   ..+++..++.++.|++.||+||   |++||+||||||+||+++.++.+|++|||.++..
T Consensus        97 ~~iv~Ey~~~~l~~~~-~---~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHhh-h---cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcc
Confidence            8999999977655543 3   2489999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhh----------hcC
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWIN----------DLL  837 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~  837 (897)
                      ....   ......||+.|+|||++.+..+++++||||+||++|||++|+.||...... ......+.          ...
T Consensus       170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHh
Confidence            4322   234556899999999999999999999999999999999999999642111 00000000          000


Q ss_pred             CchHHH---------------HhhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHhh
Q 045539          838 PVSVME---------------VIDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGADMGWIFSA  892 (897)
Q Consensus       838 ~~~~~~---------------~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~~  892 (897)
                      .....+               ..........   ..........+.+++.+|++.|| ++||||+|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~dll~~mL~~dP-~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPAD---SEHNKLKASQARDLLSKMLVIDP-AKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCS---SHHHHHHHHHHHHHHHHHSCSST-TTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCcccccccccccccccccccc---ccccccCCHHHHHHHHHHCcCCh-hHCcCHHHHhcC
Confidence            011111               1111111111   11223345668899999999999 999999999853

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=364.62  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             hcCCCcCCeeecccceEEEEEEec----CCceEEEEEechhh----HHHHHHHHHHHHHHHhcCC-CccceEeeeecCCC
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ----DGMEVAVKVFHQQY----ERALKSFEDECEVMKRIRH-RNLVKIISSCSNDD  686 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  686 (897)
                      .++|++.+.||+|+||+||+|+..    +|+.||||++++..    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999752    47899999986432    2234667899999999976 89999999999999


Q ss_pred             ceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          687 FKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       687 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ..++||||+.+|+|.+++.... .+++..+..++.|++.||+|+   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999987765 467889999999999999999   899999999999999999999999999999987


Q ss_pred             cCCCCceeeeeccccCcccCCcCccCCC--CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHhhhcCCchHHHH
Q 045539          767 LSGEDQLSIQIQTLATIGYMAPEYGTKG--RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWINDLLPVSVMEV  844 (897)
Q Consensus       767 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  844 (897)
                      +..... .......|++.|+|||.....  .++.++||||+||++|||++|+.||........             ...+
T Consensus       179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-------------~~~i  244 (322)
T d1vzoa_         179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------------QAEI  244 (322)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------------HHHH
T ss_pred             hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHH
Confidence            643322 223345799999999987654  468899999999999999999999976422211             1111


Q ss_pred             hhhhhcchhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCC-----CHHHHHh
Q 045539          845 IDTNLLRGEERFFAAKEQILLSVLNLATECTIESRDGNGA-----DMGWIFS  891 (897)
Q Consensus       845 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RP-----t~~evl~  891 (897)
                      ........++ .   ......++.+++.+|+++|| ++||     |++|+++
T Consensus       245 ~~~~~~~~~~-~---~~~~s~~~~~li~~~l~~dP-~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         245 SRRILKSEPP-Y---PQEMSALAKDLIQRLLMKDP-KKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHCCCC-C---CTTSCHHHHHHHHHHTCSSG-GGSTTSSTTTHHHHHT
T ss_pred             HHhcccCCCC-C---cccCCHHHHHHHHHHcccCH-HHcCCCCcccHHHHHc
Confidence            1111111110 0   01233567889999999999 9999     4788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-40  Score=360.82  Aligned_cols=262  Identities=22%  Similarity=0.272  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeecccceEEEEEEec-CCceEEEEEechhh--HHHHHHHHHHHHHHHhcCCCccceEeeeecCC-----Cc
Q 045539          616 TDRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQY--ERALKSFEDECEVMKRIRHRNLVKIISSCSND-----DF  687 (897)
Q Consensus       616 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  687 (897)
                      .++|++.+.||+|+||+||+|++. +|+.||||++++..  ....+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999864 79999999997543  34456788999999999999999999998533     34


Q ss_pred             eEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcccc
Q 045539          688 KALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL  767 (897)
Q Consensus       688 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~  767 (897)
                      .+++|+|+.+|+|.+++..+  .+++.++..++.||+.||+||   |++||+||||||+||+++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhccc
Confidence            46667788899999998765  499999999999999999999   8899999999999999999999999999999765


Q ss_pred             CCCCceeeeeccccCcccCCcCccCCC-CCCccchHHHHHHHHHHHHcCCCCCcccccCccchhHHh-h----------h
Q 045539          768 SGEDQLSIQIQTLATIGYMAPEYGTKG-RVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGELSLNRWI-N----------D  835 (897)
Q Consensus       768 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvil~elltg~~p~~~~~~~~~~~~~~~-~----------~  835 (897)
                      ...     .....||+.|+|||...+. .++.++||||+||++|+|++|+.||......  .....+ .          .
T Consensus       172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHT
T ss_pred             Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHHhh
Confidence            322     2345689999999976554 5689999999999999999999999652111  111110 0          0


Q ss_pred             cCCc-hHHHHhhhhhcchhhhhHH-HHHHHHHHHHHHHhHccCCCCCCCCCCHHHHHh
Q 045539          836 LLPV-SVMEVIDTNLLRGEERFFA-AKEQILLSVLNLATECTIESRDGNGADMGWIFS  891 (897)
Q Consensus       836 ~~~~-~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~~RPt~~evl~  891 (897)
                      .... ....... .+...+...+. .......++.+++.+|++.|| ++||||+|+++
T Consensus       245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP-~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSG-GGSCCHHHHHT
T ss_pred             hccchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCCh-hhCcCHHHHhc
Confidence            0000 0111111 11111100010 111233457899999999999 99999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-36  Score=328.54  Aligned_cols=267  Identities=18%  Similarity=0.240  Sum_probs=188.4

Q ss_pred             cCCCcCCeeecccceEEEEEEec-CCceEEEEEechhhHHHHHHHHHHHHHHHhcC-----------CCccceEeeeecC
Q 045539          617 DRFSENNLIGIGSFGSIYVARLQ-DGMEVAVKVFHQQYERALKSFEDECEVMKRIR-----------HRNLVKIISSCSN  684 (897)
Q Consensus       617 ~~y~~~~~lg~G~~g~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  684 (897)
                      ++|++.++||+|+||+||+|+.. +|+.||||++++... ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999874 799999999986532 3456788999988875           5789999988754


Q ss_pred             --CCceEEEEEeccCCChhH--hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCC------
Q 045539          685 --DDFKALIMKYMPNGSLEN--CLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDM------  754 (897)
Q Consensus       685 --~~~~~lv~e~~~~gsL~~--~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~------  754 (897)
                        ....+++|+++..+....  ........+++..+..++.||+.||+|||  |..||+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCcccccc
Confidence              345566777665543222  22333456899999999999999999995  458999999999999998654      


Q ss_pred             cEEEeeccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHHHHHHcCCCCCcccccCc-c----ch
Q 045539          755 VAHISDFGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIMLMEMFTKKKPTDEIFIGE-L----SL  829 (897)
Q Consensus       755 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil~elltg~~p~~~~~~~~-~----~~  829 (897)
                      .++++|||.|......     .....||+.|+|||+.....++.++||||+||+++||++|+.||....... .    ..
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            4999999999765422     234569999999999988899999999999999999999999997532110 0    01


Q ss_pred             hHHhh--hcCCchHH-------HHhhh-----hhcc--------hhhhhHHHHHHHHHHHHHHHhHccCCCCCCCCCCHH
Q 045539          830 NRWIN--DLLPVSVM-------EVIDT-----NLLR--------GEERFFAAKEQILLSVLNLATECTIESRDGNGADMG  887 (897)
Q Consensus       830 ~~~~~--~~~~~~~~-------~~i~~-----~l~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~~RPt~~  887 (897)
                      ...+.  ...+....       ...+.     .+..        .........+....++.+++.+|++.|| ++||||+
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP-~~Rpta~  323 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP-RKRADAG  323 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST-TTCBCHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh-hHCcCHH
Confidence            11110  00011000       00000     0000        0000011113455678999999999999 9999999


Q ss_pred             HHHhh
Q 045539          888 WIFSA  892 (897)
Q Consensus       888 evl~~  892 (897)
                      |+++.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99873

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=5.2e-33  Score=299.43  Aligned_cols=256  Identities=32%  Similarity=0.514  Sum_probs=209.4

Q ss_pred             CCCcEEEecCCCCCCC--CCCcccCchHHHHHHHhcc-CCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchh
Q 045539          290 KKLKVLILTGNPLDGI--LPKSKGNLSLSLEIILMDN-CSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQ  366 (897)
Q Consensus       290 ~~L~~L~Ls~N~l~~~--~p~~~~~l~~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  366 (897)
                      .+++.|+|++|.+.+.  +|..+++++ +|++|++++ |+++|.+|..|+++++|++|+|++|++++..+..+..+.+|+
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence            3688999999999874  667777776 677777765 677777777777777777777777777777777777777777


Q ss_pred             hhcccCcccccccchhhhcccccccccccccccccCCCccccccccc-ceeccccccccCCccccccccccceEEeecCC
Q 045539          367 ALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSL-RVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       367 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      .+++++|++.+.+|..+..+++|+.+++++|++++.+|..+..+..+ +.+++++|++++..|..+..+..+        
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~--------  200 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA--------  200 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS--------
T ss_pred             ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence            77777777777777777777777777777777777777777766664 667777777777666666554322        


Q ss_pred             cccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       446 ~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                            .+++++|.+.|.+|..++.+++|+.+++++|.+++.+| .++.+++|+.|+|++|+|+|.+|.++.++++|++|
T Consensus       201 ------~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L  273 (313)
T d1ogqa_         201 ------FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL  273 (313)
T ss_dssp             ------EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred             ------cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEE
Confidence                  57778888889999999999999999999999998765 68999999999999999999999999999999999


Q ss_pred             eccCCcccccCCCCCCCCCCCcccccchhhhhhhhh
Q 045539          526 NLSFNKLEGEIPRGGPFANLTAKSFMGNELLKMLLL  561 (897)
Q Consensus       526 ~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~l  561 (897)
                      +|++|+|+|.+|..+.+.+++.+++.||+.+||.++
T Consensus       274 ~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             ECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             ECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence            999999999999998999999999999999999754

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=8.4e-30  Score=282.54  Aligned_cols=342  Identities=27%  Similarity=0.391  Sum_probs=206.7

Q ss_pred             CCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccc
Q 045539           98 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARL  177 (897)
Q Consensus        98 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L  177 (897)
                      .+.+|++|++++|+|+. + +.+..|++|++|+|++|+|++..+  +.++++|++|++++|++.+ ++ .++++++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence            45566666666666652 3 345666666666666666655432  5666666666666666653 22 25666666666


Q ss_pred             ccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          178 AFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       178 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      ++++|.+++..+  ......+..+....|.+... ..................     .....+...+.........|..
T Consensus       116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  187 (384)
T d2omza2         116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-SALSGLTSLQQLSFGNQV-----TDLKPLANLTTLERLDISSNKV  187 (384)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-GGGTTCTTCSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCC
T ss_pred             cccccccccccc--cccccccccccccccccccc-cccccccccccccccccc-----chhhhhcccccccccccccccc
Confidence            666666655533  23344555555555555421 111110111111111111     1112222333333333333322


Q ss_pred             ccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccC
Q 045539          258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGN  337 (897)
Q Consensus       258 ~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~  337 (897)
                      ..                       ......+++++.+++++|.++++.|                           +..
T Consensus       188 ~~-----------------------~~~~~~l~~~~~l~l~~n~i~~~~~---------------------------~~~  217 (384)
T d2omza2         188 SD-----------------------ISVLAKLTNLESLIATNNQISDITP---------------------------LGI  217 (384)
T ss_dssp             CC-----------------------CGGGGGCTTCSEEECCSSCCCCCGG---------------------------GGG
T ss_pred             cc-----------------------ccccccccccceeeccCCccCCCCc---------------------------ccc
Confidence            21                       1224566777777777777765321                           334


Q ss_pred             ccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceec
Q 045539          338 LGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLY  417 (897)
Q Consensus       338 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  417 (897)
                      .++|++|++++|++++.  +.+..+++|+.|++++|++++..+  +..+++|++|++++|++++..  .+..++.++.++
T Consensus       218 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~  291 (384)
T d2omza2         218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLE  291 (384)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred             cCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccc
Confidence            56778888888887763  356777788888888888775443  667778888888888887443  366777888888


Q ss_pred             cccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCC
Q 045539          418 LGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSS  497 (897)
Q Consensus       418 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~  497 (897)
                      ++.|.+++.  ..+..+++++             .|++++|++++..  .+..+++|++|++++|+|++ +| .|.++++
T Consensus       292 ~~~n~l~~~--~~~~~~~~l~-------------~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~  352 (384)
T d2omza2         292 LNENQLEDI--SPISNLKNLT-------------YLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTN  352 (384)
T ss_dssp             CCSSCCSCC--GGGGGCTTCS-------------EEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTT
T ss_pred             ccccccccc--cccchhcccC-------------eEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCC
Confidence            888888752  3356666666             4455555555432  26778888999999998884 44 5888889


Q ss_pred             CcEEeccCCccCCCCchhhhhhcccceEeccCC
Q 045539          498 LEVLDLSKNKISGAIPASLQKLLYLKHLNLSFN  530 (897)
Q Consensus       498 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  530 (897)
                      |++|+|++|+|++..|  +.++++|+.|+|++|
T Consensus       353 L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9999999999886544  788888999999887

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2.2e-28  Score=271.01  Aligned_cols=341  Identities=23%  Similarity=0.336  Sum_probs=256.8

Q ss_pred             CeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEe
Q 045539           76 HRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      ..++.|++++++++. + +.++.|++|++|||++|+|++ +| .|+++++|++|++++|++.+..+  +..+++|+.|++
T Consensus        44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~  117 (384)
T d2omza2          44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL  117 (384)
T ss_dssp             TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccccccc--cccccccccccc
Confidence            358899999999874 3 468899999999999999995 44 39999999999999999987654  889999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      ++|.+++..+  ......+..+....|.+....+..................+.      .....+.........|..  
T Consensus       118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~--  187 (384)
T d2omza2         118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK------PLANLTTLERLDISSNKV--  187 (384)
T ss_dssp             CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG------GGTTCTTCCEEECCSSCC--
T ss_pred             cccccccccc--ccccccccccccccccccccccccccccccccccccccchhh------hhcccccccccccccccc--
Confidence            9999985433  445677788888888877765544333333332222222221      111233444455555554  


Q ss_pred             cccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchH
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSL  315 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (897)
                      .....+..+++++.+++++|.+++..|                       ...+++|++|++++|+++..          
T Consensus       188 ~~~~~~~~l~~~~~l~l~~n~i~~~~~-----------------------~~~~~~L~~L~l~~n~l~~~----------  234 (384)
T d2omza2         188 SDISVLAKLTNLESLIATNNQISDITP-----------------------LGILTNLDELSLNGNQLKDI----------  234 (384)
T ss_dssp             CCCGGGGGCTTCSEEECCSSCCCCCGG-----------------------GGGCTTCCEEECCSSCCCCC----------
T ss_pred             ccccccccccccceeeccCCccCCCCc-----------------------ccccCCCCEEECCCCCCCCc----------
Confidence            345667788999999999999887654                       24567899999999988742          


Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                                       ..+..+++|+.|++++|++++..+  +..+++|++|++++|++++..  .+..++.++.++++
T Consensus       235 -----------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~  293 (384)
T d2omza2         235 -----------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN  293 (384)
T ss_dssp             -----------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred             -----------------chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccc
Confidence                             235677889999999999987544  778889999999999988643  36778889999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      .|++++  +..+..+++++.|++++|++++..+  +..+++|+.|++++|+             +++ +| .++++++|+
T Consensus       294 ~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~-------------l~~-l~-~l~~l~~L~  354 (384)
T d2omza2         294 ENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK-------------VSD-VS-SLANLTNIN  354 (384)
T ss_dssp             SSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSC-------------CCC-CG-GGGGCTTCC
T ss_pred             cccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCC-------------CCC-Ch-hHcCCCCCC
Confidence            999985  3457888899999999999987533  7778888855555544             443 23 578899999


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCc
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNK  507 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  507 (897)
                      +|++++|+|++..|  +.++++|+.|+|++|.
T Consensus       355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         355 WLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             EEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             EEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            99999999997654  8999999999999983

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.5e-26  Score=247.46  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=154.0

Q ss_pred             cceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCcccc
Q 045539           64 CSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFF  143 (897)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  143 (897)
                      |.|++|.|+.            ++++ ++|+.+.  +++++|||++|+|+...+..|.++++|++|++++|++....|..
T Consensus        10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_          10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            7899999964            3455 6777664  68999999999998555567999999999999999988888888


Q ss_pred             ccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCcccccccccc
Q 045539          144 IFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNV  223 (897)
Q Consensus       144 ~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L  223 (897)
                      |.++++|++|++++|+++ .+|..+  ...|+.|.+.+|.+.++.+..+.....++.++...|...              
T Consensus        75 f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~--------------  137 (305)
T d1xkua_          75 FAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK--------------  137 (305)
T ss_dssp             TTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC--------------
T ss_pred             hhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccc--------------
Confidence            888888888888888887 455443  235555666666665554444444444444443333221              


Q ss_pred             ceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCC
Q 045539          224 ETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       224 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~  303 (897)
                               .....+..+                                             ..+++|+++++++|++.
T Consensus       138 ---------~~~~~~~~~---------------------------------------------~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_         138 ---------SSGIENGAF---------------------------------------------QGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             ---------GGGBCTTGG---------------------------------------------GGCTTCCEEECCSSCCC
T ss_pred             ---------ccCCCcccc---------------------------------------------ccccccCccccccCCcc
Confidence                     001111222                                             33445555555555444


Q ss_pred             CCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhh
Q 045539          304 GILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDEL  383 (897)
Q Consensus       304 ~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  383 (897)
                      .+ |                         ..  .+++|+.|++++|.+++..+..|.+++.++.|++++|++.+..+..+
T Consensus       164 ~l-~-------------------------~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~  215 (305)
T d1xkua_         164 TI-P-------------------------QG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL  215 (305)
T ss_dssp             SC-C-------------------------SS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred             cc-C-------------------------cc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccc
Confidence            21 1                         11  12455566666666655555556666666666666666665555566


Q ss_pred             hcccccccccccccccccCCCcccccccccceeccccccccC
Q 045539          384 CHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTS  425 (897)
Q Consensus       384 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  425 (897)
                      .++++|++|+|++|+|+ .+|..|.++++|++|+|++|+++.
T Consensus       216 ~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         216 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             cccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence            66666666666666666 456666666666666666666664

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.7e-25  Score=237.62  Aligned_cols=272  Identities=23%  Similarity=0.275  Sum_probs=199.3

Q ss_pred             cccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCccccccccccccCC
Q 045539          197 ALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSS  276 (897)
Q Consensus       197 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~  276 (897)
                      .++.++.++++++ ++|..+.   +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|           
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f-----------   75 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-----------   75 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-----------
T ss_pred             cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh-----------
Confidence            4566777777777 7777654   567788888888876555678888888888888888877766543           


Q ss_pred             CCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCcc
Q 045539          277 TPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIP  356 (897)
Q Consensus       277 ~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  356 (897)
                                .++++|++|++++|+++.+ |.                         .  ....+..|++++|.+.++.+
T Consensus        76 ----------~~l~~L~~L~l~~n~l~~l-~~-------------------------~--~~~~l~~L~~~~n~l~~l~~  117 (305)
T d1xkua_          76 ----------APLVKLERLYLSKNQLKEL-PE-------------------------K--MPKTLQELRVHENEITKVRK  117 (305)
T ss_dssp             ----------TTCTTCCEEECCSSCCSBC-CS-------------------------S--CCTTCCEEECCSSCCCBBCH
T ss_pred             ----------hCCCccCEecccCCccCcC-cc-------------------------c--hhhhhhhhhccccchhhhhh
Confidence                      5667888888888877643 11                         1  12456777777777777666


Q ss_pred             ccccCccchhhhcccCcccc--cccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcccccccc
Q 045539          357 ITFSQLQTLQALGLTRNKLA--GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNL  434 (897)
Q Consensus       357 ~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  434 (897)
                      ..+.....+..++...|...  ...+..+..+++|+.+++++|.++ .+|..+  .++|+.|++++|..++..+..+.++
T Consensus       118 ~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~  194 (305)
T d1xkua_         118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL  194 (305)
T ss_dssp             HHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTC
T ss_pred             hhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcc
Confidence            66666667777777776543  234556777888888888888887 455543  5788889999998888888888888


Q ss_pred             ccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCch
Q 045539          435 KDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA  514 (897)
Q Consensus       435 ~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  514 (897)
                      +.++.             |++++|.+++..|..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+..-..
T Consensus       195 ~~l~~-------------L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~  260 (305)
T d1xkua_         195 NNLAK-------------LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN  260 (305)
T ss_dssp             TTCCE-------------EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred             ccccc-------------cccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChh
Confidence            87774             444555555566778888999999999999998 6788999999999999999999843222


Q ss_pred             ------hhhhhcccceEeccCCccc-ccCCC
Q 045539          515 ------SLQKLLYLKHLNLSFNKLE-GEIPR  538 (897)
Q Consensus       515 ------~~~~l~~L~~L~ls~N~l~-~~~p~  538 (897)
                            ....+.+|+.|+|++|+++ ..++.
T Consensus       261 ~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~  291 (305)
T d1xkua_         261 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQP  291 (305)
T ss_dssp             SSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred             hccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence                  2345678999999999985 44443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.9e-25  Score=236.11  Aligned_cols=252  Identities=24%  Similarity=0.281  Sum_probs=149.9

Q ss_pred             EeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEee-ecCC
Q 045539           82 NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLS-INGL  160 (897)
Q Consensus        82 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs-~N~l  160 (897)
                      +.++.+++ ++|..+.  +++++|+|++|+|++..+..|.++++|++|++++|++....+..+.++..++.++.+ .|.+
T Consensus        17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred             EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence            34556666 6676654  568889999999986666678888888888888888887777777777777777664 4455


Q ss_pred             CCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSS  240 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~  240 (897)
                      +...|..|.++++|++|++++|.+..+.+..+..+++|+.+++++|+++ .+|.                        ..
T Consensus        94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~------------------------~~  148 (284)
T d1ozna_          94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPD------------------------DT  148 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCT------------------------TT
T ss_pred             ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccCh------------------------hH
Confidence            5444556666666666666666666555555555555555555555555 3433                        34


Q ss_pred             ccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHH
Q 045539          241 ITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEII  320 (897)
Q Consensus       241 l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L  320 (897)
                      |..+++|+.|++++|.+++..+..|                     .++++|+++++++|+++++               
T Consensus       149 f~~~~~L~~L~l~~N~l~~l~~~~f---------------------~~l~~L~~l~l~~N~l~~i---------------  192 (284)
T d1ozna_         149 FRDLGNLTHLFLHGNRISSVPERAF---------------------RGLHSLDRLLLHQNRVAHV---------------  192 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTT---------------------TTCTTCCEEECCSSCCCEE---------------
T ss_pred             hccccchhhcccccCcccccchhhh---------------------ccccccchhhhhhcccccc---------------
Confidence            4444455555555555544444332                     3344555555555544432               


Q ss_pred             HhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccc
Q 045539          321 LMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFS  400 (897)
Q Consensus       321 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  400 (897)
                                .|..|..+++|++|++++|++++..+..|.++++|++|+|++|.+...-+. ..-...++.+....+++.
T Consensus       193 ----------~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~  261 (284)
T d1ozna_         193 ----------HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP  261 (284)
T ss_dssp             ----------CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCB
T ss_pred             ----------ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceE
Confidence                      233344555666666666666666666666666666666666666543221 111223445555555555


Q ss_pred             cCCCcccc
Q 045539          401 GSIPSCLG  408 (897)
Q Consensus       401 ~~~p~~~~  408 (897)
                      ...|..+.
T Consensus       262 C~~p~~l~  269 (284)
T d1ozna_         262 CSLPQRLA  269 (284)
T ss_dssp             EEESGGGT
T ss_pred             eCCchHHc
Confidence            55555443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.7e-25  Score=232.99  Aligned_cols=187  Identities=20%  Similarity=0.196  Sum_probs=160.7

Q ss_pred             eEEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEecc-CccccCCccccccccccccEEEe
Q 045539           77 RVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFS-DNQLFGSLSFFIFNVSSVTTIDL  155 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~LdL  155 (897)
                      .++.|+|++|++++..+.+|.++++|++||+++|++.+..+..+.++..++.++.+ .|.+....+..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            46789999999997666789999999999999999998888889999999999875 66777888999999999999999


Q ss_pred             eecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccc
Q 045539          156 SINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       156 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      ++|.+....+..+..+++|+.+++++|+++++.+..|.++++|++|++++|+++ .+|...+..+++|+.+++++|++++
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccc
Confidence            999998777788999999999999999999999999999999999999999998 5666666677788888888888777


Q ss_pred             cccccccCCCcccEEEccccccccccCcc
Q 045539          236 TVPSSITNASKLSDLELGVNLFSGFIPNT  264 (897)
Q Consensus       236 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  264 (897)
                      ..|..|.++++|++|++++|.+.+..+..
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~  220 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEA  220 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred             cChhHhhhhhhcccccccccccccccccc
Confidence            77777777777777777777776655543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.6e-23  Score=218.55  Aligned_cols=203  Identities=23%  Similarity=0.213  Sum_probs=149.9

Q ss_pred             ccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccch
Q 045539          286 LTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTL  365 (897)
Q Consensus       286 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  365 (897)
                      +.+...+.+++.+++.++.+ |.                         .+.  +++++|+|++|+|+++.+..|.++++|
T Consensus         6 ~~~~~~~~~v~C~~~~L~~i-P~-------------------------~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L   57 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLTAL-PP-------------------------DLP--KDTTILHLSENLLYTFSLATLMPYTRL   57 (266)
T ss_dssp             EECSTTCCEEECTTSCCSSC-CS-------------------------CCC--TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred             EcccCCCeEEEccCCCCCee-Cc-------------------------CcC--cCCCEEECcCCcCCCcCHHHhhccccc
Confidence            34556677778888877742 32                         221  367788888888887666778888888


Q ss_pred             hhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCC
Q 045539          366 QALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSN  445 (897)
Q Consensus       366 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  445 (897)
                      ++|+|++|+|+. ++ .++.+++|++|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++       
T Consensus        58 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~-------  127 (266)
T d1p9ag_          58 TQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ-------  127 (266)
T ss_dssp             CEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC-------
T ss_pred             cccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccc-------
Confidence            888888888874 33 3567788888888888887 4566778888888888888888776677777777766       


Q ss_pred             cccccceeecccCcCCCCCcccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          446 SLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       446 ~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                            .|++++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|
T Consensus       128 ------~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L  200 (266)
T d1p9ag_         128 ------ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA  200 (266)
T ss_dssp             ------EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred             ------cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE
Confidence                  4444455555555666777888888888888888777777888888888888888888 788777788888888


Q ss_pred             eccCCccc
Q 045539          526 NLSFNKLE  533 (897)
Q Consensus       526 ~ls~N~l~  533 (897)
                      +|++|++.
T Consensus       201 ~L~~Np~~  208 (266)
T d1p9ag_         201 FLHGNPWL  208 (266)
T ss_dssp             ECCSCCBC
T ss_pred             EecCCCCC
Confidence            88877664

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=9.4e-23  Score=212.70  Aligned_cols=201  Identities=22%  Similarity=0.242  Sum_probs=147.5

Q ss_pred             cccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccccccCcccccccccc
Q 045539          193 FNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNY  272 (897)
Q Consensus       193 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~  272 (897)
                      .+.+.+.+.+.+++.++ .+|..+.   +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+.+          
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~----------   72 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV----------   72 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC----------
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc----------
Confidence            34455666788888887 6777654   568888888888887777788888888888888888875432          


Q ss_pred             ccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCC
Q 045539          273 LTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLT  352 (897)
Q Consensus       273 l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  352 (897)
                                   ++.+++|++|+|++|++++.                          +..+..+++|++|++++|.+.
T Consensus        73 -------------~~~l~~L~~L~Ls~N~l~~~--------------------------~~~~~~l~~L~~L~l~~~~~~  113 (266)
T d1p9ag_          73 -------------DGTLPVLGTLDLSHNQLQSL--------------------------PLLGQTLPALTVLDVSFNRLT  113 (266)
T ss_dssp             -------------CSCCTTCCEEECCSSCCSSC--------------------------CCCTTTCTTCCEEECCSSCCC
T ss_pred             -------------cccccccccccccccccccc--------------------------ccccccccccccccccccccc
Confidence                         34567888888888887642                          334556677777888877777


Q ss_pred             CCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceeccccccccCCcccccc
Q 045539          353 EPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIW  432 (897)
Q Consensus       353 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  432 (897)
                      +..+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+.
T Consensus       114 ~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~  192 (266)
T d1p9ag_         114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF  192 (266)
T ss_dssp             CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred             eeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHC
Confidence            777777777777777777777777666666777777777777777777666667777777777777777777 5666666


Q ss_pred             ccccceEEeecCCcc
Q 045539          433 NLKDILFIDVSSNSL  447 (897)
Q Consensus       433 ~l~~L~~L~ls~N~l  447 (897)
                      .+++|+.|++++|.+
T Consensus       193 ~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         193 GSHLLPFAFLHGNPW  207 (266)
T ss_dssp             TTCCCSEEECCSCCB
T ss_pred             CCCCCCEEEecCCCC
Confidence            777777666666654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=4.8e-23  Score=203.25  Aligned_cols=170  Identities=18%  Similarity=0.159  Sum_probs=122.8

Q ss_pred             CCcCCeeecccceEEEEEEecCCceEEEEEechhh------------------HHHHHHHHHHHHHHHhcCCCccceEee
Q 045539          619 FSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQY------------------ERALKSFEDECEVMKRIRHRNLVKIIS  680 (897)
Q Consensus       619 y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~  680 (897)
                      +.+.++||+|+||+||+|+..+|+.||||+++...                  ........+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34678999999999999998889999999875321                  112344567899999999999999887


Q ss_pred             eecCCCceEEEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeCCCCCCCeeeCCCCcEEEee
Q 045539          681 SCSNDDFKALIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFGHSTPIIHCDLKPSNVLLDEDMVAHISD  760 (897)
Q Consensus       681 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~h~~~ivH~Dlkp~NIll~~~~~~kL~D  760 (897)
                      +..    .+++|||+++..+.+        ++......++.|++++++||   |++||+||||||+|||++++ .++|+|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CEEEEE
Confidence            643    379999998876643        33345567999999999999   88999999999999999865 589999


Q ss_pred             ccCccccCCCCceeeeeccccCcccCCcCccCCCCCCccchHHHHHHHH
Q 045539          761 FGIAKLLSGEDQLSIQIQTLATIGYMAPEYGTKGRVCTRGDVYSYGIML  809 (897)
Q Consensus       761 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvil  809 (897)
                      ||.|.....+.........+..    -.|. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHHH
Confidence            9999765433211100000000    0011 135677889999976443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=3.1e-20  Score=201.88  Aligned_cols=61  Identities=28%  Similarity=0.389  Sum_probs=49.7

Q ss_pred             cCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCC
Q 045539          469 GGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPR  538 (897)
Q Consensus       469 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  538 (897)
                      ..+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|++|+|++|+++ .+|.
T Consensus       281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            44678999999999998 67764   578999999999998 67764   457899999999998 4554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=6.4e-20  Score=199.41  Aligned_cols=312  Identities=25%  Similarity=0.301  Sum_probs=152.1

Q ss_pred             EEEEEeecccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeee
Q 045539           78 VIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSI  157 (897)
Q Consensus        78 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~  157 (897)
                      +..|||++++++ .+|+.   .++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++.. +..   .++|++||+++
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSN  107 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECCS
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhh---ccccccccccc
Confidence            445666666665 45543   345666666666666 555443   3566666666665422 110   12355555555


Q ss_pred             cCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccc
Q 045539          158 NGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTV  237 (897)
Q Consensus       158 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~  237 (897)
                      |.+. .+|. ++.                        +++|++|++++|.++ ..|.    ....+..+.+.++..  ..
T Consensus       108 n~l~-~lp~-~~~------------------------l~~L~~L~l~~~~~~-~~~~----~~~~l~~l~~~~~~~--~~  154 (353)
T d1jl5a_         108 NQLE-KLPE-LQN------------------------SSFLKIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQL--EE  154 (353)
T ss_dssp             SCCS-SCCC-CTT------------------------CTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCC--SS
T ss_pred             cccc-cccc-hhh------------------------hccceeecccccccc-cccc----ccccccchhhccccc--cc
Confidence            5554 3332 344                        444555555554444 2221    123344444444433  22


Q ss_pred             cccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHH
Q 045539          238 PSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSL  317 (897)
Q Consensus       238 p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L  317 (897)
                      +..+..++.++.|++++|.+.......                         ...+.+..+++.+..             
T Consensus       155 ~~~l~~l~~l~~L~l~~n~~~~~~~~~-------------------------~~~~~l~~~~~~~~~-------------  196 (353)
T d1jl5a_         155 LPELQNLPFLTAIYADNNSLKKLPDLP-------------------------LSLESIVAGNNILEE-------------  196 (353)
T ss_dssp             CCCCTTCTTCCEEECCSSCCSSCCCCC-------------------------TTCCEEECCSSCCSS-------------
T ss_pred             cccccccccceeccccccccccccccc-------------------------ccccccccccccccc-------------
Confidence            344566677777777777665432211                         122233333332221             


Q ss_pred             HHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccccc
Q 045539          318 EIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGN  397 (897)
Q Consensus       318 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  397 (897)
                                   ++ .+..++.|+.+++++|.... .+..   ..++..+.+.+|++... +..   ...+...++..|
T Consensus       197 -------------~~-~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~  254 (353)
T d1jl5a_         197 -------------LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSEN  254 (353)
T ss_dssp             -------------CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSS
T ss_pred             -------------cc-cccccccccccccccccccc-cccc---ccccccccccccccccc-ccc---cccccccccccc
Confidence                         11 13345556666666665543 2222   23344445555554421 111   223344444444


Q ss_pred             ccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccc
Q 045539          398 KFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQM  477 (897)
Q Consensus       398 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L  477 (897)
                      .+.+. +..   .......++..|.+.+. +   ..+++|++|++             ++|+|+ .+|..   +++|+.|
T Consensus       255 ~~~~l-~~l---~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~L-------------s~N~l~-~lp~~---~~~L~~L  309 (353)
T d1jl5a_         255 IFSGL-SEL---PPNLYYLNASSNEIRSL-C---DLPPSLEELNV-------------SNNKLI-ELPAL---PPRLERL  309 (353)
T ss_dssp             CCSEE-SCC---CTTCCEEECCSSCCSEE-C---CCCTTCCEEEC-------------CSSCCS-CCCCC---CTTCCEE
T ss_pred             ccccc-ccc---cchhcccccccCccccc-c---ccCCCCCEEEC-------------CCCccC-ccccc---cCCCCEE
Confidence            44321 110   11233445555555431 1   22345554444             444443 34432   4678888


Q ss_pred             cccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEec
Q 045539          478 FLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNL  527 (897)
Q Consensus       478 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  527 (897)
                      +|++|+|+ .+|+.   +++|+.|+|++|+|+ .+|....   .|+.|.+
T Consensus       310 ~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~  351 (353)
T d1jl5a_         310 IASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM  351 (353)
T ss_dssp             ECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred             ECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence            88888887 56753   457888899999887 6675433   3455544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.9e-20  Score=189.18  Aligned_cols=222  Identities=15%  Similarity=0.101  Sum_probs=154.3

Q ss_pred             cEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccc
Q 045539          151 TTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGI  230 (897)
Q Consensus       151 ~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~  230 (897)
                      +.++.+++.++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+...++...+..+++++++.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 6666553  46777777777777777777788888888888888877667777777778888887654


Q ss_pred             -ccccccccccccCCCcccEEEccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCc
Q 045539          231 -NSFYGTVPSSITNASKLSDLELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKS  309 (897)
Q Consensus       231 -N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~  309 (897)
                       |.+....+..|.++++|++|++++|.+....+..+                    +..++.+..+..+++++..+.+. 
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~--------------------~~~l~~l~~~~~~n~~l~~i~~~-  146 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK--------------------IHSLQKVLLDIQDNINIHTIERN-  146 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTT--------------------TCBSSCEEEEEESCTTCCEECTT-
T ss_pred             cccccccccccccccccccccccchhhhcccccccc--------------------ccccccccccccccccccccccc-
Confidence             66777777788888888888888888765443221                    34556666777777766644332 


Q ss_pred             ccCchHHHHHHHhccCCCCCCcCccccCc-cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccc
Q 045539          310 KGNLSLSLEIILMDNCSISGNIPQVVGNL-GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLAR  388 (897)
Q Consensus       310 ~~~l~~~L~~L~l~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  388 (897)
                                              .|..+ ..++.|++++|+++++.+..|.....++.+++++|+++...+..|.++++
T Consensus       147 ------------------------~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~  202 (242)
T d1xwdc1         147 ------------------------SFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASG  202 (242)
T ss_dssp             ------------------------SSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCC
T ss_pred             ------------------------ccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCC
Confidence                                    23333 36778888888888755555544333444567777887655566788888


Q ss_pred             cccccccccccccCCCcccccccccceecccc
Q 045539          389 LHSLVLQGNKFSGSIPSCLGNLTSLRVLYLGL  420 (897)
Q Consensus       389 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  420 (897)
                      |++|+|++|+|+...+..|.++++|+.+++.+
T Consensus       203 L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         203 PVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             CCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            88888888888855556688888888877754

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=8.2e-19  Score=179.85  Aligned_cols=98  Identities=19%  Similarity=0.230  Sum_probs=60.1

Q ss_pred             cccccccCCCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCc-cccccccccccEEEeee-cCCCC
Q 045539           85 SFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSL-SFFIFNVSSVTTIDLSI-NGLSG  162 (897)
Q Consensus        85 ~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~LdLs~-N~l~~  162 (897)
                      +.+++ .+|+.+.  +++++|||++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+..
T Consensus        17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~   93 (242)
T d1xwdc1          17 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY   93 (242)
T ss_dssp             SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred             CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc
Confidence            34555 6776553  57888888888887555556788888888888888765533 34566666666666553 44444


Q ss_pred             CCCccccCccccccccccccccc
Q 045539          163 EMPREIGNLPYLARLAFATNNLV  185 (897)
Q Consensus       163 ~~p~~l~~l~~L~~L~L~~N~l~  185 (897)
                      ..+..|.++++|++|++++|++.
T Consensus        94 ~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          94 INPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             ECTTSEECCTTCCEEEEESCCCC
T ss_pred             cccccccccccccccccchhhhc
Confidence            44444444444444444444443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=2.1e-19  Score=176.97  Aligned_cols=170  Identities=18%  Similarity=0.133  Sum_probs=141.7

Q ss_pred             EeecccccccCCCCCCCCCCCceecccCccccCcC-CccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCC
Q 045539           82 NISSFNLQGTIPPQLGNLSSLQTLDLSHNKLSGNI-PSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGL  160 (897)
Q Consensus        82 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l  160 (897)
                      +.++++++ .+|+.+.  +++++|+|++|+|++.+ +..|.++++|++|+|++|++...++..+..+++|++|+|++|+|
T Consensus        14 ~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l   90 (192)
T d1w8aa_          14 DCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence            34456677 6887764  78999999999998644 56789999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCcccccccccccccccccccccccccccccccccccccccccCCccccccccccceeeccccccccccccc
Q 045539          161 SGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSS  240 (897)
Q Consensus       161 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~  240 (897)
                      ++..|..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|.+....+...+  ...++.+.+..|.++...|..
T Consensus        91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~~p~~  168 (192)
T d1w8aa_          91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGAPSK  168 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBCSSTT
T ss_pred             cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeCCChh
Confidence            977788899999999999999999999999999999999999999999854333222  245677788888888777765


Q ss_pred             ccCCCcccEEEcccccccc
Q 045539          241 ITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       241 l~~l~~L~~L~L~~N~l~~  259 (897)
                      +   ..++.++|+.|.+.-
T Consensus       169 l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         169 V---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             T---TTSBGGGSCTTTCCC
T ss_pred             h---cCCEeeecCHhhCcC
Confidence            4   455667788887753

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=6.6e-22  Score=223.51  Aligned_cols=111  Identities=21%  Similarity=0.194  Sum_probs=67.2

Q ss_pred             eEEEEEeecccccccC-CCCCCCCCCCceecccCccccC----cCCccccCCCCCcEEeccCccccCCc----ccccc-c
Q 045539           77 RVIGLNISSFNLQGTI-PPQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLYFSDNQLFGSL----SFFIF-N  146 (897)
Q Consensus        77 ~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~  146 (897)
                      .+.+||++++++++.. ..-+..+++|++|+|++|+|+.    .++..+..+++|++|||++|+|+...    ...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4677777777776521 2334556777777777777762    34455667777777777777765322    11221 1


Q ss_pred             cccccEEEeeecCCCCC----CCccccCccccccccccccccccc
Q 045539          147 VSSVTTIDLSINGLSGE----MPREIGNLPYLARLAFATNNLVGV  187 (897)
Q Consensus       147 l~~L~~LdLs~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~  187 (897)
                      ..+|++|+|++|+++..    ++..+..+++|++|+|++|+++..
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~  127 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA  127 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence            23577777777776532    234556666677777777766543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=5.8e-19  Score=179.00  Aligned_cols=208  Identities=17%  Similarity=0.281  Sum_probs=117.6

Q ss_pred             CCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccc
Q 045539           99 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLA  178 (897)
Q Consensus        99 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~  178 (897)
                      |.++..++++.+++++.+  .+..+.+|++|++++|.|+..  ..+..+++|++|++++|++++..|  +.++++|++++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence            444555667777776533  456677777777777777543  236667777777777777764322  66666777777


Q ss_pred             cccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccccc
Q 045539          179 FATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLFS  258 (897)
Q Consensus       179 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  258 (897)
                      +++|.++.+.  .+.++++|+.+++++|...+.                           ..+...+.++.+.++.+.+.
T Consensus        92 ~~~n~~~~i~--~l~~l~~L~~l~l~~~~~~~~---------------------------~~~~~~~~~~~l~~~~~~~~  142 (227)
T d1h6ua2          92 LSGNPLKNVS--AIAGLQSIKTLDLTSTQITDV---------------------------TPLAGLSNLQVLYLDLNQIT  142 (227)
T ss_dssp             CCSCCCSCCG--GGTTCTTCCEEECTTSCCCCC---------------------------GGGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--ccccccccccccccccccccc---------------------------chhccccchhhhhchhhhhc
Confidence            7766666542  355666666666666655421                           11233344444444444443


Q ss_pred             cccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCCcCccccCc
Q 045539          259 GFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGNIPQVVGNL  338 (897)
Q Consensus       259 ~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~~p~~~~~l  338 (897)
                      ...+                       +.++++|+.|++++|++.+.                           ..++++
T Consensus       143 ~~~~-----------------------~~~~~~L~~L~l~~n~~~~~---------------------------~~l~~l  172 (227)
T d1h6ua2         143 NISP-----------------------LAGLTNLQYLSIGNAQVSDL---------------------------TPLANL  172 (227)
T ss_dssp             CCGG-----------------------GGGCTTCCEEECCSSCCCCC---------------------------GGGTTC
T ss_pred             hhhh-----------------------hccccccccccccccccccc---------------------------hhhccc
Confidence            2211                       23445566666665555421                           124455


Q ss_pred             cCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          339 GNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       339 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      ++|++|+|++|+++++ + .|+++++|++|+|++|++++..  .+.++++|++|+++
T Consensus       173 ~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         173 SKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             TTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             ccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            5666666666666653 2 2556666666666666666432  25566666666665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.4e-18  Score=176.03  Aligned_cols=191  Identities=24%  Similarity=0.335  Sum_probs=96.1

Q ss_pred             cccccccccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEE
Q 045539          171 LPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDL  250 (897)
Q Consensus       171 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  250 (897)
                      |+++..++++.+++++..  .++.+.+|++|++.+|.|+ .++ .+ ..+++|++|++++|.+++..|  +..+++|+++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GV-QYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hH-hcCCCCcEeecCCceeecccc--cccccccccc
Confidence            444455666666666553  3456666677777776666 343 22 245666666666666654332  5556666666


Q ss_pred             EccccccccccCccccccccccccCCCCcccccccccccCCCcEEEecCCCCCCCCCCcccCchHHHHHHHhccCCCCCC
Q 045539          251 ELGVNLFSGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTGNPLDGILPKSKGNLSLSLEIILMDNCSISGN  330 (897)
Q Consensus       251 ~L~~N~l~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~l~~n~l~~~  330 (897)
                      ++++|.++...                       .+.++++|+++++++|...+.                         
T Consensus        91 ~~~~n~~~~i~-----------------------~l~~l~~L~~l~l~~~~~~~~-------------------------  122 (227)
T d1h6ua2          91 ELSGNPLKNVS-----------------------AIAGLQSIKTLDLTSTQITDV-------------------------  122 (227)
T ss_dssp             ECCSCCCSCCG-----------------------GGTTCTTCCEEECTTSCCCCC-------------------------
T ss_pred             ccccccccccc-----------------------ccccccccccccccccccccc-------------------------
Confidence            66655554221                       134455556666655554422                         


Q ss_pred             cCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccc
Q 045539          331 IPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL  410 (897)
Q Consensus       331 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  410 (897)
                        ..+...+.+..+.++++.+....  .+.+.++|+.|++++|++.+..  .+.++++|++|+|++|++++ ++ .++++
T Consensus       123 --~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l  194 (227)
T d1h6ua2         123 --TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASL  194 (227)
T ss_dssp             --GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGC
T ss_pred             --chhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCC
Confidence              11233444555555555554322  2344445555555555544221  24444555555555555542 22 14444


Q ss_pred             cccceecccccccc
Q 045539          411 TSLRVLYLGLNRFT  424 (897)
Q Consensus       411 ~~L~~L~L~~N~l~  424 (897)
                      ++|++|+|++|+++
T Consensus       195 ~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         195 PNLIEVHLKNNQIS  208 (227)
T ss_dssp             TTCCEEECTTSCCC
T ss_pred             CCCCEEECcCCcCC
Confidence            55555555555544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=7.4e-22  Score=223.09  Aligned_cols=115  Identities=18%  Similarity=0.251  Sum_probs=58.7

Q ss_pred             CCcEEeccCccccCCc-cccccccccccEEEeeecCCCC----CCCccccCccccccccccccccccccccccccccccc
Q 045539          125 TLKLLYFSDNQLFGSL-SFFIFNVSSVTTIDLSINGLSG----EMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALK  199 (897)
Q Consensus       125 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~LdLs~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  199 (897)
                      +|++||++.|++++.. ...+..++++++|+|++|.++.    .++..+..+++|++|+|++|+|+......+       
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l-------   75 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV-------   75 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHH-------
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHH-------
Confidence            4667777777765432 3345556666666666666552    112233444555555555555432211111       


Q ss_pred             ccccccccccccCCccccccccccceeeccccccccc----ccccccCCCcccEEEcccccccc
Q 045539          200 EIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGT----VPSSITNASKLSDLELGVNLFSG  259 (897)
Q Consensus       200 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~  259 (897)
                                   ...+.....+|++|+|++|+++..    ++..+..+++|++|+|++|.++.
T Consensus        76 -------------~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          76 -------------LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             -------------HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             -------------HHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence                         111111223455666666655432    34455666677777777776654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=3.2e-18  Score=170.93  Aligned_cols=185  Identities=24%  Similarity=0.286  Sum_probs=148.5

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      ......+..+.+++.++.  ..+.+|+.|++++|.++...  .+..+++|++|+|++|++++..  .++.+++|++|+++
T Consensus        25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~   98 (210)
T d1h6ta2          25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD   98 (210)
T ss_dssp             HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred             HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence            344567778888776653  45789999999999998743  3788999999999999999643  36789999999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      +|++++ +| .+.++++|+.|++++|.+.. + ..+..+++++.+++++|.+             ++  +..+..+++|+
T Consensus        99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l-------------~~--~~~~~~l~~L~  159 (210)
T d1h6ta2          99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKI-------------TD--ITVLSRLTKLD  159 (210)
T ss_dssp             SSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCC-------------CC--CGGGGGCTTCS
T ss_pred             cccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccc-------------cc--ccccccccccc
Confidence            999984 55 58899999999999999874 3 3577788888665555544             32  33567789999


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccC
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSF  529 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  529 (897)
                      ++++++|++++ ++ .+.++++|+.|+|++|+|+ .+| .+..+++|++|+|++
T Consensus       160 ~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         160 TLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            99999999986 43 3889999999999999998 566 599999999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1.1e-17  Score=165.38  Aligned_cols=181  Identities=27%  Similarity=0.383  Sum_probs=136.6

Q ss_pred             HHHHHHhccCCCCCCcCccccCccCCcEEEccCCCCCCCccccccCccchhhhcccCcccccccchhhhccccccccccc
Q 045539          316 SLEIILMDNCSISGNIPQVVGNLGNLLVLELGGNNLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQ  395 (897)
Q Consensus       316 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  395 (897)
                      ....+.+..+.+++.++  ...+.++++|++++|.++..  +.++.+++|++|++++|++++..+  ++++++|++|+++
T Consensus        19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~   92 (199)
T d2omxa2          19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN   92 (199)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence            44566778888876554  34678999999999999874  347888999999999999986543  8889999999999


Q ss_pred             ccccccCCCcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccc
Q 045539          396 GNKFSGSIPSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQ  475 (897)
Q Consensus       396 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~  475 (897)
                      +|.+.. ++ .++++++|+.|++++|.+...  ..+..+++|+.|++++|++             .. + +.+..+++|+
T Consensus        93 ~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l-------------~~-~-~~l~~~~~L~  153 (199)
T d2omxa2          93 NNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTI-------------SD-I-SALSGLTSLQ  153 (199)
T ss_dssp             SSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC-------------CC-C-GGGTTCTTCS
T ss_pred             cccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhh-------------cc-c-cccccccccc
Confidence            999873 44 488889999999999888753  3466777777555555443             32 2 3467788888


Q ss_pred             cccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceE
Q 045539          476 QMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHL  525 (897)
Q Consensus       476 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  525 (897)
                      .|++++|++++. + .++++++|++|++++|+|+. +| .+..+++|++|
T Consensus       154 ~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         154 QLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             EEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            888888888853 3 47888888888888888874 44 47777777765

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=6.8e-18  Score=168.49  Aligned_cols=166  Identities=22%  Similarity=0.356  Sum_probs=131.6

Q ss_pred             CCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccccc
Q 045539           98 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARL  177 (897)
Q Consensus        98 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L  177 (897)
                      .+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..+  +..+++|++|++++|+++ .+| .+.++++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCccc--cccCcccccccccccccc-ccc-ccccccccccc
Confidence            46788888999888874 33 37888899999999998877543  578888999999999888 455 58888999999


Q ss_pred             ccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccccc
Q 045539          178 AFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNLF  257 (897)
Q Consensus       178 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  257 (897)
                      ++++|.+..+.  .+.++++|+.+++++|.+++ .+  ....+++|+++++++|++++..  .++++++|+.|+|++|++
T Consensus       118 ~l~~~~~~~~~--~l~~l~~l~~l~~~~n~l~~-~~--~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         118 SLEHNGISDIN--GLVHLPQLESLYLGNNKITD-IT--VLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             ECTTSCCCCCG--GGGGCTTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--cccccccccccccccccccc-cc--cccccccccccccccccccccc--cccCCCCCCEEECCCCCC
Confidence            99998887653  47888899999999998873 22  2336789999999999997643  388999999999999988


Q ss_pred             ccccCccccccccccccCCCCcccccccccccCCCcEEEecC
Q 045539          258 SGFIPNTFVNMADNYLTSSTPELSFLSSLTNCKKLKVLILTG  299 (897)
Q Consensus       258 ~~~~~~~f~~l~~~~l~~~~~~~~~l~~l~~l~~L~~L~Ls~  299 (897)
                      +.+ +                      ++.++++|++|+|++
T Consensus       191 ~~l-~----------------------~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         191 SDL-R----------------------ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CBC-G----------------------GGTTCTTCSEEEEEE
T ss_pred             CCC-h----------------------hhcCCCCCCEEEccC
Confidence            753 2                      257789999999875

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.71  E-value=7.5e-18  Score=165.66  Aligned_cols=154  Identities=21%  Similarity=0.227  Sum_probs=80.7

Q ss_pred             ccccccccccccccCC-CcccccccccceeccccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcc
Q 045539          388 RLHSLVLQGNKFSGSI-PSCLGNLTSLRVLYLGLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPI  466 (897)
Q Consensus       388 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~  466 (897)
                      ++++|+|++|+|++.+ +..|.++++|+.|+|++|.+++..+..+..+++|++|             +|++|+|++..|.
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L-------------~Ls~N~l~~l~~~   96 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL-------------QLGENKIKEISNK   96 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE-------------ECCSCCCCEECSS
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee-------------eeccccccccCHH
Confidence            3444444444444322 2334445555555555555554444455545444422             2233333333455


Q ss_pred             cccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCchhhhhhcccceEeccCCcccccCCCCCCCCCCC
Q 045539          467 TIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPASLQKLLYLKHLNLSFNKLEGEIPRGGPFANLT  546 (897)
Q Consensus       467 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~  546 (897)
                      .|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..|.  .+..+.
T Consensus        97 ~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~--~l~~~~  173 (192)
T d1w8aa_          97 MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS--KVRDVQ  173 (192)
T ss_dssp             SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST--TTTTSB
T ss_pred             HHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh--hhcCCE
Confidence            566666777777777777766666677777777777777777643321 11223455566666776665553  344444


Q ss_pred             cccccchhhhh
Q 045539          547 AKSFMGNELLK  557 (897)
Q Consensus       547 ~~~~~~N~~~c  557 (897)
                      -..+..|...|
T Consensus       174 l~~L~~n~l~C  184 (192)
T d1w8aa_         174 IKDLPHSEFKC  184 (192)
T ss_dssp             GGGSCTTTCCC
T ss_pred             eeecCHhhCcC
Confidence            44455554444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=1.4e-17  Score=164.58  Aligned_cols=151  Identities=22%  Similarity=0.366  Sum_probs=112.0

Q ss_pred             CCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccc
Q 045539           97 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLAR  176 (897)
Q Consensus        97 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~  176 (897)
                      ..+.++++|++++|.++ .++ .+..+++|++|+|++|++++..+  +.++++|++|++++|.+. .++ .++++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSE
T ss_pred             HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccc
Confidence            35677778888888777 343 47778888888888888776544  777888888888888776 344 4778888888


Q ss_pred             cccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEccccc
Q 045539          177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVNL  256 (897)
Q Consensus       177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  256 (897)
                      |++++|.+....+  +.++++|+.|++++|++. .++.  ...+++|+.|++++|++++..  .++++++|++|++++|+
T Consensus       111 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         111 LTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNK  183 (199)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             ccccccccccccc--cchhhhhHHhhhhhhhhc-cccc--ccccccccccccccccccCCc--cccCCCCCCEEECCCCC
Confidence            8888887776543  677888888888888876 4442  336788888888888887542  47888899999999998


Q ss_pred             cccc
Q 045539          257 FSGF  260 (897)
Q Consensus       257 l~~~  260 (897)
                      ++.+
T Consensus       184 i~~i  187 (199)
T d2omxa2         184 VSDI  187 (199)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8753

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=3.6e-16  Score=163.59  Aligned_cols=60  Identities=17%  Similarity=0.160  Sum_probs=27.0

Q ss_pred             CCCCCcEEeccCccccCC-ccccccccccccEEEeeecCCCCCCCccccCccccccccccc
Q 045539          122 NMHTLKLLYFSDNQLFGS-LSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFAT  181 (897)
Q Consensus       122 ~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~  181 (897)
                      ...+|++|||++|.+... +...+..+++|++|+|++|.+++..+..++.+++|++|++++
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            334555555555544322 223344444455555554444433334444444444444444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=4.6e-15  Score=133.43  Aligned_cols=102  Identities=25%  Similarity=0.311  Sum_probs=74.8

Q ss_pred             ceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccc
Q 045539          103 QTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATN  182 (897)
Q Consensus       103 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N  182 (897)
                      |.|||++|+|+ .+| .++++++|++|++++|+|+. +|..+..+++|++|++++|+|+ .+| .++++++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            46788888887 444 37778888888888888764 4556777778888888888877 344 4777888888888888


Q ss_pred             ccccccc-cccccccccccccccccccc
Q 045539          183 NLVGVAP-VTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       183 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~  209 (897)
                      +|+.... ..+..+++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            8776643 45777778888888888776

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.6e-16  Score=164.71  Aligned_cols=60  Identities=17%  Similarity=0.128  Sum_probs=32.2

Q ss_pred             ccccccccccccccccCCccccccccccceeecccccccccccccccCCCcccEEEcccc
Q 045539          196 SALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASKLSDLELGVN  255 (897)
Q Consensus       196 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  255 (897)
                      .+|++|||++|.++......++..+++|++|+|++|.+++..+..++.+++|++|+++++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c  105 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC  105 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence            345555555555443333333444555555555555555555555666666666666653

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.2e-15  Score=142.67  Aligned_cols=111  Identities=20%  Similarity=0.182  Sum_probs=58.8

Q ss_pred             CCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCccccc
Q 045539           96 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLA  175 (897)
Q Consensus        96 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~  175 (897)
                      +.+...|++|||++|+|+ .+|..+..+++|++|+|++|+|...  ..+..+++|++|+|++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            445556666666666666 4455555666666666666666433  2345555555555555555532222334455555


Q ss_pred             cccccccccccccc-cccccccccccccccccccc
Q 045539          176 RLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       176 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  209 (897)
                      .|++++|+++.+.. ..+.++++|++|++++|.++
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc
Confidence            55555555554322 23444455555555555444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=4.3e-15  Score=140.63  Aligned_cols=130  Identities=18%  Similarity=0.111  Sum_probs=108.8

Q ss_pred             cccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccc
Q 045539          119 SIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSAL  198 (897)
Q Consensus       119 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  198 (897)
                      .+.++.+|++|+|++|+|+.. +..+..+++|++||||+|+|+ .++ .|..+++|++|++++|+++.+.+..+.++++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            477889999999999999765 567788999999999999998 554 58999999999999999999988778899999


Q ss_pred             cccccccccccccCCc-cccccccccceeecccccccccc---cccccCCCcccEEEc
Q 045539          199 KEIYLLNNSLSGSLPS-RIDLSLPNVETLNLGINSFYGTV---PSSITNASKLSDLEL  252 (897)
Q Consensus       199 ~~L~L~~N~l~~~~p~-~~~~~l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L~L  252 (897)
                      ++|++++|+++ .++. .....+++|++|++++|.++...   +..+..+++|+.||-
T Consensus        90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ccceecccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            99999999998 4543 33457899999999999986432   235778899998873

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.50  E-value=3.5e-16  Score=168.96  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=83.3

Q ss_pred             ccccccccccccccccC----CCcccccccccceeccccccccCC-----ccccccccccceEEeecCCcccccceeecc
Q 045539          386 LARLHSLVLQGNKFSGS----IPSCLGNLTSLRVLYLGLNRFTSA-----LPSTIWNLKDILFIDVSSNSLNVLIGLNFS  456 (897)
Q Consensus       386 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls  456 (897)
                      .+.|+.+++++|+++..    +...+...+.|+.|+|++|.++..     +...+..+++|+.|++++|.+...-.    
T Consensus       157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~----  232 (344)
T d2ca6a1         157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS----  232 (344)
T ss_dssp             CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH----
T ss_pred             Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccc----
Confidence            45667777777776532    222344556777777777776532     23345556666655555554421100    


Q ss_pred             cCcCCCCCcccccCCcccccccccCceecccCCCC----CC--CcCCCcEEeccCCccCCC----Cchhhh-hhcccceE
Q 045539          457 RNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIPES----FG--DLSSLEVLDLSKNKISGA----IPASLQ-KLLYLKHL  525 (897)
Q Consensus       457 ~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L  525 (897)
                           ..+...+..+++|++|+|++|.|++.-...    +.  ..+.|++||+++|+|+..    +...+. ++++|+.|
T Consensus       233 -----~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L  307 (344)
T d2ca6a1         233 -----SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL  307 (344)
T ss_dssp             -----HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred             -----ccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEE
Confidence                 012344566788888888888886532222    22  235789999999988742    233443 56789999


Q ss_pred             eccCCcccc
Q 045539          526 NLSFNKLEG  534 (897)
Q Consensus       526 ~ls~N~l~~  534 (897)
                      +|++|++..
T Consensus       308 ~l~~N~~~~  316 (344)
T d2ca6a1         308 ELNGNRFSE  316 (344)
T ss_dssp             ECTTSBSCT
T ss_pred             ECCCCcCCC
Confidence            999998853

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.47  E-value=3.2e-14  Score=127.79  Aligned_cols=103  Identities=29%  Similarity=0.344  Sum_probs=79.8

Q ss_pred             cEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcccccccccccccccccccccccccccccccccccc
Q 045539          127 KLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLVGVAPVTIFNMSALKEIYLLNN  206 (897)
Q Consensus       127 ~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  206 (897)
                      |+|+|++|+++.. + .+..+++|++||+++|+|+ .+|+.|+.+++|+.|++++|+|+++.  .+.++++|++|++++|
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC--ccccccccCeEECCCC
Confidence            6789999999744 3 4788899999999999998 67888888999999999999988873  3788888888888888


Q ss_pred             cccccCCc-cccccccccceeecccccccc
Q 045539          207 SLSGSLPS-RIDLSLPNVETLNLGINSFYG  235 (897)
Q Consensus       207 ~l~~~~p~-~~~~~l~~L~~L~L~~N~l~~  235 (897)
                      +++ .+|. ..+..+++|++|++++|.++.
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence            887 4432 333456777777777777653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=2.3e-15  Score=162.48  Aligned_cols=69  Identities=22%  Similarity=0.197  Sum_probs=36.7

Q ss_pred             CCCCCCCCCceecccCccccCc----CCccccCCCCCcEEeccCccccCC----------ccccccccccccEEEeeecC
Q 045539           94 PQLGNLSSLQTLDLSHNKLSGN----IPSSIFNMHTLKLLYFSDNQLFGS----------LSFFIFNVSSVTTIDLSING  159 (897)
Q Consensus        94 ~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~~~~~~~l~~L~~LdLs~N~  159 (897)
                      .++.+.+.|+.|+|++|.+...    +-..+...++|+.|+++++.....          +...+..+++|+.|||++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            3455566677777777766421    233455566677777766544211          11223344555566666555


Q ss_pred             CCC
Q 045539          160 LSG  162 (897)
Q Consensus       160 l~~  162 (897)
                      +..
T Consensus       105 i~~  107 (344)
T d2ca6a1         105 FGP  107 (344)
T ss_dssp             CCT
T ss_pred             ccc
Confidence            543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.41  E-value=4.2e-15  Score=145.88  Aligned_cols=112  Identities=21%  Similarity=0.296  Sum_probs=61.4

Q ss_pred             CCCCCCCCCCceecccCccccCcCCccccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCCCCccccCcc
Q 045539           93 PPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLP  172 (897)
Q Consensus        93 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~  172 (897)
                      |.+++.|++|++|+|++|+|+ .++ .+.++++|++|+|++|+|.. ++..+..+++|++|++++|+++. + +.+.+++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-L-SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-H-HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-ccccccccccccccccccccccc-c-ccccccc
Confidence            344556666666666666665 343 36666666666666666643 33334444556666666666552 2 2355555


Q ss_pred             ccccccccccccccccc-cccccccccccccccccccc
Q 045539          173 YLARLAFATNNLVGVAP-VTIFNMSALKEIYLLNNSLS  209 (897)
Q Consensus       173 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  209 (897)
                      +|+.|+|++|+|+.+.. ..+.++++|++|+|++|.+.
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccc
Confidence            55555555555554422 33455555555555555554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1.5e-12  Score=121.87  Aligned_cols=109  Identities=16%  Similarity=0.097  Sum_probs=87.4

Q ss_pred             CcceeeeEeeCCCCeEEEEEeecccccccCCCCCCCCCCCceecccCc-cccCcCCccccCCCCCcEEeccCccccCCcc
Q 045539           63 VCSWIGITCDVNSHRVIGLNISSFNLQGTIPPQLGNLSSLQTLDLSHN-KLSGNIPSSIFNMHTLKLLYFSDNQLFGSLS  141 (897)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  141 (897)
                      ||.+.+|+|+.            +++. .+|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...+
T Consensus         7 c~~~~~l~c~~------------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~   73 (156)
T d2ifga3           7 PHGSSGLRCTR------------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP   73 (156)
T ss_dssp             CSSSSCEECCS------------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred             cCCCCeEEecC------------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccc
Confidence            34577777753            3333 56777888999999999766 5886666789999999999999999999889


Q ss_pred             ccccccccccEEEeeecCCCCCCCccccCccccccccccccccc
Q 045539          142 FFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLARLAFATNNLV  185 (897)
Q Consensus       142 ~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  185 (897)
                      ..|.++++|++|||++|+|+ .+|.......+|++|+|++|.+.
T Consensus        74 ~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             TGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            99999999999999999998 56655444557888888888875

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=3.3e-12  Score=119.55  Aligned_cols=147  Identities=15%  Similarity=0.103  Sum_probs=112.7

Q ss_pred             CCCCCceecccCccccCcCCccccCCCCCcEEeccCc-cccCCccccccccccccEEEeeecCCCCCCCccccCcccccc
Q 045539           98 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLYFSDN-QLFGSLSFFIFNVSSVTTIDLSINGLSGEMPREIGNLPYLAR  176 (897)
Q Consensus        98 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~  176 (897)
                      .....+.++.+++++. ..|..+..+++|++|++++| .|....+..|.++++|+.|+|++|+|+...|..|..+++|++
T Consensus         6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            3445567899999987 67888999999999999876 488888889999999999999999999777888999999999


Q ss_pred             cccccccccccccccccccccccccccccccccccCCccccccccccceeecccccccccccccccCCCc
Q 045539          177 LAFATNNLVGVAPVTIFNMSALKEIYLLNNSLSGSLPSRIDLSLPNVETLNLGINSFYGTVPSSITNASK  246 (897)
Q Consensus       177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  246 (897)
                      |+|++|+|+.+.+..|..+ +|++|+|++|.+.-.--...+..........+..++++...|..+.+++.
T Consensus        85 L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p~  153 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPN  153 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCCC
T ss_pred             eeccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCCc
Confidence            9999999999888777665 79999999998851100000001112233344556777667777766654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.28  E-value=5.4e-14  Score=137.79  Aligned_cols=143  Identities=25%  Similarity=0.347  Sum_probs=69.3

Q ss_pred             CcEEEccCC--CCCCCccccccCccchhhhcccCcccccccchhhhcccccccccccccccccCCCcccccccccceecc
Q 045539          341 LLVLELGGN--NLTEPIPITFSQLQTLQALGLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSLRVLYL  418 (897)
Q Consensus       341 L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  418 (897)
                      ++.+++.++  .++. ++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++
T Consensus        25 ~~~~~l~~~~~~i~~-l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCCC-CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchhh-hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            444555443  2222 34445555555555555555552 22 3455555555555555554 33433333444555555


Q ss_pred             ccccccCCccccccccccceEEeecCCcccccceeecccCcCCCCCcccccCCcccccccccCceecccCC-CCCCCcCC
Q 045539          419 GLNRFTSALPSTIWNLKDILFIDVSSNSLNVLIGLNFSRNNLSGDIPITIGGLKNLQQMFLEYNRLEGSIP-ESFGDLSS  497 (897)
Q Consensus       419 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~l~~l~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~  497 (897)
                      ++|+++. ++ .                                     +..+++|+.|++++|+|+.... ..+..+++
T Consensus       101 ~~N~i~~-l~-~-------------------------------------~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~  141 (198)
T d1m9la_         101 SYNQIAS-LS-G-------------------------------------IEKLVNLRVLYMSNNKITNWGEIDKLAALDK  141 (198)
T ss_dssp             SEEECCC-HH-H-------------------------------------HHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred             ccccccc-cc-c-------------------------------------ccccccccccccccchhccccccccccCCCc
Confidence            5555543 11 2                                     3344455555555555542111 23555566


Q ss_pred             CcEEeccCCccCCCCch----------hhhhhcccceEe
Q 045539          498 LEVLDLSKNKISGAIPA----------SLQKLLYLKHLN  526 (897)
Q Consensus       498 L~~L~Ls~N~l~~~~p~----------~~~~l~~L~~L~  526 (897)
                      |+.|+|++|.++...+.          .+..+++|+.||
T Consensus       142 L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             CSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            66666666655432221          256677777765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=9.9e-08  Score=97.09  Aligned_cols=149  Identities=16%  Similarity=0.144  Sum_probs=106.9

Q ss_pred             HHHHHhcCCCcCCeeecccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceE
Q 045539          611 ELLRATDRFSENNLIGIGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKA  689 (897)
Q Consensus       611 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  689 (897)
                      |+.+..+.|+..+..+.++.+.||+.... ++.+++|+...........+.+|+..++.+. +--+.+++++..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            56666778887776555566799998754 6778899887654444445678888888775 434678888888888999


Q ss_pred             EEEEeccCCChhHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 045539          690 LIMKYMPNGSLENCLYSGTCMLDIFQRLNIMIDVALALEYLHFG------------------------------------  733 (897)
Q Consensus       690 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~~------------------------------------  733 (897)
                      +||++++|.++.+......      ....++.++++.++.||..                                    
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988865433211      2233556666666666631                                    


Q ss_pred             --------------------CCCCcEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          734 --------------------HSTPIIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       734 --------------------h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                                          ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                122479999999999999877777999997753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=4.2e-09  Score=98.68  Aligned_cols=90  Identities=22%  Similarity=0.231  Sum_probs=47.1

Q ss_pred             ccCCCCCcEEeccCccccCCccccccccccccEEEeeecCCCCC--CCccccCccccccccccccccccccccccccccc
Q 045539          120 IFNMHTLKLLYFSDNQLFGSLSFFIFNVSSVTTIDLSINGLSGE--MPREIGNLPYLARLAFATNNLVGVAPVTIFNMSA  197 (897)
Q Consensus       120 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  197 (897)
                      +..+..+..|+..+|.. ..++..+..+++|++||||+|+|+..  ++..+..+++|+.|+|++|+|+.+.+..+....+
T Consensus        38 l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            33344444444443322 22333344555666666666666532  1233455666666666666666655433444445


Q ss_pred             ccccccccccccc
Q 045539          198 LKEIYLLNNSLSG  210 (897)
Q Consensus       198 L~~L~L~~N~l~~  210 (897)
                      |++|++++|.++.
T Consensus       117 L~~L~L~~Npl~~  129 (162)
T d1koha1         117 LEELWLDGNSLSD  129 (162)
T ss_dssp             CSSCCCTTSTTSS
T ss_pred             cceeecCCCCcCc
Confidence            6666666666653

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=8.5e-09  Score=96.51  Aligned_cols=62  Identities=21%  Similarity=0.108  Sum_probs=38.9

Q ss_pred             cccccCCcccccccccCceecccCCCCCCCcCCCcEEeccCCccCCCCch-------hhhhhcccceEe
Q 045539          465 PITIGGLKNLQQMFLEYNRLEGSIPESFGDLSSLEVLDLSKNKISGAIPA-------SLQKLLYLKHLN  526 (897)
Q Consensus       465 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~  526 (897)
                      +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++.....       .+..+|+|+.||
T Consensus        84 ~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          84 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             GTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             HHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            34456677777777777777743222333445677888888887755442       255677777765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=5.1e-06  Score=83.50  Aligned_cols=130  Identities=16%  Similarity=0.155  Sum_probs=88.1

Q ss_pred             eeecccc-eEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcC--CCccceEeeeecCCCceEEEEEeccCCCh
Q 045539          624 LIGIGSF-GSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIR--HRNLVKIISSCSNDDFKALIMKYMPNGSL  700 (897)
Q Consensus       624 ~lg~G~~-g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  700 (897)
                      .+..|.. +.||+....++..+++|.......   ..+..|++.++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4445553 689999988888899998765432   34567788777774  23367788888888899999999998776


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 045539          701 ENCLYSGTCMLDIFQRLNIMIDVALALEYLHF------------------------------------------------  732 (897)
Q Consensus       701 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~Lh~------------------------------------------------  732 (897)
                      .+..      ...   ...+.++++.++.||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      111   1122333334444431                                                


Q ss_pred             -------cCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          733 -------GHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       733 -------~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                             .....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   022347999999999999987777899999765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.54  E-value=6.4e-06  Score=76.72  Aligned_cols=87  Identities=13%  Similarity=0.169  Sum_probs=48.4

Q ss_pred             CCCCCceecccCc-cccCc----CCccccCCCCCcEEeccCccccCC----ccccccccccccEEEeeecCCCCCC----
Q 045539           98 NLSSLQTLDLSHN-KLSGN----IPSSIFNMHTLKLLYFSDNQLFGS----LSFFIFNVSSVTTIDLSINGLSGEM----  164 (897)
Q Consensus        98 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~LdLs~N~l~~~~----  164 (897)
                      +.++|++|+|+++ .++..    +-..+...++|++|+|++|.+...    +...+...+.|++|+|++|.++...    
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            4567778888763 45421    233455667777888887777532    2233444566777777777665321    


Q ss_pred             CccccCcccccccccccccc
Q 045539          165 PREIGNLPYLARLAFATNNL  184 (897)
Q Consensus       165 p~~l~~l~~L~~L~L~~N~l  184 (897)
                      -..+...+.|++|+|++|.+
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSS
T ss_pred             HHHHHhCCcCCEEECCCCcC
Confidence            11233444455555555443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.50  E-value=6.5e-05  Score=80.25  Aligned_cols=77  Identities=13%  Similarity=0.142  Sum_probs=50.4

Q ss_pred             CCeeecccceEEEEEEecC-CceEEEEEechhh-------HHHHHHHHHHHHHHHhcC-C--CccceEeeeecCCCceEE
Q 045539          622 NNLIGIGSFGSIYVARLQD-GMEVAVKVFHQQY-------ERALKSFEDECEVMKRIR-H--RNLVKIISSCSNDDFKAL  690 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  690 (897)
                      .+.||.|....||+++..+ ++.|+||......       .....+...|++.++.+. +  ..+++++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3568999999999998764 6789999754321       112344567888887774 2  3456666554  445689


Q ss_pred             EEEeccCCCh
Q 045539          691 IMKYMPNGSL  700 (897)
Q Consensus       691 v~e~~~~gsL  700 (897)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.34  E-value=3.9e-05  Score=71.21  Aligned_cols=17  Identities=29%  Similarity=0.343  Sum_probs=9.2

Q ss_pred             cccCCCcEEEecCCCCC
Q 045539          287 TNCKKLKVLILTGNPLD  303 (897)
Q Consensus       287 ~~l~~L~~L~Ls~N~l~  303 (897)
                      ...+.|++|+|++|.+.
T Consensus        69 ~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          69 ETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             HHCSSCCEEECCSSBCC
T ss_pred             hhcccccceeeehhhcc
Confidence            34455556666655554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.00069  Score=69.71  Aligned_cols=157  Identities=14%  Similarity=0.102  Sum_probs=87.7

Q ss_pred             cCCHHHHHHHhcCCCcCCeee-----cccceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcc--ceE
Q 045539          606 RFSYHELLRATDRFSENNLIG-----IGSFGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL--VKI  678 (897)
Q Consensus       606 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l  678 (897)
                      ..+.+|+.....+|.+.+...     .|---+.|+.+..+| .+++|++.....  .+.+..|++++..+...++  +..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence            357788999999998765543     566678899987765 599999865422  2345556777777642222  111


Q ss_pred             ee------eecCCCceEEEEEeccCCChhHh--------------hh----c----CCCCCC------------------
Q 045539          679 IS------SCSNDDFKALIMKYMPNGSLENC--------------LY----S----GTCMLD------------------  712 (897)
Q Consensus       679 ~~------~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~----~~~~~~------------------  712 (897)
                      +.      +....+..+.++.+..+......              ++    .    ......                  
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      11223455677777766533110              00    0    000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hcCCCCcEeCCCCCCCeeeCCCCcEEEeeccCcc
Q 045539          713 IFQRLNIMIDVALALEYLH-FGHSTPIIHCDLKPSNVLLDEDMVAHISDFGIAK  765 (897)
Q Consensus       713 ~~~~~~i~~~i~~~L~~Lh-~~h~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~  765 (897)
                      .......+......+...+ ..-..|+||+|+.++||+++.+...-++||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0011112222222333321 1235789999999999999988877899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.00051  Score=71.01  Aligned_cols=134  Identities=11%  Similarity=0.123  Sum_probs=78.4

Q ss_pred             ceEEEEEEecCCceEEEEEechhhHHHHHHHHHHHHHHHhcCCCcc--ceEe-----eeecCCCceEEEEEeccCCChhH
Q 045539          630 FGSIYVARLQDGMEVAVKVFHQQYERALKSFEDECEVMKRIRHRNL--VKII-----SSCSNDDFKALIMKYMPNGSLEN  702 (897)
Q Consensus       630 ~g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~~  702 (897)
                      --.||+++.++|+.|++|+.+.... ..+++..|.+.+..+....+  +..+     ..+..++..+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            4689999999999999999875421 23567778888888752222  1111     12234567789999997754311


Q ss_pred             -----h---------hh----cC----CCCCCHH----------------------HHHHHHHHHHHHHHHH-HhcCCCC
Q 045539          703 -----C---------LY----SG----TCMLDIF----------------------QRLNIMIDVALALEYL-HFGHSTP  737 (897)
Q Consensus       703 -----~---------l~----~~----~~~~~~~----------------------~~~~i~~~i~~~L~~L-h~~h~~~  737 (897)
                           +         ++    ..    ....+..                      .....+.++...+... ...-..+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                 0         00    00    0111111                      1122233333333222 1112457


Q ss_pred             cEeCCCCCCCeeeCCCCcEEEeeccCccc
Q 045539          738 IIHCDLKPSNVLLDEDMVAHISDFGIAKL  766 (897)
Q Consensus       738 ivH~Dlkp~NIll~~~~~~kL~DFg~a~~  766 (897)
                      ++|+|+.+.||+++++  ..++||+.+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999743  45899998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.79  E-value=6.8e-05  Score=69.46  Aligned_cols=90  Identities=10%  Similarity=0.092  Sum_probs=53.1

Q ss_pred             CCCCCCCceecccC-ccccCc----CCccccCCCCCcEEeccCccccCCc----cccccccccccEEEeeecCCCCCC--
Q 045539           96 LGNLSSLQTLDLSH-NKLSGN----IPSSIFNMHTLKLLYFSDNQLFGSL----SFFIFNVSSVTTIDLSINGLSGEM--  164 (897)
Q Consensus        96 l~~l~~L~~L~Ls~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~LdLs~N~l~~~~--  164 (897)
                      ..+.++|++|+|++ +.++..    +-..+...++|++|+|++|.+....    ...+...++++.|++++|.+....  
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            34567888888887 456421    3344556778888888888776432    334455677778887777765321  


Q ss_pred             --CccccCcccccc--ccccccccc
Q 045539          165 --PREIGNLPYLAR--LAFATNNLV  185 (897)
Q Consensus       165 --p~~l~~l~~L~~--L~L~~N~l~  185 (897)
                        -..+...++|+.  |++++|.+.
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHhCccccEEeeccCCCcCc
Confidence              123444455543  333444444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.59  E-value=0.00018  Score=66.45  Aligned_cols=18  Identities=17%  Similarity=0.250  Sum_probs=10.5

Q ss_pred             ccccCCCcEEEecCCCCC
Q 045539          286 LTNCKKLKVLILTGNPLD  303 (897)
Q Consensus       286 l~~l~~L~~L~Ls~N~l~  303 (897)
                      +...++|++|+|++|.+.
T Consensus        42 l~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             HTTCCSCCEEECTTSCCC
T ss_pred             HhcCCccCeeeccCCccc
Confidence            344556666666666554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.55  E-value=0.002  Score=68.35  Aligned_cols=73  Identities=18%  Similarity=0.266  Sum_probs=50.7

Q ss_pred             CCeeecccceEEEEEEecC--------CceEEEEEechhhHHHHHHHHHHHHHHHhcC-CCccceEeeeecCCCceEEEE
Q 045539          622 NNLIGIGSFGSIYVARLQD--------GMEVAVKVFHQQYERALKSFEDECEVMKRIR-HRNLVKIISSCSNDDFKALIM  692 (897)
Q Consensus       622 ~~~lg~G~~g~Vy~a~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  692 (897)
                      ++.|+.|-.-.+|++...+        .+.|++++.-.. .. .....+|..+++.+. +.-..++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4678889999999998653        345777766522 12 223457888888885 4445688888754    6899


Q ss_pred             EeccCCCh
Q 045539          693 KYMPNGSL  700 (897)
Q Consensus       693 e~~~~gsL  700 (897)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987655